PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Dretsch, MN; Daniel, TA; Goodman, AM; Katz, JS; Denney, T; Deshpande, G; Robinson, JL				Dretsch, Michael N.; Daniel, Thomas A.; Goodman, Adam M.; Katz, Jeffrey S.; Denney, Thomas; Deshpande, Gopikrishna; Robinson, Jennifer L.			Differential neural activation when voluntarily regulating emotions in service members with chronic mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Attentional bias; emotional regulation; FMRI; mild traumatic brain injury; military; TBI	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIVE SYMPTOMS; ANTERIOR INSULAR CORTEX; FUNCTIONAL CONNECTIVITY; PAST CONCUSSIONS; COMBAT EXPOSURE; NEGATIVE AFFECT; RISK-FACTORS; ANXIETY; OPTIMIZATION	The objective of this study was to characterize the functional activation of the neural correlates of voluntary regulation of emotion in soldiers both with and without chronic mild traumatic brain injury (mTBI). Using functional magnetic resonance imaging (fMRI) and a battery of cognitive and psychological health measures, we assessed differences between active-duty U.S. soldiers with chronic mTBI (n = 37) and without (Controls, n = 35). Participants were instructed to maintain (passively view), enhance, and suppress emotions associated with negative and neutral visual stimuli. The mTBI group showed significantly greater clinical symptoms, but only a mild decrement in attention. Group contrasts, while controlling for posttraumatic stress disorder (PTSD) symptoms, revealed a differential neural activation pattern compared to controls, but only during the enhance condition. Specifically, the mTBI group showed greater activation in the precentral gyrus, postcentral gyrus, inferior parietal lobe, insula, and superior temporal gyrus. Finally, the effect of PTSD symptoms during the enhance condition was associated with accentuated activation of the frontal and limbic regions implicated in both emotion regulation and PTSD. Hyperactivation of neural regions in the mTBI group during the enhance condition may reflect vigilance towards negative contextual stimuli and/or poor strategy that might result in suboptimal allocation of resources to regulate emotions.	[Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.] Headquarters Training & Doctrine Command, Human Dimens Div, Ft Eustis, VA USA; [Daniel, Thomas A.; Goodman, Adam M.; Katz, Jeffrey S.; Denney, Thomas; Deshpande, Gopikrishna; Robinson, Jennifer L.] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas; Deshpande, Gopikrishna; Robinson, Jennifer L.] Auburn Univ, Dept Elect & Comp Engn, MRI Res Ctr, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas; Deshpande, Gopikrishna; Robinson, Jennifer L.] Auburn Univ, Alabama Adv Imaging Consortium, Birmingham, AL USA; [Katz, Jeffrey S.; Denney, Thomas; Deshpande, Gopikrishna; Robinson, Jennifer L.] Univ Alabama Birmingham, Birmingham, AL USA		Dretsch, MN (corresponding author), TRADOC, Human Dimens Div, HQ, 950 Jefferson Ave, Ft Eustis, VA 23604 USA.	dretschphd@gmail.com	Goodman, Adam/AAI-3643-2021	Goodman, Adam/0000-0002-7550-679X	U.S. Army Medical Research and Materiel Command (USAMRMC), Military Operational Medicine Research Program	This project was funded by the U.S. Army Medical Research and Materiel Command (USAMRMC), Military Operational Medicine Research Program, and was supported in part by an appointment by the Internship/Research Participation Program, Oak Ridge Institute for Science and Education (ORISE), through an agreement between the U.S. Department of Energy and the USAMRMC.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cisler JM, 2016, PSYCHOL MED, V46, P3013, DOI 10.1017/S0033291716001847; Dretsch M., 2010, 71F ADVANTAGE APPL R; Dretsch M, 2012, TRAUMATOLOGY TALLAHA, V19, P118; Dretsch M. N., 2016, OPEN NEUROIMAGING J, V10, P3; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Dretsch MN, 2012, BRAIN BEHAV, V2, P357, DOI 10.1002/brb3.53; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fitzgerald JM, 2016, PSYCHIAT RES-NEUROIM, V249, P113, DOI 10.1016/j.pscychresns.2015.12.001; Garfinkel SN, 2013, SOC COGN AFFECT NEUR, V8, P231, DOI 10.1093/scan/nss140; Goodman AM, 2016, J BEHAV THER EXP PSY, V50, P152, DOI 10.1016/j.jbtep.2015.07.006; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Greco JA, 2016, NEUROPSYCHOPHARMACOL, V41, P320, DOI 10.1038/npp.2015.255; Gross, 2014, HDB EMOTION REGULATI, P23; Gross J. J., 2014, HDB EMOTION REGULATI; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; King D. W., 2003, MANUAL DEPLOYMENT RI; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lang P. J, 2008, INT AFFECTIVE PICTUR; Linnman C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-8; Little DM, 2014, ALZHEIMERS DEMENT, V10, pS188, DOI 10.1016/j.jalz.2014.04.002; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; Nomi JS, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-41; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Osborne-Crowley K., 2016, J NEUROPSYCHOLOGY, V30, DOI 10.111/jnp.12113; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Rabinak CA, 2014, DEPRESS ANXIETY, V31, P851, DOI 10.1002/da.22243; Robinson JL, 2012, NEUROIMAGE, V60, P117, DOI 10.1016/j.neuroimage.2011.12.010; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seo D, 2014, SOC COGN AFFECT NEUR, V9, P494, DOI 10.1093/scan/nst115; Sipos ML, 2014, DEPRESS ANXIETY, V31, P124, DOI 10.1002/da.22157; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; TOMBAUGH TN, 2003, J FORENSIC NEUROPSYC, V2, P69, DOI DOI 10.1300/J151V02N03_04; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van der Horn HJ, 2016, HUM BRAIN MAPP, V37, P1645, DOI 10.1002/hbm.23126; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Walker WC, 2015, BRAIN INJURY, V29, P1581, DOI 10.3109/02699052.2015.1075151; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	64	6	7	2	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 2	2019	26	1					76	88		10.1080/23279095.2017.1362406			13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HR3RQ	WOS:000463057500008	28925716				2022-02-06	
J	Wearne, T; Osborne-Crowley, K; Rosenberg, H; Dethier, M; McDonald, S				Wearne, Travis; Osborne-Crowley, Katherine; Rosenberg, Hannah; Dethier, Marie; McDonald, Skye			Emotion recognition depends on subjective emotional experience and not on facial expressivity: evidence from traumatic brain injury	BRAIN INJURY			English	Article						Emotion recognition; facial expressivity; traumatic brain injury; emotional experience; feeling; alexithymia	DEPRESSION ANXIETY; NONVERBAL CUES; ALEXITHYMIA; PERCEPTION; PERFORMANCE; SIMULATION; MOOD; IDENTIFICATION; METAANALYSIS; IMPAIRMENTS	Background: Recognizing how others feel is paramount to social situations and commonly disrupted following traumatic brain injury (TBI). This study tested whether problems identifying emotion in others following TBI is related to problems expressing or feeling emotion in oneself, as theoretical models place emotion perception in the context of accurate encoding and/or shared emotional experiences. Methods: Individuals with TBI (n = 27; 20 males) and controls (n = 28; 16 males) were tested on an emotion recognition task, and asked to adopt facial expressions and relay emotional memories according to the presentation of stimuli (word and photos). After each trial, participants were asked to self-report their feelings of happiness, anger and sadness. Judges that were blind to the presentation of stimuli assessed emotional facial expressivity. Results: Emotional experience was a unique predictor of affect recognition across all emotions while facial expressivity did not contribute to any of the regression models. Furthermore, difficulties in recognizing emotion for individuals with TBI were no longer evident after cognitive ability and experience of emotion were entered into the analyses. Conclusions: Emotion perceptual difficulties following TBI may stem from an inability to experience affective states and may tie in with alexythymia in clinical conditions.	[Wearne, Travis; Osborne-Crowley, Katherine; Rosenberg, Hannah; McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Dethier, Marie] Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium		Wearne, T (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	t.wearne@unsw.edu.au	; McDonald, Skye/G-4118-2014	Wearne, Travis/0000-0002-7565-9163; Osborne-Crowley, Katherine/0000-0003-0295-1849; McDonald, Skye/0000-0003-0723-6094	Australian Research CouncilAustralian Research Council [DP0988689]	This research was funded by an Australian Research Council Discovery Project Grant [DP0988689].	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Allerdings MD, 2001, BRAIN COGNITION, V47, P304; Asthana HS, 1998, J AFFECT DISORDERS, V48, P57, DOI 10.1016/S0165-0327(97)00140-7; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Becerra R, 2002, BRAIN INJURY, V16, P633, DOI 10.1080/02699050110119817; Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283; Blanchard J. J., 1998, HDB SOCIAL FUNCTIONI; Borod JC, 1991, PHARMACOPSYCHOECOLOG, V4, P15; BOUHUYS AL, 1995, J AFFECT DISORDERS, V33, P215, DOI 10.1016/0165-0327(94)00092-N; Bouhuys AL, 1999, J NERV MENT DIS, V187, P595, DOI 10.1097/00005053-199910000-00002; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Brozgold A Z, 1998, Appl Neuropsychol, V5, P15, DOI 10.1207/s15324826an0501_2; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Cook R, 2013, PSYCHOL SCI, V24, P723, DOI 10.1177/0956797612463582; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; CUNNINGHAM MR, 1977, J PERS, V45, P555; Dethier M, 2013, J INT NEUROPSYCH SOC, V19, P367, DOI 10.1017/S1355617712001555; Dethier M, 2012, J CLIN EXP NEUROPSYC, V34, P936, DOI 10.1080/13803395.2012.702734; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Dimberg U., 1988, J PSYCHOPHYSIOL, V2, P277; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; Elfenbein HA, 2010, J RES PERS, V44, P199, DOI 10.1016/j.jrp.2010.01.001; Elfenbein HA, 2010, J PERS SOC PSYCHOL, V98, P301, DOI 10.1037/a0017766; Freeman J, 2001, BRIT J CLIN PSYCHOL, V40, P221, DOI 10.1348/014466501163562; Fridlund AJ, 2014, HUMAN FACIAL EXPRESS; Frigerio E, 2002, PSYCHIAT RES, V113, P161, DOI 10.1016/S0165-1781(02)00244-5; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gloster AT, 2008, J AFFECT DISORDERS, V110, P248, DOI 10.1016/j.jad.2008.01.023; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Heberlein AS, 2009, EMOT REV, V1, P162, DOI 10.1177/1754073908100441; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Johnson-Laird, 1987, COGNITION EMOTION, V1, P29, DOI DOI 10.1080/02699938708408362; Keillor JM, 2002, J INT NEUROPSYCH SOC, V8, P130, DOI 10.1017/S1355617701020136; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Kornreich C, 2002, ALCOHOL ALCOHOLISM, V37, P394, DOI 10.1093/alcalc/37.4.394; LANZETTA JT, 1970, J PERS SOC PSYCHOL, V16, P12, DOI 10.1037/h0029850; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; LUNDQVIST LO, 1995, J PSYCHOPHYSIOL, V9, P203; Marsh AA, 2007, EMOTION, V7, P239, DOI 10.1037/1528-3542.7.2.239; Marshall AD, 2010, J FAM PSYCHOL, V24, P21, DOI 10.1037/a0017952; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mayer JD, 2008, ANNU REV PSYCHOL, V59, P507, DOI 10.1146/annurev.psych.59.103006.093646; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; Mikhailova ES, 1996, BIOL PSYCHIAT, V40, P697, DOI 10.1016/0006-3223(96)00032-7; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Morris PG, 2005, BRIT J CLIN PSYCHOL, V44, P209, DOI 10.1348/014466505X34174; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; Niedenthal PM, 2000, EUR J SOC PSYCHOL, V30, P211, DOI 10.1002/(SICI)1099-0992(200003/04)30:2<211::AID-EJSP988>3.0.CO;2-3; Park S, 2008, SCHIZOPHRENIA BULL, V34, P698, DOI 10.1093/schbul/sbn048; PARKER JDA, 1993, PSYCHOTHER PSYCHOSOM, V59, P197, DOI 10.1159/000288664; Preston SD, 2007, EMPATHY IN MENTAL ILLNESS, P428, DOI 10.1017/CBO9780511543753.024; RIGGIO RE, 1986, J PERS SOC PSYCHOL, V51, P649, DOI 10.1037/0022-3514.51.3.649; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Russell JA, 2003, ANNU REV PSYCHOL, V54, P329, DOI 10.1146/annurev.psych.54.101601.145102; Salovey P., 1990, IMAG COGN PERS, V9, P185, DOI DOI 10.2190/DUGG-P24E-52WK-6CDG; Schmid PC, 2010, MOTIV EMOTION, V34, P288, DOI 10.1007/s11031-010-9170-0; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schneider W, 2002, E PRIME V1 1; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams KR, 2001, BRAIN INJURY, V15, P349, DOI 10.1080/026990501750111319; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Yi CY, 2016, J INDIVID DIFFER, V37, P16, DOI 10.1027/1614-0001/a000183; Zhang F, 2015, J SOC PERS RELAT, V32, P633, DOI 10.1177/0265407514541073; ZUCKERMAN M, 1975, J PERS SOC PSYCHOL, V32, P1068, DOI 10.1037/0022-3514.32.6.1068; ZUROFF DC, 1986, J CLIN PSYCHOL, V42, P411, DOI 10.1002/1097-4679(198605)42:3<411::AID-JCLP2270420302>3.0.CO;2-T	92	6	6	2	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		12	22		10.1080/02699052.2018.1531300			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400003	30296178	Green Submitted			2022-02-06	
J	Al-Ameri, LT; Mohsin, TS; Wahid, ATA				Al-Ameri, Laith Thamer; Mohsin, Talib Saddam; Wahid, Ali Tarik Abdul			Sleep Disorders Following Mild and Moderate Traumatic Brain Injury	BRAIN SCIENCES			English	Article						traumatic brain injury; sleep disorders; sleep latency	QUALITY INDEX; WAKE DISTURBANCES; MELATONIN; VALIDITY; SCALE	(1) Background: Sleeping disorders are frequently reported following traumatic brain injury (TBI). Different forms of sleeping disorders have been reported, such as sleepiness, insomnia, changes in sleeping latency, and others. (2) Methods: A case-control study with 62 patients who were victims of mild or moderate TBI with previous admissions to Iraqi tertiary neurosurgical centers were enrolled as the first group, and 158 patients with no history of trauma were considered as the control. All were 18 years of age or older, and the severity of the trauma and sleep disorders was assessed. The Pittsburgh sleep quality index was used to assess sleep disorders with average need for sleep per day and average sleep latency were assessed in both groups. Chi-square and t-test calculations were used to compare different variables. (3) Results: 39 patients (24.7%) of the controlled group experienced sleeping disorders compared to TBI group with 45 patients (72.6%), P-value < 0.00001. A total of 42 patients were diagnosed on admission as having a mild degree of TBI (mean GCS 13.22 +/- 1.76) and 20 patients were diagnosed with moderate TBI (mean GCS11.05 +/- 1.14. 27). A total of 27 (46.28%) patients with mild severity TBI and 18 patients (90%) of moderate severity were considered to experience sleeping disorders, P-value 0.0339. Each of the mild and moderate TBI subgroups show a P-value < 0.00001 compared to the control group. Average sleep hours needed per day for TBI and the control were 8.02 +/- 1.04 h and 7.26 +/- 0.58 h, respectively, P-value < 0.00001. Average sleep latency for the TBI and the control groups were 13.32 +/- 3.16 min and 13.93 +/- 3.07 min respectively, P-value 0.065. (4) Conclusion: Sleep disturbances are more common following mild and moderate TBI three months after the injury with more hours needed for sleep per day and no significant difference in sleep latency. Sleep disturbances increase in frequency with the increase in the severity of TBI.	[Al-Ameri, Laith Thamer; Mohsin, Talib Saddam] Univ Baghdad, Al Kindy Coll Med, Baghdad, Iraq; [Wahid, Ali Tarik Abdul] Univ Baghdad, Coll Med, Baghdad, Iraq		Al-Ameri, LT (corresponding author), Univ Baghdad, Al Kindy Coll Med, Baghdad, Iraq.	laith.thamer@yahoo.com; talib.almuhsin@gmail.com; azdh_1978@yahoo.com	Al-Ameri, Laith Thamer/W-8214-2018	Al-Ameri, Laith Thamer/0000-0002-5863-1564			Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; de la Vega R, 2015, PSYCHOL ASSESSMENT, V27, pE22, DOI 10.1037/pas0000128; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mondal P, 2013, NAT SCI SLEEP, V5, P15, DOI 10.2147/NSS.S40608; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Spira AP, 2012, J GERONTOL A-BIOL, V67, P433, DOI 10.1093/gerona/glr172; Suleiman KH, 2010, WESTERN J NURS RES, V32, P250, DOI 10.1177/0193945909348230; Viola-Saltzman M, 2016, NEUROPSYCH DIS TREAT, V12, P339, DOI 10.2147/NDT.S69105; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Wiseman-Hakes C., 2015, J SLEEP DISORD THER, V5, P224, DOI DOI 10.4172/2167-0277.1000224; Yaeger K, 2014, AM J ROENTGENOL, V202, P614, DOI 10.2214/AJR.13.11091; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	22	6	6	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-3425			BRAIN SCI	Brain Sci.	JAN	2019	9	1							10	10.3390/brainsci9010010			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HJ4UD	WOS:000457169900011	30641953	Green Submitted, Green Published, gold			2022-02-06	
J	Albrecht, JS; Al Kibria, G; Gruber-Baldini, A; Magaziner, J				Albrecht, Jennifer S.; Al Kibria, Gulam; Gruber-Baldini, Ann; Magaziner, Jay			Risk of Mortality in Individuals with Hip Fracture and Traumatic Brain Injury	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						hip fracture; traumatic brain injury; mortality; Medicare	UNITED-STATES; OLDER-ADULTS; AGE; OUTCOMES	Objectives To estimate the prevalence of diagnosed traumatic brain injury (TBI) in individuals hospitalized with hip fracture and examine its association with all-cause mortality. Design Nested cohort study. Setting National sample of Medicare beneficiaries from 2006 to 2010. Participants Beneficiaries aged 65 and older hospitalized with hip fracture. Measurements TBI at the time of hip fracture was defined using International Classification of Diseases, Ninth Revision, Clinical Modification codes. The main outcome was all-cause mortality during follow-up. Results Prevalence of TBI in individuals with hip fracture was 2.7%. Absolute risk of mortality attributable to TBI in individuals with hip fracture was 15/100 person-years. TBI was significantly associated with risk of death in multivariable analysis (hazard ratio=1.24, 95% confidence interval=1.14-1.35). Conclusion TBI was associated with greater risk of mortality in individuals with hip fracture. Practitioners should consider evaluating for presence of TBI in this vulnerable population. J Am Geriatr Soc 67:124-127, 2019.	[Albrecht, Jennifer S.; Al Kibria, Gulam; Gruber-Baldini, Ann; Magaziner, Jay] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 334C,10 S Pine St, Baltimore, MD 21201 USA.	jalbrecht@som.umaryland.edu	Kibria, Gulam Muhammed Al/E-3061-2017	Kibria, Gulam Muhammed Al/0000-0002-7037-6658; Albrecht, Jennifer/0000-0003-4838-2274	Agency for Healthcare Quality and ResearchUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1K01HS024560]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37 AG009901, P30 AG028747]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028747, R37AG009901, R21AG054143] Funding Source: NIH RePORTER	Dr. Albrecht is supported by Agency for Healthcare Quality and Research Grant 1K01HS024560. Dr. Magaziner is supported by National Institute of Aging Grants R37 AG009901 and P30 AG028747.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Givens JL, 2008, J AM GERIATR SOC, V56, P1075, DOI 10.1111/j.1532-5415.2008.01711.x; Goldacre MJ, 2002, BRIT MED J, V325, P868, DOI 10.1136/bmj.325.7369.868; Gruber-Baldini AL, 2017, J AM GERIATR SOC, V65, pe64, DOI 10.1111/jgs.14674; HCUPnet, 2012, HEALTHC COST UT PROJ; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Liu H, 2017, AGEING RES REV, V34, P64, DOI 10.1016/j.arr.2016.11.006; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Neuman MD, 2014, JAMA INTERN MED, V174, P1273, DOI 10.1001/jamainternmed.2014.2362; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Ruggiero C, 2017, OSTEOPOROSIS INT, V28, P667, DOI 10.1007/s00198-016-3784-3; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	27	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	JAN	2019	67	1					124	127		10.1111/jgs.15661			4	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	HG5RE	WOS:000455035800020	30471090	Green Accepted			2022-02-06	
J	Ben-Zion, Z; Fine, NB; Keynan, NJ; Admon, R; Halpern, P; Liberzon, I; Hendler, T; Shalev, AY				Ben-Zion, Ziv; Fine, Naomi B.; Keynan, Nimrod Jackob; Admon, Roee; Halpern, Pinchas; Liberzon, Israel; Hendler, Talma; Shalev, Arieh Y.			Neurobehavioral moderators of post-traumatic stress disorder (PTSD) trajectories: study protocol of a prospective MRI study of recent trauma survivors	EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY			English	Article						Post-Traumatic Stress Disorder (PTSD); longitudinal study; symptom trajectories; neurobehavioral moderators; Magnetic Resonance Imaging (MRI)	HIPPOCAMPAL VOLUME; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; INTEGRITY; ANXIETY; ACTIVATION; PREDICTORS; BRAIN; VULNERABILITY; DISSOCIATION	Background: Post-traumatic stress disorder (PTSD) is triggered by distinct events and is therefore amenable to studies of its early pathogenesis. Longitudinal studies during the year that follows trauma exposure revealed typical symptom trajectories leading to either recovery or protracted PTSD. Thezneurobehavioral correlates of early PTSD symptoms' trajectories have not been longitudinally explored. Objective: To present the rationale and design of a longitudinal study exploring the relationship between evolving PTSD symptoms and co-occurring cognitive functioning and structural and functional brain imaging parameters. Method: Adult civilians consecutively admitted to a general hospital emergency room (ER) for traumatic injury will be screened for early PTSD symptoms suggestive of chronic PTSD risk, and consecutively evaluated 1, 6 and 14 months following the traumatic event. Consecutive assessments will include structured clinical interviews for PTSD and comorbid disorders, self-reported depression and anxiety symptoms, a web-based assessment of cognitive domains previously linked with PTSD (e.g., memory, executive functions, cognitive flexibility), high-resolution structural MRI of both grey and white matter, functional resting-state connectivity, and fMRI tasks examining emotional reactivity and regulation, as well as motivation processing and sensitivity to risk and reward. Data analyses will explore putative cognitive predictors of non-remitting PTSD, and brain structural and functional correlates of PTSD persistence or recovery. Conclusion: This work will longitudinally document patterns of brain structures, connectivity, and functioning, predictive of (or associated with) emerging PTSD during the critical first year of after the traumatic event. It will thereby inform our understanding of the disorder's pathogenesis and underlying neuropathology. Challenges to longitudinal MRI studies of recent survivors, and methodological choices used to optimize the study's design are discussed.	[Ben-Zion, Ziv; Fine, Naomi B.; Keynan, Nimrod Jackob; Hendler, Talma] Tel Aviv Sourasky Med Ctr, Sagol Brain Inst Tel Aviv, Wohl Inst Adv Imaging, Tel Aviv, Israel; [Ben-Zion, Ziv; Hendler, Talma] Tel Aviv Univ, Sagol Sch Neurosci, POB 39040, IL-69978 Tel Aviv, Israel; [Fine, Naomi B.; Keynan, Nimrod Jackob; Hendler, Talma] Tel Aviv Univ, Fac Social Sci, Sch Psychol Sci, Tel Aviv, Israel; [Admon, Roee] Univ Haifa, Dept Psychol, Haifa, Israel; [Halpern, Pinchas] Tel Aviv Sourasky Med Ctr, Dept Emergency Med, Tel Aviv, Israel; [Liberzon, Israel] Texas A&M Hlth Sci Ctr, Dept Psychiat, Austin, TX USA; [Hendler, Talma] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Shalev, Arieh Y.] NYU Langone Med Ctr, Dept Psychiat, New York, NY USA		Ben-Zion, Z (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, POB 39040, IL-69978 Tel Aviv, Israel.; Ben-Zion, Z (corresponding author), Tel Aviv Sourasky Med Ctr, Sagol Brain Inst, Wohl Inst Adv Imaging, Weizmann 6, IL-64239 Tel Aviv, Israel.	zivbenzion@mail.tau.ac.il	Admon, Roee/AAO-6866-2021; Ben-Zion, Ziv/Y-9587-2019	Admon, Roee/0000-0002-9886-5111; Ben-Zion, Ziv/0000-0003-3629-5851; Shalev, Arieh/0000-0001-9425-050X; Liberzon, Israel/0000-0002-4990-556X; Halpern, Pinchas/0000-0002-9803-7105	National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH -103287]	This work was supported by award number R01-MH -103287 from the National Institute of Mental Health (NIMH) given to AS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Admon R, 2013, CEREB CORTEX, V23, P28, DOI 10.1093/cercor/bhr369; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Ayling E, 2012, CURR PSYCHIAT REP, V14, P197, DOI 10.1007/s11920-012-0273-z; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Ben-Zion Z, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00477; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Casada JH, 2005, J NERV MENT DIS, V193, P102, DOI 10.1097/01.nmd.0000152809.20938.37; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; De Bellis MD, 2013, CHILD MALTREATMENT, V18, P171, DOI 10.1177/1077559513497420; Do L., 2011, ENCY CHILD BEHAV DEV, P84, DOI DOI 10.1007/978-0-387-79061-9_113; Duval ER, 2018, J ANXIETY DISORD, V56, P56, DOI 10.1016/j.janxdis.2018.04.004; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fine NB, 2018, EUR J PSYCHOTRAUMATO, V9, DOI 10.1080/20008198.2018.1442602; FIRST MB, 1995, J PERS DISORD, V9, P92, DOI 10.1521/pedi.1995.9.2.92; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Freedman S. A., 1999, BRIT J PSYCHIAT J ME, V174; Freedman SA, 1999, BRIT J PSYCHIAT, V174, P353, DOI 10.1192/bjp.174.4.353; Ferrari MCF, 2008, REV BRAS PSIQUIATR, V30, P251, DOI 10.1590/S1516-44462008000300013; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; Galatzer-Levy IR, 2013, PERSPECT PSYCHOL SCI, V8, P651, DOI 10.1177/1745691613504115; Galatzer-Levy IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070084; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Guy W., 1976, ECDEU ASSESSMENT MAN, P217; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Hart RP, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01120; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnsen GE, 2008, J AFFECT DISORDERS, V111, P74, DOI 10.1016/j.jad.2008.02.007; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Klumpp H, 2011, DEPRESS ANXIETY, V28, P194, DOI 10.1002/da.20802; Koch SBJ, 2016, DEPRESS ANXIETY, V33, P592, DOI 10.1002/da.22478; Koenen KC, 2001, BRAIN COGNITION, V45, P64, DOI 10.1006/brcg.2000.1256; Koren D, 2001, BEHAV RES THER, V39, P1449, DOI 10.1016/S0005-7967(01)00025-0; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; MARMAR CR, 1994, AM J PSYCHIAT, V151, P902; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Peleg T, 2006, CNS SPECTRUMS, V11, P589, DOI 10.1017/S109285290001364X; Perkonigg A, 2005, AM J PSYCHIAT, V162, P1320, DOI 10.1176/appi.ajp.162.7.1320; Phan KL, 2009, BIOL PSYCHIAT, V66, P691, DOI 10.1016/j.biopsych.2009.02.028; Pineles SL, 2009, BEHAV RES THER, V47, P1050, DOI 10.1016/j.brat.2009.08.001; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Qi W, 2018, EUR J PSYCHOTRAUMATO, V9, DOI 10.1080/20008198.2018.1476442; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rivera-Velez GM, 2014, J CHILD SEX ABUS, V23, P55, DOI 10.1080/10538712.2014.864746; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Samuelson Kristin W, 2011, Dialogues Clin Neurosci, V13, P346; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Selverstein SM, 2007, BEHAV RES METHODS, V39, P940, DOI 10.3758/BF03192989; Shalev A. Y., 1996, EUROPEAN NEUROPSYCHO, V8, pS112; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Shalev AY, 2019, WORLD PSYCHIATRY, V18, P77, DOI 10.1002/wps.20608; Shalev AY, 2012, ARCH GEN PSYCHIAT, V69, P166, DOI 10.1001/archgenpsychiatry.2011.127; Shalev AY, 2011, PSYCHIAT SERV, V62, P765, DOI 10.1176/ps.62.7.pss6207_0765; Shalev AY, 2005, AM J PSYCHIAT, V162, P1188, DOI 10.1176/appi.ajp.162.6.1188; Shalev AY, 1997, BRIT J PSYCHIAT, V170, P558, DOI 10.1192/bjp.170.6.558; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Sripada RK, 2013, BIOL PSYCHIAT, V73, P1045, DOI 10.1016/j.biopsych.2012.12.008; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wang HH, 2010, J PSYCHIATR RES, V44, P385, DOI 10.1016/j.jpsychires.2009.10.001; Weathers F, 1993, ANN CONV INT SOC TRA, V462; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; Zoellner LA, 2013, PSYCHOL INJ LAW, V6, P277, DOI 10.1007/s12207-013-9175-6	84	6	6	2	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2000-8198	2000-8066		EUR J PSYCHOTRAUMATO	Eur. J. Psychotraumatol.	JAN 1	2019	10	1							1683941	10.1080/20008198.2019.1683941			13	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	JK9FE	WOS:000495143200001	31762950	Green Published, gold			2022-02-06	
J	Borhani, S; Abiri, R; Jiang, Y; Berger, T; Zhao, XP				Borhani, Soheil; Abiri, Reza; Jiang, Yang; Berger, Taylor; Zhao, Xiaopeng			Brain connectivity evaluation during selective attention using EEG-based brain-computer interface	BRAIN-COMPUTER INTERFACES			English	Article						Brain-computer interface; selective attention; EEG; event-related potential; Granger Causality; time-frequency; brain connectivity	GRANGER CAUSALITY; SUSTAINED ATTENTION; TIME-SERIES; SOFTWARE	Attentional deficits may be caused by neurological diseases, including Attention-Deficit/Hyperactivity Disorder (ADHD), Alzheimer's disease (AD), Traumatic Brain Injuries (TBI), etc. This work aims to evaluate selective attention under visual stimulations of faces and scenes using electroencephalogram (EEG)-based brain-computer interface. The experiment consisted of two phases: 1) image recognition and 2) attention evaluation. In phase 1, the mean response time was 547 ms vs. 633 ms to faces and scenes, respectively. In phase 2, the mean response time was 667 ms vs. 706 ms to face and scene categories, respectively. We analyzed the event-related time-frequency representation of faces and scenes and the causal relationship between object recognition and the motor response associated with category selection using the brain connectivity based on Granger causality. The developed experimental protocols and connectivity evaluation methods may provide insights for a better understanding of the neural processes for object recognition and category selection.	[Borhani, Soheil; Berger, Taylor; Zhao, Xiaopeng] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA; [Abiri, Reza] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Jiang, Yang] Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA		Zhao, XP (corresponding author), Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.	xzhao9@utk.edu	Borhani, Soheil/L-7538-2019; Zhao, Xiaopeng/A-4419-2008	Borhani, Soheil/0000-0002-4887-1417; Zhao, Xiaopeng/0000-0003-1207-5379; JIANG, Yang/0000-0003-4589-0097	Alzheimer's Tennessee; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P30AG028383, UL1TR000117]; National Science Foundation through Research Experience for Undergraduates (REU) [1659502]	This work was in part supported by Alzheimer's Tennessee, by the National Institutes of Health under grant numbers 5P30AG028383 and UL1TR000117, and by the National Science Foundation through Research Experience for Undergraduates (REU) award no. 1659502.	Abiri R, 2019, COMPLEXITY, DOI 10.1155/2019/6862031; Abiri R, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/aaf12e; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baldauf D, 2014, SCIENCE, V344, P424, DOI 10.1126/science.1247003; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borhani S, 2008, 7 INT BCI M 2018 MAY; Borhani S, 2018, 2018 ANN M SOC NEUR; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen YH, 2004, PHYS LETT A, V324, P26, DOI 10.1016/j.physleta.2004.02.032; Courellis H, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00180; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030135; Dhamala M, 2018, NEUROIMAGE, V175, P460, DOI 10.1016/j.neuroimage.2018.04.043; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Freiwald WA, 1999, J NEUROSCI METH, V94, P105, DOI 10.1016/S0165-0270(99)00129-6; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Ge T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000570; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guo SX, 2008, J NEUROSCI METH, V172, P79, DOI 10.1016/j.jneumeth.2008.04.011; Hardie SM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00134; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Jiang Y, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00052; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kaneshiro B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135697; Kleiner M, 2007, PERCEPTION, V36, P14; Kus R, 2008, ACTA NEUROBIOL EXP, V68, P103; Lin FH, 2009, HUM BRAIN MAPP, V30, P1877, DOI 10.1002/hbm.20772; Loitfelder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042862; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Mullen TR, 2014, DYNAMIC BRAIN MODELI; Naghavi N, 2019, IEEE T NEUR SYS REH, V27, P947, DOI 10.1109/TNSRE.2019.2910165; Nedungadi AG, 2009, J COMPUT NEUROSCI, V27, P55, DOI 10.1007/s10827-008-0126-2; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nudo RJ, 1997, SEMINARS NEUROSCIENC, V9, P13; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piazza C, 2016, IFMBE PROC, V57, P105, DOI 10.1007/978-3-319-32703-7_22; Pion-Tonachini L, 2017, KNOWL INF SYST, V53, P749, DOI 10.1007/s10115-017-1053-1; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Siggiridou E, 2016, IEEE T SIGNAL PROCES, V64, P1759, DOI 10.1109/TSP.2015.2500893; So K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026004; Somers M, 2015, NEUROSCI BIOBEHAV R, V51, P48, DOI 10.1016/j.neubiorev.2015.01.003; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Ullman JB, 2012, HDB PSYCHOL; Yantis S, 2008, CURR DIR PSYCHOL SCI, V17, P86, DOI 10.1111/j.1467-8721.2008.00554.x; Zhang Le, 2010, J Biomed Sci Eng, V3, P848	51	6	6	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2326-263X	2326-2621		BRAIN-COMPUT INTERFA	Brain Comput. Interfaces		2019	6	1-2					25	35		10.1080/2326263X.2019.1651186			11	Engineering, Biomedical; Neurosciences	Emerging Sources Citation Index (ESCI)	Engineering; Neurosciences & Neurology	IV6GA	WOS:000484365700003					2022-02-06	
J	Brown, S; O'Rourke, S; Schwannauer, M				Brown, Sarah; O'Rourke, Suzanne; Schwannauer, Matthias			Risk factors for inpatient violence and self-harm in forensic psychiatry: the role of head injury, schizophrenia and substance misuse	BRAIN INJURY			English	Article						Violence; risk assessment; self-harm; forensic psychiatry; head injury	TRAUMATIC BRAIN-INJURY; MENTALLY DISORDERED OFFENDERS; ADVERSE CHILDHOOD EXPERIENCES; CRIMINAL RECIDIVISM; SUICIDE ATTEMPTS; PREVALENCE; ABUSE; AGGRESSION; INTERVENTION; DYSFUNCTION	Objective: To investigate factors relevant to violence and self-harm in forensic psychiatric inpatients the cross-sectional association between four potential contributory factors; head injury, schizophrenia, drug and alcohol misuse, and self-harm or violence-related outcomes was examined.Methodology: Data were extracted from an existing dataset of routinely collected data on all patients under the care of Scotland's Forensic Mental Health Managed Care Network, of whom (n =432) met inclusion criteria. A Factorial MANOVA and Pearson's chi-square tests were conducted to assess the relationship between potential contributory factors and self-harm and violence.Results: Forty-seven individuals had a documented head injury (10.9%). The presence of head injury was significantly associated with inpatient violence and assessed violence risk. Number of historic violent offences was significantly associated with a history of drug misuse and co-morbid alcohol misuse and schizophrenia. Self-harm was significantly associated with drug misuse and a diagnosis of schizophrenia.Conclusion: These findings highlight a significant association between head injury and actual/assessed risk in forensic psychiatry, over and above that of substance misuse and a diagnosis of schizophrenia, emphasising the need for routine assessment of head injury in clinical practice. Further examination of the impact of head injury in forensic psychiatric populations is needed.	[Brown, Sarah; O'Rourke, Suzanne; Schwannauer, Matthias] Univ Edinburgh, Clin Psychol, Doorway 6,Teviot Pl, Edinburgh, Midlothian, Scotland; [O'Rourke, Suzanne] State Hosp, Dept Psychol, Carstairs, Scotland		Brown, S (corresponding author), Univ Edinburgh, Clin Psychol, Doorway 6,Teviot Pl, Edinburgh, Midlothian, Scotland.	sarah.jw.brown@ed.ac.uk	Lorente, Rosa/AAL-5850-2021				ae Forth, 2002, MANUAL STRUCTURED AS; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arango C, 1999, SCHIZOPHRENIA BULL, V25, P493, DOI 10.1093/oxfordjournals.schbul.a033396; BACHYRITA G, 1974, AM J PSYCHIAT, V131, P1015; Beck A.T., 1974, PREDICTION SUICIDE, P45; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Bolton JM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4978; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; ca Cormier, 1998, VIOLENT OFFENDERS AP; Campbell MA, 2009, CRIM JUSTICE BEHAV, V36, P567, DOI 10.1177/0093854809333610; Castano-Monsalve B, 2013, REV NEUROLOGIA, V56, P363, DOI 10.33588/rn.5607.2012412; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Daffern M, 2003, J FORENSIC PSYCHI PS, V14, P67, DOI 10.1080/1478994031000074306; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Dudeck M, 2016, PSYCHIAT RES, V240, P352, DOI 10.1016/j.psychres.2016.04.073; Eack SM, 2010, ARCH GEN PSYCHIAT, V67, P674, DOI 10.1001/archgenpsychiatry.2010.63; Esbec E, 2010, ACTAS ESP PSIQUIATRI, V38, P249; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Flannery RB, 2014, PSYCHIAT QUART, V85, P303, DOI 10.1007/s11126-014-9295-5; GLICKSOHN J, 2002, NEUROBIOLOGY CRIMINA; Golenkov A, 2013, CRIM BEHAV MENT HEAL, V23, P347, DOI 10.1002/cbm.1876; Hanson GC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-014-1340-7; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Hart S.D., 1997, HCR 20 ASSESSING RIS; Haw C, 2005, SUICIDE LIFE-THREAT, V35, P50, DOI 10.1521/suli.35.1.50.59260; Hawley CA, 2003, BRAIN INJURY, V17, P743, DOI 10.1080/0269905031000089341; Hawton K, 2007, SOC PSYCH PSYCH EPID, V42, P513, DOI 10.1007/s00127-007-0199-7; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; James K, 2012, INT J MENT HEALTH NU, V21, P301, DOI 10.1111/j.1447-0349.2011.00794.x; Johnson S., 2003, PSYCHIAT B, V27, P217, DOI 10.1192/pb.27.6.217; LEWIS DO, 1988, AM J PSYCHIAT, V145, P584; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; Lumsden J, 2005, J FORENSIC PSYCHI PS, V16, P651, DOI 10.1080/14789940500205930; Lund C, 2013, INT J LAW PSYCHIAT, V36, P250, DOI 10.1016/j.ijlp.2013.04.015; Manguno-Mire GM, 2014, BEHAV SCI LAW, V32, P641, DOI 10.1002/bsl.2138; MARTELL DA, 1992, J FORENSIC SCI, V37, P878; Maxfield MG, 1996, ARCH PEDIAT ADOL MED, V150, P390, DOI 10.1001/archpedi.1996.02170290056009; McKinlay A, 2014, AUST PSYCHOL, V49, P323, DOI 10.1111/ap.12084; McMillan TM, 2010, CAMBRIDGE HDB FORENS, P65; Murphy David, 2007, Crim Behav Ment Health, V17, P300, DOI 10.1002/cbm.664; Nijman H, 2005, AGGRESSIVE BEHAV, V31, P217, DOI 10.1002/ab.20038; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; O'Reilly K, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0548-0; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; PATTERSON WM, 1983, PSYCHOSOMATICS, V24, P343, DOI 10.1016/S0033-3182(83)73213-5; Pluck G, 2013, EUR PSYCHIAT, V28, P344, DOI 10.1016/j.eurpsy.2012.08.003; Portoghese I., 2017, BURNOUT RES, V7, P36, DOI [10.1016/j. burn.2017.11.003, DOI 10.1016/J.BURN.2017.11.003]; Riordan S, 2006, NORD J PSYCHIAT, V66, P283; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sakelliadis EI, 2010, EUR PSYCHIAT, V25, P151, DOI 10.1016/j.eurpsy.2009.07.014; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Singh JP, 2011, CLIN PSYCHOL REV, V31, P499, DOI 10.1016/j.cpr.2010.11.009; Soyka M, 2007, SCHIZOPHR RES, V94, P89, DOI 10.1016/j.schres.2007.03.027; Swogger MT, 2011, PSYCHIAT RES, V185, P363, DOI 10.1016/j.psychres.2010.07.036; Tabita B, 2012, NORD J PSYCHIAT, V66, P283, DOI 10.3109/08039488.2011.644578; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; van Heugten C M, 2013, Tijdschr Psychiatr, V55, P665; Volavka J, 2013, PSYCHIAT DANUB, V25, P24; Webster CD, 1995, HCR 20 SCHEME ASSESS; Williams HW, 2018, LANCET, VS2215-0366, P30062; Wilson HW, 2009, J CHILD PSYCHOL PSYC, V50, P769, DOI 10.1111/j.1469-7610.2008.01974.x; Witt K, 2014, SCHIZOPHR RES, V154, P61, DOI 10.1016/j.schres.2014.02.001; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079	71	6	6	3	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2019	33	3					313	321		10.1080/02699052.2018.1553064			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM7DB	WOS:000459636400007	30507315	Green Submitted			2022-02-06	
J	Choi, JY; Hart, T; Whyte, J; Rabinowitz, AR; Oh, SH; Lee, J; Kim, JJ				Choi, Joon Yul; Hart, Tessa; Whyte, John; Rabinowitz, Amanda R.; Oh, Se-Hong; Lee, Jongho; Kim, Junghoon J.			Myelin water imaging of moderate to severe diffuse traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Myelin water imaging; Diffusion tensor imaging; Processing speed index; Post traumatic amnesia	AXONAL INJURY; DIRECT VISUALIZATION; WHITE; SPECTRUM; DAMAGE; SPEED; DEMYELINATION	Traumatic axonal injury (TAI), a signature injury of traumatic brain injury (TBI), is increasingly known to involve myelin damage. The objective of this study was to demonstrate the clinical relevance of myelin water imaging (MWI) by first quantifying changes in myelin water after TAI and then correlating those changes with measures of injury severity and neurocognitive performance. Scanning was performed at 3 months post-injury in 22 adults with moderate to severe diffuse TBI and 30 demographically matched healthy controls using direct visualization of short transverse component (ViSTa) MWI. Fractional anisotropy (FA) and radial diffusivity (RD) were also obtained using diffusion tensor imaging. Duration of post-traumatic amnesia (PTA) and cognitive processing speed measured by the Processing Speed Index (PSI) from Wechsler Adult Intelligence Scale-IV, were assessed. A between-group comparison using Tract-Based Spatial Statistics revealed that there was a widespread reduction of apparent myelin water fraction (aMWF) in TBI, consistent with neuropathology involving TAI. The group difference map of aMWF yielded topography that was different from FA and RD. Importantly, aMWF demonstrated significant associations with PTA (r = - 0.564, p = .006) and PSI (r = 0.452, p = .035). In conclusion, reduced myelin water, quantified by ViSTa MWI, is prevalent in moderate-to-severe diffuse TBI and could serve as a potential biomarker for injury severity and prediction of clinical outcomes.	[Choi, Joon Yul; Lee, Jongho] Seoul Natl Univ, Inst Engn Res, Dept Elect & Comp Engn, Lab Imaging Sci & Technol, 1 Gwanak Ro,Bldg 301,Room 1008, Seoul 08826, South Korea; [Hart, Tessa; Whyte, John; Rabinowitz, Amanda R.] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Oh, Se-Hong] Hankuk Univ Foreign Studies, Dept Biomed Engn, 81 Oedae Ro, Yongin 17035, Gyeonggi Do, South Korea; [Kim, Junghoon J.] CUNY, Sch Med, City Coll New York, Dept Mol Cellular & Biomed Sci, 160 Convent Ave,Harris Hall, New York, NY 10031 USA; [Choi, Joon Yul] Cleveland Clin, Neurol Inst, Epilepsy Ctr, Cleveland, OH 44106 USA		Lee, J (corresponding author), Seoul Natl Univ, Inst Engn Res, Dept Elect & Comp Engn, Lab Imaging Sci & Technol, 1 Gwanak Ro,Bldg 301,Room 1008, Seoul 08826, South Korea.; Kim, JJ (corresponding author), CUNY, Sch Med, City Coll New York, Dept Mol Cellular & Biomed Sci, 160 Convent Ave,Harris Hall, New York, NY 10031 USA.	thart@einstein.edu; jwhyte@einstein.edu; RabinowA@einstein.edu; jonghoyi@snu.ac.kr; jkim@med.cuny.edu	Kim, Junghoon John/I-6702-2019	Kim, Junghoon John/0000-0001-5729-8993; Whyte, John/0000-0002-4381-1474	NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS065980]; Creative-Pioneering Researchers Program through Seoul National University (SNU); Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2017R1A2B2008412]	This work was supported in part by the NIH (NINDS) grant 5R01NS065980, by Creative-Pioneering Researchers Program through Seoul National University (SNU), by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2017R1A2B2008412).	Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Chevalier N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139897; Chiang CW, 2014, NEUROIMAGE, V101, P310, DOI 10.1016/j.neuroimage.2014.06.064; Choi J. Y., 2016, P INT SOC MAG RES ME; Choi JY, 2019, J MAGN RESON IMAGING, V49, P1091, DOI 10.1002/jmri.26278; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jeong IH, 2017, EUR J NEUROL, V24, P652, DOI 10.1111/ene.13266; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kim D, 2015, MAGN RESON MED, V74, P499, DOI 10.1002/mrm.25416; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Landman BA, 2010, PROC SPIE, V7623, DOI 10.1117/12.844171; Lee H. M., 2014, P INT SOC MAG RESON; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Oh S. H., 2014, P INT SOC MAG RESON; Oh SH, 2013, NEUROIMAGE, V83, P485, DOI 10.1016/j.neuroimage.2013.06.047; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Wang XJ, 2014, NMR BIOMED, V27, P843, DOI 10.1002/nbm.3129; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Wechasler D., 2008, WAIS 4 WECHSLER ADUL; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215	41	6	6	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	22								101785	10.1016/j.nicl.2019.101785			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IB2UA	WOS:000470123000063	30927603	gold, Green Published			2022-02-06	
J	Ebrahimi, P; Mozafari, J; Ilkhchi, RB; Hanafi, MG; Mousavinejad, M				Ebrahimi, Pouya; Mozafari, Javad; Ilkhchi, Reza Bahrami; Hanafi, Mohammad Ghasem; Mousavinejad, Maryam			Intravenous Tranexamic Acid for Subdural and Epidural Intracranial Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial	REVIEWS ON RECENT CLINICAL TRIALS			English	Article						Emergency medicine; intraparenchymal hemorrhage; tranexamic acid; trauma; clinical trial; hemoglobin (Hb)	TRAUMATIC BRAIN-INJURY; DAMAGE	Background: Recovery of patients with traumatic brain injury largely depends on the reduction in secondary brain damage. The present study aims at investigating the effect of Tranexamic Acid (TXA) administration within the first hours of brain trauma in the emergency department (ED). Methods: This randomized, double-blind, placebo-controlled clinical trial was carried out in patients with subdural and epidural hemorrhage. Patients with any type of bleeding were assigned into two groups of TXA and 0.9% normal saline as placebo. The rate of intracranial hemorrhage after surgery was assessed by CT-scan and amount of hemoglobin (Hb) was measured immediately before surgery and after 6 hours of surgery. Results: A total of 80 participants were randomly assigned into four groups of 20 people. There was a significant difference in the mean of intraoperative bleeding during surgery in patients receiving TXA and placebo in both SDH (Subdural hematoma) and EDH (Epidural Hemorrhage) groups (P= 0.012). The Hb drop amount had no significant difference with placebo (P< 0.0001). No complications were observed in any of the intervention and control groups during the study as well. Conclusion: The use of TXA may reduce bleeding, however, based on the results of this study, such effect was not statistically significant in controlling the epidural and subdural hemorrhage, but clinical trials with a higher sample size are suggested for further investigation in this regard.	[Ebrahimi, Pouya; Mousavinejad, Maryam] Ahvaz Jundishapur Univ Med Sci, Student Res Comm, Ahvaz, Iran; [Mozafari, Javad] Ahvaz Jundishapur Univ Med Sci, Dept Emergency Med, Ahvaz, Iran; [Ilkhchi, Reza Bahrami] Ahvaz Jundishapur Univ Med Sci, Dept Neurosurg, Ahvaz, Iran; [Hanafi, Mohammad Ghasem] Ahvaz Jundishapur Univ Med Sci, Dept Radiol, Ahvaz, Iran		Mozafari, J (corresponding author), Ahvaz Jundishapur Univ Med Sci, Dept Emergency Med, Ahvaz, Iran.	mozafari.taha@yahoo.com	Mozafari, Javad/N-4394-2017	Mozafari, Javad/0000-0002-8903-7138; bahrami ilkhchi, reza/0000-0003-0736-0853; Hanafi, Mohamad ghasem/0000-0003-1533-5244	Ahvaz Jundishapur University of Medical Sciences, Iran [GP94163]	The study was financially supported by Ahvaz Jundishapur University of Medical Sciences, Iran (Grant. GP94163).	Abrishami A, 2009, CAN J ANAESTH, V56, P202, DOI 10.1007/s12630-008-9038-x; Abul-Azm A, 2006, EUR J ANAESTH, V23, P380, DOI 10.1017/S0265021505001894; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bouget J, 2015, THROMB RES, V136, P1190, DOI 10.1016/j.thromres.2015.10.036; Cap AP, 2011, J TRAUMA, V71, pS9, DOI 10.1097/TA.0b013e31822114af; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fawzy H, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-25; Hanif Mohammed, 2004, Interact Cardiovasc Thorac Surg, V3, P603, DOI 10.1016/j.icvts.2004.07.005; Harvey V, 2014, ANN EMERG MED, V63, P460, DOI 10.1016/j.annemergmed.2013.08.028; Huang YH, 2013, J NEUROTRAUM, V30, P96, DOI 10.1089/neu.2012.2563; Kamhieh Y, 2016, CLIN OTOLARYNGOL, V41, P771, DOI 10.1111/coa.12645; Katz-Leurer M, 2014, BRAIN INJURY, V28, P127, DOI 10.3109/02699052.2013.848381; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim HI, 2014, J KOREAN NEUROSURG S, V56, P166, DOI 10.3340/jkns.2014.56.2.166; Lobato RD, 2005, NEUROCIRUGIA, V16, P217; Majima Nozomi, 2013, Masui, V62, P410; Miller JB, 2014, CLIN NEUROPSYCHOL, V28, P575, DOI 10.1080/13854046.2014.907445; Sarris I, 2007, HAEMOPHILIA, V13, P115, DOI 10.1111/j.1365-2516.2006.01386.x; Tengborn L, 2015, THROMB RES, V135, P231, DOI 10.1016/j.thromres.2014.11.012; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Waly N G, 1995, Egypt Dent J, V41, P961; Yasim Alptekin, 2005, Anadolu Kardiyol Derg, V5, P36; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.02.11; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	27	6	6	1	2	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1574-8871	1876-1038		REV RECENT CLIN TRIA	Rev. Recent Clin. Trials		2019	14	4					286	291		10.2174/1574887114666190620112829			6	Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	JM1ET	WOS:000495966200010	31218964				2022-02-06	
J	Grafton, ST; Ralston, AB; Ralston, JD				Grafton, Scott T.; Ralston, Andreas B.; Ralston, John D.			Monitoring of postural sway with a head-mounted wearable device: effects of gender, participant state, and concussion	MEDICAL DEVICES-EVIDENCE AND RESEARCH			English	Article						wearable sensor; balance impairments; postural sway; concussion	STABILITY; INJURY; BALANCE	Objective: To assess the utility of a head-mounted wearable inertial motion unit (IMU)-based sensor and 3 proposed measures of postural sway to detect outliers in athletic populations at risk of balance impairments. Methods: Descriptive statistics are used to define a normative reference range of postural sway (eyes open and eyes closed) in a cross-sectional sample of 347 college students using a wireless head-mounted IMU-based sensor. Three measures of postural sway were derived: linear sway power, eyes closed vs eyes open sway power ratio (Ec/Eo ratio), and weightbearing asymmetry (L-R ratio), and confidence intervals for these measures were calculated. Questionnaires were used to identify potentially confounding state variables. A prospective study of postural sway changes in 47 professional, college, and high school athletes was then carried out in on-field settings to provide estimates of session-to-session variability and the influence of routine physical activity on sway measures. Finally, pre-post-injury changes in sway are measured for a participant who was diagnosed with a concussion. Results: Despite the heterogenous population and sampling environments, well-defined confidence intervals were established for all 3 sway measures. Men demonstrated significantly greater sway than women. Two state variables significantly increased sway: the use of nicotine and prescription medications. In the athletes, session-to-session variability and changes due to routine physical activity remained well within 95% confidence intervals defined by the cross-sectional sample for all 3 sway measures. The increase in sway power following a diagnosed concussion was more than an order of magnitude greater than the increases due to session-to-session variability, physical activity, or other participant state variables. Conclusion: The proposed postural sway measures and head-mounted wearable sensor demonstrate analytic utility for on-field detection of abnormal sway that could be potentially useful when making remove-from-activity and return-to-activity decisions for athletes at risk of impact-induced balance impairments.	[Grafton, Scott T.] UC Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Ralston, Andreas B.; Ralston, John D.] Protxx Inc, Clin Studies Dept, Menlo Pk, CA 94025 USA		Ralston, JD (corresponding author), Protxx Inc, Menlo Pk, CA 94025 USA.	john.ralston@protxx.com		Ralston, John/0000-0002-8092-9076; Grafton, Scott/0000-0003-4015-3151			Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Beleckas C, 2017, CURR REV MUSCULOSKE, V10, P62, DOI 10.1007/s12178-017-9385-8; Caccese JB, 2018, CLIN J SPORT MED, P1, DOI 10.1097/JSM.0000000000000709; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Craig JJ, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0251-0; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Gago MF, 2014, DEMENT GER COGN D EX, V4, P22, DOI 10.1159/000357472; Grooms DR, 2016, SPORTS HEALTH, V8, P149, DOI 10.1177/1941738115619164; GUPTA A, 1991, BRIT J ANAESTH, V66, P667, DOI 10.1093/bja/66.6.667; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heick JD, 2017, INT J SPORTS PHYS TH, V12, P581; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Kincl Laurel D, 2002, Appl Occup Environ Hyg, V17, P256, DOI 10.1080/10473220252826565; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Knoll RM, 2019, OTOLARYNG HEAD NECK, V160, P122, DOI 10.1177/0194599818795695; Lanska DJ, 2000, NEUROLOGY, V55, P1201, DOI 10.1212/WNL.55.8.1201; Le Flao E, 2018, ISBS PROC ARCH, V36, P257; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Miyashita TL, 2020, SPORT BIOMECH, V19, P180, DOI 10.1080/14763141.2018.1458892; Nashner LM, PROG BRAIN RES, V80, P395; NASHNER LM, 2011, PROG BRAIN RES, V80, P395; Neville C, 2015, MED DEVICES-EVID RES, V8, P447, DOI 10.2147/MDER.S91719; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; Pan T, 2015, GAIT POSTURE, V42, P550, DOI 10.1016/j.gaitpost.2015.08.012; Pereira CB, 2001, NEUROREPORT, V12, P1223, DOI 10.1097/00001756-200105080-00033; Romberg MH, 1853, A MANUAL OF THE NERV; Salisbury JP, 2017, SF, DOI 10.1101/149831; Sankarpandi SK, 2017, BMC EAR NOSE THROAT, V17, DOI 10.1186/s12901-017-0034-z; Seigle B, 2009, GAIT POSTURE, V30, P223, DOI 10.1016/j.gaitpost.2009.05.005; Seimetz Christina, 2012, Biomed Sci Instrum, V48, P386; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Thomas KS, 2014, J NOV PHYSIOTHER, V4, P206; Weiss A., 2014, PLOS ONE, V9, P2014; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430; Yamamoto T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12329; Yates BJ, 1998, OTOLARYNG HEAD NECK, V119, P106, DOI 10.1016/S0194-5998(98)70179-2	42	6	6	1	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1470			MED DEVICES-EVID RES	MED. DEVICES-EVID. RES.		2019	12						151	164		10.2147/MDER.S205357			14	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	HX3YO	WOS:000467331700001	31118838	Green Published, Green Submitted, gold			2022-02-06	
J	Guo, H; Liu, R; Sun, ZS; Liu, B; Xiang, Y; Mao, JH; Li, GJ; Zhang, MZ				Guo, Hong; Liu, Raynald; Sun, Zhaosheng; Liu, Bing; Xiang, Yi; Mao, Jianhui; Li, Guangjie; Zhang, Mingzhe			Evaluation of Prognosis in Patients with Severe Traumatic Brain Injury Using Resting-State Functional Magnetic Resonance Imaging	WORLD NEUROSURGERY			English	Article						Default mode network; Prognosis; Resting-state fMRI; Severe traumatic brain injury	DEFAULT-MODE NETWORK; CONNECTIVITY; MRI	BACKGROUND: We investigate the change of the default mode network (DMN) by using amplitude of low-frequency fluctuation (ALFF) and functional connectivity (FC) methods in acute phase patients after severe traumatic brain injury (sTBI) and correlate these changes with prognosis. METHODS: Twenty-one patients with sTBI were included. Twenty-one healthy sex-, age-, and education-matched control subjects were recruited for the control group. Of the 21 patients with sTBI, 12 patients regained consciousness (Glasgow Outcome Scale [GOS] score > 2) and 9 patients remained unconscious (GOS score < 2). FC and ALFF values were measured in the DMN and compared between the groups. We further assessed and compared the FC and ALFF values in both groups. RESULTS: Patients with sTBI showed significantly decreased FC and ALFF values in the DMN. However, patients with a better prognosis showed a significant increase in FC and ALFF values in the DMN. The conscious subgroup showed significantly enhanced FC in the medial superior frontal gyrus, left temporal gyrus, anterior cingulate gyrus, precuneus, posterior cingulate gyrus, and parietal cortex compared with the coma subgroup. Increased ALFF values in the right frontal gyrus, right temporal gyrus, and right inferior parietal gyrus were significant in the conscious subgroup compared with the coma subgroup. CONCLUSIONS: Increases in FC and ALFF values in the DMN are related to better prognosis in patients with sTBI.	[Guo, Hong; Sun, Zhaosheng; Liu, Bing; Xiang, Yi; Mao, Jianhui; Li, Guangjie; Zhang, Mingzhe] Hebei Med Univ, Harrison Int Peace Hosp, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China; [Liu, Raynald] Capital Med Univ, Beiijing Neurosurg Inst, Beijing, Peoples R China		Zhang, MZ (corresponding author), Hebei Med Univ, Harrison Int Peace Hosp, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China.	66364321@qq.com			Key Science and Technology Research Program of Hebei Provincial Health Department [ZD2014043]	This research was supported by the Key Science and Technology Research Program of Hebei Provincial Health Department (ZD2014043).	Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Faul M, 2010, INJ PREV S1, V16, pA1; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Huang ZR, 2014, HUM BRAIN MAPP, V35, P1997, DOI 10.1002/hbm.22308; Koenig MA, 2014, NEUROCRIT CARE, V20, P348, DOI 10.1007/s12028-014-9953-3; Kondziella D, 2017, NEUROCRIT CARE, V27, P401, DOI 10.1007/s12028-017-0407-6; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	13	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2019	121						E630	E639		10.1016/j.wneu.2018.09.178			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HD9QJ	WOS:000452897000077	30292041				2022-02-06	
J	He, JP; Hao, Y; Shao, JF				He, Jin Peng; Hao, Yun; Shao, Jing Fan			Comparison of treatment methods for pediatric Monteggia fracture Met vs missed radial head dislocation	MEDICINE			English	Article						children; missed dislocation; Monteggia fracture; treatment	OPEN REDUCTION; ANNULAR LIGAMENT; MANAGEMENT; CHILDREN	Various methods are applied in the treatment of fresh and neglected Monteggia fractures. The purpose of this retrospective study was to evaluate the efficacy of various treatment methods, and assess the complexity associated with missed radial head dislocation. All fracture patients were reviewed between Jan 2012 and Dec 2016. A detailed comparison was made of the treatment methods between fresh Monteggia fractures and neglected Monteggia fractures with missed diagnosis of dislocation. A preliminary analysis of clinical information from 1081 patients in our center was investigated, and 42 were included in the final analysis. The fresh group included 25 patients with an average Mayo Elbow Performance Score of 96.3 +/- 2.7 and resulted in the following scores after treatment: 21 excellent, 3 good, and 1 fair. In the fresh group, 76% of patients received closed reduction. Treatment with a cast, elastic stable intramedullary nail, and the Kirschner wire stabilization with tension band wiring make up 80% of the choices for fixation treatment. No patients experienced associated vascular injuries, recurrent dislocation, or elbow dysfunction. The neglected group involved 17 patients with Mayo Elbow Performance Score of 92.1 +/- 9.3 and resulted in the following scores after treatment: 10 excellent, 4 good, and 3 fair. The locking compression plate (LCP) was the most common choice for postoperative immobilization in the neglected group (88.2%). Three patients in the neglected group experienced recurrent dislocation. This retrospective analysis indicates that the treatment of neglected Monteggia fractures is more complex than that of Monteggia fractures, and usually results in a worse recovery rate with a higher rate of recurrent dislocation and elbow dysfunction.	[He, Jin Peng; Shao, Jing Fan] Huazhong Univ Sci & Technol, Dept Pediat Surg, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Hao, Yun] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Radiol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China		Shao, JF (corresponding author), Huazhong Univ Sci & Technol, Dept Pediat Surg, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	shaojf65@126.com		Shao, JingFan/0000-0003-0277-8476			Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Bae, 2016, INSTR COURSE LECT, V65, P399; Di Gennaro Giovanni L, 2015, Musculoskelet Surg, V99 Suppl 1, pS75, DOI 10.1007/s12306-015-0362-3; Eamsobhana P, 2018, BONE JOINT J, V100B, P1117, DOI 10.1302/0301-620X.100B8.BJJ-2017-0866.R3; Foran I, 2017, J PEDIATR ORTHOPED, V37, pE335, DOI 10.1097/BPO.0000000000001001; Goyal T, 2015, J PEDIATR ORTHOP B, V24, P191, DOI 10.1097/BPB.0000000000000147; Hui JHP, 2005, J PEDIATR ORTHOPED, V25, P501, DOI 10.1097/01.bpo.0000158812.37225.b3; Koslowsky TC, 2006, J SHOULDER ELB SURG, V15, P119, DOI 10.1016/j.jse.2004.12.002; Leonidou A, 2012, J PEDIATR ORTHOPED, V32, P352, DOI 10.1097/BPO.0b013e31825611fc; Lu XM, 2017, J PEDIATR ORTHOPED, V37, P20, DOI 10.1097/BPO.0000000000000584; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; Park H, 2017, YONSEI MED J, V58, P829, DOI 10.3349/ymj.2017.58.4.829; Ramski DE, 2015, J PEDIATR ORTHOPED, V35, P115, DOI 10.1097/BPO.0000000000000213; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734, DOI 10.1302/0301-620X.78B5.0780734; STOLL TM, 1992, J BONE JOINT SURG BR, V74, P436, DOI 10.1302/0301-620X.74B3.1587897; TAJIMA T, 1995, J HAND SURG-AM, V20A, pS91, DOI 10.1016/S0363-5023(95)80177-4; Xu ZY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008609	17	6	6	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN	2019	98	2							e13942	10.1097/MD.0000000000013942			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ3CX	WOS:000462286300022	30633171	gold, Green Published			2022-02-06	
J	Knoll, RM; Ishai, R; Trakimas, DR; Chen, JX; Nadol, JB; Rauch, SD; Remenschneider, AK; Jung, DH; Kozin, ED				Knoll, Renata M.; Ishai, Reuven; Trakimas, Danielle R.; Chen, Jenny X.; Nadol, Joseph B., Jr.; Rauch, Steven D.; Remenschneider, Aaron K.; Jung, David H.; Kozin, Elliott D.			Peripheral Vestibular System Histopathologic Changes following Head Injury without Temporal Bone Fracture	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						traumatic brain injury; vestibular dysfunction; Scarpa's ganglion cells; temporal bone; histopathology	TRAUMATIC BRAIN-INJURY; PAROXYSMAL POSITIONAL VERTIGO; LABYRINTHINE CONCUSSION; PSYCHIATRIC-DISORDERS; UNITED-STATES; MILD HEAD; EPIDEMIOLOGY; DIZZINESS; ACTIVATION; LOCOMOTION	Objective Vestibular symptoms such as dizziness and vertigo are common after head injury and may be due to trauma to the peripheral vestibular system. The pathophysiology of peripheral vestibular symptoms following head injury without temporal bone (TB) fracture, however, is not well understood. Herein, we investigate the histopathology of the peripheral vestibular system of patients who sustained head injury without a TB fracture. Study Design Otopathology study. Setting Otopathology laboratory. Subjects and Methods TB of subjects with a history of head injury without TB fractures were included and evaluated by light microscopy. Specimens were assessed for qualitative and quantitative characteristics, such as number of Scarpa's ganglion cells in the superior and inferior vestibular nerves, vestibular hair cell and/or dendrite degeneration in vestibular end organs, presence of vestibular hydrops, and obstruction of the endolymphatic duct. Results Five cases (n = 5 TBs) had evidence of vestibular pathology. There was a decrease of 48.6% (range, 40%-59%) in the mean count of Scarpa's ganglion cells as compared with that of normative historical age-matched controls. Moderate to severe degeneration of the vestibular membranous labyrinth was identified in the posterior, superior, and lateral canals in several cases (50%, n = 4 TBs). The maculae utriculi and sacculi showed mild to severe degeneration in 2 cases. Additional findings include vestibular hydrops (25%, n = 2 TBs) and blockage of the endolymphatic duct (n = 1 TB). Conclusions Otopathologic analysis of patients with a history of head injury without TB fracture demonstrated peripheral vestibular otopathology. Future studies are necessary to determine if otopathology findings are directly attributable to head injury.	[Knoll, Renata M.; Ishai, Reuven; Trakimas, Danielle R.; Chen, Jenny X.; Nadol, Joseph B., Jr.; Rauch, Steven D.; Remenschneider, Aaron K.; Jung, David H.; Kozin, Elliott D.] Massachusetts Eye & Ear, Dept Otolaryngol, Boston, MA USA; [Knoll, Renata M.; Trakimas, Danielle R.; Chen, Jenny X.; Nadol, Joseph B., Jr.; Rauch, Steven D.; Remenschneider, Aaron K.; Jung, David H.; Kozin, Elliott D.] Harvard Med Sch, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA; [Ishai, Reuven; Nadol, Joseph B., Jr.; Rauch, Steven D.; Jung, David H.; Kozin, Elliott D.] Massachusetts Eye & Ear, Dept Otolaryngol, Otopathol Lab, Boston, MA USA; [Trakimas, Danielle R.] Univ Massachusetts, Med Ctr, Dept Otolaryngol, Worcester, MA USA		Jung, DH; Kozin, ED (corresponding author), Harvard Med Sch, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA.	David_jung@meei.harvard.edu; Elliott_kozin@meei.harvard.edu	Chen, Jenny X./AAR-9523-2021	Remenschneider, Aaron/0000-0003-0989-6264	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [L124DC013983]	National Institutes of Health (L124DC013983).	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Aron M, 2015, OTOLARYNG HEAD NECK, V153, P721, DOI 10.1177/0194599815594384; Balatsouras DG, 2017, ANN OTO RHINOL LARYN, V126, P54, DOI 10.1177/0003489416674961; Brodsky JR, 2018, LARYNGOSCOPE, V128, P2219, DOI 10.1002/lary.27119; Brusis T, 2009, LARYNGO RHINO OTOL, V88, P191, DOI 10.1055/s-0029-1192045; Chiaramonte R, 2013, NEURORADIOL J, V26, P52, DOI 10.1177/197140091302600109; COHEN H, 1992, OTOLARYNG HEAD NECK, V107, P638, DOI 10.1177/019459989210700505; Cohen HS, 2004, ORL J OTO-RHINO-LARY, V66, P11, DOI 10.1159/000077227; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Fischer J, 1943, THE INNER EAR; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall KR, 2007, MIL MED, V172, P852, DOI 10.7205/MILMED.172.8.852; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2015, NEUROL CLIN, V33, P661, DOI 10.1016/j.ncl.2015.04.004; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ishai R, 2018, OTOLARYNG HEAD NECK, V159, P526, DOI 10.1177/0194599818769861; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2009, ANN NY ACAD SCI, V1164, P229, DOI 10.1111/j.1749-6632.2009.03770.x; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kleyn A, 1933, PHLUEGER ARCH GES PH, P454; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; LINDSAY JR, 1970, ANN OTO RHINOL LARYN, V79, P699, DOI 10.1177/000348947007900403; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; MAKISHIMA K, 1976, LARYNGOSCOPE, V86, P1303, DOI 10.1288/00005537-197609000-00002; Manasse P, 1924, BEITR Z ANAT PHYSIOL, V21, P230; Mygind S.H., 1919, ACTA OTO-LARYNGOL, V1, P515; NADOL JB, 1975, ANN OTO RHINOL LARYN, V84, P841, DOI 10.1177/000348947508400617; Nager FR, 1907, Z OHRENHEILKD, V101, P217; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; PAPARELLA MM, 1983, LARYNGOSCOPE, V93, P1004; Parker DE, 1968, ACTA OTOLARYNGO S239, P7; Ralli M, 2017, CASE REP OTOLARYNGOL, V2017, DOI 10.1155/2017/6195317; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; RUBIN AM, 1995, AM J OTOL, V16, P216; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SANDO I, 1984, ACTA OTO-LARYNGOL, V97, P558, DOI 10.3109/00016488409132934; Sato G, 2013, ACTA OTO-LARYNGOL, V133, P1124, DOI 10.3109/00016489.2013.817681; SCHUKNECHT H, 1968, ARCH OTOLARYNGOL, V87, P33; SCHUKNECHT HF, 1969, ANN OTO RHINOL LARYN, V78, P253, DOI 10.1177/000348946907800205; SCHUKNECHT HF, 1956, ARCHIV OTOLARYNGOL, V63, P513; SCHUKNECHT HF, 1951, ANN OTO RHINOL LARYN, V60, P273, DOI 10.1177/000348945106000201; SCHUKNECHT HF, 1950, ANN OTO RHINOL LARYN, V59, P331, DOI 10.1177/000348945005900203; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Szczupak M, 2016, HAND CLINIC, V137, P295, DOI 10.1016/B978-0-444-63437-5.00021-2; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; US Department of Health and Human Services, 1998, REH PERS TRAUM BRAIN; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Velazquez-Villasenor L, 2000, ANN OTO RHINOL LARYN, V109, P14, DOI 10.1177/00034894001090S503; Villarreal IM, 2016, CASE REP OTOLARYNGOL, V2016, DOI 10.1155/2016/2123182; Voss O., 1936, SURG SKULL BASE FRAC; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wittmaack K., 1932, ARCH F OHRENH, V131, P59; Wittmaack KH, 1909, VERH DTSCH OTOL GES, V18, P150; YLIKOSKI J, 1982, AM J OTOL, V3, P343; Zalewski CK, 2015, OTOLARYNG HEAD NECK, V153, P257, DOI 10.1177/0194599815585098; Zhou D, 1994, Zhonghua Er Bi Yan Hou Ke Za Zhi, V29, P350; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720; [No title captured]; [No title captured]; [No title captured]; [No title captured]	74	6	6	0	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	JAN	2019	160	1					122	130		10.1177/0194599818795695			9	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	HG3JJ	WOS:000454870600016	30274548				2022-02-06	
J	Kononenko, O; Watanabe, H; Stalhandske, L; Zarelius, A; Clausen, F; Yakovleva, T; Bakalkin, G; Marklund, N				Kononenko, Olga; Watanabe, Hiroyuki; Stalhandske, Lada; Zarelius, Ann; Clausen, Fredrik; Yakovleva, Tatiana; Bakalkin, Georgy; Marklund, Niklas			Focal traumatic brain injury induces neuroplastic molecular responses in lumbar spinal cord	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; Tgfb1; c-Fos; spinal cord; plasticity	CONTROLLED CORTICAL IMPACT; MOTOR CORTEX; C-FOS; STRUCTURAL PLASTICITY; RECOVERY; REORGANIZATION; NEUROTROPHINS; CYTOKINES; NEURONS; SYSTEM	Background/Objectives: Motor impairment induced by traumatic brain injury (TBI) may be mediated through changes in spinal molecular systems regulating neuronal plasticity. We assessed whether a focal controlled cortical impact (CCI) TBI in the rat alters expression of the Tgfb1, c-Fos, Bdnf and Gap43 neuroplasticity genes in lumbar spinal cord. Approach/Methods: Adult male Sprague-Dawley rats (n = 8) were subjected to a right-side CCI over the anterior sensorimotor hindlimb representation area or sham-injury (n=8). Absolute expression levels of Tgfb1, c-Fos, Bdnf, and Gapd43 genes were measured by droplet digital PCR in ipsi- and contralesional, dorsal and ventral quadrants of the L4 and L5 spinal cord. The neuronal activity marker c-Fos was analysed by immunohistochemistry in the dorsal L4 and L5 segments. The contra- vs. ipsilesional expression pattern was examined as the asymmetry index, AI. Results: The Tgfb1 mRNA levels were significantly higher in the CCI vs. sham-injured rats, and in the contra- vs. ipsilesional dorsal domains in the CCI group. The number of c-Fos-positive cells was elevated in the L4 and L5 segments; and on the contralesional compared to the ipsilesional side in the CCI group. The c-Fos AI in the dorsal laminae was significantly increased by CCI. Conclusions: The results support the hypothesis that focal TBI induces plastic alterations in the lumbar spinal cord that may contribute to either motor recovery or maladaptive motor responses.	[Kononenko, Olga; Watanabe, Hiroyuki; Stalhandske, Lada; Zarelius, Ann; Yakovleva, Tatiana; Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Clausen, Fredrik; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Clausen, Fredrik; Marklund, Niklas] Uppsala Univ, Dept Neurosurg, Uppsala, Sweden; [Marklund, Niklas] Lund Univ, Dept Clin Sci Neurosurg, Skane Univ Hosp, EA Blocket,4th Floor,Box 188, S-22100 Lund, Sweden		Marklund, N (corresponding author), Lund Univ, Dept Clin Sci Neurosurg, Skane Univ Hosp, EA Blocket,4th Floor,Box 188, S-22100 Lund, Sweden.	Niklas.marklund@med.lu.se		Clausen, Fredrik/0000-0003-3592-4417; Bakalkin, Georgy/0000-0002-8074-9833	Local ALF funds from Uppsala University hospital; Swedish Science Research Council (VR)Swedish Research Council; Swedish Institute (Visby Program); K. and O.F. Hedstrom foundation; P.O. Zetterling foundation	This work was supported by Local ALF funds from Uppsala University hospital (to NM); research grants from the Swedish Science Research Council (VR; to GB); the Swedish Institute (Visby Program; to OK and GB); P.O. Zetterling and K. and O.F. Hedstrom foundations (to OK).	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Bae James J, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P9; Bose P, 2015, BRAIN NEUROTRAUMA MO; Bose P, 2013, J NEUROTRAUM, V30, P1177, DOI 10.1089/neu.2012.2740; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; BROWN AG, 1982, Q J EXP PHYSIOL CMS, V67, P193; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chio CC, 2016, EUR J CLIN INVEST, V46, P1063, DOI 10.1111/eci.12693; Combs HL, 2016, J NEUROTRAUM, V33, P741, DOI 10.1089/neu.2015.4136; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; DRAISCI G, 1989, MOL BRAIN RES, V6, P31, DOI 10.1016/0169-328X(89)90025-9; Grasselli G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00025; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; KIEFER R, 1995, INT J DEV NEUROSCI, V13, P331; Kim SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07394-3; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Pruitt DT, 2017, J NEUROTRAUM, V34, P2495, DOI 10.1089/neu.2016.4796; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; Sist B, 2014, EXP NEUROL, V252, P47, DOI 10.1016/j.expneurol.2013.11.019; Tennant KA, 2014, EXP NEUROL, V254, P195, DOI 10.1016/j.expneurol.2014.02.003; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Wang XY, 2015, NEUROCHEM RES, V40, P1671, DOI 10.1007/s11064-015-1634-x; Watanabe H, 2015, CEREB CORTEX, V25, P97, DOI 10.1093/cercor/bht204; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wolpaw JR, 2007, ACTA PHYSIOL, V189, P155, DOI 10.1111/j.1748-1716.2006.01656.x; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Ying Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052998	41	6	6	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2019	37	2					87	96		10.3233/RNN-180882			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU0EK	WOS:000464944000001	30856132	Green Published, hybrid			2022-02-06	
J	Krause, DA; Hansen, KA; Hastreiter, MJ; Kuhn, TN; Peichel, ML; Hollman, JH				Krause, David A.; Hansen, Kelsey A.; Hastreiter, Matthew J.; Kuhn, Taylor N.; Peichel, Molly L.; Hollman, John H.			A Comparison of Various Cervical Muscle Strength Testing Methods Using a Handheld Dynamometer	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						muscle strength dynamometer; neck muscles; reproducibility of results	SEGMENT DYNAMIC STABILIZATION; CHRONIC NECK PAIN; ISOMETRIC STRENGTH; HEAD; RELIABILITY; WOMEN	Background: Cervical muscle strength, proposed as a modifiable risk factor in concussions, can be assessed using various methods. The purpose of this study was to compare the reliability and force outputs of 3 methods that use handheld dynamometry (HHD) for assessing cervical muscle strength. Hypothesis: All 3 testing methods are reliable, and force outputs are significantly different between methods. Study Design: Repeated-measures reliability. Level of Evidence: Level 5. Methods: The study used a convenience sample of 30 participants. HHD "make tests" for cervical extension, flexion, and right and left side bending were performed using lying push tests, sitting push tests, and sitting pull tests. A sole examiner performed all tests. Two testing sessions were conducted 1 week apart. Analysis included intraclass correlation coefficients (ICCs), repeated-measures analyses of variance (alpha = 0.05) with post hoc Bonferroni tests, and minimal detectable change (MDC) calculations. Results: All testing methods were reliable; the lying push test had the greatest point estimate values (ICC, 0.89-0.95). Significant differences in force were found between the 3 testing methods. The MDC was most sensitive for the lying push method. Conclusion: Of the 3 cervical muscle testing methods investigated, the lying position with a push test had the largest ICC according to the point estimate and the most sensitive MDC. Force values between the 3 methods were significantly different, which suggests that consistent testing methods should be used. Clinical Relevance: Results from this study support the clinical use of an HHD "make test" in a lying position for assessing cervical muscle strength. The test is reliable and more sensitive to change compared with tests in a seated position.	[Krause, David A.; Hollman, John H.] Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA; [Hansen, Kelsey A.; Hastreiter, Matthew J.; Kuhn, Taylor N.; Peichel, Molly L.] Mayo Clin, Coll Med & Sci, Sch Hlth Sci, Rochester, MN 55905 USA		Krause, DA (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 First St SW, Rochester, MN 55905 USA.	krause.david@mayo.edu	Hollman, John H./AAG-9301-2019	Hollman, John/0000-0003-4690-223X			Almosnino S, 2010, J ATHL TRAINING, V45, P453, DOI 10.4085/1062-6050-45.5.453; Cagnie B, 2007, ARCH PHYS MED REHAB, V88, P1441, DOI 10.1016/j.apmr.2007.06.776; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Geary K, 2013, J MANIP PHYSIOL THER, V36, P444, DOI 10.1016/j.jmpt.2013.05.026; Jordan A, 1999, SPINE, V24, P1343, DOI 10.1097/00007632-199907010-00012; Mansell J, 2005, J ATHL TRAINING, V40, P310; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Nagai T, 2014, AVIAT SPACE ENVIR MD, V85, P529, DOI 10.3357/ASEM.3874.2014; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schmitt JS, 2004, J CLIN EPIDEMIOL, V57, P1008, DOI 10.1016/j.jclinepi.2004.02.007; STRATFORD PW, 1994, J ORTHOP SPORT PHYS, V19, P28, DOI 10.2519/jospt.1994.19.1.28; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Ylinen J, 2004, ARCH PHYS MED REHAB, V85, P1303, DOI 10.1016/j.apmr.2003.09.018; Ylinen JJ, 1999, CLIN BIOMECH, V14, P217, DOI 10.1016/S0268-0033(98)00063-1	16	6	6	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2019	11	1					59	63		10.1177/1941738118812767			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HF3KQ	WOS:000454134300007	30457924	Green Published, Bronze			2022-02-06	
J	Kumar, RG; Breslin, KB; Ritter, AC; Conley, YP; Wagner, AK				Kumar, Raj G.; Breslin, Kristen B.; Ritter, Anne C.; Conley, Yvette P.; Wagner, Amy K.			Variability with Astroglial Glutamate Transport Genetics Is Associated with Increased Risk for Post-Traumatic Seizures	JOURNAL OF NEUROTRAUMA			English	Article						astrocytes; excitotoxicity; post-traumatic epilepsy; SLC1A3; SLC1A; traumatic brain injury	TRAUMATIC BRAIN-INJURY; LEVETIRACETAM TREATMENT; SEVERE TBI; EXPRESSION; EPILEPSY; EAAT1; MODEL; TOLERABILITY; CHILDREN; SAFETY	Excitotoxicity contributes to epileptogenesis after severe traumatic brain injury (sTBI). Demographic and clinical risk factors for post-traumatic seizures (PTS) have been identified, but genetic risk remains largely unknown. Thus, we investigated whether genetic variation in astroglial glutamate transporter genes is associated with accelerated epileptogenesis and PTS risk after sTBI. Adults (n=267) 18-75 years old were assessed over a three-year period post-TBI. Single nucleotide polymorphisms (SNPs) throughout the SLC1A2 and SLC1A3 genes were assayed. Kaplan-Meier estimates and log-rank statistics were used to compare seizure frequencies by genotype. Multivariate Cox proportional hazards regression was used to estimate hazard ratios (HRs) for genotypes significant in Kaplan-Meier analyses. Thirty-nine tagging SNPs were examined (SLC1A2: n=21, SLC1A3: n=18). PTS developed in 57 (21.4%) individuals. Of those with PTS, n=20 (35.7%) had an immediate/early seizure within the first seven days, and n=36 (64.3%) had a late seizure occurring between eight days and three years post-TBI. When adjusting for multiple comparisons, rs4869682 genotypes (SLC1A3, GG vs. T-carriers) were associated with time to first seizure (p=0.003). Median time until first seizure was 20.4 days for individuals with a GG genotype and 44.8 days for T-carriers. After adjusting for covariates, rs4869682 GG-homozygotes had a 2.05 times increased PTS risk versus T-carriers (aHR=2.08, 95% confidence interval: 1.20, 3.62, p=0.009). Variation within SLC1A3 is associated with accelerated epileptogenesis and clinical PTS development after sTBI. Future studies should validate these findings and examine how genetic variation at rs4869682 may be a target for PTS prevention and treatment.	[Kumar, Raj G.; Breslin, Kristen B.; Ritter, Anne C.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Conley, Yvette/0000-0002-1784-6067	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NR013342]; DODUnited States Department of Defense [W81XWH-071-0701]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD048162]; NIDILRRUnited States Department of Health & Human Services [90DP0041]; CURE Foundation	This work was supported by National Institutes of Health (NIH) R01 NR013342, DOD W81XWH-071-0701, NIH R01 HD048162, NIDILRR 90DP0041, and the CURE Foundation. Thanks to the subjects and their families for their generous participation. Thanks to the UPMC Trauma Registry for assisting with some elements of data collection.	Adamczyk A, 2011, PSYCHIAT GENET, V21, P90, DOI 10.1097/YPG.0b013e328341a307; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beschorner R, 2007, HISTOL HISTOPATHOL, V22, P515, DOI 10.14670/HH-22.515; Bianchi MG, 2014, CELL MOL LIFE SCI, V71, P2001, DOI 10.1007/s00018-013-1484-0; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Caudle KL, 2016, RESTOR NEUROL NEUROS, V34, P257, DOI 10.3233/RNN-150580; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Ding K., 2016, TRANSLATIONAL RES TR; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Fuller KL, 2013, EPILEPSIA, V54, P45, DOI 10.1111/j.1528-1167.2012.03563.x; Goldberg-Stern H, 2013, EUR J PAEDIATR NEURO, V17, P248, DOI 10.1016/j.ejpn.2012.10.008; Halma E, 2014, SEIZURE-EUR J EPILEP, V23, P685, DOI 10.1016/j.seizure.2014.06.004; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Juengst SB, 2017, EPILEPSY BEHAV, V73, P240, DOI 10.1016/j.yebeh.2017.06.001; KIRSCHNER MA, 1994, GENOMICS, V22, P631, DOI 10.1006/geno.1994.1437; Klein P, 2012, ARCH NEUROL-CHICAGO, V69, P1290, DOI 10.1001/archneurol.2012.445; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lukyanetz EA, 2002, EPILEPSIA, V43, P9, DOI 10.1046/j.1528-1157.2002.24501.x; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Martindale JL, 2011, EMERG MED CLIN N AM, V29, P15, DOI 10.1016/j.emc.2010.08.002; Mbizvo GK, 2014, INT J NEUROSCI, V124, P627, DOI 10.3109/00207454.2013.866951; Medina A, 2013, J PSYCHIATR RES, V47, P1150, DOI 10.1016/j.jpsychires.2013.04.007; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Noble AJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009040; Petr GT, 2015, J NEUROSCI, V35, P5187, DOI 10.1523/JNEUROSCI.4255-14.2015; Petrovski S, 2009, PHARMACOGENET GENOM, V19, P147, DOI 10.1097/FPC.0b013e32831d1dfa; Rimaniol AC, 2000, J IMMUNOL, V164, P5430, DOI 10.4049/jimmunol.164.10.5430; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; Roberts RC, 2014, NEUROSCIENCE, V277, P522, DOI 10.1016/j.neuroscience.2014.07.019; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Scott HL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0004.2002; Shazadi K, 2014, EPILEPSY RES, V108, P1797, DOI 10.1016/j.eplepsyres.2014.08.022; Smith RE, 2001, AM J PSYCHIAT, V158, P1393, DOI 10.1176/appi.ajp.158.9.1393; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tekgul H, 2016, SEIZURE-EUR J EPILEP, V36, P16, DOI 10.1016/j.seizure.2016.01.017; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Verrotti A, 2015, SEIZURE-EUR J EPILEP, V31, P49, DOI 10.1016/j.seizure.2015.07.004; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Williams SM, 2005, GLIA, V49, P520, DOI 10.1002/glia.20139; Yamamoto T, 1999, ACT NEUR S, V75, P17; Zou HC, 2015, BRAIN INJURY, V29, P78, DOI 10.3109/02699052.2014.955528; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	55	6	6	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					230	238		10.1089/neu.2018.5632			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800006	29999457	Green Published			2022-02-06	
J	Li, G; Chen, JB; Gu, SS; Yang, J; Chen, YJ; Zhao, SL; Xu, J; Bai, ZL; Ren, J; Xu, L; Chen, MS; Qin, MX; Leung, KW; Sun, J				Li, Gen; Chen, Jingbo; Gu, Shanshan; Yang, Jun; Chen, Yujie; Zhao, Shuanglin; Xu, Jia; Bai, Zeling; Ren, Jian; Xu, Lin; Chen, Mingsheng; Qin, Mingxin; Leung, Kwok Wa; Sun, Jian			A Dual Parameter Synchronous Monitoring System of Brain Edema Based on the Reflection and Transmission Characteristics of Two-Port Test Network	IEEE ACCESS			English	Article						Brain edema; two-port test network; synchronous monitoring; classification	CEREBRAL-HEMORRHAGE; TISSUE CHARACTERIZATION; PHASE-SHIFT; INJURY; ISCHEMIA; RABBITS; RATS	As a common secondary disease, edema after traumatic brain injury (TBI) can increase brain volume, resulting in elevated intracranial pressure (ICP), brain shift, and cerebral hernia, and can eventually lead to death. The real-time continuous monitoring of edema may significantly reduce mortality and disability. In this paper, a dual-parameter synchronous monitoring system of edema based on the reflection and transmission characteristics of the two-port test network was established; 15 rabbits were chosen to perform 24-h reflection phase shift (RPS) and transmission phase shift (TPS) simultaneously monitoring the experiments of brain edema. With the development of brain edema, the variation law of the RPS and TPS was investigated. Combined with the power amplitude spectrum and the principle of the two-port test network, the influence of frequency on the detection sensitivity of RPS and TPS was analyzed in detail, and the optimal detection frequency point was found. After that, the classification of three different degrees of edema is performed by the BP algorithm. In the animal experiment, the RPS showed a continuous increasing trend within time, and it presented the variation of (9.35910 degrees +/- 1.65702 degrees), (12.60117 degrees +/- 2.30218 degrees), and (16.33423 degrees +/- 2.11118 degrees) after 6, 12, and 24 h, respectively. Meanwhile, the TPS showed a continuous downward trend with the variation of (-12.62555 degrees +/- 0.99441 degrees), (-19.23976 degrees +/- 1.27488 degrees), and (-27.26285 degrees +/- 2.62291 degrees) after 6, 12, and 24 h, respectively. The RPS was negatively correlated with the TPS. The RPS and the TPS together as a recognition feature can achieve 100% accurate classification of three different brain edema severities. Based on these results, it can be concluded that the system established in this paper can monitor gradual increases in brain edema severity. Furthermore, neither the RPS nor the TPS can be set as the recognition feature alone to achieve the completely accurate classification, which shows the necessity of presenting two parameters in the monitoring process.	[Li, Gen; Chen, Jingbo; Yang, Jun; Zhao, Shuanglin; Xu, Jia; Bai, Zeling; Xu, Lin; Chen, Mingsheng; Qin, Mingxin] Army Med Univ, Coll Biomed Engn, Chongqing 400030, Peoples R China; [Li, Gen] Chongqing Univ Technol, Sch Pharm & Bioengn, Chongqing 400020, Peoples R China; [Gu, Shanshan] Southwest Hosp, Dept Clin Psychol, Chongqing 400028, Peoples R China; [Chen, Yujie; Sun, Jian] Southwest Hosp, Dept Neurosurg, Chongqing 400028, Peoples R China; [Ren, Jian; Leung, Kwok Wa; Sun, Jian] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China		Qin, MX (corresponding author), Army Med Univ, Coll Biomed Engn, Chongqing 400030, Peoples R China.; Sun, J (corresponding author), Southwest Hosp, Dept Neurosurg, Chongqing 400028, Peoples R China.; Leung, KW; Sun, J (corresponding author), City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China.	173117502@qq.com; eekleung@cityu.edu.hk; 30067982@qq.com	Chen, Yujie/AAS-6995-2021; Ren, Jian/AAY-2409-2020	Chen, Yujie/0000-0002-9905-9138; Ren, Jian/0000-0001-9899-5963; Gen, Li/0000-0002-4183-4242	Brain Science Collaborative Innovation Center of Army Medical University; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51607181]; Hong Kong Scholars Program [XJ2017026]	This work was supported in part by the Brain Science Collaborative Innovation Center of Army Medical University, in part by the National Natural Science Foundation of China under Grant 51607181, and in part by the Hong Kong Scholars Program under Grant XJ2017026.	Barai A, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/8/085501; Chapple LAS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1177-1; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; Corrigan F, 2017, J NEUROTRAUM, V34, P971, DOI 10.1089/neu.2016.4589; Dai XP, 2016, CRIT CARE MED, V44, pE633, DOI 10.1097/CCM.0000000000001625; Enciso-Rodriguez FE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068500; Gonzalez CA, 2009, PHYSIOL MEAS, V30, P809, DOI 10.1088/0967-3334/30/8/006; Griffiths H, 2001, MEAS SCI TECHNOL, V12, P1126, DOI 10.1088/0957-0233/12/8/319; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Jin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097179; Jin G, 2014, BIOSENS BIOELECTRON, V52, P374, DOI 10.1016/j.bios.2013.09.019; Kawai N, 2003, J NEUROTRAUM, V20, P649, DOI 10.1089/089771503322144563; Laufer S, 2012, PHYSIOL MEAS, V33, P997, DOI 10.1088/0967-3334/33/6/997; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; LI G, 2017, SENSORS, V17; Li G, 2017, NANOSCI NANOTECH LET, V9, P1470, DOI 10.1166/nnl.2017.2493; Li G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42842; Li LY, 2015, REMOTE SENS ENVIRON, V164, P142, DOI 10.1016/j.rse.2015.04.009; Li SZ, 2014, IEEE T PLASMA SCI, V42, P1654, DOI 10.1109/TPS.2014.2320259; Lillicrap TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13276; Ljungqvist J, 2017, J NEUROTRAUM, V34, P2176, DOI 10.1089/neu.2016.4869; McBride DW, 2014, J NEUROTRAUM, V31, P1948, DOI 10.1089/neu.2014.3439; Meng XF, 2016, J NEUROSURG ANESTH, V28, P21, DOI 10.1097/ANA.0000000000000192; Nassehi D, 2011, APMIS, V119, P831, DOI 10.1111/j.1600-0463.2011.02764.x; Niknejad A., 2007, ELECTRON LETT, V43, P47; Nitsch JB, 2015, IEEE T ELECTROMAGN C, V57, P1705, DOI 10.1109/TEMC.2015.2456098; O'Toole MD, 2015, MEAS SCI TECHNOL, V26, DOI 10.1088/0957-0233/26/3/035102; Pan WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128127; Rajajee V, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1762-6; Scharfetter H, 2003, IEEE T BIO-MED ENG, V50, P870, DOI 10.1109/TBME.2003.813533; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sun J, 2014, BRAZ J MED BIOL RES, V47, P144, DOI 10.1590/1414-431X20132978; Trepte CJC, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1173-5; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Xing YQ, 2009, BRAIN RES, V1291, P113, DOI 10.1016/j.brainres.2009.07.032; Yan Q., 2016, BIOMED ENG, V62, P23, DOI [10.1515/bmt-2015-012926982603, DOI 10.1515/BMT-2015-012926982603]; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zolgharni M, 2009, PHYSIOL MEAS, V30, pS187, DOI 10.1088/0967-3334/30/6/S13; 2014, NEUROCHEM INT, V76, P23; 2016, J NEUROTRAUMA, V33, P1171; 2009, J MAGN RESON, V199, P104; 2017, J EMERGENCY MED, V53, P18; 2008, NEUROCOMPUTING, V71, P2046; 2007, AEU INT J ELECT COMM, V61, P459	45	6	6	2	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2019	7						50839	50848		10.1109/ACCESS.2019.2911178			10	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	HW5ZT	WOS:000466768600001		gold			2022-02-06	
J	Lifshitz, J; Crabtree-Nelson, S; Kozlowski, DA				Lifshitz, Jonathan; Crabtree-Nelson, Sonya; Kozlowski, Dorothy A.			Traumatic Brain Injury in Victims of Domestic Violence	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Concussion; traumatic brain injury; domestic violence; neurological symptoms; intimate partner violence; interpersonal violence; brain impairment		The article serves as the introduction to a special issue of the journal focused on traumatic brain injury in the context of domestic and intimate partner violence. The scope of the problem is enormous, where upwards of 90% of all individuals with a history of interpersonal violence have concomitant signs and symptoms of traumatic brain injury. To date, no specific assessment tools or intervention plans exist for this specific population, but draw from existing practices for athletes, soldiers, veterans, and civilians. The public health need for further investigation and collaboration drive the proposals and suggestions for best practices in specific and community-wide settings. Through awareness and education, the challenge of traumatic brain injury in domestic violence can begin to be addressed.	[Lifshitz, Jonathan] Univ Arizona, Coll Med, Phoenix, AZ USA; [Lifshitz, Jonathan] CACTIS Fdn, Scottsdale, AZ USA; [Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix VA Healthcare Syst, Phoenix, AZ USA; [Crabtree-Nelson, Sonya] Depaul Univ, Dept Social Work, 14 E Jackson Blvd,16th Floor,Off 1618, Phoenix, AZ 60604 USA; [Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Phoenix, AZ 60604 USA		Crabtree-Nelson, S (corresponding author), Depaul Univ, Dept Social Work, 14 E Jackson Blvd,16th Floor,Off 1618, Phoenix, AZ 60604 USA.	scrabtr3@depaul.edu					Baxter K., 2019, J ABUSE MALTREATMENT, V28; Cimino A. N., 2019, J ABUSE MALTREATMENT, V28; Ellis T. W., 2019, J ABUSE MALTREATMENT, V28; Higbee M., 2019, J ABUSE MALTREATMENT, V28; Hunnicutt G., 2019, J ABUSE MALTREATMENT, V28; Monahan K., 2019, J ABUSE MALTREATMENT, V28; Nemeth J. M., 2019, J ABUSE MALTREATMENT, V28; Ralston B., 2019, J ABUSE MALTREATMENT, V28; Schminkey D., 2019, J ABUSE MALTREATMENT, V28; Valera E. M., 2019, J ABUSE MALTREATMENT, V28; Wong CX, 2019, HEART LUNG CIRC, V28, P6, DOI 10.1016/j.hlc.2018.08.026	11	6	6	2	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	6			SI		655	659		10.1080/10926771.2019.1644693			5	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IM2YW	WOS:000477859700001					2022-02-06	
J	Lundine, JP; Utz, M; Jacob, V; Ciccia, AH				Lundine, Jennifer P.; Utz, Mackenzie; Jacob, Vanessa; Ciccia, Angela Hein			Putting the person in person-centered care: Stakeholder experiences in pediatric traumatic brain injury	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Children; adolescents; healthcare; rehabilitation; traumatic brain injury	HEALTH-CARE; MEDICAL HOME; CHILDREN; FAMILY; STUDENTS; PARENTS; REHABILITATION; DISABILITY; SERVICES; OUTCOMES	PURPOSE: This pilot study sought to describe the perspectives and experiences of survivors of pediatric traumatic brain injury (pTBI), their caregivers, and the medical professionals who serve them. METHODS: Thirteen people participated in semi-structured interviews: five survivors of pTBI, their primary caregivers, and three medical professionals who work with persons who have sustained pTBI. The study involved a prospective, qualitative, participatory action research model with convenience sampling. All interviews were transcribed and thematic analysis identified central concepts within and between groups. Additionally, the Consolidated Criteria for Reporting Qualitative Research (COREG) were applied. RESULTS: This study found that survivors of pTBI and their caregivers commonly noted later developing issues, social challenges, and difficulty in post-rehabilitation transitions. In addition, both caregivers and medical professionals reported the need for improved follow-up with survivors, evidence-based research, and medical and therapy providers with specific training on pTBI. CONCLUSIONS: The perspectives provided by key stakeholders in this pilot study identify common themes that should be central to driving innovation in rehabilitation research and clinical care.	[Lundine, Jennifer P.; Utz, Mackenzie] Ohio State Univ, Dept Speech & Hearing Sci, 110 Pressey Hall,1070 Carmack Rd, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH USA; [Jacob, Vanessa; Ciccia, Angela Hein] Case Western Reserve Univ, Program Commun Disorders, Dept Psychol Sci, Cleveland, OH 44106 USA		Lundine, JP (corresponding author), Ohio State Univ, Dept Speech & Hearing Sci, 110 Pressey Hall,1070 Carmack Rd, Columbus, OH 43210 USA.	Lundine.4@osu.edu	Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bedell GM, 2017, DEV NEUROREHABIL, V20, P408, DOI 10.1080/17518423.2016.1237584; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Bourgeault I., 2013, SAGE HDB QUALITATIVE; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Ciccia AH, 2016, AM J SPEECH-LANG PAT, V25, P508, DOI 10.1044/2016_AJSLP-15-0087; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; de Kloet AJ, 2015, J DEV BEHAV PEDIATR, V36, P342, DOI 10.1097/DBP.0000000000000169; Dearnley Christine, 2005, Nurse Res, V13, P19; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Di Battista A, 2014, J REHABIL MED, V46, P975, DOI 10.2340/16501977-1883; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Ewing-Cobbs L, 2013, J INT NEUROPSYCH SOC, V19, P497, DOI 10.1017/S1355617713000210; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Glang A, 2018, BRAIN INJURY, V32, P608, DOI 10.1080/02699052.2018.1433329; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Guest G., 2012, APPL THEMATIC ANAL; Haarbauer-Krupa J, 2018, NEUROREHABILITATION, V42, P259, DOI 10.3233/NRE-172410; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kelly AM, 2002, PEDIATRICS, V110, P1322; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Lantagne A, 2018, J PEDIATR PSYCHOL, DOI [10.1093/JPEPSY/JSY020/495, DOI 10.1093/JPEPSY/JSY020/495]; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Lindsay S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124679; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rashid M, 2014, J PEDIATR REHAB MED, V7, P241, DOI 10.3233/PRM-140293; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Roscigno CI, 2016, J NEUROSCI NURS, V48, pE2, DOI 10.1097/JNN.0000000000000192; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Roscigno CI, 2013, SOC SCI MED, V90, P32, DOI 10.1016/j.socscimed.2013.04.017; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Roscigno CI, 2011, BRAIN INJURY, V25, P882, DOI 10.3109/02699052.2011.581638; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Spaw AJ, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000314; Strickland B, 2004, PEDIATRICS, V113, P1485; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tyerman E, 2017, BRAIN INJURY, V31, P1553, DOI 10.1080/02699052.2017.1341999; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Walz NC, 2012, J NEUROPSYCHOL, V6, P143, DOI 10.1111/j.1748-6653.2011.02020.x; World Health Organization, 2007, INT CLASS FUNCT DIS	60	6	6	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2019	12	1					21	35		10.3233/PRM-180568			15	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	HU0FJ	WOS:000464946500004	30883376				2022-02-06	
J	Luo, LF; Weng, JF; Cen, M; Dong, XQ; Yu, WH; Du, Q; Yang, DB; Zheng, YK; Hu, W; Yu, L; Luo, SD				Luo, Li-Feng; Weng, Jian-Feng; Cen, Meng; Dong, Xiao-Qiao; Yu, Wen-Hua; Du, Quan; Yang, Ding-Bo; Zheng, Yong-Ke; Hu, Wei; Yu, Liang; Luo, Shi-Da			Prognostic significance of serum translocator protein in patients with traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Translocator protein; Prognosis; Severity; Inflammation	POSTTRAUMATIC CEREBRAL INFARCTION; ACUTE LUNG INJURY; 18 KDA; COAGULOPATHY; MODEL; PROGRESSION; HEMORRHAGE; OUTCOMES; CT	Background: Translocator protein (TP) is related to inflammation and is involved in brain injury. The objective of this study was to ascertain whether serum TP concentrations are associated with the severity and prognosis of traumatic brain injury (TBI). Methods: We quantified the serum concentrations of TP in 106 healthy controls and 106 patients with severe TBI. Recorded prognostic variables included acute lung injury, acute traumatic coagulopathy, progressive hemorrhagic injury, posttraumatic cerebral infarction, 6-month mortality and 6-month poor outcome (Glasgow Outcome Scale score of 1-3). Trauma severity was assessed by Glasgow coma scale (GCS) score. Extent of inflammatory response was indicated by serum interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a) and C-reactive protein (CRP) concentrations. Results: Patients had significantly higher serum TP concentrations than controls. Among patients, serum TP concentrations strongly and independently correlated with GCS score and serum IL-6, TNF-a and CRP concentrations. Serum TP was identified as an independent predictor for the preceding prognostic variables, its prognostic predictive ability was similar to that of GCS score and it also significantly improved prognostic predictive ability of GCS score. Conclusion: Serum TP may be intimately linked with in inflammation, disease progression and poor prognosis in TBI patients.	[Luo, Li-Feng; Weng, Jian-Feng; Cen, Meng; Yu, Liang; Luo, Shi-Da] CHC Int Hosp, Dept Neurosurg, 599 Shiji Ave, Cixi 315315, Peoples R China; [Dong, Xiao-Qiao; Yu, Wen-Hua; Du, Quan; Yang, Ding-Bo] Zhejiang Univ, Sch Med, Affiliated Hangzhou First Peoples Hosp, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China; [Zheng, Yong-Ke; Hu, Wei] Zhejiang Univ, Sch Med, Affiliated Hangzhou First Peoples Hosp, Dept Intens Care Unit, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China		Weng, JF (corresponding author), CHC Int Hosp, Dept Neurosurg, 599 Shiji Ave, Cixi 315315, Peoples R China.	cieycjwjf@163.com			Zhejiang Province Medical and Health Fund Project [2014KYA177, 2016RCB016]; Hangzhou Medical Research Fund Project [2014Z06, 2016Z10]; Ningbo Medical Research Fund Project [2016Al2]; Hangzhou science and technology Fund project [20180533B43]	The authors thank all staffs in Department of Neurosurgery, The CHC International Hospital (Cixi, China) for their technical support. This study was supported financially by the Zhejiang Province Medical and Health Fund Project (No. 2014KYA177, 2016RCB016), Hangzhou Medical Research Fund Project (No. 2014Z06, 2016Z10), Ningbo Medical Research Fund Project (No. 2016Al2) and Hangzhou science and technology Fund project (No. 20180533B43).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Belatar B, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.36.10945; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; Chen WH, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/9831079; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donat CK, 2016, NEUROMOL MED, V18, P158, DOI 10.1007/s12017-016-8385-y; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Fremont RD, 2010, J TRAUMA, V68, P1121, DOI 10.1097/TA.0b013e3181c40728; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harris T, 2012, POSTGRAD MED J, V88, P595, DOI 10.1136/postgradmedj-2011-130285; Hemmila MR, 2017, CRIT CARE CLIN, V33, P193, DOI 10.1016/j.ccc.2016.08.010; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Latronico N, 2009, J TRAUMA, V66, P1745, DOI 10.1097/TA.0b013e3181a56c8b; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Scarf AM, 2011, J NUCL MED, V52, P667, DOI 10.2967/jnumed.110.086629; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5	35	6	8	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JAN	2019	488						25	30		10.1016/j.cca.2018.10.035			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	HI9EK	WOS:000456757900005	30385279				2022-02-06	
J	Ma, HP; Chen, PS; Wong, CS; Chang, CF; Ou, JC; Tsai, YR; Chiu, WT; Tsai, SH; Liao, KH; Chiang, YH; Wang, JY; Chen, KY; Wu, JCC				Ma, Hon-Ping; Chen, Po-Shen; Wong, Chung-Shun; Chang, Cheng-Fu; Ou, Ju-Chi; Tsai, Yan-Rou; Chiu, Wen-Ta; Tsai, Shin-Han; Liao, Kuo-Hsing; Chiang, Yung-Hsiao; Wang, Jia-Yi; Chen, Kai-Yun; Wu, John Chung-Che			Psychometric Evaluation of Anxiety, Depression, and Sleep Quality after a Mild Traumatic Brain Injury: A Longitudinal Study	BEHAVIOURAL NEUROLOGY			English	Article								Introduction. Over 1 million mild traumatic brain injury (mTBI) cases are reported annually worldwide and may result in cognitive, physical, and emotional deterioration; depression; anxiety; and sleep problems. However, studies on long-term mTBI effects are limited. This study included 440 patients, and regular follow-ups of psychological assessments were performed for 2 years. Four questionnaires, including the Pittsburgh sleep quality index (PSQI), Epworth sleepiness scale (ESS), Beck's anxiety inventory (BAI), and Beck's depression inventory (BDI), were used to evaluate sleep problems, daytime sleepiness, anxiety, and depression, respectively. Results show that BAI and BDI scores considerably improved at the 6th-week, 1st-year, and 2nd-year follow-ups compared to baseline, yet these remained significantly different. In addition, anxiety and depression were prominent symptoms in a select subgroup of patients with poor initial evaluations, which improved over the 2 years. However, the ESS and PSQI scores fluctuated only mildly over the same time span. In conclusion, the mTBI patients showed a gradual improvement of anxiety and depression over the 2 years following injury. While anxiety and depression levels for mTBI patients in general did not return to premorbid status, improvements were observed. Sleep disorders persisted and were consistent with initial levels of distress.	[Ma, Hon-Ping; Chen, Po-Shen; Wong, Chung-Shun; Ou, Ju-Chi; Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei, Taiwan; [Ma, Hon-Ping; Wong, Chung-Shun] Taipei Med Univ, Sch Med, Dept Emergency Med, Taipei, Taiwan; [Ma, Hon-Ping] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chang, Cheng-Fu] Taipei City Hosp, Zhongxiao Branch, Dept Neurosurg, Taipei, Taiwan; [Chang, Cheng-Fu; Chiang, Yung-Hsiao; Wu, John Chung-Che] Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan; [Tsai, Yan-Rou; Chiang, Yung-Hsiao; Chen, Kai-Yun] Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, Taipei, Taiwan; [Tsai, Yan-Rou; Chiu, Wen-Ta; Tsai, Shin-Han; Liao, Kuo-Hsing; Chiang, Yung-Hsiao; Chen, Kai-Yun; Wu, John Chung-Che] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Chiu, Wen-Ta; Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, Taipei, Taiwan; [Liao, Kuo-Hsing] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, Yung-Hsiao; Wu, John Chung-Che] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan		Wu, JCC (corresponding author), Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan.; Chen, KY (corresponding author), Coll Med Sci & Technol, Grad Inst Neural Regenerat Med, Taipei, Taiwan.; Chen, KY; Wu, JCC (corresponding author), Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan.; Wu, JCC (corresponding author), Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan.	kychen08@tmu.edu.tw; dr.jcwu@gmail.com		Wong, Chung-Shun/0000-0003-3347-3843; Ou, Ju-Chi/0000-0003-3549-7283	Ministry of Science and Technology (MOST), TaiwanMinistry of Science and Technology, Taiwan [104-2314-B-038-031, DP2-107-21121-01-N-05]; Taipei Medical University [TMU102-AE1-B27, TMU104AE1-B03, TMU105-AE1-B03]; Taipei Medical University-Shuang Ho Hospital [103 TMU-SHH-24]	We acknowledge Taipei Medical University Hospital, Wan Fang Hospital, and Shuang Ho Hospital for their help in patient recruitment. We also acknowledge all the recruited patients for their participation. This study was supported by grants from the Ministry of Science and Technology (MOST), Taiwan (104-2314-B-038-031 and DP2-107-21121-01-N-05), Taipei Medical University (TMU102-AE1-B27, TMU104AE1-B03, and TMU105-AE1-B03), and Taipei Medical University-Shuang Ho Hospital (103 TMU-SHH-24).	Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Buysse D J, 1989, Psychiatry Res, V28, P193; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chu SF, 2016, ASIA-PAC J PUBLIC HE, V28, P519, DOI 10.1177/1010539516662956; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Huang T., 2015, HINDAWI PUBL CORP BE, V2015, P7; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joo JH, 2002, J CLIN PSYCHIAT, V63, P936, DOI 10.4088/JCP.v63n1012; Kerse N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002423; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; LANGLOIS J, 2002, THE JOURNAL OF HEAD, V21, P375, DOI DOI 10.1097/00001199-200609000-00001; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; LOBUE C, 2002, THE JOURNAL OF NEURO, V30, P7, DOI DOI 10.1176/APPI.NEUROPSYCH.17070145; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; MACGREGOR A, 2002, HTR, V25, P1, DOI DOI 10.1097/HTR.0B013E3181C2993D; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mollayeva T, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0800-z; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Suri P, 2017, ARCH PHYS MED REHAB, V98, P2118, DOI 10.1016/j.apmr.2017.04.008; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Warren AM, 2015, J TRAUMA ACUTE CARE, V79, P1062, DOI 10.1097/TA.0000000000000875	32	6	6	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2019	2019								4364592	10.1155/2019/4364592			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV9HK	WOS:000466293600001	31110595	Green Submitted, Green Published, gold			2022-02-06	
J	Rastogi, P; Lee, EG; Hadimani, RL; Jiles, DC				Rastogi, Priyam; Lee, Erik Gordan; Hadimani, Ravi L.; Jiles, David C.			Transcranial Magnetic Stimulation: Development of a Novel Deep-Brain Triple-Halo Coil	IEEE MAGNETICS LETTERS			English	Article						Biomagnetics; deep brain stimulation; transcranial magnetic stimulation; triple-halo coil	DEPRESSION	Transcranial magnetic stimulation (TMS) is a noninvasive treatment for major depressive disorder. TMS coil design plays an important role in maximizing the magnetic field strength at the required location in the brain. Development of deep-brain TMS coils to stimulate subcortical structures will expand the uses of TMS beyond the simulation of superficial cortical targets. The simulation of deep-brain regions may have beneficial effects on neurological disorders such as Parkinson's disease, posttraumatic stress disorder, and mild traumatic brain injury. In this letter, a multicoil configuration, the triple-halo coil (THC), which can stimulate deep brain structures such as the hippocampus and amygdala, is designed and tested. A finite element tool is used to determine the induced electric field and magnetic field in these regions due to the THC alone and in combination with a figure-of-8 coil. Analysis of the results is done with the help of an anatomically accurate heterogeneous head model of a 34-year-old man derived from magnetic resonance imaging. The magnetic field of the THC is measured and compared with the simulated field.	[Rastogi, Priyam; Hadimani, Ravi L.; Jiles, David C.] Iowa State Univ, Dept Elect & Comp Engn, Ames, IA 50011 USA; [Lee, Erik Gordan] Northwestern Univ, McCormick Sch Engn, Dept Biomed Engn, Evanston, IL 60208 USA; [Hadimani, Ravi L.] Virginia Commonwealth Univ, Dept Mech & Nucl Engn, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA		Rastogi, P (corresponding author), Iowa State Univ, Dept Elect & Comp Engn, Ames, IA 50011 USA.	priyamr@iastate.edu	Hadimani, Ravi L./AAB-9980-2020	Hadimani, Ravi L./0000-0001-5939-556X	Galloway Foundation; Barbara and James Palmer Endowment; Carver Charitable Trust at the Department of Electrical and Computer Engineering, Iowa State University, Ames, IA, USA	This work was supported in part by the Galloway Foundation, in part by the Barbara and James Palmer Endowment, and in part by the Carver Charitable Trust at the Department of Electrical and Computer Engineering, Iowa State University, Ames, IA, USA. The authors thank R. Jalinous, Jali Medicals, Inc., Waltham, MA, USA, for fabricating the triple-halo coil.	BARKER AT, 1985, LANCET, V1, P1106; Carpenter LL, 2017, BRAIN STIMUL, V10, P926, DOI 10.1016/j.brs.2017.06.003; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Center for Devices andRadiological Health Food andDrug Administration, 2011, CLASS 2 SPEC CONTR G; Choi E., 2015, THESIS; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Crowther LJ, 2011, J APPL PHYS, V109, DOI 10.1063/1.3563076; Deng ZD, 2014, CLIN NEUROPHYSIOL, V125, P1202, DOI 10.1016/j.clinph.2013.11.038; Deng ZD, 2013, BRAIN STIMUL, V6, P1, DOI 10.1016/j.brs.2012.02.005; Downar J, 2013, BRAIN STIMUL, V6, P231, DOI 10.1016/j.brs.2012.08.006; Fiocchi S, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON ELECTROMAGNETICS IN ADVANCED APPLICATIONS (ICEAA), P448, DOI 10.1109/ICEAA.2015.7297151; Gosselin MC, 2014, PHYS MED BIOL, V59, P5287, DOI 10.1088/0031-9155/59/18/5287; Guadagnin V, 2016, IEEE T BIO-MED ENG, V63, P1543, DOI 10.1109/TBME.2015.2498646; Harel EV, 2011, WORLD J BIOL PSYCHIA, V12, P119, DOI 10.3109/15622975.2010.510893; IT'IS Foundation, 2015, VIRT POP; Koponen LM, 2017, BRAIN STIMUL, V10, P795, DOI 10.1016/j.brs.2017.04.001; Lee EG, 2018, CLIN NEUROPHYSIOL, V129, P1873, DOI 10.1016/j.clinph.2018.04.749; Lu M, 2015, IEEE T MAGN, V51, DOI 10.1109/TMAG.2015.2436977; Marei A., 2017, BRAIN STIMUL, V10, P519, DOI [10.1016/j.brs.2017.01.516, DOI 10.1016/J.BRS.2017.01.516]; Medscape, 2013, FDA APPR 1 DEV TREAT; Neufeld E., 2012, P VPH C; Nexstim, 2009, FDA CLEARS NEXST NAV; Rastogi P, 2016, IEEE T MAGN, V52, DOI 10.1109/TMAG.2015.2514064; Rastogi P, 2018, AIP ADV, V8, DOI 10.1063/1.5007667; Rastogi P, 2017, IEEE T MAGN, V53, DOI 10.1109/TMAG.2017.2711962; Suppa A, 2016, BRAIN STIMUL, V9, P323, DOI 10.1016/j.brs.2016.01.006; Zangen A, 2005, CLIN NEUROPHYSIOL, V116, P775, DOI 10.1016/j.clinph.2004.11.008	27	6	7	2	13	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1949-307X			IEEE MAGN LETT	IEEE Magn. Lett.		2019	10								3102205	10.1109/LMAG.2019.2903993			5	Engineering, Electrical & Electronic; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Physics	HR9IP	WOS:000463473100001					2022-02-06	
J	Ren, C; Li, XH; Wu, Y; Dong, N; Tong, YL; Yao, YM				Ren, Chao; Li, Xiu-hua; Wu, Yao; Dong, Ning; Tong, Ya-lin; Yao, Yong-ming			Inhibition of Cerebral High-Mobility Group Box 1 Protein Attenuates Multiple Organ Damage and Improves T Cell-Mediated Immunity in Septic Rats	MEDIATORS OF INFLAMMATION			English	Article							TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; COGNITIVE IMPAIRMENT; KEY MEDIATOR; LUNG INJURY; SEPSIS; HMGB1; ENCEPHALOPATHY; DYSFUNCTION; ACTIVATION	Sepsis remains one of the leading causes of mortality in intensive care units, but there is a shortage of effective treatments. A dysregulated host immune response and multiple organ injury are major factors for the pathogenesis and progression of sepsis, which require specific mechanism and treatment. In the present study, we performed an intracerebroventricular (ICV) injection of BoxA, a specific antagonist of high-mobility group box 1 protein (HMGB1), in septic rats that were produced by cecal ligation and puncture surgery; we further assessed the functional changes of multiple organs and splenic T lymphocytes. We found that the inhibition of cerebral HMGB1 significantly alleviated multiple organ damage under septic exposure, including damage to the heart, liver, lungs, and kidneys; reversed the immune dysfunction of T cells; and increased the survival of septic rats. These data suggest that central HMGB1 might be a potential therapeutic target for septic challenge and that inhibition of brain HMGB1 can protect against multiple organ dysfunction induced by sepsis.	[Ren, Chao; Yao, Yong-ming] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Ren, Chao; Li, Xiu-hua; Wu, Yao; Dong, Ning; Yao, Yong-ming] Chinese Peoples Liberat Army Gen Hosp, Trauma Res Ctr, Med Ctr 4, Beijing 100048, Peoples R China; [Tong, Ya-lin] 181st Hosp Chinese PLA, Dept Burns & Plast Surg, Guilin 541002, Peoples R China; [Yao, Yong-ming] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing 100853, Peoples R China		Yao, YM (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.; Yao, YM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Trauma Res Ctr, Med Ctr 4, Beijing 100048, Peoples R China.; Yao, YM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing 100853, Peoples R China.	rc198@sina.com; 365188533@qq.com; 350844675@qq.com; 462704369@qq.com; 181tyl@sina.co; c_ff@sina.com			National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81730057, 81801935]; National Key Research and Development Program of China [2017YFC1103302]; Lijiang Scholars Program	This work was supported by grants from the National Natural Science Foundation (nos. 81730057, 81801935), the National Key Research and Development Program of China (no. 2017YFC1103302), and the Lijiang Scholars Program.	Alexander JJ, 2008, NEUROCHEM INT, V52, P447, DOI 10.1016/j.neuint.2007.08.006; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Fox A, 2014, J REHABIL RES DEV, V51, P869, DOI 10.1682/JRRD.2013.10.0233; Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Karlsson S, 2008, INTENS CARE MED, V34, P1046, DOI 10.1007/s00134-008-1032-9; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Manea M M, 2015, J Med Life, V8, P266; Min JY, 2009, STROKE, V40, P2560, DOI 10.1161/STROKEAHA.108.536086; Ostberg T, 2010, ARTHRITIS RHEUM-US, V62, P2963, DOI 10.1002/art.27590; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Ren C, 2018, INT J BIOL SCI, V14, P748, DOI 10.7150/ijbs.24576; Ren C, 2017, ONCOTARGET, V8, P92578, DOI 10.18632/oncotarget.21502; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Seifter JL, 2011, SEMIN NEUROL, V31, P139, DOI 10.1055/s-0031-1277984; Silverman HA, 2014, MOL MED, V20, P601, DOI 10.2119/molmed.2014.00147; Singh V, 2016, ANTIOXID REDOX SIGN, V24, P635, DOI 10.1089/ars.2015.6397; Song XM, 2008, SHOCK, V30, P468, DOI 10.1097/SHK.0b013e31816d5e49; Sun J, 2015, INT J CLIN EXP PATHO, V8, P1555; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Zaghloul N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01673; Zhai Q, 2017, CRIT CARE MED, V45, pE1075, DOI 10.1097/CCM.0000000000002646; Zhang LN, 2012, CHINESE MED J-PEKING, V125, P828, DOI 10.3760/cma.j.issn.0366-6999.2012.05.018	34	6	7	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2019	2019								6197084	10.1155/2019/6197084			10	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	HN6IJ	WOS:000460288900001	30881224	Green Submitted, Green Published, gold			2022-02-06	
J	Rzonca, P; Galazkowski, R; Wojcik-Fatla, A; Panasiuk, L; Gotlib, J				Rzonca, Patryk; Galazkowski, Robert; Wojcik-Fatla, Angelina; Panasiuk, Lech; Gotlib, Joanna			Missions of the Helicopter Emergency Medical Service in rural and urban areas in Poland - A comparative retrospective analysis	ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE			English	Article						Helicopter Emergency Medical Service; rural and urban areas; prehospital care	TRAUMA PATIENTS; GROUND TRANSPORT; HEMS; EPIDEMIOLOGY; ASSOCIATION; OUTCOMES; BENEFIT; ADULTS	Introduction. Mortality due to various causes, despite continuous efforts to improve the quality of medical services, is a serious problem for modern healthcare systems. Ischaemic heart disease and stroke are the cause of over 15 million deaths annually, and are therefore known as the world's number one killer. Objective. The aim of this study is to characterise the missions and the most common reasons for dispatching Helicopter Emergency Medical Service (HEMS) crews, with special emphasis on the differences between urban and rural areas. Materials and method. The study was conducted using a retrospective analysis of HEMS missions, including flights to accidents and diseases carried out by HEMS crews in Poland from January 2014 - December 2018. The final analysis included 35,213 cases of HEMS missions. Results. The study group consisted mainly of male patients (66.40%), aged 50-64 (22.06%), mean age of the entire analysed group - 47.71 (SD: 25.96). The main reason for HEMS missions were strokes (21.63%). Analysis of patients' clinical status revealed that the clinical status of patients treated in rural areas was more severe, which was indicated by the Glasgow Coma Scale - GCS (12.03 vs 12.35) and the Revised Trauma Scale - RTS (10.14 vs 10.60) scores. When assessed by the National Advisory Committee for Aeronautics (NACA) score, body injuries and fatal diseases were observed more often in patients in rural areas (NACA 7 6.12% vs 3.46%) (p<0.05). Conclusions. Multi-organ injuries, head traumas, sudden cardiac arrest, traumatic brain injuries, collapse and epilepsy, were more frequent reasons for HEMS missions in rural areas than in urban areas.	[Rzonca, Patryk] Med Univ, Lublin, Poland; [Galazkowski, Robert; Gotlib, Joanna] Med Univ, Warsaw, Poland; [Wojcik-Fatla, Angelina; Panasiuk, Lech] Inst Rural Hlth, Lublin, Poland		Rzonca, P (corresponding author), Med Univ, Lublin, Poland.	patryk.rzonca@gmail.com	; Wojcik-Fatla, Angelina/U-2098-2018; GALAZKOWSKI, ROBERT/X-2593-2018	Rzonca, Patryk/0000-0001-7008-1721; Wojcik-Fatla, Angelina/0000-0001-5260-4867; Panasiuk, Lech/0000-0001-6210-2887; GALAZKOWSKI, ROBERT/0000-0002-7205-2219			Anthony DR, 2011, GLOB PUBLIC HEALTH, V6, P906, DOI 10.1080/17441692.2010.535008; Chen XL, 2018, J TRAUMA ACUTE CARE, V85, P174, DOI 10.1097/TA.0000000000001935; Chen XL, 2018, J TRAUMA ACUTE CARE, V84, P549, DOI 10.1097/TA.0000000000001769; Cheung BH, 2014, ACAD EMERG MED, V21, P1232, DOI 10.1111/acem.12512; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Giannakopoulos GF, 2013, EUR J EMERG MED, V20, P79, DOI 10.1097/MEJ.0b013e328352ac9b; Goldstein J, 2015, CAN J EMERG MED, V17, P491, DOI 10.1017/cem.2015.20; Gorynski P., 2016, SYTUACJA ZDROWOTNA L; Hawkes C, 2017, RESUSCITATION, V110, P133, DOI 10.1016/j.resuscitation.2016.10.030; Karwan K, 2013, OPM, V12, P28; Kornhall D, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0176-3; Kosydar-Bochenek J., 2012, ZDROWIE PUBLICZNE, V122, P70; Kottmann A, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0520-3; Loggers SA, 2016, EUR J TRAUMA EMERG S, V30, P1; McCowan CL, 2007, PREHOSP EMERG CARE, V11, P383, DOI 10.1080/10903120701536867; McMullan JT, 2011, ANN EMERG MED, V57, P213, DOI 10.1016/j.annemergmed.2010.08.031; Moens D, 2015, EUR J EMERG MED, V22, P273, DOI 10.1097/MEJ.0000000000000149; Newgard CD, 2017, JAMA SURG, V152, P11, DOI 10.1001/jamasurg.2016.3329; Osteras O, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0442-5; Raatiniemi L, 2017, ACTA ANAESTH SCAND, V61, P557, DOI 10.1111/aas.12881; Raatiniemi L, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0175-2; Rzonca P., 2017, DISASTER EMERG MED J, V2, P64, DOI 10.5603/DEMJ.2017.0013; Rzonca P, 2018, MED SCI MONITOR, V24, P6053, DOI 10.12659/MSM.908962; Stewart KE, 2011, ACAD EMERG MED, V18, P1208, DOI 10.1111/j.1553-2712.2011.01207.x; Strehlow MC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011459; Turner N, 2016, J GA PUBLIC HLTH ASS, V5, P332; Villani M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2280-6; Werman HA, 1999, AM J EMERG MED, V17, P130, DOI 10.1016/S0735-6757(99)90043-8; Wu SC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112346	29	6	6	1	5	INST AGRICULTURAL MEDICINE	LUBLIN	JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND	1232-1966	1898-2263		ANN AGR ENV MED	Ann. Agr. Env. Med.		2019	26	2					355	360		10.26444/aaem/106223			6	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	IE1HM	WOS:000472136600026	31232071	Green Submitted, gold			2022-02-06	
J	Schroeppel, TJ; Sharpe, JP; Shahan, CP; Clement, LP; Magnotti, LJ; Lee, M; Muhlbauer, M; Weinberg, JA; Tolley, EA; Croce, MA; Fabian, TC				Schroeppel, Thomas J.; Sharpe, John P.; Shahan, Charles Patrick; Clement, Lesley P.; Magnotti, Louis J.; Lee, Marilyn; Muhlbauer, Michael; Weinberg, Jordan A.; Tolley, Elizabeth A.; Croce, Martin A.; Fabian, Timothy C.			Beta-adrenergic blockade for attenuation of catecholamine surge after traumatic brain injury: a randomized pilot trial	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						brain injury; propranolol; randomized controlled trial		BackgroundBeta-blockers have been proven in multiple studies to be beneficial in patients with traumatic brain injury. Few prospective studies have verified this and no randomized controlled trials. Additionally, most studies do not titrate the dose of beta-blockers to therapeutic effect. We hypothesize that propranolol titrated to effect will confer a survival benefit in patients with traumatic brain injury.MethodsA randomized controlled pilot trial was performed during a 24-month period. Patients with traumatic brain injury were randomized to propranolol or control group for a 14-day study period. Variables collected included demographics, injury severity, physiologic parameters, urinary catecholamines, and outcomes. Patients receiving propranolol were compared with the control group.ResultsOver the study period, 525 patients were screened, 26 were randomized, and 25 were analyzed. Overall, the mean age was 51.3 years and the majority were male with blunt mechanism. The mean Injury Severity Score was 21.8 and median head Abbreviated Injury Scale score was 4. Overall mortality was 20.0%. Mean arterial pressure was higher in the treatment arm as compared with control (p=0.021), but no other differences were found between the groups in demographics, severity of injury, severity of illness, physiologic parameters, or mortality (7.7% vs. 33%; p=0.109). No difference was detected over time in any variables with respect to treatment, urinary catecholamines, or physiologic parameters. Glasgow Coma Scale (GCS), Sequential Organ Failure Assessment, and Acute Physiology and Chronic Health Evaluation scores all improved over time. GCS at study end was significantly higher in the treatment arm (11.7 vs. 8.9; p=0.044). Finally, no difference was detected with survival analysis over time between groups.ConclusionsDespite not being powered to show statistical differences between groups, GCS at study end was significantly improved in the treatment arm and mortality was improved although not at a traditional level of significance. The study protocol was safe and feasible to apply to an appropriately powered larger multicenter study.Level of evidenceLevel 2-therapeutic.	[Schroeppel, Thomas J.] UCHlth Mem Hosp Cent, Dept Acute Care Surg, Colorado Springs, CO 80909 USA; [Sharpe, John P.; Shahan, Charles Patrick; Magnotti, Louis J.; Croce, Martin A.; Fabian, Timothy C.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Coll Med, Memphis, TN 38163 USA; [Clement, Lesley P.] UCHlth Mem Hosp Cent, Dept Pharm, Colorado Springs, CO USA; [Lee, Marilyn] Reg One Hlth, Dept Pharm, Memphis, TN USA; [Muhlbauer, Michael] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Coll Med, Memphis, TN 38163 USA; [Weinberg, Jordan A.] Dign Hlth Med Grp Arizona, Dept Surg, Phoenix, AZ USA; [Tolley, Elizabeth A.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA		Schroeppel, TJ (corresponding author), UCHlth Mem Hosp Cent, Dept Acute Care Surg, Colorado Springs, CO 80909 USA.	thomas.schroeppel@uchealth.org		Schroeppel, Thomas/0000-0001-9164-5004	University of Tennessee Health Science Center Institute for Research, Innovation, Synergy, and Equity (iRISE); Semmes-Murphey Foundation	This study was supported by grants from the University of Tennessee Health Science Center Institute for Research, Innovation, Synergy, and Equity (iRISE) and the Semmes-Murphey Foundation.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Ahl R., 2017, IN PRESS; Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Bukur M, 2012, J TRAUMA ACUTE CARE, V72, P1013, DOI 10.1097/TA.0b013e318241bc5b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHIOLERO RL, 1989, CRIT CARE MED, V17, P328, DOI 10.1097/00003246-198904000-00006; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; CRUICKSHANK JM, 1987, LANCET, V2, P585, DOI 10.1016/s0140-6736(87)92984-9; Faul M, 2010, TRAUMATIC BRAIN INJU; FEIBEL JH, 1981, ANN NEUROL, V9, P340, DOI 10.1002/ana.410090405; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Ley EJ, 2012, J TRAUMA ACUTE CARE, V72, P943, DOI 10.1097/TA.0b013e3182465527; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; Murry JS, 2016, J SURG RES, V200, P221, DOI 10.1016/j.jss.2015.06.045; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; NEILDWYER G, 1981, BRIT J CLIN PHARMACO, V11, P549, DOI 10.1111/j.1365-2125.1981.tb01169.x; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Zangbar B, 2016, J SURG RES, V200, P586, DOI 10.1016/j.jss.2015.08.020	43	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open	JAN	2019	4	1							e000307	10.1136/tsaco-2019-000307			6	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	VK2XU	WOS:000672553800046	31467982	gold, Green Published			2022-02-06	
J	Tremblay, S; Desjardins, M; Bermudez, P; Iturria-Medina, Y; Evans, AC; Jolicoeur, P; De Beaumont, L				Tremblay, Sebastien; Desjardins, Martine; Bermudez, Patrick; Iturria-Medina, Yasser; Evans, Alan C.; Jolicoeur, Pierre; De Beaumont, Louis			Mild traumatic brain injury: The effect of age at trauma onset on brain structure integrity	NEUROIMAGE-CLINICAL			English	Article						Mild traumatic brain injury; mTBI; Concussion; Neuroimaging; Diffusion tensor maging; Morphometry	TENSOR IMAGING FINDINGS; COGNITIVE IMPAIRMENT; SPORTS CONCUSSIONS; FOOTBALL; PLAYERS; ASSOCIATION; EXPOSURE; HISTORY	Mounting evidence suggests that mild traumatic brain injuries (mTBI) have long-term effects that interact with the aging process to precipitate cognitive decline. This line of research predicts that early exposure to brain trauma is particularly detrimental to long-term brain integrity. However, a second line of research into the effects of age at trauma onset predict that older brains are more vulnerable to the effects of mTBI than younger brains. We sought to determine whether patients who sustain a mTBI earlier in life fare better than patients who sustain a mTBI at an older age. We conducted a multi-cohort, case-control study, with participants randomly sampled from a population of patients with a history of mTBI. We recruited two cohorts of aging participants (N = 74, mean [SD] = 61.16 [6.41]) matched in age and education levels that differed in only one respect age at mTBI onset. One cohort sustained their concussion in their early twenties (24.60 [6.34] y/o), the other in their early sixties (61.05 [4.90] y/o). Each mTBI cohort had its own matched control group. Participants underwent high-resolution MRI at 3 Tesla for T-1 and diffusion-weighted images (DWI) acquisition. Images were processed and analyzed using Deformation-Based Morphometry and DWI Tract-Based Spatial Statistics to identify group differences in a 2 x 2 ANOVA design. Results showed a significant interaction on DWI measures of white matter integrity indicating larger anomalies in participants who sustained a mTBI at a younger age (F-1,F-70, P < .05, FDR corrected). These findings suggest that mTBI initiates a lifelong neurodegeneration process that outweighs the risks associated with sustaining a mTBI at an older age. Implications are important for young athletes' populations exposed to the risk of mTBI in the practice of their sports and for retired athletes aging with a history of concussions sustained at a younger age.	[Tremblay, Sebastien; Bermudez, Patrick; Iturria-Medina, Yasser; Evans, Alan C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Desjardins, Martine] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [Bermudez, Patrick; Iturria-Medina, Yasser; Evans, Alan C.] McGill Univ, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada; [Desjardins, Martine; Jolicoeur, Pierre] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [De Beaumont, Louis] Univ Montreal, Dept Surg, 5400 Blvd Gouin West, Montreal, PQ H4J 1C5, Canada		De Beaumont, L (corresponding author), Univ Montreal, Dept Surg, 5400 Blvd Gouin West, Montreal, PQ H4J 1C5, Canada.	louis.de.beaumont@umontreal.ca	Evans, Alan C/B-2373-2013	Evans, Alan C/0000-0003-3841-6098; Tremblay, Sebastien/0000-0001-6251-9797; Iturria Medina, Yasser/0000-0002-9345-0347	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR Postdoctoral FellowshipCanadian Institutes of Health Research (CIHR)	This work was supported by grants to L.D.B from the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC). The CIHR Postdoctoral Fellowship supported S.T.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belson K., 2013, NY TIMES; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P105, DOI 10.1016/j.ijpsycho.2017.09.006; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Tremblay S, 2017, EUR J NEUROSCI, V46, P1956, DOI 10.1111/ejn.13583; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139	42	6	6	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	23								101907	10.1016/j.nicl.2019.101907			6	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX6OV	WOS:000485804400092	31233955	Green Published, gold			2022-02-06	
J	Wang, YM; Peng, DW; Yang, XP; Huang, PF; Ye, HY; Hui, YT; Wang, X; Sun, WT; Wu, HC; Zhang, SJ; Wang, L; Sha, H; Shang, CZ; Dong, HJ; Hu, QL				Wang, Yanmin; Peng, Dingwei; Yang, Xiping; Huang, Pengfei; Ye, Haoyi; Hui, Yuetong; Wang, Xi; Sun, Wentao; Wu, Huancheng; Zhang, Shijun; Wang, Lei; Sha, Hong; Shang, Chongzhi; Dong, Huajiang; Hu, Qunliang			Study on Umbilical Cord-Matrix Stem Cells Transplantation for Treatment of Acute Traumatic Brain Injury in Rats	TURKISH NEUROSURGERY			English	Article						Umbilical cord; Mesenchymal stem cells; Trauma brain injury	MESENCHYMAL STROMAL CELLS; BONE-MARROW	AIM: To evaluate the effect of umbilical cord derived mesenchymal stem cells (UC-MSCs) transplantation on traumatic brain injury (TBI). MATERIAL and METHODS: UC-MSCs were isolated from human umbilical cord and TBI rat model was constructed. 30 male SD rats were randomly divided into 3 groups: control group, TBI group and MSCs transplantation group. Rats in MSCs group received the injection of a total of 1.5 x 106 MSCs (25 pl) via ventricle at operated ventricular coordinates (0 at bregma, 1.5 mm at lateral, 1.1 mm at behind, 4.5 mm in depth). RESULTS: 80% confluence of cells was formed from tissue at day 10 and the amount of CD90, CD73, CD105 positive cells increased correspondingly. In TBI model, clear hyperemia, edema and obvious infiltration of inflammatory cells in brain tissue were found. However, the manifestations were alleviated after the treatment of MSCs. In MSCs group, GFP in the brain tissue and the area around the vessels were found after the injection, while the expression levels of micro-vessel density (MVD), brain-derived neurotrophic factor (BDNF) and glial fibrillary acidic protein (GFAP) were elevated. CONCLUSION: UC-MSCs transplantation for treatment of acute TBI could effectively reduce the injury and improve the vascular reconstruction.	[Wang, Yanmin; Sun, Wentao; Wu, Huancheng; Zhang, Shijun; Hu, Qunliang] Tianjin Beichen Hosp, Tianjin, Peoples R China; [Peng, Dingwei; Yang, Xiping; Shang, Chongzhi] Specialty Med Ctr Chinese Peoples Armed Police Fo, Dept Neurosurg, Tianjin, Peoples R China; [Peng, Dingwei] Neural Restorat Key Lab Tianjin, Tianjin, Peoples R China; [Huang, Pengfei; Ye, Haoyi; Hui, Yuetong; Dong, Huajiang] Logist Univ Chinese Peoples Armed Police Forces, Tianjin, Peoples R China; [Wang, Xi] Fifth Brigade Peking Headquarters Chinese Peoples, Beijing, Peoples R China; [Wang, Lei; Sha, Hong] Chinese Acad Med Sci, Inst Biomed Engn, Tianjin, Peoples R China; [Wang, Lei; Sha, Hong] Peking Union Med Coll, Tianjin, Peoples R China		Hu, QL (corresponding author), Tianjin Beichen Hosp, Tianjin, Peoples R China.; Dong, HJ (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Tianjin, Peoples R China.; Wang, L (corresponding author), Chinese Acad Med Sci, Inst Biomed Engn, Tianjin, Peoples R China.; Wang, L (corresponding author), Peking Union Med Coll, Tianjin, Peoples R China.	leiwang2006163@163.com; dhj_424@163.com; hjhhql@sina.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801240]; CAMS Innovative Fund for Medical Science [2018-I2M-AI-012]	This project was supported by Natural Science Foundation of China (No. 81801240); the CAMS Innovative Fund for Medical Science (Project no. 2018-I2M-AI-012).	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Chan J, 2005, STEM CELLS, V23, P93, DOI 10.1634/stemcells.2004-0138; Choi M, 2014, MOL CELLS, V37, P133, DOI 10.14348/molcells.2014.2317; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Ding DC, 2015, CELL TRANSPLANT, V24, P339, DOI 10.3727/096368915X686841; Dong HJ, 2018, TURK NEUROSURG; Dong HJ, 2018, AM J TRANSL RES, V10, P901; Dong HJ, 2017, INT J CLIN EXP MED, V10, P7213; El Omar R, 2014, TISSUE ENG PART B-RE, V20, P523, DOI [10.1089/ten.teb.2013.0664, 10.1089/ten.TEB.2013.0664]; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gokcinar-Yagci B, 2015, STEM CELL REV REP, V11, P549, DOI 10.1007/s12015-015-9590-z; Gong W, 2012, CELL TRANSPLANT, V21, P207, DOI 10.3727/096368911X586756; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Huajiang D, 2018, TURKISH NEUROSURGERY; Jia YX, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0604-4; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Layla TG, 2011, NEUROL RES INT, V2011, P1; Lee WS, 2011, BIOL BLOOD MARROW TR, V17, P465, DOI 10.1016/j.bbmt.2010.04.016; Li G, 2017, TURK NEUROSURG; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Lou GH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.63; Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Qi LF, 2018, J CRANIOFAC SURG, V29, P1689, DOI 10.1097/SCS.0000000000005042; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Savukinas UB, 2016, STEM CELLS, V34, P1437, DOI 10.1002/stem.2357; Sordi V, 2009, TRANSPLANTATION, V87, pS42, DOI 10.1097/TP.0b013e3181a28533; Sun L, 2017, BEHAV BRAIN RES, V333, P258, DOI 10.1016/j.bbr.2017.07.011; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wang LX, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-016-0584-9; Zang L, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0233-1; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770	33	6	6	1	2	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2019	29	5					750	758		10.5137/1019-5149.JTN.25463-18.2			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IY3XM	WOS:000486326100019	31099884	Bronze			2022-02-06	
J	Yong, YX; Li, YM; Lian, J; Luo, CM; Zhong, DX; Han, K				Yong, Ya-Xiong; Li, Yu-Ming; Lian, Jia; Luo, Chuan-Ming; Zhong, De-Xia; Han, Ke			RETRACTED: Inhibitory role of lentivirus-mediated aquaporin-4 gene silencing in the formation of glial scar in a rat model of traumatic brain injury (Retracted article. See vol. 122, 2021)	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article; Retracted Publication						aquaporin-4 (AQP4); gene silencing; glial scar; traumatic brain injury (TBI)	EDEMA; INVOLVEMENT; EXPRESSION; RECOVERY; PROTEIN; GROWTH	Traumatic brain injury (TBI), an acute degenerative pathology of the central nervous system, is a leading cause of death and disability. As the glial scar is a mechanical barrier to nerve regeneration, inhibitory molecules in the forming scar and methods to overcome them have suggested molecular modification strategies to allow neuronal growth and functional regeneration. Herein, we aim to investigate the effects of aquaporin-4 (AQP4) gene silencing on the glial scar formation after TBI by establishing rat models. After modeling, TBI rats were transfected with AQP4 small hairpin RNA [shRNA] (AQP4 gene silencing by lentiviral vector-delivered shRNA) and empty vectors, respectively. Neurological functions of the rats were evaluated after TBI. The hematoxylin and eosin staining was conducted to observe histomorphological changes in rat brain tissues. The messenger RNA (mRNA) and protein expressions of glial fibrillary acidic protein (GFAP), vimentin, fibronectin, laminin, and AQP4 were measured by reverse transcription-quantitative polymerase chain reaction and Western blot analysis. The ratio of positive expression area was calculated, and the glial scar was observed by immunohistochemistry. At the 7th, 14th, and 28th days after TBI, TBI rats treated with AQP4 shRNA showed improved neurological function and lessened histomorphological changes. AQP4 gene silencing mediated by lentivirus decreased the mRNA and protein expressions of GFAP, vimentin, fibronectin, and laminin, the number of positive cells, the ratio of positive expression area, and the glial scar. Our study demonstrates that lentivirus-mediated AQP4 gene silencing could inhibit the formation of glial scar after TBI, which is beneficial to the recovery of neurological function.	[Yong, Ya-Xiong; Lian, Jia; Luo, Chuan-Ming; Zhong, De-Xia; Han, Ke] Sun Yat Sen Univ, Dept Neurol, Affiliated Hosp 7, 628 Zhenyuan Rd, Shenzhen 518107, Peoples R China; [Li, Yu-Ming] Guizhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Guiyang, Guizhou, Peoples R China		Yong, YX (corresponding author), Sun Yat Sen Univ, Dept Neurol, Affiliated Hosp 7, 628 Zhenyuan Rd, Shenzhen 518107, Peoples R China.	yongyaxiong@yeah.net					Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; He ZP, 2015, NEURAL REGEN RES, V10, P1082, DOI 10.4103/1673-5374.160099; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jeong SR, 2012, EXP NEUROL, V233, P312, DOI 10.1016/j.expneurol.2011.10.021; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Liu YQ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-141; Lu DC, 2011, J NEUROTRAUM; Lu L, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/584245; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Morales-Garcia JA, 2015, NEUROBIOL AGING, V36, P1160, DOI 10.1016/j.neurobiolaging.2014.10.008; Pei D, 2017, BRAIN RES BULL, V134, P121, DOI 10.1016/j.brainresbull.2017.06.020; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Prasad K, 2012, J MED SYST, V36, P2621, DOI 10.1007/s10916-011-9737-7; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rao KVR, 2010, GLIA, V58, P1490, DOI 10.1002/glia.21023; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Schallert T, 1997, ADV NEUROL, V73, P229; Wei L, 2014, CLIN EXP PHARMACOL P, V41, P134, DOI 10.1111/1440-1681.12186; Xu T, 2013, NEUROCHEM RES, V38, P1914, DOI 10.1007/s11064-013-1097-x; Yuen CM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-141; Zhang HQ, 2006, ANN NY ACAD SCI, V1086, P81, DOI 10.1196/annals.1377.014; Zheng HQ, 2014, INT J MOL SCI, V15, P10974, DOI 10.3390/ijms150610974	28	6	6	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	JAN	2019	120	1					368	379		10.1002/jcb.27390			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HB1XP	WOS:000450823500034	30246455				2022-02-06	
J	Yuan, M; Ma, MN; Wang, TY; Feng, Y; Chen, P; He, C; Liu, SJ; Guo, YX; Wang, Y; Fan, Y; Wang, LQ; Xiao-Qiang, E; Qiao, GF; Li, BY				Yuan, Mei; Ma, Mei-Na; Wang, Ting-Yu; Feng, Yan; Chen, Pei; He, Chao; Liu, Sijie; Guo, Yun-Xia; Wang, Yue; Fan, Yao; Wang, Lu-Qi; Xiao-Qiang, E.; Qiao, Guo-Fen; Li, Bai-Yan			Direct activation of tachykinin receptors within baroreflex afferent pathway and neurocontrol of blood pressure regulation	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						baroreflex afferent function; blood pressure; Substance P; tachykinin receptor	NUCLEUS-TRACTUS-SOLITARII; ENDOTHELIAL NITRIC-OXIDE; TRAUMATIC BRAIN-INJURY; RELEASE SUBSTANCE-P; BARORECEPTOR NEURONS; SEXUAL-DIMORPHISM; VAGAL AFFERENTS; NEUROPEPTIDE-Y; LOW-THRESHOLD; 17-BETA-ESTRADIOL	Aim Substance P (SP) causes vasodilation and blood pressure (BP) reduction. However, the involvement of tachykinin receptors (NKRs) within baroreflex afferent pathway in SP-mediated BP regulation is largely unknown. Methods Under control and hypertensive condition, NKRs' expressions were evaluated in nodose (NG) and nucleus of tractus solitary (NTS) of male, female, and ovariectomized (OVX) rats; BP was recorded after microinjection of SP and NKRs agonists into NG; Baroreceptor sensitivity (BRS) was tested as well. Results Immunostaining and immunoblotting data showed that NK1R and NK2R were estrogen-dependently expressed on myelinated and unmyelinated afferents in NG. A functional study showed that BP was reduced dose-dependently by SP microinjection, which was more dramatic in males and can be mimicked by NK1R and NK2R agonists. Notably, further BP elevation and BRS dysfunction were confirmed in desoxycorticosterone acetate (DOCA)-salt model in OVX compared with DOCA-salt model in intact female rats. Additionally, similar changes in NKRs' expression in NG were also detected using DOCA-salt and SHR. Compared with NG, inversed expression profiles of NKRs were also found in NTS with either gender. Conclusion The estrogen-dependent NKRs' expression in baroreflex afferent pathway participates at least partially in sexual-dimorphic and SP-mediated BP regulation under physiological and hypertensive conditions.	[Yuan, Mei; Ma, Mei-Na; Wang, Ting-Yu; Feng, Yan; Chen, Pei; He, Chao; Guo, Yun-Xia; Wang, Yue; Fan, Yao; Wang, Lu-Qi; Qiao, Guo-Fen; Li, Bai-Yan] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Med Res, Dept Pharmacol,Minist Educ,Coll Pharm, Harbin, Heilongjiang, Peoples R China; [Liu, Sijie; Xiao-Qiang, E.] Harbin Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Harbin, Heilongjiang, Peoples R China		Qiao, GF; Li, BY (corresponding author), Harbin Med Univ, Dept Pharmacol, Harbin, Heilongjiang, Peoples R China.	Qiaogf88@163.com; liby@ems.hrbmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31171122, 81573431, 81173051, 81773731]	This project was fully supported by the National Natural Science Foundation of China (31171122 and 81573431 for B.-Y. L., 81173051 and 81773731 for G.-F. Q.)	Abdala APL, 2006, BRAIN RES, V1119, P165, DOI 10.1016/j.brainres.2006.08.059; Abdala APL, 2003, AM J PHYSIOL-HEART C, V285, pH891, DOI 10.1152/ajpheart.00869.2002; Alhelal MA, 2014, ANN ALLERG ASTHMA IM, V112, P40, DOI 10.1016/j.anai.2013.10.011; Arnold AC, 2009, HYPERTENSION, V54, P1001, DOI 10.1161/HYPERTENSIONAHA.109.138065; Bellucci F, 2016, BRIT J PHARMACOL, V173, P1329, DOI 10.1111/bph.13427; Bhatia J, 2011, CARDIOVASC TOXICOL, V11, P272, DOI 10.1007/s12012-011-9122-2; Bhuiyan ME, 2011, AM J PHYSIOL-HEART C, V301, pH523, DOI 10.1152/ajpheart.00263.2011; BOSSALLER C, 1992, HERZ, V17, P284; Brown T, 2017, J CLIN HYPERTENS, V19, P1377, DOI 10.1111/jch.13097; CHAN JYH, 1990, REGUL PEPTIDES, V29, P199, DOI 10.1016/0167-0115(90)90083-9; Chavez GCSC, 2014, AM J PHYSIOL-HEART C, V307, pH910, DOI 10.1152/ajpheart.00332.2014; Chen YY, 2010, NEUROSCI BULL, V26, P219, DOI 10.1007/s12264-010-1126-6; Cheng PW, 2012, BRIT J PHARMACOL, V167, P1148, DOI 10.1111/j.1476-5381.2012.02077.x; Cheng WH, 2010, CIRC RES, V106, P788, DOI 10.1161/CIRCRESAHA.109.208439; Clevenger AC, 2018, J MOL NEUROSCI, V64, P410, DOI 10.1007/s12031-018-1038-x; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Datar P, 2004, CURR TOP MED CHEM, V4, P75, DOI 10.2174/1568026043451636; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; Dehlin HM, 2014, INT J CARDIOL, V170, P270, DOI 10.1016/j.ijcard.2013.11.010; Dehlin HM, 2013, INT J CARDIOL, V168, P4643, DOI 10.1016/j.ijcard.2013.07.190; DEPALATIS LR, 1985, ENDOCRINOLOGY, V117, P1368, DOI 10.1210/endo-117-4-1368; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; GILLIS RA, 1980, BRAIN RES, V181, P476, DOI 10.1016/0006-8993(80)90633-2; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; He JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29582; He JL, 2015, INT J CARDIOL, V182, P174, DOI 10.1016/j.ijcard.2014.12.068; Helke CJ, 2004, PEPTIDES, V25, P413, DOI 10.1016/j.peptides.2004.02.016; Karabucak B, 2005, J ENDODONT, V31, P733, DOI 10.1097/01.don.0000157988.13010.25; Levick SP, 2016, INT J CARDIOL, V204, P154, DOI 10.1016/j.ijcard.2015.11.157; Li JN, 2015, NEUROSCIENCE, V303, P166, DOI 10.1016/j.neuroscience.2015.06.049; Liu Y, 2016, ONCOTARGET, V7, P66135, DOI 10.18632/oncotarget.11880; Liu Y, 2016, HYPERTENSION, V67, P783, DOI 10.1161/HYPERTENSIONAHA.115.06815; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; MACLEAN DB, 1987, J NEUROCHEM, V48, P1794, DOI 10.1111/j.1471-4159.1987.tb05738.x; Malmstrom RE, 1995, EUR J PHARMACOL, V294, P661, DOI 10.1016/0014-2999(95)00606-0; Mistrova E, 2016, NEUROPEPTIDES, V58, P41, DOI 10.1016/j.npep.2015.12.005; MORILAK DA, 1988, NEUROSCI LETT, V94, P131, DOI 10.1016/0304-3940(88)90283-2; Mowa CN, 2003, PEPTIDES, V24, P761, DOI 10.1016/S0196-9781(03)00120-7; Nazarian A, 2014, EUR J PAIN, V18, P39, DOI 10.1002/j.1532-2149.2013.00346.x; NICOLL RA, 1980, ANNU REV NEUROSCI, V3, P227, DOI 10.1146/annurev.ne.03.030180.001303; Pisera D, 1998, J ENDOCRINOL, V159, P389, DOI 10.1677/joe.0.1590389; Potts JT, 2003, NEUROSCIENCE, V119, P201, DOI 10.1016/S0306-4522(02)00953-3; Potts JT, 1999, J PHYSIOL-LONDON, V514, P829, DOI 10.1111/j.1469-7793.1999.829ad.x; Potts JT, 2001, BRAIN RES, V893, P155, DOI 10.1016/S0006-8993(00)03308-4; Qian Z, 2013, CNS NEUROSCI THER, V19, P954, DOI 10.1111/cns.12195; Qiao GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071184; Qiao GF, 2009, AM J PHYSIOL-CELL PH, V297, pC654, DOI 10.1152/ajpcell.00059.2009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sloniecka M, 2016, MOL PHARMACOL, V89, P215, DOI 10.1124/mol.115.101014; STANFIELD PR, 1985, NATURE, V315, P498, DOI 10.1038/315498a0; Supowit SC, 2005, AM J PHYSIOL-HEART C, V289, pH1169, DOI 10.1152/ajpheart.00973.2004; Villablanca AC, 1997, MOL CELL ENDOCRINOL, V135, P109, DOI 10.1016/S0303-7207(97)00193-7; Vink R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00304; Wang LQ, 2015, ONCOTARGET, V6, P44108, DOI 10.18632/oncotarget.6586; Yamaura K, 2014, LIFE SCI, V94, P54, DOI 10.1016/j.lfs.2013.10.036; Yeh SY, 2017, NEURON, V94, P294, DOI 10.1016/j.neuron.2017.03.024; Zhang DZ, 2014, HYPERTENSION, V63, P88, DOI 10.1161/HYPERTENSIONAHA.113.02057; Zhang YY, 2015, NEUROSCI LETT, V604, P1, DOI 10.1016/j.neulet.2015.07.023; Zhong WX, 2016, NEUROPHARMACOLOGY, V103, P195, DOI 10.1016/j.neuropharm.2015.11.023	61	6	6	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JAN	2019	25	1					123	135		10.1111/cns.12993			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	HE8GS	WOS:000453684300013	29900692	Bronze, Green Published			2022-02-06	
J	Zuckerman, A; Ram, O; Ifergane, G; Matar, MA; Kaplan, Z; Hoffman, JR; Sadot, O; Cohen, H				Zuckerman, Amitai; Ram, Omri; Ifergane, Gal; Matar, Michael A.; Kaplan, Zeev; Hoffman, Jay R.; Sadot, Oren; Cohen, Hagit			Role of Endogenous and Exogenous Corticosterone on Behavioral and Cognitive Responses to Low-Pressure Blast Wave Exposure	JOURNAL OF NEUROTRAUMA			English	Article						animal model; blast wave; glucocorticoids; HPA axis; mTBI; PTSD; secondary prevention	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ANIMAL-MODEL; AXIS RESPONSE; ADRENAL AXIS; MEMORY; GLUCOCORTICOIDS; DYSFUNCTION; HYPOPITUITARISM; AFGHANISTAN	The complex interactions and overlapping symptoms of comorbid post-traumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) induced by an explosive blast wave have become a focus of attention in recent years, making clinical distinction and effective intervention difficult. Because dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is thought to underlie trauma-related (psycho)pathology, we evaluated both the endogenous corticosterone response and the efficacy of exogenous hydrocortisone treatment provided shortly after blast exposure. We employed a controlled experimental blast-wave paradigm in which unanesthetized animals were exposed to visual, auditory, olfactory, and tactile effects of an explosive blast wave produced by exploding a thin copper wire. Endogenous corticosterone concentrations were evaluated at different time points (before, and 3h, 5h and 17 days) after blast exposure. Subsequently, the efficacy of exogenous hydrocortisone (25mg/kg(-1) or 125mg/kg(-1)) injected intraperitoneally 1h after exposure was compared with that of a similarly timed saline injection. Validated cognitive and behavioral tests were used to assess both PTSD and mTBI phenotypes on days 7-14 following the blast. Retrospective analysis revealed that animals demonstrating the PTSD phenotype exhibited a significantly blunted endogenous corticosterone response to the blast compared with all other groups. Moreover, a single 125mg/kg(-1) dose of hydrocortisone administered 1h after exposure significantly reduced the occurrence of the PTSD phenotype. Hydrocortisone treatment did not have a similar effect on the mTBI phenotype. Results of this study indicate that an inadequate corticosteroid response following blast exposure increases risk for PTSD phenotype, and corticosteroid treatment is a potential clinical intervention for attenuating PTSD. The differences in patterns of physiological and therapeutic response between PTSD and mTBI phenotypes lend credence to the retrospective behavioral and cognitive classification criteria we designed, and is in keeping with the assumption that mTBI and PTSD phenotypes may reflect distinct underlying biological and clinical profiles.	[Zuckerman, Amitai; Matar, Michael A.; Kaplan, Zeev; Cohen, Hagit] Ben Gurion Univ Negev, Minist Hlth, Fac Hlth Sci, Anxiety & Stress Res Unit, Beer Sheva, Israel; [Ram, Omri; Sadot, Oren] Ben Gurion Univ Negev, Dept Mech Engn, Beer Sheva, Israel; [Ifergane, Gal] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Neurol, Headache Clin, Beer Sheva, Israel; [Hoffman, Jay R.] Univ Cent Florida, Inst Exercise Physiol & Wellness Sport & Exercise, Orlando, FL 32816 USA		Cohen, H (corresponding author), Ben Gurion Univ Negev, Minist Hlth, Fac Hlth Sci, Anxiety & Stress Res Unit, Beer Sheva, Israel.	hagitc@bgu.ac.il	Ifergane, Gal/AAD-3653-2019; Hoffman, Jay/AAF-2005-2019	Hoffman, Jay/0000-0002-0073-6603; RAM, OMRI/0000-0002-2398-9822	Israel Defense Forces (IDF) Medical Corps; Directorate of Defense & Development, Israeli Ministry of Defense (IMOD DDRD); Adelis Brain Research Awards	This study was supported by grant from the Israel Defense Forces (IDF) Medical Corps and Directorate of Defense & Development, Israeli Ministry of Defense (IMOD DDR&D) and by the Adelis Brain Research Awards.	Aerni A, 2004, AM J PSYCHIAT, V161, P1488, DOI 10.1176/appi.ajp.161.8.1488; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Brorsson C, 2014, INJURY, V45, P1149, DOI 10.1016/j.injury.2014.02.001; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cohen H, 2005, BIOL PSYCHIAT, V58, P640, DOI 10.1016/j.biopsych.2005.04.002; Cohen H, 2004, NEUROPSYCHOPHARMACOL, V29, P1962, DOI 10.1038/sj.npp.1300523; Cohen H, 2003, BIOL PSYCHIAT, V53, P463, DOI 10.1016/S0006-3223(02)01909-1; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Cohen H, 2006, BIOL PSYCHIAT, V59, P1208, DOI 10.1016/j.biopsych.2005.12.003; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Conrad CD, 1999, NEUROBIOL LEARN MEM, V72, P39, DOI 10.1006/nlme.1998.3898; De Kloet ER, 2004, ANN NY ACAD SCI, V1018, P1, DOI 10.1196/annals.1296.001; de Quervain D, 2017, NAT REV NEUROSCI, V18, P7, DOI 10.1038/nrn.2016.155; De Quervain DJF, 2007, PROG BRAIN RES, V167, P239, DOI 10.1016/S0079-6123(07)67017-4; de Quervain DJF, 2008, EUR J PHARMACOL, V583, P365, DOI 10.1016/j.ejphar.2007.11.068; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; De Quervain DJF, 2006, ANN NY ACAD SCI, V1071, P216, DOI 10.1196/annals.1364.016; Diehl LA, 2012, NEUROCHEM RES, V37, P700, DOI 10.1007/s11064-011-0660-6; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FILE SE, 1993, PHYSIOL BEHAV, V54, P1109, DOI 10.1016/0031-9384(93)90333-B; Flory JD, 2015, BIOL PSYCHIAT, V78, pE5, DOI 10.1016/j.biopsych.2015.02.003; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hoffman JR, 2017, AMINO ACIDS, V49, P871, DOI 10.1007/s00726-017-2383-8; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; McEwen BS, 2002, PSYCHIAT CLIN N AM, V25, P469, DOI 10.1016/S0193-953X(01)00009-0; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Munoz A, 2013, CURR OPIN ENDOCRINOL, V20, P354, DOI 10.1097/MED.0b013e32836318ba; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Ram O, 2012, EXP FLUIDS, V53, P1335, DOI 10.1007/s00348-012-1339-8; Rao RP, 2012, BIOL PSYCHIAT, V72, P466, DOI 10.1016/j.biopsych.2012.04.008; Roozendaal B, 2000, PSYCHONEUROENDOCRINO, V25, P213, DOI 10.1016/S0306-4530(99)00058-X; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Schelling G, 2004, ANN NY ACAD SCI, V1032, P158, DOI 10.1196/annals.1314.013; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Servatius RJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00379; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Sotnikov S, 2014, PSYCHONEUROENDOCRINO, V48, P41, DOI 10.1016/j.psyneuen.2014.06.006; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; van Ast VA, 2013, PSYCHONEUROENDOCRINO, V38, P1874, DOI 10.1016/j.psyneuen.2013.06.012; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Whitaker AM, 2015, PHYSIOL BEHAV, V147, P16, DOI 10.1016/j.physbeh.2015.03.033; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	65	6	7	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					380	394		10.1089/neu.2018.5672			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800020	29947272				2022-02-06	
J	Weaver, LK; Wilson, SH; Lindblad, AS; Churchill, S; Deru, K; Price, R; Williams, CS; Orrison, WW; Patel, JB; Walker, JM; Meehan, A; Mirow, S				Weaver, Lindell K.; Wilson, Steffanie H.; Lindblad, Anne S.; Churchill, Susan; Deru, Kayla; Price, Robert; Williams, Christopher S.; Orrison, William W.; Patel, Jigar B.; Walker, James M.; Meehan, Anna; Mirow, Susan		NORMAL Study Team	Comprehensive Evaluation of Healthy Volunteers Using Multi-Modality Brain Injury Assessments: An Exploratory, Observational Study	FRONTIERS IN NEUROLOGY			English	Article						neurological evaluation; healthy volunteers; neuroepidemiology; white matter hyperintensities; brain imaging; mild traumatic brain injury	WHITE-MATTER HYPERINTENSITIES; HEART-RATE-VARIABILITY; POST-CONCUSSIVE SYMPTOMS; OBSTRUCTIVE SLEEP-APNEA; HYPERBARIC-OXYGEN; PSYCHOMETRIC PROPERTIES; SERVICE MEMBERS; PTSD CHECKLIST; INTER-SCANNER; QUALITY INDEX	Introduction: Even though mild traumatic brain injury is common and can result in persistent symptoms, traditional measurement tools can be insensitive in detecting functional deficits after injury. Some newer assessments do not have well-established norms, and little is known about how these measures perform over time or how cross-domain assessments correlate with one another. We conducted an exploratory study to measure the distribution, stability, and correlation of results from assessments used in mild traumatic brain injury in healthy, community-dwelling adults. Materials and Methods: In this prospective cohort study, healthy adult men and women without a history of brain injury underwent a comprehensive brain injury evaluation that included self-report questionnaires and neurological, electroencephalography, sleep, audiology/vestibular, autonomic, visual, neuroimaging, and laboratory testing. Most testing was performed at 3 intervals over 6 months. Results: The study enrolled 83 participants, and 75 were included in the primary analysis. Mean age was 38 years, 58 were male, and 53 were civilians. Participants did not endorse symptoms of post-concussive syndrome, PTSD, or depression. Abnormal neurological examination findings were rare, and 6 had generalized slowing on electroencephalography. Actigraphy and sleep diary showed good sleep maintenance efficiency, but 21 reported poor sleep quality. Heart rate variability was most stable over time in the sleep segment. Dynavision performance was normal, but 41 participants had abnormal ocular torsion. On eye tracking, circular, horizontal ramp, and reading tasks were more likely to be abnormal than other tasks. Most participants had normal hearing, videonystagmography, and rotational chair testing, but computerized dynamic posturography was abnormal in up to 21% of participants. Twenty-two participants had greater than expected white matter changes for age by MRI. Most abnormal findings were dispersed across the population, though a few participants had clusters of abnormalities. Conclusions: Despite our efforts to enroll normal, healthy volunteers, abnormalities on some measures were surprisingly common.	[Weaver, Lindell K.; Churchill, Susan; Deru, Kayla] Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA; [Weaver, Lindell K.; Churchill, Susan; Deru, Kayla] Intermt LDS Hosp, Salt Lake City, UT 84143 USA; [Weaver, Lindell K.; Mirow, Susan] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA; [Wilson, Steffanie H.; Lindblad, Anne S.] Emmes Corp, Rockville, MD USA; [Price, Robert] Evans Army Community Hosp, Ft Carson, CO USA; [Williams, Christopher S.; Orrison, William W.; Patel, Jigar B.; Walker, James M.; Meehan, Anna; Mirow, Susan] Lovelace Biomed Res, Albuquerque, NM USA		Weaver, LK (corresponding author), Intermt Med Ctr, Div Hyperbar Med, Murray, UT 84107 USA.; Weaver, LK (corresponding author), Intermt LDS Hosp, Salt Lake City, UT 84143 USA.; Weaver, LK (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA.	lindell.weaver@imail.org			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-D-0039-0003]	This work is supported by the US Army Medical Research and Materiel Command under Contract No. W81XWH-15-D-0039-0003. We thank Sharon A. Gilbert, Ph.D., (Tunnell Government Services) for her participation in data and manuscript review. We acknowledge the following team members for their support and contributions to study operations, and when appropriate, for their contributions to study concept, design, and conduct:; Fort Carson Army Community Hospital: COL RP, CDR Laura Grogan, MAJ Karl Brewer, MAJ Gerald Surrett, MAJ Doug Langford, COL Otto Boneta, COL(ret) Heidi Terrio, CDR Renee Pazdan, LTC Mike Anderson, Courtney Tripp, Vicki CarberrSSSy, StephanieMazey, Don Albrandt, SFC Rommel Cruz, SSG Stanley Brown, SSG Bryan Ritchie, MG(ret) Jimmie Keenan, COL John McGrath, COL Thomas Rogers, COL Dennis LeMaster, LTC MatthewHudkins, Damon Fletcher, LonnieNelson, COL Charles Taylor, MAJ Mark Thomasulo, LTC Dave Haight, COL Mark Reeves.; Study Coordinating Center/LDS Hospital: LW, SC, KD, Anita Austin, Jeanette Davis, Christy Christiansen, Rebecca Summers, Mardee Merrill.; Emmes Corporation: Alex Brindley, Amarnath Vijayarangan, Andrew Lewandowski, Anil Kumar, AL, Bonita Bender, Caitlyn Hill, Carla Casey, Carolyn Burke, Cathryn Luther-Lemmon, Chandrapal Mandloi, Charlanna Ray, Chelsea Patrichuk, Crystal Love, Damon Collie, Daniel Falleroni, Diane Brandt, Eleanore Hernandez, Elizabeth Hebert, Ellen Lane, Ellen Parker, Erin Rosenbaum, Gayathri Natarajan, George Lindblad, Gillian Armstrong, Hardik Raizada, Harlan Campbell, Jan Peterson, Jean Crawford, Joshua Hagel, Joy Esterlitz, Kristine Nelson, Kunal Narang, Latticia Thomas, Mahesh Minnakanti, Maria Abraham, Mark Polanski, Michael Wierzbicki, Michelle Weeks, Nagaraju Peraboina, Nathan James, Nilay Shah, Noble Shore, Noga Lewin, Omid Neyzari, Priyanka Basa, Radhika Kondapaka, Rebecca Morgan, Robert Lindblad, Ross Nelson, Sarah Moore, Scott McCrimmon, Shilpa Puyamurthy, SW, Stephanie Monroe, Sunny Verma, Susan Parks, Timothy Heitman, TingTing Lu, Traci Scheer, Tricia Schurman, Whitney Sheffer, Zorayr Manukyan.; Henry M. Jackson Foundation: Jami Egan, AM, Elizabeth Searing, Mark Greeder, Barbara Mayhugh, Jill York, Jennifer Gardino, Ricki Skaggs, Challa Lowry, Derin Wester, Kris Spalloni, Teresa Thomas, Paul Garibay, Pat Nelson, Cody Turner, Cyndi Pink, Laura Crews, Tina Scheid, Gayle Russell, Tiffany Cripps, Allison Thibodeaux.; Lovelace: WO, COL (ret) CW, Mark Spitz, John Foley, JW, Paul Wetzel, SM, JP, David Cifu, Carla Wilson, Bryan Layton, Daphne Holt, Bruce Fischl, Xaomin Yue, Jeff Lewine, Darlene Harbour.; United States Army Medical Research and Materiel Command/USAMMDA: COL (ret) R. Scott Miller, COL Austin Chhoeu, Mike Husband, CAPT Brett Hart, Marie Cochran, Kyle Martin, Maria Malone, Nicole Johnston, Timothy Ebner, Krista Davis, Cory Uscilowicz, Sherree Grebenstein, Sandra Vazquez, Heather Hedrick, Thomas Jackson, Robert Labutta, Melissa Askin, Christie Lawrence, Dixion Rwakasyaguri, William McCarthy, Jennifer Rebelez, Stacey Brook, BG (ret) Lori Sutton, MAJ Keith Scorza, COL (ret) Brian McCrary, COL (ret) Ric Ricciardi, Robert Miller, MG(ret) James Gilman, LTG(ret) Eric Schoomaker, Wayman Cheatham, LT Kevin Marrs, Adam Johnson, CDR Rene Hernandez, COL Dallas Hack, CPT Leonard Skipper, Jami Brake.; National Intrepid Center of Excellence: Gerard Riedy, Terrence Oakes, Priya Santhanam, Joseph Hennessey, Jenni Pacheco, Theresa Teslovich, Mark Varvaris, Jim Kelley, JP, Pavel Krapiva.	Abraham Neethu G, 2015, Oman J Ophthalmol, V8, P14, DOI 10.4103/0974-620X.149856; Akin FW, 2011, J AM ACAD AUDIOL, V22, P460, DOI 10.3766/jaaa.22.7.6; Alaee A, 2014, IRAN J RADIOL, V11, DOI 10.5812/iranjradiol.14275; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Anic-Labat S, 1999, SLEEP, V22, P77; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Badke MB, 2004, ARCH PHYS MED REHAB, V85, P227, DOI 10.1016/j.apmr.2003.06.006; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Casanova C, 2011, EUR RESPIR J, V37, P150, DOI 10.1183/09031936.00194909; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chaikin LR., 2012, NEUROLOGICAL REHABIL, P863; Chung F, 2014, J CLIN SLEEP MED, V10, P951, DOI 10.5664/jcsm.4022; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Edwards R H, 1977, Physiotherapy, V63, P51; EWING DJ, 1991, BRIT HEART J, V65, P239; Felipe L, 2014, INT ARCH OTORHINOLAR, V18, P77, DOI 10.1055/s-0033-1352503; Fitzgerald B, 1996, SPUMS J, V26, P142; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Gschwandtner U, 2009, EUR ARCH PSY CLIN N, V259, P257, DOI 10.1007/s00406-008-0854-3; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Hayasaka S, 2007, NEUROIMAGE, V37, P721, DOI 10.1016/j.neuroimage.2007.06.009; Hirvonen TP, 1999, J VESTIBUL RES-EQUIL, V9, P119; Honaker JA, 2010, J VESTIBUL RES-EQUIL, V20, P357, DOI 10.3233/VES-2010-0365; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jacobson G, 2008, BALANCE FUNCTION ASS; Katz J, 2009, HDB CLIN AUDIOLOGY; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Kostro D, 2014, NEUROIMAGE, V98, P405, DOI 10.1016/j.neuroimage.2014.04.057; Kothari Mihir T., 2005, Indian Journal of Ophthalmology, V53, P43; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lee C T, 1998, SPUMS J, V28, P125; Lee DH., 2004, J KOREAN OPHTHALMOL, V45, P797; Lefevre F, 2007, J FR OPHTALMOL, V30, P598, DOI 10.1016/S0181-5512(07)89664-1; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Massy-Westropp Nicola M, 2011, BMC Res Notes, V4, P127, DOI 10.1186/1756-0500-4-127; McGuire S, 2013, NEUROLOGY, V81, P729, DOI 10.1212/WNL.0b013e3182a1ab12; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meehan A, 2016, UNDERSEA HYPERBAR M, V43, P567; Minassian A, 2014, PSYCHOSOM MED, V76, P292, DOI 10.1097/PSY.0000000000000056; Mirow S, 2016, UNDERSEA HYPERBAR M, V43, P531; Mirzaalian H, 2016, NEUROIMAGE, V135, P311, DOI 10.1016/j.neuroimage.2016.04.041; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Mumford JA, 2008, NEUROIMAGE, V39, P261, DOI 10.1016/j.neuroimage.2007.07.061; Neema M, 2009, AM J NEURORADIOL, V30, P911, DOI 10.3174/ajnr.A1514; NOTERMANS NC, 1994, J NEUROL NEUROSUR PS, V57, P22, DOI 10.1136/jnnp.57.1.22; OLEARY DP, 1990, NEUROL CLIN, V8, P297, DOI 10.1016/S0733-8619(18)30357-8; Pagel JF, 2011, J CLIN SLEEP MED, V7, P610, DOI 10.5664/jcsm.1462; Parkinson RB, 2002, NEUROLOGY, V58, P1525, DOI 10.1212/WNL.58.10.1525; Perri1 C.D., 2013, J BIOMED GRAPH COMPU, DOI [10.5430/jbgc.v3n3p53, DOI 10.5430/JBGC.V3N3P53]; Pu Y, 2007, AM J NEURORADIOL, V28, P1706, DOI 10.3174/ajnr.A0656; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sachdev P, 1999, Int Psychogeriatr, V11, P421, DOI 10.1017/S1041610299006031; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sun B, 2009, INT J DEV NEUROSCI, V27, P655, DOI 10.1016/j.ijdevneu.2009.08.002; Thompson C., 2016, 11 WORLD C BRAIN INJ; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Walker EA, 2002, GEN HOSP PSYCHIAT, V24, P375, DOI 10.1016/S0163-8343(02)00203-7; Walker JM, 2018, SLEEP MED, V51, P66, DOI 10.1016/j.sleep.2018.06.006; Weaver LK, 2018, UNDERSEA HYPERBAR M, V45, P129; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P485; Wetzel PA, 2018, INVEST OPHTH VIS SCI, V59, P4011, DOI 10.1167/iovs.18-23815; Williams CS, 2016, UNDERSEA HYPERBAR M, V43, P511; Williams CS, 2016, UNDERSEA HYPERBAR M, V43, P521	85	6	6	2	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 17	2018	9								1030	10.3389/fneur.2018.01030			25	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HE4UK	WOS:000453363000001	30631299	Green Published, gold			2022-02-06	
J	Sun, MJ; Brady, RD; Poel, CD; Apted, D; Semple, BD; Church, JE; O'Brien, TJ; McDonald, SJ; Shultz, SR				Sun, Mujun; Brady, Rhys D.; van der Poel, Chris; Apted, Danielle; Semple, Bridgette D.; Church, Jarrod E.; O'Brien, Terence J.; McDonald, Stuart J.; Shultz, Sandy R.			A Concomitant Muscle Injury Does Not Worsen Traumatic Brain Injury Outcomes in Mice	FRONTIERS IN NEUROLOGY			English	Article						polytrauma; weight-drop; cardiotoxin; neuroinflammation; cytokines	OXIDATIVE STRESS; SKELETAL-MUSCLE; RAT MODEL; ANIMAL-MODELS; BONE-FRACTURE; MOUSE MODEL; NEUROINFLAMMATION; PROTEIN; REGENERATION; INFLAMMATION	Traumatic brain injury (TBI) often involves multitrauma in which concurrent extracranial injury occurs. We previously demonstrated that a long bone fracture exacerbates neuroinflammation and functional outcomes in mice given a TBI. Whether other forms of concomitant peripheral trauma that are common in the TBI setting, such as skeletal muscle injury, have similar effects is unknown. As such, here we developed a novel mouse multitrauma model by combining a closed-skull TBI with a cardiotoxin (CTX)-induced muscle injury to investigate whether muscle injury affects TBI outcomes. Adult male mice were assigned to four groups: sham-TBI + sham-muscle injury (SHAM); sham-TBI + CTX-muscle injury (CTX); TBI + sham-muscle injury (TBI); TBI + CTX-muscle injury (MULTI). Some mice were euthanized at 24 h post-injury to assess neuroinflammation and cerebral edema. The remaining mice underwent behavioral testing after a 30-day recovery period, and were euthanized at 35 days post-injury for post-mortem analysis. At 24 h post-injury, both TBI and MULTI mice had elevated edema, increased expression of GFAP (i.e., a marker for reactive astrocytes), and increased mRNA levels of inflammatory chemokines. There was also an effect of injury on cytokine levels at 35 days post-injury. However, the TBI and MULTI mice did not significantly differ on any of the measures assessed. These initial findings suggest that a concomitant muscle injury does not significantly affect preclinical TBI outcomes. Future studies should investigate the combination of different injury models, additional outcomes, and other post-injury time points.	[Sun, Mujun; Semple, Bridgette D.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Brady, Rhys D.; Semple, Bridgette D.; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Brady, Rhys D.; Semple, Bridgette D.; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Med, Melbourne, Vic, Australia; [van der Poel, Chris; Apted, Danielle; Church, Jarrod E.; McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia		Shultz, SR (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia.; Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.; Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Med, Melbourne, Vic, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	Sun, Mujun/0000-0002-9923-9913; Church, Jarrod/0000-0001-8266-4043; O'Brien, Terence/0000-0002-7198-8621; McDonald, Stuart/0000-0001-5190-3179	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1087172]; La Trobe University (RFA Understanding Disease)	This work was supported by a fellowship to SS from the National Health and Medical Research Council (1087172), and a grant to SM and JC from La Trobe University (RFA Understanding Disease).	Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; CHANG CC, 1972, BRIT J PHARMACOL, V44, P752, DOI 10.1111/j.1476-5381.1972.tb07313.x; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; FIELDING RA, 1993, AM J PHYSIOL, V265, pR166, DOI 10.1152/ajpregu.1993.265.1.R166; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714; Karalaki M, 2009, IN VIVO, V23, P779; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Lu J, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.35; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; Nguyen MH, 2011, THESCIENTIFICWORLDJO, V11, P1525, DOI 10.1100/tsw.2011.137; Martinez L, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0042-x; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McDonald SJ, 2011, J ORTHOP RES, V29, P740, DOI 10.1002/jor.21302; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Paiva-Oliveira EL, 2017, HISTOCHEM CELL BIOL, V148, P49, DOI 10.1007/s00418-017-1556-6; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Ramadasan-Nair R, 2014, J BIOL CHEM, V289, P485, DOI 10.1074/jbc.M113.493270; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wolf A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147733; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393	46	6	6	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 11	2018	9								1089	10.3389/fneur.2018.01089			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HD9GD	WOS:000452868700002	30619048	Green Published, gold			2022-02-06	
J	Labrell, F; Camara-Costa, H; Dufour, C; Grill, J; Dellatolas, G; Chevignard, M				Labrell, Florence; Camara-Costa, Hugo; Dufour, Christelle; Grill, Jacques; Dellatolas, Georges; Chevignard, Mathilde			Parental stress and paediatric acquired brain injury	BRAIN INJURY			English	Article						Maternal stress; acquired brain injury; brain tumour; traumatic brain injury; childhood stroke; questionnaires; interventions	CHILDHOOD-CANCER; CHILDREN; TUMOR; SURVIVORS; OUTCOMES; MOTHERS; REHABILITATION; PREDICTORS; CAREGIVERS; ADJUSTMENT	Objective: Studies on parental stress following childhood acquired brain injury (ABI-including brain tumours (BT) and other brain injuries) are scarce. The aim of this study was to assess maternal stress in a sample of children and adolescents diagnosed with severe paediatric ABI. Methods: Seventy-eight French-speaking mothers of 37 with BT and 41 with other ABIs completed the Paediatric Inventory for Parents (PIP), the State-Trait Anxiety Inventory (STAI) and the Family Assessment Device (FAD) at a mean time since diagnosis of 1.5 years. Results: The PIP correlated significantly with the STAI and the FAD. Socio-demographic factors, such as the age of mother and child, and the mother's educational level, were correlated with both maternal stress and anxiety. Maternal stress scores were comparable between groups. Emotional functioning was the most markedly affected domain, followed by parental role. Conclusions: Emotional stress as assessed by the PIP in mothers of children with ABI is significant and should motivate specific psychosocial interventions.	[Labrell, Florence; Camara-Costa, Hugo; Dellatolas, Georges] Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM, Villejuif, France; [Labrell, Florence] INSHEA, Suresnes, France; [Dufour, Christelle; Grill, Jacques] Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France; [Chevignard, Mathilde] St Maurice Hosp, Rehabil Dept Children Acquired Neurol Injury, St Maurice, France; [Chevignard, Mathilde] St Maurice Hosp, Outreach Team Children & Adolescents Acquired Bra, St Maurice, France		Labrell, F (corresponding author), Hop Paul Brousse, INSERM 1178, CESP, Batiment 15-16,16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	florence.labrell@gmail.com	Dellatolas, Georges/AAW-1377-2021; Grill, Jacques/R-8093-2019	Camara-Costa, Hugo/0000-0002-3739-7190	Canceropole IDF [project SPELECA, AAP Emergence 2015]	This work was supported by the Canceropole IDF [project SPELECA, AAP Emergence 2015].	Ach E, 2013, PSYCHO-ONCOLOGY, V22, P1731, DOI 10.1002/pon.3202; Anderson NE, 2003, CURR OPIN NEUROL, V16, P677, DOI 10.1097/00019052-200312000-00006; Anderson V., 2012, DEV SOCIAL NEUROSCIE, P231; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2014, SOC NEUROSCI-UK, V9, P471, DOI 10.1080/17470919.2014.932308; [Anonymous], J PSYCHOSOC ONCOL; Aukema EJ, 2011, SUPPORT CARE CANCER, V19, P1637, DOI 10.1007/s00520-010-0995-6; Bemis H, 2015, J PEDIATR PSYCHOL, V40, P733, DOI 10.1093/jpepsy/jsv024; Bennett E, 2013, PSYCHO-ONCOLOGY, V22, P629, DOI 10.1002/pon.3047; Bona K, 2014, J PAIN SYMPTOM MANAG, V47, P594, DOI 10.1016/j.jpainsymman.2013.04.003; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burke K, 2014, FAM SYST HEALTH, V32, P122, DOI 10.1037/fsh0000012; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Chevignard M, 2017, NEURO-ONCOL PRACT, V4, P82, DOI 10.1093/nop/npw013; Chevignard M, 2016, ACTA PAEDIATR, V105, P574, DOI 10.1111/apa.13245; Cushing CC, 2016, J PEDIATR PSYCHOL, V41, P309, DOI [10.1093/jpepsy/jsv093, DOI 10.1093/JPEPSY/JSV093]; Dunn MJ, 2012, HEALTH PSYCHOL, V31, P176, DOI 10.1037/a0025545; Edelstein K, 2011, NEURO-ONCOLOGY, V13, P536, DOI 10.1093/neuonc/nor015; Frange P, 2009, J NEURO-ONCOL, V95, P271, DOI 10.1007/s11060-009-9927-z; Freeman Katherine, 2004, J Pediatr Oncol Nurs, V21, P87, DOI 10.1177/1043454203262691; Greenham M, 2015, DEV NEUROPSYCHOL, V40, P348, DOI 10.1080/87565641.2015.1095191; Guilfoyle SM, 2012, CHILD CARE HLTH DEV, V38, P273, DOI 10.1111/j.1365-2214.2010.01200.x; Hajek CA, 2014, J CHILD NEUROL, V29, P887, DOI 10.1177/0883073813491828; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hutchinson KC, 2009, PSYCHO-ONCOLOGY, V18, P515, DOI 10.1002/pon.1421; Kazak AE, 1998, J AM ACAD CHILD PSY, V37, P823, DOI 10.1097/00004583-199808000-00012; King TZ, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI [10.1017/S1355617711001792, DOI 10.1017/S1355617711001792]; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Narad ME, 2017, J PEDIATR PSYCHOL, V42, P304, DOI 10.1093/jpepsy/jsw079; Norberg AL, 2009, EUR J CANCER CARE, V18, P371, DOI 10.1111/j.1365-2354.2008.00976.x; Peris-Bonet R, 2006, EUR J CANCER, V42, P2064, DOI 10.1016/j.ejca.2006.05.009; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Radcliffe J, 1996, J PEDIATR PSYCHOL, V21, P529, DOI 10.1093/jpepsy/21.4.529; Rashid M, 2014, J PEDIATR REHAB MED, V7, P241, DOI 10.3233/PRM-140293; Sahler OJZ, 2013, J CLIN ONCOL, V31, P1329, DOI 10.1200/JCO.2011.39.1870; Schweitzer M.B., 1990, MANUEL INVENTAIRE AN; Speranza M, 2012, CAN J PSYCHIAT, V57, P570, DOI 10.1177/070674371205700908; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Streisand R, 2001, J PEDIATR PSYCHOL, V26, P155, DOI 10.1093/jpepsy/26.3.155; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Vander Haegen M, 2015, J PSYCHOSOC ONCOL, V33, P504, DOI 10.1080/07347332.2015.1067279; Vrijmoet-Wiersma CMJ, 2008, J PEDIATR PSYCHOL, V33, P694, DOI 10.1093/jpepsy/jsn007; WAALAND PK, 1993, BRAIN INJURY, V7, P135, DOI 10.3109/02699059309008167; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Warner EL, 2015, J ONCOL PRACT, V11, P12, DOI 10.1200/JOP.2014.001495; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	46	6	6	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1780	1786		10.1080/02699052.2018.1524931			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600022	30296189	Green Submitted			2022-02-06	
J	Cota, MR; Moses, AD; Jikaria, NR; Bittner, KC; Diaz-Arrastia, RR; Latour, LL; Turtzo, LC				Cota, Martin R.; Moses, Anita D.; Jikaria, Neekita R.; Bittner, Katie C.; Diaz-Arrastia, Ramon R.; Latour, Lawrence L.; Turtzo, L. Christine			Discordance between Documented Criteria and Documented Diagnosis of Traumatic Brain Injury in the Emergency Department	JOURNAL OF NEUROTRAUMA			English	Article						diagnosis; emergency department; traumatic brain injury	UNITED-STATES; EPIDEMIOLOGY; MANAGEMENT; ACCURACY	Accurate diagnosis of traumatic brain injury (TBI) is critical to ensure that patients receive appropriate follow-up care, avoid risk of subsequent injury, and are aware of possible long-term consequences. However, diagnosis of TBI, particularly in the emergency department (ED), can be difficult because the symptoms of TBI are vague and nonspecific, and patients with suspected TBI may present with additional injuries that require immediate medical attention. We performed a retrospective chart review to evaluate accuracy of TBI diagnosis in the ED. Records of 1641 patients presenting to the ED with suspected TBI and a head computed tomography (CT) were reviewed. We found only 47% of patients meeting the American Congress of Rehabilitation Medicine criteria for TBI received a documented ED diagnosis of TBI in medical records. After controlling for demographic and clinical factors, patients presenting at a level I trauma center, with cause of injury other than fall, without CT findings of TBI, and without loss of consciousness were more likely to lack documented diagnosis despite meeting diagnostic criteria for TBI. A greater proportion of patients without documented ED diagnosis of TBI were discharged home compared to those with a documented diagnosis of TBI (58% vs. 40%; p < 0.001). Together, these data suggest that many patients who have sustained a TBI are discharged home from the ED without a documented diagnosis of TBI, and that improved awareness and implementation of diagnostic criteria for TBI is important in the ED and for in- and outpatient providers.	[Cota, Martin R.; Moses, Anita D.; Jikaria, Neekita R.; Latour, Lawrence L.; Turtzo, L. Christine] NINDS, Stroke Diagnost & Therapeut Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Cota, Martin R.; Moses, Anita D.; Jikaria, Neekita R.; Bittner, Katie C.; Latour, Lawrence L.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Diaz-Arrastia, Ramon R.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Turtzo, LC (corresponding author), NINDS, Bldg 10,Room B1D733,10 Ctr Dr, Bethesda, MD 20814 USA.	l.turtzo@nih.gov	Latour, Larry/AAH-5663-2021	Latour, Larry/0000-0001-6160-5263	Intramural Research Program at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI); Department of Defense through the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003120] Funding Source: NIH RePORTER	Support for this work included funding from the Intramural Research Program at the National Institutes of Health and the Department of Defense through the Center for Neuroscience and Regenerative Medicine. We acknowledge Johns Hopkins Suburban Hospital and MedStar Health Washington Hospital Center for providing the data necessary for this study.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; DiMaggio CJ, 2017, ACAD EMERG MED, V24, P1244, DOI 10.1111/acem.13223; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Pogoda TK, 2014, J REHABIL RES DEV, V51, P363, DOI 10.1682/JRRD.2013.05.0115; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	21	6	6	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1335	1342		10.1089/neu.2018.5772		DEC 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000451965900001	30351183	Green Published			2022-02-06	
J	Adelgais, KM; Hansen, M; Lerner, EB; Donofrio, JJ; Yadav, K; Brown, K; Liu, YT; Denslow, P; Denninghoff, K; Ishimine, P; Olson, LM				Adelgais, Kathleen M.; Hansen, Matthew; Lerner, E. Brooke; Donofrio, J. Joelle; Yadav, Kabir; Brown, Kathleen; Liu, Yiju T.; Denslow, Paula; Denninghoff, Kurt; Ishimine, Paul; Olson, Lenora M.		SAEM Consensus Conf Emergency Med	Establishing the Key Outcomes for Pediatric Emergency Medical Services Research	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	Society-for-Academic-Emergency-Medicine Consensus Conference (AEMCC) on Aligning the Pediatric Emergency Medicine ResearchAgenda to Reduce Health Outcome Gaps	MAY, 2018	Indianapolis, IN	Soc Acad Emergency Med			EVIDENCE-BASED GUIDELINE; ENDOTRACHEAL INTUBATION; PROBABILISTIC LINKAGE; PAIN MANAGEMENT; ERRORS; SIMULATION; CARE; RISK	The evidence supporting best practices when treating children in the prehospital setting or even the effect emergency medical services (EMS) has on patient outcomes is limited. Standardizing the critical outcomes for EMS research will allow for focused and comparable effort among the small but growing group of pediatric EMS investigators on specific topics. Standardized outcomes will also provide the opportunity to collectively advance the science of EMS for children and demonstrate the effect of EMS on patient outcomes. This article describes a consensus process among stakeholders in the pediatric emergency medicine and EMS community that identified the critical outcomes for EMS care in five clinical areas (traumatic brain injury, general injury, respiratory disease/failure, sepsis, and seizures). These areas were selected based on both their known public health importance and their commonality in EMS encounters. Key research outcomes identified by participating stakeholders using a modified nominal group technique for consensus building, which included small group brainstorming and independent voting for ranking outcomes that were feasible and/or important for the field.	[Adelgais, Kathleen M.] Univ Colorado, Sch Med, Dept Pediat, Sect Pediat Emergency Med, Aurora, CO 80045 USA; [Hansen, Matthew] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR USA; [Lerner, E. Brooke] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Lerner, E. Brooke] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Donofrio, J. Joelle; Ishimine, Paul] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; [Donofrio, J. Joelle; Ishimine, Paul] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Yadav, Kabir; Liu, Yiju T.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Denslow, Paula] Tennessee Disabil Coalit, Nashville, TN USA; [Brown, Kathleen] George Washington Univ, Sch Med, Dept Emergency Med, Washington, DC USA; [Brown, Kathleen] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Denninghoff, Kurt] Univ Arizona, Sch Med, Dept Emergency Med, Tucson, AZ USA; [Olson, Lenora M.] Univ Utah, Sch Med, Dept Pediat, Div Pediat Crit Care, Salt Lake City, UT USA		Adelgais, KM (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Sect Pediat Emergency Med, Aurora, CO 80045 USA.	kathleen.adelgais@childrenscolorado.org	Lerner, E. Brooke/AAM-9590-2020	Lerner, E. Brooke/0000-0003-0043-3757; Hansen, Matthew/0000-0003-2958-6423; Yadav, Kabir/0000-0002-1092-9935	Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1R13HS026101-01];  [EAIN-6161]	Funding for this conference was made possible in part by grant number 1R13HS026101-01 from the Agency for Healthcare Research and Quality (AHRQ) and Patient-Centered Outcomes Research Institute (PCORI) engagement award EAIN-6161. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services or PCORI, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.	Browne LR, 2016, PREHOSP EMERG CARE, V20, P759, DOI 10.1080/10903127.2016.1194931; Browne LR, 2016, PREHOSP EMERG CARE, V20, P311, DOI 10.3109/10903127.2015.1102997; Centers for Disease Control and Prevention [CDC], 2016, 10 LEAD CAUS DEATH A; Cook DA, 2011, JAMA-J AM MED ASSOC, V306, P978, DOI 10.1001/jama.2011.1234; Drayna PC, 2015, PREHOSP EMERG CARE, V19, P441, DOI 10.3109/10903127.2014.995850; Duby R, 2018, PREHOSP EMERG CARE, V22, P34, DOI 10.1080/10903127.2017.1347222; Fleischman RJ, 2011, PEDIATR EMERG CARE, V27, P1130, DOI 10.1097/PEC.0b013e31823a3e73; Foltin GL, 2010, PEDIATR EMERG CARE, V26, P773, DOI 10.1097/PEC.0b013e3181fc4088; Ganss Paul E, 2013, Mo Med, V110, P125; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gausche-Hill M, 2014, PREHOSP EMERG CARE, V18, P25, DOI 10.3109/10903127.2013.844873; Graham S D, 1997, Prehosp Emerg Care, V1, P28, DOI 10.1080/10903129708958781; Guise JM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014057; Hansen M, 2016, AM J EMERG MED, V34, P599, DOI 10.1016/j.ajem.2015.12.082; Hansen ML, 2017, RESUSCITATION, V120, P51, DOI 10.1016/j.resuscitation.2017.08.015; Hewes HA, 2018, PREHOSP EMERG CARE, V22, P189, DOI 10.1080/10903127.2017.1367444; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Hoyle JD, 2016, PREHOSP EMERG CARE, V20, P117, DOI 10.3109/10903127.2015.1061625; Hoyle JD, 2012, PREHOSP EMERG CARE, V16, P59, DOI 10.3109/10903127.2011.614043; Institute of Medicine, 2006, EM MED SERV CROSSR; Institute of Medicine, 1993, EM MED SERV CHILDR; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lammers R, 2014, PREHOSP EMERG CARE, V18, P295, DOI 10.3109/10903127.2013.856501; Lammers R, 2012, ACAD EMERG MED, V19, P37, DOI 10.1111/j.1553-2712.2011.01252.x; Lammers RL, 2014, SIMUL HEALTHC, V9, P174, DOI 10.1097/SIH.0000000000000013; Lammers RL, 2009, PREHOSP EMERG CARE, V13, P345, DOI 10.1080/10903120802706161; Lang ES, 2012, ACAD EMERG MED, V19, P201, DOI 10.1111/j.1553-2712.2011.01281.x; Leonard JC, 2012, ACAD EMERG MED, V19, P161, DOI 10.1111/j.1553-2712.2011.01283.x; Lerner EB, 2014, PREHOSP EMERG CARE, V18, P52, DOI 10.3109/10903127.2013.836262; Markenson D, 2007, PEDIATRICS, V119, pE103, DOI 10.1542/peds.2005-2121; McMillan SS, 2014, HEALTH SERV OUTCOME, V14, P92, DOI 10.1007/s10742-014-0121-1; Meckler G, 2018, PREHOSP EMERG CARE, V22, P290, DOI 10.1080/10903127.2017.1371261; National EMS Information Center Technical Assistance Center, 2016, NAT EMS INF SYST; Newgard CD, 2006, ACAD EMERG MED, V13, P69, DOI 10.1197/j.aem.2005.07.029; Newgard C, 2012, ACAD EMERG MED, V19, P469, DOI 10.1111/j.1553-2712.2012.01324.x; Newgard CD, 2011, PREHOSP EMERG CARE, V15, P303, DOI 10.3109/10903127.2011.561404; Rappaport LD, 2016, PREHOSP EMERG CARE, V20, P508, DOI 10.3109/10903127.2015.1128027; Shah MI, 2016, PREHOSP EMERG CARE, V20, P499, DOI 10.3109/10903127.2016.1139217; Shah MI, 2014, PREHOSP EMERG CARE, V18, P15, DOI 10.3109/10903127.2013.844874; Silbergleit R, 2011, EPILEPSIA, V52, P45, DOI 10.1111/j.1528-1167.2011.03235.x; TSAI A, 1987, ANN EMERG MED, V16, P284; Wang HE, 2010, ANN EMERG MED, V55, P527, DOI 10.1016/j.annemergmed.2009.12.020; Wang HE, 2009, RESUSCITATION, V80, P50, DOI 10.1016/j.resuscitation.2008.08.016	43	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2018	25	12			SI		1345	1354		10.1111/acem.13637			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	HE5WA	WOS:000453464100004	30312993	Bronze			2022-02-06	
J	Al-Mufti, F; Amuluru, K; Lander, M; Mathew, M; El-Ghanem, M; Nuoman, R; Park, S; Patel, V; Singh, IP; Gupta, G; Gandhi, CD				Al-Mufti, Fawaz; Amuluru, Krishna; Lander, Megan; Mathew, Melvin; El-Ghanem, Mohammad; Nuoman, Rolla; Park, Seami; Patel, Vikas; Singh, Inder Paul; Gupta, Gaurav; Gandhi, Chirag D.			Low Glasgow Coma Score in Traumatic Intracranial Hemorrhage Predicts Development of Cerebral Vasospasm	WORLD NEUROSURGERY			English	Article						Glasgow Coma scale; Traumatic intracranial hemorrhage; Vasospasm	SUBARACHNOID HEMORRHAGE; POSTTRAUMATIC VASOSPASM; ARTERIAL SPASM; EPIDEMIOLOGY; HYPEREMIA; CHILDREN	BACKGROUND: The exact mechanism, incidence, and risk factors for cerebral vasospasm after traumatic intracranial hemorrhage (ICH) continue to be poorly characterized. The incidence of post-traumatic vasospasm (PTV) varies depending on the detection modality. OBJECTIVE: We aimed to shed light on the predictors, associations, and true incidence of cerebral vasospasm after traumatic ICH using digital subtraction angiography (DSA) as the gold standard. METHODS: We examined a prospectively maintained database of traumatic brain injury (TBI) patients to identify patients with ICH secondary to TBI enrolled between 2002 and 2015 at our trauma center. Patients with TBI-associated ICH and evidence of elevated velocities on transcranial Doppler and computed tomography angiograms, confirmed with DSA were included. The diagnostic cerebral angiograms were evaluated by 2 blinded neurointerventionalists for cerebral vasospasm. Statistical analyses were conducted to determine predictors of PTV. RESULTS: Twenty patients with ICH secondary to TBI and evidence of vasospasm underwent DSAs. Seven patients (7/20; 35%) with traumatic ICH developed cerebral vasospasm and of those, 1 developed delayed cerebral ischemia (1/7; 14%). Of these 7 patients, 6 presented with subarachnoid hemorrhage (6/7; 85%). Vasospasm was substantially more common in patients with a Glasgow Coma Scale <9 (P = 0.017) than in all other groups. CONCLUSIONS: PTV as demonstrated by DCA may be more common than previously reported. Patients who exhibit PTV were more likely to have a Glasgow Coma Scale <9. This subgroup of patients may benefit from more systematic screening for the development of PTV, and earlier monitoring for signs of delayed cerebral ischemia.	[Al-Mufti, Fawaz; Patel, Vikas; Gandhi, Chirag D.] New York Med Coll, Dept Neurol Neurosurg & Radiol, Valhalla, NY 10595 USA; [Lander, Megan; Mathew, Melvin; Gandhi, Chirag D.] Rutgers State Univ, New Jersey Med Sch, Dept Neurosurg, Newark, NJ USA; [Nuoman, Rolla; Park, Seami; Patel, Vikas; Gandhi, Chirag D.] Rutgers State Univ, New Jersey Med Sch, Dept Neurol, Newark, NJ USA; [Gandhi, Chirag D.] Rutgers State Univ, New Jersey Med Sch, Dept Radiol, Newark, NJ USA; [Gupta, Gaurav] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosurg, New Brunswick, NJ USA; [Amuluru, Krishna] Univ Pittsburgh, Med Ctr Hamot, Dept Intervent Neuroradiol, Erie, PA USA; [El-Ghanem, Mohammad] Univ Arizona, Coll Med Tucson, Dept Neurol & Med Imaging, Tucson, AZ USA; [Singh, Inder Paul] Mt Sinai Hlth Syst, Dept Neurosurg Neurol & Radiol, New York, NY USA		Al-Mufti, F (corresponding author), New York Med Coll, Dept Neurol Neurosurg & Radiol, Valhalla, NY 10595 USA.	fawazalmufti@outlook.com	Al-Mufti, Fawaz/AAZ-3360-2020; Gupta, Gaurav/AAL-3349-2020	Al-Mufti, Fawaz/0000-0003-4461-7005; Gupta, Gaurav/0000-0002-9442-6007; Amuluru, Krishna/0000-0002-8859-8574			Abraszko R, 1996, J CLIN NEUROSCI, V3, P21, DOI 10.1016/S0967-5868(96)90078-8; Armin SS, 2008, ACTA NEUROCHIR SUPPL, V104, P421; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; ARUTIUNOV AI, 1974, J NEUROSURG, V40, P459, DOI 10.3171/jns.1974.40.4.0459; COLUMELLA F, 1963, ACTA RADIOL DIAGN, V1, P239, DOI 10.1177/028418516300100217; DUCKLES SP, 1976, STROKE, V7, P174, DOI 10.1161/01.STR.7.2.174; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Hansen-Schwartz J, 2007, TRENDS PHARMACOL SCI, V28, P252, DOI 10.1016/j.tips.2007.04.002; Kallakuri S, 2010, NEUROSCIENCE, V168, P820, DOI 10.1016/j.neuroscience.2010.01.018; LEEDS NE, 1966, ACTA RADIOL DIAGN, V5, P320, DOI 10.1177/02841851660050P135; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; O'Brien NF, 2015, CRIT CARE MED, V43, P674, DOI 10.1097/CCM.0000000000000745; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Perrein A, 2015, MINERVA ANESTESIOL, V81, P1219; Provencio JJ, 2005, SEMIN NEUROL, V25, P435, DOI 10.1055/s-2005-923537; Schmieder K, 1996, ACTA NEUROL SCAND, V93, P123, DOI 10.1111/j.1600-0404.1996.tb00573.x; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; SYMON L, 1967, J NEUROL NEUROSUR PS, V30, P497, DOI 10.1136/jnnp.30.6.497; Vajramani GV, 1999, BRIT J NEUROSURG, V13, P468, DOI 10.1080/02688699943277; Viera AJ, 2005, FAM MED, V37, P360; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626; Zubkov ZY, 2000, SURG NEUROL, V53, P126; Zurynski YA, 1998, J CLIN NEUROSCI, V5, P146, DOI 10.1016/S0967-5868(98)90028-5	26	6	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2018	120						E68	E71		10.1016/j.wneu.2018.07.143			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA9ZO	WOS:000450668300010	30055364				2022-02-06	
J	Campos-Pires, R; Yonis, A; Macdonald, W; Harris, K; Edge, CJ; Mahoney, PF; Dickinson, R				Campos-Pires, Rita; Yonis, Amina; Macdonald, Warren; Harris, Katie; Edge, Christopher J.; Mahoney, Peter F.; Dickinson, Robert			A Novel In Vitro Model of Blast Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 142; Blast traumatic brain injury; primary blast injury; blast-induced neurotrauma; shock tube; in vitro model; TBI; organotypic hippocampal slice cultures	HIPPOCAMPAL SLICE CULTURES; ORGANOTYPIC CULTURES; XENON; GLUTAMATE; NEURONS; NEUROPROTECTION; VULNERABILITY; INHIBITION	Traumatic brain injury is a leading cause of death and disability in military and civilian populations. Blast traumatic brain injury results from the detonation of explosive devices, however, the mechanisms that underlie the brain damage resulting from blast overpressure exposure are not entirely understood and are believed to be unique to this type of brain injury. Preclinical models are crucial tools that contribute to better understand blast-induced brain injury. A novel in vitro blast TBI model was developed using an open-ended shock tube to simulate real-life open-field blast waves modelled by the Friedlander waveform. C57BL/6N mouse organotypic hippocampal slice cultures were exposed to single shock waves and the development of injury was characterized up to 72 h using propidium iodide, a well-established fluorescent marker of cell damage that only penetrates cells with compromised cellular membranes. Propidium iodide fluorescence was significantly higher in the slices exposed to a blast wave when compared with sham slices throughout the duration of the protocol. The brain tissue injury is very reproducible and proportional to the peak overpressure of the shock wave applied.	[Campos-Pires, Rita; Yonis, Amina; Harris, Katie; Dickinson, Robert] Imperial Coll London, Dept Surg & Canc, Anaesthet Pain Med & Intens Care Sect, London, England; [Campos-Pires, Rita; Macdonald, Warren; Dickinson, Robert] Imperial Coll London, Dept Bioengn, Royal British Leg Ctr Blast Injury Studies, London, England; [Macdonald, Warren] Imperial Coll London, Dept Bioengn, London, England; [Edge, Christopher J.] Imperial Coll London, Dept Life Sci, London, England; [Edge, Christopher J.] Royal Berkshire Hosp NHS Fdn Trust, Dept Anaesthet, Reading, Berks, England; [Mahoney, Peter F.] Royal Ctr Def Med, Med Directorate Joint Force Command, Birmingham, W Midlands, England		Dickinson, R (corresponding author), Imperial Coll London, Dept Surg & Canc, Anaesthet Pain Med & Intens Care Sect, London, England.; Dickinson, R (corresponding author), Imperial Coll London, Dept Bioengn, Royal British Leg Ctr Blast Injury Studies, London, England.	r.dickinson@imperial.ac.uk			Royal Centre for Defence Medicine, Birmingham, United Kingdom; Royal British Legion Centre for Blast Injury Studies, Imperial College London, United Kingdom; Medical Research Council, London, United KingdomUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_13064, MR/N027736/1]; Gas Safety Trust, London, United Kingdom; Fundacao para a Ciencia e a Tecnologia, Lisbon, PortugalPortuguese Foundation for Science and Technology; Westminster Medical School Research Trust, London, United Kingdom; Royal British Legion Centre for Blast Injury Studies (RBLCBIS) at Imperial College; Royal British Legion; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N027736/1, MC_PC_13064] Funding Source: UKRI	Royal Centre for Defence Medicine, Birmingham, United Kingdom, Royal British Legion Centre for Blast Injury Studies, Imperial College London, United Kingdom. Medical Research Council, London, United Kingdom (MC_PC_13064; MR/N027736/1). The Gas Safety Trust, London, United Kingdom. Rita Campos-Pires was the recipient of a doctoral training award from the Fundacao para a Ciencia e a Tecnologia, Lisbon, Portugal. Katie Harris was the recipient of a PhD studentship from the Westminster Medical School Research Trust, London, United Kingdom.; This model was developed with the support of the Royal British Legion Centre for Blast Injury Studies (RBLCBIS) at Imperial College. We would like to acknowledge the financial support of the Royal British Legion. Researchers interested in collaborations or further detail may contact the authors or RBLCBIS.	Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Campos-Pires R, 2018, J NEUROTRAUM, V35, P1037, DOI 10.1089/neu.2017.5360; Campos-Pires R, 2015, CRIT CARE MED, V43, P149, DOI 10.1097/CCM.0000000000000624; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cho SG, 2004, NEUROCHEM INT, V45, P117, DOI 10.1016/j.neuint.2003.11.012; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Edwards David P., 2016, BirdingASIA, V25, P87; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kirkman E, 2011, PHILOS T R SOC B, V366, P144, DOI 10.1098/rstb.2010.0240; Kluger Yoram, 2007, Am J Disaster Med, V2, P21; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; NEWELL DW, 1995, J NEUROSCI, V15, P7702; Nguyen T. T. H., 2016, THESIS; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Salvador-Silva M, 2004, GLIA, V45, P364, DOI 10.1002/glia.10342; Sawyer TW, 2018, SHOCK WAVES, V28, P85, DOI 10.1007/s00193-017-0756-2; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242	51	6	6	3	13	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	DEC	2018		142							e58400	10.3791/58400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI5EC	WOS:000456474300026	30614488	Bronze			2022-02-06	
J	Cheng, C; Chi, NC; Williams, E; Thompson, HJ				Cheng, Chieh; Chi, Nai-Ching; Williams, Ellita; Thompson, Hilaire J.			Examining age-related differences in functional domain impairment following traumatic brain injury	INTERNATIONAL JOURNAL OF OLDER PEOPLE NURSING			English	Article						aged; functional status; head injury; health-related quality of life; recovery	INPATIENT REHABILITATION; SEVERITY SCORE; HEALTH SURVEY; PARTICIPATION; EPIDEMIOLOGY; RELIABILITY; MORTALITY; ADULTS	Objective To examine differences in the functional recovery trajectories between younger and older adults with mild-moderate traumatic brain injury (TBI) in the first year postinjury as well as health-related quality of life. Design Observational cohort. Setting Level one trauma centre in the State of Washington. Participants Adults with mild-moderate TBI (N = 34; younger adults, n = 19, and older adults, n = 15). Interventions None. Main Outcome Measures Functional Status Examination (FSE) and health-related quality of life (HRQOL; SF-12v2). Results Older adults consistently showed significantly worse functional performance than younger adults following TBI in the following FSE domains: mobility, ability to travel, home maintenance and overall functional status. For both groups, preinjury physical health was significantly correlated with ability to travel and social integration at 12-month postinjury. Older participants' preinjury physical and mental health had significant and negative correlation with their functional status. Conclusions Our study provides insights and implications into adults' specific functional impairments following TBI, and which domains have persistent deficits. Implications for Practice Early intervention and rehabilitation should focus on improving older adults' physical functioning and mobility. Our study may also inform future research and design of post-TBI interventions for older adults.	[Cheng, Chieh] Univ Washington, Sch Nursing, Psychosocial & Community Hlth Dept, Seattle, WA 98195 USA; [Cheng, Chieh] Univ Washington, Tacoma, WA USA; [Chi, Nai-Ching] Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA; [Williams, Ellita] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Thompson, Hilaire J.] Univ Washington, Sch Nursing, Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA; [Thompson, Hilaire J.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Thompson, HJ (corresponding author), Univ Washington, Hlth Sci Bldg,Box 357266,1959 NE Pacific Ave, Seattle, WA 98195 USA.	hilairet@uw.edu		Cheng, Chieh/0000-0001-8073-5733; Chi, Nai-Ching/0000-0001-7016-8034; Thompson, Hilaire/0000-0002-5472-478X	NIH/NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077913]; NIH/NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR015715]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR015715] Funding Source: NIH RePORTER	This study was supported, in part, by grants from NIH/NCRR KL2RR025015 HT, NIH/NINDS R01NS077913 (HT) and NIH/NINR F31NR015715 (EW). The funding sources had no role in the design, conduct, or preparation of this manuscript.	BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Chang PJ, 2014, HEALTH PSYCHOL, V33, P516, DOI 10.1037/hea0000051; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Howrey BT, 2017, ARCH PHYS MED REHAB, V98, P1606, DOI 10.1016/j.apmr.2017.03.009; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Powell JM, 2007, AM J OCCUP THER, V61, P269, DOI 10.5014/ajot.61.3.269; Stienen MN, 2017, SPINE J, V17, P807, DOI 10.1016/j.spinee.2016.12.004; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tiedemann A, 2013, J GERONTOL A-BIOL, V68, P1068, DOI 10.1093/gerona/glt087; Ware J., 1998, SF 12 SCORE SF 12 PH, V2nd Ed; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	23	6	6	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-3735	1748-3743		INT J OLDER PEOPLE N	Int. J. Older People Nurs.	DEC	2018	13	4							e12208	10.1111/opn.12208			9	Geriatrics & Gerontology; Gerontology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Nursing	HB3KC	WOS:000450948900002	30129175	Green Accepted			2022-02-06	
J	Grover, H; Qian, Y; Boada, FE; Lakshmanan, K; Flanagan, S; Lui, YW				Grover, H.; Qian, Y.; Boada, F. E.; Lakshmanan, K.; Flanagan, S.; Lui, Y. W.			MRI Evidence of Altered Callosal Sodium in Mild Traumatic Brain Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CORPUS-CALLOSUM	Eleven patients with a history of mild traumatic brain injury and 10 age- and sex-matched controls underwent sodium MR imaging using a 3T scanner. Higher total sodium concentration in the genu and lower total sodium concentration in the splenium was seen in patients with mild traumatic brain injury compared with controls. The ratio of genu total sodium concentration to splenium total sodium concentration was also higher in patients with mild traumatic brain injury. The total sodium concentration appears to be altered beyond the immediate postinjury phase, and further work is needed to understand the relationship to persistent symptoms and outcome. BACKGROUND AND PURPOSE: Mild traumatic brain injury is a leading cause of death and disability worldwide with 42 million cases reported annually, increasing the need to understand the underlying pathophysiology because this could help guide the development of targeted therapy. White matter, particularly the corpus callosum, is susceptible to injury. Animal models suggest stretch-induced mechanoporation of the axonal membrane resulting in ionic shifts and altered sodium ion distribution. The purpose of this study was to compare the distribution of total sodium concentration in the corpus callosum between patients with mild traumatic brain injury and controls using sodium (Na-23) MR imaging. MATERIALS AND METHODS: Eleven patients with a history of mild traumatic brain injury and 10 age- and sex-matched controls underwent sodium (Na-23) MR imaging using a 3T scanner. Total sodium concentration was measured in the genu, body, and splenium of the corpus callosum with 5-mm ROIs; total sodium concentration of the genu-to-splenium ratio was calculated and compared between patients and controls. RESULTS: Higher total sodium concentration in the genu (49.28 versus 43.29 mmol/L, P = .01) and lower total sodium concentration in the splenium (which was not statistically significant; 38.35 versus 44.06 mmol/L, P = .08) was seen in patients with mild traumatic brain injury compared with controls. The ratio of genu total sodium concentration to splenium total sodium concentration was also higher in patients with mild traumatic brain injury (1.3 versus 1.01, P = .001). CONCLUSIONS: Complex differences are seen in callosal total sodium concentration in symptomatic patients with mild traumatic brain injury, supporting the notion of ionic dysfunction in the pathogenesis of mild traumatic brain injury. The total sodium concentration appears to be altered beyond the immediate postinjury phase, and further work is needed to understand the relationship to persistent symptoms and outcome.	[Grover, H.; Qian, Y.; Boada, F. E.; Lakshmanan, K.; Flanagan, S.; Lui, Y. W.] NYU, Langone Med Ctr, 660 1st Ave, New York, NY 10016 USA		Lui, YW (corresponding author), NYU, Langone Med Ctr, 660 1st Ave, New York, NY 10016 USA.	Yvonne.Lui@nyumc.org		Grover, Hemal/0000-0003-4231-9709; Flanagan, Steven/0000-0001-9005-5897	National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS039135-11, R21 NS090349]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB017183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135, R21NS090349] Funding Source: NIH RePORTER	This work was supported by R01 NS039135-11 and R21 NS090349, from the National Institute for Neurological Disorders and Stroke. It was also performed under the rubric of the Center for Advanced Imaging Innovation and Research (CAI<SUP>2</SUP>R; www.cai2r.net), a National Institute of Biomedical Imaging and Bioengineering Biomedical Technology Resource Center (National Institutes of Health, P41 EB017183).	Alessandri B, 1998, ACT NEUR S, V71, P237; Boada FE, 1997, MAGNET RESON MED, V38, P1022, DOI 10.1002/mrm.1910380624; Dmbska M, 1999, NORMAL PATHOLOGIC DE; Fleysher L, 2013, NMR BIOMED, V26, P9, DOI 10.1002/nbm.2813; Gardiner D, 2011, THESIS; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Harrington Michael G, 2010, Cerebrospinal Fluid Res, V7, P3, DOI 10.1186/1743-8454-7-3; Huang XJ, 2014, J NEUROTRAUM, V31, P346, DOI 10.1089/neu.2013.2899; Huang XJ, 2013, J NEUROTRAUM, V30, P39, DOI 10.1089/neu.2012.2508; Knyazeva MG, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/639430; Kokavec J, 2016, CLIN EXP OPHTHALMOL, V44, P597, DOI 10.1111/ceo.12732; Lakshmanan K, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3867; Luders E, 2010, J NEUROSCI, V30, P10985, DOI 10.1523/JNEUROSCI.5122-09.2010; Madelin G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04763; Mao Q, 2010, NEUROSURGERY, V66, P1134, DOI 10.1227/01.NEU.0000369612.31946.A2; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mirkes C, 2016, MAGN RESON MED, V75, P1278, DOI 10.1002/mrm.25688; O'Neil B, 2014, MIL MED, V179, P1250, DOI 10.7205/MILMED-D-13-00585; Paling D, 2013, BRAIN, V136, P2305, DOI 10.1093/brain/awt149; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qian YX, 2015, MAGN RESON MED, V74, P162, DOI 10.1002/mrm.25393; Qian YX, 2012, MAGN RESON MED, V68, P1808, DOI 10.1002/mrm.24192; Qian YX, 2009, MAGN RESON IMAGING, V27, P656, DOI 10.1016/j.mri.2008.10.008; Qian YX, 2004, MAGNET RESON MED, V52, P688, DOI 10.1002/mrm.20197; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schafer DP, 2006, NEURON GLIA BIOL, V2, P69, DOI 10.1017/S1740925X06000093; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; Wiggins GC, 2016, NMR BIOMED, V29, P96, DOI 10.1002/nbm.3379; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001	30	6	6	0	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	DEC	2018	39	12					2200	2204		10.3174/ajnr.A5903			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	HD7JV	WOS:000452729200014	30498019	Green Published, hybrid, Green Accepted			2022-02-06	
J	Ko, KJ; Kim, YH; Kwon, KH; Kim, MH; Jun, KW; Hwang, JK; Kim, SD; Park, SC; Kim, JI; Yun, SS; Moon, IS				Ko, K. J.; Kim, Y. H.; Kwon, K. H.; Kim, M. H.; Jun, K. W.; Hwang, J. K.; Kim, S. D.; Park, S. C.; Kim, J. I.; Yun, S. S.; Moon, I. S.			Kidney Transplantation Using Expanded-Criteria Deceased Donors: A Comparison With Ideal Deceased Donors and Non-Expanded-Criteria Deceased Donors	TRANSPLANTATION PROCEEDINGS			English	Article							RISK INDEX; OUTCOMES; SURVIVAL	Purpose. The use of expanded-criteria deceased-donor (ECD) kidneys must be evaluated within the objective perspective of critical organ shortage and graft function and survival. In this study, we aimed to compare the clinical outcomes of ECD reliance with concurrent use of ideal-criteria deceased donors (IDDs) and non-ECDs in adult renal transplantation. Methods. Between February 2000 and December 2015, we analyzed 405 deceased-donor renal transplants, specifically 129 grafts (31.9%) from ECDs, 233 grafts (57.5%) from non-ECDs, and 43 grafts (10.6%) from IDDs. ECDs were classified according to the United Network for Organ Sharing guidelines, while an IDD was defined as a younger person (10-39 years of age) with no medical risk factors who died from a traumatic head injury. Donor and recipient risk factors were separately analyzed and correlated with recipient graft function, and survival was evaluated. Results. ECDs were older (56.8 +/- 6.3 years); showed increased incidence of hypertension, diabetes, and cerebrovascular brain death; and had a higher pre-retrieval serum creatinine level than the other groups. ECD kidney recipients were also older (50.6 +/- 9.8 years), had a shorter waiting time (P = .031), and demonstrated a low frequency of re-transplantation (P = .028). Long-term renal function followed longitudinally was lower in ECD kidney recipients until five years after transplantation, while the glomerular filtration rate (GFR) level at 7 and 10 years did not differ significantly among the groups (P = .074 and .262, respectively). There were no significant differences in terms of graft survival (P = .394) or patient survival (P = .737) among the groups. Conclusions. Although the long-term renal function followed longitudinally was lower in ECD kidney recipients, the use of renal grafts from ECDs is an acceptable method to resolve the disparity of critical organ shortage. However, the classification of the high-risk group should be updated with consideration given to differences in regional characteristics.	[Ko, K. J.; Kim, Y. H.; Kwon, K. H.; Kim, M. H.; Park, S. C.; Yun, S. S.] Seoul St Marys Hosp, Dept Surg, Seoul, South Korea; [Jun, K. W.] Bucheon St Marys Hosp, Dept Surg, Gyeonggi, South Korea; [Hwang, J. K.] Daejeon St Marys Hosp, Dept Surg, Daejeon, South Korea; [Kim, S. D.] Incheon St Marys Hosp, Dept Surg, Incheon, South Korea; [Kim, J. I.] Uijeongbu St Marys Hosp, Dept Surg, Gyeonggi, South Korea; [Moon, I. S.] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Surg, Seoul, South Korea		Hwang, JK (corresponding author), Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Surg, 64 Daeheung Ro, Daejeon 34943, South Korea.	jjungyong@catholic.ac.kr		Ko, Kyungjai/0000-0002-1791-0049; Park, Sun Cheol/0000-0003-2701-0180	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Republic of Korea [2017R1D1A1B03034715]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Republic of Korea. (2017R1D1A1B03034715).	Friedewald JJ, 2012, AM J TRANSPLANT, V12, P1971, DOI 10.1111/j.1600-6143.2012.04149.x; Han M, 2014, CLIN TRANSPLANT, V28, P337, DOI 10.1111/ctr.12318; Hwang JK, 2014, TRANSPL P, V46, P431, DOI 10.1016/j.transproceed.2013.11.061; Hwang JK, 2011, J KOREAN SURG SOC, V81, P10, DOI 10.4174/jkss.2011.81.1.10; Jun H, 2017, TRANSPL P, V49, P88, DOI 10.1016/j.transproceed.2016.11.003; Kauffman HM., 1997, TRANSPLANT REV-ORLAN, V11, P165, DOI [10.1016/S0955-470X(97)80037-7, DOI 10.1016/S0955-470X(97)80037-7]; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Min SI, 2010, J KOREAN MED SCI, V25, P1122, DOI 10.3346/jkms.2010.25.8.1122; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Querard AH, 2016, TRANSPL INT, V29, P403, DOI 10.1111/tri.12736; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Salahudeen AK, 2008, TRANSPL P, V40, P1285, DOI 10.1016/j.transproceed.2008.03.131	12	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	DEC	2018	50	10					3222	3227		10.1016/j.transproceed.2018.05.028			6	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	HG4VB	WOS:000454972000050	30577189				2022-02-06	
J	Kroshus, E; Baugh, CM; Meehan, WP; Viswanath, K				Kroshus, Emily; Baugh, Christine M.; Meehan, William P., III; Viswanath, Kasisomayajula			Personal subjectivity in clinician discussion about retirement from sport post-concussion	SOCIAL SCIENCE & MEDICINE			English	Article						Sports medicine; Concussion; Preference sensitive decision; Health communication	FOOTBALL PLAYERS; HIGH-SCHOOL; RISK ATTITUDES; YOUTH SPORTS; RETURN; MANAGEMENT; SYMPTOMS; STATEMENT; PERCEPTIONS; DECISION	Background: There is increasing focus on the number of concussions after which an athlete should discontinue participating in contact or collision sports. This is a clinically subjective and, in some cases, a preference-sensitive decision. Purpose: Our goal was to assess whether there is personal subjectivity in when athletic trainers (ATs) discuss the possibility of sport retirement post-concussion with athletes. Methods: A national sample of ATs who provide clinical care to college athletes completed a questionnaire (n = 677, 34% response rate). Structural equation modeling was used to assess the association between risk perceptions, risk tolerance, social influences (beliefs about athlete, coach and parent preferences), expectancies about athlete success (on and off field), and the number of concussions after which retirement would be discussed. Results: There was a significant direct effect of AT risk tolerance on the number of concussions after which sport retirement would be discussed, among both male and female ATs (male B = 0.54, p < 0.001; female B = 0.31, p < 0.001). ATs who more strongly prioritized athletes' on-field achievements indicated that they would discuss sport retirement after a larger number of concussions compared to their peers who less strongly valued athletic achievement. Conclusions: The results suggest the potential utility of standardized approaches to communicating concussion risk consistently to athletes. This can help ensure that all athletes are uniformly able to make informed decisions about continued exposure to concussion risk that are based on their values and preferences.	[Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Micheli Ctr Sports Injury Prevent, Boston, MA USA; [Viswanath, Kasisomayajula] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Viswanath, Kasisomayajula] Dana Farber Canc Inst, Boston, MA 02115 USA		Kroshus, E (corresponding author), 2001 8th Ave, Seattle, WA 98105 USA.	ekroshus@u.washington.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Kroshus, Emily/0000-0002-7484-2601	Football Players Health Study at Harvard; National Football League Players Association	This work was conducted with the support of the Football Players Health Study at Harvard. The Football Players Health Study is funded by a grant from the National Football League Players Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Medical School, Harvard University or its affiliates or the National Football League Players Association.	Amer Acad Pediat, 2011, PEDIATRICS, V128, P182, DOI 10.1542/peds.2011-0969; [Anonymous], 2010, ATHL TRAIN SERV OV S; Bartholomew K.J., 2009, INT REV SPORT EXER P, V2, P215, DOI [10.1080/17509840903235330, DOI 10.1080/17509840903235330]; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Baughman B. C, 2018, NEUROL CLIN, P10; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Clement D, 2013, J ATHL TRAINING, V48, P512, DOI 10.4085/1062-6050-48.3.21; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Creighton DW, 2010, CLIN J SPORT MED, V20, P379, DOI 10.1097/JSM.0b013e3181f3c0fe; Dijkstra HP, 2017, BRIT J SPORT MED, V51, P419, DOI 10.1136/bjsports-2016-096209; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Graham, 2014, SPORTS RELATED CONCU; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hammitt JK, 2010, J RISK UNCERTAINTY, V40, P57, DOI 10.1007/s11166-009-9086-9; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hiploylee Carmen, 2016, Concussion, V1, pCNC20, DOI 10.2217/cnc-2016-0008; Hornbeck Kimberly, 2017, AMA J Ethics, V19, P686, DOI 10.1001/journalofethics.2017.19.7.pfor1-1707; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Knights S, 2016, J APPL SPORT PSYCHOL, V28, P291, DOI 10.1080/10413200.2015.1128992; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Laker SR, 2016, PHYS MED REH CLIN N, V27, P487, DOI 10.1016/j.pmr.2016.01.001; Liem BC, 2016, PM R S, V8, pS139; Manley G. T, 2017, BR J SPORTS MED BJSP, V2017; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BR J SPORTS MED BJSP, V2017; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Melnick E. R, 2017, J MED INTERNET RES, V19; National Collegiate Athletic Association, 2017, IND MED CAR COLL STU; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Robbins J, 2001, J SPORT BEHAV, V24, P277; Roberts CM, 2015, J SPORT SCI, V33, P935, DOI 10.1080/02640414.2014.977936; Ronay R, 2006, BRIT J SOC PSYCHOL, V45, P397, DOI 10.1348/014466605X66420; Saposnik G, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0377-1; Shrier I, 2016, SCAND J MED SCI SPOR, V26, P128, DOI 10.1111/sms.12493; Shrier I, 2017, J SCI MED SPORT, V20, P255, DOI 10.1016/j.jsams.2016.08.007; Shrier I, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-092492; Singh N, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.8732; Taylor Jim., 1994, J APPL SPORT PSYCHOL, V6, P1, DOI [10.1080/10413209408406462, DOI 10.1080/10413209408406462]; Tjong VK, 2014, AM J SPORT MED, V42, P336, DOI 10.1177/0363546513508762; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Webb W. M., 1998, Journal of Sport Behavior, V21, P338; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Wippert PM, 2008, J CLIN SPORT PSYCHOL, V2, P1, DOI 10.1123/jcsp.2.1.1; WYNNE B, 1992, SOCIAL THEORIES OF RISK, P275	56	6	6	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	DEC	2018	218						37	44		10.1016/j.socscimed.2018.07.050			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	HA6II	WOS:000450382800005	30336393				2022-02-06	
J	Larkin, MB; Graves, EKM; Boulter, JH; Szuflita, NS; Meyer, RM; Porambo, ME; Delaney, JJ; Bell, RS				Larkin, M. Benjamin; Graves, Erin K. M.; Boulter, Jason H.; Szuflita, Nicholas S.; Meyer, R. Michael; Porambo, Michael E.; Delaney, John J.; Bell, Randy S.			Two-year mortality and functional outcomes in combat-related penetrating brain injury: battlefield through rehabilitation	NEUROSURGICAL FOCUS			English	Article						ballistics; combat; functional outcomes; Glasgow Outcome Scale; military; neurosurgery; penetrating brain injury	CIVILIAN GUNSHOT WOUNDS; GLASGOW COMA SCALE; TRAUMATIC BRAIN; BALLISTIC HELMETS; BLAST INJURY; HEAD; PREDICTORS; MISSILE; SCORE	OBJECTIVE There are limited data concerning the long-term functional outcomes of patients with penetrating brain injury. Reports from civilian cohorts are small because of the high reported mortality rates (as high as 90%). Data from military populations suggest a better prognosis for penetrating brain injury, but previous reports are hampered by analyses that exclude the point of injury. The purpose of this study was to provide a description of the long-term functional outcomes of those who sustain a combat-related penetrating brain injury (from the initial point of injury to 24 months afterward). METHODS This study is a retrospective review of cases of penetrating brain injury in patients who presented to the Role 3 Multinational Medical Unit at Kandahar Airfield, Afghanistan, from January 2010 to March 2013. The primary outcome of interest was Glasgow Outcome Scale (GOS) score at 6, 12, and 24 months from date of injury. RESULTS A total of 908 cases required neurosurgical consultation during the study period, and 80 of these cases involved US service members with penetrating brain injury. The mean admission Glasgow Coma Scale (GCS) score was 8.5 (SD 5.56), and the mean admission Injury Severity Score (ISS) was 26.6 (SD 10.2). The GOS score for the cohort trended toward improvement at each time point (3.6 at 6 months, 3.96 at 24 months, p > 0.05). In subgroup analysis, admission GCS scores 5, gunshot wound as the injury mechanism, admission ISS z 26, and brain herniation on admission CT head were all associated with worse GOS scores at all time points. Excluding those who died, functional improvement occurred regardless of admission GCS score (p < 0.05). The overall mortality rate for the cohort was 21%. CONCLUSIONS Good functional outcomes were achieved in this population of severe penetrating brain injury in those who survived their initial resuscitation. The mortality rate was lower than observed in civilian cohorts.	[Larkin, M. Benjamin; Graves, Erin K. M.; Porambo, Michael E.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Larkin, M. Benjamin] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Graves, Erin K. M.] Temple Univ, Dept Neurosurg, Philadelphia, PA 19122 USA; [Boulter, Jason H.; Szuflita, Nicholas S.; Porambo, Michael E.; Delaney, John J.; Bell, Randy S.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Meyer, R. Michael] Univ Washington, Div Neurosurg, Seattle, WA 98195 USA; [Bell, Randy S.] Uniformed Serv Univ Hlth Sci, Dept Surg, Div Neurosurg, Bethesda, MD USA		Larkin, MB (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	michael.b.larkin3.mil@mail.mil		Boulter, Jason H/0000-0001-6397-8530			Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Carey ME, 2000, NEUROSURGERY, V47, P678, DOI 10.1097/00006123-200009000-00031; CAREY ME, 1982, ACTA CHIR SCAND, P351; Carey ME, 2004, YOUMANS NEUROLOGICAL, V4, P5223; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2008, P 26 ANN NAT NEUR S; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Ecklund J, 2008, P 26 ANN NAT NEUR S; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; Knuth T., 2005, GUIDELINES FIELD MAN; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lenhart MK, 2008, WAR SURG AFGHANISTAN; Lenhart MK., 2012, COMBAT CASUALTY CARE; LEVI L, 1991, British Journal of Neurosurgery, V5, P241, DOI 10.3109/02688699109005183; Levi L, 1999, MISSILE WOUNDS HEAD, P411; Ling G, 2008, P 26 ANN NAT NEUR S; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; Neal C, 2004, NEUROSURGERY, V55, P460, DOI 10.1227/00006123-200408000-00060; Riechers RG, 2005, J NEUROTRAUM, V22, P1327, DOI 10.1089/neu.2005.22.1327; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sarron JC, 2004, J TRAUMA, V57, P236, DOI 10.1097/01.TA.0000133575.48065.3F; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179	35	6	6	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2018	45	6							E4	10.3171/2018.9.FOCUS18359			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HD6HR	WOS:000452637400004	30544304	gold			2022-02-06	
J	Mikolajczyk, T; Klodowski, A; Mikoltajewska, E; Walkowiak, P; Berjano, P; Villafane, JH; Aggogeri, F; Borboni, A; Fausti, D; Petrogalli, G				Mikolajczyk, Tadeusz; Klodowski, Adam; Mikoltajewska, Emilia; Walkowiak, Pawel; Berjano, Pedro; Villafane, Jorge Hugo; Aggogeri, Francesco; Borboni, Alberto; Fausti, Davide; Petrogalli, Gianluigi			Design and control of system for elbow rehabilitation: Preliminary findings	ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						rehabilitation; assistive technology; elbow; exoskeleton; upper limb exoskeleton	STROKE REHABILITATION; ROBOTIC SYSTEMS; EXOSKELETON; IMPAIRMENT; THERAPY	Background. The use of an exoskeleton elbow is considered an effective treatment in several pathologies, including post-stroke complications, traumatic brain injury (TBI) and spinal cord injury (SCI), as well as in patients with neurodegenerative disorders. The effectiveness of rehabilitation is closely linked to a suitably chosen therapy. The treatment can be performed only by specialized personnel, significantly supported with the use of automated devices. Objectives. The aim of this study was to present a novel exoskeleton for elbow rehabilitation without a complicated control system. Material and methods. Single-degree-of-freedom (SDOF) solution in constructing the prototype of an elbow exoskeleton for rehabilitation purposes has been applied. The simplicity of the actuation mechanism was set as one of the priorities in the design; thus, a single-axis stepper motor with a controller was found to be adequate for providing a reliable and precise source of motion for the exoskeleton. Results. Technological development may provide novel solutions, such as an exoskeleton - a wearable, external structure which supports or (in selected applications) even replaces the muscle actuation in the patient. The reported advantages of the proposed exoskeleton reflect current state-of-the-art. The proposed control strategy relies on closed-loop position control, performance, low manufacturing cost, and predicted performance in a rehabilitation scenario. All these factors play an important role in establishing the directions for further research, e.g., an integrated force sensor in the device, measurements of torque interactions on the elbow joint, and assessment and response to an overload of articulation. Conclusions. This study suggests not only the clinical but also the possible economic and logistical advantages offered by the portability of the system, and its effective support for therapists applying an elbow exoskeleton.	[Mikolajczyk, Tadeusz; Walkowiak, Pawel] Univ Sci & Technol, Fac Mech Engn, Dept Prod Technol, Bydgoszcz, Poland; [Klodowski, Adam] Lappeenranta Univ Technol, Sch Energy Syst, Lab Machine Design, Lappeenranta, Finland; [Mikoltajewska, Emilia] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Fac Hlth Sci, Dept Physiotherapy, Torun, Poland; [Berjano, Pedro] Galeazzi Orthoped Inst, Inst Recovery & Care Sci Characterist, GSpine4 Spine Surg Div, Milan, Italy; [Villafane, Jorge Hugo] Fdn Don C Gnocchi, Inst Recovery & Care Sci Characterist, Milan, Italy; [Aggogeri, Francesco; Borboni, Alberto] Univ Brescia, Fac Engn, Appl Mech Res Grp, Brescia, Italy; [Fausti, Davide; Petrogalli, Gianluigi] Polibrixia Innovat Engn, Res & Dev Dept, Brescia, Italy		Mikoltajewska, E (corresponding author), Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Fac Hlth Sci, Dept Physiotherapy, Torun, Poland.	e.mikolajewska@wp.pl	Berjano, Pedro/C-1053-2017; Mikolajczyk, Tadeusz/F-6689-2016; Aggogeri, Francesco/AAK-1503-2020; Villafane, Jorge Hugo/K-6858-2015	Berjano, Pedro/0000-0002-1891-3719; Mikolajczyk, Tadeusz/0000-0002-5253-590X; Mikolajewska, Emilia/0000-0002-2769-3068; Villafane, Jorge Hugo/0000-0002-3239-7626			Bishop L, 2013, NEUROREHABILITATION, V33, P3, DOI 10.3233/NRE-130922; Brochard S, 2010, CURR OPIN NEUROL, V23, P683, DOI 10.1097/WCO.0b013e32833f61ce; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; Fausti Davide, 2015, Applied Mechanics and Materials, V783, P1, DOI 10.4028/www.scientific.net/AMM.783.1; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Hochstenbach-Waelen A, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-52; Howard A, 2013, REH ROB ICORR IEEE I, V2013; Huang LL, 2013, OCCUP THER INT, V20, P205, DOI 10.1002/oti.1360; Kiguchi K, 2001, IEEE T SYST MAN CY B, V31, P353, DOI 10.1109/3477.931520; Li C, 2014, INT J REHABIL RES, V37, P334, DOI 10.1097/MRR.0000000000000076; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Loureiro RCV, 2011, MED BIOL ENG COMPUT, V49, P1103, DOI 10.1007/s11517-011-0797-0; Lu EC, 2011, DISABIL REHABIL-ASSI, V6, P420, DOI 10.3109/17483107.2010.544370; Lum Peter, 2002, Top Stroke Rehabil, V8, P40; Maciejasz P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-3; Marchal-Crespo L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-20; Masiero S, 2014, EXPERT REV MED DEVIC, V11, P187, DOI 10.1586/17434440.2014.882766; Mikolajczyk Tadeusz, 2015, Applied Mechanics and Materials, V811, P305, DOI 10.4028/www.scientific.net/AMM.811.305; Mikolajczyk Tadeusz, 2015, Applied Mechanics and Materials, V772, P224, DOI 10.4028/www.scientific.net/AMM.772.224; Mikolajczyk T, 2013, APPL MECH MATER, V436, P390, DOI 10.4028/www.scientific.net/AMM.436.390; Morales R, 2011, MED BIOL ENG COMPUT, V49, P1145, DOI 10.1007/s11517-011-0814-3; Mottram CJ, 2009, J NEUROPHYSIOL, V102, P2026, DOI 10.1152/jn.00151.2009; Nycz CJ, 2015, IEEE ENG MED BIO, P3889, DOI 10.1109/EMBC.2015.7319243; Park JH, 2014, INT CONF UBIQ ROBOT, P138, DOI 10.1109/URAI.2014.7057415; Poli P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/153872; Pons JL, 2010, IEEE ENG MED BIOL, V29, P57, DOI 10.1109/MEMB.2010.936548; Sukal-Moulton T, 2014, NEUROREHAB NEURAL RE, V28, P13, DOI 10.1177/1545968313500564; Takahashi CD, 2008, BRAIN, V131, P425, DOI 10.1093/brain/awm311; Taveggia G, 2016, INT J REHABIL RES, V39, P29, DOI 10.1097/MRR.0000000000000137; Taveggia G, 2014, J MANIP PHYSIOL THER, V37, P242, DOI 10.1016/j.jmpt.2013.09.007; Tsagarakis NG, 2003, AUTON ROBOT, V15, P21, DOI 10.1023/A:1024484615192; Vitiello N, 2013, IEEE T ROBOT, V29, P220, DOI 10.1109/TRO.2012.2211492; Zackowski KM, 2004, BRAIN, V127, P1035, DOI 10.1093/brain/awh116	33	6	6	0	20	WROCLAW MEDICAL UNIV	WROCLAW	UL K MARCINKOWSKIEGO 2-6, WROCLAW, 50-368, POLAND	1899-5276	2451-2680		ADV CLIN EXP MED	Adv. Clin. Exp. Med.	DEC	2018	27	12					1661	1669		10.17219/acem/74556			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	HE7BH	WOS:000453577800007	30311751	gold, Green Published			2022-02-06	
J	Tarvonen-Schroder, S; Tenovuo, O; Kaljonen, A; Laimi, K				Tarvonen-Schroeder, Sinikka; Tenovuo, Olli; Kaljonen, Anne; Laimi, Katri			Comparing disability between traumatic brain injury and spinal cord injury using the 12-item WHODAS 2.0 and the WHO minimal generic data set covering functioning and health	CLINICAL REHABILITATION			English	Article						Disability; spinal cord injury; traumatic brain injury; WHODAS; WHO minimal generic data set covering functioning and health	5 PARTICIPATION INSTRUMENTS; INTERNATIONAL CLASSIFICATION; OUTCOME MEASURES; RELIABILITY; VALIDATION; VALIDITY; SCALE	Objective: To compare disability between two patient groups using short validated tools based on International Classification of Functioning, Disability and Health (ICF). Design: Cross-sectional study. Setting: University hospital specialist outpatient clinic. Subjects: A total of 94 patients with traumatic brain injury and 59 with spinal cord injury. Main measures: Disability evaluated using self-reported and proxy 12-item WHODAS 2.0 (World Health Organization Disability Assessment Schedule), and physician-rated WHO minimal generic data set covering functioning and health. Results: The two measures used showed severe but very different disabilities in these patient groups. Disability was assessed worse by physicians in the spinal cord injury population (sum 15.8 vs. 12.7, P = 0.0001), whereas disability assessed by the patients did not differ significantly between the two groups (sum 18.4 vs. 21.2). Further analysis revealed that in patients with "high disability" (the minimal generic data set score > 15), self-reported functioning was more severely impaired in the traumatic brain injury group compared to the spinal cord injury group (29.7 vs. 21.4, P < 0.0001), with no difference between these two diagnostic groups in patients with "low disability" (the minimal generic data set below 15). Patients with traumatic brain injury perceived more difficulties in cognition, getting along and participation, patients with spinal cord injury in mobility and self-care. Conclusion: Both generic measures were able to detect severe disability but also to detect differences between two patient populations with different underlying diagnoses.	[Tarvonen-Schroeder, Sinikka; Tenovuo, Olli] Turku Univ Hosp, Div Clin Neurosci, Dept Rehabil & Brain Trauma, POB 52, FI-20521 Turku, Finland; [Tarvonen-Schroeder, Sinikka; Tenovuo, Olli; Laimi, Katri] Univ Turku, POB 52, FI-20521 Turku, Finland; [Kaljonen, Anne] Univ Turku, Dept Biostat, Turku, Finland; [Laimi, Katri] Turku Univ Hosp, Dept Phys & Rehabil Med, Turku, Finland		Tarvonen-Schroder, S (corresponding author), Turku Univ Hosp, Div Clin Neurosci, Dept Rehabil & Brain Trauma, POB 52, FI-20521 Turku, Finland.; Tarvonen-Schroder, S (corresponding author), Univ Turku, POB 52, FI-20521 Turku, Finland.	sinikka.tarvonen-schroder@tyks.fi					Alexander MS, 2009, SPINAL CORD, V47, P582, DOI 10.1038/sc.2009.18; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Barclay L, 2015, INT J REHABIL RES, V38, P1, DOI 10.1097/MRR.0000000000000085; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Cieza A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-218; de Pedro-Cuesta J, 2011, GAC SANIT, V25, P21, DOI 10.1016/j.gaceta.2011.08.005; De Wolf AC, 2012, J REHABIL MED, V44, P747, DOI 10.2340/16501977-1016; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirshblum S, 2014, PHYS MED REH CLIN N, V25, P505, DOI 10.1016/j.pmr.2014.04.001; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Magasi SR, 2008, J SPINAL CORD MED, V31, P145, DOI 10.1080/10790268.2008.11760705; Noonan VK, 2010, J REHABIL MED, V42, P735, DOI 10.2340/16501977-0583; Noonan VK, 2010, J REHABIL MED, V42, P724, DOI 10.2340/16501977-0584; Noonan VK, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-93; Noonan VK, 2009, DISABIL REHABIL, V31, P1883, DOI 10.1080/09638280902846947; Noonan VK, 2010, TOP SPINAL CORD INJU, V15, P49, DOI DOI 10.1310/SCI1504-49; Nugter MA, 2017, PSYCHOTHER RES, V3, P1; Post MWM, 2008, J REHABIL MED, V40, P620, DOI 10.2340/16501977-0223; Saltychev M, 2014, INT J REHABIL RES, V37, P229, DOI 10.1097/MRR.0000000000000065; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Silva AG, 2015, PHYS THER, V95, P1628, DOI 10.2522/ptj.20140323; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Ustun T, 2010, MEASURING HLTH DISAB; van der Zee CH, 2014, ARCH PHYS MED REHAB, V95, P87, DOI 10.1016/j.apmr.2013.08.236; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; World Health Organization, 2007, INT CLASS FUNCT DIS	30	6	6	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	DEC	2018	32	12					1676	1683		10.1177/0269215518785945			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HD2HQ	WOS:000452332100011	29962230				2022-02-06	
J	Wu, P; Stayman, JW; Sisniega, A; Zbijewski, W; Foos, D; Wang, X; Aygun, N; Stevens, R; Siewerdsen, JH				Wu, P.; Stayman, J. W.; Sisniega, A.; Zbijewski, W.; Foos, D.; Wang, X.; Aygun, N.; Stevens, R.; Siewerdsen, J. H.			Statistical weights for model-based reconstruction in cone-beam CT with electronic noise and dual-gain detector readout	PHYSICS IN MEDICINE AND BIOLOGY			English	Article						cone-beam CT; model-based iterative reconstruction; image quality; dual-gain; electronic noise; traumatic brain injury; intracranial hemorrhage	FLAT-PANEL DETECTOR; IMAGE-RECONSTRUCTION; DIGITAL MAMMOGRAPHY; ARTIFACT-CORRECTION; BREAST CT; QUALITY; PERFORMANCE; SYSTEM; ARM; OPTIMIZATION	Cone-beam CT (CBCT) systems commonly incorporate a flat-panel detector (FPD) with multiple-gain readout capability to reduce electronic noise and extend dynamic range. In this work, we report a penalized weighted least-squares (PWLS) method for CBCT image reconstruction with a system model that includes the electronic noise characteristics of FPDs, including systems with dynamic-gain or dual-gain (DG) readout in which the electronic noise is spatially varying. Statistical weights in PWLS were modified to account for the contribution of the electronic noise (algorithm denoted PWLSDG), and the method was combined with a certainty-based approach that improves the homogeneity of spatial resolution (algorithm denoted PWLSCertDG). The methods were tested in phantom studies designed to stress DG readout characteristics and translated to a clinical study for CBCT of patients with head traumas. The PWLSDG method demonstrated superior noise-resolution tradeoffs compared to filtered back-projection (FBP) and conventional PWLS. For example, with spatial resolution (edge-spread function width) matched at 0.65 mm, PWLSDG reduced variance by 28%-39% and 15%-25% compared to FBP and PWLS, respectively. The PWLSCertDG method achieved more homogeneous spatial resolution than PWLSDG while maintaining similar variance reduction. These findings were confirmed in clinical studies, which showed similar to 20% variance reduction in peripheral regions of the brain, potentially improving visual image quality in detection of epidural and/or subdural intracranial hemorrhage. The results are consistent with the general notion that incorporating a more accurate system model improves performance in optimization-based statistical CBCT reconstruction-in this case, a more accurate model for (spatially varying) electronic noise to improve detectability of low-contrast lesions.	[Wu, P.; Stayman, J. W.; Sisniega, A.; Zbijewski, W.; Siewerdsen, J. H.] Johns Hopkins Univ, Dept Biomed Engn, Traylor Bldg Room 622,720 Rutland Ave, Baltimore, MD 21205 USA; [Foos, D.; Wang, X.] Carestream Hlth, Rochester, NY 14608 USA; [Aygun, N.; Siewerdsen, J. H.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD 21205 USA; [Stevens, R.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA		Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Traylor Bldg Room 622,720 Rutland Ave, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Radiol, Baltimore, MD 21205 USA.	jeff.siewerdsen@jhu.edu		Sisniega, Alejandro/0000-0003-2030-2711	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-EB-017226]; Carestream Health (Rochester, NY); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB017226] Funding Source: NIH RePORTER	This work was supported by NIH R01-EB-017226 and academic-industry partnership with Carestream Health (Rochester, NY). Thanks to Q Cao (Biomedical Engineering, Johns Hopkins University) for many useful discussions on cascaded system analysis.	Akpek Sergin, 2005, Diagn Interv Radiol, V11, P10; Antonuk L E, 1992, MED IMAGING 6 NEWPOR, P94; Baba R, 2004, DENTOMAXILLOFAC RAD, V33, P285, DOI 10.1259/dmfr/87440549; Boone JM, 2005, P SOC PHOTO-OPT INS, V5745, P319, DOI 10.1117/12.595706; Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; BOUDRY JM, 1994, J APPL PHYS, V76, P2529, DOI 10.1063/1.357614; Daly MJ, 2006, MED PHYS, V33, P3767, DOI 10.1118/1.2349687; Dang H, 2015, PHYS MED BIOL, V60, P6153, DOI 10.1088/0031-9155/60/16/6153; Dang H, 2017, PHYS MED BIOL, V62, P8693, DOI 10.1088/1361-6560/aa90fd; Erdogan H, 1999, PHYS MED BIOL, V44, P2835, DOI 10.1088/0031-9155/44/11/311; Fessler JA, 1996, IEEE T IMAGE PROCESS, V5, P493, DOI 10.1109/83.491322; FESSLER JA, 1994, IEEE T MED IMAGING, V13, P290, DOI 10.1109/42.293921; Gang GJ, 2017, PHYS MED BIOL, V62, P4777, DOI 10.1088/1361-6560/aa6a97; Gang GJ, 2014, MED PHYS, V41, P260, DOI 10.1118/1.4883816; Hsieh SS, 2013, MED PHYS, V40, DOI 10.1118/1.4789630; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; Koskinen SK, 2013, SKELETAL RADIOL, V42, P649, DOI 10.1007/s00256-012-1516-0; LANGE K, 1990, IEEE T MED IMAGING, V9, P439, DOI 10.1109/42.61759; Long Y, 2010, IEEE T MED IMAGING, V29, P1839, DOI 10.1109/TMI.2010.2050898; MAIDMENT ADA, 1994, MED PHYS, V21, P721, DOI 10.1118/1.597331; Maolinbay M, 2000, MED PHYS, V27, P1841, DOI 10.1118/1.1286721; Punnoose J, 2016, MED PHYS, V43, P4711, DOI 10.1118/1.4955438; Roos PG, 2004, P SOC PHOTO-OPT INS, V5368, P139, DOI 10.1117/12.535471; Schmidgunst C, 2007, MED PHYS, V34, P3649, DOI 10.1118/1.2760024; Siewerdsen JH, 2005, MED PHYS, V32, P241, DOI 10.1118/1.1836331; Siewerdsen JH, 2002, MED PHYS, V29, P2655, DOI 10.1118/1.1513158; Siewerdsen JH, 1997, MED PHYS, V24, P71, DOI 10.1118/1.597919; Sisniega A, 2015, PHYS MED BIOL, V60, P1415, DOI 10.1088/0031-9155/60/4/1415; Stayman J. W, 2016, MEDICAL IMAGING 2016, V9783; Stayman JW, 2014, PROC SPIE, V9033, DOI 10.1117/12.2043067; SWANK RK, 1973, J APPL PHYS, V44, P4199, DOI 10.1063/1.1662918; Szczykutowicz TP, 2014, PHYS MED BIOL, V59, DOI 10.1088/0031-9155/59/5/1305; Thibault JB, 2007, MED PHYS, V34, P4526, DOI 10.1118/1.2789499; Tilley S II, 2018, ARXIV180511631PHYS; Tilley S, 2016, PHYS MED BIOL, V61, P296, DOI 10.1088/0031-9155/61/1/296; Vedantham S, 2000, MED PHYS, V27, P558, DOI 10.1118/1.598895; Wang AS, 2014, PHYS MED BIOL, V59, P1005, DOI 10.1088/0031-9155/59/4/1005; Wang W, 2017, P FULL 3 DIM IM REC, P702; Wu P, 2019, MEDICAL IMAGING 2019; Xu J, 2016, MED PHYS, V43, P5745, DOI 10.1118/1.4963220; Xu J, 2016, PHYS MED BIOL, V61, P5973, DOI 10.1088/0031-9155/61/16/5973; Yang K, 2010, MED PHYS, V37, P3527, DOI 10.1118/1.3447720; Yang K, 2008, MED PHYS, V35, P5317, DOI 10.1118/1.3002411; Zbijewski W, 2011, MED PHYS, V38, P4700, DOI 10.1118/1.3611039; Zhao W, 1997, MED PHYS, V24, P1819, DOI 10.1118/1.598097	45	6	6	0	4	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-9155	1361-6560		PHYS MED BIOL	Phys. Med. Biol.	DEC	2018	63	24							245018	10.1088/1361-6560/aaf0b4			15	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Radiology, Nuclear Medicine & Medical Imaging	HE4CI	WOS:000453311600005	30524041				2022-02-06	
J	Arabi, M; Dirani, M; Hourani, R; Nasreddine, W; Wazne, J; Atweh, S; Samara, H; Shatila, AR; Beydoun, A				Arabi, Maher; Dirani, Maya; Hourani, Roula; Nasreddine, Wassim; Wazne, Jaafar; Atweh, Samir; Samara, Heba; Shatila, Abdel Rahman; Beydoun, Ahmad			Frequency and Stratification of Epileptogenic Lesions in Elderly With New Onset Seizures	FRONTIERS IN NEUROLOGY			English	Article						new onset epilepsy; MRI; Elderly; epiletogenic; epilepsies; partial	NATIONAL GENERAL-PRACTICE; EPILEPTIC SEIZURES; RISK-FACTORS; PREVALENCE; LEUKOARAIOSIS; DEFINITION; DISORDERS; PATIENT; DISEASE; ADULTS	Objective: To evaluate prospectively the frequency of epileptogenic lesions in a consecutive cohort of elderly patients presenting with new onset unprovoked seizures, and who underwent a complete evaluation including dedicated epilepsy protocol MRI. Methods and materials: We included all consecutive patients 60 years or older who participated in a prospective study on new onset epilepsy. The work-up included the acquisition of a dedicated epilepsy protocol MRI and a 3 h video/EEG recording. We evaluated the frequency and types of epileptogenic lesions in the whole cohort and stratified those variables by age, gender, types and number of seizures at presentation. We also correlated the EEG findings with the clinical characteristics and neuroimaging results. Results: Of the 101 patients enrolled in the study and who underwent an epilepsy protocol MRI, an epileptogenic lesion was identified in 67% of cases. The most common etiologies were vascular events, followed by tumoral causes and traumatic brain injuries. Epileptogenic lesions were more likely to be identified in patients who presented with only focal aware and impaired awareness seizures. In addition, patients with tumoral epilepsy were significantly more likely to only experience those seizure types compared to patients with other pathological substrates. Interictal/ictal discharges were detected in the EEG of 21% of patients. Epileptiform discharges were significantly more frequent in patients with an epileptogenic lesion on brain MRI, especially in those with a brain tumor. Conclusions: Our results stress the importance of obtaining a dedicated epilepsy protocol MRI in elderly patients with new onset seizures. An epileptogenic lesion will be identified in approximately two thirds of patients with important implications regarding initiation of treatment. In addition, the data underscore the value of distinguishing the types of seizures experienced at presentation as this will apprise the treating physician on the likelihood of identifying an epileptogenic lesion and on the probable etiologies.	[Arabi, Maher] Ibn Sina Hosp, Kuwait, Kuwait; [Dirani, Maya; Hourani, Roula; Nasreddine, Wassim; Atweh, Samir; Samara, Heba; Beydoun, Ahmad] Amer Univ, Beirut Med Ctr, Beirut, Lebanon; [Wazne, Jaafar; Shatila, Abdel Rahman] Rafik Hariri Univ Hosp, Beirut, Lebanon		Beydoun, A (corresponding author), Amer Univ, Beirut Med Ctr, Beirut, Lebanon.	ab29@aub.edu.lb	Beydoun, Ahmad/ABE-8111-2021	Beydoun, Ahmad/0000-0002-9047-1185	Lebanese National Council for Scientific Research Award [LCR 114110 522214]; American University of Beirut [1131613 52480 115372099990000]	Funded in part by the Lebanese National Council for Scientific Research Award number: LCR 114110 522214 and American University of Beirut (Grant number: 1131613 52480 115372099990000).	Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Beleza P, 2012, NEUROLOGIST, V18, P109, DOI 10.1097/NRL.0b013e318251e6c3; Besocke AG, 2013, EPILEPSY BEHAV, V27, P29, DOI 10.1016/j.yebeh.2012.11.041; Brodie MJ, 2009, LANCET NEUROL, V8, P1019, DOI 10.1016/S1474-4422(09)70240-6; Brodie MJ, 2005, BMJ-BRIT MED J, V331, P1317, DOI 10.1136/bmj.331.7528.1317; Cloyd J, 2006, EPILEPSY RES, V68, pS39, DOI 10.1016/j.eplepsyres.2005.07.016; delaCourt A, 1996, EPILEPSIA, V37, P141; DeReuck J, 1996, EUR NEUROL, V36, P20, DOI 10.1159/000117194; DeToledo JC, 1999, GERONTOLOGY, V45, P329, DOI 10.1159/000022114; DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854; Drury I, 1998, ELECTROEN CLIN NEURO, V106, P369, DOI 10.1016/S0013-4694(97)00158-2; Duncan JS, 2006, LANCET, V367, P1087, DOI 10.1016/S0140-6736(06)68477-8; Faught E, 2012, NEUROLOGY, V78, P448, DOI 10.1212/WNL.0b013e3182477edc; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Gasparini S, 2015, EPILEPSY RES, V109, P1, DOI 10.1016/j.eplepsyres.2014.10.012; Hakami T, 2013, NEUROLOGY, V81, P920, DOI 10.1212/WNL.0b013e3182a35193; HART YM, 1990, LANCET, V336, P1271, DOI 10.1016/0140-6736(90)92960-P; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HAUSER WA, 1992, EPILEPSIA, V33, pS6; Hernandez-Ronquillo L, 2018, EPILEPSY RES, V140, P90, DOI 10.1016/j.eplepsyres.2017.12.016; Hiyoshi T, 2000, EPILEPSIA, V41, P31, DOI 10.1111/j.1528-1157.2000.tb02217.x; Hommet C, 2008, DEMENT GERIATR COGN, V25, P293, DOI 10.1159/000119103; Lawn N, 2013, EPILEPSY RES, V107, P109, DOI 10.1016/j.eplepsyres.2013.08.009; Leppik IE, 2018, EPILEPSIA, V59, P140, DOI 10.1111/epi.14497; LOISEAU J, 1990, ANN NEUROL, V27, P232, DOI 10.1002/ana.410270304; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; LUHDORF K, 1986, ACTA NEUROL SCAND, V74, P409; MARSAN CA, 1970, EPILEPSIA, V11, P361, DOI 10.1111/j.1528-1157.1970.tb03903.x; Maxwell H, 2013, CLIN NEUROL NEUROSUR, V115, P591, DOI 10.1016/j.clineuro.2012.07.009; Moosa ANV, 2013, HAND CLINIC, V111, P493, DOI 10.1016/B978-0-444-52891-9.00053-1; Paradowski B, 2005, EPILEPTIC DISORD, V7, P91; Phabphal K, 2013, SEIZURE-EUR J EPILEP, V22, P577, DOI 10.1016/j.seizure.2013.04.009; Pugh MJV, 2009, J AM GERIATR SOC, V57, P237, DOI 10.1111/j.1532-5415.2008.02124.x; Ramsay RE, 2004, NEUROLOGY, V62, pS24, DOI 10.1212/WNL.62.5_suppl_2.S24; ROBERTS MA, 1982, AGE AGEING, V11, P24, DOI 10.1093/ageing/11.1.24; Rowan AJ, 2005, NEUROLOGY, V64, P1868, DOI 10.1212/01.WNL.0000167384.68207.3E; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Sinha S, 2012, ANN INDIAN ACAD NEUR, V15, P273, DOI 10.4103/0972-2327.104335; Smith EE, 2012, LANCET NEUROL, V11, P272, DOI 10.1016/S1474-4422(11)70307-6; Tanaka A, 2013, SEIZURE-EUR J EPILEP, V22, P772, DOI 10.1016/j.seizure.2013.06.005; Trinka E, 2003, ACTA NEUROL SCAND, V108, P33, DOI 10.1034/j.1600-0404.108.s180.5.x; United Nations, 2007, UN 2007; Urbach H, 2005, EUR RADIOL, V15, P494, DOI 10.1007/s00330-004-2629-1; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Yoshimura H, 2018, SEIZURE-EUR J EPILEP, V61, P23, DOI 10.1016/j.seizure.2018.07.013	46	6	6	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 30	2018	9								995	10.3389/fneur.2018.00995			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HC6ZD	WOS:000451949300001	30559705	Green Published, gold			2022-02-06	
J	Le, RK; Saunders, TD; Breedlove, KM; Bradney, DA; Lucas, JM; Bowman, TG				Le, Rachel K.; Saunders, Tabitha D.; Breedlove, Katherine M.; Bradney, Debbie A.; Lucas, Jill M.; Bowman, Thomas G.			Differences in the Mechanism of Head Impacts Measured Between Men's and Women's Intercollegiate Lacrosse Athletes	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						head impact biomechanics; xPatch; head trauma	RECURRENT CONCUSSION; BRAIN-INJURY; COLLEGIATE; SPORTS; RECOMMENDATIONS; EPIDEMIOLOGY; SAFETY; ISSUES; SEX	Background: Lacrosse is a rapidly growing sport in the United States. Comparing the magnitude and frequency of head impact mechanisms between sexes will provide data for injury prevention techniques and risk reduction of head injuries. Purpose: To compare sex-specific differences in the magnitude and frequency of head impact mechanisms in National Collegiate Athletic Association (NCAA) Division III intercollegiate lacrosse athletes. Study Design: Cohort study; Level of evidence, 2. Methods: A total of 31 NCAA Division III intercollegiate lacrosse athletes (16 men [mean age, 21 +/- 1 years; mean height, 179.70 +/- 5.82 cm; mean weight, 80.71 +/- 6.33 kg] and 15 women [mean age, 20 +/- 1 years; mean height, 165.43 +/- 5.25 cm; mean weight, 64.08 +/- 7.59 kg]) voluntarily participated in this study. Participants wore xPatch sensors at every event during the 2015 spring season. Sensors recorded the magnitude, frequency, and location of head impacts over 10g. Linear (g) and rotational (deg/s(2)) acceleration determined impact magnitudes. We calculated incidence rates (IRs; per 1000 athlete-exposures [AEs]) and incidence rate ratios (IRRs) with 95% CIs to determine frequency differences. Film footage from each event was synchronized with the time of each head impact for verification and mechanism coding. Sex and impact mechanism served as the independent variables. Results: A significant interaction was found between impact mechanism and sex (P < .001) and main effects for impact mechanism (P < .001) and sex (P < .001). The most common mechanism in men's lacrosse was head to body (IR, 970.55/1000 AEs [95% CI, 266.14-331.98]), and in women's lacrosse, stick to head (IR, 289.87/1000 AEs [95% CI, 124.32-184.55]) was most common. Only 9 of 419 impermissible head impacts in men's lacrosse games were classed as penalties (2%); 7 of 25 impermissible head impacts in women's lacrosse games were called as penalties (28%). Conclusion: The impact mechanisms of head to body in men's lacrosse and stick to head in women's lacrosse are penalties but occur frequently, suggesting that a focus on stressing rule enforcement is warranted. Because mechanism and sex affect the magnitude of head impacts, proper offensive and defensive techniques against opponents should be encouraged to reduce head impacts.	[Le, Rachel K.; Saunders, Tabitha D.; Breedlove, Katherine M.; Bradney, Debbie A.; Lucas, Jill M.; Bowman, Thomas G.] Univ Lynchburg, Lynchburg, VA 24501 USA; [Le, Rachel K.; Saunders, Tabitha D.; Bradney, Debbie A.; Lucas, Jill M.; Bowman, Thomas G.] Univ Lynchburg, Dept Athlet Training, 1501 Lakeside Dr, Lynchburg, VA 24501 USA; [Breedlove, Katherine M.] Univ Michigan, Dept Kinesiol, Ann Arbor, MI 48109 USA		Bowman, TG (corresponding author), Univ Lynchburg, Dept Athlet Training, 1501 Lakeside Dr, Lynchburg, VA 24501 USA.	bowman.t@lynchburg.edu	Bowman, Thomas/AAA-3036-2020; Bowman, Tom/AAU-6473-2020	Bowman, Thomas/0000-0002-0034-2946; 	Schewel Research Fund from the University of Lynchburg; A Percy Wootton Student-Faculty Research Award from the University of Lynchburg	A Percy Wootton Student-Faculty Research Award and the Schewel Research Fund from the University of Lynchburg provided funding to complete this project. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Caswell SV, 2002, J ATHL TRAINING, V37, P164; Chong A, 2017, J PUBLIC ECON, V151, P1, DOI 10.1016/j.jpubeco.2017.04.002; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Covassin T, 2003, J ATHL TRAINING, V38, P238; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hurtubise JM, 2015, INT J ATHL THER TRAI, V20, P44, DOI 10.1123/ijatt.2014-0090; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Matz SO, 2004, AM J SPORT MED, V32, P608, DOI 10.1177/0363546503262172; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; PELTZMAN S, 1975, J POLIT ECON, V83, P677, DOI 10.1086/260352; Putukian M, 2014, CURR SPORT MED REP, V13, P334, DOI 10.1249/JSR.0000000000000092; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Wasserman E, 2017, BR J SPORTS MED, V51, pA67, DOI [10.1136/bjsports-2016-097270.174, DOI 10.1136/BJSPORTS-2016-097270.174]; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	27	6	6	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	NOV 21	2018	6	11							2325967118807678	10.1177/2325967118807678			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HB7MK	WOS:000451261900001	30480018	gold, Green Published			2022-02-06	
J	Lively, S; Wong, R; Lam, D; Schlichter, LC				Lively, Starlee; Wong, Raymond; Lam, Doris; Schlichter, Lyanne C.			Sex- and Development-Dependent Responses of Rat Microglia to Pro- and Anti-inflammatory Stimulation	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						microglial activation; brain development; IFN gamma plus TNF alpha; transcription profiling; IL-4; sex; female; ion channels	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; CHANNEL EXPRESSION; K+ CHANNELS; TNF-ALPHA; MICE; DISEASE; CELLS; INFLAMMATION; ACTIVATION	Addressing potential sex differences in pre-clinical studies is crucial for developing therapeutic interventions. Although sex differences have been reported in epidemiological studies and from clinical experience, most pre-clinical studies of neuroinflammation use male rodents; however, sexual dimorphisms in microglia might affect the CNS inflammatory response. Developmental changes are also important and, in rodents, there is a critical period of sexual brain differentiation in the first 3 weeks after birth. We compared rat microglia from sex-segregated neonates (P1) and at about the time of weaning (P21). To study transitions from a basal homeostatic state (untreated), microglia were subjected to a proinflammatory (IFN gamma + TNF alpha) or anti-inflammatory (IL-4) stimulus. Responses were compared by quantifying changes in nitric oxide production, migration, and expression of nearly 70 genes, including inflammatory mediators and receptors, inflammasome molecules, immune modulators, and genes that regulate microglial physiological functions. No sex differences were seen in transcriptional responses in either age group but the IL-4-evoked migration increase was larger in male cells at both ages. Protein changes for the hallmark molecules, NOS2, COX-2, PYK2 and CD206 correlated with mRNA changes. P1 and P21 microglia showed substantial differences, including expression of genes related to developmental roles. That is, P21 microglia had a more mature phenotype, with higher basal and stimulated levels of many inflammatory genes, while P1 cells had higher expression of phagocytosis-related molecules. Nevertheless, cells of both ages responded to IL-4 and IFN gamma + TNF alpha. We examined the Kv1.3 potassium channel (a potential target for modulating neuroinflammation) and the Kir2.1 channel, which regulate several microglia functions. Kv1.3 mRNA (Kcna3) was higher at P21 under all conditions and male P21 cells had higher mRNA and Kv currents in response to IFN gamma + TNF alpha. Overall, numerous transcriptional and functional responses of microglia changed during the first 3 weeks after birth but few sex-dependent changes were seen.	[Lively, Starlee; Wong, Raymond; Lam, Doris; Schlichter, Lyanne C.] Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Wong, Raymond; Lam, Doris; Schlichter, Lyanne C.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Lam, Doris] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA		Lively, S; Schlichter, LC (corresponding author), Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada.; Schlichter, LC (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	Starlee.Lively@uhnresearch.ca; Lyanne.Schlichter@uhnresearch.ca	Lam, Doris/AAG-4796-2020	Lam, Doris/0000-0002-3882-9514	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP 119578]; Toronto General/Toronto Western Hospital Foundation	This work was supported by operating grants to LS from the Canadian Institutes of Health Research (CIHR; MOP 119578) and by the Toronto General/Toronto Western Hospital Foundation.	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Arnoux I, 2013, GLIA, V61, P1582, DOI 10.1002/glia.22503; Attaai A, 2018, GLIA, V66, P1695, DOI 10.1002/glia.23332; Barcia C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.17; Benjamini Y, 2001, ANN STAT, V29, P1165; Benveniste EN, 1995, FASEB J, V9, P1577, DOI 10.1096/fasebj.9.15.8529837; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Bianchi I, 2012, J AUTOIMMUN, V38, pJ187, DOI 10.1016/j.jaut.2011.11.012; Bilbo S. D., 2018, POLICY INSIGHTS BEHA, V5, P104, DOI [10.1177/2372732217742673, DOI 10.1177/2372732217742673]; Bowers J Michael, 2010, Biol Sex Differ, V1, P8, DOI 10.1186/2042-6410-1-8; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Chen YJ, 2018, ANN CLIN TRANSL NEUR, V5, P147, DOI 10.1002/acn3.513; Chen YJ, 2016, J CEREBR BLOOD F MET, V36, P2146, DOI 10.1177/0271678X15611434; Clarkson J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0115; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Crain JM, 2013, J NEUROSCI RES, V91, P1143, DOI 10.1002/jnr.23242; Crain JM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-24; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Dotson AL, 2017, J NEUROSCI RES, V95, P437, DOI 10.1002/jnr.23784; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Franchini L, 2004, CELL CALCIUM, V35, P449, DOI 10.1016/j.ceca.2003.11.001; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Grimaldi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25940-5; Hanamsagar R, 2017, CURR OPIN NEUROBIOL, V47, P146, DOI 10.1016/j.conb.2017.10.007; Hanamsagar R, 2017, GLIA, V65, P1504, DOI 10.1002/glia.23176; Hanamsagar R, 2016, J STEROID BIOCHEM, V160, P127, DOI 10.1016/j.jsbmb.2015.09.039; Jackson CM, 1912, BIOL BULL-US, V23, P171, DOI 10.2307/1535914; Kabba JA, 2018, CELL MOL NEUROBIOL, V38, P53, DOI 10.1007/s10571-017-0504-2; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kotecha SA, 1999, J NEUROSCI, V19, P10680, DOI 10.1523/JNEUROSCI.19-24-10680.1999; Lam D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0941-3; Lam D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00185; Lenz KM, 2013, J NEUROSCI, V33, P2761, DOI 10.1523/JNEUROSCI.1268-12.2013; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Lively S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00215; Lively S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00115; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Lopes DM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16664-z; Loram LC, 2012, PSYCHONEUROENDOCRINO, V37, P1688, DOI 10.1016/j.psyneuen.2012.02.018; Lyons SA, 2000, J CEREBR BLOOD F MET, V20, P1537, DOI 10.1097/00004647-200011000-00003; Maezawa I, 2018, BRAIN, V141, P596, DOI 10.1093/brain/awx346; Mallard C, 2019, NEUROSCIENCE, V405, P68, DOI 10.1016/j.neuroscience.2018.01.023; Manoli DS, 2018, ANN NY ACAD SCI, V1420, P26, DOI 10.1111/nyas.13564; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Menteyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006770; Nelson LH, 2017, BRAIN BEHAV IMMUN, V64, P11, DOI 10.1016/j.bbi.2017.03.010; Nelson LH, 2017, J NEUROSCI RES, V95, P447, DOI 10.1002/jnr.23821; Nguyen HM, 2017, CHANNELS, V11, P305, DOI 10.1080/19336950.2017.1300738; Nikodemova M, 2015, J NEUROIMMUNOL, V278, P280, DOI 10.1016/j.jneuroim.2014.11.018; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Peng Y, 2014, NEURO-ONCOLOGY, V16, P528, DOI 10.1093/neuonc/not221; Regitz-Zagrosek V, 2012, EMBO REP, V13, P596, DOI 10.1038/embor.2012.87; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Scolletta S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/876319; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shabab T, 2017, INT J NEUROSCI, V127, P624, DOI 10.1080/00207454.2016.1212854; Siddiqui T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106087; Siddiqui TA, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0531-9; Siddiqui TA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-250; Sivagnanam V, 2010, J NEUROIMMUNOL, V227, P111, DOI 10.1016/j.jneuroim.2010.06.021; Skaper SD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00072; Sominsky L, 2018, INT J BIOCHEM CELL B, V94, P56, DOI 10.1016/j.biocel.2017.11.012; Spanaus KS, 1998, EUR J IMMUNOL, V28, P4398, DOI 10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.3.CO;2-P; Thion MS, 2018, CELL, V172, P500, DOI 10.1016/j.cell.2017.11.042; Turano A, 2017, NEUROSCI LETT, V657, P32, DOI 10.1016/j.neulet.2017.07.052; Villa A, 2018, CELL REP, V23, P3501, DOI 10.1016/j.celrep.2018.05.048; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wan S, 2016, TRANSL STROKE RES, V7, P478, DOI 10.1007/s12975-016-0472-8; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Wu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22864; Xiong XX, 2015, STROKE, V46, P2271, DOI 10.1161/STROKEAHA.115.008897; Yanguas-Casas N., 2017, SM J NEUROL DISORD S, V3, P1014; Yanguas-Casas N, 2018, GLIA, V66, P522, DOI 10.1002/glia.23263; Zhang X, 2015, CELL PHYSIOL BIOCHEM, V35, P1571, DOI 10.1159/000373972	86	6	6	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	NOV 20	2018	12								433	10.3389/fncel.2018.00433			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HB0MC	WOS:000450706600001	30524242	Green Published, gold			2022-02-06	
J	Illman, NA; Crawford, S				Illman, Nathan Anthony; Crawford, Sarah			Late-recovery from "permanent" vegetative state in the context of severe traumatic brain injury: A case report exploring objective and subjective aspects of recovery and rehabilitation	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Disorders of consciousness; vegetative state; late emergence; rehabilitation	LONG-TERM OUTCOMES; AUTOBIOGRAPHICAL MEMORY; EPISODIC MEMORY; SELF; CONSCIOUSNESS; CAREGIVERS; DISORDERS	This article provides a detailed outline of the recovery of a young male patient during his emergence from a vegetative state (VS) 19 months after suffering a severe traumatic brain injury. Several similar cases have been documented, but these tend not to consider the subjective experience of the patient or family; our aim was therefore to provide a detailed account that emphasises our neuropsychological exploration of the impact of the injury on this person, and looks at the experience of his mother along the timeline from his accident to the end of a successful period in rehabilitation. Clinical details are presented including standardised and non-standard assessments, neuropsychological interventions, as well as reflections from the patient himself. Moreover, qualitative data from an interview with his mother is used to illustrate the emotional impact on family of such a vacillating diagnostic status and prognosis for the future. We conclude that late-emergence from VS is increasingly documented and further cases must be published to better understand this phenomenon. The present case illustrates the emotional impact this situation can have on a patient and his or her family, and gives an important insight into a patient's view of his or her life and identity following such an event.	[Illman, Nathan Anthony; Crawford, Sarah] Royal Hosp Neurodisabil, London, England		Illman, NA (corresponding author), Northwick Pk Hosp & Clin Res Ctr, RHRU, Watford Rd, Harrow HA1 3UJ, Middx, England.	nathan.illman@gmail.com					ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Babbage DR, 2004, CLIN NEUROPSYCHOL, V18, P433, DOI 10.1080/1385404049052408; Baird A, 2014, NEUROPSYCHOL REHABIL, V24, P125, DOI 10.1080/09602011.2013.858642; Boss P.G., 2006, LOSS TRAUMA RESILIEN; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; Cipolletta S, 2016, J HEALTH PSYCHOL, V21, P1197, DOI 10.1177/1359105314550348; Davidson, 1976, BEHAV MANAGEMENT ANX, P91; De Tanti A, 2016, BRAIN INJURY, V30, P1029, DOI 10.3109/02699052.2016.1147078; Dhamapurkar SK, 2016, BRAIN INJURY, V30, P230, DOI 10.3109/02699052.2015.1094132; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gill-Thwaites H, 1999, NEUROPSYCHOL REHABIL, V9, P305, DOI 10.1080/096020199389392; Giovannetti AM, 2015, BRAIN INJURY, V29, P473, DOI 10.3109/02699052.2014.990514; Hayes S. C., 2012, ACCEPTANCE COMMITMEN, V2nd; Illman NA, 2011, EPILEPSY BEHAV, V21, P36, DOI 10.1016/j.yebeh.2011.02.022; JENNETT B, 1972, LANCET, V1, P734; Kbler-Ross E., 1969, DEATH DYING; Kitzinger C, 2014, CLIN REHABIL, V28, P627, DOI 10.1177/0269215514527844; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Kuhn MH, 1954, AM SOCIOL REV, V19, P68, DOI 10.2307/2088175; Leach L., 2000, KAPLAN BAYCREST NEUR; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Magee WL, 2016, J MUSIC THER, V53, P1, DOI 10.1093/jmt/thv017; Moretta P, 2014, CLIN REHABIL, V28, P717, DOI 10.1177/0269215514521826; Neumann N, 2004, BRAIN RES PROTOC, V14, P25, DOI 10.1016/j.brainresprot.2004.09.001; Rathbone CJ, 2009, NEUROCASE, V15, P405, DOI 10.1080/13554790902849164; Rathbone CJ, 2008, MEM COGNITION, V36, P1403, DOI 10.3758/MC.36.8.1403; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Sancisi E, 2009, BRAIN INJURY, V23, P163, DOI 10.1080/02699050802660446; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Shiel A, 2000, WHIM WESSEX HEAD INJ; Soeterik SM, 2017, CLIN REHABIL, V31, P1374, DOI 10.1177/0269215517695372; Stroebe M, 1999, DEATH STUD, V23, P197, DOI 10.1080/074811899201046; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006051; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Willander J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01681; Wilson B. A., 2016, SURVIVING BRAIN DAMA	42	6	7	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 17	2018	28	8			SI		1360	1374		10.1080/09602011.2017.1313167			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GX2YR	WOS:000447587800015	28446065				2022-02-06	
J	Aguilar, MC; Gonzalez, A; Rowaan, C; De Freitas, C; Alawa, KA; Durkee, H; Feuer, WJ; Manns, F; Asfour, SS; Lam, BL; Parel, JMA				Aguilar, Mariela C.; Gonzalez, Alex; Rowaan, Cornelis; De Freitas, Carolina; Alawa, Karam A.; Durkee, Heather; Feuer, William J.; Manns, Fabrice; Asfour, Shihab S.; Lam, Byron L.; Parel, Jean-Marie A.			Automated instrument designed to determine visual photosensitivity thresholds	BIOMEDICAL OPTICS EXPRESS			English	Article							LIGHT SENSITIVITY; TENSION-TYPE; PHOTOPHOBIA; PHONOPHOBIA; DISCOMFORT; MIGRAINE	The Ocular Photosensitivity Analyzer (OPA), a new automated instrument to quantify the visual photosensitivity thresholds (VPT) in healthy and light sensitive subjects, is described. The OPA generates light stimuli of varying intensities utilizing unequal ascending and descending steps to yield the VPT. The performance of the OPA was evaluated in healthy subjects. as well as light sensitive subjects with achromatopsia or traumatic brain injury (TBI). VPT in healthy, achromatopsia, and TBI subjects were 3.2 +/- 0.6 log lux. 0.5 +/- 0.5 log lux. and 0.4 +/- 0.6 log lux, respectively. Light sensitive subjects manifested significantly lower VPT compared to healthy subjects. Longitudinal analysis revealed that the OPA reliably measured VPT in healthy subjects. (C) 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement	[Aguilar, Mariela C.; Gonzalez, Alex; Rowaan, Cornelis; De Freitas, Carolina; Alawa, Karam A.; Durkee, Heather; Manns, Fabrice; Parel, Jean-Marie A.] Univ Miami, Miller Sch Med, Ophthalm Biophys Ctr, Bascom Palmer Eye Inst,Dept Ophthalmol, Miami, FL 33136 USA; [Aguilar, Mariela C.; Asfour, Shihab S.] Univ Miami, Dept Ind Engn, Coll Engn, Coral Gables, FL 33124 USA; [Feuer, William J.; Lam, Byron L.] Univ Miami, Miller Sch Med, Anne Bates Leach Eye Ctr, Bascom Palmer Eve Inst,Dept Ophthalmol, Miami, FL 33136 USA; [Durkee, Heather; Manns, Fabrice; Parel, Jean-Marie A.] Univ Miami, Dept Biomed Engn, Coll Engn, Coral Gables, FL 33124 USA; [Parel, Jean-Marie A.] Univ New South Wales, Brien Holden Vis Inst, Sydney, NSW, Australia		Parel, JMA (corresponding author), Univ Miami, Miller Sch Med, Ophthalm Biophys Ctr, Bascom Palmer Eye Inst,Dept Ophthalmol, Miami, FL 33136 USA.; Parel, JMA (corresponding author), Univ Miami, Dept Biomed Engn, Coll Engn, Coral Gables, FL 33124 USA.; Parel, JMA (corresponding author), Univ New South Wales, Brien Holden Vis Inst, Sydney, NSW, Australia.	jmparel@med.miami.edu		Durkee, Heather/0000-0002-5476-5813	National Eye Institute (NEI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R24 EY022023, P30EY14801]; Florida Lions Eye Bank; Beauty of Sight Foundation; Society for Neuroscience - Neuroscience Scholars Program Associate; Brien Holden Vision Institute; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Henri and Flore Lesieur Foundation	National Eye Institute (NEI) (R24 EY022023, P30EY14801); Florida Lions Eye Bank and Beauty of Sight Foundation; Drs. KR Olsen and ME Hildebrandt; Drs. Raksha Urs and Aaron Hurtado; Society for Neuroscience - Neuroscience Scholars Program Associate (MCA); Brien Holden Vision Institute; an unrestricted grant from Research to Prevent Blindness; and the Henri and Flore Lesieur Foundation (JMP).	Aboshiha J, 2016, BRIT J OPHTHALMOL, V100, P115, DOI 10.1136/bjophthalmol-2014-306505; Adams WH, 2006, AM J OPHTHALMOL, V142, P82, DOI 10.1016/j.ajo.2006.02.020; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Barker F, 2017, OPTOMETRY VISION SCI, V94, P4, DOI 10.1097/OPX.0000000000001001; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Blackburn MK, 2009, OPHTHALMOLOGY, V116, P997, DOI 10.1016/j.ophtha.2008.12.031; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BOURASSA CM, 1966, NATURE, V212, P1503, DOI 10.1038/2121503a0; Callahan ML, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0867-x; Chronicle EP, 1996, CEPHALALGIA, V16, P525, DOI 10.1046/j.1468-2982.1996.1608525.x; Cortez MM, 2017, CEPHALALGIA, V37, P801, DOI 10.1177/0333102416673205; Digre KB, 2018, J NEURO-OPHTHALMOL, V38, P237, DOI 10.1097/WNO.0000000000000660; Digre KB, 2015, J NEURO-OPHTHALMOL, V35, P379, DOI 10.1097/WNO.0000000000000316; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Fleiss JL, 1999, DESIGN ANAL CLIN EXP, P1, DOI [DOI 10.1002/9781118032923.CHL, DOI 10.1002/9781118032923]; Galor A, 2016, EXPERT REV OPHTHALMO, V11, P321, DOI 10.1080/17469899.2016.1222905; Garcia-Perez MA, 2001, OPTOMETRY VISION SCI, V78, P56, DOI 10.1097/00006324-200101010-00015; Garcia-Perez MA, 2014, ATTEN PERCEPT PSYCHO, V76, P621, DOI 10.3758/s13414-013-0574-2; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Golebiowski B, 2005, OPHTHAL PHYSL OPT, V25, P246, DOI 10.1111/j.1475-1313.2005.00295.x; Hood D. C., 1986, HDB PERCEPTION HUMAN, V1, P1; Katz BJ, 2016, SURV OPHTHALMOL, V61, P466, DOI 10.1016/j.survophthal.2016.02.001; Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Lebensohn JE, 1934, ARCH OPHTHALMOL-CHIC, V12, P380; Llop S, 2016, J HEADACHE PAIN, V17, P1, DOI 10.1186/s10194-016-0629-6; Main A, 1997, HEADACHE, V37, P492, DOI 10.1046/j.1526-4610.1997.3708492.x; Main A, 2000, HEADACHE, V40, P194, DOI 10.1046/j.1526-4610.2000.00028.x; Mainster MA, 2012, AM J OPHTHALMOL, V153, P587, DOI 10.1016/j.ajo.2012.01.008; Noseda R., 2018, CEPHALALGIA; Rosenthal P, 2016, BRIT J OPHTHALMOL, V100, P128, DOI 10.1136/bjophthalmol-2014-306280; Rossi HL, 2015, HEADACHE, V55, P600, DOI 10.1111/head.12532; Sakanishi Y, 2012, OPHTHALMOLOGICA, V228, P174, DOI 10.1159/000336721; Stern CD, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P283, DOI 10.1201/b10524-9; STEVENS JC, 1963, J OPT SOC AM, V53, P375, DOI 10.1364/JOSA.53.000375; Stringham JM, 2003, J OPT SOC AM A, V20, P1852, DOI 10.1364/JOSAA.20.001852; Vanagaite J, 1997, CEPHALALGIA, V17, P733, DOI 10.1046/j.1468-2982.1997.1707733.x; Vingen JV, 1998, CEPHALALGIA, V18, P250, DOI 10.1046/j.1468-2982.1998.1805250.x; Vingen JV, 1998, CEPHALALGIA, V18, P313, DOI 10.1046/j.1468-2982.1998.1806313.x; WIRTSCHAFTER JD, 1966, ARCH OPHTHALMOL-CHIC, V75, P683; WIRTSCHAFTER JONATHAN D., 1963, TRANS AMER NEUROL ASSOC, V88, P291; Wu YW, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0095-3; Yuhas PT, 2017, OPTOMETRY VISION SCI, V94, P108, DOI 10.1097/OPX.0000000000000934; Zele AJ, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01594	43	6	6	0	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	NOV 1	2018	9	11					5583	5596		10.1364/BOE.9.005583			14	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	GZ2EZ	WOS:000449192700032	30460148	gold, Green Published			2022-02-06	
J	Catanese, A; Garrido, D; Walther, P; Roselli, F; Boeckers, TM				Catanese, Alberto; Garrido, Debora; Walther, Paul; Roselli, Francesco; Boeckers, Tobias M.			Nutrient limitation affects presynaptic structures through dissociable Bassoon autophagic degradation and impaired vesicle release	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Autophagy; Bassoon; nutrient limitation; synapses; synaptic vesicles	TRAUMATIC BRAIN-INJURY; SYNAPTIC FUNCTION; ACTIVE ZONE; PROTEIN UBIQUITINATION; INDUCED NEUROTOXICITY; NEURONAL AUTOPHAGY; CA2+ CHANNELS; SYNAPSES; METABOLISM; INHIBITION	Acute mismatch between metabolic requirements of neurons and nutrients/growth factors availability characterizes several neurological conditions such as traumatic brain injury, stroke and hypoglycemia. Although the effects of this mismatch have been investigated at cell biological level, the effects on synaptic structure and function are less clear. Since synaptic activity is the most energy-demanding neuronal function and it is directly linked to neuronal networks functionality, we have explored whether nutrient limitation (NL) affects the ultrastructure, function and composition of pre and postsynaptic terminals. We show that upon NL, presynaptic terminals show disorganized vesicle pools and reduced levels of the active zone protein Bassoon (but not of Piccolo). Moreover, NL triggers an impaired vesicle release, which is reversed by re-administration of glucose but not by the blockade of autophagic or proteasomal protein degradation. This reveals a dissociable correlation between presynaptic architecture and vesicle release, since restoring vesicle fusion does not necessarily depend from the rescue of Bassoon levels. Thus, our data show that the presynaptic compartment is highly sensitive to NL and the rescue of presynaptic function requires re-establishment of the metabolic supply rather than preventing local protein degradation.	[Catanese, Alberto; Garrido, Debora; Roselli, Francesco; Boeckers, Tobias M.] Ulm Univ, Inst Anat & Cell Biol, Ulm, Germany; [Catanese, Alberto; Garrido, Debora] Ulm Univ, Int Grad Sch Mol Med Ulm IGradU, Ulm, Germany; [Walther, Paul] Ulm Univ, Electron Microscopy Inst, Ulm, Germany; [Roselli, Francesco] Ulm Univ, Dept Neurol, Ulm, Germany		Boeckers, TM (corresponding author), Ulm Univ, Dept Anat & Cell Biol, Sch Med, Albert Einstein Allee 11, DE-89081 Ulm, Germany.	tobias.boeckers@uni-ulm.de	Catanese, Alberto/AAQ-9185-2021; roselli, francesco/O-8847-2019	roselli, francesco/0000-0001-9935-6899			Aguirre-Rueda D, 2015, INT J MED SCI, V12, P48, DOI 10.7150/ijms.10035; Allavena G, 2016, AUTOPHAGY, V12, P2085, DOI 10.1080/15548627.2016.1226733; Ashrafi G, 2017, NEURON, V93, P606, DOI 10.1016/j.neuron.2016.12.020; Backues SK, 2014, AUTOPHAGY, V10, P155, DOI 10.4161/auto.26856; Bading H, 2017, J EXP MED, V214, P569, DOI 10.1084/jem.20161673; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barth A, 2005, EXP BRAIN RES, V161, P351, DOI 10.1007/s00221-004-2079-7; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Castejon O J, 1995, J Neurosurg Sci, V39, P47; Clarke JP, 2016, J NEUROSCI RES, V94, P653, DOI 10.1002/jnr.23733; Clarkson C, 2016, J NEUROSCI, V36, P10214, DOI 10.1523/JNEUROSCI.0226-16.2016; Davis EA, 1998, J PEDIATR ENDOCR MET, V11, P177; Davydova D, 2014, NEURON, V82, P181, DOI 10.1016/j.neuron.2014.02.012; Dias RB, 2013, NEUROPHARMACOLOGY, V65, P114, DOI 10.1016/j.neuropharm.2012.09.016; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gundelfinger Eckart D, 2015, Front Synaptic Neurosci, V7, P19, DOI 10.3389/fnsyn.2015.00019; Heise C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00035; Held RG, 2016, ELIFE, V5, DOI 10.7554/eLife.14862; Herbert AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114749; HERSHKOWITZ N, 1993, J NEUROPHYSIOL, V69, P432, DOI 10.1152/jn.1993.69.2.432; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; Ivanova D, 2015, EMBO J, V34, P1056, DOI 10.15252/embj.201488796; Jang S, 2016, NEURON, V90, P278, DOI 10.1016/j.neuron.2016.03.011; Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; MacGillavry HD, 2016, EUR J NEUROSCI, V43, P179, DOI 10.1111/ejn.13129; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Monteiro P, 2017, NAT REV NEUROSCI, V18, P147, DOI 10.1038/nrn.2016.183; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Nguyen SM, 2007, J NEUROSCI METH, V161, P281, DOI 10.1016/j.jneumeth.2006.10.026; Okerlund ND, 2017, NEURON, V93, P897, DOI 10.1016/j.neuron.2017.01.026; Quaegebeur A, 2016, CELL METAB, V23, P280, DOI 10.1016/j.cmet.2015.12.007; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Regus-Leidig H, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00259; Reim Dominik, 2016, Front Synaptic Neurosci, V8, P13, DOI 10.3389/fnsyn.2016.00013; Reno CM, AM J PHYSIOL-ENDOC M, DOI [10. 1152/ajpendo. 00082. 2018, DOI 10.1152/AJPENDO.00082.2018]; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Risher WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107591; Roselli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023097; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schmeisser MJ, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-18; Schmeisser MJ, 2012, J NEUROSCI, V32, P5688, DOI 10.1523/JNEUROSCI.0111-12.2012; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sun MK, 2002, J PHARMACOL EXP THER, V300, P408, DOI 10.1124/jpet.300.2.408; Tao HZW, 2001, P NATL ACAD SCI USA, V98, P11009, DOI 10.1073/pnas.191351698; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Villinger C, 2014, METHODS MOL BIOL, V1117, P617, DOI 10.1007/978-1-62703-776-1_27; Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27; Wang N, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/827161; Wang XW, 2009, J NEUROSCI, V29, P12584, DOI 10.1523/JNEUROSCI.1255-09.2009; Wendholt D, 2006, J BIOL CHEM, V281, P13805, DOI 10.1074/jbc.M601101200; Willems E, 2012, CELL STEM CELL, V11, P242, DOI 10.1016/j.stem.2012.04.025; Won SJ, 2012, J CEREBR BLOOD F MET, V32, P1086, DOI 10.1038/jcbfm.2012.30; Wong MY, 2018, P NATL ACAD SCI USA, V115, P2234, DOI 10.1073/pnas.1719012115; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Young JE, 2009, J BIOL CHEM, V284, P2363, DOI 10.1074/jbc.M806088200	79	6	6	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2018	38	11					1924	1939		10.1177/0271678X18786356			16	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	HA3KL	WOS:000450149200006	29972341	Bronze, Green Published			2022-02-06	
J	Harrison-Felix, C; Newman, JK; Hawley, L; Morey, C; Ketchum, JM; Walker, WC; Bell, KR; Millis, SR; Braden, C; Malec, J; Hammond, FM; Eagye, CB; Howe, L				Harrison-Felix, Cynthia; Newman, Jody K.; Hawley, Lenore; Morey, Clare; Ketchum, Jessica M.; Walker, William C.; Bell, Kathleen R.; Millis, Scott R.; Braden, Cynthia; Malec, James; Hammond, Flora M.; Eagye, C. B.; Howe, Laura			Social Competence Treatment After Traumatic Brain Injury: A Multicenter, Randomized Controlled Trial of Interactive Group Treatment Versus Noninteractive Treatment	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Rehabilitation; Social skills; Treatment	HEAD-INJURY; TBI; RELIABILITY; VALIDITY; REHABILITATION; INTERVENTION; IMPAIRMENT; ABILITY; PEOPLE; SCALE	Objective: To evaluate the effectiveness of a replicable group treatment program for improving social competence after traumatic brain injury (TBI). Design: Multicenter randomized controlled trial comparing 2 methods of conducting a social competency skills program, an interactive group format versus a classroom lecture. Setting: Community and veteran rehabilitation centers. Participants: Civilian, military, and veteran adults with TBI and social competence difficulties (N = 179), at least 6 months postinjury. Interventions: The experimental intervention consisted of 13 weekly group interactive sessions (1.5h) with structured and facilitated group interactions to improve social competence, and the control consisted of 13 traditional classroom sessions using the same curriculum with brief supplemental individual sessions but without structured group interaction. Main Outcome Measures: Profile of Pragmatic Impairment in Communication (PPIC), an objective behavioral rating of social communication impairments after TBI. LaTrobe Communication Questionnaire (LCQ), Goal Attainment Scale (GAS), Satisfaction with Life Scale, Posttraumatic Stress Disorder Checklist-C (PCL) civilian version, Brief Symptom Inventory 18 (BSI-18), Scale of Perceived Social Self-Efficacy (PSSE). Results: Social competence goals (GAS) were achieved and maintained for most participants regardless of treatment method. Significant improvements in the primary outcome (PPIC) and 2 of the secondary outcomes (LCQ and BSI) were seen immediately posttreatment and at 3 months posttreatment in the alternative treatment arm only; however, these improvements were not significantly different between the group interactive structured treatment and alternative treatment arms. Similar trends were observed for PSSE and PCL-C. Conclusions: Social competence skills improved for persons with TBI in both treatment conditions. The group interactive format was not found to be a superior method of treatment delivery in this study. (C) 2018 by the American Congress of Rehabilitation Medicine	[Harrison-Felix, Cynthia; Newman, Jody K.; Hawley, Lenore; Morey, Clare; Ketchum, Jessica M.; Braden, Cynthia; Eagye, C. B.] Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA; [Harrison-Felix, Cynthia; Ketchum, Jessica M.] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Walker, William C.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Bell, Kathleen R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Millis, Scott R.] Rehabil Inst Michigan, Detroit, MI USA; [Millis, Scott R.] Wayne State Univ, Sch Med, Detroit, MI USA; [Malec, James; Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Malec, James; Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Howe, Laura] VA Palo Alto Hlth Care Syst, Polytrauma Rehabil Ctr, Livermore, CA USA; [Bell, Kathleen R.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA		Hawley, L (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	lhawley@craighospital.org	Ketchum, Jessica/AAE-8200-2020	Bell, Kathleen/0000-0002-0928-2046	US Department of DefenseUnited States Department of Defense [W81XWH-11-1-0635, PT100068]	Supported by the US Department of Defense award number W81XWH-11-1-0635 (grant no. PT100068).	[Anonymous], 1997, ASSESSMENT TOOL GUID; Bell KR, 2008, AM J PHYS MED REHAB, V87, P330, DOI 10.1097/PHM.0b013e318168d092; Bellack A. S., 1979, RES PRACTICE SOCIAL; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GOLDFRIED MR, 1969, CURRENT TOPICS CLIN, V1; Hawley L., 2008, GROUP INTERACTIVE ST; Hawley LA, 2010, BRAIN INJURY, V24, P1292, DOI 10.3109/02699052.2010.506866; Hays SJ, 2004, APHASIOLOGY, V18, P693, DOI 10.1080/02687030444000183; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoofien D, 2001, BRAIN INJURY, V15, P189; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MacNair-Semands RR, 2002, GROUP DYN-THEOR RES, V6, P219, DOI 10.1037//1089-2699.6.3.219; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Reitan R. M., 1993, HALSTED REITAN NEURO; Rose S. D., 1998, GROUP THERAPY TROUBL; Sanchez V, 2007, HEALTH EDUC RES, V22, P95, DOI 10.1093/her/cyl052; Santacroce SJ, 2004, NURS RES, V53, P63, DOI 10.1097/00006199-200401000-00010; Schmidt M, 2010, REY AUDITORY VERBAL; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Siqueland L, 2000, J Psychother Pract Res, V9, P123; Smith HM, 2000, J CAREER ASSESSMENT, V8, P283, DOI 10.1177/106907270000800306; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Weathers FW, 1991, PCL C FOR DSM 4; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th	44	6	6	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2018	99	11					2131	2142		10.1016/j.apmr.2018.05.030			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HB8TD	WOS:000451362700001	29966645	Green Submitted			2022-02-06	
J	Hsieh, CH; Rau, CS; Wu, SC; Liu, HT; Huang, CY; Hsu, SY; Hsieh, HY				Hsieh, Ching-Hua; Rau, Cheng-Shyuan; Wu, Shao-Chun; Liu, Hang-Tsung; Huang, Chun-Ying; Hsu, Shiun-Yuan; Hsieh, Hsiao-Yun			Risk Factors Contributing to Higher Mortality Rates in Elderly Patients with Acute Traumatic Subdural Hematoma Sustained in a Fall: A Cross-Sectional Analysis Using Registered Trauma Data	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury; subdural hematoma (SDH); trauma; fall; elderly; young adult; mortality; risk factor	BRAIN-INJURY; MANAGEMENT; OUTCOMES; ASPIRIN; HOSPITALIZATIONS; DETERIORATION; METAANALYSIS; MORBIDITY; THERAPY; SURGERY	Background: We aimed to explore the risk factors that contribute to the mortality of elderly trauma patients with acute subdural hematoma (SDH) resulting from a fall. Mortality rates of the elderly were compared to those of young adults. Methods: A total of 444 patients with acute traumatic subdural hematoma resulting from a fall, admitted to a level I trauma center from 1 January 2009 to 31 December 2016 were enrolled in this study. Patients were categorized into two groups: elderly patients (n = 279) and young adults (n = 165). The primary outcome of this study was patient mortality in hospital. The adjusted odds ratio (AOR) with 95% confidence interval (CI) for mortality was calculated according to gender and pre-existing comorbidities. Univariate and multivariate logistic regression analyses were performed to identify factors related to mortality in the elderly. Results: The odds ratio for mortality caused by falls in the elderly patients was four-fold higher than in the young adults, after adjusting for gender and pre-existing comorbidities. In addition, the presence of pre-existing coronary artery disease (OR 3.2, 95% CI 1.09-9.69, p = 0.035), end-stage renal disease (OR 4.6, 95% CI 1.48-14.13, p = 0.008), hematoma volume (OR 1.2, 95% CI 1.11-1.36, p < 0.001), injury severity score (OR 1.3, 95% CI 1.23-1.46, p < 0.001), and coagulopathy (OR 4.0, 95% CI 1.47-11.05, p = 0.007) were significant independent risk factors for mortality in patients with acute traumatic SDH resulting from a fall. Conclusions: In this study, we identified that pre-existing CAD, ESRD, hematoma volume, ISS, and coagulopathy were significant independent risk factors for mortality in patients with acute traumatic SDH. These results suggest that death following acute SDH is influenced both by the extent of neurological damage and the overall health of the patient at the time of injury.	[Hsieh, Ching-Hua; Hsieh, Hsiao-Yun] Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan; [Rau, Cheng-Shyuan] Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Wu, Shao-Chun] Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung 83301, Taiwan; [Liu, Hang-Tsung; Huang, Chun-Ying; Hsu, Shiun-Yuan] Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Trauma Surg, Kaohsiung 83301, Taiwan		Hsieh, CH (corresponding author), Chang Gung Univ & Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan.	m93chinghua@gmail.com; ersh2127@cloud.cgmh.org.tw; shaochunwu@gmail.com; htl1688@yahoo.com.tw; junyinhaung@yahoo.com.tw; ah.lucy@hotmail.com; sylvia19870714@hotmail.com		WU, Shaochun/0000-0002-0984-6921; Hsieh, Ching-Hua/0000-0002-0945-2746	 [CMRPG8H0291]	This research was supported by a grant from CMRPG8H0291 to C.-S.R.	Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; Anandasivam Nidharshan S, 2017, Conn Med, V81, P215; Aspegren OP, 2013, CLIN NEUROL NEUROSUR, V115, P981, DOI 10.1016/j.clineuro.2012.10.008; Bakheet MF, 2015, INT J STROKE, V10, P501, DOI 10.1111/ijs.12419; Bartek J, 2019, NEUROSURGERY, V84, P799, DOI 10.1093/neuros/nyy173; Benedetto N, 2017, BRIT J NEUROSURG, V31, P244, DOI 10.1080/02688697.2016.1244249; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Connolly BJ, 2013, J STROKE CEREBROVASC, V22, P444, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.007; De Bonis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068732; El-Fiki M, 2012, WORLD NEUROSURG, V78, P228, DOI 10.1016/j.wneu.2012.02.049; Feliciano CE, 2008, P R HEALTH SCI J, V27, P220; Hsieh CH, 2017, BIOMED J, V40, P113, DOI 10.1016/j.bj.2016.10.005; Hsieh CH, 2017, BIOMED J, V40, P121, DOI 10.1016/j.bj.2016.10.006; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Khormi YH, 2018, J NEUROTRAUM, V35, P1407, DOI 10.1089/neu.2017.5345; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Ledic Darko, 2014, Coll Antropol, V38, P1195; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; McClaskey EM, 2007, PHARMACOTHERAPY, V27, P152, DOI 10.1592/phco.27.1.152; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Parr JD, 2010, J PALLIAT MED, V13, P719, DOI 10.1089/jpm.2009.0337; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Prasad GL, 2018, WORLD NEUROSURG, V111, pE221, DOI 10.1016/j.wneu.2017.12.034; Pruitt P, 2017, ACAD EMERG MED, V24, P1377, DOI 10.1111/acem.13306; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Rao MG, 2016, J CLIN DIAGN RES, V10, pHO1, DOI 10.7860/JCDR/2016/17207.7644; Rau CS, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0063-1; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Seddighi AS, 2013, BRAIN INJURY, V27, P1666, DOI 10.3109/02699052.2013.830333; Shen J, 2013, ACTA NEUROCHIR, V155, P335, DOI 10.1007/s00701-012-1569-9; Valadka AB, 2012, WORLD NEUROSURG, V78, P231, DOI 10.1016/j.wneu.2011.12.067; Wang IK, 2014, EUR J NEUROL, V21, P894, DOI 10.1111/ene.12406; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17421; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109	42	6	6	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-7827	1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2018	15	11							2426	10.3390/ijerph15112426			9	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	HC2OB	WOS:000451640500100	30388747	Green Submitted, Green Published, gold			2022-02-06	
J	Khokhar, B; Simoni-Wastila, L; Slejko, JF; Perfetto, E; Zhan, M; Smith, GS				Khokhar, Bilal; Simoni-Wastila, Linda; Slejko, Julia F.; Perfetto, Eleanor; Zhan, Min; Smith, Gordon S.			Mortality and Associated Morbidities Following Traumatic Brain Injury in Older Medicare Statin Users	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Medicare; mortality; older adults; statins; TBI sequelae; traumatic brain injury	DRUG-INTERACTIONS; SIMVASTATIN; BENEFITS; RISK; NEUROPROTECTION; DEPRESSION; MODELS; ADULTS; RATS	Objective: To assess the relationship between posttraumatic brain injury statin use and (1) mortality and (2) the incidence of associated morbidities, including stroke, depression, and Alzheimer's disease and related dementias following injury. Setting and Participants: Nested cohort of all Medicare beneficiaries 65 years of age and older who survived a traumatic brain injury (TBI) hospitalization during 2006 through 2010. The final sample comprised 100 515 beneficiaries. Design: Retrospective cohort study of older Medicare beneficiaries. Relative risks (RR) and 95% confidence interval (CI) were obtained using discrete time analysis and generalized estimating equations. Measures: The exposure of interest included monthly atorvastatin, fluvastatin, lovastatin, pravastatin, rosuvastatin, and simvastatin use. Outcomes of interest included mortality, stroke, depression, and Alzheimer's disease and related dementias. Results: Statin use of any kind was associated with decreased mortality following TBI hospitalization discharge. Any statin use was also associated with a decrease in any stroke (RR, 0.86; 95% confidence intervals (CI), 0.81-0.91), depression (RR, 0.85; 95% CI, 0.79-0.90), and Alzheimer's disease and related dementias (RR, 0.77; 95% CI, 0.73-0.81). Conclusion: These findings provide valuable information for clinicians treating older adults with TBI as clinicians can consider, when appropriate, atorvastatin and simvastatin to older adults with TBI in order to decrease mortality and associated morbidities.	[Khokhar, Bilal] Def & Vet Brain Injury Ctr, Gen Dynam Informat Technol, Fairfax, VA USA; [Simoni-Wastila, Linda; Slejko, Julia F.; Perfetto, Eleanor] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Perfetto, Eleanor] Natl Hlth Council, Washington, DC USA; [Zhan, Min; Smith, Gordon S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Smith, Gordon S.] West Virginia Univ, Sch Publ Hlth, Morgantown, WV USA		Khokhar, B (corresponding author), Def & Vet Brain Injury Ctr, Gen Dynam Informat Technol, 1335 East West Highway, Silver Spring, MD 20910 USA.	Bilal.khokhar@gdit.com		Smith, Gordon/0000-0002-2911-3071	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AG000262-14, R01AA18707]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018313, R01AA018707] Funding Source: NIH RePORTER	Dr Khokhar was supported by National Institutes of Health grant T32AG000262-14 (Magaziner, PI) and Dr Smith was supported by National Institutes of Health grant R01AA18707. For the remaining authors none were declared.	Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Albrecht JS, 2015, J HEAD TRAUMA REHAB, V30, pE62, DOI 10.1097/HTR.0000000000000035; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Allison PaulD., 1982, SOCIOLOGICAL METHODO, V13, P61, DOI [10.2307/270718, DOI 10.2307/270718]; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; Andrus MR, 2004, PHARMACOTHERAPY, V24, P285, DOI 10.1592/phco.24.2.285.33137; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Bhatnagar S, 2016, BRAIN RES, V1640, P164, DOI 10.1016/j.brainres.2016.01.021; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Coronado VG, 2011, SURVEILLANCE TRAUMAT; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Griffen J., 2014, HDB NEUROPSYCHOLOGY, P25; Hurley LL, 2013, NEUROTOX RES, V23, P131, DOI 10.1007/s12640-012-9348-1; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Jungner M, 2013, MICROVASC RES, V88, P48, DOI 10.1016/j.mvr.2013.03.004; Khokhar B, 2017, J HEAD TRAUMA REHAB, V32, pE42, DOI 10.1097/HTR.0000000000000231; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mahmood A, 2009, NEUROSURGERY, V65, P187, DOI 10.1227/01.NEU.0000343540.24780.D6; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Masel B., 2014, UNDERSTANDING TRAUMA, P28; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Nutescu E, 2011, J THROMB THROMBOLYS, V31, P326, DOI 10.1007/s11239-011-0561-1; Orlando Alessandro, 2013, J Clin Med Res, V5, P168, DOI 10.4021/jocmr1333w; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prevention CfDCa, 2016, TBI GET FACTS; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; STAMBLER HV, 1988, PUBLIC HEALTH REP, V103, P184; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; van Rein N, 2016, AM J EPIDEMIOL, V183, P930, DOI 10.1093/aje/kwv255; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Williams D, 2002, CLIN PHARMACOKINET, V41, P343, DOI 10.2165/00003088-200241050-00003	43	6	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					E68	E76		10.1097/HTR.0000000000000369			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600008	29385012	Green Accepted, Green Submitted			2022-02-06	
J	Kislay, K; Devi, BI; Bhat, DI; Shukla, DP; Gupta, AK; Panda, R				Kislay, Kishore; Devi, Bhagavatula Indira; Bhat, Dhananjaya Ishwar; Shukla, Dhaval Prem; Gupta, Arun Kumar; Panda, Rajanikant			Novel Findings in Obstetric Brachial Plexus Palsy: A Study of Corpus Callosum Volumetry and Resting-State Functional Magnetic Resonance Imaging of Sensorimotor Network	NEUROSURGERY			English	Article						Obstetric brachial plexus palsy; Resting-state fMRI; Cortical plasticity; Corpus callosum volume	TRAUMATIC BRAIN-INJURY; DIFFUSION-TENSOR; CORTICAL REORGANIZATION; NERVE TRANSFER; CONNECTIVITY; DEGENERATION; MYELINATION; PLASTICITY; PATTERNS; SECTION	The response of the brain to obstetric brachial plexus palsy (OBPP) is not clearly understood. We propose that even a peripheral insult at the developmental stage may result in changes in the volume of white matter of the brain, which we studied using corpus callosum volumetry and resting-state functional magnetic resonance imaging (rsfMRI) of sensorimotor network. To study the central neural effects in OBPP. We performed an MRI study on a cohort of 14 children who had OBPP and 14 healthy controls. The mean age of the test subjects was 10.07 +/- 1.22 yr (95% confidence interval). Corpus callosum volumetry was compared with that of age-matched healthy subjects. Hofer and Frahm segmentation was used. Resting-state fMRI data were analyzed using the FSL software (FMRIB Software Library v5.0, Oxford, United Kingdom), and group analysis of the sensorimotor network was performed. Statistical analysis of corpus callosum volume revealed significant differences between the OBPP cohort and healthy controls, especially in the motor association areas. Independent t-test revealed statistically significant volume loss in segments I (prefrontal), II (premotor), and IV (primary sensory area). rsfMRI of sensorimotor network showed decreased activation in the test hemisphere (the side contralateral to the injured brachial plexus) and also decreased activation in the ipsilateral hemisphere, when compared with healthy controls. OBPP occurs in an immature brain and causes central cortical changes. There is secondary corpus callosum atrophy which may be due to retrograde transneuronal degeneration. This in turn may result in disruption of interhemispheric coactivation and consequent reduction in activation of sensorimotor network even in the ipsilateral hemisphere.	[Kislay, Kishore; Devi, Bhagavatula Indira; Bhat, Dhananjaya Ishwar; Shukla, Dhaval Prem; Panda, Rajanikant] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Second Floor,Neurosci Fac Block,Hosur Rd, Bangalore 560029, Karnataka, India; [Gupta, Arun Kumar] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuroimaging, Bangalore, Karnataka, India; [Gupta, Arun Kumar] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Intervent Radiol, Bangalore, Karnataka, India		Devi, BI (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Second Floor,Neurosci Fac Block,Hosur Rd, Bangalore 560029, Karnataka, India.	bidevidr@gmail.com		Panda, Rajanikant/0000-0002-0960-4340	Indian Council of Medical Research (ICMR)Indian Council of Medical Research (ICMR) [3/2/Nov-2014/PG-Thesis-HRD-17]	This study is based on the thesis of Dr Kishore Kislay and part of the research was funded by Indian Council of Medical Research (ICMR) Thesis grant (3/2/Nov-2014/PG-Thesis-HRD-17). The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Adamson C, 2014, NEUROINFORMATICS, V12, P595, DOI 10.1007/s12021-014-9236-3; Bates E, 1986, DEV NEUROPSYCHOL, V2, P1, DOI 10.1080/87565648609540323; BEATTY RM, 1982, J NEUROL NEUROSUR PS, V45, P143, DOI 10.1136/jnnp.45.2.143; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bridge H, 2012, J CLIN EXP OPHTHALMO, VS3; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; CHIMELLI L, 1985, NEUROSCI LETT, V57, P57, DOI 10.1016/0304-3940(85)90040-0; Cowan, 1970, CONT RES METHODS NEU, P217; DIETRICH RB, 1988, AM J ROENTGENOL, V150, P889, DOI 10.2214/ajr.150.4.889; Dimou S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00500; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Ewing-Cobbs L., 2008, HDB DEV COGNITIVE NE, P399; Eysel U. T., 2009, ENCY NEUROSCIENCE, P141; Feng JT, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.04.046; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; GESELL A, 1947, J GENET PSYCHOL, V70, P155; Herron TJ, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00025; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hua XY, 2012, BRAIN RES, V1471, P93, DOI 10.1016/j.brainres.2012.06.016; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lang S, 2014, NEUROSURGERY, V74, P453, DOI 10.1227/NEU.0000000000000307; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Lou L, 2006, NEUROSCIENCE, V138, P1225, DOI 10.1016/j.neuroscience.2005.11.062; Mohanty CB, 2015, NEUROSURGERY, V77, P418, DOI 10.1227/NEU.0000000000000851; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Nespoulous J.-L., 2014, BIOL FDN GESTURE MOT; Nielsen JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071275; Pawela CP, 2010, NEUROIMAGE, V49, P2467, DOI 10.1016/j.neuroimage.2009.09.054; Qiu TM, 2014, J NEUROL NEUROSUR PS, V85, P99, DOI 10.1136/jnnp-2013-304956; Rosazza C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098860; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Simon NG, 2016, WORLD NEUROSURG, V85, P325, DOI [10.1016/j.WNEU.2015.09.027, 10.1016/j.wneu.2015.09.027]; Smith S.M., 2009, NEUROIMAGE, V47, pS148; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sokki AM, 2012, NEUROSURGERY, V70, P1305, DOI 10.1227/NEU.0b013e318241017d; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Zhang DY, 2009, NEUROSURGERY, V65, P226, DOI 10.1227/01.NEU.0000350868.95634.CA	49	6	6	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2018	83	5					905	914		10.1093/neuros/nyx495			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HF1MP	WOS:000453930700019	29092081	Green Submitted			2022-02-06	
J	LaRovere, KL; Murphy, SA; Horak, R; Vittner, P; Kapur, K; Proctor, M; Tasker, RC				LaRovere, Kerri L.; Murphy, Sarah A.; Horak, Robin; Vittner, Patrick; Kapur, Kush; Proctor, Mark; Tasker, Robert C.			Pediatric Neurocritical Care: Evolution of a New Clinical Service in PICUs Across the United States	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						critical care medicine; neurocritical care; neurology; neurosurgery; pediatrics; stroke	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE; EDUCATION; IMPLEMENTATION; MANAGEMENT; NEUROLOGY; OUTCOMES; PROGRAM	Objectives: Pediatric neurocritical care as a conceptual service is relatively new, and implementation of such specialized services may improve outcomes for children with disorders of the brain or spinal cord. How many pediatric neurocritical care services currently exist in the United States, and attitudes about such a service are unknown. Design: Web-based survey, distributed by e-mail. Setting: Survey was sent to PICU Medical Directors and Program Directors of Pediatric Neurosurgery fellowship and Child Neurology residency programs. Patients: None. Interventions: None. Measurements and Main Results: A total of 378 surveys were distributed; 161 respondents representing 128 distinct hospitals completed the survey (43% response rate). Thirty-five percent (45/128) reported having a pediatric neurocritical care service. The most common type of service used a consultation model (82%; 32/39 responses). Other types of services were intensivist-led teams in the PICU (five hospitals) and dedicated PICU beds (two hospitals). Hospital characteristics associated with availability of pediatric neurocritical care services were level 1 trauma status (p = 0.017), greater numbers of PICU beds ((2) [6, n = 128] = 136.84; p < 0.01), and greater volume of children with pediatric neurocritical care conditions ((2) [3, n = 128] = 20.16; p < 0.01). The most common reasons for not having a pediatric neurocritical care service were low patient volume (34/119 responses), lack of subspecialists (30/119 responses), and lack of interest by PICU faculty (25/119 responses). The positive impacts of a pediatric neurocritical care service were improved interdisciplinary education/training (16/45 responses), dedicated expertise (13/45 responses), improved interservice communication (9/45 responses), and development/implementation of guidelines and protocols (9/45 responses). The negative impacts of a pediatric neurocritical care service were disagreement among consultants (2/45 responses) and splitting of the PICU population (2/45 responses). Conclusions: At least 45 specialized pediatric neurocritical care services exist in the United States. Eighty percent of these services are a consultation service to the PICU. Hospitals with level 1 trauma status, greater numbers of PICU beds, and greater numbers of patients with pediatric neurocritical care conditions were associated with the existence of pediatric neurocritical care as a clinical service.	[LaRovere, Kerri L.; Vittner, Patrick; Kapur, Kush; Tasker, Robert C.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Murphy, Sarah A.] Massachusetts Gen Hosp Children, Dept Pediat, Div Pediat Crit Care Med, Boston, MA USA; [Horak, Robin] Childrens Hosp Los Angeles, Dept Crit Care & Anesthesiol, Los Angeles, CA 90027 USA; [Proctor, Mark] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Tasker, Robert C.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA		LaRovere, KL (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.	kerri.larovere@childrens.harvard.edu	Kapur, Kush/AAQ-3437-2020; Tasker, Robert C/R-5837-2019	Kapur, Kush/0000-0001-9022-913X; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Dr. Kapur received support for article research from the National Institutes of Health. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Bell MJ, 2012, NEUROCRIT CARE, V17, P468, DOI 10.1007/s12028-012-9731-z; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Braithwaite D, 2003, FAM PRACT, V20, P545, DOI 10.1093/fampra/cmg509; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Horvat CM, 2016, SEMIN NEUROL, V36, P492, DOI 10.1055/s-0036-1592107; Kochanek PM, 2010, DEV NEUROSCI-BASEL, V32, P335, DOI 10.1159/000323016; LaRovere KL, 2008, NEUROLOGY, V70, pE89, DOI 10.1212/01.wnl.0000313379.57609.25; LaRovere KL, 2013, PEDIATR NEUROL, V48, P206, DOI 10.1016/j.pediatrneurol.2012.12.006; Lee JC, 2011, SEMIN PEDIATR NEUROL, V18, P128, DOI 10.1016/j.spen.2011.05.010; Markandaya M, 2012, NEUROCRIT CARE, V16, P72, DOI 10.1007/s12028-011-9628-2; Markham C, 2017, CURR OPIN PEDIATR, V29, P266, DOI 10.1097/MOP.0000000000000497; Mayer SA, 2006, NEUROCRIT CARE, V5, P82, DOI 10.1385/NCC:5:2:82; Murphy SA, 2015, NEUROCRIT CARE, V23, P149, DOI 10.1007/s12028-015-0120-2; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Rakes L, 2016, BMJ QUAL IMPROV REP, V5; Scher M, 2008, PEDIATR NEUROL, V39, P1, DOI 10.1016/j.pediatrneurol.2008.01.013; Tasker RC, 2016, JAMA-J AM MED ASSOC, V315, P749, DOI 10.1001/jama.2016.0701; Tasker RC, 2014, PEDIATR ANESTH, V24, P717, DOI 10.1111/pan.12398; Tasker RC, 2009, CURR OPIN PEDIATR, V21, P724, DOI 10.1097/MOP.0b013e328331e813; Wainwright MS, 2014, SEMIN PEDIATR NEUROL, V21, P248, DOI 10.1016/j.spen.2014.10.006	21	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	NOV	2018	19	11					1039	1045		10.1097/PCC.0000000000001708			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	GY9FL	WOS:000448945200013	30134362				2022-02-06	
J	Mustafa, AG; Alfaqih, MA; Al-Shboul, O; Al-Dwairi, A				Mustafa, Ayman G.; Alfaqih, Mahmoud A.; Al-Shboul, Othman; Al-Dwairi, Ahmed			Scavenging of lipid peroxyl radicals protects plasma lipids and proteins from peroxynitrite	BIOMEDICAL REPORTS			English	Article						peroxynitrite; oxidative stress; reactive oxygen species; lipid peroxyl radicals; thiobarbituric acid reactive substances	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; OXIDATIVE DAMAGE; OXYGEN; PEROXIDATION; SUPEROXIDE; DISEASE; ANTIOXIDANTS; GLUTATHIONE; ASCORBATE	Peroxynitrite can be produced in the vasculature from a superoxide anion reaction with nitric oxide. A surplus of peroxynitrite in the intravascular compartment is a common feature of several chronic diseases. The development of pharmacological modalities that interfere with the formation of peroxynitrite or inhibit its oxidative damage may be of utility for the prevention and/or treatment of several pathologies. Our previous investigations showed that catalytically inactivating peroxynitrite-derived free radicals with tempol or scavenging reactive aldehyde species with phenelzine protects the blood plasma and platelets from the oxidative damage of peroxynitrite. However, the degree of inhibition of the cytotoxic effects of peroxynitrite using tempol or phenelzine was modest. In the present study, the aim was to examine if scavenging lipid peroxyl radicals with U-83836E can achieve superior protection from peroxynitrite. This was assessed by treating blood plasma or platelets with 100 mu M peroxynitrite alone or in combination with U-83836E, and then measuring the levels of thiobarbituric acid reactive substances (TBARS) and protein carbonyl formation as indices of lipid peroxidation and protein oxidation, respectively. It was observed that scavenging lipid peroxyl radicals with 75-100 mu M U-83836E increasingly reversed protein carbonylation induced by peroxynitrite in blood plasma and platelets, in addition to TBARS formation in blood plasma. These findings are further discussed in the context of the mechanisms by which U-83836E may protect against the cell-damaging effects of peroxynitrite.	[Mustafa, Ayman G.] Jordan Univ Sci & Technol, Sch Med, Dept Anat, Irbid 22110, Jordan; [Alfaqih, Mahmoud A.; Al-Shboul, Othman; Al-Dwairi, Ahmed] Jordan Univ Sci & Technol, Sch Med, Dept Physiol & Biochem, POB 3030, Irbid 22110, Jordan		Alfaqih, MA (corresponding author), Jordan Univ Sci & Technol, Sch Med, Dept Physiol & Biochem, POB 3030, Irbid 22110, Jordan.	maalfaqih@just.edu.jo		Al-Dwairi, Ahmed/0000-0002-8909-9275; mustafa, ayman/0000-0002-0341-7149; Alfaqih, Mahmoud/0000-0002-6383-7014	Sabbatical Leave Research Grant by Deanship of Research at Jordan University of Science and Technology [154/2017]	Funding for this the present study was provided through a Sabbatical Leave Research Grant awarded by the Deanship of Research at Jordan University of Science and Technology (grant no. 154/2017).	Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BENZI G, 1995, NEUROBIOL AGING, V16, P661, DOI 10.1016/0197-4580(95)00066-N; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Campo GM, 1997, FREE RADICAL RES, V27, P577, DOI 10.3109/10715769709097861; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; HAKIM J, 1993, CR SOC BIOL, V187, P286; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Hemnani T, 1998, Indian J Physiol Pharmacol, V42, P440; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Maurya PK, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.08.016; Mustafa AG, 2018, ARCH PHYSIOL BIOCHEM, V124, P418, DOI 10.1080/13813455.2017.1415939; Mustafa AG, 2015, EXP BIOL MED, V240, P109, DOI 10.1177/1535370214546291; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Waris G., 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	29	6	6	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	2049-9434	2049-9442		BIOMED REP	Biomed. Rep.	NOV	2018	9	5					421	426		10.3892/br.2018.1144			6	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	GY3EP	WOS:000448431300006	30345039	Green Published, gold			2022-02-06	
J	Parker, HA; Rapport, LJ; Williams, MW; Hanks, RA; Lumley, MA; Bogg, T				Parker, Hillary A.; Rapport, Lisa J.; Williams, Michael W.; Hanks, Robin A.; Lumley, Mark A.; Bogg, Tim			Functional Independence After Acquired Brain Injury: Prospective Effects of Health Self-Efficacy and Cognitive Impairment	REHABILITATION PSYCHOLOGY			English	Article						acquired brain injury; stroke; health self-efficacy; cognition; functional independence	LONG-TERM DISABILITY; UNITED-STATES; MANAGEMENT; EXERCISE; STROKE; OUTCOMES; TUMORS; INTERVENTION; EPIDEMIOLOGY; PREDICTORS	To examine how health self-efficacy and cognitive impairment severity relate to functional independence after acquired brain injury (ABI). Design: Observational. Setting: Outpatient rehabilitation hospital. Participants: Seventy-five adults with predominately stroke or traumatic brain injury who were beginning a course of occupational therapy. Main Measures: Health self-efficacy was assessed with the Self-Rated Abilities for Health Practices. Cognitive functioning was assessed via a composite z score of neuropsychological tests. Trait affectivity was assessed with the Positive and Negative Affect Schedule. Functional independence was assessed with the Barthel Index and Lawton Instrumental Activities of Daily Living Scale. Results: Health self-efficacy correlated moderately with functional independence. A moderation threshold effect was detected that revealed for whom health self-efficacy predicted functional independence. Among participants with normal to mildly impaired cognition (>-2 z cognitive composite), health self-efficacy correlated positively with functional independence, which held after accounting for trait affectivity. In contrast, health self-efficacy was not correlated with functional independence among participants with greater impairment (<-2 z cognitive composite). Conclusions: Health self-efficacy predicts functional independence and may serve as a protective factor after ABI among individuals with relatively intact cognition. However, health self-efficacy does not predict functional independence among individuals with moderate or severe cognitive impairment, possibly due to limited self-awareness. This study extends the literature linking health self-efficacy with rehabilitation outcomes and reinforces the need for promoting self-management in ABI.	[Parker, Hillary A.; Rapport, Lisa J.; Williams, Michael W.; Lumley, Mark A.; Bogg, Tim] Wayne State Univ, Dept Psychol, 7th Floor Detroit,MI 48202, Detroit, MI 48202 USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Sch Med, Detroit, MI 48202 USA; [Williams, Michael W.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Parker, Hillary A.] Clement J Zablocki VA Med Ctr, Div Mental Hlth, 5000 West Natl Ave, Milwaukee, WI 53295 USA		Parker, HA; Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 7th Floor Detroit,MI 48202, Detroit, MI 48202 USA.; Parker, HA (corresponding author), Clement J Zablocki VA Med Ctr, Div Mental Hlth, 5000 West Natl Ave, Milwaukee, WI 53295 USA.	hillary.parker@va.gov; rapport@wayne.edu	Bogg, Tim/J-2637-2012	Bogg, Tim/0000-0002-9146-2432; Rapport, Lisa/0000-0001-8014-9523; Parker, Hillary/0000-0002-8610-5975	Wayne State University; Foundation for Rehabilitation Psychology	This project was funded by Wayne State University and the Foundation for Rehabilitation Psychology. We are grateful to the outpatient rehabilitation teams at the Rehabilitation Institute of Michigan for their support of this project.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Barlow J., 2010, INT ENCY REHABILITAT; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Becker H., 1993, HLTH VALUES J HLTH B, V17, P42; Blanchard C, 2015, REHABIL PSYCHOL, V60, P59, DOI 10.1037/rep0000024; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Brain Injury Association of America, 2014, BRAIN INJ STAT; Brenner LA, 2012, J HEAD TRAUMA REHAB, V27, pE57, DOI 10.1097/HTR.0b013e318273414c; Chen CY, 1999, AM J OCCUP THER, V53, P171, DOI 10.5014/ajot.53.2.171; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Damush TM, 2016, TRANSL BEHAV MED, V6, P457, DOI 10.1007/s13142-015-0348-6; Dehcordi SR, 2013, J NEUROSURG SCI, V57, P259; Dobkin BH, 2016, CURR OPIN NEUROL, V29, P693, DOI 10.1097/WCO.0000000000000380; Faul M, 2010, TRAUMATIC BRAIN INJU; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Golden C.J., 1978, STROOP COLOR WORD TE; Goodglass H., 1983, ASSESSMENT APHASIA O; Graf C, 2008, AM J NURS, V108, P52, DOI 10.1097/01.NAJ.0000314810.46029.74; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hamsher K., 1989, MULTILINGUAL APHASIA; Hankey GJ, 2002, STROKE, V33, P1034, DOI 10.1161/01.STR.0000012515.66889.24; Hanks RA, 2014, ARCH PHYS MED REHAB, V95, P2096, DOI 10.1016/j.apmr.2014.06.017; Hart T, 2015, REHABIL PSYCHOL, V60, P126, DOI 10.1037/rep0000031; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Heaton R. K., 2004, REVISED COMPREHENSIV; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Kim S, 2018, REHABIL PSYCHOL, V63, P148, DOI 10.1037/rep0000197; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; McKinney PA, 2004, J NEUROL NEUROSUR PS, V75, P12, DOI 10.1136/jnnp.2004.040741; Mohr JP, 1997, STROKE, V28, P1501; Morgan J. E., 2008, TXB CLIN NEUROPSYCHO; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Paech J, 2017, REHABIL PSYCHOL, V62, P89, DOI 10.1037/rep0000136; Patel MD, 2006, AGE AGEING, V35, P273, DOI 10.1093/ageing/afj074; PENDER NJ, 1987, HLTH PROMOTION NURSI; Randolph C., 2012, REPEATABLE BATTERY A; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Reitan R, 1985, HALSTEAD REITAN NEUR; Rossi V, 2012, ANXIETY STRESS COPIN, V25, P603, DOI 10.1080/10615806.2011.582948; Ryan KA, 2009, J CLIN EXP NEUROPSYC, V31, P126, DOI 10.1080/13803390802119922; Schmitt MM, 2014, REHABIL PSYCHOL, V59, P27, DOI 10.1037/a0035288; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selzler AM, 2016, REHABIL PSYCHOL, V61, P380, DOI 10.1037/rep0000106; Smith TW, 2006, CURR DIR PSYCHOL SCI, V15, P227, DOI 10.1111/j.1467-8721.2006.00441.x; Spreen O., 1998, A COMPENDIUM OF NEUR; STUIFBERGEN AK, 1994, RES NURS HEALTH, V17, P3, DOI 10.1002/nur.4770170103; Stuifbergen AK, 2010, DISABIL HEALTH J, V3, P133, DOI 10.1016/j.dhjo.2009.10.007; Tsaousides T, 2017, J HEAD TRAUMA REHAB, V32, P354, DOI 10.1097/HTR.0000000000000345; Wang R, 2013, PREV SCI, V14, P111, DOI 10.1007/s11121-011-0221-x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zucchella C, 2013, J NEURO-ONCOL, V112, P455, DOI 10.1007/s11060-013-1076-8	61	6	6	1	9	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2018	63	4					595	603		10.1037/rep0000243			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	GZ4AT	WOS:000449333400012	30247052				2022-02-06	
J	Pin-on, P; Saringkarinkul, A; Punjasawadwong, Y; Kacha, S; Wilairat, D				Pin-on, Pathomporn; Saringkarinkul, Ananchanok; Punjasawadwong, Yodying; Kacha, Srisuluck; Wilairat, Drusakorn			Serum electrolyte imbalance and prognostic factors of postoperative death in adult traumatic brain injury patients A prospective cohort study	MEDICINE			English	Article						death; electrolyte imbalance; traumatic brain injury	HEAD-INJURY; DIABETES-INSIPIDUS; DYSFUNCTION; GUIDELINES; MANAGEMENT; MODERATE; OUTCOMES; RISK	Electrolyte imbalances are common in traumatic brain injury. It shares the cause of perioperative morbidity and mortality. Types of intravenous fluid resuscitation, osmotic diuretics, massive blood loss, and intracranial pathology were considered as the potential factors to worsen electrolyte abnormalities in these patients. The aims of this study were to report the incidence of electrolyte imbalance in traumatic brain injured patients and to assess the association between electrolyte imbalance and other prognostic factors to death within 24 hours of the injury. The study was carried out in the northern university, tertiary-care hospital of Thailand. The patients aged from 18 to 65 years old, presented with traumatic brain injury, and needed for emergency craniotomy were included. We excluded the patients who had minor neurosurgical procedures, pregnancy, and undergone cardiopulmonary resuscitation from the Emergency Department. Among 145 patients recruited, 101 (70%) had Glasgow Coma Scale (GCS) score <= 8, 25 (17%) had GCS score 9 to 12, and 19 (13%) had GCS score 13 to 15. The most common diagnosis were subdural hematoma and epidural hematoma, 51% and 36%, respectively. Hypokalemia was the most common electrolyte imbalance at 65.5%. The results of the use of a multivariable logistic regression model show that the odds of postoperative death in TBI patients were increased with high levels of blood glucose, hypernatremia, and acidosis. Hypokalemia was the most common electrolyte imbalance in TBI patients. Hypernatremia, acidosis, and hyperglycemia significantly increased the odds ratio of death in the first 24 hours post TBI.	[Pin-on, Pathomporn; Saringkarinkul, Ananchanok; Punjasawadwong, Yodying; Kacha, Srisuluck; Wilairat, Drusakorn] Chiang Mai Univ, Fac Med, Dept Anesthesiol, Chiang Mai, Thailand		Pin-on, P (corresponding author), Chiang Mai Univ, Fac Med, Dept Anesthesiol, Maharaj Nakorn Chiang Mai Hosp, 110 Intawaroros Rd, Chiang Mai 50200, Thailand.	pinon.pathomporn@gmail.com			Faculty of Medicine, Chiang Mai University	Faculty of Medicine, Chiang Mai University.	Askar A, 2007, SAUDI J KIDNEY DIS T, V18, P95; Boughey JC, 2004, AM SURGEON, V70, P500; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; DENLINGER JK, 1976, BRIT J ANAESTH, V48, P995, DOI 10.1093/bja/48.10.995; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Krishnamoorthy V, 2015, J TRAUMA NURS, V22, P204, DOI 10.1097/JTN.0000000000000135; Kulesza B, 2015, JPCCR, V9, P163; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Lim Fidelindo, 2017, Nursing, V47, P26, DOI 10.1097/01.NURSE.0000515501.72414.e3; Lindsey KA, 2010, NUTRITION, V26, P784, DOI 10.1016/j.nut.2009.08.013; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; Prathep Sumidtra, 2017, Journal of the Medical Association of Thailand, V100, P843; Rafiq Mirza Faisal Ahmed, 2013, J Ayub Med Coll Abbottabad, V25, P162; Ratanalert S, 2007, EMERG MED J, V24, P25, DOI 10.1136/emj.2006.039974; Rhoney Denise H, 2006, Nutr Clin Pract, V21, P462, DOI 10.1177/0115426506021005462; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shehata M, 2010, CRIT CARE, V14, P355; Suman S, 2016, J ANESTH CRIT CARE, V5, DOI [10.15406/jaccoa.2016.05.00184, DOI 10.15406/JACCOA.2016.05.00184]; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034	27	6	6	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2018	97	45							e13081	10.1097/MD.0000000000013081			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD3XU	WOS:000452460100030	30407307	Green Published, gold			2022-02-06	
J	Reid, P; Say, I; Shah, S; Tolia, S; Musku, S; Prestigiacomo, C; Gandhi, CD				Reid, Patrick; Say, Irene; Shah, Smit; Tolia, Sneha; Musku, Shashank; Prestigiacomo, Charles; Gandhi, Chirag D.			Effect of Bone Flap Surface Area on Outcomes in Decompressive Hemicraniectomy for Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Decompressive hemicraniectomy; Glasgow Coma Scale score; Intracranial pressure; Traumatic brain injury	SEVERE HEAD-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; INTRA-CRANICAL PRESSURE; CEREBRAL-BLOOD-FLOW; CRANIECTOMY; ICP; MANAGEMENT; COMPLICATIONS; IMPACT	BACKGROUND: Decompressive hemicraniectomy to control medically refractory intracranial hypertension and cerebral edema and evacuate mass lesions in traumatic brain injury is a widely accepted treatment paradigm. However, the critical specifications of the bone flap size necessary to control the intracranial pressure (ICP) and provide improved patient outcomes is unknown. We assessed the effect of craniectomy size on the outcomes in surgical decompression for traumatic brain injury. METHODS: From 2003 to 2011, 58 cases of decompressive hemicraniectomy were performed for evacuation of hematoma and treatment of refractory ICP in adult patients with traumatic brain injury. The surface area of the decompressive bone flaps was calculated from the postoperative computed tomography scans and correlated with the ICP and Glasgow Coma Scale scores immediately postoperatively and during long-term follow-up. RESULTS: Decompressive craniectomy led to a statistically significant continued reduction in the preoperative ICP values (24.5 mm Hg; range, 5-30 mm Hg) compared with the postoperative ICP (16.7 mm Hg; range, 1-30; P = 0.006). However, no significant improvement in the preoperative Glasgow Coma Scale (7.47 mm Hg; range, 3-15; vs. 7.50 mm Hg; range, 3-15; P = 0.96) was observed with hemicraniectomy. CONCLUSION: For surface areas of 7000-16,000 mm(2), size was an independent factor in ICP reduction but not for the overall neurologic outcome.	[Reid, Patrick] Columbia Univ, Dept Neurosurg, Med Ctr, New York, NY USA; [Say, Irene] Rutgers State Univ, Rutgers New Jersey Med Sch, Dept Neurosurg, Newark, NJ 07102 USA; [Shah, Smit] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosurg, New Brunswick, NJ USA; [Tolia, Sneha] Nova Southeastern Coll Osteopath Med, Ft Lauderdale, FL USA; [Musku, Shashank] St Georges Univ, Sch Med, St Georges, Grenada; [Prestigiacomo, Charles] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH USA; [Gandhi, Chirag D.] New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA		Say, I (corresponding author), Rutgers State Univ, Rutgers New Jersey Med Sch, Dept Neurosurg, Newark, NJ 07102 USA.	irene.say24@gmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; El-Fiki ME, 2013, NEUROSURGERY, V60, P154, DOI 10.1227/01.neu.0000432695.05070.72; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1982, CLIN NEUR, V29, P162; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Perez SE, 2011, J TRAUMA, V71, P133; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schneider GH, 2002, ACT NEUR S, V81, P77; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	35	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2018	119						E922	E927		10.1016/j.wneu.2018.08.005			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GX7IO	WOS:000447941300111	30099188				2022-02-06	
J	Reuter-Rice, K; Eads, JK; Berndt, S; Doser, K				Reuter-Rice, Karin; Eads, Julia K.; Berndt, Suzanna; Doser, Karoline			The Initiation of Rehabilitation Therapies and Observed Outcomes in Pediatric Traumatic Brain Injury	REHABILITATION NURSING			English	Article						Children; Functional outcomes; Head injury; Interdisciplinary; Neurocognitive outcomes; Rehabilitation	GLASGOW COMA SCALE; UNITED-STATES; CHILDREN; CARE; INDICATORS; GUIDELINES; ADHERENCE; CENTERS; SCORE	Purpose: Pediatric traumatic brain injury (TBI) is associated with immense physical, emotional, social, and economic burden. This study examined timing and frequency of rehabilitation services provided by the inpatient interdisciplinary team in children admitted for a TBI. Understanding the timing and frequency of rehabilitation services could guide TBI recovery. Design and Methods: This is a 3-year prospective observational study of previously healthy children (n = 35) admitted for a TBI to an urban Level 1 trauma hospital. Children with mild, moderate, and severe TBI were included. Initiation and frequency of the interdisciplinary rehabilitation team's care and neurocognitive-functional outcomes were analyzed. Outcome measures included the Glasgow Outcome Scale-Extended Pediatrics and the Speech Pathology Neurocognitive-Functional Evaluation at hospital discharge and first follow-up visit. Results: The initiation and the frequency of rehabilitation services were found in all severities of TBI. Timing and frequency of services also aligned with varied severities. Children with moderate TBI showed the most improvement in Glasgow Outcome Scale-Extended Pediatrics and the Speech Pathology Neurocognitive-Functional Evaluation on their first follow-up visit, whereas children with mild and severe TBI demonstrated little change in outcome at their first follow-up visit and had varied services based on their hospital course. Conclusion: Services by interdisciplinary rehabilitation teams were provided across all brain injury severity groups, despite the lack of comprehensive rehabilitation guidelines. Varied neurocognitive and functional outcome changes measured found children with moderate TBI had the greatest change in outcomes. Further research is warranted to assess the timing and frequency of services and their relationship to neurocognitive-functional outcomes.	[Reuter-Rice, Karin; Berndt, Suzanna] Duke Univ, Sch Nursing, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA; [Reuter-Rice, Karin] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; [Reuter-Rice, Karin] Duke Inst Brain Sci, Durham, NC USA; [Eads, Julia K.] Duke Univ Hlth Syst, Durham, NC USA; [Doser, Karoline] Danish Canc Soc, Res Ctr, Survivorship Unit, Copenhagen, Denmark		Reuter-Rice, K (corresponding author), Duke Univ, Sch Nursing, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA.	karin.reuter-rice@duke.edu		Doser, Karoline Bianca/0000-0002-2746-3326; Reuter-Rice, Karin/0000-0003-1501-8994	NIH-NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [1P30 NR014139-01]	This work was supported by NIH-NINR 1P30 NR014139-01 Adaptive Leadership for Cognitive Affective Symptom Science, Institute of Nursing Research Center of Excellence (2012-2015).	Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Cicero MX, 2013, PEDIATR EMERG CARE, V29, P43, DOI 10.1097/PEC.0b013e31827b52bf; Collins C. L., 2014, INJURY EPIDEMIOLOGY, V1, P1; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Curtis K, 2011, WORLD J SURG, V35, P2332, DOI 10.1007/s00268-011-1217-1; Faul M, 2010, EMERGENCY DEP VISITS; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Nesiama JAO, 2012, PEDIATR EMERG CARE, V28, P1027, DOI 10.1097/PEC.0b013e31826cac31; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; TEASDALE G, 1974, LANCET, V2, P81; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110	23	6	6	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	NOV-DEC	2018	43	6					327	334		10.1097/rnj.0000000000000116			8	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	HA2MI	WOS:000450072400007	30395558	Green Accepted			2022-02-06	
J	Salis, C; Martin, N; Meehan, SV; McCaffery, K				Salis, Christos; Martin, Nadine; Meehan, Sarah V.; McCaffery, Kevin			Short-term memory span in aphasia: Insights from speech-timing measures	JOURNAL OF NEUROLINGUISTICS			English	Article						Short-term memory; Aphasia; Speech-timing	MEASURING WORKING-MEMORY; TRAUMATIC BRAIN-INJURY; VOWEL PRODUCTION; SENTENCE COMPREHENSION; EXECUTIVE FUNCTION; PROCESSING SPEED; IMPAIRMENT; LANGUAGE; DEFICITS; RECALL	Auditory-verbal short-term memory impairments are part and parcel of aphasia and interfere with linguistic processing. To date, the science about short-term memory impairments in aphasia has been generated and dominated by studying measures of accuracy, that is, span length. Because accuracy is expressed through speech, examining the speech-timing characteristics of persons with aphasia as they engage in spoken recall could reveal insights about the manner in which accuracy is achieved. Six speech-timing measures (e.g., response durations, pause durations) were elicited from the speech waveform of word span tasks from twelve people with aphasia. Speech-timing measures were compared to neuro-typical control participants. Speech-timing performance between erroneous and correct responses in the aphasia group was also examined. Across all measures, people with aphasia produced considerably longer speech-timing patterns in comparison to control participants. Memory load affected some measures in people with aphasia and control participants. Speech-timing in correct response trials was shorter than responses in erroneous trials. Memory span correlated only with one measure, namely, speech time (defined as the sum of each individual word duration in a response). Speech time also correlated with the following measures: Aphasia severity (Aphasia Quotient of the Western Aphasia Battery), spontaneous speech, and language comprehension (also measured by the Western Aphasia Battery). Some protracted speech-timing patterns in the aphasia group may be explained by a deregulation of activation-decay patterns. However, in the absence of further evidence from people with aphasia, possible issues around the sensitivity of some speech-timing measures limit firmer conclusions. Speech-timing measures are response-time measures, which have not been systematically studied in studies of short-term or working memory in aphasia and as such, can push the current boundaries of knowledge of short-term and working memory impairments in aphasia, not only in stroke related aphasia but also other neurological conditions.	[Salis, Christos] Newcastle Univ, Speech & Language Sci, King George VI Bldg,Queen Victoria Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Martin, Nadine; Meehan, Sarah V.; McCaffery, Kevin] Temple Univ, Dept Commun Sci & Disorders, 1301 Cecil B Moore Ave, Philadelphia, PA 19122 USA		Salis, C (corresponding author), Newcastle Univ, Speech & Language Sci, King George VI Bldg,Queen Victoria Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	christos.salis@newcastle.ac.uk			National Institute on Deafness and other Communication Disorders Center of the National Institutes of Health [R21DC 008782, R01DC013196]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC013196, R01DC001924, R01DC016094, R21DC008782] Funding Source: NIH RePORTER	Research reported in this paper was supported by National Institute on Deafness and other Communication Disorders Center of the National Institutes of Health under award number R21DC 008782 and R01DC013196. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We are grateful to all participants who assisted us in this project. We would also like to thank Kelsey Homan who carried out some of the speech-timing analysis.	Allen CM, 2012, APHASIOLOGY, V26, P428, DOI 10.1080/02687038.2011.617436; [Anonymous], E PRIM PROF COMP SOF; Attout L, 2012, APHASIOLOGY, V26, P355, DOI 10.1080/02687038.2011.604303; Barde LHF, 2010, NEUROPSYCHOLOGIA, V48, P909, DOI 10.1016/j.neuropsychologia.2009.11.010; BAUM SR, 1990, BRAIN LANG, V39, P33, DOI 10.1016/0093-934X(90)90003-Y; Bose A, 2008, BRAIN LANG, V106, P4, DOI 10.1016/j.bandl.2008.03.002; Bose A, 2007, J NEUROLINGUIST, V20, P65, DOI 10.1016/j.jneuroling.2006.05.001; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 1999, J EXP CHILD PSYCHOL, V72, P193, DOI 10.1006/jecp.1998.2486; Cowan N, 1998, J EXP PSYCHOL GEN, V127, P141, DOI 10.1037/0096-3445.127.2.141; COWAN N, 1992, J MEM LANG, V31, P668, DOI 10.1016/0749-596X(92)90034-U; COWAN N, 1994, J MEM LANG, V33, P234, DOI 10.1006/jmla.1994.1012; Cowan N, 2003, J EXP PSYCHOL GEN, V132, P113, DOI 10.1037/0096-3445.132.1.113; COWAN N, 1996, MODELS SHORT TERM ME; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Dabul B. L., 2000, APRAXIA BATTERY ADUL; DeDe G, 2014, APHASIOLOGY, V28, P692, DOI 10.1080/02687038.2014.895973; Dell G, 1997, J MEM LANG, V56, P490; Edwards JR, 2000, PSYCHOL METHODS, V5, P155, DOI 10.1037//1082-989X.5.2.155; Eling P, 2015, CORTEX, V63, P16, DOI 10.1016/j.cortex.2014.08.002; Ellis AW., 1996, HUMAN COGNITIVE NEUR; Haberlandt K, 2005, PSYCHON B REV, V12, P152, DOI 10.3758/BF03196361; Hamilton AC, 2007, CORTEX, V43, P112, DOI 10.1016/S0010-9452(08)70449-0; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Howard D, 2005, COGN NEUROPSYCHOL, V22, P42, DOI 10.1080/02643290342000582; HOWARD D, 1990, NEUROPSYCHOLOGICAL I; Hulme C, 1999, J EXP PSYCHOL LEARN, V25, P447, DOI 10.1037/0278-7393.25.2.447; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; Kertesz A., 1982, W APHASIA BATTERY; KINSBOURNE M, 1972, NEUROLOGY, V22, P1126, DOI 10.1212/WNL.22.11.1126; KYNETTE D, 1990, EXP AGING RES, V16, P117, DOI 10.1080/07340669008251538; Maas E, 2015, J SPEECH LANG HEAR R, V58, P185, DOI 10.1044/2014_JSLHR-S-13-0300; Majerus S, 2015, NEUROPSYCHOLOGIA, V77, P165, DOI 10.1016/j.neuropsychologia.2015.08.010; Martin N, 2004, BRAIN LANG, V89, P464, DOI 10.1016/j.bandl.2003.12.004; Martin N, 1997, COGNITIVE NEUROPSYCH, V14, P641; Martin N, 1996, BRAIN LANG, V52, P83, DOI 10.1006/brln.1996.0005; Martin N, 1999, INT J PSYCHOL, V34, P339, DOI 10.1080/002075999399666; Martin N, 2012, COGNITION ACQUIRED L, P275; Martin N, 2018, J NEUROLINGUIST, V48, P199, DOI 10.1016/j.jneuroling.2018.02.006; Martin N, 2012, APHASIOLOGY, V26, P253, DOI 10.1080/02687038.2011.648163; Martin N, 2009, INTERACTIONS BETWEEN SHORT-TERM AND LONG-TERM MEMORY IN THE VERBAL DOMAIN, P220; Martin Randi C., 2008, Seminars in Speech and Language, V29, P201, DOI 10.1055/s-0028-1082884; Mayer JF, 2012, J COMMUN DISORD, V45, P325, DOI 10.1016/j.jcomdis.2012.06.002; McNeil M. R., 1990, ADV PSYCHOL CEREBRAL, P349; MILLS RH, 1979, J SPEECH HEAR RES, V22, P73, DOI 10.1044/jshr.2201.73; Minkina I, 2017, SEMIN SPEECH LANG, V38, P17, DOI 10.1055/s-0036-1597261; Murray L. L., 2015, EHEARSAY ELECT J OHI, V5, P86; Murray L, 2018, NEUROPSYCHOL REHABIL, V28, P309, DOI 10.1080/09602011.2016.1174718; Murray LL, 2012, APHASIOLOGY, V26, P317, DOI 10.1080/02687038.2011.589894; Neto B, 2012, APHASIOLOGY, V26, P1352, DOI 10.1080/02687038.2012.672023; Novick JM, 2009, COGN NEUROPSYCHOL, V26, P527, DOI 10.1080/02643290903519367; Peach RK, 2016, NEUROPSYCHOLOGIA, V80, P157, DOI 10.1016/j.neuropsychologia.2015.11.015; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Posner MI, 2002, J CLIN EXP NEUROPSYC, V24, P968, DOI 10.1076/jcen.24.7.968.8389; ROMANI C, 1992, LANG COGNITIVE PROC, V7, P131, DOI 10.1080/01690969208409382; RYALLS JH, 1986, BRAIN LANG, V29, P48, DOI 10.1016/0093-934X(86)90033-7; Salis C, 2017, SEMIN SPEECH LANG, V38, P29, DOI 10.1055/s-0036-1597262; SCHWARTZ MF, 1994, BRAIN LANG, V47, P391; STERNBERG S, 1969, AM SCI, V57, P421; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Sung JE, 2009, APHASIOLOGY, V23, P1040, DOI 10.1080/02687030802592884; SWINNEY DA, 1971, J SPEECH HEAR RES, V14, P578, DOI 10.1044/jshr.1403.578; Tehan G, 2000, Q J EXP PSYCHOL-A, V53, P1012, DOI 10.1080/713755933; Towse JN, 2008, EXP PSYCHOL, V55, P371, DOI 10.1027/1618-3169.55.6.371; Tyler L. K., 1992, SPOKEN LANGUAGE COMP; Vallar G., 2002, HDB MEMORY DISORDERS, V2nd, P249; Verhaegen C, 2013, COGN NEUROPSYCHOL, V30, P544, DOI 10.1080/02643294.2014.884058; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885; Weenink D., 2015, PRAAT DOING PHONETIC; Wilshire CE, 2010, NEUROCASE, V16, P331, DOI 10.1080/13554791003620256; Wright HH, 2012, APHASIOLOGY, V26, P258, DOI 10.1080/02687038.2011.604304; Zakarias L, 2018, NEUROPSYCHOL REHABIL, V28, P369, DOI 10.1080/09602011.2016.1159579; Zimmerman D. W., 2003, UNDERSTANDING STAT, V2, P267, DOI DOI 10.1207/S15328031US0204_03	73	6	6	2	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0911-6044			J NEUROLINGUIST	J. Neurolinguist.	NOV	2018	48				SI		176	189		10.1016/j.jneuroling.2018.04.014			14	Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Linguistics; Neurosciences & Neurology; Psychology	GV3KB	WOS:000445991700013	30455550	Green Accepted			2022-02-06	
J	Sunderaraman, P; Cosentino, S; Lindgren, K; James, A; Schultheis, M				Sunderaraman, Preeti; Cosentino, Stephanie; Lindgren, Karen; James, Angela; Schultheis, Maria			Informant Report of Financial Capacity for Individuals With Chronic Acquired Brain Injury: An Assessment of Informant Accuracy	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; awareness; brain injury; cognitive function; financial capacity; financial decision making; financial management; head injury; metacognition; money management	MILD COGNITIVE IMPAIRMENT; SELF-AWARENESS; INSTRUMENTAL ACTIVITIES; FUNCTIONAL ABILITY; COMPETENCE; RATINGS; DISEASE; IMPACT; ADULTS; DISCREPANCY	Objective: Primarily, to investigate the association between informant report and objective performance on specific financial capacity (FC) tasks by adults with chronic, moderate to severe acquired brain injury, and to examine the nature of misestimates by the informants. Design: Cross-sectional design. Setting: A postacute, community-based rehabilitation center. Participants: Data were obtained from 22 chronic acquired brain injury (CABI) adults, mean age of 46.6 years (SD = 8.67), mean years of education of 13.45 years (SD = 2.15), with moderate to severe acquired brain injury (86% had traumatic brain injury), with a mean postinjury period of 17.14 years (SD = 9.5). Whereas the CABI adults completed the Financial Competence Assessment Inventory interviewa combination of self-report and performance-based assessment, 22 informants completed a specifically designed parallel version of the interview. Results: Pearson correlations and 1-sample t tests based on the discrepancy scores between informant report and CABI group's performance were used. The CABI group's performance was not associated with its informant's perceptions. One-sample t tests revealed that informants both underestimated and overestimated CABI group's performance. Conclusions: Results indicate lack of correspondence between self- and informant ratings. Further investigation revealed that misestimations by informants occurred in contrary directions with CABI adults' performance being inaccurately rated. These findings raise critical issues related to assuming that the informant report can be used as a gold standard for collecting functional data related to financial management, and the idea that obtaining objective data on financial tasks may represent a more valid method of assessing financial competency in adults with brain injury.	[Sunderaraman, Preeti; Cosentino, Stephanie] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Cognit Neurosci Div, Med Ctr, 630 West 168th St,P&S Box 16, New York, NY 10032 USA; [Sunderaraman, Preeti; Cosentino, Stephanie] Columbia Univ, Med Ctr, GH Sergievsky Ctr, 630 West 168th St,P&S Box 16, New York, NY 10032 USA; [Cosentino, Stephanie] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA; [Lindgren, Karen] Bancroft Brain Injury Serv, Cherry Hill, NJ USA; [James, Angela; Schultheis, Maria] Drexel Univ, Psychol Dept, Philadelphia, PA 19104 USA		Sunderaraman, P (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Cognit Neurosci Div, Med Ctr, 630 West 168th St,P&S Box 16, New York, NY 10032 USA.; Sunderaraman, P (corresponding author), Columbia Univ, Med Ctr, GH Sergievsky Ctr, 630 West 168th St,P&S Box 16, New York, NY 10032 USA.	ps2548@columbia.cumc.edu	Sunderaraman, Preeti/AAJ-1247-2020	Sunderaraman, Preeti/0000-0001-6011-8412; Schultheis, Maria/0000-0002-6558-548X	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F32AG053035] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F32 AG053035, K99 AG062783] Funding Source: Medline		Alves H, 2017, TRENDS COGN SCI, V21, P69, DOI 10.1016/j.tics.2016.12.006; Appelbaum P, 2016, INFORM SOCIAL SECURI, DOI 10.21922; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Cannon BJ, 2000, ARCH CLIN NEUROPSYCH, V15, P327; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chiou KS, 2016, J HEAD TRAUMA REHAB, V31, pE60, DOI 10.1097/HTR.0000000000000161; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Crowe K. M., 2005, PSYCHIAT PSYCHOL LAW, V12, P56, DOI [10.1375/pplt.2005.12.1.56, DOI 10.1375/PPLT.2005.12.1.56, http://dx.doi.org/10.1375/pplt.2005.12.1.56]; Crowe SF, 2003, NEUROPSYCHOL REHABIL, V13, P497, DOI 10.1080/09602010343000075; Deloche G, 1996, J Int Neuropsychol Soc, V2, P177; Dreer LE, 2012, REHABIL PSYCHOL, V57, P5, DOI 10.1037/a0025818; Engel L, 2016, J CLIN EXP NEUROPSYC, V38, P76, DOI 10.1080/13803395.2015.1087468; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Finkenauer C, 1998, J SOC CLIN PSYCHOL, V17, P295, DOI 10.1521/jscp.1998.17.3.295; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1996, BRAIN INJURY, V10, P1; Ghesquiere AR, 2019, GERONTOLOGIST, V59, pE109, DOI 10.1093/geront/gnx045; Goldstein G., 1995, INT J REHABILITATION, V1, DOI [10.1007/BF02214959, DOI 10.1007/BF02214959]; Griffith HR, 2003, NEUROLOGY, V60, P449, DOI 10.1212/WNL.60.3.449; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hoskin KM, 2005, REHABIL PSYCHOL, V50, P355, DOI 10.1037/0090-5550.50.4.355; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; Karagiozis H, 1998, GERONTOLOGIST, V38, P113, DOI 10.1093/geront/38.1.113; Kershaw MM, 2008, PSYCHIAT PSYCHOL LAW, V15, P40, DOI 10.1080/13218710701873965; Kershaw MM, 2010, INT CONV APPL PSYCH; Koller K, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020198; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Marcotte T.D., 2009, NEUROPSYCHOLOGY EVER; Marson DC, 2012, GENERATIONS, V36, P6; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Marson DC, 2001, AGING NEUROPSYCHOL C, V8, P164, DOI 10.1076/anec.8.3.164.827; Marson DC, 2011, FORENSIC NEUROPSYCHO, P401; Martin RC, 2012, J HEAD TRAUMA REHAB, V27, pE81, DOI 10.1097/HTR.0b013e318273de49; Martyr A, 2018, INT J GERIATR PSYCH, V33, P31, DOI 10.1002/gps.4664; Martyr A, 2014, INT J GERIATR PSYCH, V29, P852, DOI 10.1002/gps.4071; McLennan W, 1993, DISABILITY AGEING CA; Moye J, 2017, CLIN GERONTOLOGIST, V40, P1, DOI 10.1080/07317115.2016.1238676; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Ohira H, 1998, PERS SOC PSYCHOL B, V24, P986, DOI 10.1177/0146167298249006; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pfeifer L, 2013, INT PSYCHOGERIATR, V25, P1345, DOI 10.1017/S1041610213000562; Pinsker DM, 2010, CLIN GERONTOLOGIST, V33, P332, DOI 10.1080/07317115.2010.502107; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P381; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sousa LB, 2014, INT PSYCHOGERIATR, V26, P217, DOI 10.1017/S1041610213001828; Starkstein SE, 2014, CORTEX, V61, P64, DOI 10.1016/j.cortex.2014.07.019; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tracy VL, 2017, J CLIN EXP NEUROPSYC, V39, P46, DOI 10.1080/13803395.2016.1201050; Wehman PH, 2016, HDB RETURN WORK, P593; Winter L, 2016, DISABIL REHABIL, V38, P1280, DOI 10.3109/09638288.2015.1077531; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009	63	6	6	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					E85	E94		10.1097/HTR.0000000000000382			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600010	29601341	Green Accepted			2022-02-06	
J	Swiatkowski, P; Sewell, E; Sweet, ES; Dickson, S; Swanson, RA; McEwan, SA; Cuccolo, N; McDonnell, ME; Patel, MV; Varghese, N; Morrison, B; Reitz, AB; Meaney, DF; Firestein, BL				Swiatkowski, Przemyslaw; Sewell, Emily; Sweet, Eric S.; Dickson, Samantha; Swanson, Rachel A.; McEwan, Sara A.; Cuccolo, Nicholas; McDonnell, Mark E.; Patel, Mihir, V; Varghese, Nevin; Morrison, Barclay; Reitz, Allen B.; Meaney, David F.; Firestein, Bonnie L.			Cypin: A novel target for traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Cypin; Traumatic brain injury; Glutamate-induced toxicity; Guanine deaminase activity; Electrophysiology; Controlled cortical impact; Neuroprotection	PSD-95 INTERACTOR CYPIN; URIC-ACID PROTECTS; GUANINE DEAMINASE; RAT-BRAIN; DOPAMINERGIC-NEURONS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; IN-VIVO; PLASTICITY; DAMAGE	Cytosolic PSD-95 interactor (cypin), the primary guanine deaminase in the brain, plays key roles in shaping neuronal circuits and regulating neuronal survival. Despite this pervasive role in neuronal function, the ability for cypin activity to affect recovery from acute brain injury is unknown. A key barrier in identifying the role of cypin in neurological recovery is the absence of pharmacological tools to manipulate cypin activity in vivo. Here, we use a small molecule screen to identify two activators and one inhibitor of cypin's guanine deaminase activity. The primary screen identified compounds that change the initial rate of guanine deamination using a colorimetric assay, and secondary screens included the ability of the compounds to protect neurons from NMDA-induced injury and NMDA-induced decreases in frequency and amplitude of miniature excitatory postsynaptic currents. Hippocampal neurons pretreated with activators preserved electrophysiological function and survival after NMDA-induced injury in vitro, while pretreatment with the inhibitor did not. The effects of the activators were abolished when cypin was knocked down. Administering either cypin activator directly into the brain one hour after traumatic brain injury significantly reduced fear conditioning deficits 5 days after injury, while delivering the cypin inhibitor did not improve outcome after TBI. Together, these data demonstrate that cypin activation is a novel approach for improving outcome after TBI and may provide a new pathway for reducing the deficits associated with TBI in patients.	[Swiatkowski, Przemyslaw; Sweet, Eric S.; Swanson, Rachel A.; McEwan, Sara A.; Cuccolo, Nicholas; Patel, Mihir, V; Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA; [Swiatkowski, Przemyslaw] Rutgers State Univ, Grad Program Mol Biosci, 604 Allison Rd, Piscataway, NJ 08854 USA; [Sweet, Eric S.; McEwan, Sara A.; Patel, Mihir, V] Rutgers State Univ, Grad Program Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA; [Sewell, Emily; Dickson, Samantha; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [McDonnell, Mark E.; Reitz, Allen B.] Fox Chase Chem Divers Ctr Inc, Doylestown, PA 18902 USA; [Varghese, Nevin; Morrison, Barclay] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Sweet, Eric S.] West Chester Univ, Dept Biol, W Chester, PA 19383 USA		Firestein, BL (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08854 USA.	firestein@biology.rutgers.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Patel, Mihir/0000-0002-9839-8357; Sweet, Eric/0000-0003-3930-7360; McEwan, Przemyslaw/0000-0002-7702-070X; Firestein, Bonnie/0000-0002-1679-3565; Meaney, David/0000-0002-0954-4122	New Jersey Commission on Brain Injury Research grant [CBIR14IRG019]; National Institutes of Health Biotechnology Training GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM008339-20]; Predoctoral Fellowship from the New Jersey Commission on Brain Injury Research [CBIR16FEL013]; New Jersey Commission on Brain Injury Research [CBIR15FEL009]; American Academy of Neurology's 2016 Medical Student Summer Research Scholarship; Rutgers University School of Arts and Sciences Honors Program Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008339] Funding Source: NIH RePORTER	This work was funded by the New Jersey Commission on Brain Injury Research grant # CBIR14IRG019 (to B.L.F. and D.F.M.). P.S. was supported in part by National Institutes of Health Biotechnology Training Grant T32 GM008339-20 and a Predoctoral Fellowship from the New Jersey Commission on Brain Injury Research # CBIR16FEL013. M.P. was supported in part by a Predoctoral Fellowship from the New Jersey Commission on Brain Injury Research # CBIR15FEL009. N.C. was supported by the American Academy of Neurology's 2016 Medical Student Summer Research Scholarship. R.S. received funding from the Rutgers University School of Arts and Sciences Honors Program Research Fellowship.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Abe H, 2018, SCIENCE, V360, P50, DOI 10.1126/science.aao2300; Adams SM, 2018, J NEUROTRAUM, V35, P48, DOI 10.1089/neu.2017.5000; Akum BF, 2004, NAT NEUROSCI, V7, P145, DOI 10.1038/nn1179; Alonso A, 2007, NEUROLOGY, V69, P1696, DOI 10.1212/01.wnl.0000279518.10072.df; Amaro Sergio, 2008, Expert Rev Neurother, V8, P259, DOI 10.1586/14737175.8.2.259; Boer P, 2001, NEUROSCI LETT, V303, P45, DOI 10.1016/S0304-3940(01)01716-5; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Chen HX, 2007, J NEUROSCI, V27, P8378, DOI 10.1523/JNEUROSCI.0872-07.2007; Chen M, 2005, MOL BIOL CELL, V16, P5103, DOI 10.1091/mbc.E05-02-0165; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Connolly GP, 2001, BRAIN RES, V918, P20, DOI 10.1016/S0006-8993(01)02909-2; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; De Vera M, 2008, ARTHRIT RHEUM-ARTHR, V59, P1549, DOI 10.1002/art.24193; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Fan J, 2010, J NEUROCHEM, V115, P1045, DOI 10.1111/j.1471-4159.2010.06994.x; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Fernandez JR, 2008, PROTEINS, V70, P873, DOI 10.1002/prot.21683; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hatefi M, 2016, J CLIN DIAGN RES, V10, pOC20, DOI 10.7860/JCDR/2016/21918.8993; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001900; KUMAR S, 1967, BIOCHEM J, V102, P691, DOI 10.1042/bj1020691; KUMAR S, 1979, NEW ENGL J MED, V300, P1332; KUMAR S, 1976, NEUROSCI LETT, V3, P163, DOI 10.1016/0304-3940(76)90087-2; KUMAR S, 1965, J NEUROCHEM, V12, P1003, DOI 10.1111/j.1471-4159.1965.tb10260.x; Lai KO, 2013, BBA-MOL BASIS DIS, V1832, P2257, DOI 10.1016/j.bbadis.2013.08.012; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; Lin D. D, 2000, AM PHYSL SOC, V84, P2465; Llull L, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0604-7; Logallo N, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-114; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; O'Neill KM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00285; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Otis T, 1996, J NEUROSCI, V16, P7496; Paletzki RF, 2002, NEUROSCIENCE, V109, P15, DOI 10.1016/S0306-4522(01)00352-9; Patel MV, 2018, MOL NEUROBIOL, V55, P6269, DOI 10.1007/s12035-017-0849-z; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rodriguez AR, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa976a; Romanos E, 2007, J CEREBR BLOOD F MET, V27, P14, DOI 10.1038/sj.jcbfm.9600312; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schretlen DJ, 2001, J INT NEUROPSYCH SOC, V7, P805, DOI 10.1017/S135561770177703X; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Toth K, 2011, ANNU REV NUTR, V31, P139, DOI 10.1146/annurev-nutr-072610-145218; Tseng CY, 2011, J NEUROSCI, V31, P15468, DOI 10.1523/JNEUROSCI.2442-11.2011; Vites O, 2004, J BIOL CHEM, V279, P26251, DOI 10.1074/jbc.M404079200; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Wang JH, 1996, LEARN MEMORY, V3, P170, DOI 10.1101/lm.3.2-3.170; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; Yeh J, 1998, J NEUROSCI RES, V53, P78, DOI 10.1002/(SICI)1097-4547(19980701)53:1<78::AID-JNR8>3.0.CO;2-G; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1; Zhu J.E.A., 2012, PLOS ONE, V7; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	69	6	6	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	NOV	2018	119						13	25		10.1016/j.nbd.2018.07.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU5JV	WOS:000445322700002	30031156	Bronze, Green Accepted			2022-02-06	
J	Warner, K; Savage, J; Kuenze, CM; Erkenbeck, A; Comstock, RD; Covassin, T				Warner, Keegan; Savage, Jennifer; Kuenze, Christopher M.; Erkenbeck, Alexandria; Comstock, R. Dawn; Covassin, Tracey			A Comparison of High School Boys' and Girls' Lacrosse Injuries: Academic Years 2008-2009 Through 2015-2016	JOURNAL OF ATHLETIC TRAINING			English	Article						sex differences; injury rates; injury surveillance	STATES HIGH-SCHOOL; WOMENS LACROSSE; DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; EYE INJURIES; CONCUSSIONS; HEAD; MENS	Context: The sex-based differences in the structure and rules of boys' and girls' lacrosse result in very different styles of play, which may have significant implications for the rates and patterns of injuries. Objective: To compare the epidemiology of injuries sustained by boys' and girls' lacrosse players. Design: Descriptive epidemiology study. Setting: Web-based online surveillance system. Patients or Other Participants: The High School Reporting Information Online database was used to analyze injuries reported by certified athletic trainers from 2008-2009 through 2015-2016. Main Outcome Measure(s): Practice and competition injury rates, body site, diagnosis, and mechanism. Results: Boys had a higher injury rate than girls (20.9 versus 15.7 per 10 000 athlete-exposures, respectively; rate ratio = 1.3, 95% confidence interval = 1.2, 1.4). The most commonly injured body sites for boys and girls, respectively, were the lower extremities (38.0%, 56.4%) and the head/neck (28.3%, 29.8%). More specifically, the most frequently diagnosed injuries for both boys and girls, respectively, in competitions were concussions (23.1%, 25.6%), ankle ligament sprains (7.8%, 15.3%), upper leg strains (4.8%, 6.7%), and knee ligament sprains (4.2%, 6.7%). The most cited mechanism of injury overall was contact with another player (22.0%); among boys, it was contact with a stick (14.8%) and among girls, the most frequent mechanisms were overuse (25.0%) and contact with a stick (14.7%). Conclusions: Injury rates and mechanisms of injuries differed between high school boys' and girls' lacrosse players. Boys had a higher rate of injury, with the most common mechanism of injury being contact with another player compared with overuse in girls. However, similarities were seen between sexes for the most frequently injured body sites and injury diagnoses. Future authors should continue to compare differences in injury rates, equipment upgrades, and rule changes in boys' and girls' lacrosse.	[Warner, Keegan; Savage, Jennifer; Kuenze, Christopher M.; Covassin, Tracey] Michigan State Univ, 105 IM Sports Circle, E Lansing, MI 48824 USA; [Erkenbeck, Alexandria; Comstock, R. Dawn] Colorado Sch Publ Hlth, Aurora, CO USA		Covassin, T (corresponding author), Michigan State Univ, 105 IM Sports Circle, E Lansing, MI 48824 USA.	covassin@msu.edu	Kuenze, Christopher/P-7804-2017	Kuenze, Christopher/0000-0001-9184-4636			Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P255; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harmer PA, 1993, SPORT HLTH, V11, P14; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Kelley C, WOMENS LACROSSE HEAD; LAPIDUS CS, 1992, J TRAUMA, V32, P555, DOI 10.1097/00005373-199205000-00003; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Otago L, 2007, Int J Inj Contr Saf Promot, V14, P259, DOI 10.1080/17457300701602381; Rahnama N, 2002, BRIT J SPORT MED, V36, P354, DOI 10.1136/bjsm.36.5.354; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Vincent HK, 2015, SPORTS HEALTH, V7, P448, DOI 10.1177/1941738114552990; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914	18	6	6	1	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2018	53	11					1049	1055		10.4085/1062-6050-312-17			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HH3VE	WOS:000455647200004	30451536	gold, Green Published			2022-02-06	
J	Yamaki, T; Uchino, Y; Henmi, H; Kamezawa, M; Hayakawa, M; Uchida, T; Ozaki, Y; Onodera, S; Oka, N; Odaki, M; Itou, D; Kobayashi, S				Yamaki, Tomohiro; Uchino, Yoshio; Henmi, Haruko; Kamezawa, Mizuho; Hayakawa, Miyoko; Uchida, Tomoki; Ozaki, Yoshihiro; Onodera, Shinji; Oka, Nobuo; Odaki, Masaru; Itou, Daisuke; Kobayashi, Shigeki			Increased brain glucose metabolism in chronic severe traumatic brain injury as determined by longitudinal 18F-FDG PET/CT	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Brain injury; Positron emission tomography computed tomography; Longitudinal study; Fluorodeoxyglucose F-18	FDG-PET; CONSCIOUSNESS; DISORDERS; AMANTADINE; RECOVERY; RATIO	Little is known about changes in glucose metabolism in patients with chronic severe traumatic brain injury (sTBI). It remains to be elucidated how neurological manifestations of sTBI are associated with brain glucose metabolism during longitudinal follow-up. We show here that neurological manifestations are associated with changes of brain glucose metabolism by using two serial 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) images. In this longitudinal observational study, two serial 18F-FDG PET/CT images from each of 45 patients were analyzed for whole-brain maximum standardized uptake values (SUVmax). For clinical assessment, we applied two different scales: the coma recovery scale-revised and the original Chiba score with additional information regarding nutrition, excretion, facial expression, and position change of the patient's relative immobility and bedridden state. As a result, the increased FDG uptake group was associated with a high level of wakefulness (first PET, p = 0.04; second PET, p = 0.01) and small ventricular size (first PET, p = 0.01; second PET, p = 0.01). In addition, anticonvulsant withdrawal (p = 0.001), improvement of total Chiba score (p = 0.01), language expression (p = 0.03), position change (p = 0.03), and communication (p = 0.03) were accelerated in the increased FDG uptake group. Spearman's rank correlation coefficients of change in SUVmax and language expression between the first and second PET were 0.4 (p = 0.01). Our results indicate that chronic severe traumatic head injury patients have changed brain glucose metabolism. (C) 2018 Elsevier Ltd. All rights reserved.	[Yamaki, Tomohiro; Uchino, Yoshio; Oka, Nobuo; Odaki, Masaru; Itou, Daisuke; Kobayashi, Shigeki] Natl Agcy Automot Safety & Victims Aid, Rehabil Ctr Traumat Apall Chiba, Div Neurosurg, Mihama Ku, 3-30-1 Isobe,Chiba shi, Chiba, Chiba 2610012, Japan; [Yamaki, Tomohiro; Uchino, Yoshio; Henmi, Haruko; Kamezawa, Mizuho; Hayakawa, Miyoko; Uchida, Tomoki; Ozaki, Yoshihiro; Onodera, Shinji] Natl Agcy Automot Safety & Victims Aid, Div PET Imaging, Rehabil Ctr Traumat Apall Chiba, Mihama Ku, 3-30-1 Isobe, Chiba, Chiba 2610012, Japan; [Uchino, Yoshio] Sousen Hosp, Wakaba Ku, 2592 Sarashinacho, Chiba, Chiba 2650073, Japan		Yamaki, T (corresponding author), Natl Agcy Automot Safety & Victims Aid, Rehabil Ctr Traumat Apall Chiba, Div Neurosurg, Mihama Ku, 3-30-1 Isobe,Chiba shi, Chiba, Chiba 2610012, Japan.	t-yamaki@chiba-ryougo.jp; uchino@sousen.seikei-kai.or.jp; pet-nurse@chiba-ryougo.jp; m-kamezawa@chiba-ryougo.jp; m-hayakawa@chiba-ryougo.jp; t-uchida@chiba-ryougo.jp; y-ozaki@chiba-ryougo.jp; s-onodera@chiba-ryougo.jp; noka-nsu@umin.net; odaki-nsu@umin.net; tiotio1687@yahoo.co.jp; kobasige@green.ocn.ne.jp		Yamaki, Tomohiro/0000-0002-3528-3229	Rehabilitation Center for Traumatic Apallics Chiba, National Agency for Automotive Safety and Victims' Aid	We would like to thank Yasunobu Nakamura, from SATISTA (https://www.satista.jp/) for supporting statistical analyses of this manuscript. We would also like to thank Alan Purvis and Ann Turnley, PhD, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. This research was supported by Rehabilitation Center for Traumatic Apallics Chiba, National Agency for Automotive Safety and Victims' Aid.	Annen J, 2016, HUM BRAIN MAPP, V37, P3707, DOI 10.1002/hbm.23269; Annen J, 2018, ANN NEUROL, DOI [10.1002/1n1.25214, DOI 10.1002/1N125214]; Bagnato S, 2017, J NEUROTRAUM, V34, P535, DOI 10.1089/neu.2016.4418; Bodart O, 2017, NEUROIMAGE-CLIN, V14, P354, DOI 10.1016/j.nicl.2017.02.002; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; de la Cueva-Barrao L, 2009, REV NEUROLOGIA, V49, P58, DOI 10.33588/rn.4902.2008676; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Godbolt AK, 2013, J REHABIL MED, V45, P741, DOI 10.2340/16501977-1167; HAMBERG LM, 1994, J NUCL MED, V35, P1308; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; O'Hayon BB, 1998, PEDIATR NEUROSURG, V29, P245, DOI 10.1159/000028730; Oka N, 2009, J JPN COUNC TRAFFIC, V9, P44; Oka N, 2007, J JPN COUNC TRAFFIC, V7, P17; Schiff ND, 2005, PROG BRAIN RES, V150, P473, DOI 10.1016/S0079-6123(05)50033-5; Schiff ND, 2006, J HEAD TRAUMA REHAB, V21, P388, DOI 10.1097/00001199-200609000-00003; Spritzer SD, 2015, NEUROLOGIST, V19, P61, DOI 10.1097/NRL.0000000000000001; Tamashiro M, 2012, BRAIN INJURY, V26, P921, DOI 10.3109/02699052.2012.661911; Uchino Y, 2013, J NUCL MED S2, V54, P158; Weston J, 2015, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.00007286.PUB3	25	6	6	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2018	57						20	25		10.1016/j.jocn.2018.08.052			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY3YS	WOS:000448494000004	30172638				2022-02-06	
J	Ortiz, F; Zapfe, WPK; Draguhn, A; Gutierrez, R				Ortiz, Franco; Zapfe, W. P. Karel; Draguhn, Andreas; Gutierrez, Rafael			Early Appearance and Spread of Fast Ripples in the Hippocampus in a Model of Cortical Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article						ca3; dentate gyrus; epilepsy; fast ripples; hippocampus; traumatic brain injury	HIGH-FREQUENCY OSCILLATIONS; DENTATE GYRUS; PYRAMIDAL CELLS; MOSSY FIBERS; IN-VIVO; RAT; SLICES; PROPAGATION; CA3; NETWORK	Fast ripples (FRs; activity of > 250 Hz) have been considered as a biomarker of epileptic activity in the hippocampus and entorhinal cortex; it is thought that they signal the focus of seizure generation. Similar high-frequency network activity has been produced in vitro by changing extracellular medium composition, by using pro-epileptic substances, or by electrical stimulation. Here we study the propagation of these events between different subregions of the male rat hippocampus in a recently introduced experimental model of FRs in entorhinal cortex-hippocampal slices in vitro. By using a matrix of 4096 microelectrodes, the sites of initiation, propagation pathways, and spatiotemporal characteristics of activity patterns could be studied with unprecedented high resolution. To this end, we developed an analytic tool based on bidimensional current source density estimation, which delimits sinks and sources with a high precision and evaluates their trajectories using the concept of center of mass. With this methodology, we found that FRs can arise almost simultaneously at noncontiguous sites in the CA3-to-CA1 direction, underlying the spatial heterogeneity of epileptogenic foci, while continuous somatodendritic waves of activity develop. An unexpected, yet important propagation route is the propagation of activity from CA3 into the hilus and dentate gyrus. This pathway may cause reverberating activation of both regions, supporting sustained pathological network events and altered information processing in hippocampal networks.	[Ortiz, Franco; Zapfe, W. P. Karel; Gutierrez, Rafael] IPN Mexico City, Ctr Invest & Estudios Avanzados, Dept Farmacobiol, Mexico City 14330, DF, Mexico; [Ortiz, Franco] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Draguhn, Andreas; Gutierrez, Rafael] Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany		Gutierrez, R (corresponding author), IPN Mexico City, Ctr Invest & Estudios Avanzados, Dept Farmacobiol, Mexico City 14330, DF, Mexico.; Gutierrez, R (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany.	rafagut@cinvestav.mx		Gutierrez, Rafael/0000-0002-6566-3900; Draguhn, Andreas/0000-0002-6243-5582	Consejo Nacional de Ciencia y Tecnologia (CONACYT), MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT) [79408, I0110/193/10 FIB.UBST.-29-1010]; Fundacion Miguel Aleman; IBMInternational Business Machines (IBM); Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 1134]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT)	This work was supported by Grants 79408 and I0110/193/10 FIB.UBST.-29-1010 from the Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico, Fundacion Miguel Aleman and IBM to R.G. and by Grant SFB 1134 from the Deutsche Forschungsgemeinschaft to A.D. and R.G.W. P.K.Z. and F.O. were recipients of a postdoctoral and a doctoral fellowship from CONACYT, respectively. The data in this work are in partial fulfillment of the requirements for the doctoral degree of F.O. in "Programa de Doctorado en Ciencias Biomedicas," Universidad Nacional Autonoma de Mexico. We thank Dr. Elias Manjarrez for introducing us to the concept of center of mass and Prof. Oscar Herreras for invaluable feedback on the current source density analysis.	Barnett L, 2014, J NEUROSCI METH, V223, P50, DOI 10.1016/j.jneumeth.2013.10.018; Basu J, 2016, SCIENCE, V351, P138, DOI 10.1126/science.aaa5694; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; Boccara CN, 2015, HIPPOCAMPUS, V25, P838, DOI 10.1002/hipo.22407; Both M, 2008, HIPPOCAMPUS, V18, P899, DOI 10.1002/hipo.20446; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G, 1991, Hippocampus, V1, P163, DOI 10.1002/hipo.450010205; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; Dzhala VI, 2003, J NEUROSCI, V23, P7873; Ferrea E, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00080; Foffani G, 2007, NEURON, V55, P930, DOI 10.1016/j.neuron.2007.07.040; Franco LM, 2016, BRAIN STRUCT FUNCT, V221, P1793, DOI 10.1007/s00429-015-1003-1; Gafurov B, 2013, J NEUROPHYSIOL, V110, P441, DOI 10.1152/jn.00679.2012; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; HEINEMANN U, 1992, EPILEPSY RES, P273; Henze DA, 1997, J NEUROPHYSIOL, V78, P24, DOI 10.1152/jn.1997.78.1.24; Herreras O, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00101; Jefferys JGR, 2012, PROG NEUROBIOL, V98, P250, DOI 10.1016/j.pneurobio.2012.02.005; Kasyanov AM, 2000, NEUROSCIENCE, V101, P323, DOI 10.1016/S0306-4522(00)00366-3; KNEISLER TB, 1995, J PHYSIOL-LONDON, V487, P125, DOI 10.1113/jphysiol.1995.sp020866; Krook-Magnuson E, 2015, J PHYSIOL-LONDON, V593, P2379, DOI 10.1113/JP270056; LINDEBERG T, 1990, IEEE T PATTERN ANAL, V12, P234, DOI 10.1109/34.49051; Manjarrez E, 2007, BRAIN RES, V1145, P239, DOI 10.1016/j.brainres.2007.01.114; Morris G, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00519; Myers CE, 2011, HIPPOCAMPUS, V21, P1190, DOI 10.1002/hipo.20828; NOVAK JL, 1989, BRAIN RES, V497, P223, DOI 10.1016/0006-8993(89)90266-7; Ortiz F, 2015, EXP NEUROL, V271, P319, DOI 10.1016/j.expneurol.2015.06.009; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Santhakumar V, 2003, J NEUROSCI, V23, P5865; SCHARFMAN HE, 1993, NEUROSCI LETT, V156, P61, DOI 10.1016/0304-3940(93)90440-V; SCHARFMAN HE, 1994, NEUROSCIENCE, V59, P245, DOI 10.1016/0306-4522(94)90593-2; Scharfman HE, 2016, NAT REV NEUROSCI, V17, P562, DOI 10.1038/nrn.2016.87; Schmidt-Hieber C, 2008, J PHYSIOL-LONDON, V586, P1849, DOI 10.1113/jphysiol.2007.150151; Simon A, 2014, EUR J NEUROSCI, V39, P46, DOI 10.1111/ejn.12386; Soltesz I, 2018, NAT NEUROSCI, V21, P484, DOI 10.1038/s41593-018-0118-0; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Vivar C, 2012, EUR J NEUROSCI, V35, P76, DOI 10.1111/j.1460-9568.2011.07930.x; Wenzel M, 2017, CELL REP, V19, P2681, DOI 10.1016/j.celrep.2017.05.090; Wittner L, 2007, J PHYSIOL-LONDON, V584, P867, DOI 10.1113/jphysiol.2007.138131; Xiong GX, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00107; YLINEN A, 1995, J NEUROSCI, V15, P30; Zapfe WPK, 2015, 69 ANN M AM EP SOC P	50	6	7	2	3	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 17	2018	38	42					9034	9046		10.1523/JNEUROSCI.3507-17.2018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GX2YO	WOS:000447587500010	30190413	Bronze, Green Published			2022-02-06	
J	Fisher, KM; Lilak, A; Garner, J; Darian-Smith, C				Fisher, Karen M.; Lilak, Alayna; Garner, Joseph; Darian-Smith, Corinna			Extensive somatosensory and motor corticospinal sprouting occurs following a central dorsal column lesion in monkeys	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						corticospinal tract; dorsal column; functional recovery; motor; nonhuman primate; primary afferent lesion; RRID: AB_2313606; RRID: AB_2536190; somatosensory; spinal cord injury	CERVICAL-SPINAL CORD; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; MACAQUE MONKEY; UNILATERAL SECTION; RHESUS-MONKEY; CORTICAL AREAS; ELECTRICAL-STIMULATION; PROPRIOSPINAL NEURONS; FASCICULUS-CUNEATUS	The corticospinal tract (CST) forms the major descending pathway mediating voluntary hand movements in primates, and originates from approximate to nine cortical subdivisions in the macaque. While the terminals of spared motor CST axons are known to sprout locally within the cord in response to spinal injury, little is known about the response of the other CST subcomponents. We previously reported that following a cervical dorsal root lesion (DRL), the primary somatosensory (S1) CST terminal projection retracts to 60% of its original terminal domain, while the primary motor (M1) projection remains robust (Darian-Smith et al., J. Neurosci., 2013). In contrast, when a dorsal column lesion (DCL) is added to the DRL, the S1 CST, in addition to the M1 CST, extends its terminal projections bilaterally and caudally, well beyond normal range (Darian-Smith et al., J. Neurosci., 2014). Are these dramatic responses linked entirely to the inclusion of a CNS injury (i.e., DCL), or do the two components summate or interact? We addressed this directly, by comparing data from monkeys that received a unilateral DCL alone, with those that received either a DRL or a combined DRL/DCL. Approximately 4months post-lesion, the S1 hand region was mapped electrophysiologically, and anterograde tracers were injected bilaterally into the region deprived of normal input, to assess spinal terminal labeling. Using multifactorial analyses, we show that following a DCL alone (i.e., cuneate fasciculus lesion), the S1 and M1 CSTs also sprout significantly and bilaterally beyond normal range, with a termination pattern suggesting some interaction between the peripheral and central lesions.	[Fisher, Karen M.; Lilak, Alayna; Garner, Joseph; Darian-Smith, Corinna] Stanford Univ, Sch Med, Dept Comparat Med, 300 Pasteur Dr, Stanford, CA 94305 USA		Darian-Smith, C (corresponding author), Stanford Univ, Sch Med, Dept Comparat Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	cdarian@stanford.edu		Darian-Smith, Corinna/0000-0002-4753-4574	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS048425R01 NS091031]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091031] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, Grant/Award Number: R01 NS048425R01 NS091031	Ahmed A, 2018, MOL CELL BIOCHEM, V441, P181, DOI 10.1007/s11010-017-3184-9; ALSTERMARK B, 1981, EXP BRAIN RES, V42, P299, DOI 10.1007/BF00237496; Bunday KL, 2012, J NEUROPHYSIOL, V107, P2901, DOI 10.1152/jn.00850.2011; Carmel JB, 2013, EUR J NEUROSCI, V37, P1090, DOI 10.1111/ejn.12119; CHEEMA SS, 1984, J COMP NEUROL, V225, P276, DOI 10.1002/cne.902250211; Darian-Smith C, 2005, J COMP NEUROL, V491, P27, DOI 10.1002/cne.20686; Darian-Smith C, 2000, NAT NEUROSCI, V3, P476, DOI 10.1038/74852; Darian-Smith C, 2014, J NEUROSCI, V34, P12267, DOI 10.1523/JNEUROSCI.1593-14.2014; Darian-Smith C, 2013, J COMP NEUROL, V521, P2359, DOI 10.1002/cne.23289; DUM RP, 1991, J NEUROSCI, V11, P667; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Festing MFW, 2014, ILAR J, V55, P472, DOI 10.1093/ilar/ilu045; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Flynn JR, 2011, NEUROPHARMACOLOGY, V60, P809, DOI 10.1016/j.neuropharm.2011.01.016; Fregosi M, 2017, EUR J NEUROSCI, V45, P1379, DOI 10.1111/ejn.13576; Friedli L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5811; Galea MP, 1997, J COMP NEUROL, V381, P282; GALEA MP, 1994, CEREB CORTEX, V4, P166, DOI 10.1093/cercor/4.2.166; Galea MP, 1997, J COMP NEUROL, V381, P307; GLENDINNING DS, 1992, SOMATOSENS MOT RES, V9, P61, DOI 10.3109/08990229209144763; Gosgnach S, 2017, J NEUROSCI, V37, P10835, DOI 10.1523/JNEUROSCI.1829-17.2017; Hails, 2002, MODERN STAT LIFE SCI; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; Isa T, 2017, TRENDS NEUROSCI, V40, P625, DOI 10.1016/j.tins.2017.08.002; Iwamura Y, 2001, NEUROSCIENTIST, V7, P419, DOI 10.1177/107385840100700511; Jain N, 2008, J NEUROSCI, V28, P11042, DOI 10.1523/JNEUROSCI.2334-08.2008; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; JENNY AB, 1979, J COMP NEUROL, V188, P137, DOI 10.1002/cne.901880111; Jiang YQ, 2016, J NEUROSCI, V36, P193, DOI 10.1523/JNEUROSCI.3441-15.2016; JONES EG, 1969, BRAIN, V92, P717, DOI 10.1093/brain/92.4.717; Kambi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4602; Kambi N, 2011, J NEUROSCI, V31, P3696, DOI 10.1523/JNEUROSCI.5187-10.2011; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; KILLACKEY HP, 1983, J COMP NEUROL, V219, P384, DOI 10.1002/cne.902190403; Kinoshita M, 2012, NATURE, V487, P235, DOI 10.1038/nature11206; Kuypers H. G. J. M., 1981, HDB PHYSL 1, VII; LASSEK AM, 1954, NEUROLOGY, V4, P120, DOI 10.1212/WNL.4.2.120; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; LEONARD CM, 1992, SOMATOSENS MOT RES, V9, P75, DOI 10.3109/08990229209144764; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Lundell H, 2011, NEUROIMAGE, V54, P1254, DOI 10.1016/j.neuroimage.2010.09.009; McConway Kevin, 1992, Animal Behaviour, V44, P35; Morecraft RJ, 2013, J COMP NEUROL, V521, P4205, DOI 10.1002/cne.23410; Murphy BA, 2003, CLIN NEUROPHYSIOL, V114, P1477, DOI 10.1016/S1388-2457(03)00131-7; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; PierrotDeseilligny E, 1996, PROG NEUROBIOL, V48, P489, DOI 10.1016/0301-0082(96)00002-0; Qi HX, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00084; Qi HX, 2013, BEHAV BRAIN RES, V252, P363, DOI 10.1016/j.bbr.2013.05.058; Qi HX, 2011, J NEUROSCI, V31, P13662, DOI 10.1523/JNEUROSCI.2366-11.2011; Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Rosenzweig ES, 2009, J COMP NEUROL, V513, P151, DOI 10.1002/cne.21940; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; SAINBURG RL, 1993, J NEUROPHYSIOL, V70, P2136, DOI 10.1152/jn.1993.70.5.2136; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sorg BA, 2016, J NEUROSCI, V36, P11459, DOI 10.1523/JNEUROSCI.2351-16.2016; Soteropoulos DS, 2013, J NEUROSCI, V33, P9614, DOI 10.1523/JNEUROSCI.0269-13.2013; Soteropoulos DS, 2012, J PHYSIOL-LONDON, V590, P4011, DOI 10.1113/jphysiol.2011.225169; Soteropoulos DS, 2011, J NEUROSCI, V31, P11208, DOI 10.1523/JNEUROSCI.0257-11.2011; STILL AW, 1982, ANIM BEHAV, V30, P873, DOI 10.1016/S0003-3472(82)80161-9; Tohyama T, 2017, P NATL ACAD SCI USA, V114, P604, DOI 10.1073/pnas.1610787114; Ulndreaj A, 2017, J NEUROTRAUM, V34, P1209, DOI 10.1089/neu.2016.4498; Vessal M, 2007, EUR J NEUROSCI, V26, P2777, DOI 10.1111/j.1460-9568.2007.05871.x; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Woolsey C.N., 1958, BIOL BIOCH BASES BEH; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115	72	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	OCT 15	2018	526	15					2373	2387		10.1002/cne.24491			15	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	GX5RN	WOS:000447808100003	30014461	Green Accepted			2022-02-06	
J	Hunt, AW; Laupacis, D; Kawaguchi, E; Greenspoon, D; Reed, N				Hunt, Anne W.; Laupacis, Dylan; Kawaguchi, Emily; Greenspoon, Dayna; Reed, Nick			Key ingredients to an active rehabilitation programme post-concussion: perspectives of youth and parents	BRAIN INJURY			English	Article						Concussion; brain injury; active rehabilitation; pediatrics; survey	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; CHILDREN; POSTCONCUSSION; ADOLESCENTS; MANAGEMENT; EDUCATION; RECOVER; SLOW	Objective: To identify key ingredients in a six-week active rehabilitation intervention from the perspectives of youth recovering from concussion and their parents. Methods: Surveys with open- and closed-ended questions were administered to youth (N = 38) ages 10-18 years (average = 14.5 years) and their parents (n = 36) immediately post intervention. Descriptive statistics and thematic analysis were used to analyse data. Results: One hundred percent (N = 38) of youth and 100% (N = 36) of parents reported that the active rehabilitation intervention was helpful. The most helpful ingredients according to youth were: energy management strategies (47.4%, N = 18), aerobic exercise (31.6%, N = 12) and sport coordination drills (21.1%, N = 8). Qualitative analysis of youth survey questions resulted in three themes: (1) learning energy management; (2) engaging in physical activity and (3) seeking help. Themes emerging from the parent survey were: (1) encouraging recovery and confidence through structured activity; (2) recognizing youth's accountability and (3) learning to be patient and to accept uncertain timelines. Conclusions: Education about energy management is an important ingredient of the active rehabilitation intervention for youth with concussion. Parents benefit from learning how their child can be more accountable for their own rehabilitation and to be more accepting of unclear recovery timelines.	[Hunt, Anne W.; Laupacis, Dylan; Kawaguchi, Emily; Greenspoon, Dayna; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Hunt, Anne W.; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Hunt, Anne W.; Reed, Nick] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Kawaguchi, Emily] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada		Hunt, AW (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	ahunt@hollandbloorview.ca			Scotiabank	This work was supported by Scotiabank.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bellamy R, 2004, MED TEACH, V26, P359, DOI 10.1080/01421590410001679398; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Carpenter C, 2008, QUALITATIVE RES OCCU; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; DiMatteo MR, 2004, PATIENT EDUC COUNS, V55, P339, DOI 10.1016/j.pec.2003.04.003; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Hunt AW, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1664-3; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Imhoff S, 2016, J SPORTS MED, V2016, DOI [10. 1155/2016/5127374, DOI 10.1155/2016/5127374]; Kok G, 1997, PATIENT EDUC COUNS, V30, P19, DOI 10.1016/S0738-3991(96)00953-6; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	23	6	6	3	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1534	1540		10.1080/02699052.2018.1502894			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800012	30047796				2022-02-06	
J	Tolli, A; Hoybye, C; Bellander, BM; Johansson, F; Borg, J				Tolli, Anna; Hoybye, Charlotte; Bellander, Bo-Michael; Johansson, Fredrik; Borg, Jorgen			The effect of time on cognitive impairments after non-traumatic subarachnoid haemorrhage and after traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; subarachnoid haemorrhage; outcome; cognitive impairments	HIGHER CEREBRAL FUNCTIONS; NEUROLOGICAL-INSTITUTE SCREEN; 18-TO 64-YEAR-OLD SWEDES; GLASGOW OUTCOME SCALE; QUALITY-OF-LIFE; BNI SCREEN; HOSPITAL ANXIETY; CASE-FATALITY; DEPRESSION; HEALTH	Objectives: To compare the effect of time on cognitive impairments after Subarachnoid Haemorrhage and Traumatic Brain Injury and explore associations with baseline variables and global function. Methods: Patients with a Glasgow Coma Scale score of 3-13, were assessed at 3, 6 and 12 months post injury by use of BNIS for cognitive impairment, RLAS-R to categorise cognitive and behavioural function, Barthel Index to assess performance of daily living, HADS to screen for depression and anxiety, and EuroQoL-5D, LiSat-11 and Glasgow Outcome Scale Extended to assess global function. Results: BNIS T-scores did not differ significantly between groups and the proportion of patients with cognitive impairments was not significantly different at any time point. Cognition improved significantly between all time points in both groups except from 6 to 12 months after TBI. Generalised estimating equation showed non-significant signs of slower recovery of BNIS T-scores over time after SAH. Acute GCS scores were associated with BNIS T-scores after TBI but not after SAH. At 12 months, similar proportions of patients with SAH and TBI had good outcome. Conclusions: Cognitive improvements after SAH and TBI exhibit similarities and correlate with global function. GCS scores are associated with outcome after TBI but not after SAH.	[Tolli, Anna; Borg, Jorgen] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18288 Stockholm, Sweden; [Hoybye, Charlotte] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Hoybye, Charlotte] Karolinska Univ Hosp, Dept Endocrinol Metab & Diabetol, Stockholm, Sweden; [Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Sect Neurosurg, Stockholm, Sweden; [Johansson, Fredrik] Danderyd Hosp, Med Lib, Stockholm, Sweden		Tolli, A (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18288 Stockholm, Sweden.	anna.tolli@ki.se		Borg, Jorgen/0000-0002-2372-7478	Pfizer, SwedenPfizer [102230]; Stockholm County CouncilStockholm County Council [20090410]; Novo NordiskNovo Nordisk; Lars Hedlund (Karolinska Institutet) [2-1582/2016]	The study was partly funded by an unrestricted research grant from Pfizer, Sweden (102230). Anna Tolli has received support by grants from Stockholm County Council (ALF-grants 20090410), Novo Nordisk and a grant provided by Lars Hedlund (Karolinska Institutet Dnr 2-1582/2016).	Ackermark PY, 2017, EUR J PHYS REHAB MED, V53, P98, DOI 10.23736/S1973-9087.16.04202-7; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Boosman H, 2013, CLIN NEUROPSYCHOL, V27, P667, DOI 10.1080/13854046.2013.777787; Borgaro SR, 2003, J HEAD TRAUMA REHAB, V18, P284, DOI 10.1097/00001199-200305000-00006; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; Braet V, 2002, EMERG MED J, V19, P510; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Denvall V, 2002, J REHABIL MED, V34, P153, DOI 10.1080/16501970213231; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Frazer D, 2007, NEUROSURGERY, V60, P434, DOI 10.1227/01.NEU.0000255335.72662.25; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Hagen C, 1987, REHABILITATION HEAD; Haley EC, 1997, J NEUROSURG, V86, P467, DOI 10.3171/jns.1997.86.3.0467; Haug T, 2007, NEUROSURGERY, V60, P649, DOI 10.1227/01.NEU.0000255414.70807.A0; Haug T, 2010, NEUROSURGERY, V66, P475, DOI 10.1227/01.NEU.0000365364.87303.AC; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Hung CI, 2012, INT J PSYCHIAT CLIN, V16, P33, DOI 10.3109/13651501.2011.617456; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Kumar A, 2013, NEUROSURGERY, V73, P617, DOI 10.1227/NEU.0000000000000057; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Li ZQ, 2012, J INT MED RES, V40, P2145, DOI 10.1177/030006051204000612; Lo Benjamin W Y, 2015, Surg Neurol Int, V6, P135, DOI 10.4103/2152-7806.162676; LONGSTRETH WT, 1993, NEUROLOGY, V43, P712, DOI 10.1212/WNL.43.4.712; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; MAHONEY F I, 1965, Md State Med J, V14, P61; Mayer SA, 2002, NEUROLOGY, V59, P1750, DOI 10.1212/01.WNL.0000035748.91128.C2; Melin R, 2003, J REHABIL MED, V35, P84, DOI 10.1080/16501970306119; Meyer B, 2010, CEREBROVASC DIS, V30, P423, DOI 10.1159/000317078; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Naidech AM, 2009, NEUROSURGERY, V64, P1052, DOI 10.1227/01.NEU.0000343543.43180.9C; Nedergaard HK, 2017, ACTA ANAESTH SCAND, V61, P135, DOI 10.1111/aas.12832; Neukrug E., 2014, ESSENTIALS TESTING A; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Prigatano G., 1991, BNI Q, V7, P2; Prigatano GP, 1993, BNI Q, V9, P2; Redfors P, 2014, J STROKE CEREBROVASC, V23, P349, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.026; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Rosenstein LD., 1995, ADM SCORING MANUAL B; Stenberg M, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/680308; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tolli A, 2017, J ENDOCRINOL INVEST, V40, P193, DOI 10.1007/s40618-016-0546-1; Tolli A, 2015, INT J CLIN MED, V6, P411, DOI DOI 10.4236/ijcm.2015.66054; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolters AE, 2013, INTENS CARE MED, V39, P376, DOI 10.1007/s00134-012-2784-9; Wong GKC, 2014, EUR J NEUROL, V21, P725, DOI 10.1111/ene.12363; Wong GKC, 2014, TRANSL STROKE RES, V5, P286, DOI 10.1007/s12975-013-0284-z; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	70	6	6	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1465	1476		10.1080/02699052.2018.1497203			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800004	30010431	Bronze			2022-02-06	
J	Unden, J; Dalziel, SR; Borland, ML; Phillips, N; Kochar, A; Lyttle, MD; Bressan, S; Cheek, JA; Neutze, J; Donath, S; Hearps, S; Oakley, E; Dalton, S; Gilhotra, Y; Babl, FE				Unden, Johan; Dalziel, Stuart R.; Borland, Meredith L.; Phillips, Natalie; Kochar, Amit; Lyttle, Mark D.; Bressan, Silvia; Cheek, John A.; Neutze, Jocelyn; Donath, Susan; Hearps, Stephen; Oakley, Ed; Dalton, Sarah; Gilhotra, Yuri; Babl, Franz E.		Paediat Res Emergency Dept Int	External validation of the Scandinavian guidelines for management of minimal, mild and moderate head injuries in children	BMC MEDICINE			English	Article						Head trauma; Head injury; Guideline; Clinical decision rule; Infant; Child; Computed tomography; Scandinavia	TRAUMATIC BRAIN-INJURY; CLINICAL DECISION RULES; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; RADIATION-EXPOSURE; INTERRATER RELIABILITY; INITIAL MANAGEMENT; CT; PECARN; ADULTS	Background: Clinical decision rules (CDRs) aid in the management of children with traumatic brain injury (TBI). Recently, the Scandinavian Neurotrauma Committee (SNC) has published practical, evidence-based guidelines for children with Glasgow Coma Scale (GCS) scores of 9-15. This study aims to validate these guidelines and to compare them with other CDRs. Methods: A large prospective cohort of children (< 18 years) with TBI of all severities, from ten Australian and New Zealand hospitals, was used to assess the SNC guidelines. Firstly, a validation study was performed according to the inclusion and exclusion criteria of the SNC guideline. Secondly, we compared the accuracy of SNC, CATCH, CHALICE and PECARN CDRs in patients with GCS 13-15 only. Diagnostic accuracy was calculated for outcome measures of need for neurosurgery, clinically important TBI (ciTBI) and brain injury on CT. Results: The SNC guideline could be applied to 19,007/20,137 of patients (94.4%) in the validation process. The frequency of ciTBI decreased significantly with stratification by decreasing risk according to the SNC guideline. Sensitivities for the detection of neurosurgery, ciTBI and brain injury on CT were 100.0% (95% CI 89.1-100.0; 32/32), 97.8% (94.5-99.4; 179/183) and 95% (95% CI 91.6-97.2; 262/276), respectively, with a CT/admission rate of 42% (mandatory CT rate of 5%, 18% CT or admission and 19% only admission). Four patients with ciTBI were missed; none needed specific intervention. In the homogenous comparison cohort of 18,913 children, the SNC guideline performed similar to the PECARN CDR, when compared with the other CDRs. Conclusion: The SNC guideline showed a high accuracy in a large external validation cohort and compares well with published CDRs for the management of paediatric TBI.	[Cheek, John A.; Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp, Dept Emergency Med, 50 Flemington Rd, Parkville, Vic 3052, Australia; [Lyttle, Mark D.; Bressan, Silvia; Cheek, John A.; Donath, Susan; Hearps, Stephen; Oakley, Ed; Babl, Franz E.] Murdoch Childrens Res Inst, 50 Flemington Rd, Parkville, Vic 3052, Australia; [Donath, Susan; Oakley, Ed; Babl, Franz E.] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Grattan St, Parkville, Vic 3010, Australia; [Borland, Meredith L.] Princess Margaret Hosp Children, Emergency Dept, Roberts Rd, Perth, WA 6008, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, 35 Stirling Hwy, Crawley, WA 6009, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, 35 Stirling Hwy, Crawley, WA 6009, Australia; [Phillips, Natalie; Gilhotra, Yuri] Univ Queensland, Sch Med, Brisbane & Child Hlth Res Ctr, Emergency Dept,Lady Cilento Childrens Hosp, 501 Stanley St, South Brisbane, Qld 4101, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, 72 King William St, Adelaide, SA 5006, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, 212 Hawkesbury Rd, Westmead, NSW 2145, Australia; [Cheek, John A.] Monash Med Ctr, Emergency Dept, 246 Clayton Rd, Clayton, Vic 3186, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Emergency Dept, 100 Hosp Rd, Auckland 2025, New Zealand; [Dalziel, Stuart R.] Starship Childrens Hlth, Emergency Dept, 2 Pk Rd, Auckland 1023, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Liggins Inst, 85 Pk Ave, Auckland 1023, New Zealand; [Lyttle, Mark D.] Bristol Childrens Hosp, Emergency Dept, Paul OGorman Bldg,Upper Maudlin St, Bristol BS2 8BJ, Avon, England; [Lyttle, Mark D.] Univ West England, Acad Dept Emergency Care, Blackberry Hill, Bristol BS16 1XS, Avon, England; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Via Giustiniani3,2, I-35128 Padua, Italy; [Unden, Johan] Hallands Hosp, Dept Operat & Intens Care, Halmstad, Sweden; [Unden, Johan] Lund Univ, Lund, Sweden		Babl, FE (corresponding author), Royal Childrens Hosp, Dept Emergency Med, 50 Flemington Rd, Parkville, Vic 3052, Australia.; Babl, FE (corresponding author), Murdoch Childrens Res Inst, 50 Flemington Rd, Parkville, Vic 3052, Australia.	dr.johan.unden@gmail.com; franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Donath, Susan/0000-0003-2489-3977; Lyttle, Mark/0000-0002-8634-7210; Hearps, Stephen/0000-0003-2984-1172	non-commercial Swedish state sources Region Skane and Region Halland, Sweden; National Health and Medical Research Council, Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727]; National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine), Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation [3112011]; A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital; Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation, Melbourne, Australia; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia [GNT1124466]; Melbourne Children's Clinician Scientist Fellowship; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	This present study was funded by non-commercial Swedish state sources Region Skane and Region Halland, Sweden.; The APHIRST parent study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A + Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. FEB's time was part funded by a grant from the Royal Children's Hospital Foundation, Melbourne, Australia, an NHMRC Practitioner Fellowship GNT1124466 and a Melbourne Children's Clinician Scientist Fellowship. SRD's time was part funded by the Health Research Council of New Zealand (HRC13/556).	af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Astrand R, 2006, ACTA NEUROL SCAND, V113, P262, DOI 10.1111/j.1600-0404.2005.00573.x; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Gupta A, 2014, J AM MED INFORM ASSN, V21, pE347, DOI 10.1136/amiajnl-2013-002536; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lyttle MD, 2013, EMERG MED J, V30, P790, DOI 10.1136/emermed-2012-201887; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50	34	6	6	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7015			BMC MED	BMC Med.	OCT 12	2018	16								176	10.1186/s12916-018-1166-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW7ST	WOS:000447170800001	30309392	Green Published, gold			2022-02-06	
J	Morin, A; Mouzon, B; Ferguson, S; Paris, D; Saltiel, N; Lungmus, C; Mullen, M; Crawford, F				Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Saltiel, Nicole; Lungmus, Carlyn; Mullen, Mike; Crawford, Fiona			Treatment With Nilvadipine Mitigates Inflammatory Pathology and Improves Spatial Memory in Aged hTau Mice After Repetitive Mild TBI	FRONTIERS IN AGING NEUROSCIENCE			English	Article						treatment; concussion; TBI; tau; brain injury; animal model; neuroinflammation; neurodegeneration	TRAUMATIC BRAIN-INJURY; CALCIUM-CHANNEL BLOCKERS; MOUSE MODEL; INTERFERON-GAMMA; HUMAN-MONOCYTES; HEAD-INJURY; COGNITIVE FUNCTION; TAU PATHOLOGY; DISEASE; IMPAIRMENT	Mild traumatic brain injury (mTBI) is the most common form of brain trauma worldwide. The effects of mTBI are not well-studied within the elderly population, yet older adults constitute a significant portion of all mTBI patients. Few preclinical studies have focused on the effects of mTBI, or mTBI treatments, in the aged brain, and none have explored repetitive mTBI (r-mTBI). In this study, we have administered our well-characterized 5-injury model (5 r-mTBI) to hTau mice aged 24 months to explore the neurobehavioral and neuropathological outcomes, and the effects of treatment with the dihydropyridine, Nilvadipine. Our previous studies have shown that Nilvadipine inhibits spleen tyrosine kinase (Syk), is effective at reducing inflammation, tau hyperphosphorylation, and amyloid production, and it has recently been investigated in a European Phase III clinical trial for Alzheimer's disease (AD). In our 24-month-old r-mTBI mice, we observed increased neuroinflammation and a trend toward impaired cognitive performance compared to sham controls. Treatment with Nilvadipine mitigated the TBI-induced inflammatory response in aged r-mTBI animals and significantly improved spatial memory. To our knowledge, this is the only preclinical study focusing on the treatment of r-mTBI in aged, and these results suggest a therapeutic potential of Nilvadipine for consequences of mTBI.	[Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Saltiel, Nicole; Lungmus, Carlyn; Mullen, Mike; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Mullen, Mike; Crawford, Fiona] Open Univ, Milton Keynes, Bucks, England; [Morin, Alexander; Mouzon, Benoit; Ferguson, Scott; Paris, Daniel; Saltiel, Nicole; Crawford, Fiona] James A Haley Vet Adm, Tampa, FL 33637 USA		Morin, A (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Morin, A (corresponding author), Open Univ, Milton Keynes, Bucks, England.; Morin, A (corresponding author), James A Haley Vet Adm, Tampa, FL 33637 USA.	amorin@roskampinstitute.net		Morin, Alexander/0000-0002-2895-985X	Roskamp Institute	This work was supported by the Roskamp Institute.	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; Bartres-Faz D, 2001, J AM GERIATR SOC, V49, P985, DOI 10.1046/j.1532-5415.2001.49191.x; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dinarello CA, 2000, ANN RHEUM DIS, V59, P17; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Foster TC, 2012, PROG NEUROBIOL, V96, P283, DOI 10.1016/j.pneurobio.2012.01.007; Gao WW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00281; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Gemma C, 2005, EUR J NEUROSCI, V22, P1751, DOI 10.1111/j.1460-9568.2005.04334.x; GUSELLA GL, 1993, J IMMUNOL, V151, P2725; Harris JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045881; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lawlor B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006364; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lee DH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006401; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Lynch CE, 2016, BRAIN INJURY, V30, P1414, DOI 10.1080/02699052.2016.1219060; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mouzon B, 2018, BRAIN INJURY, V32, P1285, DOI 10.1080/02699052.2018.1486457; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Muhl H, 2003, INT IMMUNOPHARMACOL, V3, P1247, DOI 10.1016/S1567-5769(03)00131-0; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Pagnussat N, 2015, BRIT J PHARMACOL, V172, P3831, DOI 10.1111/bph.13180; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Paris D, 2014, J BIOL CHEM, V289, P33927, DOI 10.1074/jbc.M114.608091; Peters J, 2015, THER ADV CHRONIC DIS, V6, P160, DOI 10.1177/2040622315582353; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Primiani CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110972; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; SCHINDLER R, 1990, J IMMUNOL, V144, P2216; SCHNYDERCANDRIAN S, 1995, J LEUKOCYTE BIOL, V57, P929, DOI 10.1002/jlb.57.6.929; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; SIHVOLA M, 1989, SCAND J IMMUNOL, V29, P689, DOI 10.1111/j.1365-3083.1989.tb01173.x; Simen AA, 2011, THER ADV CHRONIC DIS, V2, P175, DOI 10.1177/2040622311399145; Spanaus KS, 1998, EUR J IMMUNOL, V28, P4398, DOI 10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.3.CO;2-P; Tateno A., 2014, GEN HOSP PSYCHIAT, V37, P97, DOI DOI 10.1016/J.GENH0SPPSYCH.2014.09.016; Teo DB, 2018, INTERN MED J, V48, P1048, DOI 10.1111/imj.13794; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tzekov R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153608; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; VanGuilder HD, 2012, J NEUROCHEM, V121, P77, DOI 10.1111/j.1471-4159.2012.07671.x; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011; Yin YL, 2016, P NATL ACAD SCI USA, V113, pE3773, DOI 10.1073/pnas.1604519113; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	73	6	6	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	OCT 11	2018	10								292	10.3389/fnagi.2018.00292			13	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	GW6AU	WOS:000447026800001	30364309	Green Published, gold			2022-02-06	
J	Hernandez, F; Camarillo, DB				Hernandez, Fidel; Camarillo, David B.			Voluntary Head Rotational Velocity and Implications for Brain Injury Risk Metrics	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; finite element modeling; head impact sensing; injury criterion; rotational velocity	DIFFUSE AXONAL INJURY; ERROR SCORING SYSTEM; CONCUSSION; IMPACT; ACCELERATION; FOOTBALL; TRENDS; KINEMATICS; MOUTHGUARD; WHIPLASH	We investigated whether humans could sustain high head rotational velocities without brain injury. Rotational velocity has long been implicated for predicting concussion risk, and has recently been used to develop the rotational velocity-based Brain Injury Criterion (BrIC). To assess the efficacy of rotational velocity and BrIC for predicting concussion risk, we instrumented 9 male subjects with sensor-laden mouthguards and measured six-degree-of-freedom head accelerations for 27 rapid voluntary head rotations. The fastest rotations produced peak rotational velocities of 12.6, 17.4, and 25.0rad/s in the coronal, sagittal, and horizontal planes, respectively. All of these exceeded the corresponding medians from padded sports impacts (8.9, 10.7, and 8.4rad/s, respectively) and, in the case of sagittal and horizontal rotation, were within 1 standard deviation of published concussion averages. In the horizontal plane, four voluntary rotations exceeded the concussive impact median BrIC. The area under the precision-recall curve was lower in BrIC (0.49) than just using horizontal rotational acceleration (0.8), which distinguished concussive and subconcussive motions better. Voluntary motions produced less than 4% max principal strain (MPS) in finite element simulation, 5 times below predictions from dummy impacts used to develop BrIC. Despite having the highest critical velocity in BrIC, coronal rotation produced more tract-oriented strain in the corpus callosum than other planes. Baseline and post-experiment neurological testing revealed no significant deficits. We find that the head can tolerate high-velocity, low-acceleration rotational inputs too slow to produce substantial brain deformation. These findings suggest that the time regime over which angular velocities occur must be carefully considered for concussion prediction.	[Hernandez, Fidel; Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA		Camarillo, DB (corresponding author), Stanford Univ, Dept Bioengn, Shriram Ctr, Room 205,443 Via Ortega, Stanford, CA 94305 USA.	dcamarillo@stanford.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [3R21EB01761101S1]; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF); Ford Foundation Predoctoral Fellowship; Child Health Research Institute-Transdisciplinary Initiatives Program	Acknowledgment is given to Jared Ostdiek, Alec McGlaughlin, and Matthew Garelli for their work on subject consenting, mouthguard development, data collection, and data processing. Acknowledgment is also given to Lyndia Wu for help developing the neurological test battery. We also acknowledge the volunteer subjects in the study for their participation. Finally, we acknowledge Calvin Kuo for thoughtfully authoring revisions to this article. The study was supported by the National Institutes of Health (NIH) 3R21EB01761101S1, National Science Foundation Graduate Research Fellowship, Ford Foundation Predoctoral Fellowship, and Child Health Research Institute-Transdisciplinary Initiatives Program.	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; Arbogast KB, 2009, STAPP CAR CRASH JO, V53, P329; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bussone WR, 2009, SAE INT J PASSEN CAR, V2, P565, DOI 10.4271/2009-01-0383; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Ewing C., 1978, 780888 SAE, V780888, P3151; Ewing C. L., 1975, P 19 STAPP CAR CRASH; Federal Motor Vehicle Safety Standards (FMVSS), 2014, 571202A FMVSS; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K.M., 2015, CONCUSSION, V1, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hernandez F., 2016, MECH EVIDENCE UNPUB; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Holbourn AHS, 1943, LANCET, V2, P438; Ivins BJ, 2010, NEUROREHABILITATION, V26, P199, DOI 10.3233/NRE-2010-0556; Khanna N.K., 2015, SPORTS HEALTH, V8, P244; KING DL, 1994, J APPL BIOMECH, V10, P51, DOI 10.1123/jab.10.1.51; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kleinberger M., 1998, DEV IMPROVED INJURY, P12; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KORNHAUSER M, 1954, J APPL MECH-T ASME, V21, P371; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2001, J ATHL TRAINING, V36, P274; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2012, ND00111M12 NOCSAE, P1; Ommaya A.K., 1966, 660804 SAE; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK., 1985, BIOMECHANICS TRAUMA, P245; Onate JA, 2007, J ATHL TRAINING, V42, P446; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Siegmund GP, 2003, SPINE, V28, P671, DOI 10.1097/00007632-200304010-00010; Susco TM, 2004, J ATHL TRAINING, V39, P241; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019	58	6	6	3	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1125	1135		10.1089/neu.2016.4758		OCT 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HQ4DQ	WOS:000447011500001	29848152	Green Published			2022-02-06	
J	Abode-Iyamah, KO; Stoner, KE; Close, LN; Watson, NAD; Flouty, OE; Grosland, NM; Howard, MA				Abode-Iyamah, Kingsley O.; Stoner, Kirsten E.; Close, Liesl N.; Watson, Nicole A. DeVries; Flouty, Oliver E.; Grosland, Nicole M.; Howard, Matthew A., III			Volume of Brain Herniation After Decompressive Craniectomy in Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Acquired skull defect; Brain herniation; Cerebral edema; Decompressive craniectomy; Hemicraniectomy; TBI; Traumatic brain injury	SITU HINGE CRANIECTOMY; INTRACRANIAL HYPERTENSION; TECHNICAL NOTE; CRANIOPLASTY; TRIAL; COMPLICATIONS; CRANIOTOMY; ELEVATION	BACKGROUND: The decompressive hemicraniectomy operation is highly effective in relieving refractory intracranial hypertension. However, one limitation of this treatment strategy is the requirement to perform a subsequent cranioplasty operation to reconstruct the skull defect-an expensive procedure with high complication rates. An implant that is capable of accommodated post-hemicraniectomy brain swelling, but also provides acceptable skull defect coverage after brain swelling abates, would theoretically eliminate the need for the cranioplasty operation. In an earlier report, the concept of using a thin, moveable plate implant for this purpose was introduced. METHODS: Measurements were obtained in a series of stroke patients to determine whether a plate offset from the skull by 5 mm would accommodate the observed post-hemicraniectomy brain swelling. The volume of brain swelling measured in all patients in the stroke series would be accommodated by a 5-mm offset plate. In the current report, we expanded our analysis to study brain swelling patterns in a different population of patients requiring a hemicraniectomy operation: those with traumatic brain injuries (TBI). RESULTS: We identified 56 patients with TBI and measured their postoperative brain herniation volumes. A moveable plate offset by 5 mm would create sufficient additional volume to accommodate the brain swelling measured in all but one patient. That patient had malignant intraoperative brain swelling and died the following day. CONCLUSIONS: These data suggest that a 5 mm offset plate will provide sufficient volume for brain expansion for almost all hemicraniectomy operations.	[Abode-Iyamah, Kingsley O.; Close, Liesl N.; Flouty, Oliver E.; Howard, Matthew A., III] Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA; [Stoner, Kirsten E.; Grosland, Nicole M.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Stoner, Kirsten E.; Watson, Nicole A. DeVries; Grosland, Nicole M.] Univ Iowa, Ctr Comp Aided Design, Iowa City, IA USA; [Grosland, Nicole M.] Univ Iowa Hosp & Clin, Dept Orthoped & Rehabil, Iowa City, IA 52242 USA		Howard, MA (corresponding author), Univ Iowa Hosp & Clin, Dept Neurosurg, Iowa City, IA 52242 USA.	Matthew-howard@uiowa.edu	flouty, oliver/AAO-2469-2021	Howard, Matthew/0000-0003-3935-8889			Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Fletcher TL, 2016, ANN BIOMED ENG, V44, P3495, DOI 10.1007/s10439-016-1666-7; Gilardino MS, 2015, J CRANIOFAC SURG, V26, P117, DOI 10.1097/SCS.0000000000001305; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Khanna R, 2016, J NEUROSURG, V125, P674, DOI 10.3171/2015.6.JNS15706; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Komotar RJ, 2007, NEUROSURGERY, V60, P258; Nagahama Y, 2018, J NEUROSURG, V129, P182, DOI 10.3171/2017.3.JNS163109; Reddy S, 2014, PLAST RECONSTR SURG, V133, P864, DOI 10.1097/PRS.0000000000000013; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Sharma R, 2017, NEUROSURGERY, V81, pE58, DOI 10.1093/neuros/nyx398; Stoner KE, 2016, WORLD NEUROSURG, V96, P101, DOI 10.1016/j.wneu.2016.08.095; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Tian RF, 2015, BRAIN RES, V1622, P339, DOI 10.1016/j.brainres.2015.06.039; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	23	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2018	118						E414	E421		10.1016/j.wneu.2018.06.204			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GU1NY	WOS:000445032000054	30257297				2022-02-06	
J	Ainsworth, M; Browncross, H; Mitchell, DJ; Mitchell, AS; Passingham, RE; Buckley, MJ; Duncan, J; Bell, AH				Ainsworth, Matthew; Browncross, Helen; Mitchell, Daniel J.; Mitchell, Anna S.; Passingham, Richard E.; Buckley, Mark J.; Duncan, John; Bell, Andrew H.			Functional reorganisation and recovery following cortical lesions: A preliminary study in macaque monkeys	NEUROPSYCHOLOGIA			English	Article						Prefrontal cortex; Neuropsychology; Resting state covariance; FMRI; Plasticity; Recovery of function	PREFRONTAL CORTEX; NEURONAL-ACTIVITY; PARIETAL CORTEX; CONNECTIVITY; NETWORKS; PROJECTIONS; MEMORY; SENSITIVITY; PERFORMANCE; SELECTIVITY	Damage following traumatic brain injury or stroke can often extend beyond the boundaries of the initial insult and can lead to maladaptive cortical reorganisation. On the other hand, beneficial cortical reorganisation leading to recovery of function can also occur. We used resting state FMRI to investigate how cortical networks in the macaque brain change across time in response to lesions to the prefrontal cortex, and how this reorganisation correlated with changes in behavioural performance in cognitive tasks. After prelesion testing and scanning, two monkeys received a lesion to regions surrounding the left principal sulcus followed by periodic testing and scanning. Later, the animals received another lesion to the opposite hemisphere and additional testing and scanning. Following the first lesion, we observed both a behavioural impairment and decrease in functional connectivity, predominantly in frontal-frontal networks. Approximately 8 weeks later, performance and connectivity patterns both improved. Following the second lesion, we observed a further behavioural deficit and decrease in connectivity that showed little recovery. We discuss how different mechanisms including alternate behavioural strategies and reorganisation of specific prefrontal networks may have led to improvements in behaviour. Further work will be needed to confirm these mechanisms.	[Ainsworth, Matthew; Mitchell, Daniel J.; Duncan, John; Bell, Andrew H.] Univ Cambridge, MRC Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge, England; [Browncross, Helen; Mitchell, Anna S.; Passingham, Richard E.; Buckley, Mark J.; Duncan, John; Bell, Andrew H.] Univ Oxford, Dept Expt Psychol, Parks Rd, Oxford, England		Bell, AH (corresponding author), Univ Oxford, Dept Expt Psychol, MRC Cognit & Brain Sci Unit, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England.	andrew.bell@psy.ox.ac.uk	Mitchell, Anna S/Q-1196-2019; Mitchell, Daniel James/T-3863-2019	Mitchell, Anna S/0000-0001-8996-1067; Mitchell, Daniel James/0000-0001-8729-3886; Duncan, John/0000-0002-9695-2764; Bell, Andrew/0000-0001-8420-4622; Ainsworth, Matthew/0000-0002-5767-7704	Medical Research Council (MRC) intramural programUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [SUAG/002/RG91365]; Medical Research Council Career Development AwardUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0800329]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K005480/1, MC_UU_00005/6, G0400593, G0800329] Funding Source: UKRI	This work was supported by the Medical Research Council (MRC) intramural program (SUAG/002/RG91365, to MA, DM, JD, and AB) and a Medical Research Council Career Development Award (G0800329, AM). The authors thank Jerome Sallet, Matthew F Rushworth, Richard N Henson for advice on connectivity analysis; Subhojit Chakraborty with data collection; Stuart Mason for training the animals, and the Oxford Biomedical Sciences Staff for their assistance with the animals.	Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Buckley MJ, 2016, CEREB CORTEX, V26, P2905, DOI 10.1093/cercor/bhw054; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Chao CC, 2015, CEREB CORTEX, V25, P365, DOI 10.1093/cercor/bht230; Cusack R, 2015, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00090; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gerbella M, 2013, CEREB CORTEX, V23, P967, DOI 10.1093/cercor/bhs096; Grayson DS, 2016, NEURON, V91, P453, DOI 10.1016/j.neuron.2016.06.005; Grefkes C, 2014, LANCET NEUROL, V13, P206, DOI 10.1016/S1474-4422(13)70264-3; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hoshi E, 1998, J NEUROPHYSIOL, V80, P3392, DOI 10.1152/jn.1998.80.6.3392; Hutchison RM, 2014, HUM BRAIN MAPP, V35, P5754, DOI 10.1002/hbm.22583; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnen VM, 2015, ELIFE, V4, DOI 10.7554/eLife.04585; Kojima S., 1981, BRAIN RES, V291, P229; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Mantini D, 2011, J NEUROSCI, V31, P12954, DOI 10.1523/JNEUROSCI.2318-11.2011; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; Meng YG, 2016, NEUROBIOL LEARN MEM, V134, P31, DOI 10.1016/j.nlm.2016.04.003; Meyer T, 2011, J NEUROSCI, V31, P6266, DOI 10.1523/JNEUROSCI.6798-10.2011; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell AS, 2007, J NEUROSCI, V27, P11888, DOI 10.1523/JNEUROSCI.1835-07.2007; Mitchell DJ, 2016, J NEUROSCI, V36, P8574, DOI 10.1523/JNEUROSCI.0810-16.2016; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Passingham REP, 2012, NEUROBIOLOGY PREFRON; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Romei V, 2016, CURR BIOL, V26, P2155, DOI 10.1016/j.cub.2016.06.009; Saleem K. S., 2006, COMBINED MRI HISTOLO; Saleem KS, 2014, J COMP NEUROL, V522, P1641, DOI 10.1002/cne.23498; Siegel JS, 2018, CORTEX, V101, P44, DOI 10.1016/j.cortex.2017.12.019; Siegel JS, 2016, P NATL ACAD SCI USA, V113, pE4367, DOI 10.1073/pnas.1521083113; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Takahara D, 2012, EUR J NEUROSCI, V36, P3365, DOI 10.1111/j.1460-9568.2012.08251.x; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; Van Essen DC, 2012, CEREB CORTEX, V22, P2227, DOI 10.1093/cercor/bhr290; Van Essen DC, 2012, NEUROIMAGE, V62, P757, DOI 10.1016/j.neuroimage.2011.10.077; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Yeterian EH, 2012, CORTEX, V48, P58, DOI 10.1016/j.cortex.2011.03.004	46	6	6	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	OCT	2018	119						382	391		10.1016/j.neuropsychologia.2018.08.024			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	HA8MM	WOS:000450543800040	30218841	Green Published, Green Submitted, hybrid			2022-02-06	
J	Estevan, I; Gandia, S; Villarrasa-Sapina, I; Bermejo, JL; Garcia-Masso, X				Estevan, Isaac; Gandia, Sergio; Villarrasa-Sapina, Israel; Luis Bermejo, Jose; Garcia-Masso, Xavier			Working Memory Task Influence in Postural Stability and Cognitive Function in Adolescents	MOTOR CONTROL			English	Article						adolescence; balance; dual task; executive function	DUAL-TASKING; WALKING PERFORMANCE; AGE; CONCUSSION; DIFFICULTY; CHILDHOOD; ATTENTION; DEMANDS; BALANCE; ADULTS	This paper describes a study on postural stability and cognitive function according to the difficulty increment of a working memory task (WMT) and age group in adolescents. One hundred and twenty-three participants (13-16 years) performed single and dual tasks in a bipedal standing position while barefoot. Four trials were conducted, consisting of single and dual tasks in three progressively difficult WMT conditions (i.e., 3-, 5-, and 7-digit sequences). Friedman' s analysis of variance and Kruskal-Wallis tests were conducted to test the effect of the WMT and age group, respectively. Both the WMT and age were found to affect performance (p < .01). As the cognitive requirements increased, the adolescents were not able to maintain their performance in both balance and cognition, while postural control and cognition were found to evolve with age.	[Estevan, Isaac; Garcia-Masso, Xavier] Univ Valencia, Dept Teaching Mus Visual & Corporal Express, Valencia, Spain; [Gandia, Sergio; Villarrasa-Sapina, Israel; Luis Bermejo, Jose] Univ Valencia, Dept Phys Educ & Sport, Valencia, Spain		Estevan, I (corresponding author), Univ Valencia, Dept Teaching Mus Visual & Corporal Express, Valencia, Spain.	isaac.estevan@uv.es	Estevan, Isaac/AAG-4285-2021; Garcia-Masso, Xavier/L-8222-2014; Villarrasa-Sapina, Israel/P-9427-2019	Estevan, Isaac/0000-0003-3748-2288; Villarrasa-Sapina, Israel/0000-0002-2831-1033; Garcia-Masso, Xavier/0000-0002-5925-4537			Abernethy B, 1993, HDB RES SPORT PSYCHO, P125; Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; BUCHANAN CM, 1992, PSYCHOL BULL, V111, P62, DOI 10.1037/0033-2909.111.1.62; Bustillo-Casero P, 2017, HUM MOVEMENT SCI, V55, P8, DOI 10.1016/j.humov.2017.07.004; Cabeza-Ruiz R, 2011, GAIT POSTURE, V33, P23, DOI 10.1016/j.gaitpost.2010.09.014; Dault MC, 2001, GAIT POSTURE, V14, P110, DOI 10.1016/S0966-6362(01)00113-8; Fraizer EV, 2008, GAIT POSTURE, V27, P271, DOI 10.1016/j.gaitpost.2007.04.002; Gabbett T, 2011, J SPORT SCI, V29, P7, DOI 10.1080/02640414.2010.514280; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Kuczmarski RJ., 2002, ADV DATA, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Larsen LR, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-144; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Mickle KJ, 2011, J SCI MED SPORT, V14, P243, DOI 10.1016/j.jsams.2010.11.002; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Palluel E, 2010, BRAIN RES, V1358, P151, DOI 10.1016/j.brainres.2010.08.051; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Remaud A, 2012, J MOTOR BEHAV, V44, P329, DOI 10.1080/00222895.2012.708680; Ruffieux J, 2015, SPORTS MED, V45, P1739, DOI 10.1007/s40279-015-0369-9; Saxena S, 2017, INT J DEV NEUROSCI, V58, P35, DOI 10.1016/j.ijdevneu.2017.01.012; Schaefer S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01167; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Wollesen B, 2016, NEUROSCIENCE, V318, P166, DOI 10.1016/j.neuroscience.2016.01.031; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yeh TT, 2015, HUM MOVEMENT SCI, V44, P134, DOI 10.1016/j.humov.2015.08.021	28	6	6	0	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1087-1640	1543-2696		MOTOR CONTROL	Motor Control	OCT	2018	22	4					425	435		10.1123/mc.2017-0063			11	Neurosciences; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Sport Sciences	HE5CR	WOS:000453389700004	29486627				2022-02-06	
J	Ho, RA; Hall, GB; Noseworthy, MD; DeMatteo, C				Ho, Rachelle A.; Hall, Geoffrey B.; Noseworthy, Michael D.; DeMatteo, Carol			An Emotional Go/No-Go fMRI study in adolescents with depressive symptoms following concussion	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Concussion; Pediatric; MRI; Executive function; Depression; mTBI	SELF-REPORTED CONCUSSIONS; COGNITIVE CONTROL; RESPONSE-INHIBITION; EXECUTIVE CONTROL; BRAIN; PERFORMANCE; ACTIVATION; ATTENTION; ANXIETY; ROBUST	Background: Following concussion, adolescents may experience both poor inhibitory control and increased depressive symptoms. fMRI research suggests that adolescents with major depressive disorder have abnormal physiological responses in the frontostriatal pathway, and exhibit poorer inhibitory control in the presence of negatively-aroused images. The scarcity of information surrounding depression following concussion in adolescents makes it difficult to identify patients at risk of depression after injury. This is the first study to examine neural activity patterns in adolescents with post-concussive depressive symptoms. Purpose: To explore the effect of depressive symptoms on inhibitory control in adolescents with concussion in the presence of emotional stimuli using fMRI. Methods: Using a prospective cohort design, 30 adolescents diagnosed with concussion between 10 and 17 years were recruited. The Children's Depression Inventory questionnaire was used to divide participants into two groups: average or elevated levels of depressive symptoms. Participants completed an Emotional Go/No-Go task involving angry or neutral faces in a 3Telsa MRI scanner. Results: Eleven participants had elevated depressive symptoms, of which 72% were hit in the occipital region of the head at the time of injury. fMRI results from the Emotional Go/No-Go task revealed activity patterns in the overall sample. Faces activated regions associated with both facial and cognitive processing. However, frontal regions that are usually associated with inhibitory control were not activated. Adolescents with elevated levels of depressive symptoms engaged more frontal lobe regions during the task than the average group. They also showed a trend towards worse symptoms following MRI scanning. Conclusions: Adolescents with elevated depressive symptoms engaged brain regions subserving evaluative processing of social interactions. This finding provides insight into the role the environment plays in contributing to the cognitive demands placed on adolescents recovering from concussion.	[Ho, Rachelle A.; DeMatteo, Carol] McMaster Univ, Rehabil Sci, 1400 Main St West, Hamilton, ON L8S 1C7, Canada; [Hall, Geoffrey B.] McMaster Univ, Psychol Neurosci & Behav, 1280 Main St West, Hamilton, ON L8S 4L8, Canada; [Noseworthy, Michael D.] McMaster Univ, Elect & Comp Engn, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Ho, Rachelle A.] McMaster Univ, Dept Psychol Neurosci & Behav, Psychol Bldg,Room 201,1280 Main St West, Hamilton, ON L8S 4K1, Canada		Ho, RA (corresponding author), McMaster Univ, Rehabil Sci, 1400 Main St West, Hamilton, ON L8S 1C7, Canada.; Ho, RA (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Psychol Bldg,Room 201,1280 Main St West, Hamilton, ON L8S 4K1, Canada.	homr@mcmaster.ca; hallg@mcmaster.ca; nosewor@mcmaster.ca; dematteo@mcmaster.ca	; Noseworthy, Michael/B-2957-2011	/0000-0002-3398-6692; Noseworthy, Michael/0000-0003-1464-159X	Canadian institute of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 133527]	This work was financially supported by the Canadian institute of Health Research (MOP 133527).	Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Billette J, 2011, STAT CANADA CAT, V82, P1; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Colich NL, 2016, J CLIN CHILD ADOLESC, V45, P21, DOI 10.1080/15374416.2014.982281; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; Derakshan N, 2009, PSYCHON B REV, V16, P1112, DOI 10.3758/PBR.16.6.1112; Dichter GS, 2009, J AFFECT DISORDERS, V114, P131, DOI 10.1016/j.jad.2008.06.027; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Durston S, 2002, DEVELOPMENTAL SCI, V5, pF9, DOI 10.1111/1467-7687.00235; Erickson K, 2005, AM J PSYCHIAT, V162, P2171, DOI 10.1176/appi.ajp.162.11.2171; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P490, DOI 10.1002/hbm.20414; Furman DJ, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-11; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Haarasilta L, 2001, PSYCHOL MED, V31, P1169, DOI 10.1017/S0033291701004573; Harrison A, 2010, PSYCHOL MED, V40, P1887, DOI 10.1017/S0033291710000036; Harvey PO, 2005, NEUROIMAGE, V26, P860, DOI 10.1016/j.neuroimage.2005.02.048; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Jansma J. M, 1985, J COGNITIVE NEUROSCI, V13, P730; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Karr JE, 2014, J CLIN EXP NEUROPSYC, V36, P15, DOI 10.1080/13803395.2013.863833; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kovacs M., 2011, CHILDRENS DEPRESSION; Lamm C, 2012, BRAIN COGNITION, V79, P181, DOI 10.1016/j.bandc.2012.02.013; Langenecker SA, 2007, BIOL PSYCHIAT, V62, P1272, DOI 10.1016/j.biopsych.2007.02.019; Levitin DJ, 2003, NEUROIMAGE, V18, P74, DOI 10.1006/nimg.2002.1297; Lim J, 2013, INT PSYCHOGERIATR, V25, P1543, DOI 10.1017/S1041610213000689; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Luo Y, 2014, HUM BRAIN MAPP, V35, P5606, DOI 10.1002/hbm.22573; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Nilsson J, 2016, ACTA PSYCHIAT SCAND, V134, P73, DOI 10.1111/acps.12570; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Portas CM, 1998, J NEUROSCI, V18, P8979; Rao Uma, 2009, Dialogues Clin Neurosci, V11, P45; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Richardson LP, 2010, ACAD PEDIATR, V10, P36, DOI 10.1016/j.acap.2009.09.011; Rogers MA, 1998, BRAIN RES BULL, V47, P297, DOI 10.1016/S0361-9230(98)00126-9; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; Shah PJ, 2002, BRIT J PSYCHIAT, V180, P434, DOI 10.1192/bjp.180.5.434; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Tavitian LR, 2014, EUR CHILD ADOLES PSY, V23, P659, DOI 10.1007/s00787-013-0492-9; Tlustos SJ, 2015, J PEDIATR REHAB MED, V8, P321, DOI 10.3233/PRM-150350; van der Heiden L, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00247; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	77	6	7	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		62	73		10.1016/j.ijpsycho.2017.09.021			12	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000009	28986325				2022-02-06	
J	Iaccarino, MA; Fitzgerald, M; Pulli, A; Woodworth, KY; Spencer, TJ; Zafonte, R; Biederman, J				Iaccarino, Mary A.; Fitzgerald, Maura; Pulli, Alexa; Woodworth, K. Yvonne; Spencer, Thomas J.; Zafonte, Ross; Biederman, Joseph			Sport concussion and attention deficit hyperactivity disorder in student athletes: A cohort study	NEUROLOGY-CLINICAL PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; DEFICIT/HYPERACTIVITY DISORDER; UNITED-STATES; ADHD; CHILDREN; ADOLESCENTS; PREVALENCE; IMPACT; GIRLS	BackgroundAttention deficit hyperactivity disorder (ADHD) is associated with impulsive behavior and inattention, making it a potential risk factor for sport-related concussion (SRC). The objectives of this study were to determine whether ADHD is an antecedent risk factor for SRC and whether ADHD complicates recovery from SRC in youth athletes.MethodsStudent athletes with a history of SRC were evaluated for the presence of ADHD using diagnostic interview and to determine whether ADHD symptoms began before or after SRC. Concussion-specific measures of concussive symptoms and cognitive function were compared in SRC + ADHD and SRC + No ADHD groups to assess SRC recovery between groups.ResultsADHD was overrepresented in youth with SRC compared with population rates. ADHD was found to be an antecedent risk factor for SRC, with age at ADHD onset earlier than the date of SRC. Student athletes with SRC and ADHD reported more concussive symptoms compared with athletes without ADHD and were more likely to have a history of greater than one concussion.ConclusionsThe results of this study support our hypothesis that ADHD is an antecedent risk factor for SRC and may contribute to a more complicated course of recovery from SRC. Future research should focus on determining whether screening, diagnosis, and treating ADHD in youth athletes may prevent SRC. Providers that care for youth athletes with ADHD should be aware of the vulnerabilities of this population toward SRC and its complications.	[Iaccarino, Mary A.; Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Zafonte, Ross] Brigham & Womens Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Fitzgerald, Maura; Pulli, Alexa; Woodworth, K. Yvonne; Spencer, Thomas J.; Biederman, Joseph] Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychopharmacol & Adul, Boston, MA 02114 USA; [Spencer, Thomas J.; Biederman, Joseph] Harvard Med Sch, Dept Psychiat, Boston, MA USA		Iaccarino, MA (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA.	miaccarino@partners.org			MGH Pediatric Psychopharmacology Council	This work was supported by the MGH Pediatric Psychopharmacology Council. The funding source had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Abrams J, 2018, J NERV MENT DIS, V206, P739, DOI 10.1097/NMD.0000000000000870; Association AP, 2000, DIAGN STAT MAN MENT; Balazs J, 2014, EUR CHILD ADOLES PSY, V23, P393, DOI 10.1007/s00787-013-0514-7; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Biederman J, 1999, J AM ACAD CHILD PSY, V38, P966, DOI 10.1097/00004583-199908000-00012; Biederman J, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11870; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Centers for Disease Control and Prevention, DAT STAT CHILDR ADHD; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Farace E, 2000, Neurosurg Focus, V8, pe6; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gioia G.A., 2000, BRIEF BEHAV RATING I; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hong SB, 2014, EUR CHILD ADOLES PSY, V23, P627, DOI 10.1007/s00787-013-0501-z; Iaccarino MA, 2018, J ATTEN DISORD; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2016, J ATTEN DISORD; Iverson GL, 2006, BRAIN INJURY MED PRI, P373; Kang JH, 2013, ACTA PAEDIATR, V102, P640, DOI 10.1111/apa.12213; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Orvaschel H, 1994, SCHEDULE AFFECTIVE D; PELHAM WE, 1990, J CONSULT CLIN PSYCH, V58, P130, DOI 10.1037/0022-006X.58.1.130; Puig-Antich J., 1987, SCHEDULE AFFECTIVE D; Roth RM, 2005, BRIEF A BEHAV RATING; Sabo D, 2008, GO OUT PLAY YOUTH SP; Seidman LJ, 2005, DEV NEUROPSYCHOL, V27, P79, DOI 10.1207/s15326942dn2701_4; Shanahan MA, 2006, J ABNORM CHILD PSYCH, V34, P585, DOI 10.1007/s10802-006-9037-8; Storebo OJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009885.pub2; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	40	6	6	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0402	2163-0933		NEUROL-CLIN PRACT	Neurol.-Clin. Pract.	OCT	2018	8	5					403	411		10.1212/CPJ.0000000000000525			9	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HI8ZJ	WOS:000456744200015	30564494	Green Published			2022-02-06	
J	Kim, H; Lee, SB; Son, Y; Czosnyka, M; Kim, DJ				Kim, Hakseung; Lee, Seung-Bo; Son, Yunsik; Czosnyka, Marek; Kim, Dong-Joo			Hemodynamic Instability and Cardiovascular Events After Traumatic Brain Injury Predict Outcome After Artifact Removal With Deep Belief Network Analysis	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						arterial pressure; brain injuries; traumatic; machine-learning; signal processing; computer-assisted	IMPACT; HYPERTENSION; HYPOTENSION; PRESSURE; CHILDREN; TIME	Background:Hemodynamic instability and cardiovascular events heavily affect the prognosis of traumatic brain injury. Physiological signals are monitored to detect these events. However, the signals are often riddled with faulty readings, which jeopardize the reliability of the clinical parameters obtained from the signals. A machine-learning model for the elimination of artifactual events shows promising results for improving signal quality. However, the actual impact of the improvements on the performance of the clinical parameters after the elimination of the artifacts is not well studied.Materials and Methods:The arterial blood pressure of 99 subjects with traumatic brain injury was continuously measured for 5 consecutive days, beginning on the day of admission. The machine-learning deep belief network was constructed to automatically identify and remove false incidences of hypotension, hypertension, bradycardia, tachycardia, and alterations in cerebral perfusion pressure (CPP).Results:The prevalences of hypotension and tachycardia were significantly reduced by 47.5% and 13.1%, respectively, after suppressing false incidents (P=0.01). Hypotension was particularly effective at predicting outcome favorability and mortality after artifact elimination (P=0.015 and 0.027, respectively). In addition, increased CPP was also statistically significant in predicting outcomes (P=0.02).Conclusions:The prevalence of false incidents due to signal artifacts can be significantly reduced using machine-learning. Some clinical events, such as hypotension and alterations in CPP, gain particularly high predictive capacity for patient outcomes after artifacts are eliminated from physiological signals.	[Kim, Hakseung; Lee, Seung-Bo; Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Son, Yunsik] Dongguk Univ, Dept Comp Engn, Seoul, South Korea; [Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England		Kim, DJ (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul 02841, South Korea.	dongjookim@korea.ac.kr	Kim, Hakseung/AAZ-8626-2021	Kim, Hakseung/0000-0001-5407-293X; czosnyka, marek/0000-0003-2446-8006	Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare [HI17C1790]; MSIP (Ministry of Science, ICT and Future Planning), Korea, under the ITRC (Information Technology Research Center) [IITP-2017-2016-0-00464]	This study was supported by the grants from the Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare (grant number: HI17C1790), and the MSIP (Ministry of Science, ICT and Future Planning), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2017-2016-0-00464) supervised by the IITP (Institute for Information & communications Technology Promotion).	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Bengio, 2012, P ICML WORKSH UNS TR, P17, DOI DOI 10.5555/3045796.3045800; Bernard K, 2012, IEEE T IMAGE PROCESS, V21, P2008, DOI 10.1109/TIP.2011.2175741; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chambrin MC, 2001, CRIT CARE, V5, P184, DOI 10.1186/cc1021; Chen LJ, 2016, CRIT CARE MED, V44, pE456, DOI 10.1097/CCM.0000000000001660; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Dahl GE, 2012, IEEE T AUDIO SPEECH, V20, P30, DOI 10.1109/TASL.2011.2134090; Fei M, 2007, INT C LIF SYST MOD S; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Hinton Geoffrey, 2010, MOMENTUM, V9, P926; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Imhoff M, 2006, ANESTH ANALG, V102, P1525, DOI 10.1213/01.ane.0000204385.01983.61; Imhoff M, 1998, INTENS CARE MED, V24, P1305, DOI 10.1007/s001340050767; Knight BP, 2001, AM J MED, V110, P335, DOI 10.1016/S0002-9343(01)00627-1; Lee HJ, 2016, IEEE T BIO-MED ENG, V63, P2169, DOI 10.1109/TBME.2015.2512278; Li Q, 2012, J ELECTROCARDIOL, V45, P596, DOI 10.1016/j.jelectrocard.2012.07.015; McGhee Beate H, 2002, Crit Care Nurse, V22, P60; McShea M, 2010, IEEE ENG MED BIOL, V29, P18, DOI 10.1109/MEMB.2009.935720; Nizami Shermeen, 2013, IEEE Rev Biomed Eng, V6, P127, DOI 10.1109/RBME.2013.2243724; Rangayyan R. M., 2002, ANN BIOMED ENG, V30, P983; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Sellmann T, 2012, DTSCH ARZTEBL INT, V109, P849, DOI 10.3238/arztebl.2012.0849; Shiozaki T, 2005, CURR HYPERTENS REP, V7, P450, DOI 10.1007/s11906-005-0040-1; Wulsin DF, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036015; Zhang Y, 2008, J BIOMED INFORM, V41, P452, DOI 10.1016/j.jbi.2008.03.011; Zhou X-H, 2009, STAT METHODS DIAGNOS	33	6	6	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2018	30	4					347	353		10.1097/ANA.0000000000000462			7	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	GV0LL	WOS:000445752500010	28991060	Green Submitted			2022-02-06	
J	Malomo, TA; Oyemolade, TA; Adeleye, AO				Malomo, Toluyemi Adefolarin; Oyemolade, Toyin Ayofe; Adeleye, Amos Olufemi			Determinants of Timing of Presentation of Neurotrauma Patients to a Neurosurgical Center in a Developing Country	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Developing country; neurosurgery; neurotrauma; timing of presentation	MORTALITY; INJURIES; TRAUMA	Background: A major goal in neurotrauma management is the prevention of secondary neuronal injuries. This goal is time bound as neurological deficits once established are usually irreversible. Late presentation is the norm in most neurotrauma patients in developing countries. Aims: The aim of the study was to review the timing of presentation of neurotrauma patients and the possible causes of their late presentation for neurosurgical care in our practice. Methods: A cross-sectional study of a 4-month prospective database of neurotrauma patients presenting to the University College Hospital, Ibadan, was done. The participants' biodata, injury characteristics, initial-care details before referral, and information on timing and causes of delay were analyzed. Results: The study subjects included 111 patients, 80.2% (89/111) were males, and 52.8% aged 21-40 years. Head injury (HI), spinal cord injury (SCI), and combined HI and SCI occurred, respectively, in 80.2%, 14.4%, and 5.4%. Road accidents followed by falls were seen in 73.9% and 14.4% (16), respectively. Just 46.8% (52/111) cases presented within 12 h of injury and only 37 (33.3%) within 4 h. Majority, 83.8% (93/111) were referrals from primary care. These referrals were delayed in 81.7% (76/93) of these. The referring health facilities were located intracity with our center in 54%. Other causes of delayed presentation of these study participants included long-distance travel to our center, lack of funds, or a combination of the above factors. Eighty-nine patients (80.2%) were brought in by family members and the remaining minority by passers-by and road safety personnel. Conclusions: Delayed referral from primary care features prominently in timing of presentation of neurotrauma patients in Nigeria. There is a need for collaboration as well as continuing medical education between the neurotrauma specialists and primary care physicians.	[Malomo, Toluyemi Adefolarin; Oyemolade, Toyin Ayofe; Adeleye, Amos Olufemi] Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria; [Adeleye, Amos Olufemi] Univ Ibadan, Div Neurol Surg, Dept Surg, Coll Med, Ibadan, Nigeria		Adeleye, AO (corresponding author), Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria.	femdoy@yahoo.com					Adeleye A O, 2017, Ann Ib Postgrad Med, V15, P34; Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Adeleye Amos Olufemi, 2016, Surg Neurol Int, V7, P54, DOI 10.4103/2152-7806.181905; Adeolu A, 2005, INTERNET J EPIDEMIOL, V2, DOI [10.5580/21d2, DOI 10.5580/21D2]; Basso A, 2001, WORLD J SURG, V25, P1174; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; Forjuoh SN, 1996, SOC SCI MED, V43, P1551, DOI 10.1016/S0277-9536(96)00051-2; Hazen A, 2006, J NATL MED ASSOC, V98, P73; Joshipura MK, 2003, INJURY, V34, P686, DOI 10.1016/S0020-1383(03)00163-3; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Management of Major Depressive Disorder Working Group, 2016, VA DOD CLIN PRACT GU; Mohan D, 2004, NATL MED J INDIA, V17, P63; Nakahara S, 2001, Inj Prev, V7, P242, DOI 10.1136/ip.7.3.242; Nantulya Vinand M, 2003, Inj Control Saf Promot, V10, P13, DOI 10.1076/icsp.10.1.13.14116; Pollack A, 2013, EMERGENCY CARE TRANS, P566; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Solagberu B, 2004, W AFR J MED, V22, P177; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Spaite DW, 2014, ACAD EMERG MED, V21, P818, DOI 10.1111/acem.12411	22	6	6	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT-DEC	2018	9	4					545	550		10.4103/jnrp.jnrp_502_17			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	GS5XO	WOS:000443748500018	30271048	gold, Green Published			2022-02-06	
J	Marcia, L; Moazzez, A; Plurad, DS; Putnam, B; Kim, DY				Marcia, Lobsang; Moazzez, Ashkan; Plurad, David S.; Putnam, Brant; Kim, Dennis Y.			Utility of Repeat Head CT in Patients on Preinjury Antithrombotic Medications	AMERICAN SURGEON			English	Article							TRAUMATIC BRAIN-INJURY; DELAYED INTRACRANIAL HEMORRHAGE; ANTICOAGULATED PATIENTS; CLOPIDOGREL; THERAPY; MILD; RISK; WARFARIN	Presently, there are no standardized guidelines regarding the necessity or timing of repeat head imaging in patients on antithrombotics (antiplatelet agents, warfarin, or novel oral anticoagulants) with suspected traumatic brain injury. This is a two-year single institutional retrospective analysis of patients with suspected traumatic brain injury on antithrombotic medications. Patients with a stable or negative repeat head CT were compared with patients who developed a new bleed or demonstrated progression of intracranial hemorrhage (ICH). Of 110 patients, 55 patients (50%) had a positive initial CT, two patients (1.8%) developed a new bleed after initially normal head CT, and 21 patients (19.1%) demonstrated worsening ICH. Patients with worsening or delayed ICH had a higher median Injury Severity Score (14 vs 5, P < 0.001), higher head/neck and face Abbreviated Injury Severity scores (both P < 0.05), and were more likely to be receiving combination therapy with warfarin and clopidogrel (4.3% vs 0%, P = 0.05). On multivariate analysis, lower face and head/neck Abbreviated Injury Severity scores were associated with a decreased risk for delayed or worsening hemorrhage (odds ratio = 0.21 and 0.46, respectively, P < 0.05). Repeat head CT in patients on a preinjury antithrombotic has a low yield. The use of combination therapy may result in an increased risk for delayed hemorrhage or hemorrhage progression.	[Marcia, Lobsang; Moazzez, Ashkan; Plurad, David S.; Putnam, Brant; Kim, Dennis Y.] Harbor UCLA Med Ctr, Dept Surg, Div Trauma Acute Care Surg Surg Crit Care, 1000 West,Carson St,Box 42, Torrance, CA 90509 USA		Kim, DY (corresponding author), Harbor UCLA Med Ctr, Dept Surg, Div Trauma Acute Care Surg Surg Crit Care, 1000 West,Carson St,Box 42, Torrance, CA 90509 USA.	dekim@dhs.lacounty.gov	Moazzez, Ashkan/AAF-1124-2019	Moazzez, Ashkan/0000-0003-1170-8111			Bhatia S., 2016, ARCH EMERG MED CRIT, V1, P1010; Centers for Disease Control and Prevention, 2015, REPORT C TRAUMATIC B; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Cohn B, 2014, J EMERG MED, V46, P410, DOI 10.1016/j.jemermed.2013.08.107; Farsi Davood, 2017, Bull Emerg Trauma, V5, P110; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2014, AM SURGEON, V80, P43; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Li J, 2012, ANN EMERG MED, V59, P457, DOI 10.1016/j.annemergmed.2012.01.010; Mason S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014324; Matsushima K, 2016, J SURG RES, V205, P186, DOI 10.1016/j.jss.2016.06.042; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Rendell S, 2013, EMERG MED J, V30, P28, DOI 10.1136/emermed-2011-200176; Smith AT, 2017, AM J EMERG MED, V35, P377, DOI DOI 10.1016/j.ajem.2016.08.024; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095	23	6	6	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2018	84	10					1626	1629					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GZ7VV	WOS:000449694500018	30747683				2022-02-06	
J	Nycz, CJ; Meier, TB; Carvalho, P; Meier, G; Fischer, GS				Nycz, Christopher J.; Meier, Tess B.; Carvalho, Paulo; Meier, Gretchen; Fischer, Gregory S.			Design Criteria for Hand Exoskeletons: Measurement of Forces Needed to Assist Finger Extension in Traumatic Brain Injury Patients	IEEE ROBOTICS AND AUTOMATION LETTERS			English	Article						Prosthetics and exoskeletons; physically assistive devices; wearable robots	SPASTICITY; ROTATION; WEAKNESS; STROKE; PART	The development of powered hand orthoses and exoskeletons for treatment of chronic motor deficits due to stroke, traumatic brain injury, and cerebral palsy has been widely explored by the robotics engineering community. The conditions arising from these disorders take several forms and clinical descriptions of the various deficits are at times difficult to interpret for those with limited interaction with patients. With devices commonly designed and evaluated on their ability to aid hand closure, well-known extension deficits that are present among these patients typically receive only secondary consideration by robotic approaches. Quantitative characterization of these extension deficits in a manner that is easily translated into engineering design criteria would greatly benefit device design and evaluation. Here, we measure the externally applied torques required to assist extension of the index finger and thumb of three patients with increased flexor tone in the hand. The average torque required to fully extend a subject's index finger MCP joint ranged from 0.22 - 0.75 N . m and the thumb's MCP from 0.29 - 1.35 N . m. The highest torques were recorded when subjects were asked to volitionally extend their fingers, causing an increase in flexor tone requiring more assistance to overcome than when they were relaxed.	[Nycz, Christopher J.; Meier, Tess B.; Carvalho, Paulo; Fischer, Gregory S.] Worcester Polytech Inst, Automat & Intervent Med Lab, Worcester, MA 01609 USA; [Meier, Gretchen] Pine Bush Phys Therapy, Pine Bush, NY 12566 USA		Nycz, CJ (corresponding author), Worcester Polytech Inst, Automat & Intervent Med Lab, Worcester, MA 01609 USA.	cjnycz@wpi.edu; tbmeier@wpi.edu; pacarvalho@wpi.edu; tbmeier@wpi.edu; gfischer@wpi.edu		Fischer, Gregory/0000-0001-6723-6614; Carvalho, Paulo/0000-0002-1616-2739			[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Arata J, 2013, IEEE INT CONF ROBOT, P3902, DOI 10.1109/ICRA.2013.6631126; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Cempini M, 2015, IEEE-ASME T MECH, V20, P705, DOI 10.1109/TMECH.2014.2315528; Chang LLY, 2008, IEEE T BIO-MED ENG, V55, P1897, DOI 10.1109/TBME.2008.919854; COLEBATCH JG, 1989, BRAIN, V112, P749, DOI 10.1093/brain/112.3.749; Gamage SSHU, 2002, J BIOMECH, V35, P87, DOI 10.1016/S0021-9290(01)00160-9; Gasser BW, 2017, INT C REHAB ROBOT, P1537, DOI 10.1109/ICORR.2017.8009466; HOLLISTER A, 1992, J ORTHOPAED RES, V10, P454, DOI 10.1002/jor.1100100319; Ivanhoe CB, 2004, AM J PHYS MED REHAB, V83, pS3, DOI 10.1097/01.PHM.0000141125.28611.3E; Kamper DG, 2006, ARCH PHYS MED REHAB, V87, P1262, DOI 10.1016/j.apmr.2006.05.013; Kang BB, 2016, IEEE INT CONF ROBOT, P3750, DOI 10.1109/ICRA.2016.7487562; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; Polygerinos P, 2015, ROBOT AUTON SYST, V73, P135, DOI 10.1016/j.robot.2014.08.014; SAHRMANN SA, 1977, ANN NEUROL, V2, P460, DOI 10.1002/ana.410020604; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Stillfried G., 2014, MRI BASED SKELETAL H, P49, DOI DOI 10.1007/978-3-319-03017-3_3; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	18	6	6	1	29	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2377-3766			IEEE ROBOT AUTOM LET	IEEE Robot. Autom. Lett.	OCT	2018	3	4					3285	3292		10.1109/LRA.2018.2852769			8	Robotics	Science Citation Index Expanded (SCI-EXPANDED)	Robotics	GO0LM	WOS:000439621000006					2022-02-06	
J	Sebastiani, A; Greve, F; Golz, C; Forster, CY; Koepsell, H; Thal, SC				Sebastiani, Anne; Greve, Frederik; Goelz, Christina; Foerster, Carola Y.; Koepsell, Hermann; Thal, Serge C.			RS1 (Rsc1A1) deficiency limits cerebral SGLT1 expression and delays brain damage after experimental traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						controlled cortical impact; Na+-D-glucose cotransporter; RS1; Rsc1A1; SGLT1; traumatic brain injury	D-GLUCOSE-COTRANSPORTER; MEMBRANE-ASSOCIATED PROTEIN; ISCHEMIC NEURONAL DAMAGE; RAT-BRAIN; TRANSPORTER SGLT1; HEAD-INJURY; EXOCYTOTIC PATHWAY; FOREBRAIN ISCHEMIA; GENE-EXPRESSION; TIME-COURSE	Acute cerebral lesions are associated with dysregulation of brain glucose homeostasis. Previous studies showed that knockdown of Na+-D-glucose cotransporter SGLT1 impaired outcome after middle cerebral artery occlusion and that widely expressed intracellular RS1 (RSC1A1) is involved in transcriptional and post-translational down-regulation of SGLT1. In the present study, we investigated whether SGLT1 is up-regulated during traumatic brain injury (TBI) and whether removal of RS1 in mice (RS1-KO) influences SGLT1 expression and outcome. Unexpectedly, brain SGLT1 mRNA in RS1-KO was similar to wild-type whereas it was increased in small intestine and decreased in kidney. One day after TBI, SGLT1 mRNA in the ipsilateral cortex was increased 160% in wild-type and 40% in RS1-KO. After RS1 removal lesion volume 1 day after TBI was reduced by 12%, brain edema was reduced by 28%, and motoric disability determined by a beam walking test was improved. In contrast, RS1 removal did neither influence glucose and glycogen accumulation 1 day after TBI nor up-regulation of inflammatory cytokines TNF-alpha, IL-1 beta and IL-6 or microglia activation 1 or 5 days after TBI. The data provide proof of principle that inhibition or down-regulation of SGLT1 by targeting RS1 in brain could be beneficial for early treatment of TBI.	[Sebastiani, Anne; Greve, Frederik; Goelz, Christina; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany; [Foerster, Carola Y.] Univ Wurzburg, Dept Anesthesiol, Wurzburg, Germany; [Koepsell, Hermann] Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Greve, Frederik/0000-0003-4729-4950	German Research Foundation (DFG)German Research Foundation (DFG) [TH1430/3-1]	The authors thank Dana Pieter and Tobias Hirnet for their excellent technical assistance. This work was financially supported by the German Research Foundation (DFG TH1430/3-1). All authors declare that they have no conflict of interest.	Bartnik-Olson Brenda L, 2013, Front Neuroenergetics, V5, P8, DOI 10.3389/fnene.2013.00008; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chintalapati C, 2016, MOL PHARMACOL, V90, P508, DOI 10.1124/mol.116.104521; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Cornford EM, 1996, J NEUROTRAUM, V13, P523, DOI 10.1089/neu.1996.13.523; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DIETRICH WD, 1993, STROKE, V24, P111, DOI 10.1161/01.STR.24.1.111; Dobbins RL, 2015, AM J PHYSIOL-GASTR L, V308, pG946, DOI 10.1152/ajpgi.00286.2014; Elfeber K, 2004, HISTOCHEM CELL BIOL, V121, P201, DOI 10.1007/s00418-004-0633-9; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; Filatova A, 2009, TRAFFIC, V10, P1599, DOI 10.1111/j.1600-0854.2009.00982.x; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Harada S, 2013, BRAIN RES, V1541, P61, DOI 10.1016/j.brainres.2013.09.041; Harada S, 2009, BRAIN RES, V1279, P174, DOI 10.1016/j.brainres.2009.05.014; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Koehler MR, 1996, CYTOGENET CELL GENET, V73, P341, DOI 10.1159/000134371; Koepsell H, 2017, PHARMACOL THERAPEUT, V170, P148, DOI 10.1016/j.pharmthera.2016.10.017; Korn T, 2001, J BIOL CHEM, V276, P45330, DOI 10.1074/jbc.M105975200; Kroiss M, 2006, AM J PHYSIOL-RENAL, V291, pF1201, DOI 10.1152/ajprenal.00067.2006; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lambotte S, 1996, DNA CELL BIOL, V15, P769, DOI 10.1089/dna.1996.15.769; LEE WH, 1993, ENDOCRINOLOGY, V133, P2540, DOI 10.1210/en.133.6.2540; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li PA, 1999, FREE RADICAL BIO MED, V27, P1033, DOI 10.1016/S0891-5849(99)00152-5; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Madunic IV, 2017, PFLUG ARCH EUR J PHY, V469, P1545, DOI 10.1007/s00424-017-2056-1; Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Osswald C, 2005, MOL CELL BIOL, V25, P78, DOI 10.1128/MCB.25.1.78-87.2005; Otori T, 2004, J NEUROTRAUM, V21, P707, DOI 10.1089/0897715041269623; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Pasternak JJ, 2008, MAYO CLIN PROC, V83, P406, DOI 10.4065/83.4.406; Poppe R, 1997, J NEUROCHEM, V69, P84, DOI 10.1046/j.1471-4159.1997.69010084.x; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Sebastiani A, 2017, J NEUROSCI METH, V276, P73, DOI 10.1016/j.jneumeth.2016.11.012; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Urabe T, 1996, J NEUROCHEM, V67, P265; Vemula S, 2009, J PHARMACOL EXP THER, V328, P487, DOI 10.1124/jpet.108.146589; VEYHL M, 1993, J BIOL CHEM, V268, P25041; Veyhl M, 2006, AM J PHYSIOL-RENAL, V291, pF1213, DOI 10.1152/ajprenal.00068.2006; Veyhl-Wichmann M, 2016, MOL PHARMACOL, V89, P118, DOI 10.1124/mol.115.101162; WIDMER H, 1992, J CEREBR BLOOD F MET, V12, P456, DOI 10.1038/jcbfm.1992.63; Wisniewski JR, 2015, J PROTEOME RES, V14, P353, DOI 10.1021/pr500833v; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yamazaki Y, 2015, NEUROSCIENCE, V310, P674, DOI 10.1016/j.neuroscience.2015.10.005; Yamazaki Y, 2017, EUR J PHARMACOL, V799, P103, DOI 10.1016/j.ejphar.2017.02.007; Yamazaki Y, 2012, BRAIN RES, V1489, P113, DOI 10.1016/j.brainres.2012.10.020; Yu AS, 2013, AM J PHYSIOL-CELL PH, V304, pC240, DOI 10.1152/ajpcell.00317.2012; Yu AS, 2010, AM J PHYSIOL-CELL PH, V299, pC1277, DOI 10.1152/ajpcell.00296.2010; Zambrowicz B, 2012, CLIN PHARMACOL THER, V92, P158, DOI 10.1038/clpt.2012.58; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	64	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2018	147	2					190	203		10.1111/jnc.14551			14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GZ5VX	WOS:000449499000005	30022488	Bronze			2022-02-06	
J	Vollavanh, LR; O'Day, KM; Koehling, EM; May, JM; Breedlove, KM; Breedlove, EL; Nauman, EA; Bradney, DA; Goff, JE; Bowman, TG				Vollavanh, Lydia R.; O'Day, Kathleen M.; Koehling, Elizabeth M.; May, James M.; Breedlove, Katherine M.; Breedlove, Evan L.; Nauman, Eric A.; Bradney, Debbie A.; Goff, J. Eric; Bowman, Thomas G.			Effect of Impact Mechanism on Head Accelerations in Men's Lacrosse Athletes	JOURNAL OF APPLIED BIOMECHANICS			English	Article						biomechanics; concussion; sport; accelerometer; gyroscope; telemetry	COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL FOOTBALL; BRAIN-INJURY; PROFESSIONAL FOOTBALL; ICE HOCKEY; CONCUSSION; EPIDEMIOLOGY; MAGNITUDE; EXPOSURES; LOCATION	Quantifying head impacts is a vital component to understanding and preventing head trauma in sport. Our objective was to establish the frequency and magnitude of head impact mechanisms in men's lacrosse athletes. Eleven male lacrosse athletes wore xPatch sensors during activity. Video footage of practices and games was analyzed to verify impacts and code them with impact mechanisms. The authors calculated incidence rates (IRs) per 1000 exposures with corresponding 95% confidence intervals (CIs) and used multivariate analysis of variances to compare the linear (g) and rotational (rad/s(2)) accelerations between mechanisms. A total of 167 head impacts were successfully verified and coded with a mechanism using video footage during 542 total exposures. The highest IR was head to body (IR = 118.08; 95% CI, 89.15-147.01), and the lowest was head to ball (IR = 3.69; 95% CI, 0-8.80) (incidence rate ratio = 32.00; 95% CI, 67.83-130.73). Analysis indicated that impact mechanism failed to significantly alter the combined dependent variables (multivariate F-10,F-306 = 1.79, P = .06, eta(2) = .06, 1-beta = 0.83). While head to head, body to head, and stick to head mechanisms are penalty-inducing offenses in men's lacrosse, head to ground. head to ball, and combination impacts have similar head accelerations. If penalties and rules are created to protect players from traumatic head injury. the authors recommend stricter enforcement.	[Vollavanh, Lydia R.; O'Day, Kathleen M.; Koehling, Elizabeth M.; Bradney, Debbie A.; Bowman, Thomas G.] Univ Lynchburg, Dept Athlet Training, Lynchburg, VA 24501 USA; [May, James M.] Univ Idaho, Athlet Training Programs, Moscow, ID 83843 USA; [Breedlove, Katherine M.] Univ Michigan, Dept Kinesiol, Ann Arbor, MI 48109 USA; [Breedlove, Evan L.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Goff, J. Eric] Lynchburg Coll, Dept Phys, Lynchburg, VA 24501 USA		Bowman, TG (corresponding author), Univ Lynchburg, Dept Athlet Training, Lynchburg, VA 24501 USA.	bowman.t@lynchburg.edu	Bowman, Tom/AAU-6473-2020; Bowman, Thomas/AAA-3036-2020	Bowman, Thomas/0000-0002-0034-2946; Goff, John/0000-0002-1277-2206			Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Bowman TG, 2015, J BIOMECH, V48, P3782, DOI 10.1016/j.jbiomech.2015.08.026; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM, 2016, J BIOMECH, V49, P2838, DOI 10.1016/j.jbiomech.2016.06.030; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Caswell SV, 2002, J ATHL TRAINING, V37, P164; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Dick R, 2007, J ATHL TRAINING, V42, P255; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Erev I, 2010, BEHAV PROCESS, V84, P366, DOI 10.1016/j.beproc.2010.01.008; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Higgins M.J., 2015, J ATHL TRAINING, V50, pS; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Irick E., 2016, STUDENT ATHLETE PART; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Lomax R.G., 2013, INTRO STAT CONCEPTS; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zimmerman D., 2010, 2010 NCAA MENS LACRO	43	6	6	0	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	OCT	2018	34	5					396	402		10.1123/jab.2017-0231			7	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	GX9XI	WOS:000448161700008	29809079				2022-02-06	
J	Sekeres, MJ; Riggs, L; Decker, A; de Medeiros, CB; Bacopulos, A; Skocic, J; Szulc-Lerch, K; Bouffet, E; Levine, B; Grady, CL; Mabbott, DJ; Josselyn, SA; Frankland, PW				Sekeres, Melanie J.; Riggs, Lily; Decker, Alexandra; de Medeiros, Cynthia B.; Bacopulos, Agnes; Skocic, Jovanka; Szulc-Lerch, Kamila; Bouffet, Eric; Levine, Brian; Grady, Cheryl L.; Mabbott, Donald J.; Josselyn, Sheena A.; Frankland, Paul W.			Impaired Recent, but Preserved Remote, Autobiographical Memory in Pediatric Brain Tumor Patients	JOURNAL OF NEUROSCIENCE			English	Article						autobiographical memory; episodic memory; hippocampus; medulloblastoma; neurogenesis; radiotherapy	MEDIAL-TEMPORAL-LOBE; POSTERIOR-FOSSA TUMORS; ADULT HIPPOCAMPAL NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; EPISODIC MEMORY; FUNCTIONAL NEUROANATOMY; CRANIAL RADIATION; SPATIAL MEMORY; TRACE THEORY; CHILDHOOD	Medulloblastomas, the most common malignant brain tumor in children, are typically treated with radiotherapy. Refinement of this treatment has greatly improved survival rates in this patient population. However, radiotherapy also profoundly affects the developing brain and is associated with reduced hippocampal volume and blunted hippocampal neurogenesis. Such hippocampal (as well as extrahippocampal) abnormalities likely contribute to cognitive impairments in this population. While several aspects of memory have been examined in this population, the impact of radiotherapy on autobiographical memory has not previously been evaluated. Here we evaluated autobiographical memory in male and female patients who received radiotherapy for posterior fossa tumors (PFTs), including medulloblastoma, during childhood. Using the Children's Autobiographical Interview, we retrospectively assessed episodic and nonepisodic details for events that either preceded (i.e., remote) or followed (i.e., recent) treatment. For post-treatment events, PFT patients reported fewer episodic details compared with control subjects. For pretreatment events, PFT patients reported equivalent episodic details compared with control subjects. In a range of conditions associated with reduced hippocampal volume (including medial temporal lobe amnesia, mild cognitive impairment, Alzheimer's disease, temporal lobe epilepsy, transient epileptic amnesia, frontal temporal dementia, traumatic brain injury, encephalitis, and aging), loss of episodic details (even in remote memories) accompanies hippocampal volume loss. It is therefore surprising that pretreatment episodic memories in PFT patients with reduced hippocampal volume are retained. We discuss these findings in light of the anterograde and retrograde impact on memory of experimentally suppressing hippocampal neurogenesis in rodents.	[Sekeres, Melanie J.; Riggs, Lily; Decker, Alexandra; de Medeiros, Cynthia B.; Skocic, Jovanka; Szulc-Lerch, Kamila; Bouffet, Eric; Mabbott, Donald J.; Josselyn, Sheena A.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, 686 Bay St, Toronto, ON M5G 1X8, Canada; [Sekeres, Melanie J.; Levine, Brian; Grady, Cheryl L.; Mabbott, Donald J.; Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Psychol, Toronto, ON M5T 1R8, Canada; [Levine, Brian] Univ Toronto, Dept Med Neurol, Toronto, ON M5T 1R8, Canada; [Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Inst Med Sci, Toronto, ON M5T 1R8, Canada; [Josselyn, Sheena A.; Frankland, Paul W.] Univ Toronto, Dept Physiol, Toronto, ON M5T 1R8, Canada; [Grady, Cheryl L.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Josselyn, Sheena A.] Canadian Inst Adv Res, Brain Mind & Consciousness Program, Toronto, ON M5G 1M, Canada; [Frankland, Paul W.] Canadian Inst Adv Res, Child & Brain Dev Program, Toronto, ON M5G 1M1, Canada; [Sekeres, Melanie J.; Bacopulos, Agnes; Levine, Brian; Grady, Cheryl L.] Baycrest, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Sekeres, Melanie J.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76798 USA; [Sekeres, Melanie J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA		Sekeres, MJ (corresponding author), Baylor Univ, Dept Psychol & Neurosci, 101 Bagby Ave, Waco, TX 76706 USA.; Frankland, PW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 686 Bay St, Toronto, ON M5G 0A4, Canada.	melanie_sekeres@baylor.edu; paul.frankland@sickkids.ca	Bouffet, Eric/AAB-8999-2020; Levine, Brian/G-4328-2010; Levine, Brian/O-2725-2019	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Szulc-Lerch, Kamila/0000-0002-4155-5227; Sekeres, Melanie/0000-0002-7952-3175	Canadian Institute of Health Research (CIHR) grants [CIHR MOP-74650, CIHR FDN-143227, CIHR MOP-62963, CIHR MOP-123537]; CIHR postdoctoral fellowshipCanadian Institutes of Health Research (CIHR)	This work was supported by Canadian Institute of Health Research (CIHR) grants to S.A.J. (CIHR MOP-74650), P.W.F. (CIHR FDN-143227), B.L. (CIHR MOP-62963), and D.J.M. (CIHR MOP-123537). P.W.F. is a CIHR Canada Research Chair in Cognitive Neurobiology. S.A.J. is a CIHR Canada Research Chair in Memory Function and Dysfunction. M.J.S. was supported by a CIHR postdoctoral fellowship. We gratefully acknowledge the technical assistance of Leigh Botley, Lyn van Kampen, Kiran Beera, Ruth Weiss, and Tammy Rayner. We thank the two anonymous reviewers for their valuable comments on this manuscript.	Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; Addis DR, 2004, HIPPOCAMPUS, V14, P752, DOI 10.1002/hipo.10215; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Amaral RSC, 2018, NEUROIMAGE, V170, P132, DOI 10.1016/j.neuroimage.2016.10.027; Armstrong GT, 2010, NEURO-ONCOLOGY, V12, P1173, DOI 10.1093/neuonc/noq104; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Bonnici HM, 2018, NEUROPSYCHOLOGIA, V110, P159, DOI 10.1016/j.neuropsychologia.2017.05.014; Bonnici HM, 2012, J NEUROSCI, V32, P16982, DOI 10.1523/JNEUROSCI.2475-12.2012; Brainerd CJ, 2002, CURR DIR PSYCHOL SCI, V11, P164, DOI 10.1111/1467-8721.00192; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Cohen NJ., 1993, MEMORY AMNESIA HIPPO; Cohen NJ, 1997, EXAMINERS MANUAL CHI; CONWAY MA, 1991, J EXP PSYCHOL GEN, V120, P395; Copeland DR, 1999, J CLIN ONCOL, V17, P3476, DOI 10.1200/JCO.1999.17.11.3476; Correa DD, 2004, NEUROLOGY, V62, P548, DOI 10.1212/01.WNL.0000109673.75316.D8; Decker AL, 2017, HIPPOCAMPUS, V27, P1140, DOI 10.1002/hipo.22758; Dede AJO, 2016, P NATL ACAD SCI USA, V113, P13474, DOI 10.1073/pnas.1615864113; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Drew MR, 2010, BEHAV NEUROSCI, V124, P446, DOI 10.1037/a0020081; Ehrstedt C, 2016, EUR J PAEDIATR NEURO, V20, P580, DOI 10.1016/j.ejpn.2016.04.009; Epp JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10838; Esopenko C, 2017, CORTEX, V89, P1, DOI 10.1016/j.cortex.2017.01.007; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Frankland PW, 2016, NEUROPSYCHOPHARMACOL, V41, P382, DOI 10.1038/npp.2015.243; Frankland PW, 2013, TRENDS NEUROSCI, V36, P497, DOI 10.1016/j.tins.2013.05.002; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Gibson E, 2012, CURR OPIN ONCOL, V24, P672, DOI 10.1097/CCO.0b013e3283571a8e; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; Hodgetts CJ, 2017, CORTEX, V94, P1, DOI 10.1016/j.cortex.2017.05.010; Huber JF, 2007, J CHILD NEUROL, V22, P848, DOI 10.1177/0883073807303995; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Irish M, 2014, HUM BRAIN MAPP, V35, P1422, DOI 10.1002/hbm.22263; Kempermann G, 2018, CELL STEM CELL, V23, P25, DOI 10.1016/j.stem.2018.04.004; Langer T, 2002, MED PEDIATR ONCOL, V38, P320, DOI 10.1002/mpo.10055; Lassaletta A, 2015, CHILD NERV SYST, V31, P1877, DOI 10.1007/s00381-015-2829-9; Lee ACH, 2005, NEUROPSYCHOLOGIA, V43, P1, DOI 10.1016/j.neuropsychologia.2004.07.017; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Mabbott DJ, 2005, J CLIN ONCOL, V23, P2256, DOI 10.1200/JCO.2005.01.158; Martinez-Canabal A, 2013, HIPPOCAMPUS, V23, P66, DOI 10.1002/hipo.22054; Miller TD, 2017, BRAIN, V140, P1212, DOI 10.1093/brain/awx070; Milton F, 2010, BRAIN, V133, P1368, DOI 10.1093/brain/awq055; Monahan MC, 2001, ARCH CLIN NEUROPSYCH, V16, P193, DOI 10.1016/S0887-6177(99)00064-5; Monje ML, 2007, ANN NEUROL, V62, P515, DOI 10.1002/ana.21214; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Murphy K, 2008, NEUROPSYCHOLOGIA, V46, P3116, DOI 10.1016/j.neuropsychologia.2008.07.004; Nieman BJ, 2015, INT J RADIAT ONCOL, V93, P882, DOI 10.1016/j.ijrobp.2015.07.2293; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Pennebaker J.W., 2007, DEV PSYCHOMETRIC PRO; Pipitone J, 2014, NEUROIMAGE, V101, P494, DOI 10.1016/j.neuroimage.2014.04.054; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Race E, 2011, J NEUROSCI, V31, P10262, DOI 10.1523/JNEUROSCI.1145-11.2011; Ramaswamy V, 2016, NEURO-ONCOLOGY, V18, P291, DOI 10.1093/neuonc/nou357; Reeves CB, 2006, J PEDIATR PSYCHOL, V31, P272, DOI 10.1093/jpepsy/jsj019; Richards BA, 2017, NEURON, V94, P1071, DOI 10.1016/j.neuron.2017.04.037; Riggs L, 2014, J INT NEUROPSYCH SOC, V20, P168, DOI 10.1017/S135561771300129X; Robin J, 2017, CURR OPIN BEHAV SCI, V17, P114, DOI 10.1016/j.cobeha.2017.07.016; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Romero K, 2012, J MEM LANG, V67, P270, DOI 10.1016/j.jml.2012.05.002; Rosenbaum RS, 2008, J COGNITIVE NEUROSCI, V20, P1490, DOI 10.1162/jocn.2008.20105; Rugg MD, 2013, CURR OPIN NEUROBIOL, V23, P255, DOI 10.1016/j.conb.2012.11.005; Scantlebury N, 2016, NEUROPSYCHOLOGY, V30, P425, DOI 10.1037/neu0000258; Sekeres MJ, 2018, NEUROSCI LETT, V680, P39, DOI 10.1016/j.neulet.2018.05.006; Sekeres MJ, 2017, STUD NEUROSCI, P17, DOI 10.1007/978-3-319-45066-7_2; Sekeres MJ, 2016, LEARN MEMORY, V23, P72, DOI 10.1101/lm.039057.115; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Siffert J, 2000, PEDIATR NEUROSURG, V33, P105, DOI 10.1159/000028985; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; St-Laurent M, 2014, HIPPOCAMPUS, V24, P560, DOI 10.1002/hipo.22249; St-Laurent M, 2009, NEUROPSYCHOLOGIA, V47, P2211, DOI 10.1016/j.neuropsychologia.2009.01.032; Steinvorth S, 2005, NEUROPSYCHOLOGIA, V43, P479, DOI 10.1016/j.neuropsychologia.2005.01.001; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Viskontas IV, 2000, J NEUROSCI, V20, P5853, DOI 10.1523/JNEUROSCI.20-15-05853.2000; Wechsler D., 1997, WECHSLER MEMORY SCAL, V14; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Willoughby KA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00053; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Winterburn JL, 2013, NEUROIMAGE, V74, P254, DOI 10.1016/j.neuroimage.2013.02.003; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158	82	6	6	0	6	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	SEP 19	2018	38	38					8251	8261		10.1523/JNEUROSCI.1056-18.2018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GU0OZ	WOS:000444951900012	30126966	Green Published, Bronze			2022-02-06	
J	Kuperman, P; Granovsky, Y; Granot, M; Bahouth, H; Fadel, S; Hyams, G; Ben Lulu, H; Aspis, O; Salame, R; Begal, J; Hochstein, D; Grunner, S; Honigman, L; Reshef, M; Sprecher, E; Bosak, N; Sterling, M; Yarnitsky, D				Kuperman, Pora; Granovsky, Yelena; Granot, Michal; Bahouth, Hany; Fadel, Shiri; Hyams, Gila; Ben Lulu, Hen; Aspis, Osnat; Salame, Rabia; Begal, Julia; Hochstein, David; Grunner, Shahar; Honigman, Liat; Reshef, Maya; Sprecher, Elliot; Bosak, Noam; Sterling, Michele; Yarnitsky, David			Psychophysic-psychological dichotomy in very early acute mTBI pain A prospective study	NEUROLOGY			English	Article							CHRONIC WHIPLASH; SENSITIZATION; ANXIETY	Objective To characterize the pain-related somatosensory and psychological presentation of very early acute patients with a mild traumatic brain injury (mTBI). Methods Patients with an mTBI participated in a prospective observational study undergoing clinical, psychophysic, and psychological assessment within 72 hours after the accident. Healthy controls underwent similar protocol. Results One hundred acute patients with an mTBI (age 36 +/- 12.5 [SD] years, range 19-67 years, 42 women) and 80 healthy controls (age 43 +/- 14.3 years, range 24-74 years, 40 women) participated. Patients with an mTBI demonstrated a pronociceptive psychophysic response in most tests such as less efficient pressure-pain threshold-conditioned pain modulation (0.19 +/- 0.19 +/-. 09 vs. 0.91 +/-. 10 kg, p < 0.001) and lower temperature needed to elicit a Pain50 response (44.72 +/- 0.26 degrees C vs 46.41 +/- 0.30 degrees C, p < 0.001). Their psychophysic findings correlated with clinical pain measures, e.g., Pain50 temperature and mean head (r = -0.21, p = 0.045) and neck (r = -0.26, p = 0.011) pain. The pain-catastrophizing magnification subscale was the only psychological variable to show a difference from the controls, while no significant correlations were found between any psychological measures and the clinical or psychophysic pain measures. Conclusions There appears to be a dichotomy between somatosensory and psychological findings in the very early acute post-mTBI stage; while the first is altered and is associated with the clinical picture, the second is unchanged. In the context of the ongoing debate on the pathophysiologic nature of the post-mTBI syndrome, our findings support its "physical" basis, free of mental influence, at least in the short time window after the injury.	[Kuperman, Pora; Granovsky, Yelena; Fadel, Shiri; Honigman, Liat; Reshef, Maya] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Granot, Michal] Univ Haifa, Fac Welf & Hlth Sci, Dept Nursing, Haifa, Israel; [Bahouth, Hany; Ben Lulu, Hen] Rambam Hlth Care Campus, TraumaEmergency Surg, Haifa, Israel; [Hyams, Gila] Rambam Hlth Care Campus, Nursing, Haifa, Israel; [Aspis, Osnat] Rambam Hlth Care Campus, ICU, Haifa, Israel; [Salame, Rabia] Rambam Hlth Care Campus, Dept Emergency Med, Haifa, Israel; [Begal, Julia; Hochstein, David; Grunner, Shahar] Rambam Hlth Care Campus, Gen Surg Dept, Haifa, Israel; [Sprecher, Elliot; Bosak, Noam; Yarnitsky, David] Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel; [Yarnitsky, David] Rambam Hlth Care Campus, Fac Med, Haifa, Israel; [Sterling, Michele] Univ Queensland, RECOVER Injury Res Ctr, NHMRC Ctr Res Excellence Rd Traff Injury Recovery, Brisbane, Qld, Australia		Yarnitsky, D (corresponding author), Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel.; Yarnitsky, D (corresponding author), Rambam Hlth Care Campus, Fac Med, Haifa, Israel.	dy@rmc.gov.il		Honigman, Liat/0000-0002-3338-4675; Sterling, Michele/0000-0003-1772-2248	Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0603]; Israeli Science FoundationIsrael Science Foundation [1415/15]	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under award W81XWH-15-1-0603 and the Israeli Science Foundation (grant 1415/15). Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Anderson-Barnes Victoria C, 2010, Continuum (Minneap Minn), V16, P17, DOI 10.1212/01.CON.0000391450.48225.73; Bar-Shalita T, 2015, RES DEV DISABIL, V45-46, P157, DOI 10.1016/j.ridd.2015.07.028; Daenen L, 2014, PAIN PRACT, V14, P588, DOI 10.1111/papr.12113; Davis CG, 2013, J FORENSIC LEG MED, V20, P74, DOI 10.1016/j.jflm.2012.05.004; Fingleton C, 2015, OSTEOARTHR CARTILAGE, V23, P1043, DOI 10.1016/j.joca.2015.02.163; Granot M, 2005, CLIN J PAIN, V21, P439, DOI 10.1097/01.ajp.0000135236.12705.2d; Haneline MT, 2009, J CHIROPR MED, V8, P119, DOI 10.1016/j.jcm.2009.04.001; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; IHLEBAEK C, 2006, NORSK EPIDEMIOLOGI, V16, P119; Kasch H, 2005, EUR J PAIN, V9, P561, DOI 10.1016/j.ejpain.2004.11.011; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Myrtveit SM, 2013, J PSYCHOSOM RES, V74, P393, DOI 10.1016/j.jpsychores.2013.02.004; Sterling M, 2003, PAIN, V106, P481, DOI 10.1016/j.pain.2003.09.013; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Sterling M, 2004, MANUAL THER, V9, P60, DOI 10.1016/j.math.2004.01.006; Sullivan Michael J L, 2002, Pain Res Manag, V7, P68; Van Oosterwijck J, 2013, EUR J PAIN, V17, P299, DOI 10.1002/j.1532-2149.2012.00193.x; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765; Wenzel HG, 2002, J PSYCHOSOM RES, V53, P831, DOI 10.1016/S0022-3999(02)00323-9	19	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 4	2018	91	10					E931	E938		10.1212/WNL.0000000000006120			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HD2UL	WOS:000452366900004	30068635				2022-02-06	
J	Anderson, V; Manikas, V; Babl, FE; Hearps, S; Dooley, J				Anderson, Vicki; Manikas, Vicky; Babl, Franz E.; Hearps, Stephen; Dooley, Julian			Impact of Moderate Exercise on Post-concussive Symptoms and Cognitive Function after Concussion in Children and Adolescents Compared to Healthy Controls	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						child; youth; concussion; recovery; exercise; cognition	POSTCONCUSSIVE SYMPTOMS; REFERRAL CENTER; BRAIN INSULT; AUSTRALIA; SPORTS; RELIABILITY; VICTORIA; INJURY; SAMPLE; RETURN	Resolution of post-concussive symptoms (PCS) is a marker of recovery. However, it is unclear whether subtle impairments re-emerge in the context of increased demands. This study examined the effect of strenuous exercise on clinical symptoms and cognitive efficiency in children and adolescents after PCS resolution following concussion. We recruited concussed children and adolescents (n =30) on presentation to an Emergency Department (ED), and compared them to community-sourced non-injured controls (n =30), matched for age, and cognitive function. At Day 2 post symptom resolution, concussed participants (and controls) completed an exercise protocol, and pre- and post exercise assessments of PCS and computer-based cognitive efficiency. Findings demonstrated that, compared to controls, participants with recent concussion showed an overall reduction in PCS post-exercise (p = 0.048), less impact of exercise on PCS than controls (p = 0.021), and faster reaction times on computer-based cognitive tasks, even where cognitive demands were high (ps <0.05). These results provide preliminary support for the use of moderate exercise for the reduction of concussion post-symptom, as suggested in recent clinical guidelines.	[Anderson, Vicki; Manikas, Vicky; Babl, Franz E.; Hearps, Stephen] Murdoch Childrens Res Inst, Clin Sci Res, Level 4 West, Parkville, Vic 3052, Australia; [Dooley, Julian] Cuyahoga Cty Court Clin, Cleveland, OH USA		Anderson, V (corresponding author), Murdoch Childrens Res Inst, Clin Sci Res, Level 4 West, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Hearps, Stephen/L-6853-2016	Hearps, Stephen/0000-0003-2984-1172	Victorian Government Operational Infrastructure grant; Australian National Health and Medical Research Council Senior Practitioner Fellowship [1079478]; Royal Children's Hospital Foundation	Funding details This study was funded by the Victorian Government Operational Infrastructure grant to the Murdoch Childrens Research Institute. Dr. Anderson is supported by an Australian National Health and Medical Research Council Senior Practitioner Fellowship (1079478). Dr Babl is part funded by a grant from the Royal Children's Hospital Foundation.	Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Audiffren M, 2009, ACTA PSYCHOL, V132, P85, DOI 10.1016/j.actpsy.2009.06.008; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bar-Or O, 1983, PPEDIAT SPORTS MED P; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gioia GA IP, 2000, BEHAV RATING INVENTO; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harriss DJ, 2017, INT J SPORTS MED, V38, P1126, DOI 10.1055/s-0043-124001; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Manikas V, 2017, J NEUROTRAUM, V34, P1932, DOI 10.1089/neu.2016.4762; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; TEASDALE G, 1974, LANCET, V2, P81; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Waters E, 2000, AUST NZ J PUBL HEAL, V24, P207, DOI 10.1111/j.1467-842X.2000.tb00145.x; Wechsler D., 2011, WECHSLER ABBREVIATED; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630; Williams J, 2016, APPL NEUROPSYCH-CHIL, V5, P35, DOI 10.1080/21622965.2014.939271	38	6	6	3	15	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	SEP	2018	39	9					696	703		10.1055/a-0592-7512			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GO9RZ	WOS:000440446200005	30068005				2022-02-06	
J	Archbold, HAP; Rankin, AT; Webb, M; Nicholas, R; Eames, NWA; Wilson, RK; Henderson, LA; Heyes, GJ; Davies, R; Bleakley, CM				Archbold, H. A. P.; Rankin, A. T.; Webb, M.; Nicholas, R.; Eames, N. W. A.; Wilson, R. K.; Henderson, L. A.; Heyes, G. J.; Davies, R.; Bleakley, C. M.			Recurrent injury patterns in adolescent rugby	PHYSICAL THERAPY IN SPORT			English	Article						Rugby; Adolescent; Youth; Recurrent injury	CONSENSUS STATEMENT; PLAYERS; UNION; FOOTBALL; SPORT; TERM; EPIDEMIOLOGY; PREVALENCE; OUTCOMES; RETURN	Objectives: To establish patterns of subsequent injury in U18 rugby, to quantify the burden of within season injury recurrence. Design: Secondary analysis of prospective data. Setting: 28 Schools in Ireland. Participants: 825 male rugby players (aged 15-18 years). Main outcome measures: Subsequent injuries were classified as: new, local or recurrent (same site and type as index injury). All recurrent injuries were sub-grouped by body part and diagnosis. Burden was based on frequency, days lost and injury proportion ratios. Results: A total of 426 injuries were eligible for analysis, of which, 121 were subsequent injuries. The majority of subsequent injuries involved a different body part than their index injury. There were n = 23 cases of within season recurrence. 78% of recurrences occurred within 2 months of return to play. Recurrent injuries comprised 5% of all injuries and their cumulative time loss was 1073 days. Recurrent injury to the ankle ligaments, lumbar muscles and concussions carried the greatest burden. Conclusion: The burden of recurrent injury in U18 rugby is lower than in the professional game. However, this population could benefit from targeted secondary prevention efforts including reconsideration of return-to-play protocols for ankle sprain, lumbar muscles and potentially concussion. (C) 2018 Published by Elsevier Ltd.	[Archbold, H. A. P.; Nicholas, R.; Eames, N. W. A.; Henderson, L. A.; Heyes, G. J.] Royal Victoria Hosp, Belfast, Antrim, North Ireland; [Rankin, A. T.] Sport Northern Ireland, Sports Inst, Belfast, Antrim, North Ireland; [Webb, M.] Ulster Rugby, Belfast, Antrim, North Ireland; [Wilson, R. K.] Musgrave Pk Hosp, Belfast, Antrim, North Ireland; [Davies, R.] Ulster Univ, Coleraine, Londonderry, North Ireland; [Bleakley, C. M.] High Point Univ, High Point, NC USA		Bleakley, CM (corresponding author), High Point Univ, Congdon Sch Hlth Sci, Dept Phys Therapy, 1 Univ Pkwy, High Point, NC 27262 USA.	cbleakle@highpoint.edu		Bleakley, Chris/0000-0001-9032-9691; Davies, Richard/0000-0002-2663-3979	Irish Rugby Football Union; MITRE Trust; Ulster Rugby	Financial support was received by the following institutions: Irish Rugby Football Union, MITRE Trust and Ulster Rugby.	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Archbold HAP, 2017, BRIT J SPORT MED, V51, P600, DOI 10.1136/bjsports-2015-095491; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Doherty C, 2017, BRIT J SPORT MED, V51, P113, DOI 10.1136/bjsports-2016-096178; Finch CF, 2014, BRIT J SPORT MED, V48, P1276, DOI 10.1136/bjsports-2012-091729; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Grauvogel J., 2017, J NEUROSURG-PEDIATR, P1; Gribble PA, 2016, BRIT J SPORT MED, V50, P1496, DOI 10.1136/bjsports-2016-096189; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hamilton GM, 2011, CLIN J SPORT MED, V21, P508, DOI 10.1097/JSM.0b013e31822e8619; Kemp S, 2016, BRIT J SPORT MED, V50, P644, DOI 10.1136/bjsports-2015-095780; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P205, DOI 10.1097/JSM.0b013e318057518f; Palmer-Green DS, 2013, AM J SPORT MED, V41, P749, DOI 10.1177/0363546512473818; Pasanen K, 2017, SCAND J MED SCI SPOR, V27, P643, DOI 10.1111/sms.12818; Podlog L, 2007, PSYCHOL SPORT EXERC, V8, P535, DOI 10.1016/j.psychsport.2006.07.008; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Toohey LA, 2018, SPORTS MED, V48, P2199, DOI 10.1007/s40279-018-0879-3; van Hilst J, 2015, J BACK MUSCULOSKELET, V28, P67, DOI 10.3233/BMR-140491; Van Reijen M, 2016, BRIT J SPORT MED, V50, P1200, DOI 10.1136/bjsports-2015-095290; Welton K. L, 2018, J ORTHOPAEDICS SPORT, V6; Whitehouse T., 2016, J ORTHOPAEDICS SPORT, V4; Williams S, 2017, INT J SPORTS MED, V38, P791, DOI 10.1055/s-0043-114862; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	26	6	6	1	11	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	SEP	2018	33						12	17		10.1016/j.ptsp.2018.06.005			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GV3FZ	WOS:000445981100003	29935429	Green Accepted			2022-02-06	
J	Caravaggio, F; Fervaha, G; Menon, M; Remington, G; Graff-Guerrero, A; Gerretsen, P				Caravaggio, Fernando; Fervaha, Gagan; Menon, Mahesh; Remington, Gary; Graff-Guerrero, Ariel; Gerretsen, Philip			The neural correlates of apathy in schizophrenia: An exploratory investigation	NEUROPSYCHOLOGIA			English	Article						Schizophrenia; Psychosis; Apathy; Avolition; Amotivation; Negative symptoms; Magnetic Resonance Imaging	ANTERIOR CINGULATE CORTEX; VOXEL-BASED MORPHOMETRY; TRAUMATIC BRAIN-INJURY; MOTIVATIONAL DEFICITS; LATERAL HYPOTHALAMUS; PARKINSONS-DISEASE; NEGATIVE SYMPTOMS; VOLUME; D-2; STIMULATION	Background: Motivational deficits represent a core negative symptom in patients with schizophrenia. Previous morphology studies have demonstrated that apathy in patients with schizophrenia is associated with reduced frontal grey matter (GM). We attempted to replicate this previous finding, and explored whether it was distinct from potential associations with a distinct subdomain of negative symptoms, namely Affective Flattening, and GM. Methods: Twenty medicated patients with schizophrenia provided structural T1-weighted images acquired on a 3-Tesla MRI scanner and negative symptoms were evaluated using the Scale for the Assessment of Negative Symptoms. Voxel-based morphometry (VBM) was used to explore the correlations between whole-brain GM and i) Apathy, and ii) Affective Flattening, respectively. Results: Apathy scores were negatively correlated with several GM clusters in frontal regions, including the frontal inferior operculum and the left dorsal anterior cingulate cortex. Only positive correlations with GM clusters were observed for Affective Flattening, particularly in the inferior temporal lobe. Notably, the regions associated with apathy scores were distinct from those associated with Affective Flattening, and these findings remained after controlling for antipsychotic medication dosage. Conclusions: We replicated previous associations between reduced frontal GM and apathy in patients with schizophrenia. Moreover, we demonstrated that these GM associations are distinct from those with Affective Flattening. The present findings set the stage for future larger-scale studies confirming the structural and neurochemical substrates of apathy in schizophrenia.	[Caravaggio, Fernando; Fervaha, Gagan; Remington, Gary; Graff-Guerrero, Ariel; Gerretsen, Philip] Ctr Addict & Mental Hlth, Res Imaging Ctr, 250 Coll St, Toronto, ON M5T 1R8, Canada; [Caravaggio, Fernando; Remington, Gary; Graff-Guerrero, Ariel; Gerretsen, Philip] Univ Toronto, Dept Psychiat, 250 Coll St, Toronto, ON M5T 1R8, Canada; [Fervaha, Gagan] Queens Univ, Sch Med, 80 Barrie St, Kingston, ON K7L 3N6, Canada; [Menon, Mahesh] Univ British Columbia, Dept Psychiat, Detwiller Pavil,2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada		Graff-Guerrero, A (corresponding author), Ctr Addict & Mental Hlth, 80 Workman Way,6th Floor, Toronto, ON M6J 1H4, Canada.	gagan.fervaha@utoronto.ca; Ariel.Graff@camh.ca					Andreasen N.C., 1989, BR J PSYCHIAT; Andreasen N.C., 1984, SCALE ASSESSMENT POS; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Caravaggio F, 2014, NEUROPSYCHOPHARMACOL, V39, P2769, DOI 10.1038/npp.2014.125; Cathomas F, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00241; Baggio HC, 2015, MOVEMENT DISORD, V30, P671, DOI 10.1002/mds.26137; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Chuang JY, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00116; Elston TW, 2017, CELL REP, V19, P2220, DOI 10.1016/j.celrep.2017.05.062; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Farrow TFD, 2005, BRIT J PSYCHIAT, V187, P481, DOI 10.1192/bjp.187.5.481; Fervaha G, 2016, PSYCHOPHARMACOLOGY, V233, P3803, DOI 10.1007/s00213-016-4415-6; Fervaha G, 2015, SCHIZOPHR RES, V169, P423, DOI 10.1016/j.schres.2015.09.012; Fervaha G, 2015, SCHIZOPHR RES, V168, P483, DOI 10.1016/j.schres.2015.07.023; Fervaha G, 2015, SCHIZOPHR RES, V166, P9, DOI 10.1016/j.schres.2015.04.040; Fervaha G, 2015, NEUROPSYCHOPHARMACOL, V40, P1539, DOI 10.1038/npp.2015.3; Fervaha G, 2013, NEUROSCI BIOBEHAV R, V37, P2649, DOI 10.1016/j.neubiorev.2013.09.001; Foussias G, 2010, SCHIZOPHRENIA BULL, V36, P359, DOI 10.1093/schbul/sbn094; Galderisi S, 2015, EUR ARCH PSY CLIN N, V265, P543, DOI 10.1007/s00406-015-0590-4; Gerretsen P, 2014, PSYCHIAT RES, V220, P1084, DOI 10.1016/j.psychres.2014.08.005; Goghari VM, 2010, NEUROSCI BIOBEHAV R, V34, P468, DOI 10.1016/j.neubiorev.2009.09.004; Hart EE, 2017, EUR J NEUROSCI, V46, P1682, DOI 10.1111/ejn.13608; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; HUSTON JP, 1971, PHYSIOL BEHAV, V6, P711, DOI 10.1016/0031-9384(71)90259-9; Kawada R, 2009, PROG NEURO-PSYCHOPH, V33, P1255, DOI 10.1016/j.pnpbp.2009.07.014; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kiang M, 2003, SCHIZOPHR RES, V63, P79, DOI 10.1016/S0920-9964(02)00433-4; Kim J, 2003, SCHIZOPHR RES, V60, P173, DOI 10.1016/S0920-9964(02)00299-2; Konstantakopoulos G, 2011, SCHIZOPHR RES, V133, P193, DOI 10.1016/j.schres.2011.07.003; Kos C, 2016, NEUROSCI BIOBEHAV R, V69, P381, DOI 10.1016/j.neubiorev.2016.08.012; Krack Paul, 2015, Lancet Neurol, V14, P465, DOI 10.1016/S1474-4422(15)00031-9; Larson EB, 2015, J NEUROSCI, V35, P3537, DOI 10.1523/JNEUROSCI.1524-14.2015; Le Heron C, 2017, NEUROPSYCHOLOGIA; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Messinger JW, 2011, CLIN PSYCHOL REV, V31, P161, DOI 10.1016/j.cpr.2010.09.002; Morch-Johnsen L, 2015, SCHIZOPHR RES, V164, P59, DOI 10.1016/j.schres.2015.03.001; Pipitone J, 2014, NEUROIMAGE, V101, P494, DOI 10.1016/j.neuroimage.2014.04.054; Roth RM, 2004, AM J PSYCHIAT, V161, P157, DOI 10.1176/appi.ajp.161.1.157; Roth RM, 2016, J NEUROPSYCH CLIN N, V28, P191, DOI 10.1176/appi.neuropsych.15100241; Sallet J, 2011, NEURAL BASIS OF MOTIVATIONAL AND COGNITIVE CONTROL, P5; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Starkstein SE, 2008, J NEUROL NEUROSUR PS, V79, P1088, DOI 10.1136/jnnp.2007.136895; Strauss GP, 2013, J PSYCHIATR RES, V47, P783, DOI 10.1016/j.jpsychires.2013.01.015; Takayanagi Y, 2013, J NEUROPSYCH CLIN N, V25, P292, DOI 10.1176/appi.neuropsych.12040093; Verhoeff NPLG, 2003, PHARMACOL BIOCHEM BE, V74, P425, DOI 10.1016/S0091-3057(02)01028-6; Voruganti L, 2001, NEUROPSYCHOPHARMACOL, V25, P642, DOI 10.1016/S0893-133X(01)00263-9; Voruganti LNP, 2006, SCHIZOPHR RES, V88, P179, DOI 10.1016/j.schres.2006.07.012; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009	52	6	6	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	SEP	2018	118		B				34	39		10.1016/j.neuropsychologia.2017.10.027			6	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	HA8LN	WOS:000450541000005	29079398				2022-02-06	
J	Flaherty, BF; Moore, HE; Riva-Cambrin, J; Bratton, SL				Flaherty, Brian F.; Moore, Hannah E.; Riva-Cambrin, Jay; Bratton, Susan L.			Repeat Head CT for Expectant Management of Traumatic Epidural Hematoma	PEDIATRICS			English	Article							COMPUTED-TOMOGRAPHY; CONSERVATIVE MANAGEMENT; RADIATION-EXPOSURE; PEDIATRIC-PATIENTS; BRAIN-INJURY; EXTRADURAL HEMATOMAS; CHILDREN; RISK; MODERATE; AGE	BACKGROUND AND OBJECTIVES: Guidelines regarding the role of repeated head computed tomography (CT) imaging in the nonoperative management of traumatic epidural hematomas (EDHs) do not exist. Consequently, some children may be exposed to unnecessary additional ionizing radiation. We describe the frequency, timing, and utility of reimaging of EDHs to identify patients who might avoid reimaging. METHODS: A retrospective cohort study of subjects aged 0 to 18 years with a traumatic EDH treated at a level I pediatric trauma center from 2003 to 2014. Radiographic and clinical findings, the frequency and timing of reimaging, and changes in neurologic status were compared between subjects whose management changed because of a meaningful CT scan and those whose did not. RESULTS: Of the 184 subjects who were analyzed, 19 (10%) had a meaningful CT. There was no difference in the frequency of CT scans between the meaningful CT scan and no meaningful CT groups (median 1 [interquartile range 1-2] in no meaningful CT and median 1 [interquartile range 1-2] in meaningful CT scans; P = .7). Only 7% of repeated CTs changed management. Neurologic status immediately before the repeat scan (odds ratio 45; 95% confidence interval 10-200) and mass effect on the initial CT (odds ratio 4; 95% confidence interval 1.5-13) were associated with a meaningful CT. Reimaging only subjects with concerning pre-CT neurologic findings or mass effect on initial CT would have decreased imaging by 54%. CONCLUSIONS: Reimaging is common, but rarely changes management. Limiting reimaging to patients with concerning neurologic findings or mass effect on initial evaluation could reduce imaging by >50%.	[Flaherty, Brian F.; Bratton, Susan L.] Univ Utah, Dept Pediat, Div Crit Care, 295 Chipeta Way, Salt Lake City, UT 84108 USA; [Moore, Hannah E.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Riva-Cambrin, Jay] Univ Calgary, Dept Clin Neurosci, Sect Neurosurg, Calgary, AB, Canada		Flaherty, BF (corresponding author), Univ Utah, Dept Pediat, Div Crit Care, 295 Chipeta Way, Salt Lake City, UT 84108 USA.	brian.flaherty@hsc.utah.edu	Bratton, Susan L./O-2353-2013; Flaherty, Brian/ABA-2534-2020	Bratton, Susan L./0000-0002-4605-8078; Flaherty, Brian/0000-0002-3486-606X			Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Bata SC, 2014, ANZ J SURG, V84, P438, DOI 10.1111/ans.12582; Bejjani GK, 1996, PEDIATR NEUROSURG, V25, P302, DOI 10.1159/000121144; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; BULLOCK R, 1985, NEUROSURGERY, V16, P602, DOI 10.1227/00006123-198505000-00003; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Duthie G, 2009, BRIT J NEUROSURG, V23, P596, DOI 10.3109/02688690902978157; Flaherty BF, 2017, J PEDIATR SURG, V52, P334, DOI 10.1016/j.jpedsurg.2016.09.005; Flaherty BF, 2013, PEDIATR NEUROSURG, V49, P208, DOI 10.1159/000363143; Hill EP, 2017, J TRAUMA ACUTE CARE, V82, P896, DOI 10.1097/TA.0000000000001406; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Khan MB, 2014, CHILD NERV SYST, V30, P1249, DOI 10.1007/s00381-014-2391-x; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Maggi G, 1998, J Neurosurg Sci, V42, P95; Marion DW, 2006, NEUROSURGERY, V58, P655; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Paiva WS, 2010, ARQ NEURO-PSIQUIAT, V68, P888, DOI 10.1590/S0004-282X2010000600011; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; Slovis TL, 2003, PEDIATRICS, V112, P971, DOI 10.1542/peds.112.4.971; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Teichert JH, 2012, PEDIATR NEUROSURG, V48, P216, DOI 10.1159/000345849; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Xiao B, 2015, J NEUROTRAUM, V32, P487, DOI 10.1089/neu.2013.3297	30	6	7	0	0	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2018	142	3							e20180385	10.1542/peds.2018-0385			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GU9RG	WOS:000445687600034	30154118	Bronze			2022-02-06	
J	Haripriya, GR; Mary, P; Dominic, M; Goyal, R; Sahadevan, A				Haripriya, G. R.; Mary, Preethy; Dominic, Mathew; Goyal, Rashmi; Sahadevan, Ambily			Incidence and Treatment Outcomes of Post Traumatic BPPV in Traumatic Brain Injury Patients	INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY			English	Article						Benign paroxysmal positional vertigo (BPPV); Traumatic brain injury (TBI); Dix-Hallpike maneuver; Epleys maneuver	PAROXYSMAL POSITIONAL VERTIGO; HEAD-INJURY; DIAGNOSIS; MANAGEMENT; DIZZINESS	The aim of this study is to assess the incidence of post traumatic BPPV and evaluate its treatment outcomes in mild and moderate traumatic head injury patients. The study population consisted of 128 patients (89 male:39 female) who were admitted with head and neck injury (Motor Vehicle Accident, Blow to the head, Fall from Height, Whiplash injury) as inpatients in Department of Neurosurgery in Tertiary care hospital in Kerala during a 2 month period from 1st April 2014 to 31st May 2014. The age range was 10-70 years and mean 39.8 with standard deviation 15.5. All cases were evaluated and serially followed up to a period of 6 months in Department of Otorhinolaryngology. In our study, the number of patients with mild injuries (Glasgow coma scale 13-15) were 108 and moderate injury (Glasgow coma scale 9-12) were 20. We found out that post traumatic BPPV was found to be 17% of the traumatic brain injury patients. All patients were treated with particle re-positioning maneuvers and were followed up for a period of 6 months. Recurrence were reported in 9 (40.9%) patients. In these patients re positioning maneuvers were repeated.	[Haripriya, G. R.] Chirayu Med Coll & Hosp, Bhopal, MP, India; [Mary, Preethy; Dominic, Mathew; Sahadevan, Ambily] Med Trust Hosp, Kochi, Kerala, India; [Goyal, Rashmi] Mahaveer Inst Med Sci, Bhopal, MP, India		Haripriya, GR (corresponding author), Chirayu Med Coll & Hosp, Bhopal, MP, India.	itsgrhari@gmail.com; preethymarycharles@gmail.com; mathewmdkent@gmail.com; drrashmi03@gmail.com; ambily.sahadevan@gmail.com	Goyal, Rashmi/AAX-2864-2020				Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; Escher A, 2007, EUR ARCH OTO-RHINO-L, V264, P1239, DOI 10.1007/s00405-007-0337-6; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; KATSARKAS A, 1978, J OTOLARYNGOL, V7, P320; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Mohan D, 2004, NATL MED J INDIA, V17, P63; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Nunez RA, 2000, OTOLARYNG HEAD NECK, V122, P647, DOI 10.1067/mhn.2000.105185; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; White JA, 2005, OTOLARYNG HEAD NECK, V133, P278, DOI 10.1016/j.otohns.2005.03.080	16	6	6	0	3	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	2231-3796	0973-7707		INDIAN J OTOLARYNGOL	Indian J. Otolaryngol. Head Neck Surg.	SEP	2018	70	3					337	341		10.1007/s12070-018-1329-0			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	GT0YQ	WOS:000444180600003	30211085	Green Published			2022-02-06	
J	Iliceto, A; Seiler, RL; Sarkar, K				Iliceto, Alessandro; Seiler, Rachel L.; Sarkar, Korak			Repetitive Transcranial Magnetic Stimulation for Treatment of Depression in a Patient With Severe Traumatic Brain Injury	OCHSNER JOURNAL			English	Article						Brain injuries-traumatic; depression; repetitive transcranial magnetic stimulation	PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; EFFICACY; VALIDITY	Background: Traumatic brain injury (TBI) commonly presents with a constellation of findings, including physical, cognitive, and psychological disturbances. Traditionally, few options have been available for long-term management of mood symptoms for post-TBI patients who are refractory to medications. Repetitive transcranial magnetic stimulation (rTMS) is a promising alternative treatment. Case Report: A 37-year-old male with history of anxiety and bipolar depression incurred a TBI after a 60-foot fall. After his physical recovery, the patient had refractory depression. Eight months after the TBI event, he underwent a 6-week course of rTMS treatment and had a 70.8% improvement in mood symptoms by the end of the therapy as indicated by the Patient Health Questionnaire-9, transitioning from severe to mild depression according to the scoring system. Clinical correlation during the months following conclusion of rTMS therapy showed no signs of remission or adverse side effects. The patient remains stable and lives independently 1 year after treatment with mood-stabilizing medications. Conclusion: This case provides evidence for successful treatment of refractory depressive symptoms after severe TBI with the addition of rTMS to psychotherapy and mood-stabilizing medications, supporting the safety and tolerability of this novel therapeutic approach. Further studies are needed to validate the contribution of rTMS for management of mood symptoms in patients with TBI.	[Iliceto, Alessandro; Seiler, Rachel L.; Sarkar, Korak] Univ Queensland, Sch Med, Ochsner Clin Sch, New Orleans, LA USA; [Sarkar, Korak] Ochsner Clin Fdn, Dept Neurol, 1514 Jefferson Hwy, New Orleans, LA 70121 USA		Sarkar, K (corresponding author), Ochsner Clin Fdn, Dept Neurol, 1514 Jefferson Hwy, New Orleans, LA 70121 USA.	korak.sarkar@ochsner.org	Iliceto, Alessandro/AAX-6266-2021				Chisari C, 2014, ARCH ITAL BIOL, V152, P247, DOI 10.12871/00039829201445; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; GEORGE MS, 1995, NEUROREPORT, V6, P1853, DOI 10.1097/00001756-199510020-00008; Klein E, 1999, ARCH GEN PSYCHIAT, V56, P315, DOI 10.1001/archpsyc.56.4.315; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee JC, 2012, CURR PHARM DESIGN, V18, P5846; Leggett Laura E, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.15r01807; Liu Y, 2015, J AFFECT DISORDERS, V187, P122, DOI 10.1016/j.jad.2015.07.044; Martin JLR, 2003, BRIT J PSYCHIAT, V182, P480, DOI 10.1192/bjp.182.6.480; Medical Advisory Secretariat, 2004, Ont Health Technol Assess Ser, V4, P1; Nielson DM, 2015, ARCH PHYS MED REHAB, V96, pS138, DOI 10.1016/j.apmr.2014.09.010; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Reti IM, 2015, BRAIN INJURY, V29, P789, DOI 10.3109/02699052.2015.1009168; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rostami R, 2017, CLIN NEUROPHYSIOL, V128, P1961, DOI 10.1016/j.clinph.2017.07.395; Tang MY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/312142; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	22	6	6	1	2	OCHSNER CLINIC	NEW ORLEANS	1514 JEFFERSON HWY, NEW ORLEANS, LA 70121 USA	1524-5012			OCHSNER J	OCHSNER J.	SEP	2018	18	3					264	267		10.31486/toj.17.0075			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	GV0EK	WOS:000445730200018	30275792	Green Published, gold			2022-02-06	
J	Lamontagne, ME; Gargaro, J; Marier-Deschenes, P; Truchon, C; Bayley, MT; Marshall, S; Kagan, C; Briere, A; Swaine, B				Lamontagne, Marie-Eve; Gargaro, Judith; Marier-Deschenes, Pascale; Truchon, Catherine; Bayley, Mark Theodore; Marshall, Shawn; Kagan, Corinne; Briere, Anabele; Swaine, Bonnie			A Survey of Perceived Implementation Gaps for a Clinical Practice Guideline for the Rehabilitation of Adults With Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; implementation; practice guideline; survey	NEEDS	Objective: Appraising current practice is an important prerequisite for implementation of clinical practice guidelines (CPGs). The study objective was to determine the perceived level of implementation, priority, and feasibility of a subset of key CPG recommendations for the rehabilitation of individuals with moderate to severe traumatic brain injury (MSTBI). Methods: Fifty-one teams at acute care and rehabilitation facilities were invited to complete an electronic survey addressing the perceived level of implementation, priority, and feasibility of 109 fundamental and priority recommendations from the CPG-MSTBI. Results: Forty-four clinical teams responded across 2 Canadian provinces. Most of the recommendations were deemed as fully or mostly implemented, while relative gaps in implementation were perceived in recommendations regarding coordination with mental health and addiction providers (>75% of respondents indicated low levels of implementation), Caregivers and Families (26%), and Psychosocial and Adaptation Issues (25%). Priority levels and perceived feasibility were generally high (>60% and >86%, respectively) for recommendations with low levels of implementation. Priority recommendations for implementation were identified for both acute care and rehabilitation settings in Quebec and Ontario. Conclusions: Assessment of clinician perception provides a helpful perspective for implementation. Exploring perceived implementation gaps based on users' needs and expectation should be a part of an implementation process.	[Lamontagne, Marie-Eve; Marier-Deschenes, Pascale] Univ Laval, Fac Med, Dept Readaptat, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada; [Lamontagne, Marie-Eve; Marier-Deschenes, Pascale] CIRRIS, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada; [Gargaro, Judith; Kagan, Corinne] Ontario Neurotrauma Fdn, Toronto, ON, Canada; [Truchon, Catherine; Briere, Anabele] INESSS, Quebec City, PQ, Canada; [Bayley, Mark Theodore] Univ Hlth Network, Brain & Spinal Cord Rehabil Program, Toronto Rehabil Inst, Toronto, ON, Canada; [Bayley, Mark Theodore] Univ Toronto, Fac Med, Toronto, ON, Canada; [Marshall, Shawn] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Marshall, Shawn] Univ Ottawa, Ottawa, ON, Canada; [Swaine, Bonnie] Montreal Metropolitain CRIR, Ctr Rech Interdisciplinaire Readaptat, Montreal, PQ, Canada; [Swaine, Bonnie] Univ Montreal, Montreal, PQ, Canada		Lamontagne, ME (corresponding author), Univ Laval, Fac Med, Dept Readaptat, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada.; Lamontagne, ME (corresponding author), CIRRIS, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada.	Marie-Eve.Lamontagne@fmed.ulaval.ca		Bayley, Mark/0000-0001-7860-9463; Lamontagne, Marie-Eve/0000-0002-3301-7429	Institut national d'excellence en sante et en services sociaux (INESSS); Ontario Neurotrauma Foundation (ONF); INESSS; ONF	The study has been funded through a contract awarded from the Institut national d'excellence en sante et en services sociaux (INESSS) and the Ontario Neurotrauma Foundation (ONF) to M.E.L., B.S., M.B., and S.M. The authors gratefully acknowledge INESSS) and ONF for their support of this project.	Canadian Institutes of Health Research, 2012, GUID KNOWL TRANSL PL; Colquhoun HL, 2012, CAN J OCCUP THER, V79, P120, DOI 10.2182/cjot.2012.79.2.7; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; de Guise E, 2016, CAN J COMMUNITY MENT, V35, P19; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Farley K, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-56; Gagliardi AR, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1533-0; Gagliardi AR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0399-1; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Grant J, 2002, BRIT MED J, V324, P156, DOI 10.1136/bmj.324.7330.156; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; Karsh BT, 2004, QUAL SAF HEALTH CARE, V13, P388, DOI 10.1136/qshc.2004.010322; Kitson AL, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P97; Kochevar LK, 2006, J GEN INTERN MED, V21, pS25, DOI 10.1111/j.1525-1497.2006.00359.x; Lockyer J., 1998, J CONTIN EDUC HEALTH, V18, P190; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Rogers E., 2010, DIFFUSION INNOVATION, V4th	18	6	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					306	316		10.1097/HTR.0000000000000430			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500013	30188460				2022-02-06	
J	Perez, OH; Green, RE; Mochizuki, G				Perez, Olinda Habib; Green, Robin E.; Mochizuki, George			Characterization of Balance Control After Moderate to Severe Traumatic Brain Injury: A Longitudinal Recovery Study	PHYSICAL THERAPY			English	Article							LOWER-LIMB SPASTICITY; TEMPORAL SYNCHRONIZATION; POSTURAL STABILITY; HEALTHY-YOUNG; SWAY; STANCE; ASYMMETRY; INDICATOR; DEFICITS; WEIGHT	Background. Balance impairments after traumatic brain injury (TBI) are common and persist after injury. Postural asymmetries in balance have been reported, but not quantified, across recovery. Objective. The objective of this study was to characterize balance recovery after moderate to severe TBI, with a focus on postural asymmetry. Design. A secondary analysis of prospectively collected data was used in this study. Methods. Data were from 45 participants with moderate to severe TBI. Participants' balance in 2 bipedal stances and 2 unipedal stances was assessed with force plates at approximately 2, 5, and 12 months after injury. Single-visit data from participants who were matched for age and served as healthy controls were collected for visual comparison using 95% confidence intervals. Spatial and temporal center-of-pressure (COP) measures were calculated from force plates in the anteroposterior (AP) and mediolateral (ML) directions. Results. Despite improvements in net ML COP postural sway from 2 to 5 months after injury, there were no changes in AP postural sway across recovery. Postural sway in individuals with TBI was higher than normative values at all time points in both directions. Interlimb synchrony did not change across recovery in either direction. TBI weight-bearing asymmetry was lower than normative values at all time points and did not change across recovery. The characteristics of unipedal stance differed between limbs. Limitations. Sample size was reduced as a result of the inclusion and exclusion criteria; future studies will benefit from a larger sample size. Conclusions. The absence of recovery in ML COP postural sway, interlimb synchrony, and weight-bearing symmetry indicated that reduced ML control may contribute to balance impairments after TBI. These impairments may extend to dynamic balance tasks and may also place individuals with TBI at a higher risk for falls.	[Perez, Olinda Habib; Green, Robin E.; Mochizuki, George] Univ Toronto, Rehabil Sci Inst, 2075 Bayview Ave,Room M6-178, Toronto, ON M4N 3M5, Canada; [Perez, Olinda Habib; Mochizuki, George] Sunnybrook Res Inst, 2075 Bayview Ave,Room M6-178, Toronto, ON M4N 3M5, Canada; [Perez, Olinda Habib; Green, Robin E.; Mochizuki, George] Toronto Rehabil Inst, 2075 Bayview Ave,Room M6-178, Toronto, ON M4N 3M5, Canada; [Green, Robin E.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Mochizuki, George] Univ Toronto, Dept Phys Therapy, 2075 Bayview Ave,Room M6-178, Toronto, ON M4N 3M5, Canada		Mochizuki, G (corresponding author), Univ Toronto, Rehabil Sci Inst, 2075 Bayview Ave,Room M6-178, Toronto, ON M4N 3M5, Canada.; Mochizuki, G (corresponding author), Sunnybrook Res Inst, 2075 Bayview Ave,Room M6-178, Toronto, ON M4N 3M5, Canada.; Mochizuki, G (corresponding author), Toronto Rehabil Inst, 2075 Bayview Ave,Room M6-178, Toronto, ON M4N 3M5, Canada.; Mochizuki, G (corresponding author), Univ Toronto, Dept Phys Therapy, 2075 Bayview Ave,Room M6-178, Toronto, ON M4N 3M5, Canada.	george.mochizuki@sunnybrook.ca		Mochizuki, George/0000-0003-2308-1643; Green, Robin/0000-0001-9451-3963	Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Ontario Innovation Trust; Ministry of Research and InnovationMinistry of Research and Innovation, Ontario; ONF-REPAR; Ontario Student Opportunity Trust Funds; CIHRCanadian Institutes of Health Research (CIHR) [MOP-86704]; PSI [12-43]; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [458054]	Equipment and space were funded with grants from the Canada Foundation for Innovation, Ontario Innovation Trust, and Ministry of Research and Innovation. O. Habib Perez was supported by ONF-REPAR and Ontario Student Opportunity Trust Funds. The Toronto Rehab Traumatic Brain Injury Recovery Study was supported by CIHR (MOP-86704), PSI (12-43), and NSERC (458054). R.E. Green holds a Tier 2 Canada Research Chair in Traumatic Brain Injury and Cognitive Rehabilitation Neuroscience.	[Anonymous], 1995, GAIT POSTURE; Arce FI, 2004, HUM MOVEMENT SCI, V22, P749, DOI 10.1016/j.humov.2003.12.002; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Brauer SG, 2004, HUM MOVEMENT SCI, V23, P489, DOI 10.1016/j.humov.2004.08.020; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; de Kam D, 2016, GAIT POSTURE, V45, P56, DOI 10.1016/j.gaitpost.2016.01.004; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Elias LJ, 1998, NEUROPSYCHOLOGIA, V36, P37, DOI 10.1016/S0028-3932(97)00107-3; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Howe JA, COMMUNITY BALANCE MO; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; Hurvitz EA, 2000, ARCH PHYS MED REHAB, V81, P587, DOI 10.1053/mr.2000.6293; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Jonsson E, 2004, CLIN BIOMECH, V19, P688, DOI 10.1016/j.clinbiomech.2004.04.002; KEENAN MA, 1984, CLIN ORTHOP RELAT R, P165; LeClair K, 1996, CLIN BIOMECH, V11, P176, DOI 10.1016/0268-0033(95)00027-5; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Manor B, 2010, NEUROLOGY, V74, P458, DOI 10.1212/WNL.0b013e3181cef647; Mansfield A, 2015, PHYSIOTHERAPY, V101, P373, DOI 10.1016/j.physio.2015.01.009; Mansfield A, 2012, NEUROREHAB NEURAL RE, V26, P627, DOI 10.1177/1545968311429688; Mansfield A, 2011, CLIN BIOMECH, V26, P312, DOI 10.1016/j.clinbiomech.2010.10.001; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; MITCHELL S, 1995, NEUROSCI LETT, V197, P133, DOI 10.1016/0304-3940(95)11924-L; Mochizuki G, 2005, J NEUROPHYSIOL, V94, P62, DOI 10.1152/jn.01322.2004; NEWTON RA, 1995, BRAIN INJURY, V9, P445, DOI 10.3109/02699059509008204; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Singer JC, 2016, NEUROREHAB NEURAL RE, V30, P626, DOI 10.1177/1545968315613862; Singer JC, 2015, IEEE T NEUR SYS REH, V23, P786, DOI 10.1109/TNSRE.2014.2353636; Singer JC, 2013, CLIN BIOMECH, V28, P921, DOI 10.1016/j.clinbiomech.2013.07.010; Springer Barbara A, 2007, J Geriatr Phys Ther, V30, P8; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; van der Kooij H, 2011, GAIT POSTURE, V34, P19, DOI 10.1016/j.gaitpost.2011.02.025; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Williams GP, 2011, PHYSIOTHER CAN, V63, P58, DOI 10.3138/ptc.2009-53; WINTER DA, 1993, NEUROSCI RES COMMUN, V12, P141; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151	47	6	6	2	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	SEP	2018	98	9					786	795		10.1093/ptj/pzy065			10	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation	GS4AY	WOS:000443574500009	29878265	Bronze			2022-02-06	
J	Rasulic, L; Savic, A; Lepic, M; Puzovic, V; Karaleic, S; Kovacevic, V; Vitosevic, F; Samardzic, M				Rasulic, L.; Savic, A.; Lepic, M.; Puzovic, V.; Karaleic, S.; Kovacevic, V.; Vitosevic, F.; Samardzic, M.			Epidemiological characteristics of surgically treated civilian traumatic brachial plexus injuries in Serbia	ACTA NEUROCHIRURGICA			English	Article						Brachial plexus; Traumatic brachial plexus injury; Epidemiology; Peripheral nerves; Peripheral nerve injury	PERIPHERAL-NERVE INJURIES; VASCULAR TRAUMA; UPPER EXTREMITY; ULNAR NERVE; ARTERIAL INJURY; UPPER-LIMB; DATA-BANK; FOREARM; SURGERY; REPAIR	Background Traumatic brachial plexus injuries are generally severe, and in many cases associated with surrounding tissue injuries, which makes them hard to diagnose at the right time. This paper presents etiological and epidemiological characteristics of surgically treated civilian traumatic brachial plexus injuries. Methods This retrospective study included 68 patients, operated due to the traumatic brachial plexus injuries at Clinic for Neurosurgery, Clinical Center of Serbia, during the 11-year period. Results The vast majority of injured patients were men in full working maturity. In our study, there were seven different etiological factors. The road traffic accidents were the most common-41 (60.3%), while the motorcycle accidents were the most dominant subtype (53.7%) of all road traffic accidents, and also representing 32.4% of all causes of trauma. Supraclavicular elements of the brachial plexus were injured in more than 80% of patients. A total of 49 (72.1%) patients from our study had one or more associated injuries. The most common associated injuries were bone fractures, brain contusions, and vascular injuries. Conclusion Although rare, non-war-related severe brachial plexus injuries represent a group of patients carrying high risk of insufficient functional recovery regardless of treatment modality, or surgical technique. Epidemiological and etiological data are therefore very important to identify the groups in risk and to induce preventive actions aimed at these patients.	[Rasulic, L.; Savic, A.; Lepic, M.; Vitosevic, F.; Samardzic, M.] Univ Belgrade, Sch Med, Belgrade, Serbia; [Rasulic, L.; Savic, A.; Samardzic, M.] Clin Ctr Serbia, Clin Neurosurg, Belgrade, Serbia; [Lepic, M.] Mil Med Acad, Clin Neurosurg, Belgrade, Serbia; [Puzovic, V.] Coll Higher Vocat Studies Sports Acad, Belgrade, Serbia; [Karaleic, S.] Univ Pristina, Fac Sports & Phys Educ, Kosovska Mitrovica, Serbia; [Kovacevic, V.] Clin Ctr Kragujevac, Clin Neurosurg, Kragujevac, Serbia; [Kovacevic, V.] Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia; [Vitosevic, F.] Clin Ctr Serbia, Dept Neuroradiol, Ctr Radiol & MRI, Belgrade, Serbia		Rasulic, L (corresponding author), Univ Belgrade, Sch Med, Belgrade, Serbia.; Rasulic, L (corresponding author), Clin Ctr Serbia, Clin Neurosurg, Belgrade, Serbia.	lukas.rasulic@gmail.com; as1_1@hotmail.com; milanlepic@gmail.com; puzovic.vladimir@gmail.com; drsladjank@gmail.com; vojinkg@gmail.com; filipvitosevic@gmail.com; drmiroslavsamardzic@gmail.com	Lepic, Milan/ABG-4180-2020; , Vladimir/ABD-9448-2021	Kovacevic, Vojin/0000-0001-5767-3095; Lepic, Milan/0000-0003-0060-5336			Akuthota V, 2009, NERVE VASCULAR INJUR; BABAR SMA, 1993, CENT AFR J MED, V39, P120; Barmparas G, 2010, J PEDIATR SURG, V45, P1404, DOI 10.1016/j.jpedsurg.2009.09.017; Bollini CA, 2006, TECHNIQUES REGIONAL, V10, P69; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Dagum A B, 1998, J Hand Ther, V11, P111; Dougherty AL, 2009, INJURY, V40, P772, DOI 10.1016/j.injury.2009.02.014; Eser F, 2009, NEUROL INDIA, V57, P434, DOI 10.4103/0028-3886.55614; EVANS L, 1983, ACCIDENT ANAL PREV, V15, P121, DOI 10.1016/0001-4575(83)90068-4; Faglioni W, 2014, ACTA NEUROCHIR, V156, P1025, DOI 10.1007/s00701-013-1948-x; Fox CJ, 2005, J VASC SURG, V41, P638, DOI 10.1016/j.jvs.2005.01.010; Franco CD, 2008, TECH REG ANESTH PAIN, V12, P134; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Gregory J., 2009, ORTHOP TRAUMA, V23, P420; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Hingson R, 2002, ACCIDENT ANAL PREV, V34, P85, DOI 10.1016/S0001-4575(01)00002-1; Islam SS, 2001, AM J IND MED, V39, P84, DOI 10.1002/1097-0274(200101)39:1<84::AID-AJIM8>3.3.CO;2-K; Jain DKA, 2012, INDIAN J PLAST SURG, V45, P498, DOI 10.4103/0970-0358.105960; JOHNSON SF, 1991, J TRAUMA, V31, P1546, DOI 10.1097/00005373-199111000-00016; Jung HS, 2016, J HAND SURG-ASIAN-PA, V21, P64, DOI 10.1142/S2424835516500090; Keskinen E, 1998, ACCIDENT ANAL PREV, V30, P323, DOI 10.1016/S0001-4575(97)00113-9; Kim DH, 2004, NEUROSURG FOCUS, V16, P1, DOI DOI 10.3171/foc.2004.16.5.4; Kouyoumdjian JA, 2006, MUSCLE NERVE, V34, P785, DOI 10.1002/mus.20624; Lundborg G, 2003, J PERIPHER NERV SYST, V8, P209, DOI 10.1111/j.1085-9489.2003.03027.x; Millesi H, 2006, MICROSURG, V26, P295, DOI 10.1002/micr.20242; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; Payne R, 2017, J NEUROSURG, V126, P979, DOI 10.3171/2016.4.JNS152672; PeekAsa C, 1996, J TRAUMA, V41, P989, DOI 10.1097/00005373-199612000-00008; Pierre-Jerome C, 2010, SURG RADIOL ANAT, V32, P315, DOI 10.1007/s00276-009-0600-1; Puzovic V, 2016, 21 ANN C EUR COLL SP; Puzovic V, 2015, VOJNOSANIT PREGL, V72, P961, DOI 10.2298/VSP140818106P; Rasulic L, 2017, J BRACHIAL PLEX PERI, V12, pE7, DOI 10.1055/s-0037-1606841; Rasulic L, 2017, ACTA NEUROCHIR, V159, P1257, DOI 10.1007/s00701-017-3205-1; Rasulic L, 2017, NEUROSURG REV, V40, P241, DOI 10.1007/s10143-016-0755-2; Rasulic L, 2015, ACTA CLIN CROAT, V54, P19; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; Saadat S, 2011, ULUS TRAVMA ACIL CER, V17, P539, DOI 10.5505/tjtes.2011.75735; SAKELLARIDES H, 1962, J BONE JOINT SURG AM, V44, P140, DOI 10.2106/00004623-196244010-00011; Salehi SH, 2014, BURNS, V40, P300, DOI 10.1016/j.burns.2013.05.019; Samardzic M, 1998, INJURIES DIS PERIPHE; Secer HI, 2007, J NEUROSURG, V107, P776, DOI 10.3171/JNS-07/10/0776; SHAW AD, 1995, INJURY, V26, P515, DOI 10.1016/0020-1383(95)00090-V; Shinar D, 2001, ACCIDENT ANAL PREV, V33, P111, DOI 10.1016/S0001-4575(00)00021-X; Siqueira MG, 2011, ARQ NEURO-PSIQUIAT, V69, P528, DOI 10.1590/S0004-282X2011000400023; Slutsky DJ, 2006, PERIPHERAL NERVE SUR; Stanec S, 1997, INJURY, V28, P463, DOI 10.1016/S0020-1383(97)00086-7; Stenning M, 2005, J BONE JOINT SURG BR, V87B, P1102, DOI 10.1302/0301-620X.87B8.15976; Tan TW, 2011, VASC ENDOVASC SURG, V45, P592, DOI 10.1177/1538574411415125; Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370; Tomsick SD, 2010, SEMIN MUSCULOSKEL R, V14, P379, DOI 10.1055/s-0030-1263254; VISSER PA, 1980, AM J SURG, V140, P596; Voin V, 2017, CUREUS, V9, DOI 10.7759/cureus.1094; Vukmirovic D, 2012, 2011 CENSUS POPULATI	55	6	6	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2018	160	9					1837	1845		10.1007/s00701-018-3640-7			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	GQ7JK	WOS:000441915100023	30056518				2022-02-06	
J	Tarvonen-Schroder, S; Kaljonen, A; Laimi, K				Tarvonen-Schroder, Sinikka; Kaljonen, Anne; Laimi, Katri			Disability in amyotrophic lateral sclerosis compared with traumatic brain injury using the World Health Organization Disability Assessment Schedule 2.0 and the International Classification of Functioning minimal generic set	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						amyotrophic lateral sclerosis; disability; International Classification of Functioning minimal generic set; traumatic brain injury; World Health Organization Disability Assessment Schedule 2.0	QUALITY-OF-LIFE; SPINAL-CORD-INJURY; REPORTED DISABILITY; RETURN; ALS; PARTICIPATION; IMPAIRMENT; VALIDATION; DEPRESSION; DIAGNOSIS	We compared the functioning of two neurological patient groups, amyotrophic lateral sclerosis (ALS) and traumatic brain injury (TBI), using brief and validated International Classification of Functioning (ICF)-based tools. A 12-item World Health Organization Disability Assessment Schedule (WHODAS 2.0) questionnaire was mailed to ALS and TBI patients and their significant others 2 weeks before their appointment at an outpatient clinic of a university hospital. In addition, a neurologist filled in the ICF minimal generic set. Two years after diagnosis, no significant differences between the two diagnosis groups were found in overall functioning or in working ability using either patient or proxy WHODAS or physician-rated minimal generic set. In single items, however, clear differences were found. Patients and significant others rated household activities, mobility, and self-care as more impaired in the group with ALS, and learning, concentrating, and maintaining friendships in the group with TBI. There were no differences between the two diagnosis groups in the WHODAS items emotional functions, engaging in community, relating with strangers, or in working ability. Both brief ICF-based generic scales, WHODAS and the ICF generic set, could show differences between these patient groups with severe disability. The results of this study should promote assessment of disability with WHODAS 2.0 in ALS and TBI.	[Tarvonen-Schroder, Sinikka] Turku Univ Hosp, Dept Rehabil & Brain Trauma, Div Clin Neurosci, POB 52, FI-20521 Turku, Finland; [Laimi, Katri] Turku Univ Hosp, Dept Phys & Rehabil Med, Turku, Finland; [Laimi, Katri] Univ Turku, Turku, Finland; [Kaljonen, Anne] Univ Turku, Dept Biostat, Turku, Finland		Tarvonen-Schroder, S (corresponding author), Turku Univ Hosp, Dept Rehabil & Brain Trauma, Div Clin Neurosci, POB 52, FI-20521 Turku, Finland.	sinikka.tarvonen-schroder@tyks.fi					Abdulla S, 2014, AMYOTROPH LAT SCL FR, V15, P392, DOI 10.3109/21678421.2014.932380; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Ang K, 2015, J PALLIAT CARE, V31, P150, DOI 10.1177/082585971503100304; Bacci ED, 2016, AMYOTROPH LAT SCL FR, V17, P157, DOI 10.3109/21678421.2015.1095930; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROWN WA, 1970, PSYCHOSOM MED, V32, P141, DOI 10.1097/00006842-197003000-00002; Cieza A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-218; de Pedro-Cuesta J, 2011, GAC SANIT, V25, P21, DOI 10.1016/j.gaceta.2011.08.005; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Felgoise SH, 2016, AMYOTROPH LAT SCL FR, V17, P179, DOI 10.3109/21678421.2015.1125499; Gaskin J, 2017, NEUROTOXICOLOGY, V61, P2, DOI 10.1016/j.neuro.2016.05.001; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kioumourtzoglou MA, 2016, AMYOTROPH LAT SCL FR, V17, P548, DOI 10.1080/21678421.2016.1208247; Kubler A, 2005, NEUROREHAB NEURAL RE, V19, P182, DOI 10.1177/1545968305276583; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Laursen B, 2012, DAN MED J, V59; McLeod JE, 2007, J NEUROL SCI, V258, P4, DOI 10.1016/j.jns.2007.03.001; McNaughton D., 2001, AUGMENTATIVE ALTERNA, V17, P179, DOI DOI 10.1080/AAC.17.3.179.195; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Mora JS, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00609; Morley D, 2016, PATIENT-RELAT OUTCOM, V7, P73, DOI 10.2147/PROM.S96822; Ng L, 2012, DISABIL REHABIL, V34, P295, DOI 10.3109/09638288.2011.606345; O'Donnell ML, 2016, J CLIN PSYCHIAT, V77, pE473, DOI 10.4088/JCP.14m09721; Pagnini F, 2013, INT J PSYCHOL, V48, P194, DOI 10.1080/00207594.2012.691977; Rabkin JG, 2015, AMYOTROPH LAT SCL FR, V16, P265, DOI 10.3109/21678421.2014.980428; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shamshiri H, 2016, J NEUROL SCI, V368, P35, DOI 10.1016/j.jns.2016.06.056; Silva AG, 2015, PHYS THER, V95, P1628, DOI 10.2522/ptj.20140323; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Stephens HE, 2016, AMYOTROPH LAT SCL FR, V17, P206, DOI 10.3109/21678421.2015.1131832; Stephens HE, 2016, AMYOTROPH LAT SCL FR, V17, P21, DOI 10.3109/21678421.2015.1074701; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Toft AMH, 2010, J TRAUMA, V69, P26, DOI 10.1097/TA.0b013e3181d3cbf2; Trail M, 2003, J NEUROL SCI, V209, P79, DOI 10.1016/S0022-510X(03)00003-0; Ustun T, 2010, MEASURING HLTH DISAB; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737	46	6	6	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	2018	41	3					224	229		10.1097/MRR.0000000000000292			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GQ7IX	WOS:000441913200006	30095553				2022-02-06	
J	Teferra, K; Tan, XG; Iliopoulos, A; Michopoulos, J; Qidwai, S				Teferra, Kirubel; Tan, X. Gary; Iliopoulos, Athanasios; Michopoulos, John; Qidwai, Siddiq			Effect of human head morphological variability on the mechanical response of blast overpressure loading	INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING			English	Article						blast-induced traumatic brain injury; image registration warping; intersubject head morphology; population-based analysis; uncertainty quantification	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; IMAGE REGISTRATION; ELEMENT; TISSUE; MODEL; ALGORITHMS; SYSTEM	A methodology is introduced to investigate the effect of intersubject head morphological variability on the mechanical response of the brain when subjected to blast overpressure loading. Nonrigid image registration techniques are leveraged to warp a manually segmented template model to an arbitrary number of subjects following a procedure to coarsely segment the subjects in batch. Finite element meshes are autogenerated, and blast analysis is conducted. The template model is initially constructed to enable the full automated implementation and application of the proposed methodology. The application of the proposed approach for an anterior-oriented blast has been demonstrated, and the results reveal that the pressure response in the brain does exhibit some dependence on head morphological variability. While the magnitude of the peak pressure response can vary by more than 30%, its location within the brain is unaffected by head morphological variability. A linear least squares analysis was conducted to demonstrate that the peak magnitude of pressure is uncorrelated with head volume while it is correlated with aspect ratio relating to the amount of exposed surface area to the blast. These features of the pressure response are likely due to the peak pressure occurring during the early stages of stress wave transmission and reflection. As a result, the pressure response due to blast overpressure loading is predominantly loading dependent while morphological variability has a secondary effect.	[Teferra, Kirubel; Tan, X. Gary; Iliopoulos, Athanasios; Michopoulos, John] US Naval Res Lab, Washington, DC 20375 USA; [Qidwai, Siddiq] NSF, Div Civil Mech & Mfg Innovat, Alexandria, VA USA		Teferra, K (corresponding author), US Naval Res Lab, Washington, DC 20375 USA.	kirubel.teferra@nrl.navy.mil			Office of Naval Research (ONR) through the Naval Research Laboratory's Basic Research ProgramOffice of Naval Research; DOD High Performance Computing Modernization Program; National Institute of Biomedical Imaging and BioEngineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Office of Naval Research (ONR) through the Naval Research Laboratory's Basic Research Program; DOD High Performance Computing Modernization Program; National Institute of Biomedical Imaging and BioEngineering	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2012, NEUROIMAGE, V62, P791, DOI 10.1016/j.neuroimage.2011.10.025; Bah MT, 2009, MED ENG PHYS, V31, P1235, DOI 10.1016/j.medengphy.2009.08.001; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2013, APPL IMAGING TECHNIQ, V4, P117; Bischoff JE, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026258; Bonet J, 1998, COMMUN NUMER METH EN, V14, P437, DOI 10.1002/(SICI)1099-0887(199805)14:5<437::AID-CNM162>3.3.CO;2-N; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Bryan R, 2010, MED ENG PHYS, V32, P57, DOI 10.1016/j.medengphy.2009.10.008; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chafi MS, 2011, INT J APPL MECH, V3, P803, DOI 10.1142/S175882511100124X; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Cotton RT, 2015, COMPUTER METHODS BIO, V19, P1; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Dryden I. L., 2016, STAT SHAPE ANAL APPL; Elkhodary, 2013, NONLINEAR FINITE ELE; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goldstein LE, 2012, SCI TRANSL MED, V4; Gordon CC, 2010, NATICKTR13018 ARM NA; Grassi L, 2011, MED ENG PHYS, V33, P112, DOI 10.1016/j.medengphy.2010.09.014; Grujicic M, 2016, INT J STRUCT INTEGR, V7, P516, DOI 10.1108/IJSI-08-2015-0027; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holdeman TC, 2009, PSYCHIAT SERV, V60, P273, DOI 10.1176/appi.ps.60.2.273; Hyde DW, 2004, CONWEP 2 1 0 8 CONVE; Jazi MS, 2016, COMPUT METHOD BIOMEC, V19, P1019, DOI 10.1080/10255842.2015.1088525; Kannan R, 2014, J PARALLEL DISTR COM, V74, P2808, DOI 10.1016/j.jpdc.2014.05.001; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Klein KF, 2015, ANN BIOMED ENG, V43, P2503, DOI 10.1007/s10439-015-1307-6; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Knupp PM, 2003, FINITE ELEM ANAL DES, V39, P217, DOI 10.1016/S0168-874X(02)00070-7; Kozic N, 2010, MED IMAGE ANAL, V14, P265, DOI 10.1016/j.media.2010.02.008; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mott DR, 2014, 52 AER SCI M NAT HAR, P948; Nahum AM, 1977, SAE TECHNICAL PAPER; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Sarvghad-Moghaddam H, 2017, SHOCK WAVES, V27, P919, DOI 10.1007/s00193-017-0749-1; Sarvghad-Moghaddam H, 2017, INT J NUMER METHODS, V33; Sarvghad-Moghaddam H, 2017, COMPUT METHOD BIOMEC, V20, P16, DOI 10.1080/10255842.2016.1193597; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Shields MD, 2015, RELIAB ENG SYST SAFE, V142, P310, DOI 10.1016/j.ress.2015.05.023; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tan X., 2013, ASME 2013 INT MECH E; Tan X.G., 2012, P ASME 2012 INT MECH, P829; Tan XG, 2016, ASME 2016 INT MECH E; Tan XG, SHOCK WAVES; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Ward C., 1980, SAE TECHNICAL PAPER; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Zhang K, 2017, J BIOMECH, V60, P253, DOI 10.1016/j.jbiomech.2017.06.015; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	72	6	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2040-7939	2040-7947		INT J NUMER METH BIO	Int. J. Numer. Meth. Biomed.	SEP	2018	34	9							e3109	10.1002/cnm.3109			18	Engineering, Biomedical; Mathematical & Computational Biology; Mathematics, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematical & Computational Biology; Mathematics	GS9VM	WOS:000444075700006	29804323				2022-02-06	
J	van Dongen, CH; Goossens, PH; van Zee, IE; Verpoort, KN; Vlieland, TPMV; van Velzen, JM				van Dongen, Caroline H.; Goossens, Paulien H.; van Zee, Inge E.; Verpoort, Kirsten N.; Vlieland, Thea P. M. Vliet; van Velzen, Judith M.			Short-Term and Long-Term Outcomes of a Vocational Rehabilitation Program for Patients with Acquired Brain Injury in The Netherlands	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Brain injury; Stroke; Traumatic brain injury; Vocational rehabilitation; Return to work	RANDOMIZED CONTROLLED-TRIAL; RESOURCE FACILITATION; LIFE SATISFACTION; WORK; RETURN; STROKE; EMPLOYMENT; STABILITY	Purpose To describe short-term and long-term work status after a vocational rehabilitation (VR) program in patients with acquired brain injury (ABI) in the Netherlands. Methods Patients with ABI who participated in a VR program between 2007 and 2010 were included in this study. The 4-month VR program included a multidisciplinary assessment, three meetings with all stakeholders and reintegration with coaching on the job. Short-term results at the end of the VR program were based on data extracted from medical records. Long-term results were determined at 3-6 years (mean 4.4 years) after the program based on patient-reported data. Outcome measures included return to work, hours at work and task adjustments. Results Fifty-eight patients were included [mean age 48 (SD 9.4) years; n = 33 male; all working before ABI]. After the intervention, 50 patients (86%) had returned to work, working on average 60% of their former hours. Working tasks were adjusted in 48 patients. At long-term follow-up 28 patients had paid work, working on average 5.3 h more than immediately after the VR program. Conclusions Directly after the intervention 86% of the patients had returned to work. After 3-6 years, 64% of these patients were still working in a paid job.	[van Dongen, Caroline H.; Goossens, Paulien H.; van Zee, Inge E.; Verpoort, Kirsten N.; Vlieland, Thea P. M. Vliet] Rijnlands Rehabil Ctr, POB 176, NL-2300 AD Leiden, Netherlands; [Goossens, Paulien H.; Vlieland, Thea P. M. Vliet] Leiden Univ, Med Ctr, Dept Orthopaed Physiotherapy & Rehabil, Leiden, Netherlands; [van Velzen, Judith M.] Heliomare, Dept Res & Dev, Wijk Aan Zee, Netherlands		van Dongen, CH (corresponding author), Rijnlands Rehabil Ctr, POB 176, NL-2300 AD Leiden, Netherlands.	chd@rrc.nl	Goossens, Paulien/AAR-7065-2021; Vlieland, Thea Vliet/AAJ-8119-2020	Goossens, Paulien/0000-0003-1591-5222; Vlieland, Thea Vliet/0000-0001-6322-3859			[Anonymous], 2012, MULT RICHTL NIET AAN; [Anonymous], DECL HELS ETH PRINC; [Anonymous], 2001, WET VERB POORTW; [Anonymous], 2003, WET VERL LOOND BIJ Z; Baldwin C, 2011, TOP STROKE REHABIL, V18, P562, DOI 10.1310/tsr1805-562; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Gamble D, 2003, J VOCATIONAL REHABIL, V19, P47; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; Kovacs F., 2013, TOWER LONDON TEST MA; Kovacs F., 2012, TEST SUSTAINED SELEC; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; Ntsiea MV, 2015, CLIN REHABIL, V29, P663, DOI 10.1177/0269215514554241; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Possl O, 2001, BRAIN INJURY, V15, P15; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Trexler LE, 2016, ARCH PHYS MED REHAB, V97, P204, DOI 10.1016/j.apmr.2015.09.016; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Westerlind E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169759; WHO, 2002, INT CLASS FUNCT DIS	32	6	6	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	SEP	2018	28	3					523	530		10.1007/s10926-017-9738-6			8	Rehabilitation; Social Issues	Social Science Citation Index (SSCI)	Rehabilitation; Social Issues	GQ7VR	WOS:000441956300011	29139017	Green Published, hybrid			2022-02-06	
J	Yeomans, C; Comyns, TM; Cahalan, R; Warrington, GD; Harrison, AJ; Hayes, K; Lyons, M; Campbell, MJ; Kenny, IC				Yeomans, Caithriona; Comyns, Thomas M.; Cahalan, Roisin; Warrington, Giles D.; Harrison, Andrew J.; Hayes, Kevin; Lyons, Mark; Campbell, Mark J.; Kenny, Ian C.			Current injury monitoring and player education practices in Irish amateur rugby union	PHYSICAL THERAPY IN SPORT			English	Article						Injury; Sport; Prevention; Education	PROFESSIONAL FOOTBALL; RISK-FACTORS; SURVEILLANCE; PREVENTION; CONCUSSION; ADHERENCE; KNOWLEDGE; SOCCER; IMPLEMENTATION; METAANALYSIS	Objectives: To ascertain current injury surveillance and player education practices in Irish amateur rugby union. Design: Cross-sectional survey. Setting: Amateur rugby clubs in Ireland. Participants: Medical professionals and rugby coaches of the top 58 amateur rugby clubs in Ireland. Main outcome measures: The survey investigated the current injury and training load monitoring practices in operation in Irish amateur rugby. It also explored whether player education sessions regarding injury prevention and concussion recognition and management were conducted in these clubs. Results: Forty-four clubs completed the survey, giving an overall response rate of 76%. Ninety-one percent of the responding clubs monitored injuries. Sixty-four percent of these clubs operated return to play protocols for all injuries, while 36% operated return to play protocols for concussion only. Injury prevention education was conducted by 71% of these clubs and 82% educated players on concussion recognition and management. Conclusions: Implementing effective injury monitoring strategies in both amateur and professional sport settings may aid in minimizing injury risk. In Ireland, 91% of the responding clubs monitored injuries and 71% educated players on injury prevention. By implementing one centralized injury surveillance system for Irish amateur rugby, injury trends can be effectively monitored and used to guide prevention strategies. (C) 2018 Elsevier Ltd. All rights reserved.	[Yeomans, Caithriona; Comyns, Thomas M.; Warrington, Giles D.; Harrison, Andrew J.; Lyons, Mark; Campbell, Mark J.; Kenny, Ian C.] Univ Limerick, Dept Phys Educ & Sport Sci, Castletroy, Limerick, Ireland; [Cahalan, Roisin] Univ Limerick, Sch Allied Hlth, Limerick, Ireland; [Cahalan, Roisin; Warrington, Giles D.; Kenny, Ian C.] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [Hayes, Kevin] Univ Limerick, Dept Math & Stat, Limerick, Ireland; [Campbell, Mark J.] Univ Limerick, Irish Software Res Ctr, Lero, Limerick, Ireland		Yeomans, C (corresponding author), Univ Limerick, Dept Phys Educ & Sport Sci, Castletroy, Limerick, Ireland.	caithriona.yeomans@ul.ie	cahalan, Roisin/AAE-9100-2020; Campbell, Mark/C-5116-2012	Yeomans, Caithriona/0000-0003-0220-2530; Campbell, Mark/0000-0001-9607-7675; Harrison, Andrew/0000-0002-5569-4885; cahalan, roisin/0000-0001-6362-3940; Warrington, Giles/0000-0001-6473-3607	Irish Rugby Football Union (IRFU)	This current study was conducted as part of the Irish Rugby Injury Surveillance (IRIS) Project. The IRIS Project is funded by the Irish Rugby Football Union (IRFU).	Barengo NC, 2014, INT J ENV RES PUB HE, V11, P11986, DOI 10.3390/ijerph111111986; Bjorneboe J, 2011, SCAND J MED SCI SPOR, V21, P713, DOI 10.1111/j.1600-0838.2009.01085.x; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Clacy A., 2017, APPL ERGON, DOI 10.1016/J.APERGO.2017.06.010; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; de Visser HM, 2012, BRIT J SPORT MED, V46, P124, DOI 10.1136/bjsports-2011-090317; Donaldson A, 2012, BRIT J SPORT MED, V46, P306, DOI 10.1136/bjsports-2011-090461; Donaldson A, 2012, INT REV SOCIOL SPORT, V47, P743, DOI 10.1177/1012690211422009; Ekegren Christina L, 2014, Inj Epidemiol, V1, P19; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Ekegren CL, 2015, J SCI MED SPORT, V18, P651, DOI 10.1016/j.jsams.2014.11.390; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Finch C. F., 2017, BRIT J SPORTS MED, DOI 10.1136/BJSPORTS-2017-098212; Finch CF, 2016, INJURY PREV, V22, P123, DOI 10.1136/injuryprev-2015-041667; Finch CF, 2012, BRIT J SPORT MED, V46, P70, DOI 10.1136/bjsports-2011-090329; Freitag A, 2015, BRIT J SPORT MED, V49, P511, DOI 10.1136/bjsports-2014-093684; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Gabbett TJ, 2004, J SPORT SCI, V22, P409, DOI 10.1080/02640410310001641638; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hagglund M, 2005, BRIT J SPORT MED, V39, P340, DOI 10.1136/bjsm.2005.018267; Holder Y., 2002, ORGANIZATION; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; McCall A, 2016, BRIT J SPORT MED, V50, P725, DOI 10.1136/bjsports-2015-095259; MCCRORY P, 2017, BRITISH JOURNAL OF S, V1136; Mckay CD, 2014, BRIT J SPORT MED, V48, P1281, DOI 10.1136/bjsports-2014-093543; Orchard JW, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.012732; Orr B, 2013, SCAND J MED SCI SPOR, V23, P271, DOI 10.1111/j.1600-0838.2011.01381.x; Steffen K, 2013, BRIT J SPORT MED, V47, P794, DOI 10.1136/bjsports-2012-091886; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; van Beijsterveldt AMC, 2015, J SCI MED SPORT, V18, P145, DOI 10.1016/j.jsams.2014.02.004; Williams S., 2017, BRIT J SPORTS MED, V51, P410, DOI 10.1136/BJSPORTS-2016-097372.319; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Bank, 2017, AQ POLL OV ISS FOC C AQ POLL OV ISS FOC C, P1; World Rugby, 2018, WORLD RUGBY RANKINGS; Yeomans C., 2018, SPORTS MED, DOI 10.1007/S40279-017-0838-4	38	6	7	0	11	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	SEP	2018	33						27	32		10.1016/j.ptsp.2018.06.008			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GV3FZ	WOS:000445981100006	29982035	Green Submitted			2022-02-06	
J	Zhang, P; Zhu, S; Zhao, M; Zhao, P; Zhao, HY; Deng, JQ; Li, JB				Zhang, Peng; Zhu, Shisheng; Zhao, Minzhu; Zhao, Peng; Zhao, Haiyi; Deng, Jianqiang; Li, Jianbo			Identification of plasma biomarkers for diffuse axonal injury in rats by iTRAQ-coupled LC-MS/MS and bioinformatics analysis	BRAIN RESEARCH BULLETIN			English	Article						Diffuse axonal injury; Proteomics; iTRAQ; Biomarkers Rats	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; HEMOPEXIN; PROTEINS; MODEL; DIAGNOSIS; CELLS	DAI is a serious and complex brain injury associated with significant morbidity and mortality. The lack of reliable objective diagnostic modalities for DAI delays administration of therapeutic interventions. Hence, identifying reliable biomarkers is urgently needed to enable early DAI diagnosis in the clinic. Herein, we established a rat model of DAI and applied an isobaric tags for a relative and absolute quantification (iTRAQ) coupled with nano-liquid chromatography-tandem mass spectrometry (nano-LC-MS/MS) proteomics approach to screen differentially expressed plasma proteins associated with DAI. A total of 58 proteins were found to be significantly modulated in blood plasma samples of the injury group in at least one time point compared to controls. Bioinformatics analysis of the differentially expressed proteins revealed that the pathogenesis of axonal injury underlying DAI is multi-stage biological process involved. Two significantly changed proteins, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and hemopexin (Hpx), were identified as potential diagnostic biomarkers for DAL and were successfully confirmed by further western blot analysis. This proteomic profiling study not only identified novel plasma biomarkers that may facilitate the development of clinically diagnostic for DAI, but also provided enhanced understanding of the molecular mechanisms underlying DAI.	[Zhang, Peng; Deng, Jianqiang] Hainan Med Univ, Dept Forens Med, Haikou 571199, Hainan, Peoples R China; [Zhu, Shisheng] Chongqing Med & Pharmaceut Coll, Fac Med Technol, Chongqing 401331, Peoples R China; [Zhao, Minzhu; Li, Jianbo] Chongqing Med Univ, Dept Forens Med, Fac Basic Med Sci, Chongqing 400016, Peoples R China; [Zhao, Peng] Zunyi Med & Pharmaceut Coll, Fac Basic Med Sci, Zunyi 563006, Peoples R China; [Zhao, Haiyi] Genecreate Biol Engn Co Ltd, Wuhan 430075, Hubei, Peoples R China		Li, JB (corresponding author), Yixueyuan Rd 1, Chongqing 400016, Peoples R China.	ljb2032008@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273344]; Scientific and Technological Research Program of Chongqing Municipal Education Commission [KJ1502703]; Science and Technology Cooperation Projects of Guizhou [2015-7572]	This work was supportedby the National Natural Science Foundation of China (81273344), the Scientific and Technological Research Program of Chongqing Municipal Education Commission (KJ1502703) and the Science and Technology Cooperation Projects of Guizhou (2015-7572).	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Cheow ESH, 2018, J PROTEOME RES, V17, P499, DOI 10.1021/acs.jproteome.7b00651; Cominetti O, 2016, J PROTEOME RES, V15, P389, DOI 10.1021/acs.jproteome.5b00901; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Dong BB, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-58; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Furtado Andre, 2013, CAFFEYS PEDIAT DIAGN, P417; Garland P, 2016, STROKE, V47, P872, DOI 10.1161/STROKEAHA.115.011956; Hahl P, 2013, J NEUROCHEM, V125, P89, DOI 10.1111/jnc.12165; Jia XX, 2012, J TRAUMA ACUTE CARE, V73, P1168, DOI 10.1097/TA.0b013e318246eaf4; Kapojos JJ, 2003, KIDNEY INT, V63, P1681, DOI 10.1046/j.1523-1755.2003.00907.x; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kokkoz C., 2017, AM J EMERG MED, V35; Li C, 2012, BIOCHEMISTRY-MOSCOW+, V77, P671, DOI 10.1134/S0006297912060156; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lin T, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0885-x; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Ma B, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0490-1; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Mallouhi A, 2014, RADIOLOGE, V54, P907, DOI 10.1007/s00117-013-2640-0; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Ren JJ, 2017, PSYCHONEUROENDOCRINO, V86, P17, DOI 10.1016/j.psyneuen.2017.09.005; Shen LM, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201700085; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Suman S, 2016, J PROTEOMICS, V148, P183, DOI 10.1016/j.jprot.2016.07.033; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Zhang P, 2018, BRAIN RES BULL, V140, P19, DOI 10.1016/j.brainresbull.2018.03.012; Zhang P, 2018, J PROTEOME RES, V17, P305, DOI 10.1021/acs.jproteome.7b00579; Zhang P, 2016, J PROTEOMICS, V133, P93, DOI 10.1016/j.jprot.2015.12.014	38	6	7	2	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2018	142						224	232		10.1016/j.brainresbull.2018.07.015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY0PK	WOS:000448223400025	30077728				2022-02-06	
J	Uski, J; Lamusuo, S; Teperi, S; Loyttyniemi, E; Tenovuo, O				Uski, Jessina; Lamusuo, Salla; Teperi, Simo; Loyttyniemi, Eliisa; Tenovuo, Olli			Mortality after traumatic brain injury and the effect of posttraumatic epilepsy	NEUROLOGY			English	Article							SEIZURES; HOSPITALIZATION; RISKS	Objective To assess the effect of posttraumatic epilepsy (PTE) on mortality and causes of death after traumatic brain injury (TBI). Methods Medical reports were collected retrospectively of patients who sustained TBI between 1996 and 2013. After defining patients with PTE and picking up 2 non-PTE matched TBI controls for every patient with PTE, the database included 714 patients. Demographic data, cause and mechanism of injury, nature of injury (focal injury, intracranial bleeding), time from accident to first seizure, remission rates, neurosurgical operations undertaken, and mortality data were collected. Results Of the 714 patients, 555 (77.7%) were men and 159 (22.3%) were women. There was an obvious increase in long-term mortality in patients with PTE compared to control TBI patients. This increase became evident after about 1 year from the injury, when approximately 95% of both non-PTE and PTE patients were alive; after that, the difference in mortality increased. The difference remained significant at least up to 15 years from the injury, when around 65% of non-PTE patients with TBI were alive compared to only 45% of patients with PTE. In patients with PTE, the mortality was 1.75 times higher (p = 0.0001). There was no significant difference in causes of death. Conclusion This study shows that long-term mortality is higher in patients with PTE than other patients with TBI, although the reasons for this difference remain unclear.	[Uski, Jessina; Lamusuo, Salla; Teperi, Simo; Loyttyniemi, Eliisa; Tenovuo, Olli] Univ Turku, Turku, Finland; [Lamusuo, Salla; Tenovuo, Olli] Turku Univ Hosp, Turku, Finland		Uski, J (corresponding author), Univ Turku, Turku, Finland.	jeelus@utu.fi			Finnish Epilepsy Research Foundation; Turku University Hospital Foundation	Study funded by the Finnish Epilepsy Research Foundation and the Turku University Hospital Foundation.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Rao VR, 2015, SEMIN NEUROL, V35, P57, DOI 10.1055/s-0035-1544239; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; Xu T, 2017, EPILEPSY BEHAV, V67, P1, DOI 10.1016/j.yebeh.2016.10.026	15	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	AUG 28	2018	91	9					E878	E883		10.1212/WNL.0000000000006077			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HD2TQ	WOS:000452364600010	30068629				2022-02-06	
J	Mao, HJ; Lu, LH; Bian, KW; Clausen, F; Colgan, N; Gilchrist, M				Mao, Haojie; Lu, Lihong; Bian, Kewei; Clausen, Fredrik; Colgan, Niall; Gilchrist, Michael			Biomechanical analysis of fluid percussion model of brain injury	JOURNAL OF BIOMECHANICS			English	Article						Fluid percussion injury; Finite element; Brain injury; Intracranial pressure; Strain	CONTROLLED CORTICAL IMPACT; INTRACRANIAL-PRESSURE; ADULT-RAT; CONTUSION	Fluid percussion injury (FPI) is a widely used experimental model for studying traumatic brain injury (TBI). However, little is known about how the brain mechanically responds to fluid impacts and how the mechanical pressures/strains of the brain correlate to subsequent brain damage for rodents during FPI. Hence, we developed a numerical approach to simulate FPI experiments on rats and characterize rat brain pressure/strain responses at a high resolution. A previous rat brain model was improved with a new hexahedral elements-based skull model and a new cerebrospinal fluid (CSF) layer. We validated the numerical model against experimentally measured pressures from FPI. Our results indicated that brain tissues under FPI experienced high pressures, which were slightly lower (10-20%) than input saline pressure. Interestingly, FPI was a mixed focus- and diffuse-type injury model with highest strains (12%) being concentrated in the ipsilateral cortex under the fluid-impact site and diffuse strains (5-10%) being spread to the entire brain, which was different from controlled cortical impact in which high strains decreased gradually away from the impact site. (C) 2018 Elsevier Ltd. All rights reserved.	[Mao, Haojie; Lu, Lihong; Bian, Kewei] Western Univ, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada; [Clausen, Fredrik] Uppsala Univ Hosp, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Colgan, Niall; Gilchrist, Michael] Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin, Ireland		Mao, HJ (corresponding author), Western Univ, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada.	hmao8@uwo.ca	Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234; Clausen, Fredrik/0000-0003-3592-4417	Faculty of Engineering at Western University; Canada Research Chairs programCanada Research Chairs	We acknowledge the financial support from the Faculty of Engineering at Western University. We also acknowledge the support from the Canada Research Chairs program.	Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Clausen F, 2005, ACTA NEUROCHIR, V147, P775, DOI 10.1007/s00701-005-0550-2; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2011, J MECH MED BIOL, V11, P1199, DOI 10.1142/S021951941100423X; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tutt BA., 2008, 8 INT LS DYNA US C D; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69	25	6	6	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	AUG 22	2018	77						228	232		10.1016/j.jbiomech.2018.07.004			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	GQ9BE	WOS:000442060100032	30031650				2022-02-06	
J	Si, B; Dumkrieger, G; Wu, T; Zafonte, R; Dodick, DW; Schwedt, TJ; Li, J				Si, Bing; Dumkrieger, Gina; Wu, Teresa; Zafonte, Ross; Dodick, David W.; Schwedt, Todd J.; Li, Jing			A Cross-Study Analysis for Reproducible Sub-classification of Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; concussion; diagnosis; classification; outcomes; head injury	OUTCOME PREDICTION; MILD; POLYMORPHISM	Objective: To identify reproducible sub-classes of traumatic brain injury (TBI) that correlate with patient outcomes. Methods: Two TBI datasets from the Federal Interagency Traumatic Brain Injury Research (FITBIR) Informatics System were utilized, Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot and Citicoline Brain Injury Treatment Trial (COBRIT). Patients included in these analyses had closed head injuries with Glasgow Comas Scale (GCS) scores of 13-15 at arrival at the Emergency Department (ED). Sparse hiearchical clustering was applied to identify TBI sub-classes within each dataset. The reproducibility of the sub-classes was evaluated by investigating similarities in clinical variable profiles and patient outcomes in each sub-class between the two datasets, as well as by using a statistical metric called in-group proportion (IGP). Results: Seven TBI sub-classes were identified in the first dataset. There were between-class differences in patient outcomes at 90 days (Glasgow Outcome Scale Extended (GOSE): p < 0.001) and 180 days (Trail Making Test (TMT): p = 0.03). Four of seven sub-classes were reproducible in the second dataset with very high IGPs (94,100, 99, 97%). Seven TBI sub-classes were also identified in the second dataset. There were significant between-class differences in patient outcomes at 180 days (GOSE: p = 0.024; Brief Symptom Inventory (BSI) p = 0.007; TMT: p < 0.001). Three of seven sub-classes were reproducible in the second dataset with very high IGPs (100% for all). Conclusions: Reproducible TBI sub-classes were identified across two independent datasets, suggesting that these sub-classes exist in a general population. Differences in patient outcomes according to sub-class assignment suggest that this sub-classification could be used to guide post-TBI prognosis.	[Si, Bing; Dumkrieger, Gina; Wu, Teresa; Li, Jing] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Dept Ind Engn & Comp Engn, Tempe, AZ 85281 USA; [Dumkrieger, Gina; Dodick, David W.; Schwedt, Todd J.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA USA		Li, J (corresponding author), Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Dept Ind Engn & Comp Engn, Tempe, AZ 85281 USA.; Schwedt, TJ (corresponding author), Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA.	schwedt.todd@mayo.edu; jing.li.8@asu.edu		Dumkrieger, Gina/0000-0001-9519-5370	NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089035]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089035] Funding Source: NIH RePORTER	NIH R21HD089035 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Friedland D., 2013, J SPINE, V4, DOI [10.4172/2165-7939.S4-005, DOI 10.4172/2165-7939.S4-005]; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Mitrishina MB, 2005, HDB NORMATIVE DATA N; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Si B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198741; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; TEASDALE G, 1974, LANCET, V2, P81; van Buuren S, 2011, J STAT SOFTW, V45, P1; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Yue JK, 2017, J CLIN NEUROSCI, V45, P293, DOI 10.1016/j.jocn.2017.07.022; Yue JK, 2017, NEUROGENETICS, V18, P29, DOI 10.1007/s10048-016-0500-6; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zabora J, 2001, PSYCHOSOMATICS, V42, P241, DOI 10.1176/appi.psy.42.3.241; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	31	6	6	1	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 13	2018	9								606	10.3389/fneur.2018.00606			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GQ1VJ	WOS:000441429500001	30150970	gold, Green Published			2022-02-06	
J	Dehghan, F; Shahrokhi, N; Khaksari, M; Soltani, Z; Asadikorom, G; Najafi, A; Shahrokhi, N				Dehghan, Fatemeh; Shahrokhi, Nader; Khaksari, Mohammad; Soltani, Zahra; Asadikorom, Gholamreza; Najafi, Ali; Shahrokhi, Nava			Does the administration of melatonin during post-traumatic brain injury affect cytokine levels?	INFLAMMOPHARMACOLOGY			English	Article						Melatonin; IL-1 beta; IL-6; TNF-alpha; IL-10; Traumatic brain injury	NITRIC-OXIDE; INFLAMMATORY CYTOKINES; OXIDATIVE DAMAGE; IMMATURE RATS; MICE MODEL; PROGESTERONE; INTERLEUKIN-1; PROTECTION; ESTROGEN; DISEASE	Increased levels of inflammatory cytokines after traumatic brain injury (TBI) can lead to brain edema and neuronal death. In this study, the effect of melatonin on pro-inflammatory (IL-1, IL-6, and TNF-alpha) and anti-inflammatory (IL-10) cytokines following TBI was investigated considering anti-inflammatory effect of melatonin. Male Wistar rats were divided into five groups: Sham, TBI, TBI + VEH (vehicle), TBI + 5 mg dose of melatonin (MEL5), TBI + 20 mg dose of melatonin (MEL20). Diffuse TBI was induced by Marmarou method. Melatonin was administered 1, 24, 48 and 72 h after TBI through i.p. Brain water content and brain levels of pro-inflammatory (IL-1, IL-6 and TNF-alpha) and anti-inflammatory (IL-10) cytokines were measured 72 h after TBI. The IL-1 levels decreased in the TBI + MEL5 and TBI + MEL20 groups in comparison to TBI + VEH group (p < 0.001). The levels of IL-6 and TNF-alpha also decreased in melatonin-treated groups compared to control group (p < 0.001). The amount of IL-10 decreased after TBI. But melatonin administration increased the IL-10 levels in comparison with TBI + VEH group (p < 0.001). The results showed that melatonin administration affected the brain levels of pro-inflammatory and anti-inflammatory cytokines involving in brain edema led to neuronal protection after TBI.	[Dehghan, Fatemeh] Kerman Univ Med Sci, Inst Neuropharmacol, Physiol Res Ctr, Afzalipour Fac Med, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran; [Khaksari, Mohammad; Soltani, Zahra; Asadikorom, Gholamreza] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Najafi, Ali] Kerman Univ Med Sci, Fac Pharm, Kerman, Iran; [Shahrokhi, Nava] Kerman Univ Med Sci, Med Sch, Kerman, Iran		Shahrokhi, N (corresponding author), Kerman Univ Med Sci, Med Sch, Kerman, Iran.	nshahrokhi@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019; Soltani, Zahra/AAC-1350-2019; Shahrokhi, Nader/AAV-3747-2020	Haddad, Mohammad Khaksari/0000-0003-0770-4281; Soltani, Zahra/0000-0002-8423-6189; Shahrokhi, Nader/0000-0002-0149-7819	Neuroscience Research Centre in Kerman University of Medical Sciences	The present study was supported by the Neuroscience Research Centre in Kerman University of Medical Sciences.	Calabrese V, 2004, IN VIVO, V18, P245; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carrillo-Vico A, 2005, J PINEAL RES, V39, P400, DOI 10.1111/j.1600-079X.2005.00265.x; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Costantino G, 1998, EUR J PHARMACOL, V363, P57, DOI 10.1016/S0014-2999(98)00673-6; Cuesta S, 2011, MECH AGEING DEV, V132, P573, DOI 10.1016/j.mad.2011.10.005; Cuzzocrea S, 1997, J PINEAL RES, V23, P106, DOI 10.1111/j.1600-079X.1997.tb00342.x; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Esposito E, 2008, J PINEAL RES, V45, P149, DOI 10.1111/j.1600-079X.2008.00569.x; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Genovese T, 2007, J PINEAL RES, V43, P140, DOI 10.1111/j.1600-079X.2007.00454.x; Gutierrez-Cuesta J, 2007, J PINEAL RES, V42, P394, DOI 10.1111/j.1600-079X.2007.00433.x; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Korkmaz A, 2009, MOL MED, V15, P43, DOI 10.2119/molmed.2008.00117; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin V, 2002, J PINEAL RES, V33, P204, DOI 10.1034/j.1600-079X.2002.02113.x; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; Mayo JC, 2005, J NEUROIMMUNOL, V165, P139, DOI 10.1016/j.jneuroim.2005.05.002; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Olcese JM, 2009, J PINEAL RES, V47, P82, DOI 10.1111/j.1600-079X.2009.00692.x; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Park JW, 2009, J PINEAL RES, V46, P415, DOI 10.1111/j.1600-079X.2009.00678.x; Permpoonputtana K, 2012, NEUROTOX RES, V23, P1; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Pozo D, 1997, J CELL BIOCHEM, V65, P430, DOI 10.1002/(SICI)1097-4644(19970601)65:3<430::AID-JCB12>3.0.CO;2-J; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1159/000025480; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Veneroso C, 2009, J PINEAL RES, V47, P184, DOI 10.1111/j.1600-079X.2009.00699.x; Vink R, 2003, ACT NEUR S, V86, P257; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189	51	6	8	0	2	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0925-4692	1568-5608		INFLAMMOPHARMACOLOGY	Inflammopharmacology	AUG	2018	26	4					1017	1023		10.1007/s10787-017-0417-1			7	Immunology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy; Toxicology	GN3XI	WOS:000438945200012	29159715				2022-02-06	
J	Dinnes, C; Hux, K				Dinnes, Carly; Hux, Karen			A Multicomponent Writing Intervention for a College Student With Mild Brain Injury	COMMUNICATION DISORDERS QUARTERLY			English	Article						treatment for; disorders; communication; cognitive impairments; exceptionalities; writing assessment; problems; adult	NARRATIVE DISCOURSE; ELICITATION TASK; WORD RETRIEVAL; HEAD-INJURY; LANGUAGE; DEFICITS; ADULTS; METAANALYSIS; MANAGEMENT; MTBI	Written expression is a high-level language process susceptible to impairment given mild traumatic brain injury (mTBI); however, minimal research exists about assessing or treating this aspect of language performance. This study's purpose was to determine the effect of a multicomponent intervention on the written expression of an undergraduate student with mTBI resulting in generalized expressive language impairment. Pretreatment, intervention, and posttreatment sessions extended over 11 weeks. Intervention addressed semantic associations, semantic mapping, proofreading, organization, foundational skills, and goal setting. Data reflected performance on intervention components, writing probes, and pre-posttreatment completion of a standardized writing measure. Calculation and plotting of correct writing sequence percentages revealed substantial improvement. Linear regression analysis confirmed the trend line slope for intervention probes differed significantly from baseline probes. Comparison of pre-posttreatment test results also confirmed substantial improvement. Multicomponent instruction similar to that recommended for other students with writing challenges may be effective for people with mTBI.	[Dinnes, Carly; Hux, Karen] Univ Nebraska, Lincoln, NE USA		Dinnes, C (corresponding author), Univ Nebraska, Barkley Mem Ctr 350, Lincoln, NE 68583 USA.	carly.dinnes@huskers.unl.edu	Hux, Karen/AAQ-2078-2020				Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; Docking KM, 2007, BRAIN LANG, V103, P236, DOI 10.1016/j.bandl.2007.07.021; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Graham S, 2007, WRITING NEXT EFFECTI; Graham S, 2007, J EDUC PSYCHOL, V99, P445, DOI 10.1037/0022-0663.99.3.445; Hammil D. D., 2009, TEST WRITTEN LANGUAG; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Head Injury Hotline, 1998, BRAIN INJ CHECKL; Heaton R.K., 2003, WISCONSIN CARD SORTI; Hux K., 2008, J MED SPEECH LANGUAG, V16, P83; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Jewell J, 2005, SCHOOL PSYCHOL REV, V34, P27; Kaplan E., 2001, BOSTON NAMING TEST; Kertesz A., 2006, W APHASIA BATTERY RE; King KA, 2006, APHASIOLOGY, V20, P233, DOI 10.1080/02687030500473155; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; MARSH NV, 1995, BRAIN INJURY, V9, P553, DOI 10.3109/02699059509008214; Mason L. H., 2008, LEARNING DISABILITIE, V23, P103, DOI DOI 10.1111/J.1540-5826.2008.00268.X; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Reitan R, 1985, HALSTEAD REITAN NEUR; Rogers LA, 2008, J EDUC PSYCHOL, V100, P879, DOI 10.1037/0022-0663.100.4.879; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Tombaugh TN, 1997, J CLIN EXP NEUROPSYC, V19, P922, DOI 10.1080/01688639708403773; TROIA GA, 2006, HDB WRITING RES, P324; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Wagner RK., 2010, TEST SILENT READING; Wheeler L, 2014, NEUROREHABILITATION, V34, P29, DOI 10.3233/NRE-131007; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Wong MN, 2010, APHASIOLOGY, V24, P1155, DOI 10.1080/02687030903168212; XMind Ltd, 2016, XMIND VERS 7 5 COMP	40	6	6	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1525-7401	1538-4837		COMMUN DISORD Q	Comm. Disord. Q.	AUG	2018	39	4					490	500		10.1177/1525740117716416			11	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	GM4CL	WOS:000438061300004					2022-02-06	
J	Gise, R; Truong, T; Parsikia, A; Mbekeani, JN				Gise, Ryan; Truong, Timothy; Parsikia, Afshin; Mbekeani, Joyce N.			Visual Pathway Injuries in Pediatric Ocular Trauma-A Survey of the National Trauma Data Bank From 2008 to 2014	PEDIATRIC NEUROLOGY			English	Article						Traumatic optic neuropathy; Pediatric ocular trauma; Visual pathway injury; Traumatic brain injury; National Trauma Data Bank	OPTIC NEUROPATHY; BRAIN-INJURY; MAJOR TRAUMA; HEAD TRAUMA; CHILDREN; DISPARITIES; EPIDEMIOLOGY; RACE	Background: Traumatic visual pathway injuries are often associated with severe head trauma and can have profound deleterious effects in developing children and their rehabilitation. We sought to elucidate the epidemiology of pediatric visual pathway injuries in the United States. Materials and Methods: This study is a retrospective evaluation of pediatric patients (less than 21 years of age) with visual pathway injuries that were submitted to the National Trauma Data Bank between 2008 to 2014. Patients were identified using the International Classification of Diseases, Ninth Revision Clinical Modification codes. Statistical analysis was performed with SPSS software. Variables were correlated using Student t test, chi-squared test, and logistic regression analyses. Results: Of the 58,765 pediatric patients (1.7%) who were admitted with ocular injuries, 970 had visual pathway injuries. The majority of these patients were male (69.2%), and the mean age was 11.6 years (+/- 7.2). Traumatic optic neuropathy was the most common (86.1%) visual pathway injury. It had the greatest odds of occurring with oculomotor nerve injury (odds ratio = 3.84; P < 0.001). Associated ocular injuries were open adnexal wounds (87.4%) and orbital fractures (23%). Common mechanisms were motor vehicle occupant (21.5%) and firearms (15.6%). Motor vehicle occupants were most likely white and firearms injury, black. In the zero to three years age group, most injuries were due to falls; injuries in the 19 to 21 years age group had the greatest association with firearms. Overall mortality was 17.6%. Conclusions: Visual pathway injuries may have devastatating sequelae and should be considered in pediatric ocular injuries. The clear majority were traumatic optic neuropathies. The common mechanisms, motor vehicle occupant and firearms, revealed age and race disparities. (C) 2018 Elsevier Inc. All rights reserved.	[Gise, Ryan; Mbekeani, Joyce N.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA; [Truong, Timothy] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA; [Parsikia, Afshin] Jacobi Med Ctr, Dept Trauma Surg, Bronx, NY USA; [Mbekeani, Joyce N.] Jacobi Med Ctr, Dept Surg Ophthalmol, Bronx, NY USA		Gise, R (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA.	ryan.gise@gmail.com			2017 Fight For Sight/North American Neuro-Ophthalmology Society (NANOS) Research Award	The authors thank Melvin E. Stone Jr MD, Associate Director, Trauma Services & Surgical Critical Care, Department of Surgery, and James Meltzer MD of the Department of Pediatrics, Jacobi Medical Center, Bronx, New York, for their contributions and support. This work was supported by the 2017 Fight For Sight/North American Neuro-Ophthalmology Society (NANOS) Research Award.	[Anonymous], 1988, PEDIATRICS, V81, P736; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Beard JH, 2017, AM J PUBLIC HEALTH, V107, P371, DOI 10.2105/AJPH.2016.303620; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Chikani V, 2016, PUBLIC HEALTH REP, V131, P704, DOI 10.1177/0033354916663491; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Falcone RA, 2007, J PEDIATR SURG, V42, P172, DOI 10.1016/j.jpedsurg.2006.09.015; Ford RL, 2012, J AAPOS, V16, P413, DOI 10.1016/j.jaapos.2012.04.009; Garcia TA, 2005, J PEDIAT OPHTH STRAB, V42, P349; Garcia TA, 2005, J TRAUMA, V59, P169, DOI 10.1097/01.TA.0000174513.79115.7A; Goldenberg-Cohen N, 2004, J AAPOS, V8, P20, DOI 10.1016/j.jaapos.2003.08.009; Hassan A, 2002, CLIN EXP OPHTHALMOL, V30, P273, DOI 10.1046/j.1442-9071.2002.00534.x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kashkouli MB, 2018, GRAEF ARCH CLIN EXP, V256, P209, DOI 10.1007/s00417-017-3816-5; Kedar S, 2006, J AAPOS, V10, P249, DOI 10.1016/j.jaapos.2006.01.181; Lee JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157388; LESSELL S, 1989, ARCH OPHTHALMOL-CHIC, V107, P382, DOI 10.1001/archopht.1989.01070010392031; Liu GT, 1997, NEUROLOGY, V49, P1748, DOI 10.1212/WNL.49.6.1748; Martin CA, 2012, J PEDIATR SURG, V47, P1196, DOI 10.1016/j.jpedsurg.2012.03.029; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; SHOKUNBI T, 1991, CHILD NERV SYST, V7, P147, DOI 10.1007/BF00776710; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tabatabaei SA, 2011, CLIN OPHTHALMOL, V5, P1021, DOI 10.2147/OPTH.S21409; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Warner N, 2010, CURR OPIN OPHTHALMOL, V21, P459, DOI 10.1097/ICU.0b013e32833f00c9; Yu-Wai-Man P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005024.pub3; Yu-Wai-Man P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006032.pub4; Zahavi A, 2016, GRAEF ARCH CLIN EXP, V254, P765, DOI 10.1007/s00417-015-3199-4	36	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	AUG	2018	85						43	50		10.1016/j.pediatrneurol.2018.04.003			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	GZ5HK	WOS:000449449600007	29859721				2022-02-06	
J	Guty, E; Arnett, P				Guty, Erin; Arnett, Peter			Post-concussion Symptom Factors and Neuropsychological Outcomes in Collegiate Athletes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Headache; Cognitive impairment; Attention; Memory; Sports injuries	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; OBSTRUCTIVE SLEEP-APNEA; INTERNATIONAL-CONFERENCE; UNITED-STATES; HEADACHE; PERFORMANCE; EPIDEMIOLOGY; PREVALENCE; MANAGEMENT	Objectives: Research indicates that symptoms following a concussion are related to cognitive dysfunction; however, less is known about how different types of symptoms may be related to cognitive outcomes or how specific domains of cognition are affected. The present study explored the relationship between specific types of symptoms and these various cognitive outcomes following a concussion. Methods: One-hundred twenty-two student-athletes with sports-related concussion were tested with a battery that included a symptom report measure and various cognitive tests. Symptoms factors were: Physical, Sleep, Cognitive, Affective and Headache. Participants were grouped into "symptom" and "no symptom" groups for each factor. Cognitive outcomes included both overall performance as well as impairment scores in which individuals were grouped into impaired and not impaired based on a cutoff of 2 or more tests at the impaired level (<80 in standard scores). These cognitive outcomes were examined for all the tests combined and then specifically for the memory tests and attention/processing speed tests. A Bonferroni correction was used, and the results were considered significant at a level of p < .008. Results: Headache symptoms were significantly (p < .008) associated with overall cognitive impairment as well as memory and attention/processing speed impairment. Sleep symptoms were related to memory impairments. Conclusions: The symptom specific relationships to cognitive outcomes demonstrated by our study can help guide treatment and accommodations for athletes following concussion.	[Guty, Erin; Arnett, Peter] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Guty, E (corresponding author), Penn State Univ, 372 Moore Bldg, University Pk, PA 16802 USA.	erin.guty@gmail.com			Penn State Psychological Clinic; Penn State Sports Medicine; EMD Serono	Special thanks to Jessica Meyer, Victoria Merritt, Margaret Cadden, Dr. Frank Hillary, and Dr. Michele Diaz for their help with various aspects of the project. We also thank Dr. Wayne Sebastianelli, MD, Director of Penn State Sports Medicine, and the Penn State Sports Medicine team, for their ongoing support of our research. This project received financial support from the Penn State Psychological Clinic and Penn State Sports Medicine. Ms. Guty does not have any conflicts of interest to report. Dr. Arnett has served as part of a paid speaker series sponsored by EMD Serono. He has also served as a consultant for Biogen IDEC.	Bailey CM, 2009, J HEAD TRAUMA REHAB, V24, P123, DOI 10.1097/HTR.0b013e31819c1caa; Basso M., 2013, NEUROPSYCHOLOGICAL D; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown G.K., 2000, BECK DEPRESSION INVE; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Cegalis J.A., 1994, VIGIL W CONTINUOUS P; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Echemendia R.J., 2004, TRAUMATIC BRAIN INJU, P480; Engleman HM, 2000, SLEEP, V23, pS102; FARACE E, 2000, NEUROSURGICAL FOCUS, V0008, P00001, DOI [DOI 10.3171/F0C.2000.8.1.152, DOI 10.3171/foc.2000.8.1.152]; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; IBM_Corp, 2016, IBM SPSS STAT WIND V; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Merritt V.C., 2014, J CLIN EXPT NEUROPSY, V36, P37; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Moore DJ, 2013, PAIN, V154, P1840, DOI 10.1016/j.pain.2013.06.006; Pardini D., 2004, BR J SPORTS MED, V38, P661; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; RHODES SK, 1995, J PEDIATR-US, V127, P741, DOI 10.1016/S0022-3476(95)70164-8; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Salorio CF, 2002, J CLIN EXP NEUROPSYC, V24, P93, DOI 10.1076/jcen.24.1.93.973; Smith A., 1991, SYMBOL DIGIT MODALIT; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; WechslerD, 2001, WECHSLER TEST ADULT; Zhu B, 2012, NEUROBIOL DIS, V48, P348, DOI 10.1016/j.nbd.2012.06.022	40	6	6	0	12	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2018	24	7					684	692		10.1017/S135561771800036X			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	GR6FA	WOS:000442739900004	29925450	Bronze			2022-02-06	
J	Han, X; Kwitt, R; Aylward, S; Bakas, S; Menze, B; Asturias, A; Vespa, P; Van Horn, J; Niethammer, M				Han, Xu; Kwitt, Roland; Aylward, Stephen; Bakas, Spyridon; Menze, Bjoern; Asturias, Alexander; Vespa, Paul; Van Horn, John; Niethammer, Marc			Brain extraction from normal and pathological images: A joint PCA/Image-Reconstruction approach	NEUROIMAGE			English	Article						Brain extraction; Image registration; PCA; Total-variation; Pathology	LOW-RANK; ATLAS; REGISTRATION	Brain extraction from 3D medical images is a common pre-processing step. A variety of approaches exist, but they are frequently only designed to perform brain extraction from images without strong pathologies. Extracting the brain from images exhibiting strong pathologies, for example, the presence of a brain tumor or of a traumatic brain injury (TBI), is challenging. In such cases, tissue appearance may substantially deviate from normal tissue appearance and hence violates algorithmic assumptions for standard approaches to brain extraction; consequently, the brain may not be correctly extracted. This paper proposes a brain extraction approach which can explicitly account for pathologies by jointly modeling normal tissue appearance and pathologies. Specifically, our model uses a three-part image decomposition: (1) normal tissue appearance is captured by principal component analysis (PCA), (2) pathologies are captured via a total variation term, and (3) the skull and surrounding tissue is captured by a sparsity term. Due to its convexity, the resulting decomposition model allows for efficient optimization. Decomposition and image registration steps are alternated to allow statistical modeling of normal tissue appearance in a fixed atlas coordinate system. As a beneficial side effect, the decomposition model allows for the identification of potentially pathological areas and the reconstruction of a quasi-normal image in atlas space. We demonstrate the effectiveness of our approach on four datasets: the publicly available IBSR and LPBA40 datasets which show normal image appearance, the BRATS dataset containing images with brain tumors, and a dataset containing clinical TBI images. We compare the performance with other popular brain extraction models: ROBEX, BEaST, MASS, BET, BSE and a recently proposed deep learning approach. Our model performs better than these competing approaches on all four datasets. Specifically, our model achieves the best median (97.11) and mean (96.88) Dice scores over all datasets. The two best performing competitors, ROBEX and MASS, achieve scores of 96.23/95.62 and 96.67/94.25 respectively. Hence, our approach is an effective method for high quality brain extraction for a wide variety of images.	[Han, Xu; Niethammer, Marc] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA; [Kwitt, Roland] Univ Salzburg, Dept Comp Sci, Salzburg, Austria; [Aylward, Stephen] Kitware Inc, Clifton Pk, NY USA; [Bakas, Spyridon] Univ Penn, Perelman Sch Med, Ctr Biomed Image Comp & Analyt, Philadelphia, PA 19104 USA; [Menze, Bjoern] Tech Univ Munich, Dept Comp Sci, Munich, Germany; [Asturias, Alexander; Van Horn, John] Univ Southern Calif, Inst Neuroimaging & Informat, Los Angeles, CA 90089 USA; [Vespa, Paul] Univ Calif Los Angeles, David Geffen Sch Med, Med Ctr, Los Angeles, CA 90095 USA		Han, X (corresponding author), Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA.	xhs400@cs.unc.edu		Van Horn, John/0000-0003-1537-0816; Menze, Bjoern/0000-0003-4136-5690	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Science Foundation (NSF)National Science Foundation (NSF) [NIH R41 NS091792, NIH/NINDS: R01NS042645, NIH/NCI: U24CA189523, NSF ECCS-1148870, EECS-1711776]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U24CA189523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS081792] Funding Source: NIH RePORTER; Directorate For EngineeringNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1148870] Funding Source: National Science Foundation	Research reported in this publication was supported by the National Institutes of Health (NIH) and the National Science Foundation (NSF) under award numbers NIH R41 NS091792, NIH/NINDS: R01NS042645, NIH/NCI: U24CA189523, NSF ECCS-1148870, and EECS-1711776. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the NSF.	Bakas S, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Doshi J, 2013, ACAD RADIOL, V20, P1566, DOI 10.1016/j.acra.2013.09.010; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Fonov V. S., 2009, NEUROIMAGE, V47, P39; Givon Lev E., 2015, scikit-cuda 0.5.1: a Python interface to GPU-powered libraries, DOI [10.5281/zenodo.40565, DOI 10.5281/ZENODO.40565]; Goldstein T., ARXIV13050546; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672; Gutierrez-Becker B, 2017, MED IMAGE ANAL, V41, P2, DOI 10.1016/j.media.2017.05.002; Han X, 2017, 2017 IEEE 14TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2017), P10, DOI 10.1109/ISBI.2017.7950456; Holmes M, 2007, WORKSHOP EFFICIENT M, V58, P249; Iglesias JE, 2011, IEEE T MED IMAGING, V30, P1617, DOI 10.1109/TMI.2011.2138152; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kleesiek J, 2016, NEUROIMAGE, V129, P460, DOI 10.1016/j.neuroimage.2016.01.024; Liu XX, 2015, IEEE T MED IMAGING, V34, P2583, DOI 10.1109/TMI.2015.2448556; Liu XX, 2014, LECT NOTES COMPUT SC, V8675, P97, DOI 10.1007/978-3-319-10443-0_13; Lowekamp B. C., FRONT NEUROINFORMATI, V7; Mahalanobis PC., 1936, P NATL I SCI INDIA, V2, P49; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Modat M, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.2.024003; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Muschelli J, 2015, NEUROIMAGE, V114, P379, DOI 10.1016/j.neuroimage.2015.03.074; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; Niethammer M, 2011, LECT NOTES COMPUT SC, V6892, P639, DOI 10.1007/978-3-642-23629-7_78; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; SONKA M, 2000, HDB MED IMAGING, V2; SPEIER W, 2011, MICCAI LECT NOT, V6893, P659; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wright J., 2009, P NIPS, P2080; Yang X, 2017, NEUROIMAGE, V158, P378, DOI 10.1016/j.neuroimage.2017.07.008; Yang X, 2016, LECT NOTES COMPUT SC, V9968, P97, DOI 10.1007/978-3-319-46630-9_10; Yeghiazaryan V, 2015, RR1508 DEP COMP SCI	43	6	7	1	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	AUG 1	2018	176						431	445		10.1016/j.neuroimage.2018.04.073			15	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GH2HU	WOS:000433223700036	29730494	Green Submitted, Green Accepted			2022-02-06	
J	Kito, K; Tanabe, K; Sakata, K; Fukuoka, N; Nagase, K; Iida, M; Iida, H				Kito, Kazuhiro; Tanabe, Kumiko; Sakata, Koji; Fukuoka, Naokazu; Nagase, Kiyoshi; Iida, Mami; Iida, Hiroki			Endothelium-dependent vasodilation in the cerebral arterioles of rats deteriorates during acute hyperglycemia and then is restored by reducing the glucose level	JOURNAL OF ANESTHESIA			English	Article						Acute hyperglycemia; Cerebral artery; Endothelium dysfunction; Oxidative stress	OXIDATIVE STRESS; POSTPRANDIAL HYPERGLYCEMIA; BLOOD-FLOW; DYSFUNCTION; THERAPY; INSULIN; PATHOPHYSIOLOGY; ACETYLCHOLINE; CONSEQUENCES; FLUCTUATIONS	Acute hyperglycemia in patients with traumatic brain injury correlates with a poor neurological outcome. We investigated the endothelium function of rat cerebral arterioles during acute hyperglycemia and after reducing the glucose levels using insulin. We also examined whether or not oxidative stress was involved in the cerebral arteriole response to acute hyperglycemia. In isoflurane-anesthetized, mechanically ventilated rats, we used closed cranial window preparation to measure the changes in the pial arteriolar diameter following the topical application of acetylcholine (ACh) or adenosine. We examined the pial arteriolar vasodilator response before hyperglycemia, during hyperglycemia, and after reducing the glucose level using insulin. After intravenous pretreatment with an NADPH oxidase inhibitor (apocynin or diphenylene iodonium), we reexamined the pial arteriolar vasodilator response following the topical application of ACh. Under control conditions, the topical application of ACh dose-dependently dilated the cerebral arterioles. The vasodilatory responses to topical ACh were impaired during hyperglycemia and improved after the administration of insulin. The vasodilatory responses to topical adenosine were not affected by the glucose levels. In the apocynin or diphenylene iodonium pretreatment group, the topical application of ACh dilated the cerebral arterioles during hyperglycemia. Acute hyperglycemia induces a dysfunction of the endothelium-dependent vasodilation of rat cerebral arterioles. The dysfunction can be reversed by improving the acute hyperglycemia and it can be prevented entirely by the administration of NADPH oxidase inhibitors. These results could suggest that controlling the glucose levels works protectivity to endothelium function of cerebral arterioles.	[Kito, Kazuhiro; Tanabe, Kumiko; Sakata, Koji; Fukuoka, Naokazu; Nagase, Kiyoshi; Iida, Hiroki] Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Yanagido 1-1, Gifu, Gifu 5011194, Japan; [Iida, Mami] Gifu Prefectural Gen Med Ctr, Dept Gen Med, Gifu, Japan		Iida, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Yanagido 1-1, Gifu, Gifu 5011194, Japan.	iida@gifu-u.ac.jp			Ministry of Education, Science, Sports and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [15K10509, 17K11046]	This work was supported by a Grant-in-Aid for Scientific Research (15K10509 and 17K11046) from the Ministry of Education, Science, Sports and Culture of Japan.	Affonso Filipe de Souza, 2003, Arq. Bras. Cardiol., V81, P161, DOI 10.1590/S0066-782X2003001000005; Alper G, 2006, DIABETES-METAB RES, V22, P190, DOI 10.1002/dmrr.586; Azuma K, 2006, ARTERIOSCL THROM VAS, V26, P2275, DOI 10.1161/01.ATV.0000239488.05069.03; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Bottle A, 2009, DIABETOLOGIA, V52, P74, DOI 10.1007/s00125-008-1170-1; Cipolla MJ, 2010, TRANSL STROKE RES, V1, P127, DOI 10.1007/s12975-010-0014-8; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Didion SP, 2005, STROKE, V36, P342, DOI 10.1161/01.STR.0000152952.42730.92; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; Hayashi T, 2005, DIABETES OBES METAB, V7, P334, DOI 10.1111/j.1463-1326.2004.00393.x; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Iida H, 2010, J THROMB THROMBOLYS, V29, P483, DOI 10.1007/s11239-009-0382-7; Jones KW, 2008, J DIABETES COMPLICAT, V22, P365, DOI 10.1016/j.jdiacomp.2007.05.006; Mah E, 2012, NUTR RES, V32, P727, DOI 10.1016/j.nutres.2012.08.002; Mah E, 2011, J NUTR, V141, P1961, DOI 10.3945/jn.111.144592; Mao XM, 2009, DIABETES-METAB RES, V25, P435, DOI 10.1002/dmrr.968; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nakahata K, 2008, ANESTHESIOLOGY, V108, P269, DOI 10.1097/01.anes.0000299830.13203.60; Nyvad J, 2017, J PHYSIOL-LONDON, V595, P5037, DOI 10.1113/JP274604; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Ongini E, 1996, TRENDS PHARMACOL SCI, V17, P364, DOI 10.1016/S0165-6147(96)10045-6; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Sercombe R, 2004, J CARDIOVASC PHARM, V44, P507, DOI 10.1097/01.fjc.0000141477.59748.84; Sogawa K, 2010, INVEST OPHTH VIS SCI, V51, P2648, DOI 10.1167/iovs.09-4070; STEINBERG HO, 1994, J CLIN INVEST, V94, P1172, DOI 10.1172/JCI117433; Tan S, 2015, NEUROSCIENCE, V303, P138, DOI 10.1016/j.neuroscience.2015.06.041; Zhong MF, 2011, J PHYSIOL-LONDON, V589, P5153, DOI 10.1113/jphysiol.2011.213686	32	6	6	0	7	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	AUG	2018	32	4					531	538		10.1007/s00540-018-2507-7			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GO5ZF	WOS:000440112700008	29786114				2022-02-06	
J	Levy, S; Gansler, D; Huey, E; Wassermann, E; Grafman, J				Levy, Sarah; Gansler, David; Huey, Edward; Wassermann, Eric; Grafman, Jordan			Assessment of Patient Self-awareness and Related Neural Correlates in Frontotemporal Dementia and Corticobasal Syndrome	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Self-awareness; Executive function; Neurodegenerative disease; Magnetic resonance imaging; Orbitofrontal cortex; Best subset regression	TRAUMATIC BRAIN-INJURY; BEHAVIORAL VARIANT; ORBITOFRONTAL CORTEX; ALZHEIMERS-DISEASE; INNER SPEECH; ANOSOGNOSIA; DEFICITS; INSIGHT; DISTURBANCES; DEGENERATION	Objective: We compared two different methods of assessing self-awareness (clinician-rated vs. self- and caregiver report) in participants with neurodegenerative conditions. Additionally, we examined the contribution of memory dysfunction to assessment of self-awareness. Method: Sixty-seven participants with various neurodegenerative disorders participated in this study. Data were collected on brain volume, neurocognitive function, demographic characteristics, and two measures of patient self-awareness, defined as (1) the discrepancy between patient and caregiver ratings of dysexecutive syndrome and (2) clinician-observed rating of patient insight. Penalized regression with best subset variable selection and 10-fold cross-validation was used to evaluate three neurocognitive frameworks: self-regulation, language, and perspective-taking, each predicting the results from the two methods of self-awareness measurement. Results: The self-regulation framework was more robustly predictive for both the clinician rating and discrepancy method than language or perspective-taking. Frameworks in which the clinician rating was the criterion were more robust than those with the discrepancy method as criterion. When a measure of memory functioning was added to the framework, there was no appreciable improvement in the prediction of self-awareness. Conclusions: A self-regulation neurocognitive framework, consisting of regions of interest and neuropsychological test scores, was more effective in understanding patient self-awareness than perspective-taking or language frameworks. Compared to the discrepancy method, a clinician rating of self-awareness was more robustly associated with relevant clinical variables of regional brain volume and neuropsychological performance, suggesting it may be a useful measure to aid clinical diagnosis.	[Levy, Sarah; Gansler, David] Suffolk Univ, Coll Arts & Sci, Dept Psychol, Boston, MA 02114 USA; [Huey, Edward] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Huey, Edward] Columbia Univ, Dept Neurol, New York, NY 10027 USA; [Wassermann, Eric] NINDS, Dept Behav Neurol Unit, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Neurol, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Shirley Ryan Abil Lab, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Weinberg Coll Arts & Sci, Feinberg Sch Med, Dept Psychiat, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Psychol, Chicago, IL 60611 USA		Gansler, D (corresponding author), Suffolk Univ, Coll Arts & Sci, Dept Psychol, Boston, MA 02114 USA.	dgansler@suffolk.edu	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Levy, Sarah/0000-0002-8254-2553	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Therapeutic Cognitive Neuroscience Fund; Smart Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke intramural funding to Dr. Jordan Grafman. Dr. Grafman's work on this manuscript was also partly supported by the Therapeutic Cognitive Neuroscience Fund and the Smart Family Foundation.	Banks S, 2008, BRAIN COGNITION, V67, P58, DOI 10.1016/j.bandc.2007.11.004; Banks SJ, 2009, J NEUROPSYCH CLIN N, V21, P299, DOI 10.1176/appi.neuropsych.21.3.299; Beer JS, 2007, TRENDS COGN SCI, V11, P187, DOI 10.1016/j.tics.2007.02.004; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Beer JS, 2010, NEUROIMAGE, V49, P2671, DOI 10.1016/j.neuroimage.2009.10.075; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Blake M.L., 2002, APHASIOLOGY, V16, P537, DOI [10.1080/02687030244000194, DOI 10.1080/02687030244000194]; Boeve BE, 2005, CUR CLIN NEUROL, P309; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; BUTTERS N, 1984, J CLIN NEUROPSYCHOL, V6, P17, DOI 10.1080/01688638408401193; Chavoix C, 2017, NEUROSCI BIOBEHAV R, V78, P1, DOI 10.1016/j.neubiorev.2017.04.015; Cocchini G, 2009, NEUROPSYCHOLOGY, V23, P223, DOI 10.1037/a0014266; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gansler D. A., 2016, NEUROLOGY NEUROSURGE, V88, P254; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Goodglass H, 1983, ASSESSMENT APHASIA R; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grace J, 2001, FRSBE FRONTAL SYSTEM; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hastie T, 2015, STAT LEARNING SPARSI; IBM Corp, 2012, IBM SPSS STAT MAC VE; Klein SB, 2003, SOC COGNITION, V21, P157, DOI 10.1521/soco.21.2.157.21317; Kuhn S., 2011, PLOS ONE, V6, P4; Leicht H, 2010, J INT NEUROPSYCH SOC, V16, P463, DOI 10.1017/S1355617710000056; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak M. D., 1982, PEDIATRICS, V70, P387; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Maier ME, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00339; Mattis S., 2001, DEMENTIA RATING SCAL; McGuire BE, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00352; Morin A, 2005, J CONSCIOUSNESS STUD, V12, P115; Morin A, 2007, BRAIN RES BULL, V74, P387, DOI 10.1016/j.brainresbull.2007.06.013; Morin A, 2011, SOC PERSONAL PSYCHOL, V5, P1004, DOI 10.1111/j.1751-9004.2011.00410.x; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; Petrovic P, 2016, SOC COGN AFFECT NEUR, V11, P1041, DOI 10.1093/scan/nsv072; Petrovic P, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00070; Prigatano G.P., 2010, STUDY ANOSOGNOSIA; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; RStudio, 2015, RSTUDIO; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2014, HDB NEUROPSYCHOLOGY; Sollberger M, 2014, BRAIN BEHAV, V4, P201, DOI 10.1002/brb3.211; Springate BA, 2014, J GERIATR PSYCH NEUR, V27, P139, DOI 10.1177/0891988714522700; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STUSS D, 2001, FRONTAL LOBES NEUROP; Stuss D. T., 1991, SELF INTERDISCPLINAR; Suchy Y., 2016, EXECUTIVE FUNCTIONIN; Tang YY, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01000; Tusche A, 2016, J NEUROSCI, V36, P4719, DOI 10.1523/JNEUROSCI.3392-15.2016; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; Vygotsky L. S., 1934, THINKING SPEECH COLL, V1; Whitwell JL, 2001, AM J NEURORADIOL, V22, P1483; Zamboni G, 2010, DEMENT GERIATR COGN, V29, P88, DOI 10.1159/000255141; Zamboni G, 2013, CORTEX, V49, P668, DOI 10.1016/j.cortex.2012.04.011; Zimmermann N, 2017, COGN NEUROPSYCHIATRY, V22, P346, DOI 10.1080/13546805.2017.1330191	65	6	6	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2018	33	5					519	529		10.1093/arclin/acx105			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GS3SF	WOS:000443539600001	29088311	Green Published, Bronze			2022-02-06	
J	Muthuchellappan, R; Shaikh, NA; Surve, RM; Ganne, URS; Philip, M				Muthuchellappan, R.; Shaikh, N. A.; Surve, R. M.; Ganne, U. R. S.; Philip, M.			Regional cerebral tissue oxygen saturation changes following blood transfusion in neuro-intensive care unit patients-a pilot observational study	TRANSFUSION MEDICINE			English	Article						blood transfusion; central venous oximetry; cerebral oximetry; neurocritical care; oxygen delivery; regional cerebral oxygen saturation	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; NEAR-INFRARED SPECTROSCOPY; CRITICALLY-ILL PATIENTS; CELL TRANSFUSION; HEMOGLOBIN CONCENTRATION; METABOLISM; AUTOREGULATION; DELIVERY; VALUES	BackgroundAlthough central venous oxygen saturation (ScvO(2)) is used to decide on red blood cell (RBC) transfusion, whether its improvement is associated with parallel improvement in cerebral oxygenation is not adequately studied. This study looked at changes in regional cerebral tissue oxygen saturation (rSO(2)) following RBC transfusion in neuro-intensive care unit (ICU) patients. MethodsIn this prospective observational pilot study, rSO(2) was measured in adult neuro-ICU patients before RBC transfusion, at the end and at 6, 12, 18 and 24h after RBC transfusion. rSO(2) measurements were taken using cerebral oximetry on both sides of the hemicraniums. Haemoglobin, central venous pressure, ScvO(2) and temperature were recorded during the study period. Arterial oxygen content, central venous oxygen content and cerebral fractional oxygen extraction were calculated. Mann Whitney U test was used to study the changes in variables at baseline and at 24 h following RBC transfusion. Friedman's test was used to study changes in parameters from baseline to 24 h post-transfusion. A P value of <0<bold></bold>05 was considered to be significant. ResultsThe data from 13 subjects were analysed. rSO(2) increased significantly following RBC transfusion on both sides of the brain (P=0<bold></bold>002, P=0<bold></bold>007), with a corresponding decrease in cerebral fractional oxygen extraction (P=0<bold></bold>001, P=0<bold></bold>007). ConclusionsRBC transfusion increased rSO(2) significantly on both sides of the brain. As patients' outcomes were not studied, whether this increase in regional cerebral oxygen saturation is beneficial or if it is because of excess DO2 is still unclear. Further studies are required to clarify this issue.	[Muthuchellappan, R.; Surve, R. M.; Ganne, U. R. S.] Natl Inst Mental Hlth & NeuroSci NIMHANS, Dept Neuroanaesthesia & Neurocrit Care, Hosur Rd, Bengaluru 560029, Karnataka, India; [Shaikh, N. A.] Dr Ram Manohar Lohia Inst Med Sci, Dept Anaesthesiol & Crit Care, Lucknow, Uttar Pradesh, India; [Philip, M.] Natl Inst Mental Hlth & NeuroSci NIMHANS, Dept Biostat, Bengaluru, India		Muthuchellappan, R (corresponding author), Natl Inst Mental Hlth & NeuroSci NIMHANS, Dept Neuroanaesthesia & Neurocrit Care, Hosur Rd, Bengaluru 560029, Karnataka, India.	mrks1974@gmail.com	Philip, Mariamma/AAR-4349-2020	Philip, Mariamma/0000-0001-6047-1494			Allport LE, 2005, NEUROLOGY, V65, P1382, DOI 10.1212/01.wnl.0000183057.96792.a8; Caille V, 2006, CRIT CARE, V10, DOI 10.1186/cc4831; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Dexter F, 1997, BRIT J ANAESTH, V79, P346, DOI 10.1093/bja/79.3.346; Dhar R, 2017, CRIT CARE MED, V45, P653, DOI 10.1097/CCM.0000000000002266; Dueck MH, 2005, ANESTHESIOLOGY, V103, P249, DOI 10.1097/00000542-200508000-00007; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Leal-Noval SR, 2017, J NEUROTRAUM, V34, P2553, DOI 10.1089/neu.2016.4794; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Reinhart K, 2004, INTENS CARE MED, V30, P1572, DOI 10.1007/s00134-004-2337-y; Roberts D.J., 2009, CRITICAL CARE, V16, P154; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Sahoo S, 2017, WORLD NEUROSURG, V98, P211, DOI 10.1016/j.wneu.2016.10.116; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Smythe Paul R, 2002, Anesthesiol Clin North Am, V20, P293, DOI 10.1016/S0889-8537(01)00003-7; Surve RM, 2016, TRANSFUSION MED, V26, P343, DOI 10.1111/tme.12332; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Weigl W, 2016, J CEREBR BLOOD F MET, V36, P1825, DOI 10.1177/0271678X16667953; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	25	6	7	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-7578	1365-3148		TRANSFUSION MED	Transfus. Med.	AUG	2018	28	4					304	309		10.1111/tme.12504			6	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	GQ3PM	WOS:000441578700006	29318718				2022-02-06	
J	Ricci, WM; McAndrew, CM; Miller, AN; Avery, MC				Ricci, William M.; McAndrew, Christopher M.; Miller, Anna N.; Avery, Matthew C.			Open Reduction and Internal Fixation of the Femoral Head via the Smith-Petersen Approach	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article; Proceedings Paper	Annual Meeting of the Orthopaedic-Trauma-Association (OTA)	OCT 11-14, 2017	Vancouver, CANADA	Orthopaed Trauma Assoc		femoral head; open reduction; hip	HIP	Pipkin described femoral head fractures in the 1950s, but controversy still exists regarding indications for surgery and approaches for operative treatment of femoral head fractures. Clear indications for operative intervention include inability to reduce the hip with closed methods, a nonconcentric reduction, fracture fragments within the articulating surface of the hip, and associated injuries (acetabulum and femoral neck fractures) with their own indications for surgery. The anterior approach described by Smith-Petersen has been modified (using only the distal portion) and used to visualize, clean, reduce, and fix these fractures with and without anterior dislocation of the hip.	[Ricci, William M.] Weill Coll Med, Hosp Special Surg, New York, NY USA; [McAndrew, Christopher M.; Miller, Anna N.; Avery, Matthew C.] Washington Univ, Dept Orthopaed Surg, St Louis, MO USA		McAndrew, CM (corresponding author), Campus Box 8233,660 S Euclid Ave, St Louis, MO 63110 USA.	cmcandrew@wustl.edu		Miller, Anna/0000-0002-7056-8502			Brumback R J, 1987, Hip, P181; PIPKIN G, 1957, J BONE JOINT SURG AM, V39, P1027, DOI 10.2106/00004623-195739050-00004; Scolaro JA, 2017, J ORTHOP TRAUMATOL, V18, P235, DOI 10.1007/s10195-017-0445-z; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44	4	6	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	AUG	2018	32			4			S16	S17		10.1097/BOT.0000000000001216			2	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Orthopedics; Sport Sciences	HB8QL	WOS:000451355400009	29985896	Bronze			2022-02-06	
J	Stathopoulos, P; Igoumenakis, D; Mezitis, M; Rallis, G				Stathopoulos, Panagiotis; Igoumenakis, Dimosthenis; Mezitis, Michalis; Rallis, George			Blindness after facial trauma: epidemiology, incidence and risk factors: a 27-year cohort study of 5708 patients	ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY			English	Article							RETROBULBAR HEMORRHAGE; OPTIC NEUROPATHY; MAXILLOFACIAL FRACTURES; SYMPATHETIC OPHTHALMIA; MIDFACIAL FRACTURES; VISUAL IMPAIRMENT; MANAGEMENT; INJURIES; DECOMPRESSION; MECHANISMS	Objectives. This was a 27-year study of a cohort of 5708 patients who had sustained maxillofacial fractures. Our purpose was to present the etiology, mechanism of trauma, site, and concomitant injuries that led to visual loss. We hypothesize that fractures caused by high-energy impact of the midface may be associated with blindness. A discussion of the treatment approaches is also included. Study Design. The study included 5708 patients who had sustained a maxillofacial fracture during the years 1985-2012. Patients' records were reviewed for gender, age, fracture site, etiology of trauma, concomitant injuries, method of treatment, length of hospital stay, and cause of blindness. The relationship of the above variables to blindness was investigated. Results. The incidence of loss of vision was 0.34%. A very strong association between firearm injuries and blindness was observed (P < .001). These patients spent much longer time in hospital (P < .01) and suffered serious concomitant injuries involving the brain. Conclusions. Retrobullbar hemorrhage should be treated with lateral canthotomy, whereas in traumatic optic neuropathy, observation seems to be the safest thing to do. In patients with penetrating injuries of the globe, the immediate involvement of an ophthalmic surgeon is of paramount importance.	[Stathopoulos, Panagiotis] Dublin Dent Univ Hosp, St James & Mater Hosp, Dublin, Ireland; [Igoumenakis, Dimosthenis] Heraklion Gen Hosp, Iraklion, Greece; [Mezitis, Michalis; Rallis, George] KAT Gen Hosp Athens, Athens, Greece		Stathopoulos, P (corresponding author), Dublin Dent Univ Hosp, 2 Lincoln Pl, Dublin D02 VX37, Ireland.	Pan_stath@yahoo.gr		Stathopoulos, Panagiotis/0000-0001-9570-119X			Allen M, 2010, INT J ORAL MAX SURG, V39, P1045, DOI 10.1016/j.ijom.2010.06.021; Ansari MH, 2005, J ORAL MAXIL SURG, V63, P229, DOI 10.1016/j.joms.2004.05.221; Ansell M J, 2010, J R Army Med Corps, V156, P106; Ashar A, 1998, J ORAL MAXIL SURG, V56, P1146, DOI 10.1016/S0278-2391(98)90757-1; Ballard Steven Roy, 2009, J Spec Oper Med, V9, P26; Bossert RP, 2009, CRANIOMAX TRAUM REC, V2, P117, DOI 10.1055/s-0029-1215874; Burkat CN, 2005, ARCH OPHTHALMOL-CHIC, V123, P1260, DOI 10.1001/archopht.123.9.1260; Carrim ZI, 2007, EUR J EMERG MED, V14, P174, DOI 10.1097/MEJ.0b013e3280b17e49; Chi MJ, 2010, OPHTHALMOLOGICA, V224, P167, DOI 10.1159/000238932; Entezari M, 2007, GRAEF ARCH CLIN EXP, V245, P1267, DOI 10.1007/s00417-006-0441-0; Erdmann D, 2008, ANN PLAS SURG, V60, P398, DOI 10.1097/SAP.0b013e318133a87b; Goodall KL, 1999, INJURY, V30, P485, DOI 10.1016/S0020-1383(99)00137-0; Han JK, 2008, AM J RHINOL, V22, P522, DOI 10.2500/ajr.2008.22.3217; HISLOP WS, 1994, INJURY, V25, P663, DOI 10.1016/0020-1383(94)90009-4; Hollier LH, 2010, J CRANIOFAC SURG, V21, P1051, DOI 10.1097/SCS.0b013e3181e5701c; Jamal BT, 2009, J ORAL MAXIL SURG, V67, P986, DOI 10.1016/j.joms.2008.12.035; JENNINGS T, 1989, BRIT J OPHTHALMOL, V73, P140, DOI 10.1136/bjo.73.2.140; Jiang RS, 2001, RHINOLOGY, V39, P71; Knight JS, 1968, BR J PLAST SURG, V21, P325; Kostakis G, 2012, OR SURG OR MED OR PA, V114, pS69, DOI 10.1016/j.tripleo.2011.08.029; Le Fort R, 1901, REV CHIRURG, V23, P208; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Li KK, 1997, J CRANIOFAC SURG, V8, P352, DOI 10.1097/00001665-199708050-00004; LUBIN JR, 1980, OPHTHALMOLOGY, V87, P109; MacKinnon CA, 2002, BRIT J PLAST SURG, V55, P1, DOI 10.1054/bjps.2001.3728; Magarakis M, 2012, PLAST RECONSTR SURG, V129, P227, DOI 10.1097/PRS.0b013e3182362a6d; McClenaghan FC, 2011, CURR OPIN OPHTHALMOL, V22, P426, DOI 10.1097/ICU.0b013e3283499420; Mehravaran R, 2013, J ORAL MAXIL SURG, V71, P1059, DOI 10.1016/j.joms.2013.01.007; Perry M, 2005, INJURY, V36, P875, DOI 10.1016/j.injury.2004.09.018; Popat H, 2007, BRIT J ORAL MAX SURG, V45, P163, DOI 10.1016/j.bjoms.2005.06.028; Rallis G, 2015, OR SURG OR MED OR PA, V119, P614, DOI 10.1016/j.oooo.2015.01.013; Rallis G, 2015, OR SURG OR MED OR PA, V119, P32, DOI 10.1016/j.oooo.2014.09.025; Scott R, 2011, PHILOS T R SOC B, V366, P251, DOI 10.1098/rstb.2010.0234; Sharabi SE, 2011, PLAST RECONSTR SURG, V127, p25E, DOI 10.1097/PRS.0b013e318200cb2d; Stacey DH, 2008, PLAST RECONSTR SURG, V121, P2057, DOI 10.1097/PRS.0b013e31817071fb; Stathopoulos P, 2017, BRIT J ORAL MAX SURG, V55, P296, DOI 10.1016/j.bjoms.2016.08.014; Steinsapir K, 2005, COMPR OPHTHALMOL UPD, V6, P11; Taher AAY, 1996, J CRANIOFAC SURG, V7, P117, DOI 10.1097/00001665-199603000-00007; Vaca EE, 2013, PLAST RECONSTR SURG, V131, P1317, DOI 10.1097/PRS.0b013e31828bd4c2; Wexler A, 2009, J CRANIOFAC SURG, V20, P12, DOI 10.1097/SCS.0b013e31819032c1; Winterton JV, 2007, J ORAL MAXIL SURG, V65, P296, DOI 10.1016/j.joms.2005.11.089; Yu-Wai-Man P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006032.pub4; Zachariades N, 1996, ORAL SURG ORAL MED O, V81, P34, DOI 10.1016/S1079-2104(96)80144-2	43	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-4403	1528-395X		OR SURG OR MED OR PA	Oral Surg. Oral Med. Oral Pathol. Oral Radiol.	AUG	2018	126	2					129	133		10.1016/j.oooo.2018.03.009			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	GN5DW	WOS:000439067800006	29673800				2022-02-06	
J	Takahashi, H; Aoki, Y; Nakajima, A; Sonobe, M; Terajima, F; Saito, M; Miyamoto, T; Koyama, K; Yamamoto, K; Furuya, T; Koda, M; Ohtori, S; Yamazaki, M; Nakagawa, K				Takahashi, Hiroshi; Aoki, Yasuchika; Nakajima, Arata; Sonobe, Masato; Terajima, Fumiaki; Saito, Masahiko; Miyamoto, Takuya; Koyama, Keita; Yamamoto, Keiichiro; Furuya, Takeo; Koda, Masao; Ohtori, Seiji; Yamazaki, Masashi; Nakagawa, Koichi			Axonal damage is remarkable in patients with acutely worsening symptoms of compression myelopathy: biomarkers in cerebrospinal fluid samples	EUROPEAN SPINE JOURNAL			English	Article						Compression myelopathy; Cerebrospinal fluid; Biomarker; Axonal damage	NEURON-SPECIFIC ENOLASE; SPINAL-CORD-INJURY; SUBUNIT NF-H; CERVICAL SPONDYLOTIC MYELOPATHY; POSTERIOR LONGITUDINAL LIGAMENT; NEUROFILAMENT HEAVY SUBUNIT; TRAUMATIC BRAIN-INJURY; PROTEIN CONCENTRATIONS; PNF-H; SERUM	To determine levels of biomarkers reflecting damage to axon, myelin, astrocytes, and neuron in cerebrospinal fluid (CSF) of patients with cervical compression myelopathy. We collected 69 CSF samples from patients before spinal surgery for acutely worsening compression myelopathy (AM, 20), chronic compression myelopathy (CM, 20), and lumbar canal stenosis (LCS 29; control). We measured levels of phosphorylated neurofilament subunit H (pNF-H), tau (reflecting axonal damage), myelin basic protein (MBP) (reflecting demyelination), S100b (reflecting astrocyte damage), and neuron-specific enolase (NSE) (reflecting neuronal damage). Change of neurological function by surgery was determined using a Japanese Orthopaedic Association (JOA) score for cervical myelopathy. Significantly higher levels of pNF-H were detected in AM compared with those in either CM or LCS (P < 0.01). Significantly higher levels of tau were detected in AM compared with those in CM (P < 0.05). Levels of MBP were undetectable in almost all the patients. Levels of S100b were equivalent in the three groups. Levels of NSE in AM and CM were significantly lower than those in LCS (P < 0.01). The recovery rate of JOA score was significantly greater for patients with AM than CM. We found a positive correlation between pNF-H and recovery of JOA score (r = 0.381, P = 0.018). The present results suggest that axonal damage is remarkable compared with demyelination, astrocytic, and neuronal damage in AM. Better clinical outcome in AM with high CSF levels of pNF-H indicates that axonal compensatory plasticity in spinal cord is preserved, and pNF-H can be predictive of good surgical outcome for AM. These slides can be retrieved under Electronic Supplementary Material. [GRAPHICS] .	[Takahashi, Hiroshi; Nakajima, Arata; Sonobe, Masato; Terajima, Fumiaki; Saito, Masahiko; Miyamoto, Takuya; Koyama, Keita; Yamamoto, Keiichiro; Nakagawa, Koichi] Toho Univ, Sakura Med Ctr, Dept Orthopaed Surg, 564-1 Shimoshizu, Sakura, Chiba 2588741, Japan; [Aoki, Yasuchika] Chiba Eastern Med Ctr, Dept Orthopaed Surg, Togane, Japan; [Furuya, Takeo; Koda, Masao; Ohtori, Seiji] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chiba, Japan; [Yamazaki, Masashi] Univ Tsukuba, Dept Orthopaed Surg, Tsukuba, Ibaraki, Japan		Takahashi, H (corresponding author), Toho Univ, Sakura Med Ctr, Dept Orthopaed Surg, 564-1 Shimoshizu, Sakura, Chiba 2588741, Japan.	hirochann@syd.odn.ne.jp	Takahashi, Hiroshi/ABI-6573-2020	Takahashi, Hiroshi/0000-0002-3497-4802; Aoki, Yasuchika/0000-0002-1018-9527	JSPS KAKENHI GrantMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25861346]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16K20072] Funding Source: KAKEN	This study was supported in part by JSPS KAKENHI Grant Number 25861346.	Ahadi R, 2015, SPINE, V40, pE823, DOI 10.1097/BRS.0000000000000654; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Baba H, 1996, J NEUROL, V243, P109, DOI 10.1007/BF02443999; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Casmiro M, 2005, EUR J NEUROL, V12, P369, DOI 10.1111/j.1468-1331.2004.01021.x; Haque A, 2016, METAB BRAIN DIS, V31, P487, DOI 10.1007/s11011-016-9801-6; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Jimenez-Jimenez FJ, 2005, ACTA NEUROL SCAND, V111, P114, DOI 10.1111/j.1600-0404.2005.00370.x; Koda M, 2016, EUR SPINE J, V25, P2294, DOI 10.1007/s00586-016-4555-8; Lima JE, 2004, BRAZ J MED BIOL RES, V37, P19, DOI 10.1590/S0100-879X2004000100003; Masaki Y, 2007, J SPINAL DISORD TECH, V20, P7, DOI 10.1097/01.bsd.0000211260.28497.35; Murphy RKJ, 2016, SPINE, V41, P751, DOI 10.1097/BRS.0000000000001337; Nagashima H, 2009, EUR SPINE J, V18, P1946, DOI 10.1007/s00586-009-1069-7; Nygaard O, 1998, SCAND J CLIN LAB INV, V58, P183; Ohya J, 2015, SPINE J, V15, P1587, DOI 10.1016/j.spinee.2015.03.013; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; Sakuma T, 2012, EUR SPINE J, V21, P482, DOI 10.1007/s00586-011-2020-2; Sampath P, 2000, SPINE, V25, P670, DOI 10.1097/00007632-200003150-00004; Schmidt MH, 2002, SEMIN NEUROL, V22, P143, DOI 10.1055/s-2002-36537; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Shibahashi K, 2016, J NEUROTRAUM, V33, P1826, DOI 10.1089/neu.2015.4237; Takahashi H, 2014, J CLIN NEUROSCI, V21, P2175, DOI 10.1016/j.jocn.2014.04.021; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Vidal PM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92512; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zhu B, 2013, EUR SPINE J, V22, P1583, DOI 10.1007/s00586-013-2817-2	28	6	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	AUG	2018	27	8					1824	1830		10.1007/s00586-018-5549-5			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	GP1ME	WOS:000440579400018	29557051				2022-02-06	
J	Martinez, JT; Petrone, P; Axelrad, A; Marini, CP				Tur Martinez, Jaume; Petrone, Patrizio; Axelrad, Alexander; Marini, Corrado P.			Comparison between thromboelastography and conventional coagulation test: Should we abandon conventional coagulation tests in polytrauma patients?	CIRUGIA ESPANOLA			Spanish	Article; Proceedings Paper	21st Annual Meeting of Surgery of the ACS	OCT 18-20, 2017	Malaga, SPAIN	ACS		Thromboelastography; Conventional coagulation test; Trauma	HEMOSTASIS	Introduction: TEG provides an in-vivo assessment of viscoelastic clot strength in whole blood compared with CCT, which may not reflect the influence of platelets. The aim of this study was to compare TEG vs. CCT in trauma patients stratified by mechanism of injury (MOI) and pre-existing coagulation status. Methods: A retrospective, observational study of 230 polytrauma patients admitted to a University Hospital Level 1 Trauma Center, with TEG and CCT on admission stratified by MOI: multiple trauma (MT), isolated traumatic brain injury (TBI) or MT+TBI. Statistical analysis included correlation between TEG and CCT in all groups and a subgroup analysis of anticoagulated patients. Data were analyzed with ANOVA, Spearman and lineal regression when appropriate. Statistical significance was accepted at P<0.05. Results: TEG was normal in 28.7%, hypercoagulable in 68.3%, hypocoagulable in 7%. There was no difference in TEG status among the groups. The coagulation status was not affected by age, ISS or shock. The CCT were abnormal in 63.6% of patients with normal TEG. Normal or hypercoagulable-TEG was found in 21/23 patients on Coumadin who had elevated INR and in 10/11 patients on NOAC. An analysis of the 23 patients on Coumadin stratified by INR showed a normal or hypercoagulable-TEG in 21/23 patients. Only 2 patients had a hypocoagulable-TEG. Mortality was 5.2% (58.3% severe TBI). Conclusions: TEG is more useful than CCT in polytrauma patients, including patients on anticoagulants. TBI could increase the incidence of hypercoagulability in trauma. CCT are not useful from the standpoint of treatment. (C) 2018 AEC. Published by Elsevier Espana, S.L.U. All rights reserved.	[Tur Martinez, Jaume] Hosp Univ Mutua Terrassa, Barcelona, Spain; [Tur Martinez, Jaume; Petrone, Patrizio; Axelrad, Alexander] NYU Winthrop Hosp, Mineola, NY 11501 USA; [Petrone, Patrizio; Marini, Corrado P.] New York Med Coll, Valhalla, NY 10595 USA		Petrone, P (corresponding author), NYU Winthrop Hosp, Mineola, NY 11501 USA.; Petrone, P (corresponding author), New York Med Coll, Valhalla, NY 10595 USA.	patrizio.petrone@gmail.com	Tur-Martinez, Jaume/AAE-2768-2020; Petrone, Patrizio/AAQ-7986-2020	Tur-Martinez, Jaume/0000-0002-1936-5881; Petrone, Patrizio/0000-0002-7629-1663			Ali JT, 2017, AM J EMERG MED, V35, P632, DOI 10.1016/j.ajem.2016.12.061; Chen A, 2009, CLIN LAB MED, V29, P391, DOI 10.1016/j.cll.2009.04.003; Chitlur M, 2010, SEMIN THROMB HEMOST, V36, P707, DOI 10.1055/s-0030-1265287; Cullinane DC, 1999, CURRENT THERAPY TRAU; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; GIBBS NM, 1994, ANAESTH INTENS CARE, V22, P534, DOI 10.1177/0310057X9402200506; HARTERT H, 1948, KLIN WOCHENSCHR, V26, P577, DOI 10.1007/BF01697545; Inaba K, 2015, J TRAUMA ACUTE CARE, V78, P1220, DOI 10.1097/TA.0000000000000536; KANG YG, 1985, ANESTH ANALG, V64, P888; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Madrazo Z, 2017, CIR ESPAN, V6, P2; TUMAN KJ, 1989, ANESTH ANALG, V69, P69; Whiting P, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19580; Wikkelso A, 2017, ANAESTHESIA, V72, P519, DOI 10.1111/anae.13765	14	6	6	0	1	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0009-739X	1578-147X		CIR ESPAN	Cir. Espan.	AUG-SEP	2018	96	7					443	449		10.1016/j.ciresp.2018.04.003			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	GQ6OD	WOS:000441836200008	29764673				2022-02-06	
J	Ugras, GA; Yuksel, S; Temiz, Z; Eroglu, S; Sirin, K; Turan, Y				Ugras, Gulay Altun; Yuksel, Serpil; Temiz, Zeynep; Eroglu, Selin; Sirin, Keziban; Turan, Yuksel			Effects of Different Head-of-Bed Elevations and Body Positions on Intracranial Pressure and Cerebral Perfusion Pressure in Neurosurgical Patients	JOURNAL OF NEUROSCIENCE NURSING			English	Article						body position; cerebral perfusion pressure; Glasgow coma scale; head of bed elevation; intracranial pressure	TRAUMATIC BRAIN-INJURY; AUTOREGULATION; OXYGENATION; HEMORRHAGE	Purpose: The aim of this study was to evaluate the effects of different head of bed (HOB) elevations and body positions on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) and to identify safe positions for neurosurgical patients with different Glasgow Coma Scale (GCS) scores. Methods: This study with a quasi-experimental, prospective repeated measures is designed with control over the intervention consisted of 30 patients hospitalized in the neurocritical care units (NCU). Patients' HOB was elevated (degree of 15,30,45) and the patients were at supine, left lateral and right lateral positions. ICP and CPP were recorded for each patient. Results: It was found that ICP increased and CPP decreased at supine, left and right lateral positions with different HOB elevations, which, however, did not reach statistical significance. When patients with a GCS score of 3-8 were at degree of 15 right and left lateral positions and 45 right lateral position; and when patients with a GCS score of 13-15 were positioned at degree of 15 left lateral, ICP and CPP changed significantly. Conclusion: The results of this study showed that different positions the patients' HOB (degree of 15,30,45) led to slight insignificant changes in ICP and CPP; and these values were maintained within the ranges established by recent guidelines.	[Ugras, Gulay Altun] Mersin Univ, Sch Hlth, Dept Surg Nursing, Mersin, Turkey; [Ugras, Gulay Altun] Mersin Univ, Dept Surg Nursing, Mersin, Turkey; [Yuksel, Serpil] Univ Necmettin Erbakan, Dept Surg Nursing, Konya, Turkey; [Temiz, Zeynep] Univ Artvin Coruh, Dept Surg Nursing, Artvin, Turkey; [Eroglu, Selin; Turan, Yuksel] Istanbul Univ, Neurosurg Intens Care Unit, Cerrahpasa Fac Med, Istanbul, Turkey; [Sirin, Keziban] Istanbul Univ, Dept Neurosurg, Cerrahpasa Fac Med, Istanbul, Turkey		Ugras, GA (corresponding author), Mersin Univ, Sch Hlth, Dept Surg Nursing, Mersin, Turkey.	carpediem0803@yahoo.com	Yuksel, Serpil/AAB-8836-2020	Yuksel, Serpil/0000-0001-6881-8288			Altun Ura G, 2015, NOROIRURJI HEMIRELII, V1, P29; Blissitt PA, 2006, AM J CRIT CARE, V15, P206; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Palazon JH, 2008, REV ESP ANEST REANIM, V55, P289; Hickey JV, 2009, CLIN PRACTICE NEUROL, P370; Jiang Y, 2015, J ADV NURS, V71, P2237, DOI 10.1111/jan.12679; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Kirkness CJ, 2008, HEART LUNG, V37, P227, DOI 10.1016/j.hrtlng.2007.05.015; Kose G, 2012, J CLIN NURS, V21, P1859, DOI 10.1111/j.1365-2702.2012.04134.x; Ledwith MB, 2010, J NEUROSCI NURS, V42, P280, DOI 10.1097/JNN.0b013e3181ecafd4; Livesay SL, 2017, J NEUROSCI NURS, V49, P372, DOI 10.1097/JNN.0000000000000321; Mahfoud F, 2010, ACTA NEUROCHIR, V152, P443, DOI 10.1007/s00701-009-0520-1; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Nyholm L, 2014, J NEUROSCI NURS, V46, P285, DOI 10.1097/JNN.0000000000000077; Peterson E, 2009, J TRAUMA, V67, P944, DOI 10.1097/TA.0b013e3181ae6e6d; Reinhard M, 2010, INTENS CARE MED, V36, P264, DOI 10.1007/s00134-009-1698-7; Rogers M, 2017, J NEUROSCI NURS, V49, P85, DOI 10.1097/JNN.0000000000000257; Schwarz S, 2002, STROKE, V33, P497, DOI 10.1161/hs0202.102376; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Weaver DL, 2015, UNDERSTANDING MED SU, P1095	20	6	7	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	AUG	2018	50	4					247	251		10.1097/JNN.0000000000000386			5	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	GM9BD	WOS:000438535200013	29985278				2022-02-06	
J	Weber, E; Spirou, A; Chiaravalloti, N; Lengenfelder, J				Weber, Erica; Spirou, Angela; Chiaravalloti, Nancy; Lengenfelder, Jeannie			Impact of Frontal Neurobehavioral Symptoms on Employment in Individuals With TBI	REHABILITATION PSYCHOLOGY			English	Article						brain injuries (traumatic); employment; executive function; neurobehavioral manifestations	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; COMMUNITY INTEGRATION; DEPRESSIVE SYMPTOMS; UNITED-STATES; PREDICTORS; SEVERITY; MODERATE; OUTCOMES; APATHY	Objective: To explore the contribution of frontal systems behavioral dysfunction on employment outcomes in individuals with traumatic brain injury (TBI), in the context of relevant predictors of work status. Method: Forty-two participants with history of moderate-to-severe TBI were classified as either "Employed" or "Unemployed." Groups did not differ on most demographic or injury variables, although the Unemployed sample reported greater symptoms of depression, pain, and fatigue (ps < 0.05). Participants completed a neuropsychological evaluation emphasizing frontal systems and Frontal Systems Behavior Scale (FrsBe; self- and informant-rated forms). Results: T tests using cognitive indicators of frontal dysfunction revealed no significant differences between groups (ps > 0.05). T tests using neurobehavioral indicators of frontal dysfunction (i.e., FrSRe) revealed differences between groups on both self- (Hedge's g = 0.71; p = .046) and informant-rated (g = 1.12; p = .001) FrSRe total T scores. Two logistic regressions for each FrSRe score were conducted, including relevant variables on which samples differed as covariates. Only the informant-rated FrSBe score remained a significant predictor of employment (FrSBe-informant: p = .038; R-squared change = 0.177). Self- and informant-rated FrSBe scores were significantly correlated in the Unemployed group (r = .403: p = .037) but not in the Employed sample (r = .102: p = .717). Conclusions: These results suggest that behavioral indicators of frontal systems dysfunction are predictive of employment status in individuals with TBI. Future work should aim to Lest the efficacy of strategies to reduce dysfunctional frontal behaviors as a means to gain and maintain employment.	[Weber, Erica; Spirou, Angela; Chiaravalloti, Nancy; Lengenfelder, Jeannie] Kessler Fdn, Traumat Brain Injury Lab, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA; [Weber, Erica; Chiaravalloti, Nancy; Lengenfelder, Jeannie] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Chiaravalloti, Nancy] Kessler Fdn, Neuropsychol & Neurosci Lab, E Hanover, NJ 07936 USA		Weber, E (corresponding author), Kessler Fdn, Traumat Brain Injury Lab, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.	eweber@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission on Brain Injury Research [10-3218-BIR-E-0]	This research was supported in part by a grant from the New Jersey Commission on Brain Injury Research (Grant 10-3218-BIR-E-0) awarded to Jeannie Lengenfelder.	Arnould A, 2015, BRAIN INJURY, V29, P1597, DOI 10.3109/02699052.2015.1075156; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; Bay E, 2012, ARCH PSYCHIAT NURS, V26, P477, DOI 10.1016/j.apnu.2012.06.002; Bull H, 2016, J NERV MENT DIS, V204, P599, DOI 10.1097/NMD.0000000000000504; Cattelani R, 2008, EUR J PHYS REHAB MED, V44, P245; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; Colantonio A, 2016, NEUROREHABILITATION, V39, P389, DOI 10.3233/NRE-161370; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Freeman W, 1939, Yale J Biol Med, V11, P527; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kamat R, 2016, PSYCHOL HEALTH MED, V21, P890, DOI 10.1080/13548506.2015.1131998; Kamat R, 2012, ARCH CLIN NEUROPSYCH, V27, P520, DOI 10.1093/arclin/acs055; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Lengenfelder J, 2015, APPL NEUROPSYCH-ADUL, V22, P7, DOI 10.1080/23279095.2013.816703; Little Deborah M, 2015, Handb Clin Neurol, V131, P465, DOI 10.1016/B978-0-444-62627-1.00027-5; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Man DWK, 2013, BRAIN INJURY, V27, P1016, DOI 10.3109/02699052.2013.794969; Mann R, 2013, SPINAL CORD, V51, P564, DOI 10.1038/sc.2013.34; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; NIDILRR, 2016, TRAUM BRAIN INJ MOD; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pearce B, 2016, BRAIN INJURY, V30, P1708, DOI 10.1080/02699052.2016.1202450; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Roy R, 2006, SOCIAL RELATIONS CHR; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Shahrbanian S, 2013, PAIN RES MANAG, V18, pE94, DOI 10.1155/2013/829464; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Spikman JM, 2016, J NEUROTRAUM, V33, P22, DOI 10.1089/neu.2014.3788; Steenstra IA, 2017, J OCCUP REHABIL, V27, P369, DOI 10.1007/s10926-016-9666-x; Tran J, 2016, SPINAL CORD, V54, P640, DOI 10.1038/sc.2016.66; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Yeates G, 2016, NEUROREHABILITATION, V38, P299, DOI 10.3233/NRE-161321	52	6	6	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2018	63	3					383	391		10.1037/rep0000208			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	GQ4ZS	WOS:000441685700007	30024202				2022-02-06	
J	Wetzel, PA; Lindblad, AS; Raizada, H; James, N; Mulatya, C; Kannan, MA; Villamar, Z; Gitchel, GT; Weaver, LK				Wetzel, Paul A.; Lindblad, Anne S.; Raizada, Hardik; James, Nathan; Mulatya, Caroline; Kannan, Mary A.; Villamar, Zoe; Gitchel, George T.; Weaver, Lindell K.			Eye Tracking Results in Postconcussive Syndrome Versus Normative Participants	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						brain concussion; eye tracking; postconcussive syndrome; smooth pursuit; saccade	TRAUMATIC BRAIN-INJURY; HYPERBARIC-OXYGEN; SMOOTH-PURSUIT; DEFICITS; DESIGN; TREMOR	PURPOSE. Standard physical, neurologic, and neuropsychologic examinations may not detect abnormalities after mild traumatic brain injury (mTBI). An analysis of eye movements may be more sensitive to neurologic dysfunction. METHODS. We performed eye tracking assessments in 71 active duty and veteran military personnel with persistent postconcussive symptoms (3 months to 5 years after mTBI) and 75 volunteers with no history of brain injury. Both eyes were sampled at 500 Hz and analyzed for various eye measurement parameters during visual tasks involving the saccadic and smooth systems. RESULTS. No difference between mTBI and normal participants in main sequence profiles was observed. On the circular task, intersaccadic interval duration was shorter in mTBI compared with normal subjects (horizontal: Cohen's D = -0.65; vertical: Cohen's D = -0.75). For reading, absolute saccadic amplitudes (Cohen's D = -0.76) and average forward saccadic amplitudes were lower (Cohen's D = -0.61). Absolute fixation velocity was higher (Cohen's D = 1.02), and overall fixation durations (Cohen's D = 0.58), regression durations (Cohen's D = 0.49), and forward saccadic durations (Cohen's D = 0.54) were longer. mTBI participants had more fixations (Cohen's D = 0.54) and regressions per line (Cohen's D = 0.70) and read fewer lines (Cohen's D = -0.38) than normal subjects. On the horizontal ramp task, mTBI participants had lower weighted smooth pursuit gains (Cohen's D = -0.55). On the horizontal step task, mTBI participants had shorter mean fixation times (Cohen's D = -0.55). CONCLUSIONS. These results suggest vulnerability of the smooth pursuit and saccadic systems in mTBI. Eye tracking shows promise as an objective, sensitive assessment of damage after mTBI. (ClinicalTrials.gov number, NCT01611194, NCT01925963.)	[Wetzel, Paul A.] Lovelace Biomed Res, Albuquerque, NM USA; [Wetzel, Paul A.; Kannan, Mary A.; Villamar, Zoe; Gitchel, George T.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Lindblad, Anne S.; Raizada, Hardik; James, Nathan; Mulatya, Caroline] Emmes Corp, 401 N Washington St,Suite 700, Rockville, MD 20850 USA; [Weaver, Lindell K.] Intermt Med Ctr, Div Hyperbar Med, Murray, UT USA; [Weaver, Lindell K.] Intermt LDS Hosp, Salt Lake City, UT USA; [Weaver, Lindell K.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA		Lindblad, AS (corresponding author), Emmes Corp, 401 N Washington St,Suite 700, Rockville, MD 20850 USA.	alindblad@emmes.com		Villamar, Zoe/0000-0003-1308-4840	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-D-0039-0003]	Supported by the US Army Medical Research and Materiel Command under Contract W81XWH-15-D-0039-0003. The views, opinions, and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.	BAHILL AT, 1982, BIOL CYBERN, V45, P1, DOI 10.1007/BF00387207; Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Gitchel GT, 2013, TREMOR OTHER HYPERK, V3; Gitchel GT, 2012, ARCH NEUROL-CHICAGO, V69, P1011, DOI 10.1001/archneurol.2012.70; Helmchen C, 2003, BRAIN, V126, P1319, DOI 10.1093/brain/awg132; HOLM S, 1979, SCAND J STAT, V6, P65; Kimmel DL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00049; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; Lynch J, 2009, ENCY NEUROSCIENCE, V7, P17; Mallahan EL, 2006, FED PRACT, V23, P56; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; MILLER GR, 1967, J VERB LEARN VERB BE, V6, P851, DOI 10.1016/S0022-5371(67)80148-8; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Pierrot-Deseilligny C, 2002, ANN NY ACAD SCI, V956, P216, DOI 10.1111/j.1749-6632.2002.tb02821.x; PIERROTDESEILLIGNY C, 1991, EXP BRAIN RES, V83, P607; Rivaud-Pechoux S, 2000, J NEUROL NEUROSUR PS, V68, P381, DOI 10.1136/jnnp.68.3.381; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013; Tian JR, 1996, J NEUROPHYSIOL, V76, P2754, DOI 10.1152/jn.1996.76.4.2754; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P491; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Wilson SH, 2016, UNDERSEA HYPERBAR M, V43, P615; Zuber BL, 1981, MODELS OCULOMOTOR BE, P193	27	6	6	2	6	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	AUG	2018	59	10					4011	4019		10.1167/iovs.18-23815			9	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ophthalmology	GP9ZB	WOS:000441273800025	30098189	gold			2022-02-06	
J	Yu, KP; Yoon, YS; Lee, JG; Oh, JS; Lee, JS; Seog, T; Lee, HY				Yu, Ki Pi; Yoon, Yong-Soon; Lee, Jin Gyeong; Oh, Ji Sun; Lee, Jeong-Seog; Seog, Taeyong; Lee, Han-Young			Effects of Electric Cortical Stimulation (ECS) and Transcranial Direct Current Stimulation (tDCS) on Rats With a Traumatic Brain Injury	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Electric cortical stimulation; Transcranial direct current stimulation; Traumatic brain injuries; Rehabilitation; Function recovery	MEDIAL PREFRONTAL CORTEX; USE-DEPENDENT PLASTICITY; MOTOR CORTEX; SPATIAL MEMORY; CHRONIC STROKE; RECOVERY; ISCHEMIA; INFARCT; REHABILITATION; ENHANCEMENT	Objective To evaluate the effects of electric cortical stimulation (ECS) and transcranial direct current stimulation (tDCS) on motor and cognitive function recovery and brain plasticity in focal traumatic brain injury (TBI) of rats model. Methods Forty rats were pre-trained to perform a single pellet reaching task (SPRT), rotarod test (RRT), and Y-maze test for 14 days, then a focal TBI was induced by a weight drop model on the motor cortex. All rats were randomly assigned to one of the three groups: anodal ECS (50 Hz and 194 mu s) (ECS group), tDCS (0.1 mA, 50 Hz and 200 mu s) (tDCS group), and no stimulation as a control group. Four-week stimulation, including rehabilitation, was started 3 days after the operation. SPRT, RRT, and Y-maze were measured from day 1 to day 28 after the TBI was induced. Histopathological and immunohistochemistry staining evaluations were performed at 4 weeks. Results SPRT was improved from day 7 to day 26 in ECS, and from day 8 to day 26 in tDCS compared to the control group (p<0.05). SPRT of ECS group was significantly improved on days 3, 8, 9, and 17 compared to the tDCS group. Y-maze was improved from day 8 to day 16 in ECS, and on days 6, 12, and 16 in the tDCS group compared to the control group (p<0.05). Y-maze of the ECS group was significantly improved on day 9 to day 15 compared to the tDCS group. The c-Fos protein expression was better in the ECS group and the tDCS group compared to the control group. Conclusion Electric stimulation in rats modified with a focal TBI is effective for motor recovery and brain plasticity. ECS induced faster behavioral and cognitive improvements compared to tDCS during the recovery period of rats with a focal TBI.	[Yu, Ki Pi; Yoon, Yong-Soon; Lee, Jin Gyeong; Seog, Taeyong] Presbyterian Med Ctr, Dept Phys Med & Rehabil, 365 Seowon Ro, Jeonju 54987, South Korea; [Yu, Ki Pi; Yoon, Yong-Soon; Oh, Ji Sun] Presbyterian Med Ctr, Med Device Clin Trial Ctr, Jeonju, South Korea; [Lee, Jeong-Seog] Chonbuk Natl Univ, Dept Biol Sci, Jeonju, South Korea; [Lee, Han-Young] Presbyterian Med Ctr, Dept Family Med, Jeonju, South Korea		Seog, T (corresponding author), Presbyterian Med Ctr, Dept Phys Med & Rehabil, 365 Seowon Ro, Jeonju 54987, South Korea.	foryou6199@naver.com		Lee, Han-Young/0000-0002-1145-5495; Yoon, YongSoon/0000-0003-4709-3964			Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Brown JA, 2006, NEUROSURGERY, V58, P464, DOI 10.1227/01.NEU.0000197100.63931.04; Conrad CD, 1997, BRAIN RES, V759, P76, DOI 10.1016/S0006-8993(97)00236-9; Day HEW, 2008, BRAIN RES, V1229, P137, DOI 10.1016/j.brainres.2008.06.085; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Ducker TB, 1976, HDB CLIN NEUROLOGY, P9; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Harvey RL, 2007, TOP STROKE REHABIL, V14, P54, DOI 10.1310/tsr1406-54; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hunter AJ, 1998, TRENDS PHARMACOL SCI, V19, P59, DOI 10.1016/S0165-6147(97)01157-7; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Kang C, 2013, ANN REHABIL MED-ARM, V37, P301, DOI 10.5535/arm.2013.37.3.301; Kim HI, 2008, SURG NEUROL, V69, P77, DOI 10.1016/j.surneu.2006.12.055; Kim SJ, 2010, J KOREAN MED SCI, V25, P1499, DOI 10.3346/jkms.2010.25.10.1499; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kreisel SH, 2007, CEREBROVASC DIS, V23, P243, DOI 10.1159/000098323; Lacroix L, 2002, BEHAV BRAIN RES, V133, P69, DOI 10.1016/S0166-4328(01)00442-9; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Martin Paula I., 2004, Seminars in Speech and Language, V25, P181; Minhas AS, 2009, IEEE ENG MED BIO, P2276, DOI 10.1109/IEMBS.2009.5335084; Moon SK, 2009, NEUROSCI LETT, V460, P152, DOI 10.1016/j.neulet.2009.05.029; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; National Research Council, 2011, GUIDE CARE USE LAB A; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Paxinos G, 2007, RAT BRAIN STEREOTAXI, P30; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Pratt WE, 2001, BEHAV BRAIN RES, V123, P165, DOI 10.1016/S0166-4328(01)00204-2; Salzman SK, 1994, NEUROBIOLOGY CENTRAL, P3; Sawaki L, 2006, STROKE, V37, P246, DOI 10.1161/01.STR.0000195130.16843.ac; Sim K.C., 2011, J INT ACAD PHYS THER, V2, P193; Teskey GC, 2003, NEUROL RES, V25, P794, DOI 10.1179/016164103771953871; Vergara-Aragon P, 2003, J NEUROSCI, V23, P579, DOI 10.1523/JNEUROSCI.23-02-00579.2003; Yang CY, 2008, ANN REHABIL MED-ARM, V32, P375; Yoon KJ, 2012, BRAIN RES, V1452, P61, DOI 10.1016/j.brainres.2012.02.062; Yoon YS, 2012, ANN REHABIL MED-ARM, V36, P596, DOI 10.5535/arm.2012.36.5.596; Yu SH, 2014, J PHYS THER SCI, V26, P247, DOI 10.1589/jpts.26.247	40	6	6	1	4	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	AUG	2018	42	4					502	513		10.5535/arm.2018.42.4.502			12	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	GT1ZX	WOS:000444278700002	30180518	Green Published, gold, Green Submitted			2022-02-06	
J	Jiang, ZZ; Xu, HM; Wan, ML; Li, ZF; Su, XY; Li, XD; Li, ZZ; Han, XX				Jiang, Zhenzhen; Xu, Hongmei; Wan, Meilin; Li, Zefu; Su, Xinyang; Li, Xiaoli; Li, Zhenzhu; Han, Xuexin			Effect of infusion speed of 7.5% hypertonic saline on brain edema in patients with craniocerebral injury: An experimental study	GENE			English	Article						Hypertonic saline; Infusion speed; Brain edema; Brain injury	INTRACRANIAL HYPERTENSION; PRESSURE; MANNITOL; EXPRESSION; MODEL; RATS	This study firstly used a rat traumatic brain injury model to compare the therapeutic effects of different intravenous infusion speed of 7.5% hypertonic saline (HS). Then the authors applied different delivery rate of 7.5% HS to two groups of patients to figure out the optimal infusion rates. A total of 100 rats were randomly divided into control group, group A (7.5% HS 6 mL/h), group B (7.5% HS 3 mL/h), and group C (7.5% HS 2 mL/h). All rats were established for the brain injury model. A total of 30 patients were selected and randomly divided into group A (250 mL/h) and group B (125 mL/h), with 15 cases in each group. Urine amount was recorded per hour; furthermore, blood was extracted from the patients to measure the levels of AQP4, NKCC1, tumour necrosis factor-alpha (TNF-a), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6). Compared with other groups, the expression levels of NKCC1 and AQP4 mRNA in group A was the lowest (P < 0.05). NKCC1 and AQP4 protein expression levels were the lowest in all the groups (P < 0.05). On the aspect of patients, group A displayed more significant difference compared with B group in terms of AQP4, NKCC1, TNF-a, 1L 1 beta, and IL-6 (P < 0.05). In the two groups, a significant difference was noted in the urine amount at 4 h after administration (P < 0.05). In our study, infusion of hypertonic saline (250 mL/h) at the optimal rate of 7.5% HS decreased the intracranial pressure, brain tissue edema, and inflammatory cytokine expression; moreover, it can promote brain tissue protection.	[Jiang, Zhenzhen] Binzhou Med Univ, Dept Nursing, Yantai, Peoples R China; [Xu, Hongmei] Binzhou Med Univ, Affiliated Hosp, Dept Hosp Infect Off, Binzhou 256603, Peoples R China; [Wan, Meilin; Su, Xinyang] Binzhou Med Univ, Affiliated Hosp, Nursing Dept, Binzhou, Peoples R China; [Li, Zefu; Li, Xiaoli; Li, Zhenzhu; Han, Xuexin] Binzhou Med Univ, Affiliated Hosp, Dept Neurosurg Med, Binzhou, Peoples R China		Xu, HM (corresponding author), Binzhou Med Univ, Affiliated Hosp, Dept Hosp Infect Off, Binzhou 256603, Peoples R China.	hmx58@163.com			Nursing Research-projects of Affiliated Hospital of Binzhou Medical University [BYFYHL-201501]	This research was supported by Nursing Research-funded projects of Affiliated Hospital of Binzhou Medical University (BYFYHL-201501).	Ajito T, 1999, J VET MED SCI, V61, P637, DOI 10.1292/jvms.61.637; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Dostal P, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0067-z; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finnie JW, 2011, J CLIN NEUROSCI, V18, P947, DOI 10.1016/j.jocn.2010.11.010; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Leinonen Ville, 2017, Handb Clin Neurol, V145, P25, DOI 10.1016/B978-0-12-802395-2.00004-3; Loos M, 2003, NEUROSCIENCE, V122, P373, DOI 10.1016/S0306-4522(03)00498-6; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Mangat HS, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1963-7; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Musumeci M, 2013, DIS MARKERS, V2013, P141, DOI 10.1155/2013/246205; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Perez CA, 2017, J NEUROSCI NURS, V49, P191, DOI 10.1097/JNN.0000000000000286; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; The Brain Trauma Foundation, 2017, J NEUROTRAUM, P563; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E	22	6	7	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	JUL 30	2018	665						201	207		10.1016/j.gene.2018.05.005			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GJ8EK	WOS:000435621900025	29729380				2022-02-06	
J	Singh, GP; Nigam, R; Tomar, GS; Monisha, M; Bhoi, SK; Arulselvi, S; Sengar, K; Akula, D; Panta, P; Anindya, R				Singh, Gyaninder Pal; Nigam, Richa; Tomar, Gaurav Singh; Monisha, Mohan; Bhoi, Sanjeev Kumar; Arulselvi, S.; Sengar, Kangana; Akula, Deepa; Panta, Prashanth; Anindya, Roy			Early and rapid detection of UCHL1 in the serum of brain-trauma patients: a novel gold nanoparticle-based method for diagnosing the severity of brain injury	ANALYST			English	Article							C-TERMINAL HYDROLASE; INTRACRANIAL LESIONS; UBIQUITIN; MILD; L1; UTILITY	The clinical diagnosis of traumatic brain injury (TBI) is based on neurological examination and neuroimaging tools such as CT scanning and MRI. However, neurological examination at times may be confounded by consumption of alcohol or drugs and neuroimaging facilities may not be available at all centers. Human ubiquitin C-terminal hydrolase (UCHL1) is a well-accepted serum biomarker for severe TBI and can be used to detect the severity of a head injury. A reliable, rapid, cost effective, bedside and easy to perform method for the detection of UCHL1 is a pre-requisite for wide clinical applications of UCHL1 as a TBI biomarker. We developed a rapid detection method for UCHL1 using surface plasmon resonance of gold nanoparticles with a limit of detection (LOD) of 0.5 ng mL(-1). It has a sensitivity and specificity of 100% each and meets an analytical precision similar to that of conventional sandwich ELISA but can be performed rapidly. Using this method we successfully detected UCHL1 in a cohort of 66 patients with TBI and were reliably able to distinguish mild TBI from moderate to severe TBI.	[Singh, Gyaninder Pal; Tomar, Gaurav Singh] All India Inst Med Sci, Dept Neuroanaesthesiol & Crit Care, JPN Apex Trauma Ctr, New Delhi 110029, India; [Nigam, Richa; Monisha, Mohan; Akula, Deepa; Anindya, Roy] Indian Inst Technol IIT Hyderabad, Dept Biotechnol, Sangareddy 502285, Telangana, India; [Bhoi, Sanjeev Kumar] All India Inst Med Sci, Dept Emergency Med, JPN Apex Trauma Ctr, New Delhi 110029, India; [Arulselvi, S.; Sengar, Kangana] All India Inst Med Sci, Dept Lab Med, JPN Apex Trauma Ctr, New Delhi 110029, India; [Panta, Prashanth] MNR Dent Coll & Hosp, Dept Oral Med & Radiol, Sangareddy 502294, Telangana, India		Anindya, R (corresponding author), Indian Inst Technol IIT Hyderabad, Dept Biotechnol, Sangareddy 502285, Telangana, India.	anindya@iith.ac.in	Subramanian, arulselvi/AAG-1670-2020; Anindya, Roy/ABD-1326-2020; Anindya, Roy/F-8241-2012; Panta, Prashanth/AAH-6254-2020; SINGH, GYANINDER/K-8621-2019; Tomar, Gaurav Singh/G-9567-2015; SINGH, GYANINDER/T-7976-2017	Subramanian, arulselvi/0000-0001-7797-6683; Anindya, Roy/0000-0001-8561-907X; Anindya, Roy/0000-0001-8561-907X; Panta, Prashanth/0000-0003-2929-6944; Tomar, Gaurav Singh/0000-0003-1333-6614; SINGH, GYANINDER/0000-0002-6702-6892	Department of Biotechnology, Ministry of Science & Technology, Government of IndiaDepartment of Biotechnology (DBT) India [BT/PR14412/NNT/28/849/2015]	The work was funded by Extra-mural research project (No. BT/PR14412/NNT/28/849/2015), Department of Biotechnology, Ministry of Science & Technology, Government of India.	Agarwal S, 2015, ANALYST, V140, P1166, DOI 10.1039/c4an01935k; Arnaoutakis GJ, 2011, J THORAC CARDIOV SUR, V142, P902, DOI 10.1016/j.jtcvs.2011.06.027; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Boudreaux DA, 2010, P NATL ACAD SCI USA, V107, P9117, DOI 10.1073/pnas.0910870107; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Case A, 2006, BIOCHEMISTRY-US, V45, P2443, DOI 10.1021/bi052135t; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Davies CW, 2012, BIOORG MED CHEM LETT, V22, P3900, DOI 10.1016/j.bmcl.2012.04.124; Day I. N., 1997, PROG NEUROBIOL, V90, P327; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Gong B, 2007, DRUG NEWS PERSPECT, V20, P365, DOI 10.1358/dnp.2007.20.6.1138160; Guarise C, 2005, LANGMUIR, V21, P5537, DOI 10.1021/la0470232; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y	26	6	8	0	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0003-2654	1364-5528		ANALYST	Analyst	JUL 21	2018	143	14					3366	3373		10.1039/c8an00533h			8	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	GM4AZ	WOS:000438056400013	29893758				2022-02-06	
J	Heiberg, G; Pedersen, SG; Friborg, O; Nielsen, JF; Holm, HS; Steinbuchel, V; Arntzen, C; Anke, A				Heiberg, Guri; Pedersen, Synne Garder; Friborg, Oddgeir; Nielsen, Jorgen Feldbaek; Holm, Henriette Stabel; Steinbuechel, von Nicole; Arntzen, Cathrine; Anke, Audny			Can the health related quality of life measure QOLIBRI-overall scale (OS) be of use after stroke? A validation study	BMC NEUROLOGY			English	Article						QOLIBRI-OS; Stroke; Health related quality of life; Validity	TRAUMATIC BRAIN-INJURY; HOSPITAL ANXIETY; SINGLE-ITEM; MEASUREMENT INSTRUMENTS; PSYCHOMETRIC EVALUATION; METHODOLOGICAL QUALITY; DEPRESSION SCALE; IMPACT; VALIDITY; RELIABILITY	Background: Brief measures of health-related quality of life (HRQOL) that assess both patient-reported functioning and well-being after stroke are scarce. The objective of this study was to examine reliability and validity of one of these measures, the patient-reported Quality of Life after Brain Injury-Overall Scale (QOLIBRI-OS), in patients after stroke. Methods: Stroke survivors were examined prospectively using survey methods. Core survey data (n = 125) and retest data (n = 36) were obtained at 3 and 12 months, respectively. Item properties (distribution, floor and ceiling effects), psychometric properties (reliability and model fit), and validity (correlations with established measures of anxiety, depression and HRQOL) of the QOLIBRI-OS were examined. Results: Missing responses on the questionnaire were low (0.5%). All items were positively skewed. No floor effects were present, whereas five out of six items showed ceiling effects. The summary QOLIBRI-OS score exhibited no floor or ceiling effects, and had excellent internal consistency (Cronbach's a = 0.93). All item-total correlations were high (0. 73-0.88). The test-retest reliability of single items varied from 0.74 to 0.91 and was 0.93 for the overall score. The confirmatory factor analysis yielded an excellent fit for a five-item version and provided tentative support for the original six-item version. The convergent validity correlations were in the hypothesized directions, thus supporting the construct validity. Conclusions: The brief QOLIBRI-OS is a valid and reliable brief health-related outcome measure that is appropriate for screening HRQOL in patients after stroke.	[Heiberg, Guri; Pedersen, Synne Garder; Arntzen, Cathrine; Anke, Audny] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Heiberg, Guri; Anke, Audny] Univ Tromso Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Tromso, Norway; [Pedersen, Synne Garder; Arntzen, Cathrine] Univ Tromso Arctic Univ Norway, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway; [Friborg, Oddgeir] Univ Tromso Arctic Univ Norway, Fac Hlth Sci, Dept Psychol, Tromso, Norway; [Nielsen, Jorgen Feldbaek; Holm, Henriette Stabel] Aarhus Univ, Hammel Neurorehabil Ctr, Aarhus, Denmark; [Nielsen, Jorgen Feldbaek; Holm, Henriette Stabel] Aarhus Univ, Univ Res Clin, Aarhus, Denmark; [Steinbuechel, von Nicole] Georg August Univ, Univ Med, Gottingen, Germany; [Heiberg, Guri] Univ Hosp North Norway Harstad, Dept Rehabil, N-9480 Harstad, Norway		Heiberg, G (corresponding author), Univ Hosp North Norway, Dept Rehabil, Tromso, Norway.; Heiberg, G (corresponding author), Univ Tromso Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Tromso, Norway.; Heiberg, G (corresponding author), Univ Hosp North Norway Harstad, Dept Rehabil, N-9480 Harstad, Norway.	guri.heiberg@unn.no	Nielsen, Jorgen Feldbak/AAR-6384-2021	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Anke, Audny/0000-0002-2491-2560; Pedersen, Synne Garder/0000-0003-3744-7466; Friborg, Oddgeir/0000-0001-6629-0782; Arntzen, Cathrine/0000-0002-8194-0437	Health region North Norway [SFP1175-14]	Health region North Norway has funded the study. Grant number SFP1175-14.	Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003; Almborg AH, 2009, J REHABIL MED, V41, P48, DOI 10.2340/16501977-0287; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Black N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f167; Buck D, 2000, STROKE, V31, P2004, DOI 10.1161/01.STR.31.8.2004; Cael S, 2015, PHYS THER, V95, P778, DOI 10.2522/ptj.20130012; de Boer AGEM, 2004, QUAL LIFE RES, V13, P311, DOI 10.1023/B:QURE.0000018499.64574.1f; Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482; Duncan F, 2012, J PSYCHOSOM RES, V73, P18, DOI 10.1016/j.jpsychores.2012.04.001; Dunning K, 2011, J PHYSIOTHER, V62, P117; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Field A., 2005, A FIELD DISCOVERING; Field A. P., 2005, ENCY BEHAV STAT, V2, P948, DOI DOI 10.1002/0470013192.BSA313; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Gardner DG, 1998, EDUC PSYCHOL MEAS, V58, P898, DOI 10.1177/0013164498058006003; Guidetti S, 2014, J REHABIL MED, V46, P963, DOI 10.2340/16501977-1865; Hoeppner BB, 2011, J SUBST ABUSE TREAT, V41, P305, DOI 10.1016/j.jsat.2011.04.005; Janssen B., 2015, EQ 5D 5L USER GUIDE; Carod-Artal FJ, 2012, EXPERT REV PHARM OUT, V12, P199, DOI [10.1586/erp.11.104, 10.1586/ERP.11.104]; Jenkinson C, 2013, STROKE, V44, P2532, DOI 10.1161/STROKEAHA.113.001847; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kimberlin CL, 2008, AM J HEALTH-SYST PH, V65, P2276, DOI 10.2146/ajhp070364; Levine DA, 2015, JAMA-J AM MED ASSOC, V314, P41, DOI 10.1001/jama.2015.6968; Loo R., 2002, J MANAGE PSYCHOL, V17, P68, DOI [10.1108/02683940210415933, DOI 10.1108/02683940210415933]; McClimans LM, 2011, THEOR MED BIOETH, V32, P47, DOI 10.1007/s11017-010-9163-8; McLeod LD, 2011, EXPERT REV PHARM OUT, V11, P163, DOI [10.1586/erp.11.12, 10.1586/ERP.11.12]; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Muehlan H, 2016, ASSESSMENT, V23, P124, DOI 10.1177/1073191115569844; Muthen L. K., 2012, MPLUS USERS GUIDE, V5th; Muus I, 2011, DISABIL REHABIL, V33, P2425, DOI 10.3109/09638288.2011.573901; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Owolabi MO, 2010, CEREBROVASC DIS, V29, P105, DOI 10.1159/000262305; Oyane NMF, 2008, J AFFECT DISORDERS, V105, P147, DOI 10.1016/j.jad.2007.05.002; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Pedersen SG, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312117752031; Petersen C, 2001, FORTSCHR NEUROL PSYC, V69, P284, DOI 10.1055/s-2001-14465; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sagen U, 2009, J PSYCHOSOM RES, V67, P325, DOI 10.1016/j.jpsychores.2009.03.007; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Soberg HL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0589-9; Sun JH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.05; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Truelle JL, 2012, BRAIN INJURY, V26, P421; Vellone E, 2015, J CARDIOVASC NURS, V30, P229, DOI 10.1097/JCN.0000000000000145; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; West SG., 2012, HDB STRUCTURAL EQUAT, P209; Whynes DK, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-94; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362; Wong GKC, 2014, J CLIN NEUROSCI, V21, P954, DOI 10.1016/j.jocn.2013.09.010; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	6	6	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JUL 18	2018	18								98	10.1186/s12883-018-1101-9			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GN5ZT	WOS:000439150100001	30021558	Green Published, gold			2022-02-06	
J	Smith-Paine, J; Wade, SL; Treble-Barna, A; Zhang, NH; Zang, HY; Martin, LJ; Yeates, KO; Taylor, HG; Kurowski, BG				Smith-Paine, Julia; Wade, Shari L.; Treble-Barna, Amery; Zhang, Nanhua; Zang, Huaiyu; Martin, Lisa J.; Yeates, Keith Owen; Taylor, H. Gerry; Kurowski, Brad G.			The Moderating Effect of the Ankyrin Repeat and Kinase Domain Containing One Gene on the Association of Family Environment with Longitudinal Executive Function following Traumatic Brain Injury in Early Childhood: A Preliminary Study	JOURNAL OF NEUROTRAUMA			English	Article						ANKK1; childhood; executive functions; genetics; traumatic brain injury	DIFFERENTIAL SUSCEPTIBILITY; COGNITIVE PERFORMANCE; APOLIPOPROTEIN E4; YOUNG-CHILDREN; SHORT-TERM; OUTCOMES; DOPAMINE; RECEPTOR; DYSFUNCTION; RECOVERY	This study examined whether the ankyrin repeat and kinase domain containing 1 gene (ANKK1) C/T single-nucleotide polymorphism (SNP) rs1800497 moderated the association of family environment with long-term executive function (EF) following traumatic injury in early childhood. Caregivers of children with traumatic brain injury (TBI) and children with orthopedic injury completed the Behavior Rating Inventory of Executive Function (BRIEF) at post-injury visits. DNA was collected to identify the rs1800497 genotype in the ANKK1 gene. General linear models examined gene-environment interactions as moderators of the effects of TBI on EF at two times post-injury (12 months and 7 years). At 12 months post-injury, analyses revealed a significant three-way interaction of genotype with level of permissive parenting and injury type. Post hoc analyses showed genetic effects were more pronounced for children with TBI from more positive family environments, such that children with TBI who were carriers of the risk allele (T-allele) had significantly poorer EF compared with non-carriers only when they were from more advantaged environments. At 7 years post-injury, analyses revealed a significant two-way interaction of genotype with level of authoritarian parenting. Post hoc analyses found that carriers of the risk allele had significantly poorer EF compared with non-carriers only when they were from more advantaged environments. These results suggest a gene-environment interaction involving the ANKK1 gene as a predictor of EF in a pediatric injury population. The findings highlight the importance of considering environmental influences in future genetic studies on recovery following TBI and other traumatic injuries in childhood.	[Smith-Paine, Julia; Wade, Shari L.; Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Zhang, Nanhua; Zang, Huaiyu] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Human Genet, Cincinnati, OH 45229 USA; [Martin, Lisa J.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Treble-Barna, Amery] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Ohio State Univ, Ctr Biobehav Hlth, Nationwide Childrens Hosp, Res Inst, Columbus, OH 43210 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Rehabil Med, Cincinnati, OH USA		Smith-Paine, J (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Julia.Smith@cchmc.org	Zang, Huaiyu/AAY-6603-2021; Martin, Lisa/E-2425-2016; Yeates, Keith/AAJ-4223-2020	Martin, Lisa/0000-0001-8702-9946; Zhang, Nanhua/0000-0001-5796-3404; Yeates, Keith/0000-0001-7680-2892	Rehabilitation Medicine Scientist Training Program (RMSTP) [K-12 HD001097-16]; National Institute for Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01NS096053]; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [8 UL1 TR000077]; Ohio Department of Public Safety; Cincinnati Children's Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096053] Funding Source: NIH RePORTER	Funding for this study was supported in part by the Rehabilitation Medicine Scientist Training Program (RMSTP) K-12 HD001097-16, National Institute for Child Health and Human Development (NICHD) R01 HD42729, National Institute of Neurological Disorders and Stroke (NINDS) and NICHD R01NS096053, Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH), Ohio Department of Public Safety and the Cincinnati Children's Research Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other supporting agencies.	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BAUMRIND D, 1966, CHILD DEV, V37, P887, DOI 10.1111/j.1467-8624.1966.tb05416.x; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Bradley RH, 2003, EARLY CHILD RES Q, V18, P294, DOI 10.1016/S0885-2006(03)00041-3; Cohen J., 2013, STAT POWER ANAL BEHA; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gioia G.A., 2000, BRIEF BEHAV RATING I; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P404, DOI 10.1097/HTR.0000000000000281; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Manuck SB, 2014, ANNU REV PSYCHOL, V65, P41, DOI 10.1146/annurev-psych-010213-115100; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; Mills-Koonce WR, 2007, DEV PSYCHOPATHOL, V19, P1073, DOI 10.1017/S0954579407000545; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Propper C, 2008, CHILD DEV, V79, P1377, DOI 10.1111/j.1467-8624.2008.01194.x; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Treble-Barna A, 2016, J INT NEUROPSYCH SOC, V22, P859, DOI 10.1017/S1355617716000631; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Zuckerman M, 1999, VULNERABILITY PSYCHO	50	6	6	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2018	35	23					2796	2802		10.1089/neu.2017.5388		JUL 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HB1WO	WOS:000439011300001	29717626	Green Published			2022-02-06	
J	Faruqui, SHA; Alaeddini, A; Jaramillo, CA; Potter, JS; Pugh, MJ				Faruqui, Syed Hasib Akhter; Alaeddini, Adel; Jaramillo, Carlos A.; Potter, Jennifer S.; Pugh, Mary Jo			Mining patterns of comorbidity evolution in patients with multiple chronic conditions using unsupervised multi-level temporal Bayesian network	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; VETERANS; PAIN; AFGHANISTAN; DISTURBANCE; PREVALENCE; COHORT; IRAQ	Over the past few decades, the rise of multiple chronic conditions has become a major concern for clinicians. However, it is still not known precisely how multiple chronic conditions emerge among patients. We propose an unsupervised multi-level temporal Bayesian network to provide a compact representation of the relationship among emergence of multiple chronic conditions and patient level risk factors over time. To improve the efficiency of the learning process, we use an extension of maximum weight spanning tree algorithm and greedy search algorithm to study the structure of the proposed network in three stages, starting with learning the inter-relationship of comorbidities within each year, followed by learning the intra-relationship of comorbidity emergence between consecutive years, and finally learning the hierarchical relationship of comorbidities and patient level risk factors. We also use a longest path algorithm to identify the most likely sequence of comorbidities emerging from and/or leading to specific chronic conditions. Using a de-identified dataset of more than 250,000 patients receiving care from the U.S. Department of Veterans Affairs for a period of five years, we compare the performance of the proposed unsupervised Bayesian network in comparison with those of Bayesian networks developed based on supervised and semi-supervised learning approaches, as well as multivariate probit regression, multinomial logistic regression, and latent regression Markov mixture clustering focusing on traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), depression (Depr), substance abuse (SuAb), and back pain (BaPa). Our findings show that the unsupervised approach has noticeably accurate predictive performance that is comparable to the best performing semi-supervised and the second-best performing supervised approaches. These findings also revealed that the unsupervised approach has improved performance over multivariate probit regression, multinomial logistic regression, and latent regression Markov mixture clustering.	[Faruqui, Syed Hasib Akhter; Alaeddini, Adel] Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78249 USA; [Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Potter, Jennifer S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA		Alaeddini, A (corresponding author), Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78249 USA.	adel.alaeddini@utsa.edu	Potter, Jennifer Sharpe/C-6720-2008; Pugh, Mary Jo/K-5336-2019	Potter, Jennifer Sharpe/0000-0002-7250-4422; Pugh, Mary Jo/0000-0003-4196-7763; Faruqui, Syed Hasib Akhter/0000-0002-5073-8690	National Institutes of Health (NIH/NIGMA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1SC2GM118266-01]; VA Health Services Research and Development ServiceUS Department of Veterans Affairs [I01 HX000329-05]; VA Clinical Services Research and Development Service [I01 CX001246]; National Institutes of Health (NIH/NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [5UG1DA020024-13]	This work was supported by National Institutes of Health (NIH/NIGMA), Grant number: 1SC2GM118266-01, Grant Title: A Novel Probabilistic Methodology for Prediction of Emerging Diseases in Patients with Multiple Chronic Conditions, PI: Alaeddini; VA Health Services Research and Development Service, Grant Number: I01 HX000329-05, Grant Title: Identifying and Validating Complex Comorbidity Clusters in OEF-OIF Veterans, PI: Pugh; VA Clinical Services Research and Development Service, Grant Number: I01 CX001246, Grant Title: Chronic Effects of Neurotrauma Epidemiology Study, Investigator: Pugh; and National Institutes of Health (NIH/NIDA), Grant Number: 5UG1DA020024-13, Grant Title: Clinical trials network Texas node, Investigator: Potter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Alaeddini A, 2017, METHOD INFORM MED, V56, P391, DOI 10.3414/ME16-01-0135; Bach FR, 2002, ADV NEUR IN, V14, P569; Cai ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120805; Cappellari L, 2003, STATA J, V3, P278, DOI 10.1177/1536867X0300300305; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; COOPER GF, 1986, COMPUT METH PROG BIO, V22, P223; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1023/A:1022649401552; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Darwiche A, 2009, MODELING AND REASONING WITH BAYESIAN NETWORKS, P1, DOI 10.1017/CBO9780511811357; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Forsberg JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019956; Heckerman D., 1995, MSRTR9506 MICR RES, P1996; Kwak C, 2002, NURS RES, V51, P406, DOI 10.1097/00006199-200211000-00009; Lappenschaar M, 2013, J CLIN EPIDEMIOL, V66, P1405, DOI 10.1016/j.jclinepi.2013.06.018; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Liao WH, 2009, PATTERN RECOGN, V42, P3046, DOI 10.1016/j.patcog.2009.04.006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Murphy K., 2001, BAYES NET TOOLBOX MA; Pearl J., 2014, PROBABILISTIC REASON; Pearl J., 2000, CAUSALITY MODELS REA; Pepe M S, 2003, STAT EVALUATION MED; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJ, 2017, ARCH PHYS MED REHABI; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Sesen MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082349; Stojadinovic A, 2013, ANN SURG ONCOL, V20, P161, DOI 10.1245/s10434-012-2555-4; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Zador Z, OPER NEUROSURG, DOI [10.1093/ONS/OPX163/4056268, DOI 10.1093/ONS/OPX163/4056268]; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762; Zhou Y, 2016, DECIS SUPPORT SYST, V87, P69, DOI 10.1016/j.dss.2016.05.001	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199768	10.1371/journal.pone.0199768			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	WOS:000438457400017	30001371	Green Published, gold			2022-02-06	
J	Lazarev, VF; Dutysheva, EA; Komarova, EY; Mikhaylova, ER; Guzhova, IV; Margulis, BA				Lazarev, Vladimir F.; Dutysheva, Elizaveta A.; Komarova, Elena Y.; Mikhaylova, Elena R.; Guzhova, Irina V.; Margulis, Boris A.			GAPDH-targeted therapy - A new approach for secondary damage after traumatic brain injury on rats	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						GAPDH; Traumatic brain injure; Toxic extracellular aggregates	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; OXIDATIVE STRESS; HUNTINGTON DISEASE; CELL-DEATH; AGGREGATION; TOXICITY; PROTEIN; MODELS; TAU	Massive neuronal death caused by a neurodegenerative pathology or damage due to ischaemia or traumatic brain injury leads to the appearance of cytosolic proteins in the extracellular space. We found that one of the most abundant cellular polypeptides, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), appearing in the medium of dying cells or body fluids is able to form aggregates that are cytotoxic to adjacent cells. Since we previously showed that the hydrocortisone derivative RX624 can inhibit the ability of GAPDH to transport the enzyme complex with polyglutamine and reduce the cytotoxicity of the complex, we explored the effects of GAPDH on SH-SY5Y neuroblastoma cells. We found that the latter treated with particular forms of GAPDH molecules die with a high efficiency, suggesting that the exogenous enzyme does kill adjacent cells. RX624 prevented the interaction of exogenous GAPDH with the cell membrane and reduced the level of death by more than 10%. We also demonstrated the efficiency of RX624 treatment in a rat model of traumatic brain injury. The chemical blocked the formation of GAPDH aggregates in the brain, inhibited the cytotoxic effects of cerebrospinal fluid and rescued the motor function of injured rats. Importantly, RX624 treatment of rats had a similar effect as the intracranial injection of anti-GAPDH antibodies. (C) 2018 Elsevier Inc. All rights reserved.	[Lazarev, Vladimir F.; Dutysheva, Elizaveta A.; Komarova, Elena Y.; Mikhaylova, Elena R.; Guzhova, Irina V.; Margulis, Boris A.] Russian Acad Sci, Inst Cytol, Tikhoretsky Pr 4, St Petersburg 194064, Russia		Lazarev, VF (corresponding author), Russian Acad Sci, Inst Cytol, Tikhoretsky Pr 4, St Petersburg 194064, Russia.	vl.lazarev@gmail.com	Lazarev, Vladimir F/O-9813-2017; Guzhova, Irina V/R-5702-2016; Guzhova, Irina/AAB-2140-2021; Dutysheva, Elizaveta/AAA-8164-2021; Mikhaylova, Elena/AAN-2169-2020	Guzhova, Irina V/0000-0002-8775-7713; Guzhova, Irina/0000-0002-8775-7713; Dutysheva, Elizaveta/0000-0003-0354-5199; Lazarev, Vladimir/0000-0002-7117-6789	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [16-38-60196 mol_a_dk]; Grant of Russian Science FoundationRussian Science Foundation (RSF) [14-50-00068]; Russian Science FoundationRussian Science Foundation (RSF) [14-50-00068] Funding Source: Russian Science Foundation	We thank Prof V.I Muronetz (Lomonosov Moscow State University, Russia) for providing us with muscle rabbit GAPDH preparation, and Dr A.L. Shavarda (Komarov Botanical Institute, Russia) for providing us with RX624. This work was supported by the Russian Foundation for Basic Research, according to research project No. 16-38-60196 mol_a_dk (VFL) and by the Grant of Russian Science Foundation No 14-50-00068 (EAD, EYK, ERM, IVG, and BAM).	Carpenter JF, 2004, LYOPHILIZATION BIOPH, P423; Guzhova IV, 2011, HUM MOL GENET, V20, P3953, DOI 10.1093/hmg/ddr314; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Lai YC, 2006, DEV NEUROSCI-BASEL, V28, P336, DOI 10.1159/000094159; Lazarev VF, 2013, ACTA NATURAE, V5, P81, DOI 10.32607/20758251-2013-5-2-81-89; Lazarev V.F., DATA BR; Lazarev VF, 2017, BIOCHEM BIOPH RES CO, V487, P723, DOI 10.1016/j.bbrc.2017.04.125; Lazarev VF, 2016, FREE RADICAL BIO MED, V92, P29, DOI 10.1016/j.freeradbiomed.2015.12.025; Lazarev VF, 2016, BIOCHEM BIOPH RES CO, V470, P766, DOI 10.1016/j.bbrc.2015.12.076; Lazarev VF, 2015, FEBS LETT, V589, P581, DOI 10.1016/j.febslet.2015.01.018; Mikhaylova ER, 2016, J NEUROCHEM, V136, P1052, DOI 10.1111/jnc.13463; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2017, J BIOL CHEM, V292, P4727, DOI 10.1074/jbc.M116.759084; Nakajima H, 2015, J BIOL CHEM, V290, P14493, DOI 10.1074/jbc.M114.635607; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Naletova I, 2008, BBA-PROTEINS PROTEOM, V1784, P2052, DOI 10.1016/j.bbapap.2008.07.013; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Yanamandra K, 2015, ANN CLIN TRANSL NEUR, V2, P278, DOI 10.1002/acn3.176	21	6	8	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JUL 2	2018	501	4					1003	1008		10.1016/j.bbrc.2018.05.099			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	GJ5NA	WOS:000435427000027	29777694				2022-02-06	
J	Armstrong, LB; Mooney, DP				Armstrong, Lindsey B.; Mooney, David P.			Pneumatoceles in pediatric blunt trauma: Common and benign	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pneumatocele; Trauma; Pediatric	PULMONARY PSEUDOCYST; CHEST TRAUMA; INJURIES; CHILDREN; LUNG	Introduction: Traumatic pneumatoceles are reported to be rare in children and to have an uncertain clinical significance. We report a single institution series of traumatic pneumatoceles to better define their frequency and clinical significance. Methods: After obtaining approval from the IRB, data were extracted from the trauma registry of a level 1 pediatric trauma center on children diagnosed with a pulmonary contusion (International Classification of Diseases-9th edition diagnosis codes: 861.21 to 861.31) who presented between June, 2006 and September, 2016. Patient demographics, mechanism of injury, injury severity score, diagnosis and procedure codes, length of hospital stay, outcome, imaging techniques and findings with attention to the identification of a pneumatocele, were examined. Results: Of the 10,229 trauma admission, 204 children were identified as having a pulmonary contusion, 25 of whom (123%) were diagnosed with a pneumatocele. Their mean age was 13 years (3-17). Seventy-six percent (19) were male. The most common mechanism of injury was a motor vehicle collision (10), followed by falls (6), and sports (5). Sixteen children (64%) suffered a long bone fracture, 12 (48%) an abdominal solid organ injury and 3 (12%) a traumatic brain injury. The mean Injury Severity Score was 17 (9-34). Twenty-three patients presented as transfers. There were no fatalities. The pneumatocele was identified on chest computerized tomography (CT) alone in 15 (60%), on chest CT and chest radiograph (CXR) in 3 (12%), the upper portions of an abdominal CT in 6 (24%) and on CXR alone in 1 (4%). Seven patients were found to have a solitary pneumatocele and 18 patients had 2 or more. The largest pneumatocele was 3.7 cm in diameter. Ten children (40%) were admitted to the intensive care unit, 3 of whom required intubation. One patient (4%) had a respiratory complication: pneumonia. Three patients underwent chest tube placement for: pneumothorax, hemothorax and hemopneumothorax. No child underwent intervention specific to the pneumatocele. Seventeen (68%) patients were seen in follow-up in Trauma Clinic and the remainder by another practitioner ranging from 1 week to 6 months after injury. One child (4%) underwent a follow-up chest CT to rule out a congenital pulmonary malformation 6 months after injury and this demonstrated complete resolution of the pneumatocele. Conclusion: The incidence of traumatic pneumatoceles among children with a pulmonary contusion was 12.3% in this series, but is probably higher given that only 24% were visible on radiographs and a small minority of children with pulmonary contusions underwent chest CT. Pneumatoceles are common in children with pulmonary contusions, but are usually small. The majority do not appear to be clinically significant nor require follow-up imaging. (C) 2017 Elsevier Inc. All rights reserved.	[Armstrong, Lindsey B.; Mooney, David P.] Harvard Med Sch, Boston Childrens Hosp, Dept Surg, 300 Longwood Ave, Boston, MA USA		Armstrong, LB (corresponding author), Boston Childrens Hosp, Dept Surg, 300 Longwood Ave Fegan 3, Boston, MA 02115 USA.	lindsey.armstrong@childrens.harvard.edu	Mooney, David/AAW-5132-2020				AMITAI I, 1983, CLIN PEDIATR, V22, P420, DOI 10.1177/000992288302200605; Cheung NK, 2013, CASE REP PEDIAT, V2013, DOI 10.1155/2013/940189; Cho HJ, 2015, J TRAUMA ACUTE CARE, V79, P425, DOI 10.1097/TA.0000000000000758; Chon SH, 2006, EUR J CARDIO-THORAC, V29, P819, DOI 10.1016/j.ejcts.2006.01.054; FAGAN CJ, 1976, RADIOLOGY, V120, P11, DOI 10.1148/120.1.11; GALEA MH, 1992, J PEDIATR SURG, V27, P1523, DOI 10.1016/0022-3468(92)90492-P; KATO R, 1989, J THORAC CARDIOV SUR, V97, P309; KHAN FA, 1974, CHEST, V66, P211, DOI 10.1378/chest.66.2.211; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Matuszczak E, 2017, KARDIOCHIR TORAKOCHI, V14, P59, DOI 10.5114/kitp.2017.66934; Phillips B, 2017, INJURY, V48, P214, DOI 10.1016/j.injury.2016.12.006; ROUX P, 1992, J PEDIATR SURG, V27, P551, DOI 10.1016/0022-3468(92)90443-B; Sangster GP, 2007, EMERG RADIOL, V14, P297, DOI 10.1007/s10140-007-0651-8; SANTOS GH, 1979, ANN THORAC SURG, V27, P359, DOI 10.1016/S0003-4975(10)63316-4; Schimpl G, 1996, EUR J PEDIATR SURG, V6, P104, DOI 10.1055/s-2008-1066483; Yang PJ, 2015, J PEDIATR-US, V167, P777, DOI 10.1016/j.jpeds.2015.06.025; Yang TC, 2010, PEDIATR NEONATOL, V51, P135, DOI 10.1016/S1875-9572(10)60024-1	17	6	6	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	JUL	2018	53	7					1310	1312		10.1016/j.jpedsurg.2017.08.002			3	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	GK9WA	WOS:000436607100008	28917584				2022-02-06	
J	Bailey, BA; Andrzejewski, SK; Greif, SM; Svingos, AM; Heaton, SC				Bailey, Brittany A.; Andrzejewski, Sophia K.; Greif, Sarah M.; Svingos, Adrian M.; Heaton, Shelley C.			The Role of Executive Functioning and Academic Achievement in the Academic Self-Concept of Children and Adolescents Referred for Neuropsychological Assessment	CHILDREN-BASEL			English	Article						executive function; self-concept; academic achievement	PERFORMANCE-BASED MEASURES; BEHAVIOR RATING INVENTORY; TRAUMATIC BRAIN-INJURY; SCHOOL PERFORMANCE; EMOTION REGULATION; ADHD; ESTEEM; CHILDHOOD; PERCEPTIONS; COMPETENCE	The current study evaluated a model of youth academic self-concept which incorporates practical executive functioning behaviors and academic achievement. Though greater academic achievement has been linked to both positive self-concept and better executive functioning, these constructs have not been examined simultaneously. It was hypothesized that academic achievement would mediate the association between problems with executive functioning and academic self-concept such that youth with more problems with executive functioning would have lower academic achievement and, in turn, lower academic self-concept. Clinical data was analyzed from a diagnostically heterogeneous sample of youth (n = 122) who underwent neuropsychological evaluation. Problems with executive functioning were assessed using the Behavior Rating Inventory of Executive Function. Academic achievement was assessed using the Woodcock-Johnson Tests of Achievement or Wechsler Individual Achievement Test. Academic self-concept was assessed using the youth-report version of the Behavioral Assessment System for Children. Surprisingly, findings indicate that academic achievement is not significantly associated with problems with executive functioning or academic self-concept. However, greater problems with executive functioning are associated with decreased academic self-concept. The overall model included several covariates and accounted for 10% of the variance in academic self-concept. Findings suggest that executive skills may be essential for aligning academic achievement with classroom performance. Though various child characteristic covariates were included, the model accounted for a small amount of variance suggesting that future studies should examine contributing contextual factors.	[Bailey, Brittany A.; Andrzejewski, Sophia K.; Greif, Sarah M.; Svingos, Adrian M.; Heaton, Shelley C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA		Bailey, BA (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA.	bbailey92@ufl.edu; sandrzej@ufl.edu; sgreif1021@ufl.edu; adrianmchambers@phhp.ufl.edu; sheaton@ufl.edu		Svingos, Adrian/0000-0001-7271-2136			Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Barkley R.A., 2012, EXECUTIVE FUNCTIONS, P3; Barkley R.A., 2012, CHOICE, V50, P762; Baumeister RF, 2011, HDB SELF REGULATION, P300; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Bracken B., 1992, MULTIDIMENSIONAL SEL; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Chiang HL, 2014, RES DEV DISABIL, V35, P963, DOI 10.1016/j.ridd.2014.02.010; Cole PM, 2004, CHILD DEV, V75, P317, DOI 10.1111/j.1467-8624.2004.00673.x; Donnellan MB, 2005, PSYCHOL SCI, V16, P328, DOI 10.1111/j.0956-7976.2005.01535.x; Elbaum B., 2002, LEARNING DISABILITIE, V17, P216, DOI [10.1111/1540-5826.00047, DOI 10.1111/1540-5826.00047]; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Graziano PA, 2007, J SCHOOL PSYCHOL, V45, P3, DOI 10.1016/j.jsp.2006.09.002; Gumora G, 2002, J SCHOOL PSYCHOL, V40, P395, DOI 10.1016/S0022-4405(02)00108-5; Han G, 2016, J CLIN CHILD ADOLESC, V45, P44, DOI 10.1080/15374416.2015.1041592; Harter S., 2015, CONSTRUCTION SELF DE; Harter S., 1990, COMPETENCE CONSIDERE, P67; Hayes A, 2013, INTRO MEDIATION MODE, P3, DOI DOI 10.1111/JEDM.12050; Hollingshead A.A., 1975, UNPUB; Hoza B, 2004, J CONSULT CLIN PSYCH, V72, P382, DOI 10.1037/0022-006X.72.3.382; Jacob R, 2015, REV EDUC RES, V85, P512, DOI 10.3102/0034654314561338; Jimerson SR, 2001, SCHOOL PSYCHOL REV, V30, P420; Latzman RD, 2010, J CLIN EXP NEUROPSYC, V32, P455, DOI 10.1080/13803390903164363; MARSH HW, 1987, J EDUC PSYCHOL, V79, P280, DOI 10.1037/0022-0663.79.3.280; McGee R, 2001, J ABNORM CHILD PSYCH, V29, P281, DOI 10.1023/A:1010353711369; McGrew K.S., 2001, WOODCOCK JOHNSON 3 T; Owens JS, 2007, CLIN CHILD FAM PSYCH, V10, P335, DOI 10.1007/s10567-007-0027-3; Preston AS, 2009, J LEARN DISABIL-US, V42, P240, DOI 10.1177/0022219408331042; Reynolds C.R., 2004, BEHAV ASSESSMENT SYS, V2; Riley T. L., 2001, ROEPER REV, V24, P20, DOI [10.1080/02783190109554120, DOI 10.1080/02783190109554120]; Roebers CM, 2012, METACOGN LEARN, V7, P151, DOI 10.1007/s11409-012-9089-9; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Smith M.D., 1997, EXCEPT CHILDREN, V43, P352, DOI [10.1177/001440297704300603, DOI 10.1177/001440297704300603]; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Stetsenko A, 2000, CHILD DEV, V71, P517, DOI 10.1111/1467-8624.00161; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Trautwein U, 2006, J PERS SOC PSYCHOL, V90, P334, DOI 10.1037/0022-3514.90.2.334; Tremblay MS, 2000, PEDIATR EXERC SCI, V12, P312, DOI 10.1123/pes.12.3.312; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wechsler D., 2009, WECHSLER INDIVIDUAL; Welsh JA, 2010, J EDUC PSYCHOL, V102, P43, DOI 10.1037/a0016738	42	6	6	4	14	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9067		CHILDREN-BASEL	Children-Basel	JUL	2018	5	7							83	10.3390/children5070083			13	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GO7BO	WOS:000440210600002	29933565	Green Submitted, gold, Green Published			2022-02-06	
J	Bianchini, KJ; Aguerrevere, LE; Curtis, KL; Roebuck-Spencer, TM; Frey, FC; Greve, KW; Calamia, M				Bianchini, Kevin J.; Aguerrevere, Luis E.; Curtis, Kelly L.; Roebuck-Spencer, Tresa M.; Frey, F. Charles; Greve, Kevin W.; Calamia, Matthew			Classification Accuracy of the Minnesota Multiphasic Personality Inventory-2 ( MMPI-2)-Restructured Form Validity Scales in Detecting Malingered Pain-Related Disability	PSYCHOLOGICAL ASSESSMENT			English	Article						classification accuracy; chronic pain; MMPI-2-RF; MPRD; validity scales	TRAUMATIC BRAIN-INJURY; CLINICAL RC SCALES; RELIABLE DIGIT SPAN; MMPI-2-RF VALIDITY; NEUROCOGNITIVE DYSFUNCTION; RESPONSE BIAS; INCREMENTAL VALIDITY; BACK-PAIN; INDICATORS; UTILITY	The symptom reports of individuals with chronic pain are multidimensional (e.g., emotional, cognitive, and somatic) and significantly contribute to increased morbidity and lost work productivity. When pain occurs in the context of a legally compensable event, reliable assessment of a patient's multifactorial symptom experience during psychological or neuropsychological evaluations is a necessity. The Validity Scales of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) have been shown useful in identifying symptom overreporting and feigning within chronic pain samples and a number of studies have emerged supporting the use of the MMPI-2-Restructured Form (MMPI-2-RF) in the detection of simulated or feigned impairment in a variety of populations. To date, only 1 other study exists examining the ability of the MMPI-2-RF to detect exaggerated complaints using a strict operationalization of malingering exclusive to chronic pain samples. The purpose of this study was to examine the classification accuracy of MMPI-2-RF Validity Scales in a group of patients with chronic pain using a criterion-groups design. The final sample consisted of 501 clinical chronic pain patients assigned to groups based on the Bianchini, Greve, and Glynn (2005) criteria for Malingered Pain-Related Disability (MPRD). Results showed that all MMPI-2-RF Validity Scales differentiated malingerers from nonmalingerers with a high degree of accuracy. At cut-offs associated with >= 95% Specificity, Sensitivities ranged from 15% (Fs) to 60% (Response Bias Scale; RBS). This study demonstrates that the MMPI-2-RF Validity Scales are capable of differentiating intentional symptom exaggeration from genuine complaints in a sample of incentivized chronic pain patients.	[Bianchini, Kevin J.; Roebuck-Spencer, Tresa M.; Frey, F. Charles; Greve, Kevin W.] Jefferson Neurobehav Grp, Metairie, LA USA; [Aguerrevere, Luis E.] Stephen F Austin State Univ, Dept Human Serv, Nacogdoches, TX 75962 USA; [Curtis, Kelly L.] High Point Univ, Dept Psychol, High Point, NC 27268 USA; [Calamia, Matthew] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA		Curtis, KL (corresponding author), High Point Univ, Dept Psychol, High Point, NC 27268 USA.	kcurtis0@highpoint.edu	Aguerrevere, Luis/P-5684-2019	Calamia, Matthew/0000-0002-7252-7181; Aguerrevere, Luis/0000-0001-9160-1044			Aguerrevere LE, 2011, J CLIN EXP NEUROPSYC, V33, P497, DOI 10.1080/13803395.2010.535503; Arbisi PA, 2008, J PERS ASSESS, V90, P122, DOI 10.1080/00223890701845146; Ben-Porath Y., 2012, INTERPRETING MMPI 2; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Ben-Porath YS, 2008, J PERS ASSESS, V90, P119, DOI 10.1080/00223890701845120; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, PORTLAND DIGIT RECOG; Block AR, 2013, CLIN NEUROPSYCHOL, V27, P81, DOI 10.1080/13854046.2012.721007; Bolinger E, 2014, ARCH CLIN NEUROPSYCH, V29, P7, DOI 10.1093/arclin/act082; Bruns D, 2009, J CLIN PSYCHOL MED S, V16, P127, DOI 10.1007/s10880-009-9148-9; Butcher J. N., 2001, MMPI 2 MINNESOTA MUL; Chmielewski M, 2017, PSYCHOL ASSESSMENT, V29, P199, DOI 10.1037/pas0000328; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Etherton JL, 2005, ASSESSMENT, V12, P101, DOI 10.1177/1073191104270789; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fishbain DA, 1999, CLIN J PAIN, V15, P244, DOI 10.1097/00002508-199912000-00002; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Friedman A., 2015, PSYCHOL ASSESSMENT M; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Goodwin BE, 2013, PSYCHOL ASSESSMENT, V25, P671, DOI 10.1037/a0032214; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P., 1996, WORD MEMORY TEST USE; Greve K. W., 2012, FORENSIC NEUROPSYCHO, P302; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve KW, 2009, ARCH PHYS MED REHAB, V90, P1117, DOI 10.1016/j.apmr.2009.01.018; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P850, DOI 10.1080/13854040802585055; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; GUO HR, 1995, AM J IND MED, V28, P591, DOI 10.1002/ajim.4700280504; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2013, CLIN NEUROPSYCHOL, V27, P509, DOI 10.1080/13854046.2012.739644; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kay NRM, 1998, INJURY, V29, P305, DOI 10.1016/S0020-1383(97)00207-6; LEAVITT F, 1986, PAIN, V25, P357, DOI 10.1016/0304-3959(86)90239-3; Marion BE, 2011, PSYCHOL INJ LAW, V4, P1, DOI 10.1007/s12207-011-9097-0; Mason LH, 2013, J PERS ASSESS, V95, P585, DOI 10.1080/00223891.2013.819512; McCord DM, 2011, J CLIN EXP NEUROPSYC, V33, P140, DOI 10.1080/13803395.2010.495056; Meyers JE, 2014, APPL NEUROPSYCH-ADUL, V21, P148, DOI 10.1080/09084282.2013.780173; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Reynolds CR, 1998, CRIT ISS NE, P261; Rogers R, 2011, J PSYCHOPATHOL BEHAV, V33, P355, DOI 10.1007/s10862-011-9222-0; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Sellbom M, 2006, J PERS ASSESS, V86, P196, DOI 10.1207/s15327752jpa8602_09; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P757, DOI 10.1037/a0020825; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P22, DOI 10.1037/a0018222; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wygant D.B., 2004, 39 ANN S REC DEV MMP; Wygant DB, 2007, ARCH CLIN NEUROPSYCH, V22, P489, DOI 10.1016/j.acn.2007.01.027; Wygant DB, 2011, PSYCHOL INJ LAW, V4, P13, DOI 10.1007/s12207-011-9098-z; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073	70	6	6	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUL	2018	30	7					857	869		10.1037/pas0000532			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GL8MS	WOS:000437476100003	29072481				2022-02-06	
J	Clark, JM; Taylor, K; Post, A; Hoshizaki, TB; Gilchrist, MD				Clark, J. Michio; Taylor, Karen; Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Comparison of Ice Hockey Goaltender Helmets for Concussion Type Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Brain injury; Ice hockey; Helmet; Impact biomechanics; Finite element modeling	BRAIN DEFORMATION METRICS; HEAD-INJURY CRITERIA; INTRACRANIAL-PRESSURE; ANGULAR ACCELERATION; PROTECTIVE CAPACITY; PART I; PREDICTORS; MOTION; RECONSTRUCTION; SIMULATIONS	Concussions are among the most common injuries sustained by ice hockey goaltenders and can result from collisions, falls and puck impacts. However, ice hockey goaltender helmet certification standards solely involve drop tests to a rigid surface. This study examined how the design characteristics of different ice hockey goaltender helmets affect head kinematics and brain strain for the three most common impact events associated with concussion for goaltenders. A NOCSAE headform was impacted under conditions representing falls, puck impacts and shoulder collisions while wearing three different types of ice hockey goaltender helmet models. Resulting linear and rotational acceleration as well as maximum principal strain were measured for each impact condition. The results indicate that a thick liner and stiff shell material are desirable design characteristics for falls and puck impacts to reduce head kinematic and brain tissue responses. However for collisions, the shoulder being more compliant than the materials of the helmet causes insufficient compression of the helmet materials and minimizing any potential performance differences. This suggests that current ice hockey goaltender helmets can be optimized for protection against falls and puck impacts. However, given collisions are the leading cause of concussion for ice hockey goaltenders and the tested helmets provided little to no protection, a clear opportunity exists to design new goaltender helmets which can better protect ice hockey goaltenders from collisions.	[Clark, J. Michio; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Clark, J. Michio; Taylor, Karen; Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada; [Post, Andrew] St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada		Clark, JM (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	michio.clark@ucd.ie			European Union's Horizon research and innovation programme under the Marie Skiodowska-Curie Grant [642662]; Ontario Graduate Scholarship in Science and Technology (OGSST)	Helmets for this research were supplied by Reebok-CCM and funding was received from the Ontario Graduate Scholarship in Science and Technology (OGSST). Two of the authors (JMC and MDG) receive funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skiodowska-Curie Grant Agreement No. 642662.	[Anonymous], 2009, Z262109 CSA; ASTM, 2014, F158712A ASTM; Beusenberg MC., 2000, P INT RES C BIOM IMP; Clark J.M., 2016, IRCOBI C MAL, P205; Clark J. M, 2015, EVALUATION PROTECTIV; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; CSA, 2009, Z262209 CSA; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Forero Rueda M.A, 2009, EQUESTRIAN HELMET DE; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hunt H., 1989, IRCOBI C STOCKHOLM, P157; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; IOS, 2003, 10256 IOS; Kendall M., 2016, COMP CHARACTERIZATIO; Kendall M, 2012, P I MECH ENG P; Kendall M., 2014, MECH CONCUSSION SPOR; Kendall M., 2012, INT RES COUNC BIOM I, P430, DOI DOI 10.1016/J.JECP.2012.07.001; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, P IRCOBI, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPrade R, 2009, 5 INT S SAF IC HOCK; Margulies S. S., 1998, SAE TECHNICAL PAPER; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; NOCSAE, 2016, 03011M16 NOCSAE DOC; NOCSAE, 2015, 04111M15 NOCSAE DOC; NOCSAE, 2015, ND00213M15 NOCSAE DO; Nur Sarah, 2015, Sports Biomech, V14, P459, DOI 10.1080/14763141.2015.1084035; Ouckama R., 2014, IRCOBI P, P62; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A., 2009, 5 INT S SAF IC HOCK; Post A, 2018, SPORTS ENG; Post A, 2012, IRCOBI C DUBL, P10; Post A., 2014, P IRCOBI C BERL GERM, P72; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Post A, 2016, COMPUT METHOD BIOMEC, V19, P366, DOI 10.1080/10255842.2015.1029921; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P159, DOI 10.1243/17543371JSET36; Rousseau P., 2014, ANAL CONCUSSION METR; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Ruan J. S., 1994, IMPACT BIOMECHANICS; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Spyrou E, 2000, SPORTS ENG, V3, P25; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Walsh E., 2012, P I MECH ENG P; Walsh E. S., 2012, ASTM S MECH CONC SPO; Walsh E. S, 2012, P I MECH ENG P; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1995, P STAPP CAR CRASH J, P121	68	6	6	4	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JUL	2018	46	7					986	1000		10.1007/s10439-018-2017-7			15	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	GH8GR	WOS:000433906500006	29600424	Green Accepted			2022-02-06	
J	Covassin, T; Petit, KM; Savage, JL; Bretzin, AC; Fox, ME; Walker, LF; Gould, D				Covassin, Tracey; Petit, Kyle M.; Savage, Jennifer L.; Bretzin, Abigail C.; Fox, Meghan E.; Walker, Lauren F.; Gould, Daniel			Sports-Related Concussion Occurrence at Various Time Points During High School Athletic Events Part 2	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						sports-related concussion; clinical incidence; epidemiology; time	MEDICAL-RESEARCH PROGRAM; STATES HIGH-SCHOOL; PROFESSIONAL FOOTBALL; INJURY RATES; PLAYERS; AUDIT; EPIDEMIOLOGY; YOUTH; LOADS; GAME	Background: Sports-related concussion (SRC) injury rates, and identifying those athletes at the highest risk, have been a primary research focus. However, no studies have evaluated at which time point during an athletic event athletes are most susceptible to SRCs. Purpose: To determine the clinical incidence of SRCs during the start, middle, and end of practice and competition among high school male and female athletes in the state of Michigan. Study Design: Descriptive epidemiological study. Methods: There were 110,774 male and 71,945 female student-athletes in grades 9 through 12 (mean time in high school, 2.32 +/- 1.1 years) who participated in sponsored athletic activities (13 sports) during the 2015-2016 academic year. An SRC was diagnosed and managed by a medical professional (ie, MD, DO, PA, NP). SRC injuries were reported by certified athletic trainers, athletic administrators, and coaches using the Michigan High School Athletic Association Head Injury Reporting System. Time of SRC was defined as the beginning, middle, or end of practice/competition. Clinical incidence was calculated by dividing the number of SRCs in a time point (eg, beginning) by the total number of participants in a sport per 100 student-athletes (95% CI). Risk ratios were calculated by dividing one time point by another time point. Results: There were 4314 SRCs reported, with the highest in football, women's basketball, and women's soccer. The total clinical incidence for all sports was 2.36 (95% CI, 2.29-2.43) per 100 student-athletes. The most common time for SRCs was the middle, followed by the end of all events. Athletes had a 4.90 (95% CI, 4.44-5.41) and 1.50 (95% CI, 1.40-1.60) times greater risk during the middle of all events when compared with the beginning and end, respectively. There was a 3.28 (95% CI, 2.96-3.63) times greater risk at the end of all events when compared with the beginning. Conclusion: Athletes were at the greatest risk for SRCs at the middle of practice and competition when compared with the beginning and end.	[Covassin, Tracey; Petit, Kyle M.; Savage, Jennifer L.; Bretzin, Abigail C.; Fox, Meghan E.; Walker, Lauren F.; Gould, Daniel] Michigan State Univ, 105 IM Sports Circle, E Lansing, MI 48824 USA; [Fox, Meghan E.] Grand Valley State Univ, Allendale, MI 49401 USA		Covassin, T (corresponding author), Michigan State Univ, 105 IM Sports Circle, E Lansing, MI 48824 USA.	covassin@msu.edu		Bretzin, Abigail/0000-0003-3730-2849	Michigan High School Athletic Association (MHSAA)	This project was supported by the Michigan High School Athletic Association (MHSAA). The content of this report is solely the responsibility of the authors and does not necessarily reflect the views of the MHSAA.	Carey DL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-096309; Cloke DJ, 2009, BRIT J SPORT MED, V43, P1119, DOI 10.1136/bjsm.2008.052050; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fauno P, 2006, INT J SPORTS MED, V27, P75, DOI 10.1055/s-2005-837485; Gabbett TJ, 2011, J SCI MED SPORT, V14, P204, DOI 10.1016/j.jsams.2010.12.002; Gabbett TJ, 2004, BRIT J SPORT MED, V38, P743, DOI 10.1136/bjsm.2003.008391; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hawkins RD, 2001, BRIT J SPORT MED, V35, P43, DOI 10.1136/bjsm.35.1.43; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Mroczek D, 2011, J HUM KINET, V28, P73, DOI 10.2478/v10078-011-0024-y; Nagle K, 2017, SPORTS HEALTH, V9, P238, DOI 10.1177/1941738116685704; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Price RJ, 2004, BRIT J SPORT MED, V38, P466, DOI 10.1136/bjsm.2003.005165; Rogalski B, 2013, J SCI MED SPORT, V16, P499, DOI 10.1016/j.jsams.2012.12.004; Small K, 2010, J SCI MED SPORT, V13, P120, DOI 10.1016/j.jsams.2008.08.005; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Woods C, 2004, BRIT J SPORT MED, V38, P36, DOI 10.1136/bjsm.2002.002352	24	6	5	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUL	2018	46	9					2270	2276		10.1177/0363546518780225			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	GN4BM	WOS:000438958100030	29927307				2022-02-06	
J	Koch, KM; Meier, TB; Karr, R; Nencka, AS; Muftuler, LT; McCrea, M				Koch, K. M.; Meier, T. B.; Karr, R.; Nencka, A. S.; Muftuler, L. T.; McCrea, M.			Quantitative Susceptibility Mapping after Sports-Related Concussion	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; INTERNATIONAL-CONFERENCE; DIFFUSION TENSOR; NCAA CONCUSSION; RECOVERY; STATEMENT	BACKGROUND AND PURPOSE: Quantitative susceptibility mapping using MR imaging can assess changes in brain tissue structure and composition. This report presents preliminary results demonstrating changes in tissue magnetic susceptibility after sports-related concussion. MATERIALS AND METHODS: Longitudinal quantitative susceptibility mapping metrics were produced from imaging data acquired from cohorts of concussed and control football athletes. One hundred thirty-six quantitative susceptibility mapping datasets were analyzed across 3 separate visits (24 hours after injury, 8 days postinjury, and 6 months postinjury). Longitudinal quantitative susceptibility mapping group analyses were performed on stability-thresholded brain tissue compartments and selected subregions. Clinical concussion metrics were also measured longitudinally in both cohorts and compared with the measured quantitative susceptibility mapping. RESULTS: Statistically significant increases in white matter susceptibility were identified in the concussed athlete group during the acute (24 hour) and subacute (day 8) period. These effects were most prominent at the 8-day visit but recovered and showed no significant difference from controls at the 6-month visit. The subcortical gray matter showed no statistically significant group differences. Observed susceptibility changes after concussion appeared to outlast self-reported clinical recovery metrics at a group level. At an individual subject level, susceptibility increases within the white matter showed statistically significant correlations with return-to-play durations. CONCLUSIONS: The results of this preliminary investigation suggest that sports-related concussion can induce physiologic changes to brain tissue that can be detected using MR imaging-based magnetic susceptibility estimates. In group analyses, the observed tissue changes appear to persist beyond those detected on clinical outcome assessments and were associated with return-to-play duration after sports-related concussion.	[Koch, K. M.; Karr, R.; Nencka, A. S.] Med Coll Wisconsin, Dept Radiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Meier, T. B.; Muftuler, L. T.; McCrea, M.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA		Koch, KM (corresponding author), Med Coll Wisconsin, Dept Radiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	kmkoch@mcw.edu	Muftuler, L. Tugan/AAG-7539-2021; Koch, Kevin/AAD-6403-2021	Muftuler, L. Tugan/0000-0002-6635-5678	GE-NFL Head Health Challenge I; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; Clinical and Translational Science Institute grant [1UL1-RR031973 (-01)]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8UL1TR000055]; Advancing a Healthier Wisconsin Research and Education Committee; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031973] Funding Source: NIH RePORTER	This work was supported, in part, by the GE-NFL Head Health Challenge I and the U.S. Army Medical Research and Materiel Command under award number W81XWH-12-1-0004. This publication was also supported by the Clinical and Translational Science Institute grant 1UL1-RR031973 (-01) and by the National Center for Advancing Translational Sciences, National Institutes of Health grant 8UL1TR000055. It was also supported by the Advancing a Healthier Wisconsin Research and Education Committee.	Anderson C., 2016, P ISMRM, P1108; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li Wei, 2013, J Neurosci Neuroeng, V2, P431; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Lin HH, 2017, P ANN M EXH INT SOC, P2395; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Liu W, 2017, P ANN M EXH INT SOC, P4534; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Mori S, 2005, MRI ATLAS HUMAN WHIT; Reichenbach JR, 2015, CLIN NEURORADIOL, V25, P225, DOI 10.1007/s00062-015-0432-9; Schweser F, 2017, P ANN M EXH INT SOC, P4517; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sun HF, 2014, MAGN RESON MED, V71, P1151, DOI 10.1002/mrm.24765; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	34	6	6	2	4	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JUL	2018	39	7					1215	1221		10.3174/ajnr.A5692			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GL6HD	WOS:000437283900010	29880474	Green Published, Green Accepted, hybrid			2022-02-06	
J	Michelson, EA; Huff, JS; Loparo, M; Naunheim, RS; Perron, A; Rahm, M; Smith, DW; Stone, JA; Berger, A				Michelson, Edward A.; Huff, J. Stephen; Loparo, Mae; Naunheim, Rosanne S.; Perron, Andrew; Rahm, Martha; Smith, David W.; Stone, Joseph A.; Berger, Ariel			Emergency Department Time Course for Mild Traumatic Brain Injury Workup	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							MINOR HEAD-INJURY; UNITED-STATES; MANAGEMENT	Introduction: Mild traumatic brain injury (mTBI) is a common cause for visits to the emergency department (ED). The actual time required for an ED workup of a patient with mTBI in the United States is not well known. National emergency medicine organizations have recommended reducing unnecessary testing, including head computed tomography (CT) for these patients.(10) Methods: To examine this issue, we developed a care map that included each step of evaluation of mTBI (Glasgow Coma Scale Score 13-15) - from initial presentation to the ED to discharge. Time spent at each step was estimated by a panel of United States emergency physicians and nurses. We subsequently validated time estimates using retrospectively collected, real-time data at two EDs. Length of stay (LOS) time differences between admission and discharged patients were calculated for patients being evaluated for mTBI. Results: Evaluation for mTBI was estimated at 401 minutes (6.6 hours) in EDs. Time related to head CT comprised about one-half of the total LOS. Real-time data from two sites corroborated the estimate of median time difference between ED admission and discharge. at 6.3 hours for mTBI. Conclusion: Limiting use of head CT as part of the workup of mTBI to more serious cases may reduce time spent in the ED and potentially improve overall ED throughput.	[Michelson, Edward A.] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Emergency Med, 4801 El Paso Dr,Suite 83200, El Paso, TX 79905 USA; [Huff, J. Stephen] Univ Virginia Hlth Syst, Dept Emergency Med, Charlottesville, VA USA; [Loparo, Mae] Univ Hosp Cleveland Med Ctr, Dept Emergency Med, Cleveland, OH USA; [Naunheim, Rosanne S.] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Perron, Andrew] Maine Med Ctr, Dept Emergency Med, Portland, ME 04102 USA; [Rahm, Martha] Barnes Jewish Hosp, Dept Emergency Med, St Louis, MO 63110 USA; [Smith, David W.] Integris Baptist Med Ctr, Dept Emergency Med, Oklahoma City, OK USA; [Stone, Joseph A.] Brody Sch Med, East Carolina Sch Med, Dept Emergency Med, Greenville, NC USA; [Berger, Ariel] Evidera, Bethesda, MD USA		Michelson, EA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Emergency Med, 4801 El Paso Dr,Suite 83200, El Paso, TX 79905 USA.	Edward.Michelson@ttuhsc.edu	Berger, Ariel/AAX-6411-2020	Berger, Ariel/0000-0002-8833-4544	BrainScope, Inc., Bethesda, Maryland, USA; U.S Army [W81XWH-14-C-1405]; Evidera, Inc.	By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. This work was funded by BrainScope, Inc., Bethesda, Maryland, USA. Facilitation of meetings, the conduct of the analyses, and manuscript development support was provided by Evidera, Inc. Data from the second part of this study was a cohort derived from a study funded in part by a research contract from the U.S Army, contract #W81XWH-14-C-1405.	American College of Emergency Physicians, CHOOS WIS 5 THINGS P; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Centers for Disease Control and Prevention Web Site, TRAUM BRAIN INJ US F; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Haydel Micelle, 2012, Emerg Med Pract, V14, P1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Rogg JG, 2017, AM J EMERG MED, V35, P1510, DOI 10.1016/j.ajem.2017.04.059	11	6	6	1	1	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	JUL	2018	19	4					635	640		10.5811/westjem.2018.5.37293			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GY8OF	WOS:000448890500002	30013697	gold, Green Published, Green Submitted			2022-02-06	
J	Puckett, Y; Zhang, K; Blasingame, J; Lorenzana, J; Parameswaran, S; Brooks, SE; Baronia, BC; Griswold, J				Puckett, Yana; Zhang, Kelly; Blasingame, Jay; Lorenzana, Jessica; Parameswaran, Shamini; Brooks, Steven E.; Baronia, Benedicto C.; Griswold, John			Safest Time to Resume Oral Anticoagulation in Patients with Traumatic Brain Injury	CUREUS			English	Article						anti-platelet therapy; anti-coagulation therapy; trauma; traumatic brain injury; thromboembolism; death; stroke	INTRACRANIAL HEMORRHAGE; ANTIPLATELET; MANAGEMENT; AGENTS; IMPACT; OUTCOMES	Objective: There is no standard protocol to guide the optimal time to resume anti-clotting agents after traumatic brain injury (TBI) in patients with a continued indication for anticoagulation/antiplatelet therapy (AAT). This study develops baseline data supporting a future prospective cohort study. We predict that there will be significantly decreased adverse events when AAT is started on or after Day 7. Methods: A retrospective chart review of 256 patients was performed. Patients admitted to a level I trauma center in West Texas between January 1, 2009, and December 31, 2012, on anticlotting agents (specifically acetylsalicylic acid, coumadin, and/or clopidogrel) and who suffered a TBI were included. Patient metrics included admission coagulation studies, type of TBI and treatment, and time to continuation of AAT. Outcomes were assessed using follow-up appointment data. The primary outcome was death (mortality). Secondary outcomes included myocardial infarction, stroke, re-bleed, venous thromboembolism, and pneumonia. Results: A total of 256 patients met the inclusion criteria. However, only 85 patients on AAT presented for the six-month follow-up. Time to AAT resumption varied from immediate to 31 days. Out of the 85 patients, 32 patients never resumed AAT, 32 patients were restarted on AAT medication in less than seven days, 10 patients restarted medication between seven and 14 days, and 11 patients restarted AAT in more than 14 days. Adverse events occurred most infrequently in the AAT group resuming therapy between seven and 14 days (10%). Adverse events were most prevalent in the AAT group that never resumed therapy (68.8%). Conclusion: While most studies suggest that the safest time for resuming AAT lies between three and 10 days, our study revealed that adverse events were minimized in patients on AAT between seven and 9.5 days.	[Puckett, Yana] Texas Tech Univ, Hlth Sci Ctr, Surg, Atlanta, GA USA; [Zhang, Kelly] Texas Tech Hlth Sci Ctr, Surg, Lubbock, TX 79430 USA; [Blasingame, Jay] Northern Calif Kaiser Permanente, Surg, Oakland, CA USA; [Lorenzana, Jessica] Northern Calif Kaiser Permanente, Med, Oakland, CA USA; [Parameswaran, Shamini] Yale New Haven Med Ctr, Thorac Surg, 20 York St, New Haven, CT 06504 USA; [Brooks, Steven E.] Texas Tech Univ, Hlth Sci Ctr, Trauma & Acute Care Surg, Lubbock, TX 79430 USA; [Baronia, Benedicto C.] Texas Tech Univ, Hlth Sci Ctr, Neurosurg, Lubbock, TX 79430 USA; [Griswold, John] Texas Tech Hlth Sci Ctr Lubbock, Gen Surg, Lubbock, TX USA		Zhang, K (corresponding author), Texas Tech Hlth Sci Ctr, Surg, Lubbock, TX 79430 USA.	kelly.zhang@ttuhsc.edu	Puckett, Yana/ABG-8917-2020		NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER		Bauersachs RM, 2012, INTERNIST, V53, P1431, DOI 10.1007/s00108-012-3146-y; Vega LB, 2017, NEFROLOGIA, V37, P244, DOI 10.1016/j.nefro.2016.08.006; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Chandrasekar S, 2013, AM J THER, V20, P61, DOI 10.1097/MJT.0b013e31820543a3; Czepluch FS, 2014, INTERNIST, V55, P382, DOI 10.1007/s00108-013-3418-1; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Gulba DC, 1996, HERZ, V21, P12; Hawryluk GWJ, 2010, J THROMB HAEMOST, V8, P1500, DOI 10.1111/j.1538-7836.2010.03882.x; Hickey K, 2012, HEART LUNG, V41, P146, DOI 10.1016/j.hrtlng.2011.07.008; Joseph B, 2014, AM SURGEON, V80, P43; Levy JH, 2014, J THORAC CARDIOV SUR, V148, P1802, DOI 10.1016/j.jtcvs.2014.09.003; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Morris Alan H, 2003, Curr Opin Crit Care, V9, P236, DOI 10.1097/00075198-200306000-00012; Nishijima DK, 2013, AM J EMERG MED, V31, P1244, DOI 10.1016/j.ajem.2013.04.035; Paramo JA, 2013, MED CLIN-BARCELONA, V141, P346, DOI 10.1016/j.medcli.2013.05.011; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Sileshi B, 2015, NAT REV NEPHROL, V11, P10, DOI 10.1038/nrneph.2014.204; Skeik N, 2014, ANN VASC SURG, V28, P503, DOI 10.1016/j.avsg.2013.07.013; Tipler PS, 2013, J CRIT CARE, V28, P148, DOI 10.1016/j.jcrc.2012.08.021; Wendon J, 2010, CRIT CARE MED, V38, pS590, DOI 10.1097/CCM.0b013e3181f20227; Wijdicks EFM, 1998, NEUROSURGERY, V42, P769, DOI 10.1097/00006123-199804000-00053; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Xu Yan, 2013, CMAJ Open, V1, pE115, DOI 10.9778/cmajo.20130032	24	6	6	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JUL	2018	10	7							e2920	10.7759/cureus.2920			9	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HB3HX	WOS:000450942900020	30186725	Green Published, Green Submitted, gold			2022-02-06	
J	Ragsdale, KA; Gramlich, MA; Beidel, DC; Neer, SM; Kitsmiller, EG; Morrison, KI				Ragsdale, Katie A.; Gramlich, Michael A.; Beidel, Deborah C.; Neer, Sandra M.; Kitsmiller, Emily G.; Morrison, Krystal I.			Does Traumatic Brain Injury Attenuate the Exposure Therapy Process?	BEHAVIOR THERAPY			English	Article						posttraumatic stress disorder; traumatic brain injury; exposure therapy; habituation; extinction	POSTTRAUMATIC-STRESS-DISORDER; COMBAT-RELATED PTSD; MULTICOMPONENT BEHAVIORAL TREATMENT; PERSISTENT POSTCONCUSSIVE SYMPTOMS; PROLONGED EXPOSURE; MANAGEMENT THERAPY; TREATMENT PROGRAM; NEUROPSYCHOLOGICAL OUTCOMES; RESIDENTIAL-TREATMENT; AFGHANISTAN VETERANS	Research indicates that exposure therapy is efficacious for combat-related posttraumatic stress disorder (PTSD) comorbid with traumatic brain injury (TBI) as is shown by reduced PTSD treatment outcome scores. What is unknown, however, is whether the process of fear extinction is attenuated in veterans with TBI history. Increased PTSD symptomatology and possible cognitive deficits associated with TBI sequelae may indicate additional or longer exposure sessions to achieve habituation and extinction comparable to individuals without TBI history. As such, a more extensive course of treatment may be necessary to achieve comparable PTSD treatment outcome scores for individuals with TBI history. Using a sample of veterans with combat-related PTSD, some of whom were comorbid for TBI, this study compared process variables considered relevant to successful treatment outcome in exposure therapy. Individuals with and without TBI demon strated similar rates of fear activation, length and number of exposure sessions, within-session habituation, between session habituation, and extinction rate; results remained consistent when controlling for differential PTSD symptomatology. Furthermore, results indicated that self-perception of executive dysfunction did not impact the exposure process. Results suggest that individuals with PTSD and TBI history engage successfully and no differently in the exposure therapy process as compared to individuals with PTSD alone. Findings further support exposure therapy as a first-line treatment for combat-related PTSD regardless of TBI history.	[Ragsdale, Katie A.; Gramlich, Michael A.; Beidel, Deborah C.; Neer, Sandra M.; Kitsmiller, Emily G.; Morrison, Krystal I.] Univ Cent Florida, Orlando, FL 32816 USA		Ragsdale, KA (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 12 Execut Pk Dr NE,Suite 300, Atlanta, GA 30329 USA.	kathleen.ann.ragsdale@emory.edu			U.S. Army Medical Research & Materiel Command-Military Operational Medicine Research Program (USAMRMC-MOMRP) [W81XWH-11-2-0038]	This study was supported by the U.S. Army Medical Research & Materiel Command-Military Operational Medicine Research Program (USAMRMC-MOMRP; contract W81XWH-11-2-0038) to the third author. The study had both MRCM HRPO and local IRB approval and does not necessarily reflect the policy/position of the government. The funding source had no involvement with the design, collection, analysis, or interpretation of the data, or the writing of the report or the decision to submit the article for publication.	Bacow TL, 2010, CHILD FAM BEHAV THER, V32, P322, DOI 10.1080/07317107.2010.515843; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Beidel DC, 2019, J ANXIETY DISORD, V61, P64, DOI 10.1016/j.janxdis.2017.08.005; Beidel DC, 2017, B MENNINGER CLIN, V81, P107, DOI 10.1521/bumc.2017.81.2.107; Beidel DC, 2017, J ANXIETY DISORD, V50, P23, DOI 10.1016/j.janxdis.2017.05.001; Beidel DC, 2011, J ANXIETY DISORD, V25, P224, DOI 10.1016/j.janxdis.2010.09.006; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benito KG, 2015, J OBSESS-COMPULS REL, V6, P147, DOI 10.1016/j.jocrd.2015.01.006; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bluett EJ, 2014, J BEHAV THER EXP PSY, V45, P97, DOI 10.1016/j.jbtep.2013.09.003; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2004, PSYCHOSOM MED, V66, P760, DOI 10.1097/01.psy.0000138121.13198.84; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Calvo MG, 1998, MOTIV EMOTION, V22, P211, DOI 10.1023/A:1022384022641; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Craske MG, 2008, BEHAV RES THER, V46, P5, DOI 10.1016/j.brat.2007.10.003; Crawford EF, 2017, J NERV MENT DIS, V205, P140, DOI 10.1097/NMD.0000000000000594; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Department of Defense, 2016, DOD NUMB TRAUM BRAIN; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Foa E.B., 2007, PROLONGED EXPOSURE T, DOI [10.1093/med:psych/9780195308501.001.0001, DOI 10.1093/MED:PSYCH/9780195308501.001.0001]; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Frueh BC, 1996, BEHAV RES THER, V34, P533, DOI 10.1016/0005-7967(96)00020-4; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Goodson J, 2011, PSYCHOL REP, V109, P573, DOI 10.2466/02.09.15.16.PR0.109.5.573-599; Haagen JFG, 2015, CLIN PSYCHOL REV, V40, P184, DOI 10.1016/j.cpr.2015.06.008; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; McIlvain SM, 2013, COGN BEHAV PRACT, V20, P375, DOI 10.1016/j.cbpra.2012.09.002; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Moustafa AA, 2013, BRAIN COGNITION, V81, P29, DOI 10.1016/j.bandc.2012.10.005; Nacasch N, 2011, J CLIN PSYCHIAT, V72, P1174, DOI 10.4088/JCP.09m05682blu; Norton PJ, 2011, J ANXIETY DISORD, V25, P654, DOI 10.1016/j.janxdis.2011.02.006; Ragsdale KA, 2016, J TRAUMA STRESS, V29, P474, DOI 10.1002/jts.22130; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Rizzo Albert, 2009, POSTTRAUMATIC STRESS, P375, DOI [DOI 10.1007/978-1-60327-329-9_18, DOI 10.1007/978-1]; Rupp C, 2017, CLIN PSYCHOL PSYCHOT, V24, P697, DOI 10.1002/cpp.2039; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Sripada RK, 2015, J ANXIETY DISORD, V30, P81, DOI 10.1016/j.janxdis.2015.01.002; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; TURNER SM, 1992, BEHAV THER, V23, P389, DOI 10.1016/S0005-7894(05)80165-0; van Minnen A, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.18805; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Walter KH, 2014, J TRAUMA STRESS, V27, P438, DOI 10.1002/jts.21934; Walter KH, 2012, J TRAUMA STRESS, V25, P426, DOI 10.1002/jts.21722; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wiederhold BK, 2002, CYBERPSYCHOL BEHAV, V5, P77, DOI 10.1089/109493102753685908; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Woon FL, 2017, COGN NEUROPSYCHIATRY, V22, P1, DOI 10.1080/13546805.2016.1255603; Yoder M, 2012, PSYCHOL SERV, V9, P16, DOI 10.1037/a0026279; Zimmermann N, 2015, BRAIN INJURY, V29, P1071, DOI 10.3109/02699052.2015.1015613	72	6	6	0	3	ASSOC ADV BEHAVIOR THERAPY	NEW YORK	305 7TH AVE #16A, NEW YORK, NY 10001-6008 USA	0005-7894	1878-1888		BEHAV THER	Behav. Therapy	JUL	2018	49	4					617	630		10.1016/j.beth.2017.09.008			14	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	GM0TD	WOS:000437768500012	29937262				2022-02-06	
J	Richard, NM; O'Connor, C; Dey, A; Robertson, IH; Levine, B				Richard, Nadine M.; O'Connor, Charlene; Dey, Ayan; Robertson, Ian H.; Levine, Brian			External Modulation of the Sustained Attention Network in Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; sustained attention; fMRI; alerting; cognitive rehabilitation	PARTIAL LEAST-SQUARES; DIFFUSE AXONAL INJURY; PRACTICAL SCALE; QUANTIFIED MRI; FMRI DATA; PERFORMANCE; TASK; DYSFUNCTION; DAMAGE; REHABILITATION	Objective: Traumatic brain injury (TBI) is associated with impairments in processing speed as well as higher-level cognitive functions that depend on distributed neural networks, such as regulating and sustaining attention. Although exogenous alerting cues have been shown to support patients in sustaining attentive, goal-directed behavior, the neural correlates of this rehabilitative effect are unclear. The purpose of this study was to explore the effects of moderate to severe TBI on activity and functional connectivity in the well-documented right-lateralized frontal-subcortical-parietal sustained attention network, and to assess the effects of alerting cues. Method: Using multivariate analysis of fMRI data, TBI patients and matched neurologically healthy (NH) comparison participants were scanned as they performed the Sustained Attention to Response Task (SART) in 60-s blocks, with or without exogenous cueing through brief auditory alerting tones. Results: Results documented inefficient voluntary control of attention in the TBI patients, with reduced functional connectivity in the sustained attention network relative to NH participants. When alerting cues were present during the SART, however, functional connectivity increased and became comparable to activity patterns seen in the NH group. Conclusions: These findings provide novel evidence of a neural mechanism for the facilitatory effects of alerting cues on goal-directed behavior in patients with damaged attentional brain systems, and support their use in cognitive rehabilitation. General Scientific Summary Traumatic brain injury (TBI) is a leading cause of disability in the U.S. and worldwide, with lasting cognitive problems including poor attention and behavior regulation. This functional neuroimaging study showed the brain's attention network is less efficient after moderate to severe TBI. Alerting tones during the attention task helped to normalize patients' brain activity. This supports the use of alerting for cognitive rehabilitation of attention problems after TBI.	[Richard, Nadine M.; O'Connor, Charlene; Dey, Ayan; Levine, Brian] Baycrest, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada; [Richard, Nadine M.; O'Connor, Charlene; Dey, Ayan; Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [O'Connor, Charlene] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Dey, Ayan] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Robertson, Ian H.] Trinity Coll, Dept Psychol & Neurosci, Hartford, CT 06106 USA; [Levine, Brian] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada		Levine, B (corresponding author), Baycrest, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	blevine@research.baycrest.org	Levine, Brian/O-2725-2019; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Dey, Ayan/0000-0001-5020-6216	Canadian Institutes of Health Research GrantCanadian Institutes of Health Research (CIHR) [MOP-202037]; Natural Sciences and Engineering Research Council of Canada postgraduate scholarshipNatural Sciences and Engineering Research Council of Canada (NSERC)	This work was supported by Canadian Institutes of Health Research Grant MOP-202037 awarded to Brian Levine and a Natural Sciences and Engineering Research Council of Canada postgraduate scholarship awarded to Nadine M. Richard. We thank all participants for their involvement in this project, and Marina Mandic for research assistance.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bellgrove MA, 2006, CORTEX, V42, P838, DOI 10.1016/S0010-9452(08)70426-X; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Dutilh G, 2012, ATTEN PERCEPT PSYCHO, V74, P454, DOI 10.3758/s13414-011-0243-2; Edgington E. S., 1980, RANDOMIZATION TESTS; Efron B., 1986, STAT SCI, V1, P54, DOI 10.1214/ss/1177013815; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Guild EB, 2015, J INT NEUROPSYCH SOC, V21, P650, DOI 10.1017/S1355617715000600; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hart EP, 2012, J NEUROL, V259, P1191, DOI 10.1007/s00415-011-6334-0; JENNETT B, 1975, LANCET, V1, P480; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Markett S, 2014, HUM BRAIN MAPP, V35, P1700, DOI 10.1002/hbm.22285; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McIntosh AR, 1999, MEMORY, V7, P523, DOI 10.1080/096582199387733; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; McIntosh AR, 1996, CEREB CORTEX, V6, P571, DOI 10.1093/cercor/6.4.571; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mottaghy FM, 2006, NEUROIMAGE, V29, P225, DOI 10.1016/j.neuroimage.2005.07.034; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Nordahl T. E., 1988, COGN BEHAV NEUROL, V1, P3; Norman D., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; O'Connor C, 2011, NEUROPSYCHOLOGY, V25, P535, DOI 10.1037/a0022767; Parasuraman R, 1998, ATTENTIVE BRAIN, P221; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raja Beharelle A, 2012, NEUROIMAGE, V60, P1528, DOI 10.1016/j.neuroimage.2012.01.037; Raja Beharelle A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00164; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robertson I. H., 2004, COGNITIVE NEUROSCIEN, VIII, P563; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; SAMPSON PD, 1989, NEUROTOXICOL TERATOL, V11, P477, DOI 10.1016/0892-0362(89)90025-1; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schneider W., 2001, E PRIME USERS GUIDE; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; SPSS Inc, 2009, PASW STAT WINDOWS PASW STAT WIND VERS; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEASDALE G, 1974, LANCET, V2, P81; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009	71	6	6	1	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2018	32	5					541	553		10.1037/neu0000442			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GK8VT	WOS:000436509600003	29733624				2022-02-06	
J	Vedantam, A; Robertson, CS; Gopinath, SP				Vedantam, Aditya; Robertson, Claudia S.; Gopinath, Shankar P.			Quantitative cerebral blood flow using xenon-enhanced CT after decompressive craniectomy in traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; cerebral blood flow; xenon-enhanced CT; decompressive craniectomy	INTRACRANIAL-PRESSURE; OUTCOME PREDICTION; OXYGENATION; PERFUSION	OBJECTIVE Few studies have reported on changes in quantitative cerebral blood flow (CBF) after decompressive craniectomy and the impact of these measures on clinical outcome. The aim of the present study was to evaluate global and regional CBF patterns in relation to cerebral hemodynamic parameters in patients after decompressive craniectomy for traumatic brain injury (TBI). METHODS The authors studied clinical and imaging data of patients who underwent xenon-enhanced CT (XeCT) CBF studies after decompressive craniectomy for evacuation of a mass lesion and/or to relieve intractable intracranial hypertension. Cerebral hemodynamic parameters prior to decompressive craniectomy and at the time of the XeCT CBF study were recorded. Global and regional CBF after decompressive craniectomy was measured using XeCT. Regional cortical CBF was measured under the craniectomy defect as well as for each cerebral hemisphere. Associations between CBF, cerebral hemodynamics, and early clinical outcome were assessed. RESULTS Twenty-seven patients were included in this study. The majority of patients (88.9%) had an initial Glasgow Coma Scale score <= 8. The median time between injury and decompressive surgery was 9 hours. Primary decompressive surgery (within 24 hours) was performed in the majority of patients (n = 18, 66.7%). Six patients had died by the time of discharge. XeCT CBF studies were performed a median of 51 hours after decompressive surgery. The mean global CBF after decompressive craniectomy was 49.9 +/- 21.3 ml/100 g/min. The mean cortical CBF under the craniectomy defect was 46.0 +/- 21.7 ml/100 g/min. Patients who were dead at discharge had significantly lower postcraniectomy CBF under the craniectomy defect (30.1 +/- 22.9 vs 50.6 +/- 19.6 ml/100 g/min; p = 0.039). These patients also had lower global CBF (36.7 +/- 23.4 vs 53.7 +/- 19.7 ml/100 g/min; p = 0.09), as well as lower CBF for the ipsilateral (33.3 +/- 27.2 vs 51.8 +/- 19.7 ml/100 g/min; p = 0.07) and contralateral (36.7 +/- 19.2 vs 55.2 +/- 21.9 ml/100 g/min; p = 0.08) hemispheres, but these differences were not statistically significant. The patients who died also had significantly lower cerebral perfusion pressure (52 +/- 17.4 vs 75.3 +/- 10.9 mm Hg; p = 0.001). CONCLUSIONS In the presence of global hypoperfusion, regional cerebral hypoperfusion under the craniectomy defect is associated with early mortality in patients with TBI. Further study is needed to determine the value of incorporating CBF studies into clinical decision making for severe traumatic brain injury.	[Vedantam, Aditya; Robertson, Claudia S.; Gopinath, Shankar P.] Baylor Coll Med, Dept Neurosurg, 7200 Cambridge St,Ste 9A,MS BCM650, Houston, TX 77030 USA		Gopinath, SP (corresponding author), Baylor Coll Med, Dept Neurosurg, 7200 Cambridge St,Ste 9A,MS BCM650, Houston, TX 77030 USA.	shankarg@bcm.edu					Akbik OS, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0672-3; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; Fridley J, 2015, J NEUROTRAUM, V32, P75, DOI 10.1089/neu.2014.3350; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YONAS H, 1991, J CEREBR BLOOD F MET, V11, P716, DOI 10.1038/jcbfm.1991.128	17	6	7	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2018	129	1					241	246		10.3171/2017.4.JNS163036			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GP2JB	WOS:000440655000030	29027859	Bronze			2022-02-06	
J	Moustafa, F; Roubin, J; Pereira, B; Barres, A; Saint-Denis, J; Perrier, C; Mondet, M; Dutheil, F; Schmidt, J				Moustafa, Fares; Roubin, Jean; Pereira, Bruno; Barres, Alain; Saint-Denis, Jennifer; Perrier, Christophe; Mondet, Marine; Dutheil, Frederic; Schmidt, Jeannot			Predictive factors of intracranial bleeding in head trauma patients receiving antiplatelet therapy admitted to an emergency department	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; ATRIAL-FIBRILLATION; COMPUTED-TOMOGRAPHY; REGRESSION-ANALYSIS; CLOPIDOGREL USE; RISK-FACTORS; CT FINDINGS; HEMORRHAGE; MILD; SCORE	Background: In head trauma cases involving antiplatelet agent treatment, the French Society of Emergency Medicine recommends performing computed tomography (CT) scans to detect brain lesions, 90% of which are normal. The value of CT is still debatable given the scarce number of studies and controversial results. Methods: We used the RATED registry (Registry of patient with Antithrombotic agents admitted to an Emergency Department, NCT02706080) to assess factors of cerebral bleeding related to antiplatelet agents following head trauma. Results: From January 2014 to December 2015, 993 patients receiving antiplatelet agents were recruited, 293 (29.5%) of whom underwent CT scans for brain trauma. Intracranial bleeding was found in 26 (8.9%). Multivariate analysis revealed these patients more likely to have a history of severe hemorrhage (odds ratio [OR]: 8.47, 95% confidence interval [CI]: 1.56-45.82), dual antiplatelet therapy (OR: 6.46, 95% CI: 1.46-28.44), headache or vomiting (OR: 4.27, 95% CI: 1.44-2.60), and abnormal Glasgow coma scale (OR: 8.60; 95% CI: 2.85-25.99) compared to those without intracranial bleeding. The predictive model derived from these variables achieved 98.9% specificity and a negative predictive value of 92%. The area under the ROC curve (AUROC) was 0.85 (95% CI: 0.77-0.93). Conclusions: Our study demonstrated that the absence of history of severe hemorrhage, dual antiplatelet therapy, headache or vomiting, and abnormal Glasgow coma scale score appears to predict normal CT scan following traumatic brain injury in patients taking antiplatelets. This finding requires confirmation by prospective studies.	[Moustafa, Fares; Roubin, Jean; Saint-Denis, Jennifer; Perrier, Christophe; Mondet, Marine; Dutheil, Frederic; Schmidt, Jeannot] Clermont Ferrand Univ Hosp, Emergency Dept, Clermont Ferrand, France; [Moustafa, Fares; Saint-Denis, Jennifer; Dutheil, Frederic; Schmidt, Jeannot] Univ Clermont Auvergne, Clermont Ferrand, France; [Pereira, Bruno] Clermont Ferrand Univ Hosp, Biostat Unit, DRCI, Clermont Ferrand, France; [Barres, Alain] Univ Hosp Clermont Ferrand, Dept Med Informat, Clermont Ferrand, France; [Dutheil, Frederic] Australian Catholic Univ, Sch Exercise Sci, Melbourne, Vic, Australia; [Dutheil, Frederic] CNRS, UMR 6024, LAPSCO, Physiol & Psychosocial Stress Team, Clermont Ferrand, France; [Moustafa, Fares] CHU Clermont Ferrand, Serv Urgences, 58 Rue Montalembert, F-63003 Clermont Ferrand 1, France		Moustafa, F (corresponding author), Clermont Ferrand Univ Hosp, Emergency Dept, Clermont Ferrand, France.; Moustafa, F (corresponding author), Univ Clermont Auvergne, Clermont Ferrand, France.	fmoustafa@chu-clermontferrand.fr	Moustafa, Fares/Z-2829-2019; Dutheil, Frederic/O-9707-2014	Dutheil, Frederic/0000-0002-1468-6029; MOUSTAFA, Fares/0000-0003-0949-1558			Af Geijerstam J-L, MED OUTCOME IMMEDIAT, DOI [10.1136/bmj.38918.669317.4F, DOI 10.1136/BMJ.38918.669317.4F]; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Burt Catharine W, 2007, Adv Data, P1; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Demidenko E, 2007, STAT MED, V26, P3385, DOI 10.1002/sim.2771; Di Bartolomeo S, 2014, J TRAUMA ACUTE CARE, V76, P437, DOI 10.1097/TA.0b013e3182aa80f9; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Gallagher SF, 2003, AM J SURG, V185, P131, DOI 10.1016/S0002-9610(02)01208-4; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; Hair JF., 2014, MULTIVARIATE DATA AN, V7; Hamden K, 2014, AM J EMERG MED, V32, P890, DOI 10.1016/j.ajem.2014.04.051; Harris R.J., 2014, PRIMER MULTIVARIATE; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Levine M, 2014, AM J EMERG MED, V32, P71, DOI 10.1016/j.ajem.2013.08.063; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; McCaig Linda F, 2004, Adv Data, P1; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; O'Brien EC, 2015, EUR HEART J, V36, P3258, DOI 10.1093/eurheartj/ehv476; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Palareti G, 2009, THROMB HAEMOSTASIS, V102, P268, DOI 10.1160/TH08-11-0730; Pedhazur E. J., 1975, MULTIPLE REGRESSION, V70, DOI [10.2307/2285468, DOI 10.2307/2285468]; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Reddy S, 2014, AM SURGEON, V80, P975; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI 10.1089/neu.2009-0928; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schuetz P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1098-z; Schuetz P, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-12; SCHWAB CW, 1992, ARCH SURG-CHICAGO, V127, P701; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Siracuse JJ, 2010, SURGERY, V148, P724, DOI 10.1016/j.surg.2010.07.014; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tazarourte K, 2014, CRIT CARE, V18, DOI [10.1186/cc13843, 10.1007/s13341-014-0474-7]; Thaler HW, 2015, J NEUROSURG, V123, P1202, DOI 10.3171/2014.12.JNS142276; Tosteson TD, 2003, STAT MED, V22, P1069, DOI 10.1002/sim.1388; Turedi S, 2008, J EMERG MED, V34, P253, DOI 10.1016/j.jemermed.2007.05.055; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393	58	6	6	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUN 19	2018	26								50	10.1186/s13049-018-0515-0			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GK1LT	WOS:000435878200001	29914560	Green Published, gold			2022-02-06	
J	Phillips, KF; Deshpande, LS; DeLorenzo, RJ				Phillips, Kristin F.; Deshpande, Laxmikant S.; DeLorenzo, Robert J.			Hypothermia Reduces Mortality, Prevents the Calcium Plateau, and Is Neuroprotective Following Status Epilepticus in Rats	FRONTIERS IN NEUROLOGY			English	Article						status epilepticus; pilocarpine; hypothermia; intra neuronal calcium levels; mortality; neuroprotection; Sprague-Dawley rats	CULTURED HIPPOCAMPAL-NEURONS; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; HOMEOSTATIC MECHANISMS; SYNAPTIC PLASTICITY; RYANODINE RECEPTORS; ACQUIRED EPILEPSY; MILD HYPOTHERMIA	Status Epilepticus (SE) is a major neurological emergency and is considered a leading cause of Acquired Epilepsy (AE). We have shown that SE produces neuronal injury and prolonged alterations in hippocampal calcium levels ([Ca2+](i)) that may underlie the development of AE. Interventions preventing the SE-induced Ca2+ plateau could therefore prove to be beneficial in lowering the development of AE after SE. Hypothermia is used clinically to prevent neurological complications associated with Traumatic Brain Injury, cardiac arrest, and stroke. Here, we investigated whether hypothermia prevented the development of Ca2+ plateau following SE. SE was induced in hippocampal neuronal cultures (HNC) by exposing them to no added MgCl2 solution for 3 h. To terminate SE, low Mg2+ solution was washed off with 31 degrees C (hypothermic) or 37 degrees C (normothermic) physiological recording solution. [Ca2+](i) was estimated with ratiometric Fura-2 imaging. HNCs washed with hypothermic solution exhibited [Ca2+](i) ratios, which were significantly lower than ratios obtained from HNCs washed with normothermic solution. For in vivo SE, the rat pilocarpine (PILO) model was used. Moderate hypothermia (30-33 degrees C) in rats was induced at 30-min post-SE using chilled ethanol spray in a cold room. Hypothermia following PILO-SE significantly reduced mortality. Hippocampal neurons isolated from hypothermia-treated PILO SE rats exhibited [Ca2+](i) ratios which were significantly lower than ratios obtained from PILO SE rats. Hypothermia also provided significant neuroprotection against SE-induced delayed hippocampal injury as characterized by decreased FluoroJade C labeling in hypothermia-treated PILO SE rats. We previously demonstrated that hypothermia reduced Ca2+ entry via N-methyl-D-aspartate and ryanodine receptors in HNC. Together, our studies indicate that by targeting these two receptor systems hypothermia could interfere with epileptogenesis and prove to be an effective therapeutic intervention for reducing SE-induced AE.	[Phillips, Kristin F.; Deshpande, Laxmikant S.; DeLorenzo, Robert J.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23284 USA; [Deshpande, Laxmikant S.; DeLorenzo, Robert J.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA		DeLorenzo, RJ (corresponding author), Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23284 USA.; DeLorenzo, RJ (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	robert.delonanzo@vcuhealth.org	Deshpande, Laxmikant S./B-7679-2013	Deshpande, Laxmikant S./0000-0003-1491-1561	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS092494-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS092494] Funding Source: NIH RePORTER	This research was supported by the National Institute of Neurological Disorders and Stroke (NINDS), Grant Number R56NS092494-01 to RD.	Adasme T, 2011, P NATL ACAD SCI USA, V108, P3029, DOI 10.1073/pnas.1013580108; Baker KD, 2013, NEUROSCI BIOBEHAV R, V37, P1211, DOI 10.1016/j.neubiorev.2013.04.011; Bengtson CP, 2012, ADV EXP MED BIOL, V970, P377, DOI 10.1007/978-3-7091-0932-8_17; Bennett AE, 2014, CLIN NEUROL NEUROSUR, V126, P103, DOI 10.1016/j.clineuro.2014.08.032; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bodalia A, 2013, ACTA PHARMACOL SIN, V34, P49, DOI 10.1038/aps.2012.139; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Chadwick W, 2012, CURR ALZHEIMER RES, V9, P110, DOI 10.2174/156720512799015055; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; DeLorenzo RJ, 2007, INT REV NEUROBIOL, V81, P59, DOI 10.1016/S0074-7742(06)81005-6; Deshpande LS, 2008, EPILEPSIA, V49, P1795, DOI 10.1111/j.1528-1167.2008.01667.x; Deshpande LS, 2007, EUR J PHARMACOL, V558, P52, DOI 10.1016/j.ejphar.2006.11.030; Deshpande LS, 2016, ANN NY ACAD SCI, V1374, P176, DOI 10.1111/nyas.13122; Deshpande LS, 2016, NEUROTOXICOL TERATOL, V56, P81, DOI 10.1016/j.ntt.2016.05.002; Deshpande LS, 2014, NEUROTOXICOLOGY, V44, P17, DOI 10.1016/j.neuro.2014.04.006; Deshpande LS, 2010, TOXICOL SCI, V116, P623, DOI 10.1093/toxsci/kfq157; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Furtado MD, 2010, EPILEPSIA, V51, P1503, DOI 10.1111/j.1528-1167.2009.02478.x; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Hauser WA, 1990, EPILEPSY FREQUENCY C; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Karnatovskaia LV, 2014, NEUROHOSPITALIST, V4, P153, DOI 10.1177/1941874413519802; Kim Do-Hyung, 2017, J Epilepsy Res, V7, P109, DOI 10.14581/jer.17017; Kim HJ, 2014, AM J EMERG MED, V32, P1378, DOI 10.1016/j.ajem.2014.08.045; Kuramatsu JB, 2015, CEREBROVASC DIS, V40, P228, DOI 10.1159/000439178; LANIER WL, 1995, J NEUROSURG ANESTH, V7, P216, DOI 10.1097/00008506-199507000-00021; Lascarrou JB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0103-5; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Nagarkatti N, 2008, NEUROSCI LETT, V436, P289, DOI 10.1016/j.neulet.2008.02.076; Nagarkatti N, 2010, EUR J NEUROSCI, V32, P80, DOI 10.1111/j.1460-9568.2010.07262.x; Nagarkatti N, 2009, EXPERT REV NEUROTHER, V9, P813, DOI 10.1586/ERN.09.21; Nosaka N, 2017, ACTA MED OKAYAMA, V71, P1, DOI 10.18926/AMO/54819; Phillips KF, 2016, NEUROTOXICOLOGY, V52, P127, DOI 10.1016/j.neuro.2015.11.014; Phillips KF, 2013, EUR J PHARMACOL, V698, P186, DOI 10.1016/j.ejphar.2012.10.010; Pitkanen A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022822; Pitkanen A, 2013, EPILEPSIA, V54, P35, DOI 10.1111/epi.12297; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Raza M, 2004, P NATL ACAD SCI USA, V101, P17522, DOI 10.1073/pnas.0408155101; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; Scholefield B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009442.pub2; Scholefield BR, 2013, EMERG MED J, V30, P24, DOI 10.1136/emermed-2011-200348; Sherman AL, 2014, PHYS MED REH CLIN N, V25, P519, DOI 10.1016/j.pmr.2014.04.003; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Yao Z, 2018, WORLD NEUROSURG, V111, P404, DOI 10.1016/j.wneu.2018.01.020; Yenari MA, 2002, J CEREBR BLOOD F MET, V22, P29, DOI 10.1097/00004647-200201000-00004; Zhang ZJ, 2001, MOL BRAIN RES, V95, P75, DOI 10.1016/S0169-328X(01)00247-9; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357	52	6	6	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 11	2018	9								438	10.3389/fneur.2018.00438			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI8WN	WOS:000434806600001	29942282	Green Published, gold			2022-02-06	
J	Agarwal, P; Abdullah, KG; Ramayya, AG; Nayak, NR; Lucas, TH				Agarwal, Prateek; Abdullah, Kalil G.; Ramayya, Ashwin G.; Nayak, Nikhil R.; Lucas, Timothy H.			A Retrospective Propensity Score-Matched Early Thromboembolic Event Analysis of Prothrombin Complex Concentrate vs Fresh Frozen Plasma for Warfarin Reversal Prior to Emergency Neurosurgical Procedures	NEUROSURGERY			English	Article						Prothrombin complex concentrate; Fresh frozen plasma; Anticoagulation reversal; Warfarin; Thrombotic complication; Emergency neurosurgical procedure; Propensity score matching	K ANTAGONIST REVERSAL; ORAL ANTICOAGULANT REVERSAL; TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; VITAMIN-K; INTRACEREBRAL HEMORRHAGE; PULMONARY-EMBOLISM; RANDOMIZED-TRIAL; URGENT REVERSAL; RAPID REVERSAL	BACKGROUND: Reversal of therapeutic anticoagulation prior to emergency neurosurgical procedures is required in the setting of intracranial hemorrhage. Multifactor prothrombin complex concentrate (PCC) promises rapid efficacy but may increase the probability of thrombotic complications compared to fresh frozen plasma (FFP). OBJECTIVE: To compare the rate of thrombotic complications in patients treated with PCC or FFP to reverse therapeutic anticoagulation prior to emergency neurosurgical procedures in the setting of intracranial hemorrhage at a level I trauma center. METHODS: Sixty-three consecutive patients on warfarin therapy presenting with intracranial hemorrhage who received anticoagulation reversal prior to emergency neurosurgical procedures were retrospectively identified between 2007 and 2016. They were divided into 2 cohorts based on reversal agent, either PCC (n = 28) or FFP (n = 35). The thrombotic complications rates within 72 h of reversal were compared using the chi(2) test. A multivariate propensity score matching analysis was used to limit the threat to interval validity from selection bias arising from differences in demographics, laboratory values, history, and clinical status. RESULTS: Thrombotic complications were uncommon in this neurosurgical population, occurring in 1.59% (1/63) of treated patients. There was no significant difference in the thrombotic complication rate between groups, 3.57% (1/28; PCC group) vs 0% (0/35; FFP group). Propensity score matching analysis validated this finding after controlling for any selection bias. CONCLUSION: In this limited sample, thrombotic complication rates were similar between use of PCC and FFP for anticoagulation reversal in the management of intracranial hemorrhage prior to emergency neurosurgical procedures.	[Agarwal, Prateek; Abdullah, Kalil G.; Ramayya, Ashwin G.; Nayak, Nikhil R.; Lucas, Timothy H.] Univ Penn, Dept Neurosurg, Ctr Neuroengn & Therapeut, 3400 Spruce St, Philadelphia, PA 19104 USA		Agarwal, P (corresponding author), Univ Penn, Dept Neurosurg, Ctr Neuroengn & Therapeut, 3400 Spruce St, Philadelphia, PA 19104 USA.	prateek.agarwal@uphs.upenn.edu					Aguilar MI, 2007, MAYO CLIN PROC, V82, P82, DOI 10.1016/s0025-6196(11)60970-1; Beynon C, 2015, J EMERG MED, V49, P778, DOI 10.1016/j.jemermed.2015.05.032; Beynon C, 2015, J NEUROSURG ANESTH, V27, P246, DOI 10.1097/ANA.0000000000000104; Beynon C, 2014, ACTA NEUROCHIR, V156, P741, DOI 10.1007/s00701-014-2032-x; Bobbitt L, 2011, THROMB RES, V128, P577, DOI 10.1016/j.thromres.2011.04.017; Boulis NM, 1999, NEUROSURGERY, V45, P1113, DOI 10.1097/00006123-199911000-00020; Cabral KP, 2013, CLIN NEUROL NEUROSUR, V115, P770, DOI 10.1016/j.clineuro.2012.07.006; Cappabianca G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1172-6; Cartmill M, 2000, BRIT J NEUROSURG, V14, P458; Chapman SA, 2011, ANN PHARMACOTHER, V45, P869, DOI 10.1345/aph.1P605; Demeyere R, 2010, VOX SANG, V99, P251, DOI 10.1111/j.1423-0410.2010.01339.x; Desmettre T, 2012, THROMB RES, V130, pE178, DOI 10.1016/j.thromres.2012.05.029; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Evans G, 2001, BRIT J HAEMATOL, V115, P998, DOI 10.1046/j.1365-2141.2001.03214.x; Felton D, 2016, J EMERG MED, V50, P1, DOI 10.1016/j.jemermed.2015.07.001; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; FREDRIKSSON K, 1992, STROKE, V23, P972, DOI 10.1161/01.STR.23.7.972; Frontera JA, 2014, NEUROCRIT CARE, V21, P397, DOI 10.1007/s12028-014-9972-0; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Goldstein JN, 2015, LANCET, V385, P2077, DOI 10.1016/S0140-6736(14)61685-8; Haghpanah S, 2013, CLIN APPL THROMB-HEM, V19, P277, DOI 10.1177/1076029612450772; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Hickey M, 2013, CIRCULATION, V128, P360, DOI 10.1161/CIRCULATIONAHA.113.001875; Hirsh J, 2003, J AM COLL CARDIOL, V41, P1633, DOI 10.1016/S0735-1097(03)00416-9; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Imberti D, 2013, J THROMB THROMBOLYS, V36, P102, DOI 10.1007/s11239-012-0817-4; Joseph B, 2015, NEUROSURGERY, V76, P601, DOI 10.1227/NEU.0000000000000685; Kalina M, 2008, AM SURGEON, V74, P858; Kerebel D, 2013, CRIT CARE, V17, DOI 10.1186/cc11923; Lankiewicz MW, 2006, J THROMB HAEMOST, V4, P967, DOI 10.1111/j.1538-7836.2006.01815.x; Lin DM, 2013, TRANSFUS MED REV, V27, P91, DOI 10.1016/j.tmrv.2013.01.002; Lubelski D, 2015, SPINE J, V15, P1277, DOI 10.1016/j.spinee.2015.02.026; Lubetsky A, 2004, THROMB RES, V113, P371, DOI 10.1016/j.thromres.2004.04.004; Majeed A, 2012, THROMB RES, V129, P146, DOI 10.1016/j.thromres.2011.07.024; Makris M, 1997, THROMB HAEMOSTASIS, V77, P477; Matsushima K, 2015, AM J SURG, V209, P413, DOI 10.1016/j.amjsurg.2014.08.019; Milling TJ, 2016, ANN EMERG MED, V67, P96, DOI 10.1016/j.annemergmed.2015.04.036; Mohrien KM, 2014, NEUROCRIT CARE, V21, P67, DOI 10.1007/s12028-014-9984-9; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Pandey S, 2012, TRANSFUSION, V52, p65S, DOI 10.1111/j.1537-2995.2012.03663.x; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Preston FE, 2002, BRIT J HAEMATOL, V116, P619, DOI 10.1046/j.0007-1048.2001.03295.x; Quick JA, 2015, AM SURGEON, V81, P646; Refaai MA, 2015, TRANSFUSION, V55, P2722, DOI 10.1111/trf.13191; Riess HB, 2007, THROMB RES, V121, P9, DOI 10.1016/j.thromres.2007.02.009; Rolston JD, 2014, J NEUROSURG, V121, P908, DOI 10.3171/2014.6.JNS131419; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Sridharan M, 2016, THROMB RES, V139, P160, DOI 10.1016/j.thromres.2015.11.024; Stecker Mark, 2014, Open Neurol J, V8, P1, DOI 10.2174/1874205X01408010001; Steiner T, 2016, LANCET NEUROL, V15, P566, DOI 10.1016/S1474-4422(16)00110-1; Switzer JA, 2012, STROKE, V43, P2500, DOI 10.1161/STROKEAHA.112.661454; Tilton R, 2014, ANN PHARMACOTHER, V48, P1106, DOI 10.1177/1060028014537897; Tran H, 2011, INTERN MED J, V41, P337, DOI 10.1111/j.1445-5994.2010.02237.x; Vigue B, 2007, INTENS CARE MED, V33, P721, DOI 10.1007/s00134-007-0528-z; Woo CH, 2014, WORLD NEUROSURG, V81, P110, DOI 10.1016/j.wneu.2012.12.002; Yanamadala V, 2014, J CLIN NEUROSCI, V21, P1881, DOI 10.1016/j.jocn.2014.05.001; Yasaka M, 2002, THROMB RES, V108, P25, DOI 10.1016/S0049-3848(02)00402-4; Yasaka M, 2003, ANN HEMATOL, V82, P121, DOI 10.1007/s00277-002-0568-y	58	6	6	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2018	82	6					877	886		10.1093/neuros/nyx327			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GO1GL	WOS:000439697700027	29106685				2022-02-06	
J	Gelbart, B; Schlapbach, L; Ganeshalingham, A; Ganu, S; Erickson, S; Oberender, F; Hoq, M; Williams, G; George, S; Festa, M				Gelbart, Ben; Schlapbach, Luregn; Ganeshalingham, Anusha; Ganu, Subodh; Erickson, Simon; Oberender, Felix; Hoq, Monsurul; Williams, Gary; George, Shane; Festa, Marino		Australian New Zealand Intensive	Fluid bolus therapy in critically ill children: a survey of practice among paediatric intensive care doctors in Australia and New Zealand	CRITICAL CARE AND RESUSCITATION			English	Article							CLINICAL-PRACTICE PARAMETERS; DENGUE SHOCK SYNDROME; ACUTE KIDNEY INJURY; SEPTIC SHOCK; HEMODYNAMIC SUPPORT; RESPIRATORY VARIATION; INITIAL MANAGEMENT; AMERICAN-COLLEGE; RESPONSIVENESS; RESUSCITATION	Objective: Fluid bolus therapy (FBT) is a widely used intervention in paediatric critical illness. The aim of this study was to describe the attitudes and practices towards FBT of paediatric intensive care doctors in Australia and New Zealand. Design: An internet-based survey of paediatric intensive care doctors in Australia and New Zealand between 7 and 30 November 2016. Setting: Paediatric intensive care units with greater than 400 admissions annually. Participants: Paediatric intensive care specialists and junior medical staff. Main outcome measures: Preferences for FBT and markers of fluid responsiveness. Results: There were 106/175 respondents (61 %); 0.9% saline and 4% albumin are used frequently or almost always by 86% and 57% of respondents respectively. The preferred volume and duration were 10 mL/kg in less than 10 minutes. The highest rated markers of fluid responsiveness were heart rate and blood pressure rated as "good" or "very good" by 75% and 58% of respondents respectively. Central venous saturations and serum lactate were the highest rated biochemical markers. The most frequently expected magnitude of change for heart rate and blood pressure was 6-15% by 89% and 76% of respondents respectively. The preferred fluid composition for sepsis, trauma, traumatic brain injury and acute lung injury was 0.9% saline, and 4% albumin for post-operative cardiac surgery. Conclusions: Paediatric intensive care doctors prefer 0.9% saline and 4% albumin for FBT. Heart rate and blood pressure are the most preferred markers to assess fluid responsiveness. Preferences for FBT in specific conditions exist.	[Gelbart, Ben] Royal Childrens Hosp, Paediat Intens Care Unit, Melbourne, Vic, Australia; [Gelbart, Ben; Hoq, Monsurul] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Gelbart, Ben] Univ Melbourne, Melbourne, Vic, Australia; [Schlapbach, Luregn] Univ Queensland, Paediat Crit Care Res Grp, Mater Res Inst, Brisbane, Qld, Australia; [Schlapbach, Luregn] Lady Cilento Childrens Hosp, Paediat Intens Care Unit, Brisbane, Qld, Australia; [Schlapbach, Luregn] Univ Bern, Bern Univ Hosp, Dept Pediat, Inselspital, Bern, Switzerland; [Schlapbach, Luregn] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Ganeshalingham, Anusha] Starship Childrens Hlth, Auckland, New Zealand; [Ganu, Subodh] Womens & Childrens Hosp Network, Adelaide, SA, Australia; [Ganu, Subodh] Univ Adelaide, Adelaide, SA, Australia; [Erickson, Simon] Princess Margaret Hosp Children, Paediat Intens Care Unit, Perth, WA, Australia; [Oberender, Felix] Monash Med Ctr, Melbourne, Vic, Australia; [Oberender, Felix] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Williams, Gary] Sydney Childrens Hosp, Paediat Intens Care Unit, Sydney, NSW, Australia; [George, Shane] Gold Coast Univ Hosp, Southport, Qld, Australia; [George, Shane] Univ Queensland, Brisbane, Qld, Australia; [George, Shane] Griffith Univ, Brisbane, Qld, Australia; [Festa, Marino] Childrens Hosp Westmead, Paediat Intens Care Unit, Sydney, NSW, Australia		Gelbart, B (corresponding author), Royal Childrens Hosp, Paediat Intens Care Unit, Melbourne, Vic, Australia.; Gelbart, B (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Gelbart, B (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.	Ben.gelbart@rch.org.au	Schlapbach, Luregn J/F-7465-2017; George, Shane/E-2019-2015; Hoq, Mohammad/AAU-9642-2020	Schlapbach, Luregn J/0000-0003-2281-2598; George, Shane/0000-0002-8880-1245; Hoq, Dr. Monsurul/0000-0002-0504-9335	Australian and New Zealand Intensive Care Society	We thank the Paediatric Study Group of the Australian and New Zealand Intensive Care Society for supporting this study. We acknowledge the contribution of Glenn Eastwood, Austin Health, for his assistance with the online survey tool, and Neil Glassford for his advice and guidance with the survey design.	Akech S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010021; Akech SO, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-71; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Brewster D, 2012, J PAEDIATR CHILD H, V48, P548, DOI 10.1111/j.1440-1754.2012.02431.x; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Carcillo JA, 2012, PEDIATR CRIT CARE ME, V13, P210, DOI 10.1097/PCC.0b013e3182231667; Choi DY, 2010, PEDIATR CARDIOL, V31, P1166, DOI 10.1007/s00246-010-9776-8; Chowdhury AH, 2013, ANN SURG, V258, P1118, DOI 10.1097/SLA.0000000000000346; Davis AL, 2017, CRIT CARE MED, V45, P1061, DOI 10.1097/CCM.0000000000002425; de Oliveira CF, 2008, INTENS CARE MED, V34, P1065, DOI 10.1007/s00134-008-1085-9; Desgranges FP, 2016, PEDIATR ANESTH, V26, P37, DOI 10.1111/pan.12803; Duke T, 2011, LANCET, V378, P1685, DOI 10.1016/S0140-6736(11)60881-7; Dung NM, 1999, CLIN INFECT DIS, V29, P787, DOI 10.1086/520435; Durand P, 2008, INTENS CARE MED, V34, P888, DOI 10.1007/s00134-008-1021-z; Gan H, 2013, ANESTH ANALG, V117, P1380, DOI 10.1213/ANE.0b013e3182a9557e; Gelbart B, 2015, PEDIATR CRIT CARE ME, V16, pE297, DOI 10.1097/PCC.0000000000000507; Glassford NJ, 2015, ANAESTH INTENS CARE, V43, P750, DOI 10.1177/0310057X1504300613; Glassford NJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0696-5; Hazle MA, 2013, PEDIATR CRIT CARE ME, V14, P44, DOI 10.1097/PCC.0b013e3182712799; Hilton AK, 2012, CRIT CARE, V16, DOI 10.1186/cc11154; Hjortrup PB, 2016, INTENS CARE MED, V42, P1695, DOI 10.1007/s00134-016-4500-7; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Kellum JA, 2012, CRIT CARE, V16, P253, DOI DOI 10.1186/CC10860; Li YH, 2016, EUR J PEDIATR, V175, P39, DOI 10.1007/s00431-015-2592-7; Long E, 2015, EMERG MED AUSTRALAS, V27, P245, DOI 10.1111/1742-6723.12400; Macdonald SPJ, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2137-7; Maitland K, 2005, CLIN INFECT DIS, V40, P538, DOI 10.1086/427505; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mcnab S, 2015, LANCET, V385, P1190, DOI 10.1016/S0140-6736(14)61459-8; Myburgh J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-67; Nhan NT, 2001, CLIN INFECT DIS, V32, P204, DOI 10.1086/318479; Renner J, 2012, BRIT J ANAESTH, V108, P108, DOI 10.1093/bja/aer371; Renner J, 2011, ANAESTHESIA, V66, P582, DOI 10.1111/j.1365-2044.2011.06715.x; Santhanam I, 2008, PEDIATR EMERG CARE, V24, P647, DOI 10.1097/PEC.0b013e31818844cf; Saxena R, 2015, INTENS CARE MED, V41, P2161, DOI 10.1007/s00134-015-4075-8; Schlapbach LJ, 2015, LANCET INFECT DIS, V15, P46, DOI 10.1016/S1473-3099(14)71003-5; Semler MW, 2017, AM J RESP CRIT CARE, V195, P1362, DOI 10.1164/rccm.201607-1345OC; Sinitsky L, 2015, PEDIATR CRIT CARE ME, V16, P205, DOI 10.1097/PCC.0000000000000318; Upadhyay M, 2005, INDIAN PEDIATR, V42, P223; Valentine SL, 2012, CRIT CARE MED, V40, P2883, DOI 10.1097/CCM.0b013e31825bc54d; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334	44	6	6	0	3	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	JUN	2018	20	2					131	138					8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ4YT	WOS:000462417900009	29852852				2022-02-06	
J	Genrikhs, EE; Voronkov, DN; Kapkaeva, MR; Gudasheva, TA; Glibka, YA; Isaev, NK; Stelmashook, EV				Genrikhs, Elisaveta E.; Voronkov, Dmitriy N.; Kapkaeva, Marina R.; Gudasheva, Tatyana A.; Glibka, Yuliya A.; Isaev, Nickolay K.; Stelmashook, Elena V.			The delayed protective effect of GK-2, a dipeptide mimetic of Nerve Growth Factor, in a model of rat traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Neuroprotection; Dipeptide mimetic of nerve growth factor; GK-2; Oxidative stress	INDUCED NEUROLOGICAL DEFICIT; NEURONS; MITOCHONDRIA; INHIBITION; PATHOLOGY; ISCHEMIA; DISEASE; DAMAGE; LIGAND; EDEMA	The delayed protective effect of GK-2, a dipeptide mimetic of Nerve Growth Factor, was investigated on the model of focal one-sided traumatic brain injury (TBI) of the sensorimotor cortex region on the 180th day after the injury. TBI caused a reliably disruption of the functions of the limbs contralateral to injury focus. The intraperitoneal administration of GK-2 (1 mg/kg) from 1st to 4th and from 7th to 10th days after TBI reduced the impairment of the motor functions of the limbs. This therapeutic effect significant manifested itself from the 7th day and continued until the end of the experiment - on the 180th day after TBI. Morphological studies of the animal brains on the 180th day after TBI demonstrated a decrease in the number of neurons in the V layer of the cerebral cortex and a decrease in the thickness of the corpus callosum. The treatment of animals with GK-2 after TBI statistically significant prevented a decrease in the density of neurons in the ipsilateral hemisphere and a decrease in the thickness of the corpus callosum in the contralateral hemisphere in comparison with untreated animals. Additionally, we showed in vitro that GK-2 exhibits neuroprotective properties under oxidative stress in primary hippocampal cultures. Our results demonstrate that the use of GK-2 at the early stages of development of traumatic brain damage can prevent such delayed damage as neuronal and axonal degeneration as well as reduce TBI-related disruptions of brain functions.	[Genrikhs, Elisaveta E.; Voronkov, Dmitriy N.; Kapkaeva, Marina R.; Glibka, Yuliya A.; Isaev, Nickolay K.; Stelmashook, Elena V.] Res Ctr Neurol, Volokolamskoe Shosse 80, Moscow 125367, Russia; [Gudasheva, Tatyana A.] VV Zakusov Inst Pharmacol, Moscow, Russia; [Isaev, Nickolay K.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Isaev, Nickolay K.] Moscow MV Lomonosov State Univ, Biol Fac, Moscow 119234, Russia		Isaev, NK (corresponding author), Moscow MV Lomonosov State Univ, Biol Fac, AN Belozersky Inst Physicochem Biol, Leninskiye Gory1,B 40, Moscow 119991, Russia.	isaev@genebee.msu.ru	Genrikhs, Elizaveta E/C-3854-2012; Stelmashook, Elena V/B-4442-2012; Voronkov, Dmitry N/B-3910-2012; Isaev, Nikolay K/B-4194-2012; Kapkaeva, Marina/AAO-1646-2020	Voronkov, Dmitry N/0000-0001-5222-5322; Genrikhs, Elizaveta/0000-0002-3203-0250; Kapkaeva, Marina/0000-0002-2833-2897	Russian Science FoundationRussian Science Foundation (RSF) [16-15-10108]	This work was supported by the Russian Science Foundation grant No. 16-15-10108.	Aboulkassim T, 2011, MOL PHARMACOL, V80, P498, DOI 10.1124/mol.111.071332; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Bruno MA, 2004, J NEUROSCI, V24, P8009, DOI 10.1523/JNEUROSCI.1508-04.2004; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Colangelo AM, 2008, J NEUROSCI, V28, P2698, DOI 10.1523/JNEUROSCI.5201-07.2008; Davis A E, 2000, Crit Care Nurs Q, V23, P1; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Genrikhs EE, 2017, B EXP BIOL MED+, V164, P211, DOI 10.1007/s10517-017-3960-2; Genrikhs EE, 2015, J DRUG TARGET, V23, P347, DOI 10.3109/1061186X.2014.997736; GIACANELLI F, 1959, Riv Patol Nerv Ment, V80, P467; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gudasheva T.A., 2017, US Pat., 9683014B29, Patent No. 9683014; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hampel H, 1998, ARCH NEUROL-CHICAGO, V55, P193, DOI 10.1001/archneur.55.2.193; HICKS SP, 1977, EXP NEUROL, V56, P410, DOI 10.1016/0014-4886(77)90357-0; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Isaev NK, 2017, BIOCHEMISTRY-MOSCOW+, V82, P291, DOI 10.1134/S0006297917030075; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Isaev NK, 2004, NEUROREPORT, V15, P2227, DOI 10.1097/00001756-200410050-00017; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Li L, 2017, J NEUROTRAUM, V34, P182, DOI 10.1089/neu.2015.4315; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Ostrovskaya RU, 2017, ACTA NATURAE, V9, P94, DOI 10.32607/20758251-2017-9-2-94-102; Paxinos G., 1997, ATLAS ANATOMY RAT BR; Pei D, 2017, BRAIN RES BULL, V134, P121, DOI 10.1016/j.brainresbull.2017.06.020; Plotnikov EY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P145, DOI 10.1134/S0006297910020045; Povarnina PY, 2017, B EXP BIOL MED+, V164, P173, DOI 10.1007/s10517-017-3951-3; Seredenin S B, 2015, Zh Nevrol Psikhiatr Im S S Korsakova, V115, P63, DOI 10.17116/jnevro20151156163-70; Seredenin SB, 2011, B EXP BIOL MED+, V151, P584; Seredenin SB, 2011, B EXP BIOL MED+, V150, P432, DOI 10.1007/s10517-011-1161-y; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Stelmashook EV, 2015, INT J NEUROSCI, V125, P375, DOI 10.3109/00207454.2014.935376; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059	37	6	8	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUN	2018	140						148	153		10.1016/j.brainresbull.2018.05.002			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO0ZR	WOS:000439675700019	29730416				2022-02-06	
J	Guan, J; Karsy, M; Brock, AA; Eli, IM; Manton, GM; Ledyard, HK; Hawryluk, GWJ; Park, MS				Guan, Jian; Karsy, Michael; Brock, Andrea A.; Eli, Ilyas M.; Manton, Gabrielle M.; Ledyard, Holly K.; Hawryluk, Gregory W. J.; Park, Min S.			Vitamin D status and 3-month Glasgow Outcome Scale scores in patients in neurocritical care: prospective analysis of 497 patients	JOURNAL OF NEUROSURGERY			English	Article						Glasgow Outcome Scale; hypovitaminosis; multivariable analysis; prospective study; risk factors; vitamin D; traumatic brain injury	ACUTE PHYSIOLOGY SCORE; D DEFICIENCY; SAPS-II; MORTALITY; SEVERITY; STROKE	OBJECTIVE Vitamin D deficiency has been associated with a variety of negative outcomes in critically ill patients, but little focused study on the effects of hypovitaminosis D has been performed in the neurocritical care population. In this study, the authors examined the effect of vitamin D deficiency on 3-month outcomes after discharge from a neurocritical care unit (NCCU). METHODS The authors prospectively analyzed 25-hydroxy vitamin D levels in patients admitted to the NCCU of a quaternary care center over a 6-month period. Glasgow Outcome Scale (GOS) scores were used to evaluate their 3-month outcome, and univariate and multivariate logistic regression was used to evaluate the effects of vitamin D deficiency. RESULTS Four hundred ninety-seven patients met the inclusion criteria. In the binomial logistic regression model, patients without vitamin D deficiency (> 20 ng/dl) were significantly more likely to have a 3-month GOS score of 4 or 5 than those who were vitamin D deficient (OR 1.768 [95% CI 1.095-2.852]). Patients with a higher Simplified Acute Physiology Score (SAPS II) (OR 0.925 [95% CI 0.910-0.940]) and those admitted for stroke (OR 0.409 [95% CI 0.209-0.803]) or those with an "other" diagnosis (OR 0.409 [95% CI 0.217-0.772]) were significantly more likely to have a 3-month GOS score of 3 or less. CONCLUSIONS Vitamin D deficiency is associated with worse 3-month postdischarge GOS scores in patients admitted to an NCCU. Additional study is needed to determine the role of vitamin D supplementation in the NCCU population.	[Guan, Jian; Karsy, Michael; Brock, Andrea A.; Eli, Ilyas M.; Manton, Gabrielle M.; Hawryluk, Gregory W. J.; Park, Min S.] Univ Utah, Dept Neurosurg, Clin Neurosci Ctr, 175 N Med Dr East, Salt Lake City, UT 84132 USA; [Ledyard, Holly K.] Univ Utah, Dept Neurol, Clin Neurosci Ctr, Salt Lake City, UT USA		Park, MS (corresponding author), Univ Utah, Dept Neurosurg, Clin Neurosci Ctr, 175 N Med Dr East, Salt Lake City, UT 84132 USA.	neuropub@hsc.utah.edu	Karsy, Michael/AAH-8583-2020	Karsy, Michael/0000-0002-0422-7937; Guan, Jian/0000-0002-4762-7113			Al-Badr W, 2008, CLIN J AM SOC NEPHRO, V3, P1555, DOI 10.2215/CJN.01150308; Amrein K, 2014, JAMA-J AM MED ASSOC, V312, P1520, DOI 10.1001/jama.2014.13204; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Dobnig H, 2011, J NEUROL SCI, V311, P15, DOI 10.1016/j.jns.2011.08.046; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Flynn L, 2012, AM J SURG, V203, P379, DOI 10.1016/j.amjsurg.2011.09.012; Guan J, 2017, J NEUROSURG, V127, P1, DOI 10.3171/2016.4.JNS16169; Handschu R, 2005, J NEUROL, V252, P1249, DOI 10.1007/s00415-005-0853-5; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Holter JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158536; JENNETT B, 1975, LANCET, V1, P480; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lucidarme O, 2010, INTENS CARE MED, V36, P1609, DOI 10.1007/s00134-010-1875-8; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Moon BH, 2015, J CLIN NEUROSCI, V22, P111, DOI 10.1016/j.jocn.2014.05.031; Park SK, 2009, J KOREAN MED SCI, V24, P420, DOI 10.3346/jkms.2009.24.3.420; Pincus M, 2011, HENRYS CLIN DIAGNOSI; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Ravindra VM, 2015, WORLD NEUROSURG, V83, P1114, DOI 10.1016/j.wneu.2014.12.031; Roch A, 2011, CRIT CARE, V15, DOI 10.1186/cc9984; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P345; Schlogl M, 2014, CLIN INTERV AGING, V9, P559, DOI 10.2147/CIA.S51785; Schuiling WJ, 2005, NEUROSURGERY, V57, P230, DOI 10.1227/01.NEU.0000166536.42876.9C; Venkatram S, 2011, CRIT CARE, V15, DOI 10.1186/cc10585; Zhang YP, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0684-9	30	6	7	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2018	128	6					1635	1641		10.3171/2017.2.JNS163037			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GP2IM	WOS:000440653000004	28799870	Bronze			2022-02-06	
J	Higgins, KL; Caze, T; Maerlender, A				Higgins, Kathryn L.; Caze, Todd; Maerlender, Arthur			Validity and Reliability of Baseline Testing in a Standardized Environment	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Neuropsychological testing; Collegiate athletes; Baseline; Concussion; Concussion assessment	CONCUSSION; PERFORMANCE; IMPACT; UTILITY	Objective: The Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) is a computerized neuropsychological test battery commonly used to determine cognitive recovery from concussion based on comparing post-injury scores to baseline scores. This model is based on the premise that ImPACT baseline test scores are a valid and reliable measure of optimal cognitive function at baseline. Growing evidence suggests that this premise may not be accurate and a large contributor to invalid and unreliable baseline test scores may be the protocol and environment in which baseline tests are administered. This study examined the effects of a standardized environment and administration protocol on the reliability and performance validity of athletes' baseline test scores on ImPACT by comparing scores obtained in two different group-testing settings. Method: Three hundred-sixty one Division 1 cohort-matched collegiate athletes' baseline data were assessed using a variety of indicators of potential performance invalidity; internal reliability was also examined. Results: Thirty-one to thirty-nine percent of the baseline cases had at least one indicator of low performance validity, but there were no significant differences in validity indicators based on environment in which the testing was conducted. Internal consistency reliability scores were in the acceptable to good range, with no significant differences between administration conditions. Conclusions: These results suggest that athletes may be reliably performing at levels lower than their best effort would produce.	[Higgins, Kathryn L.; Caze, Todd; Maerlender, Arthur] Univ Nebraska Lincoln, Ctr Brain Biol & Behav, C64 East Stadium,POB 880156, Lincoln, NE 68588 USA		Higgins, KL (corresponding author), Univ Nebraska Lincoln, Ctr Brain Biol & Behav, C64 East Stadium,POB 880156, Lincoln, NE 68588 USA.	drkatehiggins@gmail.com					Barth JT, 1989, MILD HEAD INJURY, P257; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Broglio S, 2014, NATL ATHLETIC TRAINE; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Higgins K., 2015, THESIS; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; ImPACT Applications Inc., 2011, TECHN MAN ONL IMPACT; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Larrabee G., 2016, NAT AC NEUR 36 ANN C; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Pallant, 2005, SPSS SURVIVAL MANUAL; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732	28	6	6	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2018	33	4					437	443		10.1093/arclin/acx071			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GP6ES	WOS:000440971000007	28961684	Green Published, Bronze			2022-02-06	
J	Kawarai, Y; Tanaka, H; Kobayashi, T; Shozu, M				Kawarai, Yoshimasa; Tanaka, Hirokazu; Kobayashi, Tatsuya; Shozu, Makio			Progesterone as a Postnatal Prophylactic Agent for Encephalopathy Caused by Prenatal Hypoxic Ischemic Insult	ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; EXTREMELY PRETERM INFANTS; NEONATAL ENCEPHALOPATHY; CORPUS-CALLOSUM; CEREBRAL-PALSY; CLINICAL-TRIAL; FEMALE RATS; FOLLOW-UP; NEUROPROTECTION; ALLOPREGNANOLONE	Brain damage caused by hypoxic ischemic insult during the perinatal period causes hypoxic ischemic encephalopathies (HIEs). Therapeutic hypothermia is indicated for HIE, but because the therapeutic burden is large for its limited therapeutic effectiveness, another strategy is needed. Progesterone (P-4) plays a neuroprotective role through the actions of its metabolite, allopregnanolone (Allo), on P-4 receptor, g-aminobutyric acid type A receptors or both. We examined the therapeutic potential of P-4 using a newborn rat model of HIE. Fetal rats were exposed to transient ischemic hypoxia by 30-minute bilateral uterine artery clamping on gestational day 18. After spontaneous birth, newborn pups were subcutaneously injected with P-4 (0.10 or 0.01 mg), medroxyprogesterone acetate (MPA; 0.12 mg), or Allo (0.10 mg) through postnatal days (PDs) 1 to 9. Brain damage in the rats was assessed using the rotarod test at PD50. The HIE insult reduced the rats' ability in the rotarod task, which was completely reversed by P-4 and Allo, but not by MPA. Histological examination revealed that the HIE insult decreased neuronal (the cortex and the hippocampal CA1 region) and oligodendroglial cell density (the corpus callosum) through PD0 to PD50. The axon fiber density and myelin sheath thickness in the corpus callosum were also reduced at PD50. The time-course study revealed that P-4 restored oligodendroglial cells by PD5, which was followed by neuroprotective action of P-4 that lasted long over the injection period. These results suggest that P-4 protects the neonatal brain from HIE insult via restoration of oligodendroglial cells.	[Kawarai, Yoshimasa; Tanaka, Hirokazu; Kobayashi, Tatsuya; Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba 2608670, Japan; [Tanaka, Hirokazu] Int Univ Hlth & Welf, Sch Med, Dept Obstet & Gynecol, Narita 2868686, Japan		Shozu, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Reprod Med, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608670, Japan.	shozu@faculty.chiba-u.jp		Kawarai, Yoshimasa/0000-0002-9886-6384	Japan Society for the Promotion of Science KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23659772, 15K20127]	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23659772 (to M.S.) and 15K20127 (to Y.K.).	Aboitiz F, 2003, BIOL RES, V36, P89, DOI 10.4067/S0716-97602003000100007; Aboukhabar HA, 2017, RES OPIN ANESTH INTE, V4, P84; Corrigan J, 2015, NEUROMETHODS, V104, P15, DOI 10.1007/978-1-4939-2709-8_2; Cotten CM, 2014, J PEDIATR-US, V164, P973, DOI 10.1016/j.jpeds.2013.11.036; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Dixon BJ, 2015, INT J MOL SCI, V16, P22368, DOI 10.3390/ijms160922368; Geddes RI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146419; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; GURPIDE E, 1972, AM J OBSTET GYNECOL, V113, P21, DOI 10.1016/0002-9378(72)90447-4; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Hirst JJ, 2016, J STEROID BIOCHEM, V160, P181, DOI 10.1016/j.jsbmb.2015.09.012; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Ishihara Y, 2013, J STEROID BIOCHEM, V135, P1, DOI 10.1016/j.jsbmb.2012.12.013; Jantzie LL, 2013, PEDIATR RES, V74, P658, DOI 10.1038/pr.2013.155; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kitamura Y, 2006, BRAIN RES, V1093, P123, DOI 10.1016/j.brainres.2006.03.041; Liao Y, 2013, BONE MARROW TRANSPL, V48, P890, DOI 10.1038/bmt.2012.169; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; MCAULEY JW, 1993, PHARMACOL BIOCHEM BE, V45, P77, DOI 10.1016/0091-3057(93)90089-C; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Nelson KB, 2015, NEW ENGL J MED, V373, P946, DOI 10.1056/NEJMra1505261; Nguyen PN, 2004, J PHYSIOL-LONDON, V560, P593, DOI 10.1113/jphysiol.2004.069336; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; O'Neill M, 2000, CURRENT PROTOCOLS NE; Ojima K, 1996, REPROD TOXICOL, V10, P221, DOI 10.1016/0890-6238(96)00025-1; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Pazol K, 2009, PHYSIOL BEHAV, V97, P58, DOI 10.1016/j.physbeh.2009.01.021; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; PULSINELLI WA, 1988, STROKE, V19, P913, DOI 10.1161/01.STR.19.7.913; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Rio-Hortega P. D, 1932, CYTOLOGY CELLULAR PA, P482; Robinson S, 2005, NEUROBIOL DIS, V18, P568, DOI 10.1016/j.nbd.2004.10.024; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Shi Y, 2012, ANIMAL MODELS ACUTE, P149; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; TAKAGI I, 1990, J ELECTRON MICROSC, V39, P67; Thome UH, 2006, PEDIATR RES, V60, P619, DOI 10.1203/01.pdr.0000242262.55324.aa; Trotter A, 2007, ARCH DIS CHILD-FETAL, V92, pF94, DOI 10.1136/adc.2006.097170; Trotter A, 2001, J CLIN ENDOCR METAB, V86, P601, DOI 10.1210/jc.86.2.601; Trotter A, 2012, J CLIN ENDOCR METAB, V97, P1041, DOI 10.1210/jc.2011-2612; VALENTINO KL, 1982, J NEUROCYTOL, V11, P583, DOI 10.1007/BF01262426; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; Watanabe K, 2012, J MATERN-FETAL NEO M, V25, P1254, DOI 10.3109/14767058.2011.636094; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu SP, 2017, CURR TOP DEV BIOL, V125, P171, DOI 10.1016/bs.ctdb.2017.03.001; Yager JY, 2009, PEDIATR NEUROL, V40, P156, DOI 10.1016/j.pediatrneurol.2008.10.025; Zakar T, 2011, NEW ENGL J MED, V364, P972, DOI 10.1056/NEJMcibr1100071; Zhang AG, 1997, J CEREBR BLOOD F MET, V17, P123, DOI 10.1097/00004647-199702000-00001; Zhu TT, 2016, J CHILD NEUROL, V31, P1235, DOI 10.1177/0883073816650039	59	6	8	0	3	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	JUN	2018	159	6					2264	2274		10.1210/en.2018-00148			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	GM9XU	WOS:000438610400001	29648595	Green Published, hybrid			2022-02-06	
J	Lusch, B; Weholt, J; Maia, PD; Kutz, JN				Lusch, Bethany; Weholt, Jake; Maia, Pedro D.; Kutz, J. Nathan			Modeling cognitive deficits following neurodegenerative diseases and traumatic brain injuries with deep convolutional neural networks	BRAIN AND COGNITION			English	Article						Traumatic brain injury; Neurodegenerative disease; Focal axonal swellings; Convolutional neural networks	DIFFUSE AXONAL INJURY; IN-VITRO; PARKINSONS-DISEASE; NERVE-FIBERS; MILD; DEGENERATION; DEMENTIA; BETA; ABNORMALITIES; REGENERATION	The accurate diagnosis and assessment of neurodegenerative disease and traumatic brain injuries (TBI) remain open challenges. Both cause cognitive and functional deficits due to focal axonal swellings (FAS), but it is difficult to deliver a prognosis due to our limited ability to assess damaged neurons at a cellular level in vivo. We simulate the effects of neurodegenerative disease and TBI using convolutional neural networks (CNNs) as our model of cognition. We utilize biophysically relevant statistical data on FAS to damage the connections in CNNs in a functionally relevant way. We incorporate energy constraints on the brain by pruning the CNNs to be less over-engineered. Qualitatively, we demonstrate that damage leads to human-like mistakes. Our experiments also provide quantitative assessments of how accuracy is affected by various types and levels of damage. The deficit resulting from a fixed amount of damage greatly depends on which connections are randomly injured, providing intuition for why it is difficult to predict impairments. There is a large degree of subjectivity when it comes to interpreting cognitive deficits from complex systems such as the human brain. However, we provide important insight and a quantitative framework for disorders in which FAS are implicated.	[Lusch, Bethany; Weholt, Jake; Maia, Pedro D.; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA		Lusch, B (corresponding author), Univ Washington, Lewis Hall 202,Box 353925, Seattle, WA 98195 USA.	herwaldt@uw.edu	Lusch, Bethany/AAQ-7328-2020	Lusch, Bethany/0000-0002-9521-9990; D. Maia, Pedro/0000-0002-3335-4257	National Physical Science Consortium; National Security AgencyNational Security Agency	B. Lusch would like to acknowledge fellowship support from the National Physical Science Consortium and National Security Agency.	Abadi M, 2015, TENSORFLOW LARGE SCA; Adalbert R, 2009, BRAIN, V132, P402, DOI 10.1093/brain/awn312; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bishop C. M., 1995, NEURAL NETWORKS PATT; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Cayco-Gajic A., 2017, BIORXIV; Chatfield K., 2014, BMVC; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; CHOROMANSKA A, 2015, AISTATS; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Daianu M., 2016, SPIE P, V9784, P1; Del Razo MJ, 2016, SIAM J SCI COMPUT, V38, pB347, DOI 10.1137/15M1010750; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Edlow BL, 2016, NEUROCRIT CARE, V24, P342, DOI 10.1007/s12028-015-0216-8; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Faul M, 2010, TRAUMATIC BRAIN INJU; Fayaz I, 2000, J NEUROSCI METH, V102, P69, DOI 10.1016/S0165-0270(00)00282-X; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Guclu U, 2016, ADV NEURAL INF PROCE, P2101; Guclu U, 2015, J NEUROSCI, V35, P10005, DOI 10.1523/JNEUROSCI.5023-14.2015; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hellman AN, 2010, LAB CHIP, V10, P2083, DOI 10.1039/b927153h; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Henninger N., 2016, BRAIN, P1; Herwerth M, 2016, ANN NEUROL, V79, P794, DOI 10.1002/ana.24630; Hilgetag C. C., 2006, PLOS COMPUTATIONAL B, V2; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Huang G. B., 2007, 0749 U MASS AMH; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Jurevic S., 2011, GREEN PEPPER; Karlsson P, 2016, SCAND J PAIN, V10, P28, DOI 10.1016/j.sjpain.2015.08.007; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Kinnunen K. M., 2010, BRAIN, P1; Kriegeskorte N, 2015, ANNU REV VIS SCI, V1, P417, DOI 10.1146/annurev-vision-082114-035447; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Laukka J. J., 2016, NEUROSCIENCE LETT; Lauria G, 2003, NEUROLOGY, V61, P631, DOI 10.1212/01.WNL.0000070781.92512.A4; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Louis ED, 2009, MOVEMENT DISORD, V24, P1600, DOI 10.1002/mds.22567; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maia PD, 2017, J COMPUT NEUROSCI, V42, P323, DOI 10.1007/s10827-017-0643-y; Maia PD, 2015, J NEUROSCI METH, V253, P233, DOI 10.1016/j.jneumeth.2015.06.022; Maia PD, 2014, J COMPUT NEUROSCI, V37, P317, DOI 10.1007/s10827-014-0504-x; Maia PD, 2014, J COMPUT NEUROSCI, V36, P141, DOI 10.1007/s10827-013-0459-3; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Parkhi O.M., 2015, P BR MACH VIS, DOI [DOI 10.5244/C.29.41, 10.5244/C.29.41]; Patterson BW, 2015, ANN NEUROL, V78, P439, DOI 10.1002/ana.24454; Poggio T, 2016, VIEWS REV MCGOVERN C, P1; Poggio T., 2016, SPONSORED SUPPLEMENT, P9; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 1999, J NEUROSCI, V19, P4263; Sporn Olaf, 2011, NETWORKS BRAIN; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tagliaferro P, 2016, J PARKINSON DIS, V6, P1, DOI 10.3233/JPD-150769; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Vedaldi Andrea, 2015, P ACM INT C MULT; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Weinberger, 2013, ADV NEURAL INFORM PR, V26, P3093, DOI DOI 10.5555/2999792.2999957; Yamins DLK, 2016, NAT NEUROSCI, V19, P356, DOI 10.1038/nn.4244; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111	91	6	6	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	JUN	2018	123						154	164		10.1016/j.bandc.2018.02.012			11	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GE1RO	WOS:000430994600019	29597065	Green Submitted			2022-02-06	
J	Mahmoodpoor, A; Shokouhi, G; Hamishehkar, H; Soleimanpour, H; Sanaie, S; Porhomayon, J; Rasouli, F; Nader, ND				Mahmoodpoor, Ata; Shokouhi, Ghaffar; Hamishehkar, Hadi; Soleimanpour, Hassan; Sanaie, Sarvin; Porhomayon, Jahan; Rasouli, Fatemeh; Nader, Nader D.			A pilot trial of L-carnitine in patients with traumatic brain injury: Effects on biomarkers of injury	JOURNAL OF CRITICAL CARE			English	Article						L-Carnitine; Traumatic brain injury; Neuron specific enolase; Outcome	ACETYL-L-CARNITINE; NEURON-SPECIFIC ENOLASE; ISCHEMIA-REPERFUSION INJURY; NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; NMR-SPECTROSCOPY; PROGNOSTIC VALUE; HEAD-INJURY; RAT-BRAIN; MECHANISMS	Objective: To investigate the effects of L-Carnitine on neuron specific enolase (NSE) as a marker of inflammation in patients with traumatic brain injury (TBI). Methods: Forty patients with severe TBI were randomized into 2 groups. The (LCA-) group received standard treatment with placebo while the (LCA+) group received l-Carnitine 2 g/day for one week. NSE was measured on days 1, 3 and 7 after the initiation of the study. Neurocognitive and neurobehavioral disorders were recorded on the first and third months. Results: Neurocognitive function and NSE significantly improved within one week in both groups. Patient mortality was similar in LCA+ and LCA- groups (P value: 0.76). Brain edema was present in 7 patients in LCA+ group and 13 patients in LCA-group (P value: 0.044). While there was no difference in NSE levels between the two groups. Neurological function was preserved in the LCA+ group with an exception of attention deficit, which was frequent in the LCA+ group. Conclusion: We concluded that despite improvements in neurobehavioral function and the degree of cerebral edema, 7-days of treatment with L-Carnitine failed to reduce serum NSE levels or improve mortality rate at 90 days in patients with TBI. Published by Elsevier Inc.	[Mahmoodpoor, Ata; Rasouli, Fatemeh] Tabriz Univ Med Sci, Dept Anesthesiol Crit Care Med, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran; [Hamishehkar, Hadi] Tabriz Univ Med Sci, Dept Clin Pharm, Tabriz, Iran; [Soleimanpour, Hassan] Tabriz Univ Med Sci, Dept Emergency Med, Tabriz, Iran; [Sanaie, Sarvin] Tabriz Univ Med Sci, TB & Lung Dis Res Ctr, Tabriz, Iran; [Porhomayon, Jahan; Nader, Nader D.] SUNY Buffalo, Dept Anesthesiol, Buffalo, NY USA		Nader, ND (corresponding author), SUNY Buffalo, 77 Goodell St,Suite 550, Buffalo, NY 14203 USA.	jahanpor@buffalo.edu; nnader@buffalo.edu	mahmoodpoor, ata/AAR-9972-2021; Nader, Nader/AAO-9442-2020; Tabrizi, Ghaffar Shokouhi/L-6326-2017; mahmoodpoor, Ata/AAD-6597-2021; Soleimanpour, Hassan/AAZ-4667-2020	Nader, Nader/0000-0002-5744-7319; Tabrizi, Ghaffar Shokouhi/0000-0001-5081-9928; mahmoodpoor, Ata/0000-0002-4361-6230; Soleimanpour, Hassan/0000-0002-1311-4096			ANGELUCCI L, 1988, J NEUROSCI RES, V20, P491, DOI 10.1002/jnr.490200413; Aureli T, 2000, NEUROCHEM RES, V25, P395, DOI 10.1023/A:1007501306623; Aureli T, 1999, EUR J BIOCHEM, V263, P287, DOI 10.1046/j.1432-1327.1999.00524.x; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Bigini P, 2002, NEUROSCI LETT, V329, P334, DOI 10.1016/S0304-3940(02)00667-5; Binienda Z, 2004, NEUROSCI LETT, V367, P264, DOI 10.1016/j.neulet.2004.05.031; Brooks J O 3rd, 1998, Int Psychogeriatr, V10, P193, DOI 10.1017/S1041610298005304; Cakir O, 2003, CARDIOVASC SURG, V11, P375, DOI 10.1016/S0967-2109(03)00077-2; Calikoglu C, 2015, ACTA MEDICA MEDITERR, V31, P777; El-Maraghi S, 2013, EGYPT J CRIT CARE ME, V1, P25, DOI 10.1016/j.ejccm.2012.12.002; Ergun R, 1998, NEUROL RES, V20, P418; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Hao JJ, 2011, BRIT J NUTR, V106, P648, DOI 10.1017/S0007114511000493; Ishii T, 2000, JPN J PHARMACOL, V83, P119, DOI 10.1254/jjp.83.119; Karalija A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041086; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kocogullari CU, 2008, SURG TODAY, V38, P237, DOI 10.1007/s00595-007-3614-5; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; McDermott S, 2005, DISABIL REHABIL, V27, P117, DOI 10.1080/09638280400007380; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patterson C M, 1998, J Ark Med Soc, V95, P109; Pettegrew JW, 2000, MOL PSYCHIATR, V5, P616, DOI 10.1038/sj.mp.4000805; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Rabchevsky AG, 2011, PHARMACOL THERAPEUT, V132, P15, DOI 10.1016/j.pharmthera.2011.05.001; Rahman A, 2001, EUR J CARDIO-THORAC, V20, P65, DOI 10.1016/S1010-7940(01)00756-4; ROSENTHAL RE, 1992, STROKE, V23, P1312, DOI 10.1161/01.STR.23.9.1312; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scafidi S, 2010, J NEUROCHEM, V114, P820, DOI 10.1111/j.1471-4159.2010.06807.x; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; TAGLIALATELA G, 1991, DEV BRAIN RES, V59, P221, DOI 10.1016/0165-3806(91)90102-O; Zanelli SA, 2005, ANN NY ACAD SCI, V1053, P153, DOI 10.1196/annals.1344.013	31	6	6	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	JUN	2018	45						128	132		10.1016/j.jcrc.2018.01.029			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG4VX	WOS:000432695500021	29454227				2022-02-06	
J	Newman, MA; Hirsch, MA; Peindl, RD; Habet, NA; Tsai, TJ; Runyon, MS; Huynh, T; Zheng, N				Newman, Mark A.; Hirsch, Mark A.; Peindl, Richard D.; Habet, Nahir A.; Tsai, Tobias J.; Runyon, Michael S.; Toan Huynh; Zheng, Nigel		Carolinas Trauma Network Res Grp	Reliability of the sub-components of the instrumented timed up and go test in ambulatory children with traumatic brain injury and typically developed controls	GAIT & POSTURE			English	Article						Traumatic brain injury; Reliability; Timed up and go test; Gait; Inpatient rehabilitation	FUNCTIONAL INDEPENDENCE MEASURE; EQUIVALENCE RELIABILITY; GAIT CHARACTERISTICS; BALANCE ABILITIES; ADOLESCENTS; MOBILITY; INDIVIDUALS; ORIENTATION; SEVERITY; RECOVERY	Background: Studies have evaluated the test-re-test reliability of subcomponents of the timed up and-go test in adults by using body-worn inertial sensors. However, studies in children have not been reported in the literature. Research Question: To evaluate the within-session reliability of subcomponents of a newly developed electronically augmented timed 'upand-go' test (EATUG) in ambulatory children with traumatic brain injury (TBI) and children with typical development (TD). Method: The timed up and go test was administered to twelve consecutive ambulatory children with moderate to severe TBI (6 males and 6 females, age 10.5 +/- 1.5 years, range 8-13 years, during inpatient rehabilitation at 27.0 +/- 11.8 days following injury) and 10 TD age and sex-matched children (5 males and 5 females, 10.4 +/- 1.3 years, range 8-11 years). Participants wore a single chest-mounted inertial measurement sensor package with custom software that measured angular and acceleration velocity and torso flexion and extension angles, while they performed 6 trials of the EATUG test. Measures were derived from the overall time to complete the TUG test, angular velocity and angular displacement data for torso flexion and extension during sitto-stand and stand-to-sit segments and both mean and peak angular velocities for two turning segments (i.e. turning around a cone and turning-before-sitting). Results: Within-session reliability of the subcomponents of the TUG test for children with TBI assessed by the intra-class correlation coefficient was ICC (1,1) = 0.84, (range 0.82-0.96), and for TD children ICC (1,1) = 0.73, (range 0.53-0.89). Scores on Total Time, maximum torso flexion/extension angle and peak flexion angular velocity during sit-tostand, and peak turn angular velocity for both turns around the cone and turns before sitting were lower for children with TBI than for TD children (p <= 0.05). Significance: The EATUG test is a reliable measure of physical function in children with TBI who are being discharged from inpatient rehabilitation.	[Newman, Mark A.; Hirsch, Mark A.; Tsai, Tobias J.] Carolinas Med Ctr, Dept Phys Med & Rehabil, Carolinas Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA; [Peindl, Richard D.; Habet, Nahir A.] Atrium Hlth Musculoskeletal Inst, 1000 Blythe Blvd, Charlotte, NC 28203 USA; [Runyon, Michael S.] Carolinas Med Ctr, Dept Emergency Med, 1000 Blythe Blvd, Charlotte, NC 28203 USA; [Toan Huynh] Carolinas Med Ctr, Dept Surg, Div Acute Care Surg, 1000 Blythe Blvd, Charlotte, NC 28203 USA; [Zheng, Nigel] Univ North Carolina Charlotte, Ctr Biomed Engn & Sci, 9201 Univ City Blvd, Charlotte, NC 28223 USA		Newman, MA (corresponding author), Carolinas Med Ctr, Dept Phys Med & Rehabil, Carolinas Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.	Mark.Newman@carolinashealthcare.org	Hirsch, Mark A./D-2798-2016; Runyon, Michael/AAR-8899-2021; Zheng, Nigel/O-2600-2016	Hirsch, Mark A./0000-0002-8997-7971; Runyon, Michael/0000-0002-1703-4317; Newman, Mark/0000-0002-0444-8246; Zheng, Nigel/0000-0003-3095-3251	Carolinas Trauma Network Research Group; Carolinas HealthCare System	We thank D. Hamm for her contribution to the data collection, T.M. Jensen, J.P. Niemeier, J. Raddatz, T. Guerrier, the Carolinas Trauma Network Research Group, and the clinical and administrative staff in the Department of Physical Medicine and Rehabilitation at Levine Children's Hospital, Carolinas Medical Center for their support. We thank the subjects and their families for their participation. This work was supported by a grant from Carolinas HealthCare System to Dr. Mark A. Hirsch. Role of the funding source: The funding source had no influence on the study design, method or analysis.	Austin CA, 2013, BRAIN INJURY, V27, P1056, DOI 10.3109/02699052.2013.794964; Baque E, 2016, BRAIN INJURY, V30, P1143, DOI 10.3109/02699052.2016.1165869; Cohen J., 2013, STAT POWER ANAL BEHA; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Field A., 2017, DISCOVERING STAT USI, V5th; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Fragala MA, 2002, BRAIN INJURY, V16, P149, DOI 10.1080/02699050110103328; Gan SM, 2008, NEUROREHAB NEURAL RE, V22, P745, DOI 10.1177/1545968308316474; Granger C, 1989, GUIDE USE FUNCTIONAL; Herman T, 2014, EXP BRAIN RES, V232, P713, DOI 10.1007/s00221-013-3778-8; Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P131; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2011, NEUROREHABILITATION, V29, P45, DOI 10.3233/NRE-2011-0676; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P254, DOI 10.1097/PEP.0b013e3181820dd8; Kissane AL, 2015, BRAIN INJURY, V29, P1711, DOI 10.3109/02699052.2015.1075174; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Liu J., 2016, PSYCHIATRY, V28, P115, DOI DOI 10.11919/J.ISSN.1002-0829.216045; Martin K, 2017, PEDIATR PHYS THER, V29, P77, DOI 10.1097/PEP.0000000000000333; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Nicolini-Panisson RD, 2014, DEV MED CHILD NEUROL, V56, P490, DOI 10.1111/dmcn.12290; Ottenbacher KJ, 1996, DEV MED CHILD NEUROL, V38, P907; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; Sabharwal S, 2008, CLIN ORTHOP RELAT R, V466, P2910, DOI 10.1007/s11999-008-0524-9; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sperle PA, 1997, AM J OCCUP THER, V51, P35, DOI 10.5014/ajot.51.1.35; van Lummel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151881; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Weiss A., 2016, J AM MED DIR ASSOC, V17, pe9; Williams EN, 2005, DEV MED CHILD NEUROL, V47, P518, DOI 10.1017/S0012162205001027; Wuest S, 2016, J REHABIL RES DEV, V53, P599, DOI 10.1682/JRRD.2015.04.0065	34	6	6	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JUN	2018	63						248	253		10.1016/j.gaitpost.2018.05.014			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	GJ3UW	WOS:000435225300041	29778065				2022-02-06	
J	Patel, KG; Sabini, RC				Patel, Komal G.; Sabini, Rosanna C.			Safety of Osteopathic Cranial Manipulative Medicine as an Adjunct to Conventional Postconcussion Symptom Management: A Pilot Study	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article						concussion; osteopathic cranial manipulative medicine	CHRONIC POSTTRAUMATIC HEADACHE; CONCUSSIONS; PREVALENCE; RETURN; PLAY	Context: Osteopathic cranial manipulative medicine is not a well-established adjunct to conventional treatment for patients with postconcussion symptoms. Objective: To determine whether adjunctive osteopathic cranial manipulative medicine is safe for patients with concussion when accompanied by conventional treatments. Design: Prospective observational pilot study. Setting: Outpatient concussion clinic. Participants: Patients who sustained a concussion were prospectively recruited from an outpatient concussion clinic by a neuropsychologist specialized in concussion. All participants were identified to have a cranial dysfunction. Intervention: Each eligible participant received 1 session of the osteopathic cranial manipulative medicine vault hold technique. Main Outcome Measures: Self-reported adverse events during or after 1 session of the osteopathic cranial manipulative medicine procedure and improvement in concussion symptoms at return to follow-up. Results: None of the 9 participants reported adverse events during or immediately after receiving osteopathic cranial manipulative medicine. Five of the 7 participants who returned for follow-up demonstrated improvement in their overall concussion symptoms based on the Post-Concussion Symptom Scale scores. Conclusions: Osteopathic cranial manipulative medicine was considered a safe adjunctive treatment option to improve concussion-related symptoms and recovery.	[Patel, Komal G.; Sabini, Rosanna C.] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Hempstead, NY USA; [Sabini, Rosanna C.] Southside Hosp, Bay Shore, NY USA		Patel, KG (corresponding author), 1554 Northern Blvd, Manhasset, NY 11030 USA.	kpatel21@northwell.edu					Anderson RE, 2006, HEADACHE, V46, P1273, DOI 10.1111/j.1526-4610.2006.00535.x; Castillo I, 2016, J AM OSTEOPATH ASSOC, V116, P178, DOI 10.7556/jaoa.2016.034; Channell MK, 2009, J AM OSTEOPATH ASSOC, V109, P509; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Frymann V, 1966, J Am Osteopath Assoc, V65, P1059; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greenman PE, 2000, PHYS MED REHABILITAT, P125; Greenman Philip E., 1995, Journal of the American Osteopathic Association, V95, P182; Jakel A, 2011, J AM OSTEOPATH ASSOC, V111, P685; Khusid MA, 2015, MIL MED, V180, P132, DOI 10.7205/MILMED-D-14-00195; Koziminski M, 2008, AM ACAD OSTEOPATH J, V18, P30; Laker SR, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0510-3; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Obermann M, 2015, THER ADV NEUROL DISO, V8, P311, DOI 10.1177/1756285615605699; Sabini RC, 2014, PHYSICIAN SPORTSMED, V42, P10, DOI 10.3810/psm.2014.09.2070; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Sutherland W G, 2000, J Am Osteopath Assoc, V100, P568; Sutherland WG, 2003, TEACHINGS SCI OSTEOP, P119; Tapia RN, 2017, PHYS MED REH CLIN N, V28, P287, DOI 10.1016/j.pmr.2016.12.006; Timoshkin EM, 2008, J AM OSTEOPATH ASSOC, V108, P652; Zasler ND, 2011, J HEAD TRAUMA REHAB, V26, P397, DOI 10.1097/HTR.0b013e31822721f8	25	6	6	0	2	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	JUN	2018	118	6					403	409		10.7556/jaoa.2018.061			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HC4ZL	WOS:000451813200012	29710088				2022-02-06	
J	Punchak, M; Abdelgadir, J; Obiga, O; Itait, M; Najjuma, JN; Haglund, MM; Kitya, D				Punchak, Maria; Abdelgadir, Jihad; Obiga, Oscar; Itait, Martha; Najjuma, Josephine N.; Haglund, Michael M.; Kitya, David			Mechanism of Pediatric Traumatic Brain Injury in Southwestern Uganda: A Prospective Cohort of 100 Patients	WORLD NEUROSURGERY			English	Article						Low- and middle-income countries; Pedestrian injuries; Pediatric head trauma	HEAD-INJURY; EPIDEMIOLOGY; ACCIDENTS; IMPACT	BACKGROUND: Road traffic incidents (RTIs), falls, and violence contribute to more than two thirds of pediatric traumatic brain injuries in sub-Saharan Africa. In this study, we sought to assess mechanisms of pediatric traumatic brain injury in an effort to propose interventions for more effective pediatric head injury prevention. METHODS: A cohort of 100 patients who were <18 years treated at Mbarara Regional Referral Hospital between November 2016 and June 2017 were enrolled in the study. Information on etiology of injury was obtained via a questionnaire administered to patient caretakers at the time of admission. RESULTS: The mean age was found to be 7.5 years (standard deviation 5.2) and 38% were female. In our sample, 61% had computed tomography imaging done, of whom 88.5% had a positive finding. A majority of patients presented with a mild head injury (55%). RTIs were the predominant mechanism of injury across age groups (75%). Across all age groups, falls were responsible for a greater proportion of injuries in children aged 10-14 years (13.3%), whereas the greatest proportion of intentional injuries was reported in age group 10-14 and 15-17 years, 20% and 31.3%, respectively. Patients involved in pedestrian RTIs were significantly younger compared with those injured in nonpedestrian RTIs. Most parents (87.9%) were not with their children at the time of a pedestrian RTI. CONCLUSIONS: In Southwestern Uganda, the majority of pediatric neurotrauma patients are injured pedestrians, with no adult supervision at the time of the injury. Conducting a public awareness and education campaign on the necessity of child supervision is critical to decreasing pediatric head injuries in Uganda.	[Punchak, Maria; Abdelgadir, Jihad; Haglund, Michael M.] Duke Univ, Div Global Neurosurg & Neurol, Durham, NC 27708 USA; [Punchak, Maria] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Abdelgadir, Jihad; Haglund, Michael M.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA; [Obiga, Oscar; Itait, Martha; Najjuma, Josephine N.; Kitya, David] Mbarara Reg Referral Hosp, Dept Neurosurg, Mbarara, Uganda; [Haglund, Michael M.] Duke Univ, Global Hlth Inst, Durham, NC 27708 USA		Haglund, MM (corresponding author), Duke Univ, Div Global Neurosurg & Neurol, Durham, NC 27708 USA.; Haglund, MM (corresponding author), Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA.; Haglund, MM (corresponding author), Duke Univ, Global Hlth Inst, Durham, NC 27708 USA.	Michael.haglund@duke.edu	Nambi, JOSEPHINE Najjuma/AAV-5629-2021	Najjuma, Josephine/0000-0001-5894-5961			Abdelgadir J, 2018, J CLIN NEUROSCI, V47, P79, DOI 10.1016/j.jocn.2017.10.004; Abdelgadir J, 2017, WORLD NEUROSURG, V102, P526, DOI 10.1016/j.wneu.2017.03.019; Agrawal A, 2008, Afr J Paediatr Surg, V5, P15, DOI 10.4103/0189-6725.41630; Anderson GA, 2017, SURGERY, V161, P1710, DOI 10.1016/j.surg.2017.01.009; Assiry KA, 2014, ONLINE J MED MED SCI, V5, P44; Barton BK, 2007, J PEDIATR PSYCHOL, V32, P517, DOI 10.1093/jpepsy/jsm014; Chabok SY, 2012, ARCH TRAUMA RES, V1, P19, DOI 10.5812/atr.5289; Chong SL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010618; DiMaggio C, 2002, ACAD EMERG MED, V9, P54; Durkin MS, 1999, PEDIATRICS, V10, P1999; Fakharian E, 2014, CHIN J TRAUMATOL, V17, P153, DOI 10.3760/cma.j.issn.1008-1275.2014.03.006; Gopal Karmacharya B, 2015, AM J PUBLIC HLTH RES, V3, P76; Haglund MM, 2017, NEUROSURGERY, V80, P656, DOI 10.1093/neuros/nyw159; Idro R., 2015, BRAIN DEGENERATION D, P183; Bonilla-Escobar FJ, 2014, COLOMB MEDICA, V45, P132; Kumar R, 2009, CHILD NERV SYST, V25, P813, DOI 10.1007/s00381-009-0820-z; Ministry of Health, 2012, HLTH FAC INV; Ministry of Health of the Republic of Uganda, 2016, ANN HLTH SECT PERF R; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salvarani CP, 2009, SURG NEUROL, V72, P6, DOI 10.1016/j.surneu.2007.10.008; Sanyang E, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080856; Saxena S., 2006, NEUR DIS PUBL HLTH C, P27; Schwebel DC, 2003, J PEDIATR PSYCHOL, V28, P2003; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; Uganda Bureau of Statistics, 2016, NAT POP HOUS CENS 20	30	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2018	114						E396	E402		10.1016/j.wneu.2018.02.191			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8PI	WOS:000432959600044	29530703				2022-02-06	
J	Rowson, B; Terrell, EJ; Rowson, S				Rowson, Bethany; Terrell, Evan J.; Rowson, Steven			Quantifying the effect of the facemask on helmet performance	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Concussion; biomechanics; head acceleration; hockey; football	HEAD IMPACT EXPOSURE; ICE HOCKEY PLAYERS; PROFESSIONAL FOOTBALL; YOUTH FOOTBALL; CONCUSSION; INJURIES; NECK	Evaluating and improving helmet design play a crucial role in reducing sports-related concussions. Despite widespread use of facemasks by football and hockey players, no helmet standards currently exist to test helmets equipped with facemasks. The purpose of this study was to determine the effect that attached facial protection has on the head kinematics resulting from impacts to the helmet shell. Helmets were fit to a modified NOCSAE (National Operating Committee on Standards for Athletic Equipment) headform and subjected to blows from a pneumatic impactor. A total of 240 impact tests were performed to evaluate the effect of the facemask on four helmet models (two for football, two for hockey). For each helmet model, one sample was tested with a facemask and another without a facemask. Tests were conducted at two impact velocities (6, 9m/s) and three impact locations (front, side, and rear boss) for a total of six impact conditions. Five trials were performed for each helmet sample at each condition. Two-factor analyses of variance were used to quantify effects on linear and rotational head acceleration and Severity Index due to impact location and facemask presence. Significant effects varied by helmet model and impact location and were more commonly associated with football helmets. Differences in facemask effects between sports are likely attributed to differences in facemask-shell attachment mechanisms, and differences in the structure of the facemask itself. The effects of the facemask on linear and rotational acceleration were small, approximately 5% for both football and hockey helmets. On average, peak accelerations were decreased with the addition of a facemask, but individual differences were mixed and varied by helmet type and impact location. These small differences would not greatly affect impact performance tests in the lab. The results of this study have direct applications toward helmet standard development.	[Rowson, Bethany; Terrell, Evan J.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA		Rowson, B (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	browson@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596			Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Gadd C, 1966, 660793 SAE; Gadd C, 1961, NATL RES COUNCIL PUB, P141; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Stevens ST, 2006, J SCI MED SPORT, V9, P238, DOI 10.1016/j.jsams.2006.03.025; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004	21	6	6	1	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	JUN	2018	232	2					94	101		10.1177/1754337117707859			8	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	GG3VX	WOS:000432622900003		Bronze			2022-02-06	
J	Tarvonen-Schroder, S; Tenovuo, O; Kaljonen, A; Laimi, K				Tarvonen-Schroder, Sinikka; Tenovuo, Olli; Kaljonen, Anne; Laimi, Katri			USABILITY OF WORLD HEALTH ORGANIZATION DISABILITY ASSESSMENT SCHEDULE IN CHRONIC TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						activities and participation; disability; functioning; ICF; severity; chronic traumatic brain injury; WHODAS	QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; REHABILITATION; ICF; PARTICIPATION; RETURN; EPIDEMIOLOGY; PERSPECTIVE; POPULATION	Objectives: To investigate functioning measured with the 12-item World Health Organization Disability Assessment Schedule (WHODAS 2.0) in patients with mild, moderate and severe traumatic brain injury, and to compare patients' experiences with assessments made by their significant others and by consultant neurologists. Methods: A total of 112 consecutive patients with traumatic brain injury (29 mild, 43 moderate, 40 severe) and their significant others completed a 12-item WHODAS 2.0 survey. A neurologist assessed functioning with the International Classification of Functioning, Disability and Health minimal generic set. Results: The total patient and proxy WHODAS 2.0 sum score was rated as severe, and impairments in household tasks, learning, community life, emotional functions, concentrating, dealing with strangers, maintaining friendships, and working ability as around moderate in all 3 severity groups. In standing, walking, washing, and dressing oneself the reported impairments increased from mild in mild traumatic brain injury to moderate in severe traumatic brain injury. A neurologist rated the overall functioning, working ability, and motor activities most impaired in severe traumatic brain injury, while there were no between-group differences in energy and drive functions and emotional functions. Conclusion: Patients with chronic traumatic brain injury perceive a diversity of significant difficulties in activities and participation irrespective of the severity of the injury. We recommend assessing disability in traumatic brain injury with the short and understandable WHODAS 2.0 scale, when planning client-oriented services.	[Tarvonen-Schroder, Sinikka; Tenovuo, Olli] Turku Univ Hosp, Dept Rehabil & Brain Trauma, Div Clin Neurosci, Turku, Finland; [Laimi, Katri] Turku Univ Hosp, Dept Phys & Rehabil Med, Turku, Finland; [Laimi, Katri] Univ Turku, Turku, Finland; [Kaljonen, Anne] Univ Turku, Dept Biostat, Turku, Finland		Tarvonen-Schroder, S (corresponding author), Turku Univ Hosp, Div Clin Neurosci, POB 52, FIN-20521 Turku, Finland.	sinikka.tarvonen-schroder@tyks.fi					Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Brands I, 2018, CLIN REHABIL, V32, P116, DOI 10.1177/0269215517718367; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cieza A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-218; Cnossen MC, 2017, J REHABIL MED, V49, P395, DOI 10.2340/16501977-2216; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; Eme R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050046; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Laursen B, 2012, DAN MED J, V59; Laxe S, 2014, DISABIL REHABIL, V36, P82, DOI 10.3109/09638288.2013.780641; Li M, 2016, OPEN ACCESS, V1, P1; Mathar H, 2017, CLIN REHABIL, V31, P1674, DOI 10.1177/0269215517708821; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Montgomery GK, 2010, BRAIN INJURY, V24, P1455, DOI 10.3109/02699052.2010.506634; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; O'Donnell ML, 2016, J CLIN PSYCHIAT, V77, pE473, DOI 10.4088/JCP.14m09721; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shafiei E, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.29729; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Silva AG, 2015, PHYS THER, V95, P1628, DOI 10.2522/ptj.20140323; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Toft AMH, 2010, J TRAUMA, V69, P26, DOI 10.1097/TA.0b013e3181d3cbf2; Ustun T, 2010, MEASURING HLTH DISAB; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; World Health Organization, 2007, INT CLASS FUNCT DIS	40	6	6	1	3	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JUN	2018	50	6					514	518		10.2340/16501977-2345			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GL5HE	WOS:000437194300005	29767229	Green Submitted, gold			2022-02-06	
J	Wang, F; Chen, FX; Wang, GB; Wei, SS; Fang, F; Kang, DZ; Lin, YX				Wang, Feng; Chen, Fuxiang; Wang, Genbo; Wei, Shushan; Fang, Fu; Kang, Dezhi; Lin, Yuanxiang			Rapamycin provides anti-epileptogenic effect in a rat model of post-traumatic epilepsy via deactivation of mTOR signaling pathway	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						post-traumatic epilepsy; mammalian target of rapamycin; rapamycin; traumatic brain injury; seizures	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; MAMMALIAN TARGET; MOUSE MODEL; SEIZURES; INHIBITION; DISEASE	The mammalian target of rapamycin (mTOR) signaling pathway has attracted much attention in recent years. However, the contribution of mTOR activation to the development of post-traumatic epilepsy (PTE) remains largely unknown. The purpose of the present study was to investigate the activation of mTOR signaling in a rat model of FeCl2-induced PTE, and to explore the potential effect of its specific inhibitor rapamycin. The results indicated that the expression levels of p-mTOR and p-P70S6K, the overactivation biomarkers of mTOR signaling, increased significantly in hippocampal and perilesional cortex following PTE induction. Notably, they were significantly decreased in the aformementioned brain regions following rapamycin treatment. Furthermore, the frequency and number of behavioral seizures and epileptic brain injury were also greatly reduced. These results suggest that hyperactivation of the mTOR signaling pathway is a crucial mechanism of PTE development, and it may be considered a novel therapeutic target for PTE treatment.	[Wang, Feng; Chen, Fuxiang; Wang, Genbo; Wei, Shushan; Fang, Fu; Kang, Dezhi; Lin, Yuanxiang] Fujian Med Univ, Affiliated Hosp 1, Dept Neurosurg, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China		Wang, F; Lin, YX (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Neurosurg, 20 Chazhong Rd, Fuzhou 350005, Fujian, Peoples R China.	15005018772@163.com; linyuanxiang1234@163.com			Natural Science Foundation of Fujian ProvinceNatural Science Foundation of Fujian Province [2015J01387]; Medical and Health Science and Technology Innovation Program of Fujian Province [2014-CXB-14]; Key Clinical Specialty Discipline Construction program of Fujian, China [2012-SLCZD-2]	This study was sponsored by the Natural Science Foundation of Fujian Province (no. 2015J01387), and the Medical and Health Science and Technology Innovation Program of Fujian Province (no. 2014-CXB-14), and the Key Clinical Specialty Discipline Construction program of Fujian, China (no. 2012-SLCZD-2).	Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Bhuyan P, 2015, EXP NEUROL, V271, P329, DOI 10.1016/j.expneurol.2015.06.012; Buckmaster PS, 2011, EPILEPSIA, V52, P2057, DOI 10.1111/j.1528-1167.2011.03253.x; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Chauvette S, 2016, J NEUROSCI METH, V260, P185, DOI 10.1016/j.jneumeth.2015.08.030; Cho CH, 2011, EXP MOL MED, V43, P231, DOI 10.3858/emm.2011.43.5.032; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Crino PB, 2016, NAT REV NEUROL, V12, P379, DOI 10.1038/nrneurol.2016.81; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Fan WB, 2017, J NEURO-ONCOL, V131, P485, DOI 10.1007/s11060-016-2327-2; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Gong XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092961; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Irimia A, 2015, J CLIN NEUROSCI, V22, P627, DOI 10.1016/j.jocn.2014.09.019; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee HJ, 2016, NEONATOLOGY, V110, P93, DOI 10.1159/000444360; Lippman-Bell JJ, 2013, EPILEPSIA, V54, P1922, DOI 10.1111/epi.12378; Liu P, 2016, INT J BIOL SCI, V12, P1032, DOI 10.7150/ijbs.15624; Lloyd BA, 2017, BEHAV BRAIN RES, V323, P56, DOI 10.1016/j.bbr.2017.01.033; Nguyen LH, 2015, EPILEPSIA, V56, P636, DOI 10.1111/epi.12946; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rankin-Gee EK, 2015, EPILEPSIA, V56, P1124, DOI 10.1111/epi.13026; Sancho-Rieger J, 2002, REV NEUROLOGIA, V35, pS39; Sha LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039152; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Ueda Y, 1998, EXP NEUROL, V153, P123, DOI 10.1006/exnr.1998.6869; van Vliet EA, 2016, EPILEPSIA, V57, P70, DOI 10.1111/epi.13245; WILLMORE LJ, 1984, J NEUROSURG, V60, P467, DOI 10.3171/jns.1984.60.3.0467; Wong Michael, 2013, Biomed J, V36, P40, DOI 10.4103/2319-4170.110365; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhou CH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0415-4	33	6	8	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2018	15	6					4763	4770		10.3892/etm.2018.6004			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GJ3FB	WOS:000435174400024	29904395	Green Submitted, Green Published, gold			2022-02-06	
J	Wauters, L; Marquardt, TP				Wauters, Lisa; Marquardt, Thomas P.			Category, Letter, and Emotional Verbal Fluency in Spanish-English Bilingual Speakers: A Preliminary Report	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Verbal fluency; Language; Emotional processing; Cross-cultural; Assessment	BRAIN; PERFORMANCE; ACQUISITION; PROFICIENCY	Objective: The purpose of this study was to compare the performance of bilingual speakers on an emotional verbal fluency task to category and letter verbal fluency tasks. A second purpose was to compare performances on these tasks to language proficiency ratings. Method: Twelve verbal fluency tasks were administered to 21 Spanish-English bilingual speakers. Results were analyzed for differences between fluency types (category, letter, and emotional) and languages (English and Spanish). Results: Participants generated the most items in category fluency tasks and the least items in emotional fluency tasks. The number of items generated for letter and emotional fluency tasks were not significantly different, but both were significantly lower than the number of items generated in category fluency. More items were generated for positive emotions than for negative emotions. Differences between languages for category and letter fluency tasks were significantly correlated with differences in language proficiency ratings, but this finding was not found for emotional fluency tasks. Conclusions: Self-ratings of proficiency and language dominance correlated significantly with performance on category and letter fluency tasks and may be useful predictors of differences between languages on these tasks. Emotional fluency was not significantly correlated with language proficiency ratings, suggesting that performance on emotional fluency may be more significantly affected by emotional processing ability. The emotional verbal fluency task has potential as a component of neuropsychological evaluations to screen easily and quickly for emotional processing deficits, including those associated with traumatic brain injury and depression. Additionally, results support a positivity bias in language and cognition processes.	[Wauters, Lisa; Marquardt, Thomas P.] Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA		Wauters, L (corresponding author), Univ Texas Austin, Dept Commun Sci & Disorders, Austin, TX 78712 USA.	ldwaut@utexas.edu			Ben F. Love Regents Professorship at the University of Texas	This research received financial support from the Ben F. Love Regents Professorship at the University of Texas.	Adamovich B. B., 1992, SCALES COGNITIVE ABI; Andreou G, 2013, ADHD-ATTEND DEFICIT, V5, P343, DOI 10.1007/s12402-013-0112-z; Ardila A, 1998, APHASIOLOGY, V12, P131, DOI 10.1080/02687039808250468; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Bialystok E, 2008, J EXP PSYCHOL LEARN, V34, P859, DOI 10.1037/0278-7393.34.4.859; Borod Joan C, 2002, Appl Neuropsychol, V9, P23, DOI 10.1207/S15324826AN0901_4; Brickman AM, 2005, ARCH CLIN NEUROPSYCH, V20, P561, DOI 10.1016/j.acn.2004.12.006; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Gollan TH, 2012, BILING-LANG COGN, V15, P594, DOI 10.1017/S1366728911000332; Gollan TH, 2004, J EXP PSYCHOL LEARN, V30, P246, DOI 10.1037/0278-7393.30.1.246; Gollan TH, 2002, NEUROPSYCHOLOGY, V16, P562, DOI 10.1037//0894-4105.16.4.562; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Grosjean F., 1998, BILINGUALISM LANGUAG, V1, P131, DOI [10.1017/S136672899800025X, DOI 10.1017/S136672899800025X]; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Kertesz A., 1982, W APHASIA BATTERY TE; Klumpp H, 2010, INT J PSYCHOPHYSIOL, V75, P77, DOI 10.1016/j.ijpsycho.2009.10.003; Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050; Laws KR, 2010, CORTEX, V46, P595, DOI 10.1016/j.cortex.2009.04.009; Lorenzen B, 2008, AM J SPEECH-LANG PAT, V17, P299, DOI 10.1044/1058-0360(2008/026); Luk G, 2013, J COGN PSYCHOL, V25, P605, DOI 10.1080/20445911.2013.795574; Luo L, 2010, COGNITION, V114, P29, DOI 10.1016/j.cognition.2009.08.014; Magaud E, 2010, SCHIZOPHR RES, V123, P53, DOI 10.1016/j.schres.2010.05.005; Marrero MZ, 2002, CLIN PSYCHOL REV, V22, P463, DOI 10.1016/S0272-7358(01)00109-X; Munoz ML, 1999, BRAIN LANG, V66, P249, DOI 10.1006/brln.1998.2021; Munoz ML, 2003, APHASIOLOGY, V17, P1115, DOI 10.1080/02687030344000427; Newcombe F., 1969, MISSILE WOUNDS BRAIN; Paradis M., 2001, HDB NEUROPSYCHOLOGY, V3, P69; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pettit L, 2013, J INT NEUROPSYCH SOC, V19, P986, DOI 10.1017/S1355617713000829; Portocarrero JS, 2007, ARCH CLIN NEUROPSYCH, V22, P415, DOI 10.1016/j.acn.2007.01.015; Quinn C, 2012, NEUROLOGY, V79, P583, DOI 10.1212/WNL.0b013e3182635720; Roberts PM, 2002, APHASIOLOGY, V16, P635, DOI [DOI 10.1080/02687030244000220, 10.1080/02687030244000220]; Rosselli M, 2002, INT J NEUROSCI, V112, P759, DOI 10.1080/00207450290025752; Rude SS, 2002, COGNITION EMOTION, V16, P423, DOI 10.1080/02699930143000554; Sass K, 2013, BEHAV SCI-BASEL, V3, P372, DOI 10.3390/bs3030372; Sass K, 2012, HUM BRAIN MAPP, V33, P676, DOI 10.1002/hbm.21241; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Sheppard C, 2016, J INT NEUROPSYCH SOC, V22, P350, DOI 10.1017/S135561771500123X; Skrandies W, 2011, JPN PSYCHOL RES, V53, P65, DOI 10.1111/j.1468-5884.2010.00456.x; Zhao QH, 2013, NEUROSCI BULL, V29, P75, DOI 10.1007/s12264-013-1301-7	48	6	6	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2018	33	4					444	457		10.1093/arclin/acx063			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GP6ES	WOS:000440971000008	28961685				2022-02-06	
J	Wei, QX; He, CC; Chen, J; Chen, DY; Wang, JB				Wei, Qiuxu; He, Chaochao; Chen, Jian; Chen, Deyong; Wang, Junbo			Wireless Passive Intracranial Pressure Sensor Based on a Microfabricated Flexible Capacitor	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						Flexible pressure sensor; intracranial pressure (ICP); PDMS wrinkles; readout method; wireless passive pressure sensor	TRAUMATIC BRAIN-INJURY; POLYDIMETHYLSILOXANE; IMPLANT	This paper presents a wireless passive pressure sensor based on a microfabricated flexible pressure-sensitive capacitor specifically designed to monitor intracranial pressure (ICP) in patients with traumatic brain injuries. The flexible pressure-sensitive capacitor is featured by creatively utilizing the PDMS wrinkles spontaneously generated during PDMS etching to construct a cavity structure for sensitivity improvement. Moreover, a flexible reader coil used for signal readout was optimized to perform better coupling with the sensor in a large enough detection range for ICP monitoring. In addition, the flexible pressure-sensitive capacitor is capable of conforming to curved topographies of skulls and dura maters due to its flexible character and thin thickness. The experimental results show that the proposed sensor reaches a lower resonant frequency, a higher quality factor, and a better sensitivity, compared with previous reports. The abovementioned flexible character and favorable performances make the proposed sensor a potential candidate for the future application in ICP monitoring.	[Wei, Qiuxu; He, Chaochao; Chen, Jian; Chen, Deyong; Wang, Junbo] Chinese Acad Sci, Inst Elect, State Key Lab Transducer Technol, Beijing 100190, Peoples R China; [Wei, Qiuxu; He, Chaochao; Chen, Jian; Chen, Deyong; Wang, Junbo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China		Wang, JB (corresponding author), Chinese Acad Sci, Inst Elect, State Key Lab Transducer Technol, Beijing 100190, Peoples R China.	weiqiuxu@163.com; jbwang@mail.ie.ac.cn		wei, qiu xu/0000-0003-1201-6432	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61372054, 61431019]	This work was supported by the National Natural Science Foundation of China under Grant 61372054 and Grant 61431019. The review of this paper was arranged by Editor D. J. Young.	[Anonymous], 2011, SPEC COAST SYST; Behfar MH, 2016, IEEE ENG MED BIO, P1950, DOI 10.1109/EMBC.2016.7591105; Bowden N, 1999, APPL PHYS LETT, V75, P2557, DOI 10.1063/1.125076; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen PJ, 2010, J MICROELECTROMECH S, V19, P721, DOI 10.1109/JMEMS.2010.2049825; Cheng XL, 2017, MICROSYST NANOENG, V3, DOI 10.1038/micronano.2016.74; Efimenko K, 2005, NAT MATER, V4, P293, DOI 10.1038/nmat1342; Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004; Gwer S, 2013, CHILD NERV SYST, V29, P927, DOI 10.1007/s00381-013-2036-5; Hill S, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4964717; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Khan MWA, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON ELECTROMAGNETICS IN ADVANCED APPLICATIONS (ICEAA), P383, DOI 10.1109/ICEAA.2015.7297141; Khan MWA, 2016, IEEE MICROW WIREL CO, V26, P549, DOI 10.1109/LMWC.2016.2574836; Meng E, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/4/045004; Moradi E, 2014, 2014 IEEE RFID TECHNOLOGY AND APPLICATIONS CONFERENCE (RFID-TA), P145, DOI 10.1109/RFID-TA.2014.6934217; Park HG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12356; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Tang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16527; Wang RX, 2010, J MICROELECTROMECH S, V19, P367, DOI 10.1109/JMEMS.2009.2039773; Weerakkody Ruwan Alwis, 2012, Acta Neurochir Suppl, V114, P181, DOI 10.1007/978-3-7091-0956-4_35; Xue N, 2012, J MICROELECTROMECH S, V21, P1338, DOI 10.1109/JMEMS.2012.2206072; Zhang X, 2017, PHYSIOL MEAS, V38, P143, DOI 10.1088/1361-6579/aa7256; Zierhofer CM, 1996, IEEE T BIO-MED ENG, V43, P708, DOI 10.1109/10.503178	24	6	6	10	57	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9383	1557-9646		IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	JUN	2018	65	6					2592	2600		10.1109/TED.2018.2825247			9	Engineering, Electrical & Electronic; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Physics	GG1QR	WOS:000432462200079					2022-02-06	
J	Xiao, YP; Shu, DP; Bei, MJ; Ji, T; Kan, WS; Li, SG				Xiao, Ya-Ping; Shu, Dong-Ping; Bei, Ming-Jian; Ji, Tao; Kan, Wu-Sheng; Li, Shao-Gang			The clinical application of a novel method of internal fixation for femoral neck fractures-dynamic locking compression system	JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH			English	Article						Femoral neck fractures; Internal fixation; Aged; Surgery; Locking compression plate	CANCELLOUS SCREW FIXATION; CANNULATED SCREWS; VARUS COLLAPSE; HIP FRACTURE; TARGON(R) FN; RISK-FACTORS	Background: Femoral neck fractures are the commonly encountered injury in orthopedic practice and result in significant morbidity and mortality. Currently, how to treat femoral neck fractures safely and effectively is still a challenge. The objective of this study is to evaluate the efficiency of dynamic compression locking system for femoral neck fractures. Methods: This is a retrospective study conducted from May 2015 to October 2016. The study included 36 patients suffering from femoral neck fractures who underwent closed reduction and were fixed using dynamic compression locking system. All surgeries were performed by the same surgeon. The study was conducted by telephone and on-site follow-up. The Garden classification and anatomical site classification were categorized for all patients. We assessed radiographic outcomes of union, femoral neck shortening, screw back-out, and femoral head avascular necrosis. We also evaluated functional outcome using the Harris hip score. Other outcomes included the length of surgery, duration of hospital stay, injury to surgery time, intraoperative hemorrhage, time to clinical bone union, and other fracture complications. Results: All patients were followed up 12 to 29 months with an average of 21.58 +/- 5.41 months. All cases were caused by falls including 17 males and 19 females with an average age of 65.33 +/- 9.30 years old ranging from 53 to 82 years old. Among them, injury to surgery time ranged between 1 and 4 days with an average of 2.58 +/- 1.05 days. Duration of hospital stay was 8 to 21 days with an average of 15.33 +/- 3.71 days. Intraoperative hemorrhage was 40 to 80 ml with an average of 61.67 +/- 12.31 ml. Operation time was from 35 to 80 min with average of 50.25 +/- 11.77 min. According to Garden classification, 9 cases (25%) were type II and 27 cases (75%) were type Ill. According to the anatomical site classification, 8 cases (22.2%) were subcapital femoral neck fractures, 19 cases (52.8%) trans-cervical, and 9 cases (25%) basi-cervical. At present, the follow-up has not found the fracture complications of femoral head avascular necrosis, fracture nonunion, and re-fracture. All patients achieved solid bone union. The mean time of clinical bone union was 3 to 4 months. Among all patients, there were only 3 cases of femoral neck shortening < 5 mm and 1 case of screw back-out = 4 mm. For Harris scoring, average Harris scale at the end of the follow-up was 93.42 +/- 3.95 ranging from 85 to 98. There were 32 cases of excellent function scores on the Harris scale and 4 cases of good function scores on the Harris scale. Therefore, the excellent and good rate of Harris hip scores was 100%. Conclusions: Femoral neck dynamic compression locking system for femoral neck fractures in elderly patients can provide effective stability and reduce complications and revision rates.	[Xiao, Ya-Ping; Shu, Dong-Ping; Ji, Tao; Li, Shao-Gang] China Resources & WISCO Gen Hosp, Dept Orthoped Surg, 209 Yejin Rd, Wuhan, Hubei, Peoples R China; [Bei, Ming-Jian] Hebei Med Univ, Dept Orthoped Surg, Shijiazhuang, Hebei, Peoples R China; [Kan, Wu-Sheng] Huazhong Univ Sci & Technol, Wuhan Puai Hosp, Dept Orthoped Surg, Wuhan, Hubei, Peoples R China		Li, SG (corresponding author), China Resources & WISCO Gen Hosp, Dept Orthoped Surg, 209 Yejin Rd, Wuhan, Hubei, Peoples R China.	1310439232@qq.com; Lsg66128@sina.com			Wuhan municipal health and family planning research fund [WX17A14]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31171136]	L SG receives research support from Wuhan municipal health and family planning research fund (Grant No: WX17A14). B MJ receives research support from the National Natural Science Foundation of China (Grant No: 31171136).	Aggarwal A, 2014, CHIN J TRAUMATOL, V17, P99, DOI 10.3760/cma.j.issn.1008-1275.2014.02.008; Akcay S, 2014, J ORTHOP TRAUMA, V28, pE208, DOI 10.1097/BOT.0000000000000150; Basso T, 2015, ACTA ORTHOP, V86, DOI 10.3109/17453674.2015.1056702; Biber R, 2014, INT ORTHOP, V38, P595, DOI 10.1007/s00264-013-2176-y; Brandt E, 2011, INJURY, V42, P183, DOI 10.1016/j.injury.2010.08.021; Florschutz AV, 2015, J ORTHOP TRAUMA, V29, P121, DOI 10.1097/BOT.0000000000000291; Araujo TPF, 2014, INJURY, V45, pS36, DOI 10.1016/S0020-1383(14)70019-1; Frihagen F, 2008, INJURY, V39, P1147, DOI 10.1016/j.injury.2008.03.027; Gjertsen JE, 2008, ACTA ORTHOP, V79, P583, DOI 10.1080/17453670810016588; Lee KBL, 2004, ANN ACAD MED SINGAP, V33, P248; Manohara R, 2014, J ORTHOP SURG-HONG K, V22, P282, DOI 10.1177/230949901402200303; Nishiyama Daisuke, 2013, Eur J Orthop Surg Traumatol, V23, P907, DOI 10.1007/s00590-012-1103-z; Osarumwense D, 2015, CLIN ORTHOP SURG, V7, P22, DOI 10.4055/cios.2015.7.1.22; Parker MJ, 2009, J BONE JOINT SURG AM, V91A, P490; Parker MJ, 1998, ACTA ORTHOP SCAND, V69, P138, DOI 10.3109/17453679809117614; Rosell PAE, 2003, INJURY, V34, P529, DOI 10.1016/S0020-1383(02)00414-X; Saglam N, 2014, ACTA ORTHOP TRAUMATO, V48, P196, DOI 10.3944/AOTT.2014.3159; Takigawa N, 2016, INJURY, V47, pS44, DOI 10.1016/S0020-1383(16)30854-3; Wang T, 2014, ORTHOPEDICS, V37, pE1117, DOI 10.3928/01477447-20141124-60; Weil YA, 2012, J ORTHOP TRAUMA, V26, P19, DOI 10.1097/BOT.0b013e318214f321; Xia Xi, 2014, Zhongguo Gu Shang, V27, P706; Yang JJ, 2013, J BONE JOINT SURG AM, V95A, P61, DOI 10.2106/JBJS.K.01081; Yang R.R., 2016, BME CLIN MED, V3, P225; Yang RR, 2016, BIOMECHANICAL RES HO; Zhang Guo-Zhu, 2012, Zhongguo Gu Shang, V25, P1002; Zhang Nian-nian, 2013, Zhongguo Gu Shang, V26, P565; Zlowodzki M, 2008, J BONE JOINT SURG BR, V90B, P1487, DOI 10.1302/0301-620X.90B11.20582	27	6	7	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1749-799X			J ORTHOP SURG RES	J. Orthop. Surg. Res.	MAY 31	2018	13								131	10.1186/s13018-018-0827-9			8	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	GH9IB	WOS:000433981800001	29855311	Green Published, gold			2022-02-06	
J	Gao, F; Li, D; Rui, Q; Ni, HB; Liu, HX; Jiang, F; Tao, L; Gao, R; Dang, BQ				Gao, Fan; Li, Di; Rui, Qin; Ni, Haibo; Liu, Huixiang; Jiang, Feng; Tao, Li; Gao, Rong; Dang, Baoqi			Annexin A7 Levels Increase in Rats With Traumatic Brain Injury and Promote Secondary Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						AnnexinA7; traumatic brain injury; secondary brain injury; neuron apoptosis; rat models	EXCITOTOXICITY; FAMILY	The incidence of traumatic brain injury (TBI) has been increasing annually. Annexin A7 is a calcium-dependent phospholipid binding protein. It can promote melting of the cell membrane. Recent studies have shown that it plays an important role in atherosclerosis, other cardiovascular diseases, and a variety of tumors. However, few studies of ANXA7 in TBI have been performed. We here observed how ANXA7 changes after TBI and discuss whether brain injury is associated with the use of ANXA7 antagonist intervention. Experimental Results: 1. After TBI, ANXA7 levels were higher than in the sham group, peaking 24 h after TBI. 2. The use of siA7 was found to reduce the expression of A7 in the injured brain tissue, and also brain edema, BBB damage, cell death, and apoptosis relative to the sham group. Conclusion : ANXA7 promotes the development of secondary brain injury (SBI) after TBI.	[Gao, Fan; Dang, Baoqi] Nanjing Univ Chinese Med, Zhangjiagang Hosp Tradit Chinese Med, Dept Rehabil, Suzhou, Peoples R China; [Li, Di; Ni, Haibo; Liu, Huixiang; Jiang, Feng; Gao, Rong] First Peoples Hosp Zhangjiagang, Dept Neurosurg, Suzhou, Peoples R China; [Li, Di] First Peoples Hosp Zhangjiagang, Translat Med Ctr, Suzhou, Peoples R China; [Rui, Qin] First Peoples Hosp Zhangjiagang, Clin Lab, Suzhou, Peoples R China; [Tao, Li] First Peoples Hosp Zhangjiagang, Dept Pharm, Suzhou, Peoples R China		Dang, BQ (corresponding author), Nanjing Univ Chinese Med, Zhangjiagang Hosp Tradit Chinese Med, Dept Rehabil, Suzhou, Peoples R China.; Gao, R (corresponding author), First Peoples Hosp Zhangjiagang, Dept Neurosurg, Suzhou, Peoples R China.	tsong@vip.sina.com; zhenjiangdbq@163.com			Youth Natural Science Foundation of Zhangjiagang Hospital of Traditional Chinese Medicine [zzyq1602]; Zhangjiagang Science & Technology Pillar Program [ZKS1712]	This work was supported by Youth Natural Science Foundation of Zhangjiagang Hospital of Traditional Chinese Medicine (zzyq1602), Zhangjiagang Science & Technology Pillar Program (ZKS1712).	Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gerelsaikhan T, 2012, BBA-MOL CELL RES, V1823, P1796, DOI 10.1016/j.bbamcr.2012.06.010; Guo CM, 2013, CLIN CHIM ACTA, V423, P83, DOI 10.1016/j.cca.2013.04.018; Hamasaki MY, 2018, J NEUROSCI RES, V96, P371, DOI 10.1002/jnr.24184; Herr Claudia, 2003, BMC Biochem, V4, P8, DOI 10.1186/1471-2091-4-8; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Liu F, 2016, NEUROPEPTIDES, V58, P1, DOI 10.1016/j.npep.2016.03.004; Moga MM, 2005, NEUROSCI LETT, V380, P42, DOI 10.1016/j.neulet.2005.01.022; Newport DJ, 2015, AM J PSYCHIAT, V172, P950, DOI 10.1176/appi.ajp.2015.15040465; Paul G, 2015, J CLIN INVEST, V125, P1339, DOI 10.1172/JCI79635; POLLARD HB, 1988, P NATL ACAD SCI USA, V85, P2974, DOI 10.1073/pnas.85.9.2974; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rick M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-25; Tincani A, 1998, REV RHUM, V65, P614; Turnay J, 2005, BIOCHEM J, V389, P899, DOI 10.1042/BJ20041918; Viviani B, 2014, NEUROTOXICOLOGY, V43, P10, DOI 10.1016/j.neuro.2014.03.004; Wang Y, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-18; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975; Zhou SN, 2011, HISTOL HISTOPATHOL, V26, P571, DOI 10.14670/HH-26.571	22	6	6	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 29	2018	12								357	10.3389/fnins.2018.00357			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH4JN	WOS:000433369800001	29896083	Green Published, gold			2022-02-06	
J	Gobel, J; Motori, E; Bergami, M				Goebel, Jana; Motori, Elisa; Bergami, Matteo			Spatiotemporal control of mitochondrial network dynamics in astroglial cells	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Mitochondrial dynamics; Astroglial cells; Calcium; Cell metabolism; Brain injury	PERMEABILITY TRANSITION PORE; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; TRAUMATIC BRAIN-INJURY; DOMINANT OPTIC ATROPHY; BERGMANN GLIAL-CELLS; IN-VIVO; ENDOPLASMIC-RETICULUM; ASTROCYTE PROCESSES; NITRIC-OXIDE	Mitochondria are increasingly recognized for playing important roles in regulating the evolving metabolic state of mammalian cells. This is particularly true for nerve cells, as dysregulation of mitochondrial dynamics is invariably associated with a number of neuropathies. Accumulating evidence now reveals that changes in mitochondrial dynamics and structure may play equally important roles also in the cell biology of astroglial cells. Astroglial cells display significant heterogeneity in their morphology and specialized functions across different brain regions, however besides fundamental differences they seem to share a surprisingly complex meshwork of mitochondria, which is highly suggestive of tightly regulated mechanisms that contribute to maintain this unique architecture. Here, we summarize recent work performed in astrocytes in situ indicating that this may indeed be the case, with astrocytic mitochondrial networks shown to experience rapid dynamic changes in response to defined external cues. Although the mechanisms underlying this degree of mitochondrial re-shaping are far from being understood, recent data suggest that they may contribute to demarcate astrocyte territories undergoing key signalling and metabolic functions. (C) 2017 Elsevier Inc. All rights reserved.	[Goebel, Jana; Bergami, Matteo] Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Goebel, Jana; Bergami, Matteo] Univ Hosp Cologne, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Motori, Elisa] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, Joseph Stelzmann Str 9B, D-50931 Cologne, Germany; [Bergami, Matteo] Univ Cologne, Ctr Mol Med CMMC, Robert Koch Str 21, D-50931 Cologne, Germany		Bergami, M (corresponding author), CECAD Univ Hosp Cologne, Cologne, Germany.	matteo.bergami@uk-koeln.de	Bergami, Matteo/AAI-9972-2020; Motori, Elisa/AAM-2028-2021	Gobel, Jana/0000-0002-3848-2661	UoC advanced post-doc grant program; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [CRC 1218]; European Research Council (ERC-StG)European Research Council (ERC) [67844]	This work was supported by the UoC advanced post-doc grant program, Deutsche Forschungsgemeinschaft (CRC 1218) and European Research Council (ERC-StG-2015, grant number 67844) to M.B.	Agarwal A, 2017, NEURON, V93, P587, DOI 10.1016/j.neuron.2016.12.034; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Belanger M, 2011, J NEUROCHEM, V116, P564, DOI 10.1111/j.1471-4159.2010.07135.x; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Berridge MV, 2016, CURR OPIN GENET DEV, V38, P75, DOI 10.1016/j.gde.2016.04.003; Berridge MV, 2016, CELL METAB, V24, P376, DOI 10.1016/j.cmet.2016.08.023; Bindocci E, 2017, SCIENCE, V356, DOI 10.1126/science.aai8185; Bird MJ, 2014, BBA-GEN SUBJECTS, V1840, P1380, DOI 10.1016/j.bbagen.2013.10.017; BROWN GC, 1995, NEUROSCI LETT, V193, P201, DOI 10.1016/0304-3940(95)11703-Y; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Collins TJ, 2003, J EXP BIOL, V206, P1993, DOI 10.1242/jeb.00244; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; De Stefani D, 2016, ANNU REV BIOCHEM, V85, P161, DOI 10.1146/annurev-biochem-060614-034216; Deheshi S, 2015, J NEUROCHEM, V133, P684, DOI 10.1111/jnc.13090; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Fu W, 2013, NEUROSCIENCE, V250, P520, DOI 10.1016/j.neuroscience.2013.07.029; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Grosche J, 2002, J NEUROSCI RES, V68, P138, DOI 10.1002/jnr.10197; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Ito U, 2009, STROKE, V40, P2173, DOI 10.1161/STROKEAHA.108.534990; Jackson JG, 2015, J NEUROSCI, V35, P15199, DOI 10.1523/JNEUROSCI.2049-15.2015; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; Jacobson J, 2002, J CELL SCI, V115, P1175; Castejon OJ, 2015, FOLIA NEUROPATHOL, V53, P173, DOI 10.5114/fn.2015.54419; Kanemaru K, 2014, CELL REP, V8, P311, DOI 10.1016/j.celrep.2014.05.056; Keil VC, 2011, PFLUG ARCH EUR J PHY, V462, P693, DOI 10.1007/s00424-011-1012-8; Kolikova J, 2006, BRAIN CELL BIOL, V35, P75, DOI 10.1007/s11068-006-9000-1; Larsen NJ, 2011, NEUROSCIENCE, V196, P251, DOI 10.1016/j.neuroscience.2011.08.016; Lee S, 2016, DEV CELL, V37, P174, DOI 10.1016/j.devcel.2016.03.023; Lezi E, 2012, ADV EXP MED BIOL, V942, P269, DOI 10.1007/978-94-007-2869-1_12; Li HL, 2014, CELL CALCIUM, V56, P457, DOI 10.1016/j.ceca.2014.09.008; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Liu T, 2014, NEUROSCI LETT, V579, P24, DOI 10.1016/j.neulet.2014.07.002; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Molnar T, 2016, J NEUROSCI, V36, P3184, DOI 10.1523/JNEUROSCI.4069-15.2016; Moss J, 2016, P NATL ACAD SCI USA, V113, pE2536, DOI 10.1073/pnas.1514652113; Motori E, 2013, CELL METAB, V18, P844, DOI 10.1016/j.cmet.2013.11.005; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Naon D, 2016, P NATL ACAD SCI USA, V113, P11249, DOI 10.1073/pnas.1606786113; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Nguyen TT, 2014, P NATL ACAD SCI USA, V111, pE3631, DOI 10.1073/pnas.1402449111; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Pardo B, 2011, J CEREBR BLOOD F MET, V31, P90, DOI 10.1038/jcbfm.2010.146; Parnis J, 2013, J NEUROSCI, V33, P7206, DOI 10.1523/JNEUROSCI.5721-12.2013; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Patrushev I, 2013, CELL CALCIUM, V54, P343, DOI 10.1016/j.ceca.2013.08.003; Qi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep07984; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Rungta RL, 2016, GLIA, V64, P2093, DOI 10.1002/glia.23042; Rusakov DA, 2015, NAT REV NEUROSCI, V16, P226, DOI 10.1038/nrn3878; San Martin A, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011004; Schmidt S, 2011, HUM MOL GENET, V20, P1197, DOI 10.1093/hmg/ddq564; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sheng ZH, 2017, TRENDS CELL BIOL, V27, P403, DOI 10.1016/j.tcb.2017.01.005; Shigetomi E, 2016, TRENDS CELL BIOL, V26, P300, DOI 10.1016/j.tcb.2016.01.003; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Srinivasan R, 2016, NEURON, V92, P1181, DOI 10.1016/j.neuron.2016.11.030; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; Stephen TL, 2015, J NEUROSCI, V35, P15996, DOI 10.1523/JNEUROSCI.2068-15.2015; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Tan AR, 2011, CELL CALCIUM, V49, P108, DOI 10.1016/j.ceca.2010.12.002; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	103	6	6	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	MAY 27	2018	500	1			SI		17	25		10.1016/j.bbrc.2017.06.191			9	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	GF3IE	WOS:000431838000004	28676398	Green Submitted			2022-02-06	
J	Wang, JW; Han, F; Zhao, Q; Xia, B; Dai, JL; Wang, Q; Le, CY; Huang, SM; Li, Z; Liu, JJ; Yang, M; Wan, CW; Wang, J				Wang, Jiawen; Han, Feng; Zhao, Qian; Xia, Bin; Dai, Jialin; Wang, Qian; Le, Cuiyun; Huang, Shimei; Li, Zhu; Liu, Jiangjin; Yang, Ming; Wan, Changwu; Wang, Jie			Clinicopathological Characteristic of Traumatic Head Injury in Juvenile, Middle-Aged and Elderly Individuals	MEDICAL SCIENCE MONITOR			English	Article						Age Factors; Head Injuries, Closed; Population Characteristics	BRAIN-INJURY; EPIDEMIOLOGY; POPULATION	Background: Traumatic head injury is a leading cause of death and disability worldwide. How clinicopathological features differ by age remains unclear. This epidemiological study analyzed the clinicopathological features of patients with head injury belonging to 3 age groups. Material/Methods: Data of patients with traumatic head injury were obtained from the Department of Cerebral Surgery of the Affiliated Hospital of Guizhou Medical University and the Guizhou Provincial People's Hospital in 2011-2015. Their clinicopathological parameters were assessed. The patients were divided into 3 age groups: elderly (>= 65 years), middle-aged (18-64 years), and juvenile (<= 17 years) individuals. Results: Among 3356 hospitalizations for traumatic head injury (2573 males and 783 females, 654 died (19.49%), the highest and lowest mortality rates were in the elderly and juvenile groups, respectively. Fall was the most common cause in juvenile and elderly individuals (32.79% and 43.95%, respectively), while traffic injury was most common in the elderly group (35.08%). The manners of injury differed considerably among the 3 age groups. Scalp injury, skull fracture, intracranial hematoma, and cerebral injury were the most common mechanisms in juvenile (67.32%), middle-aged (63.50%), elderly (69.56%) and middle-aged (90.44%) individuals, respectively. Scalp injury and skull fracture types differed among the groups. Epidural, subdural, and intracerebral hematomas were most common in juvenile, middle-aged, and elderly individuals, respectively. Cerebral contusion showed the highest frequency in the 3 groups, and concussion the lowest. Conclusions: Patients with traumatic HI show remarkable differences in clinicopathological features among juvenile, middle-aged, and elderly individuals.	[Wang, Jiawen; Xia, Bin; Dai, Jialin; Wang, Qian; Le, Cuiyun; Huang, Shimei; Li, Zhu; Liu, Jiangjin; Wan, Changwu; Wang, Jie] Guizhou Med Univ, Dept Forens Med, Guiyang, Guizhou, Peoples R China; [Han, Feng; Yang, Ming] Guizhou Med Univ, Affiliated Hosp, Dept Neurosurg, Guiyang, Guizhou, Peoples R China; [Zhao, Qian] Guizhou Prov Peoples Hosp, Dept Neurosurg, Guiyang, Guizhou, Peoples R China		Wan, CW; Wang, J (corresponding author), Guizhou Med Univ, Dept Forens Med, Guiyang, Guizhou, Peoples R China.	2668503694@qq.com; Wj6400@gmc.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81660309]; Guizhou Medical University [YJ2016-10]; Guizhou Province Modern Forensic Engineering Research Center [[2016]1345]	National Natural Science Foundation of China (No. 81660309), Guizhou Medical University PhD Startup Fund Project (YJ2016-10), and the Guizhou Province Modern Forensic Engineering Research Center ([2016]1345)	Aghakhani K, 2014, J FORENSIC LEG MED, V28, P36, DOI 10.1016/j.jflm.2014.09.009; Bener Abdulbari, 2011, Sultan Qaboos Univ Med J, V11, P244; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; El-Menyar A, 2017, WORLD NEUROSURG, V107, P6, DOI [10.1016/J.WNEU.2017.07.070, 10.1016/j.wneu.2017.07.070]; Ferrell Richard B, 2002, Curr Psychiatry Rep, V4, P354; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Home Safety Council, 2008, NAT NONPR URG CAR PR; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2004, THOMAS KE TRAUMATIC; Lotfi-Sadigh S, 2015, ANAL RES CLIN MED, V3, P57; Lutze M, 2015, INT EMERG NURS, V23, P168, DOI 10.1016/j.ienj.2014.10.004; Makhlouf F, 2014, CHILD ABUSE NEGLECT, V38, P37, DOI 10.1016/j.chiabu.2013.08.016; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Menon Anand, 2008, J Forensic Leg Med, V15, P75, DOI 10.1016/j.jflm.2007.06.001; Munoz-Sanchez M, 2005, CHILD NERV SYST, V21, P128, DOI 10.1007/s00381-004-1036-x; National Institutes of Health Consensus Panel Issues Report, 1993, J AM ACAD DERMATOL 1, V28, P278; Numminen HJ, 2011, EUR J NEUROL, V18, P460, DOI 10.1111/j.1468-1331.2010.03179.x; Park H, 2015, FORENSIC SCI INT, V255, P102, DOI 10.1016/j.forsciint.2015.08.002; RUNYAN CW, 1985, AM J PUBLIC HEALTH, V75, P1429, DOI 10.2105/AJPH.75.12.1429; Salem AMO, 2013, OCCUP MED-OXFORD, V63, P358, DOI 10.1093/occmed/kqt037; Samad SV, 2016, TRAUMA MON, V21; Secer HI, 2007, ACTA NEUROCHIR, V149, P777, DOI 10.1007/s00701-007-1236-8; Siman-Tov M, 2016, BRAIN INJURY, V30, P83, DOI 10.3109/02699052.2015.1104551; Spencer SD, 2012, INT J PALEOPATHOL, V2, P112, DOI 10.1016/j.ijpp.2012.09.007; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tokdemir M, 2009, MED SCI MONITOR, V15, pPI1; Younis R, 2011, BRAIN INJURY, V25, P282, DOI 10.3109/02699052.2010.546823	34	6	6	1	3	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	MAY 18	2018	24						3256	3264		10.12659/MSM.908728			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	GG3UC	WOS:000432617600001	29773781	Green Published, Green Submitted			2022-02-06	
J	Lien, S; Dickman, JD				Lien, Steven; Dickman, J. David			Vestibular Injury After Low-Intensity Blast Exposure	FRONTIERS IN NEUROLOGY			English	Article						blast injuries; vestibuloocular reflex; optokinetic response; traumatic brain injury; semicircular canal damage	TRAUMATIC BRAIN-INJURY; VESTIBULOOCULAR REFLEXES; TYMPANIC-MEMBRANE; COMPENSATION; MODEL; EXCITABILITY; DYSFUNCTION; PRESSURE; RECOVERY; NEURONS	The increased use of close range explosives has led to a higher incidence of exposure to blast-related head trauma. Exposure to primary blast waves is a significant cause of morbidity and mortality. Active service members and civilians who have experienced blast waves report high rates of vestibular dysfunction, such as vertigo, oscillopsia, imbalance, and dizziness. Accumulating evidence suggests that exposure to blast-wave trauma produces damage to both the peripheral and central vestibular system; similar to previous findings that blast exposure results in damage to auditory receptors. In this study, mice were exposed to a 63 kPa peak blast-wave over pressure and were examined for vestibular receptor damage as well as behavioral assays to identify vestibular dysfunction. We observed perforations to the tympanic membrane in all blast animals. We also observed significant loss of stereocilia on hair cells in the cristae and macule up to 1 month after blast-wave exposure; damage that is likely permanent. Significant reductions in the ability to perform the righting reflex and balance on a rotating rod that lasted several weeks after blast exposure were prominent behavioral effects. We also observed a significant reduction in horizontal vestibuloocular reflex gain and phase lags in the eye movement responses that lasted many weeks following a single blast exposure event. OKN responses were absent immediately following blast exposure, but began to return after several weeks' recovery. These results show that blast-wave exposure can lead to peripheral vestibular damage (possibly central deficits as well) and provides some insight into causes of vestibular dysfunction in blast-trauma victims.	[Lien, Steven; Dickman, J. David] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; [Dickman, J. David] Rice Univ, Dept Biosci, Houston, TX 77005 USA; [Dickman, J. David] Rice Univ, Dept Psychol, Houston, TX 77251 USA		Dickman, JD (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.; Dickman, JD (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.; Dickman, JD (corresponding author), Rice Univ, Dept Psychol, Houston, TX 77251 USA.	dickman@bcm.edu			National Institute on Deafness and Other Communication disordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R21 DC015602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM121312] Funding Source: NIH RePORTER	This work was supported by the National Institute on Deafness and Other Communication disorders (R21 DC015602).	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Allum JHJ, 2017, OTOL NEUROTOL, V38, pE531, DOI 10.1097/MAO.0000000000001477; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Brugeaud A, 2007, J NEUROSCI, V27, P3503, DOI 10.1523/JNEUROSCI.5185-06.2007; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Centers for Disease Control and Prevention, 2015, EXPL BLAST INJ PRIM; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; Curthoys IS, 2000, CURR OPIN NEUROL, V13, P27, DOI 10.1097/00019052-200002000-00006; DAMON EG, 1968, AEROSPACE MED, V39, P1039; Darlington CL, 2002, EUR J NEUROSCI, V15, P1719, DOI 10.1046/j.1460-9568.2002.02024.x; de Jeu M, 2012, JOVE-J VIS EXP, DOI 10.3791/3971; Desai SS, 2005, J NEUROPHYSIOL, V93, P267, DOI 10.1152/jn.00747.2003; Dickman JD, 2004, HEARING RES, V188, P89, DOI 10.1016/S0378-5955(03)00377-0; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Gan RZ, 2016, HEARING RES, V340, P25, DOI 10.1016/j.heares.2016.01.004; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; Hess BJM, 1997, CURR OPIN NEUROBIOL, V7, P860, DOI 10.1016/S0959-4388(97)80147-X; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hirvonen TP, 2005, J NEUROPHYSIOL, V93, P643, DOI 10.1152/jn.00160.2004; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Horrocks C L, 2001, J R Army Med Corps, V147, P28; Jagade MV, 2008, INDIAN J OTOLARYNGOL, V60, P324, DOI 10.1007/s12070-008-0110-1; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Laurens J, 2011, EXP BRAIN RES, V210, P407, DOI 10.1007/s00221-011-2568-4; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Minor LB, 2009, J VESTIBUL RES-EQUIL, V19, P159, DOI 10.3233/VES-2009-0353; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Murai N, 2004, EUR ARCH OTO-RHINO-L, V261, P82, DOI 10.1007/s00405-003-0644-5; NEWLANDS SD, 1990, EXP BRAIN RES, V82, P359, DOI 10.1007/BF00231255; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Raphan T, 1985, Rev Oculomot Res, V1, P123; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2002, ANN NY ACAD SCI, V956, P64, DOI 10.1111/j.1749-6632.2002.tb02809.x; Sultemeier DR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00331; Szirmai A, 2013, EUR ARCH OTO-RHINO-L, V270, P87, DOI 10.1007/s00405-012-1939-1; THURSTON SE, 1987, NEUROLOGY, V37, P53, DOI 10.1212/WNL.37.1.53; Van Campen L E, 1999, J Am Acad Audiol, V10, P467; Wang Y, 2014, J NEUROTRAUM, V31, P498, DOI [10.1089/NEU.2013.3074, 10.1089/neu.2013.3074]; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Yakushin SB, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00386; Zakir M, 2006, J NEUROSCI, V26, P2881, DOI 10.1523/JNEUROSCI.3903-05.2006	63	6	6	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 14	2018	9								297	10.3389/fneur.2018.00297			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF4XS	WOS:000431968000001	29867715	gold, Green Published			2022-02-06	
J	Agimi, Y; Regasa, LE; Ivins, B; Malik, S; Helmick, K; Marion, D				Agimi, Yll; Regasa, Lemma Ebssa; Ivins, Brian; Malik, Smon; Helmick, Katherine; Marion, Donald			Rote of Department of Defense Policies in Identifying Traumatic Brain Injuries Among Deployed US Service Members, 2001-2016	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							MILITARY PERSONNEL; UNITED-STATES; COMBAT; SEVERITY; RISK; POPULATION; DISABILITY; OUTCOMES; HEALTH; ARMY	Objectives. To examine the role of Department of Defense policies in identifying theater-sustained traumatic brain injuries (TBIs). Methods. We conducted a retrospective study of 48 172 US military service members who sustained their first lifetime TBIs between 2001 and 2016 while deployed to Afghanistan or Iraq. We used multivariable negative binomial models to examine the changes in TBI incidence rates following the introduction of Department of Defense policies. Results.Two Army policies encouraging TBI reporting were associated with an increase of 251% and 97% in TBIs identified following their implementation, respectively. Among airmen, the introduction of TBI-specific screening questions to the Post-Deployment Health Assessment was associated with a 78% increase in reported TBIs. The 2010 Department of Defense Directive Type Memorandum 09-033 was associated with another increase of 80% in the likelihood of being identified with a TBI among soldiers, a 51% increase among sailors, and a 124% increase among Marines. Conclusions. Department of Defense and service-specific policies introduced between 2006 and 2013 significantly increased the number of battlefield TBIs identified, successfully improving the longstanding problem of underreporting of TBIs.	[Agimi, Yll; Regasa, Lemma Ebssa; Ivins, Brian; Malik, Smon; Helmick, Katherine; Marion, Donald] Def Hlth Agcy, Def & Vet Brain Injury Ctr, 1335 East West Hwy 4-214E, Silver Spring, MD 20910 USA; [Agimi, Yll] Salient CRGT, Springfield, VA USA; [Regasa, Lemma Ebssa; Ivins, Brian; Marion, Donald] Gen Dynam Informat Technol, Fairfax, VA USA		Agimi, Y (corresponding author), Def Hlth Agcy, Def & Vet Brain Injury Ctr, 1335 East West Hwy 4-214E, Silver Spring, MD 20910 USA.	yll.agimi.ctr@mail.mil	AGIMI, YLL/AAL-9337-2021		Defense and Veterans Brain Injury Center, an agency of US Department of Defense	This work was done with support from the Defense and Veterans Brain Injury Center, an agency of US Department of Defense.	[Anonymous], 2012, REP MEM REG TRAUM BR; [Anonymous], 2008, PRED APPR IN THEAT B; Armed Forces Health Surveillance Branch, 2016, SURV CAS DEF NEUR TR; Armed Forces Health Surveillance Center, 2015, MSMR, V22, P12; Armed Forces Health Surveillance Center, 2015, CAS DEF DAT AN HLTH; Blast Injury Research Program Coordinating Office, 2016, FY16 INJ PREV PROGR; Blast Injury Research Program Coordinating Office, 2015, EV PROT BOD SENS SYS; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Concussion in soldiers on the battlefield, 2006, CONC SOLD BATTL ALL; Defense and Veterans Brain Injury Center, 2017, DVBIC WORLDW NUMB TB; Defense Casualty Analysis System, 2018, DEF MAN POW DAT CTR; Defense Health Agency, 2017, UPP LOW EXTR AMP RAT; Defense Manpower Data Center, 2013, CONT TRACK SYST DEPL; Defense Technical Information Center, DEP DEF POL GUID MAN; Department of Defense, 2013, MENT HLTH ADV TEAM 9; Department of Defense, 2017, DEF MANP DAT CTR; Department of Defense, 2011, JIEDDO HELM STUD PRO; Department of Defense Deputy Secretary ofDefense, 2010, DEP SECR DEF DIR TYP; Dismuke CE, 2015, AM J PUBLIC HEALTH, V105, P1696, DOI 10.2105/AJPH.2014.302545; DVBIC Event Monitoring Summary (EMS), 2014, DVBIC EV MON SUMM EM; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hilbe J.M., 2008, NEGATIVE BINOMIAL RE, V1st; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Prabhakar A., 2014, COMMUNICATION; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Shen Y, 2009, EFFECT OEF OIF DEPLO; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Army, 2017, ARM JOINT KNOWL ONL; US Army Training and Doctrine Command, 2015, US ARM COMB VEH MOD; US Marine Corps, 2017, MARADMINS; US Marine Corps, US MAR CORPS TRAUM B; US Navy, 2011, NAV MED TRAIN REQ HL; US Navy, 2011, TRAUM BRAIN INJ CAR; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wood David., 2012, HUFFINGTON POST; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	47	6	6	0	1	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	MAY	2018	108	5					683	688		10.2105/AJPH.2018.304347			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GO7RT	WOS:000440272300047	29565670	Green Published			2022-02-06	
J	Bajaj, S; Dailey, NS; Rosso, IM; Rauch, SL; Killgore, WDS				Bajaj, Sahil; Dailey, Natalie S.; Rosso, Isabelle M.; Rauch, Scott L.; Killgore, William D. S.			Time-dependent differences in cortical measures and their associations with behavioral measures following mild traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						concussion; cortical plasticity; cortical structure; cortical surface area; cortical thickness; cortical volume; sleep	HUMAN CEREBRAL-CORTEX; POOR SLEEP QUALITY; COGNITIVE RESERVE; SURFACE-AREA; THICKNESS; DISTURBANCES; PREVALENCE; ATTENTION; VOLUME; ABNORMALITIES	There is currently a critical need to establish an improved understanding of time-dependent differences in brain structure following mild traumatic brain injury (mTBI). We compared differences in brain structure, specifically cortical thickness (CT), cortical volume (CV), and cortical surface area (CSA) in 54 individuals who sustained a recent mTBI and 33 healthy controls (HCs). Individuals with mTBI were split into three groups, depending on their time since injury. By comparing structural measures between mTBI and HC groups, differences in CT reflected cortical thickening within several areas following 0-3 (time-point, TP1) and 3-6 months (TP2) post-mTBI. Compared with the HC group, the mTBI group at TP2 showed lower CSA within several areas. Compared with the mTBI group at TP2, the mTBI group during the most chronic stage (TP3: 6-18 months post-mTBI) showed significantly higher CSA in several areas. All the above reported differences in CT and CSA were significant at a cluster-forming p < .01 (corrected for multiple comparisons). We also found that in the mTBI group at TP2, CT within two clusters (i.e., the left rostral middle frontal gyrus (L. RMFG) and the right postcentral gyrus (R. PostCG)) was negatively correlated with basic attention abilities (L. RMFG: r = -.41, p = .05 and R. PostCG: r = -.44, p = .03). Our findings suggest that alterations in CT and associated neuropsychological assessments may be more prominent during the early stages of mTBI. However, alterations in CSA may reflect compensatory structural recovery during the chronic stages of mTBI.	[Bajaj, Sahil; Dailey, Natalie S.; Killgore, William D. S.] Univ Arizona, Dept Psychiat, SCAN Lab, Tucson, AZ 85724 USA; [Rosso, Isabelle M.; Rauch, Scott L.; Killgore, William D. S.] Harvard Med Sch, McLean Hosp, Dept Psychiat, Belmont, MA USA		Killgore, WDS (corresponding author), Univ Arizona, Dept Psychiat, 1501 N Campbell Ave,Room 7303B, Tucson, AZ 85724 USA.	killgore@psychiatry.arizona.edu	Bajaj, Sahil/C-6580-2016; Rosso, Isabelle M/AAA-6166-2019	Bajaj, Sahil/0000-0003-0629-6036; Dailey, Natalie S./0000-0003-4800-4118; Rosso, Isabelle/0000-0001-6988-3858	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-1-0056, W81XWH-12-1-0109, W81XWH-12-1-0386]	U.S. Army Medical Research and Materiel Command, Grant/Award Numbers: W81XWH-11-1-0056, W81XWH-12-1-0109, W81XWH-12-1-0386	Alchanatis M, 2005, J SLEEP RES, V14, P69, DOI 10.1111/j.1365-2869.2004.00436.x; Altena E, 2010, BIOL PSYCHIAT, V67, P182, DOI 10.1016/j.biopsych.2009.08.003; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersson M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-41; ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56; Balslev D, 2013, J NEUROSCI, V33, P18311, DOI 10.1523/JNEUROSCI.1112-13.2013; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bellesi M, 2013, J NEUROSCI, V33, P14288, DOI 10.1523/JNEUROSCI.5102-12.2013; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Budd JML, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00042; Buysse D J, 1989, Psychiatry Res, V28, P193; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; CDC, 2003, REP C MILD TRAUM BRA; Chao LL, 2014, SLEEP, V37, P445, DOI 10.5665/sleep.3472; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dean PJA, 2013, NEUROREPORT, V24, P677, DOI 10.1097/WNR.0b013e3283637aa4; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dretsch M. N., 2017, APPL NEUROPSYCHOL, P1; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gautam P, 2015, BEHAV BRAIN RES, V287, P331, DOI 10.1016/j.bbr.2015.03.018; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Gregory MD, 2016, CURR BIOL, V26, P1301, DOI 10.1016/j.cub.2016.03.021; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hofman MA, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00015; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerr AL, 2011, J COMMUN DISORD, V44, P538, DOI 10.1016/j.jcomdis.2011.04.011; Killgore WDS, 2016, NEUROSCI LETT, V612, P238, DOI 10.1016/j.neulet.2015.12.033; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Lillie Elizabeth M, 2013, Biomed Sci Instrum, V49, P297; Lim ASP, 2016, SLEEP, V39, P227, DOI 10.5665/sleep.5354; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Mota B, 2015, SCIENCE, V349, P74, DOI 10.1126/science.aaa9101; Novack TA, 2000, BRAIN INJURY, V14, P987; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; RICHMAN DP, 1975, SCIENCE, V189, P18; Schnack HG, 2015, CEREB CORTEX, V25, P1608, DOI 10.1093/cercor/bht357; Sexton CE, 2014, NEUROLOGY, V83, P967, DOI 10.1212/WNL.0000000000000774; Spira AP, 2016, SLEEP, V39, P1121, DOI 10.5665/sleep.5768; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stoffers Diederick, 2012, Front Neurol, V3, P105, DOI 10.3389/fneur.2012.00105; Suh S, 2016, SLEEP, V39, P161, DOI 10.5665/sleep.5340; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Toro R, 2012, EVOL BIOL, V39, P600, DOI 10.1007/s11692-012-9201-8; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Urban JE, 2012, J NEUROTRAUM, V29, P2774, DOI 10.1089/neu.2012.2373; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	84	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	MAY	2018	39	5					1886	1897		10.1002/hbm.23951			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GC3UZ	WOS:000429710500002	29359498	Bronze, Green Published			2022-02-06	
J	Brett, BL; Kuhn, AW; Yengo-Kahn, AM; Jeckell, AS; Solomon, GS; Zuckerman, SL				Brett, Benjamin L.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Jeckell, Aaron S.; Solomon, Gary S.; Zuckerman, Scott L.			On-Field Signs Predict Future Acute Symptoms After Sport-Related Concussion: A Structural Equation Modeling Study	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mild traumatic brain injury; Sport-related concussion; Trauma; Sports medicine; Symptoms; Structural equation modeling; Head injuries	TRAUMATIC BRAIN-INJURY; ASSOCIATION POSITION STATEMENT; CLINICAL ARTICLE; BASE-LINE; EARLY INTERVENTION; FOOTBALL PLAYERS; POSTURAL CONTROL; HIGH-SCHOOL; ATTENTION; CHILDREN	Objectives: This study investigated the relationship between on-field, objective signs immediately following sport-related concussion and self-reported symptom endorsement within 1 day post injury. Methods: A retrospective case series of 237 concussed high school athletes was performed. On-field signs were evaluated immediately post injury. Self-reported symptoms (2 clusters) were collected within 1 day post injury. A two-step structural equation model and follow-up bivariate regression analyses of significant on-field signs and symptom clusters were performed. Results: Signs of immediate memory, beta = 0.20, p = .04, and postural instability, beta = 0.19, p < .01, significantly predicted a greater likelihood of endorsing the cognitive-migraine-fatigue symptom cluster within 1 day post injury. Regarding signs correlated with specific symptoms, immediate memory was associated with symptoms of trouble remembering, chi(2) = 37.92, p < .001, odds ratio (OR) = 3.89 (95% confidence interval (CI) [2.47, 6.13]), and concentration difficulties, chi(2) = 10.84, p = .001, OR = 2.13 (95% CI [1.37, 3.30]). Postural instability was associated with symptom endorsement of trouble remembering, chi(2) = 12.08, p < .001, OR = 1.76 (95% CI [1.29, 2.40]). Conclusions: Certain post-concussion on-field signs exhibited after injury were associated with specific symptom endorsement within 1 day post injury. Based on these associations, individualized education-based interventions and academic accommodations may help reduce unanticipated worry from parents, students, and teachers following a student-athlete's sport-related concussion, especially in cases of delayed onset symptoms.	[Brett, Benjamin L.] Vet Affairs Connecticut Healthcare Syst, Dept Psychol, West Haven, CT 06516 USA; [Brett, Benjamin L.] Univ Memphis, Dept Counseling Educ Psychol & Res, Memphis, TN 38152 USA; [Brett, Benjamin L.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Jeckell, Aaron S.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Jeckell, Aaron S.] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA		Brett, BL (corresponding author), Vet Affairs Connecticut Healthcare Syst, Dept Psychol, West Haven, CT 06516 USA.	blbrett@memphis.edu	Yengo-Kahn, Aaron/AAV-7647-2020	Yengo-Kahn, Aaron/0000-0002-5989-3064; Kuhn, Andrew/0000-0003-1836-7575	athletic department of Tennessee Tech University; athletic department of University of Tennessee; Nashville Predators; Tennessee Titans	Mr. Brett, Mr. Kuhn, and Drs. Yengo-Kahn, Jeckell, and Zuckerman report no conflicts of interest. Dr. Solomon is a consultant for the Nashville Predators, Tennessee Titans, and the athletic departments of Tennessee Tech University and the University of Tennessee, fees paid to institution. He is also a consultant to the National Football League Department of Health and Safety. No contents of this work have been previously presented. No grants or outside funding supported this work.	ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Byrne B.M., 1994, STRUCTURAL EQUATION; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; FLEISHMAN J, 1987, EDUC PSYCHOL MEAS, V47, P925, DOI 10.1177/0013164487474008; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kuhn AW, 2017, NEUROSURGERY, V64, P211, DOI 10.1093/neuros/nyx294; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Reilly DS, 2008, J MOTOR BEHAV, V40, P90, DOI 10.3200/JMBR.40.2.90-102; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Tatham, 1998, MULTIVARIATE DATA AN; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Yengo-Kahn AM, 2015, PHYSICIAN SPORTSMED, V43, P227, DOI 10.1080/00913847.2015.1071638; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	52	6	6	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2018	24	5					476	485		10.1017/S1355617717001321			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	GD5LH	WOS:000430548000007	29307322				2022-02-06	
J	Chen, JH; Li, PP; Yang, K; Chen, L; Zhu, J; Hu, X; Wang, YH				Chen, Jun-Hui; Li, Pei-Pei; Yang, Kun; Chen, Lei; Zhu, Jie; Hu, Xu; Wang, Yu-Hai			Value of Ventricular Intracranial Pressure Monitoring for Traumatic Bifrontal Contusions	WORLD NEUROSURGERY			English	Article						Bifrontal contusions; Goal orientation; ICP monitoring	SEVERE HEAD-INJURY; BRAIN-INJURY; HYPERTONIC SALINE; MILD HYPOTHERMIA; COMPLICATIONS; DECOMPRESSION; EPIDEMIOLOGY; HEMORRHAGE; EXPANSION; OXYGEN	OBJECTIVE: To investigate clinical efficacy of and optimal therapeutic strategy for ventricular intracranial pressure monitoring (V-ICPM) in patients with traumatic bifrontal contusions (TBCs). METHODS: From 8760 patients with traumatic brain injury treated between January 2010 and January 2016, a retrospective analysis was performed on 105 patients with TBCs who underwent V-ICPM and 282 patients with TBCs who did not. All patients underwent treatment at the 101st Hospital of PLA, Wuxi, China. Rates of successful conservative treatment, decompressive craniectomy, and bifrontal craniotomy; incidence of neurologic dysfunction; length of stay; and medical expenses were compared between groups. RESULTS: Glasgow Outcome Scale was used to assess all patients during follow-up (range, 6 months to 5.5 years). There were no significant differences in prognosis between the 2 groups (P = 0.100). Compared with the patients who did not undergo V-ICPM, the V-ICPM group had a significantly better successful conservative treatment rate (64.8% vs. 47.2%, P = 0.002), decompressive craniectomy rate (8.1% vs. 22.1%, P = 0.008), and bifrontal craniotomy rate (5.7% vs. 15.6%, P = 0.01); shorter length of stay (P = 0.000); and lower medical expenses (P = 0.004). CONCLUSIONS: Patients with TBCs should be strictly, closely, and dynamically observed by neurosurgery intensive care unit physicians and nurses. Patients should undergo ventricular intracranial pressure probe implantation in a timely manner. V-ICPM can help optimize treatment. Although V-ICPM did not significantly improve the prognosis of patients, it had many other advantages. V-ICPM warrants further clinical research and may be beneficial for patients with TBCs.	[Chen, Jun-Hui; Li, Pei-Pei; Yang, Kun; Chen, Lei; Zhu, Jie; Hu, Xu; Wang, Yu-Hai] PLA, Hosp 101, Dept Neurosurg, Wuxi, Peoples R China; [Li, Pei-Pei] Anhui Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Hefei, Anhui, Peoples R China		Wang, YH (corresponding author), PLA, Hosp 101, Dept Neurosurg, Wuxi, Peoples R China.	wangyuhai67@126.com	Chen, Junhui/AAS-1669-2021; Junhui, Chen/AAU-4572-2021	Junhui, Chen/0000-0002-9410-9722			Abbasi Hamid Reza, 2013, Bull Emerg Trauma, V1, P81; Bao L, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-306; Bekar A, 1998, NEUROSURG REV, V21, P254, DOI 10.1007/BF01105781; Centers for Disease Control and Prevention, 2001, RAT TBI REL EM DEP V; Chambers IR, 2001, J NEUROL NEUROSUR PS, V71, P383, DOI 10.1136/jnnp.71.3.383; Chari A, 2015, FLUIDS BARRIERS CNS, V12, pO14, DOI DOI 10.1186/2045-8118-12-S1-O14; Chen Hui, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P307; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dey M, 2015, NEUROSURGERY, V76, P291, DOI 10.1227/NEU.0000000000000624; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Dong L, 2016, CLIN NEUROL NEUROSUR, V148, P42, DOI 10.1016/j.clineuro.2016.06.004; Gao L, 2013, WORLD NEUROSURG, V80, P879, DOI 10.1016/j.wneu.2013.01.020; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Heydari ST, 2013, PUBLIC HEALTH, V127, P704, DOI 10.1016/j.puhe.2013.05.003; Hung KS, 2004, J CLIN NEUROSCI, V11, P849, DOI 10.1016/j.jocn.2003.06.009; Kirkman MA, 2016, CURR ANESTHESIOL REP, V6, P214; Kouvarellis AJ, 2011, CHILD NERV SYST, V27, P1139, DOI 10.1007/s00381-011-1464-3; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; Lu ZF, 2016, WORLD NEUROSURG, V93, P261, DOI 10.1016/j.wneu.2016.06.021; Maas AI, 2008, J TRAUMA, V65, P966, DOI 10.1097/TA.0b013e318184ee7b; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Mani Arash, 2015, Bull Emerg Trauma, V3, P93; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Pittella JEH, 1999, ARQ NEURO-PSIQUIAT, V57, P848, DOI 10.1590/S0004-282X1999000500018; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Redelmeier DA, 2003, LANCET, V361, P2177, DOI 10.1016/S0140-6736(03)13770-1; Rehman Tausif, 2008, Cases J, V1, P203, DOI 10.1186/1757-1626-1-203; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Suazo JAC, 2000, CRIT CARE MED, V28, P3268, DOI 10.1097/00003246-200009000-00024; Tokutomi T, 2004, NEUROCRIT CARE, V1, P171, DOI 10.1385/NCC:1:2:171; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Wang YH, 2014, TURK NEUROSURG, V24, P214, DOI 10.5137/1019-5149.JTN.8135-13.1; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9; Zeng T, 2010, CHIN J TRAUMATOL, V13, P146, DOI 10.3760/cma.j.issn.1008-1275.2010.03.003; Zhang XJ, 2011, TRAFFIC INJ PREV, V12, P614, DOI 10.1080/15389588.2011.609925; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhao YD, 2001, WORLD J SURG, V25, P1202	49	6	7	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2018	113						E690	E701		10.1016/j.wneu.2018.02.122			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	GG8JD	WOS:000432942700083	29501515				2022-02-06	
J	da Silva, FC; Gomes, AO; Palacio, PRD; Politti, F; da Silva, DDT; Mesquita-Ferrari, RA; Fernandes, KPS; Bussadori, SK				da Silva, Fernanda Cordeiro; Gomes, Andrea Oliver; da Costa Palacio, Paulo Roberto; Politti, Fabiano; Teixeira da Silva, Daniela de Fatima; Mesquita-Ferrari, Raquel Agnelli; Santos Fernandes, Kristianne Porta; Bussadori, Sandra Kalil			Photobiomodulation improves motor response in patients with spinal cord injury submitted to electromyographic evaluation: randomized clinical trial	LASERS IN MEDICAL SCIENCE			English	Article						Spinal injuries; Phototherapy; Electromyography	LASER; RECOVERY	Photobiomodulation is a treatment that has been widely used in neurotrauma and neurodegenerative diseases. In the present study, low-level laser therapy was administered to patients with spinal cord injury. Twenty-five individuals were divided into two groups: placebo photobiomodulation plus physiotherapy and active photobiomodulation plus physiotherapy. Electromyographic evaluations were performed before and after 12 sessions of phototherapy as well as 30 days after the end of treatment. In the active phototherapy group, median frequency values of the brachial biceps and femoral quadriceps muscles were higher at rest and during isotonic contraction 30 days after photobiomodulation (p = 0.0258). No significant results were found regarding the rest and isotonic conditions in the pre-photobiomodulation period (p = 0.950) or immediately following photobiomodulation (p = 0.262). The data provide evidence that phototherapy improves motor responses in individuals with spinal cord injury, as demonstrated by differences in the EMG signal before and after treatment. Trial registration: NCT 03031223.	[da Silva, Fernanda Cordeiro; Gomes, Andrea Oliver; da Costa Palacio, Paulo Roberto; Politti, Fabiano; Mesquita-Ferrari, Raquel Agnelli; Santos Fernandes, Kristianne Porta; Bussadori, Sandra Kalil] Nove de Julho Univ UNINOVE, Postgrad Program Rehabil Sci, Rua Vergueiro 235-249, BR-01504000 Sao Paulo, SP, Brazil; [Teixeira da Silva, Daniela de Fatima; Mesquita-Ferrari, Raquel Agnelli; Santos Fernandes, Kristianne Porta; Bussadori, Sandra Kalil] Nove de Julho Univ UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Rua Vergueiro 235-249, BR-01504000 Sao Paulo, SP, Brazil		Bussadori, SK (corresponding author), Nove de Julho Univ UNINOVE, Postgrad Program Rehabil Sci, Rua Vergueiro 235-249, BR-01504000 Sao Paulo, SP, Brazil.; Bussadori, SK (corresponding author), Nove de Julho Univ UNINOVE, Postgrad Program Biophoton Appl Hlth Sci, Rua Vergueiro 235-249, BR-01504000 Sao Paulo, SP, Brazil.	fera2408@hotmail.com; an_oliver@hotmail.com; paulopalacio@live.com; fpolitti@ig.com.br; fatesi@uol.com.br; raquel.mesquita@gmail.com; kristianneporta@uninove.br; sandra.skb@gmail.com	da Silva, Fernanda Cordeiro/J-6929-2016; Politti, Fabiano/C-4534-2012; Fernandes, Kristianne Porta Santos/I-4417-2016; Bussadori, Sandra Kalil/J-5458-2014; de Fatima Teixeira da Silva, Daniela/K-3071-2012	Politti, Fabiano/0000-0001-6383-0034; Fernandes, Kristianne Porta Santos/0000-0001-7156-9286; Bussadori, Sandra Kalil/0000-0002-9853-1138; de Fatima Teixeira da Silva, Daniela/0000-0002-7228-6146			Abreu EMC, 2015, REV NEUROCIENC, V23, P297; Alves AN, 2016, LASER MED SCI, V31, P679, DOI 10.1007/s10103-016-1908-9; Ando T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.098002; Bohbot A, 2010, CELL TRANSPLANT, V19, P179, DOI 10.3727/096368910X492643; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Nguyen DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-224; Holanda VM, 2016, LASER SURG MED, V48, P653, DOI 10.1002/lsm.22522; Paula AA, 2014, LASER MED SCI, V29, P1849, DOI 10.1007/s10103-014-1586-4; Politti F, 2016, J ELECTROMYOGR KINES, V31, P119, DOI 10.1016/j.jelekin.2016.10.006; Ren Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/945034; Song J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42521; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Veronez S, 2016, LASER MED SCI, P1; Wang X, 2017, J CEREB BLOOD FLOW M; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30540; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729	16	6	6	0	5	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	MAY	2018	33	4					883	890		10.1007/s10103-018-2447-3			8	Engineering, Biomedical; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Surgery	GD5YK	WOS:000430584600022	29441450				2022-02-06	
J	Eshete, A; Taye, F				Eshete, Akine; Taye, Fikirewold			Magnitude of Severe Head Injury and Its Associated Factors among Head Injury Patients in Gedeo Zone, Southern Ethiopia: A Two-Year Retrospective Study	ETHIOPIAN JOURNAL OF HEALTH SCIENCES			English	Article						Head Injury; Glasgow Coma Scale; Severe Head Injury	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY	BACKGROUND: Severe head injury is a major public health threat that is the main cause of morbidity and mortality in all age groups of the world's populations including Ethiopia. In view of this, this study was assessed the severity of head injury and its contributing factors. METHODS: A Two-year retrospective study was conducted at Dilla University Referral Hospital, from December 2014 to November 2016. All head injury patients admitted to the surgical ward were included. Bivariate and multivariate regression analyses were used to identify factors associated with severity of head injury. RESULTS: A total of 106 eligible head injury patient charts were reviewed. The magnitude of severe head injury was 32.1%. Young populations, mainly males, were the highest risk groups, and road traffic accident was the main cause of severe head injury. In adjusted analysis, age interval greater than 45 years (aOR, 5.41; 95% CI: 1.05-29.09), alcohol consumption before the trauma (aOR, 4.16, 95% CI: 1.18, 14.61), delayed presentation (beyond 24 hours) after injury (aOR, 4.717; 95% CI: 1.02-21.81), and respiratory rate greater than 30 breaths per minute (aOR, 7.34; 95% CI: 1.88-28.73) were significantly associated with severe head injury. CONCLUSIONS: Severe head injury remains an important public health problem. Young adults were the highest risk groups of populations. Prevention of road traffic accidents, continuous awareness creation about the consequences of road traffic accident and close neurological monitoring offered by neuro-intensive care unit are recommended.	[Eshete, Akine] Dilla Univ, Sch Publ Hlth, Coll Hlth Sci & Med, Addis Ababa, Ethiopia; [Taye, Fikirewold] Dilla Univ, Dept Obstet, Coll Hlth Sci & Med, Addis Ababa, Ethiopia; [Taye, Fikirewold] Dilla Univ, Dept Gynecol, Coll Hlth Sci & Med, Addis Ababa, Ethiopia		Eshete, A (corresponding author), Dilla Univ, Sch Publ Hlth, Coll Hlth Sci & Med, Addis Ababa, Ethiopia.	akine.eshete@yahoo.com	Eshete, Akine/AAR-3074-2020				Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Agrawal Deepak, 2016, Asian J Neurosurg, V11, P143, DOI 10.4103/1793-5482.145081; Al-Kuwaiti A, 2012, ULUS TRAVMA ACIL CER, V18, P213, DOI 10.5505/tjtes.2012.03710; Gbalipre FB, 2014, PALGO J MED MED SCI, V1, P1; Hoxha S., 2014, OPEN ACCESS J SCI TE, V2, P1; Indeshaw k, 2015, THESIS; Jasper U. S., 2014, Journal of Scientific Research and Reports, V3, P2055, DOI 10.9734/JSRR/2014/9645; Khanzada Khalid, 2011, KJMS, V3, P79; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Landes M, 2017, AFR J EMERG MED, V7, P130, DOI 10.1016/j.afjem.2017.04.001; Lynch Catherine, 2013, EPIDEMIOLOGY PREDICT, P1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Seid M, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0035-4; Tien HC, ARCH SURG, V141, P1185; United Nations, 2017, REP UN SECR GEN; World Health Organization, 2002, PROJ MORT BURD DIS 2	17	6	7	0	1	JIMMA UNIV, ETHIOPIA	JIMMA	PO BOX 378, JIMMA, OROMIA 00000, ETHIOPIA	1029-1857	2413-7170		ETHIOP J HEALTH SCI	Ethiop. J. Health Sci.	MAY	2018	28	3					323	330		10.4314/ejhs.v28i3.10			8	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	GG8FJ	WOS:000432932900010	29983532	Green Published, gold, Green Submitted			2022-02-06	
J	Homme, JL				Homme, James (Jim) L.			Pediatric Minor Head Injury 2.0 Moving from Injury Exclusion to Risk Stratification	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Pediatric minor head trauma; Traumatic brain injury; Clinical decision rule; PECARN; CATCH; CHALICE; Risk stratification; Shared decision making	TRAUMATIC BRAIN-INJURIES; COMPUTED-TOMOGRAPHY USE; ISOLATED SKULL FRACTURE; EMERGENCY-DEPARTMENT; DECISION RULES; UNITED-STATES; CHILDREN; SPORTS; ASSOCIATION; PECARN	Visits for pediatric minor blunt head trauma continue to increase. Variability exists in clinician evaluation and management of this generally low-risk population. Clinical decision rules identify very-low-risk children who can forgo neuroimaging. Observation before imaging decreases neuroimaging rates. Outcome data can be used to risk stratify children into more discrete categories. Decision aids improve knowledge and accuracy of risk perception and facilitate identification of caregiver preferences, allowing for shared decision making. For children in whom imaging is performed and is normal or shows isolated linear skull fractures, deterioration and neurosurgical intervention are rare and hospital admission can be avoided.	[Homme, James (Jim) L.] Mayo Clin, Dept Emergency Med, Div Pediat Emergency Med, 200 First St Southwest, Rochester, MN 55905 USA		Homme, JL (corresponding author), Mayo Clin, Dept Emergency Med, Div Pediat Emergency Med, 200 First St Southwest, Rochester, MN 55905 USA.	homme.james@mayo.edu					Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Badawy MK, 2017, ACAD EMERG MED, V24, P595, DOI 10.1111/acem.13168; Berger RP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3756; Blanchard A, 2016, PEDIAT EMERG CARE; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Glass T, 2015, AM J EMERG MED, V33, P1458, DOI 10.1016/j.ajem.2015.06.069; Green SM, 2013, ANN EMERG MED, V62, P132, DOI 10.1016/j.annemergmed.2013.02.006; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; Hess EP, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-253; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lee LK, 2011, J PEDIATR-US, V158, P1003, DOI 10.1016/j.jpeds.2010.11.036; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Nishijima DK, 2015, JAMA PEDIATR, V169, P1141, DOI 10.1001/jamapediatrics.2015.2743; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rogers AJ, 2013, PEDIATRICS, V132, pE356, DOI 10.1542/peds.2013-0299; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604; White IK, 2016, J NEUROSURG-PEDIATR, V17, P602, DOI 10.3171/2015.9.PEDS15352; Wong AC, 2011, PEDIATR EMERG CARE, V27, P182, DOI 10.1097/PEC.0b013e31820d64f7; Wootton-Gorges SL, 2017, J AM COLL RADIOL, V14, pS338, DOI 10.1016/j.jacr.2017.01.036	45	6	6	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	MAY	2018	36	2					287	+		10.1016/j.emc.2017.12.015			20	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GE3EW	WOS:000431097600003	29622323	hybrid			2022-02-06	
J	Johnson, MA; Borgman, MA; Cannon, JW; Kuppermann, N; Neff, LP				Johnson, M. Austin; Borgman, Matthew A.; Cannon, Jeremy W.; Kuppermann, Nathan; Neff, Lucas P.			Severely Elevated Blood Pressure and Early Mortality in Children with Traumatic Brain Injuries: The Neglected End of the Spectrum	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD TRAUMA; FLOW; HYPERTENSION; HYPOTENSION; EDEMA	Introduction: In adults with traumatic brain injuries (TBI), hypotension and hypertension at presentation are associated with mortality. The effect of age-adjusted blood pressure in children with TBI has been insufficiently studied. We sought to determine if age-adjusted hypertension in children with severe TBI is associated with mortality. Methods: This was a retrospective analysis of the Department of Defense Trauma Registry (DoDTR) between 2001 and 2013. We included for analysis patients < 18 years with severe TBI defined as Abbreviated Injury Severity (AIS) scores of the head >= 3. We defined hypertension as moderate for systolic blood pressures (SBP) between the 95th and 99th percentile for age and gender and severe if greater than the 99th percentile. Hypotension was defined as SBP < 90 mmHg for children > 10 years or < 70mmHg + (2 x age) for children <= 10 years. We performed multivariable logistic regression and Cox regression to determine if BP categories were associated with mortality. Results: Of 4,990 children included in the DoDTR, 740 met criteria for analysis. Fifty patients (6.8%) were hypotensive upon arrival to the ED, 385 (52.0%) were normotensive, 115 (15.5%) had moderate hypertension, and 190 (25.7%) had severe hypertension. When compared to normotensive patients, moderate and severe hypertension patients had similar Injury Severity Scores, similar AIS head scores, and similar frequencies of neurosurgical procedures. Multivariable logistic regression demonstrated that hypotension (odd ratio [OR] 2.85, 95 confidence interval [CI] 1.26-6.47) and severe hypertension (OR 2.58, 95 CI 1.32-5.03) were associated with increased 24-hour mortality. Neither hypotension (Hazard ratio (HR) 1.52, 95 CI 0.74-3.11) nor severe hypertension (HR 1.65, 95 CI 0.65-2.30) was associated with time to mortality. Conclusion: Pediatric age-adjusted hypertension is frequent after severe TBI. Severe hypertension is strongly associated with 24-hour mortality. Pediatric age-adjusted blood pressure needs to be further evaluated as a critical marker of early mortality.	[Johnson, M. Austin; Kuppermann, Nathan] Univ Calif Davis, Med Ctr, Dept Emergency Med, 4150 V St,Suite 2100, Sacramento, CA 95817 USA; [Borgman, Matthew A.] Brooke Army Med Ctr, Dept Pediat, Ft Sam Houston, TX 78234 USA; [Borgman, Matthew A.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Cannon, Jeremy W.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Neff, Lucas P.] David Grant USAF Med Ctr, Travis Air Force Base, Dept Gen Surg, Fairfield, CA USA; [Neff, Lucas P.] Univ Calif Davis, Med Ctr, Dept Surg, Sacramento, CA 95817 USA; [Neff, Lucas P.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Johnson, MA (corresponding author), Univ Calif Davis, Med Ctr, Dept Emergency Med, 4150 V St,Suite 2100, Sacramento, CA 95817 USA.	ausjohnson@ucdavis.edu	Borgman, Matthew A/L-9477-2015; Cannon, Jeremy/T-3875-2019	Borgman, Matthew A/0000-0002-2008-7380; Cannon, Jeremy/0000-0002-2969-9316	National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108964]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000002, TL1 TR000133]	By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. Dr. Johnson is the recipient of a training grant from the National Heart, Lung and Blood Institute: K12HL108964. This project was partly supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR000002 and TL1 TR000133.	[Anonymous], TBI DAT STAT; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Chieregato A, 2007, NEUROSURGERY, V60, P115, DOI 10.1227/01.NEU.0000249194.76527.28; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Eckert MJ, 2014, J TRAUMA ACUTE CARE, V77, P852, DOI 10.1097/TA.0000000000000443; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; NHLBI, 2005, DIAGN EV TREATM HIGH, P1; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shiozaki T, 2005, CURR HYPERTENS REP, V7, P450, DOI 10.1007/s11906-005-0040-1; The brain Trauma Foundation, GUID AC MED MAN SEV; The Brain Trauma Foundation, GUID MAN SEV TRAUM B; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	27	6	6	0	0	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	MAY	2018	19	3					452	459		10.5811/westjem.2018.2.36404			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GH2SG	WOS:000433251500002	29760839	gold, Green Published			2022-02-06	
J	Kumar, A; Alvarado, A; Shah, K; Arnold, PM				Kumar, Ashwath; Alvarado, Anthony; Shah, Kushal; Arnold, Paul M.			Necessity of Repeat Computed Tomography Imaging in Isolated Mild Traumatic Subarachnoid Hemorrhage	WORLD NEUROSURGERY			English	Article						Blunt head trauma; Cranial bleeding; CT scan; Subarachnoid hemorrhage; Trauma	BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; HEAD-INJURY; CT SCANS; COAGULATION; RISK; PROGRESSION; IMPACT	BACKGROUND: The standard of care for mild isolated traumatic subarachnoid hemorrhage (itSAH) involves serial head computed tomography (CT) examinations at dedicated time intervals to monitor neurologic status and hemorrhagic progression. Considering recent evidence questioning such an aggressive monitoring protocol, this study aimed to assess the necessity of repeat head CT imaging in managing itSAH. METHODS: All patients who presented to our academic institution with mild traumatic brain injury were evaluated. Patients >= 18 years of age presenting with mild, blunt itSAH (Glasgow Coma Scale [GCS] score 13-15) were included. Patients with significant polytrauma or coagulopathy were excluded. Patient demographics (age and sex), imaging results (CT progression), and outcomes (final GCS score, discharge status, interventions, and 30-day readmission) were all recorded. RESULTS: Of 190 cases identified for inclusion, 58 (30.5%) met all study criteria (age, 59.5 +/- 18.0 y; 30 men). Five (8.6%) patients presented with repeat CT progression, with none reporting 30-day readmission or adverse event on follow-up. Comparison of cases with and without CT progression found no meaningful differences in age or sex. Of the 3 patients readmitted, none demonstrated CT progression, and cause of readmission was unrelated to head trauma in all cases. Two patients demonstrated clinical deterioration (final GCS score <14), and neither case showed progression on CT, was readmitted, or received neurosurgical intervention of any kind. CONCLUSIONS: Our findings suggest that serial CT imaging has little efficacy in changing mild itSAH management and is poorly correlated with clinical progression. A less aggressive management protocol may he more appropriate for managing this patient population.	[Kumar, Ashwath] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Alvarado, Anthony; Shah, Kushal; Arnold, Paul M.] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66103 USA		Kumar, A (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	akyt7@mail.umkc.edu					Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Brenner DJ, 2012, RADIOLOGY, V265, P330, DOI 10.1148/radiol.12121248; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Ditty BJ, 2015, J NEUROSURG, V123, P649, DOI 10.3171/2014.10.JNS132713; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Gates M, 2017, WORLD NEUROSURG, V100, P417, DOI 10.1016/j.wneu.2017.01.046; Hayashi T, 2016, WORLD NEUROSURG, V86, DOI 10.1016/j.wneu.2015.09.108; Kim BC, 2014, J KOREAN NEUROSURG S, V56, P428, DOI 10.3340/jkns.2014.56.5.428; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Lee JJ, 2018, J NEUROSURG, V128, P236, DOI 10.3171/2016.5.JNS16255; Lee JJ, 2014, J NEUROTRAUM, V31, P595, DOI 10.1089/neu.2013.3152; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Rubino S, 2014, J NEUROSURG, V121, P944, DOI 10.3171/2014.6.JNS132204; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Schwed AC, 2016, AM SURGEON, V82, P898; Shravat BP, 2006, EMERG MED J, V23, P109, DOI 10.1136/emj.2004.022327; Stippler M, 2017, WORLD NEUROSURG, V105, P265, DOI 10.1016/j.wneu.2017.05.008; Sumritpradit P, 2016, NEUROL RES INT, V2016, DOI 10.1155/2016/2737028; von der Brelie C, 2015, J TRAUMA ACUTE CARE, V79, P295, DOI 10.1097/TA.0000000000000722; Wu C, 2012, J TRAUMA ACUTE CARE, V73, P1247, DOI 10.1097/TA.0b013e318265d24e	23	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2018	113						399	403		10.1016/j.wneu.2018.02.010			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8JD	WOS:000432942700177	29438791				2022-02-06	
J	Liu, CB; Yang, DG; Meng, QR; Li, DP; Yang, ML; Sun, W; Zhang, WH; Cai, C; Du, LJ; Li, J; Gao, F; Yu, Y; Zhang, X; Zuo, ZT; Li, JJ				Liu, Chang-Bin; Yang, De-Gang; Meng, Qian-Ru; Li, Da-Peng; Yang, Ming-Liang; Sun, Wei; Zhang, Wen-Hao; Cai, Chang; Du, Liang-Jie; Li, Jun; Gao, Feng; Yu, Yan; Zhang, Xin; Zuo, Zhen-Tao; Li, Jian-Jun			Dynamic correlation of diffusion tensor imaging and neurological function scores in beagles with spinal cord injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; spinal cord injury; diffusion tensor imaging; fractional anisotropy; apparent diffusion coefficient; white matter; gray matter; Texas Spinal Cord Injury Score; beagles; neural regeneration	TRAUMATIC AXONAL INJURY; LOCOMOTOR RECOVERY; BRAIN-INJURY; MULTIPLE-SCLEROSIS; CORPUS-CALLOSUM; RAT MODEL; CONTUSION; MRI; MECHANISMS; SEVERITY	Exploring the relationship between different structure of the spinal cord and functional assessment after spinal cord injury is important. Quantitative diffusion tensor imaging can provide information about the microstructure of nerve tissue and can quantify the pathological damage of spinal cord white matter and gray matter. In this study, a custom-designed spinal cord contusion-impactor was used to damage the T-10 spinal cord of beagles. Diffusion tensor imaging was used to observe changes in the whole spinal cord, white matter, and gray matter, and the Texas Spinal Cord Injury Score was used to assess changes in neurological function at 3 hours, 24 hours, 6 weeks, and 12 weeks after injury. With time, fractional anisotropy values after spinal cord injury showed a downward trend, and the apparent diffusion coefficient, mean diffusivity, and radial diffusivity first decreased and then increased. 'The apparent diffusion-coefficient value was highly associated with the Texas Spinal Cord Injury Score for the whole spinal cord (R = 0.919, P = 0.027), white matter (R = 0.932, P = 0.021), and gray matter (R = 0.882, P = 0.048). Additionally, the other parameters had almost no correlation with the score (P > 0.05). In conclusion, the highest and most significant correlation between diffusion parameters and neurological function was the apparent diffusion-coefficient value for white matter, indicating that it could be used to predict the recovery of neurological function accurately after spinal cord injury.	[Liu, Chang-Bin; Yang, De-Gang; Meng, Qian-Ru; Li, Da-Peng; Yang, Ming-Liang; Sun, Wei; Zhang, Wen-Hao; Cai, Chang; Du, Liang-Jie; Li, Jun; Gao, Feng; Yu, Yan; Zhang, Xin; Li, Jian-Jun] Capital Med Univ, Sch Rehabil Med, Beijing, Peoples R China; [Liu, Chang-Bin; Yang, De-Gang; Meng, Qian-Ru; Li, Da-Peng; Yang, Ming-Liang; Sun, Wei; Zhang, Wen-Hao; Cai, Chang; Du, Liang-Jie; Li, Jun; Gao, Feng; Yu, Yan; Zhang, Xin; Li, Jian-Jun] China Rehabil Res Ctr, Dept Spinal & Neural Funct Reconstruct, Beijing, Peoples R China; [Liu, Chang-Bin; Yang, De-Gang; Meng, Qian-Ru; Li, Da-Peng; Yang, Ming-Liang; Sun, Wei; Zhang, Wen-Hao; Cai, Chang; Du, Liang-Jie; Li, Jun; Gao, Feng; Yu, Yan; Zhang, Xin; Li, Jian-Jun] Beijing Key Lab Neural Injury & Rehabil, Beijing, Peoples R China; [Zuo, Zhen-Tao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [Zuo, Zhen-Tao] Chinese Acad Sci, Innovat Ctr Excellence Brain Sci, Beijing, Peoples R China; [Zuo, Zhen-Tao] Univ Chinese Acad Sci, Sinodanish Coll, Beijing, Peoples R China		Li, JJ (corresponding author), Capital Med Univ, Sch Rehabil Med, Beijing, Peoples R China.; Li, JJ (corresponding author), China Rehabil Res Ctr, Dept Spinal & Neural Funct Reconstruct, Beijing, Peoples R China.; Li, JJ (corresponding author), Beijing Key Lab Neural Injury & Rehabil, Beijing, Peoples R China.	13718331416@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272164]; Special Fund for Basic Scientific Research of Central Public Research Institutes in China [2015CZ-6, 2016CZ-4]; Beijing Institute for Brain Disorders in China [201601,0000-100031]; Supporting Program of the "Twelve Five-year Plan" for Science & Technology Research of China [2012BAI34B02]; Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2015CB351701]	This study was supported by the National Natural Science Foundation of China, No. 81272164; the Special Fund for Basic Scientific Research of Central Public Research Institutes in China, No. 2015CZ-6, 2016CZ-4; the Beijing Institute for Brain Disorders in China, No. 201601,0000-100031; the Supporting Program of the "Twelve Five-year Plan" for Science & Technology Research of China, No. 2012BAI34B02; a grant from the Ministry of Science and Technology of China, No. 2015CB351701.	Bakshi R, 2008, LANCET NEUROL, V7, P615, DOI 10.1016/S1474-4422(08)70137-6; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beal MW, 2001, J AM VET MED ASSOC, V218, P1598, DOI 10.2460/javma.2001.218.1598; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Boekhoff TM, 2012, J SPINAL DISORD TECH, V25, pE81, DOI 10.1097/BSD.0b013e31823f2f55; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; Budzik JF, 2011, EUR RADIOL, V21, P426, DOI 10.1007/s00330-010-1927-z; Cerda-Gonzalez S, 2006, JAVMA-J AM VET MED A, V228, P230, DOI 10.2460/javma.228.2.230; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; Ditunno JF, 2004, SPINAL CORD, V42, P383, DOI 10.1038/sj.sc.3101603; Dong X, 2016, SPINAL CORD, V54, P947, DOI 10.1038/sc.2016.35; Ellingson BM, 2008, J MAGN RESON IMAGING, V28, P1068, DOI 10.1002/jmri.21578; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Hall MG, 2009, IEEE T MED IMAGING, V28, P1354, DOI 10.1109/TMI.2009.2015756; Herrera JJ, 2008, J NEUROSCI RES, V86, P443, DOI 10.1002/jnr.21481; Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190; Jeffery ND, 2006, SPINAL CORD, V44, P584, DOI 10.1038/sj.sc.3101912; Jirjis MB, 2013, J NEUROTRAUM, V30, P1577, DOI 10.1089/neu.2013.2897; Jones JGA, 2013, AM J NEURORADIOL, V34, P471, DOI 10.3174/ajnr.A3199; Kang Y, 2018, J NEURORESTORATOLOGY, V6, P1, DOI 10.2147/JN.S143236; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Kirshblum SC, 2007, ARCH PHYS MED REHAB, V88, pS62, DOI 10.1016/j.apmr.2006.12.003; Koskinen E, 2013, J NEUROTRAUM, V30, P1587, DOI 10.1089/neu.2013.2943; KUCHARCZYK J, 1991, MAGNET RESON MED, V19, P311, DOI 10.1002/mrm.1910190220; Leong D, 2015, NEURORADIOL J, V28, P12, DOI 10.15274/NRJ-2014-10110; Levine GJ, 2009, PREV VET MED, V89, P121, DOI 10.1016/j.prevetmed.2009.02.016; Lin M, 2016, MAGN RESON MED, V76, P290, DOI 10.1002/mrm.25816; Lindberg PG, 2016, EUR RADIOL, V26, P733, DOI 10.1007/s00330-015-3876-z; Little JW, 1999, ARCH PHYS MED REHAB, V80, P587, DOI 10.1016/S0003-9993(99)90204-6; Liu CB, 2018, J NEUROSCI RES, V96, P1093, DOI 10.1002/jnr.24222; Lu H, 2003, CHINESE MED J-PEKING, V116, P1063; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McEwen ML, 2006, J NEUROTRAUM, V23, P1632, DOI 10.1089/neu.2006.23.1632; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Mulcahey MJ, 2012, SPINE, V37, pE797, DOI 10.1097/BRS.0b013e3182470a08; Oh J, 2013, MULT SCLER J, V19, P427, DOI 10.1177/1352458512456614; Olby NJ, 2001, AM J VET RES, V62, P1624, DOI 10.2460/ajvr.2001.62.1624; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scholtes F, 2006, NEUROSURGERY, V59, P671, DOI 10.1227/01.NEU.0000228929.15492.A9; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Shields CB, 2006, SURG NEUROL, V66, P475, DOI 10.1016/j.surneu.2006.04.009; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Sundberg LM, 2010, J NEUROTRAUM, V27, P1753, DOI 10.1089/neu.2010.1369; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Wang F, 2014, NEUROREPORT, V25, P1386, DOI 10.1097/WNR.0000000000000278; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Webb AA, 2010, CAN VET J, V51, P598; Young W, 2002, PROG BRAIN RES, V137, P231	60	6	6	0	3	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2018	13	5					877	886		10.4103/1673-5374.232485			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GI1LE	WOS:000434131200026	29863019	gold, Green Published			2022-02-06	
J	Mohotti, D; Fernando, PLN; Zaghloul, A				Mohotti, Damith; Fernando, P. L. N.; Zaghloul, Amir			Evaluation of possible head injuries ensuing a cricket ball impact	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Head-injuries; Head impact; Cricket helmet; LS-DYNA		Background and objective: The aim of this research is to study the behaviour of a human head during the event of an impact of a cricket ball. While many recent incidents were reported in relation to head injuries caused by the impact of cricket balls, there is no clear information available in the published literature about the possible threat levels and the protection level of the current protective equipment. This research investigates the effects of an impact of a cricket ball on a human head and the level of protection offered by the existing standard cricket helmet. Method: An experimental program was carried out to measure the localised pressure caused by the impact of standard cricket balls. The balls were directed at a speed of 110 km/h on a 3D printed head model, with and without a standard cricket helmet. Numerical simulations were carried out using advanced finite element package LS-DYNA to validate the experimental results. Results: The experimental and numerical results showed approximately a 60% reduction in the pressure on the head model when the helmet was used. Both frontal and side impact resulted in head acceleration values in the range of 225-250 g at a ball speed of 110 km/h. There was a 36% reduction observed in the peak acceleration of the brain when wearing a helmet. Furthermore, numerical simulations showed a 67% reduction in the force on the skull and a 95% reduction in the skull internal energy when introducing the helmet. Conclusions: (1) Upon impact, high localised pressure could cause concussion for a player without helmet. (2) When a helmet was used, the acceleration of the brain observed in the numerical results was at noncritical levels according to existing standards. (3) A significant increase in the threat levels was observed for a player without helmet, based on force, pressure, acceleration and energy criteria, which resulted in recommending the compulsory use of the cricket helmet. (4) Numerical results showed a good correlation with experimental results and hence, the numerical technique used in this study can be recommended for future applications. (C) 2018 Elsevier B.V. All rights reserved.	[Mohotti, Damith; Fernando, P. L. N.; Zaghloul, Amir] Univ Sydney, Sch Civil Engn, Fac Engn & IT, Darlington, NSW 2006, Australia		Mohotti, D (corresponding author), Univ Sydney, Sch Civil Engn, Fac Engn & IT, Darlington, NSW 2006, Australia.	damith.mohotti@sydney.edu.au		Fernando, Lakshitha/0000-0001-5959-1368			Andersson F., 2016, THESIS; Baumgartner D., 2001, IRCOBI C ISL MAN UK; Baumgartner D., 2007, 20 INT TECHN C ENH S; Bin Tan L, 2012, INT J IMPACT ENG, V50, P99, DOI 10.1016/j.ijimpeng.2012.06.003; Briggs S., 2005, TELEGRAPH; British Standards Institution, 1994, 59931994 BS; British Standards Institution, 2013, 79282013 BS; Cheng N., 2008, THESIS; Claessens M., 1997, FINITE ELEMENT MODEL; Clair V. J. M. S., 1993, ASSESSMENT CURRENT B; Fernando A. F., KAUSHAL SILVA AIRLIF; Gittings P., CRICKET HIT FRESH TR; Gurdjian E. S., 1970, IMPACT INJURY CRASH; LSTC, 2007, LS DYNA KEYW US MAN; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Masuri, IMP TEST; Mowry SE, 2015, OTOL NEUROTOL, V36, P1562, DOI 10.1097/MAO.0000000000000848; National Highway Traffic Safety Administration: Department of Transportation, 1997, 218 FMVSS NAT HIGHW; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pearlman J, 2014, TELEGRAPH; Sahoo D, 2014, 2014 IRCOBI C BERL G, P106; Sarron JC, 2000, J TRAUMA, V49, P923, DOI 10.1097/00005373-200011000-00021; Walker HL, 2010, ACCIDENT ANAL PREV, V42, P2094, DOI 10.1016/j.aap.2010.06.022; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	24	6	6	1	22	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	MAY	2018	158						193	205		10.1016/j.cmpb.2018.02.017			13	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Medical Informatics	FZ7MW	WOS:000427786400018	29544785				2022-02-06	
J	Moore, M; Jimenez, N; Graves, JM; Rue, T; Fann, JR; Rivara, FP; Vavilala, MS				Moore, Megan; Jimenez, Nathalia; Graves, Janessa M.; Rue, Tessa; Fann, Jesse R.; Rivara, Frederick P.; Vavilala, Monica S.			Racial Disparities in Outpatient Mental Health Service Use Among Children Hospitalized for Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						capitated payer model; Medicaid; mental health; racial disparities; service access; service utilization; transitions of care; traumatic brain injury	QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; DEPRESSIVE SYMPTOMS; BEHAVIORAL OUTCOMES; RISK-FACTORS; ADOLESCENTS; MILD; PREVALENCE; DISABILITY	Objective: To examine racial differences in mental health service utilization after hospitalization for traumatic brain injury (TBI) among children with Medicaid insurance. Design and Main Measures: Retrospective analysis of the MarketScan Multi-State Medicaid database from 2007 to 2012 was performed. Outpatient mental health service utilization (psychiatric and psychological individual and group services) was compared at TBI hospitalization, from discharge to 3 months and from 4 to 12 months after discharge, between children of non-Hispanic white (NHW), non-Hispanic black (NHB), Hispanic, and Other racial groups. Multivariable mixed-effects Poisson regression models with robust standard errors were utilized. Results: A total of 5674 children (aged <21 years) were included in the study. There were no differences by race/ethnicity in mental health service utilization during hospitalization. At 3 months postdischarge, NHB children and children in the Other racial category were significantly less likely to receive outpatient mental health services than NHW children (NHB relative risk [RR] = 0.84; 95% confidence interval [CI], 0.72-0.98; Other RR = 0.72; 95% CI, 0.57-0.90). At 12 months, all racial minority children were significantly less likely to receive outpatient mental health services than NHW children (NHB RR = 0.84; 95% CI, 0.75-0.94; Hispanic RR = 0.72; 95% CI, 0.55-0.94; Other RR = 0.71; 95% CI, 0.60-0.84). Conclusions: Racial disparities in utilization of outpatient mental health services exist for minority children hospitalized for TBI and insured by Medicaid. Future research should focus on improving transitions of care from inpatient to outpatient services for these children.	[Moore, Megan] Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA; [Moore, Megan; Jimenez, Nathalia; Rivara, Frederick P.; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rue, Tessa] Univ Washington, Inst Translat Hlth Sci, Seattle, WA 98195 USA; [Jimenez, Nathalia; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Hlth, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Jimenez, Nathalia; Rivara, Frederick P.] Seattle Childrens Hosp, Seattle, WA USA; [Graves, Janessa M.] Washington State Univ, Coll Nursing, Spokane, WA USA		Moore, M (corresponding author), Univ Washington, Sch Social Work, 4101 15th Ave NE,Box 354900, Seattle, WA 98195 USA.	mm99@uw.edu	Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634; Jimenez, Nathalia/0000-0002-6785-8330	National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD078453-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421, KL2TR002317] Funding Source: NIH RePORTER	This work was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2TR000421 to Dr Moore) and the National Institute of Child Health and Human Development (1K23HD078453-01 to Dr Jimenez).	American Public Health Association, 2013, MAJ AFF CAR ACT DEL; [Anonymous], 1999, JAMA, V282, P974; [Anonymous], 2012, MARK DAT; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Belsher BE, 2015, J TRAUMA STRESS, V28, P153, DOI 10.1002/jts.21994; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Centers for Medicare & Medicaid Services, MED FIN REIMB; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Clark DE, 2009, ICDPIC STATA MODULE; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Faul M, 2010, TRAUMATIC BRAIN INJU; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Ginsburg PB, 2012, HEALTH AFFAIR, V31, P1977, DOI 10.1377/hlthaff.2012.0350; Hansen LG, HLTH RES DATA REAL W; Holbrook TL, 2005, J TRAUMA, V59, P1126, DOI 10.1097/01.ta.0000196433.61423.f2; Jimenez N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2462; Jimenez N, 2015, ARCH PHYS MED REHAB, V96, P1255, DOI 10.1016/j.apmr.2015.02.019; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kaiser Family Foundation, STAT HLTH FACTS MED; Kassam-Adams N, 2013, JAMA PEDIATR, V167, P1158, DOI 10.1001/jamapediatrics.2013.2741; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Landolt MA, 2009, AUST NZ J PSYCHIAT, V43, P746, DOI 10.1080/00048670903001919; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Robertson Charlene M. T., 2001, Pediatr Crit Care Med, V2, P145, DOI 10.1097/00130478-200104000-00009; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Zatzick D, 2015, J TRAUMA STRESS, V28, P391, DOI 10.1002/jts.22041; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	43	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					177	184		10.1097/HTR.0000000000000348			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500122	29194176	Green Accepted			2022-02-06	
J	Nakatani, Y; Nakayama, T; Nishiyama, K; Takahashi, Y				Nakatani, Yuka; Nakayama, Takeo; Nishiyama, Kei; Takahashi, Yoshimitsu			Effect of target temperature management at 32-34 degrees C in cardiac arrest patients considering assessment by regional cerebral oxygen saturation: A multicenter retrospective cohort study	RESUSCITATION			English	Article						Out-of-Hospital cardiac arrest; Resuscitation; Propensity score; Retrospective studies; Hypothermia; Induced; Spectroscopy; Near-Infrared	AMERICAN-HEART-ASSOCIATION; EMERGENCY CARDIOVASCULAR CARE; MILD THERAPEUTIC HYPOTHERMIA; INTERNATIONAL LIAISON COMMITTEE; RESUSCITATION OUTCOME REPORTS; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; EUROPEAN RESUSCITATION; STROKE FOUNDATION; SOUTHERN AFRICA	Aim: Target temperature management (TTM) is used in comatose post-cardiac arrest patients, but the recommended temperature range is wide. This study aimed to assess the effectiveness of TTM at 32-34 degrees C while considering the degree of cerebral injury and cerebral circulation, as assessed by regional cerebral oxygen saturation (rSO(2)). Methods: This is a secondary analysis of prospectively collected registry data from comatose patients who were transferred to 15 hospitals in Japan after out-of-hospital cardiac arrest (OHCA) from 2011 to 2013. The primary outcome was all-cause mortality at 90 days after OHCA, and the secondary outcome was favorable neurological outcomes as evaluated according to the Cerebral Performance Category. We monitored rSO(2) noninvasively with near-infrared spectroscopy, which could assess cerebral perfusion and the balance of oxygen delivery and uptake. Results: We stratified 431 study patients into three groups according to rSO(2) on hospital arrival: rSO(2) >= 40% (n = 296), rSO(2) 41-60% (n = 67), and rSO(2) >= 61% (n = 68). Propensity score analysis revealed that TTM at 32-34 degrees C decreased all-cause mortality in patients with rSO(2) 41-60% (average treatment effect on treated [ATT] by propensity score matching [PSM] -0.51, 95%CI -0.70 to -0.33; ATT by inverse probability of treatment weighting [IPW] -0.52, 95%CI -0.71 to -0.34), and increased favorable neurological outcomes in patients with rSO(2) 41-60% (ATT by PSM 0.50, 95%CI 0.32-0.68; ATT by IPW 0.52, 95%CI 0.35-0.69). Conclusion: TTM at 32-34 degrees C effectively decreased all-cause mortality in comatose OHCA patients with rSO(2) 41-60% on hospital arrival in Japan.	[Nakatani, Yuka; Nakayama, Takeo; Takahashi, Yoshimitsu] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Sakyo Ku, Yoshidakonoecho, Kyoto, Japan; [Nishiyama, Kei] Natl Hosp Org Kyoto Med Ctr, Fushimi Ku, 1-1 Fukakusa Mukaihatakecho, Kyoto, Japan		Nakatani, Y (corresponding author), Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Sakyo Ku, Yoshidakonoecho, Kyoto, Japan.	tsujimura.yuka.67z@st.kyoto-u.ac.jp		Nakayama, Takeo/0000-0002-7918-6252	Japan Society for the Promotion of Science (JSPS) (KAKENHI)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [24390400, 26462753]; University Management Expenses by Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI, grant numbers 24390400 and 26462753). This study was also supported in part by unrestricted University Management Expenses by Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. We thank Noritoshi Ito for his advice in preparing the manuscript, especially regarding data collection.	[Anonymous], 2017, EM LIF SAV TECHN ACT; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bosson NE, 2016, THER HYPOTHERMIA TEM, V6, P71, DOI 10.1089/ther.2015.0030; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Casati A, 2005, ANESTH ANALG, V101, P740, DOI 10.1213/01.ane.0000166974.96219.cd; Chan PS, 2016, JAMA-J AM MED ASSOC, V316, P1375, DOI 10.1001/jama.2016.14380; Choi SW, 2016, RESUSCITATION, V100, P51, DOI 10.1016/j.resuscitation.2015.12.012; CHOPP M, 1989, J CEREBR BLOOD F MET, V9, P141, DOI 10.1038/jcbfm.1989.21; Ebell MH, 1994, AM FAM PHYSICIAN, V50, P1303; EBELL MYH, 1994, AM FAM PHYSICIAN, V50, P1293; Engsig M, 2016, CLIN EPIDEMIOL, V8, P761, DOI 10.2147/CLEP.S114946; Frydlandad M, 2015, RESUSCITATION, V89, P142, DOI 10.1016/j.resuscitation.2014.12.033; Guo S., 2015, PROPENSITY SCORE ANA; HEGNAUER AH, 1954, AM J PHYSIOL, V178, P138, DOI 10.1152/ajplegacy.1954.178.1.138; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Hirose Tomoya, 2016, BMC Res Notes, V9, P428, DOI 10.1186/s13104-016-2239-4; Holzer M, 2002, NEW ENGL J MED, V346, P549; Ito N, 2014, RESUSCITATION, V85, P778, DOI 10.1016/j.resuscitation.2014.02.012; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; JENNETT B, 1975, LANCET, V1, P480; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kurth CD, 2001, ANN THORAC SURG, V72, P187, DOI 10.1016/S0003-4975(01)02632-7; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; MEZROW CK, 1992, ANN THORAC SURG, V54, P609, DOI 10.1016/0003-4975(92)91002-Q; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Natsukawa T, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0104-5; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nishiyama K, 2015, RESUSCITATION, V96, P135, DOI 10.1016/j.resuscitation.2015.07.049; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Perkins GD, 2015, CIRCULATION, V132, P1286, DOI 10.1161/CIR.0000000000000144; Rittenberger JC, 2013, NEW ENGL J MED, V369, P2262, DOI 10.1056/NEJMe1312700; Ro YS, 2015, RESUSCITATION, V90, P35, DOI 10.1016/j.resuscitation.2015.02.006; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; STATACORP, 2015, STAT TREATM EFF REF STAT TREATM EFF REF; Storm C, 2014, RESUSCITATION, V85, P1037, DOI 10.1016/j.resuscitation.2014.04.021; Taccone FS, 2014, NEW ENGL J MED, V370, P1357, DOI 10.1056/NEJMc1401250; Tobias JD, 2006, EXPERT REV MED DEVIC, V3, P235, DOI 10.1586/17434440.3.2.235; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yao FSF, 2004, J CARDIOTHOR VASC AN, V18, P552, DOI 10.1053/j.jvca.2004.07.007	41	6	6	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	MAY	2018	126						185	190		10.1016/j.resuscitation.2018.02.007			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	GC8VP	WOS:000430076700046	29432783				2022-02-06	
J	You, XL; Liew, BS; Rosman, AK; Musa, KI; Idris, Z				You, Xinli; Liew, Boon S.; Rosman, Azmin K.; Musa, Kamarul Imran; Idris, Zamzuri			The estimated cost of surgically managed isolated traumatic head injury secondary to road traffic accidents	NEUROSURGICAL FOCUS			English	Article						cost of care; Malaysia; head injury; road traffic accidents	BRAIN-INJURY; OUTCOMES; HEALTH	OBJECTIVE Traumatic brain injury due to road traffic accidents occurs mainly in the younger age group in which injury-related disability leads to long-term impact on employment and economic and social consequences across the lifespan. This study was designed to assign a monetary cost (in Malaysian ringgits [RM]) to the treatment of patients with surgically treated isolated traumatic head injury as determined up to 1 year after injury. METHODS Relevant resource items used were identified and valued using the direct measurement of costs method, cost accounting methods, standard unit costs method, fees, charges and/or market prices method. These values were then tabulated to generate the total costs for each patient, via a combination of macro-costing and micro-costing methods. Malaysian currency values were converted to US dollars according to the average conversion rate for the period from January to May 2016: RM1 = US$0.2452. RESULTS This costing study analyzed data from 49 patients. The estimated cost for the 1st year of care for all patients was RM1,471,919.80 (US$360,914.735), with a mean (+/- SD) cost per case of RM30,039.18 +/- 22,986.25 or $7365.61 +/- $5636.23. The mean cost of care per case was RM11,041.35 +/- 10,936.88 or $2707.34 +/- $2681.72 for mild head injury, RM32,550.00 +/- 20,998.76 or $7981.26 +/- $5148.90 for moderate head injury, and RM36,917.86 +/- 23,697.34 or $9052.26 +/- $5810.59 for severe head injury. Severe head injury (p = 0.001), sustaining 2 or more intracranial pathologies (p = 0.01), having a poor Glasgow Outcome Scale (GOS) score (GOS score 1-3) (p = 0.02), requiring a tracheostomy (p < 0.001), and contracting pneumonia (p < 0.001) were significantly associated with higher cost. Logistic regression analysis revealed that cost of care increased by RM591.60 or $145.06 per year increment of age (beta = RM591.60, p = 0.05). CONCLUSIONS The mean cost of treatment for traumatic head injury is high compared to the per capita income of RM37,900 in 2016. The cost values generated in this study provide baseline cost estimates that the authors hope will be used as a guide to determine where adequate funding should be allocated to provide timely and appropriate delivery of care.	[You, Xinli; Idris, Zamzuri] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian, Kelantan, Malaysia; [Musa, Kamarul Imran] Univ Sains Malaysia, Sch Med Sci, Dept Community Med, Kubang Kerian, Kelantan, Malaysia; [Idris, Zamzuri] Univ Sains Malaysia, Sch Med Sci, Ctr Neurosci Serv & Res, Kubang Kerian, Kelantan, Malaysia; [You, Xinli; Liew, Boon S.; Rosman, Azmin K.] Hosp Sungai Buloh, Dept Neurosurg, Sungai Buloh, Selangor, Malaysia		You, XL (corresponding author), Univ Sains Malaysia, Sch Med Sci, Kelantan, Malaysia.	dryou@protonmail.com	Idris, Zamzuri/AAB-6764-2022; Musa, Kamarul Imran/N-3198-2015; Boon Seng, Liew/F-4685-2014	Idris, Zamzuri/0000-0002-9470-0571; Musa, Kamarul Imran/0000-0002-3708-0628; Boon Seng, Liew/0000-0001-7322-5487	Hospital Sungai Buloh Neurosurgery Department; Hospital Sungai Buloh Clinical Research Centre	This study was supported by Hospital Sungai Buloh Neurosurgery Department and Hospital Sungai Buloh Clinical Research Centre. We would like to thank the Director General of Health Malaysia for his permission to publish this article.	Coronado V.G., 2012, BRAIN INJURY MED PRI; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Economic Planning Unit, 2016, MAL EC FIG; Fishman PA, 2009, MED CARE, V47, pS70, DOI 10.1097/MLR.0b013e3181a75a7f; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Lu J, 2013, J NEUROTRAUM, V30, P1925, DOI 10.1089/neu.2013.2891; Malaysia Department of Statistics, 2016, REP HOUS INC BAS AM; Malaysia National Health Accounts Unit, 2017, MAL NAT HLTH ACC HLT; Ministry of Health Malaysia, 2016, KEM KES MAL KKM HLTH; Ministry of Health Malaysia, 2015, EARL MAN HEAD INJ AD; Ministry of Health Malaysia:, 2014, MAL HLTH INF MAN SYS; World Health Organization, 2015, GLOB STAT REP ROAD S	12	6	6	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2018	44	5							E7	10.3171/2018.1.FOCUS17796			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GE5VP	WOS:000431292300007	29712526	gold			2022-02-06	
J	dos Santos, JGRP; Zaninotto, ALC; Zangaro, RA; Carneiro, AMC; Neville, IS; de Andrade, AF; Teixeira, MJ; Paiva, WS				Rocha Peixoto dos Santos, Joao Gustavo; Costa Zaninotto, Ana Luiza; Zangaro, Renato Amaro; Costa Carneiro, Ana Maria; Neville, Iuri Santana; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Effects of transcranial LED therapy on the cognitive rehabilitation for diffuse axonal injury due to severe acute traumatic brain injury: study protocol for a randomized controlled trial	TRIALS			English	Article						Brain injuries; Diffuse axonal injury; Low-level light therapy; Neurologic manifestations; Quality of life; Brain diseases; Trauma; Central nervous system diseases; Nervous system diseases; Craniocerebral trauma	GLASGOW OUTCOME SCALE; LEVEL LASER THERAPY; INFRARED LIGHT; HEAD-INJURY; UNITED-STATES; PHOTOBIOMODULATION; MICE; DISABILITY; DAMAGE; SYNAPTOGENESIS	Background: Photobiomodulation describes the use of red or near-infrared light to stimulate or regenerate tissue. It was discovered that near-infrared wavelengths (800-900 nm) and red (600 nm) light-emitting diodes (LED) are able to penetrate through the scalp and skull and have the potential to improve the subnormal cellular activity of compromised brain tissue. Different experimental and clinical studies were performed to test LED therapy for traumatic brain injury (TBI) with promising results. One of the proposals of this present study is to develop different approaches to maximize the positive effects of this therapy and improve the quality of life of TBI patients. Methods/design: This is a double-blinded, randomized, controlled trial of patients with diffuse axonal injury (DAI) due to a severe TBI in an acute stage (less than 8 h). Thirty two patients will be randomized to active coil helmet and inactive coil (sham) groups in a 1:1 ratio. The protocol includes 18 sessions of transcranial LED stimulation (627 nm, 70 mW/cm(2), 10 J/cm(2)) at four points of the frontal and parietal regions for 30 s each, totaling 120 s, three times per week for 6 weeks, lasting 30 min. Patients will be evaluated with the Glasgow Outcome Scale Extended (GOSE) before stimulation and 1, 3, and 6 months after the first stimulation. The study hypotheses are as follows: (1) transcranial LED therapy (TCLT) will improve the cognitive function of DAI patients and (2) TCLT will promote beneficial hemodynamic changes in cerebral circulation. Discussion: This study evaluates early and delayed effects of TCLT on the cognitive rehabilitation for DAI following severe acute TBI. There is a paucity of studies regarding the use of this therapy for cognitive improvement in TBI. There are some experimental studies and case series presenting interesting results for TBI cognitive improvement but no clinical trials.	[Rocha Peixoto dos Santos, Joao Gustavo; Neville, Iuri Santana; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Dept Neurol Surg, Sch Med, 255 Dr Eneas de Carvalho Aguiar Ave, BR-05403010 Sao Paulo, SP, Brazil; [Costa Zaninotto, Ana Luiza] Univ Sao Paulo, Div Neuropsychol, Gen Hosp, Sao Paulo, Brazil; [Zangaro, Renato Amaro] Ctr Innovat Technol & Educ CITE SJ dos Campos, BR-12245650 Sao Paulo, Brazil; [Costa Carneiro, Ana Maria] Univ Sao Paulo, Sch Nursing, Sao Paulo, Brazil		dos Santos, JGRP (corresponding author), Univ Sao Paulo, Dept Neurol Surg, Sch Med, 255 Dr Eneas de Carvalho Aguiar Ave, BR-05403010 Sao Paulo, SP, Brazil.	joao.gustavo.rps@gmail.com	Santos, Joao Gustavo Rocha Peixoto dos/Y-8201-2018; Zaninotto, Ana Luiza C./I-4095-2016; Neville, Iuri S/P-5360-2014; Paiva, Wellingson S/G-5517-2013; Neville, Iuri/AAI-2852-2021; Zangaro, Renato/K-5961-2015	Santos, Joao Gustavo Rocha Peixoto dos/0000-0001-8494-3556; Zaninotto, Ana Luiza C./0000-0003-0639-0612; Neville, Iuri S/0000-0002-8561-9069; Paiva, Wellingson S/0000-0002-5165-7040; Neville, Iuri/0000-0002-8561-9069; Zangaro, Renato/0000-0001-6962-3001			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Ambrogini P, 2013, BRAIN RES, V1534, P1, DOI 10.1016/j.brainres.2013.08.023; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2005, BRAIN INJURY, V19, P113; Bogdanova Y., 2014, ARCH PHYS MED REHAB, V95, pe77; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P573; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Edwards P, 2005, LANCET, V365, P1957; Faul M., 2013, TRAUMATIC BRAIN INJU; Gennarelli TA, 1993, HEAD INJURY, P137; Gennarelli TA., 2008, ABBREVIATED INJURY S; GENTRY LR, 1994, RADIOLOGY, V191, P1; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marklund N, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00540; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCLELLAN DR, 1990, COMA EMERGING PATIEN, P389; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Michalikova S, 2008, NEUROBIOL LEARN MEM, V89, P480, DOI 10.1016/j.nlm.2007.07.014; Naeser M, 2012, PROCD SOC BEHV, V61, P138, DOI 10.1016/j.sbspro.2012.10.116; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron U, 2001, LASER SURG MED, V28, P204, DOI 10.1002/lsm.1039; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pitzschke A, 2015, PHYS MED BIOL, V60, P2921, DOI 10.1088/0031-9155/60/7/2921; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salgado ASI, 2015, LASER MED SCI, V30, P339, DOI 10.1007/s10103-014-1669-2; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sompol P, 2006, J MOL NEUROSCI, V29, P279, DOI 10.1385/JMN:29:3:279; Strangman GE, 2014, NEUROIMAGE, V85, P136, DOI 10.1016/j.neuroimage.2013.04.090; Su E, 2016, TRANSLATIONAL RES TR; Tomei G, 1991, J Neurosurg Sci, V35, P61; US Food and Drug Administration, 2011, CLASS 2 SPEC CONTR G; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; Wang H, 1996, Zhonghua Wai Ke Za Zhi, V34, P229; Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu Q, 2010, SPIE P, V7552; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003	70	6	8	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1745-6215			TRIALS	Trials	APR 24	2018	19								249	10.1186/s13063-018-2632-5			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GE6SO	WOS:000431359600003	29690927	gold, Green Published			2022-02-06	
J	Hansen, KR; DeWalt, GJ; Mohammed, AI; Tseng, HA; Abdulkerim, ME; Bensussen, S; Saligrama, V; Nazer, B; Eldred, WD; Han, X				Hansen, Kyle R.; DeWalt, Gloria J.; Mohammed, Ali I.; Tseng, Hua-an; Abdulkerim, Moona E.; Bensussen, Seth; Saligrama, Venkatesh; Nazer, Bobak; Eldred, William D.; Han, Xue			Mild Blast Injury Produces Acute Changes in Basal Intracellular Calcium Levels and Activity Patterns in Mouse Hippocampal Neurons	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; GCaMP; head trauma; in vivo imaging	TRAUMATIC BRAIN-INJURY; CELLULAR RESOLUTION; MECHANICAL INJURY; WIDE-FIELD; DYNAMICS; MODEL; OVERPRESSURE; DEFICITS; REPRESENTATIONS; INHIBITION	Mild traumatic brain injury (mTBI) represents a serious public health concern. Although much is understood about long-term changes in cell signaling and anatomical pathologies associated with mTBI, little is known about acute changes in neuronal function. Using large scale Ca2+ imaging in vivo, we characterized the intracellular Ca2+ dynamics in thousands of individual hippocampal neurons using a repetitive mild blast injury model in which blasts were directed onto the cranium of unanesthetized mice on two consecutive days. Immediately following each blast event, neurons exhibited two types of changes in Ca2+ dynamics at different time scales. One was a reduction in slow Ca2+ dynamics that corresponded to shifts in basal intracellular Ca2+ levels at a time scale of minutes, suggesting a disruption of biochemical signaling. The second was a reduction in the rates of fast transient Ca2+ fluctuations at the sub-second time scale, which are known to be closely linked to neural activity. Interestingly, the blast-induced changes in basal Ca2+ levels were independent of the changes in the rates of fast Ca2+ transients, suggesting that blasts had heterogeneous effects on different cell populations. Both types of changes recovered after similar to 1h. Together, our results demonstrate that mTBI induced acute, heterogeneous changes in neuronal function, altering intracellular Ca2+ dynamics across different time scales, which may contribute to the initiation of longer-term pathologies.	[Han, Xue] Boston Univ, Dept Biomed Engn, 44 Cummington St,Room 403, Boston, MA 02215 USA; [DeWalt, Gloria J.; Eldred, William D.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Saligrama, Venkatesh; Nazer, Bobak] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA		Han, X (corresponding author), Boston Univ, Dept Biomed Engn, 44 Cummington St,Room 403, Boston, MA 02215 USA.	xuehan@bu.edu		Saligrama, Venkatesh/0000-0002-0675-2268; Hansen, Kyle/0000-0003-2782-7289; Abdulkerim, Moona/0000-0002-0607-7215	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2NS082126]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS087950-01]; Pew Foundation; Alfred P. Sloan FoundationAlfred P. Sloan Foundation; Defense Advanced Research Projects Agency (DARPA) Young Faculty AwardUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); Boston University Biomedical Engineering Department; Boston University Photonic Center; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE-1247312]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [DP2NS082126] Funding Source: NIH RePORTER	X.H. acknowledges funding from the National Institutes of Health (NIH) director's new innovator award (1DP2NS082126), the National Institute of Neurological Disorders and Stroke (NINDS) (1R01NS087950-01), the Pew Foundation, the Alfred P. Sloan Foundation, Defense Advanced Research Projects Agency (DARPA) Young Faculty Award, Boston University Biomedical Engineering Department, and Boston University Photonic Center. K.R.H. is supported by a National Science Foundation Graduate Research Fellowship under Grant No. DGE-1247312. We thank members of the Han and Eldred Labs for technical support of the study and suggestions on the manuscript. K.R.H. and H.T. performed all data analysis. A.I.M. and S.B. performed surgical window procedures. A.I.M. and M.E.A., performed in vivo imaging. G.J.D. performed immunocytochemistry and aided in animal handling during blast procedures. B.N. and V.S. assisted with analysis methods. W.D.E, and X.H. supervised the study. All authors contributed to manuscript preparation.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Allen WE, 2017, NEURON, V94, P891, DOI 10.1016/j.neuron.2017.04.017; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Badura A, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.2.025008; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Berlin S, 2015, NAT METHODS, V12, P852, DOI [10.1038/NMETH.3480, 10.1038/nmeth.3480]; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Burgess Paula, 2010, J Emerg Trauma Shock, V3, P164, DOI 10.4103/0974-2700.62120; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Deneux T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12190; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gee JM, 2014, NEURON, V83, P1058, DOI 10.1016/j.neuron.2014.07.024; Gerberding JL, 2003, STEPS PREVENT SERIOU; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hemphill M, 2017, J NEUROTRAUM, V34, pA3; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Homma Ryot, 2009, V489, P43, DOI 10.1007/978-1-59745-543-5_3; Huuskonen MT, 2017, NEUROTHERAPEUTICS, V14, P519, DOI 10.1007/s13311-016-0504-9; Issa JB, 2014, NEURON, V83, P944, DOI 10.1016/j.neuron.2014.07.009; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2007, WIEN KLIN WOCHENSCHR, V119, P20, DOI 10.1007/s00508-006-0759-y; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mohammed AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep20986; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Poort J, 2015, NEURON, V86, P1478, DOI 10.1016/j.neuron.2015.05.037; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sam K, 2017, BIOPHYS J, V112, p159A, DOI 10.1016/j.bpj.2016.11.875; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Scott BB, 2013, NEURON, V80, P371, DOI 10.1016/j.neuron.2013.08.002; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stuhmiller JH, 1997, TOXICOLOGY, V121, P91, DOI 10.1016/S0300-483X(97)03658-5; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Wachowiak M, 2013, J NEUROSCI, V33, P5285, DOI 10.1523/JNEUROSCI.4824-12.2013; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang LQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9966; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6353845; Zaremba JD, 2017, NAT NEUROSCI, V20, P1612, DOI 10.1038/nn.4634; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	71	6	6	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	13					1523	1536		10.1089/neu.2017.5029		APR 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GJ4CQ	WOS:000429546800001	29343209	Green Published			2022-02-06	
J	Petty, HR				Petty, Howard R.			Frontiers of Complex Disease Mechanisms: Membrane Surface Tension May Link Genotype to Phenotype in Glaucoma	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						surface tension; glaucoma; open-angle; cell membrane; oxidative stress; pressures	OPEN-ANGLE GLAUCOMA; POLYUNSATURATED FATTY-ACIDS; GENOME-WIDE ASSOCIATION; S-TRANSFERASE M1; LIPID-BILAYER-MEMBRANES; COMMON VARIANTS; MACULAR DEGENERATION; SINGLE-CELL; CHOLESTEROL OXIDATION; GENETIC POLYMORPHISMS	Although many monogenic diseases are understood based upon structural changes of gene products, less progress has been made concerning polygenic disease mechanisms. This article presents a new interdisciplinary approach to understand complex diseases, especially their genetic polymorphisms. I focus upon primary open angle glaucoma (POAG). Although elevated intraocular pressure (IOP) and oxidative stress are glaucoma hallmarks, the linkages between these factors and cell death are obscure. Reactive oxygen species (ROS) promote the formation of oxidatively truncated phosphoglycerides (OTP), free fatty acids, lysophosphoglycerides, oxysterols, and other chemical species that promote membrane disruption and decrease membrane surface tension. Several POAG-linked gene polymorphisms identify proteins that manage damaged lipids and/or influence membrane surface tension. POAG-related genes expected to participate in these processes include: ELOVL5, ABCA1, APOE4, GST CYP46A1, MYOC, and CAV. POAG-related gene products are expected to influence membrane surface tension, strength, and repair. I propose that heightened IOP overcomes retinal ganglion cell (RGC) membrane compressive strength, weakened by damaged lipid accumulation, to form pores. The ensuing structural failure promotes apoptosis and blindness. The linkage between glaucoma genotype and phenotype is mediated by physical events. Force balancing between the IOP and compressive strength regulates pore nucleation; force balancing between pore line tension and membrane surface tension regulates pore growth. Similar events may contribute to traumatic brain injury, Alzheimer's disease, and macular degeneration.	[Petty, Howard R.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA		Petty, HR (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	hpetty@umich.edu		, Howard/0000-0001-8516-3666	Mildred E. Swanson Foundation	This work was supported by the Mildred E. Swanson Foundation.	Abu-Amero KK, 2009, BRIT J OPHTHALMOL, V93, P1101, DOI 10.1136/bjo.2008.152983; Abu-Amero KK, 2008, MOL VIS, V14, P425; Al Nimer F, 2013, ANTIOXID REDOX SIGN, V18, P784, DOI 10.1089/ars.2011.4440; Al-Dabbagh NM, 2009, MOL VIS, V15, P912; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; ANDERSON DR, 1972, BRIT J OPHTHALMOL, V56, P146, DOI 10.1136/bjo.56.3.146; Arbault S, 1997, CARCINOGENESIS, V18, P569, DOI 10.1093/carcin/18.3.569; Arouri A, 2013, PROG LIPID RES, V52, P130, DOI 10.1016/j.plipres.2012.09.002; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Bacot S, 2007, J LIPID RES, V48, P816, DOI 10.1194/jlr.M600340-JLR200; Bailey JNC, 2016, NAT GENET, V48, P189, DOI 10.1038/ng.3482; Basu R, 2016, CELL, V165, P100, DOI 10.1016/j.cell.2016.01.021; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Carquin M, 2016, PROG LIPID RES, V62, P1, DOI 10.1016/j.plipres.2015.12.004; Chen R, 2009, J BIOL CHEM, V284, P26297, DOI 10.1074/jbc.M109.018978; Chen YH, 2014, NAT GENET, V46, P1115, DOI 10.1038/ng.3078; Cheng JPX, 2015, J CELL BIOL, V211, P53, DOI 10.1083/jcb.201504042; Chidlow G, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00478; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Clark AF, 2001, FASEB J, V15, P1251, DOI 10.1096/fj.00-0663fje; Cwiklik L, 2010, CHEM PHYS LETT, V486, P99, DOI 10.1016/j.cplett.2010.01.010; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Donegan RK, 2012, J BIOL CHEM, V287, P43370, DOI 10.1074/jbc.M112.408906; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Fourgeux C, 2012, INVEST OPHTH VIS SCI, V53, P7026, DOI 10.1167/iovs.12-9652; Fourgeux C, 2009, INVEST OPHTH VIS SCI, V50, P5712, DOI 10.1167/iovs.09-3655; FRANCIS JW, 1988, J CELL PHYSIOL, V135, P1, DOI 10.1002/jcp.1041350102; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Gao J., 2018, BIOMED RES, V29, P280; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gefen A, 2016, J BIOMECH, V49, P1321, DOI 10.1016/j.jbiomech.2015.10.030; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Girotti AW, 1998, J LIPID RES, V39, P1529; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Gonzalez-Rodriguez D, 2016, BIOPHYS J, V111, P2711, DOI 10.1016/j.bpj.2016.11.001; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; GULCAN HG, 1993, INVEST OPHTH VIS SCI, V34, P3187; Guven M, 2011, OPHTHALMIC RES, V46, P31, DOI 10.1159/000321940; Haluska CK, 2012, BBA-BIOMEMBRANES, V1818, P666, DOI 10.1016/j.bbamem.2011.11.025; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Hategan A, 2003, BIOPHYS J, V85, P2746, DOI 10.1016/S0006-3495(03)74697-9; Heberle FA, 2013, J AM CHEM SOC, V135, P6853, DOI 10.1021/ja3113615; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Hilsch M, 2017, BEILSTEIN J ORG CHEM, V13, P720, DOI 10.3762/bjoc.13.71; Hoffman EA, 2009, INVEST OPHTH VIS SCI, V50, P1313, DOI 10.1167/iovs.08-2326; Houlden H, 2006, J NEUROL NEUROSUR PS, V77, P1106, DOI 10.1136/jnnp.2006.095513; HSU RC, 1980, BLOOD, V56, P109; Huang WB, 2013, GENE, V526, P80, DOI 10.1016/j.gene.2013.05.032; Hysi PG, 2014, NAT GENET, V46, P1126, DOI 10.1038/ng.3087; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Inman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065389; Ishikawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33886; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Itri Rosangela, 2014, Biophys Rev, V6, P47, DOI 10.1007/s12551-013-0128-9; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Jafarian Z, 2018, NEUROL RES, V40, P41, DOI 10.1080/01616412.2017.1390902; Javitt NB, 2008, STEROIDS, V73, P149, DOI 10.1016/j.steroids.2007.10.004; Johnson LA, 2014, NEUROBIOL DIS, V64, P150, DOI 10.1016/j.nbd.2013.12.016; Jovanovic P, 2010, BOSNIAN J BASIC MED, V10, P83, DOI 10.17305/bjbms.2010.2743; Juronen E, 2000, EXP EYE RES, V71, P447, DOI 10.1006/exer.2000.0899; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Khandelia H, 2009, BIOPHYS J, V96, P2734, DOI 10.1016/j.bpj.2009.01.007; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kim DH, 2008, BIOPHYS J, V95, P620, DOI 10.1529/biophysj.107.114983; Kindzelskii AL, 1999, J IMMUNOL, V162, P3188; Ko ML, 2005, FREE RADICAL BIO MED, V39, P365, DOI 10.1016/j.freeradbiomed.2005.03.025; Koldamova R, 2010, BBA-MOL CELL BIOL L, V1801, P824, DOI 10.1016/j.bbalip.2010.02.010; Kolsch H, 2002, MOL PSYCHIATR, V7, P899, DOI 10.1038/sj.mp.4001109; KRAUSE TL, 1994, J NEUROSCI, V14, P6638; Kulig W, 2016, CHEM PHYS LIPIDS, V199, P144, DOI 10.1016/j.chemphyslip.2016.03.001; Kumar S, 2016, GENE, V577, P119, DOI 10.1016/j.gene.2015.11.032; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Larrayoz IM, 2010, INVEST OPHTH VIS SCI, V51, P4942, DOI 10.1167/iovs.09-4854; Lewis J T, 1978, Ann N Y Acad Sci, V308, P124, DOI 10.1111/j.1749-6632.1978.tb22018.x; Liao RF, 2014, MOL VIS, V20, P1025; LIN PS, 1979, CELL BIOL INT REP, V3, P51, DOI 10.1016/0309-1651(79)90068-7; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu XB, 2008, J CLIN BIOCHEM NUTR, V43, P26, DOI 10.3164/jcbn.2008040; Liu YT, 2017, EXP EYE RES, V160, P62, DOI 10.1016/j.exer.2017.05.002; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Lu Y, 2013, GENE, V527, P311, DOI 10.1016/j.gene.2013.06.031; Lulevich V, 2006, LANGMUIR, V22, P8151, DOI 10.1021/la060561p; Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009; Mabuchi F, 2015, AM J OPHTHALMOL, V159, P437, DOI 10.1016/j.ajo.2014.11.023; Mabuchi F, 2011, INVEST OPHTH VIS SCI, V52, P4626, DOI 10.1167/iovs.11-7382; Madey E, 2001, J EXP BOT, V52, P669, DOI 10.1093/jexbot/52.357.669; Makky A, 2015, J PHYS CHEM B, V119, P5857, DOI 10.1021/jp512339m; Mason RP, 1997, FREE RADICAL BIO MED, V23, P419, DOI 10.1016/S0891-5849(97)00101-9; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; McKay GJ, 2011, HUM MUTAT, V32, P1407, DOI 10.1002/humu.21577; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1; Meguro A, 2010, OPHTHALMOLOGY, V117, P1331, DOI 10.1016/j.ophtha.2009.12.001; Mertins O, 2014, BIOPHYS J, V106, P162, DOI 10.1016/j.bpj.2013.11.4457; Minagawa Hirohisa, 2009, J Neurosci Res, V87, P2498, DOI 10.1002/jnr.22073; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Moreira EF, 2001, J BIOL CHEM, V276, P18570, DOI 10.1074/jbc.M011259200; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Neufeld AH, 1999, SURV OPHTHALMOL, V43, pS129, DOI 10.1016/S0039-6257(99)00010-7; Njie-Mbye YF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00366; O'Callaghan YC, 2001, CELL BIOL TOXICOL, V17, P127, DOI 10.1023/A:1010914306375; Olkkonen VM, 2012, BIOMOLECULES, V2, P76, DOI 10.3390/biom2010076; Peeters EAG, 2005, J BIOMECH, V38, P1685, DOI 10.1016/j.jbiomech.2004.07.018; Perkumas KM, 2007, EXP EYE RES, V84, P209, DOI 10.1016/j.exer.2006.09.020; Peter C, 2012, AUTOIMMUNITY, V45, P568, DOI 10.3109/08916934.2012.719947; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Rodriguez IR, 2010, J LIPID RES, V51, P2847, DOI 10.1194/jlr.R004820; Rosetti CM, 2017, J PHYS CHEM B, V121, P1587, DOI 10.1021/acs.jpcb.6b10836; Runas KA, 2015, SOFT MATTER, V11, P499, DOI 10.1039/c4sm01478b; Sanchez D, 2008, BIOPHYS J, V95, P3017, DOI 10.1529/biophysj.108.129551; Sandre O, 1999, P NATL ACAD SCI USA, V96, P10591, DOI 10.1073/pnas.96.19.10591; Schellenberg G D, 2000, Curr Psychiatry Rep, V2, P158, DOI 10.1007/s11920-000-0061-z; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shen SS, 2005, J BIOL CHEM, V280, P1652, DOI 10.1074/jbc.M410136200; Shimazawa M, 2009, BRAIN RES, V1251, P269, DOI 10.1016/j.brainres.2008.11.031; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Tam SP, 2006, AM J PHYSIOL-CELL PH, V291, pC490, DOI 10.1152/ajpcell.00055.2006; Tang SKY, 2017, SCIENCE, V356, P1022, DOI 10.1126/science.aam6496; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; Tejero I, 2007, J PHYS CHEM B, V111, P5684, DOI 10.1021/jp0650782; Tezel G, 2005, INVEST OPHTH VIS SCI, V46, P3177, DOI 10.1167/iovs.05-0208; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; TINT GS, 1995, J LIPID RES, V36, P89; Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1; Unal M, 2007, BRIT J OPHTHALMOL, V91, P527, DOI 10.1136/bjo.2006.102418; Usery RD, 2017, BIOPHYS J, V112, P1431, DOI 10.1016/j.bpj.2017.02.033; Vohra R, 2013, SURV OPHTHALMOL, V58, P311, DOI 10.1016/j.survophthal.2012.08.010; Volinsky R, 2012, BIOPHYS J, V103, P247, DOI [10.1016/j.bpj.2012.06.017, 10.1016/j.bpj.2012.06.01]; Wang QC, 2016, CELL, V165, P1454, DOI 10.1016/j.cell.2016.04.051; Wang Y, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-60; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wielkoszynski T, 2006, BIOESSAYS, V28, P387, DOI 10.1002/bies.20383; Wiggs JL, 2017, HUM MOL GENET, V26, pR21, DOI 10.1093/hmg/ddx184; Xu LB, 2009, J AM CHEM SOC, V131, P13037, DOI 10.1021/ja9029076; Yassine HN, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0194-x; Ying HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047307; Yucel I, 2005, VISION RES, V45, P1107, DOI 10.1016/j.visres.2004.11.018; Yusupov M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06412-8; Zareparsi S, 2004, INVEST OPHTH VIS SCI, V45, P1306, DOI 10.1167/iovs.03-1253; Zhang Y, 2016, AM J CLIN NUTR, V103, P330, DOI 10.3945/ajcn.115.124081; Zhelev DV, 1998, BIOPHYS J, V75, P321, DOI 10.1016/S0006-3495(98)77516-2; Zielinski ZAM, 2017, J ORG CHEM, V82, P2817, DOI 10.1021/acs.joc.7b00152	150	6	6	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	APR 6	2018	6								32	10.3389/fcell.2018.00032			16	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	HG9BX	WOS:000455302000001	29682502	Green Published, gold			2022-02-06	
J	Wang, JT; Su, EM; Wang, H; Guo, C; Lawrence, DA; Eitzman, DT				Wang, Jintao; Su, Enming; Wang, Hui; Guo, Chiao; Lawrence, Daniel A.; Eitzman, Daniel T.			Traumatic Brain Injury Leads to Accelerated Atherosclerosis in Apolipoprotein E Deficient Mice	SCIENTIFIC REPORTS			English	Article							ACUTE MYOCARDIAL-INFARCTION; SYMPATHETIC-NERVOUS-SYSTEM; ASSOCIATION; DYSFUNCTION; ACTIVATION; MODERATE; DAMAGE; CELLS; MODEL	Traumatic brain injury (TBI) has been associated with atherosclerosis and cardiovascular mortality in humans. However the causal relationship between TBI and vascular disease is unclear. This study investigated the direct role of TBI on vascular disease using a murine model of atherosclerosis. Apolipoprotein E deficient mice were placed on a western diet beginning at 10 weeks of age. Induction of TBI or a sham operation was performed at 14 weeks of age and mice were sacrificed 6 weeks later at 20 weeks of age. MRI revealed evidence of uniform brain injury in all mice subjected to TBI. There were no differences in total cholesterol levels or blood pressure between the groups. Complete blood counts and flow cytometry analysis performed on peripheral blood 6 weeks following TBI revealed a higher percentage of Ly6C-high monocytes in mice subjected to TBI compared to sham-treated mice. Mice with TBI also showed elevated levels of plasma soluble E-selectin and bone marrow tyrosine hydroxylase. Analysis of atherosclerosis at the time of sacrifice revealed increased atherosclerosis with increased Ly6C/G immunostaining in TBI mice compared to sham-treated mice. In conclusion, progression of atherosclerosis is accelerated following TBI. Targeting inflammatory pathways in patients with TBI may reduce subsequent vascular complications.	[Wang, Jintao; Su, Enming; Wang, Hui; Guo, Chiao; Lawrence, Daniel A.; Eitzman, Daniel T.] Univ Michigan, Dept Internal Med, Cardiovasc Res Ctr, Ann Arbor, MI 48109 USA		Eitzman, DT (corresponding author), Univ Michigan, Dept Internal Med, Cardiovasc Res Ctr, Ann Arbor, MI 48109 USA.	deitzman@umich.edu		Lawrence, Daniel/0000-0003-3126-1935	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL088419]; VA Merit AwardUS Department of Veterans Affairs [BX002776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL088419, R01HL055374] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002776] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (HL088419 to D.T.E.) and a VA Merit Award (BX002776 to DTE).	Adabag AS, 2008, JAMA-J AM MED ASSOC, V300, P2022, DOI 10.1001/jama.2008.553; Ahmadi N, 2015, BRAIN INJURY, V29, P1635, DOI 10.3109/02699052.2015.1075149; Assmus B, 2012, EUR HEART J, V33, P1911, DOI 10.1093/eurheartj/ehr388; Bodary PF, 2007, J THROMB HAEMOST, V5, P599, DOI 10.1111/j.1538-7836.2007.02388.x; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dutta P, 2016, ARTERIOSCL THROM VAS, V36, P1802, DOI 10.1161/ATVBAHA.116.307519; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Karakas M, 2013, CIRC RES, V112, P13, DOI 10.1161/CIRCRESAHA.112.281097; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Liu NK, 2013, BRAIN RES, V1499, P121, DOI 10.1016/j.brainres.2012.12.031; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Luo W, 2012, ATHEROSCLEROSIS, V220, P110, DOI 10.1016/j.atherosclerosis.2011.10.012; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Ohman MK, 2011, ATHEROSCLEROSIS, V219, P33, DOI 10.1016/j.atherosclerosis.2011.07.012; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Riera Maria, 2010, J Trauma, V68, pE13, DOI 10.1097/TA.0b013e3181469d5b; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Stubbendorff M, 2014, JOVE-J VIS EXP, DOI 10.3791/51459; Su EJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00385; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; von Leden R. E., 2016, J NEUROTRAUM; Wang H, 2015, HYPERTENSION, V65, P758, DOI 10.1161/HYPERTENSIONAHA.114.04648; Wright AP, 2010, ATHEROSCLEROSIS, V212, P414, DOI 10.1016/j.atherosclerosis.2010.06.022	38	6	6	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 4	2018	8								5639	10.1038/s41598-018-23959-2			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GB5HR	WOS:000429095600048	29618740	Green Published, gold			2022-02-06	
J	Akcil, EF; Dilmen, OK; Vehid, H; Tunali, Y				Akcil, Eren Fatma; Dilmen, Ozlem Korkmaz; Vehid, Hayriye; Tunali, Yusuf			Can Amantadine Ameliorate Neurocognitive Functions After Subarachnoid Haemorrhage? A Preliminary Study	TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION			English	Article						Amantadine; subarachnoid haemorrhage; neurocognitive functions	TRAUMATIC BRAIN-INJURY; NMDA RECEPTOR ANTAGONIST; MEMANTINE; MICRODIALYSIS; DEFICITS; TRIAL; SCALE; STATE; COMA	Objective: Aneurysmal subarachnoid haemorrhage (SAH) may have devastating effects on patients. Motor and neurocognitive impairments may arise depending on the location and grade of the SAH. Although the effects of amantadine on neurocognitive function after traumatic brain injury have been widely studied to the best of our knowledge, their effects on recovery from SAH in humans have not been studied. The present study aimed to evaluate how amantadine influences improvement in neurocognitive function in patients with aneurysmal SAH over a period of six months. Methods: This preliminary study included 12 patients with aneurysmal SAH who were admitted to the neurointensive care unit of Cerrahpasa Faculty of Medicine. Patients in Group A (n=5) received the standard treatment for SAH and amantadine for 30 days after admission, and those in Group C (n=7) received only the standard treatment. Neurocognitive function was evaluated using the Coma Recovery Scale-Revised and Disability Rating Scale on the first and fifth days and at the third and sixth months after admission. The primary endpoint of the present study was to compare the effects of amantadine in combination with the standard treatment to those of the standard treatment alone on the neurocognitive function of patients with SAH for over 6 months. Results: Compared to the standard treatment alone, amantadine administration with the standard treatment during the early period of SAH may improve recovery. Conclusion: Amantadine along with the standard treatment can ameliorate neurocognitive function after SAH.	[Akcil, Eren Fatma; Dilmen, Ozlem Korkmaz; Tunali, Yusuf] Istanbul Univ, Dept Anesthesiol & Reanimat, Cerrahpasa Sch Med, Istanbul, Turkey; [Vehid, Hayriye] Istanbul Univ, Dept Biostat, Cerrahpasa Sch Med, Istanbul, Turkey		Akcil, EF (corresponding author), Istanbul Univ, Dept Anesthesiol & Reanimat, Cerrahpasa Sch Med, Istanbul, Turkey.	erenfat@yahoo.com	Dilmen, Ozlem Korkmaz/AAI-1626-2019; tunali, yusuf/AAD-7239-2019; Akcil, Eren Fatma/AAD-2652-2021	Dilmen, Ozlem Korkmaz/0000-0002-5221-0144; Akcil, Eren Fatma/0000-0002-5956-2265			Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dilmen OK, 2015, TURK J ANAESTHESIOL, V43, P1, DOI 10.5152/TJAR.2014.26680; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Huang CY, 2015, INT J MOL SCI, V16, P14171, DOI 10.3390/ijms160614171; Huang CY, 2015, MOL NEUROBIOL, V51, P1038, DOI 10.1007/s12035-014-8767-9; James RF, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0421-6; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Krivonos O V, 2010, Neurosci Behav Physiol, V40, P529, DOI 10.1007/s11055-010-9292-6; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Oliveira MD, 2014, NEUROCRIT CARE, V21, P152, DOI 10.1007/s12028-013-9884-4; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Peeters M, 2002, BRAIN RES, V949, P32, DOI 10.1016/S0006-8993(02)02961-X; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Rammes G, 2008, CURR NEUROPHARMACOL, V6, P55, DOI 10.2174/157015908783769671; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Saniova B, 2004, J NEURAL TRANSM, V111, P511, DOI 10.1007/s00702-004-0112-4; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Spritzer SD, 2015, NEUROLOGIST, V19, P61, DOI 10.1097/NRL.0000000000000001; Urushitani M, 2001, J NEUROSCI RES, V63, P377, DOI 10.1002/1097-4547(20010301)63:5<377::AID-JNR1032>3.0.CO;2-#; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Wild AR, 2013, NEUROPHARMACOLOGY, V73, P138, DOI 10.1016/j.neuropharm.2013.05.013; Zafonte RD, 1998, BRAIN INJURY, V12, P617	26	6	6	0	1	AVES	SISLI	BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY	2149-0937	2149-276X		TURK J ANAESTHESIOL	Turk. J. Anaesthesiol. Reanim.	APR	2018	46	2					100	107		10.5152/TJAR.2018.20280			8	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	GE2KU	WOS:000431044900007	29744244	Green Published, gold			2022-02-06	
J	Clark, JM; Hoshizaki, TB; Gilchrist, MD				Clark, J. Michio; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Assessing women's lacrosse head impacts using finite element modelling	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Concussion; Brain strain; Impact mechanics; Injury prevention; Helmet	TRAUMATIC BRAIN-INJURIES; DYNAMIC-RESPONSE; EYE INJURIES; EPIDEMIOLOGY; RECONSTRUCTION; ACCELERATION; MECHANISMS; HELMETS; GIRLS; FACE	Recently studies have assessed the ability of helmets to reduce peak linear and rotational acceleration for women's lacrosse head impacts. However, such metisures have had low correlation with injury, Maximum principal strain interprets loading curves which provide better injury prediction than peak linear and rotational acei. oration, especially in compliant situations which create low magnitude accelerations but long impact durations, The purpose of this study was to assess head and helmet impacts in women's lacrosse using finite element modelling, Linear and rotational acceleration loading curves from women's lacrosse impacts to a helmeted and an unhelmeted Hybrid III headform were input into the University College Dublin Brain Trauma. Model, The finite element model was used to calculate maximum principal strain in the cerebrum. The results demonstrated for unhelmeted impacts,.falls and ball impacts produce higher maximum pi in.cipal strain values than stick and shoulder collisions. The strain values for falls and ball impacts were found to be within the range of concussion and traumatic brain injury, The results also showed that men's lacrosse helmets reduced maximum principal strain for follow through slashing, falls and ball impacts, These. findings are novel and dernon,sti.ate that for high risk events, maximum principal snain can be reduced by implementing the use of helmets if the rules of the sport do not effectively manage such situations,	[Clark, J. Michio; Gilchrist, Michael D.] Univ Coll Dublin Belfield, Sch Mech & Mat Engn, Dublin 4, Ireland; [Clark, J. Michio; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, 200 Lees Ave,Room A206, Ottawa, ON K1N 6N5, Canada		Clark, JM (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Sch Mech Engn, Room 218B, Dublin 4, Ireland.	michio.clark@ucd.ie					Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Clark J. M, 2015, EVALUATION PROTECTIV; Clark JM, 2017, COMPUT METHOD BIOMEC, V20, P1299, DOI 10.1080/10255842.2017.1341977; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Clark JM, 2016, AM J SPORT MED, V44, P1047, DOI 10.1177/0363546515623272; Clark JMichio, 2015, P IRCOBI C LYON FRAN; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P262; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly MC, 2007, INVESTIGATIONS HEAD; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Goldenberg Michael S., 1995, Journal of Athletic Training, V30, P37; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Harmer P, 1993, SPORT HLTH, V11, P14; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Horgan T.J., 2005, FINITE ELEMENT MODEL; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kendall M., 2016, COMP CHARACTERIZATIO; King A. I., 2003, P IRCOBI C; Kleiven, 2002, FINITE ELEMENT MODEL; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kleiven Svein, 2002, P INT RES COUNC BIOM; Krustrup P, 2005, MED SCI SPORT EXER, V37, P1242, DOI 10.1249/01.mss.0000170062.73981.94; LAPIDUS CS, 1992, J TRAUMA, V32, P555, DOI 10.1097/00005373-199205000-00003; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Luders Eileen, 2010, SEX DIFFERENCES BRAI; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mohr M, 2008, J STRENGTH COND RES, V22, P341, DOI 10.1519/JSC.0b013e318165fef6; Nahum AM, 1977, P 21 STAPP CAR CRASH; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Otago L, 2007, Int J Inj Contr Saf Promot, V14, P259, DOI 10.1080/17457300701602381; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Post A, 2015, ACCIDENT ANAL PREV, V79, P33, DOI 10.1016/j.aap.2015.03.017; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rodowicz KA, 2015, ANN BIOMED ENG, V43, P949, DOI 10.1007/s10439-014-1154-x; Rousseau P., 2014, ANAL CONCUSSION METR; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Ruan J. S., 1994, IMPACT BIOMECHANICS; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Trosseille X, 1992, 01487191 SAE, P19; Waicus KM, 2002, CLIN J SPORT MED, V12, P24, DOI 10.1097/00042752-200201000-00008; Webster DA, 1999, MED SCI SPORT EXER, V31, P938, DOI 10.1097/00005768-199907000-00004; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; WILLINGER R, 1994, ACCIDENT ANAL PREV, V26, P767, DOI 10.1016/0001-4575(94)90053-1; Xiang Joe, 2014, AM J SPORTS MED, V42, P2082; Zanetti Katrina, 2013, P IRCOBI C; Zhang J, 2006, BIOMED SCI INSTRUM, V43, P24; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, P 39 STAPP CAR CRASH	58	6	6	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	APR	2018	80						20	26		10.1016/j.jmbbm.2018.01.020			7	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GA7AK	WOS:000428486800003	29414471	Green Submitted			2022-02-06	
J	Kapoor, N; Ciuffreda, KJ				Kapoor, Neera; Ciuffreda, Kenneth Joseph			Assessment of neuro-optometric rehabilitation using the Developmental Eye Movement (DEM) test in adults with acquired brain injury	JOURNAL OF OPTOMETRY			English	Article						Traumatic brain injury (TBI); Cerebral vascular accident (CVA)/stroke; Developmental Eye Movement (DEM) test; Eye movements; Neuro-optometric rehabilitation		Purpose: This pilot study sought to determine the efficacy of using the Developmental Eye Movement (DEM) test in the adult, acquired brain injury (ABI) population to quantify clinically the effects of controlled, laboratory-performed, oculomotor-based vision therapy/vision rehabilitation. Methods: Nine adult subjects with mild traumatic brain injury (mTBI) and five with stroke were assessed before and after an eight-week, computer-based, versional oculomotor (fixation, saccades, pursuit, and simulated reading) training program (9.6 h total). The protocol incorporated a cross-over, interventional design with and without the addition of auditory feedback regarding two-dimensional eye position. The clinical outcome measure was the Developmental Eye Movement (DEM) test score (ratio, errors) taken before, midway, and immediately following training. Results: For the DEM ratio parameter, improvements were found in 80-89% of the subjects. For the DEM error parameter, improvements were found in 100% of the subjects. Incorporation of the auditory feedback component revealed a trend toward enhanced performance. The findings were similar for both DEM parameters, as well as for incorporation of the auditory feedback, in both diagnostic groups. Discussion: The results of the present study demonstrated considerable improvements in the DEM test scores following the oculomotor-based training, thus reflecting more time-optimal and accurate saccadic tracking after the training. The DEM test should be considered as another clinical test of global saccadic tracking performance in the ABI population. (C) 2017 Spanish General Council of Optometry. Published by Elsevier Espana, S.L.U.	[Kapoor, Neera] NYU, Sch Med, Langone Med Ctr RUSK Rehabil, Dept Rehabil Med, 240 East 38th St,Room 15-32, New York, NY 10016 USA; [Ciuffreda, Kenneth Joseph] SUNY Coll Optometry, State Coll Optometry, 33 West 42nd St, New York, NY 10036 USA; [Kapoor, Neera] SUNY State Coll Optometry, New York, NY 10036 USA		Kapoor, N (corresponding author), NYU, Sch Med, Langone Med Ctr RUSK Rehabil, Dept Rehabil Med, 240 East 38th St,Room 15-32, New York, NY 10016 USA.; Kapoor, N (corresponding author), SUNY State Coll Optometry, New York, NY 10036 USA.	Neera.Kapoor@nyumc.org			Langeloth Foundation	The authors thank the Langeloth Foundation for support of this research. The authors thank Dr. Jan Ygge for the loan of the eye movement software programs.	Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Ciuffreda KJ, 2002, MODELS VISUAL SYSTEM, P741; Ciuffreda KJ., 2016, ADV OPHTHALMOL OPTOM, V1, P307, DOI [10.1016/j.yaoo.2016.03.013, DOI 10.1016/J.YAOO.2016.03.013]; Ciufredda KJ, 2009, OPTOM VIS DEV, V40, P16; Fayos B, 1998, J BEHAV OPTOMETRY, V9, P143; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Gessel LM, 2007, J ATHL TRAINING, V42, P495; GUR S, 1992, ISRAEL J MED SCI, V28, P622; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Hyden J, 2016, PHYS MED REHABIL N A, P77; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kapoor N, 2011, TXB TRAUMATIC BRAIN, P363; Kapoor N, 2009, MED MANAGEMENT ADULT, P407; Koenig G S, 1997, J Am Optom Assoc, V68, P155; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Radomski MV, 2014, AM J OCCUP THER, V68, P422, DOI 10.5014/ajot.2014.011445; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Tannen B, 2016, VIS DEV REHABIL, V2, P170; Tannen N., 2016, VIS DEV REHABIL, V2, P237; Thiagarajan P., 2012, THESIS; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Thiagarajan P, 2015, BRAIN INJURY, V29, P1475, DOI 10.3109/02699052.2015.1070905; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Yadav NK, 2015, BRAIN INJURY, V29, P352, DOI 10.3109/02699052.2014.979229; Yadav NK, 2014, BRAIN INJURY, V28, P922, DOI 10.3109/02699052.2014.887227	38	6	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1888-4296	1989-1342		J OPTOM	J. Optom.	APR-JUN	2018	11	2					103	112		10.1016/j.optom.2017.01.001			10	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	VJ1QG	WOS:000540844800006	28676352	Green Published, gold			2022-02-06	
J	Krutsch, V; Gesslein, M; Loose, O; Weber, J; Nerlich, M; Gaensslen, A; Bonkowsky, V; Krutsch, W				Krutsch, Volker; Gesslein, Markus; Loose, Oliver; Weber, Johannes; Nerlich, Michael; Gaensslen, Axel; Bonkowsky, Viktor; Krutsch, Werner			Injury mechanism of midfacial fractures in football causes in over 40% typical neurological symptoms of minor brain injuries	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Midfacial fracture; Concussion; Football; Soccer; Prevention; Return-to-play	FACIAL FRACTURES; CONSENSUS STATEMENT; SOCCER PLAYERS; CONCUSSION; SPORTS; MANAGEMENT; TRAUMA	The injury mechanisms of midfacial fractures may be typical causes of concussion, but hardly any scientific data on midfacial injuries sustained in football are available. Head and brain trauma represent frequent injuries in athletes of different sports that require appropriate treatment by sports and trauma physicians. This study investigated the management of midfacial fractures in football and the association of such fractures with concomitant brain injury. In a prospective cohort study lasting 24 months (2012 to 2013), midfacial injuries of football players were analysed with regard to the injury mechanisms, first aid procedures on the field, treatment and return-to-play. To analyse concomitant and potentially overlooked minor brain injuries due to the trauma, we retrospectively investigated the neurological symptoms of the study population. The study included 132 football players (37 semi-professionals and 95 amateurs) with midfacial fractures. The main injury mechanisms were head-to-head and head-to-elbow trauma. The mean period of return-to-play after trauma was 33.5 days, which was significantly shortened if a protective face mask was worn (mean 10.4 days earlier, p = 0.0006). Semi-professional football players returned to play earlier (p = 0.009) and more often used protective face masks (p = 0.001). 55 players (41.6%) had neurological symptoms immediately after trauma as a possible sign of concomitant minor brain injury. 5 of 132 players with concussion had been hospitalised for 24 h, but no persistent neurological symptoms were detected. In football, midfacial fractures represent moderate-to-severe injuries with time away from sports of more than 4 weeks. Over 40% of athletes with a midfacial fracture showed concomitant neurological symptoms as a sign of minor brain injury. Therefore, sports physicians and other staff supervising athletes in daily practice should be aware of the presence of neurological symptoms. Level III.	[Krutsch, Volker; Bonkowsky, Viktor] Paracelsus Med Univ, Gen Hosp Nuremberg, Dept Otorhinolaryngol Head & Neck Surg, Nurnberg, Germany; [Gesslein, Markus] Paracelsus Med Univ, Gen Hosp Nuremberg, Dept Trauma Surg, Nurnberg, Germany; [Loose, Oliver] Clin St Hedwig, Clin Paediat Surg, Regensburg, Germany; [Weber, Johannes; Nerlich, Michael; Krutsch, Werner] Univ Med Ctr Regensburg, FIFA Med Ctr Excellence, Dept Trauma Surg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany; [Gaensslen, Axel] Clin Wolfsburg, Dept Trauma Surg, Wolfsburg, Germany		Krutsch, W (corresponding author), Univ Med Ctr Regensburg, FIFA Med Ctr Excellence, Dept Trauma Surg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	werner.krutsch@ukr.de	GeSSlein, Markus/O-4858-2019	GeSSlein, Markus/0000-0003-3863-1580; Loose, Oliver/0000-0001-8498-5772	Centre of Clinical Studies at the University Medical Centre Regensburg; ZNS-Hannelore-Kohl-Stiftung in Bonn/Germany; "AG Pravention" of the German Society of Orthopaedic and Trauma Surgery (DGOU)	We are grateful for the support of the Centre of Clinical Studies at the University Medical Centre Regensburg, the support by the ZNS-Hannelore-Kohl-Stiftung in Bonn/Germany and the "AG Pravention" of the German Society of Orthopaedic and Trauma Surgery (DGOU).	Akoglu Ebru, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.01.2011.3787; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bjorneboe J, 2014, BRIT J SPORT MED, V48, P774, DOI 10.1136/bjsports-2012-091856; Cerulli G, 2002, J CRANIOFAC SURG, V13, P627, DOI 10.1097/00001665-200209000-00006; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Delilbasi C, 2004, ORAL SURG ORAL MED O, V97, P23, DOI 10.1016/j.tripleo.2003.10.008; Dvorak J., 2009, FOOTBALL MED MANUAL; Dvorak J., 2000, AM J SPORT MED, V28, P1; Dvorak J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.034579; Dvorak J, 2011, BRIT J SPORT MED, V45, P626, DOI 10.1136/bjsm.2010.079905; Eufinger H, 2000, SPORTVERLETZ SPORTSC, V14, P35, DOI 10.1055/s-2000-3821; Farrior EH, 2015, FACIAL PLAST SURG, V31, P270, DOI 10.1055/s-0035-1555627; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fuller CW, 2006, CLIN J SPORT MED, V16, P97, DOI 10.1097/00042752-200603000-00003; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Goiato MC, 2012, J CRANIOFAC SURG, V23, P1201, DOI 10.1097/SCS.0b013e31824e240e; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hallen A, 2014, J SPORT SCI, V32, P1229, DOI 10.1080/02640414.2014.905695; Herrero H, 2014, AM J SPORT MED, V42, P78, DOI 10.1177/0363546513507767; Higuera S, 2007, PLAST RECONSTR SURG, V120, p64S, DOI 10.1097/01.prs.0000260722.91183.50; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Kemp S, 2016, BRAIN INJURY, V16, P1; Kloss FR, 2011, INT J ORAL MAX SURG, V40, P33, DOI 10.1016/j.ijom.2010.08.006; Klugl M, 2010, CLIN J SPORT MED, V20, P407, DOI 10.1097/JSM.0b013e3181f4a99c; Koch M, 2016, ARCH ORTHOP TRAUM SU, V136, P353, DOI 10.1007/s00402-015-2350-3; Krutsch W, 2016, KNEE SURG SPORT TR A, V24, P2271, DOI 10.1007/s00167-014-3357-y; Krutsch W, 2014, ARCH ORTHOP TRAUM SU, V134, P1301, DOI 10.1007/s00402-014-2041-5; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Maladiere E, 2001, INT J ORAL MAX SURG, V30, P291, DOI 10.1054/ijom.2001.0059; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Procacci P, 2009, J CRANIOFAC SURG, V20, P15, DOI 10.1097/SCS.0b013e3181909c55; Reehal P, 2010, CURR SPORT MED REP, V9, P27, DOI 10.1249/JSR.0b013e3181cd2c04; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Roth J, 2012, J CRANIO MAXILL SURG, V40, P608, DOI 10.1016/j.jcms.2011.10.020; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI33, DOI 10.1136/bjsm.2005.019059; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Sobin L, 2016, JAMA FACIAL PLAST SU, V18, P15, DOI 10.1001/jamafacial.2015.1339; van Beek GJ, 1999, INT J ORAL MAX SURG, V28, P424, DOI 10.1016/S0901-5027(99)80055-1	46	6	6	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	APR	2018	26	4					1295	1302		10.1007/s00167-017-4431-z			8	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	GB1FM	WOS:000428796600042	28180920				2022-02-06	
J	Lee, DH; Lee, BK; Noh, SM; Cho, YS				Lee, D. H.; Lee, B. K.; Noh, S. M.; Cho, Y. S.			High fibrin/fibrinogen degradation product to fibrinogen ratio is associated with 28-day mortality and massive transfusion in severe trauma	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Trauma; Prognosis; Massive transfusion; Fibrinogen; Fibrin/fibrinogen degradation products (FDP); D-dimer	DISSEMINATED INTRAVASCULAR COAGULATION; HOSPITAL CARDIAC-ARREST; BRAIN-INJURY; COAGULOPATHY; FIBRINOLYSIS; OUTCOMES; PREDICT	There is a lack of association between coagulation biomarkers and long-term mortality in severe trauma. We aimed to investigate the association between coagulation biomarkers on admission and outcome of late stage of trauma. This retrospective observational study included patients admitted with severe trauma between 2012 and 2015. We used the area under the receiver operating characteristic curve (AUROC) of coagulation biomarkers to determine 28-day mortality. Head Abbreviated Injury Scale scores greater than 3 were defined as traumatic brain injury (TBI). The primary outcome was 28-day mortality and the secondary outcome was massive transfusion. Of the 1266 patients included in the study, 28-day mortality rate was 19.7% (n = 249) and 7.9% (n = 100) of patients received massive transfusion. The AUROC of fibrin/fibrinogen degradation product (FDP) to fibrinogen ratio had a significantly higher prognostic performance than other markers. Multivariate analysis revealed that d-dimer level [odds ratio (OR) 1.033; 95% confidence interval (CI) 1.016-1.051] and FDP/fibrinogen ratio (OR 1.007; 95% CI 1.001-1.013) were independently associated with 28-day mortality. d-dimer (OR 1.028; 95% CI 1.003-1.055) and FDP/fibrinogen ratio (OR 1.035; 95% CI 1.012-1.058) were associated with 28-day mortality in the TBI group. In the non-TBI group, d-dimer was associated with 28-day mortality (OR 1.033; 95% CI 1.008-1.059), but the FDP/fibrinogen ratio was not. FDP/fibrinogen ratio, not d-dimer level, was an independent predictor for massive transfusion (OR 1.005; 95% CI 1.001-1.010). High FDP/fibrinogen ratio on arrival is a predictor of 28-day mortality and the requirement for massive transfusion in severe trauma.	[Lee, D. H.; Lee, B. K.; Cho, Y. S.] Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea; [Noh, S. M.] Chonnam Natl Univ Hosp, Dept Trauma Ctr, Gwangju, South Korea		Lee, BK (corresponding author), Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea.	bbukkuk@hanmail.net	Lee, Byung Kook/M-2236-2018	Lee, Byung Kook/0000-0003-3571-9448			Aoki M, 2016, INJURY, V47, P1702, DOI 10.1016/j.injury.2016.05.012; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Dekker SE, 2016, J SURG RES, V205, P147, DOI 10.1016/j.jss.2016.06.023; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; GANDO S, 1995, CRIT CARE MED, V23, P1835, DOI 10.1097/00003246-199511000-00009; Gando S, 1997, THROMB HAEMOSTASIS, V77, P278; Gando S, 2001, SEMIN THROMB HEMOST, V27, P585, DOI 10.1055/s-2001-18864; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Hayakawa M, 2016, SHOCK, V45, P308, DOI 10.1097/SHK.0000000000000542; Hayakawa M, 2015, SEMIN THROMB HEMOST, V41, P35, DOI 10.1055/s-0034-1398379; Hayakawa M, 2011, SURGERY, V149, P221, DOI 10.1016/j.surg.2010.06.010; Hess JR, 2006, J TRAUMA, V60, pS12, DOI 10.1097/01.ta.0000199545.06536.22; Lansink KWW, 2013, EUR J TRAUMA EMERG S, V39, P375, DOI 10.1007/s00068-013-0278-2; MacLeod JBA, 2014, INJURY, V45, P910, DOI 10.1016/j.injury.2013.11.004; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; McQuilten ZK, 2017, INJURY, V48, P1074, DOI 10.1016/j.injury.2016.11.021; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Mitra B, 2011, RESUSCITATION, V82, P1208, DOI 10.1016/j.resuscitation.2011.04.007; Ono Y, 2017, RESUSCITATION, V111, P62, DOI 10.1016/j.resuscitation.2016.11.017; Oshiro A, 2014, CRIT CARE, V18, DOI 10.1186/cc13816; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Skaga NO, 2008, INJURY, V39, P612, DOI 10.1016/j.injury.2007.11.426; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Wada H, 2008, SEMIN THROMB HEMOST, V34, P33, DOI 10.1055/s-2008-1066021	25	6	7	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	APR	2018	44	2					291	298		10.1007/s00068-017-0844-0			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GB6SG	WOS:000429202500020	28921171				2022-02-06	
J	Oyesanya, TO; Snedden, TR				Oyesanya, Tolu O.; Snedden, Traci R.			Pediatric nurses' perceived knowledge and beliefs of evidence-based practice in the care of children and adolescents with moderate-to-severe traumatic brain injury	JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING			English	Article						beliefs; evidence-based practice; nursing; pediatric; traumatic brain injury (TBI)	HEALTH-CARE; RECOVERY; PERCEPTIONS; IMPLEMENTATION; PROVIDERS; ATTITUDES; EDUCATION; SKILLS; TBI	PurposePediatric nurses play a significant role in all phases of traumatic brain injury (TBI) recovery, particularly during the hospital stay. Although evidence-based nursing practice is known to improve patient outcomes, limited research exists on nurses' evidence-based perceived knowledge and beliefs specific to TBI care. As nurses' perceived knowledge and beliefs are known to guide their practice behaviors, this assessment is important to overall TBI outcomes. The purpose of this study was to evaluate pediatric nurses' evidence-based perceived knowledge and beliefs in providing care for children and adolescents with moderate-to-severe TBI. Design and methodsData for this study were obtained from a larger parent study on nurses' perceptions of caring for patients of all ages with moderate-to-severe TBI. The parent study was an exploratory, cross-sectional electronic survey of registered nurses across all hospital departments within a large Midwestern health system. Only data specific to pediatric nurses (n=330) were analyzed for this study. Descriptive statistics and latent class analysis (LCA) were performed. ResultsPediatric nurses, on average, were 38.79 years, female (90.37%), had over a decade of nursing experience (13.55 years), and practiced as a staff nurse (80.07%) on an inpatient unit (45.51%). Findings indicated pediatric nurses reported overall low levels of evidence-based perceived knowledge and had inaccurate beliefs about caring for patients with TBI. LCA indicated two distinct homogenous subgroups specific to evidence-based perceived knowledge: low (41%) and high (59%). Nurses in the low evidence-based perceived knowledge group were younger, had less nursing experience, worked primarily on an inpatient unit, and cared for patients with TBI at a higher frequency compared to high evidence-based perceived knowledge nurses. Additionally, there were significant differences in beliefs about sex-based patient differences after TBI and the role of nurses in caring for patients with TBI based on level of evidence-based perceived knowledge. Practice implicationsAssessing nurses' perceived knowledge and beliefs of evidence-based practice is a foundational step toward implementing evidence-based care for patients with moderate-to-severe TBI. Implications of these findings indicate the need to provide additional education to increase pediatric nurses' perceived knowledge and ensure accurate beliefs about evidence-based TBI care.	[Oyesanya, Tolu O.] Crawford Res Inst, Atlanta, GA USA; [Snedden, Traci R.] Univ Wisconsin, Sch Nursing, Madison, WI USA		Oyesanya, TO (corresponding author), Shepherd Ctr, Crawford Res Inst, Atlanta, GA 30309 USA.	tolu_oyesanya@shepherd.org		Oyesanya, Tolu/0000-0001-8821-4510; Snedden, Traci/0000-0002-1550-2340	University of Wisconsin-Madison, School of Nursing Eckburg Research and Eckburg Dissteration Award; NIH/NIGMS Initiative for Maximizing Student Development [R25GM083252]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	The authors thank university faculty and staff and to staff at the participating study recruitment locations. This research was funded by the University of Wisconsin-Madison, School of Nursing Eckburg Research and Eckburg Dissteration Award. This project was supported by the NIH/NIGMS Initiative for Maximizing Student Development (PI, M. Carnes) Grant# R25GM083252. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Funding sources had no involvement with study design, data collection, analysis, interpretation, or decision to submit the article for publication. Funding sources had no involvement in conducting the research or preparation of this article.	Agency for Healthcare Research and Quality, 2015, EV BAS PRACT CTR EPC; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baker M, 2012, NURS EDUC TODAY, V32, P71, DOI 10.1016/j.nedt.2011.01.011; Centers for Disease Control and Prevention, 2016, TBI DAT STAT; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Edwards G., 2006, BRIT J NURSING, V15; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Faul M, 2010, TRAUMATIC BRAIN INJU; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; GrOnvik C. K. U., 2016, OPEN J NURSING, V6, P699, DOI DOI 10.4236/OJN.2016.69072; Guyatt G., 2012, MED ROUNDTABLE GEN M, V1, P75; HERLING RW, 2000, ADV DEV HUMAN RESOUR, V0002, P00001; Hintze J., 2006, NCSS PASS AND GESS; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Jaglal SB, 2014, BMC HEALTH SERV RES, V14, P1; Kline RB., 2016, PRINCIPLES PRACTICE, V4th edn.; Lehman C, 2015, SPECIALTY PRACTICE R, P511; Leung K, 2014, J ADV NURS, V70, P2181, DOI 10.1111/jan.12454; Li T., 2004, P 21 INT C MACH LEAR, P68, DOI DOI 10.1145/1015330.1015404; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; Long AF, 2002, NURS EDUC TODAY, V22, P136, DOI 10.1054/nedt.2001.0671; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; McQuillan K. A., 2002, TRAUMA NURSING RESUS, P394; Melnyk B.M., 2011, EVIDENCE BASED PRACT; Melnyk Bernadette Mazurek, 2004, Worldviews Evid Based Nurs, V1, P185, DOI 10.1111/j.1524-475X.2004.04024.x; Muthen L.K., 2010, MPLUS USERS GUIDE ST; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Pryor J, 2002, J ADV NURS, V39, P249; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rycroft-Malone J, 2004, J ADV NURS, V47, P81, DOI 10.1111/j.1365-2648.2004.03068.x; Sackett David L, 1996, EVIDENCE BASED MED W; Sredl D, 2011, TEACH LEARN NURS, V6, P73, DOI 10.1016/j.teln.2010.06.001; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thoroddsen A, 2010, INT J NURS TERMIN CL, V21, P69, DOI 10.1111/j.1744-618X.2010.01148.x; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Verloo H, 2017, J EVAL CLIN PRACT, V23, P139, DOI 10.1111/jep.12653; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Wunsch D, 2008, CLUSTERING, V10; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	48	6	6	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1539-0136	1744-6155		J SPEC PEDIATR NURS	J. Spec. Pediatr. Nurs.	APR	2018	23	2							e12209	10.1111/jspn.12209			11	Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Pediatrics	GC9MI	WOS:000430121300003	29427544	Green Accepted			2022-02-06	
J	Rygard, SL; Holst, LB; Perner, A				Rygard, Sofie Louise; Holst, Lars Brokso; Perner, Anders			Blood Product Administration in the Critical Care and Perioperative Settings	CRITICAL CARE CLINICS			English	Article						Critical care; ICU; Perioperative; Plasma; Platelets; Thrombocytes; Anemia; Red blood cells	CELL TRANSFUSION STRATEGIES; RANDOMIZED-CONTROLLED-TRIAL; RECOMBINANT-HUMAN-ERYTHROPOIETIN; TRAUMATIC BRAIN-INJURY; ILL PATIENTS; RESTRICTIVE TRANSFUSION; CLINICAL-PRACTICE; IRON SUPPLEMENTATION; PLATELET TRANSFUSION; PREOPERATIVE ANEMIA	The critical care and perioperative settings are high consumers of blood products, with multiple units and different products often given to an individual patient. The recommendation of this article is always to consider the risks and benefits for a specific blood product for a specific patient in a specific clinical setting. Optimize patient status by treating anemia and preventing the need for red blood cell transfusion. Consider other options for correction of anemia and coagulation disorders, and use an imperative non-overtransfusion policy for all blood products.	[Rygard, Sofie Louise; Holst, Lars Brokso; Perner, Anders] Copenhagen Univ Hosp, Rigshosp, Dept Intens Care, Inge Lehmansvej 5,Opg 3,3 Sal,4131, DK-2100 Copenhagen O, Denmark; [Perner, Anders] CRIC, Tagensvej 22, DK-2200 Copenhagen N, Denmark		Perner, A (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Intens Care, Inge Lehmansvej 5,Opg 3,3 Sal,4131, DK-2100 Copenhagen O, Denmark.	anders.perner@regionh.dk		Perner, Anders/0000-0002-4668-0123	CSL Behring; Fresenius Kabi Pharmaceutical; Ferring PharmaceuticalFerring Pharmaceuticals	The Department of Intensive Care, Rigshospitalet, receives support for research from CSL Behring, Fresenius Kabi, and Ferring Pharmaceuticals.	Amrein K, 2012, BLOOD REV, V26, P33, DOI 10.1016/j.blre.2011.09.003; Baron DM, 2016, BRIT J ANAESTH, V117, P610, DOI 10.1093/bja/aew308; Berezina TL, 2002, J SURG RES, V102, P6, DOI 10.1006/jsre.2001.6306; Blazekovic SJ, 2014, INT ORTHOP, V38, P341, DOI 10.1007/s00264-013-2185-x; Bolton-Maggs PHB, 2016, 2015 ANN SHOT REPORT; Bouchard D, 2008, CAN J SURG, V51, P422; Carless PA, 2010, COCHRANE DATABASE SY; Carson JL, 2015, LANCET, V385, P1183, DOI 10.1016/S0140-6736(14)62286-8; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Chang R, 2017, CRIT CARE CLIN, V33, P15, DOI 10.1016/j.ccc.2016.08.007; Cooper DJ, 2017, NEW ENGL J MED, V377, P1858, DOI 10.1056/NEJMoa1707572; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Daniels PR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h2391; Dara SI, 2005, CRIT CARE MED, V33, P2667, DOI [10.1097/01.CCM.0000186745.53059.F0, 10.1097/01.CCM.0000151062.00501.60]; Department of Health and Human Services, 2011, 2011 NATL BLOOD COLL; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Docherty AB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1638-9; Docherty AB, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1351; Douketis JD, 2015, NEW ENGL J MED, V373, P823, DOI 10.1056/NEJMoa1501035; Durila M, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0073-1; Fischer DP, 2014, CRIT CARE, V18, DOI 10.1186/cc13884; Fominskiy E, 2015, BRIT J ANAESTH, V115, P511, DOI 10.1093/bja/aev317; Fowler AJ, 2015, BRIT J SURG, V102, P1314, DOI 10.1002/bjs.9861; Froessler B, 2016, ANN SURG, V264, P41, DOI 10.1097/SLA.0000000000001646; Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3; Goodnough LT, 2003, TRANSFUSION, V43, P668, DOI 10.1046/j.1537-2995.2003.00367.x; Hall DP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011756.pub2; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Heming N, 2011, CRIT CARE, V15, DOI 10.1186/cc9992; Henry DA, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003602; Henry David A, 2011, Cochrane Database Syst Rev, pCD001886, DOI 10.1002/14651858.CD001886.pub4; Hoeks MPA, 2017, BRIT J HAEMATOL, V178, P137, DOI 10.1111/bjh.14641; Holst LB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1354; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Hunt BJ, 2014, NEW ENGL J MED, V370, P847, DOI 10.1056/NEJMra1208626; Karam O, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010654.pub2; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kotze A, 2012, BRIT J ANAESTH, V108, P943, DOI 10.1093/bja/aes135; Kozek-Langenecker SA, 2021, GEMATOL TRANSFUZIOL, V66, P88, DOI 10.1097/EJA.0000000000000630; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Litton E, 2016, INTENS CARE MED, V42, P1715, DOI 10.1007/s00134-016-4465-6; Meier J, 2016, BRIT J ANAESTH, V116, P255, DOI 10.1093/bja/aev456; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; *NAT BLOOD AUTH, 2012, PAT BLOOD MAN GUID M; National Toxicology Program, 2012, Natl Toxicol Program Tech Rep Ser, P1; Norgaard A, 2014, BLOOD TRANSFUS-ITALY, V12, P509, DOI 10.2450/2014.0282-13; Pasricha SRS, 2010, MED J AUSTRALIA, V193, P525, DOI 10.5694/j.1326-5377.2010.tb04038.x; Perner A, 2012, NEW ENGL J MED, V367, P82; Pieracci FM, 2014, CRIT CARE MED, V42, P2048, DOI 10.1097/CCM.0000000000000408; Prakash D, 2012, CRIT CARE CLIN, V28, P333, DOI 10.1016/j.ccc.2012.04.012; Prescott LS, 2016, CANCER TREAT REV, V46, P1, DOI 10.1016/j.ctrv.2016.03.010; Reiter N, 2013, DAN MED J, V60; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-450; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roubinian N, 2016, HEMATOL ONCOL CLIN N, V30, P529, DOI 10.1016/j.hoc.2016.01.001; Shah A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1486-z; Shander A, 2004, AM J MED, V116, P58, DOI 10.1016/j.amjmed.2003.12.013; Silver M, 2006, CRIT CARE MED, V34, P2310, DOI 10.1097/01.CCM.0000233873.17954.42; Stanworth SJ, 2013, TRANSFUSION, V53, P1050, DOI 10.1111/j.1537-2995.2012.03866.x; Stanworth SJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10129; Tinmouth A, 2013, TRANSFUSION, V53, P2222, DOI 10.1111/trf.12231; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Walsh TS, 2013, CRIT CARE MED, V41, P2354, DOI 10.1097/CCM.0b013e318291cce4; Wikkelso A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub3; WOLFE LC, 1985, TRANSFUSION, V25, P185, DOI 10.1046/j.1537-2995.1985.25385219897.x; Yang L, 2012, TRANSFUSION, V52, P1673, DOI 10.1111/j.1537-2995.2011.03515.x; Zarychanski R, 2007, CAN MED ASSOC J, V177, P725, DOI 10.1503/cmaj.071055; Zhao C, 2015, J CARDIOVASC PHARM, V65, P593, DOI 10.1097/FJC.0000000000000229; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	76	6	6	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	APR	2018	34	2					299	311		10.1016/j.ccc.2017.12.005			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA6RX	WOS:000428462700012	29482908				2022-02-06	
J	Colello, RJ; Colello, IA; Abdelhameid, D; Cresswell, KG; Merchant, R; Beckett, E				Colello, Raymond J.; Colello, Ian A.; Abdelhameid, Duaa; Cresswell, Kellen G.; Merchant, Randall; Beckett, Ethan			Making Football Safer: Assessing the Current National Football League Policy on the Type of Helmets Allowed on the Playing Field	JOURNAL OF NEUROTRAUMA			English	Article						acceleration; concussion; football helmet; g-force	CHRONIC TRAUMATIC ENCEPHALOPATHY; HEAD IMPACT EXPOSURE; PROFESSIONAL FOOTBALL; CONCUSSION; PLAYERS; PERFORMANCE; EQUIPMENT; SEASON	In an effort to reduce concussions in football, a helmet safety-rating system was developed in 2011 that rated helmets based on their ability to reduce g-forces experienced by the head across a range of impact forces measured on the playing field. Although this was considered a major step in making the game safer, the National Football League (NFL) continues to allow players the right to choose what helmet to wear during play. This prompted us to ask: What helmets do NFL players wear and does this helmet policy make the game safer? Accordingly, we identified the helmets worn by nearly 1000 players on Week 13 of the 2015-2016 season and Week 1 of the 2016-2017 season. Using stop-motion footage, we found that players wore a wide range of helmets with varying safety ratings influenced in part by the player's position and age. Moreover, players wearing lower safety-rated helmets were more likely to receive a concussion than those wearing higher safety-rated helmets. Interestingly, many players suffering a concussion in 2015 did not switch to a higher safety-rated helmet in 2016. Using a helmet-to-helmet impactor, we found that the g-forces experienced in the highest safety-rated helmets were roughly 30% less than that for the lowest safety-rated helmets. These results suggest that the current NFL helmet policy puts players at increased risk of receiving a concussion as many players are wearing low safety-rated helmets, which transmits more energy to the brain than higher safety-rated helmets, following collision. Thus, to reduce concussions, the NFL should mandate that players only wear helmets that receive the highest safety rating.	[Colello, Raymond J.; Colello, Ian A.; Abdelhameid, Duaa; Beckett, Ethan] Virginia Commonwealth Univ, Dept Anat & Neurobiol, 1101 East Marshall St,POB 980709, Richmond, VA 23298 USA; [Cresswell, Kellen G.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Merchant, Randall] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA		Colello, RJ (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, 1101 East Marshall St,POB 980709, Richmond, VA 23298 USA.	raymond.colello@vcuhealth.org		Cresswell, Kellen/0000-0002-7929-8166	Virginia Commonwealth University's President Quest fund; Virginia Neuroscience Initiative; Morrow Foundation	The authors would like to thank Mike Grieve of Custom Design and Fabrication South for designing and constructing the helmet impactor, Dr. Rene Morrissey for critically reviewing this manuscript and the Virginia Commonwealth University's President Quest fund, the Virginia Neuroscience Initiative, and the Morrow Foundation for providing funding for this project.	Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Jadischke R, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034306; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; National Operating Committee for the Safety of Athletic Equipment, 2007, 00106M07 NAT OP COMM; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pieroth EM, 2014, PROG NEUROL SURG, V28, P171, DOI 10.1159/000358778; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	34	6	6	2	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	11					1213	1223		10.1089/neu.2017.5446		MAR 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GG7EW	WOS:000428415000001	29421963				2022-02-06	
J	Ondruschka, B; Rosinsky, F; Trauer, H; Schneider, E; Dressler, J; Franke, H				Ondruschka, Benjamin; Rosinsky, Franziska; Trauer, Heiner; Schneider, Eckhardt; Dressler, Jan; Franke, Heike			Drug- and/or trauma-induced hyperthermia? Characterization of HSP70 and myoglobin expression	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; METHAMPHETAMINE-INDUCED HYPERTHERMIA; BRAIN-INJURY; MYOCARDIAL-INFARCTION; DEATH; HEAT-SHOCK-PROTEIN-70; INDUCTION; HSP27; RHABDOMYOLYSIS; NEUROTOXICITY	Introduction Heat shock protein 70 (HSP70) expression could be discussed as an adaption that promotes repair and counteracts cell damage. Myoglobin is released upon muscle damage of several pathways. The purpose of the present study was to determine whether the expression of HSP70 in kidney, heart and brain and of myoglobin in the kidney were associated with the cause of death and the survival times after lethal intoxications with three of the drugs most widely used in our local area (Saxony, Germany) as well as after fatal traumatic brain injury (TBI). Methods We retrospectively collected kidney, heart and brain samples of 50 autopsy cases with toxicological proved lethal intoxication (main drugs methamphetamine, morphine, alcohol), 14 TBI cases and 15 fatalities with acute myocardial injury in age- and gender-matched compilations. Results Our main findings suggest that HSP70 is associated with hyperthermal and other stress factors of most cell populations. HSP70 expressions in kidney and heart muscle are useful for a differentiation between fatal intoxications and cases without toxicological influence (p < 0.05). There were significant differences in the cerebral expression patterns between meth-amphetamine-and morphine-associated deaths compared to alcohol fatalities (p < 0.05). An intensive staining of HSP70 in the pericontusional zone and the hippocampus after TBI (especially neuronal and vascular) was shown even after short survival times and may be useful as an additional marker in questions of vitality or wound age. A relevant myoglobin decoration of renal tubules was only shown for methamphetamine abuse in the study presented. Conclusion In sum, the immunohistochemical characteristics presented can be supportive for determining final death circumstances and minimal trauma survival times but are not isolated usefully for the detection of drug-or trauma-induced hyperthermia.	[Ondruschka, Benjamin; Rosinsky, Franziska; Trauer, Heiner; Dressler, Jan] Univ Leipzig, Inst Legal Med, Med Fac, Leipzig, Germany; [Schneider, Eckhardt] Grp Practice Leipzig, Dept Pathol, Leipzig, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Med Fac, Leipzig, Germany		Ondruschka, B (corresponding author), Univ Leipzig, Inst Legal Med, Med Fac, Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de			German Research Foundation (DFG)German Research Foundation (DFG); University of Leipzig within the program of Open Access Publishing	We acknowledge support from the German Research Foundation (DFG) and the University of Leipzig within the program of Open Access Publishing.	Ammon-Treiber S, 2004, CELL STRESS CHAPERON, V9, P182, DOI 10.1379/CSC-42.1; BLAKE MJ, 1990, J BIOL CHEM, V265, P15275; Bonds BW, 2015, BRAIN INJURY, V29, P1642, DOI 10.3109/02699052.2015.1075157; Bratzke H, 2011, RECHTSMEDIZIN, V21, P258, DOI 10.1007/s00194-011-0760-2; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; CHAVERON M, 1995, CELL BIOL TOXICOL, V11, P161, DOI 10.1007/BF00756518; CIOCCA DR, 1993, JNCI-J NATL CANCER I, V85, P1558, DOI 10.1093/jnci/85.19.1558; Guisasola MC, 2016, MED CLIN-BARCELONA, V146, P292, DOI 10.1016/j.medcli.2015.12.011; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; Darke S, 2016, ADDICTION, V111, P1607, DOI 10.1111/add.13429; Dettmeyer R, 2016, RECHTSMEDIZIN, V26, P444, DOI 10.1007/s00194-016-0100-7; Dettmeyer R, 2013, RECHTSMEDIZIN, V23, P333; Doberentz E, 2014, INT J LEGAL MED, V128, P967, DOI 10.1007/s00414-014-0994-0; Doberentz E, 2017, FORENSIC SCI MED PAT; Doberentz E, 2017, INT J LEGAL MED; Doberentz E, 2016, FORENSIC SCI MED PAT, V12, P33, DOI 10.1007/s12024-015-9730-4; Dybdahl B, 2005, HEART, V91, P299, DOI 10.1136/hrt.2003.028092; Fracasso T, 2011, INT J LEGAL MED, V125, P537, DOI 10.1007/s00414-011-0547-8; Franke H, 2013, PURINERG SIGNAL, V9, P451, DOI 10.1007/s11302-013-9366-3; Freyaldenhoven TE, 1997, ANN NY ACAD SCI, V825, P167, DOI 10.1111/j.1749-6632.1997.tb48427.x; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; GOTO S, 1993, BRAIN RES, V626, P351, DOI 10.1016/0006-8993(93)90602-J; Hecker JG, 2011, CELL STRESS CHAPERON, V16, P119, DOI 10.1007/s12192-010-0224-8; Ishigami Akiko, 2003, Journal of Medical Investigation, V50, P112; Ishigami Akiko, 2003, Leg Med (Tokyo), V5, P42, DOI 10.1016/S1344-6223(03)00005-1; Jeng Wilson, 2015, F1000Res, V4, DOI 10.12688/f1000research.7214.1; Kacimi R, 2015, GLIA, V63, P1200, DOI 10.1002/glia.22811; Kacprzak M, 2012, CARDIOL J, V19, P369, DOI 10.5603/CJ.2012.0067; Kennedy D, 2014, IUBMB LIFE, V66, P327, DOI 10.1002/iub.1274; Kita T, 2000, Nihon Hoigaku Zasshi, V54, P367; Kitamura O., 2009, LEGAL MED, V11, p63 ; Kiyatkin EA, 2011, J NEURAL TRANSM, V118, P47, DOI 10.1007/s00702-010-0477-5; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Kunitz O, 2003, ANAESTHESIST, V52, P511, DOI 10.1007/s00101-003-0474-2; Kuperman DI, 1997, BRAIN RES, V771, P221, DOI 10.1016/S0006-8993(97)00710-5; Mash DC, 2009, FORENSIC SCI INT, V190, pE13, DOI 10.1016/j.forsciint.2009.05.012; Matsumoto RR, 2014, PHARMACOL THERAPEUT, V144, P28, DOI 10.1016/j.pharmthera.2014.05.001; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Milroy CM, 2011, HISTOPATHOLOGY, V59, P579, DOI 10.1111/j.1365-2559.2010.03728.x; Muralidharan S, 2014, J IMMUNOL, V193, P1975, DOI 10.4049/jimmunol.1303468; Nikolov R, 2010, METHOD FIND EXP CLIN, V32, P401, DOI 10.1358/mf.2010.32.6.1514688; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Plotnikov EY, 2009, BBA-MOL BASIS DIS, V1792, P796, DOI 10.1016/j.bbadis.2009.06.005; Preuss J, 2008, FORENSIC SCI INT, V176, P248, DOI 10.1016/j.forsciint.2007.09.017; Richards JR, 1999, AM J EMERG MED, V17, P681, DOI 10.1016/S0735-6757(99)90159-6; Schober K, 2015, INT J LEGAL MED, V129, P701, DOI 10.1007/s00414-014-1129-3; Sharma HS, 2011, CURR NEUROPHARMACOL, V9, P223, DOI 10.2174/157015911795017100; Tomita M, 2011, CHEM-BIOL INTERACT, V190, P54, DOI 10.1016/j.cbi.2011.01.025; Wagner R, 2016, RECHTSMEDIZIN, V26, P363; Wang SH, 2003, J BIOMECH ENG-T ASME, V125, P794, DOI 10.1115/1.1632522; Weber M., 2017, INT J LEGAL MED; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhang J, 2012, CHIN J TRAUMATOL, V15, P338, DOI 10.3760/cma.j.issn.1008-1275.2012.06.004	56	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2018	13	3							e0194442	10.1371/journal.pone.0194442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1RF	WOS:000428093900065	29566034	Green Published, gold, Green Submitted			2022-02-06	
J	Aiolfi, A; Benjamin, E; Recinos, G; Castro, ADL; Inaba, K; Demetriades, D				Aiolfi, Alberto; Benjamin, Elizabeth; Recinos, Gustavo; Castro, Alejandro De Leon; Inaba, Kenji; Demetriades, Demetrios			AIR VERSUS GROUND TRANSPORTATION IN ISOLATED SEVERE HEAD TRAUMA: A NATIONAL TRAUMA DATA BANK STUDY	JOURNAL OF EMERGENCY MEDICINE			English	Article						isolated severe head trauma; helicopter transport; ground transport; outcomes	EMERGENCY MEDICAL-SERVICES; HELICOPTER TRANSPORT; BRAIN-INJURY; SYSTEM; SURVIVAL; OUTCOMES; MORTALITY; IMPACT; SCENE; TIME	Background: The effect of prehospital helicopter emergency medical services (HEMS) on mortality has been analyzed previously in polytrauma patients with discordant results. Objective: Our aim was to compare outcomes in patients with isolated severe blunt traumatic brain injuries (TBIs) transported by HEMS or ground emergency medical services (GEMS). Methods: We conducted a National Trauma Data Bank study (2007-2014). All adult patients (>= 16 years old) who sustained an isolated severe blunt TBI and were transported by HEMS or GEMS were included in the study. Results: There were 145,559 patients who met the inclusion criteria. Overall, 116,391 (80%) patients were transported via GEMS and 29,168 (20%) via HEMS. Median transportation time was longer for HEMS patients (41 vs. 25 min; p < 0.001). HEMS patients were more likely to have hypotension (2.7% vs. 1.5%; p < 0.001), Glasgow Coma Scale (GCS) score < 9 (38.2% vs. 10.9%; p < 0.001), and head Abbreviation Injury Scale (AIS) score of 5 (20.1% vs. 9.7%; p < 0.001). Stepwise logistic regression analysis identified age >= 65 years old, male sex, hypotension, GCS score < 9, prehospital intubation, and head AIS scores 4 and 5 as independent predictors of mortality. Helicopter transportation was independently associated with improved survival (odds ratio [OR] 0.55; 95% confidence interval [CI] 0.47-0.67; p < 0.001). Admission to a Level I trauma center was an independent predictor of survival (OR 0.64; 95% CI 0.53-0.82; p = 0.001). Regardless of head AIS, helicopter transport was an independent predictor of survival (AIS 3: OR 0.35; p < 0.001; AIS 4: OR 0.44; p < 0.001; AIS 5: OR 0.76; p < 0.001). A prolonged transport time was not an independent predictor of mortality. Conclusions: Helicopter transport, in adult patients with isolated severe TBI, is associated with improved survival. (C) 2017 Elsevier Inc. All rights reserved.	[Aiolfi, Alberto; Benjamin, Elizabeth; Recinos, Gustavo; Castro, Alejandro De Leon; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, Los Angeles, CA USA		Aiolfi, A (corresponding author), Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, IPT, 2051 Marengo St,C5L100, Los Angeles, CA 90033 USA.		Aiolfi, Alberto/ABA-7242-2020; INABA, KENJI/AAC-8532-2020; Benjamin, Elizabeth/AAD-2457-2020	Aiolfi, Alberto/0000-0002-7764-6075; De Leon Castro, Luis Alejandro/0000-0001-7623-8603			Andruszkow H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146897; [Anonymous], 2015, NTDB RES DATA SET US; Bekelis K, 2015, ANN SURG, V261, P579, DOI 10.1097/SLA.0000000000000672; Brathwaite CEM, 1998, J TRAUMA, V45, P140, DOI 10.1097/00005373-199807000-00029; Brown JB, 2010, J TRAUMA, V69, P1030, DOI 10.1097/TA.0b013e3181f6f450; Buchanan IM, 2016, CAN J EMERG MED, V18, P363, DOI 10.1017/cem.2016.15; Cunningham P, 1997, J TRAUMA, V43, P940, DOI 10.1097/00005373-199712000-00013; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Di Bartolomeo Stefano, 2005, Prehosp Emerg Care, V9, P79; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; Galvagno SM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009228.pub3; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; NICHOLL JP, 1995, BRIT MED J, V311, P217, DOI 10.1136/bmj.311.6999.217; Ryb GE, 2013, J TRAUMA ACUTE CARE, V74, P149, DOI 10.1097/TA.0b013e31827890cc; Talving P, 2009, WORLD J SURG, V33, P2469, DOI 10.1007/s00268-009-0185-1; Taylor CB, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2009.09.030; Thomas SH, 2002, J TRAUMA, V52, P136, DOI 10.1097/00005373-200201000-00023; Vercruysse GA, 2015, J TRAUMA ACUTE CARE, V78, P510, DOI 10.1097/TA.0000000000000553	19	6	6	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAR	2018	54	3					328	334		10.1016/j.jemermed.2017.11.019			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FZ3OI	WOS:000427498200016	29258783				2022-02-06	
J	Bender, AK; Bucholz, KK; Heath, AC; McCutcheon, VV				Bender, Annah K.; Bucholz, Kathleen K.; Heath, Andrew C.; McCutcheon, Vivia V.			Comparison of Characteristics of Female Drivers with Single and Multiple DUI Convictions	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Driving Under the Influence; Alcohol Use Disorder; Drunk Driving; Women	INTIMATE PARTNER VIOLENCE; TRAUMATIC BRAIN-INJURY; PSYCHIATRIC-DISORDERS; ALCOHOL INVOLVEMENT; RISK-FACTORS; FOLLOW-UP; CHILDHOOD EXPERIENCES; DRIVING OFFENDERS; DRINKING PATTERNS; REPEAT OFFENDERS	BackgroundWomen are increasingly involved in drunk driving and fatal crashes, yet except for the screening performed in criminal justice settings, little is known about their life context, psychiatric histories, and family backgrounds. This study describes a sample of women with histories of arrest for driving under the influence of alcohol (DUI) who were interviewed outside a criminal justice setting and contrasts women with single versus multiple DUI convictions. MethodsWomen with recent documented histories of DUI participated in a study of women's health behaviors. Thirty-six women with 1 DUI and 62 with 2 or more DUIs participated in a diagnostic telephone interview which assessed demographics, alcohol use and problems, psychiatric problems, treatment, and partner violence. ResultsThe sample overall had high rates of co-occurring psychiatric problems, parental alcohol problems, early sexual and physical abuse, and head injuries. Alcohol use severity and the prevalence of head injuries and partner alcohol problems were significantly higher among women with multiple DUIs than women with a single DUI. Measures reflecting life context, such as marital status, number of children, and childhood trauma, were not associated with number of DUIs. ConclusionsFindings suggest that DUI recidivism in women is accounted for primarily by AUD severity and is not influenced by previous life events such as partner violence, psychiatric problems, and family context such as divorce/separation or number of children. Multiple DUIs in women may mark an alcohol severity threshold beyond which few factors account for additional risk.	[Bender, Annah K.] Univ Missouri, Coll Nursing, St Louis, MO 63121 USA; [Bucholz, Kathleen K.; Heath, Andrew C.; McCutcheon, Vivia V.] Washington Univ, Sch Med, Dept Psychiat, Midwest Alcoholism Res Ctr, St Louis, MO 63110 USA		Bender, AK (corresponding author), Univ Missouri, Coll Nursing, St Louis, MO 63121 USA.	bendera@umsl.edu	McCutcheon, Vivia/J-1161-2019	McCutcheon, Vivia/0000-0002-2694-5438; Bucholz, Kathleen/0000-0003-3794-0736	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AA018146]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K01AA018146, K05AA017688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA015035] Funding Source: NIH RePORTER	Funding for this study was provided by NIH grant AA018146 (VVM).	Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beck KH, 2011, TRAFFIC INJ PREV, V12, P306, DOI 10.1080/15389588.2011.564693; BUCHOLZ KK, 1995, J STUD ALCOHOL, V56, P500, DOI 10.15288/jsa.1995.56.500; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Bullers S, 2001, ADDICT BEHAV, V26, P181, DOI 10.1016/S0306-4603(00)00099-X; Burrus SWM, 2011, JUVENILE FAM COURT J, V62, P1, DOI 10.1111/j.1755-6988.2011.01062.x; C'de Baca J, 2001, J STUD ALCOHOL, V62, P615, DOI 10.15288/jsa.2001.62.615; Caetano R, 2000, J SUBST ABUSE, V11, P123, DOI 10.1016/S0899-3289(00)00015-8; Centers for Disease Control and Prevention, 2013, NAT HOSP AMB MED CAR; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Dakof GA, 2009, JUVENILE FAM COURT J, V60, P11, DOI 10.1111/j.1755-6988.2009.01033.x; Dawson DA, 2006, J STUD ALCOHOL, V67, P195, DOI 10.15288/jsa.2006.67.195; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Foran HM, 2008, J FAM VIOLENCE, V23, P141, DOI 10.1007/s10896-007-9136-5; Gilbert P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001988; Glass RJ, 2000, J SUBST ABUSE TREAT, V19, P369, DOI 10.1016/S0740-5472(00)00132-X; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Grucza RA, 2008, ALCOHOL CLIN EXP RES, V32, P763, DOI 10.1111/j.1530-0277.2008.00635.x; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; Hohman M, 2017, J SOC WORK PRACT ADD, V17, P95, DOI 10.1080/1533256X.2017.1302885; Keyes KM, 2011, ALCOHOL CLIN EXP RES, V35, P2101, DOI 10.1111/j.1530-0277.2011.01562.x; Kleschinsky JH, 2009, J STUD ALCOHOL DRUGS, V70, P751, DOI 10.15288/jsad.2009.70.751; La Flair LN, 2013, DRUG ALCOHOL DEPEN, V132, P491, DOI 10.1016/j.drugalcdep.2013.03.012; Lacey, 2000, STATE KNOWLEDGE ALCO; Lapham S, 2000, ALCOHOL ALCOHOLISM, V35, P464, DOI 10.1093/alcalc/35.5.464; Lapham SC, 2006, J STUD ALCOHOL, V67, P707, DOI 10.15288/jsa.2006.67.707; Lapham SC, 2000, ALCOHOL CLIN EXP RES, V24, P1647, DOI 10.1097/00000374-200011000-00007; Lapham SC, 2006, ACCIDENT ANAL PREV, V38, P162, DOI 10.1016/j.aap.2005.08.009; Lapham SC, 2001, ARCH GEN PSYCHIAT, V58, P943, DOI 10.1001/archpsyc.58.10.943; Laplante DA, 2008, J STUD ALCOHOL DRUGS, V69, P209, DOI 10.15288/jsad.2008.69.209; Leadley K, 2000, J SUBST ABUSE, V11, P253, DOI 10.1016/S0899-3289(00)00025-0; Liang B, 2013, J DRUG ISSUES, V43, P270, DOI 10.1177/0022042612471811; Marshal Michael P, 2003, Clin Psychol Rev, V23, P959, DOI 10.1016/j.cpr.2003.09.002; McCutcheon VV, 2011, ALCOHOL CLIN EXP RES, V35, P1985, DOI 10.1111/j.1530-0277.2011.01550.x; McCutcheon VV, 2009, ADDICT BEHAV, V34, P432, DOI 10.1016/j.addbeh.2008.12.003; Miller BA, 1999, J STUD ALCOHOL, V60, P632, DOI 10.15288/jsa.1999.60.632; Norbeck J S, 1984, Birth Defects Orig Artic Ser, V20, P45; Peirce RS, 2000, HEALTH PSYCHOL, V19, P28, DOI 10.1037/0278-6133.19.1.28; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rosenquist JN, 2010, ANN INTERN MED, V152, P426, DOI 10.7326/0003-4819-152-7-201004060-00007; Russell M, 2001, SUBST USE MISUSE, V36, P1417, DOI 10.1081/JA-100106958; Schumacher JA, 2001, AGGRESS VIOLENT BEH, V6, P281, DOI 10.1016/S1359-1789(00)00027-6; Stith SM, 2004, AGGRESS VIOLENT BEH, V10, P65, DOI 10.1016/j.avb.2003.09.001; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Tsai VW, 2010, INJURY PREV, V16, P17, DOI 10.1136/ip.2009.022301; Voas RB, 2011, ALCOHOL CLIN EXP RES, V35, p309A; Widom CS, 2001, ALCOHOL RES HEALTH, V25, P52	49	6	6	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	MAR	2018	42	3					646	653		10.1111/acer.13590			8	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	FY0GV	WOS:000426489600018	29437240	Green Accepted			2022-02-06	
J	Chermann, JF; Romeas, T; Marty, F; Faubert, J				Chermann, Jean-Francois; Romeas, Thomas; Marty, Flore; Faubert, Jocelyn			Perceptual-cognitive three-dimensional multiple-object tracking task can help the monitoring of sport-related concussion	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article								Objectives While the rate of sport-related concussion is increasing, more effective tools are needed to help monitor the diagnosis and return to play of athletes. The threedimensional multiple-object tracking (3D-MOT) exercise is a perceptual-cognitive task that has shown predictive power towards the dynamic requirements of real-world activities such as sport. This study introduced the use of the 3D-MOT task, along with the Standardized Assessment of Concussion (SAC) and Modified Balance Error Scoring System (M-BESS) tests, for diagnosis and return to play in professional sports. Methods Fifty-nine professional athletes were tested with the 3D-MOT, SAC and M-BESS tests at 48 hours following the injury. The same measures were employed to evaluate the return to play following the standard concussion management protocol. The SAC and M-BESS tests were also performed in pre-season (baseline) in 32 out of the 59 athletes. Results The injured athletes exhibited poor performance on 3D-MOT at 48 hours post injury compared with return to play (p<0.001) as well as compared with healthy professionals' performance scores (p<0.001). Importantly, learning rate, which participants are thought to have an expert advantage on this perceptual-cognitive task, was totally disrupted at 48 hours post injury compared with healthy professionals (p<0.001). The 3D-MOT performance was also correlated to the total number of symptoms (p=0.020), SAC (p=0.031) and M-BESS (p=0.004) scores at 48 hours. Not surprisingly, SAC and M-BESS tests' usefulness for monitoring concussion was found to be weak, particularly when test performance following the injury was compared to baseline (p=0.056 and 0.349 for SAC and M-BESS, respectively). Conclusion 3D-MOT could help monitor sport-related concussion in professional athletes. The discussion also covers the critical importance of perceptual-cognitive assessment following concussion in the athletic population.	[Chermann, Jean-Francois; Marty, Flore] Consultat Commot & Sport, 2 Rue Convent, Paris, France; [Romeas, Thomas] Inst Natl Sport Quebec, Sport Sci, Montreal, PQ, Canada; [Faubert, Jocelyn] Univ Montreal, Sch Optometry, Montreal, PQ, Canada		Romeas, T (corresponding author), Inst Natl Sport Quebec, Sport Sci, Montreal, PQ, Canada.	romes.romeas@umontreal.ca	Romeas, Thomas/S-6034-2019	Romeas, Thomas/0000-0002-3298-5719			[Anonymous], 2017, P INTERSERVICE IND T; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; CASANOVA Filipe, 2009, REV PORT CIENC DESPO, V9, P115; Chermann JF, 2016, TRAUMATOLOGIE SPORT, V33, P88; Chermann JF, 2014, ASIAN J SPORTS MED, V5; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Christie B, 2016, EFFECTS MILD TRAUMAT, P128; Corbin-Berrigan LA, 2018, NEUROREPORT, V29, P559, DOI 10.1097/WNR.0000000000000988; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Decq P, 2011, J TRAUMATOLOGIE SPOR, V28, P227; Faubert J., 2013, J VIS, V13, P1292, DOI [10.1167/13.9.1292, DOI 10.1167/13.9.1292]; Faubert J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01154; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Fehd HM, 2008, COGNITION, V108, P201, DOI 10.1016/j.cognition.2007.11.008; Fehd HM, 2010, J VISION, V10, DOI 10.1167/10.4.19; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Halker RB, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0397-2; Haran FJ, 2016, BRAIN INJURY, V30, P280, DOI 10.3109/02699052.2015.1118766; Harenberg S, 2016, J SURG EDUC, V73, P386, DOI 10.1016/j.jsurg.2015.11.013; Hellwig CS, 2015, DETERMINING FALSE PO; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Kelly M, 2017, CUREUS, V9, DOI 10.7759/cureus.1251; Knudson D., 1997, J PHYS ED RECREATION, V68, P17, DOI [DOI 10.1080/07303084.1997.10604922, 10.1080/07303084.1997.10604922]; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; Marshall SW, 2001, J ATHL TRAINING, V36, P334; Marteniuk R., 1976, INFORM PROCESSING MO; Marty F, 2017, J TRAUMATOLOGIE SPOR, V34, P155; Maruta J, 2017, MIL MED, V182, P120, DOI 10.7205/MILMED-D-16-00093; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2017, BR J SPORTS MED, V12; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Michaels J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185909; Mueller FO, 2008, RES NCFCI; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; National Academies Press (US), 2014, NAT RES COUNC SPORTS; Oslund KR, 2017, BRIT J SPORT MED, V51; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Romeas T, 2016, PSYCHOL SPORT EXERC, V22, P1, DOI 10.1016/j.psychsport.2015.06.002; Snedden TR, 2017, CLIN J SPORT MED, V27, P462, DOI 10.1097/JSM.0000000000000389; Thomas RE, 2016, BMJ OPEN SPORT EXERC, V2, DOI DOI 10.1136/BMJSEM-2015-000095; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	51	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	MAR	2018	4	1							e000384	10.1136/bmjsem-2018-000384			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ4QA	WOS:000596798200088	30305922	Green Published, gold			2022-02-06	
J	Elliott, JE; De Luche, SE; Churchill, MJ; Moore, C; Cohen, AS; Meshul, CK; Lim, MM				Elliott, Jonathan E.; De Luche, Samuel E.; Churchill, Madeline J.; Moore, Cindy; Cohen, Akiva S.; Meshul, Charles K.; Lim, Miranda M.			Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice	SLEEP			English	Article						sleep; wakefulness; branched-chain amino acids; hypocretin; electron microscopy	CHAIN AMINO-ACIDS; HYPOCRETIN OREXIN DEFICIENCY; MOUSE MODEL; STRIATAL GLUTAMATE; EXTRACELLULAR POTASSIUM; MOTOR DEFICITS; SLEEP; NARCOLEPSY; DISTURBANCES; AROUSAL	Study Objectives: In previous work, dietary branched-chain amino acid (BCAA) supplementation, precursors to de novo glutamate and gamma-aminobutyric acid (GABA) synthesis, restored impaired sleep-wake regulation and orexin neuronal activity following traumatic brain injury (TBI) in mice. TBI was speculated to reduce orexin neuronal activity through decreased regional excitatory (glutamate) and/or increased inhibitory (GABA) input. Therefore, we hypothesized that TBI would decrease synaptic glutamate and/or increase synaptic GABA in nerve terminals contacting orexin neurons, and BCAA supplementation would restore TBI-induced changes in synaptic glutamate and/or GABA. Methods: Brain tissue was processed for orexin pre-embed diaminobenzidine labeling and glutamate or GABA postembed immunogold labeling. The density of glutamate and GABA immunogold within presynaptic nerve terminals contacting orexin-positive lateral hypothalamic neurons was quantified using electron microscopy in three groups of mice (n = 8 per group): Sham/noninjured controls, TBI without BCAA supplementation, and TBI with BCAA supplementation (given for 5 days, 48 hr post-TBI). Glutamate and GABA were also quantified within the cortical penumbral region (layer VIb) adjacent to the TBI lesion. Results: In the hypothalamus and cortex, TBI decreased relative glutamate density in presynaptic terminals making axodendritic contacts. However, BCAA supplementation only restored relative glutamate density within presynaptic terminals contacting orexin-positive hypothalamic neurons. BCAA supplementation did not change relative glutamate density in presynaptic terminals making axosomatic contacts, or relative GABA density in presynaptic terminals making axosomatic or axodendritic contacts, within either the hypothalamus or cortex. Conclusions: These results suggest TBI compromises orexin neuron function via decreased glutamate density and highlight BCAA supplementation as a potential therapy to restore glutamate density to orexin neurons.	[Elliott, Jonathan E.; De Luche, Samuel E.; Churchill, Madeline J.; Moore, Cindy; Meshul, Charles K.; Lim, Miranda M.] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mail Code P3-RD42, Portland, OR 97239 USA; [Elliott, Jonathan E.; Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Cohen, Akiva S.] Univ Penn, Dept Anesthesiol & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Dept Anesthesiol, Philadelphia, PA 19104 USA; [Meshul, Charles K.] Oregon Hlth & Sci Univ, Dept Behav Neurosci & Pathol, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med & Behav Neurosci, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA		Lim, MM (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd,Mail Code P3-RD42, Portland, OR 97239 USA.	lmir@ohsu.edu			VA Portland Health Care SystemUS Department of Veterans Affairs; VA Career Development Award [IK2 BX002712]; American Sleep Medicine Foundation [105-JF-14, 110-BK-14]; Portland VA Research Foundation; VA Merit ReviewUS Department of Veterans Affairs [I01 BX001643A]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 AT 002688]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288] Funding Source: NIH RePORTER; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT002688] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000552, I01BX001643] Funding Source: NIH RePORTER	This material is the result of work supported with resources and the use of facilities at the VA Portland Health Care System, the VA Career Development Award # IK2 BX002712, the American Sleep Medicine Foundation (# 105-JF-14, # 110-BK-14), and the Portland VA Research Foundation (to M.M.L.); VA Merit Review # I01 BX001643A (to C.K.M.); and National Institutes of Health T32 AT 002688 (to J.E.E.) The contents do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government.	Acuna-Goycolea C, 2004, J NEUROSCI, V24, P3013, DOI 10.1523/JNEUROSCI.5416-03.2004; Alexandre C, 2013, CURR OPIN NEUROBIOL, V23, P752, DOI 10.1016/j.conb.2013.04.008; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2016, SLEEP MED CLIN, V11, P19, DOI 10.1016/j.jsmc.2015.10.004; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2006, J NEUROL NEUROSUR PS, V77, P402, DOI 10.1136/jnnp.2005.067207; Baumann CR, 2005, SLEEP MED REV, V9, P253, DOI 10.1016/j.smrv.2005.01.005; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Burgess CR, 2012, J NEUROSCI, V32, P12305, DOI 10.1523/JNEUROSCI.2630-12.2012; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Centers for Disease and Control, 2016, TRAUM BRAIN INJ CONC; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Combremont ALW, 2016, CEREB CORTEX, V26, P3553, DOI 10.1093/cercor/bhw158; Combremont ALW, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00088; CROMPTON MR, 1971, LANCET, V1, P669; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Deadwyler SA, 2007, J NEUROSCI, V27, P14239, DOI 10.1523/JNEUROSCI.3878-07.2007; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Holmer HK, 2005, SYNAPSE, V57, P100, DOI 10.1002/syn.20163; Hood RL, 2016, BRAIN RES, V1646, P535, DOI 10.1016/j.brainres.2016.06.032; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Kanbayashi T, 2002, J SLEEP RES, V11, P91, DOI 10.1046/j.1365-2869.2002.00284.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kiyashchenko LI, 2002, J NEUROSCI, V22, P5282; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; MESHUL CK, 1994, BRAIN RES, V648, P181, DOI 10.1016/0006-8993(94)91117-7; Meshul CK, 1999, NEUROSCIENCE, V88, P1, DOI 10.1016/S0306-4522(98)00189-4; Mieda M, 2004, P NATL ACAD SCI USA, V101, P4649, DOI 10.1073/pnas.0400590101; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Nishino S, 2007, NEUROPEPTIDES, V41, P117, DOI 10.1016/j.npep.2007.01.003; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Paxinos G., 2012, PAXINOS FRANKLINS MO; Peyron C, 1998, J NEUROSCI, V18, P9996; PHEND KD, 1992, J HISTOCHEM CYTOCHEM, V40, P1011, DOI 10.1177/40.7.1376741; Robinson S, 2003, EXP NEUROL, V180, P73, DOI 10.1016/S0014-4886(02)00050-X; Rosin DL, 2003, J COMP NEUROL, V465, P593, DOI 10.1002/cne.10860; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sakai R, 2004, J NEUROCHEM, V88, P612, DOI 10.1111/j.1471-4159.2004.02179.x; Sakurai T, 2005, SLEEP MED REV, V9, P231, DOI 10.1016/j.smrv.2004.07.007; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Scammell TE, 2015, NEW ENGL J MED, V373, P2654, DOI 10.1056/NEJMra1500587; Scammell Thomas E, 2015, J Clin Psychiatry, V76, pe13, DOI 10.4088/JCP.14046tx1c; Scammell TE, 2011, ANNU REV PHARMACOL, V51, P243, DOI 10.1146/annurev-pharmtox-010510-100528; Sconce MD, 2015, NEUROSCIENCE, V299, P156, DOI 10.1016/j.neuroscience.2015.04.069; Sconce MD, 2015, NEUROSCIENCE, V290, P454, DOI 10.1016/j.neuroscience.2014.12.080; See RE, 2002, J NEUROCHEM, V82, P172, DOI 10.1046/j.1471-4159.2002.00974.x; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Spinelli KJ, 2014, J NEUROSCI, V34, P2037, DOI 10.1523/JNEUROSCI.2581-13.2014; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Thomasy HE, 2016, NEUROBIOL SLEEP CIRC, P1; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Touchon JC, 2004, SYNAPSE, V51, P287, DOI 10.1002/syn.10306; Walker RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035025; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xiong GX, 2014, J NEUROTRAUM, V31, P1396, DOI 10.1089/neu.2013.3110; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Yudkoff M, 2005, J NUTR, V135, p1531S, DOI 10.1093/jn/135.6.1531S; Yudkoff M, 1997, GLIA, V21, P92, DOI 10.1002/(SICI)1098-1136(199709)21:1<92::AID-GLIA10>3.0.CO;2-W	86	6	6	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	MAR	2018	41	3							zsx212	10.1093/sleep/zsx212			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY8NZ	WOS:000427123100016	29315422	Green Published, hybrid			2022-02-06	
J	Henker, C; Hoppmann, MC; Sherman, MUS; Glass, A; Piek, J				Henker, Christian; Hoppmann, Marie-Cristin; Sherman, Maryam Umar Swaleh; Glass, Aenne; Piek, Juergen			Validation of a Novel Clinical Score: The Rostock Functional and Cosmetic Cranioplasty Score	JOURNAL OF NEUROTRAUMA			English	Article						clinical score; cranioplasty; outcome; RFCC; temporal muscle	MIDDLE-CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; MALIGNANT INFARCTION; MULTICENTER; HEMICRANIECTOMY; RECONSTRUCTION; PRESERVATION; CRANIOTOMY; SURGERY	With a rising number of cranioplasty (CP) procedures and an increasing percentage of patients with a good clinical outcome and prolonged survival after CP, looking at the functional and aesthetic outcome of these patients becomes more and more important. The aim of our study was to evaluate a novel score, combining functional and cosmetics aspects after CP, created at our institution: the Rostock Functional and Cosmetic Cranioplasty (RFCC-) Score. A total of 27 patients were enrolled, representing all indications for a secondary CP after decompressive craniectomy or extended temporal trephination with a complete separation of the temporalis muscle. Besides the clinical evaluation, five different already established clinical rating systems were tested and compared with our score. For reasons of objectivity, the score was also tested against the patient's own rating. Our findings showed that the RFCC-Score, derived from a health professional, is superior to other scoring systems, which only display a facet of the functional state of the patient. Our score is objective and independent of a disposition for a depression of the patient. It can be obtained without the need of a verbal communication, making it applicable for nearly all patients after CP. The score is time-saving, clearly arranged, and reliable, which are inevitable requirements for the comparing and evaluation of different surgical techniques and associated complications of CP.	[Henker, Christian; Hoppmann, Marie-Cristin; Sherman, Maryam Umar Swaleh; Piek, Juergen] Univ Med Rostock, Dept Neurosurg, Rostock, Germany; [Glass, Aenne] Univ Med Rostock, Inst Biostat & Informat Med, Rostock, Germany		Henker, C (corresponding author), Univ Med Rostock, Dept Neurosurg, Rostock, Germany.	Christian.Henker@med.uni-rostock.de		Henker, Christian/0000-0002-7591-3192			Abdulazim A, 2012, SCI WORLD J, DOI 10.1100/2012/427081; Alotaibi NM, 2017, J NEUROSURG, V127, P1315, DOI 10.3171/2016.9.JNS161383; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COURVILLE C B, 1959, Bull Los Angel Neuro Soc, V24, P1; Di Rienzo A, 2013, NEUROL MED-CHIR, V53, P590; Flanigan P, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13552; Gallagher C, 2004, J ORAL REHABIL, V31, P110, DOI 10.1046/j.0305-182X.2003.01209.x; Giese H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009273; Goldstein JA, 2013, CURR OPIN OTOLARYNGO, V21, P400, DOI 10.1097/MOO.0b013e328363003e; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2016, J NEUROSURG-PEDIATR, V17, P701, DOI 10.3171/2015.11.PEDS15556; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Huber MB., 2017, INT J ENV RES PUBLIC, P14; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jabbarli R, 2017, WORLD NEUROSURG, V98, P689, DOI 10.1016/j.wneu.2016.12.012; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kadri PAS, 2004, J NEUROSURG, V100, P517, DOI 10.3171/jns.2004.100.3.0517; Kolias AG, 2014, BRIT J NEUROSURG, V28, P310, DOI 10.3109/02688697.2013.859657; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Marbacher S, 2012, NEUROSURG REV, V35, P527, DOI 10.1007/s10143-012-0376-3; Munroe AR, 1924, CAN MED ASSOC J, V14, P47; Ohrbach R, 2008, J OROFAC PAIN, V22, P219; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rahme R, 2012, J NEUROSURG, V117, P749, DOI 10.3171/2012.6.JNS111140; Rocha-Filho PAS, 2007, ORAL SURG ORAL MED O, V104, pE17, DOI 10.1016/j.tripleo.2007.05.029; Schulte F, 2010, ARCH MED SCI, V6, P827, DOI 10.5114/aoms.2010.19286; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Steinbock R.T., 1986, JAMA-J AM MED ASSOC, V255, P101; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Trnovec S, 2009, NEUROREHABILITATION, V24, P267, DOI 10.3233/NRE-2009-0477; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Welling LC, 2015, J NEUROSURG, V122, P1012, DOI 10.3171/2014.11.JNS146; Zawawi Khalid H, 2003, J Can Dent Assoc, V69, P737	41	6	6	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	8					1030	1036		10.1089/neu.2017.5512		MAR 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GC0DM	WOS:000426670700001	29256820				2022-02-06	
J	Hillebregt, CF; Cholten, EWM; Ketelaar, M; Post, MWM; Visser-Meily, JMA				Hillebregt, Chantal F.; Cholten, Eline W. M.; Ketelaar, Marjolijn; Post, Marcel W. M.; Visser-Meily, Johanna M. A.			Effects of family group conferences among high-risk patients of chronic disability and their significant others: study protocol for a multicentre controlled trial	BMJ OPEN			English	Article							SPINAL-CORD-INJURY; CAREGIVER STRAIN INDEX; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; GROUP DECISION-MAKING; SELF-EFFICACY SCALE; LOWER-LIMB AMPUTEES; STROKE PATIENTS; UTRECHT SCALE	Introduction Many patients arid family members experience a large gap between the protected environment during inpatient medical rehabilitation and life in the community after discharge. They feel insufficiently prepared to cope with the consequences of their disability in daily life. This study protocol describes the design measuring the effectiveness and implementation of family group conferences on the empowerment of patients with a high risk of chronic disability and their significant others. Methods and analysis A multicentre controlled trial will be carried out in 12 rehabilitation centres in the Netherlands. A total of 328 clinically admitted patients will participate (>= 18 years, diagnosed with acquired brain injury, spinal cord injury or leg amputation), arid their significant others will be included. During three family group conferences, supported by the social worker, the patient, significant other and their social network will be stimulated in collaboration, to set up participation goals, determine the needed help arid make a concrete action plan. Self-reported questionnaires will he collected at baseline, clinical discharge, and 3 months and 6 months following clinical discharge. Empowerment as the primary outcome is operationahsed as self-efficacy and participation. Secondary outcome measures are psychological (eg, coping, neuroticism) and environmental (eg, family functioning, social support) factors. This is the first controlled trial evaluating the effectiveness of family group conferences in rehabilitation medicine among adult patients arid their significant others, providing us with knowledge in improving rehabilitation care. Ethics and dissemination This study has been approved by the Medical Ethics Committee of the University Medical Center Utrecht (number 15-617/C). The results will be published in peer-reviewed journals and presented in local, national and international conferences.	[Hillebregt, Chantal F.; Cholten, Eline W. M.; Ketelaar, Marjolijn; Post, Marcel W. M.; Visser-Meily, Johanna M. A.] Univ Utrecht & De Hoogstr Rehabil, Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Post, Marcel W. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands		Visser-Meily, JMA (corresponding author), Univ Utrecht & De Hoogstr Rehabil, Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Ctr Excellence Rehabil Med, Utrecht, Netherlands.	j.m.a.visser-meily@umcUtrecht.nl	Post, Marcel/AAS-2502-2021	Hillebregt, Chantal/0000-0003-2959-7835; Ketelaar, Marjolijn/0000-0002-8324-518X; Scholten, Eline/0000-0003-3846-0419	ZonMwNetherlands Organization for Health Research and Development; Netherlands Organisation for Health Research and DevelopmentNetherlands Organization for Health Research and Development; Fonds Nuts Ohra and Revalidatiefonds [630000003]	This study is financially supported by ZonMw, the Netherlands Organisation for Health Research and Development, Fonds Nuts Ohra and Revalidatiefonds, grant number: 630000003.	Amtmann D, 2012, ARCH PHYS MED REHAB, V93, P1757, DOI 10.1016/j.apmr.2012.05.001; [Anonymous], 2015, CQ INDEX CVA; [Anonymous], 1989, ANN REV POPUL LAW, V16, P513; Asscher JJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-154; Aujoulat I, 2007, PATIENT EDUC COUNS, V66, P13, DOI 10.1016/j.pec.2006.09.008; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bamm EL, 2008, ARCH PHYS MED REHAB, V89, P1618, DOI 10.1016/j.apmr.2007.12.034; Bandura A, 2002, SOCIAL FDN THOUGHT A, P94; Bandura A., 1978, ADV BEHAV RES THER, V1, P139, DOI [10.1016/0146-6402(78)90002-4, DOI 10.1016/0146-6402(78)90002-4]; Barclay L, 2015, INT J REHABIL RES, V38, P1, DOI 10.1097/MRR.0000000000000085; Berendsen AJ, 2009, PATIENT EDUC COUNS, V77, P123, DOI 10.1016/j.pec.2009.01.011; Bloemen-Vrencken JHA, 2007, CLIN REHABIL, V21, P997, DOI 10.1177/0269215507079835; Bode C, 2008, PSYCHOL GEZONDH, V36, P81, DOI 10.1007/BF03077476; Boele FW, 2013, J NEURO-ONCOL, V111, P303, DOI 10.1007/s11060-012-1012-3; BOSSCHER RJ, 1997, NEDERLANDS TIJDSCHRI, V0052; Bosscher RJ, 1998, BEHAV RES THER, V36, P339, DOI 10.1016/S0005-7967(98)00025-4; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burford G., 1995, MANUAL COORDINATORS; Carpenter C, 2007, ARCH PHYS MED REHAB, V88, P427, DOI 10.1016/j.apmr.2006.12.043; Christens BD, 2012, AM J COMMUN PSYCHOL, V50, P114, DOI 10.1007/s10464-011-9483-5; Cijsouw A, 2017, SPINAL CORD, V55, P47, DOI 10.1038/sc.2016.80; Cohen L., 1988, STAT POWER ANAL BEHA; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; Creasy KR, 2015, REHABIL NURS, V40, P349, DOI 10.1002/rnj.188; Crisp R., 1989, AUST SOC WORK, V42, P39; de Jong G, 2011, INT J MENT HEALTH NU, V20, P63, DOI 10.1111/j.1447-0349.2010.00701.x; De Wit L, 2008, DISABIL REHABIL, V30, P1858, DOI 10.1080/09638280701708736; Deelman BG., 1981, SAN TEST AFASIE TEST; Efraimsson E, 2004, J CLIN NURS, V13, P562, DOI 10.1111/j.1365-2702.2004.00900.x; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Feldman HM, 1999, J DEV BEHAV PEDIATR, V20, P111, DOI 10.1097/00004703-199904000-00007; Ferguson E, 1999, BRIT J HEALTH PSYCH, V4, P97, DOI 10.1348/135910799168506; Fisher MI, 2010, REHABIL ONCOL, V28, P19, DOI 10.1097/01893697-201028030-00003; Frain MP, 2009, J REHABIL, V75, P27; French DP, 2014, ANN BEHAV MED, V48, P225, DOI 10.1007/s12160-014-9593-z; Fronek P, 2005, AUST SOC WORK, V58, P395, DOI DOI 10.1111/J.1447-0748.2005.00235.X; Fumagalli LP, 2015, HEALTH POLICY, V119, P384, DOI 10.1016/j.healthpol.2014.10.017; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Hudson P, 2009, PALLIATIVE MED, V23, P150, DOI 10.1177/0269216308099960; Huntsman L., 2006, FAMILY GROUP CHILD W; ISRAEL BA, 1994, HEALTH EDUC QUART, V21, P149, DOI 10.1177/109019819402100203; Jackson S, 1999, BRIT J SOC WORK, V29, P621, DOI 10.1093/bjsw/29.4.621; Joling KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042145; Joling KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030936; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; KEMPEN GIJM, 1995, SOC INDIC RES, V35, P303, DOI 10.1007/BF01079163; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Korpershoek C, 2011, J ADV NURS, V67, P1876, DOI 10.1111/j.1365-2648.2011.05659.x; Kovacs PJ, 2006, J SOC WORK END-LIFE, V2, P13, DOI 10.1300/J457v02n01_03; Kruithof WJ, 2015, CLIN REHABIL, V29, P1224, DOI 10.1177/0269215515570378; Loupis YM, 2013, J STROKE CEREBROVASC, V22, P883, DOI 10.1016/j.jstrokecerebrovasdis.2012.12.003; Lupton C, 1998, BRIT J SOC WORK, V28, P107; MacKean GL, 2005, HEALTH EXPECT, V8, P74, DOI 10.1111/j.1369-7625.2005.00319.x; Maluccio Anthony., 2000, CHILD WELFARE OUTCOM; McKevitt C, 2004, STROKE, V35, P1499, DOI 10.1161/01.STR.0000127532.64840.36; Merkel-Holguin L., 2004, J SOCIOLOGY SOCIAL W, V31, P155; Merkel-Holguin L, 2015, BRIT J SOC WORK, V45, P724, DOI 10.1093/bjsw/bcu092; Metze RN, 2016, THESIS; Metze RN, 2015, J AGING STUD, V34, P68, DOI 10.1016/j.jaging.2015.04.005; Metze RN, 2015, J AGING STUD, V34, P57, DOI 10.1016/j.jaging.2015.04.003; Monaghan J, 2005, CLIN REHABIL, V19, P194, DOI 10.1191/0269215505cr837oa; Moore GF, 2015, PROCESS EVALUATION C; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neuendorf K. A., 2017, CONTENT ANAL GUIDEBO; Nogales-Gonzalez C, 2015, AGING MENT HEALTH, V19, P1022, DOI 10.1080/13607863.2014.995593; Onrust SA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1062-2; OZER EM, 1990, J PERS SOC PSYCHOL, V58, P472, DOI 10.1037/0022-3514.58.3.472; Pennell J, 2000, CHILD WELFARE, V79, P131; Pennell J, 2010, CHILD YOUTH SERV REV, V32, P1012, DOI 10.1016/j.childyouth.2010.03.029; Peter C, 2014, ARCH PHYS MED REHAB, V95, P1662, DOI 10.1016/j.apmr.2014.04.012; Petticrew, 2008, DEV EVALUATING COMPL; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Post MW, 2012, ARCH PHYS MED REHAB, V93, P1832, DOI 10.1016/j.apmr.2012.03.025; Post MWM, 2007, CLIN REHABIL, V21, P1050, DOI 10.1177/0269215507079140; Post MWM, 2012, DISABIL REHABIL, V34, P478, DOI 10.3109/09638288.2011.608148; Post MWM, 2009, CLIN REHABIL, V23, P909, DOI 10.1177/0269215509341524; Post MWM, 2005, SPINAL CORD, V43, P311, DOI 10.1038/sj.sc.3101704; Post MWM, 2013, ARCH PHYS MED REHAB, V94, pe20; RAPPAPORT J, 1987, AM J COMMUN PSYCHOL, V15, P121, DOI 10.1007/BF00919275; Rauktis ME, 2013, CHILD YOUTH SERV REV, V35, P287, DOI 10.1016/j.childyouth.2012.11.001; Reed M, 2015, AUST SOC WORK, V68, P244, DOI 10.1080/0312407X.2014.913070; Rigby H, 2009, INT J STROKE, V4, P285, DOI 10.1111/j.1747-4949.2009.00289.x; RIGER S, 1993, AM J COMMUN PSYCHOL, V21, P279, DOI 10.1007/BF00941504; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Rommers GM, 2008, DISABIL REHABIL, V30, P1106, DOI 10.1080/09638280701478702; Rowlands J, 1995, Dev Pract, V5, P101, DOI 10.1080/0961452951000157074; Ryall NH, 2003, DISABIL REHABIL, V25, P833, DOI 10.1080/0963828021000056460; Saillard E.K., 2011, SYSTEMATIC VERSUS IN; Sales E, 2003, QUAL LIFE RES, V12, P33, DOI 10.1023/A:1023513218433; SANDERMAN R, 1991, PSYCHOL REP, V69, P1091, DOI 10.2466/pr0.1991.69.3f.1091; Sanderman R., 2012, METEN PERSOONLIJKHEI, V2nd; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Schreurs PJG., 1993, HANDLEIDING UTRECHTS; Schulenberg SE, 2011, J HAPPINESS STUD, V12, P861, DOI 10.1007/s10902-010-9231-9; Schulenberg SE, 2010, J HAPPINESS STUD, V11, P95, DOI 10.1007/s10902-008-9124-3; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schulz R, 2009, REHABIL PSYCHOL, V54, P1, DOI 10.1037/a0014932; Smit B, 1999, NETWERKEN MENSEN MET; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stewart AL, 1992, MEASURING FUNCTIONIN; Sundell K, 2004, CHILD ABUSE NEGLECT, V28, P267, DOI 10.1016/j.chiabu.2003.09.018; Teasell Robert W, 2003, Top Stroke Rehabil, V10, P29; Teerenstra S, 2012, STAT MED, V31, P2169, DOI 10.1002/sim.5352; van den Heuvel ETP, 2001, CLIN REHABIL, V15, P669, DOI 10.1191/0269215501cr446oa; van der Zee CH, 2014, ARCH PHYS MED REHAB, V95, P87, DOI 10.1016/j.apmr.2013.08.236; van der Zee CH, 2011, J REHABIL MED, V43, P1003, DOI 10.2340/16501977-0879; van der Zee CH, 2010, J REHABIL MED, V42, P752, DOI 10.2340/16501977-0589; van Eijk L M, 1994, Tijdschr Gerontol Geriatr, V25, P192; van Exel NJA, 2004, CLIN REHABIL, V18, P203, DOI 10.1191/0269215504cr723oa; van Koppenhagen CF, 2009, AM J PHYS MED REHAB, V88, P887, DOI 10.1097/PHM.0b013e3181b71afe; van Leeuwen CMC, 2012, DISABIL REHABIL, V34, P76, DOI 10.3109/09638288.2011.587089; van Mierlo ML, 2015, J PSYCHOSOM RES, V79, P137, DOI 10.1016/j.jpsychores.2015.05.007; Van Regenmortel T., 2008, ZWANGER EMPOWERMENT; Verhage F, 1964, INTELLIGENTIE LEEFTI; Vilans, 2015, TOOLK PERS ZORG; Visser-Meily A, 2006, DISABIL REHABIL, V28, P1557, DOI 10.1080/09638280600648215; Visser-Meily JMA, 2005, SCAND J CARING SCI, V19, P310, DOI 10.1111/j.1471-6712.2005.00355.x; Visser-Meily JMA, 2004, CLIN REHABIL, V18, P601, DOI 10.1191/0269215504cr776oa; Visser-Meily JMA, 2012, INVENTARISATIELIJST; Vrijhoef HJM, 2009, HEALTH EXPECT, V12, P417, DOI 10.1111/j.1369-7625.2009.00557.x; Wallerstein N., 2006, WHAT IS EVIDENCE EFF; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, P1793, DOI 10.1016/j.apmr.2004.04.024; Witteveen E, 2015, HEEL HET LEVEN; Woolrich Rachel A, 2006, Psychol Health Med, V11, P80, DOI 10.1080/13548500500294211; World Health Organization, 2007, INT CLASS FUNCT DIS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmerman MA, 1995, AM J COMMUN PSYCHOL, V23, P581, DOI 10.1007/BF02506983; Zimmerman MA, 1998, REHABIL PSYCHOL, V43, P3, DOI 10.1037/0090-5550.43.1.3	133	6	6	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	MAR	2018	8	3							e018883	10.1136/bmjopen-2017-018883			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH7YZ	WOS:000433881200072	29523560	Green Published, gold			2022-02-06	
J	Iguchi, N; Kosaka, J; Bertolini, J; May, CN; Lankadeva, YR; Bellomo, R				Iguchi, Naoya; Kosaka, Junko; Bertolini, Joseph; May, Clive N.; Lankadeva, Yugeesh R.; Bellomo, Rinaldo			Differential effects of isotonic and hypotonic 4% albumin solution on intracranial pressure and renal perfusion and function	CRITICAL CARE AND RESUSCITATION			English	Article							TRAUMATIC BRAIN-INJURY; FLUID RESUSCITATION; SALINE	Objectives: Albumin is used to resuscitate trauma patients but may increase intracranial pressure (ICP). Its effects on renal blood flow and function are unknown. Our aim was to examine the effects of hypertonic albumin on ICP and renal function, and if any effects are due to the hypotonicity of the solution containing albumin or to albumin itself. Design, setting and subjects: Cross-over, randomised controlled experimental study of six adult Merino ewes in the animal facility of a research institute. Method: Sheep were implanted with flow probes around the pulmonary and renal arteries and an ICP monitoring catheter in a lateral cerebral ventricle. Conscious sheep received normal saline, commercially available hypotonic 4% albumin solution (4% Albumex [278 mOsm/kg]) or a novel isotonic 4% albumin solution (288 mOsm/kg), with at least 48 hours between each intervention. Results: Commercial hypotonic albumin solution increased ICP (by 8.5 mmHg [SEM, 2.1 mmHg]; P < 0.01), but neither isotonic albumin solution nor saline significantly changed ICP. The increase in ICP with hypotonic albumin solution was associated with an increase in central venous pressure (CVP) (by 5.4 mmHg [SEM, 0.6 mmHg]; P < 0.001), but no significant changes in cardiac output or stroke volume. None of the infusions changed renal blood flow, plasma creatinine level, creatinine clearance or plasma or urinary electrolyte levels. Conclusion: Compared with saline or isotonic albumin solution, hypotonic albumin solution increased ICP and CVP, but did not alter arterial pressure, cardiac output renal blood flow or renal function. Our findings support the view that the tonicity of the albumin solution, rather than the albumin itself, is responsible for increasing ICP.	[Iguchi, Naoya; Kosaka, Junko; May, Clive N.; Lankadeva, Yugeesh R.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Bertolini, Joseph] CSL Behring Australia, Melbourne, Vic, Australia; [Bellomo, Rinaldo] Univ Melbourne, Sch Med, Melbourne, Vic, Australia		Iguchi, N (corresponding author), Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.	naoya.iguchi@florey.edu.au	Lankadeva, Yugeesh/R-9253-2019	Lankadeva, Yugeesh/0000-0002-3589-9111	Victorian Government through the Operational Infrastructure Scheme; CSL Behring (Australia); National Heart Foundation of AustraliaNational Heart Foundation of Australia	We received funding from the Victorian Government through the Operational Infrastructure Scheme, and from CSL Behring (Australia). Yugeesh Lankadeva was supported by a Postdoctoral Fellowship from the National Heart Foundation of Australia and Joseph Bertolini is employed by CSL. None of the other authors had any competing financial interests relevant to this study.	Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Langenberg C, 2006, KIDNEY INT, V69, P1996, DOI 10.1038/sj.ki.5000440; MOUW DR, 1974, LAB ANIM SCI, V24, P505; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Reinhart K, 2012, INTENS CARE MED, V38, P368, DOI 10.1007/s00134-012-2472-9; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274	8	6	6	3	6	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	MAR	2018	20	1					48	53					6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM5DL	WOS:000438150800007	29458321				2022-02-06	
J	King, JE; Pape, MM; Kodosky, PN				King, John E.; Pape, Marcy M.; Kodosky, Paula N.			Vestibular Test Patterns in the NICoE Intensive Outpatient Program Patient Population	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				BLAST INJURY; POSTTRAUMATIC DIZZINESS; HEAD-INJURY; CONSEQUENCES; CONCUSSION; VERTIGO; EAR	The National Intrepid Center of Excellence (NICoE), on the campus of Walter Reed National Military Medical Center, was developed to help improve the lives of active duty service members (SMs) with traumatic brain injury (TBI) and comorbid behavioral health (BH) conditions. During the NICoE intensive outpatient program, SM who have all been identified as having some degree of TBI, undergo extensive interdisciplinary evaluations, including comprehensive vestibular assessment. These SMs sometimes present with vestibular symptoms ranging from lightheadedness to vertigo associated with the dual TBI/BH diagnoses, and vestibular testing results reported elsewhere have varied among this population. The study's purpose was to collate the vestibular test results obtained from a sample of the NICoE patients to determine if specific tests have a tendency to be abnormal in these SMs. Results indicate that oculomotor tests, particularly pursuit and saccade, were most often abnormal. The vertical subtests of the pursuit and saccade tests were abnormal more frequently than the horizontal subtests, suggesting that the vertical subtests should be utilized when evaluating the TBI population. Overall, oculomotor tests of vertical pursuit and saccades, as well as tests of central vestibular function, appear useful for detecting neurologic changes in active duty SMs with chronic symptoms after TBI.	[King, John E.; Pape, Marcy M.; Kodosky, Paula N.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA		King, JE (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA.		King, John/AAQ-1425-2021				Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; [Anonymous], 2016, I PORT NOTC NEUR TES; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Barber H O, 1973, Adv Otorhinolaryngol, V19, P276; Best C, 2006, J NEUROL NEUROSUR PS, V77, P658, DOI 10.1136/jnnp.2005.072934; Cohen JT, 2002, ISRAEL MED ASSOC J, V4, P559; Defense and Veterans Brain Injury Center, DOD WORLDW NUMB TRAU; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Furman JM, 2015, ANN NY ACAD SCI, V1343, P90, DOI 10.1111/nyas.12645; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Jacobson GP, 1993, HDB BALANCE FUNCTION, P193; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Miltary Family, STAT PTSD MIL MEMB; O'Connor M, 2011, LIVING LIFE FULLY BR; Pape MM, 2016, AM PHYS THER ASS COM; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; SHUPAK A, 1993, ARCH OTOLARYNGOL, V119, P1362; Sylvia FR, 2001, MIL MED, V166, P918, DOI 10.1093/milmed/166.10.918; Szczupak M, 2016, HAND CLINIC, V137, P295, DOI 10.1016/B978-0-444-63437-5.00021-2; TOGLIA JU, 1970, ARCHIV OTOLARYNGOL, V92, P485; Van Campen L E, 1999, J Am Acad Audiol, V10, P467	25	6	6	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			237	244		10.1093/milmed/usx170			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GC0JM	WOS:000429463600035	29635576	hybrid			2022-02-06	
J	Malec, JF; Hammond, FM				Malec, James F.; Hammond, Flora M.			Minimal Clinically Important Difference for the Rasch Neuropsychiatric Inventory Irritability and Aggression Scale for Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Aggression; Behavior; Brain injuries; Rehabilitation		Objective: To determine the minimal clinically important difference (MCID) for a Rasch measure derived from the Irritability/Lability and Agitation/Aggression subscales of the Neuropsychiatric Inventory (NPI) the Rasch NPI Irritability and Aggression Scale for Traumatic Brain Injury (NPI-TBI-IA). Design: Distribution-based statistical methods were applied to retrospective data to determine candidates for the MCID. These candidates were evaluated by anchoring the NPI-TBI-IA to Global Impression of Change (GIC) ratings by participants, significant others, and a supervising physician. Setting: Postacute rehabilitation outpatient clinic. Participants: 274 cases with observer ratings; 232 cases with self-ratings by participants with moderate-severe TBI at least 6 months postinjury. Interventions: Not applicable. Main Outcome Measure: NPI-TBI-IA. Results: For observer ratings on the NPI-TBI-IA, anchored comparisons found an improvement of 0.5 SD was associated with at least minimal general improvement on GIC by a significant majority (69%-80%); 0.5 SD improvement on participant NPI-TBI-IA self-ratings was also associated with at least minimal improvement on the GIC by a substantial majority (77%-83%). The percentage indicating significant global improvement did not increase markedly on most ratings at higher levels of improvement on the NPI-TBI-IA. Conclusions: A 0.5 SD improvement on the NPI-TBI-IA indicates the MCID for both observer and participant ratings on this measure. Archives of Physical Medicine and Rehabilitation 2018;99:603-6 (C) 2017 by the American Congress of Rehabilitation Medicine	[Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, 355 W 16th St, Indianapolis, IN 46202 USA; [Malec, James F.; Hammond, Flora M.] Rehabil Hosp Indiana, 355 W 16th St, Indianapolis, IN 46202 USA; [Malec, James F.] Mayo Clin, Rochester, MN USA		Malec, JF (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 355 W 16th St, Indianapolis, IN 46202 USA.; Malec, JF (corresponding author), Rehabil Hosp Indiana, 355 W 16th St, Indianapolis, IN 46202 USA.	jfmalec@iupui.edu			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133A20016, H133A080035, 90DP0001-01-01]	The contents of this article were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant nos. H133A20016, H133A080035, 90DP0001-01-01). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hammond FM, CARBAMAZEPINE TREATM; Linacre J. M., 1997, RASCH MEASUREMENT T, V11, P580; Malec JF, 2017, J HEAD TRAUMA REHAB, V32, pE47, DOI 10.1097/HTR.0000000000000268; Malec JF, 2017, ARCH PHYS MED REHABI; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Turner D, 2010, J CLIN EPIDEMIOL, V63, P28, DOI 10.1016/j.jclinepi.2009.01.024; Wright A, 2012, J MAN MANIP THER, V20, P160, DOI 10.1179/2042618612Y.0000000001	12	6	6	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2018	99	3					603	606		10.1016/j.apmr.2017.06.038			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FZ7UL	WOS:000427809500022	28918102	Green Submitted			2022-02-06	
J	Meng, LN; Nguyen, CM; Patel, S; Mlynash, M; Caulfield, AF				Meng, Lina; Nguyen, Cherwyn M.; Patel, Samit; Mlynash, Michael; Caulfield, Anna Finley			Association between continuous peripheral i.v. infusion of 3% sodium chloride injection and phlebitis in adults	AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY			English	Article						adverse drug event; adverse drug reaction; hyperosmolar agents; hypertonic saline; osmotherapy; phlebitis	TRAUMATIC BRAIN-INJURY; CARE; PREVENTION; MANAGEMENT; CATHETERS	Purpose. One institution's experience with use of peripheral i.v. (PIV) catheters for prolonged infusions of 3% sodium chloride injection at rates up to 100 mL/hr is described. Methods. A prospective, observational, 13-month quality assurance project was conducted at an academic medical center to evaluate frequencies of patient and catheter phlebitis among adult inpatients who received both an infusion of 3% sodium chloride injection for a period of >= 4 hours through a dedicated PIV catheter and infusions of routine-care solutions (RCSs) through separate PIV catheters during the same hospital stay. Results. Sixty patients received PIV infusions through a total of 291 catheters during the study period. The majority of patients (78%) received infusions of 3% sodium chloride injection for intracranial hypertension, with 30% receiving such infusions in the intensive care unit. Phlebitis occurred in 28 patients (47%) during infusions of 3% sodium chloride and 26 patients (43%) during RCS infusions (p = 0.19). Catheter phlebitis occurred in 73 catheters (25%), with no significant difference in the frequencies of catheter phlebitis with infusion of 3% sodium chloride versus RCSs (30% [32 of 106 catheters]) versus 22% [41 of 185 catheters]), p = 0.16). Conclusion. Patient and catheter phlebitis rates were not significantly different with infusions of 3% sodium chloride injection versus RCSs, suggesting that an osmolarity cutoff value of 900 mOsm/L for peripheral infusions of hypertonic saline solutions may not be warranted.	[Meng, Lina; Nguyen, Cherwyn M.; Patel, Samit] Stanford Hlth Care, Stanford, CA 94304 USA; [Mlynash, Michael; Caulfield, Anna Finley] Stanford Hlth Care, Dept Neurol & Neurol Sci, Stanford, CA USA		Meng, LN (corresponding author), Stanford Hlth Care, Stanford, CA 94304 USA.	lmeng@stanfordhealthcare.org		Meng, Lina/0000-0002-6874-7798			Anderson ADG, 2003, BRIT J SURG, V90, P1048, DOI 10.1002/bjs.4328; [Anonymous], SOD CHLOR MON; Brown D, 2013, J FAM PRACTICE, V62, P200; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Infusion Nurses Society , 2011, J INFUS NURS, V34, pS65; Jones GM, 2017, AM J CRIT CARE, V26, P37, DOI 10.4037/ajcc2017439; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Losiniecki A, 2010, CURR TREAT OPTION NE, V12, P142, DOI 10.1007/s11940-010-0063-z; LUNDGREN A, 1993, J ADV NURS, V18, P963, DOI 10.1046/j.1365-2648.1993.18060963.x; Luu JL, 2011, PEDIATR EMERG CARE, V27, P1113, DOI 10.1097/PEC.0b013e31823aff59; MAKI DG, 1991, ANN INTERN MED, V114, P845, DOI 10.7326/0003-4819-114-10-845; Mirtallo J, 2004, JPEN-PARENTER ENTER, V28, pS39, DOI 10.1177/0148607104028006S39; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Perez C, 2015, NEUROLOGY S, V84; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Saini R, 2011, NURS MIDWIFERY RES J, V7, P22; Soifer NE, 1998, ARCH INTERN MED, V158, P473, DOI 10.1001/archinte.158.5.473; TIMMER JG, 1991, CLIN NUTR, V10, P71, DOI 10.1016/0261-5614(91)90090-Y; Tzamaloukas AH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005199; Uslusoy E, 2008, J AM ACAD NURSE PRAC, V20, P172, DOI 10.1111/j.1745-7599.2008.00305.x	21	6	6	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-2082	1535-2900		AM J HEALTH-SYST PH	Am. J. Health-Syst. Pharm.	MAR 1	2018	75	5					284	291		10.2146/ajhp161028			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FX3GF	WOS:000425958800007	29472509				2022-02-06	
J	Muslubas, IS; Karacorlu, M; Hocaoglu, M; Ersoz, MG; Arf, S				Muslubas, Isil Sayman; Karacorlu, Murat; Hocaoglu, Mumin; Ersoz, Mehmet Giray; Arf, Serra			Anatomical and functional outcomes following vitrectomy for dense vitreous hemorrhage related to Terson syndrome in children	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Pars plana vitrectomy; Pars plicata vitrectomy; Terson syndrome; Vitreous hemorrhage	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE	Our purpose was to assess anatomical and functional outcomes of vitrectomy in pediatric cases of Terson syndrome. A total of 11 eyes of seven children diagnosed with Terson syndrome secondary to traumatic brain injury and 17 eyes of 12 children diagnosed with Terson syndrome secondary to nontraumatic brain hemorrhage who had 20-gauge or 23-gauge pars plana or pars plicata vitrectomy were included in this retrospective study. The primary outcome was the change in visual acuity from the preoperative examination to postoperative final follow-up. Secondary outcomes were anatomic surgical success and postoperative complications. The mean time between diagnosis and surgery was 62 +/- 35 days (range, 30-150), and the average age at the time of the surgery was 4.5 +/- 6.4 years (range, 3 months to 17 years). The mean preoperative logarithm of the minimum angle of resolution (logMAR) (Snellen) best corrected visual acuity (BCVA) was 2.6 +/- 0.7 (20/7260) (n = 9) and in the remaining 19 eyes it was recorded as noncentral, unsteady, nonmaintained fixation. The mean follow-up period was 50 +/- 54 months (range, 12-192 months). At the last follow-up visit, the mean logMAR BCVA was 0.46 +/- 0.6 (20/60) (n = 19) and in eight eyes it was recorded as fix-and-follow. One eye developed a retinal detachment 14 months after the first operation, and one eye developed an epiretinal membrane after 2 years. Anatomical success was recorded in all patients at the final visit. In children with massive vitreous hemorrhage secondary to Terson syndrome, vitrectomy is an effective procedure and offers a rapid visual improvement. Earlier surgical treatment prevents amblyopia and blood-related potential complications.	[Muslubas, Isil Sayman; Karacorlu, Murat; Hocaoglu, Mumin; Ersoz, Mehmet Giray; Arf, Serra] Istanbul Retina Inst, Hakki Yeten Cad Unimed Ctr 19-7, TR-34349 Istanbul, Turkey		Karacorlu, M (corresponding author), Istanbul Retina Inst, Hakki Yeten Cad Unimed Ctr 19-7, TR-34349 Istanbul, Turkey.	mkaracorlu@gmail.com	Hocaoglu, Mumin/B-5999-2017; Ersoz, Mehmet Giray/B-4195-2019; muslubas, isil sayman/B-3948-2019	Ersoz, Mehmet Giray/0000-0002-2336-0696; muslubas, isil sayman/0000-0002-5464-8713			Al-Jarallah A, 2000, J CHILD NEUROL, V15, P284, DOI 10.1177/088307380001500503; Capone A, 2003, RETINA-J RET VIT DIS, V23, P792, DOI 10.1097/00006982-200312000-00008; Czorlich P, 2015, NEUROSURG REV, V38, P129, DOI 10.1007/s10143-014-0564-4; Garweg JG, 2009, ACTA OPHTHALMOL, V87, P222, DOI 10.1111/j.1755-3768.2008.01200.x; Gnanaraj L, 2000, RETINA-J RET VIT DIS, V20, P374, DOI 10.1097/00006982-200007000-00009; Ko F, 2010, OPHTHALMOLOGY, V117, P1423, DOI 10.1016/j.ophtha.2009.11.028; Kuhn F, 1998, OPHTHALMOLOGY, V105, P472, DOI 10.1016/S0161-6420(98)93030-5; Maguire SA, 2013, EYE, V27, P28, DOI 10.1038/eye.2012.213; MANSCHOT WA, 1954, AM J OPHTHALMOL, V38, P501, DOI 10.1016/0002-9394(54)90700-X; Narayanan R, 2017, OPHTHALMOLOGY, V124, P118, DOI 10.1016/j.ophtha.2016.09.009; Rishi P, 2013, J AAPOS, V17, P64, DOI 10.1016/j.jaapos.2012.10.013; Schloff S, 2002, OPHTHALMOLOGY, V109, P1472, DOI 10.1016/S0161-6420(02)01086-2; SCHULTZ PN, 1991, OPHTHALMOLOGY, V98, P1814; Spirn MJ, 2006, OPHTHALMOLOGY, V113, P848, DOI 10.1016/j.ophtha.2005.12.027; Srinivasan S, 2006, EYE, V20, P1099, DOI 10.1038/sj.eye.6702134; Sudhalkar A, 2013, AM J OPHTHALMOL, V156, P1267, DOI 10.1016/j.ajo.2013.05.042; Terson A, 1900, CLIN OPHTHALMOL, V6, P309; VELIKAY M, 1994, OPHTHALMOLOGY, V101, P35; WEINGEIST TA, 1986, OPHTHALMOLOGY, V93, P1435	19	6	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	MAR	2018	256	3					503	510		10.1007/s00417-017-3887-3			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	FX4QC	WOS:000426062100009	29288413				2022-02-06	
J	Regasa, LE; Kaplan, DA; Martin, EMM; Langbein, J; Johnson, F; Chase, C				Regasa, Lemma Ebssa; Kaplan, Dorothy A.; Martin, Elisabeth M. Moy; Langbein, Jean; Johnson, Felicia; Chase, Carla			Mortality Following Hospital Admission for US Active Duty Service Members Diagnosed With Penetrating Traumatic Brain Injury, 2004-2014	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						admission; fatality rate; military; mortality; penetrating; survival; traumatic brain injury	GUNSHOT WOUNDS; COMBAT WOUNDS; HEAD-INJURY; PREDICTORS; CIVILIANS; MILITARY; OUTCOMES; TBI	Objective: To examine mortality among active duty US military service members (SMs) with the diagnosis of penetrating traumatic brain injury (PTBI) and a hospital admission between 2004 and 2014. Design: Data on SMs with PTBI and an admission to a military or civilian hospital were obtained from the 2004 to 2014 Military Health System data repository. After applying exclusion criteria, data on 1226 SMs were analyzed. Main Measures: The number of observed deaths per 100 identified patients with PTBI and time to death from admission were used as main measures. Results: Approximately 25% of the 1226 patients with PTBI included in this study died following admission, with 44.6% of the all deaths occurring within a day following hospital admission and 75% occurring within the first week. Severe comorbid conditions and intentionally self-inflicted injuries are associated with higher mortality rate. SMs' gender, age, year of hospital admission, and service were significantly associated with likelihood of death following PTBI hospitalization. Males had a higher likelihood of dying following hospital admission compared with females (odds ratio = 2.7, confidence interval = 1.03-7.9). SMs in the 35- to 44-year-old and 45- to 64-year-old groups had up to a 2.6 times higher odds of death following their admission compared with the 25- to 34-year-old group. Age, admission year, service, and rank were significantly associated with SMs' time to death from hospitalization. Patients between the ages of 45 and 64 years were significantly more likely to die earlier than other age groups. Furthermore, cases in the Navy Afloat group had a higher fatality rate and were more likely to die earlier than patients in other services. PTBI comorbid conditions and injury type did not significantly affect time to death. Conclusion: This study quantifies case fatality rate among hospitalized US SMs with the diagnosis of PTBI. We report a 23.1% crude case fatality rate among the current cohort. Early intensive care for these patients may be the key to improving survival rates.	[Regasa, Lemma Ebssa; Kaplan, Dorothy A.; Martin, Elisabeth M. Moy; Langbein, Jean; Johnson, Felicia; Chase, Carla] Def & Vet Brain Injury Ctr, 1335 East West Hwy,Ste 600, Silver Spring, MD 20910 USA; [Regasa, Lemma Ebssa; Johnson, Felicia] Gen Dynam Informat Technol, Fairfax, VA USA; [Kaplan, Dorothy A.] Salient CRGT, Fairfax, VA USA; [Langbein, Jean] Brandon Green Management Grp, Silver Spring, MD USA; [Chase, Carla] US PHS, Washington, DC 20201 USA		Regasa, LE (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Hwy,Ste 600, Silver Spring, MD 20910 USA.	lemma.e.regasa.ctr@mail.mil			Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	Supported by Defense and Veterans Brain Injury Center.	Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; AFHSB, TRAUMATIC BRAIN INJU; Amoroso PJ, 2000, AM J PREV MED, V18, P164, DOI 10.1016/S0749-3797(99)00176-2; [Anonymous], DOD WORLDW NUMB TBI; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Center for Disease Control and Prevention, 2012, PRINC EP PUBL HLTH P, P511; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Ghorbani P, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-18; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Marshall SA, 2012, TRAUMATIC BRAIN INJU; ODASD, 2014, 2014 DEM PROF MIL CO; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; SAS, 2016, SAS STAT 14 2 US GUI; Selvin S, 2008, SURVIVAL ANAL EPIDEM; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; Van Wyck D.W., 2015, J NEUROL NEUROPHYSIO, V6, P336; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179; Zafonte RD, 2001, NEUROL RES, V23, P219, DOI 10.1179/016164101101198370	25	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					123	132		10.1097/HTR.0000000000000380			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200013	29517592				2022-02-06	
J	Robinson, JS; Collins, RL; Miller, BI; Pacheco, VH; Wisdom, NM				Robinson, Jordan S.; Collins, Robert L.; Miller, Brian I.; Pacheco, Vitor H.; Wisdom, Nicholas M.			The Severe Impairment Profile: A Conceptual Shift	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Dementia; Malingering/Symptom Validity Testing; Assessment; Elderly/geriatrics/aging; Learning and memory	SYMPTOM VALIDITY TEST; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; ALZHEIMERS-DISEASE; DEMENTIA PROFILE; HIGH SPECIFICITY; RESPONSE BIAS; VERBAL MEMORY; TESTS	Objective: The current study sought to evaluate and replicate the severe impairment profile (SIP) of the Word Memory Test (WMT) in patients referred for dementia evaluations. Method: The sample consisted of 125 patients referred for a neuropsychological evaluation at a large Veterans Affairs Medical Center. Patients were assigned a Clinical Dementia Rating (CDR) by blind raters, and were classified according to their performance on performance validity testing. Subsequent chart reviews were conducted to help in more accurately determining the presence of severe memory impairment likely due to an underlying dementing process versus poor effort/task engagement. Results: In our sample, 51% of patients failed easy WMT subtests and 93% of these patients obtained the SIP. The rates of failure on these easy subtests generally coincided with both more severely impaired CDR ratings, as well as more impaired delayed memory composite scores. Upon chart review, it was determined that there were likely a significant portion of classification errors using the SIP, with a positive posttest probability of impairment based on having the SIP being 65% as opposed to 28% for a negative result. Conclusions: Our findings suggest that the SIP does not appear to function effectively in a mixed dementia sample where there is increased potential for secondary gain. Additional concern is expressed regarding the overall likelihood of obtaining the SIP and subsequent inferential decisions related to obtaining an SIP. Future research should examine more optimal cut scores or alternative methods for more accurately classifying patients in different clinical contexts and patterns of impairment.	[Robinson, Jordan S.; Collins, Robert L.; Miller, Brian I.; Pacheco, Vitor H.; Wisdom, Nicholas M.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Robinson, Jordan S.; Collins, Robert L.; Miller, Brian I.; Pacheco, Vitor H.; Wisdom, Nicholas M.] Baylor Coll Med, Houston, TX 77030 USA; [Robinson, Jordan S.] VA Puget Sound Healthcare Syst, Lakewood, WA USA		Collins, RL (corresponding author), Michael E DeBakey VAMC, Neurol Care Line, Houston, TX 77030 USA.	Robert.Collins3@va.gov					Aggleton JP, 2006, TRENDS COGN SCI, V10, P455, DOI 10.1016/j.tics.2006.08.003; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Benedict, 2001, HOPKINS VERBAL LEARN; Bush S. S., 2012, NEUROPSYCHOLOGICAL P, P27; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Clark LR, 2012, CLIN NEUROPSYCHOL, V26, P1201, DOI 10.1080/13854046.2012.728626; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Delis D.C., 2000, CALIFORNIA VERBAL LE; DUNNETT CW, 1980, J AM STAT ASSOC, V75, P796, DOI 10.2307/2287161; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2004, MANUAL MED SYMPTOM V; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Kiewel NA, 2012, CLIN NEUROPSYCHOL, V26, P965, DOI 10.1080/13854046.2012.694478; Koen JD, 2014, NEUROPSYCHOL REV, V24, P332, DOI 10.1007/s11065-014-9266-5; Morris JC, 1997, NEUROLOGY, V48, P1508, DOI 10.1212/WNL.48.6.1508; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Randolph C., 1998, REPEATABLE BATTERY A; Richardson W. S., 2000, EVIDENCE BASED MED P, V2nd; Rienstra A, 2013, ARCH CLIN NEUROPSYCH, V28, P463, DOI 10.1093/arclin/act026; Rienstra A, 2013, J CLIN EXP NEUROPSYC, V35, P59, DOI 10.1080/13803395.2012.751361; Saling MM, 2009, BRAIN, V132, P570, DOI 10.1093/brain/awp012; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Wechsler D., 2009, WECHSLER MEMORY SCAL; Whearty KM, 2015, J PSYCHIATR RES, V68, P397, DOI 10.1016/j.jpsychires.2015.04.018; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	38	6	6	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2018	33	2					238	246		10.1093/arclin/acx069			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY4QD	WOS:000426808700010	29471393	hybrid			2022-02-06	
J	Short, SS; Fenton, SJ; Scaife, ER; Bucher, BT				Short, Scott S.; Fenton, Stephen J.; Scaife, Eric R.; Bucher, Brian T.			Helmet under-utilization by children during equestrian events is associated with increased traumatic brain injury	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric; Equestrian; Helmet; Traumatic brain injury	HEAD	Purpose: Awareness of equestrian related injury remains limited. Studies evaluating children after equestrian injury report under-utilization of safety equipment and rates of operative intervention as high as 33%. Methods: We hypothesized that helmets are underutilized during equestrian activity and lack of use is associated with increased traumatic brain injury. We queried the trauma database of a level one pediatric trauma center for all cases of equestrian and rodeo related injury from 2005 to 2015. Analysis was conducted using SAS 9.4. Results: Of 312 children identified, 142 were assessed for use of a helmet. Only 28 children (19.7%) had documented use of a helmet. Most injuries occurred while riding a horse (83%) or bull (13%) with traumatic brain injury being the most common injury (51%). Helmet use was associated with decreased ISS (7.1 vs. 11.3, p < 0.01), TBI (32.4% vs. 55.3%, p = 0.03), and ICU admission (10.7% vs. 29%, p = 0.05). Multivariable analysis reveals lack of helmet use to be an independent predictor of TBI (OR 2.5, 95% CI 1.1-6.3). Conclusion: Helmets are underutilized by children during equestrian related activity. Increased awareness of TBI and education encouraging helmet use may decrease morbidity associated with equestrian activities. (C) 2017 Elsevier Inc. All rights reserved.	[Short, Scott S.; Fenton, Stephen J.; Scaife, Eric R.; Bucher, Brian T.] Univ Utah, Sch Med, Dept Surg, Div Pediat Surg, 100 N Mario Ceppechi Dr,Suite 3800, Salt Lake City, UT 84113 USA		Short, SS (corresponding author), 100 N Mario Cappechi Dr,Suite 3800, Salt Lake City, UT 84132 USA.	Scott.Short@imail2.org; Stephen.Fenton@imail2.org; Eric.Scaife@imail2.org; Brian.Bucher@imail2.org					Bachynski KE, 2016, NEW ENGL J MED, V374, P405, DOI 10.1056/NEJMp1513993; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; BIXBYHAMMETT DM, 1992, PEDIATRICS, V89, P1173; BOND GR, 1995, PEDIATRICS, V95, P487; Cuenca AG, 2009, J PEDIATR SURG, V44, P148, DOI 10.1016/j.jpedsurg.2008.10.025; Jagodzinski Tanya, 2005, WMJ, V104, P50; Ji M, 2006, ACCIDENT ANAL PREV, V38, P128, DOI 10.1016/j.aap.2005.08.002; Kuhl HN, 2014, SPORTS HEALTH, V6, P136, DOI 10.1177/1941738113508073; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Temes RT, 1997, J TRAUMA, V43, P492, DOI 10.1097/00005373-199709000-00017; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612; Zuckerman SL, 2015, WORLD NEUROSURG, V83, P1098, DOI 10.1016/j.wneu.2014.12.030	12	6	6	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAR	2018	53	3					545	547		10.1016/j.jpedsurg.2017.03.043			3	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	FZ4SA	WOS:000427580900030	28365105				2022-02-06	
J	Stewart-Willis, JJ; Heyanka, D; Proctor-Weber, Z; England, H; Bruhns, M				Stewart-Willis, Jada J.; Heyanka, Daniel; Proctor-Weber, Zoe; England, Heather; Bruhns, Maya			Premorbid IQ Predicts Postconcussive Symptoms in OEF/OIF/OND Veterans with mTBI	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Premorbid IQ; mTBI; Postconcussive syndrome; PTSD; Depression	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; SLEEP QUALITY; COGNITIVE COMPLAINTS; TASK-FORCE; MILD TBI; HEALTH; CONCUSSION; OUTCOMES	Objective: Extant literature has demonstrated that symptoms of postconcussive syndrome (PCS) persist well beyond the expected 3-month post-injury recovery period in a minority of individuals with mild traumatic brain injury (mTBI). Suboptimal performance on validity measures and pre- and post-injury psychosocial stressors - rather than actual mTBI or current cognitive functioning - have been identified as predictors of chronic PCS. Whether premorbid IQ has any influence on chronic PCS has been understudied, in the context of established psychogenic etiologies. Method: The sample included 31 veterans, who underwent mTBI neuropsychological evaluations six or more months post-injury in a VA outpatient neuropsychology clinic. A two-step multiple linear regression was conducted to examine the effects on the outcome variable, PCS (Neurobehavioral Symptom Inventory), of the following predictors: cognitive functioning (Repeatable Battery for the Assessment of Neuropsychological Status; Attention, Immediate Memory, and Delayed Memory Indices), performance validity, depression (Beck Depression Inventory-Second Edition), posttraumatic stress disorder (PTSD Checklist, Civilian Version), quality of sleep (Pittsburgh Sleep Quality Index), pain (Brief Pain Inventory), education, and Premorbid IQ (Wechsler Test of Adult Reading). Results: The overall regression model containing all nine predictor variables was statistically significant. Depression (p < .05) and premorbid IQ (p < .05) were the most salient predictors of chronic PCS; in that lower premorbid IQ and greater endorsed symptoms of depression were associated with higher PCS scores. In Step 2 of the multiple linear regression, the WTAR explained an additional 6.7% of the variance in PCS after controlling for psychosocial stressors and current cognitive ability. Conclusion: The findings support premorbid IQ as a unique and relevant predictor of chronic PCS, with significance variance accounted for beyond education, cognitive functioning, and psychosocial variables. Given the predictive relationship between premorbid IQ and PCS, adapting postconcussive interventions to meet the specific needs of individuals with varying levels of intellect may be important in minimizing ongoing symptomatology.	[Stewart-Willis, Jada J.; Heyanka, Daniel; Proctor-Weber, Zoe; England, Heather] Bay Pines VA Hlth Care Syst, CW Bill Young VA Med Ctr, Neuropsychol Serv, Bay Pines, FL 33744 USA; [Bruhns, Maya] Ctr Head Injuries Edison, JFK Johnson Rehabil Inst, Rehabil Serv, Edison, NJ 08820 USA		Stewart-Willis, JJ (corresponding author), Bay Pines VA Hlth Care Syst, CW Bill Young VA Healthcare Syst, 10,000 Bay Pines Blvd 116B, Bay Pines, FL 33744 USA.	Jada.Stewart@gmail.com					[Anonymous], 2010, IBM SPSS STAT WIND V; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Boone K.B., 2007, ASSESSMENT FEIGNED C; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CLEELAND CS, 1991, EFFECT CANC QUALITY; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Griffin SL, 2002, ARCH CLIN NEUROPSYCH, V17, P497, DOI 10.1016/S0887-6177(01)00136-6; HAAGA DAF, 1991, BEHAV RES THER, V29, P277, DOI 10.1016/0005-7967(91)90118-M; Hanson K. L., 2016, J CLIN EXPT NEUROPSY, V19, P1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P697, DOI 10.1007/978-0-387-76978-3_22; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Larson E, 2013, REHABIL PSYCHOL, V58, P245, DOI 10.1037/a0032953; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; *PSYCH CORP, 2001, WECHSL TEST AD READ; Rabinowitz A. R., 2013, NEUROPSYCHOLOGY, V27, P81, DOI [10.1037/a003-3023, DOI 10.1037/A003-3023]; Randolph C., 1998, REPEATABLE BATTERY A; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Weathers F. W., 1994, PCL C FOR DSM 4; Wilmoth JM, 2010, J GERONTOL B-PSYCHOL, V65, P744, DOI 10.1093/geronb/gbq072; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008	60	6	6	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2018	33	2					206	215		10.1093/arclin/acx053			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FY4QD	WOS:000426808700007	28595276	hybrid			2022-02-06	
J	Tornberg, A; Jacobsson, L				Tornberg, Anna; Jacobsson, Lars			Care and consequences of traumatic brain injury in Neolithic Sweden: A case study of ante mortem skull trauma and brain injury addressed through the bioarchaeology of care	INTERNATIONAL JOURNAL OF OSTEOARCHAEOLOGY			English	Article						Battle Axe Culture; bioarchaeology of care; interpersonal violence; Neolithic; skull trauma; transition analysis; traumatic brain injury	ISOTOPES; NITROGEN; COLLAGEN; VIOLENCE; DIET	A number of papers have provided insight into frequencies of violence-related trauma, especially skull trauma, in Northern European skeletal assemblages dating to the Neolithic and Bronze Age. Although the cases are often well described, they lack further discussion about the consequences of skull trauma for the injured individual and the implications for the surrounding society, especially considering severe skull trauma leading to traumatic brain injuries. In this paper, we address questions of trauma and care for one individual associated with the Swedish-Norwegian Battle Axe Culture who suffered from 2 severe ante mortem skull traumas probably leading to brain injuries. These questions are addressed using the Web-based application and analytic tool Index of Care. We found that daily care, both short term with basic needs such as nutrition and grooming and long term with cognitive impairments, was available in the Neolithic society. Considering the frequent number of ante mortem skull trauma in the Neolithic and Bronze Age skeletal assemblages, traumatic brain injury was probably a common phenomenon. We argue that the care provided was a necessity for survival and maintenance of a socially sustainable society.	[Tornberg, Anna] Lund Univ, Dept Archaeol & Ancient Hist, Box 192, S-22100 Lund, Sweden; [Jacobsson, Lars] Kalix Hosp, Med Rehabil Sect, Dept Gen Med, Sunderby Hosp, Lulea, Sweden; [Jacobsson, Lars] Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden; [Jacobsson, Lars] Lund Univ, Dept Hlth Sci, Lund, Sweden		Tornberg, A (corresponding author), Lund Univ, Dept Archaeol & Ancient Hist, Box 192, S-22100 Lund, Sweden.	anna.tornberg@ark.lu.se	Tornberg, Anna/AAM-4215-2020	Tornberg, Anna/0000-0002-3323-8512	Ebbe Kock Foundation [EK20150038]	Ebbe Kock Foundation, Grant/Award Number: EK20150038	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Ambrose S., 1993, PREHISTORIC HUMAN BO, P1; Andersson M., 2003, ACTA ARCHAEOLOGICAL, V8; Andrushko VA, 2008, AM J PHYS ANTHROPOL, V137, P4, DOI 10.1002/ajpa.20836; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Bergqvist J., 2013, LAKARE LAKANDE LAKEK; Boldsen J., 2002, PALEODEMOGRAPHY AGE; Brink K., 2009, PALISSADERNAS TID ST; Brink K., 2010, ARKEOLOGISKA FORHIST; Buikstra JE, 1994, STAND DAT COLL HUM S; Case T., 1995, ANAL SCALPING CASES; Damm C., 1991, J DANISH ARCHAEOL, V10, P199, DOI DOI 10.1080/0108464X; Eriksson G, 2013, J ANTHROPOL ARCHAEOL, V32, P288, DOI 10.1016/j.jaa.2012.01.002; Fibiger L, 2013, AM J PHYS ANTHROPOL, V150, P190, DOI 10.1002/ajpa.22192; Fokkens H., 1998, UNDERSTANDING NEOLIT; Fornander E., 2013, J NORD ARCHAEOL SCI, V18, P13; Furholt M., 2014, P PREHIST SOC, V80, DOI [10.1017/ppr.2013.20, DOI 10.1017/PPR.2013.20]; Fyllingen H., 2003, NORWEGIAN ARCHAEOLOG, V36, P1; Gibson S, 1999, CARIES RES, V33, P101, DOI 10.1159/000016503; Griffen J., 2014, HDB NEUROPSYCHOLOGY, P25; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Harrod RP, 2012, BIOARCHAEOLOGY VIOLE; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jantzen D, 2011, ANTIQUITY, V85, P417, DOI 10.1017/S0003598X00067843; Jim S, 2004, GEOCHIM COSMOCHIM AC, V68, P61, DOI 10.1016/S0016-7037(03)00216-3; Jolly S., 2017, NEW DEV BIOARCHAEOLO; Judd M. A., 2011, COMPANION PALEOPATHO; Kochanek P. M., 2007, BRAIN INJURY MED PRI; Kolb B., 2009, FUNDAMENTALS HUMAN N; Kristiansen, 1989, J DANISH ARCHAEOLOGY, V8, P211, DOI DOI 10.1080/; Kristiansen K, 2017, ANTIQUITY, V91, P334, DOI 10.15184/aqy.2017.17; Larsson L., 1992, ARCHAEOLOGY CULTURAL, P91; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Luria A, 1992, APE PRIMITIVE MAN CH; Luria A.R., 1973, WORKING BRAIN INTRO; Malmer M., 1986, STRIDSOKSETID SYDSKA; Malmer M. P., 1962, ACTA ARCHAEOLOGICA L, V2; Malmer M. P., 1989, REPORT SERIES, V36, P7; Martin R, 1957, SYSTEMATISCHER DARST; Miller B.L., 2007, HUMAN FRONTAL LOBES, V2nd; Milner GR, 2015, INT J PALEOPATHOL, V9, P59, DOI 10.1016/j.ijpp.2015.02.002; Milner GR, 2012, AM J PHYS ANTHROPOL, V148, P98, DOI 10.1002/ajpa.22047; Nerlich A., 2003, TREPANATION HIST DIS; Nowak J., 2002, THESIS; O'Connell TC, 2012, AM J PHYS ANTHROPOL, V149, P426, DOI 10.1002/ajpa.22140; Olausson D., 2014, LANDSCAPES HIST SOC; Olausson D., 2015, NEOLITHIC DIVERSITIE; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Rankin K., 2007, HUMAN FRONTAL LOBES; Reimer P, 2015, ENGLISH HERITAGE RES, V5; Roberts C., 2011, SOCIAL BIOARCHAEOLOG; Roebuck-Spencer T, 2014, HDB NEUROPSYCHOLOGY; Rosenberg N, 2007, J SHOULDER ELB SURG, V16, P510, DOI 10.1016/j.jse.2006.12.002; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schwarcz H., 2002, BIOGEOCHEMICAL APPRO; Sjogren K.-G, 2013, COUNTERPOINT ESSAYS; Sjovold T., 1990, HUM EVOL, V5, P431, DOI DOI 10.1007/BF02435593; Stuss D. T., 2007, HUMAN FRONTAL LOBES; Symes S. A., 2014, COMPANION FORENSIC A; Tilley L, 2015, BIOARCHAEOL SOC THEO, P1, DOI 10.1007/978-3-319-18860-7; Tilley L, 2014, INT J PALEOPATHOL, V6, P5, DOI 10.1016/j.ijpp.2014.01.003; Tilley L, 2011, INT J PALEOPATHOL, V1, P35, DOI 10.1016/j.ijpp.2011.02.003; Toomela A., 2003, CULTURAL GUIDANCE DE; Tornberg A, 2018, J ARCHAEOL SCI-REP, V17, P58, DOI 10.1016/j.jasrep.2017.10.031; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; VANDERMERWE NJ, 1982, AM SCI, V70, P596; White T. D., 2012, HUMAN OSTEOLOGY, V3rd; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; [No title captured]	74	6	6	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1047-482X	1099-1212		INT J OSTEOARCHAEOL	Int. J. Osteoarchaeol.	MAR-APR	2018	28	2					188	198		10.1002/oa.2646			11	Anthropology; Archaeology	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Anthropology; Archaeology	GC9MH	WOS:000430121200011					2022-02-06	
J	Todd, R; Bhalerao, S; Vu, MT; Soklaridis, S; Cusimano, MD				Todd, Ryan; Bhalerao, Shree; Vu, Michael T.; Soklaridis, Sophie; Cusimano, Michael D.			Understanding the psychiatric effects of concussion on constructed identity in hockey players: Implications for health professionals	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; BIOGRAPHICAL DISRUPTION; LIVED EXPERIENCE; LEAGUE PLAYERS; ICE HOCKEY; DEPRESSION; RECOVERY; CHILDREN; SUICIDE	Objective The following study was undertaken to investigate the effect of concussion and psychiatric illness on athletes and their caregivers. Methods Semi-structured interviews with 20 ice hockey stakeholders (17 men and 3 women) including minor and professional players, coaches, parents, and physicians were conducted over two years (2012-2014). These interviews were analyzed using grounded theory. Results From this analysis, a common biographical theme emerged whereby the subject's identity as a hockey player, constructed early in life over many years, was disrupted by concussion. Furthermore, some players underwent a biographical deconstruction when they experienced post-concussive mental illness, which was amplified by isolation, stigma from peers, and lack of a clear life trajectory. Many players obtained support from family and peers and were able to recover, as evidenced by the biographical reconstruction of their identity posthockey concussion. Conclusions and implications for practice Understanding the process of biographical deconstruction and reconstruction has significant psychosocial treatment implications for both healthcare professionals and caregivers of this population. Specifically, the authors suggest that interpersonal psychotherapy (IPT) that focuses on role transitions may create opportunities to facilitate the process of biographical reconstruction and life transition.	[Todd, Ryan] Univ Calgary, Dept Psychiat, Calgary, AB, Canada; [Bhalerao, Shree] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Bhalerao, Shree] St Michaels Hosp, Med Psychiat, Toronto, ON, Canada; [Vu, Michael T.] St Michaels Hosp, Toronto, ON, Canada; [Soklaridis, Sophie] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Soklaridis, Sophie] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Surg Educ & Publ Hlth, Toronto, ON, Canada; [Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Toronto, ON, Canada		Todd, R (corresponding author), Univ Calgary, Dept Psychiat, Calgary, AB, Canada.	ryan.todd@albertahealthservices.ca	Cusimano, Michael/X-4059-2019; Soklaridis, Sophie/ABG-2223-2020	Soklaridis, Sophie/0000-0001-5119-8473; Vu, Michael/0000-0001-7875-8901	Physicians' Services Incorporated (PSI) Foundation - Resident Research Grant	The authors would like to acknowledge the support of the Physicians' Services Incorporated (PSI) Foundation - Resident Research Grant in funding this research. Further information can be found at http://www.psifoundation.org/	Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Block CK, 2013, BRAIN INJURY, V27, P775, DOI 10.3109/02699052.2013.775487; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Bourke A, 2003, J SPORT SOC ISSUES, V27, P399, DOI 10.1177/0193732503255478; Brock S.C., 1994, QUAL HEALTH RES, V4, P411, DOI [DOI 10.1177/104973239400400405, 10.1177/104973239400400405]; Burns GN, 2012, PERS INDIV DIFFER, V52, P280, DOI 10.1016/j.paid.2011.10.020; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Busch R, 1998, NEUROPSYCHOL REV, V8, P950; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Carr, 1986, TIME NARRATIVE HIST; Charmaz K., 2014, BROKERAGE CLOSURE IN; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Epstein RS, 1994, NEUROPSYCHIATRY TRAU; Faircloth CA, 2004, SOCIOL HEALTH ILL, V26, P242, DOI 10.1111/j.1467-9566.2004.00388.x; Finkbeiner NW, 2016, CANADIAN J PSYCHIAT, V61; Fleming J, 2012, SCAND J OCCUP THER, V19, P184, DOI 10.3109/11038128.2011.611531; Fralick M, 2016, CANADIAN MED ASS J; Frank Ellen, 2014, Am J Psychother, V68, P385; Gee CJ, 2010, AGGRESSION COMPETITI; Gordon S., 2012, NEW SPORT EXERCISE P, P567; Gould D, 1997, SPORT PSYCHOL, V11, P361, DOI 10.1123/tsp.11.4.361; Green G, 2007, SOC SCI MED, V65, P524, DOI 10.1016/j.socscimed.2007.03.007; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hunt S., MASTER STATUS; Johnson TS, 2009, W J BLACK STUDIES, V33, P98; Klerman GL., 1984, INTERPERSONAL PSYCHO; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Leamy M, 2011, BRIT J PSYCHIAT, V199, P445, DOI 10.1192/bjp.bp.110.083733; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Malagon-Maldonado G, 2014, HERD-HEALTH ENV RES, V7, P120, DOI 10.1177/193758671400700411; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Markowitz John C, 2004, World Psychiatry, V3, P136; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2016, CAN J PSYCHIAT, V61, P257, DOI 10.1177/0706743716644952; Messner M.A., 2007, OUT PLAY CRITICAL ES; Miller MD, 2007, INT J GERIATR PSYCH, V22, P101, DOI 10.1002/gps.1699; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morse J., 2004, SAGE ENCY SOCIAL SCI, P1123, DOI DOI 10.4135/9781412950589; Novotna G, 2013, DRUG-EDUC PREV POLIC, V20, P140, DOI 10.3109/09687637.2012.714015; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Purposive sampling, SAGE DICT SOCIAL RES; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Soklaridis S, 2011, DISABIL REHABIL, V33, P2372, DOI 10.3109/09638288.2011.573056; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Strauss A., 1990, BASICS QUALITATIVE R; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; WIDMEYER WN, 1984, J PSYCHOL, V117, P77, DOI 10.1080/00223980.1984.9923661; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	58	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2018	13	2							e0192125	10.1371/journal.pone.0192125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FW8RO	WOS:000425604300029	29466377	Green Published, Green Submitted, gold			2022-02-06	
J	Belousov, AB; Nishimune, H; Denisova, JV; Fontes, JD				Belousov, Andrei B.; Nishimune, Hiroshi; Denisova, Janna V.; Fontes, Joseph D.			A potential role for neuronal connexin 36 in the pathogenesis of amyotrophic lateral sclerosis	NEUROSCIENCE LETTERS			English	Article						Gap junctions; Connexin 36; Amyotrophic lateral sclerosis; Spinal cord; Neurodegenerative diseases	GAP-JUNCTIONS; CELL-DEATH; DISEASE PROGRESSION; MOUSE MODEL; SURVIVAL; SOD1; NEURODEGENERATION; BRAIN	Neuronal gap junctional protein connexin 36 (Cx36) contributes to neuronal death following a range of acute brain insults such as ischemia, traumatic brain injury and epilepsy. Whether Cx36 contributes to neuronal death and pathological outcomes in chronic neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), is not known. We show here that the expression of Cx36 is significantly decreased in lumbar segments of the spinal cord of both human ALS subjects and SOD1(G93A) mice as compared to healthy human and wild-type mouse controls, respectively. In purified neuronal cultures prepared from the spinal cord of wild-type mice, knockdown of Cx36 reduces neuronal death caused by overexpression of the mutant human SOD1-G93A protein. Taken together, these data suggest a possible contribution of Cx36 to ALS pathogenesis. A perspective for the use of blockers of Cx36 gap junction channels for ALS therapy is discussed.	[Belousov, Andrei B.; Denisova, Janna V.] Univ Kansas, Med Ctr, Dept Mol, Kansas City, KS 66103 USA; [Belousov, Andrei B.; Denisova, Janna V.] Univ Kansas, Med Ctr, Dept Integrat Physiol, Kansas City, KS 66103 USA; [Nishimune, Hiroshi] Univ Kansas, Med Ctr, Dept Anat, Kansas City, KS 66103 USA; [Nishimune, Hiroshi] Univ Kansas, Med Ctr, Dept Cell Biol, Kansas City, KS 66103 USA; [Fontes, Joseph D.] Univ Kansas, Med Ctr, Dept Biochem, Kansas City, KS 66103 USA; [Fontes, Joseph D.] Univ Kansas, Med Ctr, Dept Mol Biol, Kansas City, KS 66103 USA		Belousov, AB (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, 2146 W 39th Ave, Kansas City, KS 66160 USA.	abelousov@kumc.edu	Nishimune, Hiroshi/B-7226-2013	Fontes, Joseph/0000-0003-4796-343X	University of Kansas Medical Center Research Institute;  [NIH1R01NS078214];  [P30 AG035982];  [UL1 TR000001];  [NIHHD002528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG051470, P30AG035982] Funding Source: NIH RePORTER	This research was supported by a Lied basic science award from the University of Kansas Medical Center Research Institute to A.B.B and NIH1R01NS078214 to H.N. The study also was supported in part by P30 AG035982 and UL1 TR000001. Core support was provided by NIHHD002528. Human spinal cord samples were obtained from the NIH NeuroBioBank's Brain and Tissue repository at the University of Mariland-Baltimore and the University of Miami.	Belousov AB, 2013, TRENDS NEUROSCI, V36, P227, DOI 10.1016/j.tins.2012.11.001; Belousov AB, 2012, NEUROSCI LETT, V524, P16, DOI 10.1016/j.neulet.2012.06.065; Brooks B. R., 2000, AMYOTROPHIC LATERAL, P31; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Fontes JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125395; Jouroukhin Y, 2013, NEUROBIOL DIS, V56, P79, DOI 10.1016/j.nbd.2013.04.012; Li X, 2008, J NEUROSCI, V28, P9769, DOI 10.1523/JNEUROSCI.2137-08.2008; Liu RG, 1999, RADIAT RES, V151, P133, DOI 10.2307/3579763; Park WM, 2011, J NEUROSCI, V31, P5909, DOI 10.1523/JNEUROSCI.6787-10.2011; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; Vaccari JCDR, 2007, J NEUROPHYSIOL, V98, P2878, DOI 10.1152/jn.00362.2007; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Wang YF, 2010, J NEUROPHYSIOL, V104, P3551, DOI 10.1152/jn.00656.2010; Yoo YE, 2011, EXP NEUROL, V231, P147, DOI 10.1016/j.expneurol.2011.06.003	21	6	6	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 14	2018	666						1	4		10.1016/j.neulet.2017.12.027			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FX6ZB	WOS:000426234700001	29246791	Green Accepted, Bronze			2022-02-06	
J	Powell, MA; Black, RT; Smith, TL; Reeves, TM; Phillips, LL				Powell, Melissa A.; Black, Raiford T.; Smith, Terry L.; Reeves, Thomas M.; Phillips, Linda L.			Mild Fluid Percussion Injury Induces Diffuse Axonal Damage and Reactive Synaptic Plasticity in the Mouse Olfactory Bulb	NEUROSCIENCE			English	Article						traumatic brain injury; olfactory bulb; axon injury; synaptic plasticity	TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; GENE DELETION CAUSES; MARKER PROTEIN; MICROGLIAL ACTIVATION; SENSORY NEURONS; INCREASED EXPRESSION; ADULT NEUROGENESIS	Despite the regenerative capacity of the olfactory bulb (OB), head trauma causes olfactory disturbances in up to 30% of patients. While models of olfactory nerve transection, olfactory receptor neuron (ORN) ablation, or direct OB impact have been used to examine OB recovery, these models are severe and not ideal for study of OB synaptic repair. We posited that a mild fluid percussion brain injury (mFPI), delivered over mid-dorsal cortex, would produce diffuse OB deafferentation without confounding pathology. Wild type FVB/NJ mice were subjected to mFPI and OB probed for ORN axon degeneration and onset of reactive synaptogenesis. OB extracts revealed 3 d postinjury elevation of calpain-cleaved 150-kDa alpha II-spectrin, an indicator of axon damage, in tandem with reduced olfactory marker protein (OMP), a protein specific to intact ORN axons. Moreover, mFPI also produced a 3-d peak in GFAP+ astrocyte and IBA1+ microglial reactivity, consistent with postinjury inflammation. OB glomeruli showed disorganized ORN axons, presynaptic degeneration, and glial phagocytosis at 3 and 7 d postinjury, all indicative of deafferentation. At 21 d after mFPI, normal synaptic structure re-emerged along with OMP recovery, supporting ORN afferent reinnervation. Robust 21 d postinjury upregulation of GAP-43 was consistent with the time course of ORN axon sprouting and synapse regeneration reported after more severe olfactory insult. Together, these findings define a cycle of synaptic degeneration and recovery at a site remote to non-contusive brain injury. We show that mFPI models diffuse ORN axon damage, useful for the study of time-dependent reactive synaptogenesis in the deafferented OB. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Powell, Melissa A.; Black, Raiford T.; Smith, Terry L.; Reeves, Thomas M.; Phillips, Linda L.] Virginia Commonwealth Univ, Med Ctr, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23298 USA		Phillips, LL (corresponding author), Virginia Commonwealth Univ, Med Ctr, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23298 USA.	powellma3@vcu.edu; Raiford.Black@vcuhealth.org; Terry.Smith@vcuhealth.org; Thomas.Reeves@vcuhealth.org; Linda.Phillips@vcuhealth.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 044372, NS 056247, NS 057758]; NIH-NCI Cancer Center Grant [P30 CA016059]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057758, R01NS056247, R56NS044372, R01NS044372] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (grants NS 044372, NS 056247, NS 057758). The authors also wish to thank Judy Williamson for expert assistance with TEM tissue preparation and Frances White for guidance on confocal imaging. Microscopy was performed at the VCU Microscopy Facility, supported, in part, by funding from NIH-NCI Cancer Center Grant P30 CA016059.	Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Babizhayev MA, 2011, CURR CLIN PHARMACOL, V6, P236, DOI 10.2174/157488411798375903; BAILEY MS, 1993, J COMP NEUROL, V328, P501, DOI 10.1002/cne.903280405; Bakos SR, 2010, CHEM SENSES, V35, P655, DOI 10.1093/chemse/bjq056; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Chang CY, 2003, NEUROSCI RES, V45, P325, DOI 10.1016/S0168-0102(02)00236-5; Chao TI, 1997, J COMP NEUROL, V388, P191; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; CIZKOVA D, 1995, ARCH ITAL BIOL, V133, P237; Costanzo RM, 2008, NEUROREPORT, V19, P327, DOI 10.1097/WNR.0b013e3282f50c7b; Costanzo RM, 2006, NEUROREPORT, V17, P1787, DOI 10.1097/WNR.0b013e32800fef87; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; Costanzo RM, 2012, BRAIN INJURY MED PRI; Cummings DM, 2000, J COMP NEUROL, V421, P362; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; GONZALEZ MD, 1994, J NEUROSCI, V14, P6121; Gorup D, 2015, NEUROSCI LETT, V597, P176, DOI 10.1016/j.neulet.2015.04.042; GRAZIADEI PPC, 1978, P NATL ACAD SCI USA, V75, P5230, DOI 10.1073/pnas.75.10.5230; GRAZIADEI PPC, 1979, NEUROSCIENCE, V4, P713, DOI 10.1016/0306-4522(79)90002-2; GRAZIADEI PPC, 1980, J NEUROCYTOL, V9, P145, DOI 10.1007/BF01205155; GRAZIADEI PPC, 1979, ACTA ANAT, V104, P220; Griff ER, 2000, BRAIN RES, V866, P227, DOI 10.1016/S0006-8993(00)02291-5; HAGAN PJ, 1967, ARCHIV OTOLARYNGOL, V85, P85; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HARRIS AS, 1988, J NEUROSCI, V8, P2640; Herzog C, 1999, BRAIN RES, V849, P155, DOI 10.1016/S0006-8993(99)02075-2; Holtmaat AJGD, 1995, J NEUROSCI, V15, P7953; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Hwang IK, 2008, NEUROSCI LETT, V435, P251, DOI 10.1016/j.neulet.2008.02.050; INAMITSU M, 1990, J LARYNGOL OTOL, V104, P959, DOI 10.1017/S0022215100114483; JENNINGS RA, 1995, BRAIN RES, V683, P159, DOI 10.1016/0006-8993(95)00361-S; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kass MD, 2013, J NEUROSCI, V33, P6594, DOI 10.1523/JNEUROSCI.1442-12.2013; KELLER A, 1976, J BIOL CHEM, V251, P6232; KNYIHARCSILLIK E, 1992, J NEUROSCI RES, V32, P93, DOI 10.1002/jnr.490320112; Kobayashi M, 2013, NEUROSCI RES, V76, P125, DOI 10.1016/j.neures.2013.03.015; Kobayashi M, 2009, CHEM SENSES, V34, P573, DOI 10.1093/chemse/bjp038; Koster NL, 1996, BRAIN RES, V724, P117, DOI 10.1016/0006-8993(96)00281-8; Lazarini F, 2014, J NEUROSCI, V34, P14430, DOI 10.1523/JNEUROSCI.5366-13.2014; Lazarini F, 2012, J NEUROSCI, V32, P3652, DOI 10.1523/JNEUROSCI.6394-11.2012; Lee AC, 2011, J NEUROSCI, V31, P2974, DOI 10.1523/JNEUROSCI.5067-10.2011; Liu HA, 2011, EXP NEUROL, V228, P270, DOI 10.1016/j.expneurol.2011.01.021; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; MARGOLIS FL, 1991, PROG BRAIN RES, V89, P97; Marin C, 2017, NEUROSCIENCE, V364, P28, DOI 10.1016/j.neuroscience.2017.09.008; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; MORRISON EE, 1995, NEUROSCI LETT, V198, P213, DOI 10.1016/0304-3940(95)11943-Q; Nathan BP, 2001, EXP NEUROL, V172, P128, DOI 10.1006/exnr.2001.7762; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; OLEY N, 1975, J COMP PHYSIOL PSYCH, V88, P477, DOI 10.1037/h0076401; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Phillips LL, 2014, NEURAL REGEN RES, V9, P362, DOI 10.4103/1673-5374.128237; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Proskynitopoulos PJ, 2017, SURG NEUROL INT S10, V7, pS263; Radomski KL, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-142; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Rodriguez-Gil DJ, 2015, P NATL ACAD SCI USA, V112, P5821, DOI 10.1073/pnas.1417955112; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Schwob JE, 1999, J COMP NEUROL, V412, P439, DOI 10.1002/(SICI)1096-9861(19990927)412:3<439::AID-CNE5>3.0.CO;2-H; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Shin T, 2005, BRAIN RES, V1041, P95, DOI 10.1016/j.brainres.2005.02.019; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smithson LJ, 2010, J NEUROSCI RES, V88, P858, DOI 10.1002/jnr.22254; Steuer E, 2014, J NEUROTRAUM, V31, P1277, DOI 10.1089/neu.2013.3296; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; STONE LM, 1994, J NEUROSCI, V14, P301; STROEMER RP, 1993, NEUROSCI LETT, V162, P51, DOI 10.1016/0304-3940(93)90557-2; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Tsukatani T, 2003, NEUROREPORT, V14, P1135, DOI 10.1097/00001756-200306110-00007; VALVERDE F, 1991, J COMP NEUROL, V307, P658, DOI 10.1002/cne.903070411; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; YEE KK, 1995, PHYSIOL BEHAV, V58, P959, DOI 10.1016/0031-9384(95)00159-G; Youngentob SL, 2001, BEHAV NEUROSCI, V115, P626, DOI 10.1037//0735-7044.115.3.626; Youngentob SL, 1999, NEUROREPORT, V10, P15, DOI 10.1097/00001756-199901180-00003	94	6	6	2	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 10	2018	371						106	118		10.1016/j.neuroscience.2017.11.045			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FX2FZ	WOS:000425876200009	29203228	Green Accepted			2022-02-06	
J	Lefebvre, G; Chamard, E; Proulx, S; Tremblay, S; Halko, M; Soman, S; de Guise, E; Pascual-Leone, A; Theoret, H				Lefebvre, Genevieve; Chamard, Emilie; Proulx, Sebastien; Tremblay, Sara; Halko, Mark; Soman, Salil; de Guise, Elaine; Pascual-Leone, Alvaro; Theoret, Hugo			Increased Myo-Inositol in Primary Motor Cortex of Contact Sports Athletes without a History of Concussion	JOURNAL OF NEUROTRAUMA			English	Article						brain imaging; concussion; physical activity; sports; subconcussive	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; PROFESSIONAL SOCCER PLAYERS; WHITE-MATTER; NEUROPSYCHOLOGICAL PERFORMANCE; CARDIORESPIRATORY FITNESS; NEUROMETABOLIC CHANGES; AEROBIC FITNESS; GLUTAMATE; FOOTBALL	The objective of the study was to determine whether repetitive hits to the head at a subclinical level are associated with structural and functional brain abnormalities and whether these effects are influenced by high levels of fitness associated with intense physical activity. Seventy-two college students were recruited: 24 nonathletic, 24 athletes practicing a varsity contact sport, and 24 athletes practicing a varsity noncontact sport. They were recruited for a neuropsychological evaluation and a magnetic resonance imaging session that included magnetic resonance spectroscopy of primary motor cortex (M1) and prefrontal cortex and susceptibility-weighted imaging. There was no evidence for reduced cognitive performance or presence of micro bleeds in contact sports athletes. Abnormalities in contact sports athletes were found for myo-inositol concentration (mIns) in M1, where levels were significantly higher compared with noncontact sports athletes (p=0.016) and nonathletes (p=0.029). In prefrontal cortex, glutamate + glutamine (Glx) was significantly reduced in contact sports athletes compared with noncontact sports athletes (p=0.016), and a similar reduction was observed for gamma-aminobutyric acid (GABA) levels (p=0.005). Varsity contact sports are associated with area-specific alterations in mIns concentration in the primary motor cortex. In the prefrontal cortex, high levels of fitness could modulate the effects of head impact exposure on prefrontal metabolite concentration. Indeed, although athletes in contact and noncontact sports show different neurometabolic profiles, they do not differ from sedentary controls.	[Lefebvre, Genevieve; Chamard, Emilie; Tremblay, Sara; de Guise, Elaine; Theoret, Hugo] Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Proulx, Sebastien] McGill Univ, Montreal, PQ, Canada; [Halko, Mark; Pascual-Leone, Alvaro] Harvard Med Sch, Div Cognit Neurol, Boston, MA USA; [Halko, Mark; Pascual-Leone, Alvaro] Harvard Med Sch, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA USA; [Soman, Salil] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiol, Div Neuroradiol, Boston, MA USA; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Inst Neurorrehabilitac Guttmann, Barcelona, Spain; [Theoret, Hugo] CHU St Justine, Res Ctr, Montreal, PQ, Canada		Theoret, H (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	hugo.theoret@umontreal.ca	Pascual-Leone, Alvaro/AAC-5101-2019; Tremblay, Sara/X-5471-2019; Proulx, Sebastien/AAX-5694-2021; Halko, Mark A./G-8633-2016	Pascual-Leone, Alvaro/0000-0001-8975-0382; Proulx, Sebastien/0000-0003-1709-3277; Halko, Mark A./0000-0002-7427-0789; Theoret, Hugo/0000-0002-7458-8797	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Football Players Health Study at Harvard University; Harvard Catalyst | The Harvard Clinical and Translational Science Center (NCRR); Harvard Catalyst | The Harvard Clinical and Translational Science Center (NCATS NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 RR025758]	This work was supported by a grant from the Canadian Institutes of Health Research, the Football Players Health Study at Harvard University, and Harvard Catalyst | The Harvard Clinical and Translational Science Center (NCRR and the NCATS NIH, UL1 RR025758).	Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BREWER J, 1995, SPORTS MED, V20, P129, DOI 10.2165/00007256-199520030-00001; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; Dennis A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00351; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Da Silva CD, 2008, J SPORT SCI MED, V7, P309; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Erickson KI, 2012, BRAIN BEHAV, V2, P32, DOI 10.1002/brb3.30; Fernandes RJ, 2008, INT J SPORTS MED, V29, P145, DOI 10.1055/s-2007-965113; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gonzales MM, 2013, BRAIN TOPOGR, V26, P126, DOI 10.1007/s10548-012-0248-8; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Huang RW, 2015, BRAIN STRUCT FUNCT, V220, P625, DOI 10.1007/s00429-013-0677-5; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Kemp S, 2016, BRAIN INJURY, V30, P1068, DOI 10.3109/02699052.2016.1148776; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Maddock RJ, 2016, J NEUROSCI, V36, P2449, DOI 10.1523/JNEUROSCI.3455-15.2016; Maddock RJ, 2011, NEUROIMAGE, V57, P1324, DOI 10.1016/j.neuroimage.2011.05.048; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Pate RR, 2006, ARCH PEDIAT ADOL MED, V160, P1005, DOI 10.1001/archpedi.160.10.1005; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Ring-Dimitriou S, 2008, EUR J APPL PHYSIOL, V102, P505, DOI 10.1007/s00421-007-0615-4; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Wilke S, 2017, J NEUROTRAUM, V34, P281, DOI 10.1089/neu.2016.4399; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhu N, 2014, NEUROLOGY, V82, P1339, DOI 10.1212/WNL.0000000000000310; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	74	6	6	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	7					953	962		10.1089/neu.2017.5254		FEB 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC0NF	WOS:000424833600001	29279021	Green Published			2022-02-06	
J	Borja, MJ; Chung, S; Lui, YW				Borja, Maria J.; Chung, Sohae; Lui, Yvonne W.			Diffusion MR Imaging in Mild Traumatic Brain Injury	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						DWI; Diffusion; MR imaging; Mild traumatic brain injury; Kurtosis; Advanced imaging	AXONAL INJURY; SEX-DIFFERENCES; HEAD-INJURY; TENSOR; KURTOSIS; MEMORY; DTI; ABNORMALITIES; DYSFUNCTION; IMPAIRMENT	Remarkable advances have been made in the last decade in the use of diffusion MR imaging to study mild traumatic brain injury (mTBI). Diffusion imaging shows differences between patients with mTBI and healthy control groups in multiple different metrics using a variety of techniques, supporting the notion that there are micro structural injuries in patients with mTBI that radiologists have been insensitive to. Future areas of discovery in diffusion MR imaging and mTBI include larger longitudinal studies to better understand the evolution of the injury and unravel the biophysical meaning that the detected changes in diffusion MR imaging represent.	[Borja, Maria J.; Lui, Yvonne W.] NYU, Sch Med, Dept Radiol, 660 1st Ave, New York, NY 10016 USA; [Chung, Sohae] NYU, Sch Med, Bernard & Irene Schwartz Ctr Biomed Imaging, Ctr Adv Imaging Innovat & Res,Dept Radiol, 660 1st Ave, New York, NY 10016 USA		Borja, MJ (corresponding author), NYU, Sch Med, Dept Radiol, 660 1st Ave, New York, NY 10016 USA.	Maria.BorjaAngulo@nyumc.org	Chung, Sohae/S-9249-2019				Al Brashdi YH, 2015, NEURORADIOL J, V28, P409, DOI 10.1177/1971400915598071; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2015, NEUROIMAGE, V118, P334, DOI 10.1016/j.neuroimage.2015.05.061; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hoch MJ, 2016, BJR CASE REP, V2, DOI 10.1259/bjrcr.20150299; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Koerte IK, 2016, TRANSLATIONAL RES TR, V2016; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malcolm JG, 2010, IEEE T MED IMAGING, V29, P1664, DOI 10.1109/TMI.2010.2048121; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P457; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wintermark M, 2015, AM J NEURORADIOL, V36, pE12, DOI 10.3174/ajnr.A4254; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x	58	6	8	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					117	+		10.1016/j.nic.2017.09.009			11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900012	29157848				2022-02-06	
J	Gray, M; Chung, J; Aguila, F; Williams, TG; Teraoka, JK; Harris, OA				Gray, Max; Chung, Joyce; Aguila, Fatima; Williams, T. Gavin; Teraoka, Jeffrey K.; Harris, Odette A.			Long-Term Functional Outcomes in Military Service Members and Veterans After Traumatic Brain Injury/Polytrauma Inpatient Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Adult; Brain injuries, traumatic; Comorbidity; Female; Humans; Male; Military science; Rehabilitation	POSTTRAUMATIC-STRESS-DISORDER; INJURY; POLYTRAUMA; POPULATION; PREDICTION; MODERATE; PROGRAM; ADULTS; BLAST; NEEDS	Objective: To determine the effect of the established polytrauma/traumatic brain injury (TBI) infrastructure on immediate posttreatment functional gains, the long-term sustainability of any gains, and participation-related community reintegration outcomes in a baseline cohort of patients 8 years postadmission. Design: Retrospective review and prospective repeated measures of an inception cohort. Setting: Polytrauma rehabilitation center (PRC). Participants: Patients consecutively admitted to the PRC inpatient rehabilitation unit during its first full fiscal year, 2006 (N=44). Interventions: The PRC infrastructure and formalized rehabilitation for polytrauma/TBI. Main Outcome Measures: FIM scores at admission, discharge, 3 months, and 8 years postdischarge; participation-related socioeconomic factors reflecting community reintegration 8 years after admission. Results: Functional gains were statistically significantly increased from admission to discharge. Improvements were maintained at both 3 months postdischarge and 8 years postdischarge. The socioeconomic data collected at 8-year follow-up showed >50% either competitively employed or continuing their education and 100% living in a noninstitutionalized setting. Conclusions: This study addresses a concern regarding the long-term functional outcomes of rehabilitation patients treated by the established infrastructure of the Polytrauma System of Care inpatient rehabilitation centers. The results suggest that polytrauma/TBI rehabilitation care using a comprehensive, integrated approach is effective and durable in achieving functional gains and successful community reintegration within our initial PRC cohort. Follow-up of subsequent fiscal year cohorts would add to the validity of these outcome findings. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Gray, Max; Chung, Joyce; Aguila, Fatima; Williams, T. Gavin; Teraoka, Jeffrey K.; Harris, Odette A.] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Williams, T. Gavin] Stanford Univ, Sch Med, Phys Med & Rehabil, Stanford, CA 94305 USA; [Harris, Odette A.] Def & Vet Brain Injury Ctr, Palo Alto, CA USA; [Harris, Odette A.] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA		Teraoka, JK (corresponding author), VA Palo Alto Hlth Care Syst, Phys Med & Rehabil, 3810 Miranda Ave,MC117, Palo Alto, CA 94304 USA.	Jeff.Teraoka@va.gov			Veterans Affairs Palo Alto Health Care SystemUS Department of Veterans Affairs; Department of Veterans Affairs Central Office leadership; American Congress of Rehabilitation Medicine	Supported by the Veterans Affairs Palo Alto Health Care System and the Department of Veterans Affairs Central Office leadership.; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benedict SM, 2010, GENERATIONS, V34, P106; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fischer Hannah, 2009, US MILITARY CASUALTY; Gatchel RJ, 2009, MIL MED, V174, P270, DOI 10.7205/MILMED-D-03-1607; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; McGeary D, 2011, J CLIN PSYCHOL MED S, V18, P155, DOI 10.1007/s10880-011-9236-5; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; US. Department of Veterans Affairs, 2015, POL TBI SYST CAR DEF	23	6	6	1	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S33	S39		10.1016/j.apmr.2017.08.465			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900005	28866009				2022-02-06	
J	Hasan, KM; Keser, Z; Schulz, PE; Wilde, EA				Hasan, Khader M.; Keser, Zafer; Schulz, Paul E.; Wilde, Elisabeth A.			Multimodal Advanced Imaging for Concussion	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Concussion; Multimodal imaging; Traumatic brain injury (TBI); Quantitative MR imaging; Cortical thickness; Diffusion tensor imaging (DTI); Kurtosis; Intravoxel incoherent motion (IVIM)	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; DIFFUSION KURTOSIS; AXONAL INJURY; HEAD TRAUMA; PATHOLOGY; NEURODEGENERATION; ENCEPHALOPATHY; STATEMENT; IMPACT	In the United States alone, 1.6 to 3.8 million people have sports-related concussions yearly. The pathomechanisms of concussions may not be directly measured by conventional neuroimaging; advanced models may be needed to address the shortcomings of the current clinical protocols. Multimodal advanced imaging may provide more accurate diagnosis and predict the clinical course of concussion, assessing the efficacy of existing and emerging multifaceted therapies. In this article, the authors present an overview and pictorial display of conventional and advanced multimodal MR imaging methods that have been applied to identify the brain structures affected in traumatic brain injuries.	[Hasan, Khader M.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Diagnost & Intervent Imaging, 6431 Fannin St,MSB 2-100, Houston, TX 77030 USA; [Keser, Zafer; Schulz, Paul E.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, 6431 Fannin St, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Phys Med & Rehabil, 7200 Cambridge St,Suite 9A, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Neurol, 7200 Cambridge St,Suite 9A, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Dept Radiol, 7200 Cambridge St,Suite 9A, Houston, TX 77030 USA		Hasan, KM (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Diagnost & Intervent Imaging, 6431 Fannin St,MSB 2-100, Houston, TX 77030 USA.	Khader.M.Hasan@uth.tmc.edu	Keser, Zafer/J-4586-2019; Hasan, Khader M./ABB-5767-2020	Keser, Zafer/0000-0001-6415-0874; 	DUNN Research Foundation	This work was supported by the DUNN Research Foundation.	Ali R, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15326; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Furst AJ, 2016, NEUROLOGY, V86, P798, DOI 10.1212/WNL.0000000000002426; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grossman EJ, 2015, NEUROIMAGE, V118, P334, DOI 10.1016/j.neuroimage.2015.05.061; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris MA, 2013, OCCUP ENVIRON MED, V70, P839, DOI 10.1136/oemed-2013-101444; Hasan KM, 2011, J NEUROSCI, V31, P16826, DOI 10.1523/JNEUROSCI.4184-11.2011; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Li L, 2016, NEUROSCI LETT, V610, P92, DOI 10.1016/j.neulet.2015.10.058; Liu J, 2016, J NEUROTRAUM, V33, P10, DOI 10.1089/neu.2014.3856; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2016, BRAIN IMAGING BEHAV; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McIntosh TK, 1996, LAB INVEST, V74, P315; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	55	6	7	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					31	+		10.1016/j.nic.2017.09.001			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900005	29157851				2022-02-06	
J	Kerr, HA; Ledet, EH; Ata, A; Newitt, JL; Barbara, MS; Kahanda, M; Schlueter, ES				Kerr, Hamish A.; Ledet, Eric H.; Ata, Ashar; Newitt, Jennifer L.; Barbara, Matthew Santa; Kahanda, Milan; Schlueter, Erin Sperry			Does instructional video footage improve tackle technique?	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Concussion; head acceleration; injury prevention; kinematics; kinetics; rugby union; skill acquisition; youth sport	INJURY PREVENTION PROGRAM; HIGH-SCHOOL FOOTBALL; NATIONAL RUGBY SAFETY; PROSPECTIVE COHORT; HEAD ACCELERATION; UNION FOOTBALL; PLAYERS; BOKSMART; CONTACT; RISK	There is a high incidence of injury during rugby tackling. Tackle biomechanics are linked to this injury risk. The effectiveness of educational methods in teaching safe rugby tackling for players of various ages and experience levels has not been elucidated. We hypothesized that watching an educational video on rugby tackling technique would alter lower extremity kinematics and reduce cervical spine and head acceleration during tackling. Kinematics and kinetics of 50 collegiate and high school-aged rugby players were recorded while tackling an opponent in a laboratory setting. Movement of the lower extremity, upper body, and head were quantified with a motion analysis system. Participants were shown video instruction on tackling technique then performed another series of tackles. Data were compared pre- and post-educational intervention. A fixed effects model was used to compare the effect of repetition versus educational intervention. Skilled collegiate players tackled with significantly greater mean knee flexion angle post-educational intervention relative to pre-instruction, indicative of better technique. The fixed effects model indicated that video instruction decreased acceleration by a mean 51.8m/s(2) in collegiate players. However, the effect of repetition was shown to increase peak acceleration by a mean 11.2m/s(2). In contrast, the educational intervention resulted in an increased acceleration of 15.4m/s(2) for high school players, but the effect of repetition was shown to decrease acceleration by a mean of 5.2m/s(2). Experienced players respond as expected to video instructional intervention. Repetition may be more important for younger rugby players to learn effective tackling.	[Kerr, Hamish A.; Ata, Ashar; Newitt, Jennifer L.; Kahanda, Milan; Schlueter, Erin Sperry] Albany Med Ctr, Dept Med, Albany, NY USA; [Ledet, Eric H.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Barbara, Matthew Santa] UPMC, Dept Phys Med & Rehabil, Pittsburgh, PA USA		Kerr, HA (corresponding author), Albany Med Coll, 724 Watervliet Shaker Rd, Albany, NY 12208 USA.	kerrh@mail.amc.edu					Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brown JC, 2016, SCAND J MED SCI SPOR, V26, P221, DOI 10.1111/sms.12414; Brown R, 2016, WORLD RUGB MED C LON; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Chadwick S, 2011, 2011452011 COV U; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Freitag A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1587; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Heck JF, 2004, J ATHL TRAINING, V39, P101; Hendricks S, 2017, BRIT J SPORT MED, V51, P829, DOI 10.1136/bjsports-2016-096347; Hendricks S, 2014, J SPORT SCI MED, V13, P557; Hendricks S, 2012, SAFETY SCI, V50, P266, DOI 10.1016/j.ssci.2011.08.061; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Imwalle LE, 2009, J STRENGTH COND RES, V23, P2223, DOI 10.1519/JSC.0b013e3181bc1a02; IRB, 2008, RUGB READ; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Margolis LH, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2604; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Meeuwisse WH., 1994, CLIN J SPORT MED, V4, P166, DOI [10.1097/00042752-199407000-00004, DOI 10.1097/00042752-199407000-00004]; Nicol A, 2011, J PUBLIC HEALTH-UK, V33, P256, DOI 10.1093/pubmed/fdq047; Nowinski Chris, 2013, Cerebrum, V2013, P2; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ong N.T., 2012, SKILL ACQUISITION SP, P22, DOI [10.4324/9780203133712-11, DOI 10.4324/9780203133712-11]; Pain MTG, 2008, J SPORT SCI, V26, P855, DOI 10.1080/02640410801910319; Patricios J, 2014, CURR SPORT MED REP, V13, P142, DOI 10.1249/JSR.0000000000000049; Patricios JS, 2014, CURR SPORT MED REP, V13, P326, DOI 10.1249/JSR.0000000000000086; Peck KY, 2013, SPORTS HEALTH, V5, P327, DOI 10.1177/1941738113487165; Pollock AM, 2016, BRIT J SPORT MED, V50, P963, DOI 10.1136/bjsports-2016-096220; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Quarrie KL, 2001, BRIT J SPORT MED, V35, P157, DOI 10.1136/bjsm.35.3.157; Roberts SP, 2015, BRIT J SPORT MED, V49, P536, DOI 10.1136/bjsports-2013-092988; Sakadjian A, 2014, J STRENGTH COND RES, V28, P1613, DOI 10.1519/JSC.0000000000000290; Stokes JV, 2010, J APPL BEHAV ANAL, V43, P509, DOI 10.1901/jaba.2010.43-509; Trewartha G, 2008, J SPORT SCI, V26, P845, DOI 10.1080/02640410701885629; Tucker R, 2016, BRIT J SPORT MED, V50, P921, DOI 10.1136/bjsports-2016-096322; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278; Willigenburg NW, 2016, AM J SPORT MED, V44, P753, DOI 10.1177/0363546515622389; Wu WL, 2007, J STRENGTH COND RES, V21, P251, DOI 10.1519/00124278-200702000-00045; Wulf G., 2004, SKILL ACQUISITION SP, P121; Zetou E, 2002, PERCEPT MOTOR SKILL, V94, P1131, DOI 10.2466/PMS.94.2.1131-1142	52	6	6	1	15	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	FEB	2018	13	1					3	15		10.1177/1747954117711867			13	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	FX3QA	WOS:000425985400001					2022-02-06	
J	Krueger, E; Popovic-Maneski, L; Nohama, P				Krueger, Eddy; Popovic-Maneski, Lana; Nohama, Percy			Mechanomyography-Based Wearable Monitor of Quasi-Isometric Muscle Fatigue for Motor Neural Prostheses	ARTIFICIAL ORGANS			English	Article						Mechanomyography; Wavelet; Functional electrical stimulation; Spinal cord injury; Muscle fatigue	FUNCTIONAL ELECTRICAL-STIMULATION; SPINAL-CORD-INJURY; PARASTEP(R)1 AMBULATION SYSTEM; CONTRACTILE PROPERTIES; MYOELECTRIC SIGNALS; TRAINING-PROGRAM; FREQUENCY; PARAPLEGIA; EMG; NEUROPROSTHESIS	A motor neural prosthesis based on surface functional electrical stimulation (sFES) can restore functional movement (e.g., standing, walking) in patients with a spinal cord injury (SCI). sFES generates muscle contractions in antigravity muscles and allows balance-assisted standing. This induced standing has several benefits, such as improved cardiovascular function, decreased incidence of urinary infections, reduced joint contractures, and muscle atrophy. The duration of sFES assisted standing is limited due to the quick onset of muscle fatigue. Currently, there is no method available to reliably estimate real-time muscle fatigue during sFES. Simply monitoring the M-wave changes is not suitable due to the high signal disturbances that arise during multi-channel electrical stimulation. Mechanomyography (MMG) is immune to electrical stimulation artifacts and can be used to detect subtle vibrations on the surface of the skin related to activation of the underlying muscle's motor units (MU). The aim of this study was to develop a method for detecting muscle fatigue brought on by sFES. The method was tested in three different heads of the quadriceps muscle in SCI patients during electrically elicited quasi-isometric contraction. Six spinal cord-injured male volunteers, with no voluntary control of the quadriceps muscle participated in the study. Electrical bursts of voltage-controlled monophasic square pulses at frequencies of 1 kHz (50% duty cycle) at 50 Hz (15% duty cycle) were used to generate thigh muscle contractions that controlled the knee joint in the sagittal plane. The pulse amplitudes were set to position the knee joint at a 5 degrees angle from the horizontal plane and when the knee angle dropped to 20 degrees (e.g., the quadriceps were unable to hold the lower leg in the desired position), the test was terminated. Two data segments lasting 10 s each, at the beginning and end of each test, were analyzed. The muscle contraction was assessed by MMG sensors positioned on the rectus femoris, vastus lateralis, and vastus medialis muscles. Data segments were decomposed into 11 frequency bands using a Cauchy wavelet transform. In the initial time interval (non-fatigued muscle), the power peak was concentrated in the 11.31 Hz frequency band. In the final interval (muscle fatigued) this peak shifted to lower frequencies (2 and 6 Hz frequency bands). The decreased frequency was most prominent during the last 4 s of the recordings. It was shown that MMG could be used as a real-time indicator of muscle fatigue during FES-induced isometric contraction of quadriceps; hence, MMG could be used in closed-loop control as a fatigue detector. Subsequent studies for non-isometric contractions could possibly lead to prediction of muscle fatigue before contractile failure during functional use of the muscle.	[Krueger, Eddy] Univ Estadual Londrina, Neural Engn & Rehabil Lab, Londrina, Brazil; [Krueger, Eddy; Nohama, Percy] Univ Tecnol Fed Parana, Curitiba, Parana, Brazil; [Popovic-Maneski, Lana] Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia; [Nohama, Percy] Pontificia Univ Catolica Parana, Grad Program Hlth Technol, Curitiba, Parana, Brazil		Nohama, P (corresponding author), Pontificia Univ Catolica Parana, Grad Program Hlth Technol, Curitiba, Parana, Brazil.	percy.weihmayer@gmail.com	Krueger, Eddy/H-8213-2013; Nohama, Percy/Q-3647-2019	Krueger, Eddy/0000-0003-3890-1595; Nohama, Percy/0000-0002-8051-8453	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [484325/2011-6]; Ministry of Education, Science and Technological Development of SerbiaMinistry of Education, Science & Technological Development, Serbia [III 44008]	We would like to thank Ana Carolina Moura Xavier Rehabilitation Center for allowing and providing the clinical setting to conduct this research and CNPq for scholarships and financial resources (Process n. 484325/2011-6). This work was partly supported by the Grant III 44008 from the Ministry of Education, Science and Technological Development of Serbia. Our acknowledgments to Vance Bergeron for English review.	Baldi JC, 1998, SPINAL CORD, V36, P463, DOI 10.1038/sj.sc.3100679; Beck TW, 2008, BIOMED SIGNAL PROCES, V3, P255, DOI 10.1016/j.bspc.2008.01.005; BEDBROOK G, 1981, CARE MANAGEMENT SPIN; BELLEMARE F, 1983, J NEUROPHYSIOL, V50, P1380, DOI 10.1152/jn.1983.50.6.1380; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BIGLANDRITCHIE B, 1979, EXP NEUROL, V64, P414, DOI 10.1016/0014-4886(79)90280-2; Burke D, 2009, J PHYSIOL-LONDON, V587, P491, DOI 10.1113/jphysiol.2008.163170; Burt AA, 2004, CURR ORTHOPAED, V18, P26, DOI 10.1016/j.cuor.2004.01.001; Ce E, 2016, EUR J APPL PHYSL, V116, P911; Ce E, 2015, SPORT SCI HLTH, V11, P1, DOI DOI 10.1007/S11332-015-0219-Z; Chesler NC, 1997, J ELECTROMYOGR KINES, V7, P27, DOI 10.1016/S1050-6411(96)00016-8; Cohen J., 2013, STAT POWER ANAL BEHA, DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]; Decker MJ, 2010, J ELECTROMYOGR KINES, V20, P1163, DOI 10.1016/j.jelekin.2010.07.015; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Gandevia S, 1995, FATIGUE NEURAL MUSCU; Gerrits HL, 1999, MUSCLE NERVE, V22, P1249, DOI 10.1002/(SICI)1097-4598(199909)22:9<1249::AID-MUS13>3.3.CO;2-E; Gollee H, 2004, IEEE T NEUR SYS REH, V12, P73, DOI 10.1109/TNSRE.2003.822765; Graupe D, 2000, NEUROL RES, V22, P703; Guest RS, 1997, ARCH PHYS MED REHAB, V78, P804, DOI 10.1016/S0003-9993(97)90191-X; Hille B., 1991, IONIC CHANNELS EXCIT, V2nd; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P497, DOI 10.1113/jphysiol.1952.sp004719; Islam MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058902; KARU ZZ, 1995, IEEE T BIO-MED ENG, V42, P809, DOI 10.1109/10.398642; Kern H, 2010, NEUROREHAB NEURAL RE, V24, P709, DOI 10.1177/1545968310366129; Kesar TM, 2010, PHYS THER, V90, P55, DOI 10.2522/ptj.20090140; Kobetic R., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P66, DOI 10.1109/86.313148; Kralj A.R., 1989, FUNCTIONAL ELECT STI; Krueger E, 2013, 10 IASTED INT C BIOM, P237; Krueger-Beck E, 2010, IEEE ENG MED BIO, P626, DOI 10.1109/IEMBS.2010.5627274; Langzam E, 2007, J ELECTROMYOGR KINES, V17, P275, DOI 10.1016/j.jelekin.2006.03.001; Malesevic NM, 2010, MUSCLE NERVE, V42, P556, DOI 10.1002/mus.21736; Maneski LZP, 2013, MUSCLE NERVE, V48, P930, DOI 10.1002/mus.23840; Marion MS, 2010, MUSCLE NERVE, V41, P857, DOI 10.1002/mus.21603; MARSOLAIS EB, 1987, J BONE JOINT SURG AM, V69A, P728, DOI 10.2106/00004623-198769050-00014; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; MERLETTI R, 1992, CRIT REV BIOMED ENG, V19, P293; Mizrahi J., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P57, DOI 10.1109/86.313147; MORENOARANDA J, 1981, J BIOMECH, V14, P587, DOI 10.1016/0021-9290(81)90084-1; Nash MS, 1997, ARCH PHYS MED REHAB, V78, P808, DOI 10.1016/S0003-9993(97)90192-1; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Nguyen R, 2011, ARTIF ORGANS, V35, P1174, DOI 10.1111/j.1525-1594.2010.01195.x; Peron S, 2009, NAT NEUROSCI, V12, P318, DOI 10.1038/nn.2259; POPOVIC D, 1989, IEEE T BIO-MED ENG, V36, P729, DOI 10.1109/10.32105; Popovic D, 2003, MED ENG PHYS, V25, P63, DOI 10.1016/S1350-4533(02)00188-1; Popovic D., 2012, CONTROL MOVEMENT PHY; Popovic LZ, 2009, IEEE ENG MED BIO, P6785, DOI 10.1109/IEMBS.2009.5333983; Reilly JP, 1992, ELECT STIMULATION EL; Schiefer MA, 2008, IEEE T NEUR SYS REH, V16, P195, DOI 10.1109/TNSRE.2008.918425; Seki K., 2003, ANN C INT FUNCT EL S; Shin I, 2016, INT J PRECIS ENG MAN, V17, P473, DOI 10.1007/s12541-016-0059-z; Tarata MT, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-3; Thrasher A, 2005, ARTIF ORGANS, V29, P453, DOI 10.1111/j.1525-1594.2005.29076.x; Vaz M A, 1996, Electromyogr Clin Neurophysiol, V36, P221; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; Ward AR, 2004, MED ENG PHYS, V26, P569, DOI 10.1016/j.medengphy.2004.04.007; Yao WX, 2000, J NEUROPHYSIOL, V83, P441, DOI 10.1152/jn.2000.83.1.441; Yu NY, 2010, ARTIF ORGANS, V34, pE117, DOI 10.1111/j.1525-1594.2009.00956.x	58	6	6	3	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	FEB	2018	42	2					208	218		10.1111/aor.12973			11	Engineering, Biomedical; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Transplantation	FV9BP	WOS:000424882000015	28762503	Green Accepted			2022-02-06	
J	Long, B; Koyfman, A				Long, Brit; Koyfman, Alex			Secondary Gains Advances in Neurotrauma Management	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Neurotrauma; Traumatic brain injury; Spinal cord injury; Intracranial pressure; Mean arterial pressure; Tier	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SPINAL-CORD-INJURY; RAPID-SEQUENCE INTUBATION; NERVE SHEATH DIAMETER; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; DECOMPRESSIVE CRANIECTOMY; SURGICAL-MANAGEMENT	Neurotrauma is a leading cause of death and is associated with many secondary injuries. A balance of mean arterial pressure (MAP) and intracranial pressure (ICP) is required to ensure adequate cerebral blood flow and cerebral perfusion pressure. Evaluation and management in the emergency department entails initial stabilization and resuscitation while assessing neurologic status. ICP management follows a tiered approach. Intubation requires consideration of preoxygenation, head of bed elevation, first-pass success, and adequate analgesia and sedation. Early consultation with neurosurgery is needed for definitive therapy. Focused evaluation and management play a significant role in optimizing patient outcomes.	[Long, Brit] San Antonio Mil Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Koyfman, Alex] Univ Texas Southwestern Med Ctr Dallas, Dept Emergency Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA		Long, B (corresponding author), San Antonio Mil Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	Brit.long@yahoo.com					Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; [Anonymous], 2008, EARLY ACUTE MANAGEME; [Anonymous], 2014, EMERGENCY NEUROLOGIC; [Anonymous], 2007, GUIDELINES MANAGEMEN; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Barr RM, 2007, FUNDAMENTALS DIAGNOS, P69; BarrientosVega R, 1997, CRIT CARE MED, V25, P33, DOI 10.1097/00003246-199701000-00009; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; BERING EA, 1961, AM J PHYSIOL, V200, P417; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bishop CV, 2006, ANZ J SURG, V76, P53, DOI 10.1111/j.1445-2197.2006.03642.x; Bochicchio GV, 2006, JPEN-PARENTER ENTER, V30, P503, DOI 10.1177/0148607106030006503; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bracken MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001046.pub2; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Brown MM, 1996, EUR J ANAESTH, V13, P474, DOI 10.1046/j.1365-2346.1996.00973.x; Bucher J, 2015, J EMERG MED, V49, P920, DOI 10.1016/j.jemermed.2015.06.078; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Center N. S. C. I. S., 2013, SPIN CORD INJ FACTS; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chang WTW, 2014, EMERG MED CLIN N AM, V32, P889, DOI 10.1016/j.emc.2014.07.008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CORK RC, 1984, ANESTH ANALG, V63, P60; DAHLGREN N, 1981, ANAESTHESIA, V36, P1022, DOI 10.1111/j.1365-2044.1981.tb08676.x; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dickneite G, 2014, THROMB HAEMOSTASIS, V111, P189, DOI 10.1160/TH13-05-0431; Ditunno JF, 2004, SPINAL CORD, V42, P383, DOI 10.1038/sj.sc.3101603; Dixon BJ, 2005, ANESTHESIOLOGY, V102, P1110, DOI 10.1097/00000542-200506000-00009; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Eller T, 2014, CLIN CHEM LAB MED, V52, P835, DOI 10.1515/cclm-2013-0936; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Faul M, 2010, TRAUMATIC BRAIN INJU; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Finfer S, 2004, NEW ENGL J MED, V350, P2247; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; GIBBS JM, 1972, BRIT J ANAESTH, V44, P1298, DOI 10.1093/bja/44.12.1298; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Gruen P, 2002, NEUROIMAG CLIN N AM, V12, P339, DOI 10.1016/S1052-5149(02)00013-8; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hadley M, 2002, NEUROSURGERY, V50, pS58; Hadley MN, 2013, NEUROSURGERY, V72, P5, DOI 10.1227/NEU.0b013e3182773549; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HASSAN HG, 1991, ACTA ANAESTH SCAND, V35, P442, DOI 10.1111/j.1399-6576.1991.tb03325.x; Hassen GW, 2015, J EMERG MED, V48, P450, DOI 10.1016/j.jemermed.2014.09.060; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hillier SL, 1997, BRAIN INJURY, V11, P649; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; HUG CC, 1993, ANESTH ANALG, V77, pS21; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Jia XF, 2013, J INTENSIVE CARE MED, V28, P12, DOI 10.1177/0885066611403270; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; KASSELL NF, 1982, STROKE, V13, P59, DOI 10.1161/01.STR.13.1.59; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; KOENIG KL, 1992, ANN EMERG MED, V21, P929, DOI 10.1016/S0196-0644(05)82930-0; KOVARIK WD, 1994, ANESTH ANALG, V78, P469; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; Lin CC, 2012, AM J EMERG MED, V30, P1782, DOI 10.1016/j.ajem.2012.02.013; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Manno EM, 2005, MAYO CLIN PROC, V80, P420, DOI 10.4065/80.3.420; Marion DW, 2006, NEUROSURGERY, V58, P655; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MAXWELL RE, 1971, J NEUROSURG, V34, P477, DOI 10.3171/jns.1971.34.4.0477; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McManus ML, 1998, ANESTHESIOLOGY, V88, P1586, DOI 10.1097/00000542-199806000-00023; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; MOSS E, 1979, BRIT J ANAESTH, V51, P347, DOI 10.1093/bja/51.4.347; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nankovic V, 1995, Lijec Vjesn, V117 Suppl 2, P30; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oddo M, 2009, EVIDENCED BASED PRAC, P399; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Orlando regional healthcare education and development, 2004, OV AD TRAUM BRAIN IN; Otterspoor LC, 2008, CURR OPIN ANESTHESIO, V21, P544, DOI 10.1097/ACO.0b013e32830f44fb; Palma L, 2006, J Neurosurg Sci, V50, P63; Patel N, 2013, J TRAUMA ACUTE CARE, V74, P771; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perkins ZB, 2013, J TRAUMA ACUTE CARE, V74, P1074, DOI 10.1097/TA.0b013e3182827305; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Potgieter DW, 2011, ANAESTH INTENS CARE, V39, P95, DOI 10.1177/0310057X1103900116; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robinson N, 2001, EMERG MED J, V18, P453, DOI 10.1136/emj.18.6.453; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Scalfani MT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.008; Seder DB, 2010, NEUROCRIT CARE, V17, pS4; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Servadei F, 2002, ACT NEUR S, V81, P81; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; SINGH H, 1995, J CLIN ANESTH, V7, P5, DOI 10.1016/0952-8180(94)00013-T; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith J, 2006, TXB SURG, P446; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Stein DM, 2012, NEUROCRIT CARE, V17, P102, DOI 10.1007/s12028-012-9759-0; Stein DM, 2009, J TRAUMA, V66, P132, DOI 10.1097/TA.0b013e318142d146; Stevens RD, 2003, J NEUROSURG ANESTH, V15, P215, DOI 10.1097/00008506-200307000-00009; Stevens RD, 2012, NEUROCRIT CARE, V17, P60, DOI 10.1007/s12028-012-9754-5; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Swadron SP, 2012, NEUROCRIT CARE, V17, P112, DOI 10.1007/s12028-012-9760-7; Sydenham E, 2009, COCHRANE DB SYST REV; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Tee JW, 2013, SPINE, V38, P999, DOI 10.1097/BRS.0b013e31828432a3; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thenuwara K, 2002, ANESTHESIOLOGY, V96, P416, DOI 10.1097/00000542-200202000-00029; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Ugur B, 2007, CLIN DRUG INVEST, V27, P269, DOI 10.2165/00044011-200727040-00006; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wang LC, 2013, ANESTHESIOLOGY, V118, P903, DOI 10.1097/ALN.0b013e31828156ff; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P306, DOI 10.1016/0003-9993(94)90034-5; Weingart S, EMCRIT PODCAST 78 IN; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wilson MH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-24; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	179	6	6	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	FEB	2018	36	1					107	+		10.1016/j.emc.2017.08.007			28	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FQ8TD	WOS:000418635200008	29132572				2022-02-06	
J	Rakers, SE; Scheenen, ME; Westerhof-Evers, HJ; de Koning, ME; van der Horn, HJ; van der Naalt, J; Spikman, JM				Rakers, Sandra E.; Scheenen, Myrthe E.; Westerhof-Evers, Herma J.; de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje; Spikman, Jacoba M.			Executive Functioning in Relation to Coping in Mild Versus Moderate-Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						executive functioning; coping; traumatic brain injury; injury severity	COGNITIVE IMPAIRMENT; ECOLOGICAL VALIDITY; SELF-AWARENESS; PERSPECTIVE; PREDICTORS; SYMPTOMS; PATTERNS; SEQUELAE; STRESS; HEALTH	Objective: To examine associations between executive functioning (EF) and coping styles, separately for mild and moderate-severe traumatic brain injury (TBI) in the chronic phase postinjury. Method: Patients with mild (n = 47) and moderate-severe TBI (n = 59) were included, in addition to healthy controls (HCs; n = 51). Assessment consisted of EF tests (Trail Making Test, Zoo Map Test, Controlled Oral Word Association Test) and questionnaires examining EF (Dysexecutive Questionnaire) and coping styles (Utrecht Coping List). Results: Moderate-severe TBI patients showed significant more EF deficits, lower active coping and higher passive coping than mild TBI patients and HCs, whereas mild TBI patients did not differ from HCs. In the moderate-severe TBI group, a higher number of self-reported EF problems was related to lower levels of active coping, r = -.43, p < .01 and higher levels of passive coping, r = .58, p < .001, with proxy-reports relating to lower levels of active coping, r = -.33, p < .05. For mild TBI, a higher amount of self-reported EF problems was related to lower levels of active coping, r = -.38, p < .05 and higher levels of passive coping, r = .55, p < .001, with proxy-reports relating to higher levels of passive coping, r = .39, p < .05. Except for mental flexibility, EF performances were not associated with coping. Conclusions: This study shows strong associations between reported EF problems in daily life and coping styles. For moderate-severe TBI, proxy-reports may reflect EF impairments that complicate active problem-solving. However, reported EF problems by mild and moderate-severe TBI patients are also likely to reflect a psychological distress related to the way patients are inclined to deal with stressing situations that put a demand on their executive abilities.	[Rakers, Sandra E.; Scheenen, Myrthe E.; Westerhof-Evers, Herma J.; de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1, NL-9700RB Groningen, Netherlands; [Westerhof-Evers, Herma J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands		Rakers, SE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1, NL-9700RB Groningen, Netherlands.	s.e.rakers@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation	This research was supported by grants from the Dutch Brain Foundation and was in part presented at the Eleventh World Congress on Brain Injury, The Hague, the Netherlands, March 2-5, 2016.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Brands I, 2014, J REHABIL MED, V46, P869, DOI 10.2340/16501977-1849; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Folkman S., 1984, STRESS; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gregorio GW, 2015, BRIT J CLIN PSYCHOL, V54, P291, DOI 10.1111/bjc.12074; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schreurs P. J. G., 1993, UTRECHT COPING LIST; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Sherer M, 2014, HDB NEUROPSYCHOLOGY; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman J. M., 2015, BRAIN INJURY, V9052, P1; Spikman JM, 2016, J NEUROTRAUM, V33, P22, DOI 10.1089/neu.2014.3788; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wilder-Willis KE, 2002, SCHIZOPHR RES, V55, P259, DOI 10.1016/S0920-9964(01)00211-0; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	47	6	6	0	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	FEB	2018	32	2					213	219		10.1037/neu0000399			7	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FY7LU	WOS:000427044500009	29035067	Green Published			2022-02-06	
J	Rosenthal, S; Gray, M; Fatima, H; Sair, HI; Whitlow, CT				Rosenthal, Scott; Gray, Matthew; Fatima, Hudaisa; Sair, Haris I.; Whitlow, Christopher T.			Functional MR Imaging: Blood Oxygen Level-Dependent and Resting State Techniques in Mild Traumatic Brain Injury	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Functional MR imaging; Blood oxygen level dependent; Resting state; Mild traumatic brain injury	DEFAULT-MODE NETWORK; SPORTS-RELATED CONCUSSION; CONNECTIVITY; ABNORMALITIES; ASSOCIATIONS; INDIVIDUALS; BIOMARKER; RECOVERY; OUTCOMES; METRICS	This article discusses mild traumatic brain injury (mTBI)-associated effects on brain functional connectivity assessed via resting-state functional MR imaging. Several studies have reported acute postinjury default mode network hyperconnectivity, followed by a period of decreased connectivity before later connectivity normalization in some patients. Other studies have reported mTBI-associated effects on connectivity that remain evident for up to 5 years or more. Discordance in the published literature regarding the direction of network connectivity changes (eg, increased versus decreased connectivity) may reflect differences in timing of data collection post injury, as well as the need to standardize MR imaging acquisition protocols and processing methods.	[Rosenthal, Scott; Gray, Matthew; Fatima, Hudaisa; Whitlow, Christopher T.] Wake Forest Sch Med, RIIPL, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Rosenthal, Scott; Gray, Matthew; Fatima, Hudaisa; Whitlow, Christopher T.] Wake Forest Sch Med, Div Neuroradiol, Dept Radiol, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Sair, Haris I.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Neuroradiol, 601 North Caroline St, Baltimore, MD 21205 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Biomed Engn, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, CTSI, Med Ctr Blvd, Winston Salem, NC 27157 USA		Whitlow, CT (corresponding author), Wake Forest Sch Med, Dept Radiol, Clin Translat Sci Inst, Dept Biomed Engn, Med Ctr Blvd, Winston Salem, NC 27157 USA.	cwhitlow@wakehealth.edu					Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sours C, 2015, BRAIN CONNECT, V5, P442, DOI 10.1089/brain.2014.0333; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Toth A., 2015, BRAIN NEUROTRAUMA MO, P329; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Whitlow CT, 2011, RADIOLOGY, V259, P516, DOI 10.1148/radiol.11101708; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Xiong KL, 2016, NEURORADIOLOGY, V58, P733, DOI 10.1007/s00234-016-1675-0; Young GR, 2017, JAMA-J AM MED ASSOC, V317, P1375, DOI 10.1001/jama.2017.1322; Zhan J, 2015, J NERV MENT DIS, V203, P786, DOI 10.1097/NMD.0000000000000368; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhou YX, 2017, J MAGN RESON IMAGING, V46, P518, DOI 10.1002/jmri.25548; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; Zhu DC, 2014, J NEUROIMAGING, V24, P176, DOI 10.1111/j.1552-6569.2012.00768.x	46	6	6	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					107	+		10.1016/j.nic.2017.09.008			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900011	29157847				2022-02-06	
J	Waheed, S; Baig, MA; Siddiqui, E; Jamil, D; Bashar, M; Feroze, A				Waheed, Shahan; Baig, Muhammad Akbar; Siddiqui, Emaduddin; Jamil, Danyal; Bashar, Masharib; Feroze, Asher			Prognostic significance of optic nerve sheath diameter on computed tomography scan with severity of blunt traumatic brain injury in the emergency department	JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION			English	Article						Traumatic brain injury; Head injury; Optic nerve sheath diameter; Computed tomography	INTRACRANIAL-PRESSURE; ULTRASONOGRAPHY	Optic nerve sheath diameter measurement (ONSD) has been associated with identifying the prognosis of traumatic brain injury (TBI) patients. The study was planned to evaluate the prognostic value of ONSD measured on the initial brain computed tomography (CT) scan performed on patients with blunt TBI in the emergency department(ED). This retrospective cross-sectional study was conducted at the Aga Khan University Hospital, Karachi, and comprised data of moderate and severe TBI patients from January to December 2014. ONSD for each eye on the initial CT scan and Glasgow Coma Scale (GCS) was measured upon patient presentation. Correlation between presentation GCS and ONSD was done through Pearson's correlation. Receiver operator curve (ROC) analysis was done to measure the predictive values of ONSD for mortality. Of the 276 patients, 211(76%) were males and 65(23%) females. ONSD was measured on 160(58%) patients. The mean ONSD measured on CT scan was 3.8 +/- 1. The Pearson's correlation between the severity of brain injury as per GCS at presentation and ONSD was not significant (-0.182). We concluded that ONSD measured on the initial CT brain scan had good association with the severity of blunt TBI in patients presenting to the ED.	[Waheed, Shahan; Baig, Muhammad Akbar; Siddiqui, Emaduddin] Aga Khan Univ Hosp, Dept Emergency Med, Karachi, Pakistan; [Jamil, Danyal; Bashar, Masharib] Dow Univ Hlth Sci, Karachi, Pakistan; [Feroze, Asher] Aman Fdn, Karachi, Pakistan		Baig, MA (corresponding author), Aga Khan Univ Hosp, Dept Emergency Med, Karachi, Pakistan.	dr_akbar2007@hotmail.com					Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Cammarata G, 2011, J TRAUMA, V71, P779, DOI 10.1097/TA.0b013e3182220673; Carenini BB, 2002, ACTA OPHTHALMOL SCAN, V80, P40; Coronado VG, SURVEILLANCE TRAUMAT; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hansen HC, 2011, ACTA OPHTHALMOL, V89, pE528, DOI 10.1111/j.1755-3768.2011.02159.x; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Umerani MS, 2014, TURK NEUROSURG, V24, P19, DOI 10.5137/1019-5149.JTN.7080-12.1; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Watanabe Y, 2006, J NEUROSURG, V105, P190, DOI 10.3171/sup.2006.105.7.190	13	6	6	0	2	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0030-9982			J PAK MED ASSOC	J. Pak. Med. Assoc.	FEB	2018	68	2					268	271					4	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	GG1OR	WOS:000432456900021	29479105				2022-02-06	
J	Wilson, KM; de Joux, NR; Finkbeiner, KM; Russell, PN; Retzler, JR; Helton, WS				Wilson, Kyle M.; de Joux, Neil R.; Finkbeiner, Kristin M.; Russell, Paul N.; Retzler, Jenny R.; Helton, William S.			Prolonging the response movement inhibits the feed-forward motor program in the sustained attention to response task	ACTA PSYCHOLOGICA			English	Article						Attention; SART; Sustained attention; Speed accuracy trade-off; Response inhibition; Mind-wandering	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; MIND; PERFORMANCE; FAILURES; STIMULI; LAPSES; ADHD; VARIABILITY; VIGILANCE	Despite widespread use in clinical and experimental contexts, debate continues over whether or not the Sustained Attention to Response Task (SART) successfully measures sustained attention. Altering physical aspects of the response movement required to SART stimuli may help identify whether performance is a better measure of perceptual decoupling, or response strategies and motor inhibition. Participants completed a SART where they had to manually move a mouse cursor to respond to stimuli, and another SART where this extra movement was not required, as in a typical SART. Additionally, stimuli were located at either a close or a far distance away. Commission errors were inversely related to distance in the manual movement condition, as the farther distance led to longer response times which gave participants more time to inhibit prepotent responses and thus prevent commission errors. Self-reported measures of mental demand and fatigue suggested there were no differences in mental demands between the manual and automatic condition; instead the differences were primarily in physical demands. No differences were found for task-unrelated thoughts between the manual and automatic condition. The movement effect combined with participants' subjective reports are evidence for time dependent action stopping, not greater cognitive engagement. These findings support a response strategy perspective as opposed to a perceptual decoupling perspective, and have implications for authors considering using the SART. Applied implications of this research are also discussed.	[Wilson, Kyle M.] Univ Huddersfield, Dept Psychol, Huddersfield HD1 3DH, W Yorkshire, England; [de Joux, Neil R.] Univ Nottingham, Dept Psychol, Nottingham, England; [Finkbeiner, Kristin M.; Russell, Paul N.] Univ Canterbury, Dept Psychol, Christchurch, New Zealand; [Retzler, Jenny R.] Univ York, York Hlth Econ Consortium, York, N Yorkshire, England; [Helton, William S.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA		Wilson, KM (corresponding author), Univ Huddersfield, Dept Psychol, Huddersfield HD1 3DH, W Yorkshire, England.	k.wilson@hud.ac.uk		Wilson, Kyle/0000-0003-4587-6105; Retzler, Jenny/0000-0002-0008-3104			Anderson JR., 1998, ATOMIC COMPONENTS TH; Bailey L. L., 2001, P 11 INT S AV PSYCH, P1; Bellgrove MA, 2006, CORTEX, V42, P838, DOI 10.1016/S0010-9452(08)70426-X; Blakely M. J., 2014, THESIS; Chan RCK, 2001, BRAIN INJURY, V15, P819, DOI 10.1080/02699050110034325; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; de Joux NR, 2017, NEUROPSYCHOLOGIA, V94, P106, DOI 10.1016/j.neuropsychologia.2016.12.001; Diaz-Ramiro E., 2010, REV PSICOLOGIA TRABA, V26, P191, DOI [DOI 10.5093/TR2010V26N3A3, 10.5093/tr2010v26n3a3]; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Egeland K., 2014, THESIS; Finkbeiner KM, 2015, EXP BRAIN RES, V233, P1061, DOI 10.1007/s00221-014-4179-3; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Hancock N. J., 2015, THESIS; HART S G, 1988, P139; Head J, 2016, EXPT BRAIN RES, P1; Head J., 2013, CONSCIOUSNESS CONG I, Vi22, P323; Head J, 2014, ACTA PSYCHOL, V153, P87, DOI 10.1016/j.actpsy.2014.09.007; Head J, 2014, EXP BRAIN RES, V232, P565, DOI 10.1007/s00221-013-3765-0; Head J, 2012, CONSCIOUS COGN, V21, P1617, DOI 10.1016/j.concog.2012.08.009; Head J, 2012, EXP BRAIN RES, V216, P103, DOI 10.1007/s00221-011-2914-6; Helton WS, 2011, THEOR ISS ERGON SCI, V12, P397, DOI 10.1080/1463922X.2010.539288; Helton WS, 2011, EXP BRAIN RES, V209, P401, DOI 10.1007/s00221-011-2563-9; Helton WS, 2010, CONSCIOUS COGN, V19, P77, DOI 10.1016/j.concog.2010.01.006; Helton WS, 2009, CONSCIOUS COGN, V18, P600, DOI 10.1016/j.concog.2009.06.002; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Helton WS, 2005, BRIT J PSYCHOL, V96, P249, DOI 10.1348/000712605X38369; HOLM S, 1979, SCAND J STAT, V6, P65; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Manly T., 2000, CLIN NEUROPSYCHOLOGI, V3; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McVay JC, 2009, J EXP PSYCHOL LEARN, V35, P196, DOI 10.1037/a0014104; Mullins C, 2005, J AM ACAD CHILD PSY, V44, P169, DOI 10.1097/00004583-200502000-00009; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Park E, 2009, KOREAN J LAB MED, V29, P1, DOI 10.3343/kjlm.2009.29.1.1; Peebles D, 2004, PROCEEDINGS OF THE SIXTH INTERNATIONAL CONFERENCE ON COGNITIVE MODELING, P231; Ramautar JR, 2004, BRAIN COGNITION, V56, P234, DOI 10.1016/j.bandc.2004.07.002; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Seli P, 2013, FRONT PSYCHOL, V4, P1, DOI DOI 10.3389/FPSYG.2013; Seli P, 2013, BEHAV RES METHODS, V45, P355, DOI 10.3758/s13428-012-0266-1; Seli P, 2012, CONSCIOUS COGN, V21, P277, DOI 10.1016/j.concog.2011.09.017; Sellers J., 2014, P HUM FACT ERG SOC A, V58, P989, DOI DOI 10.1177/154193121; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Szalma JL, 2014, ERGONOMICS, V57, P1315, DOI 10.1080/00140139.2014.921329; Wilson KM, 2015, HUM FACTORS, V57, P1219, DOI 10.1177/0018720815605703; Wilson KM, 2015, CONSCIOUS COGN, V33, P406, DOI 10.1016/j.concog.2015.02.014	55	6	6	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-6918	1873-6297		ACTA PSYCHOL	Acta Psychol.	FEB	2018	183						75	84		10.1016/j.actpsy.2018.01.001			10	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	FW8HT	WOS:000425573000010	29351864	hybrid, Green Published			2022-02-06	
J	Plummer, MP; Notkina, N; Timofeev, I; Hutchinson, PJ; Finnis, ME; Gupta, AK				Plummer, Mark P.; Notkina, Natalia; Timofeev, Ivan; Hutchinson, Peter J.; Finnis, Mark E.; Gupta, Arun K.			Cerebral metabolic effects of strict versus conventional glycaemic targets following severe traumatic brain injury	CRITICAL CARE			English	Article						Traumatic brain injury; Insulin; Glucose; Microdialysis	CRITICALLY-ILL PATIENTS; INTENSIVE INSULIN THERAPY; GLUCOSE-METABOLISM; MICRODIALYSIS; IMPACT; HYPERGLYCEMIA; HYPOGLYCEMIA; CHEMISTRY; TRIAL; DEATH	Background: Optimal glycaemic targets for patients with severe traumatic brain injury remain unclear. The primary objective of this microdialysis study was to compare cerebral metabolism with strict versus conventional glycaemic control. Methods: We performed a prospective single-centre randomised controlled within-subject crossover study of 20 adult patients admitted to an academic neurointensive care unit with severe traumatic brain injury. Patients underwent randomised, consecutive 24-h periods of strict (4-7 mmol/L; 72-126 mg/dl) and conventional (<10 mmol/L; 180 mg/dl) glycaemic control with microdialysis measurements performed hourly. The first 12 h of each study period was designated as a 'washout' period, with the subsequent 12 h being the period of interest. Results: Cerebral glucose was lower during strict glycaemia than with conventional control (mean 1.05 [95% CI 0.58-1. 51] mmol/L versus 1.28 [0.81-1.74] mmol/L; P = 0.03), as was lactate (3.07 [2.44-3.70] versus 3.56 [2.81-4.30]; P <0.001). There were no significant differences in pyruvate or the lactate/pyruvate ratio between treatment phases. Strict glycaemia increased the frequency of low cerebral glucose (<0.8 mmol/L; OR 1.91 [95% CI 1.01-3.65]; P <0.05); however, there were no differences in the frequency of critically low glucose (<0.2 mmol/L) or critically elevated lactate/pyruvate ratio between phases. Conclusions: Compared with conventional glycaemic targets, strict blood glucose control was associated with lower mean levels of cerebral glucose and an increased frequency of abnormally low glucose levels. These data support conventional glycaemic targets following traumatic brain injury.	[Plummer, Mark P.; Gupta, Arun K.] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge CB2 0QQ, England; [Notkina, Natalia; Gupta, Arun K.] Univ Cambridge, Dept Med, Div Anaesthesia, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Timofeev, Ivan; Hutchinson, Peter J.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Finnis, Mark E.] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA 5000, Australia		Gupta, AK (corresponding author), Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge CB2 0QQ, England.; Gupta, AK (corresponding author), Univ Cambridge, Dept Med, Div Anaesthesia, Addenbrookes Hosp, Cambridge CB2 0QQ, England.	akg01@icloud.com	Timofeev, Ivan/AAE-7019-2019	Hutchinson, Peter/0000-0002-2796-1835; Timofeev, Ivan/0000-0002-1168-0393; Plummer, Mark/0000-0002-9640-1911	Academy Medical of Sciences / Health Foundation; NIHRNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390, G1002277, G0601025, G0502030] Funding Source: UKRI	None to declare. PJH was supported by the Academy Medical of Sciences / Health Foundation, NIHR and the MRC.	Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Jauch-Chara K, 2014, NEUROSCIENCE, V283, P202, DOI 10.1016/j.neuroscience.2014.04.059; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Laver S, 2004, ANAESTH INTENS CARE, V32, P311, DOI 10.1177/0310057X0403200302; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Schlenk F, 2009, NEUROCRIT CARE, V11, P56, DOI 10.1007/s12028-009-9222-z; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Yatabe T, 2017, INTENS CARE MED, V43, P16, DOI 10.1007/s00134-016-4558-2	28	6	6	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	JAN 25	2018	22								16	10.1186/s13054-017-1933-5			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT7KM	WOS:000423331300001	29368635	Green Published, gold, Green Submitted			2022-02-06	
J	Tchantchou, F; Puche, AA; Leiste, U; Fourney, W; Blanpied, TA; Fiskum, G				Tchantchou, Flaubert; Puche, Adam A.; Leiste, Ulrich; Fourney, William; Blanpied, Thomas A.; Fiskum, Gary			Rat Model of Brain Injury to Occupants of Vehicles Targeted by Land Mines: Mitigation by Elastomeric Frame Designs	JOURNAL OF NEUROTRAUMA			English	Article						acceleration; blast; blood-brain barrier; inflammation; synapses	IMPROVES FUNCTIONAL RECOVERY; SPECTRIN BREAKDOWN PRODUCTS; ALPHA-II-SPECTRIN; UP-REGULATION; MOUSE MODEL; PHOSPHORYLATION; INFLAMMATION; HIPPOCAMPUS; SURVIVAL; BARRIER	Many victims of blast traumatic brain injury (TBI) are occupants of vehicles targeted by land mines. A rat model of under-vehicle blast TBI was used to test the hypothesis that the ensuing neuropathology and altered behavior are mitigated by vehicle frame designs that dramatically reduce blast-induced acceleration (G force). Male rats were restrained on an aluminum platform that was accelerated vertically at up to 2850g, in response to detonation of an explosive positioned under a second platform in contact with the top via different structures. The presence of elastomeric, polyurea-coated aluminum cylinders between the platforms reduced acceleration by 80% to 550g compared with 2350g with uncoated cylinders. Moreover, 67% of rats exposed to 2850g, and 20% of those exposed to 2350g died immediately after blast, whereas all rats subjected to 550g blast survived. Assays for working memory (Y maze) and anxiety (Plus maze) were conducted for up to 28 days. Rats were euthanized at 24h or 29 days, and their brains were used for histopathology and neurochemical measurements. Rats exposed to 2350g blasts exhibited increased cleaved caspase-3 immunoreactive neurons in the hippocampus. There was also increased vascular immunoglobulin (Ig)G effusion and F4/80 immunopositive macrophages/microglia. Blast exposure reduced hippocampal levels of synaptic proteins Bassoon and Homer-1, which were associated with impaired performance in the Y maze and the Plus maze tests. These changes observed after 2350g blasts were reduced or eliminated with the use of polyurea-coated cylinders. Such advances in vehicle designs should aid in the development of the next generation of blast-resistant vehicles.	[Tchantchou, Flaubert; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Tchantchou, Flaubert; Fiskum, Gary] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Puche, Adam A.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Blanpied, Thomas A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Leiste, Ulrich; Fourney, William] Univ Maryland, Sch Engn, Dept Aerosp Engn, Baltimore, MD 21201 USA		Fiskum, G (corresponding author), Univ Maryland, Sch Med, 685 W Baltimore St,MSTF 5-34, Baltimore, MD 21201 USA.	gfiskum@som.umaryland.edu		Blanpied, Thomas/0000-0003-4957-557X	US ArmyUnited States Department of Defense [W81XWH-13-1-0016]; US Air ForceUnited States Department of Defense [FA8650-11-2-6D04]	We thank Ashley Moore and Julie L. Proctor for their participation in the blast experiments. This study was funded by US Army W81XWH-13-1-0016 and US Air Force FA8650-11-2-6D04.	Agoston D.V., 2015, BRAIN NEUROTRAUMA MO; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bonsmann J., 2015, J DYNAMIC BEHAV MAT, V1, P259, DOI DOI 10.1007/S40870-015-0023-5; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; CHABAI AJ, 1965, J GEOPHYS RES, V70, P5075, DOI 10.1029/JZ070i020p05075; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Hilton KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068062; Hopkinson B., 1915, BRIT ORDNANCE BOARD; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Kurbatskaya K, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0299-2; Liu Y, 2004, J IMMUNOL, V172, P7, DOI 10.4049/jimmunol.172.1.7; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; McKinstry SU, 2014, J NEUROSCI, V34, P9455, DOI 10.1523/JNEUROSCI.4699-13.2014; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Proctor JL, 2017, J TRAUMA ACUTE CARE, V83, pS35, DOI 10.1097/TA.0000000000001478; Proctor JL, 2014, J TRAUMA ACUTE CARE, V77, pS83, DOI 10.1097/TA.0000000000000340; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Schober ME, 2014, BRAIN RES, V1574, P105, DOI 10.1016/j.brainres.2014.05.046; Subramanian M, 2007, J IMMUNOL, V179, P2330, DOI 10.4049/jimmunol.179.4.2330; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com; Tchantchou F, 2017, EXP NEUROL, V289, P9, DOI 10.1016/j.expneurol.2016.12.001; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Tom V.B., US TODAY; Zhao X, 2013, INT J IMPACT ENG, V54, P31, DOI 10.1016/j.ijimpeng.2012.10.016	31	6	7	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1192	1203		10.1089/neu.2017.5401		JAN 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000423423600001	29187028	Green Published			2022-02-06	
J	Muller, AM; Virji-Babul, N				Muller, Angela M.; Virji-Babul, Naznin			Stuck in a State of Inattention? Functional Hyperconnectivity as an Indicator of Disturbed Intrinsic Brain Dynamics in Adolescents With Concussion: A Pilot Study	ASN NEURO			English	Article						concussion; adolescents; attention; intrinsic dynamics; multimodal magnetic resonance imaging; networks; rich club	SPORTS-RELATED CONCUSSION; CONNECTIVITY; INJURY; NETWORKS; EPIDEMIOLOGY; PARCELLATION; ACTIVATIONS; INTEGRITY; ATTENTION	Sports-related concussion in youth is a major public health issue. Evaluating the diffuse and often subtle changes in structure and function that occur in the brain, particularly in this population, remains a significant challenge. The goal of this pilot study was to evaluate the relationship between the intrinsic dynamics of the brain using resting-state functional magnetic resonance imaging (rs-fMRI) and relate these findings to structural brain correlates from diffusion tensor imaging in a group of adolescents with sports-related concussions (n=6) and a group of healthy adolescent athletes (n=6). We analyzed rs-fMRI data using a sliding windows approach and related the functional findings to structural brain correlates by applying graph theory analysis to the diffusion tensor imaging data. Within the resting-state condition, we extracted three separate brain states in both groups. Our analysis revealed that the brain dynamics in healthy adolescents was characterized by a dynamic pattern, shifting equally between three brain states; however, in adolescents with concussion, the pattern was more static with a longer time spent in one brain state. Importantly, this lack of dynamic flexibility in the concussed group was associated with increased nodal strength in the left middle frontal gyrus, suggesting reorganization in a region related to attention. This preliminary report shows that both the intrinsic brain dynamics and structural organization are altered in networks related to attention in adolescents with concussion. This first report in adolescents will be used to inform future studies in a larger cohort.	[Muller, Angela M.; Virji-Babul, Naznin] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada		Muller, AM (corresponding author), Univ British Columbia, Ctr Brain Hlth, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	angelamartinamueller@outlook.com		Virji-Babul, Naznin/0000-0002-8984-5848	Mitacs Accelerate Award [IT06624]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: AMM was funded by a Mitacs Accelerate Award (IT06624).	Agarwal S, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.495; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Betzel RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30770; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Burianova H, 2015, NEUROBIOL AGING, V36, P2830, DOI 10.1016/j.neurobiolaging.2015.07.006; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Deco G, 2017, NEUROIMAGE, V146, P197, DOI 10.1016/j.neuroimage.2016.10.047; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gollo LL, 2015, PHILOS T R SOC B, V370, P54, DOI 10.1098/rstb.2014.0165; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Hellyer PJ, 2014, J NEUROSCI, V34, P451, DOI 10.1523/JNEUROSCI.1853-13.2014; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones DT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039731, 10.1371/journal.pone.0044294]; Karahanolu FI, 2015, NAT COMMUN, V6; Laumann TO, 2017, CEREB CORTEX, V27, P4719, DOI 10.1093/cercor/bhw265; Leemans A., 2009, 17 ANN M INT SOC MAG, DOI DOI 10.1093/OCCMED/KQR069; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Marstaller L, 2015, NEUROSCIENCE, V290, P369, DOI 10.1016/j.neuroscience.2015.01.049; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Mayr U, 2014, COGNITIVE PSYCHOL, V72, P1, DOI 10.1016/j.cogpsych.2014.02.001; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Misic B, 2016, CEREB CORTEX, V26, P3285, DOI 10.1093/cercor/bhw089; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Olsen A, 2015, CEREB CORTEX, V25, P2170, DOI 10.1093/cercor/bhu023; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rolls ET, 2015, NEUROIMAGE, V122, P1, DOI 10.1016/j.neuroimage.2015.07.075; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005	68	6	6	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	JAN 22	2018	10									10.1177/1759091417753802			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT5DD	WOS:000423173300001	29357675	Green Published, gold			2022-02-06	
J	DeWalt, GJ; Mahajan, B; Foster, AR; Thompson, LDE; Marttini, AA; Schmidt, EV; Mansuri, S; D'Souza, D; Patel, SB; Tenenbaum, M; Brandao-Viruet, KI; Thompson, D; Duong, B; Smith, DH; Blute, TA; Eldred, WD				DeWalt, Gloria J.; Mahajan, Biraaj; Foster, Andrea R.; Thompson, Lauren D. E.; Marttini, Andrew A.; Schmidt, Eric V.; Mansuri, Sara; D'Souza, Dwayne; Patel, Shama B.; Tenenbaum, Madeline; Brandao-Viruet, Karla I.; Thompson, Dominique; Duong, Bryan; Smith, Danica H.; Blute, Todd A.; Eldred, William D.			Region-specific alterations in astrocyte and microglia morphology following exposure to blasts in the mouse hippocampus	NEUROSCIENCE LETTERS			English	Article						Stratum lacunosm moleculare; Outer molecular layer; Glia; Blast injury; Ketamine/xylazine	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; ANESTHETICS; NEURODEGENERATION; DISEASE; BLOOD	Traumatic brain injury (TBI) is a serious public health concern, especially injuries from repetitive insults. The main objective of this study was to immunocytochemically examine morphological alterations in astrocytes and microglia in the hippocampus 48 h following a single blast versus multiple blasts in adult C57BL/6 mice. The effects of ketamine and xylazine (KX), two common anesthetic agents used in TBI research, were also evaluated due to the confounding effect of anesthetics on injury outcome. Results showed a significant increase in hypertrophic microglia that was limited to the outer molecular layer of the dentate gyrus, but only in the absence of KX. Although the presence or absence of KX had no effect on astrocytes following a single blast, a significant decrease in astrocytic immunoreactivity was observed in the stratum lacunosum moleculare following multiple blasts in the absence of KX. The morphological changes in astrocytes and microglia reported in this study reveal region-specific differences in the absence of KX that could have significant implications for our interpretation of glial alterations in animal models of injury.	[DeWalt, Gloria J.; Mahajan, Biraaj; Foster, Andrea R.; Thompson, Lauren D. E.; Marttini, Andrew A.; Schmidt, Eric V.; Mansuri, Sara; D'Souza, Dwayne; Patel, Shama B.; Tenenbaum, Madeline; Brandao-Viruet, Karla I.; Thompson, Dominique; Duong, Bryan; Smith, Danica H.; Blute, Todd A.; Eldred, William D.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA		DeWalt, GJ (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	dewaltg@bu.edu	Thompson, Lester D. R./J-8404-2016	Thompson, Lester D. R./0000-0003-3714-1432	Boston University Undergraduate Research Opportunities Program; HHMIHoward Hughes Medical Institute; Summer Undergraduate Research Fellowship Program (National Science Foundation)	Boston University Undergraduate Research Opportunities Programs to: ARF, LDET, EVS, DD, SBP, MT, KBV. HHMI to: ARF. Summer Undergraduate Research Fellowship Program (National Science Foundation) to: AAM, DT.	Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; AMADUCCI L, 1981, NEUROSCI LETT, V21, P27, DOI 10.1016/0304-3940(81)90052-5; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Armstrong C, 2011, J COMP NEUROL, V519, P1476, DOI 10.1002/cne.22577; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V82, P3213, DOI 10.1152/jn.1999.82.6.3213; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Franklin K. B. J., 2008, MOUSE BRAIN STEREOTA, P256; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Huuskonen MT, 2017, NEUROTHERAPEUTICS, V14, P519, DOI 10.1007/s13311-016-0504-9; Jinno S, 2007, GLIA, V55, P1334, DOI 10.1002/glia.20552; Kannan G, 2017, J CONTROL RELEASE, V263, P192, DOI 10.1016/j.jconrel.2017.03.032; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lei X, 2012, INT J MOL SCI, V13, P6772, DOI 10.3390/ijms13066772; LUNDANDERSEN H, 1979, PHYSIOL REV, V59, P305, DOI 10.1152/physrev.1979.59.2.305; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; PARDRIDGE WM, 1983, PHYSIOL REV, V63, P1481, DOI 10.1152/physrev.1983.63.4.1481; Patt S, 1999, EXP TOXICOL PATHOL, V51, P119, DOI 10.1016/S0940-2993(99)80084-0; Peredeny JV, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00017; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; SHIMADA M, 1992, J ANAT, V180, P89; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang LQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9966; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	46	6	6	1	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 18	2018	664						160	166		10.1016/j.neulet.2017.11.016			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FX6ZK	WOS:000426235600026	29133177				2022-02-06	
J	Avila-Luna, A; Galvez-Rosas, A; Alfaro-Rodriguez, A; Reyes-Legorreta, C; Garza-Montano, P; Gonzalez-Pina, R; Bueno-Nava, A				Avila-Luna, Alberto; Galvez-Rosas, Arturo; Alfaro-Rodriguez, Alfonso; Reyes-Legorreta, Celia; Garza-Montano, Paloma; Gonzalez-Pina, Rigoberto; Bueno-Nava, Antonio			Dopamine D-1 receptor activation maintains motor coordination in injured rats but does not accelerate the recovery of the motor coordination deficit	BEHAVIOURAL BRAIN RESEARCH			English	Article						Dopamine; Striatum; D-1 receptor; Motor coordination; Cortical injury	TRAUMATIC BRAIN-INJURY; LIPID-PEROXIDATION; BASAL GANGLIA; CORTEX; D1; CEREBELLUM; EPIDEMIOLOGY; ORGANIZATION; EXPRESSION; DEPLETION	The sensorimotor cortex and the striatum are interconnected by the corticostriatal pathway, suggesting that cortical injury alters the striatal function that is associated with skilled movements and motor learning, which are functions that may be modulated by dopamine (DA). In this study, we explored motor coordination and balance in order to investigate whether the activation of D-1 receptors (D(1)Rs) modulates functional recovery after cortical injury. The results of the beam-walking test showed motor deficit in the injured group at 24, 48 and 96 h post-injury, and the recovery time was observed at 192 h after cortical injury. In the sham and injured rats, systemic administration of the D1R antagonist SCH-23390 (1 mg/kg) alone at 24, 48, 96 and 192 h significantly (P < 0.01) increased the motor deficit, while administration of the D1R agonist SKF-38393 alone (2, 3 and 4 mg/kg) at 24, 48, 96 and 192 h post-injury did not produce a significant difference; however, the co-administration of SKF-38393 and SCH-23390 prevented the antagonist-induced increase in the motor deficit. The cortical + striatal injury showed significantly increased the motor deficit at 24, 48, 96 and 192 h post-injury (P < 0.01) but did not show recovery at 192 h. In conclusion, the administration of the D1R agonist did not accelerate the motor recovery, but the activation of D(1)Rs maintained motor coordination, confirming that an intact striatum may be necessary for achieving recovery.	[Avila-Luna, Alberto; Galvez-Rosas, Arturo; Alfaro-Rodriguez, Alfonso; Reyes-Legorreta, Celia; Garza-Montano, Paloma; Gonzalez-Pina, Rigoberto; Bueno-Nava, Antonio] Inst Nacl Rehabil Luis Guillermo Ibarra Ibarra, Secretaria Salud, Div Neurociencias, Calzada Mexico Xochimilco 289, Mexico City 14389, DF, Mexico		Bueno-Nava, A (corresponding author), Inst Nacl Rehabil Luis Guillermo Ibarra Ibarra, Secretaria Salud, Div Neurociencias, Calzada Mexico Xochimilco 289, Mexico City 14389, DF, Mexico.	abueno@inr.gob.mx	Gonzalez-Pina, Rigoberto/AAE-9961-2020	GONZALEZ-PINA, RIGOBERTO/0000-0002-0323-043X; Bueno-Nava, Antonio/0000-0003-0291-4554; Alfaro-Rodriguez, Alfonso/0000-0002-4599-1253			Agmo A., 1996, J NEURAL T, V1999, P219; Alfaro-Rodriguez A, 2013, NEUROSCI LETT, V552, P5, DOI 10.1016/j.neulet.2013.07.026; Avila-Luna A, 2015, NEUROCHEM RES, V40, P1431, DOI 10.1007/s11064-015-1611-4; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barili P, 2000, BRAIN RES, V854, P130, DOI 10.1016/S0006-8993(99)02306-9; Bergson C, 1995, J NEUROSCI, V15, P7821; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bostan AC, 2010, NEUROPSYCHOL REV, V20, P261, DOI 10.1007/s11065-010-9143-9; BRAILOWSKY S, 1986, BRAIN RES, V362, P322, DOI 10.1016/0006-8993(86)90457-9; Bueno-Nava A, 2012, NEUROCHEM RES, V37, P1783, DOI 10.1007/s11064-012-0790-5; Bueno-Nava A, 2008, NEUROSCI LETT, V443, P32, DOI 10.1016/j.neulet.2008.07.046; Bueno-Nava A, 2010, NEUROCHEM RES, V35, P1538, DOI 10.1007/s11064-010-0213-4; Cadet JL, 2010, CNS NEUROL DISORD-DR, V9, P526; Chagniel L, 2012, BEHAV BRAIN RES, V228, P9, DOI 10.1016/j.bbr.2011.11.019; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Daskalakis ZJ, 2004, J PHYSIOL-LONDON, V557, P689, DOI 10.1113/jphysiol.2003.059808; Davis EJH, 2007, NEUROSCIENCE, V146, P784, DOI 10.1016/j.neuroscience.2007.01.039; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; FESTING MFW, 1994, LAB ANIM, V28, P212, DOI 10.1258/002367794780681697; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; IMPERATO A, 1987, EUR J PHARMACOL, V142, P177, DOI 10.1016/0014-2999(87)90672-8; Kantak SS, 2012, NEUROREHAB NEURAL RE, V26, P282, DOI 10.1177/1545968311420845; Mc William, 1993, CANADIAN COUNCIL ANI, V1, P211; Mendoza G, 2014, PROG NEUROBIOL, V122, P73, DOI 10.1016/j.pneurobio.2014.09.001; MOLLOY AG, 1984, PSYCHOPHARMACOLOGY, V82, P409, DOI 10.1007/BF00427697; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rangel-Barajas C, 2015, AGING DIS, V6, P349, DOI 10.14336/AD.2015.0330; Reep RL, 2003, J COMP NEUROL, V467, P271, DOI 10.1002/cne.10868; Rioult-Pedotti M.S., 2015, PLOS ONE, P2015; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Silberberg G, 2015, CURR OPIN NEUROBIOL, V33, P182, DOI 10.1016/j.conb.2015.05.002; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; TRIGGS WJ, 1984, J NEUROCHEM, V42, P976, DOI 10.1111/j.1471-4159.1984.tb12699.x; Van Vleet TM, 2003, BEHAV BRAIN RES, V138, P165, DOI 10.1016/S0166-4328(02)00246-2; Van Vleet TM, 2000, PSYCHOBIOLOGY, V28, P57; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x	41	6	6	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 15	2018	336						145	150		10.1016/j.bbr.2017.08.026			6	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FK3JT	WOS:000413382100018	28842271				2022-02-06	
J	Boyko, A; Ksenofontov, A; Ryabov, S; Baratova, L; Graf, A; Bunik, V				Boyko, Alexandra; Ksenofontov, Alexander; Ryabov, Sergey; Baratova, Lyudmila; Graf, Anastasia; Bunik, Victoria			Delayed Influence of Spinal Cord Injury on the Amino Acids of NO center dot Metabolism in Rat Cerebral Cortex Is Attenuated by Thiamine	FRONTIERS IN MEDICINE			English	Article						amino acids metabolism; cerebral cortex; nitric oxide precursors; glutathione; spinal cord injury; thiamine	ENDOPLASMIC-RETICULUM STRESS; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; GUANIDINO COMPOUNDS; OXIDATIVE STRESS; 2-OXOGLUTARATE DEHYDROGENASE; GLUTATHIONE SYNTHESIS; CARDIOVASCULAR RISK; NEURODEGENERATION; HOMOARGININE	Severe spinal cord injuries (SCIs) result in chronic neuroinflammation in the brain, associated with the development of cognitive and behavioral impairments. Nitric oxide (NO.) is a gaseous messenger involved in neuronal signaling and inflammation, contributing to nitrosative stress under dysregulated production of reactive nitrogen species. In this work, biochemical changes induced in the cerebral cortex of rats 8 weeks after SCI are assessed by quantification of the levels of amino acids participating in the NO. and glutathione metabolism. The contribution of the injury-induced neurodegeneration is revealed by comparison of the SCI-and laminectomy (LE)-subjected animals. Effects of the operative interventions are assessed by comparison of the operated (LE/SCI) and non-operated animals. Lower ratios of citrulline (Cit) to arginine (Arg) or Cit to ornithine and a more profound decrease in the ratio of lysine to glycine distinguish SCI animals from those after LE. The data suggest decreased NO. production from both Arg and homoarginine in the cortex 8 weeks after SCI. Both LE and SCI groups show a strong decrease in the level of cortex glutathione. The neurotropic, anti-inflammatory, and antioxidant actions of thiamine (vitamin B1) prompted us to study the thiamine effects on the SCI-induced changes in the NO. and glutathione metabolism. A thiamine injection (400 mg/kg intraperitoneally) within 24 h after SCI abrogates the changes in the cerebral cortex amino acids related to NO. Thiamine-induced normalization of the brain glutathione levels after LE and SCI may involve increased supply of glutamate for glutathione biosynthesis. Thus, thiamine protects from sequelae of SCI on NO.-related amino acids and glutathione in cerebral cortex.	[Boyko, Alexandra; Bunik, Victoria] Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Ksenofontov, Alexander; Baratova, Lyudmila; Bunik, Victoria] Lomonosov Moscow State Univ, Belozersky Inst Phys Chem Biol, Moscow, Russia; [Ryabov, Sergey] Minist Hlth Russian Federat, Russian Cardiol Res & Prod Complex, Moscow, Russia; [Graf, Anastasia] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia; [Graf, Anastasia] Moscow Inst Phys & Technol, Fac Nano Bio Informat & Cognit Technol, Moscow, Russia		Bunik, V (corresponding author), Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Moscow, Russia.; Bunik, V (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Phys Chem Biol, Moscow, Russia.	bunik@belozersky.msu.ru	Boyko, Alexandra/AAE-6377-2019; Ksenofontov, Alexander/AAH-1774-2021; Boyko, Alexandra/S-5622-2017; Bunik, Victoria/E-3427-2012; Ksenofontov, Alexander L/D-6747-2012	Boyko, Alexandra/0000-0003-4322-3215; Ksenofontov, Alexander/0000-0003-1585-7907; Boyko, Alexandra/0000-0003-4322-3215; Bunik, Victoria/0000-0002-2552-8560; Ksenofontov, Alexander L/0000-0003-1585-7907; Ryabov, Sergey/0000-0001-8674-8551	Lomonosov Moscow State University [01201353083]; Russian Science FoundationRussian Science Foundation (RSF) [14-15-00133]	Current financial support of the project is provided by Lomonosov Moscow State University (Research Topic No. 01201353083). Financial support of Russian Science Foundation (project No. 14-15-00133, closed in 2016) for the rat model of SCI in Russian Cardiology Research-and-Production Complex, Ministry of Health of the Russian Federation, and quantification of amino acids in the Department of Chromatographic Analysis, Belozersky Institute of Physico-Chemical Biology, is acknowledged.	Ainan S, 2017, J BANGLADESH SOC PHY, V12, P1, DOI [10.3329/jbsp.v12i1.33921, DOI 10.3329/JBSP.V12I1.33921]; Balz D, 2003, INT J DEV NEUROSCI, V21, P75, DOI 10.1016/S0736-5748(02)00138-7; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Buck A, 2017, AMINO ACIDS, V49, P783, DOI 10.1007/s00726-017-2382-9; Bunik VI, 2017, STUD NAT PROD CHEM, V53, P375, DOI 10.1016/B978-0-444-63930-1.00011-9; Bunik V. I., 2014, J ALZHEIMERS DIS PAR, V4, P173, DOI DOI 10.4172/2161-0460.1000173; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cooper AJL, 1997, BIOL CHEM, V378, P793; Cynober L, 2010, CLIN NUTR, V29, P545, DOI 10.1016/j.clnu.2010.07.006; da Silva CG, 1999, BRAIN RES, V838, P78, DOI 10.1016/S0006-8993(99)01671-6; Dasari VR, 2008, NEUROCHEM RES, V33, P134, DOI 10.1007/s11064-007-9426-6; Davids M, 2012, FEBS LETT, V586, P3653, DOI 10.1016/j.febslet.2012.08.020; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Forstermann U, 2006, BIOL CHEM, V387, P1521, DOI 10.1515/BC.2006.190; Gibson GE, 2005, MOL NEUROBIOL, V31, P43, DOI 10.1385/MN:31:1-3:043; Graf A, 2013, INT J BIOCHEM CELL B, V45, P175, DOI 10.1016/j.biocel.2012.07.002; Hansen CN, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00011; Hiramatsu M, 2003, MOL CELL BIOCHEM, V244, P57, DOI 10.1023/A:1022491419813; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Jure I, 2017, NEURAL REGEN RES, V12, P1044, DOI 10.4103/1673-5374.211177; Jure I, 2017, NEUROCHEM RES, V42, P2178, DOI 10.1007/s11064-017-2225-9; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Ke ZJ, 2003, J NEUROPATH EXP NEUR, V62, P195, DOI 10.1093/jnen/62.2.195; Ke ZJ, 2006, NEUROCHEM INT, V49, P548, DOI 10.1016/j.neuint.2006.04.011; Khan M, 2018, BEHAV BRAIN RES, V340, P63, DOI 10.1016/j.bbr.2016.10.037; Khandare AL, 2013, NEUROTOXICOLOGY, V34, P269, DOI 10.1016/j.neuro.2012.11.004; [Ксенофонтов А.Л. Ksenofontov A.L.], 2017, [Биохимия, Biochemistry (Moscow), Biokhimiya], V82, P1538; Liu DX, 2017, MOL NEUROBIOL, V54, P5440, DOI 10.1007/s12035-016-0079-9; Liu HT, 2015, REV NEUROSCIENCE, V26, P105, DOI 10.1515/revneuro-2014-0041; Liu P, 2014, NEUROBIOL AGING, V35, P1992, DOI 10.1016/j.neurobiolaging.2014.03.013; Ljubisavljevic S, 2015, REV NEUROSCIENCE, V26, P49, DOI 10.1515/revneuro-2014-0060; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Marz W, 2010, CIRCULATION, V122, P967, DOI 10.1161/CIRCULATIONAHA.109.908988; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Mengel A, 2017, PLANT PHYSIOL, V173, P1434, DOI 10.1104/pp.16.01734; Mkrtchyan G, 2017, SHOCK, V47, P60; Moallem Seyed Adel, 2008, Iran Biomed J, V12, P173; Navarro D, 2008, J NEUROCHEM, V106, P603, DOI 10.1111/j.1471-4159.2008.05410.x; Ryabov SI, 2014, B EXP BIOL MED+, V157, P85, DOI 10.1007/s10517-014-2498-9; Sierra A, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/610343; Song XS, 2009, ANESTHESIOLOGY, V110, P387, DOI 10.1097/ALN.0b013e3181942f1e; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Tardivo V, 2015, INT J NEUROSCI, V125, P81, DOI 10.3109/00207454.2014.908877; Trofimova L, 2016, CURR ANAL CHEM, V12, P349, DOI 10.2174/1573411011666151006220356; Tsepkova PM, 2017, BIOCHEMISTRY-MOSCOW+, V82, P723, DOI 10.1134/S0006297917060098; Ucal M, 2017, J NEUROTRAUM, V34, P475, DOI 10.1089/neu.2016.4411; Wanchu A, 1999, NITRIC OXIDE-BIOL CH, V3, P454, DOI 10.1006/niox.1999.0261; Wang ZB, 2005, PAIN, V114, P266, DOI 10.1016/j.pain.2004.12.027; Wu GA, 2014, J REHABIL RES DEV, V51, P1265, DOI 10.1682/JRRD.2014.01.0009; Wu JF, 2016, J NEUROTRAUM, V33, P1919, DOI 10.1089/neu.2015.4348; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014	54	6	7	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	JAN 15	2018	4								249	10.3389/fmed.2017.00249			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT0BM	WOS:000422785400001	29379782	Green Published, gold			2022-02-06	
J	Abdulkarim, A; Juhdi, A; Coffey, P; Edelson, L				Abdulkarim, A.; Juhdi, A.; Coffey, P.; Edelson, Lily			Equestrian Injury Presentations to a Regional Trauma Centre in Ireland	EMERGENCY MEDICINE INTERNATIONAL			English	Article							GREAT-BRITAIN; HORSE; DEMOGRAPHICS; PATTERNS; JOCKEYS	Background. The Irish Equestrian industry provides over 12,500 full time job equivalents contributing in excess of (sic)454 million to the Irish economy annually. For such an important industry there is a paucity of information relating to equestrian injuries. Aims. The aim of this study was to determine the demographics, characteristics, and outcomes of equestrian related injuries presenting to the emergency department of a regional trauma centre in Ireland over the course of one year. Methods. Retrospective analysis of all 30,700 presentations to the emergency department (ED) of the Midland Regional Hospital (MRH) Tullamore in 2013 was performed to identify equestrian related presentations. Patient demographics, mechanism of injury, radiology results, management, and follow-up data were collected and analysed using Microsoft Excel software. Results. A total of 149 equestrian related presentations were identified during the study period. There were significantly more females involved in equestrian injuries than males (58% versus 42%). Falling from a horse contributed to significantly more presentations and admissions than any other cause. 36% of presentations were associated with a radiological abnormality. Types of injuries identified included skeletal fractures (27.5%), joint dislocation/subluxation (5%), concussion (12.5%), and splenic laceration/intraperitoneal haemorrhage (1%). Admission or transfer to tertiary care was required for 18% of equestrian injuries. Only 43% of presentations were discharged back to primary care from the emergency department. Conclusion. This study identifies a high incidence of morbidities associated with equestrian presentations. In addition we recognised populations at risk of specific injuries and described high-risk mechanisms of injury.	[Abdulkarim, A.; Coffey, P.] Midland Reg Hosp, Dept Trauma & Orthopaed Surg, Tullamore, Ireland; [Abdulkarim, A.] Royal Coll Surg, Dublin, Ireland; [Juhdi, A.] Our Ladys Hosp, Dept Orthoped Surg, Navan, Ireland; [Edelson, Lily] Univ Limerick, Limerick, Ireland		Abdulkarim, A (corresponding author), Midland Reg Hosp, Dept Trauma & Orthopaed Surg, Tullamore, Ireland.; Abdulkarim, A (corresponding author), Royal Coll Surg, Dublin, Ireland.	aliameir@gmail.com	Abdulkarim, Ali/U-1412-2019	Abdulkarim, Ali/0000-0002-8246-2641			Balendra G, 2007, BRIT J SPORT MED, V41, P162, DOI 10.1136/bjsm.2006.033894; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Boran S, 2011, IRISH J MED SCI, V180, P859, DOI 10.1007/s11845-011-0730-4; Central Statistics Office, 2011, POP MIDL REG AUTH; Craven JA, 2008, EMERG MED AUSTRALAS, V20, P357, DOI 10.1111/j.1742-6723.2008.01107.x; Curry BA, 2016, OCCUP MED-OXFORD, V66, P222, DOI 10.1093/occmed/kqv150; Fahey A. G., 2012, HORSE SPORT IRELAND; Hasler Rebecca M, 2011, J Trauma Manag Outcomes, V5, P4, DOI 10.1186/1752-2897-5-4; Horse Sport Ireland, 2015, PROT HEADG REQ FEI E; Ikinger CM, 2016, ANIMALS, V6, DOI 10.3390/ani6020014; Khan I, 2004, MED SCI SPORT EXER, V36, pS311; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; Mayberry JC, 2007, J TRAUMA, V62, P735, DOI 10.1097/ta.0b013e318031b5d4; POUNDER DJ, 1984, MED J AUSTRALIA, V141, P632, DOI 10.5694/j.1326-5377.1984.tb113173.x; Quinn K., 2007, PROFILE IRISH SPORT; Sandiford N, 2013, JRSM SHORT REPORTS, V4, P1; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; The Turf Club, 2015, RUL RAC IR NAT HUNT; Turner M, 2008, BRIT J SPORT MED, V42, P763, DOI 10.1136/bjsm.2007.040337; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403; Young JD, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115603924	21	6	6	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2840	2090-2859		EMERG MED INT	Emerg. Med. Int.		2018	2018								7394390	10.1155/2018/7394390			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	GK0ZA	WOS:000435840700001	29971165	Green Published, Green Submitted, gold			2022-02-06	
J	Abolfotouh, MA; Hussein, MA; Abolfotouh, SM; Al-Marzoug, A; Al-Teriqi, S; Al-Suwailem, A; Hijazi, RA				Abolfotouh, Mostafa A.; Hussein, Mohamed A.; Abolfotouh, Sameh M.; Al-Marzoug, Alanoud; Al-Teriqi, Suliman; Al-Suwailem, Abeer; Hijazi, Ra'ed A.			Patterns of injuries and predictors of inhospital mortality in trauma patients in Saudi Arabia	OPEN ACCESS EMERGENCY MEDICINE			English	Article						MVCs; case fatality; injury severity; mechanism of injury; Saudi; causes of injury	ROAD TRAFFIC ACCIDENTS; MOTOR-VEHICLE CRASHES; GERIATRIC TRAUMA; BRAIN-INJURY; HEAD-INJURY; SYSTEMS; SCORE; ASSOCIATION; MANAGEMENT; OUTCOMES	Background: The aim of this study was to describe the pattern of traumatic injuries and determine the predictors of inhospital mortality in patients admitted to the emergency department. Patients and methods: This is a retrospective cohort study of 3,786 patients with traumat injuries admitted to the emergency department of King Abdulaziz Medical City, Riyadh, Saudi Arabia, between January 2012 and December 2014. Data on patient characteristics, trauma characteristics and outcomes were extracted from medical records. A negative binomial regression model was utilized to identify significant predictors of inhospital mortality. Results: Of all injured patients, 77.5% were male, 29.8% were aged 15-25 years and 25.7% were aged 26-45 years. Blunt trauma was the main mechanism of injury, including motor vehicle crashes (MVCs) in 52.0% and falls in 25.8% of patients. Most patients had injuries to the extremities (61.3%), followed by the head (32.2%), chest (16.9%) and abdomen (8.9%). Injuries were mild in 49.7% of patients, moderate in 30.2% and severe in 20.1%. The sex of the patients was significantly associated with the mechanism of injury (p<0.001), severity (p<0.001), anatomical site of injury (p<0.001), admission to the intensive care unit (p<0.001), need for trauma team activation (p<0.001) and type of transportation to hospital (p<0.001). The predictors of inhospital mortality were age (rate ratio [RR] for each 10-year increase=1.174; p<0.001), falls and burns (RR=2.337 and 1.728; p<0.001) and moderate and severe injuries (RR=6.438 and 181.780; p<0.001). Conclusion: Our results suggest different patterns of trauma injuries according to patient age and sex. MVCs were the leading cause of injuries, but falls and burns had the highest inhospital mortality. This suggests the need for a comprehensive national education and prevention programs that address all causes of injuries.	[Abolfotouh, Mostafa A.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Res Training & Dev Sect, Riyadh, Saudi Arabia; [Hussein, Mohamed A.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Biostat & Bioinformat Dept, Riyadh, Saudi Arabia; [Abolfotouh, Sameh M.] OrthoCure Med Ctr, Dhabi, U Arab Emirates; [Al-Marzoug, Alanoud] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia; [Al-Teriqi, Suliman] Imam Muhammad Ibn Saud Islamic Univ, Coll Med, Riyadh, Saudi Arabia; [Al-Suwailem, Abeer] King Saud Univ, Coll Med, Riyadh, Saudi Arabia; [Hijazi, Ra'ed A.] Minist Natl Guard Hlth Affairs, Emergency Care Ctr, King Abdulaziz Med City, Riyadh, Saudi Arabia		Abolfotouh, MA (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Res Training & Dev Sect, Riyadh, Saudi Arabia.; Abolfotouh, MA (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Mail Code 1515,POB 22490, Riyadh 11426, Saudi Arabia.	mabolfotouh@gmail.com	Abolfotouh, Mostafa/I-5772-2019	Abolfotouh, Mostafa/0000-0003-3787-429X; Al-Marzoug, Alanoud/0000-0001-8730-9104	King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, MNG-HA, KSA	This study was initiated and supported by King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, MNG-HA, KSA. The final draft of the manuscript was English language edited by Macmillan Science Communication. This study was presented in the International Conference in Emergency Medicine and Public Health - Qatar 2016:24 and published as an abstract in the Journal of Emergency Medicine, Trauma & Acute Care (JEMTAC).	Abbas AK, 2011, ANN SAUDI MED, V31, P347, DOI 10.4103/0256-4947.83208; Al-Shammari N, 2009, TRAFFIC INJ PREV, V10, P552, DOI 10.1080/15389580903175313; Alghnam S, 2017, ANN SAUDI MED, V37, P1, DOI 10.5144/0256-4947.2017.1; Ansari S, 2000, PUBLIC HEALTH, V114, P37, DOI 10.1016/S0033-3506(00)00306-1; Attia A. F., 1997, Eastern Mediterranean Health Journal, V3, P452; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barrimah I, 2012, INT J HEALTH SCI-IJH, V6, P31, DOI 10.12816/0005971; Bolandparvaz S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007812; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; El-Menyar Ayman, 2014, J Trauma Manag Outcomes, V8, P8, DOI 10.1186/1752-2897-8-8; Estahbanati HK, 2002, BURNS, V28, P340, DOI 10.1016/S0305-4179(02)00024-4; Farace E, 2000, Neurosurg Focus, V8, pe6; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Groohi B, 2002, BURNS, V28, P569, DOI 10.1016/S0305-4179(02)00099-2; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haider AH, 2009, J SURG RES, V153, P138, DOI 10.1016/j.jss.2008.04.011; Hwabejire JO, 2014, JAMA SURG, V149, P1054, DOI 10.1001/jamasurg.2014.473; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Kim YJ, 2012, NURS CRIT CARE, V17, P138, DOI 10.1111/j.1478-5153.2012.00498.x; Kobusingye O, 2001, Inj Prev, V7, P46, DOI 10.1136/ip.7.1.46; Kobusingye OC, 2000, J TRAUMA, V48, P498, DOI 10.1097/00005373-200003000-00022; Kobusingye OC, 2002, INJ PREV, V8, P133, DOI 10.1136/ip.8.2.133; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lansink KWW, 2007, CURR OPIN CRIT CARE, V13, P686, DOI 10.1097/MCC.0b013e3282f1e7a4; MACKENZIE EJ, 1984, AM J EMERG MED, V2, P537, DOI 10.1016/0735-6757(84)90081-0; Mansuri FA, 2015, SAUDI MED J, V36, P418, DOI 10.15537/smj.2015.4.10003; Markogiannakis H, 2006, EMERG MED J, V23, P27, DOI 10.1136/emj.2004.022392; Markogiannakis H, 2008, ULUS TRAVMA ACIL CER, V14, P125; Memish ZA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140176; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Moore L, 2010, WORLD J SURG, V34, P2069, DOI 10.1007/s00268-010-0588-z; Nagata I, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018635; Nizamo Hanifa, 2006, Int J Inj Contr Saf Promot, V13, P1, DOI 10.1080/17457300500151705; Northern Ireland Statistics and Research Agency (NISRA), 2009, 2009 MID YEAR POP ES; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Papa L, 2006, J TRAUMA, V61, P261, DOI 10.1097/01.ta.0000221789.53864.ba; Ruikar M., 2013, J ORTHOP TRAUMATOL R, V6, P1, DOI DOI 10.4103/0975-7341.118718; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Scheidler MG, 2000, J TRAUMA, V49, P864, DOI 10.1097/00005373-200011000-00012; Sieling BA, 2004, AM SURGEON, V70, P793; SWIERZEWSKI MJ, 1994, J TRAUMA, V37, P404, DOI 10.1097/00005373-199409000-00012; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Trajano AD, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-22; Tyson Anna F, 2015, J Surg Educ, V72, pe66, DOI 10.1016/j.jsurg.2014.09.010; Wilson B, 1999, CASE STUDIES NEUROPS; World Health Organization, 2002, D O I A V P NONC DIS; World Health Organization, 2002, GEND ROAD TRAFF INJ	51	6	6	1	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1500			OPEN ACCESS EMERG M	Open Access Emerg. Med.		2018	10						89	99		10.2147/OAEM.S166026			11	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	GO8MQ	WOS:000440345200001	30104908	gold, Green Published, Green Submitted			2022-02-06	
J	Allen, CJ; Subhawong, TK; Hanna, MM; Chelala, L; Bullock, MR; Schulman, CI; Proctor, KG				Allen, Casey J.; Subhawong, Ty K.; Hanna, Mena M.; Chelala, Lydia; Bullock, M. Ross; Schulman, Carl I.; Proctor, Kenneth G.			Does Vasopressin Exacerbate Cerebral Edema in Patients with Severe Traumatic Brain Injury?	AMERICAN SURGEON			English	Article							SEVERE HEAD-INJURY; TOMOGRAPHIC SCAN CHARACTERISTICS; INITIAL INTRACRANIAL-PRESSURE; LOW-DOSE VASOPRESSIN; PERFUSION-PRESSURE; SEPTIC SHOCK; ARGININE-VASOPRESSIN; LINEAR RELATIONSHIP; RESUSCITATION; HYPERTENSION	Arginine vasopressin (AVP) is often used as an alternative pressor to catecholamines (CATs). However, unlike CATs, AVP is a powerful antidiuretic that could promote edema. We tested the hypothesis that AVP promoted cerebral edema and/or increased requirements for osmotherapy, relative to those who received CATs, for cerebral perfusion pressure (CPP) management after traumatic brain injury (TBI). This is a retrospective review of 286 consecutive TBI patients with intracranial pressure monitoring at a single institution from September 2008 to January 2015. Cerebral edema was quantitated using CT attenuation in prespecified areas of gray and white matter. Results: To maintain CPP > 60 mm Hg,205 patients required no vasopressors, 41 received a single CAT, 12 received AVP, and 28 required both. Those who required no pressors were generally less injured; required less hyperosmolar therapy and less total fluid; and had lower plasma Na, lower intracranial pressure, less edema, and lower mortality (all P < 0.05). Edema; daily mean, minimum, and maximum Na levels; and mortality were similar with AVP versus CATs, but the daily requirement of mannitol and 3 per cent NaCl were reduced by 45 and 35 per cent (both P < 0.05). In patients with TBI who required CPP therapy, AVP reduced the requirements for hyperosmolar therapy and did not delay resolution or increase cerebral edema compared with CATs.	[Allen, Casey J.; Hanna, Mena M.; Schulman, Carl I.; Proctor, Kenneth G.] Univ Miami, Miller Sch Med, Dewitt Daughtry Dept Surg, Div Trauma, Miami, FL 33136 USA; [Allen, Casey J.; Hanna, Mena M.; Schulman, Carl I.; Proctor, Kenneth G.] Univ Miami, Miller Sch Med, Dewitt Daughtry Dept Surg, Div Surg Crit Care, Miami, FL 33136 USA; [Subhawong, Ty K.; Chelala, Lydia] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA; [Bullock, M. Ross] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA		Proctor, KG (corresponding author), Univ Miami, Sch Med, Daughtry Family Dept Surg, Div Trauma,Ryder Trauma Ctr,Surg, 1800 NW 10th Ave, Miami, FL 33136 USA.; Proctor, KG (corresponding author), Univ Miami, Sch Med, Daughtry Family Dept Surg, Div Surg Crit Care,Ryder Trauma Ctr,Surg, 1800 NW 10th Ave, Miami, FL 33136 USA.	kproctor@miami.edu	Schulman, Carl/AAE-7448-2021; Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628; Schulman, Carl/0000-0001-8899-4350	Office of Naval ResearchOffice of Naval Research [N140610670]; U.S. Army Medical Research & Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [09078015]	Supported in part by Grants #N140610670 from the Office of Naval Research and #09078015 from U.S. Army Medical Research & Material Command.	Anantasit N, 2014, CRIT CARE MED, V42, P1812, DOI 10.1097/CCM.0000000000000333; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Chen W, 2013, JOVE-J VIS EXP, DOI 10.3791/3871; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Cohn SM, 2013, J TRAUMA ACUTE CARE, V75, P620, DOI 10.1097/TA.0b013e31829eff31; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Earle SA, 2007, J AM COLL SURGEONS, V204, P261, DOI 10.1016/j.jamcollsurg.2006.11.014; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Feinstein AJ, 2005, J TRAUMA, V59, P82; Ferguson-Myrthil N, 2012, CARDIOL REV, V20, P153, DOI 10.1097/CRD.0b013e31824e2294; Galton C, 2011, NEUROCRIT CARE, V14, P354, DOI 10.1007/s12028-011-9525-8; Holmes Cheryl L, 2004, Curr Opin Crit Care, V10, P442, DOI 10.1097/01.ccx.0000144769.19213.0c; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Human T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.03.003; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kirkman MA, 2013, NEUROCRIT CARE, V18, P406, DOI 10.1007/s12028-012-9805-y; Krismer Anette C, 2004, Crit Care Med, V32, pS432, DOI 10.1097/01.CCM.0000134267.91520.C0; Landry DW, 2010, CRIT CARE, V14, DOI 10.1186/cc9344; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Malay MB, 1999, J TRAUMA, V47, P699, DOI 10.1097/00005373-199910000-00014; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; McMahon PJ, 2009, J TRAUMA, V67, P461, DOI 10.1097/TA.0b013e3181aa01e4; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; MIZUTANI T, 1990, SURG NEUROL, V33, P178, DOI 10.1016/0090-3019(90)90181-N; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robin JK, 2003, J TRAUMA, V54, pS149, DOI 10.1097/01.TA.0000064523.93060.60; Russell JA, 2013, AM J RESP CRIT CARE, V188, P356, DOI 10.1164/rccm.201302-0355OC; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Szmydynger-Chodobska J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079328; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Van Haren RM, 2013, J TRAUMA ACUTE CARE, V75, P1024, DOI 10.1097/TA.0b013e3182a99d48; Wang D, 2004, J TRAUMA, V56, P972; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431	40	6	6	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JAN	2018	84	1					43	50					8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FX2WR	WOS:000425926200021	29428027				2022-02-06	
J	Analytis, P; McKay, A; Hamilton, M; Williams, G; Warren, N; Ponsford, J				Analytis, Penelope; McKay, Adam; Hamilton, Megan; Williams, Gavin; Warren, Narelle; Ponsford, Jennie			Physical activity: perceptions of people with severe traumatic brain injury living in the community	BRAIN INJURY			English	Article						Physical activity; thematic analysis; traumatic brain injury	INDIVIDUALS; EXERCISE; ADULTS; BARRIERS; PARTICIPATION; PROGRAM; HEALTH; SCALE; HOME	Primary objective: Increasing physical activity (PA) among people with severe traumatic brain injury (TBI) represents an important long-term rehabilitation goal. To design effective interventions to promote PA, the factors associated with PA engagement post-TBI need to be understood. Research design: A qualitative study design was employed to investigate the factors influencing PA engagement in people with severe TBI living in the community. Methods and Procedures: Face-to-face interviews were conducted with eight people with severe TBI three to five years post-injury. A constant comparative method of data collection and analysis was adopted. Main outcomes and results: Interviews were analysed using thematic analysis. Three themes were identified: continuance of self and PA (perception of self, stage of life, and PA normality), beliefs about PA (knowledge of PA and associated benefits), and purpose of PA engagement (reasons for being physically active). Lifelong PA habits and current life priorities impacted on PA engagement post-TBI and influenced whether TBI-associated impairments were considered as a barrier to PA. Conclusion: Among this group of people, PA engagement post-TBI was influenced by perceptions of lifelong PA habits and current life priorities. Interventions to increase PA need to address these perceptions and adapt PA to account for life priorities within the context of TBI-associated impairments.	[Analytis, Penelope; McKay, Adam; Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, 18 Innovat Walk, Melbourne, Vic 3800, Australia; [Analytis, Penelope; McKay, Adam; Ponsford, Jennie] Epworth Heathcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Hamilton, Megan; Williams, Gavin] Epworth Healthcare, Physiotherapy Dept, Melbourne, Vic, Australia; [Williams, Gavin] Univ Melbourne, Physiotherapy Dept, Melbourne, Vic, Australia; [Warren, Narelle] Monash Univ, Sch Social Sci, Melbourne, Vic, Australia		Analytis, P (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, 18 Innovat Walk, Melbourne, Vic 3800, Australia.	penelope.analytis@monash.edu	Warren, Narelle/H-9318-2019; Ponsford, Jennie/H-8341-2014; McKay, Adam/M-6003-2017	Warren, Narelle/0000-0003-2623-4078; Williams, Gavin/0000-0003-2758-7473; Ponsford, Jennie/0000-0003-0430-125X; McKay, Adam/0000-0002-0479-7681; Analytis, Penelope/0000-0001-5252-9916			Andelic N, 2015, J NEUROL, V262, P523, DOI 10.1007/s00415-014-7595-1; Australian Bureau of Statistics, 2011, 4364 0 55 004 AUSTR; Ball K, 2004, PUBLIC HEALTH NUTR, V7, P433, DOI 10.1079/PHN2003541; Beck F, 2010, BRIT J HEALTH PSYCH, V15, P663, DOI 10.1348/135910709X479096; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown WJ., 2012, DEV EVIDENCE BASED P; Cerin E, 2008, MEAS PHYS EDUC EXERC, V12, P31, DOI 10.1080/10913670701715190; Damush TM, 2007, REHABIL NURS, V32, P253, DOI 10.1002/j.2048-7940.2007.tb00183.x; Das P, 2012, LANCET, V380, P189, DOI 10.1016/S0140-6736(12)61024-1; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Driver S, 2006, ADAPT PHYS ACT Q, V23, P148, DOI 10.1123/apaq.23.2.148; Driver S., 2009, J COGNITIVE REHABILI, V33, P4, DOI DOI 10.1519/SSC.0B013E318211F99D; Driver S, 2013, BRAIN INJURY, V27, P1173, DOI 10.3109/02699052.2013.804197; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Gemmell C, 2006, BRAIN INJURY, V20, P151, DOI 10.1080/02699050500442998; Gill IJ, 2012, BRAIN INJURY, V26, P909, DOI 10.3109/02699052.2012.661118; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hamilton M, 2015, BRAIN INJURY, V29, P1572, DOI 10.3109/02699052.2015.1075145; Hassett LM, 2011, BRAIN INJURY, V25, P698, DOI 10.3109/02699052.2011.579934; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Ingledew DK, 2008, PSYCHOL HEALTH, V23, P807, DOI 10.1080/08870440701405704; Jones TM, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-39; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Levins SM, 2004, PHYS THER, V84, P496, DOI 10.1093/ptj/84.6.496; Markland D, 2004, J SPORT EXERCISE PSY, V26, P191, DOI 10.1123/jsep.26.2.191; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; QSR International Pty Ltd, 2012, NVIVO QUAL DAT AN SO; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Rimmer JH, 2008, J REHABIL RES DEV, V45, P315, DOI 10.1682/JRRD.2007.02.0042; Ryan R.M., 2009, HELL J PSYCHOL, V6, P107, DOI [DOI 10.1080/17509840701827437, 10.1080/17509840701827437]; Saebu M, 2011, SCAND J MED SCI SPOR, V21, P730, DOI 10.1111/j.1600-0838.2010.01097.x; Schmid AA, 2016, DISABIL REHABIL, V38, P914, DOI 10.3109/09638288.2015.1062927; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Self M, 2013, ADAPT PHYS ACT Q, V30, P20, DOI 10.1123/apaq.30.1.20; van der Ploeg HP, 2004, SPORTS MED, V34, P639, DOI 10.2165/00007256-200434100-00002; Williams G, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318279536d; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; World Health Organization, 2002, COMM LANG FUNCT DIS; Young James A, 2007, Phys Med Rehabil Clin N Am, V18, P145, DOI 10.1016/j.pmr.2006.11.008; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	49	6	6	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					209	217		10.1080/02699052.2017.1395479			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600007	29211502				2022-02-06	
J	Armstead, WM; Hekierski, H; Yarovoi, S; Higazi, A; Cines, DB				Armstead, William M.; Hekierski, Hugh; Yarovoi, Serge; Higazi, Abd Al-Roof; Cines, Douglas B.			tPA variant tPA-A(296-299) Prevents impairment of cerebral autoregulation and necrosis of hippocampal neurons after stroke by inhibiting upregulation of ET-1	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						cerebral autoregulation; stroke; tPA; signal transduction; ET-1	TISSUE-PLASMINOGEN ACTIVATOR; RECEPTOR-RELATED PROTEIN; TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; NERVOUS-SYSTEM; CELL-DEATH; ERK MAPK; AGE; CEREBROVASODILATION; PERMEABILITY	Tissue-type plasminogen activator (tPA) is neurotoxic and exacerbates uncoupling of cerebral blood flow (CBF) and metabolism after stroke, yet it remains the sole FDA-approved drug for treatment of ischemic stroke. Upregulation of c-Jun-terminal kinase (JNK) after stroke contributes to tPA-mediated impairment of autoregulation, but the role of endothelin-1 (ET-1) is unknown. Based on the Glasgow Coma Scale, impaired autoregulation is linked to adverse outcomes after TBI, but correlation with hippocampal histopathology after stroke has not been established. We propose that given after stroke, tPA activates N-Methyl-D-Aspartate receptors (NMDA-Rs) and upregulates ET-1 in a JNK dependent manner, imparing autoregulation and leading to histopathology. After stroke, CBF was reduced in the hippocampus and reduced further during hypotension, which did not occur in hypotensive sham pigs, indicating impairment of autoregulation. Autoregulation and necrosis of hippocampal CA1 and CA3 neurons were further impaired by tPA, but were preserved by the ET-1 antagonist BQ 123 and tPA-A,(296-299) a variant that is fibrinolytic but does not bind to NMDA-Rs. Expression of ET-1 was increased by stroke and potentiated by tPA but returned to sham levels by tPA-A(296-299) and the JNK antagonist SP600125. Results show that JNK releases ET-1 after stroke. Tissue-type plasminogen activator -A(296-299) prevents impairment of cerebral autoregulation and histopathology after stroke by inhibiting upregulation of ET-1.	[Armstead, William M.; Hekierski, Hugh] Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19103 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Yarovoi, Serge; Higazi, Abd Al-Roof; Cines, Douglas B.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Higazi, Abd Al-Roof] Hebrew Univ Jerusalem, Dept Clin Biochem, Hadassah Med Sch, Jerusalem, Israel		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19103 USA.	armsteaw@uphs.upenn.edu		Cines, Douglas/0000-0001-5986-504X	RO1 from the NIH [NS090998]	This study was supported by RO1 from the NIH, grant number: NS090998.	ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Armstead WM, 2008, BRAIN RES, V1231, P121, DOI 10.1016/j.brainres.2008.06.115; Armstead WM, 2017, J NEUROTRAUM, V34, P1666, DOI 10.1089/neu.2016.4770; Armstead WM, 2016, STROKE, V47, P2096, DOI 10.1161/STROKEAHA.116.012678; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2011, PEDIATR CRIT CARE ME, V12, pE369, DOI 10.1097/PCC.0b013e3181fe40a7; Armstead WM, 2010, AM J PHYSIOL-REG I, V299, pR480, DOI 10.1152/ajpregu.00256.2010; Armstead WM, 2010, J NEUROCHEM, V113, P303, DOI 10.1111/j.1471-4159.2010.06613.x; Armstead WM, 2004, CURR PHARM DESIGN, V10, P2185, DOI 10.2174/1381612043384178; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2002, PEDIATR RES, V51, P586, DOI 10.1203/00006450-200205000-00007; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Choi EK, 2015, INT J SURG, V22, P74, DOI 10.1016/j.ijsu.2015.08.016; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Girling KJ, 1999, ANESTH ANALG, V89, P175, DOI 10.1097/00000539-199907000-00031; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Kuluz JW, 2007, STROKE, V38, P1932, DOI 10.1161/STROKEAHA.106.475244; LAPCHAK PA, 2002, CURR NEUROL NEUROSCI, V2, P1, DOI DOI 10.1007/s11910-002-0051-0; Lemarchand E, 2016, CELL DEATH DIFFER, V23, P123, DOI 10.1038/cdd.2015.76; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lopez-Atalaya JP, 2008, J CEREBR BLOOD F MET, V28, P1212, DOI 10.1038/jcbfm.2008.14; Macrez R, 2011, STROKE, V42, P2315, DOI 10.1161/STROKEAHA.110.606293; Makarova AM, 2011, J BIOL CHEM, V286, P23044, DOI 10.1074/jbc.M110.210195; Mantuano E, 2015, J CELL SCI, V128, P3478, DOI 10.1242/jcs.173765; Marcos-Contreras OA, 2016, BLOOD, V128, P2423, DOI 10.1182/blood-2016-03-705384; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Ross J, 2003, AM J PHYSIOL-REG I, V285, pR149, DOI 10.1152/ajpregu.00003.2003; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shin HK, 2002, J CEREBR BLOOD F MET, V22, P869, DOI 10.1097/00004647-200207000-00012; Simao F, 2017, BLOOD, V129, P2280, DOI 10.1182/blood-2016-09-740670; Strickland S, 2001, THROMB HAEMOSTASIS, V86, P138; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212	42	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN	2018	96	1					128	137		10.1002/jnr.24112			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FX1KZ	WOS:000425811000013	28703856				2022-02-06	
J	Arnould, A; Rochat, L; Azouvi, P; van der Linden, M				Arnould, Annabelle; Rochat, Lucien; Azouvi, Philippe; van der Linden, Martial			Self-appraisals and episodic memory: Different psychological factors related to patient versus informant reports of apathy in severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Awareness; cognitive impairments; motivation; self-efficacy; self-esteem	AMYOTROPHIC-LATERAL-SCLEROSIS; CONFIRMATORY FACTOR-ANALYSIS; MILD COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; DEPRESSION SCALE; HOSPITAL ANXIETY; MULTIDIMENSIONAL APATHY; EXECUTIVE DYSFUNCTION; BASAL GANGLIA; EFFICACY	Introduction: Apathy is a core feature in patients with traumatic brain injury (TBI). The psychological processes underlying apathy are still unclear, and the few studies conducted on this subject have essentially focused on cognitive processes and informant reports of apathetic manifestations. The aims of the present study were to examine self-reports versus informant reports of diminished initiative/interest, as well as their relationship with different cognitive factors (attention/executive mechanisms, episodic memory, and multitasking) and personal identity factors (self-esteem and self-efficacy beliefs). Method: To this end, 74 participants (38 patients with severe TBI matched with 36 control participants) were given three questionnaires to assess self-esteem, general self-efficacy beliefs, and anxio-depressive symptoms and five tasks to assess cognitive processes, including real-life multitasking. In addition, a questionnaire that assessed self-awareness of functional competencies and a questionnaire that assessed lack of initiative/interest were administered to each participant and their relatives. Results: The main results showed that patients demonstrated an awareness of their lack of initiative/interest and that self-reported lack of initiative/interest was best predicted by low general self-efficacy beliefs and self-esteem, whereas informant-reported lack of initiative/interest was predicted by episodic memory difficulties. Conclusions: These results shed new light on the psychological processes related to apathetic manifestations, as well as the differing perspectives and lived experiences of patients and external observers in the TBI population, which opens interesting prospects for psychological interventions.	[Arnould, Annabelle; Rochat, Lucien; van der Linden, Martial] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, Geneva, Switzerland; [Arnould, Annabelle; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, 104 Blvd Raymond Poincare, F-92380 Garches, France; [Arnould, Annabelle; Azouvi, Philippe] Univ Versailles St Quentin En Yvelines, HANDIReSP, EA 4047, Versailles, France; [Rochat, Lucien; van der Linden, Martial] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [van der Linden, Martial] Univ Liege, Cognit Psychopathol Unit, Liege, Belgium		Arnould, A (corresponding author), Hop Raymond Poincare, AP HP, Dept Phys Med & Rehabil, 104 Blvd Raymond Poincare, F-92380 Garches, France.	annabelle.arnould@aphp.fr		Rochat, Lucien/0000-0002-9992-2720			Alpay E, 2000, SELF CONCEPT SELF ES; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Arnould A, 2018, J NEUROPSYCHOL, V12, P101, DOI 10.1111/jnp.12107; Arnould A, 2015, BRAIN INJURY, V29, P1597, DOI 10.3109/02699052.2015.1075156; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI; Bayard S, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/231469; Bogart KR, 2011, HEALTH PSYCHOL, V30, P386, DOI 10.1037/a0022851; Brands I, 2015, CLIN REHABIL, V29, P611, DOI 10.1177/0269215514549484; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cassar R, 2013, PSYCHIAT RES, V210, P830, DOI 10.1016/j.psychres.2013.09.017; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Chen G, 2004, J ORGAN BEHAV, V25, P375, DOI 10.1002/job.251; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Cosco TD, 2012, J PSYCHOSOM RES, V72, P180, DOI 10.1016/j.jpsychores.2011.06.008; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Dumont M, 2003, CAN J BEHAV SCI, V35, P254, DOI 10.1037/h0087206; Esposito F, 2014, AGING MENT HEALTH, V18, P521, DOI 10.1080/13607863.2013.856865; Esposito F, 2014, ARCH GERONTOL GERIAT, V58, P43, DOI 10.1016/j.archger.2013.09.002; Esposito F, 2012, DEMENT GER COGN D EX, V2, P456, DOI 10.1159/000345037; Esposito F, 2010, ALZ DIS ASSOC DIS, V24, P131, DOI 10.1097/WAD.0b013e3181c9c168; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gendolla GHE, 2005, EUR PSYCHOL, V10, P187, DOI 10.1027/1016-9040.10.3.187; Grant PM, 2009, SCHIZOPHRENIA BULL, V35, P798, DOI 10.1093/schbul/sbn008; Guindon MH, 2002, J COUNS DEV, V80, P204, DOI 10.1002/j.1556-6678.2002.tb00184.x; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lee I. A., 2013, CALCULATION TEST DIF; Lengenfelder J, 2015, APPL NEUROPSYCH-ADUL, V22, P7, DOI 10.1080/23279095.2013.816703; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levaux M. N., 2012, CASE REPORTS PSYCHIA, V2012; Levaux MN, 2012, ALTER, V6, P267, DOI 10.1016/j.alter.2012.08.003; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McKinlay A, 2008, AGING MENT HEALTH, V12, P647, DOI 10.1080/13607860802343225; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; Newark PE, 2016, J ATTEN DISORD, V20, P279, DOI 10.1177/1087054712459561; Njomboro Progress, 2012, Curr Gerontol Geriatr Res, V2012, P846075, DOI 10.1155/2012/846075; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Norton S, 2013, J PSYCHOSOM RES, V74, P74, DOI 10.1016/j.jpsychores.2012.10.010; Ownsworth T., 2014, UNDERSTANDING TRAUMA, P235; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Prat-Sala M, 2010, BRIT J EDUC PSYCHOL, V80, P283, DOI 10.1348/000709909X480563; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Radakouic R, 2017, CORTEX, V94, P142, DOI 10.1016/j.cortex.2017.06.023; Radakovic R, 2018, INT J GERIATR PSYCH, V33, P151, DOI 10.1002/gps.4697; Radakovic R, 2016, J NEUROL NEUROSUR PS, V87, P663, DOI 10.1136/jnnp-2015-310772; Reitan R, 1985, HALSTEAD REITAN NEUR; Robert PH, 2006, DEMENT GERIATR COGN, V21, P192, DOI 10.1159/000090766; Robert PH, 2002, INT J GERIATR PSYCH, V17, P1099, DOI 10.1002/gps.755; Rochat L, 2013, NEUROLOGY, V81, P1674, DOI 10.1212/01.wnl.0000435290.49598.1d; Rosenberg M., 1965, SOC ADOLESCENT SELF; Santangelo G, 2017, AMYOTROPH LAT SCL FR, V18, P434, DOI 10.1080/21678421.2017.1313865; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schwarzer R, 1999, ANXIETY STRESS COPIN, V12, P145, DOI 10.1080/10615809908248327; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Starkstein SE, 2005, J NEUROL NEUROSUR PS, V76, P1070, DOI 10.1136/jnnp.2004.052795; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; VALLIERES EF, 1990, INT J PSYCHOL, V25, P305, DOI 10.1080/00207599008247865; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Vazire S, 2006, J RES PERS, V40, P472, DOI 10.1016/j.jrp.2005.03.003; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; Zahodne LB, 2009, MOVEMENT DISORD, V24, P677, DOI 10.1002/mds.22441; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann P., 2009, TAP TESTS EVALUATION	84	6	6	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2018	40	7					650	662		10.1080/13803395.2017.1411468			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GK8AR	WOS:000436438200002	29316833				2022-02-06	
J	Baratta, PL; Spence, JR				Baratta, Patricia L.; Spence, Jeffrey R.			Capturing the noonday demon: development and validation of the State Boredom Inventory	EUROPEAN JOURNAL OF WORK AND ORGANIZATIONAL PSYCHOLOGY			English	Article						Boredom; multidimensional; scale development; scale validation; diary study	TRAUMATIC BRAIN-INJURY; WORKPLACE BOREDOM; CIRCUMPLEX MODEL; WORK; PRONENESS; SCALE; JOB; QUESTIONNAIRE; VALIDITY; CONSEQUENCES	For centuries, scholars have positioned state boredom as an impediment to organizational productivity and performance given its unpleasant and distracting qualities. However, research on state boredom has been impeded by a lack of definitional consensus and measurement issues. In this article, we sought to advance organizational research on state boredom by developing the State Boredom Inventory (SBI), an 11-item measure grounded in a theoretically derived definition of state boredom. Across five studies using 10 independent samples, we develop the SBI and provide validity evidence for our measure, including content validity and convergent and discriminant validity. Our data support the conceptualization of state boredom as a higher-order multidimensional construct with three underlying dimensions: disengagement, unpleasant low arousal, and inattention.	[Baratta, Patricia L.; Spence, Jeffrey R.] Univ Guelph, Dept Psychol, Guelph, ON, Canada		Baratta, PL (corresponding author), Univ Guelph, Dept Psychol, Guelph, ON, Canada.	pbaratta@uoguelph.ca			Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC)	This work was supported by the Social Sciences and Humanities Research Council of Canada.	ANDERSON JC, 1991, J APPL PSYCHOL, V76, P732, DOI 10.1037/0021-9010.76.5.732; Baratta PL, 2015, RES EMOTION ORGAN, V11, P139, DOI 10.1108/S1746-979120150000011007; Barrett LF, 1998, J PERS SOC PSYCHOL, V74, P967, DOI 10.1037/0022-3514.74.4.967; Bauer JA, 2015, HUM PERFORM, V28, P307, DOI 10.1080/08959285.2015.1021040; Berlyne D. E., 1960, CONFLICT AROUSAL CUR; Bozeman DP, 2001, J APPL PSYCHOL, V86, P161, DOI 10.1037/0021-9010.86.1.161; Bruursema K, 2011, WORK STRESS, V25, P93, DOI 10.1080/02678373.2011.596670; Burn CC, 2017, ANIM BEHAV, V130, P141, DOI 10.1016/j.anbehav.2017.06.006; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Casini L, 1999, BEHAV PROCESS, V45, P73, DOI 10.1016/S0376-6357(99)00010-8; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Conway JM, 2010, J BUS PSYCHOL, V25, P325, DOI 10.1007/s10869-010-9181-6; Crockett AC, 2015, J HEALTH PSYCHOL, V20, P670, DOI 10.1177/1359105315573439; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Culp NA, 2006, PERS INDIV DIFFER, V41, P999, DOI 10.1016/j.paid.2006.02.018; Dickens Charles., 1853, BLEAK HOUSE; Diener E, 2009, SOC INDIC RES SER, V39, P1, DOI 10.1007/978-90-481-2354-4_1; Eastwood JD, 2012, PERSPECT PSYCHOL SCI, V7, P482, DOI 10.1177/1745691612456044; Edwards JR, 2001, ORGAN RES METHODS, V4, P265, DOI 10.1177/109442810143005; Edwards MC, 2009, SOC PERSONAL PSYCHOL, V3, P507, DOI 10.1111/j.1751-9004.2009.00194.x; El Akremi A, 2018, J MANAGE, V44, P619, DOI 10.1177/0149206315569311; Elpidorou A., 2017, PHENOMENOL COGN SCI, P1, DOI [10.1007/s11097-017-9515-1, DOI 10.1007/S11097-017-9515-1]; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Eren A, 2016, SOC PSYCHOL EDUC, V19, P895, DOI 10.1007/s11218-016-9348-8; Fahlman SA, 2013, ASSESSMENT, V20, P68, DOI 10.1177/1073191111421303; Fahlman SA, 2009, J SOC CLIN PSYCHOL, V28, P307, DOI 10.1521/jscp.2009.28.3.307; FARMER R, 1986, J PERS ASSESS, V50, P4, DOI 10.1207/s15327752jpa5001_2; Fenichel O., 1951, ORG PATHOLOGY THOUGH, P349, DOI [10.1037/10584-018, DOI 10.1037/10584-018]; Ferris DL, 2008, J APPL PSYCHOL, V93, P1348, DOI 10.1037/a0012743; FISHER CD, 1993, HUM RELAT, V46, P395, DOI 10.1177/001872679304600305; Fiske D. W., 1961, FUNCTIONS VARIED EXP; Frankl V., 1984, MANS SEARCH MEANING; GABRIEL MA, 1988, CLIN SOC WORK J, V16, P156, DOI 10.1007/BF00754447; Game AM, 2007, PERS REV, V36, P701, DOI 10.1108/00483480710774007; GEIWITZ PJ, 1966, J PERS SOC PSYCHOL, V3, P592, DOI 10.1037/h0023202; Gerritsen CJ, 2014, CONSCIOUS COGN, V27, P27, DOI 10.1016/j.concog.2013.10.001; Goldberg Y, 2013, BEHAV SCI-BASEL, V3, P434, DOI 10.3390/bs3030434; Goldberg YK, 2011, J SOC CLIN PSYCHOL, V30, P647, DOI 10.1521/jscp.2011.30.6.647; GREENSON RR, 1953, J AM PSYCHOANAL ASS, V1, P7, DOI 10.1177/000306515300100102; Guglielmi D, 2013, WORK, V45, P311, DOI 10.3233/WOR-121528; Hafsteinsson LG, 2007, EDUC PSYCHOL MEAS, V67, P719, DOI 10.1177/0013164406299101; Hamilton J. A., 1981, PROGR EXPT PERSONALI, V10, P281; Hansen J, 2013, J EXP PSYCHOL GEN, V142, P336, DOI 10.1037/a0029283; Harju LK, 2016, PERS REV, V45, P374, DOI 10.1108/PR-05-2015-0125; Harris MB, 2000, J APPL SOC PSYCHOL, V30, P576, DOI 10.1111/j.1559-1816.2000.tb02497.x; HEBB DO, 1955, PSYCHOL REV, V62, P243, DOI 10.1037/h0041823; HILL AB, 1985, BRIT J PSYCHOL, V76, P235, DOI 10.1111/j.2044-8295.1985.tb01947.x; Hinkin TR, 1998, ORGAN RES METHODS, V1, P104, DOI 10.1177/109442819800100106; Hofmann DA, 1998, J MANAGE, V24, P623, DOI 10.1177/014920639802400504; Hooper D., 2008, EJBRM, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]; HUNT SD, 1982, J MARKETING RES, V19, P269, DOI 10.2307/3151627; Hunter A., 2016, EXP BRAIN RES, V236, P2483, DOI DOI 10.1007/S00221-016-4749-7; Isac-Garcia J., 2016, EXPT BRAIN RES, P1; ISOAHOLA SE, 1987, J SOC CLIN PSYCHOL, V5, P356, DOI 10.1521/jscp.1987.5.3.356; JACKSON SW, 1981, B HIST MED, V55, P172; Judge TA, 2006, J APPL PSYCHOL, V91, P126, DOI 10.1037/0021-9010.91.1.126; Kass SJ, 2001, J BUS PSYCHOL, V16, P317, DOI 10.1023/A:1011121503118; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Law KS, 1998, ACAD MANAGE REV, V23, P741, DOI 10.5465/amr.1998.1255636; LEARY MR, 1986, J PERS SOC PSYCHOL, V51, P968, DOI 10.1037/0022-3514.51.5.968; Lee T. W., 1986, MANHATTAN COLL J BUS, V15, P22; LEVY ST, 1984, J AM PSYCHOANAL ASS, V32, P387, DOI 10.1177/000306518403200207; Lewinsky H, 1943, BRIT J EDUC PSYCHOL, V13, P147, DOI 10.1111/j.2044-8279.1943.tb02734.x; LONDON H, 1972, J ABNORM PSYCHOL, V80, P29, DOI 10.1037/h0033311; Loukidou L, 2009, INT J MANAG REV, V11, P381, DOI 10.1111/j.1468-2370.2009.00267.x; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Malkovsky E, 2012, EXP BRAIN RES, V221, P59, DOI 10.1007/s00221-012-3147-z; Mann S, 2014, CREATIVITY RES J, V26, P165, DOI 10.1080/10400419.2014.901073; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marsh J., 1983, MANAGEMENT ED DEV, V14, P120, DOI [10.1177/135050768301400206, DOI 10.1177/135050768301400206]; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Martin M., 2006, QUAL RES PSYCHOL, V3, P193, DOI [10.1191/1478088706qrp066oa, DOI 10.1191/1478088706QRP0660A, DOI 10.1191/1478088706QRP066OA]; Menon S, 2003, J CONSUM PSYCHOL, V13, P316, DOI 10.1207/S15327663JCP1303_12; MIKULAS WL, 1993, PSYCHOL REC, V43, P3; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; NETEMEYER RG, 1990, J APPL PSYCHOL, V75, P148, DOI 10.1037/0021-9010.75.2.148; OHANLON JF, 1981, ACTA PSYCHOL, V49, P53, DOI 10.1016/0001-6918(81)90033-0; Ohly S, 2006, J ORGAN BEHAV, V27, P257, DOI 10.1002/job.376; PETERS E, 1975, SOC RES, V42, P493; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Ponticus E., 2006, PRAKTIKOS CHAPTERS P; Raffaelli Q, 2017, EXP BRAIN RES, DOI [10.1007/s00221-017-4922-7, DOI 10.1007/S00221-017-4922-7]; Ramsey, 2000, THE I; Reijseger G, 2013, ANXIETY STRESS COPIN, V26, P508, DOI 10.1080/10615806.2012.720676; Remington NA, 2000, J PERS SOC PSYCHOL, V79, P286, DOI 10.1037//0022-3514.79.2.286; Rizopoulos D, 2006, J STAT SOFTW, V17; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; SCERBO MW, 1993, J GEN PSYCHOL, V120, P293, DOI 10.1080/00221309.1993.9711149; Schaufeli W.B., 2014, PEOPLE WORK INTRO CO, V1st ed., P293; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; Seibert SE, 1999, J APPL PSYCHOL, V84, P416, DOI 10.1037/0021-9010.84.3.416; Skowronski M, 2012, PERS REV, V41, P143, DOI 10.1108/00483481211200006; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Spence JR, 2014, PERS PSYCHOL, V67, P705, DOI 10.1111/peps.12051; Spielberger C., 1983, ADV PERSONALITY ASSE, V2, P159; Steger MF, 2006, J COUNS PSYCHOL, V53, P80, DOI 10.1037/0022-0167.53.1.80; Vafeas M, 2016, IND MARKET MANAG, V55, P59, DOI 10.1016/j.indmarman.2016.02.013; van der Heijden GAH, 2012, EUR J WORK ORGAN PSY, V21, P349, DOI 10.1080/1359432X.2011.578824; van Hooff MLM, 2014, J OCCUP HEALTH PSYCH, V19, P348, DOI 10.1037/a0036821; van Tilburg WAP, 2012, MOTIV EMOTION, V36, P181, DOI 10.1007/s11031-011-9234-9; van Wyk SM, 2016, SA J IND PSYCHOL, V42, DOI 10.4102/sajip.v42i1.1326; VANDEWIELE M, 1980, J GENET PSYCHOL, V137, P267, DOI 10.1080/00221325.1980.10532825; Vodanovich SJ, 2003, J PSYCHOL, V137, P569, DOI 10.1080/00223980309600636; Vogel-Walcutt JJ, 2012, EDUC PSYCHOL REV, V24, P89, DOI 10.1007/s10648-011-9182-7; Walumbwa FO, 2008, J MANAGE, V34, P89, DOI 10.1177/0149206307308913; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watt JD, 2010, J BUS PSYCHOL, V25, P163, DOI 10.1007/s10869-009-9138-9; WENZEL S, 1967, SIN SLOTH ACEDIA MED; Yik M, 2011, EMOTION, V11, P705, DOI 10.1037/a0023980	111	6	6	1	18	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1359-432X	1464-0643		EUR J WORK ORGAN PSY	Eur. J. Work Organ. Psychol.		2018	27	4					477	492		10.1080/1359432X.2018.1481830			16	Psychology, Applied; Management	Social Science Citation Index (SSCI)	Psychology; Business & Economics	GQ4JY	WOS:000441639000008					2022-02-06	
J	Bondi, CO; Yelleswarapu, NK; Day-Cooney, J; Memarzadeh, K; Folweiler, KA; Bou-Abboud, CE; Leary, JB; Cheng, JP; Tehranian-DePasquale, R; Kline, AE				Bondi, Corina O.; Yelleswarapu, Narayana K.; Day-Cooney, Julian; Memarzadeh, Kimiya; Folweiler, Kaitlin A.; Bou-Abboud, Carine E.; Leary, Jacob B.; Cheng, Jeffrey P.; Tehranian-DePasquale, Roya; Kline, Anthony E.			Systemic administration of donepezil attenuates the efficacy of environmental enrichment on neurobehavioral outcome after experimental traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Beam-walking; behavior; controlled cortical impact (CCI); donepezil; functional recovery; hippocampus; learning and memory; Morris water maze; traumatic brain injury	CORTICAL IMPACT INJURY; NICOTINIC ACETYLCHOLINE-RECEPTORS; REDUCED EVOKED RELEASE; UNITED-STATES; COGNITIVE DEFICITS; CHOLINESTERASE-INHIBITORS; HISTOLOGICAL BENEFITS; CHOLINERGIC SYSTEM; AGONIST 8-OH-DPAT; SPATIAL MEMORY	Background: The acetylcholinesterase inhibitor (AChEI) donepezil (DON) is recommended as a potential treatment for cognition after clinical traumatic brain injury (TBI) and therefore may be prescribed as an adjunct therapy during rehabilitation. However, a dose-response study evaluating DON after a controlled cortical impact (CCI) injury in rats did not reveal cognitive benefits. Objective: The aim of this study was to determine the effect of DON on behavioral and histological outcome when combined with environmental enrichment (EE), a preclinical model of neurorehabilitation. It was hypothesized that the combined treatments would produce a synergistic effect yielding improved recovery over neurorehabilitation alone. Methods: Isoflurane-anesthetized adult male rats received a CCI or sham injury and then were randomly assigned to EE or standard (STD) housing plus systemic injections of DON (0.25 mg/kg) or vehicle (VEH; 1.0 mL/kg saline) once daily for 19 days beginning 24 hr after injury. Function was assessed by established motor and cognitive tests on post-injury days 1-5 and 14-19, respectively. Cortical lesion volume was quantified on day 19. Results: DON was ineffective when administered alone. In contrast, EE conferred significant motor and cognitive benefits, and reduced cortical lesion volume vs. STD (p < 0.05). Combining the therapies weakened the efficacy of rehabilitation as revealed by diminished motor and cognitive recovery in the TBI+EE+DON group vs. the TBI+EE+VEH group (p < 0.05). Conclusion: These data replicate previous findings showing that EE is beneficial and DON is ineffective after CCI and add to the literature a novel and unpredicted finding that supports neither the hypothesis nor the use of DON for TBI. Investigation of other AChEIs after CCI injury is necessary to gain further insight into the value of this therapeutic strategy.	[Bondi, Corina O.; Yelleswarapu, Narayana K.; Day-Cooney, Julian; Memarzadeh, Kimiya; Folweiler, Kaitlin A.; Bou-Abboud, Carine E.; Leary, Jacob B.; Cheng, Jeffrey P.; Tehranian-DePasquale, Roya; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Bondi, Corina O.; Yelleswarapu, Narayana K.; Day-Cooney, Julian; Memarzadeh, Kimiya; Folweiler, Kaitlin A.; Bou-Abboud, Carine E.; Leary, Jacob B.; Cheng, Jeffrey P.; Tehranian-DePasquale, Roya; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA USA; [Yelleswarapu, Narayana K.] Michigan State Univ, Coll Osteopath Med, Neurosci Grad Program, E Lansing, MI 48824 USA; [Day-Cooney, Julian] Univ Chicago, Grossman Inst Neurosci, Chicago, IL 60637 USA; [Memarzadeh, Kimiya] Univ Texas McGovern, Sch Med, Neurobiol & Anat, Houston, TX USA; [Folweiler, Kaitlin A.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Bou-Abboud, Carine E.] Univ Hosp, Med Ctr, 11100 Euclid Ave, Cleveland, OH USA		Kline, AE (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Crit Care Med & Psychol, Sch Med,Phys Med & Rehabil,John G Rangos Res Ctr, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Crit Care Med & Psychol, Sch Med,John G Rangos Res Ctr,Safar Ctr Resuscita, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu		Memarzadeh, Kimiya/0000-0003-1737-663X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians /UPMC Academic Foundation; UMPC Rehabilitation Institute	This work was supported, in part, by NIH grants HD069620, HD069620-S1, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians /UPMC Academic Foundation, and the UMPC Rehabilitation Institute (COB).	Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Balsters JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024126; Basselin M, 2009, J ALZHEIMERS DIS, V17, P369, DOI 10.3233/JAD-2009-1058; Bentham P, 2004, LANCET, V363, P2105; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Bontempi B, 2003, NEUROPSYCHOPHARMACOL, V28, P1235, DOI 10.1038/sj.npp.1300150; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Cavedo E, 2016, J CLIN PSYCHIAT, V77, pE1631, DOI 10.4088/JCP.15m10413; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cummings JL, 2003, AM J GERIAT PSYCHIAT, V11, P131, DOI 10.1176/appi.ajgp.11.2.131; de la Tremblaye PB, 2017, J NEUROTRAUM, V34, P1610, DOI 10.1089/neu.2016.4790; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Faul M, 2010, TRAUMATIC BRAIN INJU; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Gawel K, 2016, N-S ARCH PHARMACOL, V389, P1059, DOI 10.1007/s00210-016-1269-8; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; Hernandez CM, 2006, J PHARMACOL EXP THER, V316, P679, DOI 10.1124/jpet.105.093047; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Holschneider DP, 2013, J NEUROTRAUM, V30, P907, DOI 10.1089/neu.2012.2657; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kosasa T, 1999, EUR J PHARMACOL, V380, P101, DOI 10.1016/S0014-2999(99)00545-2; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McCarthy AD, 2011, PHARMACOL BIOCHEM BE, V98, P76, DOI 10.1016/j.pbb.2010.11.019; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Riekkinen M, 1997, NEUROREPORT, V8, P645, DOI 10.1097/00001756-199702100-00013; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Seltzer Ben, 2005, Expert Opin Drug Metab Toxicol, V1, P527, DOI 10.1517/17425255.1.3.527; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shin SS, 2015, NEURAL REGEN RES, V10, P1552, DOI 10.4103/1673-5374.165309; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wise LE, 2007, NEUROPSYCHOPHARMACOL, V32, P1805, DOI 10.1038/sj.npp.1301297; Yelleswarapu NK, 2012, NEUROSCI LETT, V515, P153, DOI 10.1016/j.neulet.2012.03.033; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793	69	6	6	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2018	36	1					45	57		10.3233/RNN-170781			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV8XZ	WOS:000424872200005	29439368				2022-02-06	
J	Bradley-Whitman, MA; Roberts, KN; Abner, EL; Scheff, SW; Lynn, BC; Lovell, MA				Bradley-Whitman, Melissa A.; Roberts, Kelly N.; Abner, Erin L.; Scheff, Stephen W.; Lynn, Bert C.; Lovell, Mark A.			A novel method for the rapid detection of post-translationally modified visinin-like protein 1 in rat models of brain injury	BRAIN INJURY			English	Article						Biomarker; head injury; mild brain injury; traumatic brain injury	FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; TRAUMATIC INTRACRANIAL LESIONS; CALCIUM-MYRISTOYL SWITCH; EARLY ALZHEIMER-DISEASE; CA2+ SENSOR VILIP-1; FLUORO-JADE-B; CEREBROSPINAL-FLUID; HIPPOCAMPAL-NEURONS; NEUROSURGICAL INTERVENTION	Background: Although elevated serum levels of visinin-like protein 1 (VILIP-1), a neuron-specific calcium sensor protein, are associated with ischaemic stroke, only a single study has evaluated VILIP-1 as a biomarker of traumatic brain injury (TBI). The current proof-of-concept study was designed to determine whether serum VILIP-1 levels increase post-injury in a well-characterized rat unilateral cortical contusion model.Methods: Lateral flow devices (LFDs) rapidly (<20min) detected trace serum levels (pg/mL) of VILIP-1 in a small input sample volume (10 mu L). Temporal profiles of serum levels at baseline and post-injury were measured in male Sprague Dawley rats subjected to very mild-, mild unilateral-cortical contusion, or naive surgery and in male Sprague Dawley rats following a diffuse TBI or sham surgery.Results: Mean serum levels were significantly elevated by 0.5h post-injury and remained so throughout the temporal profile compared with baseline in very mild and mild unilateral contusions but not in naive surgeries. Serum levels were also elevated in a small cohort of animals subjected to a diffuse TBI injury.Conclusions: Overall, the current study demonstrates that the novel LFD is a reliable and rapid point-of-care diagnostic for the detection and quantification of serum levels of UB-VILIP-1 in a clinically relevant time frame.	[Bradley-Whitman, Melissa A.; Scheff, Stephen W.; Lovell, Mark A.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Roberts, Kelly N.] Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Abner, Erin L.] Univ Kentucky, Sanders Brown Ctr Aging, Coll Publ Hlth, Lexington, KY 40536 USA; [Abner, Erin L.] Univ Kentucky, Coll Publ Hlth, Dept Epidemiol, Lexington, KY USA; [Scheff, Stephen W.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Lynn, Bert C.] Univ Kentucky, Sanders Brown Ctr Aging, Mass Spectrometry, Facil, Lexington, KY 40536 USA; [Lynn, Bert C.; Lovell, Mark A.] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA		Lovell, MA (corresponding author), Sanders Brown Ctr Aging, 800 South Limestone St, Lexington, KY 40536 USA.	malove2@uky.edu		Lynn, Bert/0000-0001-8426-3024	Kentucky Spinal Cord Head Injury Research Trust [13-7]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028383] Funding Source: NIH RePORTER	This research was supported by Kentucky Spinal Cord Head Injury Research Trust #13-7 (to MAL). Drs Lovell, Lynn, and Bradley Whitman hold an equity interest in Fawkes Diagnostics LLC., which has licensed the use of the LFD for detection of VILIP-1 (Patent Number: US 9,482,675 B1).	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Brackmann M, 2005, J CELL SCI, V118, P2495, DOI 10.1242/jcs.02376; Brasure M, 2012, MULTIDISCIPLINARY PO; Braunewell KH, 2001, J NEUROCHEM, V78, P1277, DOI 10.1046/j.1471-4159.2001.00506.x; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Giza CC, 2001, J ATHL TRAINING, V36, P228; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/S0968-0004(06)80021-6; Jagoda AS, 2009, J EMERG NURS, V35, pe5, DOI DOI 10.1016/J.JEN.2008.12.010; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kester MI, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0142-1; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Lee JY, 2015, J KOREAN NEUROSURG S, V58, P93, DOI 10.3340/jkns.2015.58.2.93; Lee JM, 2008, CLIN CHEM, V54, P1617, DOI 10.1373/clinchem.2008.104497; Li ZM, 2004, BIOCHEM BIOPH RES CO, V319, P1171, DOI 10.1016/j.bbrc.2004.05.098; Liebl MP, 2014, FREE RADICAL BIO MED, V72, P41, DOI 10.1016/j.freeradbiomed.2014.04.008; Lin L, 2002, BIOCHEM BIOPH RES CO, V296, P827, DOI 10.1016/S0006-291X(02)00943-9; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Luo XN, 2013, J NEUROCHEM, V127, P681, DOI 10.1111/jnc.12331; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathisen PM, 1999, J BIOL CHEM, V274, P31571, DOI 10.1074/jbc.274.44.31571; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mroczko B, 2015, J ALZHEIMERS DIS, V43, P1031, DOI 10.3233/JAD-141050; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Posti JP, 2016, J NEUROTRAUM, V34, P1; Prevention CfDCa, 2015, C TRAUM BRAIN INJ US; Rebaud S, 2014, BBA-BIOMEMBRANES, V1838, P2698, DOI 10.1016/j.bbamem.2014.06.021; Rebaud S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093948; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shahim P, 2015, BRAIN INJURY, V29, P872, DOI 10.3109/02699052.2015.1018324; Spilker C, 2003, MOL CELL NEUROSCI, V24, P766, DOI 10.1016/S1044-7431(03)00242-2; Spilker C, 2002, J NEUROSCI, V22, P7331; Stejskal D, 2011, BIOMED PAP, V155, P263, DOI 10.5507/bp.2011.049; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sutphen CL, 2015, JAMA NEUROL, V72, P1029, DOI 10.1001/jamaneurol.2015.1285; Tarawneh R, 2012, NEUROLOGY, V78, P709, DOI 10.1212/WNL.0b013e318248e568; Tarawneh R, 2015, JAMA NEUROL, V72, P656, DOI 10.1001/jamaneurol.2015.0202; Tarawneh R, 2011, ANN NEUROL, V70, P274, DOI 10.1002/ana.22448; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Unden J, 2004, SCAND J INFECT DIS, V36, P10, DOI 10.1080/00365540310017294; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wolf H, 2015, J NEUROTRAUM, V32, P23, DOI 10.1089/neu.2013.3202; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; YEALY D M, 1991, Emergency Medicine Clinics of North America, V9, P707; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z	66	6	6	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	3					363	380		10.1080/02699052.2017.1418907			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FU3PV	WOS:000423764700011	29283288				2022-02-06	
J	Brooks, MA; Bazarian, JJ; Prichep, LS; Dastidar, SG; Talavage, TM; Barr, W				Brooks, M. Alison; Bazarian, Jeffrey J.; Prichep, Leslie S.; Dastidar, Samanwoy Ghosh; Talavage, Thomas M.; Barr, William			The Use of an Electrophysiological Brain Function Index in the Evaluation of Concussed Athletes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain function index; brain injury; concussion; electrophysiological data; mild TBI	COLLEGIATE FOOTBALL PLAYERS; UNITED-STATES; INJURY; RECOVERY; SPORT; 1ST	Objective: To evaluate the effectiveness of the electroencephalographic (EEG) Brain Function Index (BFI) for characterizing sports-related concussive injury and recovery. Participants: Three hundred fifty-four (354) male contact sport high school and college athletes were prospectively recruited from multiple locations over 6 academic years of play (244 control baseline athletes and 110 athletes with a concussion). Methods: Using 5 to 10 minutes of eyes closed resting EEG collected from frontal and frontotemporal regions, a BFI was computed for all subjects and sessions. Group comparisons were performed to test for the significance of the difference in the BFI score between the controls at baseline and athletes with a concussion at several time points. Results: There was no significant difference in BFI between athletes with a concussion at baseline (ie, prior to injury) and controls at baseline (P = .4634). Athletes with a concussion, tested within 72 hours of injury, exhibited significant differences in BFI compared with controls (P = .0036). The significant differences in BFI were no longer observed at 45 days following injury (P = .19). Conclusion: Controls and athletes with a concussion exhibited equivalent BFI scores at preseason baseline. The concussive injury (measured within 72 hours) significantly affected brain function reflected in the BFI in the athletes with a concussion. The BFI of the athletes with a concussion returned to levels seen in controls by day 45, suggesting recovery. The BFI may provide an important objective marker of concussive injury and recovery.	[Brooks, M. Alison] Univ Wisconsin Madison, Dept Orthoped & Pediat, Madison, WI USA; [Bazarian, Jeffrey J.] Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA; [Prichep, Leslie S.; Barr, William] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Barr, William] NYU, Sch Med, Dept Neurol, New York, NY USA; [Prichep, Leslie S.; Dastidar, Samanwoy Ghosh] BrainScope Co Inc, Bethesda, MD USA; [Talavage, Thomas M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA		Prichep, LS (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	prichl01@nyumc.org		Talavage, Thomas/0000-0003-4977-6398	BrainScope Company, Inc; GENFL Head Health Challenge I	Data acquisition for this study was supported in part by research grants to the clinical sites from BrainScope Company, Inc, and from GENFL Head Health Challenge I. Drs Talavage and Brooks were principal investigators at clinical data acquisition sites. During the first 3 years of data acquisition, Dr Barr was an expert concussion consultant to BrainScope Company, Inc. Dr Bazarian was a principal investigator in a related data acquisition study and served as a thought leader in the field of concussion for BrainScope Company, Inc. Dr Ghosh Dastidar is a biomedical engineer who serves as a senior algorithm development specialist at BrainScope Co, Inc and holds company options. During the period of data acquisition, Dr Prichep was the Director of the Brain Research Laboratories, Department of Psychiatry, at NYU School of Medicine, and served as a paid consultant to BrainScope Company, Inc. Currently, Dr Prichep is the Chief Scientific Officer of BrainScope Company, Inc, and a Professor at NYU School of Medicine. Dr Prichep holds potential financial interest through patented technology licensed by BrainScope Company, Inc, from NYU School of Medicine and company options. BrainScope Company, Inc, had no role other than indicated above, in the conduct of these studies. Strict adherence to ethical concerns was followed all subjects signed written informed consents for participation in the study.	Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Bigler E., 2014, CONCUSSIONS ATHLETIC, P181; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanley D, 2017, J NEUROTRAU IN PRESS; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	27	6	6	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					1	6		10.1097/HTR.0000000000000328			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300008	28520677				2022-02-06	
S	Campolo, M; Esposito, E; Cuzzocrea, S		Skaper, SD		Campolo, Michela; Esposito, Emanuela; Cuzzocrea, Salvatore			A Controlled Cortical Impact Preclinical Model of Traumatic Brain Injury	NEUROTROPHIC FACTORS: METHODS AND PROTOCOLS, 2ND EDITION	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury; Stereotaxic support; Craniotomy; Mice	TREATMENT STRATEGIES; PATHOPHYSIOLOGY; RATS; MICE	Over the past three decades, attempts at understanding the multifaceted mechanisms underlying the pathophysiology of traumatic brain injury (TBI) have seen the development of numerous animal models to investigate changes in molecular and cellular pathways and neurobehavioral outcomes. Until now, controlled cortical impact (CCI) represents the most frequently used mechanical model to induce TBI, given its accuracy, easy of control, and, most importantly, its ability to produce brain injuries similar to those seen in humans. The CCI model is based on the use of an impact system that delivers a physical impact to the exposed dura of an animal. This chapter will describe in detail the electromagnetic CCI model of TBI in mice.	[Campolo, Michela; Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA		Campolo, M (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy.		Campolo, Michela/K-6432-2016	Cuzzocrea, Salvatore/0000-0001-6131-3690			Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bruschetta Giuseppe, 2017, Front Neurosci, V11, P6, DOI 10.3389/fnins.2017.00006; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	22	6	6	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-7571-6; 978-1-4939-7570-9	METHODS MOL BIOL	Methods Mol. Biol.		2018	1727						385	391		10.1007/978-1-4939-7571-6_30	10.1007/978-1-4939-7571-6		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BK2PH	WOS:000433438800031	29222798				2022-02-06	
J	Carlozzi, NE; Sherman, CW; Angers, K; Belanger, MP; Austin, AM; Ryan, KA				Carlozzi, Noelle E.; Sherman, Carey W.; Angers, Kaley; Belanger, Mitchell P.; Austin, Amy M.; Ryan, Kelly A.			Caring for an individual with mild cognitive impairment: a qualitative perspective of health-related quality of life from caregivers	AGING & MENTAL HEALTH			English	Article						Mild cognitive impairment; cognitive disorders; caregiver; quality of life; qualitative research; focus groups	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; NEUROPSYCHIATRIC SYMPTOMS; FAMILY CAREGIVERS; PARKINSONS-DISEASE; DEMENTIA CAREGIVER; VASCULAR DEMENTIA; BEHAVIOR PROBLEMS; CONCEPTUAL-MODEL; PHYSICAL HEALTH	Objectives: Little is known regarding the effect that caring for an individual with Mild Cognitive Impairment (MCI) has on health-related quality of life (HRQOL). We sought to identify the most important aspects of HRQOL related to caring for an individual with MCI.Methods: Six focus groups were conducted with caregivers of individuals with MCI (n = 32). Qualitative frequency analysis was used to analyze the data.Results: Findings indicated that caregivers most frequently discussed social health, including changes in social roles and an increased need for social support (51.2% of the total discussion). This was followed by mental health concerns (37.9%) centering on anger/frustration, and a need for patience in the caregiving role, as well as caregiver-specific anxiety. Other topics included physical health (10.0%; including the impact that stress and burden have on medical heath), and caregivers' cognitive health (0.9%; including memory problems in relation to caregiver strain, sleep disruption, and cognitive fatigue).Conclusions: Findings illustrate the multiple domains of HRQOL that are affected in individuals providing care for someone with MCI. Moreover, the findings highlight the need for extending support services to MCI caregivers, a group that is typically not offered support services due to the less severe' nature of an MCI diagnosis.	[Carlozzi, Noelle E.; Belanger, Mitchell P.; Austin, Amy M.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Sherman, Carey W.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Angers, Kaley; Ryan, Kelly A.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu			Michigan Alzheimer's Disease Center - Pilot Program Grant; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [2KL2TR000434]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002240, KL2TR000434] Funding Source: NIH RePORTER	Michigan Alzheimer's Disease Center - Pilot Program Grant (NC, KR, CS); National Center for Advancing Translational Sciences [grant number 2KL2TR000434].	Bin Sallim A, 2015, J AM MED DIR ASSOC, V16, P1034, DOI 10.1016/j.jamda.2015.09.007; Blieszner R, 2010, GERONTOLOGIST, V50, P11, DOI 10.1093/geront/gnp068; Boltz M, 2015, ALZ DIS ASSOC DIS, V29, P236, DOI 10.1097/WAD.0000000000000072; Bruce JM, 2008, DEMENT GERIATR COGN, V25, P385, DOI 10.1159/000122587; Carlozzi N. E., 2011, QUALITY LIFE MEASURE, P71; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Carlozzi NE, 2013, ARCH PHYS MED REHAB, V94, P1721, DOI 10.1016/j.apmr.2013.02.024; Carlozzi NE, 2013, J HEALTH PSYCHOL, V18, P212, DOI 10.1177/1359105312438109; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Cheng ST, 2016, GERONTOLOGIST, V56, P451, DOI 10.1093/geront/gnu118; Cupidi C, 2012, INT PSYCHOGERIATR, V24, P1827, DOI 10.1017/S1041610212001032; D'Onofrio G, 2015, INT J GERIATR PSYCH, V30, P891, DOI 10.1002/gps.4232; Dunkin JJ, 1998, NEUROLOGY, V51, pS53, DOI 10.1212/WNL.51.1_Suppl_1.S53; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; Fisher GG, 2011, J AM GERIATR SOC, V59, P488, DOI 10.1111/j.1532-5415.2010.03304.x; Folkman S., 1984, STRESS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garand L, 2005, INT J GERIATR PSYCH, V20, P512, DOI 10.1002/gps.1318; Gaugler JE, 2000, PSYCHOL AGING, V15, P437, DOI 10.1037/0882-7974.15.3.437; Georges J, 2008, INT J GERIATR PSYCH, V23, P546, DOI 10.1002/gps.1984; Glaser B., 1967, DISCOVERY GROUNDED T; Gronning H, 2013, DAN MED J, V60; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hayashi S, 2013, INT PSYCHOGERIATR, V25, P1357, DOI 10.1017/S1041610213000537; Ikeda C, 2015, PSYCHIAT RES, V226, P242, DOI 10.1016/j.psychres.2014.12.055; Joling KJ, 2015, AM J GERIAT PSYCHIAT, V23, P293, DOI 10.1016/j.jagp.2014.05.005; Jones RW, 2015, ALZHEIMERS DEMENT, V11, P280, DOI 10.1016/j.jalz.2014.03.001; Kamiya M, 2014, GERIATR GERONTOL INT, V14, P45, DOI 10.1111/ggi.12260; Karlin N J, 2001, Am J Alzheimers Dis Other Demen, V16, P177, DOI 10.1177/153331750101600306; Kelleher M, 2016, INT J GERIATR PSYCH, V31, P799, DOI 10.1002/gps.4394; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kuo LM, 2014, DEMENT GERIATR COGN, V38, P310, DOI 10.1159/000360414; Lee D, 2014, J CLIN NEUROL, V10, P304, DOI 10.3988/jcn.2014.10.4.304; Mannion Edel, 2008, Nurs Older People, V20, P33; Matsumoto N, 2007, DEMENT GERIATR COGN, V23, P219, DOI 10.1159/000099472; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mioshi E, 2009, DEMENT GERIATR COGN, V27, P76, DOI 10.1159/000193626; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ornstein K, 2014, INT J AGING HUM DEV, V78, P133, DOI 10.2190/AG.78.2.c; Ostojic D, 2014, ACTA CLIN CROAT, V53, P17; Paradise M, 2015, AGING MENT HEALTH, V19, P72, DOI 10.1080/13607863.2014.915922; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Peng HL, 2016, CLIN NURS RES, V25, P448, DOI 10.1177/1054773815610747; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pinquart M, 2005, GERONTOLOGIST, V45, P90, DOI 10.1093/geront/45.1.90; Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126, DOI 10.1093/geronb/62.2.P126; PRUCHNO RA, 1989, J GERONTOL, V44, pS177, DOI 10.1093/geronj/44.5.S177; QSR International Pty Ltd, 2012, NVIV QUAL DAT AN SOF; Richardson TJ, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0367-2; Rinaldi P, 2005, INT J GERIATR PSYCH, V20, P168, DOI 10.1002/gps.1267; Roberto KA, 2013, DEMENTIA-LONDON, V12, P45, DOI 10.1177/1471301211421233; Rocca P, 2010, DEMENT GERIATR COGN, V30, P57, DOI 10.1159/000315513; Ryan KA, 2012, DEMENT GERIATR COGN, V34, P206, DOI 10.1159/000339955; Santos RL, 2014, ARQ NEURO-PSIQUIAT, V72, P931, DOI 10.1590/0004-282X20140155; Savla J, 2013, PSYCHOL AGING, V28, P666, DOI 10.1037/a0032654; Savla J, 2011, J GERONTOL B-PSYCHOL, V66, P653, DOI 10.1093/geronb/gbr041; SCHULZ R, 1990, J GERONTOL, V45, pP181, DOI 10.1093/geronj/45.5.P181; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schulz R, 2008, AM J NURS, V108, P23, DOI 10.1097/01.NAJ.0000336406.45248.4c; Seeher K, 2013, ALZHEIMERS DEMENT, V9, P346, DOI 10.1016/j.jalz.2012.01.012; Springate B, 2013, J APPL GERONTOL, V32, P765, DOI 10.1177/0733464811433486; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Szeto JYY, 2016, J PARKINSON DIS, V6, P589, DOI 10.3233/JPD-160823; Trigg R, 2015, INT J GERIATR PSYCH, V30, P400, DOI 10.1002/gps.4150; Trivedi SC, 2013, INDIAN J PSYCHIAT, V55, P154, DOI 10.4103/0019-5545.111454; Vitaliano PP, 1996, J GERONTOL B-PSYCHOL, V51, pP290, DOI 10.1093/geronb/51B.5.P290; Vitaliano PP, 1997, ANN BEHAV MED, V19, P117, DOI 10.1007/BF02883328; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; von Kanel R, 2012, SLEEP, V35, P247, DOI 10.5665/sleep.1632; Waite A, 2004, INT J GERIATR PSYCH, V19, P582, DOI 10.1002/gps.1136; Yektatalab Shahrzad, 2013, J Caring Sci, V2, P187, DOI 10.5681/jcs.2013.023; Yikilkan H, 2014, ARCH PSYCHIAT NURS, V28, P193, DOI 10.1016/j.apnu.2014.01.001; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	79	6	6	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1360-7863	1364-6915		AGING MENT HEALTH	Aging Ment. Health		2018	22	9					1190	1198		10.1080/13607863.2017.1341468			9	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	HA4WV	WOS:000450267000013	28699777	Green Accepted			2022-02-06	
J	Cations, M; Draper, B; Low, LF; Radford, K; Trollor, J; Brodaty, H; Sachdev, P; Gonski, P; Broe, GA; Withall, A				Cations, Monica; Draper, Brian; Low, Lee-Fay; Radford, Kylie; Trollor, Julian; Brodaty, Henry; Sachdev, Perminder; Gonski, Peter; Broe, Gerald Anthony; Withall, Adrienne			Non-Genetic Risk Factors for Degenerative and Vascular Young Onset Dementia: Results from the INSPIRED and KGOW Studies	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; early onset dementia; epidemiology; frontotemporal; Lewy body; lifestyle; modifiable; protective; risk; vascular; young onset dementia	REGIONAL ABORIGINAL AUSTRALIANS; ALZHEIMERS-DISEASE; DEPRESSIVE SYMPTOMS; NATIONWIDE COHORT; LIFE-COURSE; POPULATION; PREVALENCE; BURDEN; INJURY; URBAN	Background: Several brain reserve, vascular risk, and other modifiable factors have been associated with late-onset dementia, but their association with young onset dementia (YOD) has not been adequately explored. Objective: To examine the association of cognitive reserve enhancing factors, cardiovascular risk factors (including smoking), depression, alcohol use, and traumatic brain injury (TBI) with non-autosomal dominant degenerative and/or vascular YOD. Methods: Data for this matched case-control study were taken from two larger studies conducted in NSW, Australia. One comprised all people with YOD within a geographical region, while the other exclusively included Aboriginal and Torres Strait Islander participants. Dementia diagnosis was confirmed by clinical consensus, and risk exposure was retrospectively self- and/or informant-reported. Results: Participants were 96 people with YOD (58.4% with probable Alzheimer's disease) and 175 age-group, sex, and sample matched control participants. Poor educational attainment, low participation in cognitive leisure activity, stroke, transient ischemic attack, and self-reported very heavy alcohol use were related to the risk of primary degenerative and/or vascular YOD. The effect of hypertension and depression varied depending on when they occurred relative to dementia onset. Current smoking was significantly associated with risk in univariate analyses but did not retain significance in multivariate modelling. There was no association with hypercholesterolemia, diabetes, or TBI of any kind. Some compensation for low educational attainment was possible via a complex occupation later in life. Conclusion: Non-genetic factors have a role in YOD, though the relative importance of each factor may be different to late onset dementia. The timing and severity of exposure, as well as the potential for compensation with later protective exposures, are important considerations for potential prevention strategies.	[Cations, Monica; Gonski, Peter; Withall, Adrienne] UNSW Sydney, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; [Cations, Monica; Draper, Brian; Brodaty, Henry; Sachdev, Perminder] UNSW Sydney, Sch Psychiat, Dementia Ctr Res Collaborat, Sydney, NSW, Australia; [Draper, Brian; Radford, Kylie; Brodaty, Henry] Prince Wales Hosp, Acad Dept Old Age Psychiat, Randwick, NSW, Australia; [Low, Lee-Fay] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Broe, Gerald Anthony] Neurosci Res Australia, Sydney, NSW, Australia; [Radford, Kylie; Broe, Gerald Anthony] UNSW Sydney, Sch Med Sci, Sydney, NSW, Australia; [Trollor, Julian; Brodaty, Henry; Sachdev, Perminder] UNSW Sydney, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Trollor, Julian] UNSW Sydney, Sch Psychiat, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia; [Sachdev, Perminder] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW, Australia; [Gonski, Peter] South Eastern Sydney Local Hlth Dist, Div Aged & Extended Care Southcare, Sutherland Hosp, Sydney, NSW, Australia		Cations, M (corresponding author), UNSW Sydney, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.	monica.cations@sa.gov.au	Low, Lee-Fay/AAX-5302-2020; Cations, Monica/L-9663-2018; Sachdev, Perminder/ABC-1137-2020; Withall, Adrienne/AAI-3943-2021; Radford, Kylie/D-5338-2011	Cations, Monica/0000-0002-9262-0463; Sachdev, Perminder/0000-0002-9595-3220; Withall, Adrienne/0000-0001-7079-465X; Trollor, Julian/0000-0002-7685-2977; Radford, Kylie/0000-0001-8095-5314	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [INSPIRED (1008267), KGOWS (510347)]; NHMRC Career Development FellowshipNational Health and Medical Research Council of Australia; NHMRC Dementia Research Development FellowshipNational Health and Medical Research Council of Australia	The Australian National Health and Medical Research Council provided funding for both INSPIRED (1008267) and KGOWS (510347). Funding was provided for this combined sub-study by the Dementia Centre for Research Collaboration, Alzheimer's Australia Dementia Research Foundation, and Brain Sciences UNSW. The studies were conducted at the Dementia Centre for Research Collaboration and at Neuroscience Research Australia, both at UNSW Sydney, Australia. A/Prof Low is supported by an NHMRC Career Development Fellowship and Dr Radford is supported by an NHMRC Dementia Research Development Fellowship.	Al Hazzouri AZ, 2011, AM J EPIDEMIOL, V173, P1148, DOI 10.1093/aje/kwq483; Ashby-Mitchell K, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0238-x; Australian Institute of Health and Welfare, 2014, 2013 NAT DRUG STRAT; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Brown L, 2017, EC COST DEMENTIA AUS; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cations M, 2016, EUR J EPIDEMIOL, V31, P107, DOI 10.1007/s10654-015-0103-9; Chen YH, 2017, J ALZHEIMERS DIS, V60, P1045, DOI 10.3233/JAD-170367; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Draper B, 2016, INTERN MED J, V46, P779, DOI 10.1111/imj.13099; Draper B, 2016, INT J GERIATR PSYCH, V31, P1217, DOI 10.1002/gps.4430; Freyne A, 1999, INT J GERIATR PSYCH, V14, P784, DOI 10.1002/(SICI)1099-1166(199909)14:9<784::AID-GPS16>3.0.CO;2-2; Garre-Olmo J, 2010, NEUROLOGY, V75, P1249, DOI 10.1212/WNL.0b013e3181f5d4c4; Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1; Heser K, 2013, PSYCHOL MED, V43, P1597, DOI 10.1017/S0033291712002449; Hosmer D. W., 2004, APPL LOGISTIC REGRES; I. B. M. Corporation, 2015, IBM SPSS STAT; Jarmolowicz AI, 2015, AM J ALZHEIMERS DIS, V30, P299, DOI 10.1177/1533317514545825; Kadohara K, 2017, EUR J NEUROL, V24, P944, DOI 10.1111/ene.13312; Li G, 2011, ARCH GEN PSYCHIAT, V68, P970, DOI 10.1001/archgenpsychiatry.2011.86; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Low LF, 2010, NEUROSCI BIOBEHAV R, V34, P408, DOI 10.1016/j.neubiorev.2009.08.007; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Nordstrom P, 2013, JAMA INTERN MED, V173, P1612, DOI 10.1001/jamainternmed.2013.9079; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Panegyres PK, 2014, EUR J NEUROL, V21, P1149, DOI 10.1111/ene.12453; Power MC, 2011, EPIDEMIOLOGY, V22, P646, DOI 10.1097/EDE.0b013e31822708b5; Prince M., 2014, DEMENTIA RISK REDUCT; Radford K, 2015, DEMENT GERIATR COGN, V40, P22, DOI 10.1159/000377673; Radford K, 2015, ALZHEIMERS DEMENT, V11, P271, DOI 10.1016/j.jalz.2014.03.007; Radford K, 2014, INT PSYCHOGERIATR, V26, P1033, DOI 10.1017/S1041610213002561; Scazufca M, 2008, INT J EPIDEMIOL, V37, P879, DOI 10.1093/ije/dyn125; Sharp SI, 2011, INT J GERIATR PSYCH, V26, P661, DOI 10.1002/gps.2572; Slade J, 2009, MENTAL HLTH AUSTR 2; Stern C, 2010, INT J EVID-BASED HEA, V8, P2, DOI 10.1111/j.1744-1609.2010.00150.x; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Wang HX, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002251; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Withall A, 2013, AUSTRALASIAN EPIDEMI, V20, P9; Withall A, 2014, INT PSYCHOGERIATR, V26, P1955, DOI 10.1017/S1041610214001835	45	6	6	1	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2018	62	4					1747	1758		10.3233/JAD-171027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GB2BK	WOS:000428855700023	29614682				2022-02-06	
J	Cushman, D; Hendrick, J; Teramoto, M; Fogg, B; Bradley, S; Hansen, C				Cushman, Daniel; Hendrick, John; Teramoto, Masaru; Fogg, Benjamin; Bradley, Sean; Hansen, Colby			Reliability of the balance error scoring system in a population with protracted recovery from mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; concussion; stance; reliability; components; post-concussion syndrome	POSTURAL STABILITY; NORMATIVE DATA; CONCUSSION; CHILDREN; PERFORMANCE; MANAGEMENT; SYMPTOMS; PLAYERS	Objective: This study aimed to identify the Balance Error Scoring System's (BESS) intraclass reliability in a cohort of patients with prolonged symptoms using variance component analysis and intraclass correlation coefficient (ICC).Setting: Outpatient sports medicine/concussion clinic.Participants: A total of 241 paediatric and 102 adult patients with symptoms lasting longer than 10 days.Interventions: BESS testing.Design: Retrospective review.Main outcome measures: Percent variance for each BESS component and intraclass reliability. A five-component model (including all components except for firm double-leg) and a four- component model (including all components except for firm and foam doubleleg) were also performed to compare ICC values.Results: The largest source of variance came from stance (41.1%). The BESS components firm single (25.5%) and foam tandem (27.5%) stances accounted for the largest percentages of variance, while firm double (1.1%) and foam double (6.9%) accounted for the smallest percentages. The ICC for all patients was 0.800, and increased both if the firm double stance was excluded, or if both double-leg stances were excluded.Conclusion: BESS reliability appears to be high in a concussed cohort, regardless of age. Removing the two double-leg stance portions increases the ICC of the test without failing to identify balance deficits.	[Cushman, Daniel; Teramoto, Masaru; Hansen, Colby] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT USA; [Hendrick, John] Univ Utah, Dept Emergency Med, Salt Lake City, UT USA; [Fogg, Benjamin] Univ Utah, Sch Med, Salt Lake City, UT USA; [Bradley, Sean] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA		Bradley, S (corresponding author), 590 Wakara Way, Salt Lake City, UT 84108 USA.	Bradley.sean.m@gmail.com	Hansen, Colby/AAP-7680-2021	Hansen, Colby/0000-0002-8012-2483; Cushman, Daniel/0000-0002-4580-1173			[Anonymous], 2013, Br J Sports Med, V47, P259; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Diaz DS, 2014, SEMIN SPEECH LANG, V35, P204, DOI 10.1055/s-0034-1384682; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Garson GD, 2012, VARIANCE COMPONENTS; Graham R, 2014, SPORTS RELATED CONCU, P99; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hansen C, 2017, CLIN J SPORT MED, V27, P64, DOI 10.1097/JSM.0000000000000293; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; Nuzzo RL, 2016, PM&R, V8, P268, DOI 10.1016/j.pmrj.2016.02.001; Pan T, 2015, GAIT POSTURE, V42, P550, DOI 10.1016/j.gaitpost.2015.08.012; Portney LG, 2000, FDN CLIN RES APPL PR, V2, P588; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Stuart E, 2015, CURR RES, V2, P22; Valovich TC, 2003, J ATHL TRAINING, V38, P51	28	6	6	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					569	574		10.1080/02699052.2018.1432891			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200007	29393686				2022-02-06	
J	Darling, SJ; De Luca, C; Anderson, V; McCarthy, M; Hearps, S; Seal, ML				Darling, Simone J.; De Luca, Cinzia; Anderson, Vicki; McCarthy, Maria; Hearps, Stephen; Seal, Marc L.			White Matter Microstructure and Information Processing at the Completion of Chemotherapy-Only Treatment for Pediatric Acute Lymphoblastic Leukemia	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							LONG-TERM SURVIVORS; AUTOMATED BATTERY CANTAB; TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE OUTCOMES; RADIAL DIFFUSIVITY; WORKING-MEMORY; CONTEMPORARY TREATMENT; CRANIAL IRRADIATION; VOXELWISE ANALYSIS; CORPUS-CALLOSUM	Little is known about white matter microstructure and its role in information processing abilities of children treated for acute lymphoblastic leukemia (ALL) early posttreatment. Twenty-one survivors of ALL and 18 controls (7-16years) underwent neurocognitive assessment. A subsample underwent diffusion-weighted magnetic resonance imaging. The ALL group performed poorer on measures of processing capacity, and had widespread areas of decreased fractional anisotropy and increased radial diffusivity. Significant group by white matter microstructure interactions was found when predicting processing speed. Findings provide evidence for an atypical brain-behavior relationship early posttreatment for childhood ALL. Replication in a larger sample is required.	[Darling, Simone J.; De Luca, Cinzia; Anderson, Vicki; McCarthy, Maria; Hearps, Stephen; Seal, Marc L.] Murdoch Childrens Res Inst, Clin Sci, Parkville, Vic, Australia; [Darling, Simone J.; Anderson, Vicki; Seal, Marc L.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [De Luca, Cinzia; McCarthy, Maria] Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Parkville, Vic, Australia		Darling, SJ (corresponding author), Royal Childrens Hosp, MCRI, Level 4 West,Flemington Rd, Melbourne, Vic 3052, Australia.	simone.darling@mcri.edu.au	Hearps, Stephen/L-6853-2016; Seal, Marc L/J-9290-2019	Seal, Marc L/0000-0002-8396-140X; Hearps, Stephen/0000-0003-2984-1172	Leukaemia Foundation; Royal Children's Hospital Foundation; Monash HealthMonash University; Victorian Government's Operational Infrastructure Support Program; Australian Government Research Training Program ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science; Murdoch Children's Research Institute Postgraduate Health Research Scholarship (MCRI) Postgraduate Health Research Scholarship	The ALLaboard study was generously supported by The Leukaemia Foundation, The Royal Children's Hospital Foundation, Monash Health and the Victorian Government's Operational Infrastructure Support Program. Simone Darling was financially supported by an Australian Government Research Training Program Scholarship and an Murdoch Children's Research Institute Postgraduate Health Research Scholarship (MCRI) Postgraduate Health Research Scholarship.	Akiba T, 1996, ACTA NEUROPATHOL, V92, P8, DOI 10.1007/s004010050482; Anderson FS, 2009, PEDIATR BLOOD CANCER, V52, P159, DOI 10.1002/pbc.21700; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Aukema EJ, 2009, INT J RADIAT ONCOL, V74, P837, DOI 10.1016/j.ijrobp.2008.08.060; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Billiet T, 2018, JNCI-J NATL CANCER I, V110, P905, DOI 10.1093/jnci/djy009; Bourgeois J.-P., 1999, NEW COGNITIVE NEUROS, P45; Cheung YT, 2015, NEUROSCI BIOBEHAV R, V53, P108, DOI 10.1016/j.neubiorev.2015.03.016; Cohen J., 2013, STAT POWER ANAL BEHA; Conklin HM, 2012, JNCI-J NATL CANCER I, V104, P1386, DOI 10.1093/jnci/djs344; Constantinidis C, 2016, NAT REV NEUROSCI, V17, P438, DOI 10.1038/nrn.2016.43; Counsell SJ, 2008, BRAIN, V131, P3201, DOI 10.1093/brain/awn268; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; Cowan N., 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Deoni SCL, 2015, NEUROIMAGE, V115, P147, DOI 10.1016/j.neuroimage.2015.04.058; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Edelmann MN, 2014, BRAIN, V137, P2973, DOI 10.1093/brain/awu230; Edelmann MN, 2013, PEDIATR BLOOD CANCER, V60, P1778, DOI 10.1002/pbc.24644; ElAlfy M, 2014, PEDIATR HEMAT ONCOL, V31, P194, DOI 10.3109/08880018.2013.871763; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; Genc S, 2017, NEUROIMAGE, V156, P286, DOI 10.1016/j.neuroimage.2017.05.017; Genschaft M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078599; Hearps S, 2017, PEDIATR BLOOD CANCER, V64, P225, DOI 10.1002/pbc.26188; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Iyer NS, 2015, BLOOD, V126, P346, DOI 10.1182/blood-2015-02-627414; Janve VA, 2013, NEUROIMAGE, V74, P298, DOI 10.1016/j.neuroimage.2013.02.034; Jones D., 2011, DIFFUSION MRI THEORY; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kanellopoulos A, 2016, PEDIATR BLOOD CANCER, V63, P133, DOI 10.1002/pbc.25690; Katz AJ, 2015, CANCER CAUSE CONTROL, V26, P1627, DOI 10.1007/s10552-015-0657-6; Kesler SR, 2016, BRAIN CONNECT, V6, P273, DOI 10.1089/brain.2015.0409; Kesler SR, 2014, PEDIATR BLOOD CANCER, V61, P1295, DOI 10.1002/pbc.25022; Kesler SR, 2010, BRAIN IMAGING BEHAV, V4, P256, DOI 10.1007/s11682-010-9104-1; Khong PL, 2006, J CLIN ONCOL, V24, P884, DOI 10.1200/JCO.2005.02.4505; Kingma A, 2001, J PEDIATR-US, V139, P413, DOI 10.1067/mpd.2001.117066; Klarborg B, 2013, HUM BRAIN MAPP, V34, P3216, DOI 10.1002/hbm.22139; Krull KR, 2016, J CLIN ONCOL, V34, P2644, DOI 10.1200/JCO.2015.65.4574; Krull KR, 2013, J CLIN ONCOL, V31, P4407, DOI 10.1200/JCO.2012.48.2315; Krull KR, 2013, J CLIN ONCOL, V31, P2182, DOI 10.1200/JCO.2012.46.7944; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lesnik PG, 1998, ARCH NEUROL-CHICAGO, V55, P1561, DOI 10.1001/archneur.55.12.1561; Liu S. X., 2013, EFFECT SIZE STAT POW, P27; Luciana M, 2003, J CHILD PSYCHOL PSYC, V44, P649, DOI 10.1111/1469-7610.00152; Mabbott DJ, 2006, NEURO-ONCOLOGY, V8, P244, DOI 10.1215/15228517-2006-002; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nkhoma OWW, 2013, J NUTR, V143, P1324, DOI 10.3945/jn.112.171280; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Peterson CC, 2008, PEDIATR BLOOD CANCER, V51, P99, DOI 10.1002/pbc.21544; Pui CH, 2013, SEMIN HEMATOL, V50, P185, DOI 10.1053/j.seminhematol.2013.06.007; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Robinson KE, 2010, PEDIATR BLOOD CANCER, V54, P585, DOI 10.1002/pbc.22362; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Schuitema I, 2013, J CLIN ONCOL, V31, P3378, DOI 10.1200/JCO.2012.46.7050; Seal ML, 2008, SCHIZOPHR RES, V101, P106, DOI 10.1016/j.schres.2007.12.489; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stevens J.P., 2002, APPL MULTIVARIATE ST, V4th ed.; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tamnes CK, 2015, PEDIATR BLOOD CANCER, V62, P1027, DOI 10.1002/pbc.25386; Uban KA, 2017, PSYCHONEUROENDOCRINO, V83, P111, DOI 10.1016/j.psyneuen.2017.05.019; von der Weid N, 2003, EUR J CANCER, V39, P359, DOI 10.1016/S0959-8049(02)00260-5; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Walsh KS, 2016, PEDIATR BLOOD CANCER, V63, P191, DOI 10.1002/pbc.25759; Wartenberg D, 2008, HEMATOL MALIG, P77, DOI 10.1007/978-3-540-72304-2_5; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wechsler D, 2003, WISC 4 AUSTR TECHNIC; Wechsler D., 2011, WASI 2 MANUAL; Wechsler D., 2008, WAIS 4 TECHNICAL INT; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zeller B, 2013, J CLIN ONCOL, V31, P2078, DOI 10.1200/JCO.2012.47.4031; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	85	6	6	2	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2018	43	5					385	402		10.1080/87565641.2018.1473401			18	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	GH6GX	WOS:000433543300001	29781717				2022-02-06	
S	Gowda, R; Jaffa, M; Badjatia, N		Romanovsky, AA		Gowda, Ram; Jaffa, Matthew; Badjatia, Neeraj			Thermoregulation in brain injury	THERMOREGULATION: FROM BASIC NEUROSCIENCE TO CLINICAL NEUROLOGY, PT II	Handbook of Clinical Neurology		English	Article; Book Chapter							THERAPEUTIC TEMPERATURE MODULATION; INTENSIVE-CARE-UNIT; CEREBRAL-BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; INTRAVENOUS THROMBOLYSIS; MILD HYPOTHERMIA; RISK-FACTORS; FEVER; TRIAL; MANAGEMENT	Different mechanisms explain thermoregulatory dysfunction following ischemic stroke, hemorrhagic stroke, and traumatic brain injury. Temperature instability following brain injury likely involves hypothalamic injury, pathologic changes in cerebral blood flow, metabolic derangement, and a neurogenic inflammatory response. Although targeted temperature management (TTM) exerts pleiotropic effects, the heterogeneity of brain injury has hindered identification of patient subsets most likely to benefit from TTM. Early optimism about TTM's role in brain injury has been tempered by the failure of successive clinical trials to show improved patient outcomes. However, given the deleterious effects of fever, aggressive fever management is still warranted in the critically ill neurologic patient.	[Gowda, Ram; Jaffa, Matthew; Badjatia, Neeraj] Univ Maryland, Sch Med, Dept Neurol, Program Trauma, Baltimore, MD 21201 USA		Badjatia, N (corresponding author), 22 S Greene St, Baltimore, MD 21201 USA.	nbadjatia@umm.edu	Badjatia, Neeraj/AAS-4855-2021	Badjatia, Neeraj/0000-0003-1509-9034			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arbour RB, 2013, CRIT CARE NURS CLIN, V25, P297, DOI 10.1016/j.ccell.2013.02.010; Aujla Gurpreet Singh, 2017, Ther Hypothermia Temp Manag, V7, P147, DOI 10.1089/ther.2016.0031; Badjatia N, 2010, NEUROSURGERY, V66, P696, DOI 10.1227/01.NEU.0000367618.42794.AA; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Childs CLK, 2013, CRIT CARE, V17, P14; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Commichau C, 2003, NEUROLOGY, V60, P837, DOI 10.1212/01.WNL.0000047344.28843.EB; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; Den Hertog HM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001247.pub2; Deogaonkar Anupa, 2005, Neurol India, V53, P202; Fernandez A, 2007, NEUROLOGY, V68, P1013, DOI 10.1212/01.wnl.0000258543.45879.f5; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Horn CM, 2014, J NEUROINTERV SURG, V6, P91, DOI [10.1136/neurintsurg-2013-010656, 10.1136/neurintsurg-2013-010743]; Jarrah S, 2011, NEUROCRIT CARE, V14, P382, DOI 10.1007/s12028-011-9506-y; Karaszewski B, 2006, ANN NEUROL, V60, P438, DOI 10.1002/ana.20957; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Lord AS, 2014, NEUROCRIT CARE, V21, P200, DOI 10.1007/s12028-013-9948-5; Lyden P, 2016, STROKE, V47, P2888, DOI 10.1161/STROKEAHA.116.014200; MacLellan CL, 2009, J NEUROTRAUM, V26, P313, DOI 10.1089/neu.2008.0580; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Mcilvoy Laura, 2004, J Neurosci Nurs, V36, P23; MELLERGARD P, 1995, SURG NEUROL, V43, P91, DOI 10.1016/0090-3019(95)80049-M; Mrozek S., 2012, ANESTHESIOLOGY RES P, V2012, P13; Nichol A, 2015, CRIT CARE RESUSC, V17, P92; Piironen K, 2014, STROKE, V45, P486, DOI 10.1161/STROKEAHA.113.003180; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Rabinstein AA, 2007, J NEUROL NEUROSUR PS, V78, P1278, DOI 10.1136/jnnp.2006.112730; Scaravilli V, 2011, NEUROCRIT CARE, V15, P287, DOI 10.1007/s12028-011-9588-6; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Seule MA, 2009, NEUROSURGERY, V64, P86, DOI 10.1227/01.NEU.0000336312.32773.A0; Staykov D, 2013, NEUROCRIT CARE, V18, P178, DOI 10.1007/s12028-012-9762-5; Steiner AA, 2001, AM J PHYSIOL-REG I, V280, pR448, DOI 10.1152/ajpregu.2001.280.2.R448; Su YY, 2016, STROKE, V47, P457, DOI 10.1161/STROKEAHA.115.009789; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; van der Worp HB, 2014, INT J STROKE, V9, P642, DOI 10.1111/ijs.12294; Wang H, 2014, FRONT NEUROSCI, V8, P17; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zenker W, 1996, ANAT EMBRYOL, V193, P1	52	6	7	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-464075-8; 978-0-444-64074-1	HAND CLINIC			2018	157						789	797		10.1016/B978-0-444-64074-1.00049-5			9	Clinical Neurology; Neurosciences; Physiology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Physiology	BN0MQ	WOS:000473226000023	30459041				2022-02-06	
J	Groussard, PY; Pigot, H; Giroux, S				Groussard, Pierre-Yves; Pigot, Helene; Giroux, Sylvain			From conception to evaluation of mobile services for people with head injury: A participatory design perspective	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Participatory design; Assistive technology; Traumatic brain injury	ASSISTIVE TECHNOLOGY; MEMORY; SYSTEM; INDIVIDUALS; COGNITION	Adults with cognitive impairments lack the means to organise their daily life, plan their appointments, cope with fatigue, and manage their budget. They manifest interest in using new technologies to be part of society. Unfortunately, the applications offered on smart phones are often beyond their cognitive abilities. The goal of this study was to design a mobile cognitive assistant to enhance autonomy of people living with acquired traumatic brain injury. Participatory design methodologies guided this research by involving adults with cognitive impairments (CI) and their caregivers in the early stages of the design process. The population of the study is composed of four male adults who present cognitive impairments (three with head injury and one with stroke) and three caregivers. The first phase of this research was to design the Services Assistance Mobile and Intelligent (SAMI) application based on the needs expressed by the participants. During three focus groups, needs emerged concerning planning, health monitoring and money management and led to the implementation of assistive solutions on an Android mobile phone. During the second phase, the participants evaluated the mobile assistant SAMI at home for eight weeks. The results demonstrate that the participants were able to participate actively in the conception of SAMI and to use it successfully. People with CI showed a slight improvement in their life satisfaction. Due to the small number of participants, these promising results need to be confirmed by a larger-scale study.	[Groussard, Pierre-Yves; Pigot, Helene; Giroux, Sylvain] Univ Sherbrooke, Fac Sci, Dept Informat, Lab DOMUS, Sherbrooke, PQ, Canada		Groussard, PY (corresponding author), Univ Sherbrooke, Fac Sci, Dept Informat, Lab DOMUS, Sherbrooke, PQ, Canada.	pierre-yves.groussard@Usherbrooke.ca		Pigot, Helene/0000-0001-5520-5677; Giroux, Sylvain/0000-0003-0602-5957	Natural Science and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC) [CRDPJ 363681-2007]	This work was supported by the Natural Science and Engineering Research Council of Canada [CRDPJ 363681-2007].	Ballegaard SA, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1807; Boucher N., 2006, MILIEU VIE STIMULANT; Braddock D., 2004, Journal of Special Education Technology, V19, P49; Carmien S., 2005, ACM Transactions on Computer-Human Interaction, V12, P233, DOI 10.1145/1067860.1067865; Carmien S., 2004, 2004 C HUM FACT COMP, P1051; Caron J, 1997, Sante Ment Que, V22, P195; Cole E, 1999, NEUROREHABILITATION, V12, P39; Cole E., 1999, HSW DISTORSION LEICH, P111; Cole E., 2013, MORGAL CLAYPOOL SERI, V2, P1, DOI [10.2200/s00478ed1v01y201302arh003, DOI 10.2200/S00478ED1V01Y201302ARH003]; Cyr M., 1993, SANTE MENTALE QUEBEC, V18, P135, DOI [10.7202/032275ar, DOI 10.7202/032275AR]; Dolbec A., 2000, INTRO RECHERCHE ED; Druin A, 2002, BEHAV INFORM TECHNOL, V21, P1, DOI [10.1080/01449290110108659, 10.1080/014492901101008659]; Fougeyrollas P., 2010, FUNAMBULE FIL TOILE; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Giroux S, 2013, COMPUTER SCI AMBIENT, P225; Gregory J, 2003, INT J ENG EDUC, V19, P62; Haigh KZ, 2002, AAAI 02 WORKSH AUT C, P39; Havet-Thomassin V, 2004, ENCEPHALE, V30, P171; Imbeault H, 2014, NEUROPSYCHOL REHABIL, V24, P71, DOI 10.1080/09602011.2013.858641; Kawarada A, 2000, P ANN INT IEEE EMBS, V22, P531, DOI 10.1109/IEMBS.2000.900794; Liu AL, 2008, DISABIL REHABIL-ASSI, V3, P69, DOI 10.1080/17483100701500173; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; Mihailidis Alex, 2008, BMC Geriatr, V8, P28, DOI 10.1186/1471-2318-8-28; Phillips B, 1993, Assist Technol, V5, P36; Pigot H., 2004, P 2 INT C SMART HOM, V2004, P15; Pigot H., 2015, 17 C E HLTH NETW APP; PIGOT H, 2008, ENG HDB SMART TECHNO, P217; Pigot H, 2005, ASSIST TECHNOL RES S, V15, P25; Pollack ME, 2003, ROBOT AUTON SYST, V44, P273, DOI 10.1016/S0921-8890(03)00077-0; Powell LE, 2012, NEUROPSYCHOL REHABIL, V22, P85, DOI 10.1080/09602011.2011.640466; Sablier J, 2012, ASSIST TECHNOL, V24, P67, DOI 10.1080/10400435.2012.659324; Scherer MJ, 2005, CRIT REV PHYS REHABI, V17, P195, DOI [DOI 10.1615/CritRevPhysRehabilMed.v17.i3.30, DOI 10.1615/CRITREVPHYSREHABILMED.V17.I3.30]; Schulze H., 2004, P 6 INT ACM SIGACCES, P79; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Venkatasubramanian K., 2008, HEALTHNET 08 P 2 INT, P1; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Wachsmuth S, 2007, COMPUT VIS IMAGE UND, V108, P135, DOI 10.1016/j.cviu.2006.10.018; Wessels R., 2003, TECHNOL DISABIL, V15, P231; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wu M, 2004, P PART DES C 2004, P214, DOI DOI 10.1145/1011870.1011895; Wu M, 2005, P SIGCHI C HUM FACT, P511, DOI DOI 10.1145/1054972.1055043; Yao-Jen Chang, 2008, 2008 Second International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth), P108, DOI 10.1109/PCTHEALTH.2008.4571043	44	6	6	2	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	5			SI		667	688		10.1080/09602011.2015.1117499			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	GD4WO	WOS:000430503700002	26679473				2022-02-06	
B	Guyer, AE; Jarcho, JM		Bukowski, WM; Laursen, B; Rubin, KH		Guyer, Amanda E.; Jarcho, Johanna M.			Neuroscience and Peer Relations	HANDBOOK OF PEER INTERACTIONS, RELATIONSHIPS, AND GROUPS			English	Article; Book Chapter							ANTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; NEURAL RESPONSE; SOCIAL EXCLUSION; DEVELOPMENTAL NEUROSCIENCE; REJECTION SENSITIVITY; ADULT HEALTH; RISK-TAKING; CHILDHOOD; CHILDREN		[Guyer, Amanda E.] Univ Calif Davis, Ctr Mind & Brain, Dept Human Ecol, Davis, CA 95616 USA; [Jarcho, Johanna M.] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA		Guyer, AE (corresponding author), Univ Calif Davis, Ctr Mind & Brain, Dept Human Ecol, Davis, CA 95616 USA.						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Bishop SJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00152; Brown B. B., 2009, HDB ADOLESCENT PSYCH, P74, DOI [10.1002/9780470479193.adlpsy002004, DOI 10.1002/9780470479193.ADLPSY002004]; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Casement MD, 2014, DEV COGN NEUROS-NETH, V8, P18, DOI 10.1016/j.dcn.2013.12.003; Chassin L., 2009, HDB ADOLESCENT PSYCH, V3rd, P665, DOI DOI 10.1002/9780470479193.ADLPSY001022; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Cohen JR, 2013, PRINCIPLES FRONTAL L, P417, DOI DOI 10.1093/MED/9780199837755.003.0030; Colby JB, 2011, NEUROIMAGE, V54, P25, DOI 10.1016/j.neuroimage.2010.08.014; Copeland WE, 2013, JAMA PSYCHIAT, V70, P419, DOI 10.1001/jamapsychiatry.2013.504; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Davey CG, 2011, BIOL PSYCHIAT, V69, P734, DOI 10.1016/j.biopsych.2010.12.004; Downey G, 1998, CHILD DEV, V69, P1074, DOI 10.2307/1132363; Dunbar RIM, 2012, TRENDS COGN SCI, V16, P101, DOI 10.1016/j.tics.2011.11.013; Eisenberger NI, 2015, ANNU REV PSYCHOL, V66, P601, DOI 10.1146/annurev-psych-010213-115146; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Falk EB, 2014, J ADOLESCENT HEALTH, V54, pS22, DOI 10.1016/j.jadohealth.2013.12.035; Furman W., 2015, HDB CHILD PSYCHOL DE, V3, P932; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gonzalez MZ, 2015, SOC COGN AFFECT NEUR, V10, P921, DOI 10.1093/scan/nsu137; Guyer AE, 2008, ARCH GEN PSYCHIAT, V65, P1303, DOI 10.1001/archpsyc.65.11.1303; Guyer AE, 2015, J ABNORM CHILD PSYCH, V43, P863, DOI 10.1007/s10802-015-9973-2; Guyer AE, 2014, DEV PSYCHOPATHOL, V26, P229, DOI 10.1017/S0954579413000941; Guyer AE, 2012, SOC COGN AFFECT NEUR, V7, P81, DOI 10.1093/scan/nsr043; Guyer AE, 2009, CHILD DEV, V80, P1000, DOI 10.1111/j.1467-8624.2009.01313.x; Gweon H, 2012, CHILD DEV, V83, P1853, DOI 10.1111/j.1467-8624.2012.01829.x; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Happe F, 2014, J CHILD PSYCHOL PSYC, V55, P553, DOI 10.1111/jcpp.12162; Heverly-Fitt S, 2016, J PEDIATR PSYCHOL, V41, P235, DOI 10.1093/jpepsy/jsv085; Hostinar CE, 2015, DEVELOPMENTAL SCI, V18, P281, DOI 10.1111/desc.12195; Howarth GZ, 2013, SOC DEV, V22, P146, DOI 10.1111/sode.12006; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jarcho JM, 2016, PSYCHOL SCI, V27, P821, DOI 10.1177/0956797616638319; Jarcho JM, 2015, DEV COGN NEUROS-NETH, V13, P21, DOI 10.1016/j.dcn.2015.03.002; Jarcho JM, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-14; Jones RM, 2011, J NEUROSCI, V31, P13039, DOI 10.1523/JNEUROSCI.2972-11.2011; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Lau JYF, 2012, INT J BEHAV DEV, V36, P36, DOI 10.1177/0165025411406854; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; London B, 2007, J RES ADOLESCENCE, V17, P481, DOI 10.1111/j.1532-7795.2007.00531.x; Masten CL, 2011, DEV COGN NEUROS-NETH, V1, P260, DOI 10.1016/j.dcn.2011.01.004; Masten CL, 2012, SOC COGN AFFECT NEUR, V7, P106, DOI 10.1093/scan/nsq098; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Moor BG, 2010, SOC NEUROSCI-UK, V5, P461, DOI 10.1080/17470910903526155; Nelson EE, 2005, PSYCHOL MED, V35, P163, DOI 10.1017/S0033291704003915; Nelson EE, 2016, DEV COGN NEUROS-NETH, V17, P118, DOI 10.1016/j.dcn.2015.12.008; Nelson EE, 2014, TRENDS COGN SCI, V18, P99, DOI 10.1016/j.tics.2013.11.003; Nelson EE, 2011, DEV COGN NEUROS-NETH, V1, P233, DOI 10.1016/j.dcn.2011.01.002; Olino TM, 2015, J CHILD ADOL PSYCHOP, V25, P711, DOI 10.1089/cap.2014.0165; Olweus D, 1993, BULLYING SCH WHAT WE; Pauli WM, 2016, P NATL ACAD SCI USA, V113, P1907, DOI 10.1073/pnas.1507610113; Peake SJ, 2013, NEUROIMAGE, V82, P23, DOI 10.1016/j.neuroimage.2013.05.061; Platt B, 2013, DEPRESS ANXIETY, V30, P809, DOI 10.1002/da.22120; Powers KE, 2013, J COGNITIVE NEUROSCI, V25, P1887, DOI 10.1162/jocn_a_00446; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Rubin K. H., 2015, HDB CHILD PSYCHOL DE, V4, P175, DOI [10.1002/9781118963418.childpsy405, DOI 10.1002/9781118963418.CHILDPSY405]; Saxe R, 2006, SOC NEUROSCI-UK, V1, pI, DOI 10.1080/17470910601117463; Schriber RA, 2016, DEV COGN NEUROS-NETH, V19, P1, DOI 10.1016/j.dcn.2015.12.009; Sebastian C, 2010, BRAIN COGNITION, V72, P134, DOI 10.1016/j.bandc.2009.06.008; Shultz S, 2007, P ROY SOC B-BIOL SCI, V274, P2429, DOI 10.1098/rspb.2007.0693; Silk JS, 2014, SOC COGN AFFECT NEUR, V9, P1798, DOI 10.1093/scan/nst175; Silk JS, 2012, SOC COGN AFFECT NEUR, V7, P93, DOI 10.1093/scan/nsr044; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Spielberg JM, 2015, SOC COGN AFFECT NEUR, V10, P1084, DOI 10.1093/scan/nsu165; Stanley DA, 2013, NEURON, V80, P816, DOI 10.1016/j.neuron.2013.10.038; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Suleiman AB, 2016, DEV COGN NEUROS-NETH, V17, P145, DOI 10.1016/j.dcn.2015.12.007; Takizawa R, 2014, AM J PSYCHIAT, V171, P777, DOI 10.1176/appi.ajp.2014.13101401; Tan PZ, 2014, DEV COGN NEUROS-NETH, V8, P28, DOI 10.1016/j.dcn.2014.01.006; Telzer EH, 2015, SOC COGN AFFECT NEUR, V10, P389, DOI 10.1093/scan/nsu064; van den Bos W, 2011, PSYCHOL SCI, V22, P60, DOI 10.1177/0956797610391102; Von Der Heide R, 2014, SOC COGN AFFECT NEUR, V9, P1962, DOI 10.1093/scan/nsu009; Welborn BL, 2016, SOC COGN AFFECT NEUR, V11, P100, DOI 10.1093/scan/nsv095; Will GJ, 2016, J ABNORM CHILD PSYCH, V44, P43, DOI 10.1007/s10802-015-9983-0; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Wolke D, 2013, PSYCHOL SCI, V24, P1958, DOI 10.1177/0956797613481608; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531	83	6	6	0	0	GUILFORD PRESS	NEW YORK	370 SEVENTH AVE, SUITE 1200, NEW YORK, NY, UNITED STATES			978-1-4625-4121-8; 978-1-4625-2501-0				2018							177	199					23	Psychology, Developmental; Psychology, Social; Sociology	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology; Sociology	BR2CB	WOS:000637109000011					2022-02-06	
S	Helbok, R; Beer, R		Deisenhammer, F; Teunissen, CE; Tumani, H		Helbok, Raimund; Beer, Ronny			Cerebrospinal fluid and brain extracellular fluid in severe brain trauma	CEREBROSPINAL FLUID IN NEUROLOGIC DISORDERS	Handbook of Clinical Neurology		English	Article; Book Chapter							CEREBRAL PERFUSION-PRESSURE; FIBRILLARY ACIDIC PROTEIN; CORTICAL SPREADING DEPOLARIZATIONS; INTENSIVE INSULIN THERAPY; NERVOUS-SYSTEM INFECTIONS; INTRACRANIAL-PRESSURE; HEAD-INJURY; INTRACEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; METABOLIC CRISIS	Traumatic brain injury is a major cause of morbidity and mortality worldwide. Pathophysiologic mechanisms of secondary brain injury are complex and still not fully understood. Cerebrospinal fluid deserves attention to detect infectious complications and to identify biomarkers of disease severity and impending secondary brain injury. As an adjunct, cerebral microdialysis (CMD) allows online measurements of biomarkers derived directly from brain extracellular fluid. We critically review relevant literature related to infectious complications detectable in the cerebrospinal fluid in trauma patients. We then address the current role of CMD in clinical practice in the identification and prediction of secondary brain injury after severe trauma. Moreover we discuss the role of CMD-derived biomarkers in prognostication. Finally we challenge common treatment strategies and provide novel treatment concepts using brain-derived biomarkers as endpoints. We suggest a personalized treatment strategy for individual patients with severe traumatic brain injury.	[Helbok, Raimund; Beer, Ronny] Med Univ Innsbruck, Dept Neurol, Neurocrit Care Unit, Anichstr 35, A-6020 Innsbruck, Austria		Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Neurocrit Care Unit, Anichstr 35, A-6020 Innsbruck, Austria.	Raimund.Helbok@tirol-kliniken.at	Helbok, Raimund/AAA-8361-2021				Aarabi B, 1998, NEUROSURGERY, V42, P500, DOI 10.1097/00006123-199803000-00014; Adamides AA, 2009, J AM COLL SURGEONS, V209, P531, DOI 10.1016/j.jamcollsurg.2009.05.028; Afinowi R, 2009, J NEUROSCI METH, V181, P95, DOI 10.1016/j.jneumeth.2009.02.021; Alvis-Miranda Hernando Raphael, 2016, Bull Emerg Trauma, V4, P65; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Azeredo FJ, 2014, CLIN PHARMACOKINET, V53, P205, DOI 10.1007/s40262-014-0131-8; Bache S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0505-1; Barker FG, 2007, NEUROSURGERY, V60, P887, DOI 10.1227/01.NEU.0000255425.31797.23; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; Beer R, 2007, ANTIMICROB AGENTS CH, V51, P379, DOI 10.1128/AAC.00515-06; Beer R, 2010, CURR OPIN CRIT CARE, V16, P117, DOI 10.1097/MCC.0b013e328338cb5f; Beer R, 2009, NEUROCRIT CARE, V10, P363, DOI 10.1007/s12028-008-9155-y; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Blennow K, 2004, NEUROLOGY, V62, P159, DOI 10.1212/WNL.62.1.159; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bouras TIM, 2011, J NEUROTRAUMA; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Camacho EF, 2011, INFECTION, V39, P47, DOI 10.1007/s15010-010-0073-5; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carpenter KLH, 2014, EUR J PHARM SCI, V57, P87, DOI 10.1016/j.ejps.2013.12.012; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Conen A, 2008, CLIN INFECT DIS, V47, P73, DOI 10.1086/588298; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Dahlin AP, 2014, ANAL CHEM, V86, P8671, DOI 10.1021/ac501880u; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; Ederoth P, 2004, BRIT J CLIN PHARMACO, V57, P427, DOI 10.1046/j.1365-2125.2003.02032.x; Elvy J, 2008, J ANTIMICROB CHEMOTH, V61, P461, DOI 10.1093/jac/dkm501; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Frasca D, 2012, BRIT J ANAESTH, V109, P830, DOI 10.1093/bja/aes369; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Helbok R, 2015, J NEUROL NEUROSUR PS, V86, P79, DOI 10.1136/jnnp-2013-307326; Helbok R, 2011, J NEUROL NEUROSUR PS, V82, P378, DOI 10.1136/jnnp.2009.198754; Helbok R, 2010, NEUROCRIT CARE, V12, P317, DOI 10.1007/s12028-009-9327-4; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hillered L, 2008, CRIT CARE MED, V36, P2952, DOI 10.1097/CCM.0b013e3181872178; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Hutchinson PJ, 2002, BRIT J CLIN PHARMACO, V53, P275, DOI 10.1046/j.0306-5251.2001.01552.x; Hwang JH, 2010, BRAIN RES, V1359, P208, DOI 10.1016/j.brainres.2010.08.047; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Kestle JRW, 2006, J NEUROSURG, V105, P177, DOI 10.3171/ped.2006.105.3.177; Kim JH, 2012, WORLD NEUROSURG, V77, P135, DOI 10.1016/j.wneu.2011.04.017; Ko SB, 2011, ARCH NEUROL-CHICAGO, V68, P1323, DOI 10.1001/archneurol.2011.240; Kofler M, 2017, J CEREB BLOOD FLOW M; Kofler M, 2016, NEUROCRIT CARE, V25, P273, DOI 10.1007/s12028-016-0272-8; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Korinek AM, 2005, BRIT J NEUROSURG, V19, P155, DOI 10.1080/02688690500145639; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Lo CH, 2007, J NEUROSURG, V106, P378, DOI 10.3171/jns.2007.106.3.378; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]; Lyden P, 2002, STROKE, V33, P122, DOI 10.1161/hs0102.101478; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Jimenez CM, 2013, WORLD NEUROSURG, V79, P749, DOI 10.1016/j.wneu.2012.06.025; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Mellergard P, 2008, NEUROSURGERY, V62, P151, DOI 10.1227/01.NEU.0000311072.33615.3A; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Myrianthefs P, 2006, ANTIMICROB AGENTS CH, V50, P3971, DOI 10.1128/AAC.00051-06; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nordstrom CH, 2016, ACTA NEUROCHIR, V158, P1231, DOI 10.1007/s00701-016-2835-z; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Paraforou Theoniki, 2011, BMC Res Notes, V4, P540, DOI 10.1186/1756-0500-4-540; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Pellerin L, 2008, CURR OPIN CLIN NUTR, V11, P701, DOI 10.1097/MCO.0b013e328312c368; Perez-Barcena J, 2011, CRIT CARE MED, V39, P533, DOI 10.1097/CCM.0b013e318205c7a4; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Piilgaard H, 2011, J CEREBR BLOOD F MET, V31, P1588, DOI 10.1038/jcbfm.2011.28; Poeppl W, 2012, INT J ANTIMICROB AG, V39, P343, DOI 10.1016/j.ijantimicag.2011.11.019; Pople I, 2012, NEUROSURGERY, V71, P6, DOI 10.1227/NEU.0b013e3182544e31; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; PRUITT BA, 2001, J TRAUMA, V51, pS; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Qutub AA, 2005, BRAIN RES REV, V49, P595, DOI 10.1016/j.brainresrev.2005.03.002; Raby CA, 1998, J NEUROCHEM, V71, P2505; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Schiefecker AJ, 2015, NEUROCRIT CARE, V22, P293, DOI 10.1007/s12028-014-0050-4; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schlenk F, 2008, CRIT CARE, V12, DOI 10.1186/cc6776; Schmidt JM, 2012, CRITICAL CARE, V16, pR15; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Sen J, 2005, ACTA NEUROCHIR, V147, P897, DOI 10.1007/s00701-005-0526-2; Shannon RJ, 2013, J PHARMACOKINET PHAR, V40, P343, DOI 10.1007/s10928-013-9306-4; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; Thelin EP, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00159; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Thomas R, 2012, BRIT J NEUROSURG, V26, P175, DOI 10.3109/02688697.2011.603856; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293; Tunkel AR, 2017, CLIN INFECT DIS, V64, pE34, DOI 10.1093/cid/ciw861; UNGERSTEDT U, 1974, B SCHWEIZ AKAD MED, V30, P44; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vajramani GV, 2005, BRIT J NEUROSURG, V19, P496, DOI 10.1080/02688690500495299; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 2008, CRIT CARE, V12, DOI 10.1186/cc6986; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang Qiong, 2007, Chin J Traumatol, V10, P246; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wijman CAC, 2012, NEUROCRIT CARE, V16, P42, DOI 10.1007/s12028-011-9609-5; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906; Yokobori S, 2013, J NEUROSURG, V118, P370, DOI 10.3171/2012.10.JNS12725; Yokobori S, 2011, J TRAUMA, V71, P1235, DOI 10.1097/TA.0b013e3182140dd7; Yokobori S, 2011, NEUROL MED-CHIR, V51, P265, DOI 10.2176/nmc.51.265; You WD, 2016, CHIN J TRAUMATOL, V19, P11, DOI 10.1016/j.cjtee.2016.01.004; Zanier ER, 2013, BRIT J ANAESTH, V111, P424, DOI 10.1093/bja/aet149; Zazulia AR, 2009, STROKE, V40, P1638, DOI 10.1161/STROKEAHA.108.536037; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Ziai WC, 2006, CRIT CARE CLIN, V22, P661, DOI 10.1016/j.ccc.2006.11.009; Ziai WC, 2009, CURR OPIN NEUROL, V22, P277, DOI 10.1097/WCO.0b013e32832c1396	201	6	6	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-804324-0; 978-0-12-804279-3	HAND CLINIC			2018	146						237	258		10.1016/B978-0-12-804279-3.00014-9			22	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BN0DR	WOS:000472710600016	29110773				2022-02-06	
J	Holleman, M; Vink, M; Nijland, R; Schmand, B				Holleman, Meike; Vink, Martie; Nijland, Rinske; Schmand, Ben			Effects of intensive neuropsychological rehabilitation for acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Acquired brain injury; neuropsychological rehabilitation; holistic neuropsychological rehabilitation	RANDOMIZED CONTROLLED-TRIAL; COMPREHENSIVE DAY TREATMENT; QUALITY-OF-LIFE; COGNITIVE REHABILITATION; PSYCHIATRIC-DISORDERS; QOLIBRI; PROGRAM	The objective of the study was to examine the effects of a comprehensive neuropsychological rehabilitation programme (Intensive NeuroRehabilitation, INR) on the emotional and behavioural consequences of acquired brain injury (ABI). The participants were 75 adult patients suffering from ABI (33 traumatic brain injury, 14 stroke, 10 tumour, 6 hypoxia, 12 other), all of whom were admitted to the INR treatment programme. The main outcome measures were: general psychological well-being (Symptom-Checklist-90), depression and anxiety (Beck Depression Inventory-II, Hospital Anxiety and Depression Scale, State Trait Anxiety Inventory), and quality of life (Quality of Life in Brain Injury). The study was a non-blinded, waiting-list controlled trial. During the waiting-list period no or minimal care was provided. Multivariate analysis of the main outcome measures showed large effect sizes for psychological well-being (partial (2)=.191, p<.001), depression (partial (2)=.168, p<.001), and anxiety (partial (2)=.182, p<.001), and a moderate effect size for quality of life (partial (2)=.130, p=.001). Changes on neuropsychological tests did not differ between the groups. It was concluded that the INR programme improved general psychological well-being, depressive symptoms, anxiety, and quality of life. The programme does not affect cognitive functioning.	[Holleman, Meike; Vink, Martie; Nijland, Rinske] Amsterdam Rehabil Res Ctr, Reade, Amsterdam, Netherlands; [Holleman, Meike] Jeroen Bosch Hosp, Dept Med Psychol, Henri Dunantstr 1, NL-5223 GZ Shertogenbosch, Netherlands; [Schmand, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Schmand, Ben] Univ Amsterdam, Fac Social & Behav Sci, Programmagrp Brein & Cognitie, Amsterdam, Netherlands		Holleman, M (corresponding author), Amsterdam Rehabil Res Ctr, Reade, Amsterdam, Netherlands.; Holleman, M (corresponding author), Jeroen Bosch Hosp, Dept Med Psychol, Henri Dunantstr 1, NL-5223 GZ Shertogenbosch, Netherlands.	meikeholleman@outlook.com					Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arrindell W.A., 2003, SCL 90 SYMPTOM CHECK; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Brickenkamp R., 2011, D2 AANDACHTS EN CONC; Christensen A. L., 1992, SCAND J REHABIL MED, V5, P155; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Derogatis L. R., 1977, SCL 90 MANUAL 1 SCOR; Geurtsen GJ, 2010, J REHABIL MED, V42, P97, DOI 10.2340/16501977-0508; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hashimoto K, 2006, J REHABIL MED, V38, P20, DOI 10.1080/16501970510038473; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; LUTEIJN F, 1983, GRONINGER INTELLIGEN; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; Reitan R, 1985, HALSTEAD REITAN NEUR; RUFF R M, 1990, Brain Injury, V4, P339, DOI 10.3109/02699059009026187; Saan RJ, 1986, 15 WOORDEN TEST A B; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schmand B., 2012, NORMEN PSYCHOLOGISCH; Schmand BL., 1992, NEDERLANDSE LEESLIJS NEDERLANDSE LEESTEST; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Undurraga J, 2012, NEUROPSYCHOPHARMACOL, V37, P851, DOI 10.1038/npp.2011.306; Van Balen H. G. G., 1993, RIVERMEAD BEHAV MEMO; Van der Ploeg H. M., 1979, ZELF BEOORDELINGS VR; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wechsler D., 2000, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	6	6	3	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	4					649	662		10.1080/09602011.2016.1210013			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GA4CA	WOS:000428276000010	27487525				2022-02-06	
J	Hu, W; Jiang, J; Yang, F; Liu, J				Hu, Wei; Jiang, Jian; Yang, Feng; Liu, Jun			The impact of bone marrow-derived mesenchymal stem cells on neovascularisation in rats with brain injury	FOLIA NEUROPATHOLOGICA			English	Article						bone marrow mesenchymal stem cells; rat; traumatic brain injury; neovascularisation	ISCHEMIA-REPERFUSION; ENHANCE ANGIOGENESIS; PROGENITOR	Introduction: The impact of bone marrow-derived mesenchymal stem cells (BM-MSCs) on neovascularisation in rats with craniocerebral injury (CI) was investigated. Material and methods: The rate CI model was established by the free-fall method, and then rats were randomly divided into a transplanted group (EG) and a control group (CG). Rats in the transplanted group were injected with BM-MSCs in the lateral ventricle, while those in the control group were injected with normal saline. Modified neurological severity scores (mNSSs) were compared. Furthermore, CD34+CD133 double-labelled cells (CD34+CD133+cells) in the peripheral blood and expression of CD31 and neuron-specific enolase in injured tissues were detected. Results: There were significant intra-and intergroup differences in modified neurological severity scores at different time points. The number of CD34+CD133+ cells in the peripheral blood of CG initially decreased, but it increased later and peaked 6 h after injury, then gradually decreased and returned to normal 24 h after injury. Cells in the peripheral blood of EG continued to increase until 24 h after injury, reaching a number higher than that in CG (p < 0.05). The postoperative expression of neuron-specific enolase in EG was higher than that in CG (p < 0.05). The positive expression of CD31 was lower in the two groups before surgery, but the expression in EG was higher than that in CG after surgery (p < 0.05). Conclusions: Bone marrow-derived mesenchymal stem cells transplantation can increase the number of endothelial progenitor cells in the peripheral blood of rats with traumatic brain injury and increase the expression of peripheral angiogenetic markers and neuronal markers. The neurological function in EG improved significantly compared to that of CG.	[Hu, Wei] Enze Hosp Taizhou, Enze Med Ctr Grp, Dept Neurosurg, Taizhou 318050, Peoples R China; [Jiang, Jian; Yang, Feng; Liu, Jun] First Peoples Hosp Jiujiang, Dept Neurosurg, Jiujiang, Peoples R China		Hu, W (corresponding author), Enze Hosp Taizhou, Enze Med Ctr Grp, Dept Neurosurg, Taizhou 318050, Peoples R China.	docweihu@163.com					Andrews AM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00043; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Braghirolli DI, 2017, BIOMED MATER, V12, DOI 10.1088/1748-605X/aa5bbc; Carrion B, 2013, EXP CELL RES, V319, P2964, DOI 10.1016/j.yexcr.2013.09.007; Chamoto K, 2012, AM J RESP CELL MOL, V46, P283, DOI 10.1165/rcmb.2011-0249OC; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Kanayasu-Toyoda T, 2016, STEM CELLS, V34, P1251, DOI 10.1002/stem.2300; Kim SJ, 2009, AM J PATHOL, V174, P1972, DOI 10.2353/ajpath.2009.080819; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Lapi D, 2015, J VASC RES, V52, P22, DOI 10.1159/000381096; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Paprocka M, 2012, VASC PHARMACOL, V56, P361, DOI 10.1016/j.vph.2011.08.151; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ratajska A, 2017, CELLS TISSUES ORGANS, V203, P141, DOI 10.1159/000448551; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Ryu S, 2016, NEURAL REGEN RES, V11, P298, DOI 10.4103/1673-5374.177739; Sherman M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0641-4; Tang YH, 2014, J CEREBR BLOOD F MET, V34, P1138, DOI 10.1038/jcbfm.2014.61; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yu AY, 2014, NEUROREPORT, V25, P1272, DOI 10.1097/WNR.0000000000000259; Zhao JX, 2015, CHINESE MED J-PEKING, V128, P2839, DOI 10.4103/0366-6999.167374	23	6	7	0	1	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1641-4640	1509-572X		FOLIA NEUROPATHOL	Folia Neuropathol.		2018	56	2					112	123		10.5114/fn.2018.76615			12	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GL2WN	WOS:000436986900005	30509031	gold, Green Submitted			2022-02-06	
J	Jasey, N; Ward, I; Lequerica, A; Chiaravalloti, ND				Jasey, Neil; Ward, Irene; Lequerica, Anthony; Chiaravalloti, Nancy D.			The therapeutic value of cranioplasty in individuals with brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; stroke; craniectomy; rehabilitation; recovery	DECOMPRESSIVE CRANIECTOMY; CRANIAL DEFECT; RECOVERY; HEMICRANIECTOMY; IMPROVEMENT	Primary objective: To examine the effect of cranioplasty on recovery.Research design: Retrospective cohort study.Method and procedures: Retrospective chart review conducted in 2011 and 2012 on adult inpatients with craniectomy who completed a continuous episode of inpatient rehabilitation before and after receiving their cranioplasty. Patients were matched 1:1 or age, gender, functional level at admission, injury severity and length of stay with inpatients who completed rehabilitation before cranioplasty. Main outcome measures include FIMTM (Functional Independence Measure) and FIMTM efficiency [(FIMTM discharge - FIM(TM)admission)/number of days in rehabilitation]. To examine within and between group differences, analyses included paired and independent t-tests, Pearson correlations and chi-square analyses.Results: Twenty-six individuals (13 from the cranioplasty group and 13 from the comparison group) were analysed. FIMTM efficiency increased following cranioplasty [0.29 to 0.61; t(12)=-2.77, p=0.017]. The mean FIMTM efficiency for the cranioplasty group was below that of the comparison group prior to cranioplasty [0.280.37 and 0.39 +/- 0.32, p=.41], but increased following cranioplasty [0.61 +/- 0.71 and 0.39 +/- 0.32, p=.32]. An improvement in FIMTM efficiency following cranioplasty was more commonly seen among individuals with less severe brain injuries (75%, (2)=3.8, df=1, p=0.053).Conclusion: Rate of recovery increased following cranioplasty and exceeded that of the comparison group suggesting that cranioplasty may contribute to improvement.	[Jasey, Neil; Ward, Irene] Kessler Inst Rehabil, Brain Injury Program, W Orange, NJ 07052 USA; [Jasey, Neil; Ward, Irene; Lequerica, Anthony; Chiaravalloti, Nancy D.] State Univ New Jersey, Dept Phys Med & Rehabil, New Jersey Med Sch, New Brunswick, NJ USA; [Lequerica, Anthony; Chiaravalloti, Nancy D.] Kessler Fdn, Brain Injury Res, E Hanover, NJ USA		Jasey, N (corresponding author), Kessler Inst Rehabil, Brain Injury Program, W Orange, NJ 07052 USA.	njasey@kessler-rehab.com		Chiaravalloti, Nancy/0000-0003-2943-7567			Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Agrawal M, 2014, BRAIN INJURY, V28, P292, DOI 10.3109/02699052.2013.865266; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Center for Medicare & Medicaid Services, INP REH FAC PAT ASS; Cruz-Flores S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003435.pub2; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Gagnon D, 2005, J REHABIL MED, V37, P45, DOI 10.1080/16501970410015055; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul S, 2013, BRIT J NEUROSURG, V27, P636, DOI 10.3109/02688697.2013.817532; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Muramatsu H, 2007, INT J REHABIL RES, V30, P103, DOI 10.1097/MRR.0b013e32813a2e34; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; SEGAL DH, 1994, NEUROSURGERY, V34, P729, DOI 10.1227/00006123-199404000-00024; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Sung JJ, 2011, J CRANIOFAC SURG, V22, P1536, DOI 10.1097/SCS.0b013e31821da32f; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Voss HU, 2011, CLIN IMAG, V35, P253, DOI 10.1016/j.clinimag.2010.07.008; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Winkler P A, 2000, Neurosurg Focus, V8, pe9; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470	29	6	6	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	3					318	324		10.1080/02699052.2017.1419283			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FU3PV	WOS:000423764700005	29283285				2022-02-06	
J	Jaywant, A; Barredo, J; Ahern, DC; Resnik, L				Jaywant, Abhishek; Barredo, Jennifer; Ahern, David C.; Resnik, Linda			Neuropsychological assessment without upper limb involvement: a systematic review of oral versions of the Trail Making Test and Symbol-Digit Modalities Test	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Executive function; attention; cognition; rehabilitation; upper extremity	MENTAL ALTERNATION TEST; INFORMATION-PROCESSING SPEED; BRIEF REPEATABLE BATTERY; TRAUMATIC BRAIN-INJURY; REMITTING MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; MINIMAL ASSESSMENT; NORMATIVE DATA; INPATIENT REHABILITATION; DIAGNOSTIC-ACCURACY	The Trail Making Test (TMT) and written version of the Symbol Digit Modalities Test (SDMT) assess attention, processing speed, and executive functions but their utility is limited in populations with upper limb dysfunction. Oral versions of the TMT and SDMT exist, but a systematic review of their psychometric properties and clinical utility has not been conducted, which was the goal of this study. Searches were conducted in PubMed and PsycINFO, test manuals, and the reference lists of included articles. Four measures were identified: the SDMT-oral, oral TMT-A, oral TMT-B, and the Mental Alternation Test (MAT). Two investigators independently reviewed abstracts to identify peer-reviewed articles that reported on these measures in adult populations. From each article, one investigator extracted information on reliability, validity, responsiveness, minimum detectable change, normative data, and demographic influences. A second investigator verified the accuracy of the data in a random selection of 10% of papers. The quality of the evidence for each psychometric property was rated on a 4-point scale (unknown, poor, adequate, excellent). Results showed excellent evidence for the SDMT-oral, adequate evidence for the oral TMT-B and MAT, and adequate to poor evidence for the oral TMT-A. These findings inform the clinical assessment of attention, processing speed, and executive functions in individuals with upper limb disability.	[Jaywant, Abhishek; Barredo, Jennifer; Resnik, Linda] Providence VA Med Ctr, Ctr Excellence Neurorestorat & Neurotechnol, 830 Chalkstone Ave, Providence, RI 02908 USA; [Jaywant, Abhishek; Ahern, David C.] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Barredo, Jennifer] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA; [Ahern, David C.] Miriam Hosp, Providence, RI 02906 USA; [Jaywant, Abhishek] Weill Cornell Med, Dept Psychiat, 525 East 68th St, New York, NY 10065 USA; [Jaywant, Abhishek] Weill Cornell Med, Dept Rehabil Med, 525 East 68th St, New York, NY 10065 USA		Jaywant, A (corresponding author), Providence VA Med Ctr, Ctr Excellence Neurorestorat & Neurotechnol, 830 Chalkstone Ave, Providence, RI 02908 USA.; Jaywant, A (corresponding author), Weill Cornell Med, Dept Psychiat, 525 East 68th St, New York, NY 10065 USA.; Jaywant, A (corresponding author), Weill Cornell Med, Dept Rehabil Med, 525 East 68th St, New York, NY 10065 USA.	abj2006@med.cornell.edu	Jaywant, Abhishek/AAK-4727-2021; Barredo, Jennifer/AAK-3195-2021; Barredo, Jennifer/AAB-9208-2021	Jaywant, Abhishek/0000-0003-4307-5742; Barredo, Jennifer/0000-0003-4932-2433	Department of Veteran's Affairs Rehabilitation Research and Development (RRD)US Department of Veterans Affairs [A9264-S, N9228C]; Veterans AffairsUS Department of Veterans Affairs [IK6RX003097] Funding Source: NIH RePORTER	This work was conducted at the Providence VA Medical Center and supported by the Department of Veteran's Affairs Rehabilitation Research and Development (RR&D) under grants A9264-S and N9228C.	Abraham E, 1996, ARCH CLIN NEUROPSYCH, V11, P697, DOI 10.1016/S0887-6177(96)80005-9; Akbar N, 2011, COGN BEHAV NEUROL, V24, P115, DOI 10.1097/WNN.0b013e31822a20ae; Akbar N, 2010, MULT SCLER J, V16, P1500, DOI 10.1177/1352458510379615; Albinet CT, 2012, BRAIN COGNITION, V79, P1, DOI 10.1016/j.bandc.2012.02.001; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato MP, 2010, MULT SCLER, V16, P1474, DOI 10.1177/1352458510380089; American Psychological Association, 2014, STAND ED PSYCH TEST; Army Individual Test Battery, 1944, MAN DIR SCOR; Arnett PA, 2008, J INT NEUROPSYCH SOC, V14, P454, DOI 10.1017/S1355617708080508; Arrondo G, 2009, MULT SCLER J, V15, P509, DOI 10.1177/1352458508101321; Arsalidou M, 2013, HUM BRAIN MAPP, V34, P3031, DOI 10.1002/hbm.22124; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Barulli MR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007069; Bastug G, 2013, ARCH CLIN NEUROPSYCH, V28, P411, DOI 10.1093/arclin/act035; Beatty W W, 1995, Appl Neuropsychol, V2, P139, DOI 10.1207/s15324826an0203&4_6; Benedict RHB, 2008, MULT SCLER J, V14, P940, DOI 10.1177/1352458508090923; Benedict RHB, 2007, J NEUROL, V254, P22, DOI 10.1007/s00415-007-2007-4; Benedict RHB, 2007, MULT SCLER, V13, P722, DOI 10.1177/1352458507075592; Benedict RHB, 2006, J NEUROL SCI, V245, P67, DOI 10.1016/j.jns.2005.05.020; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Berg D, 2000, ARCH NEUROL-CHICAGO, V57, P1289, DOI 10.1001/archneur.57.9.1289; Berrigan LI, 2014, CLIN NEUROPSYCHOL, V28, P281, DOI 10.1080/13854046.2013.871337; Brooks JBB, 2011, ARQ NEURO-PSIQUIAT, V69, P887, DOI 10.1590/S0004-282X2011000700007; Bilgi E, 2015, ARQ NEURO-PSIQUIAT, V73, P90, DOI 10.1590/0004-282X20140144; Billick SB, 2001, COMPR PSYCHIAT, V42, P202, DOI 10.1053/comp.2001.23146; Borghi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069820; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Brochet B, 2008, MULT SCLER J, V14, P1242, DOI 10.1177/1352458508094398; Bruce JM, 2007, J INT NEUROPSYCH SOC, V13, P544, DOI 10.1017/S1355617707070658; Cercy SP, 2012, INT J GERIATR PSYCH, V27, P914, DOI 10.1002/gps.2802; Cercy SP, 2010, ACAD EMERG MED, V17, P307, DOI 10.1111/j.1553-2712.2010.00682.x; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Christodoulou C, 2003, NEUROLOGY, V60, P1793, DOI 10.1212/01.WNL.0000072264.75989.B8; Clark MS, 2004, AUST PSYCHOL, V39, P244, DOI 10.1080/00050060412331295126; Damasceno A, 2015, MULT SCLER RELAT DIS, V4, P137, DOI 10.1016/j.msard.2015.01.006; Day Anne M, 2015, Curr Drug Abuse Rev, V8, P26; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Dent A, 2000, BRIT J CLIN PSYCHOL, V39, P311, DOI 10.1348/014466500163329; Dickinson MD, 2011, APPL NEUROPSYCHOL, V18, P136, DOI 10.1080/09084282.2010.547785; Drake AS, 2010, MULT SCLER J, V16, P228, DOI 10.1177/1352458509354552; Dusankova JB, 2012, CLIN NEUROPSYCHOL, V26, P1186, DOI 10.1080/13854046.2012.725101; Eshaghi A, 2012, CLIN NEUROPSYCHOL, V26, P975, DOI 10.1080/13854046.2012.694912; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Findlay Leanne, 2010, Health Rep, V21, P85; Forn C, 2008, J CLIN EXP NEUROPSYC, V30, P789, DOI 10.1080/13803390701779560; Forn C, 2013, BRAIN COGNITION, V82, P152, DOI 10.1016/j.bandc.2013.04.003; Forn C, 2009, NEUROSCI LETT, V456, P11, DOI 10.1016/j.neulet.2009.03.081; Gich J, 2015, MULT SCLER J, V21, P1332, DOI 10.1177/1352458515572405; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V80, P732, DOI 10.2466/pms.1995.80.3.732; GRIGSBY J, 1994, PERCEPT MOTOR SKILL, V78, P883, DOI 10.2466/pms.1994.78.3.883; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hancock L, 2017, DISABIL REHABIL-ASSI, V12, P504, DOI 10.3109/17483107.2016.1158326; Holtzer R, 2013, MULT SCLER J, V19, P1518, DOI 10.1177/1352458513477922; Honarmand K, 2011, J NEUROL, V258, P244, DOI 10.1007/s00415-010-5736-8; Hoogs Marietta, 2011, Int J MS Care, V13, P57, DOI 10.7224/1537-2073-13.2.57; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Hubacher M, 2012, EUR NEUROL, V67, P377, DOI 10.1159/000336736; JONES BN, 1993, ANN INTERN MED, V119, P1001, DOI 10.7326/0003-4819-119-10-199311150-00006; Jover R, 2005, J HEPATOL, V42, P659, DOI 10.1016/j.jhep.2004.12.030; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Koh CL, 2011, ARCH CLIN NEUROPSYCH, V26, P356, DOI 10.1093/arclin/acr029; Kourtidou P, 2013, J HEAD TRAUMA REHAB, V28, P433, DOI 10.1097/HTR.0b013e3182585d06; Langdon DW, 2013, EUR NEUROL, V69, P346, DOI 10.1159/000345698; Law M., 2004, OUTCOME MEASURES RAT; Leiter RG., 1949, PSYCHOL SERVICE CTR, V1, P11; Lopez-Gongora M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0296-2; McComb E, 2011, J CLIN EXP NEUROPSYC, V33, P234, DOI 10.1080/13803395.2010.509916; McComb E, 2010, NEUROEPIDEMIOLOGY, V35, P298, DOI 10.1159/000321176; Mike A, 2011, AM J NEURORADIOL, V32, P515, DOI 10.3174/ajnr.A2340; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mitsis EM, 2010, INT J GERIATR PSYCH, V25, P531, DOI 10.1002/gps.2373; Moller F, 2011, MULT SCLER J, V17, P1002, DOI 10.1177/1352458511402410; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Morrow SA, 2010, MULT SCLER J, V16, P1385, DOI 10.1177/1352458510378021; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; Muller M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003582; Nocentini U, 2006, FUNCT NEUROL, V21, P93; Nokes Kathleen M, 2007, Clin Nurs Res, V16, P336, DOI 10.1177/1054773807308764; Nunnari D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/519785; Obradovic D, 2012, NEUROL SCI, V33, P1369, DOI 10.1007/s10072-012-1099-5; Parmenter BA, 2007, MULT SCLER J, V13, P52, DOI 10.1177/1352458506070750; Parmenter BA, 2010, J INT NEUROPSYCH SOC, V16, P6, DOI 10.1017/S1355617709990750; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Patti F, 2009, MULT SCLER, V15, P779, DOI 10.1177/1352458509105544; POLUBINSKI JP, 1986, PERCEPT MOTOR SKILL, V62, P975, DOI 10.2466/pms.1986.62.3.975; Potagas C, 2008, J NEUROL SCI, V267, P100, DOI 10.1016/j.jns.2007.10.002; Prohaska TR, 2009, GERONTOLOGIST, V49, DOI 10.1093/geront/gnp079; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Randolph JJ, 2005, J INT NEUROPSYCH SOC, V11, P205, DOI 10.1017/S1355617705050253; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; Reitan R, 1985, HALSTEAD REITAN NEUR; Resnik L., ARCH PHYS MED REHABI; Richardson JL, 2002, J INT NEUROPSYCH SOC, V8, P781, DOI 10.1017/S1355617702860064; Ricker, 1994, Assessment, V1, P47, DOI 10.1177/1073191194001001007; Ricker JH, 1996, NEUROPSY NEUROPSY BE, V9, P50; Rovaris M, 2002, J NEUROL SCI, V195, P103, DOI 10.1016/S0022-510X(01)00690-6; Ruchinskas RA, 2003, CLIN NEUROPSYCHOL, V17, P137, DOI 10.1076/clin.17.2.137.16498; Salib E, 2002, INT J GERIATR PSYCH, V17, P1157, DOI 10.1002/gps.738; Sandroff BM, 2013, MENT HEALTH PHYS ACT, V6, P205, DOI 10.1016/j.mhpa.2013.08.001; Sandroff BM, 2014, J NEUROL, V261, P363, DOI 10.1007/s00415-013-7204-8; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Smith A., 1991, SYMBOL DIGIT MODALIT; Smith MM, 2007, J CLIN EXP NEUROPSYC, V29, P804, DOI 10.1080/13803390601064493; Solari A, 2004, J NEUROL SCI, V222, P99, DOI 10.1016/j.jns.2004.04.027; Sonder JM, 2014, MULT SCLER J, V20, P481, DOI 10.1177/1352458513501570; Stephens S, 2004, INT J GERIATR PSYCH, V19, P1053, DOI 10.1002/gps.1209; Tam JW, 2013, CLIN NEUROPSYCHOL, V27, P962, DOI 10.1080/13854046.2013.797500; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Unverzagt FW, 2007, J INT NEUROPSYCH SOC, V13, P799, DOI 10.1017/S1355617707071020; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; van Hooren SAH, 2007, AGING NEUROPSYCHOL C, V14, P40, DOI 10.1080/138255890969483; Vanotti S, 2015, APPL NEUROPSYCH-ADUL, V22, P46, DOI 10.1080/23279095.2013.831866; Veenhof C, 2006, ARTHRIT RHEUM-ARTHR, V55, P480, DOI 10.1002/art.22001; Warlop NP, 2009, BRAIN COGNITION, V71, P410, DOI 10.1016/j.bandc.2009.05.004; Wieder L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-167; Wright V., 2009, J PROSTHET ORTHOT, V21, pP3, DOI DOI 10.1097/JPO.0B013E3181AE9637; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y	125	6	6	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	7					1055	1077		10.1080/09602011.2016.1240699			23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GM7WO	WOS:000438408000001	27756192				2022-02-06	
J	Jia, K; Tong, X; Liang, F				Jia, Kai; Tong, Xin; Liang, Fang			Effects of sequential nutritional support on nutritional status and expression of regulatory T lymphocyte in patients with early severe traumatic brain injury	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						severe traumatic brain injury; enteral nutrition; sequential nutrition; regulatory T lymphocytes	ENTERAL NUTRITION; CELLS; STROKE	Objective: To investigate the effects of sequential nutritional support on nutritional status and immune regulation in patients with early severe traumatic brain injury (STBI). Patients and methods: A total of 62 patients diagnosed with STBI enrolled from Chaoyang Hospital (Beijing, China) from February 2015 to October 2016 were divided into two groups. The observational group (n=34) was given sequential nutritional support and the control group (n=28) was given the standard formula of whole protein enteral preparations. The energy supply for the two groups was 30 kcal/kg/d and protein 1.6 g/kg/d, respectively. The albumin (ALB), total protein (TP), high-sensitivity C-reactive protein (Hs-CRP), neuron-specific enolase (NSE), Glasgow Coma Score (GCS), and regulatory T cells before and after nutritional treatment were measured in both groups. Results: At the 14th day, the levels of ALB (41.7 +/- 4.2 g/L) and TP (70.6 +/- 4.9 g/L) were significantly higher than those in the control group (33.5 +/- 2.3 g/L and 62.3 +/- 3.9 g/L) (P<0.05). The levels of Hs-CRP and NSE were significantly lower in the observational group (0.96 +/- 0.82 mg/L and 11.96 +/- 7.82 ng/L) than in the control group (1.17 +/- 0.74 mg/L and 19.17 +/- 6.74 ng/L) (P<0.05). The GCS score in the observational group (11.5 +/- 2.9) was significantly higher than that in the control group (8.1 +/- 1.7) (P<0.05). The percentage of Tregs in the peripheral CD4(+) lymphocytes was significantly lower in the observational group than in the control group (P<0.05). Conclusion: The effect of sequential nutritional support is better than conventional nutritional support in patients with STBI. The findings call for early identification of malnutrition and individual nutritional support.	[Jia, Kai; Tong, Xin] Capital Med Univ, Beijing Chao Yang Hosp, Dept Nutr, 8 South Gongti Rd, Beijing 100020, Peoples R China; [Liang, Fang] Capital Med Univ, Beijing Chao Yang Hosp, Dept Hyperbar Oxygen, Beijing 100020, Peoples R China		Jia, K (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Dept Nutr, 8 South Gongti Rd, Beijing 100020, Peoples R China.	ndazhj@163.com					Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Chapple LAS, 2016, CRIT CARE, V20, DOI 10.1186/s13054-015-1177-1; Chiang YH, 2012, J NEUROTRAUM, V29, P75, DOI 10.1089/neu.2011.1801; Friedel D, 2014, WORLD J GASTROENTERO, V20, P17746, DOI 10.3748/wjg.v20.i47.17746; He F, 2013, WIRES SYST BIOL MED, V5, P153, DOI 10.1002/wsbm.1187; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Lee JC, 2016, BRAIN PATHOL, V26, P581, DOI 10.1111/bpa.12334; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mottonen M, 2005, CLIN EXP IMMUNOL, V140, P360, DOI 10.1111/j.1365-2249.2005.02754.x; Mousavi SN, 2014, J RES MED SCI, V19, P420; Pandey A, 2016, IRAN J NEUROL, V15, P146; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Yang Y, 2008, INT IMMUNOPHARMACOL, V8, P542, DOI 10.1016/j.intimp.2007.12.006; Zhang X, 2015, JPEN-PARENTER ENTER, V39, P114, DOI 10.1177/0148607113501881	20	6	7	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2021			NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2018	14						1561	1567		10.2147/NDT.S149802			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	GK1LQ	WOS:000435877800003	29950840	Green Published, gold, Green Submitted			2022-02-06	
J	Egea-Guerrero, JJ; Rodriguez-Rodriguez, A; Quintana-Diaz, M; Freire-Aragon, MD; Raya-Collados, D; Hernandez-Garcia, C; Ortiz-Manzano, A; Vilches-Arenas, A; Diez-Naz, A; Guerrero, JM; Murillo-Cabezas, F				Jose Egea-Guerrero, Juan; Rodriguez-Rodriguez, Ana; Quintana-Diaz, Manuel; Dolores Freire-Aragon, Maria; Raya-Collados, Diego; Hernandez-Garcia, Conary; Ortiz-Manzano, Alvaro; Vilches-Arenas, Angel; Diez-Naz, Ana; Miguel Guerrero, Juan; Murillo-Cabezas, Francisco			Validation of S100B use in a cohort of Spanish patients with mild traumatic brain injury: a multicentre study	BRAIN INJURY			English	Article						Traumatic brain injury; brain damage; S100B; CT scan; biomarkers	MINOR HEAD-INJURY; SCANDINAVIAN GUIDELINES; COMPUTED-TOMOGRAPHY; INITIAL MANAGEMENT; SERUM-LEVELS; ADULTS; PROTEIN; MARKER; DAMAGE	Introduction: The aim of this study was to validate the S100B protein as a diagnostic tool for ruling out the presence of intracranial lesion (IL) after mild traumatic brain injury (mTBI). Subjects with a Glasgow Coma Scale (GCS) score of 15 and at least one neurological symptom post-trauma were selected from a large Spanish cohort.Methods: A number of 260 patients with mTBI were enrolled. Blood samples were extracted within 6h and CT scan performed within 24h post-injury. Blood samples were also drawn from 18 healthy subjects.Results: CT scan revealed the presence of IL in 22 patients (8.5%). Patients with mTBI had higher S100B serum levels (p=0.008) than the healthy subjects (p<0.001). The ROC analysis of S100B discriminated between patients with and without IL (AUC: 0.671; 95%CI: 0.574-0.769; p=0.008). The multivariate analysis identified male gender (OR: 5.39; 95%CI: 1.45-20.10; p=0.012), age>65 (OR: 2.97; 95%CI: 1.04-8.44; p=0.041) and S100B level >0.10 mu g/L (OR: 7.93; 95%CI: 1.03-60.76; p=0.046) as independent risk factors for IL in patients with mTBI.Conclusion: Measurement of S100B within 6h of mTBI accurately predicts risk of IL in patients with a GCS score of 15 and at least one neurological symptom.	[Jose Egea-Guerrero, Juan; Dolores Freire-Aragon, Maria; Murillo-Cabezas, Francisco] Univ Seville, Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, IBIS,CSIC, Seville, Spain; [Rodriguez-Rodriguez, Ana; Diez-Naz, Ana] Univ Seville, Virgen del Rocio Univ Hosp, Emergency Dept, IBIS,CSIC, Avda Manuel Siurot S-N, Seville 41013, Spain; [Quintana-Diaz, Manuel] La Paz Univ Hosp, Crit Care & Emergency Med, Madrid, Spain; [Raya-Collados, Diego] Virgen de las Nieves Univ Hosp, Crit Care & Emergency Med, Granada, Spain; [Hernandez-Garcia, Conary; Miguel Guerrero, Juan] Univ Seville, Virgen del Rocio Univ Hosp, Dept Clin Biochem, IBIS,CSIC, Seville, Spain; [Ortiz-Manzano, Alvaro] Torrecardenas Hosp, Crit Care & Emergency Med, Almeria, Spain; [Vilches-Arenas, Angel] Univ Seville, Dept Prevent Med & Publ Hlth, Seville, Spain		Rodriguez-Rodriguez, A (corresponding author), Univ Seville, Virgen del Rocio Univ Hosp, Emergency Dept, IBIS,CSIC, Avda Manuel Siurot S-N, Seville 41013, Spain.	rodriguezana13m@gmail.com	Murillo-Cabezas, Francisco/AAO-3348-2021; Egea-Guerrero, Juan Jose JJ/P-5080-2014; Guerrero, Josep M./Y-2929-2019; Vilches-Arenas, Angel/C-1167-2015	Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; Guerrero, Josep M./0000-0001-5236-4592; Vilches-Arenas, Angel/0000-0003-2197-3760; Guerrero, Juan Miguel/0000-0001-7553-0119			Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Egea-Guerrero JJ, 2015, MED INTENSIVA, V39, P167, DOI 10.1016/j.medin.2014.09.008; Egea-Guerrero JJ, 2014, MED INTENSIVA, V38, P218, DOI 10.1016/j.medin.2013.03.015; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; F Vcj RE, 2011, EMERGENCIAS, V23, P15; Foerch C, 2007, STROKE, V38, P2491, DOI 10.1161/STROKEAHA.106.480111; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Rodriguez-Rodriguez A, 2014, J NEUROL SCI, V341, P119, DOI 10.1016/j.jns.2014.04.020; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y	26	6	7	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					459	463		10.1080/02699052.2018.1429019			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400009	29355397				2022-02-06	
J	Kahn, LG; Linden, MA; McKinlay, A; Gomez, D; Glang, A				Kahn, Laurie Gutmann; Linden, Mark A.; McKinlay, Audrey; Gomez, Doug; Glang, Ann			An international perspective on educators' perceptions of children with Traumatic Brain Injury	NEUROREHABILITATION			English	Article						Teachers; knowledge; traumatic brain injury (TBI); qualitative; semi-structured interviews	SELF-EFFICACY; HEAD-INJURY; TBI; STUDENTS; POPULATION; SCHOOL; PREVALENCE; ADOLESCENTS; PERFORMANCE; SERVICES	BACKGROUND: Educators lack understanding of traumatic brain injury (TBI), which can lead to a lack of appropriate assessment and intervention methods for these students. OBJECTIVE(S): This qualitative study explored what experienced teachers perceive, believe, and know about pediatric TBI. METHODS: Following development of a standardized interview protocol, 46 teachers from Australia, New Zealand, Northern Ireland, and the United States took part in semi-structured interviews. Topics included understanding of the effects of TBI on school performance, supporting a child with TBI in the classroom, and challenges and teaching efficacy in working with students with TBI. RESULTS: The themes we identified were: personal experience with TBI, lack of content knowledge, non-TBI-specific adaptations, collaboration with experts, need for specific training, confidence in working with students with TBI, and knowledge of students' rights to service provision. Our findings show that although teachers had little knowledge of TBI, many felt they would be able to adequately support a child with appropriate input from specialists. CONCLUSION: Teachers fill their knowledge gaps about TBI with their own personal experiences and prior information about working with students with disabilities. These findings support important implications for changes in how we educate and support teachers.	[Kahn, Laurie Gutmann] Moravian Coll, 1200 Main St, Bethlehem, PA 18018 USA; [Linden, Mark A.] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland; [McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch, New Zealand; [Gomez, Doug; Glang, Ann] Univ Oregon, Ctr Brain Injury Res & Training, Eugene, OR 97403 USA		Kahn, LG (corresponding author), Moravian Coll, 1200 Main St, Bethlehem, PA 18018 USA.	kahnl@moravian.edu	Linden, Mark/L-7754-2019	Linden, Mark/0000-0002-3832-4102; McKinlay, Audrey/0000-0001-9846-8514			Allinder R.M., 1994, TEACH EDUC SPEC EDUC, V17, P86, DOI [10.1177/088840649401700203, DOI 10.1177/088840649401700203]; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, SELF EFFICACY EXERCI; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Brantlinger E, 2005, EXCEPT CHILDREN, V71, P195, DOI 10.1177/001440290507100205; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Case R. J. L., 2017, NZ J ED STUDIES, P1; Clarke V, 2013, PSYCHOLOGIST, V26, P120; Davies S., 2013, PHYS DISABILITIES ED, V32, P55; Department of Education Northern Ireland, 2005, REC CHILDR SPEC ED N; Department of Education Northern Ireland, 2005, COD PRACT ID ASS SPE; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Ernst WJ, 2016, EXCEPTIONALITY, V24, P123, DOI 10.1080/09362835.2015.1107832; Ettel D, 2016, EXCEPTIONALITY ED IN, V26, P1, DOI DOI 10.5206/EEI.V26I1.7732; Ettel D., 2014, TXB REV; Gabbe BJ, 2014, J EPIDEMIOL COMMUN H, V68, P466, DOI 10.1136/jech-2013-203427; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; GIBSON S, 1984, J EDUC PSYCHOL, V76, P569, DOI 10.1037/0022-0663.76.4.569; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Glang A, 2008, J HEAD TRAUMA REHAB, V23, P243, DOI 10.1097/01.HTR.0000327256.46504.9f; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Miles M., 2020, QUALITATIVE DATA ANA, V4th ed.; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; O'Rourke C., 2017, DISABILITY REHABILIT, P1; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Saldana J, 2015, CODING MANUAL QUALIT; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Strauss A., 2008, BASICS QUALITATIVE R, DOI 10.1080/13504620500081384.; Taylor C. A., 2017, MMWR SURVEILLANCE SU, V66; Trainor A. A., 2014, QUALITATIVE SPECIAL; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; U.S. Department of Education, 2015, IDEA B; Vieluf S, 2013, TEACH TEACH EDUC, V35, P92, DOI 10.1016/j.tate.2013.05.006; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	58	6	6	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	3					299	309		10.3233/NRE-172380			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE2RW	WOS:000431063300006	29660961	Green Published			2022-02-06	
J	Kreutziger, J; Lederer, W; Schmid, S; Ulmer, H; Wenzel, V; Nijsten, MW; Werner, D; Schlechtriemen, T				Kreutziger, Janett; Lederer, Wolfgang; Schmid, Stefan; Ulmer, Hanno; Wenzel, Volker; Nijsten, Maarten W.; Werner, Daniel; Schlechtriemen, Thomas			Blood glucose concentrations in prehospital trauma patients with traumatic shock: A retrospective analysis	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article							INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; STRESS HYPERGLYCEMIA; MYOCARDIAL-INFARCTION; CELL-SURVIVAL; BRAIN-INJURY; OXYGEN-CONSUMPTION; WHOLE-BLOOD; HYPOGLYCEMIA; RESISTANCE	BACKGROUNDDeranged glucose metabolism after moderate to severe trauma with either high or low concentrations of blood glucose is associated with poorer outcome. Data on prehospital blood glucose concentrations and trauma are scarce.OBJECTIVESThe primary aim was to describe the relationship between traumatic shock and prehospital blood glucose concentrations. The secondary aim was to determine the additional predictive value of prehospital blood glucose concentration for traumatic shock when compared with vital parameters alone.DESIGNRetrospective analysis of the predefined, observational database of a nationwide Helicopter Emergency Medical Service (34 bases).SETTINGEmergency trauma patients treated by Helicopter Emergency Medical Service between 2005 and 2013 were investigated.PATIENTSAll adult trauma patients (18 years) with recorded blood glucose concentrations were enrolled.OUTCOMESPrimary outcome: upper and lower thresholds of blood glucose concentration more commonly associated with traumatic shock. Secondary outcome: additional predictive value of prehospital blood glucose concentrations when compared with vital parameters alone.RESULTSOf 51936 trauma patients, 20177 were included. In total, 220 (1.1%) patients died on scene. Hypoglycaemia (blood glucose concentration 2.8mmoll(-1) or less) was observed in 132 (0.7%) patients, hyperglycaemia (blood glucose concentration exceeding 15mmoll(-1)) was observed in 265 patients (1.3%). Blood glucose concentrations more than 10mmoll(-1) (n=1308 (6.5%)) and 2.8mmoll(-1) or less were more common in patients with traumatic shock (P<0.0001). The Youden index for traumatic shock ((sensitivity+specificity)-1) was highest when blood glucose concentration was 3.35mmoll(-1) (P<0.001) for patients with low blood glucose concentrations and 7.75mmol l(-1) (P<0.001) for those with high blood glucose concentrations. In logistic regression analysis of patients with spontaneous circulation on scene, prehospital blood glucose concentrations (together with common vital parameters: Glasgow Coma Scale, heart rate, blood pressure, breathing frequency) significantly improved the prediction of traumatic shock in comparison with prediction by common vital parameters alone (P<0.0001).CONCLUSIONIn adult trauma patients, low and high blood glucose concentrations were more common in patients with traumatic shock. Prehospital blood glucose concentration measurements in addition to common vital parameters may help identify patients at risk of traumatic shock.	[Kreutziger, Janett; Lederer, Wolfgang] Med Univ Innsbruck, Dept Anaesthesia & Intens Care Med, Anichstr 35, A-6020 Innsbruck, Austria; [Schmid, Stefan] Med Univ Innsbruck, Dept Gen & Surg Intens Care Med, Innsbruck, Austria; [Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, Innsbruck, Austria; [Wenzel, Volker] Med Campus Bodensee, Dept Anaesthesiol Intens Care Med Emergency Med &, Friedrichshafen, Germany; [Nijsten, Maarten W.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Werner, Daniel] German Helicopter Emergency Med Serv ADAC Luftret, Emergency Med Serv Saarland, Bexbach, Netherlands; [Schlechtriemen, Thomas] German Helicopter Emergency Med Serv ADAC Luftret, Munich, Germany		Kreutziger, J (corresponding author), Med Univ Innsbruck, Dept Anaesthesia & Intens Care Med, Anichstr 35, A-6020 Innsbruck, Austria.	janett.kreutziger@i-med.ac.at	Ulmer, Hanno/S-6615-2019; Kreutziger, Janett/AAU-4102-2021	Ulmer, Hanno/0000-0001-5911-1002; Kreutziger, Janett/0000-0001-5363-8858			Alfonsi P, 2003, ANAESTHESIA, V58, P1228, DOI 10.1046/j.1365-2044.2003.03444.x; Aslan B, 2014, AM J CLIN PATHOL, V142, P857, DOI 10.1309/AJCPP5YS2MVSKBYY; Bilhimer MH, 2017, AM J EMERG MED, V35, P87, DOI 10.1016/j.ajem.2016.10.009; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; BLUMBERG D, 1995, J SURG ONCOL, V59, P220, DOI 10.1002/jso.2930590404; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Brunauer A, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0719-2; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Chen JH, 2015, LEGAL MED-TOKYO, V17, P475, DOI 10.1016/j.legalmed.2015.08.004; CHERNOW B, 1982, CRIT CARE MED, V10, P409, DOI 10.1097/00003246-198206000-00019; Deutsche Diabetes Hilfe, 2016, DTSCH GES DIAB; Deutsche Gesellschaft fur Unfallchirurgie, 2016, LEITL POL SCHWERV BE; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; FRANK SM, 1995, ANESTHESIOLOGY, V83, P241, DOI 10.1097/00000542-199508000-00002; Gijzen K, 2012, CLIN CHEM LAB MED, V50, P1985, DOI 10.1515/cclm-2012-0104; Grimble RF, 2002, CURR OPIN CLIN NUTR, V5, P551, DOI 10.1097/00075197-200209000-00015; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; HART BB, 1989, CRIT CARE MED, V17, P1203, DOI 10.1097/00003246-198911000-00021; Hern HG, 2017, PREHOSP EMERG CARE, V21, P63, DOI 10.1080/10903127.2016.1189637; Holstein A, 2000, AM J EMERG MED, V18, P690, DOI 10.1053/ajem.2000.7324; HOLTKAMP HC, 1975, CLIN CHIM ACTA, V59, P41, DOI 10.1016/0009-8981(75)90216-8; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Kreutziger J, 2015, INJURY, V46, P15, DOI 10.1016/j.injury.2014.09.018; Kreutziger J, 2009, J TRAUMA, V67, P704, DOI 10.1097/TA.0b013e3181b22e37; Kreutziger J, 2009, INTENS CARE MED, V35, P1234, DOI 10.1007/s00134-009-1446-z; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; LANG CH, 1991, ENDOCRINOLOGY, V128, P645, DOI 10.1210/endo-128-2-645; Losser MR, 2010, CRIT CARE, V14, DOI 10.1186/cc9100; Ma GC, 2006, N-S ARCH PHARMACOL, V373, P415, DOI 10.1007/s00210-006-0102-1; Malfitano C, 2014, WORLD J CARDIOL, V6, P449, DOI 10.4330/wjc.v6.i6.449; Malfitano C, 2010, EUR J HEART FAIL, V12, P659, DOI 10.1093/eurjhf/hfq053; Marette A, 2002, CURR OPIN CLIN NUTR, V5, P377, DOI 10.1097/00075197-200207000-00005; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; MESSELKEN M, 2003, NOTFALL RETTUNGSMED, V6, P189; MESZAROS K, 1988, FASEB J, V2, P3083, DOI 10.1096/fasebj.2.15.3056766; Meyer C, 2003, AM J PHYSIOL-ENDOC M, V285, pE819, DOI 10.1152/ajpendo.00145.2003; Molina PE, 1997, NEUROIMMUNOMODULAT, V4, P28, DOI 10.1159/000097312; MORRISON B, 1973, CLIN CHIM ACTA, V45, P293, DOI 10.1016/0009-8981(73)90441-5; Pereira AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129568; Pulzi SA, 2009, SAO PAULO MED J, V127, P259, DOI 10.1590/S1516-31802009000500003; Ramachandran B, 2011, PEDIATR CRIT CARE ME, V12, pE297, DOI 10.1097/PCC.0b013e3182192804; Shimizu T, 2007, ANN SURG, V245, P297, DOI 10.1097/01.sla.0000232523.88621.17; Stiftung-Warentest, 2012, TEST, V7, P86; Strapazzon G, 2012, ANN EMERG MED, V60, P193, DOI 10.1016/j.annemergmed.2011.11.015; STUMVOLL M, 1995, J CLIN INVEST, V96, P2528, DOI 10.1172/JCI118314; Van Cromphaut SJ, 2009, BEST PRACT RES-CLIN, V23, P375, DOI 10.1016/j.bpa.2009.08.005; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Verbruggen SCAT, 2011, CRIT CARE MED, V39, P2518, DOI 10.1097/CCM.0b013e3182257410; Vogelzang M, 2006, J TRAUMA, V60, P873, DOI 10.1097/01.ta.0000195715.63978.80; WOOLF PD, 1986, ANN EMERG MED, V15, P1401, DOI 10.1016/S0196-0644(86)80926-X; Wouters M, ESICM PAR 2013; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	56	6	7	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	JAN	2018	35	1					33	42		10.1097/EJA.0000000000000733			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	FR2AN	WOS:000418869400005	29135535				2022-02-06	
J	Lorenz, LS; Charrette, AL; O'Neil-Pirozzi, TM; Doucett, JM; Fong, J				Lorenz, Laura S.; Charrette, Ann L.; O'Neil-Pirozzi, Therese M.; Doucett, Julia M.; Fong, Jeffrey			Healthy body, healthy mind: A mixed methods study of outcomes, barriers and supports for exercise by people who have chronic moderate-to-severe acquired brain injury	DISABILITY AND HEALTH JOURNAL			English	Article						Physical activity; Interviews; Participation; Functional status; Traumatic brain injury	QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; OLDER-ADULTS; WALK TEST; INDIVIDUALS; RELIABILITY; STROKE; VALIDITY; PROGRAM; SPEED	Background: Few people with chronic moderate-to-severe brain injury are following recommended physical activity guidelines. Objective: Investigate effects of planned, systematic physical activity while cultivating social and emotional well-being of people with chronic moderate-to-severe brain injury. Hypothesis: Moderate-to-intensive physical activity would be associated with improvements in impairment and activity limitation measures (endurance, mobility, gait speed) immediately post-intervention and six weeks later (study week 12). Methods: The intervention was a single group pre-/post-intervention study with 14 people with chronic moderate-to-severe brain injury who live in brain injury group homes and exercised 60-90 min, 3 days per week for 6 weeks at a maximum heart rate of 50-80%. Pre-post measures (administered weeks 0, 6 and 12) were the 6 Minute Walk Test, High-level Mobility Assessment Tool and 10 Meter Walk Test. The qualitative component used a brief survey and semi-structured interview guide with participants, family members, and staff. Results: Following program completion, post-intervention group changes were noted on all outcome measures and greater than minimal detectable change for people with brain injury. Three transitioned from low to high ambulatory status and maintained this change at 12 weeks. During interviews, participants agreed the program was stimulating. More than eighty percent liked working out in a group and felt better being active. Conclusions: Program impact included physical, cognitive and social/emotional aspects. Social aspects (group format, trainers) were highly motivating and supported by residents, family, and staff. Investments in transportation and recruiting and training interns to assist participants are critical to program sustainability and expansion. (C) 2017 Elsevier Inc. All rights reserved.	[Lorenz, Laura S.; Charrette, Ann L.; O'Neil-Pirozzi, Therese M.] Support Living Inc, Res Council, Brain Injury Wellness Ctr, 7 Oakland St, Lexington, MA 02420 USA; [Lorenz, Laura S.] Brandeis Univ, Heller Sch Social Policy & Management, 415 South St, Waltham, MA 02453 USA; [Charrette, Ann L.] MCPHS Univ, Phys Therapy Dept, 10 Lincoln Sq, Worcester, MA 01541 USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, 360 Huntington Ave, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Spaulding Harvard Traumat Brain Injury Model Syst, 300 1st Ave, Charlestown, MA 02129 USA; [Doucett, Julia M.] Community Rehab Care, 51 Water St,205, Watertown, MA 02472 USA; [Fong, Jeffrey] MCPHS Univ, Sch Pharm, Worcester, MA USA		Lorenz, LS (corresponding author), 7 Oakland St, Lexington, MA 02420 USA.	llorenz@brandeis.edu; Ann.charrette@mcphs.edu; oneil-pirozzi@neu.edu; juliamdoucett@gmail.com		Lorenz, Laura/0000-0003-0898-4537	Massachusetts Rehabilitation Commission; chronic ABI in Massachusetts (US)	The Massachusetts Rehabilitation Commission provided grant funding to subsidize physical activity participation by adults with chronic ABI in Massachusetts (US).	Anderson C, 2017, DISABIL HEALTH J, V10, P157, DOI 10.1016/j.dhjo.2016.09.006; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bodde AE, 2009, DISABIL HEALTH J, V2, P57, DOI 10.1016/j.dhjo.2008.11.004; Buchele G, 2016, J AM MED DIR ASSOC, V17, P609, DOI 10.1016/j.jamda.2016.02.032; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Charrette AL, 2016, BRAIN INJURY, V30, P1213, DOI 10.1080/02699052.2016.1187766; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Fang J, 2012, PREVALENCE STROKE US; Fulk George D., 2008, Physiotherapy Theory and Practice, V24, P195, DOI 10.1080/09593980701588284; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hayes HA, 2011, J NEUROL PHYS THER, V35, P2, DOI 10.1097/NPT.0b013e31820b5a9d; Killington MJ, 2010, BRAIN INJURY, V24, P970, DOI 10.3109/02699052.2010.489792; Langhammer B, 2008, BRAIN INJURY, V22, P135, DOI 10.1080/02699050801895423; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lorenz LS, 2010, SOCIOL HEALTH ILL, V32, P862, DOI 10.1111/j.1467-9566.2010.01244.x; Mathews AE, 2010, J AGING PHYS ACTIV, V18, P119, DOI 10.1123/japa.18.2.119; Merali S, 2016, HEALTH SOC CARE COMM, V24, pE101, DOI 10.1111/hsc.12282; Moore, 2009, ACSMS EXERCISE MANAG, P287; Morris S, 2009, EUR J PHYSIOTHER, V11, P218, DOI 10.3109/14038190902856778; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; O'Neil-Pirozzi TM, 2015, BRAIN INJURY, V29, P1547, DOI 10.3109/02699052.2015.1075147; Patterson SL, 2007, ARCH PHYS MED REHAB, V88, P115, DOI 10.1016/j.apmr.2006.10.025; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Physical Activity Guidelines writing group, 2008, PHYS ACT GUID AM; Ravenek MJ, 2013, INT J QUAL METH, V12, P436, DOI 10.1177/160940691301200122; Rimmer JH, 2010, AM J PHYS MED REHAB, V89, P249, DOI 10.1097/PHM.0b013e3181c9fa9d; Saunders DH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub5; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Self M, 2013, ADAPT PHYS ACT Q, V30, P20, DOI 10.1123/apaq.30.1.20; The Quote Garden, 1998, QUOT GARD HARV QUOT; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS1, DOI 10.1016/j.apmr.2011.07.202; van de Port IGL, 2007, AM J PHYS MED REHAB, V86, P935, DOI 10.1097/PHM.0b013e31802ee464; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031-9406(05)61264-3, DOI 10.1016/S0031-9406(05)61264-3, 10.1016/S0031_9406(05)61264_3]; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Williams G, 2012, CLIN REHABIL, V26, P741, DOI 10.1177/0269215511429163; Wolf SL, 1999, PHYS THER, V79, P1122, DOI 10.1093/ptj/79.12.1122; World Health Organization, 2002, COMM LANG FUNCT DIS; Wycherley TP, 2012, DIABETIC MED, V29, P632, DOI 10.1111/j.1464-5491.2011.03451.x; Young HJ, 2015, DISABIL HEALTH J, V8, P345, DOI 10.1016/j.dhjo.2014.12.003; Zitomer MR, 2014, ADAPT PHYS ACT Q, V31, P193, DOI 10.1123/apaq.2013-0084	49	6	6	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	JAN	2018	11	1					70	78		10.1016/j.dhjo.2017.08.005			9	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	FP4ZY	WOS:000417627400014	28870419				2022-02-06	
J	Lubitz, AF; Eid, M; Niedeggen, M				Lubitz, Alexander F.; Eid, Michael; Niedeggen, Michael			Complainer Profile Identification (CPI): properties of a new questionnaire on subjective cognitive complaints	AGING NEUROPSYCHOLOGY AND COGNITION			English	Article						Subjective cognitive complaints; complainer profile; executive complaints; depression; aging stereotypes	OBJECTIVE MEMORY IMPAIRMENT; TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; ALZHEIMERS-DISEASE; OLDER-ADULTS; MAJOR DEPRESSION; SOCIAL NETWORK; DEMENTIA; PERFORMANCE; COMMUNITY	Subjective cognitive complaints (SCC) and their role as a possible indicator for subsequent dementia became of growing interest in recent research. In contrast to studies that focused primarily on memory complaints, we aimed to (a) evaluate a questionnaire to register SCC in multiple cognitive domains (Complainer Profile Identification, CPI), (b) assess the association between SCC and psychosocial variables, and (c) assess whether complainer types can be differentiated. Confirmatory factor analysis to evaluate construct validity was computed based on a sample of 734 healthy participants (mean [M]=43.15years). On a subsample of 644 participants, the relationship between the total level of SCC with age, depression, social integration, and aging stereotypes was assessed utilizing multiple regression analysis. Differences in complainer types were assessed by multivariate analysis of variance. The results indicate sound psychometric properties of the CPI. The overall level of SCC is largely influenced by depressiveness, whereas executive complainers show the highest level of depressive affect, being overall younger and less socially integrated.	[Lubitz, Alexander F.; Eid, Michael; Niedeggen, Michael] Free Univ Berlin, Dept Educ Sci & Psychol, Berlin, Germany		Lubitz, AF (corresponding author), Free Univ Berlin, Dept Educ Sci & Psychol, Berlin, Germany.	alex.lubitz@fu-berlin.de					Abdulrab K, 2008, EUR PSYCHIAT, V23, P321, DOI 10.1016/j.eurpsy.2008.02.004; Beblo T, 2010, Z NEUROPSYCHOL, V21, P143, DOI 10.1024/1016-264X/a000013; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Buckley R, 2013, INT PSYCHOGERIATR, V25, P1307, DOI 10.1017/S1041610213000665; Canevelli M, 2013, AM J ALZHEIMERS DIS, V28, P560, DOI 10.1177/1533317513494441; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; Davis~ AM, 1995, CLIN REHABIL, V9, P238, DOI DOI 10.1177/026921559500900310; Duits A, 2008, J NEUROL NEUROSUR PS, V79, P143, DOI 10.1136/jnnp.2007.114595; Duke LM, 2000, NEUROPSYCHOL REV, V10, P75, DOI 10.1023/A:1009096603879; Edmonds EC, 2014, J INT NEUROPSYCH SOC, V20, P836, DOI 10.1017/S135561771400068X; Ehrensperger MM, 2010, INT PSYCHOGERIATR, V22, P91, DOI 10.1017/S1041610209990962; Farias ST, 2008, NEUROPSYCHOLOGY, V22, P531, DOI 10.1037/0894-4105.22.4.531; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; Fydrich T., 2007, FRAGEBOGEN SOZIALEN; Gevins A, 1996, ELECTROEN CLIN NEURO, V98, P327, DOI 10.1016/0013-4694(96)00288-X; Graham NL, 2004, J NEUROL NEUROSUR PS, V75, P61; Greenberg SA, 2007, AM J NURS, V107, P60, DOI 10.1097/01.NAJ.0000292204.52313.f3; Heun R, 2006, EUR ARCH PSY CLIN N, V256, P28, DOI 10.1007/s00406-005-0596-4; Hohman TJ, 2011, J AM GERIATR SOC, V59, P1908, DOI 10.1111/j.1532-5415.2011.03589.x; Holtzman RE, 2004, J GERONTOL B-PSYCHOL, V59, pP278, DOI 10.1093/geronb/59.6.P278; Horn W., 1983, L P S LEISTUNGSPRUFS; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Jungwirth S, 2004, J AM GERIATR SOC, V52, P263, DOI 10.1111/j.1532-5415.2004.52066.x; Kalbe, 2006, INVENTAR GEDACHTNISD; Kliegel Matthias, 2005, Eur J Ageing, V2, P13, DOI 10.1007/s10433-005-0017-6; Koppara Alexander, 2015, Alzheimers Dement (Amst), V1, P194, DOI 10.1016/j.dadm.2015.02.005; Lautenschlager NT, 2005, AM J GERIAT PSYCHIAT, V13, P731, DOI 10.1176/appi.ajgp.13.8.731; Lineweaver TT, 2016, AGING NEUROPSYCHOL C, V23, P327, DOI 10.1080/13825585.2015.1099606; Luck T, 2015, ACTA PSYCHIAT SCAND, V131, P290, DOI 10.1111/acps.12328; Marshall GA, 2014, CURR ALZHEIMER RES, V11, P853; MATTHEWS G, 1994, PERS INDIV DIFFER, V17, P617, DOI 10.1016/0191-8869(94)90134-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muller S V, 2013, STORUNGEN EXEKUTIVFU; Ottowitz WE, 2002, HARVARD REV PSYCHIAT, V10, P86, DOI 10.1080/10673220216210; Pachana N A, 1996, J Int Neuropsychol Soc, V2, P505; Reid LM, 2006, DEMENT GERIATR COGN, V22, P471, DOI 10.1159/000096295; Riedel-Heller SG, 1999, EUR ARCH PSY CLIN N, V249, P197, DOI 10.1007/s004060050087; Salem LC, 2015, INT J GERIATR PSYCH, V30, P1177, DOI 10.1002/gps.4272; Sarkisian CA, 2005, GERONTOLOGIST, V45, P240, DOI 10.1093/geront/45.2.240; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23; Schmand B, 1997, BRIT J PSYCHIAT, V171, P373, DOI 10.1192/bjp.171.4.373; Schofield PW, 1997, AM J PSYCHIAT, V154, P609; Seeman TE, 2001, HEALTH PSYCHOL, V20, P243, DOI 10.1037//0278-6133.20.4.243; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sindi S, 2012, STRESS, V15, P130, DOI 10.3109/10253890.2011.599047; Slavin MJ, 2015, AM J GERIAT PSYCHIAT, V23, P906, DOI 10.1016/j.jagp.2014.09.001; Small GW, 2006, AM J GERIAT PSYCHIAT, V14, P538, DOI 10.1097/01.JGP.0000219279.72210.ca; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sturm W., 2015, LPS 50 LEISTUNGSPRUF; SWETS JA, 1961, PSYCHOL REV, V68, P301, DOI 10.1037/0033-295X.68.5.301; Tsai AYJ, 2008, INT J GERIATR PSYCH, V23, P1172, DOI 10.1002/gps.2050; Valentijn SAM, 2005, PATIENT EDUC COUNS, V57, P106, DOI 10.1016/j.pec.2004.05.002; van der Flier WM, 2004, J NEUROL, V251, P671, DOI 10.1007/s00415-004-0390-7; Veiel HOF, 1997, J CLIN EXP NEUROPSYC, V19, P587, DOI 10.1080/01688639708403745; Volz-Sidiropoulou E., 2007, Z NEUROPSYCHOL, V18, P299, DOI DOI 10.1024/1016-264X.18.4.299; Wang PN, 2000, J AM GERIATR SOC, V48, P295, DOI 10.1111/j.1532-5415.2000.tb02649.x; Youn JC, 2009, DEMENT GERIATR COGN, V27, P310, DOI 10.1159/000205512; Zimmermann P., 1989, FRAGEBOGEN ERLEBTER; Zimprich D, 2003, INT J AGING HUM DEV, V57, P339, DOI 10.2190/G0ER-ARNM-BQVU-YKJN	61	6	6	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1382-5585	1744-4128		AGING NEUROPSYCHOL C	Aging Neuropsychol. Cogn.		2018	25	1					99	121		10.1080/13825585.2016.1267325			23	Psychology, Developmental; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	FU4FN	WOS:000423809000006	27937808				2022-02-06	
J	MacAllister, WS; Maiman, M; Marsh, M; Whitman, L; Vasserman, M; Cohen, RJ; Salinas, CM				MacAllister, William S.; Maiman, Moshe; Marsh, Megan; Whitman, Lindsay; Vasserman, Marsha; Cohen, Robyn J.; Salinas, Christine M.			Sensitivity of the Wisconsin Card Sorting Test (64-Card Version) versus the Tower of London (Drexel Version) for detecting executive dysfunction in children with epilepsy	CHILD NEUROPSYCHOLOGY			English	Article						Executive function; Problem-solving; Child; Adolescent; Epilepsy	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE; NEUROPSYCHOLOGICAL ASSESSMENT; CHILDHOOD EPILEPSY; NORMATIVE DATA; FULL WCST; ADOLESCENTS; ADHD; MATHEMATICS	Executive function deficits are common in children and adolescents with epilepsy. Though the Wisconsin Card Sorting Task (WCST) is often considered the gold standard for executive function assessment, its sensitivityparticularly in the case of the 64-card version (WCST-64)is insufficiently established in pediatric samples, including children and adolescents with epilepsy. The present investigation assesses the sensitivity of the WCST-64 in children and adolescents with epilepsy in comparison to another measure: the Tower of London - Drexel Version (TOL-DX). A total of 88 consecutively referred children and adolescents with epilepsy were administered both the WCST-64 and TOL-DX as part of a comprehensive neuropsychological evaluation. The sensitivity of WCST-64 and TOL-DX variables were established and relations with epilepsy severity measures and other executive function measures were assessed. Of the WCST-64 variables, Perseverative Responses is the most sensitive, but detected executive function impairment in only 19% of this clinically referred sample; in contrast, the TOL-DX Rule Violations detected executive function impairment in half of the sample. Further, TOL-DX performances are more strongly related to epilepsy severity variables and other executive function measures in comparison to the WCST-64. Despite its popularity amongst clinicians, the WCST-64 is not as sensitive to executive dysfunction in comparison to other measures of comparable administration time, such as the TOL-DX.	[MacAllister, William S.] NYU, Dept Neurol, Comprehens Epilepsy Ctr, New York, NY 10016 USA; [Maiman, Moshe] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Vasserman, Marsha] NYU, Langone Med Ctr, Child & Adolescent Psychiat, New York, NY 10003 USA; [Cohen, Robyn J.] Arnold Palmer Hosp Children, Dept Neuropsychol, Orlando, FL USA; [Salinas, Christine M.] Space Coast Neuropsychol Ctr, Melbourne, FL USA		MacAllister, WS (corresponding author), NYU, Comprehens Epilepsy Ctr, 223 East 34th St, New York, NY 10016 USA.	William.macallister@nyumc.org	Maiman, Moshe/ABB-2658-2021	Vasserman, Marsha/0000-0003-4221-8983			Adjutant General's Office, 1944, ARM IND TEST BATT MA; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2010, STUD NEUROPSYCHOL NE, P1; Axelrod BN, 1997, ASSESSMENT, V4, P41, DOI 10.1177/107319119700400105; Axelrod BN, 2002, CLIN NEUROPSYCHOL, V16, P7, DOI 10.1076/clin.16.1.7.8331; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Berg AT, 2008, EPILEPSIA, V49, P608, DOI 10.1111/j.1528-1167.2007.01461.x; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Campiglia M, 2014, EPILEPSY BEHAV, V39, P12, DOI 10.1016/j.yebeh.2014.07.023; Cantin RH, 2016, J EXP CHILD PSYCHOL, V146, P66, DOI 10.1016/j.jecp.2016.01.014; Culbertson WC., 2001, TOWER LONDON DREXEL; D'Agati E, 2012, BRAIN DEV-JPN, V34, P812, DOI 10.1016/j.braindev.2012.03.001; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; de Lima AB, 2014, ARQ NEURO-PSIQUIAT, V72, P954, DOI 10.1590/0004-282X20140191; Demakis GJ, 2003, NEUROPSYCHOLOGY, V17, P255, DOI 10.1037/0894-4105.17.2.255; Diamond A, 2006, LIFESPAN COGNITION M, P70; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dunn DW, 2003, DEV MED CHILD NEUROL, V45, P50, DOI 10.1017/S0012162203000094; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Gioia GA IP, 2000, BEHAV RATING INVENTO; Guimaraes CA, 2007, J CHILD NEUROL, V22, P836, DOI 10.1177/0883073807304701; Heaton R., 2000, WISCONSIN CARD SORTI; Hermann BP, 2002, PROG BRAIN RES, V135, P429; Hermann B, 2007, BRAIN, V130, P3135, DOI 10.1093/brain/awm227; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Hoie B, 2006, DEV MED CHILD NEUROL, V48, P519, DOI 10.1017/S0012162206001095; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Jones JE, 2010, EPILEPSY BEHAV, V18, P211, DOI 10.1016/j.yebeh.2010.03.015; Koziol L. F., 2009, SUBCORTICAL STRUCTUR, DOI [10.1007/978-0-387-84868-6, DOI 10.1007/978-0-387-84868-6]; Krivitzky LS, 2015, CHILD NEUROPSYCHOL, P1, DOI [10.1080/09297049.2015.1054272, DOI 10.1080/09297049.2015.1054272]; Longo CA, 2013, EPILEPSY BEHAV, V26, P102, DOI 10.1016/j.yebeh.2012.11.003; MacAllister WS, 2016, CHILD NEUROPSYCHOL, V22, P65, DOI 10.1080/09297049.2014.967670; MacAllister WS, 2014, APPL NEUROPSYCH-CHIL, V3, P215, DOI 10.1080/21622965.2013.839605; MacAllister WS, 2012, APPL NEUROPSYCH-CHIL, V1, P121, DOI 10.1080/21622965.2012.709421; MacAllister WS, 2012, CHILD NEUROPSYCHOL, V18, P404, DOI 10.1080/09297049.2011.613812; Martin RC, 2000, EPILEPSIA, V41, P1626; Martin RC, 2000, NEUROPSYCHOLOGY, V14, P501, DOI 10.1037/0894-4105.14.4.501; Merrick EE, 2003, CLIN NEUROPSYCHOL, V17, P153, DOI 10.1076/clin.17.2.153.16512; Miller M, 2010, J ABNORM CHILD PSYCH, V38, P315, DOI 10.1007/s10802-009-9369-2; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Neri ML, 2012, EPILEPSY BEHAV, V24, P403, DOI 10.1016/j.yebeh.2012.04.131; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Park J, 2013, EPILEPSY BEHAV, V29, P166, DOI 10.1016/j.yebeh.2013.07.010; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Raiford S. E., 2005, TECHNICAL REPORT 4 W; Rhodes MG, 2004, PSYCHOL AGING, V19, P482, DOI 10.1037/0882-7974.19.3.482; Riva D, 2002, J CHILD NEUROL, V17, P661, DOI 10.1177/088307380201700902; Rzezak P, 2009, EPILEPSY BEHAV, V15, P376, DOI 10.1016/j.yebeh.2009.04.014; Sesma HW, 2009, CHILD NEUROPSYCHOL, V15, P232, DOI 10.1080/09297040802220029; Sherman EMS, 2006, EPILEPSIA, V47, P1936, DOI 10.1111/j.1528-1167.2006.00816.x; Sherman EMS, 2012, EPILEPSIA, V53, P1060, DOI 10.1111/j.1528-1167.2012.03493.x; Slick DJ, 2006, CHILD NEUROPSYCHOL, V12, P181, DOI 10.1080/09297040600611320; Smith-Seemiller L, 2001, ARCH CLIN NEUROPSYCH, V16, P489, DOI 10.1016/S0887-6177(00)00062-7; Vega C, 2011, ARCH CLIN NEUROPSYCH, V26, P158, DOI 10.1093/arclin/acq097; Wagner G, 2006, NEUROPSYCHOLOGIA, V44, P2337, DOI 10.1016/j.neuropsychologia.2006.05.014; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 2011, WASI 2 WECHSLER ABBR	59	6	6	2	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2018	24	3					354	369		10.1080/09297049.2016.1265101			16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FY5UB	WOS:000426900000005	28049367				2022-02-06	
J	Maddux, AB; DeWitt, PE; Mourani, PM; Bennett, TD				Maddux, Aline B.; DeWitt, Peter E.; Mourani, Peter M.; Bennett, Tellen D.			Hospital Readmissions After Pediatric Trauma	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injuries; critical care; patient readmission; pediatric; traumatic	QUALITY-OF-LIFE; BRAIN-INJURY; FUNCTIONAL OUTCOMES; CRITICAL-CARE; RISK-FACTORS; CHILDREN; REHOSPITALIZATION; VARIABILITY; POPULATION; MECHANISM	Objectives: To determine the rate, etiology, and timing of unplanned and planned hospital readmissions and to identify risk factors for unplanned readmission in children who survive a hospitalization for trauma. Design: Multicenter retrospective cohort study of a probabilistically linked dataset from the National Trauma Data Bank and the Pediatric Health Information System database, 2007-2012. Setting: Twenty-nine U.S. children's hospitals. Patients: 51,591 children (< 18 yr at admission) who survived more than or equal to a 2-day hospitalization for trauma. Measurements and Main Results: The primary outcome was unplanned readmission within 1 year of discharge from the injury hospitalization. Secondary outcomes included any readmission, reason for readmission, time to readmission, and number of readmissions within 1 year of discharge. The primary exposure groups were isolated traumatic brain injury, both traumatic brain injury and other injury, or nontraumatic brain injury only. We hypothesized a priori that any traumatic brain injury would be associated with both planned and unplanned hospital readmission. We used All Patient Refined Diagnosis Related Groups codes to categorize readmissions by etiology and planned or unplanned. Overall, 4,301/49,982 of the patients (8.6%) with more than or equal to 1 year of observation time were readmitted to the same hospital within 1 year. Many readmissions were unplanned: 2,704/49,982 (5.4%) experienced an unplanned readmission in the first year. The most common reason for unplanned readmission was infection (22%), primarily postoperative or posttraumatic infection (38% of readmissions for infection). Traumatic brain injury was associated with lower odds of unplanned readmission in multivariable analyses. Seizure or RBC transfusion during the index hospitalization were the strongest predictors of unplanned, earlier, and multiple readmissions. Conclusions: Many survivors of pediatric trauma experience unplanned, and potentially preventable, hospital readmissions in the year after discharge. Identification of those at highest risk of readmission can guide targeted in-hospital or postdischarge interventions.	[Maddux, Aline B.; Mourani, Peter M.; Bennett, Tellen D.] Univ Colorado, Pediat Crit Care, Sch Med, Aurora, CO 80045 USA; [Maddux, Aline B.; Mourani, Peter M.; Bennett, Tellen D.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [DeWitt, Peter E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Bennett, Tellen D.] Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA		Maddux, AB (corresponding author), Univ Colorado, Pediat Crit Care, Sch Med, Aurora, CO 80045 USA.; Maddux, AB (corresponding author), Childrens Hosp Colorado, Aurora, CO 80045 USA.	aline.maddux@childrenscolo-rado.org		Maddux, Aline/0000-0002-0949-4284; Bennett, Tellen/0000-0003-1483-4236	Eunice Kennedy Shriver National Institute for Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State of Colorado Traumatic Brain Injury Research Program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	Supported, in part, by the Eunice Kennedy Shriver National Institute for Child Health and Human Development (grant K23HD074620 to Dr. Bennett).; Dr. Bennett's institution received funding from the National Institute of Child Health and Human Development and the State of Colorado Traumatic Brain Injury Research Program, and he received support for article research from the National Institutes of Health. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Aitken ME, 2002, PEDIATRICS, V110, P337, DOI 10.1542/peds.110.2.337; American College of Surgeons Committee on Trauma, 2009, NAT TRAUM DAT BANK R; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Auger KA, 2014, J HOSP MED, V9, P251, DOI 10.1002/jhm.2134; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Bennett TD, 2015, METHOD INFORM MED, V54, P328, DOI 10.3414/ME14-01-0093; Bennett TD, 2017, PEDIATR CRIT CARE ME, V18, P442, DOI 10.1097/PCC.0000000000001120; Berry JG, 2011, JAMA-J AM MED ASSOC, V305, P682, DOI 10.1001/jama.2011.122; Bratton SL, 2012, PEDIATR CRIT CARE ME, V13, P407, DOI 10.1097/PCC.0b013e318238b428; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Czaja AS, 2009, J TRAUMA, V67, P805, DOI 10.1097/TA.0b013e318185e1fb; Fantus Richard J, 2015, Bull Am Coll Surg, V100, P37; Fawcett VJ, 2015, J AM COLL SURGEONS, V220, P330, DOI 10.1016/j.jamcollsurg.2014.11.012; Feudtner C, 2009, PEDIATRICS, V123, P286, DOI 10.1542/peds.2007-3395; Frieden TR, 2014, TRAUMATIC BRAIN INJU; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Haider AH, 2011, J PEDIATR SURG, V46, P1557, DOI 10.1016/j.jpedsurg.2011.04.055; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Khan A, 2015, JAMA PEDIATR, V169, P905, DOI 10.1001/jamapediatrics.2015.1129; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Macpherson AK, 2003, J TRAUMA, V55, P454, DOI 10.1097/01.TA.0000042158.79688.51; Malangoni M, 2015, J TRAUMA ACUTE CARE, V79, P724; Moore L, 2014, ANN SURG, V259, P374, DOI 10.1097/SLA.0b013e31828b0fae; Morris DS, 2014, INJURY, V45, P56, DOI 10.1016/j.injury.2013.04.029; Muszynski JA, 2015, TRANSFUSION, V55, P766, DOI 10.1111/trf.12896; Naseem HUR, 2016, J SURG RES, V205, P456, DOI 10.1016/j.jss.2016.06.035; National Center for Injury Prevention and Control, 2014, 10 LEAD CAUS DEATH A; Olufajo OA, 2016, AM J SURG, V211, P649, DOI 10.1016/j.amjsurg.2015.09.018; Petrey LB, 2015, J TRAUMA ACUTE CARE, V79, P717, DOI 10.1097/TA.0000000000000844; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Ruzas CM, 2017, NEUROCRIT CARE, V26, P256, DOI 10.1007/s12028-016-0329-8; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Schoell SL, 2016, TRAFFIC INJ PREV, V17, P27, DOI 10.1080/15389588.2016.1201203; Slonim AD, 2010, PEDIATRICS, V125, P1208, DOI 10.1542/peds.2009-1451; US Centers for Medicare & Medicaid Services, 2016, READM RED PROGR; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7; Wiseman T, 2013, INJURY, V44, P1383, DOI 10.1016/j.injury.2012.02.015	41	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2018	19	1					E31	E40		10.1097/PCC.0000000000001383			10	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	FS4NF	WOS:000419769000005	29210926	Green Accepted			2022-02-06	
J	Makley, MJ; Monden, KR; Philippus, A; Tarwater, PM; Newman, J; Biggs, J; Spier, E; Weintraub, A				Makley, Michael J.; Monden, Kimberley R.; Philippus, Angela; Tarwater, Patrick M.; Newman, Jody; Biggs, Jennifer; Spier, Eric; Weintraub, Alan			Objective measures of sleep and wakefulness in patients with moderate to severe brain injury on an inpatient rehabilitation unit. Pearls and pitfalls of actigraph monitoring	NEUROREHABILITATION			English	Article						Brain injury; traumatic brain injury; sleep disruption; actigraph; actigraph scoring; sleep rest interval; sleep efficiency; wakefulness after sleep onset; total sleep time; rehabilitation	DISTURBANCES; PREVALENCE; DISORDERS	BACKGROUND: As awareness of disrupted sleep in patients with traumatic brain injury (TBI) increases so does interest in finding objective measures of sleep. As a result, many clinicians are turning to actigraphs to monitor sleep in patients with altered consciousness. Actigraphs are accelerometers which have been used in sleep research for over four decades. OBJECTIVE: The purpose of the present study was to determine the best method for scoring actigraphs in a TBI population and to describe the benefits and pitfalls of using actigraphs with patients on a brain injury rehabilitation unit. METHODS: A retrospective chart review of 43 patients compared three different ways of scoring night time rest periods: autoscoring, manual scoring, and set interval scoring for the sleep parameters of sleep efficiency, wakefulness after sleep onset, and total sleep time. Nursing compliance with using the event marker on the device to set rest period was also analyzed. RESULTS: The autoscoring method of determining the rest interval showed an inflation of sleep efficiency. For each sleep parameter compared, the strongest correlations were observed between the manual and set interval scoring methods. Compliance using event markers to set rest interval was low (16.7%). CONCLUSIONS: Set interval scoring is the most efficient method to determine the rest interval in TBI patients. The use of event markers was an unreliable method to determine rest period.	[Makley, Michael J.; Monden, Kimberley R.; Philippus, Angela; Newman, Jody; Biggs, Jennifer; Spier, Eric; Weintraub, Alan] Craig Hosp, Englewood, CO USA; [Makley, Michael J.; Spier, Eric; Weintraub, Alan] CNS Med Grp, Englewood, CO USA; [Makley, Michael J.; Spier, Eric; Weintraub, Alan] Univ Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Tarwater, Patrick M.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA		Makley, MJ (corresponding author), Univ Colorado, Sch Med, Dept Phys Med & Rehabil, CNS Med Grp,Craig Hosp, 3425 South Clarkson, Englewood, CO 80113 USA.	mmakley@craighospital.org	Monden, Kimberley/AAE-9831-2020	Monden, Kimberley/0000-0002-5207-0452; Philippus, Angela/0000-0001-7427-8660			Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Ancoli-Israel S, 2015, BEHAV SLEEP MED, V13, pS4, DOI 10.1080/15402002.2015.1046356; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Walker M., 2017, WHY WE SLEEP UNLOCKI	12	6	6	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	3					277	285		10.3233/NRE-182537			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HA8FK	WOS:000450524200004	30373965				2022-02-06	
J	McDonald, S; Honan, C; Allen, SK; El-Helou, R; Kelly, M; Kumfor, F; Piguet, O; Hazelton, JL; Padgett, C; Keage, HAD				McDonald, Skye; Honan, Cynthia; Allen, Samantha K.; El-Helou, Rebecca; Kelly, Michelle; Kumfor, Fiona; Piguet, Olivier; Hazelton, Jessica L.; Padgett, Christine; Keage, Hannah A. D.			Normal adult and adolescent performance on TASIT-S, a short version of The Assessment of Social Inference Test	CLINICAL NEUROPSYCHOLOGIST			English	Article						Social cognition; assessment; clinical disorders	TRAUMATIC BRAIN-INJURY; ECOLOGICAL VALIDITY; FRONTOTEMPORAL DEMENTIA; EMOTION RECOGNITION; ALZHEIMERS-DISEASE; FACIAL EXPRESSION; MIND IMPAIRMENTS; OLDER-ADULTS; PERCEPTION; SCHIZOPHRENIA	There is a need for short, reliable, sensitive assessment tools to measure social cognition. The Awareness of Social Inference Test (TASIT) is an ecologically valid instrument that uses videos of actors engaged in everyday conversations to assess emotion perception, the ability to detect lies, sarcasm and sincerity, and the ability to judge what others are thinking, intending, feeling, and saying. A recently developed short version of TASIT retains the structure of the original test and its clinical sensitivity. In this paper, we compare TASIT-S performance in healthy adolescents, adults, and older adults as well as the effects of country (U.S.A. and Australia), English familiarity and gender. In this study 616 Australians including 226 adolescents (13-19) and 390 adults aged 20-75 + along with 180 U.S. residents (aged 20-74) completed one, two, or three parts of TASIT-S either face to face (Australians) or on-line (US residents). Results indicated that there were minor differences in TASIT-S performance (Part 3 only) based on country of residence and no significant effects for English familiarity in adolescents (not examined in adults). There were no gender effects. Young and middle aged adults (20-59) tended to perform better than adolescents and older adults on most parts of TASIT-S. In general, TASIT-S scores decreased moderately with advancing age. In conclusion, TASIT-S is a useful screen for social cognitive impairment in English speakers that is appropriate for use from adolescence through to older age. It produces comparable scores in the U.S.A. and Australia.	[McDonald, Skye; Allen, Samantha K.; El-Helou, Rebecca] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Honan, Cynthia; Padgett, Christine] Univ Tasmania, Sch Med, Div Psychol, Launceston, Tas, Australia; [Kelly, Michelle] Univ Newcastle, Sch Psychol, Newcastle, NSW, Australia; [Kumfor, Fiona; Piguet, Olivier; Hazelton, Jessica L.] Univ Sydney, Brain & Mind Ctr, Fac Sci, Sydney, NSW, Australia; [Kumfor, Fiona; Piguet, Olivier; Hazelton, Jessica L.] Univ Sydney, Sch Psychol, Fac Sci, Sydney, NSW, Australia; [Kumfor, Fiona; Piguet, Olivier] Univ Sydney, ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Keage, Hannah A. D.] Univ South Australia, Sch Psychol Social Work & Social Policy, Cognit Neurosci Lab, Adelaide, SA, Australia		McDonald, S (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW, Australia.	s.mcdonald@unsw.edu.au	Kumfor, Fiona/D-8839-2016; Kumfor, Fiona/AAK-9997-2020; Kelly, Michelle/J-9739-2019; Keage, Hannah/C-6470-2011; McDonald, Skye/G-4118-2014; Piguet, Olivier/C-9658-2011; Padgett, Christine/J-2774-2013; Honan, Cynthia/O-6332-2017	Kumfor, Fiona/0000-0002-3208-075X; Kelly, Michelle/0000-0003-0375-816X; Keage, Hannah/0000-0002-6814-4997; McDonald, Skye/0000-0003-0723-6094; Piguet, Olivier/0000-0002-6696-1440; Padgett, Christine/0000-0003-4398-4268; Honan, Cynthia/0000-0001-5735-4270; El-Helou, Rebecca/0000-0001-9462-9675; Hazelton, Jessica/0000-0002-0784-6071	Moving Ahead: Centre of Research Excellence in Brain Recovery and ForeFront; National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1023043, APP1037746, PG1081923]; Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders Memory ProgramAustralian Research Council [CE11000102]; NHMRC-ARC Dementia Research Development FellowshipAustralian Research CouncilNational Health and Medical Research Council of Australia [APP1097026]; NHMRC Senior Research FellowshipNational Health and Medical Research Council of Australia [APP1103258]	This work was supported by Moving Ahead: Centre of Research Excellence in Brain Recovery and ForeFront, a collaborative research group dedicated to the study of frontotemporal dementia and motor neuron disease, as well as a project grant from the National Health and Medical Research Council (NHMRC), [grant number APP1023043, APP1037746, PG1081923] and the Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders Memory Program [grant number CE11000102]. FK is supported by a NHMRC-ARC Dementia Research Development Fellowship [APP1097026]. OP is supported by an NHMRC Senior Research Fellowship [APP1103258].	Abbott JD, 2013, LATERALITY, V18, P437, DOI 10.1080/1357650X.2012.703206; Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; Bivona U, 2015, RESTOR NEUROL NEUROS, V33, P335, DOI 10.3233/RNN-140484; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2008, Q J EXP PSYCHOL, V61, P40, DOI 10.1080/17470210701508715; Bliksted V, 2017, NEUROPSYCHOLOGY, V31, P209, DOI 10.1037/neu0000309; Burdon P, 2016, INT J LANG COMM DIS, V51, P589, DOI 10.1111/1460-6984.12233; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Calder AJ, 2003, NEUROPSYCHOLOGIA, V41, P195, DOI 10.1016/S0028-3932(02)00149-5; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chung YS, 2011, SCHIZOPHRENIA BULL, V37, P1048, DOI 10.1093/schbul/sbq012; Cooper CL, 2014, BRAIN INJURY, V28, P122, DOI 10.3109/02699052.2013.848379; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Ekman P., 1976, PICTURES FACIAL AFFE; Embretson S.E., 2013, ITEM RESPONSE THEORY; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Fonseca Rochele Paz, 2007, Estud. psicol. (Campinas), V24, P529, DOI 10.1590/S0103-166X2007000400012; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Genova HM, 2016, J INT NEUROPSYCH SOC, V22, P83, DOI 10.1017/S1355617715001137; Green MF, 2012, SCHIZOPHRENIA BULL, V38, P854, DOI 10.1093/schbul/sbq171; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Greve Kevin W., 1994, Clinical Gerontologist, V15, P75; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Honan, 2017, AWARENESS SOCIAL INF; Honan CA, 2016, CLIN NEUROPSYCHOL, V30, P243, DOI 10.1080/13854046.2015.1136691; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hsieh S, 2013, DEMENT GERIATR COGN, V36, P242, DOI 10.1159/000351671; Hsieh S, 2013, J GERIATR PSYCH NEUR, V26, P174, DOI 10.1177/0891988713495448; Janssen G, 2014, COLOMB APPL LINGUIST, V16, P167, DOI 10.14483/udistrital.jour.calj.2014.2.a03; Joanette Y, 2015, MONTREAL PROTOCOL EV; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kern RS, 2009, PSYCHOL MED, V39, P645, DOI 10.1017/S0033291708003966; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kumfor F, 2017, CORTEX, V93, P166, DOI 10.1016/j.cortex.2017.05.022; Kumfor F, 2014, BRAIN, V137, P3061, DOI 10.1093/brain/awu246; Kumfor F, 2011, SOC NEUROSCI-UK, V6, P502, DOI 10.1080/17470919.2011.620779; Ladegaard N, 2014, PSYCHIAT RES, V216, P37, DOI 10.1016/j.psychres.2013.12.010; Lavrencic LM, 2016, AGING NEUROPSYCHOL C, V23, P61, DOI 10.1080/13825585.2015.1048773; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2015, BRAIN IMPAIR, V16, P3, DOI 10.1017/BrImp.2015.7; Meyers JE., 1995, REY COMPLEX FIGURE T; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Moraitou D, 2013, PSYCHOGERIATRICS, V13, P139, DOI 10.1111/psyg.12016; Pell MD, 2014, NEUROPSYCHOLOGY, V28, P905, DOI 10.1037/neu0000090; Phillips LH, 2015, DEV PSYCHOL, V51, P1840, DOI 10.1037/dev0000063; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Savla GN, 2013, SCHIZOPHRENIA BULL, V39, P979, DOI 10.1093/schbul/sbs080; Shany-Ur T, 2012, CORTEX, V48, P1329, DOI 10.1016/j.cortex.2011.08.003; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Vaskinn A, 2009, J NERV MENT DIS, V197, P700, DOI 10.1097/NMD.0b013e3181b3ae62; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	70	6	6	2	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2018	32	4					700	719		10.1080/13854046.2017.1400106			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GD3XQ	WOS:000430437500005	29130370				2022-02-06	
J	Montgomery, LR; Hubscher, CH				Montgomery, Lynnette R.; Hubscher, Charles H.			Altered vasopressin and natriuretic peptide levels in a rat model of spinal cord injury: implications for the development of polyuria	AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY			English	Article						urinary dysfunction; bladder; neurotrauma; corticosterone	MEDULLARY COLLECTING DUCT; ANTIDIURETIC-HORMONE; SUPRAOPTIC NUCLEUS; GENE-EXPRESSION; RENAL ACTIONS; ATRIAL; BRAIN; SECRETION; INHIBITION; ENDOTHELIN	Urinary dysfunction is a common complaint following spinal cord injury (SCI) and is a leading issue for individuals with SCI that impacts their quality of life. One urinary complication that has received little attention is SCI-induced polyuria, even though individuals with SCI will significantly restrict their fluid intake to decrease urine production, leading to sequelae of medical complications. Understanding the mechanisms instigating the development of polyuria will allow us to target interventions that may alleviate polyuria symptoms, leading to significant improvements in the quality of life and urinary health of individuals with SCI. In a rat SCI contusion model, an increase in the amount of urine excreted over a 24-h period (P <= 0.001) was found at 2 wk postinjury. The urine excreted was more dilute with decreased urinary creatinine and specific gravity (P <= 0.001). Several factors important in fluid balance regulation, vasopressin (AVP), natriuretic peptides. and corticosterone (CORT), also changed significantly postinjury. AVP levels decreased (P = 0.042), whereas atrial natriuretic peptide (ANP) and CORT increased (P = 0.05 and P = 0.031, respectively) at 2 wk postinjury. There was also a positive correlation between the increase in ANP and urine volume postinjury (P = 0.033). The changes in AVP, ANP, and CORT are conducive to producing polyuria, and the timing of these changes coincides with the development of SCI-induced polyuria. This study identifies several therapeutic targets that could be used to ameliorate polyuria symptoms and improve quality of life in individuals with SCI.	[Hubscher, Charles H.] Univ Louisville, Dept Anat Sci & Neurobiol, 511 S Floyd St, Louisville, KY 40202 USA; Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40202 USA		Hubscher, CH (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, 511 S Floyd St, Louisville, KY 40202 USA.	chhubs01@louisville.edu		Hubscher, Charles/0000-0002-6678-750X	Paralyzed Veterans of America Research Foundation [3042]; Kentucky Spinal Cord and Head Injury Research Trust [KSCHIRT 14-5]; Department of DefenseUnited States Department of Defense [W81XWH-15-1-0656]	Funding support for this work was provided through the Paralyzed Veterans of America Research Foundation (Grant 3042), Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT 14-5), and the Department of Defense (W81XWH-15-1-0656).	Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BERL T, 1974, J CLIN INVEST, V53, P219, DOI 10.1172/JCI107541; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; DANANBERG J, 1992, AM J PHYSIOL, V263, pH1377; Denys MA, 2017, J UROLOGY, V197, P445, DOI 10.1016/j.juro.2016.08.001; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; GERSTBERGER R, 1992, EXP PHYSIOL, V77, P587, DOI 10.1113/expphysiol.1992.sp003622; Goh MY, 2017, SPINAL CORD, V55, P39, DOI 10.1038/sc.2016.100; Gutkowska J, 1997, PHYSIOL REV, V77, P465, DOI 10.1152/physrev.1997.77.2.465; HAACK D, 1977, AM J PHYSIOL, V233, pF403, DOI 10.1152/ajprenal.1977.233.5.F403; HORIO T, 1993, METABOLISM, V42, P94, DOI 10.1016/0026-0495(93)90178-Q; Houben AJHM, 2005, FUND CLIN PHARMACOL, V19, P411, DOI 10.1111/j.1472-8206.2005.00336.x; Hubscher CH, 2016, AM J PHYSIOL-RENAL, V310, pF1258, DOI 10.1152/ajprenal.00557.2015; Inoue T, 2001, CARDIOVASC RES, V51, P470, DOI 10.1016/S0008-6363(01)00248-6; JACOBOWITZ DM, 1985, NEUROENDOCRINOLOGY, V40, P92, DOI 10.1159/000124058; Kilinc S, 1999, SPINAL CORD, V37, P332, DOI 10.1038/sj.sc.3100814; KINNUNEN P, 1993, ENDOCRINOLOGY, V132, P1961, DOI 10.1210/en.132.5.1961; KURTZMAN NA, 1975, NEPHRON, V15, P167, DOI 10.1159/000180511; Liu C, 2011, J PHARMACOL EXP THER, V339, P203, DOI 10.1124/jpet.111.184796; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Magga J, 1997, CIRCULATION, V96, P3053, DOI 10.1161/01.CIR.96.9.3053; MARINGREZ M, 1986, NATURE, V324, P473, DOI 10.1038/324473a0; MCKENZIE AL, 1995, J NEUROTRAUM, V12, P257, DOI 10.1089/neu.1995.12.257; MILLER HA, 1995, MOL CELL ENDOCRINOL, V109, P63, DOI 10.1016/0303-7207(95)03486-Q; NONOGUCHI H, 1988, J CLIN INVEST, V82, P1383, DOI 10.1172/JCI113742; OBANA K, 1985, BIOCHEM BIOPH RES CO, V132, P1088, DOI 10.1016/0006-291X(85)91918-7; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Popovich PG, 2001, J NEUROTRAUM, V18, P957, DOI 10.1089/089771501750451866; RAFF H, 1987, AM J PHYSIOL, V252, pR635, DOI 10.1152/ajpregu.1987.252.4.R635; Rowland NE, 2007, COMPARATIVE MED, V57, P149; Ruskoaho H, 1997, J MOL MED, V75, P876, DOI 10.1007/s001090050179; RUSKOAHO H, 1991, CAN J PHYSIOL PHARM, V69, P1514, DOI 10.1139/y91-227; Salzman SK, 1996, J NEUROTRAUM, V13, P93, DOI 10.1089/neu.1996.13.93; Schrier R W, 1976, Trans Am Clin Climatol Assoc, V87, P161; SCHRIER RW, 1979, AM J PHYSIOL, V236, pF321, DOI 10.1152/ajprenal.1979.236.4.F321; SICA DA, 1993, ARCH PHYS MED REHAB, V74, P969; STANDAERT DG, 1987, NATURE, V329, P151, DOI 10.1038/329151a0; STEWART RE, 1988, NEUROSCI BIOBEHAV R, V12, P151, DOI 10.1016/S0149-7634(88)80007-1; STRICKER EM, 1986, AM J PHYSIOL, V250, pR267, DOI 10.1152/ajpregu.1986.250.2.R267; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; Szollar SM, 1997, ARCH PHYS MED REHAB, V78, P455, DOI 10.1016/S0003-9993(97)90155-6; Thunhorst RL, 2007, AM J PHYSIOL-REG I, V293, pR1444, DOI 10.1152/ajpregu.00294.2007; Tomida M, 1998, STROKE, V29, P1584, DOI 10.1161/01.STR.29.8.1584; Trudel E, 2012, J NEUROENDOCRINOL, V24, P577, DOI 10.1111/j.1365-2826.2012.02298.x; UEDA S, 1988, BIOCHEM BIOPH RES CO, V155, P733, DOI 10.1016/S0006-291X(88)80556-4; Ward PJ, 2012, J NEUROTRAUM, V29, P2490, DOI 10.1089/neu.2012.2402; YAMADA H, 1988, HISTOCHEMISTRY, V89, P411, DOI 10.1007/BF00492595; YAMAMOTO S, 1991, J NEUROENDOCRINOL, V3, P45, DOI 10.1111/j.1365-2826.1991.tb00237.x; ZEIDEL ML, 1990, ANNU REV PHYSIOL, V52, P747	50	6	6	0	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1931-857X	1522-1466		AM J PHYSIOL-RENAL	Am. J. Physiol.-Renal Physiol.	JAN	2018	314	1					F58	F66		10.1152/ajprenal.00229.2017			9	Physiology; Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Urology & Nephrology	FT9KC	WOS:000423469900006	28877880				2022-02-06	
J	Mormile, MEE; Langdon, JL; Hunt, TN				Mormile, Megan Elizabeth Evelyn; Langdon, Jody L.; Hunt, Tamerah Nicole			The Role of Gender in Neuropsychological Assessment in Healthy Adolescents	JOURNAL OF SPORT REHABILITATION			English	Article						concussion; female; male; neuropsychological testing	SPORTS-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; BASE-LINE; EPIDEMIOLOGY; COLLEGIATE; IMPACT; METAANALYSIS; MANAGEMENT	Context: Research in college athletes has revealed significant gender differences in areas of verbal memory, visual memory, and reaction time. Additionally, research has focused on differences in neuropsychological components and gender in college populations; however, such differences in gender have not been documented in healthy adolescent populations. Purpose: To identify potential differences between males and females using different components of a common computerized neuropsychological test. Methods: A computerized neuropsychological test battery (ImPACT (R)) was administered to 662 high-school age adolescent athletes (male: n = 451 female: n = 262). Differences between genders were calculated using a 1-way ANOVA. All statistical analyses were conducted using SPSS 23.0. Significance levels were set a priori at P < .05. Results: A 1-way ANOVA revealed statistically significant differences between males and females for composite reaction time (F-1,F-660 = 10.68, P = .001) and total symptom score (F-1,F-660 = 81.20, P < .001). However, no statistically significant differences were found between males and females in composite verbal memory, visual memory, visual motor, or impulse control (P > .05). Conclusions: Significant differences between males and females were discovered for composite reaction time and total symptom scores, with females reporting more symptoms and slower reaction times at a baseline assessment. Increased symptom reporting by females may be attributed to both hormonal differences and increased honesty. Quicker reaction times in males may support theories that repetition of activities and quicker muscle contraction are gender dependent. However, additional research is necessary to understand gender differences in adolescent athletes during periods of cognitive and physical maturation.	[Mormile, Megan Elizabeth Evelyn; Langdon, Jody L.; Hunt, Tamerah Nicole] Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA 30458 USA		Mormile, MEE (corresponding author), Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA 30458 USA.	meganevelyne@gmail.com	Langdon, Jody/AAY-4638-2021		National Operating Committee on Standards of Athletic Equipment (NOCSAE) in Overland Park, KS	This research was supported by the National Operating Committee on Standards of Athletic Equipment (NOCSAE) in Overland Park, KS.	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dykiert D., 2011, THESIS; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; HYDE JS, 1981, AM PSYCHOL, V36, P892, DOI 10.1037/0003-066X.36.8.892; Irick E., 2015, NCAA SPORTS SPONSORS; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Jain Aditya, 2015, Int J Appl Basic Med Res, V5, P124, DOI 10.4103/2229-516X.157168; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maki PM, 2002, NEUROPSYCHOLOGIA, V40, P518, DOI 10.1016/S0028-3932(01)00126-9; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; National Federation of State High School Association, 2015, 2014 2015 HIGH SCH A; NEWCOMBE N, 1983, SEX ROLES, V9, P377, DOI 10.1007/BF00289672; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shields S. A., 1982, J WOMEN CULTURE SOC, V7, P769, DOI DOI 10.1086/493921; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Toole T., 1993, WOMEN SPORT PHYS ACT, V2, P41, DOI DOI 10.1123/WSPAJ.2.1.41; U.S. Department of Labor Bureau of Labor Statistics., 2015, OCC OUTL HDB; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	36	6	6	0	8	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2018	27	1					16	21		10.1123/jsr.2016-0140			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FX9MA	WOS:000426422700005	27992286				2022-02-06	
J	Naess-Schmidt, ET; Blicher, JU; Tietze, A; Rask, CU; Svendsen, SW; Schroder, A; Thastum, MM; Tuborgh, AH; Frederiksen, OV; Ostergaard, L; Eskildsen, SF; Hansen, B; Jespersen, S; Nielsen, JF				Naess-Schmidt, Erhard Trillingsgaard; Blicher, Jakob Udby; Tietze, Anna; Rask, Charlotte Ulrikka; Svendsen, Susanne Wulff; Schroder, Andreas; Thastum, Mille Moller; Tuborgh, Astrid Hoeg; Frederiksen, Oana-Veronica; Ostergaard, Leif; Eskildsen, Simon Fristed; Hansen, Brian; Jespersen, Sune; Nielsen, Jorgen Feldbaek			Diffusion MRI findings in patients with extensive and minimal post-concussion symptoms after mTBI and healthy controls: a cross sectional study	BRAIN INJURY			English	Article						Concussion; kurtosis; microstructure; mild traumatic brain injury	TRAUMATIC-BRAIN-INJURY; MINOR HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; COGNITIVE IMPAIRMENT; WATER DIFFUSION; RISK-FACTORS; MILD; KURTOSIS; COHORT; QUESTIONNAIRE	Primary objectives: We hypothesized that the microstructure of the corpus callosum, thalamus and hippocampus, as measured with diffusion and Mean of the Kurtosis Tensor (MKT) MRI, differs between healthy subjects and patients with extensive and minimal post-concussion symptoms (PCS) and that MKT measures correlate with PCS severity and self-reported cognitive symptoms. Research design: A cross-sectional study comparing patients with extensive PCS and patients with minimal PCS 2-5 months after mild traumatic brain injury (mTBI) with each other and with an external healthy control group. Methods and procedures: Diffusion MRI was obtained in 25 patients with extensive PCS and in 25 patients with minimal PCS as measured by the Rivermead Post-concussion Symptoms Questionnaire. The patients were matched on age, sex and time since accident. Data from an external healthy control group (n = 27) was included. Main outcome and results: There was no difference in MKT between the two groups with mTBI and no correlation between MKT and PCS. There was no difference between the three groups in other diffusion measures. Conclusions: Our results did not point to microstructural changes in the corpus callosum, thalamus and hippocampus in relation to PCS after mTBI.	[Naess-Schmidt, Erhard Trillingsgaard; Svendsen, Susanne Wulff; Frederiksen, Oana-Veronica; Nielsen, Jorgen Feldbaek] Aarhus Univ, Hammel Neurorehabil Ctr, Dept Clin Med, Hammel, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Svendsen, Susanne Wulff; Frederiksen, Oana-Veronica; Nielsen, Jorgen Feldbaek] Aarhus Univ, Univ Res Clin, Hammel, Denmark; [Blicher, Jakob Udby; Tietze, Anna; Ostergaard, Leif; Eskildsen, Simon Fristed; Hansen, Brian; Jespersen, Sune] Aarhus Univ, Inst Clin Med, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Tietze, Anna; Ostergaard, Leif] Aarhus Univ Hosp, Dept Neuroradiol, Aarhus, Denmark; [Rask, Charlotte Ulrikka; Schroder, Andreas; Thastum, Mille Moller; Tuborgh, Astrid Hoeg] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, Aarhus, Denmark; [Rask, Charlotte Ulrikka] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, Aarhus, Denmark; [Jespersen, Sune] Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark		Naess-Schmidt, ET (corresponding author), Inst Clin Med, Hammel Neurorehabil Ctr, 15 Voldbyvej, DK-8450 Hammel, Denmark.; Naess-Schmidt, ET (corresponding author), Inst Clin Med, Univ Res Clin, 15 Voldbyvej, DK-8450 Hammel, Denmark.	erhanaes@rm.dk	Nass-Schmidt, Erhard/AAP-8212-2021; Tietze, Anna/H-3333-2018; Jespersen, Sune Norhoj/B-1914-2008; Ostergaard, Lars/AAA-3020-2020; Nielsen, Jorgen Feldbak/AAR-6384-2021; Ostergaard, Leif/A-9281-2008; Eskildsen, Simon/K-3934-2019; Nass-Schmidt, Erhard T/E-8425-2019	Nass-Schmidt, Erhard/0000-0002-2539-0362; Tietze, Anna/0000-0002-2601-9055; Jespersen, Sune Norhoj/0000-0003-3146-4329; Ostergaard, Lars/0000-0003-2459-0511; Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Ostergaard, Leif/0000-0003-2930-6997; Eskildsen, Simon/0000-0003-4242-9158; Nass-Schmidt, Erhard T/0000-0002-2539-0362; Rask, Charlotte Ulrikka/0000-0002-7426-0353; Blicher, Jakob/0000-0003-3443-4790; Ostergaard, Lars/0000-0002-7619-605X	Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01EB012874-01]	The authors declare no conflicts of interest. The project was supported by the Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab). BH acknowledges support from NIH 1R01EB012874-01.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Benjamini Y, 1995, J ROYAL STAT SOC B, V46, P1; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; Diaz- Arrastia R, 2009, EPILEPSIA, V2, P50; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glenn GR, 2015, NMR BIOMED, V28, P448, DOI 10.1002/nbm.3271; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hansen B, 2016, NEUROIMAGE, V142, P371, DOI 10.1016/j.neuroimage.2016.08.022; Hansen B, 2016, MAGN RESON MED, V76, P1455, DOI 10.1002/mrm.26055; Hansen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23999; Hansen B, 2014, MAGN RESON MED, V71, P2250, DOI 10.1002/mrm.25090; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Munivenkatappa A., 2015, BRAIN INJURY, P1; Naess-Schmidt E, 2015, PATCH BAS TECHN MED, DOI [10.1007/978-3-319-28194-022, DOI 10.1007/978-3-319-28194-0]; Naess-Schmidt E, 2016, INT J COMPUT ASS RAD, V11, P1979, DOI 10.1007/s11548-016-1433-0; Naess-Schmidt ET, 2017, BRAIN INJURY, V31, P230, DOI 10.1080/02699052.2016.1229034; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sun PZ, 2014, NMR BIOMED, V27, P1413, DOI 10.1002/nbm.3188; Thastum MT, 2017, NEUROREHABILITATION; Tietze A, 2015, AM J NEURORADIOL, V36, P1472, DOI 10.3174/ajnr.A4311; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	59	6	6	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	1					91	98		10.1080/02699052.2017.1377352			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7VS	WOS:000427072300010	29095055				2022-02-06	
J	Narad, ME; Bedell, G; King, JA; Johnson, J; Turkstra, LS; Haarbauer-Krupa, J; Wade, SL				Narad, Megan E.; Bedell, Gary; King, Jessica A.; Johnson, Jeremy; Turkstra, Lyn S.; Haarbauer-Krupa, Julie; Wade, Shari L.			Social Participation and Navigation (SPAN): Description and usability of app-based coaching intervention for adolescents with TBI	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Pediatric traumatic brain injury; peer coaching; social participation	TRAUMATIC BRAIN-INJURY; MENTORING PROGRAM; PEER SUPPORT; CHILDREN; OUTCOMES; COMMUNITY; SCHOOL; REHABILITATION; INTEGRATION; PARENTS	Background: Adolescents with brain injury (BI) often experience impairment in participation, which is an important predictor of outcomes. Objective: Describe the Social Participation and Navigation (SPAN) program, and report participant feedback and preliminary outcomes. Method: Four adolescents and four coaches participated. SPAN included a mobile app, online didactic information, and peer coaching. Adolescents met weekly with coaches via video-conference, developed participation goals, and plans to achieve goals. Social and behavioral functioning before and after was assessed, and feedback about SPAN was collected. Results: SPAN was well received. Participants used the app to define and achieve goals. Medium to large effect sizes were found on adolescent self-reported measures, with negligible effects on parent-report measures. Positive and critical feedback is described. Conclusions: Findings support the usability of SPAN, which has the potential to improve social participation of adolescents with a history of TBI through an innovative use of technology and peer coaching.	[Narad, Megan E.; King, Jessica A.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Bedell, Gary] Tufts Univ, Dept Occupat Therapy, Medford, MA USA; [Johnson, Jeremy] Georgia Tech Univ, Interact Media Technol Ctr, Atlanta, GA USA; [Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA; [Haarbauer-Krupa, Julie] Childrens Healthcare Atlanta, Div Rehabil Serv, Atlanta, GA USA; [Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Dept Speech Language Pathol, Hamilton, ON, Canada		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil & Behav Med & Clin Psychol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	megan.narad@cchmc.org	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; Bedell, Gary/0000-0002-9555-8861	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) GrantUnited States Department of Health & Human Services [H133G130272]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD088011] Funding Source: NIH RePORTER	This research was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) Grant # H133G130272. NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS) in the USA. The contents of this manuscript were developed under a grant from the The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should assume endorsement by the Federal Government.	Achenbach TM, 1991, MANUAL SELF REPORT A; Agnihotri S, 2010, DEV NEUROREHABIL, V13, P369, DOI 10.3109/17518423.2010.499409; Bedell GM, 2017, DEV NEUROREHABIL, V20, P408, DOI 10.1080/17518423.2016.1237584; Bedell Gary M, 2002, Pediatr Rehabil, V5, P107, DOI 10.1080/1363849021000013540; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BERNDT TJ, 1979, DEV PSYCHOL, V15, P608, DOI 10.1037/0012-1649.15.6.608; Braga LW, 2012, NEUROREHABILITATION, V30, P205, DOI 10.3233/NRE-2012-0746; Carter EW, 2006, RES PRACT PERS SEV D, V31, P284, DOI 10.1177/154079690603100402; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Cooley E, 1997, ACQUIRED BRAIN INJUR; Dennis JM, 2005, J COLL STUDENT DEV, V46, P223, DOI 10.1353/csd.2005.0023; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Duckenfield M., 2000, SERVICE LEARNING CUR, P1; Eccles JS, 2003, J SOC ISSUES, V59, P865, DOI 10.1046/j.0022-4537.2003.00095.x; Gauvin-Lepage J, 2010, BRAIN INJURY, V24, P1087, DOI 10.3109/02699052.2010.494593; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; Gresham FM, 2001, EXCEPT CHILDREN, V67, P331, DOI 10.1177/001440290106700303; Haarbauer-Krupa J, 2010, J HEAD TRAUMA REHAB, V25, P396; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Jacoby B., 1996, SERVICE LEARNING HIG, P3; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Joseph DH, 2001, DIABETES EDUCATOR, V27, P703, DOI 10.1177/014572170102700511; Kolakowsky-Hayner SA, 2012, NEUROREHABILITATION, V31, P63, DOI 10.3233/NRE-2012-0775; Larson RW, 1999, PSYCHOL BULL, V125, P701, DOI 10.1037/0033-2909.125.6.701; Laugeson E.A., 2013, PEERS CURRICULUM SCH; Law M, 2011, BRAIN INJURY, V25, P587, DOI 10.3109/02699052.2011.572945; Lenhart A., TEENS TECHNOLOGY FRI; Lenhart A, 2015, TEENS SOCIAL MEDIA T, P4; Mahoney JL, 2003, J EDUC PSYCHOL, V95, P409, DOI 10.1037/0022-0663.95.2.409; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; SELMAN RL, 1997, FOSTERING FRIENDSHIP; SELMAN RL, 1990, MAKING FRIEND YOUTH; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stronach ST, 2008, APHASIOLOGY, V22, P1054, DOI 10.1080/02687030701632187; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor TP, 2007, J APPL SOC PSYCHOL, V37, P320, DOI 10.1111/j.0021-9029.2007.00162.x; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; TURKSTRA L, 2007, NEUROPHYSIOLOGY NEUR, V17, P15, DOI DOI 10.1044/NNSLD17.3.15; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	65	6	6	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2018	21	7			SI		439	448		10.1080/17518423.2017.1354092			10	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	GR1HR	WOS:000442284100003	28762859	Green Accepted			2022-02-06	
J	Nguyen, S; McKenzie, D; McKay, A; Wong, DN; Rajaratnam, SMW; Spitz, G; Williams, G; Mansfield, D; Ponsford, J				Nguyen, Sylvia; McKenzie, Dean; McKay, Adam; Wong, Dana; Rajaratnam, Shantha M. W.; Spitz, Gershon; Williams, Gavin; Mansfield, Darren; Ponsford, Jennie			Exploring predictors of treatment outcome in cognitive behavior therapy for sleep disturbance following acquired brain injury	DISABILITY AND REHABILITATION			English	Article						Classification and regression trees; cognitive behavior therapy; sleep; predictors; treatment outcome; acquired brain injury	PSYCHOLOGICAL TREATMENT; HOSPITAL ANXIETY; CHRONIC INSOMNIA; DEPRESSION; QUALITY; EFFICACY; DEFICITS; FATIGUE; DISORDERS; UTILITY	Purpose: To identify predictors of treatment response to cognitive behavior therapy (CBT) for sleep disturbance following acquired brain injury (ABI). Methods: Classification and regression tree (CART) analysis was conducted on individual patient data from two pilot randomized controlled trials (RCTs): one in traumatic brain injury (TBI), the other in stroke. The combined sample comprised 32 participants; 15 receiving CBT and 17 allocated to treatment as usual (TAU). The outcome was reliable improvement on the Pittsburgh Sleep Quality Index (PSQI). Results: Study group was a statistically significant predictor of outcome, with CBT participants more likely to achieve reliable improvements than TAU (OR = 4.88, p = 0.042). Study group (CBT vs. TAU) exhibited an area under the ROC curve (AUROC) of 69%. In separate CART analyzes, verbal memory (CVLT-II >45.5), age (<47.5) and baseline depression (HADS-D>6) predicted positive outcomes in CBT recipients. Each of these variables added a small (similar to 5%) but not statistically significant amount to AUROC over study group. Conclusions: In this ABI sample, better memory, younger age, and higher baseline depression were associated with positive treatment response to CBT although individually these variables were not better than group alone in predicting outcomes. The present findings generate hypotheses for further investigation in future studies. IMPLICATIONS FOR REHABILITATION Cognitive behavior therapy improves sleep quality over treatment as usual in persons with acquired brain injury. Individuals who are younger in age with better memory and co-morbid symptoms of depression are more likely to respond to the treatment. These findings are based on a small sample and can be considered hypothesis generating for future clinical studies.	[Nguyen, Sylvia; McKay, Adam; Wong, Dana; Rajaratnam, Shantha M. W.; Spitz, Gershon; Mansfield, Darren; Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, Melbourne, Vic, Australia; [Nguyen, Sylvia; McKenzie, Dean; McKay, Adam; Wong, Dana; Spitz, Gershon; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKenzie, Dean; Williams, Gavin] Epworth HealthCare, Melbourne, Vic, Australia; [McKenzie, Dean] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia		Nguyen, S (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	sylvia.nguyen@monash.edu	; Spitz, Gershon/H-7755-2014; McKay, Adam/M-6003-2017	Rajaratnam, Shantha/0000-0001-7527-8558; Spitz, Gershon/0000-0002-7810-1480; Wong, Dana/0000-0001-9619-1929; McKay, Adam/0000-0002-0479-7681	NHMRC Centre of Research ExcellenceNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [1023043]; Epworth Research Institute [80969]	This work was supported by the NHMRC Centre of Research Excellence under grant 1023043, Epworth Research Institute under grant 80969.	ALPERSON J, 1979, BEHAV THER, V10, P347, DOI 10.1016/S0005-7894(79)80024-6; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Bakken LN, 2014, J ADV NURS, V70, P639, DOI 10.1111/jan.12228; Besga A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00231; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Brieman L., 1984, CLASSIFICATION REGRE; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Cuijpers P, 2013, CAN J PSYCHIAT, V58, P376, DOI 10.1177/070674371305800702; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; Delis D. C., 2000, MANUAL CALIFORNIAN V; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Driessen E, 2010, J CONSULT CLIN PSYCH, V78, P668, DOI 10.1037/a0020570; Driskell LD, 2016, REHABIL PSYCHOL, V61, P112, DOI 10.1037/rep0000079; Espie CA, 2001, J CONSULT CLIN PSYCH, V69, P58, DOI 10.1037//0022-006X.69.1.58; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gigerenzer G., 2015, SIMPLY RATIONAL DECI; Hamilton KE, 2002, CLIN PSYCHOL REV, V22, P875, DOI 10.1016/S0272-7358(02)00106-X; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JARRETT RB, 1991, PSYCHIAT RES, V37, P245, DOI 10.1016/0165-1781(91)90061-S; Karaca B, 2016, J STROKE CEREBROVASC, V25, P727, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.015; King MW, 2014, J CONSULT CLIN PSYCH, V82, P895, DOI 10.1037/a0035886; Kneebone II, 2016, COGN BEHAV PRACT, V23, P99, DOI 10.1016/j.cbpra.2015.02.001; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lancee J, 2013, DEPRESS ANXIETY, V30, P149, DOI 10.1002/da.22004; Leppavuori A, 2002, CEREBROVASC DIS, V14, P90, DOI 10.1159/000064737; Lovato N, 2013, SLEEP MED, V14, P888, DOI 10.1016/j.sleep.2013.05.008; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McKenzie DP, 2015, J PSYCHOSOM RES, V79, P566, DOI 10.1016/j.jpsychores.2015.08.003; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Nguyen S, NEUROPSYCHOL REHABIL; Nguyen S, ARCH PHYS MED REHABI; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Pearce SC, 2016, J CLIN EXP NEUROPSYC, V38, P1, DOI 10.1080/13803395.2015.1078295; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Quarmby L, 2007, BEHAV RES THER, V45, P1085, DOI 10.1016/j.brat.2006.08.019; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Sagen U, 2009, J PSYCHOSOM RES, V67, P325, DOI 10.1016/j.jpsychores.2009.03.007; Stiles-Shields C, 2015, PSYCHOL MED, V45, P3205, DOI 10.1017/S0033291715001208; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Witten IH, 2017, DATA MINING PRACTICA; World Health Organization, 2006, NEON PER MORT COUNTR, P1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	6	6	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	16					1906	1913		10.1080/09638288.2017.1315461			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GE9GR	WOS:000431538500005	28420282				2022-02-06	
J	O'Dell, MW; Brashear, A; Jech, R; Lejeune, T; Marque, P; Bensmail, D; Ayyoub, Z; Simpson, DM; Volteau, M; Vilain, C; Picaut, P; Gracies, JM				O'Dell, Michael W.; Brashear, Allison; Jech, Robert; Lejeune, Thierry; Marque, Philippe; Bensmail, Djamel; Ayyoub, Ziyad; Simpson, David M.; Volteau, Magali; Vilain, Claire; Picaut, Philippe; Gracies, Jean Michel			Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study	PM&R			English	Article							TOXIN TYPE-A; BOTULINUM-TOXIN; DOUBLE-BLIND; UPPER-EXTREMITY; ARM SPASTICITY; STROKE; PLACEBO; EFFICACY; SAFETY; PATHOPHYSIOLOGY	Background: AbobotulinumtoxinA has beneficial effects on spasticity and active movements in hemiparetic adults with upper limb spasticity (ULS). However, evidence-based information on optimal dosing for clinical use is limited. Objective: To describe joint-specific dose effects of abobotulinumtoxinA in adults with ULS. Design: Secondary analysis of a phase 3 study (NCT01313299). Setting: Multicenter, international, double-blind, placebo-controlled clinical trial. Participants: A total of 243 adults with ULS > 6 months after stroke or traumatic brain injury, aged 52.8 (13.5) years and 64.3% male, randomized 1: 1: 1 to receive a single-injection cycle of placebo or abobotulinumtoxinA 500 U or 1000 U (total dose). Methods: The overall effects of injected doses were assessed in the primary analysis, which showed improvement of angles of catch in finger, wrist, and elbow flexors and of active range of motion against these muscle groups. This secondary analysis was performed at each of the possible doses received by finger, wrist, and elbow flexors to establish possible dose effects. Main Outcome Measures: Angle of arrest (X-V1) and angle of catch (X-V3) were assessed with the Tardieu Scale, and active range of motion (X-A). Results: At each muscle group level (finger, wrist, and elbow flexors) improvements in all outcome measures assessed (X-V1, X-V3, X-A) were observed. In each muscle group, increases in abobotulinumtoxinA dose were associated with greater improvements in X-V3 and X-A, suggesting a dose-dependent effect. Conclusions: Previous clinical trials have established the clinical efficacy of abobotulinumtoxinA by total dose only. The wide range of abobotulinumtoxinA doses per muscle groups used in this study allowed observation of dose-dependent improvements in spasticity and active movement. This information provides a basis for future abobotulinumtoxinA dosing recommendations for health care professionals based on treatment objectives and quantitative assessment of spasticity and active range of motion at individual joints.	[O'Dell, Michael W.] Weill Cornell Med, Dept Rehabil Med, Baker Pavil,Box 142,525 East 68th St, New York, NY 10065 USA; [Brashear, Allison] Wake Forest Baptist Med Ctr, Dept Neurol, Winston Salem, NC USA; [Jech, Robert] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Jech, Robert] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Jech, Robert] Gen Univ Hosp, Prague, Czech Republic; [Lejeune, Thierry] Univ Catholic Louvain, Clin Univ St Luc, Phys Med & Rehabil Dept, Brussels, Belgium; [Marque, Philippe] Hosp Rangueil, Serv Med Phys & Readaptat, Toulouse, France; [Bensmail, Djamel] Univ Versailles St Quentin, Hop Raymond Poincare, AP HP, Garches, France; [Ayyoub, Ziyad] Los Angeles Cty Rancho Los Amigos Natl Rehabil Ct, Downey, CA USA; [Simpson, David M.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Volteau, Magali; Vilain, Claire; Picaut, Philippe] Ipsen Innovat, Les Ulis, France; [Gracies, Jean Michel] Univ Paris Est Creteil, Hop Univ Henri Mondor, Serv Reeduc Neurolocomotrice, EA BIOTN 7377, Creteil, France		O'Dell, MW (corresponding author), Weill Cornell Med, Dept Rehabil Med, Baker Pavil,Box 142,525 East 68th St, New York, NY 10065 USA.	mio2005@med.cornell.edu	MARQUE, Philippe/AAC-4798-2019; Bensmail, Djamel/R-6035-2018	Bensmail, Djamel/0000-0001-9360-9330; Lejeune, Thierry/0000-0001-5741-7753; Jech, Robert/0000-0002-9732-8947	IpsenIpsen	Medical writing and submission support, under the direction of the authors, were provided by Jacqueline Harte and Germanicus Hansa-Wilkinson of Watermeadow Medical, an Ashfield Company, funded by Ipsen.	Ashford S, 2013, PHYSIOTHER RES INT, V18, P178, DOI 10.1002/pri.1554; Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402; Bakheit AMO, 2004, J NEUROL NEUROSUR PS, V75, P1558, DOI 10.1136/jnnp.2003.035139; Bhakta BB, 2000, J NEUROL NEUROSUR PS, V69, P217, DOI 10.1136/jnnp.69.2.217; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Dashtipour K, 2015, AM J PHYS MED REHAB, V94, P229, DOI 10.1097/PHM.0000000000000208; Demetrios M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009689.pub2; Esquenazi A, 2013, TOXICON, V67, P115, DOI 10.1016/j.toxicon.2012.11.025; Esquenazi A, 2009, TOXICON, V54, P634, DOI 10.1016/j.toxicon.2009.01.022; Foley N, 2013, ARCH PHYS MED REHAB, V94, P977, DOI 10.1016/j.apmr.2012.12.006; Gracies JM, 2010, EUR J PHYS REHAB MED, V46, P411; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2010, ARCH PHYS MED REHAB, V91, P421, DOI 10.1016/j.apmr.2009.11.017; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Hubble J, 2013, CLIN NEUROPHARMACOL, V36, P122, DOI 10.1097/WNF.0b013e318296e630; Jost WH, 2014, J NEUROL SCI, V337, P86, DOI 10.1016/j.jns.2013.11.022; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; Rosales RL, 2012, NEUROREHAB NEURAL RE, V26, P812, DOI 10.1177/1545968311430824; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy, 2009, SPAST AD MAN US BOT; Shaw LC, 2011, STROKE, V42, P1371, DOI 10.1161/STROKEAHA.110.582197; Sheean G, 2010, EUR J NEUROL, V17, P74, DOI 10.1111/j.1468-1331.2010.03129.x; Simpson DM, 2016, NEUROLOGY, V86, P1818, DOI 10.1212/WNL.0000000000002560; Smith SJ, 2000, CLIN REHABIL, V14, P5, DOI 10.1191/026921500666642221; Suputtitada A, 2005, DISABIL REHABIL, V27, P176, DOI 10.1080/09638280400009360; Turner-Stokes L, 2013, BMJ OPEN, V3; Watanabe T, 2015, SPASTICITY DIAGNOSIS; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303; Yelnik AP, 2007, J NEUROL NEUROSUR PS, V78, P845, DOI 10.1136/jnnp.2006.103341	29	6	6	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	JAN	2018	10	1					1	10		10.1016/j.pmrj.2017.06.008			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FU4XF	WOS:000423855200001	28634000	hybrid			2022-02-06	
S	Parsons, JT; Baugh, C		Hainline, B; Stern, RA		Parsons, John T.; Baugh, Christine			The evolving landscape of policies, rules, and law in sport-related concussion	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							RUGBY PLAYERS; HEAD-INJURY; ICE HOCKEY; KNOWLEDGE; EDUCATION; FOOTBALL; MANAGEMENT; EVOLUTION; EQUIPMENT; CHILDREN	Beginning in 2009 with the passage of the Zackery Lystedt law in the state ofWashington, all 50 states have passed concussion laws that implement a mandatory framework of care for high school and youth athletes. The structure of these laws generally shares the three primary components of the Lystedt law: (1) preseason concussion education; (2) mandatory removal from play with suspected concussion; and (3) clearance from a healthcare professional prior to return to play. These same three policy components are also found at the collegiate and professional levels of sport, either through established policy or labor contracts. This chapter explores concussion-specific legal and policy developments that currently inform concussion management practices across multiple levels of the US athletic system.	[Parsons, John T.] Natl Collegiate Athlet Assoc, Sport Sci Inst, Indianapolis, IN USA; [Baugh, Christine] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA		Parsons, JT (corresponding author), POB 6222, Indianapolis, IN 46206 USA.	jparsons@ncaa.org					Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, P3; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2011, J SCH HLTH, V85, p233 238; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Foreman M, 2010, SIDELINED SAFETY NEW; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Harvey HH, 2013, AM J PUBLIC HEALTH, pe1 ; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; LaRoche AAN, 2016, CLIN J SPORT MED, V26; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lowrey Kerri McGowan, 2016, J Health Care Law Policy, V19, P99; Lowrey KM, 2014, REVISING GAME PLAN P; Major League Baseball, 2012, 2012 2016 BASIC AGRE; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; National Basketball Association, 2016, NAT BASK ASS CONC PO; National Collegiate Athletic Association, 2018, CONC SAF PROT MAN; National Collegiate Athletic Association, 2017, INT CONS YEAR ROUND; National Collegiate Athletic Association, 2010, CONC MAN PLAN; National Collegiate Athletic Association, 2015, INF CONC SAF PROT CO; National Collegiate Athletic Association, 2017, CONC SAF PROT CHECKL; National Collegiate Athletic Association, 2015, CONC SAF PROT; National Collegiate Athletic Association Sports Science Institute, 2017, INT CONS DIAGN MAN S; National Football League, 2015, FIND OUT MORE ZACKER; National Football League, 2011, COLLECTIVE BARGAININ; National Football League, 2016, NFL HEAD NECK SPINE; National Operating Committee on Standards for Athletic Equipment, 2015, STAND PERF SPEC NEWL; National Operating Committee on Standards for Athletic Equipment, 2015, STAND PERF SPEC REC; National Operating Committee on Standards for Athletic Equipment, 2016, NOCSAE FIN 1 EV FOOT; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Pachman S, 2017, J ATHL TRAINING, V52, P186, DOI 10.4085/1062-6050-52.1.03; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Redding R, 2016, 2016 2017 NCAA FOOTB; Register-Mihalik JK, 2013, J ATHL TRAIN; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Soccer US, 2015, FREQUENTLY ASKED QUE; Steiner ME, 2016, SPORTS HEALTH, V8, P217, DOI 10.1177/1941738115626689; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; The Network for Public Health Law, 2016, YOUTH SPORT CONCUSSI; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290	60	6	6	0	1	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						257	267		10.1016/B978-0-444-63954-7.00025-2			11	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100027	30482354				2022-02-06	
J	Peixoto, C; Hyland, L; Buchanan, DM; Langille, E; Nahas, R				Peixoto, Cayden; Hyland, Lindsay; Buchanan, Derrick Matthew; Langille, Erika; Nahas, Richard			The polytrauma clinical triad in patients with chronic pain after motor vehicle collision	JOURNAL OF PAIN RESEARCH			English	Article						chronic pain; mTBI; concussion; PTSD; MVC	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; CONCUSSION SYMPTOMS QUESTIONNAIRE; SPINAL-CORD-INJURY; POSTCONCUSSION SYNDROME; MISSED DIAGNOSIS; BACK-PAIN; VETERANS; ACCIDENT; PTSD	Background: The polytrauma clinical triad (PCT) is a complex disorder composed of three comorbid diagnoses of chronic pain, post-traumatic stress disorder (PTSD), and postconcussion syndrome (PCS). PCT has been documented in veterans returning from deployment, but this is the first report on PCT prevalence in nonmilitary personnel after a motor vehicle collision (MVC). Methods: Data were drawn from routine intake assessments completed by 71 patients referred to a community-based clinic for chronic pain management. All patients completed the post-traumatic stress disorder checklist for the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (PCL-5), and Rivermead Post-Concussion Symptoms Questionnaire (RPQ) during a standardized intake assessment. An additional modified RPQ score was derived to address previously reported symptom overlap between PCS and chronic pain. Results: Standard and modified RPQ scores yielded PCS prevalence rates of 100% and 54.9% in our sample, respectively. Results suggest that a modified RPQ score, limited to visual and vestibular symptoms, may be more useful PCS screening criteria in patients with chronic pain. PTSD screening criteria on the PCL-5 were met by 85.9% of the patients. More than half of the patients referred for chronic pain after MVC met criteria for PCT (52.1%). Patients who met PCT criteria reported worse headache, overall pain, and sleep quality outcomes. Conclusion: Among patients in our sample with chronic pain after MVC, more than half met criteria for PCT. A modified approach to RPQ scoring limited to visual and vestibular symptoms may he required to screen for PCS in these patients.	[Peixoto, Cayden] Seekers Ctr, 942 Merivale Rd, Ottawa, ON K1Z 5Z9, Canada; [Hyland, Lindsay; Buchanan, Derrick Matthew; Langille, Erika] Carleton Univ, Dept Neurosci, Ottawa, ON, Canada; [Nahas, Richard] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada		Peixoto, C (corresponding author), Seekers Ctr, 942 Merivale Rd, Ottawa, ON K1Z 5Z9, Canada.	cayden@seekerscentre.com		Nahas, Richard/0000-0002-9054-4401			Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Dunn AS, 2011, J REHABIL RES DEV, V48, P493, DOI 10.1682/JRRD.2010.05.0104; Freeman M D, 2006, Pain Res Manag, V11, P79; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Irish LA, 2013, DEPRESS ANXIETY, V30, P475, DOI 10.1002/da.22034; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Jenewein J, 2009, J PSYCHOSOM RES, V66, P119, DOI 10.1016/j.jpsychores.2008.07.011; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kushner DS, 2015, NEURAL REGEN RES, V10, P859, DOI 10.4103/1673-5374.158329; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Matar ZS, 2008, INTERNET J SURG, V14, P11; McFarlane AC, 2010, WORLD PSYCHIATRY, V9, P3; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; Moshourab RA, 2015, BRAIN NEUROTRAUMA MO; Nash S., 2014, Annals of Physical and Rehabilitation Medicine, V57, P600, DOI 10.1016/j.rehab.2014.08.010; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Payal P, 2013, WORLD J EMERG MED, V4, P15, DOI [10.5847/wjem.j.issn.1920-8642.2013.01.003, 10.5847/wjem.j.1920-8642.2013.01.003]; Phillips Ceri J, 2009, Rev Pain, V3, P2, DOI 10.1177/204946370900300102; Porreca F, 2009, PAIN MED, V10, P654, DOI 10.1111/j.1526-4637.2009.00583.x; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Stupar Maja, 2007, J Can Chiropr Assoc, V51, P83; Su E, 2016, TRANSLATIONAL RES TR; Sullivan KA, 2012, CLIN NEUROPSYCHOL, V26, P1255, DOI 10.1080/13854046.2012.735254; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Thompson C, 2016, BRAIN INJURY, V30, P770; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Tripepi G, 2010, NEPHRON CLIN PRACT, V115, pC94, DOI 10.1159/000312871; U.S. Department of Veteran Affairs, POL TBI SYST CAR; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; Viano DC, 2015, TRAFFIC INJ PREV, V16, P747, DOI 10.1080/15389588.2015.1013188; Weathers FW, PTSD CHECKLIST DSM 5; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02950-3	52	6	6	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-7090			J PAIN RES	J. Pain Res.		2018	11						1927	1936		10.2147/JPR.S165077			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GU1IW	WOS:000445014300002	30288087	Green Published, Green Submitted, gold			2022-02-06	
J	Polson, D; Villalba, N; Freeman, K				Polson, David; Villalba, Nuria; Freeman, Kalev			Optimization of a diagnostic platform for oxidation-reduction potential (ORP) measurement in human plasma	REDOX REPORT			English	Article						Oxidation-reduction potential; oxidative stress; plasma	TRAUMATIC BRAIN-INJURY; ANTIOXIDANT THERAPY; STRESS; SEMEN	Objectives: Oxidation-reduction potential (ORP) measurement can demonstrate the extent of oxidative stress in patients with severe illness and/or injury. A novel ORP diagnostic platform using disposable sensors (RedoxSYS) has been validated by comparison to mass spectrometry, but the optimal methods of sample handling for best performance of the device have not been described.Methods: We sought to optimize ORP measurement in human plasma under controlled conditions. We hypothesized that the anticoagulant, freeze-thawing, and storage duration would influence measured ORP levels.Results: The platform was sensitive to exogenous oxidation with hydrogen peroxide and reduction with ascorbic acid. Plasma anticoagulated with heparin was more sensitive to differences in ORP than plasma prepared in citrate. ORP measurements decreased slightly after a freeze-thaw cycle, but once frozen, ORP was stable for up to one month.Discussion: We confirm that ORP detects oxidative stress in plasma samples. Optimal measurement of plasma ORP requires blood collection in heparin anticoagulant tubes and immediate analysis without a freeze-thaw cycle.	[Polson, David; Villalba, Nuria; Freeman, Kalev] Univ Vermont, Dept Surg, Larner Coll Med, 89 Beaumont Ave,Given Bldg,Room E301, Burlington, VT 05405 USA		Freeman, K (corresponding author), Univ Vermont, Dept Surg, Larner Coll Med, 89 Beaumont Ave,Given Bldg,Room E301, Burlington, VT 05405 USA.	Kalev.freeman@uvm.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 GM123010, UM1 HL120877]; Aytu BioScience, Inc.	This study was funded by NIH (RO1 GM123010; UM1 HL120877) and Aytu BioScience, Inc.	Agarwal A, 2016, THER ADV UROL, V8, P302, DOI 10.1177/1756287216652779; Agarwal A, 2016, FERTIL STERIL, V106, P566, DOI 10.1016/j.fertnstert.2016.05.013; Ahmad KA, 2017, FREE RADICAL RES, V51, P428, DOI 10.1080/10715762.2017.1322205; Al-Waili N, 2017, REDOX REP, V22, P99, DOI 10.1080/13510002.2017.1297885; Aslan M, 2013, REDOX REP, V18, P76, DOI 10.1179/1351000212Y.0000000033; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Bjugstad KB, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6974257; Bobe G, 2017, REDOX BIOL, V12, P121, DOI 10.1016/j.redox.2017.02.010; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chrysselis MC, 2001, EXPERT OPIN THER PAT, V11, P33, DOI 10.1517/13543776.11.1.33; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; He F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00486; Newsholme P, 2016, BIOCHEM J, V473, P4527, DOI 10.1042/BCJ20160503C; Olmeda B, 2010, BBA-BIOMEMBRANES, V1798, P1281, DOI 10.1016/j.bbamem.2010.03.008; Rael LT, 2015, ELECTROANAL, V27, P2567, DOI 10.1002/elan.201500178; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI 10.1089/neu.2008-0816; Rahman I, 2004, REDOX REP, V9, P125, DOI 10.1179/135100004225005219; Sela S, 2001, KIDNEY INT, V59, pS159, DOI 10.1046/j.1523-1755.2001.59780159.x; SHAPIRO HM, 1972, J SURG RES, V13, P138, DOI 10.1016/0022-4804(72)90057-1; Stagos D, 2015, REDOX REP, V20, P154, DOI 10.1179/1351000214Y.0000000118; Zhi LZ, 2013, REDOX REP, V18, P63, DOI 10.1179/1351000213Y.0000000042	23	6	6	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1351-0002	1743-2928		REDOX REP	Redox Rep.		2018	23	1					125	129		10.1080/13510002.2018.1456000			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB2GR	WOS:000428870200001	29606080	gold, Green Published			2022-02-06	
J	Randolph, JJ				Randolph, John J.			Positive neuropsychology: The science and practice of promoting cognitive health	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Activity engagement; cognitive health; lifestyle factors; positive psychology	TRAUMATIC BRAIN-INJURY; INCIDENT ALZHEIMER-DISEASE; OLDER-ADULTS; PHYSICAL-ACTIVITY; MULTIPLE-SCLEROSIS; MEMORY; LIFE; RISK; AGE; IMPAIRMENT	Positive psychology has influenced multiple subfields within psychology and areas outside of psychology. While positive psychology's focus on positive mental health and character strengths did not appear to meaningfully impact neuropsychology in its earlier stages, more recent indications suggest that the neuropsychological literature, and perhaps the field as a whole, has begun to embrace related research and practice applications. In this context, positive neuropsychology has emerged as a neuropsychological orientation focused on the study and practice of promoting cognitive health. The present review discusses the origins of positive neuropsychology and elaborates on its six key evidence-based domains: compensatory strategy use, activity engagement, prevention of cognitive impairment, public education, exceptional cognition, and positive cognitive outcomes in neuropsychiatric populations. This broad perspective on cognitive wellness can easily be embraced by both clinicians and researchers and offers multiple directions for future growth. Ultimately, consideration of various methods to promote cognitive health can inform our understanding of optimal brain function, maximize functioning in individuals with cognitive limitations, and enhance quality of life among populations served by neuropsychologists.	[Randolph, John J.] Geisel Sch Med Dartmouth, Dept Psychiat, Lebanon, NH USA		Randolph, JJ (corresponding author), 20 W Pk St,Suite 215, Lebanon, NH 03766 USA.	john.randolph@randolphnp.com					Annear MJ, 2020, J APPL GERONTOL, V39, P62, DOI 10.1177/0733464817752085; Arnett P., 2013, SECONDARY INFLUENCES; Banks S, 2010, SLEEP, V33, P1013, DOI 10.1093/sleep/33.8.1013; Barreto PD, 2016, MAYO CLIN PROC, V91, P1515, DOI 10.1016/j.mayocp.2016.06.032; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Boots EA, 2015, ARCH CLIN NEUROPSYCH, V30, P634, DOI 10.1093/arclin/acv041; Boyle PA, 2012, ARCH GEN PSYCHIAT, V69, P499, DOI 10.1001/archgenpsychiatry.2011.1487; Boyle PA, 2010, ARCH GEN PSYCHIAT, V67, P304, DOI 10.1001/archgenpsychiatry.2009.208; Chang YK, 2014, ARCH CLIN NEUROPSYCH, V29, P217, DOI 10.1093/arclin/acu003; Cheng ST, 2014, AM J GERIAT PSYCHIAT, V22, P63, DOI 10.1016/j.jagp.2013.01.060; CICERONE KD, 1992, NEUROREHABILITATION, V2, P73, DOI DOI 10.3233/NRE-1992-2304; de Frias CM, 2014, ARCH CLIN NEUROPSYCH, V29, P16, DOI 10.1093/arclin/act089; Dolcos S, 2012, NEUROPSYCHOLOGY, V26, P209, DOI 10.1037/a0026760; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Echemendia R. J., 2013, POSITIVE NEUROPSYCHO; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fox KCR, 2014, NEUROSCI BIOBEHAV R, V43, P48, DOI 10.1016/j.neubiorev.2014.03.016; Gefen T, 2018, CORTEX, V99, P69, DOI 10.1016/j.cortex.2017.10.015; Gefen T, 2015, J NEUROSCI, V35, P1781, DOI 10.1523/JNEUROSCI.2998-14.2015; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Harrison TM, 2012, J INT NEUROPSYCH SOC, V18, P1081, DOI 10.1017/S1355617712000847; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hosking Diane E, 2015, Prev Med Rep, V2, P498, DOI 10.1016/j.pmedr.2015.06.008; Hu Y, 2012, COGNITIVE PSYCHOL, V64, P235, DOI 10.1016/j.cogpsych.2012.01.001; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; Jorm AF, 2012, AM PSYCHOL, V67, P231, DOI 10.1037/a0025957; Kim ES, 2013, J PSYCHOSOM RES, V74, P427, DOI 10.1016/j.jpsychores.2013.01.013; Krueger KR, 2009, EXP AGING RES, V35, P45, DOI 10.1080/03610730802545028; Leckie RL, 2014, NEUROPSYCHOLOGIA, V59, P103, DOI 10.1016/j.neuropsychologia.2014.04.018; Liao J, 2017, AM J EPIDEMIOL, V186, P787, DOI 10.1093/aje/kwx142; Liao J, 2014, AM J EPIDEMIOL, V180, P1118, DOI 10.1093/aje/kwu236; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Luria Alexander, 1968, MIND MNEMONIST; Maher AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186413; MEICHENBAUM DH, 1971, J ABNORM PSYCHOL, V77, P115, DOI 10.1037/h0030773; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; OConnor M. K., 2013, POSITIVE NEUROPSYCHO, P121, DOI [10.1007/978-1-4614-6605-5_7, DOI 10.1007/978-1-4614-6605-5_7]; Opdebeeck C, 2018, PSYCHOL MED, V48, P61, DOI 10.1017/S003329171700126X; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Perry W, 2001, J INT NEUROPSYCH SOC, V7, P344, DOI 10.1017/S1355617701733085; Pillai JA, 2011, J INT NEUROPSYCH SOC, V17, P1006, DOI 10.1017/S1355617711001111; Rabinowitz AR, 2009, NEUROPSYCHOLOGY, V23, P581, DOI 10.1037/a0016064; Raji CA, 2014, AM J PREV MED, V47, P444, DOI 10.1016/j.amepre.2014.05.037; Randolph J, 2015, ARCH CLIN NEUROPSYCH, V30, P583; Randolph J. J., 2018, 46 ANN M INT NEUR SO; Randolph J J ., 2013, POSITIVE NEUROPSYCHO, P1; Randolph J. J., 2015, SUPERBRAINS 2015 C L; Randolph J. S., 2013, POSITIVE NEUROPSYCHO, DOI [10.1007/978-1-4614-6605-5_3, DOI 10.1007/978-1-4614-6605-5_3]; Reiter K, 2015, J INT NEUROPSYCH SOC, V21, P757, DOI 10.1017/S135561771500079X; Ruff RM, 2003, ARCH CLIN NEUROPSYCH, V18, P847, DOI 10.1016/j.acn.2003.07.002; Sabia S, 2012, ARCH GEN PSYCHIAT, V69, P627, DOI 10.1001/archgenpsychiatry.2011.2016; Schmitter-Edgecombe M., 2013, POSITIVE NEUROPSYCHO, P143, DOI [10.1007/978-1-4614-6605-5_8, DOI 10.1007/978-1-4614-6605-5_8]; Seligman MEP, 1999, AM PSYCHOL, V54, P559; Sohlberg M., 2001, COGNITIVE REHABILITA; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; Tan WJ, 2012, DEMENT GER COGN D EX, V2, P433, DOI 10.1159/000343079; Tian Q, 2014, J GERONTOL A-BIOL, V69, P1284, DOI 10.1093/gerona/glt287; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Ukueberuwa DM, 2014, J INT NEUROPSYCH SOC, V20, P751, DOI 10.1017/S1355617714000587; Waters F, 2011, J INT NEUROPSYCH SOC, V17, P571, DOI 10.1017/S1355617711000610; Wilson RS, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7060056; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Woods SP, 2010, ARCH CLIN NEUROPSYCH, V25, P724, DOI 10.1093/arclin/acq069; Yu L, 2015, STROKE, V46, P1071, DOI 10.1161/STROKEAHA.114.008010	68	6	6	3	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	4			SI		287	294		10.1080/23279095.2018.1457465			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GG4SF	WOS:000432685800002	29781728				2022-02-06	
J	Rigon, A; Voss, MW; Turkstra, LS; Mutlu, B; Duff, MC				Rigon, Arianna; Voss, Michelle W.; Turkstra, Lyn S.; Mutlu, Bilge; Duff, Melissa C.			Different aspects of facial affect recognition impairment following traumatic brain injury: The role of perceptual and interpretative abilities	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Affect perception; emotion recognition; facial affect recognition; traumatic brain injury; verbal categorization	EMOTION RECOGNITION; FUNCTIONAL CONNECTIVITY; PROCESSING SPEED; NORMATIVE DATA; TRAIL; EXPRESSIONS; RELIABILITY; VALIDATION; VALIDITY; DEFICITS	It is well established that many individuals with traumatic brain injury (TBI) are impaired at facial affect recognition, yet little is known about the mechanisms underlying such deficits. In particular, little work has examined whether the breakdown of facial affect recognition abilities occurs at the perceptual level (e.g., recognizing a smile) or at the verbal categorization stage (e.g., assigning the label "happy" to a smiling face). The aim of the current study was to investigate the integrity of these two distinct facial affect recognition subskills in a sample of 38 individuals with moderate-to-severe TBI and 24 demographically matched healthy individuals. Participants were administered an affect matching (perceptual skills) and an affect labeling (verbal categorization skills) task. Statistical analyses revealed that, while individuals with TBI showed significantly higher levels of impairment in the verbal categorization task than in the perceptual task, they performed less well than healthy comparison participants on both tasks. These findings indicate that facial affect recognition impairment can occur at different cognitive stages following TBI, suggesting the necessity of careful screening to offer targeted treatment. Moreover, they provide further neuropsychological evidence supporting the notion that distinct types of subskills are necessary to achieve successful recognition of facial affects.	[Rigon, Arianna] Univ Iowa, Interdisciplinary Neurosci Program, 420-I Seashore Hall,328 Iowa Ave, Iowa City, IA 52242 USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA 52242 USA; [Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Mutlu, Bilge] Univ Wisconsin, Dept Comp Sci, 1210 W Dayton St, Madison, WI 53706 USA; [Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN USA		Rigon, A (corresponding author), Univ Iowa, Interdisciplinary Neurosci Program, 420-I Seashore Hall,328 Iowa Ave, Iowa City, IA 52242 USA.	arianna.rigon@vanderbilt.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NICHD/NCMRR (National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research) [R01 HD071089]; American Psychological Foundation Benton-Meier Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	The current work was supported by NICHD/NCMRR (National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research) [grant number R01 HD071089]; and by an American Psychological Foundation Benton-Meier Fellowship.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Costa PJ, 2014, J BIOPHARM STAT, V24, P1115, DOI 10.1080/10543406.2014.926366; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Duchaine BC, 2004, NEUROLOGY, V62, P1219, DOI 10.1212/01.WNL.0000118297.03161.B3; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; LEVIN HS, 1975, J PSYCHOL, V91, P223, DOI 10.1080/00223980.1975.9923946; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Neumann D, 2014, BRAIN IMAGING BEHAV, V8, P460, DOI 10.1007/s11682-013-9285-5; Palermo R., 2017, J EXPT PSYCHOL HUMAN; Palermo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068126; Rigon A, 2017, NEUROIMAGE-CLIN, V13, P370, DOI 10.1016/j.nicl.2016.12.010; Rigon A., NEUROPSYCHOLOGY; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Salthouse TA, 2011, INTELLIGENCE, V39, P222, DOI 10.1016/j.intell.2011.03.001; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; SPARROW SS, 1985, J PEDIATR PSYCHOL, V10, P215, DOI 10.1093/jpepsy/10.2.215; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Turkstra LS, 2017, BRAIN IMPAIR, V18, P49, DOI 10.1017/BrImp.2016.29; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Zupan B., 2016, BRAIN IMPAIR, P1; Zupan B, 2015, BRAIN INJURY, V29, P877, DOI 10.3109/02699052.2015.1011233	44	6	6	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2018	40	8					805	819		10.1080/13803395.2018.1437120			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GU2MD	WOS:000445103200005	29562838	Green Accepted			2022-02-06	
J	Robbins, MS; Rosen, NL				Robbins, Matthew S.; Rosen, Noah L.			Headache Interest in Academic Neurology Leadership: A Cross-Sectional Study	HEADACHE			English	Article						headache; education; residency; fellowship; faculty; leadership	CAREER SATISFACTION; SPECIALISTS; DISORDERS; DIRECTORS; EDUCATION; MEDICINE; BURNOUT	BackgroundHeadache disorders are exceedingly common, debilitating neurological conditions, and there is a striking paucity of headache specialists nationally. However, headache education is underrepresented in the curriculum of neurology residency programs and few neurology residents elect to pursue headache medicine fellowships. We aimed to explore the possibility that a low degree of headache interest among neurology department chairs and residency program directors (PDs) underlies this mismatch. MethodsWe performed a cross-sectional analysis of chairs and PDs associated with ACGME neurology residency programs. Data sources included the ACGME program list, faculty profiles on institutional webpages, Doximity profiles, the American Headache Society (AHS) membership directory, and the roster of United Council for Neurologic Specialties (UCNS) headache diplomates. A headache interest was deemed to be present with the presence of a declared headache or concussion interest, completion of a headache fellowship, active AHS membership, or UCNS certification. ResultsOur review included 137 residency programs comprising 127 department chairs, 132 PDs, and 5 faculty who were both chairs and PDs. Of all faculty, 62 (23.5%) were women. Headache expertise was declared by 10 (7.6%) chairs and 13 (9.5%) PDs. Headache fellowship training was pursued by 1 (0.8%) chair and 5 (3.6%) PDs, and among all faculty was the 10th most common subspecialty fellowship pursued. Three (2.3%) chairs and 7 (5.1%) PDs were AHS members. Seven (5.3%) chairs and 10 (7.3%) PDs were UCNS headache certified. An overall headache interest was present in 29 (11.0%) faculty, including 14 (10.6%) chairs and 15 (10.9%) PDs. A graduate degree aside from an MD (eg, PhD, MPH) was more likely to be achieved in faculty without a headache interest (29.4%) than faculty with a headache interest (6.9%, P=.0076). Residency programs where either the chair or PD had a headache interest were just as likely to feature a UCNS headache fellowship program than programs without chair or PD headache interest (25.0 vs 23.0%, P=.83). ConclusionsCurrent neurology department chairs and residency PDs have low rates of headache interest, which may influence the emphasis of headache education in neurology training. Headache interest is associated with lower rates of other graduate degrees, and future analysis should examine if academic faculty interested in headache are less likely to be in leadership positions because of a lack of research funding, opportunities, or accomplishments.	[Robbins, Matthew S.] Montefiore Headache Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY USA; [Rosen, Noah L.] Hofstra North Shore LIJ Med Ctr, Dept Neurol, Pain & Headache Ctr, Cushing Neurosci Inst, Manhasset, NY USA		Robbins, MS (corresponding author), Montefiore Headache Ctr, 1250 Waters Pl,8th Floor, Bronx, NY 10461 USA.	marobbin@montefiore.org					Adornato BT, 2011, NEUROLOGY, V77, P1921, DOI 10.1212/WNL.0b013e318238ee13; Ahmed ZA, 2016, HEADACHE, V56, P871, DOI 10.1111/head.12822; Busis NA, 2017, NEUROLOGY, V88, P797, DOI 10.1212/WNL.0000000000003640; de Dhaem OB, 2017, NEUROLOGY, V88, pE122, DOI 10.1212/WNL.0000000000003763; Evans RW, 2015, HEADACHE, V55, P1448, DOI 10.1111/head.12708; Gallagher RM, 2005, HEADACHE, V45, P866, DOI 10.1111/j.1526-4610.2005.05155.x; Jordan JT, 2016, NEUROLOGY, V86, pe112, DOI 10.1212/WNL.0000000000002463; Kommineni M, 2005, HEADACHE, V45, P862, DOI 10.1111/j.1526-4610.2005.05154.x; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; London ZN, 2015, NEUROLOGY, V84, P2206, DOI 10.1212/WNL.0000000000001650; Mauser ED, 2014, HEADACHE, V54, P1347, DOI 10.1111/head.12406; Minen MT, 2015, HEADACHE, V55, P1092, DOI 10.1111/head.12623; Robbins MS, 2016, HEADACHE, V56, P79, DOI 10.1111/head.12695; Robbins MS, 2010, SEMIN NEUROL, V30, P107, DOI 10.1055/s-0030-1249220; Schwedt TJ, 2009, HEADACHE, V49, P162, DOI 10.1111/j.1526-4610.2008.01323.x; Steiner TJ, 2015, J HEADACHE PAIN, V16, P1, DOI 10.1186/s10194-015-0544-2; Stone J, 2010, CLIN NEUROL NEUROSUR, V112, P747, DOI 10.1016/j.clineuro.2010.05.011; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]	18	6	6	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JAN	2018	58	1					102	108		10.1111/head.13186			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR4WP	WOS:000419067600009	28940337				2022-02-06	
J	Rosenbaum, AM; Gordon, WA; Joannou, A; Berman, BA				Rosenbaum, Amy M.; Gordon, Wayne A.; Joannou, Antigone; Berman, Brady A.			Functional outcomes following post-acute rehabilitation for moderate-to-severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; subacute rehabilitation; outcome assessment	PROSPECTIVE-PAYMENT SYSTEM; INPATIENT REHABILITATION; COGNITIVE REHABILITATION; POSTACUTE REHABILITATION; COMMUNITY INTEGRATION; MODEL SYSTEMS; CONSCIOUSNESS; PREDICTORS; RECOVERY; PROGRAM	Objective: The objective of this study was to examine the benefits of long-term inpatient rehabilitation for individuals with moderate-to-severe traumatic brain injuries (TBIs).Methods: Retrospective database review of 67 individuals with moderate-to-severe TBI admitted to a specialised inpatient TBI program. Outcome measures are as follows: (1) functional independence measure + functional assessment measure (FIM+FAM; admission, discharge, change scores); (2) discharge designation (community vs. long-term care (LTC)).Results: There was a mean improvement on FIM+FAM of 54.19 points (SD=35.63) or 67% between admission and discharge (t(66)=-12.45, p<0.001). Mean time post-injury upon completion of therapy was 409.59days (SD=343.93). Upon completion of rehabilitation, 50 (75%) participants were discharged to community and 17 to LTC. Among those returning to community, those with longer length of stays were more severely disabled on admission (t(35.9)=-4.86, p<0.001). Controlling for admission functional status, individuals returning to community following >90days of therapy required a mean of 378.94days (SD=298.86) to achieve comparable gains to those less impaired who received shorter periods of rehabilitation (F(1)=0.530, p=0.47).Conclusion: Continued specialised inpatient services following acute inpatient rehabilitation for individuals with moderate-to-severe TBI can reduce the level of dependency and enhance the likelihood of return to community living.	[Rosenbaum, Amy M.; Joannou, Antigone; Berman, Brady A.] Pk Terrace Care Ctr, Traumat Brain Injury Rehabil Dept, Rego Pk, NY USA; [Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Sch Med, Dept Rehabil Med, New York, NY USA; [Berman, Brady A.] NYS Off Mental Hlth, Rockland Psychiat Ctr, Dept Psychol, Orangeburg, NY USA		Rosenbaum, AM (corresponding author), Pk Terrace Care Ctr, 59-20 Van Doren St, Rego Pk, NY 11368 USA.	ashapi1@hotmail.com					Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Benge JF, 2010, BRAIN INJURY, V24, P844, DOI 10.3109/02699051003724960; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cooney MT, 2016, CLIN MED, V16, P109, DOI 10.7861/clinmedicine.16-2-109; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eum RS, 2017, J HEAD TRAUMA REHAB, V32, P158, DOI 10.1097/HTR.0000000000000246; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Griesbach GS, 2015, J NEUROTRAUM, V32, P704, DOI 10.1089/neu.2014.3754; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Haskins E.C., 2012, COGNITIVE REHABILITA; Hayden ME, 2013, PM&R, V5, P319, DOI 10.1016/j.pmrj.2012.12.005; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P1305, DOI 10.1016/j.apmr.2012.04.030; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; Howrey BT, 2017, ARCH PHYS MED REHAB, V98, P1606, DOI 10.1016/j.apmr.2017.03.009; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; McLafferty FS, 2016, NEUROREHABILITATION, V39, P423, DOI 10.3233/NRE-161373; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010	30	6	7	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	7					907	914		10.1080/02699052.2018.1469040			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GH6GT	WOS:000433542900012	29738278				2022-02-06	
J	Sama, DM; Carlson, SW; Joseph, B; Saenger, S; Metzger, F; Saatman, KE				Sama, Diana M.; Carlson, Shaun W.; Joseph, Binoy; Saenger, Stefanie; Metzger, Friedrich; Saatman, Kathryn E.			Assessment of systemic administration of PEGylated IGF-1 in a mouse model of traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Contusion; doublecortin; hippocampus; insulin-like growth factor-1; neurogenesis; neuroprotection; PEGylation	GROWTH-FACTOR-I; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; CORTICAL IMPACT; IMPROVES; NEURONS; SURVIVAL; RATS; OVEREXPRESSION; DEFICIENCY	Background: Traumatic brain injury can result in lasting cognitive dysfunction due to degeneration of mature hippocampal neurons as well as the loss of immature neurons within the dentate gyrus. While endogenous neurogenesis affords a partial recovery of the immature neuron population, hippocampal neurogenesis may be enhanced through therapeutic intervention. Insulin-like growth factor-1 (IGF-1) has the potential to improve cognitive function and promote neurogenesis after TBI, but its short half-life in the systemic circulation makes it difficult to maintain a therapeutic concentration. IGF-1 modified with a polyethylene glycol moiety (PEG-IGF-1) exhibits improved stability and half-life while retaining its ability to enter the brain from the periphery, increasing its viability as a translational approach. Objective: The goal of this study was to evaluate the ability of systemic PEG-IGF-1 administration to attenuate acute neuronal loss and stimulate the recovery of hippocampal immature neurons in brain-injured mice. Methods: In a series of studies utilizing a well-established contusion brain injury model, PEG-IGF-1 was administered subcutaneously after injury. Serum levels of PEG were verified using ELISA and histological staining was used to investigate numbers of degenerating neurons and cortical contusion size at 24 h after injury. Immunofluorescent staining was used to evaluate numbers of immature neurons at 10 d after injury. Results: Although subcutaneous injections of PEG-IGF-1 increased serum IGF-1 levels in a dose-dependent manner, no effects were observed on cortical contusion size, neurodegeneration within the dentate gyrus, or recovery of hippocampal immature neuron numbers. Conclusions: In contrast to its efficacy in rodent models of neurodegenerative diseases, PEG- IGF-1 was not effective in ameliorating early neuronal loss after contusion brain trauma.	[Sama, Diana M.; Carlson, Shaun W.; Joseph, Binoy; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, 741 S Limestone St, Lexington, KY 40536 USA; [Carlson, Shaun W.] Univ Pittsburgh, Dept Neurol Surg, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Saenger, Stefanie; Metzger, Friedrich] Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev pRED, Grenzacherstr, Basel, Switzerland; [Metzger, Friedrich] Versameb AG, Peter Merian Str, Basel, Switzerland		Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, 741 S Limestone St, Lexington, KY 40536 USA.	k.saatman@uky.edu		Carlson, Shaun/0000-0002-1413-5075	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS072302, P30 NS051220, F32 NS083182]; Kentucky Spinal Cord and Head Injury Research Trust [14-12A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS051220, R01NS072302, F32NS083182] Funding Source: NIH RePORTER	Work was supported, in part, through NIH grants R01 NS072302, P30 NS051220, and F32 NS083182 and Kentucky Spinal Cord and Head Injury Research Trust grant 14-12A. We thank Jennifer Brelsfoard, Travis Stewart and Jelena Anna Juras for technical assistance.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Bake S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091427; Carlson SW, 2018, J NEUROTRAUM, V35, P1467, DOI 10.1089/neu.2017.5374; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Chen C, 2016, NEUROSCIENCE, V335, P114, DOI 10.1016/j.neuroscience.2016.08.038; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Dodge JC, 2008, MOL THER, V16, P1056, DOI 10.1038/mt.2008.60; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dyer AH, 2016, NEUROSCIENCE, V325, P89, DOI 10.1016/j.neuroscience.2016.03.056; El Ayadi A, 2016, EXP BRAIN RES, V234, P1863, DOI 10.1007/s00221-016-4572-1; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Hatton J, 1997, J NEUROSURG, V86, P779, DOI 10.3171/jns.1997.86.5.0779; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jablonka S, 2011, EXP NEUROL, V232, P261, DOI 10.1016/j.expneurol.2011.09.015; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kletzl H, 2017, GROWTH HORM IGF RES, V33, P9, DOI 10.1016/j.ghir.2017.01.001; Kreber LA, 2016, J NEUROTRAUM, V33, P1607, DOI 10.1089/neu.2015.4127; Krieger F, 2014, BRAIN, V137, P1374, DOI 10.1093/brain/awu059; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Martins KJB, 2013, GROWTH HORM IGF RES, V23, P128, DOI 10.1016/j.ghir.2013.03.002; Metzger F, 2011, J BIOL CHEM, V286, P19501, DOI 10.1074/jbc.M110.172189; Nagano I, 2005, J NEUROL SCI, V235, P61, DOI 10.1016/j.jns.2005.04.011; National Research Council, 2011, GUIDE CARE USE LAB A; Nieto-Estevez V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00052; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Parker K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00336-z; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Rizk NN, 2007, ENDOCRINE, V31, P66, DOI 10.1007/s12020-007-0012-0; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Saenger S, 2011, GROWTH HORM IGF RES, V21, P292, DOI 10.1016/j.ghir.2011.07.006; Saenger S, 2012, AMYOTROPH LATERAL SC, V13, P418, DOI 10.3109/17482968.2012.679944; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Schabitz WR, 2001, STROKE, V32, P1226, DOI 10.1161/01.STR.32.5.1226; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Scranton RA, 2015, J CLIN MED, V4, P1463, DOI 10.3390/jcm4071463; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; VACCARELLO MA, 1993, J CLIN ENDOCR METAB, V77, P273, DOI 10.1210/jc.77.1.273; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zhu W, 2008, STROKE, V39, P1254, DOI 10.1161/STROKEAHA.107.500801	57	6	6	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2018	36	4					559	569		10.3233/RNN-180831			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO0CI	WOS:000439587600009	29889090				2022-02-06	
J	Saunders, GH; Frederick, MT; Arnold, ML; Silverman, SC; Chisolm, TH; Myers, PJ				Saunders, Gabrielle H.; Frederick, Melissa T.; Arnold, Michelle L.; Silverman, ShienPei C.; Chisolm, Theresa H.; Myers, Paula J.			A Randomized Controlled Trial to Evaluate Approaches to Auditory Rehabilitation for Blast-Exposed Veterans with Normal or Near-Normal Hearing Who Report Hearing Problems in Difficult Listening Situations	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article						auditory processing disorder; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MINI-MENTAL STATE; TRAINING-PROGRAM; RECOGNITION PERFORMANCE; SPEECH-RECOGNITION; NOISE; BENEFITS; MEMORY; FM; ENHANCEMENT	Background: Blast exposure is a major source of injury among Service members in the Iraq and Afghanistan conflicts. Many of these blast-exposed veterans report hearing-related problems such as difficulties understanding speech in noise and rapid speech, and following instructions and long conversations that are disproportionate to their measured peripheral hearing sensitivity. Evidence is mounting that these complaints result from damage to the central auditory processing system. Purpose: To evaluate the effectiveness of audiological rehabilitative interventions for blast-exposed veterans with normal or near-normal peripheral hearing and functional hearing difficulties. Research Design: A randomized controlled trial with four intervention arms. Study Sample: Ninety-nine blast-exposed veterans with normal or near-normal peripheral hearing who reported functional hearing difficulties. Intervention: Four interventions were compared: compensatory communication strategies (CCS) education, CCS and use of a personal frequency modulation system (FM + CCS), CCS and use of an auditory training program (AT + CCS), and use of all three interventions combined (FM + AT + CCS). Data Collection and Analysis: All participants tested before, and immediately following an 8-week intervention period. The primary outcome measures upon which the study was powered assessed speech understanding in noise and self-reported psychosocial impacts of the intervention. In addition, auditory temporal processing, auditory working memory, allocation of attention, and hearing and cognitive self-report outcomes were assessed. Results: Use of FM + CCS resulted in significant benefit for speech understanding in noise and self-reported hearing benefits, and FM + AT + CCS provided more self-reported cognitive benefits than FM + CCS, AT + CCS, or CCS. Further, individuals liked and reported using the FM system, but there was poor adherence to and high attrition among individuals assigned to receive AT. Conclusions: It is concluded that a FM system (or remote microphone via Bluetooth system) is an effective intervention for blast-exposed veterans with normal or near-normal hearing and functional hearing difficulties and should be routinely considered as an intervention approach for this population when possible.	[Saunders, Gabrielle H.; Frederick, Melissa T.; Silverman, ShienPei C.] VA Portland Hlth Care Syst, Natl Ctr Rehabilitat Auditory Res, Portland, OR 97239 USA; [Saunders, Gabrielle H.] Oregon Hlth & Sci Univ, Dept Otolaryngol, Portland, OR 97201 USA; [Arnold, Michelle L.; Chisolm, Theresa H.] Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL USA; [Myers, Paula J.] James A Haley Vet Hosp, Tampa, FL 33612 USA		Saunders, GH (corresponding author), VA Portland Hlth Care Syst, Natl Ctr Rehabilitat Auditory Res, Portland, OR 97239 USA.	gabrielle.saunders@va.gov	Saunders, Gabrielle/V-2288-2019	Saunders, Gabrielle/0000-0002-9997-0845	VA Rehabilitation Research and Development grant [C7054R]	This study was funded by VA Rehabilitation Research and Development grant no. C7054R.	Abrams HB, 2015, AM J AUDIOL, V24, P333, DOI 10.1044/2015_AJA-15-0002; Agnew JA, 2004, BRAIN LANG, V88, P21, DOI 10.1016/S0093-934X(03)00157-3; American Speech-Language-Hearing Association (ASHA), 2005, GUID MAN PUR TON THR; Anderson KL, 2004, LANG SPEECH HEAR SER, V35, P169, DOI 10.1044/0161-1461(2004/017); Anderson S, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00097; [Anonymous], 1969, IEEE T ACOUST SPEECH, VAU17, P225; Atcherson Samuel R., 2015, Seminars in Hearing, V36, P150, DOI 10.1055/s-0035-1555118; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Bellis Teri James, 2015, Handb Clin Neurol, V129, P537, DOI 10.1016/B978-0-444-62630-1.00030-5; Bellis TJ, 2008, CONT ISSUES COMMUN S, V35, P143; Boothroyd A, 2004, EAR HEARING, V25, P22, DOI 10.1097/01.AUD.0000111260.46595.EC; Burk MH, 2008, J SPEECH LANG HEAR R, V51, P759, DOI 10.1044/1092-4388(2008/054); Burk MH, 2006, EAR HEARING, V27, P263, DOI 10.1097/01.aud.0000215980.21158.a2; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Chisolm Theresa Hnath, 2007, Trends Amplif, V11, P73, DOI 10.1177/1084713807300879; Couch JR, 2016, HEADACHE, V56, P1004, DOI 10.1111/head.12837; Day H., 1996, CAN J REHABIL, V9, P159; Department of Veterans Affairs. Quality Enhancement Research Initiative, 2014, POL BLAST REL INJ; Fabry D, 2007, HEAR J, V60, P32, DOI DOI 10.1097/01.HJ.0000299170.11367.24; Ferguson MA, 2014, EAR HEARING, V35, pE110, DOI 10.1097/AUD.0000000000000020; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; FREEDMAN R, 1987, SCHIZOPHRENIA BULL, V13, P669, DOI 10.1093/schbul/13.4.669; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gatehouse S, 2004, INT J AUDIOL, V43, P85, DOI 10.1080/14992020400050014; Golden C.J., 1978, MANUAL STROOP COLOR; Golden CJ., 2002, STROOP COLOR WORD TE; Grose JH, 2001, J ACOUST SOC AM, V109, P1587, DOI 10.1121/1.1354983; HaegerstromPortnoy G, 1997, INVEST OPHTH VIS SCI, V38, P207; Henshaw H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062836; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Jensen NS, 2009, NCRAR C EAR BRAIN SY; Jerger J, 1996, EAR HEARING, V17, P490, DOI 10.1097/00003446-199612000-00005; Johnston KN, 2009, INT J AUDIOL, V48, P371, DOI 10.1080/14992020802687516; Katz J., 1998, THE SSW TEST MANUAL; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Lewis M Samantha, 2004, J Am Acad Audiol, V15, P426, DOI 10.3766/jaaa.15.6.4; Lister Jennifer J, 2006, Am J Audiol, V15, P133, DOI 10.1044/1059-0889(2006/017); Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Miller James D, 2007, J Acoust Soc Am, V122, P3063; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peru A, 2003, NEUROPSYCHOLOGIA, V41, P634, DOI 10.1016/S0028-3932(02)00203-8; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHNIC; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rodemerk KS, 2015, J AM ACAD AUDIOL, V26, P724, DOI 10.3766/jaaa.15008; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Ronnberg N, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01490; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Saunders GH, 2016, EAR HEARING, V37, P381, DOI 10.1097/AUD.0000000000000283; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schafer Erin C, 2006, Am J Audiol, V15, P114, DOI 10.1044/1059-0889(2006/015); Schrank FA, 2007, WJ 3 COMPUSCORE PROF; Schulz KF, 2011, INT J SURG, V9, P672, DOI [10.7326/0003-4819-152-11-201006010-00232, 10.1016/j.ijsu.2011.09.004]; Sharma M, 2012, INT J AUDIOL, V51, P506, DOI 10.3109/14992027.2012.670272; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Spina L., 2006, COGNITIVE SELF REPOR; Stecker GC, 2006, J REHABIL RES DEV, V43, P537, DOI 10.1682/JRRD.2005.11.0171; Sticka C, 2011, INT J AUDIOL, V51, P754; Sweetow RW, 2006, J AM ACAD AUDIOL, V17, P538, DOI 10.3766/jaaa.17.8.2; Sweetow RW, 2010, J AM ACAD AUDIOL, V21, P586, DOI 10.3766/jaaa.21.9.4; Thibodeau L, 2010, AM J AUDIOL, V19, P36, DOI 10.1044/1059-0889(2010/09-0014); Tremblay KL, 2009, CLIN NEUROPHYSIOL, V120, P128, DOI 10.1016/j.clinph.2008.10.005; Vander Werff KR, 2012, PERSPECTIVES HEARING, V16, P3, DOI DOI 10.1044/HHD16.13; Vaughan N, 2006, J AM ACAD AUDIOL, V17, P506, DOI 10.3766/jaaa.17.7.6; Verfaellie M, 2016, J HEAD TRAUMA REHAB, V31, P309, DOI 10.1097/HTR.0000000000000197	70	6	6	0	9	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	1050-0545	2157-3107		J AM ACAD AUDIOL	J. Am. Acad. Audiol.	JAN	2018	29	1					44	62		10.3766/jaaa.16143			19	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	GA5KT	WOS:000428373300006	29309023				2022-02-06	
J	Schellinger, SK; Munson, B; Kennedy, MRT				Schellinger, Sarah K.; Munson, Benjamin; Kennedy, Mary R. T.			Public perceptions of traumatic brain injury: predictors of knowledge and the effects of education	BRAIN INJURY			English	Article						Public knowledge; public education; concussion; misconceptions	COMMON MISCONCEPTIONS; FAMILY-MEMBERS; CONCUSSION; REHABILITATION; PROFESSIONALS; STUDENTS; HOCKEY; MILD; TBI	Aim: Existing research suggests that the public demonstrates inadequate knowledge about traumatic brain injury (TBI), indicating a need for public education initiatives; however, limited research exists on the effectiveness of these initiatives. The purposes of this study were to (1) identify whether any demographic/personal variables (e.g. gender, age, experience with TBI) predicted TBI knowledge and (2) determine whether presenting an educational video to members of the general public would improve knowledge about TBI. Methods: Participants included 392 adults recruited from a state fair. Participants were divided into two groups, one of which viewed a 6-min video about TBI, and one which viewed an unrelated video. Participants completed measures relating to their backgrounds and knowledge about TBI. Results: Greater educational attainment and professional experience with TBI were predictive of better TBI knowledge (F(1, 336) = 13.76 and 6.92, respectively, p < 0.01); no other demographic or personal variables predicted knowledge. Participants who viewed the TBI video demonstrated significantly better knowledge than participants who did not (F(1, 336) = 52.41, p < 0.0001). Conclusion: These results indicate that public education can result in immediate gains in public knowledge about TBI. Further research should include randomized controlled trials to determine long-term effectiveness of public education campaigns.	[Schellinger, Sarah K.] St Xavier Univ, Commun Sci & Disorders, Chicago, IL 60655 USA; [Munson, Benjamin] Univ Minnesota Twin Cities, Speech Language Hearing Sci, Minneapolis, MN USA; [Kennedy, Mary R. T.] Chapman Univ, Commun Sci & Disorders, Orange, CA USA		Schellinger, SK (corresponding author), St Xavier Univ, Commun Sci & Disorders, Chicago, IL 60655 USA.	schellinger@sxu.edu		Munson, Benjamin/0000-0002-1547-6912	National Center for Advancing Translational Sciences of the National Institutes of Health through the Clinical and Translational Science Institute at the University of Minnesota [UL1TR000114]	This research was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114, awarded through the Clinical and Translational Science Institute at the University of Minnesota. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Coco K, 2011, J NEUROSCI NURS, V43, P337, DOI 10.1097/JNN.0b013e318234ea0b; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Faul M, 2010, TRAUMATIC BRAIN INJU; Garcia JM, 2014, HEALTH EDUC J, V73, P588, DOI 10.1177/0017896913510512; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Glang A, 2008, NEUROREHABILITATION, V23, P477; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lefebvre Helene, 2012, J Trauma Nurs, V19, P197, DOI 10.1097/JTN.0b013e318275990d; Lefebvre H, 2012, BRAIN INJURY, V26, P1084, DOI 10.3109/02699052.2012.666364; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Mavis I, 2013, BRAIN INJURY, V27, P587, DOI 10.3109/02699052.2013.772236; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; O'Jile JR., 1997, INT J REHABILITATION, V3, P61, DOI [10.1007/BF02766798, DOI 10.1007/BF02766798]; Pappadis MR, 2011, J HEAD TRAUMA REHAB, V26, P301, DOI 10.1097/HTR.0b013e3181e7832b; Pretorius C, 2013, SAJP-S AFR J PSYCHI, V19, P75, DOI 10.7196/SAJP.436; Ralph A, 2013, BRAIN INJURY, V27, P1475, DOI 10.3109/02699052.2013.823653; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Team RC, 2015, R FDN STAT COMP; VAUGHN SL, 1994, BRAIN INJURY, V8, P149, DOI 10.3109/02699059409150966; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P	33	6	6	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1377	1385		10.1080/02699052.2018.1492737			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000010	29985666				2022-02-06	
J	Skora, W; Stanczyk, R; Pajor, A; Jozefowicz-Korczynska, M				Skora, Wojciech; Stanczyk, Ramzes; Pajor, Anna; Jozefowicz-Korczynska, Magdalena			Vestibular system dysfunction in patients after mild traumatic brain injury	ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE			English	Article						vertigo; dizziness; mild traumatic brain injury; disequilibrium	HEAD-INJURY; DIZZINESS; BALANCE; DIAGNOSIS; EPIDEMIOLOGY; MANAGEMENT; DEFICITS; VERTIGO	Introduction. In the literature there are some discrepancies concerning the occurrence of vertigo and disequilibrium, as well as the type of vestibular dysfunction in patients after mild traumatic brain injury (MTBI). Objective. The aim of the study was to assess the type of vestibular system dysfunction in MTBI patients after injury at baseline and 6-month follow-up. Materials and method. From a group of 188 patients with vertigo/dizziness and balance instability after MTBI, prospective analysis in 50 patients with abnormal videonystagmography (VNG) were conducted. Anamnesis, otoneurological examination, self-assessed Dizziness Handicap Inventory (DHI) and VNG test were carried in each patient twice - at baseline and after 6 months. Results. A significant improvement in the DHI total score (9.8 points, p<0.001) and in the subscales was found after 6 months. At baseline, VNG test showed the peripheral vestibular system dysfunction in 19 cases (38%), central vestibular dysfunction in 20 patients (40%) and mixed vestibular dysfunction in 11 cases (44%). After 6 months, the VNG records normalization was observed in 19 patients (38%), an improvement was significantly more frequently related to peripheral disorders, compared to central ones (p<0.001). Conclusions. In patients after mild traumatic brain injury, about one-fourth of them had vestibular system dysfunction with the same frequency of peripheral, central and mixed lesions in videonystagmography. Subjective post-traumatic symptoms and vestibular system dysfunction in patients after MTBI decrease after 6-month follow-up. However, more than half of patients still have abnormal VNG results, which indicate dysfunction of the central vestibular system.	[Skora, Wojciech] S Rybicki Mem Reg Hosp Skierniewice, Otolaryngol Dept, Ul Rybickiego 1, PL-96100 Skierniewice, Poland; [Stanczyk, Ramzes; Pajor, Anna; Jozefowicz-Korczynska, Magdalena] Med Univ Lodz, Norbert Barlicki Mem Univ Hosp 1, Otolaryngol Dept, Balance Disorder Unit, Lodz, Poland		Skora, W (corresponding author), S Rybicki Mem Reg Hosp Skierniewice, Otolaryngol Dept, Ul Rybickiego 1, PL-96100 Skierniewice, Poland.	wojciech.skora@centrumlaryngologii.pl	Jozefowicz-Korczynska, Magdalena/R-4573-2019; Jozefowicz-Korczynska, Magdalena/S-9432-2016	Pajor, Anna/0000-0002-1740-4269; Jozefowicz-Korczynska, Magdalena/0000-0003-0066-1856	Medical University in Lodz, Poland [503/2-036-02/503-21-002]	The study received financial support from the Medical University in Lodz, Poland (Grant No. 503/2-036-02/503-21-002).	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2015, NEUROL CLIN, V33, P661, DOI 10.1016/j.ncl.2015.04.004; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jozefowicz-Korczynska M, ADV CLIN EXP MED; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Lei-Rivera L, 2013, NEUROREHABILITATION, V32, P463, DOI 10.3233/NRE-130869; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; Marzo SJ, 2004, LARYNGOSCOPE, V114, P1720, DOI 10.1097/00005537-200410000-00008; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Naguib MB, 2012, J LARYNGOL OTOL, V126, P26, DOI 10.1017/S002221511100291X; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Szczupak M, 2016, HAND CLINIC, V137, P295, DOI 10.1016/B978-0-444-63437-5.00021-2; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670	28	6	6	0	0	INST AGRICULTURAL MEDICINE	LUBLIN	JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND	1232-1966	1898-2263		ANN AGR ENV MED	Ann. Agr. Env. Med.		2018	25	4					665	668		10.26444/aaem/81138			4	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	HF4HG	WOS:000454193500017	30586971	gold, Green Submitted			2022-02-06	
S	Spadoni, AD; Huang, MX; Simmons, AN		Vermetten, E; Baker, DG; Risbrough, VB		Spadoni, Andrea D.; Huang, Mingxiong; Simmons, Alan N.			Emerging Approaches to Neurocircuits in PTSD and TBI: Imaging the Interplay of Neural and Emotional Trauma	BEHAVIORAL NEUROBIOLOGY OF PTSD	Current Topics in Behavioral Neurosciences		English	Article; Book Chapter						Diffusion tensor imaging (DTI); fMRI; Functional neuroimaging; Magnetic resonance imaging; Magnetoencephalography (MEG); Neuroimaging; Positron-emission tomography (PET); Posttraumatic stress disorder; PTSD; Traumatic brain injury (TBI)	POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER ABNORMALITIES; SURFACE-BASED ANALYSIS; DIFFUSE AXONAL INJURY; BRAIN-INJURY; HIPPOCAMPAL VOLUME; FUNCTIONAL CONNECTIVITY; DELTA WAVES; ANXIETY DISORDER; ENDURING FREEDOM	Posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) commonly co-occur in general and military populations and have a number of overlapping symptoms. While research suggests that TBI is risk factor for PTSD and that PTSD may mediate TBI-related outcomes, the mechanisms of these relationships are not well understood. Neuroimaging may help elucidate patterns of neurocircuitry both specific and common to PTSD and TBI and thus help define the nature of their interaction, refine diagnostic classification, and may potentially yield opportunities for targeted treatments. In this review, we provide a summary of some of the most common and the most innovative neuroimaging approaches used to characterize the neural circuits associated with PTSD, TBI, and their comorbidity. We summarize the state of the science for each disorder and describe the few studies that have explicitly attempted to characterize the neural substrates of their shared and dissociable influence. While some promising targets in the medial frontal lobes exist, there is not currently a comprehensive understanding of the neurocircuitry mediating the interaction of PTSD and TBI. Future studies should exploit innovative neuroimaging approaches and longitudinal designs to specifically target the neural mechanisms driving PTSD-TBI-related outcomes.	[Spadoni, Andrea D.; Simmons, Alan N.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Spadoni, Andrea D.; Simmons, Alan N.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Huang, Mingxiong] VA San Diego Healthcare Syst, Radiol & Res Serv, San Diego, CA USA; [Huang, Mingxiong] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA		Spadoni, AD (corresponding author), VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA.; Spadoni, AD (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	aspadoni@ucsd.edu; mxhuang@ucsd.edu; alan@ucsd.edu	Simmons, Alan N/A-9815-2008	Simmons, Alan N/0000-0003-3963-2112; Spadoni, Andrea/0000-0002-8367-6406	CSRD VA [IK2 CX000864] Funding Source: Medline		Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; ADAMS JH, 1982, INJURY, V13, P444, DOI 10.1016/0020-1383(82)90105-X; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Assemlal HE, 2007, IEEE IMAGE PROC, P1261; Badre D, 2012, CEREB CORTEX, V22, P527, DOI 10.1093/cercor/bhr117; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chen SN, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-3; COHEN D, 1968, SCIENCE, V161, P784, DOI 10.1126/science.161.3843.784; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Dickie EW, 2011, NEUROPSYCHOLOGIA, V49, P1771, DOI 10.1016/j.neuropsychologia.2011.02.055; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Dretsch Michael N, 2017, Open Neuroimag J, V11, P46, DOI 10.2174/1874440001711010046; Drevets WC, 1999, BIOL PSYCHIAT, V46, P1375, DOI 10.1016/S0006-3223(99)00189-4; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Elsinga PH, 2006, CURR MED CHEM, V13, P2139, DOI 10.2174/092986706777935258; Engdahl B, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066005; Molina ME, 2010, WORLD J BIOL PSYCHIA, V11, P493, DOI 10.3109/15622970701472094; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Felmingham K, 2010, J ABNORM PSYCHOL, V119, P241, DOI 10.1037/a0017551; Fonzo GA, 2010, BIOL PSYCHIAT, V68, P433, DOI 10.1016/j.biopsych.2010.04.028; FRASURESMITH N, 1995, HEALTH PSYCHOL, V14, P388, DOI 10.1037/0278-6133.14.5.388; Friston KJ, 2008, NEUROIMAGE, V41, P849, DOI 10.1016/j.neuroimage.2008.02.054; Friston KJ, 1996, CEREB CORTEX, V6, P156, DOI 10.1093/cercor/6.2.156; Friston KJ, 2003, NEUROIMAGE, V19, P1240, DOI 10.1016/S1053-8119(03)00144-7; Gean AD, 1994, IMAGING HEAD TRAUMA; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011; Gewirtz JC, 2000, BEHAV BRAIN RES, V110, P83, DOI 10.1016/S0166-4328(99)00187-4; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang CW, 2016, CLIN NEUROPHYSIOL, V127, P2308, DOI 10.1016/j.clinph.2016.02.007; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Huang MX, 2006, NEUROIMAGE, V31, P1025, DOI 10.1016/j.neuroimage.2006.01.029; Huettel S. A., 2004, FUNCTIONAL MAGNETIC; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kandel E.R., 2013, PRINCIPLES NEURAL SC, V5th; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kelmendi B, 2017, CLIN PSYCHOL-SCI PR, V24, P281, DOI 10.1111/cpsp.12202; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; King AP, 2009, NEUROIMAGE, V47, P872, DOI 10.1016/j.neuroimage.2009.05.088; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Kitayama N, 2007, J NERV MENT DIS, V195, P1027, DOI 10.1097/NMD.0b013e31815c044f; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lei D, 2015, RADIOLOGY, V276, P818, DOI 10.1148/radiol.15141700; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Li L, 2016, EBIOMEDICINE, V4, P176, DOI 10.1016/j.ebiom.2016.01.012; Li L, 2016, CHINESE MED J-PEKING, V129, P1091, DOI 10.4103/0366-6999.180518; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Liberzon I, 1999, BIOL PSYCHIAT, V45, P817, DOI 10.1016/S0006-3223(98)00246-7; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Linnman C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-8; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mohammadian M, 2017, NEUROIMAGE-CLIN, V13, P174, DOI 10.1016/j.nicl.2016.11.016; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Naumova AV, 2017, NEUROIMAGE, V147, P985, DOI 10.1016/j.neuroimage.2016.09.036; Nelson MD, 2017, CNS SPECTRUMS, V22, P363, DOI 10.1017/S1092852916000833; Newsome MR, 2016, J INT NEUROPSYCH SOC, V22, P790, DOI 10.1017/S135561771600062X; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Penny W, 2003, IEEE T MED IMAGING, V22, P504, DOI 10.1109/TMI.2003.809140; Peres JFP, 2011, J PSYCHIATR RES, V45, P727, DOI 10.1016/j.jpsychires.2010.11.004; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Portnow LH, 2013, NEUROLOGY, V80, P952, DOI 10.1212/WNL.0b013e318285c135; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Povlishock JT, 1989, MORPHOPATHOLOGICAL C; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shin YB, 2006, BRAIN INJURY, V20, P661, DOI 10.1080/02699050600677071; Simmons A, 2009, PSYCHOSOM MED, V71, P373, DOI 10.1097/PSY.0b013e3181a56ed8; Simmons AN, 2008, BIOL PSYCHIAT, V64, P681, DOI 10.1016/j.biopsych.2008.05.027; Simmons AN, 2013, PSYCHOTHER PSYCHOSOM, V82, P382, DOI 10.1159/000348867; Simmons AN, 2012, NEUROREPORT, V23, P234, DOI 10.1097/WNR.0b013e3283503275; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strigo IA, 2010, BIOL PSYCHIAT, V68, P442, DOI 10.1016/j.biopsych.2010.03.034; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Venkatesan, 1999, MAGNETIC RESONANCE I; Vermetten E, 2003, BIOL PSYCHIAT, V54, P693, DOI 10.1016/S0006-3223(03)00634-6; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Villarreal G, 2004, PSYCHIAT RES-NEUROIM, V131, P227, DOI 10.1016/j.pscychresns.2004.05.002; Wang EW, 2013, NEUROL RES, V35, P285, DOI 10.1179/1743132812Y.0000000138; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yarnykh VL, 2015, RADIOLOGY, V274, P210, DOI 10.1148/radiol.14140528; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049; Zhang L, 2012, ACTA NEUROPSYCHIATR, V24, P34, DOI 10.1111/j.1601-5215.2011.00580.x; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	156	6	7	2	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1866-3370		978-3-319-94824-9; 978-3-319-94823-2	CURR TOP BEHAV NEURO	Cur. Top. Behav. Neurosci.		2018	38						163	192		10.1007/7854_2017_35	10.1007/978-3-319-94824-9		30	Psychology, Biological; Behavioral Sciences; Neurosciences; Psychiatry	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Behavioral Sciences; Neurosciences & Neurology; Psychiatry	BN6WM	WOS:000486443500009	29285732				2022-02-06	
J	Swaine, B; Cullen, N; Messier, F; Bayley, M; Lavoie, A; Marshall, S; Sirois, MJ; Turgeon-Fournier, A; Lamoureux, J; Shun, PLW				Swaine, Bonnie; Cullen, Nora; Messier, Frederic; Bayley, Mark; Lavoie, Andre; Marshall, Shawn; Sirois, Marie-Josee; Turgeon-Fournier, Alexis; Lamoureux, Julie; Shun, Priscilla Lam Wai			Post-acute care referral and inpatient rehabilitation admission criteria for persons with brain injury across two Canadian provinces	DISABILITY AND REHABILITATION			English	Article						Health services accessibility; brain injuries; decision making; patient selection; neurological rehabilitation; Canada	PREDICTING DISCHARGE; LENGTH; STAY; SELECTION; MODERATE; OUTCOMES; PATIENT; PROGRAM; MODEL; TBI	Purpose: Investigate health care providers' perceptions of referral and admission criteria to brain injury inpatient rehabilitation in two Canadian provinces. Methods: Health care providers (n = 345) from brain injury programs (13 acute care and 16 rehabilitation facilities) participated in a cross-sectional web-based survey. The participants rated the likelihood of patients (traumatic brain injury and cerebral hypoxia) to be referred/admitted to rehabilitation and the influence of 19 additional factors (e.g., tracheostomy). The participants reported the perceived usefulness of referral/admission policies and assessment tools used. Results: Ninety-one percent acute care and 98% rehabilitation participants reported the person with traumatic brain injury would likely or very likely be referred/admitted to rehabilitation compared to respectively 43% and 53% for the patient with hypoxia. Two additional factors significantly decreased the likelihood of referral/admission: older age and the combined presence of minimal learning ability, memory impairment and physical aggression. Some significant inter-provincial variations in the perceived referral/admission procedure were observed. Most participants reported policies were helpful. Similar assessment tools were used in acute care and rehabilitation. Conclusions: Health care providers appear to consider various factors when making decisions regarding referral and admission to rehabilitation. Variations in the perceived likelihood of referral/admission suggest a need for standardized referral/admission practices.	[Swaine, Bonnie; Shun, Priscilla Lam Wai] Univ Montreal, Fac Med, Sch Rehabil, Montreal, PQ, Canada; [Swaine, Bonnie; Messier, Frederic; Shun, Priscilla Lam Wai] Ctr Interdisciplinary Res Rehabil Greater Montrea, Quebec City, PQ, Canada; [Cullen, Nora; Bayley, Mark; Lamoureux, Julie] Toronto Rehabil Inst, Toronto, ON, Canada; [Lavoie, Andre; Sirois, Marie-Josee; Turgeon-Fournier, Alexis] Univ Quebec, Ctr Hosp Affilie, Pavillon Enfant Jesus, Quebec City, PQ, Canada; [Marshall, Shawn] Ottawa Hosp, Rehabil Ctr, Ottawa, ON, Canada		Swaine, B (corresponding author), Univ Montreal, Sch Rehabil, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca		Cullen, Nora/0000-0001-6359-9418; Lam Wai Shun, Priscilla/0000-0001-5642-7490; Bayley, Mark/0000-0001-7860-9463; Sirois, Marie-josee/0000-0001-9775-6960	Ontario Neurotrauma Foundation; Quebec rehabilitation research network [2007-ONF-REPAR-519]	This work was supported by the Ontario Neurotrauma Foundation and the Quebec rehabilitation research network under Grant 2007-ONF-REPAR-519.	Agence de la Santeet Des Services Sociaux de Montreal, 2010, CADR REF SERV POSTH; Buntin MB, 2005, HEALTH SERV RES, V40, P413, DOI 10.1111/j.1475-6773.2005.0i366.x; Burton CR, 2015, DISABIL REHABIL, V37, P1955, DOI 10.3109/09638288.2014.991454; Cullen N, 2012, EVIDENCE BASED REV M; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Foster M, 2000, BRAIN INJURY, V14, P1035; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Foster M., 2004, BRAIN IMPAIR, V5, P3; Greater Toronto Area Rehab Network, 2009, INP REH REF GUID; HAAS JF, 1988, ARCH PHYS MED REHAB, V69, P329; Hoofien D, 2001, BRAIN INJURY, V15, P189; Institut national d'excellence en sante et en services sociaux (INESSS), 2016, GUID PRAT CLIN READ; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; Malec JF, 2009, BRAIN INJURY, V23, P22, DOI 10.1080/02699050802590320; New PW., 2009, TOREHJ, V2, P24, DOI [10.2174/1874943700902010024, DOI 10.2174/1874943700902010024]; Ontario Neurotrauma Foundation, 2011, EV BAS REV MOD SEV A; Rogers S, 2015, ARCH PHYS MED REHAB, V96, P276, DOI 10.1016/j.apmr.2014.09.018; Shun PLW, 2017, AUST OCCUP THER J, V64, P149, DOI 10.1111/1440-1630.12327; Sirois MJ, 2007, AM J PHYS MED REHAB, V86, P563, DOI 10.1097/PHM.0b013e31806e84d2; Statacorp, 2011, STAT STAT SOFTW REL; Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Willems Deborah, 2012, Healthc Policy, V7, pe105; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149	30	6	6	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	6					697	704		10.1080/09638288.2016.1262911			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FY5XL	WOS:000426911500012	27976928	Green Submitted			2022-02-06	
J	Tang, M; Li, X; Liu, P; Wang, JW; He, FP; Zhu, XC				Tang, Min; Li, Xia; Liu, Ping; Wang, Jianwen; He, Fangping; Zhu, Xiongchao			Bradykinin B2 Receptors Play a Neuroprotective Role in Hypoxia/reoxygenation Injury Related to Pyroptosis Pathway	CURRENT NEUROVASCULAR RESEARCH			English	Article						Bradykinin B2 receptor; hypoxia/reoxygenation; GSDMD; pyroptosis; ischemic stroke; inflammatory responses	KALLIKREIN-KININ SYSTEM; TRAUMATIC BRAIN-INJURY; CELL-DEATH; ISCHEMIC-STROKE; INHIBITING APOPTOSIS; CEREBRAL-ISCHEMIA; INFLAMMATION; MICE; PATHOPHYSIOLOGY; MECHANISMS	Background: Kinins are pro-inflammatory peptides that mediate numerous vascular and pain responses in tissue injury. Kinins exert their biological functions via two G-protein-coupled receptors: Bradykinin 1 Receptor (B1R) and Bradykinin 2 Receptor (B2R). We previously demonstrated the up-regulation of B2R after Hypoxia/Reoxygenation (H/R) injury in primary cultured cortical neurons. However, the role of B2R in inflammasome-induced pyroptosis remains unknown. Methods: We induced H/R neuronal injury in primary cultured cortical neurons harvested from embryonic day 17 brains. Next, we examined the neuroprotective function of B2R in H/R-induced neuronal apoptosis or necrosis using an annexin V FITC/Propidium Iodide (PI) double-staining technique. The pyroptosis signaling cascade, including caspase-1, IL-1 beta and IL-18 levels and Cleaved Gasdermin D (GSDMD) expression was examined by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) and western blotting to explore the underlying molecular mechanism. Results: H/R injury significantly increased B2R protein expression (P<0.05) as well as the percentage of early apoptotic and necrotic or late apoptotic neurons as verified by the annexin V FITC/PI flow cytometric analysis. Bradykinin (BK), a specific B2R agonist, caused a significant decrease in apoptotic neuronal death after H/R injury, while HOE140, a specific B2R antagonist, markedly reduced the neuroprotective effect of B2R. Following H/R injury, BK downregulated the caspase-1, IL-1 beta and IL-18 levels (P<0.01). In contrast, pretreatment with HOE140 significantly increased caspase-1, IL-113, and IL-18 levels (P<0.01). Further analysis revealed that GSDMD, a key executioner of pyroptosis, is a target for B2R-mediated inhibition of neuronal pyroptosis. Cleaved GSDMD expression was significantly inhibited by BK pretreatment and significantly enhanced by HOE140 pretreatment (P<0.01). Conclusion: These results indicate that activation of B2R plays an important role in pyroptosis mediated by H/R injury.	[Tang, Min; Li, Xia; Liu, Ping; Wang, Jianwen; He, Fangping; Zhu, Xiongchao] Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China		Tang, M (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	nowherett@zju.edu.cn			Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [Q14H090009]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81500904]	This work was funded by the Natural Science Foundation of Zhejiang Province (grant number Q14H090009) and National Natural Science Foundation of China (grant number 81500904).	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Bekbosynov A Zh, 2013, Angiol Sosud Khir, V19, P26; Benakis C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00461; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012; Cuartero MI, 2015, BRAIN RES, V1623, P53, DOI 10.1016/j.brainres.2015.04.047; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Hopp S, 2015, NEURAL REGEN RES, V10, P885, DOI 10.4103/1673-5374.158339; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kayashima Y, 2012, CURR OPIN NEPHROL HY, V21, P92, DOI 10.1097/MNH.0b013e32834d54b1; Kim JY, 2014, CURR MED CHEM, V21, P2076, DOI 10.2174/0929867321666131228205146; Langhauser F, 2012, BLOOD, V120, P4082, DOI 10.1182/blood-2012-06-440057; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Noda M, 2007, NEUROCHEM INT, V51, P185, DOI 10.1016/j.neuint.2007.06.017; Ponticelli C, 2009, J CLIN INVEST, V119, P768, DOI 10.1172/JCI38786; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; Sharma JN, 2013, INFLAMMOPHARMACOLOGY, V21, P1, DOI 10.1007/s10787-012-0137-5; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sridharan V, 2012, CANCER RES, V72, P4984, DOI 10.1158/0008-5472.CAN-12-1831; Viel TA, 2011, CURR ALZHEIMER RES, V8, P59; Wanderer AA, 2008, CLIN IMMUNOL, V128, P127, DOI 10.1016/j.clim.2008.03.514; Wang Z, 2014, J NEUROSCI RES, V92, P651, DOI 10.1002/jnr.23325; Xia CF, 2006, HUM GENE THER, V17, P206, DOI 10.1089/hum.2006.17.206; Xia CF, 2004, HYPERTENSION, V43, P452, DOI 10.1161/01.HYP.0000110905.29389.e5; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100	33	6	7	0	18	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.		2018	15	2					138	144		10.2174/1567202615666180528073141			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU0AH	WOS:000444909300007	29804533				2022-02-06	
J	Thastum, MM; Rask, CU; Naess-Schmidt, ET; Jensen, JS; Frederiksen, OV; Tuborgh, A; Svendsen, SW; Nielsen, JF; Schroder, A				Thastum, Mille Moeller; Rask, Charlotte Ulrikka; Naess-Schmidt, Erhard Trillingsgaard; Jensen, Jens Soendergaard; Frederiksen, Oana-Veronica; Tuborgh, Astrid; Svendsen, Susanne Wulff; Nielsen, Joergen Feldbaek; Schroder, Andreas			Design of an early intervention for persistent post-concussion symptoms in adolescents and young adults: A feasibility study	NEUROREHABILITATION			English	Article						Brain concussion; behavior therapy; early intervention; feasibility study; mild traumatic brain injury; post-concussion syndrome; rivermead post-concussion symptoms questionnaire	TRAUMATIC-BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; MILD HEAD-INJURY; POSTCONCUSSION SYNDROME; COLLABORATING-CENTER; TASK-FORCE; RISK-FACTORS; REST; QUESTIONNAIRE; RECOVERY	BACKGROUND: About 5-15 % of patients with concussion experience persistent post-concussion symptoms (PCS) longer than 3 months post-injury. OBJECTIVE: To explore the feasibility of a new intervention for young patients with persistent PCS and long-term changes after intervention. METHODS: Thirty-two consecutive patients (15-30 years) with persistent PCS 2-4 months post-injury were recruited from a cohort study or referred to a non-randomized feasibility study of an individually tailored, 8-week, multidisciplinary intervention. Assessment was performed at baseline, end of intervention (EOI), and at 3- and 12-month follow-up (FU). Main measures were The Experience of Service Questionnaire (ESQ), Rivermead Post-Concussion Symptoms Questionnaire (RPQ) and The Quality of Life after Brain Injury - Overall Scale (QOLIBRI-OS). RESULTS: Twenty-three (72%) patients completed the intervention. The ESQ demonstrated high patient satisfaction. There was a decrease of PCS and an increase in quality of life from baseline to EOI: RPQ score -8.9 points, 95% CI 4.5 to 13.3, p < 0.001; QOLIBRI-OS score +10.5 points, 95% CI 2.5 to 18.5, p = 0.010. Improvement was maintained at 3- and 12-month FU. CONCLUSION: The new early intervention is feasible and may prevent chronification of PCS. An RCT is currently performed to evaluate the effect of the intervention.	[Thastum, Mille Moeller; Rask, Charlotte Ulrikka; Jensen, Jens Soendergaard; Tuborgh, Astrid; Schroder, Andreas] Aarhus Univ Hosp, Res Clin Funct Disorders, Aarhus, Denmark; [Rask, Charlotte Ulrikka; Tuborgh, Astrid] Aarhus Univ Hosp, Child & Adolescent Psychiat Ctr, Risskov, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Frederiksen, Oana-Veronica; Svendsen, Susanne Wulff; Nielsen, Joergen Feldbaek] Aarhus Univ, Hammel Neurorehabil Ctr, Aarhus, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Frederiksen, Oana-Veronica; Svendsen, Susanne Wulff; Nielsen, Joergen Feldbaek] Aarhus Univ, Univ Res Clin, Aarhus, Denmark		Thastum, MM (corresponding author), Aarhus Univ Hosp, Res Clin Funct Disorders, Aarhus, Denmark.	miltha@rm.dk	Nass-Schmidt, Erhard T/E-8425-2019; Nass-Schmidt, Erhard/AAP-8212-2021; Nielsen, Jorgen Feldbak/AAR-6384-2021	Nass-Schmidt, Erhard T/0000-0002-2539-0362; Nass-Schmidt, Erhard/0000-0002-2539-0362; Nielsen, Jorgen Feldbak/0000-0001-5339-171X	Danish Foundation "Folkesundhed i Midten"	The Danish Foundation "Folkesundhed i Midten".	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Ambrosini PJ, 2000, J AM ACAD CHILD PSY, V39, P49, DOI 10.1097/00004583-200001000-00016; Barber Andrew J, 2006, J Child Health Care, V10, P9; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; Christensen KS, 2005, FAM PRACT, V22, P448, DOI 10.1093/fampra/cmi025; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Eastman A, 2015, NEUROREHABILITATION, V37, P235, DOI 10.3233/NRE-151256; Fink P, 2004, J PSYCHOSOM RES, V57, P17, DOI 10.1016/S0022-3999(03)00374-X; Hansen Z, 2010, PHYSIOTHERAPY, V96, P87, DOI 10.1016/j.physio.2009.09.008; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P., 2017, BRIT J SPORTS MED; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Pahl K. M., 2010, EVIDENCE BASED PSYCH; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Samwel HJA, 2007, INT J BEHAV MED, V14, P237, DOI 10.1007/BF03002998; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schroder A., 2014, SCI AM MED, V4, P1, DOI [10.2310/7900.1300, DOI 10.2310/7900.1300]; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Steinbeck K, 2009, INT J OBESITY, V33, P2, DOI 10.1038/ijo.2008.263; Sterling M, 2014, J PHYSIOTHER, V60, P5, DOI 10.1016/j.jphys.2013.12.004; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Winkler R, 2015, J HEAD TRAUMA REHAB, V30, P324, DOI 10.1097/HTR.0000000000000114	53	6	6	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	2					155	167		10.3233/NRE-172391			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS1MK	WOS:000443290000006	30040756				2022-02-06	
J	Thomas, A; Greenwald, BD				Thomas, Alphonsa; Greenwald, Brian D.			Nonpharmacological management of sleep disturbances after traumatic brain injury	NEUROREHABILITATION			English	Article						Sleep; traumatic brain injury; nonpharmacologic	RANDOMIZED CONTROLLED-TRIAL; THERAPY; INTERVENTIONS; MANIPULATION	BACKGROUND: Sleep plays an integral role in several physiologic functions such as cognition and functional ability. Sleep disturbances are common after brain injury and can interfere with rehabilitation and recovery. There are several pathways by which sleep is initiated, and thus various ways to target common complaints as well. OBJECTIVES: To review alternative and non-pharmacological treatment approaches to sleep disorders following TBI. METHODS: The authors present a review of the literature on various alternative treatment methods for treating sleep disorders, and discuss evidence for safety and efficacy. CONCLUSIONS: Typical management include conservative measures and pharmacologic treatment. This article provides a review of the available nonpharmacologic treatment options for sleep disorders in patients with traumatic brain injury. There are a number of non-pharmacological treatment methods available for treatment of sleep disorders in this population.	[Thomas, Alphonsa; Greenwald, Brian D.] JFK Med Ctr, Johnson Rehabil Inst, Edison, NJ USA		Greenwald, BD (corresponding author), JFK Med Ctr, Johnson Rehabil Inst, Ctr Brain Injuries, 65 James St, Edison, NJ 08820 USA.	Brian.Greenwald@hackensackmeridian.org					Babson KA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0775-9; Barshikar S, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0792-4; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Chiu HY, 2017, J NEUROSCI NURS, V49, P380, DOI 10.1097/JNN.0000000000000325; Cutler MJ, 2005, J ALTERN COMPLEM MED, V11, P103, DOI 10.1089/acm.2005.11.103; Elliott JE, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx212; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Fernandez-San-Martin MI, 2010, SLEEP MED, V11, P505, DOI 10.1016/j.sleep.2009.12.009; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Kingston J, 2010, J CHIROPR MED, V9, P121, DOI 10.1016/j.jcm.2010.03.003; Kirsch DL, 2013, PSYCHIAT CLIN N AM, V36, P169, DOI 10.1016/j.psc.2013.01.006; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Osier ND, 2017, NEUROSCI LETT, V650, P18, DOI 10.1016/j.neulet.2017.03.053; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Wetzler G, 2017, MED ACUPUNCT, V29, P239, DOI 10.1089/acu.2017.1222; Wu LM, 2018, J CLIN SLEEP MED, V14, P31, DOI 10.5664/jcsm.6874; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397; Zou Tao, 2016, Shanghai Arch Psychiatry, V28, P121, DOI 10.11919/j.issn.1002-0829.216060	25	6	6	1	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	43	3					355	360		10.3233/NRE-182535			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HA8FK	WOS:000450524200011	30347629				2022-02-06	
J	Unterhofer, C; Hartmann, S; Freyschlag, CF; Thome, C; Ortler, M				Unterhofer, Claudia; Hartmann, Sebastian; Freyschlag, Christian F.; Thome, Claudius; Ortler, Martin			Severe head injury in very old patients: to treat or not to treat? Results of an online questionnaire for neurosurgeons	NEUROSURGICAL REVIEW			English	Article						Acute subdural hematoma; End-of-life decision; Decision-making process	TRAUMATIC BRAIN-INJURY; ACUTE SUBDURAL-HEMATOMA; PROGNOSTIC MODELS; ELDERLY-PATIENTS; MORTALITY; MORBIDITY; COHORT; MULTICENTER; CRANIECTOMY; OUTCOMES	Due to the aging population, neurosurgeons are confronted with an increasing number of very old patients suffering from traumatic brain injury. Many of these patients present with an acute subdural hematoma. There is a lack of data on neurosurgical decision-making in elderly people. We investigated the importance of imaging criteria, patients' wishes, their surrogates' wishes, and patient demographics on treatment decisions chosen by neurosurgeons. An online questionnaire was sent to all German neurosurgical units via the German Society of Neurosurgery (DGNC). The survey was based on the reported case of an unconscious 81-year-old patient with an acute subdural hematoma and consisted of 13 questions. Of these questions, nine addressed indication and treatment plan and four evaluated the neurosurgeon's interest in gathering additional information on the patient's social environment and supposed patient's wishes or advance directive. Eighty-five percent of the interviewed neurosurgeons would perform an emergency operation in the presented case. Midline shift (84%), hematoma thickness (81%), and time between traumatic injury and treatment (81%) were considered to be the most important factors for surgical treatment. Gathering information on the social environment of the patient (66%) and discussion with family members (57%) were felt to be either unimportant. Neurosurgeons in Central Europe tend to treat acute subdural hematoma in very old patients based on imaging findings and according to mechanistic views. Social circumstances and patient wishes are considered to be less important. Education of the medical profession and the general public should aim to bring these factors into focus in the decision-making process.	[Unterhofer, Claudia; Hartmann, Sebastian; Freyschlag, Christian F.; Thome, Claudius; Ortler, Martin] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria		Unterhofer, C (corresponding author), Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria.	claudia.unterhofer@tirol-kliniken.at; sebastian.hartmann@i-med.ac.at; christian.freyschlag@i-med.ac.at; claudius.thome@tirol-kliniken.at; martin.ortler@i-med.ac.at	Freyschlag, Christian/K-5913-2019	Freyschlag, Christian/0000-0002-8228-8217			Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Burla C, 2014, MED HEALTH CARE PHIL, V17, P389, DOI 10.1007/s11019-014-9559-8; Carney N, 2016, NEUROSURGERY; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Heyland DK, 2015, INTENS CARE MED, V41, P1911, DOI 10.1007/s00134-015-4028-2; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lee L, 2016, J NEUROSURG, V124, P546, DOI 10.3171/2014.12.JNS142053; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721; Marcoux J, 2016, J NEUROSURG, V125, P642, DOI 10.3171/2015.6.JNS15175; Mulligan P, 2013, J NEUROSCI RURAL PRA, V4, P250, DOI 10.4103/0976-3147.118760; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pilitsis J, 2013, CLIN NEUROL NEUROSUR, V115, P1429, DOI 10.1016/j.clineuro.2013.01.017; Quill TE, 2012, NEW ENGL J MED, V366, P1653, DOI 10.1056/NEJMp1201535; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tsermoulas G, 2016, WORLD NEUROSURG, V88, P569, DOI 10.1016/j.wneu.2015.10.045; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	31	6	6	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	JAN	2018	41	1					183	187		10.1007/s10143-017-0833-0			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FR6HO	WOS:000419166400019	28220369				2022-02-06	
J	Waligora-Dupriet, AJ; Lafleur, S; Charrueau, C; Choisy, C; Cynober, L; Butel, MJ; Moinard, C				Waligora-Dupriet, Anne-Judith; Lafleur, Sophie; Charrueau, Christine; Choisy, Caroline; Cynober, Luc; Butel, Marie Jose; Moinard, Christophe			Head injury profoundly affects gut microbiota homeostasis: Results of a pilot study	NUTRITION			English	Article						Head trauma; Gut microbiota; Dysbiosis	TRAUMATIC BRAIN-INJURY; INFECTIOUS COMPLICATIONS; MODEL; THERAPY; RATS	Objectives: Head injury (HI) induces a hypercatabolic state, dysimmunity, and septic complications that increase morbidity and mortality. Although compromised immune function is usually incriminated in infection occurrence, gut dysbiosis could also be involved in this phenomenon and, to our knowledge, has never been considered. To assess if HI could affect microbiota, we explored the impact of HI on intestinal microbiota in a rodent model of fluid percussion. Methods: Nineteen rats were randomly assigned to two groups: Healthy rats fed ad libitum (n = 7) and HI rats (n = 12), which received standard enteral nutrition for 4 d. Four days after HI, rats were euthanized and cecal contents were sampled. Cecal microbiota was assessed using real-time quantitative polymerase chain reaction. Results: HI significantly decreased the cecal content of strict anaerobic groups, Bacteroides/Prevotella group (HI 8.9 versus healthy controls 9.3 median log(10) colony forming units [CFU]/g, P = 0.007), Clostridium cluster XIVab (HI 7.9 versus healthy controls 8.9 median log(10) CFU/g, P = 0.002), Lactobacillus/Leuconostoc group (HI 8.5 versus healthy controls 9.4 median logic, CFU/g, P = 0.044), and Bifidobacterium sp. (HI 3.0 versus healthy controls 8.2 median log(10) CFU/g, P < 0.001). In contrast, colonization by Escherichia coli was dramatically increased (HI 10.5 versus healthy controls 7.0 median log(10) CFU/g, P < 0.001). Conclusions: HI profoundly modified the gut microbiota homeostasis and thus could contribute to infection in head trauma patients. These preliminary results open a new field of research in the management of patients with HI. (C) 2017 Elsevier Inc. All rights reserved.	[Waligora-Dupriet, Anne-Judith; Lafleur, Sophie; Butel, Marie Jose] Univ Paris 05, Sorbonne Paris Cite, Fac Pharm Paris, Probiot,Antibiot,Ecosyst Intestinal EA4065, Paris, France; [Charrueau, Christine] Univ Paris 05, Sorbonne Paris Cite, Fac Pharm Paris, UTCBS,CNRS,UMR 8258,Inserm,U1022, Paris, France; [Choisy, Caroline; Cynober, Luc; Moinard, Christophe] Univ Paris 05, Sorbonne Paris Cite, Fac Pharm Paris, Lab Biol Nutr EA4466, Paris, France; [Cynober, Luc] Hop Cochin, Serv Biochim, Paris, France; [Cynober, Luc] Hop Hotel Dieu, AP HP, Paris, France		Waligora-Dupriet, AJ (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Pharm Paris, Probiot,Antibiot,Ecosyst Intestinal EA4065, Paris, France.	anne-judith.waligora@parisdescartes.fr	Cynober, Luc/ABB-2368-2020	Waligora-Dupriet, Anne-Judith/0000-0002-4885-5302	Nestle Health Science (Noisiel, France)	This study was supported in part by an unrestricted grant from Nestle Health Science (Noisiel, France).	Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Charrueau C, 2016, CLIN NUTR, V35, P1291, DOI 10.1016/j.clnu.2016.04.018; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Moinard C, 2012, J NEUROTRAUM, V29, P335, DOI 10.1089/neu.2011.1862; Neau E, 2016, APPL ENVIRON MICROB, V82, P1722, DOI 10.1128/AEM.03440-15; Shimizu Kentaro, 2015, Burns, V41, pe28, DOI 10.1016/j.burns.2014.10.019; Shimizu K, 2013, DIGEST DIS SCI, V58, P23, DOI 10.1007/s10620-012-2334-x; Sidler JA, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14009; Wischmeyer PE, 2016, CURR OPIN CRIT CARE, V22, P347, DOI 10.1097/MCC.0000000000000321	10	6	7	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JAN	2018	45						104	107		10.1016/j.nut.2017.06.026			4	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	FN7IY	WOS:000416193100016	29129229				2022-02-06	
J	Walker, WC; Hirsch, S; Carne, W; Nolen, T; Cifu, DX; Wilde, EA; Levin, HS; Brearly, TW; Eapen, BC; Williams, R				Walker, William C.; Hirsch, Shawn; Carne, William; Nolen, Tracy; Cifu, David X.; Wilde, Elisabeth A.; Levin, Harvey S.; Brearly, Timothy W.; Eapen, Blessen C.; Williams, Rick			Chronic Effects of Neurotrauma Consortium (CENC) multicentre study interim analysis: Differences between participants with positive versus negative mild TBI histories	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; veterans; military deployment; neuropsychological test; post-concussion syndrome; cohort study	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIVE SYMPTOMS; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; BLAST EXPOSURE; OEF/OIF VETERANS; IRAQI FREEDOM; POSTCONCUSSIVE SYMPTOMS; SERVICE MEMBERS; SELF-REPORT	Objectives: Compare characteristics and outcomes of combat-exposed military personnel with positive versus negative mild traumatic brain injury (mTBI) histories.Setting: Recruitment was from registration lists and ambulatory clinics at four veterans administration hospitals.Participants: Consented veterans and service members completing initial evaluation by September 2016 (n=492).Design: Observational with cross-sectional analyses.Main measures: Multimodal assessments including structured interviews, record review, questionnaires, neuroendocrine labs and neurocognitive and sensorimotor performance.Results: In unadjusted comparisons to those absent lifetime mTBI, the mTBI positive group (84%) had greater combat exposure, more potential concussive events, less social support and more comorbidities, including asthma, sleeping problems and post-traumatic stress disorder. They also fared worse on all sensory and pain symptom scores and self-reported functional and global outcomes. They had poorer scores on Wechsler Adult Intelligence Scale-IV coding (processing speed), TMT-B (visual-motor integration and executive function) and two posturography subtests, but were otherwise equal to TBI negative participants on neurocognitive and sensorimotor testing and neuroendocrine levels.Conclusions: Although differences in characteristics exist which were not adjusted for, participants with historical mTBI have greater symptomatology and life functioning difficulties compared with non-TBI. Performance measures were less dissimilar between groups. These findings will guide further research within this accruing cohort.	[Walker, William C.; Carne, William; Cifu, David X.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Walker, William C.; Carne, William; Cifu, David X.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [Hirsch, Shawn; Nolen, Tracy; Williams, Rick] RTI Int, RTP, Durham, NC USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Houston, TX 77030 USA; [Brearly, Timothy W.] Salisbury VA Med Ctr, Salisbury, NC USA; [Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Eapen, Blessen C.] UT Hlth San Antonio, Dept Rehabil Med, San Antonio, TX USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, MCV Stn, Box 677, Richmond, VA 23298 USA.	william.walker@vcuhealth.org	Brearly, Timothy/T-1739-2019	Brearly, Timothy/0000-0002-6320-0654; Hirsch, Shawn/0000-0001-6280-9559; Cifu, David/0000-0003-1600-9387; Nolen, Tracy/0000-0003-2512-343X	Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC)	This material is based upon work supported with resources and the use of facilities at: Hunter Holmes McGuire Veterans Affairs Medical Center (VAMC) in Richmond, VA; James A. Haley Veterans Hospital (VH), Tampa, FL; Michael E. DeBakey VAMC, Houston, TX; Audie L. Murphy Memorial VH, San Antonio, TX; and is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC).	Andrikopoulos J, 2014, JAMA NEUROL, V71, P654, DOI 10.1001/jamaneurol.2013.6408; [Anonymous], 2013, NATL RES ACTION PLAN; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brundage John F, 2015, MSMR, V22, P2; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; CEVETTE MJ, 1995, OTOLARYNG HEAD NECK, V112, P676, DOI 10.1016/S0194-5998(95)70175-3; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cripps A, 2013, J SPORT REHABIL, V22, P67, DOI 10.1123/jsr.22.1.67; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Llewellyn DJ, 2008, AM J PSYCHOL, V121, P363, DOI 10.2307/20445472; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Stratton KJ, 2014, J PAIN, V15, P1023, DOI 10.1016/j.jpain.2014.07.002; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Walker WC, 2013, J HEAD TRAUMA REHAB, V28, P68, DOI 10.1097/HTR.0b013e318255dfd0; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; West TA, 2014, J FAM PRACTICE, V63, P11; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079	56	6	6	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	9					1079	1089		10.1080/02699052.2018.1479041			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL0ZJ	WOS:000436823600003	29851515				2022-02-06	
J	Walker, WC; Nowak, KJ; Kenney, K; Franke, LM; Eapen, BC; Skop, K; Levin, H; Agyemang, AA; Tate, DF; Wilde, EA; Hinds, S; Nolen, TL				Walker, William C.; Nowak, Kayla J.; Kenney, Kimbra; Franke, Laura Manning; Eapen, Blessen C.; Skop, Karen; Levin, Harvey; Agyemang, Amma A.; Tate, David F.; Wilde, Elisabeth A.; Hinds, Sidney; Nolen, Tracy L.			Is balance performance reduced after mild traumatic brain injury?: Interim analysis from chronic effects of neurotrauma consortium (CENC) multi-centre study	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; balance; pain; veteran; military	POSTTRAUMATIC-STRESS-DISORDER; BACK-PAIN PATIENTS; SERVICE MEMBERS; POSTURAL STABILITY; IRAQI FREEDOM; AUDIT-C; INSTABILITY; CONCUSSION; SYMPTOMS; VALIDITY	Objectives: Determine if mild traumatic brain injury (mTBI) history is associated with balance disturbances.Setting: Chronic Effects of Neurotrauma Consortium (CENC) centres.Participants: The CENC multi-centre study enrols post-9/11 era Service Members and Veterans with combat exposure. This sample (n=322) consisted of enrolees completing initial evaluation by September 2016 at the three sites conducting computerized dynamic post-urography (CDP) testing.Design: Observational study with cross-sectional analyses using structural equation modelling.Main Measures: Comprehensive structured interviews were used to diagnose all lifetime mild traumatic brain injuries (mTBIs). The outcome, Sensory Organization Test (SOT), was measured on CDP dual-plate force platform. Other studied variables were measured by structured interviews, record review and questionnaires.Results: The overall positive/negative mTBI classification did not have a significant effect on the composite equilibrium score. However, the repetitive mTBI classification showed lower scores for participants with 3 mTBI versus 1-2 lifetime mTBIs. For repetitive mTBI, pain interference acted as a mediator for the indirect effect, and a direct effect was evident on some sensory condition equilibrium scores.Conclusion: These findings show that repeated mTBI, partially mediated by pain, may lead to later balance disturbances among military combatants. Further study of CDP outcomes within this accruing cohort is warranted.	[Walker, William C.; Franke, Laura Manning; Agyemang, Amma A.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980677, Richmond, VA 23298 USA; [Walker, William C.] Hunter Holmes McGuire VA Med Ctr, Dept Phys Med & Rehabil, Richmond, VA USA; [Nowak, Kayla J.; Nolen, Tracy L.] RTI Int, Clin Res Network Ctr, Res Triangle Pk, NC USA; [Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Eapen, Blessen C.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Skop, Karen] James A Haley Vet Hosp, Dept Phys Med & Rehabil Serv, Tampa, FL 33612 USA; [Levin, Harvey; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Dept Phys Med & Rehabil, Houston, TX USA; [Levin, Harvey; Wilde, Elisabeth A.] Baylor Coll Med, Houston, TX 77030 USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Wilde, Elisabeth A.] Univ Utah, Salt Lake City, UT USA; [Hinds, Sidney] US Army, Med Res & Mat Command, Ft Detrick, MD USA		Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980677, Richmond, VA 23298 USA.	william.walker@vcuhealth.org	Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920; Nolen, Tracy/0000-0003-2512-343X	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	This work was supported by grant funding from: Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135.	[Anonymous], 2012, DOD VA CODE PROPOSAL; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; BYL NN, 1991, SPINE, V16, P325, DOI 10.1097/00007632-199103000-00012; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CEVETTE MJ, 1995, OTOLARYNG HEAD NECK, V112, P676, DOI 10.1016/S0194-5998(95)70175-3; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chaudhry H, 2004, J REHABIL RES DEV, V41, P713, DOI 10.1682/JRRD.2003.09.0140; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cripps A, 2013, J SPORT REHABIL, V22, P67, DOI 10.1123/jsr.22.1.67; Cuesta-Vargas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096529; Duong TT, 2004, ARCH PHYS MED REHAB, V85, P1291, DOI 10.1016/j.apmr.2003.11.032; Ehsani F, 2017, J BACK MUSCULOSKELET, V30, P649, DOI 10.3233/BMR-150361; Fairchild AJ, 2009, PREV SCI, V10, P87, DOI 10.1007/s11121-008-0109-6; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Goto F, 2011, NEUROSCI LETT, V487, P204, DOI 10.1016/j.neulet.2010.10.023; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; MacKinnon DP., 2008, ERLBAUM, DOI [DOI 10.1007/978-1-4842-0043-8_5, DOI 10.4324/9780203809556]; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Mientjes MIV, 1999, CLIN BIOMECH, V14, P710, DOI 10.1016/S0268-0033(99)00025-X; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pickett TC, 2007, J REHABIL RES DEV, V44, P983, DOI 10.1682/JRRD.2007.01.0001; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Quek J, 2018, GAIT POSTURE, V60, P93, DOI 10.1016/j.gaitpost.2017.11.016; Rochelle KSH, 2006, J CHILD PSYCHOL PSYC, V47, P1159, DOI 10.1111/j.1469-7610.2006.01641.x; RUBIN AM, 1995, AM J OTOL, V16, P216; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Stijntjes M, 2015, GERONTOLOGY, V61, P124, DOI 10.1159/000364916; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Van Ryckeghem DML, 2018, CLIN PSYCHOL REV, V59, P16, DOI 10.1016/j.cpr.2017.10.008; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vitesnikova J, 2014, INJURY, V45, P1440, DOI 10.1016/j.injury.2014.01.004; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Wada M, 2001, NEUROSCI LETT, V302, P157, DOI 10.1016/S0304-3940(01)01662-7; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000251; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Walker WC, 2011, PM&R, V3, P6, DOI 10.1016/j.pmrj.2010.11.001; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Wechsler D., 2009, TEST PREMORBID FUNCT	58	6	6	3	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1156	1168		10.1080/02699052.2018.1483529			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200002	29894203				2022-02-06	
J	Wang, HC; Wang, BD; Chen, MS; Chen, H; Sun, CF; Shen, G; Zhang, JM				Wang, Hong-Cai; Wang, Bo-Ding; Chen, Mao-Song; Chen, Hai; Sun, Cheng-Feng; Shen, Gang; Zhang, Jian-Min			Neuroprotective effect of berberine against learning and memory deficits in diffuse axonal injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						berberine; traumatic brain injury; activating transcription factor 2; vascular endothelial growth factor; p38 mitogen-activated protein kinase	KAPPA-B PATHWAY; MODEL; VEGF; INFLAMMATION; INVOLVEMENT; EXPRESSION; P38MAPK; CELLS; MCP-1; NEURORECOVERY	The aim of the present study was to assess the neuroprotective effect of berberine against learning and memory deficits in diffuse axonal injury (DAI). DAI rats were orally gavaged with berberine at a dose of 200 mg/kg of body weight for 4 weeks. Behavioral tests were used to analyze the neuroprotective effect of berberine against DAI-induced learning and memory deficits. In the present study, treatment with berberine significantly protected against DAI-induced inhibition of learning and memory in rats. Notably, berberine significantly suppressed the levels of tumor necrosis factor, interleukin-1 beta and monocyte chemoattractant protein-1, as well as reduced the protein expression levels of nuclear factor-kappa B, Bcl-2-associated X protein and cytochrome c in DAI rats. In addition, berberine significantly suppressed the protein expression of p38 mitogen-activated protein kinase, activating transcription factor 2 and vascular endothelial growth factor in DAI rats. These results suggested that berberine exhibited a neuroprotective effect against learning and memory deficits in severe DAI through the suppression of inflammation, angiogenesis and apoptosis in a rat model.	[Wang, Hong-Cai; Wang, Bo-Ding; Zhang, Jian-Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Wang, Hong-Cai; Wang, Bo-Ding; Chen, Mao-Song; Chen, Hai; Sun, Cheng-Feng; Shen, Gang] Med Ctr Ningbo, Li Hui Li Hosp, Dept Neurosurg, Ningbo 315041, Zhejiang, Peoples R China		Zhang, JM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	zjm135zjm135@163.com			Ningbo Committee of Science and Technology [2011A610041, 2014C50089]; Ningbo Social Development Research Project [2013A05, 2014A03]	The current study was supported by the Ningbo Committee of Science and Technology (grant nos. 2011A610041 and 2014C50089) and the Ningbo Social Development Research Project (grant nos. 2013A05 and 2014A03).	Ahmed T, 2015, PHARMACOL REP, V67, P970, DOI 10.1016/j.pharep.2015.03.002; Berger S, 2012, EUR J CELL BIOL, V91, P640, DOI 10.1016/j.ejcb.2012.02.003; Chang AYW, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-96; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115694; Chen MH, 2015, METAB BRAIN DIS, V30, P137, DOI 10.1007/s11011-014-9580-x; Dai PF, 2015, EXP THER MED, V10, P869, DOI 10.3892/etm.2015.2585; Fei XJ, 2014, GENET MOL RES, V13, P10537, DOI 10.4238/2014.December.12.16; Guedes RP, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-122; Haskins M, 2016, NEUROSCI LETT, V610, P165, DOI 10.1016/j.neulet.2015.11.002; Hu YY, 2011, J ETHNOPHARMACOL, V137, P1462, DOI 10.1016/j.jep.2011.08.034; Jang SH, 2013, NEUROSCI LETT, V543, P47, DOI 10.1016/j.neulet.2013.02.058; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Kimura H, 2014, BIOCHEM BIOPH RES CO, V454, P320, DOI 10.1016/j.bbrc.2014.10.077; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Liu WH, 2009, MOL CELL BIOCHEM, V325, P99, DOI 10.1007/s11010-008-0024-y; Liu YF, 2014, CAN J NEUROL SCI, V41, P200, DOI 10.1017/S0317167100016589; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Moein P, 2013, BRAIN INJURY, V27, P1454, DOI 10.3109/02699052.2013.825009; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Pires ENS, 2014, BRAIN RES, V1557, P26, DOI 10.1016/j.brainres.2014.02.021; Su E, 2016, FRONT NEUROSCI; Suehiro E, 2011, NEUROL MED-CHIR, V51, P551, DOI 10.2176/nmc.51.551; Tovar-y-Romo LB, 2010, J NEUROCHEM, V115, P1090, DOI 10.1111/j.1471-4159.2010.06766.x; Tsang CM, 2015, BBA-MOL BASIS DIS, V1852, P541, DOI 10.1016/j.bbadis.2014.12.004; Vuletic S, 2016, J HEAD TRAUMA REHAB, V31, P147, DOI 10.1097/HTR.0000000000000221; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Xu D, 2015, INT J CLIN EXP MED, V8, P8641; Yosimichi G, 2001, EUR J BIOCHEM, V268, P6058, DOI 10.1046/j.0014-2956.2001.02553.x	30	6	7	2	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JAN	2018	15	1					1129	1135		10.3892/etm.2017.5496			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FV0WL	WOS:000424281600163	29399112	gold, Green Published			2022-02-06	
J	Weddell, RA; Wood, RL				Weddell, Rodger A.; Wood, Rodger Ll.			Perceived personality change after traumatic brain injury II: comparing participant and informant perspectives	BRAIN INJURY			English	Article						Emotion recognition; empathy; frontal lobe; executive functioning; depression	EXPRESSED EMOTION; ORBITOFRONTAL CORTEX; FOLLOW-UP; SELF; FAMILY; RELATIVES; RECOVERY; ANXIETY; LESIONS; DAMAGE	Objective: The objective of this paper was to correlate informant personality change (PC) judgements following moderate-severe traumatic brain injury with quantitative neurobehavioural measures and to contrast the neurobehavioural correlates of informant and participant judgements of PC.Participants: Informant-participant pairs were recruited from a medico-legal clinic passing effort tests (N=31) and a National Health Service clinic (N=40).Measures: Participants were assessed on Wechsler tests of general ability, tests of executive functioning (Zoo Map and Fluency) and emotional distress (Beck Depression Inventory-FastScreen, Hospital Anxiety and Depression Scale and State-Trait Anger Expression Inventory-II). Informants' expressed emotion towards participants was assessed with the family questionnaire. Both completed the DEX, the Frontal and Social Behavior Questionnaire and PC ratings.Results: The correlates of participant and informant ratings of participant PC partially overlapped. For example, participant self-reported PC was associated with self-reported dysexecutive symptoms and emotional distress. In contrast, informant report of participant PC was associated with lower perceived emotional recognition and empathy, informant report of dysexecutive symptoms and high informant expressed emotion.Conclusions: It is argued that whilst researchers aim to exhaustively quantify specific neurobehavioural changes and their clusters, partially overlapping subsets of these changes evoke the PC judgements of participants and informants. The clinical implications of this are briefly considered.	[Weddell, Rodger A.] Morriston Hosp, Neuropsychol Dept, Swansea, W Glam, Wales; [Weddell, Rodger A.; Wood, Rodger Ll.] Swansea Univ, Brain Injury Res Grp, Swansea, W Glam, Wales		Weddell, RA (corresponding author), Morriston Hosp, Neuropsychol Dept, Swansea, W Glam, Wales.; Weddell, RA (corresponding author), Swansea Univ, Brain Injury Res Grp, Swansea, W Glam, Wales.	r.a.weddell@swansea.ac.uk					Ambady N, 2002, J PERS SOC PSYCHOL, V83, P947, DOI 10.1037//0022-3514.83.4.947; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Barrash J, 2011, J CLIN EXP NEUROPSYC, V33, P833, DOI 10.1080/13803395.2011.561300; Barrowclough C, 2003, CLIN PSYCHOL REV, V23, P849, DOI 10.1016/S0272-7358(03)00075-8; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Bodley-Scott SEM, 2015, BRAIN IMPAIR, V16, P205, DOI 10.1017/BrImp.2015.22; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brown G.K., 2000, BECK DEPRESSION INVE; Burgess P, 1996, BEHAV ASSESSMENT DYS; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Corruble E, 2002, PSYCHIAT RES, V109, P17, DOI 10.1016/S0165-1781(01)00366-3; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; de Guise E, 2015, BRAIN INJURY, V29, P730, DOI 10.3109/02699052.2015.1004748; Delis DC., 2001, DELIS KAPLAN EXECUTI; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; FORGAS JP, 1987, J PERS SOC PSYCHOL, V53, P53, DOI 10.1037/0022-3514.53.1.53; FRANKLIN SB, 1995, J VEG SCI, V6, P99, DOI 10.2307/3236261; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gartstein MA, 2009, J APPL DEV PSYCHOL, V30, P149, DOI 10.1016/j.appdev.2008.12.001; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, pE14, DOI 10.1176/appi.neuropsych.23.2.E14; Green P., 2003, GREENS WORD MEMORY T; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hooley JM, 2000, APPL PREV PSYCHOL, V9, P135, DOI 10.1016/S0962-1849(05)80001-0; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Karsten J, 2012, J PSYCHIATR RES, V46, P644, DOI 10.1016/j.jpsychires.2012.01.024; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kurtz JE, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199806000-00002; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Lannoo E, 1997, J PSYCHOSOM RES, V43, P505, DOI 10.1016/S0022-3999(97)00152-9; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McCrae RR, 1998, J PERS, V66, P285, DOI 10.1111/1467-6494.00013; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Mezulis AH, 2004, PSYCHOL BULL, V130, P711, DOI 10.1037/0033-2909.130.5.711; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Reekie YL, 2008, P NATL ACAD SCI USA, V105, P9787, DOI 10.1073/pnas.0800417105; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Spielberger C. D., 1999, STATE TRAIT ANGER EX; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; van Honk J, 2001, ARCH GEN PSYCHIAT, V58, P973, DOI 10.1001/archpsyc.58.10.973-a; Vazire S, 2010, J PERS SOC PSYCHOL, V98, P281, DOI 10.1037/a0017908; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Weddell RA, 2016, BRAIN INJURY, V30, P1362, DOI 10.1080/02699052.2016.1195921; Wiedemann G, 2002, PSYCHIAT RES, V109, P265, DOI 10.1016/S0165-1781(02)00023-9; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Yeates G.N., 2013, NEURODISABILITY PSYC, V1, P151; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	70	6	6	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					442	452		10.1080/02699052.2018.1429657			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400007	29364001				2022-02-06	
J	Xu, HL; Liu, MD; Yuan, XH; Liu, CX				Xu, Hong-Liang; Liu, Meng-Dong; Yuan, Xiao-Hong; Liu, Chun-Xi			Suppression of cortical TRPM7 protein attenuates oxidative damage after traumatic brain injury via Akt/endothelial nitric oxide synthase pathway	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; TRPM7; Oxidative stress; Akt; eNOS	CHANNELS	Neuronal death after traumatic brain injury (TBI) is a complex process resulting from a combination of factors, many of which are still unknown. Transient receptor potential melastatin 7 (TRPM7) is a transient receptor potential channel that has been demonstrated to mediate ischemic and traumatic neuronal injury in vitro. In the present study, TRPM7 was suppressed in the rat cerebral cortex by intracortical injections of viral vectors bearing shRNA specific for TRPM7 to investigate its potential role in an in vivo TBI model. We found that TRPM7 suppression significantly reduced brain edema, brain contusion volume and motor functional deficits, which was sustained for at least 2 weeks after the insult. These protective effects were accompanied by inhibited apoptosis in injured cortex. Also, TRPM7 suppression attenuated lipid peroxidation, decreased the expression of protein carbonyl, and preserved the endogenous antioxidant enzyme activities. The results of western blot analysis showed that TRPM7 suppression markedly increased the phosphorylation of Ala and endothelial nitric oxide synthase (eNOS). In addition, blocking Akt/eNOS pathway activation by the specific inhibitor LY294002 (LY, 10 mu L, 10 mmol/L) or L-NIO (0.5 mg/kg) partially reversed the protective effects of TRPM7 suppression and its anti-oxidative activities. Taken together, these findings demonstrated that regional inhibition of TRPM7 in cerebral cortex exerts neuroprotective effects against TBI through activation of Akt/eNOS pathway. Thus, TRPM7 might represent a potential drug development target for the treatment of TBI. (C) 2017 Elsevier Ltd. All rights reserved.	[Xu, Hong-Liang; Yuan, Xiao-Hong; Liu, Chun-Xi] Zhejiang Canc Hosp, Dept Anesthesiol, 1 Banshan Dong Rd, Hangzhou 310022, Zhejiang, Peoples R China; [Liu, Meng-Dong] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shaanxi, Peoples R China		Liu, CX (corresponding author), Zhejiang Canc Hosp, Dept Anesthesiol, 1 Banshan Dong Rd, Hangzhou 310022, Zhejiang, Peoples R China.	zhechliuchunxi@126.com					Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts MM, 2005, NEUROSCIENTIST, V11, P116, DOI 10.1177/1073858404272966; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Bae CYJ, 2011, ACTA PHARMACOL SIN, V32, P725, DOI 10.1038/aps.2011.60; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Chen W, 2014, NEUROCHEM INT, V68, P28, DOI 10.1016/j.neuint.2014.01.015; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Coombes E, 2011, ANTIOXID REDOX SIGN, V14, P1815, DOI 10.1089/ars.2010.3549; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Endres M, 2004, TRENDS NEUROSCI, V27, P283, DOI 10.1016/j.tins.2004.03.009; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Huang LJ, 2014, INT J MOL SCI, V15, P11817, DOI 10.3390/ijms150711817; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kuras Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043859; Li W.T., 2015, NEUROCHEM INT; Liu HT, 2015, REV NEUROSCIENCE, V26, P105, DOI 10.1515/revneuro-2014-0041; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nunez-Villena F, 2011, ANTIOXID REDOX SIGN, V15, P2425, DOI 10.1089/ars.2010.3825; Peters M, 2012, J NEUROTRAUM, V29, P2831, DOI 10.1089/neu.2012.2575; Ridnour LA, 2004, BIOL CHEM, V385, P1, DOI 10.1515/BC.2004.001; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yu HL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033584, 10.1371/journal.pone.0051239]; Zhang E, 2015, J NEUROSCI RES, V93, P1165, DOI 10.1002/jnr.23529; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	36	6	7	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2018	112						197	205		10.1016/j.neuint.2017.07.010			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FU1ZZ	WOS:000423649300020	28736242				2022-02-06	
J	Yuksen, C; Sittichanbuncha, Y; Patumanond, J; Muengtaweepongsa, S; Sawanyawisuth, K				Yuksen, Chaiyaporn; Sittichanbuncha, Yuwares; Patumanond, Jayanton; Muengtaweepongsa, Sombat; Sawanyawisuth, Kittisak			Clinical predictive score of intracranial hemorrhage in mild traumatic brain injury	THERAPEUTICS AND CLINICAL RISK MANAGEMENT			English	Article						predictive model; CT brain; risk score	NEW-ORLEANS CRITERIA; CT HEAD RULE; EXTERNAL VALIDATION; COMPUTED-TOMOGRAPHY; PERFORMANCE	Background: Mild traumatic brain injury (TBI) is a common condition at the Emergency Medicine Department. Head computer tomography (CT) scans in mild TBI patients must be properly justified in order to avoid unnecessary exposure to X-rays and to reduce the hospital/transfer costs. This study aimed to evaluate which clinical factors are associated with intracranial hemorrhage in Asian population and to develop a user-friendly predictive model. Methods: The study was conducted retrospectively at the Emergency Medicine Department in Ramathibodi Hospital, a university-affiliated super tertiary care hospital in Bangkok, Thailand. The study period was between September 2013 and August 2016. The inclusion criteria were age >15 years and having received a head CT scan after presenting with mild TBI. Those patients with mild TBI and no symptoms/deterioration after 24 h of clinical observation were excluded. The predictive model and prediction score for intracranial hemorrhage was developed by multivariate logistic regression analysis. Results: During the study period, there were 708 patients who met the study criteria. Of those, 100 patients (14.12%) had positive head CT scan results. There were seven independent factors that were predictive of intracranial hemorrhage. The clinical risk scores to predict intracranial hemorrhage are developed with an accuracy of 92%. The score of >3 had the likelihood of intracranial hemorrhage by 1.47 times. Conclusion: Clinical predictive score of >3 was associated with intracranial hemorrhage in mild TBI.	[Yuksen, Chaiyaporn; Sittichanbuncha, Yuwares] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Emergency Med, Rama 6 Rd, Bangkok 10400, Thailand; [Patumanond, Jayanton] Thammasat Univ, Fac Med, Clin Epidemiol Unit, Pathum Thani, Thailand; [Patumanond, Jayanton] Thammasat Univ, Fac Med, Clin Res Ctr, Pathum Thani, Thailand; [Muengtaweepongsa, Sombat] Thammasat Univ, Fac Med, Dept Med, Pathum Thani, Thailand; [Sawanyawisuth, Kittisak] Khon Kaen Univ, Fac Med, Dept Med, Khon Kaen, Thailand; [Sawanyawisuth, Kittisak] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, BNOJPH, Sleep Apnea Res Grp, Khon Kaen, Thailand; [Sawanyawisuth, Kittisak] Khon Kaen Univ, Res & Training Ctr Enhancing Qual Life Working Ag, Khon Kaen, Thailand		Sittichanbuncha, Y (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Emergency Med, Rama 6 Rd, Bangkok 10400, Thailand.	yuwares.sit@mahidol.ac.th	Muengtaweepongsa, Sombat/C-1402-2010	Muengtaweepongsa, Sombat/0000-0003-3715-4428; Yuksen, Chaiyaporn/0000-0002-4890-7176	Thailand Research Fund (TRF)Thailand Research Fund (TRF) [IRG 5780016]; TRF Senior Research Scholar Grant from the Thailand Research Fund (TRF) [RTA5880001]; Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Thailand, through the Health Cluster (SHeP-GMS), Khon Kaen University; Faculty of Medicine, Khon Kaen University, Thailand [RG59301]	The study was funded by the Thailand Research Fund (TRF) (IRG 5780016), the TRF Senior Research Scholar Grant from the Thailand Research Fund (TRF grant number RTA5880001), the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission, Thailand, through the Health Cluster (SHeP-GMS), Khon Kaen University, and the grant from Faculty of Medicine, Khon Kaen University, Thailand (Grant Number RG59301).	Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	15	6	6	0	7	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-203X			THER CLIN RISK MANAG	Therap. Clin. Risk Manag.		2018	14						213	218		10.2147/TCRM.S147079			6	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	FV0WH	WOS:000424281100001	29440905	Green Published, Green Submitted, gold			2022-02-06	
J	Zheng, MX; Hua, XY; Jiang, S; Qiu, YQ; Shen, YD; Xu, WD				Zheng, Mou-Xiong; Hua, Xu-Yun; Jiang, Su; Qiu, Yan-Qun; Shen, Yun-Dong; Xu, Wen-Dong			Contralateral peripheral neurotization for a hemiplegic hindlimb after central neurological injury	JOURNAL OF NEUROSURGERY			English	Article						central neurologic injury; contralateral L-6 neurotization; hemiplegia; hindlimb	NERVE ROOT TRANSFER; LUMBOSACRAL PLEXUS; CEREBRAL-PALSY; RHESUS-MONKEYS; AVULSION; STROKE; REHABILITATION; RHIZOTOMY; EXTREMITY	OBJECTIVE Contralateral peripheral neurotization surgery has been successfully applied to rescue motor function of the hemiplegic upper extremity in patients with central neurological injury (CNI). It may contribute to strengthened neural pathways between the contralesional cortex and paretic limbs. However, the effect of this surgery in the lower extremities remains unknown. In the present study the authors explored the effectiveness and safety of contralateral peripheral neurotization in treating a hemiplegic lower extremity following CNI in adult rats. METHODS Controlled cortical impact (CCI) was performed on the hindlimb motor cortex of 36 adult Sprague-Dawley rats to create severe unilateral traumatic brain injury models. These CCI rats were randomly divided into 3 groups. At 1 month post-CCI, the experimental group (Group 1, 12 rats) underwent contralateral L-6 to L-6 transfer, 1 control group (Group 2, 12 rats) underwent bilateral L-6 nerve transection, and another control group (Group 3, 12 rats) underwent an L-6 laminectomy without injuring the L-6 nerves. Bilateral L-6 nerve transection rats without CCI (Group 4, 12 rats) and naive rats (Group 5, 12 rats) were used as 2 additional control groups. Beam and ladder rung walking tests and CatWalk gait analysis were performed in each rat at baseline and at 0.5, 1, 2, 4, 6, 8, and 10 months to detect the skilled walking functions and gait parameters of both hindlimbs. Histological and electromyography studies were used at the final followup to verify establishment of the traumatic brain injury model and regeneration of the L6-L6 neural pathway. RESULTS In behavioral tests, comparable motor injury in the paretic hindlimbs was observed after CCI in Groups 1-3. Group 1 started to show significantly lower slip and error rates in the beam and ladder rung walking tests than Groups 2 and 3 at 6 months post-CCI (p < 0.05). In the CatWalk analysis, Group 1 also showed a higher mean intensity and swing speed after 8 months post-CCI and a longer stride length after 6 months post-CCI than Groups 2 and 3 (p < 0.05). Transection of L-6 resulted in transient skilled walking impairment in the intact hindlimbs in Groups 1 and 2 (compared with Group 3) and in the bilateral hindlimbs in Group 4 (compared with Group 5). All recovered to baseline level within 2 months. Histological study of the rat brains verified comparable injured volumes among Groups 1-3 at final examinations, and electromyography and toluidine blue staining indicated successful regeneration of the L6-L6 neural pathways in Group 1. CONCLUSIONS Contralateral L-6 neurotization could be a promising and safe surgical approach for improving motor recovery of the hemiplegic hindlimb after unilateral CNI in adult rats. Further investigations are needed before extrapolating the present conclusions to humans. https://thejns.org/doi/abs/10.3171/2016.4.JNS152046	[Zheng, Mou-Xiong; Hua, Xu-Yun; Jiang, Su; Shen, Yun-Dong; Xu, Wen-Dong] Jingan Dist Ctr Hosp, Dept Hand & Upper Extrem Surg, 259 Xikang Rd, Shanghai 200040, Peoples R China; [Zheng, Mou-Xiong; Hua, Xu-Yun; Jiang, Su; Qiu, Yan-Qun; Shen, Yun-Dong; Xu, Wen-Dong] Jingan Dist Ctr Hosp, Dept Cent Lab, Shanghai, Peoples R China; [Zheng, Mou-Xiong; Hua, Xu-Yun; Jiang, Su; Qiu, Yan-Qun; Shen, Yun-Dong; Xu, Wen-Dong] Huashan Hosp, Dept Hand Surg, Shanghai, Peoples R China; [Xu, Wen-Dong] Fudan Univ, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Zheng, Mou-Xiong; Hua, Xu-Yun; Jiang, Su; Shen, Yun-Dong; Xu, Wen-Dong] Minist Hlth, Key Lab Hand Reconstruct, Shanghai, Peoples R China; [Zheng, Mou-Xiong; Hua, Xu-Yun; Jiang, Su; Shen, Yun-Dong; Xu, Wen-Dong] Shanghai Key Lab Peripheral Nerve & Microsurg, Shanghai, Peoples R China		Xu, WD (corresponding author), Jingan Dist Ctr Hosp, Dept Hand & Upper Extrem Surg, 259 Xikang Rd, Shanghai 200040, Peoples R China.	wendongxu@fudan.edu.cn			Shanghai Training Plan and Fund for Young Doctors [20141062]; National High Technology Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2015AA020501]	This work was supported by the Shanghai Training Plan and Fund for Young Doctors (20141062) and the National High Technology Research and Development Program of China (863 Program; Grant No. 2015AA020501).	Bozkurt A, 2008, J NEUROSCI METH, V173, P91, DOI 10.1016/j.jneumeth.2008.05.020; Bunata R, 2014, J HAND SURG-AM, V39, P1425, DOI 10.1016/j.jhsa.2013.12.017; Dobkin BH, 2005, NEW ENGL J MED, V352, P1677, DOI 10.1056/NEJMcp043511; Fukuhara T, 2004, NEUROSURGERY, V54, P1268, DOI 10.1227/01.NEU.0000119605.32216.2E; Grunt S, 2014, DEV MED CHILD NEUROL, V56, P302, DOI 10.1111/dmcn.12277; GU YD, 1992, J HAND SURG-BRIT EUR, V17B, P518, DOI 10.1016/S0266-7681(05)80235-9; Hua XY, 2015, NEUROSURGERY, V76, P187, DOI 10.1227/NEU.0000000000000590; JANJUA MZ, 1984, BRAIN RES, V310, P311, DOI 10.1016/0006-8993(84)90154-9; Legg L, 2004, LANCET, V363, P352; Li YC, 2014, INJURY, V45, P1015, DOI 10.1016/j.injury.2014.01.014; Lin HD, 2013, J NEUROSURG, V119, P714, DOI 10.3171/2013.5.JNS121218; Lin HD, 2013, MUSCLE NERVE, V47, P241, DOI 10.1002/mus.23507; Lin HD, 2012, NEUROSURGERY, V70, P170, DOI 10.1227/NEU.0b013e31822c4b39; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Metz Gerlinde A, 2009, J Vis Exp, DOI 10.3791/1204; Parkkinen S, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/410972; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Songcharoen P, 2001, J HAND SURG-AM, V26A, P1058, DOI 10.1053/jhsu.2001.27764; Xu WD, 2011, MICROSURG, V31, P404, DOI 10.1002/micr.20877; Zhu L, 2015, BONE JOINT J, V97B, P358, DOI 10.1302/0301-620X.97B3.34330	21	6	7	0	11	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2018	128	1					304	311		10.3171/2016.4.JNS152046			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FR3AW	WOS:000418939300037	28338437				2022-02-06	
J	Nickell, CRG; Peng, H; Hayes, DM; Chen, KY; McClain, JA; Nixon, K				Nickell, Chelsea R. Geil; Peng, Hui; Hayes, Dayna M.; Chen, Kevin Y.; McClain, Justin A.; Nixon, Kimberly			Type 2 Neural Progenitor Cell Activation Drives Reactive Neurogenesis after Binge-Like Alcohol Exposure in Adolescent Male Rats	FRONTIERS IN PSYCHIATRY			English	Article						neurogenesis; neural stem cell; ethanol; adolescence; alcohol use disorders	ADULT HIPPOCAMPAL NEUROGENESIS; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; TRANSIENT GLOBAL-ISCHEMIA; DENTATE GYRUS; ETHANOL EXPOSURE; USE DISORDERS; PSYCHIATRIC COMORBIDITY; ENHANCED NEUROGENESIS; EPIDEMIOLOGIC SURVEY	Excessive alcohol consumption during adolescence remains a significant health concern as alcohol drinking during adolescence increases the likelihood of an alcohol use disorder in adulthood by fourfold. Binge drinking in adolescence is a particular problem as binge-pattern consumption is the biggest predictor of neurodegeneration from alcohol and adolescents are particularly susceptible to the damaging effects of alcohol. The adolescent hippocampus, in particular, is highly susceptible to alcohol-induced structural and functional effects, including volume and neuron loss. However, hippocampal structure and function may recover with abstinence and, like in adults, a reactive burst in hippocampal neurogenesis in abstinence may contribute to that recovery. As the mechanism of this reactive neurogenesis is not known, the current study investigated potential mechanisms of reactive neurogenesis in binge alcohol exposure in adolescent, male rats. In a screen for cell cycle perturbation, a dramatic increase in the number of cells in all phases of the cycle was observed at 7 days following binge ethanol exposure as compared to controls. However, the proportion of cells in each phase was not different between ethanol-exposed rats and controls, indicating that cell cycle dynamics are not responsible for the reactive burst in neurogenesis. Instead, the marked increase in hippocampal proliferation was shown to be due to a twofold increase in proliferating progenitor cells, specifically an increase in cells colabeled with the progenitor cell marker Sox2 and S-phase (proliferation) marker, BrdU, in ethanol-exposed rats. To further characterize the individual subtypes of neural progenitor cells (NPCs) affected by adolescent binge ethanol exposure, a fluorescent quadruple labeling technique was utilized to differentiate type 1, 2a, 2b, and 3 progenitor cells simultaneously. At one week into abstinence, animals in the ethanol exposure groups had an increase in proliferating type 2 (intermediate progenitors) and type 3 (neuroblast) progenitors but not type 1 neural stem cells. These results together suggest that activation of type 2 NPCs out of quiescence is likely the primary mechanism for reactive hippocampal neurogenesis following adolescent alcohol exposure.	[Nickell, Chelsea R. Geil; Peng, Hui; Hayes, Dayna M.; Chen, Kevin Y.; McClain, Justin A.; Nixon, Kimberly] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40506 USA; [Hayes, Dayna M.] Radford Univ, Dept Psychol, Radford, VA 24142 USA; [McClain, Justin A.] Gwynedd Mercy Univ, Sch Arts & Sci, Div Nat & Computat Sci, Gwynedd Valley, PA USA		Nixon, K (corresponding author), Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY 40506 USA.	kim-nixon@uky.edu	Nixon, Kimberly/Y-9270-2019	Nixon, Kimberly/0000-0002-3466-9912; Chen, Kevin/0000-0002-8134-3376	National Institutes of Health grantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AA016959, R21AA016307, T32DA016176, F31AA023459, R03NS089433, R21AA025563]; University of Kentucky Department of Pharmaceutical Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS089433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA016307, F31AA023459, R21AA025563, R01AA016959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA016176] Funding Source: NIH RePORTER	The authors thank M. Ayumi Deeny for excellent technical assistance and gratefully acknowledge National Institutes of Health grants R01AA016959 (KN), R21AA016307 (KN), T32DA016176 (CGN), F31AA023459 (CGN), R03NS089433 (HP), and R21AA025563 (KN/HP) as well as the University of Kentucky Department of Pharmaceutical Sciences for support of the work described herein.	Ahmadi A, 2013, NEUROPSYCHOPHARMACOL, V38, P2197, DOI 10.1038/npp.2013.119; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Caldwell LC, 2005, ALCOHOL ALCOHOLISM, V40, P194, DOI 10.1093/alcalc/agh134; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Cameron HA, 2015, ANNU REV PSYCHOL, V66, P53, DOI 10.1146/annurev-psych-010814-015006; Campbell JC, 2014, EXP BRAIN RES, V232, P2775, DOI 10.1007/s00221-014-3958-1; Chae JH, 2004, MOL CELLS, V18, P271; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Clark DB, 2008, ALCOHOL CLIN EXP RES, V32, P375, DOI 10.1111/j.1530-0277.2007.00601.x; Clark Duncan B, 2002, Paediatr Drugs, V4, P493, DOI 10.2165/00148581-200204080-00002; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Collins MA, 1996, ALCOHOL CLIN EXP RES, V20, P284, DOI 10.1111/j.1530-0277.1996.tb01641.x; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews FT, 2006, NEUROSCIENCE, V137, P437, DOI 10.1016/j.neuroscience.2005.08.090; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Crews FT, 2009, ALCOHOL ALCOHOLISM, V44, P115, DOI 10.1093/alcalc/agn079; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Diaz F, 2013, J NEUROSCI, V33, P6278, DOI 10.1523/JNEUROSCI.5885-12.2013; Doremus TL, 2005, ALCOHOL CLIN EXP RES, V29, P1796, DOI 10.1097/01.alc.0000183007.65998.aa; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Geil CR, 2014, PROG NEURO-PSYCHOPH, V54, P103, DOI 10.1016/j.pnpbp.2014.05.003; GERDES J, 1984, J IMMUNOL, V133, P1710; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Golub HM, 2015, ALCOHOL CLIN EXP RES, V39, P1967, DOI 10.1111/acer.12843; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Gulley JM, 2013, NEUROSCIENCE, V249, P3, DOI 10.1016/j.neuroscience.2013.05.026; Hansson AC, 2010, INT J NEUROPSYCHOPH, V13, P583, DOI 10.1017/S1461145710000246; Harford TC, 2005, ALCOHOL CLIN EXP RES, V29, P810, DOI 10.1097/01.ALC.0000164381.67723.76; Hargreaves GA, 2009, ALCOHOL CLIN EXP RES, V33, P86, DOI 10.1111/j.1530-0277.2008.00814.x; He J, 2005, EUR J NEUROSCI, V21, P2711, DOI 10.1111/j.1460-9568.2005.04120.x; He J, 2009, ALCOHOL CLIN EXP RES, V33, P129, DOI 10.1111/j.1530-0277.2008.00823.x; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; HUNT WA, 1993, ALCOHOL, V10, P559, DOI 10.1016/0741-8329(93)90083-Z; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jacobus J, 2013, ANNU REV CLIN PSYCHO, V9, P703, DOI 10.1146/annurev-clinpsy-050212-185610; Jhaveri DJ, 2012, DEV NEUROBIOL, V72, P1044, DOI 10.1002/dneu.22027; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Kelso ML, 2011, NEUROSCIENCE, V197, P381, DOI 10.1016/j.neuroscience.2011.09.019; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kunze A, 2006, NEUROBIOL DIS, V21, P324, DOI 10.1016/j.nbd.2005.07.013; Leasure JL, 2010, ALCOHOL CLIN EXP RES, V34, P404, DOI 10.1111/j.1530-0277.2009.01105.x; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li Q, 2006, ALCOHOL CLIN EXP RES, V30, P119, DOI 10.1111/j.1530-0277.2006.00006.x; Liu JL, 1998, J NEUROSCI, V18, P7768; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mandyam CD, 2012, TRENDS NEUROSCI, V35, P250, DOI 10.1016/j.tins.2011.12.005; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1097/00000374-199804000-00018; McClain JA, 2014, ADDICT BIOL, V19, P687, DOI 10.1111/adb.12075; McClain JA, 2011, J COMP NEUROL, V519, P2697, DOI 10.1002/cne.22647; Medina KL, 2007, NEUROTOXICOL TERATOL, V29, P141, DOI 10.1016/j.ntt.2006.10.010; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Mhatre MC, 2001, PHARMACOL BIOCHEM BE, V68, P339, DOI 10.1016/S0091-3057(00)00481-0; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Morris SA, 2010, ALCOHOL, V44, P89, DOI 10.1016/j.alcohol.2009.10.017; Morris SA, 2010, HIPPOCAMPUS, V20, P596, DOI 10.1002/hipo.20665; Nagel BJ, 2005, PSYCHIAT RES-NEUROIM, V139, P181, DOI 10.1016/j.pscychresns.2005.05.008; National Institute on Alcohol Abuse and Alcoholism (NIAAA), 2017, DRINK LEV DEF; National Research Council, 2011, GUIDE CARE USE LAB A; Nixon K, 2006, HIPPOCAMPUS, V16, P287, DOI 10.1002/hipo.20162; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Nixon K, 2010, CURR OPIN PSYCHIATR, V23, P227, DOI 10.1097/YCO.0b013e32833864fe; Noori HR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00140; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Packard D S Jr, 1973, Differentiation, V1, P397, DOI 10.1111/j.1432-0436.1973.tb00137.x; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, EPILEPSY RES, V50, P179, DOI 10.1016/S0920-1211(02)00078-5; Pawlak R, 2002, NEUROSCI LETT, V327, P83, DOI 10.1016/S0304-3940(02)00369-5; Penland S, 2001, ALCOHOL, V24, P45, DOI 10.1016/S0741-8329(01)00142-2; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Richardson HN, 2009, NEUROBIOL DIS, V36, P1, DOI 10.1016/j.nbd.2009.05.021; Risher ML, 2015, ALCOHOL CLIN EXP RES, V39, P989, DOI 10.1111/acer.12725; Risher ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062940; Rohde P, 1996, J AM ACAD CHILD PSY, V35, P101, DOI 10.1097/00004583-199601000-00018; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schoenfeld TJ, 2017, BIOL PSYCHIAT, V82, P914, DOI 10.1016/j.biopsych.2017.05.013; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schulenberg JE., 2017, MONITORING FUTURE NA; Schweinsburg AD, 2010, ALCOHOL, V44, P111, DOI 10.1016/j.alcohol.2009.09.032; Segi-Nishida E, 2008, P NATL ACAD SCI USA, V105, P11352, DOI 10.1073/pnas.0710858105; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Silveri MM, 2016, NEUROSCI BIOBEHAV R, V70, P244, DOI 10.1016/j.neubiorev.2016.06.042; Somkuwar SS, 2016, BRAIN STRUCT FUNCT, V221, P4319, DOI 10.1007/s00429-015-1163-z; Spanos M, 2012, BEHAV BRAIN RES, V230, P158, DOI 10.1016/j.bbr.2012.02.010; Spear LP, 2014, NEUROTOXICOL TERATOL, V41, P51, DOI 10.1016/j.ntt.2013.11.006; Spear LP, 2011, CHILD DEV PERSPECT, V5, P231, DOI 10.1111/j.1750-8606.2011.00182.x; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Stephens DN, 2005, BIOL PSYCHIAT, V58, P392, DOI 10.1016/j.biopsych.2005.04.025; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Taffe MA, 2010, P NATL ACAD SCI USA, V107, P11104, DOI 10.1073/pnas.0912810107; Tapia-Rojas C, 2018, MOL NEUROBIOL, V55, P4473, DOI 10.1007/s12035-017-0613-4; van Hoof JJ, 2011, J ADOLESCENT HEALTH, V48, P212, DOI 10.1016/j.jadohealth.2010.06.001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; White Aaron M, 2005, Recent Dev Alcohol, V17, P161, DOI 10.1007/0-306-48626-1_8; White AM, 2004, ANN NY ACAD SCI, V1021, P206, DOI 10.1196/annals.1308.026; World Health Organization, 2008, HIGHL CHILD AD HLTH; Yttri EA, 2004, ALCOHOL CLIN EXP RES, V28, P1433, DOI 10.1097/01.alc.0000147657.51745.a7; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Yun S, 2016, NAT MED, V22, P1239, DOI 10.1038/nm.4218; Zeigler DW, 2005, PREV MED, V40, P23, DOI 10.1016/j.ypmed.2004.04.044; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	128	6	6	0	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	DEC 15	2017	8								283	10.3389/fpsyt.2017.00283			14	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FQ0JQ	WOS:000418042200001	29326611	Green Published, gold			2022-02-06	
J	Albanese, BJ; Macatee, RJ; Schmidt, NB; Leeson, B; Clemans, TA; Mintz, J; Rudd, MD; Bryan, CJ				Albanese, Brian J.; Macatee, Richard J.; Schmidt, Norman B.; Leeson, Bruce; Clemans, Tracy A.; Mintz, Jim; Rudd, M. David; Bryan, Craig J.			Interactive Effects of Traumatic Brain Injury and Anxiety Sensitivity Cognitive Concerns on Post-traumatic Stress Among Active Duty Soldiers	COGNITIVE THERAPY AND RESEARCH			English	Article						Post-traumatic Stress Disorder; Anxiety sensitivity; Traumatic brain injury; Active duty soldiers	PSYCHOMETRIC PROPERTIES; DISTRESS TOLERANCE; CLINICAL-SAMPLE; PTSD CHECKLIST; SUICIDE RISK; SYMPTOMS; INTERVENTION; VETERANS; DISORDER; GENDER	Traumatic brain injury (TBI) history has been repeatedly linked with heightened risk for post-traumatic stress (PTS) among active duty soldiers. Yet, no research to date has examined the relationship between TBI and PTS in the context of anxiety sensitivity cognitive concerns (ASCC), a well-established cognitive-affective risk factor for PTS that may intensify the effects of TBI on PTS via the amplification of TBI-related symptoms of cognitive dyscontrol. The present study tested the moderating effects of ASCC on the relationship between the number of lifetime probable TBIs and PTS among a sample of 89 trauma-exposed active duty soldiers. Results demonstrated that high ASCC potentiated the relationship between number of probable TBIs and PTS while low ASCC muted this association. Interestingly, ASCC was more closely related to PTS among those with a greater number of probable TBIs compared to those with zero past TBIs. These results underscore the importance of ASCC in the association of TBI and PTS.	[Albanese, Brian J.; Macatee, Richard J.; Schmidt, Norman B.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Leeson, Bruce] US Army MEDDAC, Ft Carson, CO USA; [Clemans, Tracy A.; Rudd, M. David; Bryan, Craig J.] Univ Utah, Natl Ctr Vet Studies, 260 S Cent Campus Dr,Room 205, Salt Lake City, UT 84112 USA; [Clemans, Tracy A.; Bryan, Craig J.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Mintz, Jim] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Rudd, M. David] Univ Memphis, Presidents Off, Memphis, TN 38152 USA		Bryan, CJ (corresponding author), Univ Utah, Natl Ctr Vet Studies, 260 S Cent Campus Dr,Room 205, Salt Lake City, UT 84112 USA.; Bryan, CJ (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	craig.bryan@utah.edu	Rudd, M. David/AAF-1359-2019; Schmidt, Norman B/C-6426-2015	Schmidt, Norman B/0000-0003-4125-9601; Clemans, Tracy/0000-0001-5994-1508	Military Suicide Research Consortium (MSRC) - Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0181]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH093311] Funding Source: NIH RePORTER	This work was in part supported by the Military Suicide Research Consortium (MSRC), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-10-2-0181. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the MSRC or the Department of Defense.	Albanese BJ, 2018, PSYCHIATRY, V81, P71, DOI 10.1080/00332747.2017.1309867; Albanese BJ, 2017, PSYCHIAT RES, V252, P242, DOI 10.1016/j.psychres.2017.01.099; Allan NP, 2015, COGN BEHAV THERAPY, V44, P512, DOI 10.1080/16506073.2015.1075227; Allan NP, 2015, PERS INDIV DIFFER, V74, P78, DOI 10.1016/j.paid.2014.10.003; APA, 2013, DSM, V5; Asmundson Gordon J. G., 2008, Cognitive Behaviour Therapy, V37, P66, DOI 10.1080/16506070801969005; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Bardeen JR, 2015, J PSYCHOPATHOL BEHAV, P1; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Beck A. T., 1996, BECK DEPRESSION INVE, P78204; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boffa JW, 2016, BEHAV THER, V47, P367, DOI 10.1016/j.beth.2016.02.006; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Capron DW, 2013, BEHAV THER, V44, P349, DOI 10.1016/j.beth.2012.12.002; Chavarria J, 2015, J STUD ALCOHOL DRUGS, V76, P957, DOI 10.15288/jsad.2015.76.957; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Fergus TA, 2012, PERS INDIV DIFFER, V53, P213, DOI 10.1016/j.paid.2012.03.017; First M., 2015, STRUCTURED CLIN INTE; Gadermann AM, 2012, DEPRESS ANXIETY, V29, P797, DOI 10.1002/da.21924; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jones CR, 2012, SOC PSYCHOL PERS SCI, V3, P556, DOI 10.1177/1948550611430166; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kessler RC, 2002, NEUROPSYCHOPHARMACOL, V67, P982; Lang AJ, 2002, DEPRESS ANXIETY, V16, P77, DOI 10.1002/da.10062; Leyro TM, 2010, PSYCHOL BULL, V136, P576, DOI 10.1037/a0019712; Macatee RJ, 2015, J BEHAV THER EXP PSY, V48, P33, DOI 10.1016/j.jbtep.2015.01.007; Norr AM, 2016, PERS INDIV DIFFER, V90, P210, DOI 10.1016/j.paid.2015.11.014; Norr AM, 2015, J PSYCHIATR RES, V62, P101, DOI 10.1016/j.jpsychires.2015.01.014; Olatunji BO, 2015, J ANXIETY DISORD, V34, P76, DOI 10.1016/j.janxdis.2015.06.002; Olatunji BO, 2009, PSYCHOL BULL, V135, P974, DOI 10.1037/a0017428; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Reiss S., 1985, THEORETICAL ISSUES B, P107; Richey JA, 2012, BEHAV THER, V43, P285, DOI 10.1016/j.beth.2011.06.004; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schmidt NB, 2014, J CONSULT CLIN PSYCH, V82, P1023, DOI 10.1037/a0036651; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; TAYLOR S, 2003, J COGN PSYCHOTHER, V17, P179, DOI DOI 10.1891/088983903780906147; Taylor S, 2007, PSYCHOL ASSESSMENT, V19, P176, DOI 10.1037/1040-3590.19.2.176; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vujanovic Anka A., 2008, Cognitive Behaviour Therapy, V37, P76, DOI 10.1080/16506070801969039; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Weathers F., 2013, CLIN ADM PTSD DSM 5	51	6	6	1	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0147-5916	1573-2819		COGNITIVE THER RES	Cogn. Ther. Res.	DEC	2017	41	6					902	910		10.1007/s10608-017-9863-8			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	FK7LH	WOS:000413687200008	30220753	Green Accepted			2022-02-06	
J	Balasundaram, AP; Athens, J; Schneiders, AG; McCrory, P; Sullivan, SJ				Balasundaram, A. P.; Athens, J.; Schneiders, A. G.; McCrory, P.; Sullivan, S. J.			Do post-concussion-like symptom responses change following exercise or sports participation in a non-concussed cohort?	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						real-world context; reliable change index; return-to-play; rugby union; sport-related concussion; training	BETA-ENDORPHIN; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; PHYSICAL-ACTIVITY; SEX-DIFFERENCES; HIGH-SCHOOL; ZURICH; GENDER; LEVEL	The purposes of this study were (a) to determine the reliable change in post-concussion-like symptoms reported following self-selected exercise or sports activities and (b) to explore the potential influence of gender and exercise parameters on post-concussion-like symptoms reported by a non-concussed cohort following exercise/training. A pre-to-post observational design was used. A convenience sample of students aged 18-30years who visited a university recreation center to engage in their chosen exercise activity and a purposeful sample of men's and women's rugby union players engaged in their regular training sessions were included in the study. All participants reported their symptoms using the symptom scale of the Sport Concussion Assessment Tool 2. The reliable change index was used to determine the change in symptom scores reported from pre-to post-exercise/training. Multiple linear regression analysis was used to model the exercise variables to explain the impact on the reporting of symptoms. A total of 260 participants (146 males and 114 females) completed their self-selected exercise activity or rugby union training. Approximately two-thirds of all participants did not demonstrate a change (increase or decrease) in total symptom score (201/260, 77.9%) and/or symptom severity score (212/260, 81.9%) from pre-to post-exercise/training. The symptom response following exercise or sports training did not change in the majority of participants. Clinicians need to be aware of these findings to make informed decisions on return-to-play following a concussive brain injury.	[Balasundaram, A. P.] Univ Oslo, Inst Hlth & Soc, Dept Hlth Sci, N-0373 Oslo, Norway; [Balasundaram, A. P.; Sullivan, S. J.] Univ Otago, Sch Physiotherapy, Ctr Hlth Act & Rehabil Res, Dunedin, New Zealand; [Athens, J.] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; [Schneiders, A. G.] Cent Queensland Univ, Sch Human Hlth & Social Sci, Branyan, Australia; [McCrory, P.] Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia		Balasundaram, AP (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Hlth Sci, N-0373 Oslo, Norway.	a.p.balasundaram@medisin.uio.no	McCrory, Paul/Q-8688-2019; Balasundaram, Arun Prasad/D-1270-2017	Balasundaram, Arun Prasad/0000-0001-8256-857X; McCrory, Paul/0000-0003-4850-0568			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; Borg G., 1998, BORGS PERCEIVED EXER; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; CURRIE JL, 2010, INT J SPORTS SOC, V1, P203; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Fox KR, 1999, PUBLIC HEALTH NUTR, V2, P411, DOI 10.1017/S1368980099000567; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Goldfarb AH, 1998, MED SCI SPORT EXER, V30, P1672, DOI 10.1097/00005768-199812000-00003; HARBER VJ, 1984, SPORTS MED, V1, P154, DOI 10.2165/00007256-198401020-00004; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; KRAEMER RR, 1989, EUR J APPL PHYSIOL O, V58, P845, DOI 10.1007/BF02332217; Leclerc S., 2002, Medicine & Science in Sports & Exercise, V34, pS103, DOI 10.1097/00005768-200205001-00573; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mrazik M, 2013, J ATHL TRAINING, V48, P654, DOI 10.4085/1062-6050-48.3.19; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Pennebaker JW, 2000, SCIENCE OF SELF-REPORT, P299; PIERCE EF, 1994, BRIT J SPORT MED, V28, P164, DOI 10.1136/bjsm.28.3.164; Rocheleau CA, 2004, PSYCHOL HEALTH, V19, P491, DOI 10.1080/08870440310001613509; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; THOREN P, 1990, MED SCI SPORT EXER, V22, P417; VALOVICH M, 2012, AM J SPORTS MED, V40, P927; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; Yeung RR, 1996, J PSYCHOSOM RES, V40, P123, DOI 10.1016/0022-3999(95)00554-4	33	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2017	27	12					2002	2008		10.1111/sms.12844			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FO0DA	WOS:000416411800050	28107556	Green Published			2022-02-06	
J	Banihashemi, L; Wallace, ML; Sheu, LK; Lee, MC; Gianaros, PJ; Mackenzie, RP; Insana, SP; Germain, A; Herringa, RJ				Banihashemi, Layla; Wallace, Meredith L.; Sheu, Lei K.; Lee, Michael C.; Gianaros, Peter J.; Mackenzie, Robert P.; Insana, Salvatore P.; Germain, Anne; Herringa, Ryan J.			Childhood maltreatment moderates the effect of combat exposure on cingulum structural integrity	DEVELOPMENT AND PSYCHOPATHOLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TENSOR IMAGING TRACTOGRAPHY; ADMINISTERED PTSD SCALE; TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; STRIA TERMINALIS; ADRENOCORTICAL RESPONSES; MINDFULNESS MEDITATION; HIPPOCAMPAL VOLUME; IRAQ RANDOMIZATION	Limbic white matter pathways link emotion, cognition, and behavior and are potentially malleable to the influences of traumatic events throughout development. However, the impact of interactions between childhood and later life trauma on limbic white matter pathways has yet to be examined. Here, we examined whether childhood maltreatment moderated the effect of combat exposure on diffusion tensor imaging measures within a sample of military veterans (N = 28). We examined five limbic tracts of interest: two components of the cingulum (cingulum, cingulate gyrus, and cingulum hippocampus [CGH]), the uncinate fasciculus, the fornix/stria terminalis, and the anterior limb of the internal capsule. Using effect sizes, clinically meaningful moderator effects were found only within the CGH. Greater combat exposure was associated with decreased CGH fractional anisotropy (overall structural integrity) and increased CGH radial diffusivity (perpendicular water diffusivity) among individuals with more severe childhood maltreatment. Our findings provide preliminary evidence of the moderating effect of childhood maltreatment on the relationship between combat exposure and CGH structural integrity. These differences in CGH structural integrity could have maladaptive implications for emotion and memory, as well as provide a potential mechanism by which childhood maltreatment induces vulnerability to later life trauma exposure.	[Banihashemi, Layla; Wallace, Meredith L.; Sheu, Lei K.; Lee, Michael C.; Gianaros, Peter J.; Mackenzie, Robert P.; Insana, Salvatore P.; Germain, Anne; Herringa, Ryan J.] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Herringa, Ryan J.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA		Banihashemi, L (corresponding author), Univ Pittsburgh, Dept Psychiat, 3811 Ohara St, Pittsburgh, PA 15213 USA.	layla.banihashemi@pitt.edu	Herringa, Ryan/P-2648-2014; Banihashemi, Layla/AAW-4037-2021; Banihashemi, Layla/AAM-7391-2021	Herringa, Ryan/0000-0002-1936-7959; Banihashemi, Layla/0000-0001-6317-0494; 	American Academy of Child & Adolescent Psychiatry (AACAP) Pilot Research Award; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH102406-01, MH096944, MH080696, MH083035, MH100267]; Department of Defense Congressionally Directed Medical Research ProgramUnited States Department of Defense [PT073961, PR054093]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH102406, R34MH080696, K08MH100267, K01MH096944, R21MH083035] Funding Source: NIH RePORTER	The authors thank Benjamin Paul, Ashlee McKeon, Ryan Stocker, and Noelle Rode for their assistance with participant screening, MRI procedures, and data organization. This work was supported by the American Academy of Child & Adolescent Psychiatry (AACAP) Pilot Research Award (to R.J.H.); National Institute of Mental Health Grants MH102406-01 (to L.B.), MH096944 (to M.L.W.), MH080696 and MH083035 (to A.G.), and MH100267 (to R.J.H.); and Department of Defense Congressionally Directed Medical Research Program Grants PT073961 and PR054093 (to A.G.).	Adelmann G, 1996, ANAT EMBRYOL, V193, P481; Adler AB, 2009, MIL MED, V174, P21, DOI 10.7205/MILMED-D-00-2208; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Axer H, 2000, J NEUROSCI METH, V94, P165, DOI 10.1016/S0165-0270(99)00132-6; Baker LM, 2013, BRAIN IMAGING BEHAV, V7, P196, DOI 10.1007/s11682-012-9215-y; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Bernstein D., 1998, MANUAL CHILDHOOD TRA; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Berntsen D, 2012, PSYCHOL SCI, V23, P1557, DOI 10.1177/0956797612457389; Bifulco A, 1997, J CHILD PSYCHOL PSYC, V38, P365, DOI 10.1111/j.1469-7610.1997.tb01520.x; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Birn RM, 2014, DEPRESS ANXIETY, V31, P880, DOI 10.1002/da.22291; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Briere J, 2015, PSYCHIAT CLIN N AM, V38, P515, DOI 10.1016/j.psc.2015.05.004; Cabrera OA, 2007, AM J PREV MED, V33, P77, DOI 10.1016/j.amepre.2007.03.019; Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5; Castro CA, 2012, J TRAUMA STRESS, V25, P376, DOI 10.1002/jts.21721; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2013, NEUROSCI BIOBEHAV R, V37, P1724, DOI 10.1016/j.neubiorev.2013.07.001; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Cicchetti D, 2016, ANNU REV PSYCHOL, V67, P187, DOI 10.1146/annurev-psych-122414-033259; CRAGG BG, 1959, EXP NEUROL, V1, P187, DOI 10.1016/0014-4886(59)90001-9; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; DEOLMOS JS, 1972, J COMP NEUROL, V146, P303, DOI 10.1002/cne.901460303; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; FELDMAN S, 1980, NEUROSCIENCE, V5, P1323, DOI 10.1016/0306-4522(80)90204-3; First M., 1995, STRUCTURED CLIN INTE, V9, P92; FLOOD JF, 1995, NEUROBIOL LEARN MEM, V64, P139, DOI 10.1006/nlme.1995.1053; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Gorka AX, 2014, BIOL MOOD ANXIETY DI, V4, DOI 10.1186/2045-5380-4-12; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hanson JL, 2013, CHILD DEV, V84, P1566, DOI 10.1111/cdev.12069; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Heilbronner SR, 2014, J NEUROSCI, V34, P10041, DOI 10.1523/JNEUROSCI.5459-13.2014; Herringa RJ, 2013, PSYCHOL MED, V43, P1533, DOI 10.1017/S0033291712002310; Hildyard KL, 2002, CHILD ABUSE NEGLECT, V26, P679, DOI 10.1016/S0145-2134(02)00341-1; Huang H, 2012, NEUROPSYCHOPHARMACOL, V37, P2693, DOI 10.1038/npp.2012.133; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Keding TJ, 2015, NEUROPSYCHOPHARMACOL, V40, P537, DOI 10.1038/npp.2014.239; King BM, 2003, PHYSIOL BEHAV, V78, P563, DOI 10.1016/S0031-9384(03)00042-8; Koenen KC, 2007, PSYCHOL MED, V37, P181, DOI 10.1017/S0033291706009019; Korgaonkar MS, 2015, EBIOMEDICINE, V2, P37, DOI 10.1016/j.ebiom.2014.12.002; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuo JR, 2012, ARCH GEN PSYCHIAT, V69, P1080, DOI 10.1001/archgenpsychiatry.2012.73; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Long ZL, 2013, J AFFECT DISORDERS, V150, P798, DOI 10.1016/j.jad.2013.03.004; Luders E, 2011, NEUROIMAGE, V57, P1308, DOI 10.1016/j.neuroimage.2011.05.075; Lyden H, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.21; McLaughlin KA, 2010, PSYCHOL MED, V40, P1647, DOI 10.1017/S0033291709992121; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Mori S, 2005, MRI ATLAS HUMAN WHIT; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nemeroff CB, 2016, NEURON, V89, P892, DOI 10.1016/j.neuron.2016.01.019; OSBORNE B, 1979, BEHAV NEURAL BIOL, V25, P227, DOI 10.1016/S0163-1047(79)90584-3; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Scott KM, 2012, BRIT J PSYCHIAT, V200, P469, DOI 10.1192/bjp.bp.111.103267; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Tang YY, 2016, DRUG ALCOHOL DEPEN, V163, pS13, DOI 10.1016/j.drugalcdep.2015.11.041; Tang YY, 2015, NAT REV NEUROSCI, V16, P213, DOI 10.1038/nrn3916; Teicher MH, 2016, J CHILD PSYCHOL PSYC, V57, P241, DOI 10.1111/jcpp.12507; Ugwu ID, 2015, BRAIN STRUCT FUNCT, V220, P1997, DOI 10.1007/s00429-014-0769-x; van Huijzen, 2008, HUMAN CENTRAL NERVOU; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wasserstein R.L., 2016, AM STAT; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; West S. G., 1991, MULTIPLE REGRESSION; Woodward SH, 2013, NEUROIMAGE-CLIN, V2, P670, DOI 10.1016/j.nicl.2013.04.016	80	6	6	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0954-5794	1469-2198		DEV PSYCHOPATHOL	Dev. Psychopathol.	DEC	2017	29	5			SI		1735	1747		10.1017/S0954579417001365			13	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	FX3EF	WOS:000425952800016	29162178	Green Accepted			2022-02-06	
J	Bittencourt, S; Ferrazoli, E; Valente, MF; Romariz, S; Janisset, NRLL; Macedo, CE; Antonio, BD; Barros, V; Mundim, M; Porcionatto, M; Aarao, MC; Miranda, MF; Rodrigues, AM; de Almeida, ACG; Longo, BM; Mello, LE				Bittencourt, Simone; Ferrazoli, Eneas; Valente, Maria Fernanda; Romariz, Simone; Janisset, Nilma R. L. L.; Macedo, Carlos Eduardo; Antonio, Bruno de Brito; Barros, Vanessa; Mundim, Mayara; Porcionatto, Marimelia; Aarao, Mayra Consuelo; Miranda, Maisa Ferreira; Rodrigues, Antonio Marcio; Guimaraes de Almeida, Antonio-Carlos; Longo, Beatriz M.; Mello, Luiz E.			Modification of the natural progression of epileptogenesis by means of biperiden in the pilocarpine model of epilepsy	EPILEPSY RESEARCH			English	Article						Disease modifying agents; Anti-epileptogenesis; Symptomatic epilepsies; Neuronal plasticity; Anticholinergic drugs	INDUCED STATUS EPILEPTICUS; TEMPORAL-LOBE EPILEPSY; M1 MUSCARINIC RECEPTOR; SMALL GTPASE RHO; DENTATE GYRUS; MOUSE MODEL; OPEN-FIELD; RATS; SEIZURES; BRAIN	Brain injuries are often associated with the later development of epilepsy. Evidence suggests that morphological and functional changes occur in the remaining neural tissue during a silent (or latent) period in which no seizures are expressed. It is believed that this silent (reorganization) period may provide a therapeutic window for modifying the natural history of disease progression. Here we provide evidence that biperiden, a muscarinic anticholinergic agent, is able to alter disease progression in an animal model of epilepsy. We observed that biperiden was capable of slowing the manifestation of the first spontaneous epileptic seizure and effectively reduced the severity and number of recurrent, spontaneous epileptic seizures during the animals' lifespan. Biomolecular (microdialysis) and electrophysiological (extracellular field recordings) studies determined that biperiden was capable of elevating the threshold of hippocampal excitability, thereby making the hippocampal glutamatergic pathways less responsive to stimuli when high concentrations of potassium were used in vivo or in vitro. Notably, there was no hindrance of long-term memory or learning (a potential problem given the amnestic nature of biperiden). We conclude that biperiden has antiepileptogenic potential and may represent an opportunity for the prevention of post-traumatic epilepsy.	[Bittencourt, Simone; Ferrazoli, Eneas; Valente, Maria Fernanda; Romariz, Simone; Janisset, Nilma R. L. L.; Macedo, Carlos Eduardo; Barros, Vanessa; Longo, Beatriz M.; Mello, Luiz E.] Univ Fed Sao Paulo, Dept Physiol, BR-04039032 Sao Paulo, SP, Brazil; [Antonio, Bruno de Brito] Univ Fed Sao Paulo, Dept Psychobiol, BR-04039032 Sao Paulo, SP, Brazil; [Mundim, Mayara; Porcionatto, Marimelia] Univ Fed Sao Paulo, Dept Biochem, BR-04039032 Sao Paulo, SP, Brazil; [Aarao, Mayra Consuelo; Miranda, Maisa Ferreira; Rodrigues, Antonio Marcio; Guimaraes de Almeida, Antonio-Carlos] Univ Fed Sao Joao Del Rei, Dept Biosyst Engn, BR-36307352 Sao Joao Del Rei, MG, Brazil		Mello, LE (corresponding author), Dept Physiol, Rua Pedro de Toledo 669,3 Andar Frente, BR-04039032 Sao Paulo, SP, Brazil.	lemello@unifesp.br	ALMEIDA, ANTONIO-CARLOS G/B-8028-2008; Porcionatto, Marimelia/C-3322-2012; Mundim, Mayara V/N-9985-2015; Macedo, Carlos Eduardo/A-7184-2013; Rodrigues, Antonio M/D-3953-2012; Bittencourt, Simone/N-9393-2019	ALMEIDA, ANTONIO-CARLOS G/0000-0003-4893-338X; Porcionatto, Marimelia/0000-0001-6287-916X; Macedo, Carlos Eduardo/0000-0001-9708-3313; Rodrigues, Antonio M/0000-0002-2678-9180; Bittencourt, Simone/0000-0003-4872-0747; Mundim, Mayara/0000-0002-9771-977X	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPEMIGFundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); FAPESP/CInAPCeFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	The authors would like to thank Vegeflora Extracoes do Nordeste LTDA and Cristalia Produtos Quimicos Farmaceuticos LTDA for kindly donating the pilocarpine hydrochloride and biperiden, respectively. This work was supported by CNPq, CAPES, FAPEMIG and FAPESP/CInAPCe. The authors declare no competing financial interests.	Almeida A.G., 2011, UNDERLYING MECH EPIL; ANAGNOSTARAS SG, 1995, NEUROBIOL LEARN MEM, V64, P191, DOI 10.1006/nlme.1995.0001; Anagnostaras SG, 1999, NEUROPSYCHOPHARMACOL, V21, P731, DOI 10.1016/S0893-133X(99)00083-4; Arida RM, 1999, EPILEPSY RES, V34, P99, DOI 10.1016/S0920-1211(98)00092-8; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Bumanglag AV, 2008, J COMP NEUROL, V510, P561, DOI 10.1002/cne.21801; Calabresi P, 1998, EUR J NEUROSCI, V10, P2887, DOI 10.1111/j.1460-9568.1998.00294.x; Chauviere L, 2009, J NEUROSCI, V29, P5402, DOI 10.1523/JNEUROSCI.4699-08.2009; CUNHA JM, 1978, PHARMACOLOGY, V16, P259, DOI 10.1159/000136777; Engel J, 2007, EPILEPSY COMPREHENSI; Fujikawa DG, 1996, BRAIN RES, V725, P11, DOI 10.1016/0006-8993(96)00203-X; Gao ZG, 1998, J PHARM PHARMACOL, V50, P1299, DOI 10.1111/j.2042-7158.1998.tb03349.x; Gorgati C, 2009, THESIS; Hamilton SE, 2001, LIFE SCI, V68, P2489, DOI 10.1016/S0024-3205(01)01043-8; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Jensen MS, 1997, J NEUROPHYSIOL, V77, P1224, DOI 10.1152/jn.1997.77.3.1224; Jones SVP, 2003, MOL PHARMACOL, V64, P987, DOI 10.1124/mol.64.4.987; JUSTICE JB, 1993, J NEUROSCI METH, V48, P263, DOI 10.1016/0165-0270(93)90097-B; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023852; Lanzafame AA, 2003, RECEPTOR CHANNEL, V9, P241, DOI 10.1080/10606820390217078; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEITE JP, 1990, NEUROSCI BIOBEHAV R, V14, P511, DOI 10.1016/S0149-7634(05)80076-4; LEMOS T, 1995, EXP BRAIN RES, V102, P423; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Loscher W, 2002, TRENDS PHARMACOL SCI, V23, P113, DOI 10.1016/S0165-6147(00)01974-X; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; Matzen J, 2008, SEIZURE-EUR J EPILEP, V17, P76, DOI 10.1016/j.seizure.2007.07.008; MCDONOUGH JH, 1993, NEUROSCI BIOBEHAV R, V17, P203, DOI 10.1016/S0149-7634(05)80151-4; MELDRUM BS, 1985, GREENFIELDS NEUROPAT, P921; Mello L.E.A.M, 2005, World International Patent Office (WIPO), Patent No. 20070043082; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Mikati MA, 2008, EPILEPSY RES, V81, P161, DOI 10.1016/j.eplepsyres.2008.05.009; Nogueira GS, 2015, NEUROSCIENCE, V303, P59, DOI 10.1016/j.neuroscience.2015.06.057; PARSONS LH, 1994, CRIT REV NEUROBIOL, V8, P189; Paxinos G, 2006, RAT BRAIN STEREOTAXI; Pereira HAA, 2005, EPILEPSIA, V46, P118, DOI 10.1111/j.1528-1167.2005.01017.x; Pillay N, 2009, EPILEPSIA, V50, P2611, DOI 10.1111/j.1528-1167.2009.02103.x; Pitkanen A., 2012, JASPERS BASIC MECH E, V4th; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rossignol TM, 2006, PFLUG ARCH EUR J PHY, V452, P164, DOI 10.1007/s00424-005-0014-9; Sanabria E., 2000, EPILEPSIA, P27; Sillanpaa M, 2008, BRAIN, V131, P938, DOI 10.1093/brain/awn037; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Terry AV, 2009, FRONT NEUROSCI, P267; Touret M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-69; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Yoshiyama Y, 2012, NEUROBIOL DIS, V45, P329, DOI 10.1016/j.nbd.2011.08.017	50	6	6	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	DEC	2017	138						88	97		10.1016/j.eplepsyres.2017.10.019			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ2VU	WOS:000418216900013	29096134				2022-02-06	
J	Gallo, V; McElvenny, D; Hobbs, C; Davoren, D; Morris, H; Crutch, S; Zetterberg, H; Fox, NC; Kemp, S; Cross, M; Arden, NK; Davies, MAM; Malaspina, A; Pearce, N				Gallo, Valentina; McElvenny, Damien; Hobbs, Catherine; Davoren, Donna; Morris, Huw; Crutch, Sebastian; Zetterberg, Henrik; Fox, Nick C.; Kemp, Simon; Cross, Matthew; Arden, Nigel K.; Davies, Madeleine A. M.; Malaspina, Andrea; Pearce, Neil			BRain health and healthy AgeINg in retired rugby union players, the BRAIN Study: study protocol for an observational study in the UK	BMJ OPEN			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SERUM NEUROFILAMENT LIGHT; SMELL IDENTIFICATION TEST; SPORTS-RELATED CONCUSSION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; PHYSICAL-ACTIVITY; BINDING DEFICITS; INJURY SEVERITY; RISK-FACTORS	Introduction Relatively little is known about the long-term health of former elite rugby players, or former sportspeople more generally. As well as the potential benefits of being former elite sportspersons, there may be potential health risks from exposures occurring during an individual's playing career, as well as following retirement. Each contact sport has vastly different playing dynamics, therefore exposing its players to different types of potential traumas. Current evidence suggests that these are not necessarily comparable in terms of pathophysiology, and their potential long-term adverse effects might also differ. There is currently limited but increasing evidence that poorer age-related and neurological health exists among former professional sportsmen exposed to repetitive concussions; however the evidence is limited on rugby union players, specifically. Methods and analysis We present the protocol for a cross-sectional study to assess the association between self-reported history of concussion during a playing career, and subsequent measures of healthy ageing and neurological and cognitive impairment. We are recruiting a sample of approximately 200 retired rugby players (former Oxford and Cambridge University rugby players and members of the England Rugby International Club) aged 50 years or more, and collecting a number of general and neurological health-related outcome measures though validated assessments. Biomarkers of neurodegeneration (neurofilaments and tau) will be also be measured. Although the study is focusing on rugby union players specifically, the general study design and the methods for assessing neurological health are likely to be relevant to other studies of former elite sportspersons. Ethics and dissemination The study has been approved by the Ethical Committee of London School of Hygiene and Tropical Medicine (reference: 11634-2). It is intended that results of this study will be published in peer-reviewed medical journals, communicated to participants, the general public and all relevant stakeholders.	[Gallo, Valentina] Imperial Coll London, Sch Publ Hlth, London, England; [Gallo, Valentina; Hobbs, Catherine; Davoren, Donna; Pearce, Neil] London Sch Hyg & Trop Med, Epidemiol & Med Stat, London, England; [Gallo, Valentina] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England; [McElvenny, Damien] Inst Occupat Med, Res Div, Edinburgh, Midlothian, Scotland; [Morris, Huw] UCL, Dept Clin Neurosci, London, England; [Crutch, Sebastian; Fox, Nick C.] UCL, Inst Neurol, Dementia Res Ctr, London, England; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Zetterberg, Henrik] UK Dementia Res Inst, London, England; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Phys, Dept Psychiat & Neurochem, Molndal, Sweden; [Kemp, Simon; Cross, Matthew] RFU, London, England; [Arden, Nigel K.; Davies, Madeleine A. M.] Univ Oxford, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Oxford, England; [Malaspina, Andrea] Queen Mary Univ London, Blizard Inst, Dept Neurosci & Trauma, London, England		Gallo, V (corresponding author), Imperial Coll London, Sch Publ Hlth, London, England.; Gallo, V (corresponding author), London Sch Hyg & Trop Med, Epidemiol & Med Stat, London, England.; Gallo, V (corresponding author), Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England.	v.gallo@qmul.ac.uk	Fox, Nick C/B-1319-2009; Morris, Huw R/B-8527-2008; Gallo, Valentina/X-1139-2018	Fox, Nick C/0000-0002-6660-657X; Morris, Huw R/0000-0002-5473-3774; Gallo, Valentina/0000-0002-1268-8629; Hobbs, Catherine/0000-0002-2324-5882; Crutch, Sebastian/0000-0002-4160-0139; Davies, Madeleine/0000-0002-6047-7340; Pearce, Neil/0000-0002-9938-7852; Kemp, Simon/0000-0002-3250-2713	Drake FoundationSmithsonian InstitutionSmithsonian National Museum of Natural History; Institute of Occupational Medicine (IOM); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0401247, G0801306, UKDRI-1001, G116/143, UKDRI-1003] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0801306, UKDRI-1003, G116/143, UKDRI-1001, G0401247] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0513-10134] Funding Source: researchfish	This study is funded by a grant from the Drake Foundation (www.drakefoundation.org/) to the London School of Hygiene and Tropical Medicine, with subcontracts to Queen Mary University of London (QMUL) and the Institute of Occupational Medicine (IOM).	Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bremander AB, 2007, SCAND J MED SCI SPOR, V17, P120, DOI 10.1111/j.1600-0838.2006.00544.x; Capano CP, 2001, BIOESSAYS, V23, P24, DOI 10.1002/1521-1878(200101)23:1<24::AID-BIES1004>3.3.CO;2-8; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Collins NJ, 2011, ARTHRIT CARE RES, V63, pS208, DOI 10.1002/acr.20632; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Davies MAM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12130-y; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DOTY RL, 1989, PERCEPT PSYCHOPHYS, V45, P381, DOI 10.3758/BF03210709; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forster S, 2011, PSYCHON B REV, V18, P1064, DOI 10.3758/s13423-011-0172-z; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Giovannoni G, 1999, J NEUROL NEUROSUR PS, V67, P624, DOI 10.1136/jnnp.67.5.624; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hamilton CB, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0358-6; Harris MA, 2013, OCCUP ENVIRON MED, V70, P839, DOI 10.1136/oemed-2013-101444; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Johnson VE, 2009, J NEUROTRAUM, V26, P1197, DOI [10.1089/neu.2008.0843, 10.1089/neu.2008-0843]; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Jordan Barry D, 2014, Continuum (Minneap Minn), V20, P1588, DOI 10.1212/01.CON.0000458972.94013.e1; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; Kaukiainen A, 2009, NEUROTOXICOLOGY, V30, P1187, DOI 10.1016/j.neuro.2009.03.010; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kirchhoff C, 2008, CRIT CARE, V12, DOI 10.1186/cc7013; Kokmen E, 1996, MAYO CLIN PROC, V71, P275, DOI 10.4065/71.3.275; Kuh D, 2014, P NUTR SOC, V73, P237, DOI 10.1017/S0029665113003923; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Kuopio AM, 1999, MOVEMENT DISORD, V14, P928, DOI 10.1002/1531-8257(199911)14:6<928::AID-MDS1004>3.0.CO;2-Z; Lehman EJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt188; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P201, DOI 10.1001/archneur.55.2.201; Lu CH, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000244; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mc Fie S, 2017, J SCI MED SPORT; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Naj AC, 2017, AM J MED GENET B, V174, P5, DOI 10.1002/ajmg.b.32499; Nelson HE, 2013, NEUROPSYCHOL REHABIL; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; NIH, 2010, ARCH PHYS MED REHAB, V91, P1637; Nilsdotter A, 2011, ARTHRIT CARE RES, V63, pS200, DOI 10.1002/acr.20549; Nofuji Y, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.11.003; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papp KV, 2014, CLIN NEUROPSYCHOL, V28, P771, DOI 10.1080/13854046.2014.911351; Parra MA, 2010, BRAIN, V133, P2702, DOI 10.1093/brain/awq148; Pearce N, 2004, ENVIRON HEALTH PERSP, V112, P1047, DOI 10.1289/ehp.6927; Pearce N, 2015, NEUROBIOL AGING, V36, P1383, DOI 10.1016/j.neurobiolaging.2014.12.024; Pertzov Y, 2013, BRAIN, V136, P2474, DOI 10.1093/brain/awt129; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Pupillo E, 2014, ANN NEUROL, V75, P708, DOI 10.1002/ana.24150; Rentz DM, 2011, NEUROPSYCHOLOGIA, V49, P2776, DOI 10.1016/j.neuropsychologia.2011.06.006; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Rugbjerg Kathrine, 2008, BMJ, V337, pa2494, DOI 10.1136/bmj.a2494; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Say MJ, 2011, NEUROPSYCHOLOGIA, V49, P264, DOI 10.1016/j.neuropsychologia.2010.11.016; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schoon Y, 2014, EUR J PHYS REHAB MED, V50, P693; Seidler A, 1996, NEUROLOGY, V46, P1275, DOI 10.1212/WNL.46.5.1275; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Shahim P, 2017, JAMA NEUROL, V74, P360, DOI 10.1001/jamaneurol.2016.5905; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shallice T, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.002.2007; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; TEASDALE G, 1974, LANCET, V2, P81; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 2011, WECHSLER ABBREVIATED; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	92	6	6	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	DEC	2017	7	12							e017990	10.1136/bmjopen-2017-017990			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU4MH	WOS:000423826700094	29282262	Green Accepted, Green Published, gold			2022-02-06	
J	Gladish, JR; Powell, DW; Allison, LE; Queen, RM				Gladish, Jonathan R.; Powell, Douglas W.; Allison, Lindsey E.; Queen, Robin M.			Center of pressure profiles in unilateral compared to bilateral end-stage ankle osteoarthritis patients	JOURNAL OF ORTHOPAEDIC RESEARCH			English	Article						ankle osteoarthritis; postural stability; center of pressure; unilateral; bilateral	POSTURAL CONTROL; CEREBRAL CONCUSSION; WEIGHT DISTRIBUTION; BALANCE; GAIT; STABILITY; ARTHROPLASTY; REPLACEMENT; INSTABILITY; DYNAMICS	Ankle osteoarthritis (OA) compromises ankle joint stability in regards to static balance. Unilateral and bilateral osteoarthritis patients often exhibit different limb-loading patterns during static balance tasks. Symmetrical loading has been posited to improve balance performance. Therefore, the purpose of this study was to quantify balance performance in both ankle osteoarthritis patient groups. Twenty-two unilateral and twenty-one bilateral ankle osteoarthritis patients performed three 10-s quiet standing trials with their feet together. Ground reaction force data were collected from force platforms with one under each foot. Center of pressure excursion in the anteroposterior and mediolateral directions as well as the resultant center of pressure were calculated using custom Matlab software. A 2x2 repeated measures ANOVA with Cohen's d were used to analyze the differences between groups (unilateral vs. bilateral) and between limbs (affected vs. unaffected) (=0.05). No significant differences were found between limbs or groups in either the anteroposterior or mediolateral direction for any measured variable. Though not statistically different, moderate to large effect sizes were observed for mean resultant distance between unilateral and bilateral (d=0.096, d: 1.0) as well as anteroposterior excursion (p=0.077, d: 1.731) and mean velocity (p=0.084, d: 1.50) between affected and unaffected limbs. These large effect sizes suggested clinically relevant differences may exist, particularly in the anteroposterior direction. These findings may suggest that center of pressure is a better measure of postural strategy while center of mass measures may be more representative of postural steadiness. (c) 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:2749-2754, 2017.	[Gladish, Jonathan R.; Queen, Robin M.] Virginia Tech, Dept Biomed Engn & Mech, Kevin P Granata Biomech Lab, Blacksburg, VA 24061 USA; [Powell, Douglas W.; Allison, Lindsey E.] Univ Memphis, Sch Hlth Sci, Musculoskeletal Anal Lab, Memphis, TN 38152 USA		Gladish, JR (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Kevin P Granata Biomech Lab, Blacksburg, VA 24061 USA.	jgladish@vt.edu					Abidi N A, 2000, J Am Acad Orthop Surg, V8, P200; Achache V, 2013, ANN PHYS REHABIL MED, V56, pe225; Anker LC, 2008, GAIT POSTURE, V27, P471, DOI 10.1016/j.gaitpost.2007.06.002; Blaszczyk JW, 2001, ACTA NEUROBIOL EXP, V61, P105; Bodfish JW, 2001, AM J MENT RETARD, V106, P123, DOI 10.1352/0895-8017(2001)106<0123:SAMCDI>2.0.CO;2; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Butler RJ, 2015, J ARTHROPLASTY, V30, P286, DOI 10.1016/j.arth.2014.08.031; Cavanaugh J. T., 2004, GAIT POSTURE, V20, P55; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chiu YP, 2015, PHYSIOTHERAPY, V101, pe243; Cohen J., 2013, STAT POWER ANAL BEHA; Conti SF, 2008, FOOT ANKLE INT, V29, P1069, DOI 10.3113/FAI.2008.1069; Cromwell RL, 2004, J AGING PHYS ACTIV, V12, P90, DOI 10.1123/japa.12.1.90; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Early John S, 2008, Foot Ankle Clin, V13, P635, DOI 10.1016/j.fcl.2008.08.005; Freeman M A, 1965, J Bone Joint Surg Br, V47, P678; Freyler K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144529; Genthon N, 2005, J BIOMECH, V38, P2037, DOI 10.1016/j.jbiomech.2004.09.024; Hintermann B, 2002, AM J SPORT MED, V30, P402, DOI 10.1177/03635465020300031601; Hintermann B, 2005, CHARACTERISTICS DISE, P5; Horisberger M, 2009, J ORTHOP TRAUMA, V23, P60, DOI 10.1097/BOT.0b013e31818915d9; Horisberger M, 2009, CLIN BIOMECH, V24, P303, DOI 10.1016/j.clinbiomech.2008.12.005; Hubbard TJ, 2009, ARCH PHYS MED REHAB, V90, P1136, DOI 10.1016/j.apmr.2008.11.020; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Lewek MD, 2014, J APPL BIOMECH, V30, P31, DOI 10.1123/jab.2012-0208; Lobet S, 2012, CLIN BIOMECH, V27, P625, DOI 10.1016/j.clinbiomech.2012.01.009; McKeon PO, 2008, J ATHL TRAINING, V43, P293, DOI 10.4085/1062-6050-43.3.293; MICHELSON JD, 1995, J BONE JOINT SURG BR, V77B, P219, DOI 10.1302/0301-620X.77B2.7706334; MYKLEBUST JB, 1995, ANN BIOMED ENG, V23, P711, DOI 10.1007/BF02584470; Newell K, 1998, DEGREES FREEDOM DEV, P80; Nuesch C, 2012, CLIN BIOMECH, V27, P613, DOI 10.1016/j.clinbiomech.2011.12.016; O'Connor SM, 2009, J NEUROPHYSIOL, V102, P1411, DOI 10.1152/jn.00131.2009; Peyron JG, 1984, EPIDEMIOLOGY OSTEOAR, P9; Powell DW, 2015, HUM MOVEMENT SCI, V44, P73, DOI 10.1016/j.humov.2015.08.013; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; RIEMANN BL, 2000, CONTRIBUTION OF THE, P37; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Rougier PR, 2009, AM J PHYS MED REHAB, V88, P896, DOI 10.1097/PHM.0b013e3181b331af; Saltzman Charles L, 2005, Iowa Orthop J, V25, P44; Tabe R, 2015, J KERMANSHAH U MED S, V18, P648; Valderrabano V, 2006, AM J SPORT MED, V34, P612, DOI 10.1177/0363546505281813; Valderrabano V, 2007, CLIN BIOMECH, V22, P894, DOI 10.1016/j.clinbiomech.2007.05.003; Valderrabano V, 2007, FOOT ANKLE INT, V28, P281, DOI 10.3113/FAI.2007.0281; Valderrabano V, 2006, J ORTHOP RES, V24, P2159, DOI 10.1002/jor.20261; Valderrabano V, 2009, CLIN ORTHOP RELAT R, V467, P1800, DOI 10.1007/s11999-008-0543-6; WALTER JH, 1991, J AM PODIAT MED ASSN, V81, P399, DOI 10.7547/87507315-81-8-399; Williams DSB, 2016, J SPORT HEALTH SCI, V5, P70, DOI 10.1016/j.jshs.2016.01.010; Yamamoto R, 2001, DIABETES RES CLIN PR, V52, P213, DOI 10.1016/S0168-8227(01)00236-4	49	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0736-0266	1554-527X		J ORTHOP RES	J. Orthop. Res.	DEC	2017	35	12					2749	2754		10.1002/jor.23585			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics	FR2ZH	WOS:000418935200021	28449194	Bronze			2022-02-06	
J	Jang, SH; Ha, JW; Kim, HY; Seo, YS				Jang, Sung Ho; Ha, Ji Wan; Kim, Hyun Young; Seo, You Sung			Recovery of injured Broca's portion of arcuate fasciculus in the dominant hemisphere in a patient with traumatic brain injury	MEDICINE			English	Article						arcuate fasciculus; diffusion tensor imaging; diffusion tensor tractography; head trauma; language	CONDUCTION APHASIA; LANGUAGE; STROKE; TRACTOGRAPHY; PLASTICITY; DORSAL; TRACTS	Rationale:Recovery of injured AF in patients with traumatic brain injury (TBI) has not been reported. In this study, we report on a patient with TBI who recovered from an injury to Broca's portion of AF in the dominant hemisphere, diagnosed by diffusion tensor tractography (DTT).Patient concerns:A 28-year-old right-handed male patient suffered head trauma resulting from sliding while riding a motorcycle.Diagnoses:He was diagnosed with a traumatic contusional hemorrhage in the left frontal lobe, subarachnoid hemorrhage, and subdural hemorrhage in the left fronto-temporal lobe.Interventions:He underwent craniectomy on the left fronto-temporal area, and hematoma removal for the subdural hemorrhage in the neurosurgery department of a university hospital. Two weeks after the injury, he was transferred to the rehabilitation department of another university hospital. He showed severe aphasia and brain MRI showed leukomalactic lesion in the left frontal lobe.Outcomes:The result WAB for the patient showed severe aphasia, with an aphasia quotient of 45.3 percentile. However, his aphasia improved rapidly by 9 months with an aphasia quotient at the 100.0 percentile. 2-week DTT detected discontinuity in the subcortical white matter at the branch to Broca's area of left AF. By contrast, on 9-month DTT, the discontinued portion of left AF was elongated to the left Broca's area.Lessons:Recovery of injured Broca's portion of AF in the dominant hemisphere along with excellent improvement of aphasia was demonstrated in a patient with TBI. This study has important implications in brain rehabilitation because the mechanism of recovery from aphasia following TBI has not been elucidated.	[Jang, Sung Ho; Seo, You Sung] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu, South Korea; [Ha, Ji Wan; Kim, Hyun Young] Daegu Univ, Dept Speech Pathol, Yeongcheon Si, Gyeongsangbuk D, South Korea		Seo, YS (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu, South Korea.	yousung1008@daum.net			National Research Foundation (NRF) of Korea - Korean Government (MSIP) [2015R1A2A2A01004073]	This work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MSIP) (2015R1A2A2A01004073).	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Anderson JM, 1999, BRAIN LANG, V70, P1, DOI 10.1006/brln.1999.2135; Axer H, 2013, BRAIN LANG, V127, P192, DOI 10.1016/j.bandl.2012.04.015; Bernal B, 2009, BRAIN, V132, P2309, DOI 10.1093/brain/awp206; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; Hosomi A, 2009, NEURORADIOLOGY, V51, P549, DOI 10.1007/s00234-009-0534-7; Jang SH, 2013, FRONT HUM NEUROSCI, P7; Jang SH, 2014, AM J PHYS MED REHAB, V93, pE15, DOI 10.1097/PHM.0000000000000202; Kim H, 2004, J CLIN EXP NEUROPSYC, V26, P1011, DOI 10.1080/13803390490515397; Kim SH, 2013, AM J NEURORADIOL, V34, P785, DOI 10.3174/ajnr.A3259; Lee AY, 2012, NEUROSCI LETT, V528, P16, DOI 10.1016/j.neulet.2012.08.053; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Menon E. B., 1993, Singapore Medical Journal, V34, P45; Nucifora PGP, 2005, NEUROREPORT, V16, P791, DOI 10.1097/00001756-200505310-00002; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raboyeau G, 2008, NEUROLOGY, V70, P290, DOI 10.1212/01.wnl.0000287115.85956.87; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Yamada K, 2007, NEUROLOGY, V68, P789, DOI 10.1212/01.wnl.0000256348.65744.b2	24	6	6	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2017	96	51							e9183	10.1097/MD.0000000000009183			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT2QY	WOS:000422992300045	29390458	Green Published, gold			2022-02-06	
J	Merrell, AJ; Christensen, WF; Seeley, MK; Bowden, AE; Fullwood, DT				Merrell, A. Jake; Christensen, William F.; Seeley, Matthew K.; Bowden, Anton E.; Fullwood, David T.			Nano-Composite Foam Sensor System in Football Helmets	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Football helmet; Impact detection; Piezoelectric foam; Self-sensing foam; Impact energy; Impact velocity; Acceleration; Severity index	HEAD IMPACT EXPOSURE; SPORT-RELATED CONCUSSION; RECURRENT CONCUSSION; ACCELERATION MEASUREMENT; YOUTH FOOTBALL; PLAYERS; VALIDATION; INJURY; RISK; CURVES	American football has both the highest rate of concussion incidences as well as the highest number of concussions of all contact sports due to both the number of athletes and nature of the sport. Recent research has linked concussions with long term health complications such as chronic traumatic encephalopathy and early onset Alzheimer's. Understanding the mechanical characteristics of concussive impacts is critical to help protect athletes from these debilitating diseases and is now possible using helmet-based sensor systems. To date, real time on-field measurement of head impacts has been almost exclusively measured by devices that rely on accelerometers or gyroscopes attached to the player's helmet, or embedded in a mouth guard. These systems monitor motion of the head or helmet, but do not directly measure impact energy. This paper evaluates the accuracy of a novel, multifunctional foam-based sensor that replaces a portion of the helmet foam to measure impact. All modified helmets were tested using a National Operating Committee Standards for Athletic Equipment-style drop tower with a total of 24 drop tests (4 locations with 6 impact energies). The impacts were evaluated using a headform, instrumented with a tri-axial accelerometer, mounted to a Hybrid III neck assembly. The resultant accelerations were evaluated for both the peak acceleration and the severity indices. These data were then compared to the voltage response from multiple Nano Composite Foam sensors located throughout the helmet. The foam sensor system proved to be accurate in measuring both the HIC and Gadd severity index, as well as peak acceleration while also providing additional details that were previously difficult to obtain, such as impact energy.	[Merrell, A. Jake; Bowden, Anton E.; Fullwood, David T.] Brigham Young Univ, Dept Mech Engn, Provo, UT 84602 USA; [Christensen, William F.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA; [Seeley, Matthew K.] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA		Merrell, AJ (corresponding author), Brigham Young Univ, Dept Mech Engn, Provo, UT 84602 USA.	jakemerrell@gmail.com		Christensen, William/0000-0002-8068-1031	National Science FoundationNational Science Foundation (NSF) [CMMI-1538447, IIP1549719]; Div Of Civil, Mechanical, & Manufact InnNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1538447] Funding Source: National Science Foundation	This material and research are based upon work supported by the National Science Foundation under Grant Numbers CMMI-1538447 and IIP1549719. All helmet testing was performed at Virginia Polytechnic Institute and State University's Biomedical Engineering and Mechanics helmet testing lab.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Conidi FX, 2015, PRACT NEUROL, V15, P32; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Foster JK, 1977, HYBRID 3 BIOMECHANIC; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gadd C., 1966, SAE TECHNICAL PAPER; GURDJIAN E S, 1964, J Trauma, V4, P309; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Higgins M, 2007, J ATHL TRAINING, V42, P5; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Knox T., 2009, DTIC DOCUMENT; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Miyashita T., 2016, ATHLETIC TRAINING SP; NOCSAE, 2014, STAND PERF SPEC NEWL; NOCSAE, 2015, STAND TEST METH EQ U; Olvey SE, 2004, NEUROSURGERY, V54, P672, DOI 10.1227/01.NEU.0000108782.68099.29; Patel Dilip R, 2002, Adolesc Med, V13, P569; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Tianyi Frank-Leonel, 2017, J Med Case Rep, V11, P87, DOI 10.1186/s13256-017-1245-z; Versace J, 1971, SAE TECHNICAL PAPER; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Zanetti EM, 2013, J SPORT SCI, V31, P767, DOI 10.1080/02640414.2012.750005	45	6	6	2	33	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2017	45	12					2742	2749		10.1007/s10439-017-1910-9			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FN1DS	WOS:000415726200003	28884239				2022-02-06	
J	Woodcock, TM; Frugier, T; Nguyen, TT; Semple, BD; Bye, N; Massara, M; Savino, B; Besio, R; Sobacchi, C; Locati, M; Morganti-Kossmann, MC				Woodcock, Thomas M.; Frugier, Tony; Tan Thanh Nguyen; Semple, Bridgette Deanne; Bye, Nicole; Massara, Matteo; Savino, Benedetta; Besio, Roberta; Sobacchi, Cristina; Locati, Massimo; Morganti-Kossmann, Maria Cristina			The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CLOSED-HEAD INJURY; AXONAL INJURY; CUTTING EDGE; D6; INFLAMMATION; EXPRESSION; ASTROCYTES; MCP-1; MICE	The atypical chemokine receptor ACKR2 promotes resolution of acute inflammation by operating as a scavenger receptor for inflammatory CC chemokines in several experimental models of inflammatory disorders, however its role in the brain remains unclear. Based on our previous reports of increased expression of inflammatory chemokines and their corresponding receptors following traumatic brain injury (TBI), we hypothesised that ACKR2 modulates neuroinflammation following brain trauma and that its deletion exacerbates cellular inflammation and chemokine production. We demonstrate increased CCL2 and ACKR2 mRNA expression in post-mortem human brain, whereby ACKR2 mRNA levels correlated with later times post-TBI. This data is consistent with the transient upregulation of ACKR2 observed in mouse brain after closed head injury (CHI). As compared to WT animals, ACKR2(-/-) mice showed a higher mortality rate after CHI, while the neurological outcome in surviving mice was similar. At day 1 post-injury, ACKR2(-/-) mice displayed aggravated lesion volume and no differences in CCL2 expression and macrophage recruitment relative to WT mice. Reciprocal regulation of ACKR2 and CCL2 expression was explored in cultured astrocytes, which are recognized as the major source of CCL2 and also express ACKR2. ACKR2 mRNA increased as early as 2 hours after an inflammatory challenge in WT astrocytes. As expected, CCL2 expression also dramatically increased at 4 hours in WT astrocytes but was significantly lower in ACKR2(-/-) astrocytes, possibly indicating a co-regulation of CCL2 and ACKR2 in these cells. Conversely, in vivo, CCL2 mRNA/ protein levels were increased similarly in ACKR2(-/-) and WT brains at 4 and 12 hours after CHI, in line with the lack of differences in cerebral macrophage recruitment and neurological recovery. In conclusion, ACKR2 is induced after TBI and has a significant impact on mortality and lesion development acutely following CHI, while its role in chemokine expression, macrophage activation, brain pathology, and neurological recovery at later time-points is minor. Concordant to evidence in multiple sclerosis experimental models, our data corroborate a distinct role for ACKR2 in cerebral inflammatory processes compared to its reported functions in peripheral tissues.	[Woodcock, Thomas M.; Tan Thanh Nguyen] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Woodcock, Thomas M.; Tan Thanh Nguyen] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Frugier, Tony] Univ Melbourne, Sch Biomed Sci, Dept Pharmacol & Therapeut, Melbourne, Vic, Australia; [Semple, Bridgette Deanne] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Bye, Nicole] Univ Tasmania, Sch Med, Div Pharm, Hobart, Tas, Australia; [Massara, Matteo; Savino, Benedetta; Sobacchi, Cristina; Locati, Massimo] Humanitas Clin & Res Ctr, Rozzano, Italy; [Massara, Matteo; Savino, Benedetta; Locati, Massimo] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Besio, Roberta] Univ Pavia, Dept Mol Med, Pavia, Italy; [Sobacchi, Cristina] CNR, Ist Ric Genet, Milan, Italy; [Sobacchi, Cristina] CNR, Biomed Milan Unit, Milan, Italy; [Morganti-Kossmann, Maria Cristina] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Morganti-Kossmann, Maria Cristina] Monash Univ, Australian New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia; [Morganti-Kossmann, Maria Cristina] Univ Arizona, Barrow Neurol Inst, Dept Child Hlth, Phoenix, AZ 85004 USA		Locati, M (corresponding author), Humanitas Clin & Res Ctr, Rozzano, Italy.; Locati, M (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.; Morganti-Kossmann, MC (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Morganti-Kossmann, MC (corresponding author), Monash Univ, Australian New Zealand Intens Care Res Ctr, Melbourne, Vic, Australia.; Morganti-Kossmann, MC (corresponding author), Univ Arizona, Barrow Neurol Inst, Dept Child Hlth, Phoenix, AZ 85004 USA.	massimo.locati@unimi.it; cristina.morganti-kossmann@monash.edu	Locati, Massimo/ABF-6807-2021; SOBACCHI, CRISTINA/J-9345-2018; Massara, Matteo/P-5023-2018; Besio, Roberta/AAQ-7151-2020; Savino, Benedetta/K-4488-2014; Locati, Massimo/H-8404-2015	SOBACCHI, CRISTINA/0000-0002-2684-7184; Massara, Matteo/0000-0001-6724-5633; Besio, Roberta/0000-0003-1430-2934; Savino, Benedetta/0000-0002-2996-9515; Locati, Massimo/0000-0003-3077-590X; Morganti-Kossmann, Cristina/0000-0002-0807-2063	Victorian Neurotrauma Initiative/Traffic Accident Commission; Neurotrauma Tissue/Fluid bank within the National Neural Tissue Resource Centre [D003]; European CommunityEuropean Commission; Australian Postgraduate AwardAustralian Government	The Victorian Neurotrauma Initiative/Traffic Accident Commission provided funding for Research Fellowships to MCM-K and NB, and for the establishment of the Neurotrauma Tissue/Fluid bank within the National Neural Tissue Resource Centre, Project Grant D003. The European Community's Seventh Framework Program (FP7/2007-2013, SYBIL and TIMER projects) provided funding to CS and ML, and the Programma Nazionale per la Ricerca-Consiglio Nazionale delle Ricerche (Aging project) to CS. BS was the recipient of the Australian Postgraduate Award during the course of her PhD.	ALOISI F, 1992, J IMMUNOL, V149, P2358; Babcock AA, 2003, J NEUROSCI, V23, P7922; Bell MD, 1996, NEUROSCIENCE, V74, P283, DOI 10.1016/0306-4522(96)00083-8; Berres ML, 2009, BIOL CHEM, V390, P1039, DOI 10.1515/BC.2009.119; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; Bonecchi R, 2008, BLOOD, V112, P493, DOI 10.1182/blood-2007-08-108316; Bordon Y, 2009, J IMMUNOL, V182, P5032, DOI 10.4049/jimmunol.0802802; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Calvo CF, 1996, EUR J NEUROSCI, V8, P1725, DOI 10.1111/j.1460-9568.1996.tb01316.x; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Di Liberto D, 2008, J EXP MED, V205, P2075, DOI 10.1084/jem.20070608; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fouillet A, 2012, BRAIN RES, V1437, P115, DOI 10.1016/j.brainres.2011.11.049; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Hansell CAH, 2011, BLOOD, V117, P5413, DOI 10.1182/blood-2010-11-317115; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Kiyota T, 2013, NEUROBIOL AGING, V34, P1060, DOI 10.1016/j.neurobiolaging.2012.08.009; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu LP, 2006, J IMMUNOL, V177, P17, DOI 10.4049/jimmunol.177.1.17; Lo Iacono N, 2012, J BONE MINER RES, V27, P2501, DOI 10.1002/jbmr.1712; Long YS, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8749417; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; McKimmie CS, 2006, BIOCHEM SOC T, V34, P1002, DOI 10.1042/BST0341002; McKimmie CS, 2010, BIOCHEM BIOPH RES CO, V394, P1006, DOI 10.1016/j.bbrc.2010.03.111; McKimmie CS, 2008, J IMMUNOL, V181, P8170, DOI 10.4049/jimmunol.181.11.8170-a; Neil SJD, 2005, J VIROL, V79, P9618, DOI 10.1128/JVI.79.15.9618-9624.2005; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Otto VI, 2002, J NEUROCHEM, V80, P824, DOI 10.1046/j.0022-3042.2001.00748.x; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Rot A, 2013, J IMMUNOL, V190, P6450, DOI 10.4049/jimmunol.1201429; Semple BD, 2010, J CEREBRAL BLOOD FLO, P30; Semple BD, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-67; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Song L, 2004, MICROVASC RES, V67, P78, DOI 10.1016/j.mvr.2003.07.001; SOZZANI S, 1994, J IMMUNOL, V152, P3615; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Sul OJ, 2012, J CELL PHYSIOL, V227, P1619, DOI 10.1002/jcp.22879; Vetrano S, 2010, GUT, V59, P197, DOI 10.1136/gut.2009.183772; Wang Lei, 2002, Hematology, V7, P113; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Yoshimura T, 1992, Cytokines, V4, P131; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	65	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2017	12	11							e0188305	10.1371/journal.pone.0188305			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN8QZ	WOS:000416291900059	29176798	Green Published, Green Accepted, gold			2022-02-06	
J	Baerg, J; Thirumoorthi, A; Hazboun, R; Vannix, R; Krafft, P; Zouros, A				Baerg, Joanne; Thirumoorthi, Arul; Hazboun, Rajaie; Vannix, Rosemary; Krafft, Paul; Zouros, Alexander			Cervical spine injuries in young children: pattern and outcomes in accidental versus inflicted trauma	JOURNAL OF SURGICAL RESEARCH			English	Article						Cervical spine; Imaging protocol; Pediatric trauma; Inflicted trauma; Traumatic brain injury	ABUSIVE HEAD TRAUMA; CLINICAL ARTICLE; CONSCIOUSNESS; FEATURES; LEVEL; COMA	Background: The aim of the study was to compare the cervical spine (c-spine) pattern of injury and outcomes in children below 3 y with a head injury from confirmed inflicted versus accidental trauma. Methods: After Institutional Review Board approval, data were prospectively collected between July 2011 and January 2016. Inclusion criteria were age below 3 y, a loss of consciousness, and any one of the following initial head computed tomography (CT) findings (subdural hematoma, intraventricular, intraparenchymal, subarachnoid hemorrhage, or cerebral edema). A protocol of brain and neck magnetic resonance imaging and magnetic resonance angiography was instituted. Brain and neck imaging results, clinical variables, and outcomes were recorded. Data were compared by t-test for continuous and Fisher exact test for categorical variables. Results: 73 children were identified, 52 (71%) with inflicted and 21 (29%) with accidental trauma. The median age was 11 mo; (range: 1-35 mo). Ten (14%) had c-spine injuries, 7/52 (13%) inflicted, and 3/21 (14%) accidental. The mechanism was shaking for all inflicted and motor vehicle accident or pedestrian struck for accidental c-spine injuries. The inflicted group were significantly younger (P = 0.03), had higher Injury Severity Scores (P = 0.02), subdural hematomas (P = 0.03), fractures (P = 0.03), retinal hemorrhages (P = 0.02), brain infarcts (P = 0.01), and required cardiopulmonary resuscitation (P = 0.01). Seven with inflicted trauma died from brain injury (9.5%), one had atlanto-occipital dissociation. Six mortalities (86%) had no c-spine injury. Six with inflicted c-spine injuries survived with neurologic impairment, whereas three with accidental survived without disability, including one atlanto-occipital dissociation. Conclusions: Compared to accidental trauma, young children with inflicted c-spine injuries have more multisystem trauma, long-term disability from brain injury, and an injury pattern consistent with shaking. (C) 2017 Elsevier Inc. All rights reserved.	[Baerg, Joanne; Thirumoorthi, Arul; Hazboun, Rajaie; Vannix, Rosemary] Loma Linda Univ, Div Pediat Surg, Childrens Hosp, Rm 21111,Coleman Pavil,11175 Campus St, Loma Linda, CA 92354 USA; [Krafft, Paul; Zouros, Alexander] Loma Linda Univ, Childrens Hosp, Div Pediat Neurosurg, Loma Linda, CA 92354 USA		Baerg, J (corresponding author), Loma Linda Univ, Div Pediat Surg, Childrens Hosp, Rm 21111,Coleman Pavil,11175 Campus St, Loma Linda, CA 92354 USA.	jbaerg@llu.edu		Baerg, Joanne/0000-0002-0388-8485			Adib O, 2016, SKELETAL RADIOL, V45, P1607, DOI 10.1007/s00256-016-2481-9; Anderson RCE, 2010, J NEUROS-PEDIATR, V5, P292, DOI 10.3171/2009.10.PEDS09159; Arbuthnot MK, 2017, SURG CLIN N AM, V97, P35, DOI 10.1016/j.suc.2016.08.003; Astur N, 2013, J BONE JOINT SURG AM, V95A, P2213, DOI 10.2106/JBJS.L.01295; Bradford R, 2013, J NEUROSURG-PEDIATR, V12, P110, DOI 10.3171/2013.4.PEDS12596; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; Buehner Michelle, 2017, Tex Med, V113, pe1; CAFFEY J, 1974, PEDIATRICS, V54, P396; Chin K, 2016, INSTR COURSE LECT, V65, P345; Choudhary AK, 2014, PEDIATR RADIOL, V44, P1130, DOI 10.1007/s00247-014-2959-3; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; da Silva MR, 2016, INT ORTHOP, V40, P1111, DOI 10.1007/s00264-016-3158-7; High K, 2016, PEDIAT EMERG CARE; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Jacob R., 2016, AJNR AM J NEURORADIO; Jordan LC, 2011, NAT REV NEUROL, V7, P199, DOI 10.1038/nrneurol.2011.23; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Knox JB, 2014, J PEDIATR ORTHOPED, V34, P698, DOI 10.1097/BPO.0000000000000167; Litz CN, 2017, J PEDIATR SURG, V52, P625, DOI 10.1016/j.jpedsurg.2016.08.026; Pannu GS, J PEDIAT ORTHOP; Shin JI, 2016, SPINE, V41, P283, DOI 10.1097/BRS.0000000000001176; TEASDALE G, 1974, LANCET, V2, P81; Van de Voorde P, 2008, RESUSCITATION, V76, P175, DOI 10.1016/j.resuscitation.2007.07.007; Vazquez E, 2014, PEDIATR RADIOL, V44, P589, DOI 10.1007/s00247-014-3216-5	24	6	6	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2017	219						366	373		10.1016/j.jss.2017.06.053			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FK8RF	WOS:000413775200053	29078907				2022-02-06	
J	Bertisch, H; Krellman, JW; Bergquist, TF; Dreer, LE; Ellois, V; Bushnik, T				Bertisch, Hilary; Krellman, Jason W.; Bergquist, Thomas F.; Dreer, Laura E.; Ellois, Valerie; Bushnik, Tamara			Characteristics of Firearm Brain Injury Survivors in the Traumatic Brain Injury Model Systems (TBIMS) National Database: A Comparison of Assault and Self-Inflicted Injury Survivors	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Meeting of the American-Academy-of-Clinical-Neuropsychology	JUN 25, 2014	New York, NY	Amer Acad Clin Neuropsychol		Brain injuries, traumatic; Firearms; Rehabilitation; Suicide	GLASGOW OUTCOME SCALE; GUNSHOT WOUNDS; HEAD; DISABILITY; VALIDITY; VIOLENCE; SHOTGUN; SUICIDE; IMPACT; DEATH	Objective: To characterize and compare subgroups of survivors with assault-related versus self-inflicted traumatic brain injuries (TBIs) via firearms at the time of inpatient rehabilitation and at 1-, 2-, and 5-year follow-up. Design: Secondary analysis of data from the Traumatic Brain Injury Model Systems National Database (TRIMS NDB), a multicenter, longitudinal cohort study. Setting: Retrospective analyses of a subset of individuals enrolled in the TBIMS NDB. Participants: Individuals 16 years and older (N=399; 310 via assault, 89 via self-inflicted injury) with a primary diagnosis of TBI caused by firearm injury enrolled in the TBIMS NDB. Interventions: Not applicable. Main Outcome Measures: Disability Rating Scale, Glasgow Outcome Scale Extended, sociodemographic variables (sex, age, race, marital status), injury-related/acute care information (posttraumatic amnesia, loss of consciousness, time from injury to acute hospital discharge), and mental health variables (substance use history, psychiatric hospitalizations, suicide history, incarcerations). Results: Individuals who survived TBI secondary to a firearm injury differed by injury mechanism (assault vs self-inflicted) on critical demographic, injury-related/acute care, and mental health variables at inpatient rehabilitation and across long-term recovery. Groups differed in terms of geographic area, age, ethnicity, education, marital status, admission Glasgow Coma Scale score, and alcohol abuse, suicide attempts, and psychiatric hospitalizations at various time points. Conclusions: These findings have implications for prevention (eg, mental health programming and access to firearms in targeted areas) and for rehabilitation planning (eg, by incorporating training with coping strategies and implementation of addictions-related services) for firearm-related TBI, based on subtype of injury. (C) 2016 by the American Congress of Rehabilitation Medicine	[Bertisch, Hilary; Ellois, Valerie; Bushnik, Tamara] NYU, Sch Med, Rusk Rehabil, New York, NY USA; [Krellman, Jason W.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA; [Bergquist, Thomas F.] Mayo Clin, Coll Med, Dept Phys Med & Rehabil, Rochester, MN USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Bertisch, H (corresponding author), NYU Rusk Rehabil, 240 E 38th St, New York, NY 10016 USA.	Hilary.bertisch@nyumc.org			Traumatic Brain Injury Model Systems (TBIMS) National Data and Statistical Center from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR); Rusk Rehabilitation at New York University School of Medicine [90DP0047]; Icahn School of Medicine at Mount Sinai Hospital [90DP0038]; Mayo Clinic [90DP0030]; University of Alabama at Birmingham [90DP0044]; NIDILRRUnited States Department of Health & Human Services	Supported by the Traumatic Brain Injury Model Systems (TBIMS) National Data and Statistical Center grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR); Rusk Rehabilitation at New York University School of Medicine (grant no. 90DP0047); Icahn School of Medicine at Mount Sinai Hospital (grant no. 90DP0038); Mayo Clinic (grant no. 90DP0030); and University of Alabama at Birmingham (grant no. 90DP0044).; The TBIMS National Database is supported by the NIDILRR and created and maintained by the TBIMS Centers Program. This article is intended to promote the exchange of ideas among researchers and policymakers. The views expressed in it are part of ongoing research and analysis and do not necessarily reflect the position of the U.S. Department Health and Human Services.	American Association of Neurological Surgeons, 2015, GUNSH WOUND HEAD TRA; Ball CG, 2015, CAN J SURG, V58, P284, DOI 10.1503/cjs.012814; Bizhan Aarabi, 2015, Handb Clin Neurol, V127, P181, DOI 10.1016/B978-0-444-52892-6.00012-X; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cullen EF, 2010, AM J FOREN MED PATH, V31, P255, DOI 10.1097/PAF.0b013e3181e12823; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harada K, 2014, LEGAL MED-TOKYO, V16, P95, DOI 10.1016/j.legalmed.2013.12.005; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Joseph B, 2014, AM J SURG, V207, P89, DOI 10.1016/j.amjsurg.2013.06.014; Karaca MA, 2015, ULUS TRAVMA ACIL CER, V21, P248, DOI 10.5505/tjtes.2015.64495; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Kim H, 2008, J TRAUMA, V65, P1287, DOI 10.1097/TA.0b013e31817196f5; Lawson BD, 2016, MIL MED, V181, P887, DOI 10.7205/MILMED-D-15-00184; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Mauritz W, 2014, BRAIN INJURY, V28, P1096, DOI 10.3109/02699052.2014.904522; McCauley SR, 2010, J NEUROTRAUM, V27, P991, DOI 10.1089/neu.2009.1195; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Pavelites JJ, 2010, FORENSIC SCI MED PAT, V6, P298, DOI 10.1007/s12024-010-9177-6; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reddy AK, 2014, JAMA OPHTHALMOL, V132, P730, DOI 10.1001/jamaophthalmol.2013.8201; Rivara FP, 2013, INJURY PREV, V19, P224, DOI 10.1136/injuryprev-2013-040837; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Rowhani-Rahbar A, 2015, ANN INTERN MED, V162, P492, DOI 10.7326/M14-2362; Sharpe D., 2015, 2015 ANN IEEE IND C, V20, P1; TEASDALE G, 1974, LANCET, V2, P81; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte RD, 1997, BRAIN INJURY, V11, P403; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226; [No title captured]	35	6	6	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2017	98	11					2288	2294		10.1016/j.apmr.2017.04.006			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	FL5KK	WOS:000414275500023	28478127	Bronze			2022-02-06	
J	Billings, JM; Eder, M; Flood, WC; Dhami, DS; Natarajan, S; Whitlow, CT				Billings, John M.; Eder, Maxwell; Flood, William C.; Dhami, Devendra Singh; Natarajan, Sriraam; Whitlow, Christopher T.			Machine Learning Applications to Resting-State Functional MR Imaging Analysis	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Machine learning; MR imaging; Computer science; Function MR imaging; Resting state function MR imaging	MILD COGNITIVE IMPAIRMENT; MAJOR DEPRESSIVE DISORDER; SUPPORT VECTOR MACHINE; TRAUMATIC BRAIN-INJURY; CONNECTIVITY PATTERNS; ALZHEIMERS-DISEASE; CLASSIFICATION; FMRI; SCHIZOPHRENIA; NETWORK	Machine learning is one of the most exciting and rapidly expanding fields within computer science. Academic and commercial research entities are investing in machine learning methods, especially in personalized medicine via patient-level classification. There is great promise that machine (earning methods combined with resting state functional MR imaging will aid in diagnosis of disease and guide potential treatment for conditions thought to be impossible to identify based on imaging alone, such as psychiatric disorders. We discuss machine learning methods and explore recent advances.	[Billings, John M.; Eder, Maxwell; Flood, William C.; Whitlow, Christopher T.] Wake Forest Sch Med, RIIPL, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Billings, John M.; Eder, Maxwell; Flood, William C.; Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol, Div Neuroradiol, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Dhami, Devendra Singh; Natarajan, Sriraam] Indiana Univ, Sch Informat & Comp, Informat East Bldg,Room 257,919 E 10th St, Bloomington, IN 47408 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Biomed Engn, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, CTSI, Med Ctr Blvd, Winston Salem, NC 27157 USA		Whitlow, CT (corresponding author), Wake Forest Sch Med, Dept Radiol, Div Neuroradiol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	cwhitlow@wakehealth.edu		Eder, Maxwell/0000-0003-0763-1852	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS091602]	Supported by the National Institutes of Health R01 NS091602 (C.T. Whitlow).	Alahmadi HH, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00117; Bohland JW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00078; Brown MRG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00069; Cao LL, 2014, PSYCHIAT CLIN NEUROS, V68, P110, DOI 10.1111/pcn.12106; Challis E, 2015, NEUROIMAGE, V112, P232, DOI 10.1016/j.neuroimage.2015.02.037; Chen CP, 2015, NEUROIMAGE-CLIN, V8, P238, DOI 10.1016/j.nicl.2015.04.002; Chen H, 2016, PROG NEURO-PSYCHOPH, V64, P1, DOI 10.1016/j.pnpbp.2015.06.014; Chiang S, 2015, J MAGN RESON IMAGING, V41, P1689, DOI 10.1002/jmri.24696; Chyzhyk D, 2015, NEURAL NETWORKS, V68, P23, DOI 10.1016/j.neunet.2015.04.002; Chyzhyk D, 2015, INT J NEURAL SYST, V25, DOI 10.1142/S0129065715500070; Dey S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00064; Dyrba M, 2015, HUM BRAIN MAPP, V36, P2118, DOI 10.1002/hbm.22759; Ghiassian S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166934; Iidaka T, 2015, CORTEX, V63, P55, DOI 10.1016/j.cortex.2014.08.011; Kassraian-Fard P, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00177; Khazaee A, 2017, BEHAV BRAIN RES, V322, P339, DOI 10.1016/j.bbr.2016.06.043; Khazaee A, 2016, BRAIN IMAGING BEHAV, V10, P799, DOI 10.1007/s11682-015-9448-7; Kim JW, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv052; Kim J, 2016, NEUROIMAGE, V124, P127, DOI 10.1016/j.neuroimage.2015.05.018; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; La Corte V, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00204; Li YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073186; Lin CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085354; Liu F, 2015, BRAIN STRUCT FUNCT, V220, P101, DOI 10.1007/s00429-013-0641-4; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Lui YW, 2014, NEUROLOGY, V83, P1235, DOI 10.1212/WNL.0000000000000834; Meier TB, 2012, NEUROIMAGE, V60, P601, DOI 10.1016/j.neuroimage.2011.12.052; Mikolas P, 2016, PSYCHOL MED, V46, P2695, DOI 10.1017/S0033291716000878; Morris LS, 2016, BIOL PSYCHIAT, V79, P499, DOI 10.1016/j.biopsych.2015.06.009; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Ou JL, 2015, BRAIN IMAGING BEHAV, V9, P663, DOI 10.1007/s11682-014-9320-1; Paldino MJ, 2017, NEUROIMAGE-CLIN, V13, P201, DOI 10.1016/j.nicl.2016.12.005; Plitt M, 2015, P NATL ACAD SCI USA, V112, pE6699, DOI 10.1073/pnas.1510098112; Premi E, 2016, J ALZHEIMERS DIS, V51, P249, DOI 10.3233/JAD-150340; Ramasubbu R, 2016, NEUROIMAGE-CLIN, V12, P320, DOI 10.1016/j.nicl.2016.07.012; Rive MM, 2016, BIPOLAR DISORD, V18, P612, DOI 10.1111/bdi.12446; Roberts G, 2017, BIOL PSYCHIAT, V81, P718, DOI 10.1016/j.biopsych.2016.08.018; Sato JR, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00068; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; SIDHU GS, 2012, FRONT SYST NEUROSCI, V6; Sikora Magdalena, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P68; Skatun K. C., 2016, SCHIZOPHR B; Suk HI, 2016, NEUROIMAGE, V129, P292, DOI 10.1016/j.neuroimage.2016.01.005; Suk HI, 2015, NEUROINFORMATICS, V13, P277, DOI 10.1007/s12021-014-9241-6; Uddin LQ, 2015, CEREB CORTEX, V25, P4740, DOI 10.1093/cercor/bhu161; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Vergun S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00440; Wang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051769, 10.1371/journal.pone.0039845, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wang XH, 2013, EUR J RADIOL, V82, P1552, DOI 10.1016/j.ejrad.2013.04.009; Wee CY, 2012, NEUROIMAGE, V59, P2045, DOI 10.1016/j.neuroimage.2011.10.015; Wei MB, 2013, PSYCHIAT RES-NEUROIM, V214, P306, DOI 10.1016/j.pscychresns.2013.09.008; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Yang ZY, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00184; Zeng LL, 2014, HUM BRAIN MAPP, V35, P1630, DOI 10.1002/hbm.22278; Zhang WJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/763965; Zhu DJ, 2014, HUM BRAIN MAPP, V35, P2911, DOI 10.1002/hbm.22373	57	6	6	3	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	NOV	2017	27	4					609	+		10.1016/j.nic.2017.06.010			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FL5KF	WOS:000414275000007	28985932				2022-02-06	
J	Chartrain, AG; Awad, AJ; Sarkiss, CA; Feng, R; Liu, YB; Mocco, J; Bederson, JB; Mayer, SA; Dangayach, NS; Gordon, E				Chartrain, Alexander G.; Awad, Ahmed J.; Sarkiss, Christopher A.; Feng, Rui; Liu, Yangbo; Mocco, J.; Bederson, Joshua B.; Mayer, Stephan A.; Dangayach, Neha S.; Gordon, Errol			A step-down unit transfer protocol for low-risk aneurysmal subarachnoid hemorrhage	NEUROSURGICAL FOCUS			English	Article						aneurysmal subarachnoid hemorrhage; step-down unit; intensive care unit; transfer protocol; high-volume center	TRAUMATIC INTRACRANIAL HEMORRHAGE; ADULT PATIENTS; BRAIN-INJURY; FISHER SCALE; CARE; ADMISSION; PATIENT; BEDS	OBJECTIVE Patients who have experienced subarachnoid hemorrhage (SAH) often receive care in the setting of the ICU. However, SAH patients may not all require extended ICU admission. The authors established a protocol on January 1, 2015, to transfer select, low-risk patients to a step-down unit (SDU) to streamline care for SAH patients. This study describes the results of the implemented protocol. METHODS In this retrospective chart review, patients presenting with SAH between January 2011 and September 2016 were reviewed for inclusion. The control group consisted of patients admitted prior to establishment of the SDU transfer protocol, while the intervention group consisted of patients admitted afterward. RESULTS Of the patients in the intervention group, 79.2% (57/72) were transferred to the SDU during their admission. Of these transferred patients, 29.8% (17/57) required return to the neurosurgical ICU (NSICU). There were no instances of morbidity or mortality directly related to care in the SDU. Patients in the intervention group had a mean reduced NSICU length of stay, by 1.95 days, which trended toward significance, and a longer average hospitalization, by 2.7 days, which also trended toward significance. In-hospital mortality and 90-day readmission rate were not statistically different between the groups. In addition, early transfer timing prior to 7 days was associated with neither a higher return rate to the NSICU nor higher 90-day readmission rate. CONCLUSIONS In this retrospective study, the authors demonstrated that the transfer protocol was safe, feasible, and effective in reducing the ICU length of stay and was independent of transfer timing. Confirmation of these results is needed in a large, multicenter study.	[Chartrain, Alexander G.; Awad, Ahmed J.; Sarkiss, Christopher A.; Feng, Rui; Liu, Yangbo; Mocco, J.; Bederson, Joshua B.; Dangayach, Neha S.; Gordon, Errol] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Dangayach, Neha S.; Gordon, Errol] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Mayer, Stephan A.] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA		Gordon, E (corresponding author), Icahn Sch Med Mt Sinai, Neurol & Neurosurg, NSICU, 1468 Madison Ave,Annenberg Bldg,8th Fl, New York, NY 10029 USA.	errol.gordon@mountsinai.org					Albertine P, 2016, AM J EMERG MED, V34, P521, DOI 10.1016/j.ajem.2015.12.035; Bardes JM, 2016, AM SURGEON, V82, P36; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Nuno M, 2012, NEUROCRIT CARE, V17, P312, DOI 10.1007/s12028-012-9740-y; Prin M, 2014, AM J RESP CRIT CARE, V190, P1210, DOI 10.1164/rccm.201406-1117PP; Richards BF, 2012, J NEUROINTERV SURG, V4, DOI 10.1136/neurintsurg-2011-010058; Rosner J, 2013, NEUROSURGERY, V60, P98, DOI 10.1227/01.neu.0000430309.86573.2d; Sinuff T, 2004, CRIT CARE MED, V32, P1588, DOI 10.1097/01.CCM.0000130175.38521.9F; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	17	6	6	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E15	10.3171/2017.8.FOCUS17448			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800015	29088946	gold			2022-02-06	
J	Fouche, PF; Jennings, PA; Smith, K; Boyle, M; Blecher, G; Knott, J; Raji, M; Rosengarten, P; Augello, MR; Bernard, S				Fouche, Pieter Francsois; Jennings, Paul Andrew; Smith, Karen; Boyle, Malcolm; Blecher, Gabriel; Knott, Jonathan; Raji, Mani; Rosengarten, Pamela; Augello, Michael Roberto; Bernard, Stephen			Survival in Out-of-hospital Rapid Sequence Intubation of Non-Traumatic Brain Pathologies	PREHOSPITAL EMERGENCY CARE			English	Article						airway; non-traumatic brain pathologies; paramedic; rapid sequence intubation	GLASGOW COMA SCALE; UNRESPONSIVENESS SCORE; CARDIAC-ARREST; FULL OUTLINE; ACUTE STROKE; INJURY; COMORBIDITY; MORTALITY; FREQUENCY; CHILDREN	Introduction: Rapid sequence intubation (RSI) is not only used in traumatic brain injuries in the out-of-hospital setting, but also for non-traumatic brain pathologies (NTBP) such as brain tumors, meningitis, encephalitis, hypoxic/anoxic brain injury, stroke, arteriovenous malformations, tumors, aneurysms, brain hemorrhage, as well as brain injury due to diabetes, seizures and toxicity, metabolic conditions, and alcohol and drug overdose. Previous research suggests that RSI is common in non-traumatic coma, but with an unknown prevalence of NTBP in those that receive RSI. If NTBP is common and if brain trauma RSI evidence is not valid for NTBP then a sizable proportion of NTBP receive this treatment without evidence of benefit. This study calculated the out-of-hospital NTBP prevalence in patients that had received RSI and explored factors that predicted survival. Methods: A retrospective cohort study based on data collected from an ambulance service and seven hospitals based in Melbourne, Australia. Non-traumatic brain pathologies were defined using ICD10-AM codes for the calculation of NTBP prevalence. Logistic regression modelled out-of-hospital predictors of survival to hospital discharge after adjustment for comorbidities. Results: The seven participating hospitals treated 2,277 patients that received paramedic RSI for all illnesses and indications from January 1, 2008 to December 31, 2015, with survival data available for 1,940 (85%). Of the 1,940, 1,125 (58%) patients had at least one hospital-diagnosed NTBP. Sixty-nine percent all of NTBP survived to hospital discharge, compared to 65% for traumatic intracranial injury. Strokes were the most common and had poor survival to discharge (37%) compared to the second most common NTBP toxicity/toxic encephalopathy that had very high survival (98%). No out-of-hospital clinical intervention or prehospital time interval predicted survival. Factors that did predict survival include Glasgow Coma Scale (GCS), duration of mechanical ventilation, age, ICU length of stay, and comorbidities. Conclusions: Non-traumatic brain pathologies are seven times more prevalent than traumatic brain injuries in patients that underwent out-of-hospital RSI in Victoria, Australia. Since the mechanisms through which RSI impacts mortality might differ between traumatic brain injuries and NTBP, and given that NTBP is very prevalent, it follows that the use of RSI in NTBP could be unsupported.	[Fouche, Pieter Francsois; Jennings, Paul Andrew] Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Melbourne, Vic, Australia; [Smith, Karen] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Smith, Karen] Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Melbourne, Vic, Australia; [Smith, Karen] Univ Western Australia, Discipline Emergency Med, Perth, WA, Australia; [Bernard, Stephen] Ambulance Victoria, Res & Evaluat, Melbourne, Vic, Australia; [Boyle, Malcolm] Griffith Univ, Sch Med, Brisbane, Qld, Australia; [Blecher, Gabriel] Monash Univ, Clin Sci Monash Hlth, Monash Emergency Res Collaborat, Melbourne, Vic, Australia; [Blecher, Gabriel] Monash Hlth, Monash Med Ctr, Emergency Program, Melbourne, Vic, Australia; [Knott, Jonathan] Royal Melbourne Hosp, Dept Emergency Med, Melbourne, Vic, Australia; [Raji, Mani] Austin Hlth, Dept Emergency Med, Heidelberg, Vic, Australia; [Rosengarten, Pamela] Monash Univ, Peninsula Clin Sch, Cent Clin Sch, Melbourne, Vic, Australia; [Rosengarten, Pamela] Monash Univ, Peninsula Hlth Emergency Med, Melbourne, Vic, Australia; [Augello, Michael Roberto] St Vincents Hosp, Emergency Med, Melbourne, Vic, Australia		Fouche, PF (corresponding author), Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Bldg H,McMahons Rd, Frankston, Vic 3199, Australia.	pfouche@ambulance.nsw.gov.au	Boyle, Malcolm/A-4301-2008; Jennings, Paul/AAF-2016-2019	Boyle, Malcolm/0000-0003-4186-1280; Jennings, Paul/0000-0002-5605-7589; Augello, Michael/0000-0003-3999-1465; Blecher, Gabriel/0000-0001-8537-2011; Fouche, Pieter/0000-0002-7299-1363; Fouche, Pieter/0000-0003-2245-783X; Smith, Karen/0000-0002-9057-0685			Bernard SA, 2015, EMERG MED J, V32, P60, DOI 10.1136/emermed-2013-202930; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bushnell CD, 1999, NEUROLOGY, V52, P1374, DOI 10.1212/WNL.52.7.1374; Chan V, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0631-2; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chevignard M, 2010, CHILD CARE HLTH DEV, V36, P31, DOI 10.1111/j.1365-2214.2009.00949.x; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Elmer J, 2013, CRIT CARE MED, V41, P1992, DOI 10.1097/CCM.0b013e31828a3f4d; Fouche PF, 2017, RESUSCITATION, V110, P56, DOI 10.1016/j.resuscitation.2016.10.020; Fouche PF, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0282-8; Gaither JB, 2012, ANN EMERG MED, V60, P732, DOI 10.1016/j.annemergmed.2012.06.017; Grmec S, 2001, CRIT CARE, V5, P19; Gunning M, 2013, SAMJ, S. Afr. med. j., V103, P632, DOI 10.7196/samj.6656; Holmes J, 2012, PREHOSP EMERG CARE, V16, P210, DOI 10.3109/10903127.2011.640416; Hosmer DW, 2013, WILEY SER PROBAB ST, P1; Khuu W, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-14; Lee VE, 2000, EDUC PSYCHOL, V35, P125, DOI 10.1207/S15326985EP3502_6; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Mansour OY, 2015, ALEX J MED, V51, P247, DOI 10.1016/j.ajme.2014.10.002; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Perkins ZB, 2013, INJURY, V44, P618, DOI 10.1016/j.injury.2012.03.019; Reith J, 1997, STROKE, V28, P1585, DOI 10.1161/01.STR.28.8.1585; Royston P, 2008, MULTIVARIABLE MODEL MULTIVARIABLE MODEL; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; SHINTON RA, 1988, J NEUROL NEUROSUR PS, V51, P273, DOI 10.1136/jnnp.51.2.273; Soni N, 2008, BRIT J ANAESTH, V101, P446, DOI 10.1093/bja/aen240; Vadeboncoeur TF, 2006, J EMERG MED, V30, P131, DOI 10.1016/j.jemermed.2005.04.019; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Victoria A, 2016, CLIN PRACTICE GUIDEL, P42; Wang HE, 2011, RESUSCITATION, V82, P378, DOI 10.1016/j.resuscitation.2010.12.014; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Young GB, 2009, ANN NY ACAD SCI, V1157, P32, DOI 10.1111/j.1749-6632.2009.04471.x	34	6	6	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	NOV-DEC	2017	21	6					700	708		10.1080/10903127.2017.1325952			9	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	FN3TI	WOS:000415922000005	28622071	Green Accepted			2022-02-06	
J	Hockel, K; Diedler, J; Neunhoeffer, F; Heimberg, E; Nagel, C; Schuhmann, MU				Hockel, Konstantin; Diedler, Jennifer; Neunhoeffer, Felix; Heimberg, Ellen; Nagel, Carmen; Schuhmann, Martin U.			Time spent with impaired autoregulation is linked with outcome in severe infant/paediatric traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Paediatric; Traumatic brain injury; Outcome; Cerebral autoregulation; Pressure reactivity; PRx	CEREBROVASCULAR PRESSURE REACTIVITY; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURIES; INTRACRANIAL-PRESSURE; BLOOD-FLOW; CRITICAL THRESHOLDS; CHILDREN; METABOLISM; SCORE; AGE	It could be shown in traumatic brain injury (TBI) in adults that the functional status of cerebrovascular autoregulation (AR), determined by the pressure reactivity index (PRx), correlates to and even predicts outcome. We investigated PRx, cerebral perfusion pressure (CPP) and intracranial pressure (ICP) and their correlation to outcome in severe infant and paediatric TBI. Seventeen patients (range, 1 day to 14 years) with severe TBI (median GCS at presentation, 4) underwent long-term computerised ICP and mean arterial pressure (MAP) monitoring using dedicated software to determine CPP and PRx and optimal CPP (CPP level where PRx shows best autoregulation) continuously. Outcome was determined at discharge and at follow-up using the Glasgow Outcome Scale. Favourable outcome was reached in eight patients, unfavourable outcome in seven patients. Two patients died. Nine patients underwent decompressive craniectomy to control ICP during Intensive Care Unit treatment. When dichotomised to outcome, no significant difference was found for overall ICP, CPP and PRx. The time with severely impaired AR (PRx > 0.2) was significantly longer for patients with unfavourable outcome (64 h vs 6 h,p = 0.001). Continuously impaired AR of 24 h and age < 1 year was associated to unfavourable outcome. Children with favourable outcome spent the entire monitoring time at or above the optimal CPP. Integrity of AR has a similar role for outcome after TBI in the paediatric population as in adults. The amount of time spent with deranged AR seems to be associated with outcome; a factor especially critical for infant patients. The results of this preliminary study need to be validated in the future.	[Hockel, Konstantin; Diedler, Jennifer; Schuhmann, Martin U.] Univ Hosp Tubingen, Sect Paediat Neurosurg, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany; [Neunhoeffer, Felix; Heimberg, Ellen] Univ Childrens Hosp Tubingen, Paediat Intens Care Med, Tubingen, Germany; [Nagel, Carmen] Univ Childrens Hosp Tubingen, Dept Paediat Surg, Tubingen, Germany		Hockel, K (corresponding author), Univ Hosp Tubingen, Sect Paediat Neurosurg, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	Konstantin.hockel@med.uni-tuebingen.de					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Nagel C, 2016, ACTA NEUROCHIR SUPPL, V122, P239, DOI 10.1007/978-3-319-22533-3_48; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Rhee C, 2013, 15 INT C INTR PRESS; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817	29	6	6	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2017	159	11					2053	2061		10.1007/s00701-017-3308-8			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FJ4ZZ	WOS:000412754600004	28871418				2022-02-06	
J	Holdnack, JA; Tulsky, DS; Slotkin, J; Tyner, CE; Gershon, R; Iverson, GL; Heinemann, AW				Holdnack, James A.; Tulsky, David S.; Slotkin, Jerry; Tyner, Callie E.; Gershon, Richard; Iverson, Grant L.; Heinemann, Allen W.			NIH Toolbox Premorbid Ability Adjustments: Application in a Traumatic Brain Injury Sample	REHABILITATION PSYCHOLOGY			English	Article						premorbid ability; reading adjustment; traumatic brain injury; cognition; NIH Toolbox	COGNITION BATTERY; WAIS-IV; WMS-IV; NEUROPSYCHOLOGICAL ASSESSMENT; WECHSLER TEST; HEAD-INJURY; INTELLIGENCE; VALIDITY; PERFORMANCE; DEMENTIA	Purpose/Objective: Metrics to estimate premorbid cognitive ability, such as word reading tests, are important for clinical determination of cognitive changes following brain injury. In the present study, reading adjusted scores for the National Institutes of Health Toolbox Cognition Battery (NIHTB-CB) fluid tests were developed and validated with a sample of individuals with traumatic brain injury (TBI), to evaluate the clinical utility of reading-adjusted scores. Research Method/Design: The development sample included 843 adult participants, ages 20-85, from the NIHTB-CB standardization sample. A sample of 158 participants with complicated mild or moderate TBI (n = 74) or severe TBI (n = 84) were administered the NIHTB-CB, and comprised the validation sample. Scores were derived for the five fluid tests using four adjustment models: age-only, demographiconly, age- and-reading, and demographic-and-reading referenced scores. Results: Estimated premorbid ability varies depending on the reference model. Scores from each of the four reference models differentiated the comparison and TBI samples at the group level. However, performance varied by premorbid ability. Conclusions/Implications: Premorbid ability affects identification of cognitive difficulties after TBI. Reading referenced scores provide an individualized estimate of the effects of premorbid ability than demographic characteristics alone. Each model identified a similar number of individuals as having cognitive difficulties; however, the models differed on which individuals had cognitive difficulties. The models had higher disagreement rates in the clinical compared with the comparison sample, particularly for individuals with lower premorbid ability. Clinical use and caveats are discussed.	[Holdnack, James A.; Tulsky, David S.; Slotkin, Jerry; Tyner, Callie E.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Bear, DE 19701 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Bear, DE 19701 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Bear, DE 19701 USA; [Gershon, Richard] Northwestern Univ, Dept Med Social Sci, Evanston, IL 60208 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; [Heinemann, Allen W.] Shirley Ryan AbilityLab, Chicago, IL USA		Holdnack, JA (corresponding author), Univ Delaware, Ctr Assessment Res & Translat, 5 Rose Hill Dr, Bear, DE 19701 USA.	jhold@udel.edu	Tyner, Callie/K-8935-2019; Heinemann, Allen W./AAI-2790-2021	Tyner, Callie/0000-0003-2945-392X; Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509; Iverson, Grant/0000-0001-7348-9570	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090024, H122G070138]; Institutional Development Award (IDeA) from National Institute of General Medical Sciences of the National Institutes of Health [U54-GM104941]; Mooney-Reed Charitable Foundation; Heinz Family Foundation; ImPACT Applications, Inc.; ImPACT(R) Applications Systems; CNS Vital Signs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104941] Funding Source: NIH RePORTER	Standardization data from NIH Toolbox used with permission. This research was supported by Grants H133B090024, H122G070138 from the National Institute on Disability, Independent Living, and Rehabilitation Research. Support for JAH was also provided by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant U54-GM104941(PI: Binder-Macleod). GLI acknowledges support from the Mooney-Reed Charitable Foundation, the Heinz Family Foundation, and ImPACT Applications, Inc. This work is related in part to the TBI Endpoints Development Initiative and a grant titled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials. GLI has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical practice in forensic neuropsychology involving individuals who have sustained mild TBIs. He has received honorariums for serving on research panels that provide scientific peer review of programs. He is a coinvestigator, collaborator, or consultant on grants relating to mild TBI funded by several organizations. He has received research support from test publishing companies in the past, including ImPACT (R) Applications Systems and CNS Vital Signs. He receives royalties for one neuropsychological test (Wisconsin Card Sorting Test-64 Card Version).	BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Beaumont JL, 2013, NEUROLOGY, V80, pS87, DOI 10.1212/WNL.0b013e3182872e70; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC, P21; Delis DC., 2001, DELIS KAPLAN EXECUTI; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2012, ARCH CLIN NEUROPSYCH, V27, P440, DOI 10.1093/arclin/acs043; Fine EM, 2011, CLIN NEUROPSYCHOL, V25, P1331, DOI 10.1080/13854046.2011.609838; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Heled E, 2012, J CLIN EXP NEUROPSYC, V34, P151, DOI 10.1080/13803395.2011.625351; Holdnack JA, 2013, PRACT RESOUR MENT, P217, DOI 10.1016/B978-0-12-386934-0.00005-5; JohnsonGreene D, 1997, ARCH CLIN NEUROPSYCH, V12, P635, DOI 10.1016/S0887-6177(96)00046-7; Johnstone B, 2002, ARCH CLIN NEUROPSYCH, V17, P273, DOI 10.1016/S0887-6177(01)00112-3; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Manly J., 2003, CLIN INTERPRETATION, P181, DOI DOI 10.1016/B978-012703570-3/50010-9; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Martin P. K., 2016, ASSESSMENT; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Morris PG, 2005, BRIT J CLIN PSYCHOL, V44, P209, DOI 10.1348/014466505X34174; Mungas D, 2014, J INT NEUROPSYCH SOC, V20, P579, DOI 10.1017/S1355617714000307; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; Pearson, 2001, MAN WECHSL TEST AD R; Pearson, 2009, TEST PREM FUNCT ADV; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P769, DOI 10.1016/S0887-6177(97)00051-6; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Sinclair KL, 2013, J CLIN EXP NEUROPSYC, V35, P210, DOI 10.1080/13803395.2012.762340; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STORANDT M, 1995, NEUROPSYCHOLOGY, V9, P174, DOI 10.1037/0894-4105.9.2.174; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tulsky D., REHABILITAT IN PRESS; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554; Wright MJ, 2014, J CLIN EXP NEUROPSYC, V36, P268, DOI 10.1080/13803395.2014.884543	44	6	6	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					496	508		10.1037/rep0000198			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT1CK	WOS:000422871400010	29265870	Bronze, Green Accepted			2022-02-06	
J	Jeong, HW; Choi, SW; Youm, JY; Lim, JW; Kwon, HJ; Song, SH				Jeong, Hee-Won; Choi, Seung-Won; Youm, Jin-Young; Lim, Jeong-Wook; Kwon, Hyon-Jo; Song, Shi-Hun			Mortality and Epidemiology in 256 Cases of Pediatric Traumatic Brain Injury : Korean Neuro-Trauma Data Bank System (KNTDBS) 2010-2014	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain Injuries; Pediatrics; Epidemiology; Mortality; Republic of Korea; Database	HEAD-INJURY; CHILDREN; AGE; MECHANISMS; MANAGEMENT; SKULL	Objective : Among pediatric injury, brain injury is a leading cause of death and disability. To improve outcomes, many developed countries built neurotrauma databank (NTDB) system but there was not established nationwide coverage NTDB until 2009 and there have been few studies on pediatric traumatic head injury (THI) patients in Korea. Therefore, we analyzed epidemiology and outcome from the big data of pediatric THI. Methods : We collected data on pediatric patients from 23 university hospitals including 9 regional trauma centers from 2010 to 2014 and analyzed their clinical factors (sex, age, initial Glasgow coma scale, cause and mechanism of head injury, presence of surgery). Results : Among all the 2617 THI patients, total number of pediatric patients was 256. The average age of the subjects was 9.07 (standard deviation +/- 6.3) years old. The male-to female ratio was 1.87 to 1 and male dominance increases with age. The most common cause for trauma were falls and traffic accidents. Age (p=0.007), surgery (p<0.001), mechanism of trauma (p=0.016), subdural hemorrhage (SDH) (p<0.001), diffuse axonal injury (DAI) (p<0.001) were statistically significant associated with severe brain injury. Conclusion : Falls were the most common cause of trauma, and age, surgery, mechanism of trauma, SDH, DAI increased with injury severity. There is a critical need for effective fall and traffic accidents prevention strategies for children, and we should give attention to these predicting factors for more effective care.	[Jeong, Hee-Won; Choi, Seung-Won; Youm, Jin-Young; Lim, Jeong-Wook; Kwon, Hyon-Jo; Song, Shi-Hun] Chungnam Natl Univ Hosp, Dept Neurosurg, 282 Munhwa Ro, Daejeon 35015, South Korea		Choi, SW (corresponding author), Chungnam Natl Univ Hosp, Dept Neurosurg, 282 Munhwa Ro, Daejeon 35015, South Korea.	swchoi@cnu.ac.kr		Kwon, Hyon-Jo/0000-0003-1077-2461; Lim, jeongwook/0000-0003-1395-3145; Youm, Jin-Young/0000-0001-9609-0415			BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BERNEY J, 1994, CHILD NERV SYST, V10, P509, DOI 10.1007/BF00335073; DUHAIME AC, 1992, PEDIATRICS, V90, P179; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Goldsmith W, 2004, AM J FOREN MED PATH, V25, P89, DOI 10.1097/01.paf.0000127407.28071.63; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hyun DK, 2001, J KOREAN NEUROSURG S, V30, P54; Jalalvandi F, 2016, GLOBAL J HLTH SCI, V8, P139; Jo HJ, 2015, J TRAUMA INJ, V28, P149; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim HB, 2012, J KOREAN MED SCI, V27, P437, DOI 10.3346/jkms.2012.27.4.437; Kim JK, 1998, J KOREAN NEUROSURG S, V27, P625; Lee KW, 1999, J KOREAN NEUROSURG S, V28, P42; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mannix R, 2013, ANN EMERG MED, V62, P327, DOI 10.1016/j.annemergmed.2013.02.027; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Park CO, 1992, J KOREAN NEUROSURG S, V21, P176; Prevention Centers for Disease Control and Prevention National Center for Injury Prevention and Contorl, TRAUMATIC BRAIN INJU; Statistics Korea, ANN REP CAUS DEATH S; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424	21	6	7	0	7	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2017	60	6					710	716		10.3340/jkns.2016.1010.001			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FS9WW	WOS:000422771000013	29142631	Green Published, gold, Green Submitted			2022-02-06	
J	Kilianski, J; Peeters, S; Debad, J; Mohmed, J; Wolf, SE; Minei, JP; Diaz-Arrastia, R; Gatson, JW				Kilianski, Joseph; Peeters, Sophie; Debad, Jeff; Mohmed, Joseph; Wolf, Steven E.; Minei, Joseph P.; Diaz-Arrastia, Ramon; Gatson, Joshua W.			Plasma creatine kinase B correlates with injury severity and symptoms in professional boxers	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						CKBB; Mild TBI; Concussion	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; BLOOD; DYSFUNCTION; BIOMARKERS; APOPTOSIS; TAU	Introduction: Each year in the United States, approximately 1.7 million people sustain a traumatic brain injury (TBI). Of these TBI events, about 75 percent are characterized as being mild brain injuries. Immediately following TBI, a secondary brain damage persists for hours, days, and even months. Previously, detection of neuronal and glial biomarkers have proven to be useful to predict neurological outcomes. Here, we hypothesized that creatine kinase, brain (CKBB) is a sensitive biomarker for acute secondary brain injury in professional boxers. Methods: Blood (8 cc) was collected from the boxing athletes (n = 18) prior to and after competition (similar to 30 min). The plasma levels of CKBB were measured using the Meso Scale Diagnostic (MSD) electro-chemiluminescence (ECL) array-based multiplex format. Additional data such as number of blows to the head and symptom score (Rivermead Post Concussion Symptoms Questionnaire) were collected. Results: At approximately 30 min after the competition, the plasma levels of CKBB were significantly elevated in concussed professional boxers and correlated with the number of blows to the head and symptom scores. Additionally, receiver operating curve (ROC) analysis yielded a 77.8% sensitivity and a specificity of 82.4% with an area under the curve (AUC) of 90% for CKBB as an identifier of secondary brain injury within this population. Conclusion: This study describes the detection of CKBB as a brain biomarker to detect secondary brain injury in professional athletes that have experienced multiple high impact blows to the head. This acute biomarker may prove useful in monitoring secondary brain injury after injury. (C) 2017 Elsevier Ltd. All rights reserved.	[Mohmed, Joseph; Wolf, Steven E.; Minei, Joseph P.; Gatson, Joshua W.] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Kilianski, Joseph; Peeters, Sophie; Gatson, Joshua W.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Debad, Jeff] Meso Scale Diagnost LLC, Rockville, MD 20850 USA		Gatson, JW (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joshua.gatson@utsouthwestern.edu		Wolf, Steven/0000-0003-2972-3440			Bogoslovsky T, 2016, DIAGNOSTICS, P6; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; BRAYNE CEG, 1982, LANCET, V2, P1308; Carr ME, 2009, MIL MED, V174, P622, DOI 10.7205/MILMED-D-02-4708; Conti AC, 1998, J NEUROSCI, V18, P5663; Coplin WM, 1999, ARCH NEUROL-CHICAGO, V56, P1348, DOI 10.1001/archneur.56.11.1348; CORSELLIS JAN, 1989, BRIT MED J, V298, P105, DOI 10.1136/bmj.298.6666.105; Davis PC, 2007, AM J NEURORADIOL, V28, P1619; Debad JD, 2004, MG ELEC CH, P359; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Gatson J, 2014, JAMA NEUROL, V71, P677, DOI 10.1001/jamaneurol.2014.443; Gatson JW, 2014, J NEUROSURG, P1; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kozlov AV, 2017, BIOCH BIOPHYS ACTA; Meixensberger J, 1998, LANGENBECK ARCH SURG, V383, P214, DOI 10.1007/s004230050121; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; RABOW L, 1985, ACTA NEUROCHIR, V76, P137, DOI 10.1007/BF01418476; RABOW L, 1989, ACTA NEUROCHIR, V100, P155, DOI 10.1007/BF01403604; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; SOMER H, 1975, J NEUROL NEUROSUR PS, V38, P572, DOI 10.1136/jnnp.38.6.572; Tucker B, 2017, J EMERG MED; Unterharnscheidt F, 1995, Rev Neurol, V23, P661; Unterharnscheidt F, 1995, Rev Neurol, V23, P833; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	34	6	7	1	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2017	45						100	104		10.1016/j.jocn.2017.07.021			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL3GQ	WOS:000414111300017	28797606				2022-02-06	
J	Kroshus, E; Parsons, J; Hainline, B				Kroshus, Emily; Parsons, John; Hainline, Brian			Calling Injury Timeouts for the Medical Evaluation of Concussion: Determinants of Collegiate Football Officials' Behavior	JOURNAL OF ATHLETIC TRAINING			English	Article						referee; injury identification; self-efficacy; injunctive norms	SELF-EFFICACY; YOUTH	Context: Sports officials can play an important role in concussion safety by calling injury timeouts so that athletic trainers can evaluate athletes with possible concussions. Understanding the determinants of whether officials call an injury timeout when they suspect a concussion has important implications for the design of interventions to better support officials in this role. Objective: To assess the knowledge of US collegiate football officials about concussion symptoms and to determine the associations between knowledge, perceived injunctive norms, and self-efficacy in calling injury timeouts for suspected concussions. Design: Cross-sectional study. Setting: Electronic survey. Patients or Other Participants: Of the 3074 US collegiate football officials contacted, 1324 (43% response rate) participated. Main Outcome Measure(s): Concussion knowledge, injunctive norms (belief about what others would want them to do), and behavioral self-efficacy (confidence in their ability to call injury timeouts for suspected concussions in athletes during challenging game-day conditions). Results: Officials reported calling approximately 1 injury timeout for a suspected concussion every 4 games during the 2015 season. Structural equation modeling indicated that officials with more concussion-symptom knowledge had greater self-efficacy. Independent of an official's symptom knowledge, injunctive norms that were more supportive of calling an injury timeout were associated with greater self-efficacy. Conclusions: Concussion education for officials is important because when officials are aware of concussion symptoms, they are more confident in calling injury timeouts. Beyond increasing symptom knowledge, fostering sports environments that encourage concussion safety can support officials in calling injury timeouts. Athletic trainers can help by educating stakeholders, including officials, about the importance of concussion safety. When officials believe that other stakeholders support concussion safety, they are more likely to call injury timeouts if they suspect a concussion has occurred.	[Kroshus, Emily] Univ Washington Seattle, Seattle Childrens Res Inst, Dept Pediat, Seattle, WA USA; [Kroshus, Emily] Univ Washington Seattle, Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Parsons, John; Hainline, Brian] Natl Collegiate Athlet Assoc, Indianapolis, IN USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 West 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@uw.edu					BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bandura A, 1986, SOCIAL FDN THOUGHT A; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Fuller CW, 2004, AM J SPORT MED, V32, p17S, DOI 10.1177/0363546503261249; Gerrard M, 2008, DEV REV, V28, P29, DOI 10.1016/j.dr.2007.10.001; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; National Collegiate Athletic Association, STUD ATHL PART 1981; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; SCAT3, 2013, BRIT J SPORT MED, V47, P259; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016	14	6	6	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2017	52	11					1041	1047		10.4085/1062-6050-52.11.17			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FR0MQ	WOS:000418756400007	29140129	Green Published, Bronze			2022-02-06	
J	Li, W; Li, N; Sui, B; Yang, DP				Li, Wei; Li, Ning; Sui, Bing; Yang, Daping			Anti-aging effect of fullerenol on skin aging through derived stem cells in a mouse model	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						fullerenol; skin aging; stem cells; peroxisome proliferator-activated receptor-gamma; forkhead box protein O1	TRAUMATIC BRAIN-INJURY; GASTROESOPHAGEAL VARICES; INFLAMMATORY RESPONSE; HONOKIOL; BETA; INHIBITION; APOPTOSIS; SYSTEMS	Fullerenol is similar to graphite in terms of structure. In the present study, the anti-aging effect of fullerenol on skin through derived stem cells in a mouse model was assessed and the potential mechanism of fullerenol was investigated. The anti-aging effect of fullerenol effectively inhibited the retention rate of transplanted adipose-derived stem cells and increased the thickness of the dermal portion of skin and collagen ratio in mice. The effect of fullerenol on the proliferation of stem cells was observed. Treatment with fullerenol effectively promoted the mRNA expression of Runt-related transcription factor 2, alkaline phosphatase and osteocalcin in a mouse model of skin aging induced by D-galactose. However, fullerenol treatment effectively suppressed the protein expression of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and increased forkhead box protein O1 (FoxO1) protein expression in the mice model of skin aging induced by D-galactose. These results demonstrate that the anti-aging effect of fullerenol on skin through derived stem cells may be mediated in mice via the PPAR-gamma/FoxO1 signaling pathway.	[Li, Wei; Li, Ning; Sui, Bing; Yang, Daping] Harbin Med Univ, Affiliated Hosp 2, Dept Plast Surg, 246 Xuefu Rd, Harbin 150081, Heilongjiang, Peoples R China		Yang, DP (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Plast Surg, 246 Xuefu Rd, Harbin 150081, Heilongjiang, Peoples R China.	yangdaping@aliyun.com					Chen YJ, 2014, J ORTHOP RES, V32, P573, DOI 10.1002/jor.22577; Chiang J, 2009, EUR J PHARMACOL, V610, P119, DOI 10.1016/j.ejphar.2009.03.035; Clark RA, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-37; Erden A, 2009, CLIN IMAG, V33, P22, DOI 10.1016/j.clinimag.2008.06.023; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Huang LY, 2012, CHINESE MED J-PEKING, V125, P4312, DOI 10.3760/cma.j.issn.0366-6999.2012.23.027; Injac Rade, 2013, Methods Mol Biol, V1028, P75, DOI 10.1007/978-1-62703-475-3_5; Ishikawa C, 2012, BBA-GEN SUBJECTS, V1820, P879, DOI 10.1016/j.bbagen.2012.03.009; Kakutani H, 2005, HEPATOL RES, V33, P259, DOI 10.1016/j.hepres.2005.09.003; Kalinin S, 2007, NEUROBIOL AGING, V28, P1206, DOI 10.1016/j.neurobiolaging.2006.06.003; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Liu JM, 2013, SPECTROCHIM ACTA A, V115, P136, DOI 10.1016/j.saa.2013.06.031; Liu QH, 2013, SPINE J, V13, P1571, DOI 10.1016/j.spinee.2013.04.004; Lo EAG, 2015, ANN PHARMACOTHER, V49, P207, DOI 10.1177/1060028014559244; Marmulla R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00346; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; Senbel AM, 2014, VASC PHARMACOL, V62, P24, DOI 10.1016/j.vph.2014.04.004; Soontornniyomkij V, 2010, HUM PATHOL, V41, P1601, DOI 10.1016/j.humpath.2010.04.011; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Turkstra LS, 2012, J HEAD TRAUMA REHAB, V27, P424, DOI 10.1097/HTR.0b013e31823346fc; Weng TI, 2012, SHOCK, V37, P478, DOI 10.1097/SHK.0b013e31824653be; Yang XL, 2014, INT J NANOMED, V9, P4023, DOI 10.2147/IJN.S66785; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256; Zwan MD, 2014, Q J NUCL MED MOL IM, V58, P398	25	6	6	2	10	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	NOV	2017	14	5					5045	5050		10.3892/etm.2017.5163			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FM4GS	WOS:000414973100152	29201212	Green Published, gold			2022-02-06	
J	Merritt, ED; Brown, CN; Queen, RM; Simpson, KJ; Schmidt, JD				Merritt, Eric D.; Brown, Cathleen N.; Queen, Robin M.; Simpson, Kathy J.; Schmidt, Julianne D.			Concussion History and Time Since Concussion Do not Influence Static and Dynamic Balance in Collegiate Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						mild traumatic brain injury; head trauma; posture; Balance Error Scoring System; Y Balance Test	TRAUMATIC BRAIN-INJURY; POSTURAL STABILITY; FOOTBALL PLAYERS; RECOVERY; SPORT; STATEMENT; GAIT	Context: Dynamic balance deficits exist following a concussion, sometimes years after injury. However, clinicians lack practical tools for assessing dynamic balance. Objectives: To determine if there are significant differences in static and dynamic balance performance between individuals with and without a history of concussion. Design: Cross sectional. Setting: Clinical research laboratory. Patients or Other Participants: 45 collegiate student-athletes with a history of concussion (23 males, 22 females; age = 20.0 +/- 1.4 y; height = 175.8 +/- 11.6 cm; mass = 76.4 +/- 19.2 kg) and 45 matched controls with no history of concussion (23 males, 22 females; age = 20.0 +/- 1.3 y; height = 178.8 +/- 13.2 cm; mass = 75.7 +/- 18.2 kg). Interventions: Participants completed a static (Balance Error Scoring System) and dynamic (Y Balance Test-Lower Quarter) balance assessment. Main Outcome Measures: A composite score was calculated from the mean normalized Y Balance Test-Lower Quarter reach distances. Firm, foam, and overall errors were counted during the Balance Error Scoring System by a single reliable rater. One-way ANOVAs were used to compare balance performance between groups. Pearson's correlations were performed to determine the relationship between the time since the most recent concussion and balance performance. A Bonferonni adjusted a priori alpha < 0.025 was used for all analyses. Results: Static and dynamic balance performance did not significantly differ between groups. No significant correlation was found between the time since the most recent concussion and balance performance. Conclusions: Collegiate athletes with a history of concussion do not present with static or dynamic balance deficits when measured using clinical assessments. More research is needed to determine whether the Y Balance Test-Lower Quarter is sensitive to acute balance deficits following concussion.	[Merritt, Eric D.] Life Univ, Coll Chiropract, Marietta, GA USA; [Simpson, Kathy J.; Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Queen, Robin M.] Kevin P Granata Biomech Lab, Dept Biomed Engn & Mech, Blacksburg, VA USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA.	schmidtj@uga.edu			Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-14-2-0151]	The authors would like to thank Nicole Hoffman and Emily Miller, as well as the sports medicine staff, undergraduate assistants, student-athletes, and coaches for their cooperation with this study. Data collection and sharing for this project was conducted with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). Moreover, the U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Ford Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (DHP funds).	Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gribble PA, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093175; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Karimi MT, 2011, J RES MED SCI, V16, P530; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nardone A, 2010, EUR J PHYS REHAB MED, V46, P221; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Plisky PJ, 2006, J ORTHOP SPORT PHYS, V36, P911, DOI 10.2519/jospt.2006.2244; Plisky Phillip J, 2009, N Am J Sports Phys Ther, V4, P92; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	27	6	6	0	10	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	NOV	2017	26	6					518	523		10.1123/jsr.2016-0119			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FP4AA	WOS:000417557900006	27834575				2022-02-06	
J	Powierza, CS; Clark, MD; Hughes, JM; Carneiro, KA; Mihalik, JP				Powierza, Camilla S.; Clark, Michael D.; Hughes, Jaime M.; Carneiro, Kevin A.; Mihalik, Jason P.			Validation of a Self-Monitoring Tool for Use in Exercise Therapy	PM&R			English	Article							SPORT-RELATED CONCUSSION; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; ACTIVITY TRACKER; DEVICE; ADOLESCENTS; RELIABILITY; CONSUMER; CHILDREN; RECOVERY	Background: Aerobic exercise at a subsymptom heart rate has been recommended as therapy for postconcussion syndrome. Assessing adherence with an accurate heart rate-monitoring instrument is difficult, limiting the proliferation of large-scale randomized controlled trials. Objective: To evaluate the validity of the Fitbit Charge HR compared with electrocardiogram (EKG) to monitor heart rate during a treadmill-based exercise protocol. Design: A methods comparison study. Setting: Sports medicine research center within a tertiary care institution. Participants: A convenience sample of 22 healthy participants (12 female) aged 18-26 years (mean age: 22 +/- 2 years). Methods: Fitbit Charge HR heart rate measurements were compared with EKG data concurrently collected while participants completed the Buffalo Concussion Treadmill Test. Main Outcome Measures: Agreement between Fitbit Charge HR and EKG was assessed by intraclass correlation coefficients (ICC3,1), Bland-Altman limits of agreement, and percent error. Results: We observed a strong single-measure absolute agreement between Fitbit Charge HR and EKG (intraclass correlation coefficient = 0.83; 95% confidence interval 0.67-0.90). Fitbit Charge HR underestimated heart rate compared with EKG (mean difference = -6.04 bpm; standard deviation = 10.40 bpm; Bland-Altman 95% limits of agreement = -26.42 to 14.35 bpm). A total of 69.9% of Fitbit heart rate measurements were within 10% error compared with EKG, and 91.5% of all heart rate measurements were within 20% error. Conclusions: Although the mean bias in measuring heart rate was relatively small, the limits of agreement between the Fitbit Charge HR and EKG were broad. Thus, the Fitbit Charge HR would not be a suitable option for monitoring heart rate within a narrow range. For the purposes of postconcussion exercise therapy, the relatively inexpensive cost, easy implementation, and low maintenance make Fitbit Charge HR a viable option for assessing adherence to an exercise program when expensive clinical equipment is unavailable.	[Powierza, Camilla S.; Clark, Michael D.] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA; [Clark, Michael D.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Clark, Michael D.] Univ North Carolina Chapel Hill, Dept Allied Hlth Sci, Human Movement Sci Curriculum, Chapel Hill, NC USA; [Hughes, Jaime M.] Univ North Carolina Chapel Hill, Program Integrat Med, Chapel Hill, NC USA; [Hughes, Jaime M.; Carneiro, Kevin A.] Univ North Carolina Chapel Hill, Dept Phys Med & Rehabil, Chapel Hill, NC USA; [Mihalik, Jason P.] Univ North Carolina Chapel Hill, Human Movement Sci Curriculum, Dept Allied Hlth Sci, Stallings Evans Sports Med Ctr 2201, Campus Box 8700, Chapel Hill, NC 27599 USA		Mihalik, JP (corresponding author), Univ North Carolina Chapel Hill, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC USA.; Mihalik, JP (corresponding author), Univ North Carolina Chapel Hill, Human Movement Sci Curriculum, Dept Allied Hlth Sci, Stallings Evans Sports Med Ctr 2201, Campus Box 8700, Chapel Hill, NC 27599 USA.	jmihalik@email.unc.edu		Hughes, Jaime/0000-0001-6410-0068; Clark, Michael/0000-0002-5019-0290	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F30NS090816, T35DK007386, T32ATT003378]; Matthew Gfeller Sport-Related Traumatic Brain Injury Research Center; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT003378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK007386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F30NS090816] Funding Source: NIH RePORTER	Disclosures related to this publication: grant, National Institutes of Health (Michael Clark recipient of F30 [F30NS090816], Camilla Powierza supported by T35DK007386 and T32ATT003378) (money to institution)r This work was supported by National Institutes of Health grants F30NS090816, T35DK007386, and T32ATT003378 and internal funding from the Matthew Gfeller Sport-Related Traumatic Brain Injury Research Center.	Akerberg A, 2015, STUD HEALTH TECHNOL, V211, P105, DOI 10.3233/978-1-61499-516-6-105; Bai Y, 2016, MED SCI SPORT EXER, V48, P151, DOI 10.1249/MSS.0000000000000727; Baker JG, 2012, REHABIL RES PRACT, V2012, P1; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Butler MJ, 2016, PHYSIOL MEAS, V37, pN27, DOI 10.1088/0967-3334/37/5/N27; Cadmus-Bertram LA, 2015, AM J PREV MED, V49, P414, DOI 10.1016/j.amepre.2015.01.020; Charge HR Fitbit, PRODUCT MANUAL; Dannecker KL, 2013, MED SCI SPORT EXER, V45, P2105, DOI 10.1249/MSS.0b013e318299d2eb; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Diaz KM, 2015, INT J CARDIOL, V185, P138, DOI 10.1016/j.ijcard.2015.03.038; Dontje Manon L., 2015, Journal of Medical Engineering & Technology, V39, P286, DOI 10.3109/03091902.2015.1050125; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Iyriboz Y, 1991, Br J Sports Med, V25, P162; Jo E, 2016, J SPORT SCI MED, V15, P540; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lee J, 2015, STUD HEALTH TECHNOL, V210, P458, DOI 10.3233/978-1-61499-512-8-458; Leth S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010211; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Meltzer LJ, 2015, SLEEP, V38, P1323, DOI 10.5665/sleep.4918; NORTON LH, 1992, INT J SPORTS MED, V13, P523, DOI 10.1055/s-2007-1021310; Perez-Macias JM, 2014, IEEE ENG MED BIO, P4979, DOI 10.1109/EMBC.2014.6944742; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rafolt D, 2004, BIOMED TECH, V49, P22, DOI 10.1515/BMT.2004.005; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Sasaki JE, 2015, J PHYS ACT HEALTH, V12, P149, DOI 10.1123/jpah.2012-0495; Stahl Sarah E, 2016, BMJ Open Sport Exerc Med, V2, pe000106; Takacs J, 2014, J SCI MED SPORT, V17, P496, DOI 10.1016/j.jsams.2013.10.241; Takalokastari T, 2014, IEEE J BIOMED HEALTH, V18, P1058, DOI 10.1109/JBHI.2013.2282934; Vooijs M, 2014, INTERACT J MED RES, V3, P12, DOI 10.2196/ijmr.3056	33	6	6	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	NOV	2017	9	11					1077	1084		10.1016/j.pmrj.2017.03.012			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FO8DS	WOS:000417113500002	28400221	Green Accepted			2022-02-06	
J	Ren, DX; Fan, J; Puccio, AM; Okonkwo, DO; Beers, SR; Conley, Y				Ren, Dianxu; Fan, Jun; Puccio, Ava M.; Okonkwo, David O.; Beers, Sue R.; Conley, Yvette			Group-Based Trajectory Analysis of Emotional Symptoms Among Survivors After Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; depressive symptom; life satisfaction; longitudinal data; severe TBI; trajectory analysis	QUALITY-OF-LIFE; DEPRESSION; SATISFACTION; REHABILITATION; DEFICITS; ANXIETY; IMPACT; RISK	Objectives: Depressive symptoms and anxiety are fairly common emotional outcomes after severe traumatic brain injury (TBI). Life satisfaction is a main factor in the general construct of subjective well-being. However, there is limited literature available on the interrelationship between emotional outcomes and life satisfaction post-severe TBI over time. The purpose of this study was to characterize distinct patterns of change in depressive symptoms, anxiety, and life satisfaction over 24 months after severe TBI and evaluate the interrelationship of different trajectory groups among them as well as associated subject characteristics. Methods: This prospective study used longitudinal data collected from the University of Pittsburgh Brain Trauma Research Center from survivors of severe TBI (N = 129). In addition to demographic and injury-related data, depressive symptoms, anxiety, and life satisfaction were collected at 3, 6, 12, and 24 months postinjury. A group-based trajectory model was performed to identify distinct longitudinal patterns of depressive symptoms, anxiety, and life satisfaction. The interrelationships of distinct trajectory groups were examined using (2) tests. A multivariate logistic regression model was used to examine the predictors of different emotional symptom trajectories. Results: The group-based trajectory model identified 2 distinct patterns of each of 3 outcomes: constantly low and constantly high depressive symptoms group (70.4% vs 29.6%), constantly low and constantly high anxiety group (69.1% vs 30.9%), and low-decreasing and high-stable life satisfaction groups (56.3% vs 43.7%). A strong pairwise association was observed between trajectory group membership for depressive symptoms and anxiety (P < .0001), depressive symptoms and life satisfaction (P < .0001), and anxiety and life satisfaction (P < .001). Subjects with increased severe injury were more likely to belong to the high-stable depressive symptoms group, while there were no significant associations between age, gender, race, education, marriage status and distinct depressive symptoms, anxiety, and life satisfaction trajectory groups. Conclusions: A group-based trajectory model revealed patterns of emotional symptoms that have not been fully explored among survivors of severe TBI. There appear to be distinct trajectory patterns for depressive symptoms, anxiety, and life satisfaction, respectively. There was strong interrelationship among emotional symptoms. The findings add to our understanding of psychosocial outcomes experienced over time after severe TBI.	[Ren, Dianxu] Univ Pittsburgh, Sch Nursing, Ctr Res & Evaluat, 3500 Victoria St,360 Victoria Bldg, Pittsburgh, PA 15261 USA; [Conley, Yvette] Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, 3500 Victoria St,360 Victoria Bldg, Pittsburgh, PA 15261 USA; [Fan, Jun] Palo Alto Hlth Care Syst, Vet Affairs, Palo Alto, CA USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Sch Nursing, Dept Neurol Surg, 3500 Victoria St,360 Victoria Bldg, Pittsburgh, PA 15261 USA; [Beers, Sue R.] Univ Pittsburgh, Sch Nursing, Dept Psychiat, 3500 Victoria St,360 Victoria Bldg, Pittsburgh, PA 15261 USA		Ren, DX (corresponding author), Univ Pittsburgh, Sch Nursing, 3500 Victoria St,360 Victoria Bldg, Pittsburgh, PA 15261 USA.	Dir8@pitt.edu		Conley, Yvette/0000-0002-1784-6067	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NR013342-01]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013342] Funding Source: NIH RePORTER	Dr Yvette Conley received NIH R01 grant "Genomic Variability and Symptomatology After Traumatic Brain Injury" (R01 NR013342-01).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Beekman ATF, 2000, AM J PSYCHIAT, V157, P89, DOI 10.1176/ajp.157.1.89; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jang Y, 2004, GERONTOLOGIST, V44, P311, DOI 10.1093/geront/44.3.311; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kotz S., 2000, WILEY SER PROB STAT; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meijer RR, 2011, PSYCHOL ASSESSMENT, V23, P193, DOI 10.1037/a0021292; Nagin D.S., 2005, GROUP BASED MODELING; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapaport MH, 2005, AM J PSYCHIAT, V162, P1171, DOI 10.1176/appi.ajp.162.6.1171; RIVASVAZQUEZ RA, 2004, RES PRACT, V35, P74, DOI DOI 10.1037/0735-7028.35.1.74; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Strine TW, 2009, J NERV MENT DIS, V197, P61, DOI 10.1097/NMD.0b013e3181924ad8; Tang ST, 2008, QUAL LIFE RES, V17, P387, DOI 10.1007/s11136-008-9316-7; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	39	6	7	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					E29	E37		10.1097/HTR.0000000000000294			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100004	28195956	Green Accepted			2022-02-06	
J	Rietdijk, R; Power, E; Brunner, M; Togher, L				Rietdijk, Rachael; Power, Emma; Brunner, Melissa; Togher, Leanne			Reliability of Videoconferencing Administration of a Communication Questionnaire to People With Traumatic Brain Injury and Their Close Others	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						communication; questionnaires; reliability; self-report; telehealth	DEPRESSION RATING-SCALE; FACE-TO-FACE; ADULTS; EXPERIENCES; TELEREHABILITATION; ABILITY; MODE; CARE; FEASIBILITY; CAREGIVERS	Objectives: To compare in-person with videoconferencing administration of a communication questionnaire for people with traumatic brain injury (TBI) and their close others. Design: Repeated-measures design with randomized order of administration. Participants: Twenty adults with severe TBI and their close others. Methods: Both participants with TBI and their close others completed the La Trobe Communication Questionnaire (LCQ) via interview with a clinician, once via Skype and once during a home visit. Measures: Total LCQ score and time taken for completion. Results: There were no significant differences between videoconferencing and in-person conditions in the total scores or time taken to complete the questionnaire. Conclusions: Videoconferencing-based administration of the LCQ is as reliable and efficient as in-person administration.	[Rietdijk, Rachael; Power, Emma; Brunner, Melissa; Togher, Leanne] Univ Sydney, Speech Pathol, Fac Hlth Sci, Lidcombe, NSW, Australia; [Rietdijk, Rachael; Power, Emma; Brunner, Melissa; Togher, Leanne] Univ New South Wales, Sch Psychol, NHMRC CRE Brain Recovery Moving Ahead, Sydney, NSW, Australia; [Brunner, Melissa] Univ Newcastle, Fac Educ & Arts, Discipline Speech Pathol, Newcastle, NSW, Australia		Rietdijk, R (corresponding author), Univ Sydney, Fac Hlth Sci, POB 170, Lidcombe, NSW 1825, Australia.	rman7827@uni.sydney.edu.au	Togher, Leanne/AAC-7083-2019; Brunner, Melissa/AAS-5965-2020; Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Brunner, Melissa/0000-0001-6823-5189; Togher, Leanne/0000-0002-4518-6748; Power, Emma/0000-0002-2638-0406	Institute for Safety, Compensation and Recovery Research (ISCRR); Australian Postgraduate AwardAustralian Government; NHMRCNational Health and Medical Research Council of Australia	This research was supported by a development grant from the Institute for Safety, Compensation and Recovery Research (ISCRR), an Australian Postgraduate Award, and an NHMRC Moving Ahead CRE Seed Grant. The authors thank the staff of Hunter Brain Injury Service, Liverpool Brain Injury Rehabilitation Unit, New England Brain Injury Rehabilitation Service, Royal Rehabilitation Centre, and speech pathologist Colleen Kerr for assistance with recruitment. The authors also thank the participating families for their contributions to this research.	[Anonymous], 2015, PASS 14 POWER ANAL S; Armfield NR, 2015, INT J MED INFORM, V84, P737, DOI 10.1016/j.ijmedinf.2015.06.006; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Brennan DM, 2004, TELEMED J E-HEALTH, V10, P147, DOI 10.1089/1530562041641237; Bui T. T. N., 2013, THESIS; Caute A, 2012, INT J SPEECH-LANG PA, V14, P329, DOI 10.3109/17549507.2012.663789; Cohn ER, 2011, SIG 18 PERSPECT TELE, V1, P26, DOI DOI 10.1044/tele1.1.26; Degeneffe CE, 2014, SOC WORK, V60, P19; Dobscha SK, 2005, TELEMED J E-HEALTH, V11, P84, DOI 10.1089/tmj.2005.11.84; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Hoepner JK, 2013, BRAIN INJURY, V27, P464, DOI 10.3109/02699052.2013.765600; Huijgen BCH, 2008, J TELEMED TELECARE, V14, P249, DOI 10.1258/jtt.2008.080104; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Kobak KA, 2004, J TELEMED TELECARE, V10, P231, DOI 10.1258/1357633041424368; Kobak KA, 2008, DEPRESS ANXIETY, V25, P913, DOI 10.1002/da.20392; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Man DWK, 2006, BRAIN INJURY, V20, P959, DOI 10.1080/02699050600909789; Man DWK, 2006, NEUROREHABILITATION, V21, P205; McDermott GL, 2014, BRAIN INJURY, V28, P81, DOI 10.3109/02699052.2013.857790; McGrath N, 2008, J HEAD TRAUMA REHAB, V23, P388, DOI 10.1097/01.HTR.0000341434.74875.c8; Nguyen M, 2012, CYBERPSYCH BEH SOC N, V15, P103, DOI 10.1089/cyber.2011.0277; Ng EMW, 2013, BRAIN INJURY, V27, P548, DOI 10.3109/02699052.2013.766927; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Riegler LJ, 2013, MED SCI MONITOR, V19, P269, DOI 10.12659/MSM.883885; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Rutherford C, 2016, QUAL LIFE RES, V25, P559, DOI 10.1007/s11136-015-1110-8; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Savoie J, 2014, ARCH CLIN NEUROPSYCH, V29; Soong W, 2005, INT J REHABIL RES, V28, P341, DOI 10.1097/00004356-200512000-00006; Theadom A, 2014, BRAIN INJURY, V28, P995, DOI 10.3109/02699052.2014.888767; Theodoros D, 2008, TELEMED J E-HEALTH, V14, P552, DOI 10.1089/tmj.2007.0091; Tsaousides T, 2014, NEUROPSYCHOL REHABIL, V24, P784, DOI 10.1080/09602011.2014.907186; Turkstra LS, 2012, J HEAD TRAUMA REHAB, V27, P424, DOI 10.1097/HTR.0b013e31823346fc	36	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					E38	E44		10.1097/HTR.0000000000000282			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100005	28195950				2022-02-06	
J	Shen, LJ; Zhou, J; Guo, M; Yang, CS; Xu, QC; Lv, QW; Yang, SB; Huang, HB				Shen, Liang-Jun; Zhou, Jing; Guo, Mi; Yang, Chun-Song; Xu, Qi-Chen; Lv, Qing-Wei; Yang, Song-Bin; Huang, Hang-Bin			Serum lipocalin-2 concentrations and mortality of severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Lipocalin-2; Mortality; Severity; Neuroinflammation	C-REACTIVE PROTEIN; NGAL; ISCHEMIA; IRON; NEUROINFLAMMATION; PATHOPHYSIOLOGY; INFLAMMATION; HEMORRHAGE; EXPRESSION; BIOMARKERS	Background. Lipocalin-2 is related to acute brain injury. We assessed the prognostic value of serum lipocalin-2 in head trauma. Methods: Blood samples were collected from 115 controls and 115 patients with severe traumatic brain injury. Trauma severity was assessed by Glasgow Coma Scale (GCS) scores at baseline. Thirty-day mortality and overall survival time were recorded. Results: Compared with the controls, serum lipocalin-2 concentrations were significantly increased in the patients. Lipocalin-2 concentrations were independently associated with GCS scores (t = -7.271, P < 0.001) and serum C-reactive protein concentrations (t = 4.325, P < 0.001). Under receiver operating characteristic curve for 30-day mortality, sensitivity and specificity were 85.7% and 63.2% respectively for lipocalin-2 concentrations at a cutoff value of 591 ng/ml. Additionally, area under curve (AUC) of lipocalin-2 concentrations [AUC, 0.825; 95% confidence interval (95% CI), 0.743-0.889] was equivalent to that of GCS scores (AUC, 0.869; 95% CI, 0.793-0.925; P = 0.413). Moreover, serum lipocalin-2 concentrations > 591 ng/ml emerged as an independent predictor for 30-day mortality (odds ratio, 4.360; 95% CI, 1.908-12.430) and overall survival (hazard ratio, 3.820; 95% CI, 1.935-10.500). Conclusions: Enhanced serum concentration of lipocalin-2 at admission is associated with trauma severity and neuroinflammation as well as is a predictor of mortality after head trauma.	[Shen, Liang-Jun; Zhou, Jing; Guo, Mi; Yang, Chun-Song; Xu, Qi-Chen; Lv, Qing-Wei; Yang, Song-Bin; Huang, Hang-Bin] Zhejiang Univ, Affiliated Hosp 1, Shengzhou Branch Hosp, Shengzhou Peoples Hosp,Dept Neurosurg, 666 Dangui Rd, Shengzhou 312400, Zhejiang, Peoples R China		Shen, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Shengzhou Branch Hosp, Shengzhou Peoples Hosp,Dept Neurosurg, 666 Dangui Rd, Shengzhou 312400, Zhejiang, Peoples R China.	shengzhoushenlj@163.com					Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Anwaar I, 1998, CEREBROVASC DIS, V8, P310, DOI 10.1159/000015873; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Chan CPY, 2012, CLIN BIOCHEM, V45, P1308, DOI 10.1016/j.clinbiochem.2012.06.014; Dong M, 2013, BRAIN RES, V1505, P86, DOI 10.1016/j.brainres.2013.02.008; Dong XQ, 2017, CLIN CHIM ACTA, V471, P298, DOI 10.1016/j.cca.2017.06.020; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Falke P, 2000, CEREBROVASC DIS, V10, P97, DOI 10.1159/000016037; Fernandez-Cadenas I, 2013, PHARMACOGENOMICS, V14, P495, DOI [10.2217/PGS.13.19, 10.2217/pgs.13.19]; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hochmeister S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154797; Hui L, 2014, EXP THER MED, V7, P1683, DOI 10.3892/etm.2014.1666; Ip JPK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-124; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jin M, 2014, J CEREBR BLOOD F MET, V34, P1306, DOI 10.1038/jcbfm.2014.83; Kaneko T, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0545-y; Katano M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2587; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; Lee S., 2011, J BIOL CHEM, V286; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2012, J NEUROSCI RES, V90, P540, DOI 10.1002/jnr.22779; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; MacManus JP, 2004, J CEREBR BLOOD F MET, V24, P657, DOI 10.1097/01.WCB.0000123141.67811.91; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; O'Connor E, 2004, ANAESTH INTENS CARE, V32, P465, DOI 10.1177/0310057X0403200402; Ozyurt E, 2015, TURK NEUROSURG, V25, P877, DOI 10.5137/1019-5149.JTN.9181-13.0; Rathore KI, 2011, J NEUROSCI, V31, P13412, DOI 10.1523/JNEUROSCI.0116-11.2011; Shen LJ, 2014, CLIN CHIM ACTA, V427, P37, DOI 10.1016/j.cca.2013.09.047; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zammit Christopher, 2013, Emerg Med Pract, V15, P1; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016; Zhao JB, 2016, J NEUROL SCI, V368, P392, DOI 10.1016/j.jns.2016.07.060	48	6	6	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	NOV	2017	474						130	135		10.1016/j.cca.2017.09.016			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FK6LV	WOS:000413616100021	28943289				2022-02-06	
J	Noain, D; Buchele, F; Schreglmann, SR; Valko, PO; Gavrilov, YV; Morawska, MM; Imbach, LL; Baumann, CR				Noain, Daniela; Buchele, Fabian; Schreglmann, Sebastian R.; Valko, Philipp O.; Gavrilov, Yuri V.; Morawska, Marta M.; Imbach, Lukas L.; Baumann, Christian R.			Increased Sleep Need and Reduction of Tuberomammillary Histamine Neurons after Rodent Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						histamine; orexin/hypocretin; post-traumatic pleiosomnia; rat model of sleep-wake disturbances; sleep-wake centers; sleep-wake disturbances; traumatic brain injury; tuberomammillary nucleus	WAKE DISTURBANCES; DAYTIME SLEEPINESS; MODEL; DISORDERS; MILD; WAKEFULNESS; PATTERNS; IMPACT; DAMAGE	Although sleep-wake disturbances are prevalent and well described after traumatic brain injury, their pathophysiology remains unclear, most likely because human traumatic brain injury is a highly heterogeneous entity that makes the systematic study of sleep-wake disturbances in relation to trauma-induced histological changes a challenging task. Despite increasing interest, specific and effective treatment strategies for post-traumatic sleep-wake disturbances are still missing. With the present work, therefore, we aimed at studying acute and chronic sleep-wake disturbances by electrophysiological means, and at assessing their histological correlates after closed diffuse traumatic brain injury in rats with the ultimate goal of generating a model of post-traumatic sleep-wake disturbances and associated histopathological findings that accurately represents the human condition. We assessed sleep-wake behavior by means of standard electrophysiological recordings before and 1, 7, and 28 days after sham or traumatic brain injury procedures. Sleep-wake findings were then correlated to immunohistochemically labeled and stereologically quantified neuronal arousal systems. Compared with control animals, we found that closed diffuse traumatic brain injury caused increased sleep need one month after trauma, and sleep was more consolidated. As histological correlate, we found a reduced number of histamine immunoreactive cells in the tuberomammillary nucleus, potentially related to increased neuroinflammation. Monoaminergic and hypocretinergic neurotransmitter systems in the hypothalamus and rostral brainstem were not affected, however. These results suggest that our rat traumatic brain injury model reflects human post-traumatic sleep-wake disturbances and associated histopathological findings very accurately, thus providing a study platform for novel treatment strategies for affected patients.	[Noain, Daniela; Buchele, Fabian; Schreglmann, Sebastian R.; Valko, Philipp O.; Gavrilov, Yuri V.; Morawska, Marta M.; Imbach, Lukas L.; Baumann, Christian R.] Univ Zurich, Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland		Noain, D (corresponding author), Univ Hosp Zurich, Dept Neurol, Frauenklinikstr 26, CH-8091 Zurich, Switzerland.	daniela.noain@usz.ch	Gavrilov, Yury/AAA-2915-2019	Gavrilov, Yury/0000-0003-1409-7686; Morawska, Marta/0000-0003-1612-6786; Buechele, Fabian/0000-0001-7091-1676; Imbach, Lukas/0000-0002-6135-8642; Schreglmann, Sebastian/0000-0002-4129-5808; Baumann, Christian/0000-0003-3417-1978; Noain, Daniela/0000-0001-5482-7933	Swiss National Science Foundation (SNSF)Swiss National Science Foundation (SNSF) [125504]; University of Zurich	This project was supported by the Swiss National Science Foundation (SNSF, grant no. 125504) and by the Clinical Research Priority Program "Sleep and Health'' of the University of Zurich.	Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; GUILLEMINAULT C, 1983, NEUROLOGY, V33, P1584, DOI 10.1212/WNL.33.12.1584; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jin YC, 2017, WORLD NEUROSURG, V100, P351, DOI 10.1016/j.wneu.2017.01.033; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404	31	6	6	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					85	93		10.1089/neu.2017.5067		OCT 2017	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000414461900001	28762870	Green Submitted			2022-02-06	
J	Pawlukiewicz, A; Yengo-Kahn, AM; Solomon, G				Pawlukiewicz, Alec; Yengo-Kahn, Aaron M.; Solomon, Gary			The Effect of Pretest Exercise on Baseline Computerized Neurocognitive Test Scores	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						sport-related concussion; exercise; neurocognitive assessment; ImPACT	SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; TEST-PERFORMANCE; ONLINE VERSION; IMPACT; EPIDEMIOLOGY; METAANALYSIS; INJURY; SEX	Background: Baseline neurocognitive assessment plays a critical role in return-to-play decision making following sport-related concussions. Prior studies have assessed the effect of a variety of modifying factors on neurocognitive baseline test scores. However, relatively little investigation has been conducted regarding the effect of pretest exercise on baseline testing. Purpose/Hypothesis: The aim of our investigation was to determine the effect of pretest exercise on baseline Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) scores in adolescent and young adult athletes. We hypothesized that athletes undergoing self-reported strenuous exercise within 3 hours of baseline testing would perform more poorly on neurocognitive metrics and would report a greater number of symptoms than those who had not completed such exercise. Study Design: Cross-sectional study; Level of evidence, 3. Methods: The ImPACT records of 18,245 adolescent and young adult athletes were retrospectively analyzed. After application of inclusion and exclusion criteria, participants were dichotomized into groups based on a positive (n = 664) or negative (n = 6609) selfreported history of strenuous exercise within 3 hours of the baseline test. Participants with a positive history of exercise were then randomly matched, based on age, sex, education level, concussion history, and hours of sleep prior to testing, on a 1: 2 basis with individuals who had reported no pretest exercise. The baseline ImPACT composite scores of the 2 groups were then compared. Results: Significant differenceswere observed for the ImPACTcomposite scores of verbalmemory, visualmemory, reaction time, and impulse control as well as for the total symptom score. No significant between-group difference was detected for the visual motor composite score. Furthermore, pretest exercisewas associatedwith a significant increase inthe overall frequency of invalidtest results. Conclusion: Our results suggest a statistically significant difference in ImPACT composite scores between individuals who report strenuous exercise prior to baseline testing compared with those who do not. Since return-to-play decision making often involves documentation of return to neurocognitive baseline, the baseline test scores must be valid and accurate. As a result, we recommend standardization of baseline testing such that no strenuous exercise takes place 3 hours prior to test administration.	[Pawlukiewicz, Alec; Yengo-Kahn, Aaron M.; Solomon, Gary] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Pawlukiewicz, Alec; Yengo-Kahn, Aaron M.; Solomon, Gary] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron M.; Solomon, Gary] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA		Pawlukiewicz, A (corresponding author), Vanderbilt Sports Concuss Ctr, 1500 21st Ave S,Suite 1506, Nashville, TN 37212 USA.	alec.j.pawlukiewicz@vanderbilt.edu	Yengo-Kahn, Aaron/AAV-7647-2020; Solomon, Gary/K-9011-2019	Yengo-Kahn, Aaron/0000-0002-5989-3064; 	Tennessee Titans (NFL); Nashville Predators (NHL)	G.S. receives consulting fees from the Tennessee Titans (NFL), the Nashville Predators (NHL), and the athletic departments of several universities (fees paid to institution) and is a member of the ImPACT Scientific Advisory Board and receives reimbursement for expenses to board meetings.	Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Durlak JA, 2009, J PEDIATR PSYCHOL, V34, P917, DOI 10.1093/jpepsy/jsp004; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leclerc S., 2002, Medicine & Science in Sports & Exercise, V34, pS103, DOI 10.1097/00005768-200205001-00573; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, IMPACT 2007 6 0 CLIN; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	27	6	6	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	OCT 23	2017	5	10							2325967117734496	10.1177/2325967117734496			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FK6TH	WOS:000413637600001	29114564	Green Published, gold			2022-02-06	
J	Fehlings, MG; Noonan, VK; Atkins, D; Burns, AS; Cheng, CL; Singh, A; Dvorak, MF				Fehlings, Michael G.; Noonan, Vanessa K.; Atkins, Derek; Burns, Anthony S.; Cheng, Christiana L.; Singh, Anoushka; Dvorak, Marcel F.			Optimizing Clinical Decision Making in Acute Traumatic Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article							CARE	Spinal cord injury (SCI) is a devastating event causing lifelong disability that results in a significant decrease in quality of life and immense cost to the health care system, individuals and their families. Providing specialized and timely care can improve recovery and reduce costs, but to make this a reality requires understanding of the current care delivery processes and the care journey. The objective of this focus issue is to examine the current state of health care delivery and discover opportunities to improve access and timing to specialized care for individuals with tSCI. This issue provides an overview of care throughout the SCI continuum and its impact on individuals with tSCI using pan-Canadian data. The issue also presents findings from the RHI Access to Care and Timing (ACT) Project, a multi-center research study involving a multi-disciplinary team of Canadian researchers and clinicians. The initial articles describe the current state of the tSCI care journey including a comparison of environmental barriers, health status, and quality-of-life outcomes between patients living in rural and urban settings. The issue concludes with an article describing the national knowledge translation efforts of using the evidence from the articles published here to inform practice and policy change. Overall, this focus issue will be an excellent reference to guide and optimize evidence informed decision-making in the care of those with tSCI. The evidence can be transferred to care in non-traumatic SCI and other conditions that benefit from timely access to specialized care such as stroke and traumatic brain injury.	[Fehlings, Michael G.] Univ Toronto, Dept Surg, 399 Bathurst St,Suite 4ww-449, Toronto, ON M5T 2S8, Canada; [Burns, Anthony S.] Univ Toronto, Div Physiatry, Dept Med, Toronto, ON, Canada; [Noonan, Vanessa K.; Cheng, Christiana L.] Rick Hansen Inst, Vancouver, BC, Canada; [Atkins, Derek] Univ British Columbia, Sauder Sch Business, Operat & Logist Div, Vancouver, BC, Canada; [Dvorak, Marcel F.] Univ British Columbia, Dept Orthopaed, Vancouver, BC, Canada; [Singh, Anoushka] Toronto Western Hosp, SCI Clin Res Unit, Toronto, ON, Canada		Fehlings, MG (corresponding author), Univ Toronto, Dept Surg, 399 Bathurst St,Suite 4ww-449, Toronto, ON M5T 2S8, Canada.	Michael.Fehlings@uhn.ca		Burns, Anthony/0000-0002-8679-3958; Dvorak, Marcel/0000-0002-9404-8448; Fehlings, Michael/0000-0002-5722-6364			Ahn H, 2017, J NEUROTRAUM, V34, P2917, DOI 10.1089/neu.2016.4936; Burns AS, 2017, J NEUROTRAUM, V34, P2910, DOI 10.1089/neu.2016.4935; Cheng CL, 2017, J NEUROTRAUM, V34, P2856, DOI 10.1089/neu.2016.4929; Cheng CL, 2017, J NEUROTRAUM, V34, P2867, DOI 10.1089/neu.2016.4930; Dvorak MF, 2017, J NEUROTRAUM, V34, P2924, DOI 10.1089/neu.2016.4937; Fehlings MG, 2017, J NEUROTRAUM, V34, P2934, DOI 10.1089/neu.2016.4938; Glennie RA, 2017, J NEUROTRAUM, V34, P2877, DOI 10.1089/neu.2016.4931; Marion TE, 2017, J NEUROTRAUM, V34, P2883, DOI 10.1089/neu.2016.4933; Noonan VK, 2017, J NEUROTRAUM, V34, P2848, DOI 10.1089/neu.2016.4928; Noonan VK, 2012, J NEUROTRAUM, V29, P2272, DOI 10.1089/neu.2012.2317; Parent S, 2011, J NEUROTRAUM, V28, P1363, DOI 10.1089/neu.2009.1151; Santos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072552; Truchon C, 2017, J NEUROTRAUM, V34, P2901, DOI 10.1089/neu.2016.4932; White BAB, 2017, J NEUROTRAUM, V34, P2892, DOI 10.1089/neu.2016.4934	14	6	6	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2017	34	20					2841	2842		10.1089/neu.2016.4926			2	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FJ8YG	WOS:000413053900001	28056628	Green Published, Bronze			2022-02-06	
J	Boone, DR; Leek, JM; Falduto, MT; Torres, KEO; Sell, SL; Parsley, MA; Cowart, JC; Uchida, T; Micci, MA; DeWitt, DS; Prough, DS; Hellmich, HL				Boone, Deborah R.; Leek, Jeanna M.; Falduto, Michael T.; Torres, Karen E. O.; Sell, Stacy L.; Parsley, Margaret A.; Cowart, Jeremy C.; Uchida, Tatsuo; Micci, Maria-Adelaide; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.			Effects of AAV-mediated knockdown of nNOS and GPx-1 gene expression in rat hippocampus after traumatic brain injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RNA INTERFERENCE; WORKING-MEMORY; CLINICAL-TRIALS; ISCHEMIC-INJURY; DOWN-REGULATION; NEURODEGENERATION; INHIBITION; WAKEFULNESS; CHALLENGES	Virally mediated RNA interference (RNAi) to knock down injury-induced genes could improve functional outcome after traumatic brain injury (TBI); however, little is known about the consequences of gene knockdown on downstream cell signaling pathways and how RNAi influences neurodegeneration and behavior. Here, we assessed the effects of adeno-associated virus (AAV) siRNA vectors that target two genes with opposing roles in TBI pathogenesis: the allegedly detrimental neuronal nitric oxide synthase (nNOS) and the potentially protective glutathione peroxidase 1 (GPx-1). In rat hippocampal progenitor cells, three siRNAs that target different regions of each gene (nNOS, GPx-1) effectively knocked down gene expression. However, in vivo, in our rat model of fluid percussion brain injury, the consequences of AAV-siRNA were variable. One nNOS siRNA vector significantly reduced the number of degenerating hippocampal neurons and showed a tendency to improve working memory. GPx-1 siRNA treatment did not alter TBI-induced neurodegeneration or working memory deficits. Nevertheless, microarray analysis of laser captured, virus-infected neurons showed that knockdown of nNOS or GPx-1 was specific and had broad effects on downstream genes. Since nNOS knockdown only modestly ameliorated TBI-induced working memory deficits, despite widespread genomic changes, manipulating expression levels of single genes may not be sufficient to alter functional outcome	[Boone, Deborah R.; Leek, Jeanna M.; Sell, Stacy L.; Parsley, Margaret A.; Cowart, Jeremy C.; Uchida, Tatsuo; Micci, Maria-Adelaide; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Falduto, Michael T.; Torres, Karen E. O.] GenUs Biosyst, Northbrook, IL USA		Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	Department of Anesthesiology, University of Texas Medical Branch; GenUs Biosystems;  [R01 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052532] Funding Source: NIH RePORTER	The funder, GenUs Biosystems provided support in the form of salaries for authors [MTF and KEOT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by R01 NS052532 (HLH) and in part by the Department of Anesthesiology, University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The funder, GenUs Biosystems provided support in the form of salaries for authors [MTF and KEOT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Supported by R01 NS052532 (HLH) and in part by the Department of Anesthesiology, University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2010, METHODS MOL BIOL, V623, P313, DOI 10.1007/978-1-60761-588-0_20; [Anonymous], 2004, SAS STATO 9 1 US GUI; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Barthet G, 2013, NEUROBIOL AGING, V34, P499, DOI 10.1016/j.neurobiolaging.2012.02.024; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Boudreau RL, 2011, HUM MOL GENET, V20, pR21, DOI 10.1093/hmg/ddr137; Cabrera GT, 2016, METHODS MOL BIOL, V1382, P67, DOI 10.1007/978-1-4939-3271-9_5; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Cavas M, 2006, PROG NEURO-PSYCHOPH, V30, P56, DOI 10.1016/j.pnpbp.2005.06.013; Chabrier PE, 1999, CELL MOL LIFE SCI, V55, P1029, DOI 10.1007/s000180050353; Chakrabarti S, 2012, J LEUKOCYTE BIOL, V91, P947, DOI 10.1189/jlb.1011513; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Christophel TB, 2017, TRENDS COGN SCI, V21, P111, DOI 10.1016/j.tics.2016.12.007; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Davidson BL, 2004, LANCET NEUROL, V3, P145, DOI 10.1016/S1474-4422(04)00678-7; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fei F, 2014, NEUROSCIENCE, V267, P187, DOI 10.1016/j.neuroscience.2014.02.037; Geib BR, 2017, HUM BRAIN MAPP, V38, P2242, DOI 10.1002/hbm.23518; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Greco R, 2017, EUR J PHARMACOL, V16, P30075; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hallock HL, 2016, J NEUROSCI, V36, P8372, DOI 10.1523/JNEUROSCI.0991-16.2016; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hortobagyi T, 2003, NEUROSCIENCE, V121, P983, DOI 10.1016/S0306-4522(03)00482-2; Hu Q, 2011, BRAIN RES, V1367, P347, DOI 10.1016/j.brainres.2010.10.002; Joshi CR, 2017, J NEUROIMMUNE PHARM, V12, P51, DOI 10.1007/s11481-016-9724-3; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Klemm V, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120119; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Landegger LD, 2017, NAT BIOTECHNOL, V35, P280, DOI 10.1038/nbt.3781; Ledford H, 2017, CRISPR STUDIES MUDDY; LeVaillant CJ, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.78; Liu M, 2012, MOL BIOL REP, V39, P593, DOI 10.1007/s11033-011-0775-5; Liu PK, 2002, ANN NY ACAD SCI, V962, P226, DOI 10.1111/j.1749-6632.2002.tb04071.x; Lu PY, 2005, ADV GENET, V54, P117, DOI 10.1016/S0065-2660(05)54006-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mahairaki V, 2009, J NEUROSCI METH, V179, P292, DOI 10.1016/j.jneumeth.2009.02.006; Mandel RJ, 2004, CURR OPIN MOL THER, V6, P482; Masat E, 2013, DISCOV MED, V15, P379; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Munkacsy G, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.66; Munoz MF, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00059; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Park SM, 2016, NEURAL REGEN RES, V11, P1081, DOI 10.4103/1673-5374.187039; Park SY, 2016, MOL NEU ROBIOL; Paulson H., 2005, NEUROLOGY; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; Scammell TE, 2017, NEURON, V93, P747, DOI 10.1016/j.neuron.2017.01.014; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sell SL, 2016, J NEUROTRAUMA; Shabestari RM, 2017, BIOMED PHARMACOTHER, V87, P274, DOI 10.1016/j.biopha.2016.12.070; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Torres-Ruiz R, 2017, BRIEF FUNCT GENOMICS, V16, P4, DOI 10.1093/bfgp/elw025; Towne C, 2011, MOL THER, V19, P274, DOI 10.1038/mt.2010.260; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang M, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.151, 10.1038/NPLANTS.2016.151]; Xiong Ye, 2004, J Stroke Cerebrovasc Dis, V13, P129, DOI 10.1016/j.jstrokecerebrovasdis.2004.05.001; Zhang Y, 2003, J GENE MED, V5, P1039, DOI 10.1002/jgm.449; Zhang Z, 2015, NEUROSCIENCE, V300, P219, DOI 10.1016/j.neuroscience.2015.05.025; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037; Zhou L, 2010, NAT MED; Zoubovsky SP, 2011, BIOCHEM BIOPH RES CO, V408, P707, DOI 10.1016/j.bbrc.2011.04.097	78	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185943	10.1371/journal.pone.0185943			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	WOS:000412627400040	29016640	Green Published, Green Submitted, gold			2022-02-06	
J	Abou-El-Hassan, H; Dia, B; Choucair, K; Eid, SA; Najdi, F; Baki, L; Talih, F; Eid, AA; Kobeissy, F				Abou-El-Hassan, Hadi; Dia, Batoul; Choucair, Khalil; Eid, Stephanie A.; Najdi, Farah; Baki, Lama; Talih, Farid; Eid, Assaad A.; Kobeissy, Firas			Traumatic brain injury, diabetic neuropathy and altered-psychiatric health: The fateful triangle	MEDICAL HYPOTHESES			English	Article							CONTROLLED CORTICAL IMPACT; SMALL-FIBER NEUROPATHY; OXIDATIVE STRESS; MOUSE MODEL; PERIPHERAL NEUROPATHY; COGNITIVE IMPAIRMENT; MAJOR DEPRESSION; GLYCEMIC CONTROL; SCHWANN-CELLS; NITRIC-OXIDE	Traumatic brain injury is a detrimental medical condition particularly when accompanied by diabetes. There are several comorbidities going along with diabetes including, but not limited to, kidney failure, obesity, coronary artery disease, peripheral vascular disease, hypertension, stroke, neuropathies and amputations. Unlike diabetes type 1, diabetes type 2 is more common in adults who simultaneously suffer from other comorbid conditions making them susceptible to repetitive fall incidents and sustaining head trauma. The resulting brain insult exacerbates current psychiatric disorders such as depression and anxiety, which, in turn, increases the risk of sustaining further brain traumas. The relationship between diabetes, traumatic brain injury and psychiatric health constitutes a triad forming a non-reversible vicious cycle. At the proteomic and psychiatric levels, cellular, molecular and behavioral alterations have been reported with the induction of non-traumatic brain injury in diabetic models such as stroke. However, research into traumatic brain injury has not been systematically investigated. Thus, in cases of diabetic neuropathy complicated with traumatic brain injury, utilizing fine structural and analytical techniques allows the identification of key biological markers that can then be used as innovative diagnostics as well as novel therapeutic targets in an attempt to treat diabetes and its sequelae especially those arising from repetitive mild brain trauma. (C) 2017 Elsevier Ltd. All rights reserved.	[Abou-El-Hassan, Hadi; Choucair, Khalil] Amer Univ Beirut, Med Ctr, Fac Med, Beirut, Lebanon; [Dia, Batoul; Eid, Stephanie A.; Eid, Assaad A.] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol, Beirut, Lebanon; [Najdi, Farah; Baki, Lama; Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Talih, Farid] Amer Univ Beirut, Dept Psychiat, Fac Med, Med Ctr, Beirut, Lebanon		Eid, AA (corresponding author), Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol, Beirut, Lebanon.; Kobeissy, F (corresponding author), Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon.	ae49@aub.edu.lb; firasko@gmail.com	talih, farid/AAF-5850-2020; Kobeissy, Firas/E-7042-2017	talih, farid/0000-0001-7147-7701; Kobeissy, Firas/0000-0002-5008-6944; Baki, Lama/0000-0002-1875-7672; Eid, Stephanie/0000-0003-3775-7544	American University of Beirut Medical Center	This work was supported by a Collaborative Grant from the American University of Beirut Medical Center.	Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Badescu S V, 2016, J Med Life, V9, P120; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Baker Robert J., 2000, Indian Journal of Pediatrics, V67, P317, DOI 10.1007/BF02820676; BALE RN, 1973, BRIT J PSYCHIAT, V122, P337, DOI 10.1192/bjp.122.3.337; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; BELLUSH LL, 1991, DIABETES, V40, P217, DOI 10.2337/diabetes.40.2.217; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Bouilleret V, 2009, NEUROIMAGE, V45, P267, DOI 10.1016/j.neuroimage.2008.12.019; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Butterfield DA, 2014, BBA-MOL BASIS DIS, V1842, P1693, DOI 10.1016/j.bbadis.2014.06.010; Calcutt NA, 2004, DIABETOLOGIA, V47, P718, DOI 10.1007/s00125-004-1354-2; Calkin CV, 2013, ANN MED, V45, P171, DOI 10.3109/07853890.2012.687835; Cameron NE, 1997, DIABETES, V46, pS31, DOI 10.2337/diab.46.2.S31; Cameron NE, 1999, DIABETES RES CLIN PR, V45, P137, DOI 10.1016/S0168-8227(99)00043-1; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; CAVANAGH PR, 1992, DIABETIC MED, V9, P469, DOI 10.1111/j.1464-5491.1992.tb01819.x; Ceretta LB, 2012, ACTA DIABETOL, V49, pS227, DOI 10.1007/s00592-012-0435-9; Chen YS, 2005, DIABETES, V54, P3112, DOI 10.2337/diabetes.54.11.3112; Cheng HT, 2009, J NEUROPATH EXP NEUR, V68, P1229, DOI 10.1097/NEN.0b013e3181bef710; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; CHU PC, 1986, DIABETES, V35, P481, DOI 10.2337/diabetes.35.4.481; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Cinci L, 2015, J BIOCHEM MOL TOXIC, V29, P274, DOI 10.1002/jbt.21695; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; COURTEIX C, 1993, PAIN, V53, P81, DOI 10.1016/0304-3959(93)90059-X; COX DJ, 1992, J CONSULT CLIN PSYCH, V60, P628, DOI 10.1037/0022-006X.60.4.628; Dauch JR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-64; de Vet E, 2011, OBES REV, V12, pe130, DOI 10.1111/j.1467-789X.2010.00784.x; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; DEARY IJ, 1993, DIABETES, V42, P341, DOI 10.2337/diabetes.42.2.341; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DEJGAARD A, 1991, DIABETIC MED, V8, P162, DOI 10.1111/j.1464-5491.1991.tb01564.x; Di Luca M, 1999, DIABETOLOGIA, V42, P693, DOI 10.1007/s001250051217; DIGIULIO AM, 1989, J NEUROSCI RES, V24, P355, DOI 10.1002/jnr.490240303; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M, 2010, TRAUMATIC BRAIN INJU; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Ferguson SC, 2003, DIABETES, V52, P149, DOI 10.2337/diabetes.52.1.149; FLOOD JF, 1990, DIABETES, V39, P1391, DOI 10.2337/diabetes.39.11.1391; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Gao R, 2014, FEBS LETT, V588, P3225, DOI 10.1016/j.febslet.2014.07.004; Gardoni F, 2002, J NEUROCHEM, V80, P438, DOI 10.1046/j.0022-3042.2001.00713.x; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hanlon JT, 2002, J GERONTOL A-BIOL, V57, pM473, DOI 10.1093/gerona/57.7.M473; Hege MA, 2015, INT J OBESITY, V39, P353, DOI 10.1038/ijo.2014.99; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnson MS, 2007, J PAIN, V8, P637, DOI 10.1016/j.jpain.2007.04.004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kan M, 2012, J NEUROPATH EXP NEUR, V71, P494, DOI 10.1097/NEN.0b013e3182580673; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kawakami-Mori F, 2012, AM J PHYSIOL-ENDOC M, V302, pE425, DOI 10.1152/ajpendo.00227.2011; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Klein JP, 2003, LANCET NEUROL, V2, P548, DOI 10.1016/S1474-4422(03)00503-9; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Korf ESC, 2006, DIABETES CARE, V29, P2268, DOI 10.2337/dc06-0243; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; LEEDOM L, 1991, PSYCHOSOMATICS, V32, P280, DOI 10.1016/S0033-3182(91)72066-5; Levin, 1997, Semin Clin Neuropsychiatry, V2, P207; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Li J, 2013, INT J MOL SCI, V14, P24438, DOI 10.3390/ijms141224438; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Li ZG, 2004, LIFE SCI, V76, P249, DOI 10.1016/j.lfs.2004.03.039; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu H, 2015, AM J MED SCI, V350, P204, DOI 10.1097/MAJ.0000000000000540; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; LOZOVSKY D, 1981, SCIENCE, V214, P1031, DOI 10.1126/science.6458088; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Ludman EJ, 2004, GEN HOSP PSYCHIAT, V26, P430, DOI 10.1016/j.genhosppsych.2004.08.010; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; LUSTMAN PJ, 1988, DIABETES CARE, V11, P605, DOI 10.2337/diacare.11.8.605; LUSTMAN PJ, 1992, DIABETES CARE, V15, P1631, DOI 10.2337/diacare.15.11.1631; Maalouf RM, 2012, AM J PHYSIOL-CELL PH, V302, pC597, DOI 10.1152/ajpcell.00331.2011; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Maurer MS, 2005, J GERONTOL A-BIOL, V60, P1157, DOI 10.1093/gerona/60.9.1157; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller BR, 2014, AM HEALTH DRUG BENEF, V7, P452; MOORADIAN AD, 1988, ARCH INTERN MED, V148, P2369, DOI 10.1001/archinte.148.11.2369; Muller KA, 2008, DIABETES, V57, P1693, DOI 10.2337/db08-0022; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; Mutambudzi M, 2016, J AM GERIATRICS SOC; Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703; Naziroglu M, 2012, NEUROCHEM RES, V37, P2065, DOI 10.1007/s11064-012-0850-x; Niedowicz DM, 2005, CELL BIOCHEM BIOPHYS, V43, P289, DOI 10.1385/CBB:43:2:289; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; O'Brien PD, 2014, ILAR J, V54, P259, DOI 10.1093/ilar/ilt052; Okie S, 2005, NEW ENGL J MED, V353, P1, DOI 10.1056/NEJMp058129; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183; Peng ZR, 2014, J NEUROL SCI, V342, P114, DOI 10.1016/j.jns.2014.04.037; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Pittenger GL, 2005, METAB SYNDR RELAT D, V3, P113, DOI 10.1089/met.2005.3.113; Pittenger GL, 2004, DIABETES CARE, V27, P1974, DOI 10.2337/diacare.27.8.1974; Prasad Shikha, 2014, J Pharmacovigil, V2, P125; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; REAVEN GM, 1990, DIABETES CARE, V13, P16, DOI 10.2337/diacare.13.1.16; Rennick PM, P 76 ANN CONV AM PSY, V3, P473; Reske-Nielsen E, 1966, Diabetologia, V1, P233, DOI 10.1007/BF01257917; Reske-Nielsen E, 1962, ACTA NEUROL SCAND S4, P273; RICHARDSON JTE, 1990, NEUROSCI BIOBEHAV R, V14, P385, DOI 10.1016/S0149-7634(05)80060-0; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Rincon F, 2013, CURR OPIN NEUROL, V26, P29, DOI 10.1097/WCO.0b013e32835c4f04; Rizk NN, 2006, BRAIN RES, V1096, P204, DOI 10.1016/j.brainres.2006.04.060; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; ROWLAND NE, 1989, NEUROSCI BIOBEHAV R, V13, P199, DOI 10.1016/S0149-7634(89)80054-5; Rustad JK, 2011, PSYCHONEUROENDOCRINO, V36, P1276, DOI 10.1016/j.psyneuen.2011.03.005; RUTHERFORD WH, 1977, LANCET, V1, P1; RYAN C, 1985, PEDIATRICS, V75, P921; RYAN CM, 1992, DIABETES, V41, P107, DOI 10.2337/diabetes.41.1.107; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sandalio LM, 2015, ANN BOT-LONDON, V116, P475, DOI 10.1093/aob/mcv074; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schwartz AV, 2008, DIABETES CARE, V31, P391, DOI 10.2337/dc07-1152; Schwartz AV, 2012, DIABETES CARE, V35, P1525, DOI 10.2337/dc11-2184; Schwartz AV, 2002, DIABETES CARE, V25, P1749, DOI 10.2337/diacare.25.10.1749; Shah GN, 2013, BIOCHEM BIOPH RES CO, V440, P354, DOI 10.1016/j.bbrc.2013.09.086; Sharma AN, 2010, PHYSIOL BEHAV, V101, P381, DOI 10.1016/j.physbeh.2010.07.002; Sharma S, 2006, EUR J PHARMACOL, V536, P256, DOI 10.1016/j.ejphar.2006.03.006; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Shi YK, 2014, LANCET, V383, P1947, DOI 10.1016/S0140-6736(14)60886-2; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; SIMA AAF, 1978, ACTA NEUROPATHOL, V41, P85, DOI 10.1007/BF00689757; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh R, 2014, PHARMACOL RES, V80, P21, DOI 10.1016/j.phrs.2013.12.005; Singh VP, 2014, KOREAN J PHYSIOL PHA, V18, P1, DOI 10.4196/kjpp.2014.18.1.1; Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Sung JH, 2015, J SURG RES; TIKUISIS P, 1991, J APPL PHYSIOL, V70, P2673, DOI 10.1152/jappl.1991.70.6.2673; TJOLSEN A, 1991, J PHARMACOL METHOD, V25, P241, DOI 10.1016/0160-5402(91)90014-V; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Toth Z, 1997, J BRAIN RES, V38, P173; Toth Z E, 1997, Neurobiology (Bp), V5, P499; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Uher R, 2005, J NEUROL NEUROSUR PS, V76, P852, DOI 10.1136/jnnp.2004.048819; Umegaki H, 2014, CLIN INTERV AGING, V9, DOI 10.2147/CIA.S48926; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vareniuk I, 2007, EXP NEUROL, V205, P425, DOI 10.1016/j.expneurol.2007.03.019; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI 10.1212/01.CON.0000455884.29545.d2; Vornov JJ, 2013, J PHARMACOL EXP THER, V346, P406, DOI 10.1124/jpet.113.205039; W.H. Organization, 2015, WHO DIAB PROGR REP; Wang L, 2014, NEUROSCIENCE, V259, P155, DOI 10.1016/j.neuroscience.2013.11.057; Wang L, 2011, NEUROSCIENCE, V193, P399, DOI 10.1016/j.neuroscience.2011.07.039; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; WELSH B, 1991, NEUROCHEM RES, V16, P453, DOI 10.1007/BF00965566; Wozniak KM, 2012, J PHARMACOL EXP THER, V343, P746, DOI 10.1124/jpet.112.197665; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu ZNS, 2014, J ULTRAS MED, V33, P1763, DOI 10.7863/ultra.33.10.1763; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Yassin MMI, 2002, WORLD J SURG, V26, P115, DOI 10.1007/s00268-001-0169-2; Yu Z, 2015, CELL PHYSIOL BIOCHEM, V37, P67, DOI 10.1159/000430334; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhou XY, 2015, PHYSIOL BEHAV, V151, P412, DOI 10.1016/j.physbeh.2015.08.015	186	6	8	0	4	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	OCT	2017	108						69	80		10.1016/j.mehy.2017.08.008			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	FN1SN	WOS:000415771600015	29055405				2022-02-06	
J	Alosco, ML; Jarnagin, J; Rowland, B; Liao, HJ; Stern, RA; Lin, A				Alosco, Michael L.; Jarnagin, Johnny; Rowland, Benjamin; Liao, Huijun; Stern, Robert A.; Lin, Alexander			Magnetic Resonance Spectroscopy as a Biomarker for Chronic Traumatic Encephalopathy	SEMINARS IN NEUROLOGY			English	Article						MR spectroscopy; chronic traumatic encephalopathy; neurochemistry; metabolism; repetitive head impacts	MILD COGNITIVE IMPAIRMENT; REPETITIVE BRAIN TRAUMA; ALZHEIMERS-DISEASE; MR SPECTROSCOPY; INJURY; NEUROCHEMISTRY; MYOINOSITOL; CONCUSSION; METABOLISM; DEMENTIAS	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with exposure to repetitive head impacts (RHI). Currently, CTE can only be diagnosed after death by postmortem, as validated in vivo biomarkers of CTE do not yet exist. Proton magnetic resonance spectroscopy (MRS) measures brain tissue metabolism in vivo and could facilitate a probable CTE diagnosis during life. Here, we propose MRS as one potential biomarker for CTE through a review of CTE neuropathology, and the extant literature that has examined the acute and long-term effects of RHI exposure on brain chemistry. There is preliminary empirical support for MRS in the detection of later-life neurological impairment associated with RHI exposure, but further ante- and postmortem research is needed before MRS can be considered a diagnostic biomarker for CTE.	[Alosco, Michael L.; Jarnagin, Johnny; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Rowland, Benjamin; Liao, Huijun; Lin, Alexander] Harvard Med Sch, Brigham & Womens Hosp, Ctr Clin Spect, Dept Radiol, 4 Blackfan St HIM-820, Boston, MA 02115 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA		Lin, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ctr Clin Spect, Dept Radiol, 4 Blackfan St HIM-820, Boston, MA 02115 USA.	aplin@bwh.harvard.edu	, Bob/ABA-8507-2020	Rowland, Benjamin/0000-0002-5033-6261	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG13846, R01 NS 078337, R56 9500304025, U01 NS093334]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1F32NS096803-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS096803, R01NS078337, U01NS093334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	This work was supported by grants from the NIH (P30 AG13846; R01 NS 078337; R56 9500304025; U01 NS093334). Michael L. Alosco is supported by the National Institutes of Health under grant number 1F32NS096803-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. There were no restrictions on the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication.	Alosco M L, 2017, 25 ANN M INT SOC MAG; Alosco ML, 2017, J NEUROPSYCH CLIN N, V29, P6, DOI 10.1176/appi.neuropsych.16030043; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chang L, 1996, LIFE SCI, V58, P2049, DOI 10.1016/0024-3205(96)00197-X; Coulthard E, 2006, J NEUROL, V253, P861, DOI 10.1007/s00415-006-0045-y; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Duffy SL, 2014, ALZHEIMERS DEMENT, V10, P67, DOI 10.1016/j.jalz.2013.01.005; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffith HR, 2009, INT REV NEUROBIOL, V84, P105, DOI [10.1016/S0074-7742(09)00406-I, 10.1016/S0074-7742(09)00406-1]; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Kantarci K, 2008, RADIOLOGY, V248, P210, DOI 10.1148/radiol.2481071590; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihara M, 2006, NEUROREPORT, V17, P413, DOI 10.1097/01.wnr.0000203353.52622.05; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Mueller SG, 2006, NMR BIOMED, V19, P655, DOI 10.1002/nbm.1062; Murray ME, 2014, J NEUROSCI, V34, P16247, DOI 10.1523/JNEUROSCI.2027-14.2014; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Ramadan S, 2013, NMR BIOMED, V26, P1630, DOI 10.1002/nbm.3045; Ramadan S, 2011, RADIOLOGY, V259, P540, DOI 10.1148/radiol.11101123; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Thomas MA, 2001, MAGNET RESON MED, V46, P58, DOI 10.1002/mrm.1160; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wang H, 2015, J ALZHEIMERS DIS, V46, P1049, DOI 10.3233/JAD-143225; Watson R, 2009, DEMENT GERIATR COGN, V28, P493, DOI 10.1159/000264614	46	6	6	2	11	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	OCT	2017	37	5					503	509		10.1055/s-0037-1608764			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FO9AY	WOS:000417181600004	29207411				2022-02-06	
J	de la Tremblaye, PB; Wellcome, JL; de Witt, BW; Cheng, JP; Skidmore, ER; Bondi, CO; Kline, AE				de la Tremblaye, Patricia B.; Wellcome, Jody L.; de Witt, Benjamin Wells; Cheng, Jeffrey P.; Skidmore, Elizabeth R.; Bondi, Corina O.; Kline, Anthony E.			Rehabilitative Success After Brain Trauma by Augmenting a Subtherapeutic Dose of Environmental Enrichment With Galantamine	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						behavioral outcome; controlled cortical impact; environmental enrichment; functional recovery; galantamine; learning and memory; Morris water maze; traumatic brain injury	CONTROLLED CORTICAL IMPACT; LONG-TERM POTENTIATION; COGNITIVE FUNCTION; COMBINATION THERAPIES; CONTROLLED-TRIAL; CLINICAL-TRIALS; MOTOR CORTEX; IN-VIVO; INJURY; RECOVERY	Background. Environmental enrichment (EE) confers benefits after traumatic brain injury (TBI) when provided daily for > 6 hours, but not 2 or 4 hours, which more accurately reflects the daily amount of clinical rehabilitation. The lack of benefit with sub-therapeutic EE suggests that augmentation with galantamine (GAL), which enhances cognition after TBI, may be indicated to confer benefits. Objective. To test the hypothesis that 2 and 4 hours of EE paired with GAL will provide benefits comparable to 24 hours of EE alone. Moreover, all EE groups will perform better than the standard (STD)-housed GAL group. Methods. Anesthetized rats received a TBI or sham injury and then were randomized to receive intraperitoneal injections of GAL (2 mg/kg) or saline vehicle (VEH; 1 mL/kg) beginning 24 hours after surgery and once daily while receiving EE for 2, 4, or 24 hours. Motor and cognitive assessments were conducted on postoperative days 1-5 and 14-19, respectively. Results. Motor function was significantly improved in the TBI + 24-hour EE group versus the TBI + STD + VEH and TBI + STD + GAL groups (P < .05). Cognitive performance was enhanced in all EE groups as well as in the TBI + STD + GAL versus TBI + STD + VEH (P < .05). Moreover, the 2- and 4-hour EE groups receiving GAL did not differ from the 24-hour EE group (P > .05) and performed better than GAL alone (P < .05). Conclusions. The findings support the hypothesis and have clinical relevance because, often, only brief rehabilitation may be available in the clinic and, thus, augmenting with a pharmacotherapy such as GAL may lead to outcomes that are significantly better than either therapy alone.	[de la Tremblaye, Patricia B.; Wellcome, Jody L.; de Witt, Benjamin Wells; Cheng, Jeffrey P.; Skidmore, Elizabeth R.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Pittsburgh, PA USA; [de Witt, Benjamin Wells] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA; [Skidmore, Elizabeth R.] Amer Soc Neurorehabil, St Louis Pk, MN USA		Kline, AE (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Phys Med & Rehabil,Sch Med, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Safar Ctr Resuscitat Res,Sch Med, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; UMPC Rehabilitation Institute (COB); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS099674, R01NS084967, R21NS099683, R03NS094950, R01NS060005] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported, in part, by NIH grants HD069620, HD069620-S1, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation, and the UMPC Rehabilitation Institute (COB).	Adkins DL, 2015, NEUROREHAB NEURAL RE, V29, P989, DOI 10.1177/1545968315576577; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Blesa R, 2003, DEMENT GERIATR COGN, V15, P79, DOI 10.1159/000067974; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Combs HL, 2016, J NEUROTRAUM, V33, P741, DOI 10.1089/neu.2015.4136; de la Tremblaye PB, 2017, J NEUROTRAUM, V34, P1610, DOI 10.1089/neu.2016.4790; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Egea J, 2012, NEUROPHARMACOLOGY, V62, P1082, DOI 10.1016/j.neuropharm.2011.10.022; Ezoulin MJM, 2008, NEUROTOXICOLOGY, V29, P270, DOI 10.1016/j.neuro.2007.11.004; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gatson JW, 2015, BRAIN RES BULL, V112, P35, DOI 10.1016/j.brainresbull.2015.01.008; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Hullinger R, 2015, NEUROBIOL LEARN MEM, V125, P126, DOI 10.1016/j.nlm.2015.08.006; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kokiko ON, 2007, BRAIN INJURY, V21, P259, DOI 10.1080/02699050701209964; Kreber LA, 2016, BRAIN RES, V1640, P152, DOI 10.1016/j.brainres.2016.01.016; Leary JB, 2017, J NEUROTRAUM, V34, P444, DOI 10.1089/neu.2016.4438; Lorrio S, 2007, J PHARMACOL EXP THER, V322, P591, DOI 10.1124/jpet.107.122747; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McLafferty FS, 2016, NEUROREHABILITATION, V39, P423, DOI 10.3233/NRE-161373; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Moriguchi S, 2009, HIPPOCAMPUS, V19, P844, DOI 10.1002/hipo.20572; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Reid RT, 2008, J NEURAL TRANSM, V115, P1437, DOI 10.1007/s00702-008-0107-7; Schilstrom B, 2007, NEUROPSYCHOPHARMACOL, V32, P43, DOI 10.1038/sj.npp.1301087; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stavrakov G, 2017, CHEM BIOL DRUG DES, V90, P709, DOI 10.1111/cbdd.12991; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	60	6	6	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	OCT-NOV	2017	31	10-11					977	985		10.1177/1545968317739999			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FP9DX	WOS:000417948800012	29130805	Green Accepted, Bronze			2022-02-06	
J	Donnelly, JE; Young, AMH; Brady, K				Donnelly, Joseph E.; Young, Adam M. H.; Brady, Ken			Autoregulation in paediatric TBI-current evidence and implications for treatment	CHILDS NERVOUS SYSTEM			English	Article						Autoregulation; Traumatic brain injury; Cerebral perfusion pressure	CEREBROVASCULAR PRESSURE REACTIVITY; CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; NEAR-INFRARED SPECTROSCOPY; INTRACRANIAL-PRESSURE; BLOOD-FLOW; ARTERIAL; CIRCULATION; CHILDREN; TIME	Children who survive acute traumatic brain injury are at risk of death from subsequent brain swelling and secondary injury. Strict physiologic management in the ICU after traumatic brain injury is believed to be key to survival, and cerebral perfusion pressure is a prominent aspect of post brain injury care. However, optimal cerebral perfusion pressure targets for children are not known. Autoregulation monitoring has been used to delineate individualized optimal perfusion pressures for patients with traumatic brain injury. The methods to do so are diverse, confusing, and not universally validated. In this manuscript, we discuss the history of autoregulation monitoring, outline and categorize the methods used to measure autoregulation, and review the available validation data for methods used to monitor autoregulation. Impaired autoregulation after traumatic brain injury is associated with a poor prognosis. Observational data suggests that optimal neurologic outcome and survival are associated with optimal perfusion pressure defined by autoregulation monitoring. No randomized, controlled, interventional data is available to assess autoregulation monitoring after pediatric traumatic brain injury.	[Donnelly, Joseph E.; Young, Adam M. H.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Brain Phys Lab, Cambridge, England; [Brady, Ken] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Anesthesia,Crit Care, 6621 Fannin St,WT 17417B, Houston, TX 77030 USA		Brady, K (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Anesthesia,Crit Care, 6621 Fannin St,WT 17417B, Houston, TX 77030 USA.	kmbrady@bcm.edu	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Brady, Ken/0000-0002-3260-0233			AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Addison Paul S, 2015, IEEE Rev Biomed Eng, V8, P78, DOI 10.1109/RBME.2015.2436978; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2012, J NEUROTRAUM, V29, P1483, DOI 10.1089/neu.2011.2248; Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; BENTSEN N, 1975, STROKE, V6, P497, DOI 10.1161/01.STR.6.5.497; Brady K M, 2010, Journal of Physics: Conference Series, V224, DOI 10.1088/1742-6596/224/1/012089; Brady K, 2015, ANESTH ANALG, V121, P1121, DOI 10.1213/ANE.0000000000000952; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Brady KM, 2010, ANESTH ANALG, V111, P191, DOI 10.1213/ANE.0b013e3181e054ba; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Diedler J, 2011, ANESTH ANALG, V113, P849, DOI 10.1213/ANE.0b013e3182285dc0; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Drummond JC, 1997, ANESTHESIOLOGY, V86, P1431, DOI 10.1097/00000542-199706000-00034; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Hori D, 2016, INTERACT CARDIOV TH, V22, P445, DOI 10.1093/icvts/ivv371; Hori D, 2015, ANESTH ANALG, V121, P1187, DOI 10.1213/ANE.0000000000000930; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kety SS, 1944, AM J MED SCI, V208, P809, DOI [10.1097/00000441-194412000-00013, DOI 10.1097/00000441-194412000-00013]; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2016, ACTA NEUROCHIR SUPPL, V122, P221, DOI 10.1007/978-3-319-22533-3_44; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LASSEN NA, 1964, CIRC RES, V15, P201; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Massaro AN, 2015, J NEUROPHYSIOL, V114, P818, DOI 10.1152/jn.00353.2015; Mytar J, 2012, NEUROSURGERY, V71, P138, DOI 10.1227/NEU.0b013e318251795a; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Ragauskas A, 2005, ACTA NEUROCHIR SUPPL, V95, P367; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roy C S, 1890, J Physiol, V11, P85; Smirl JD, 2014, J APPL PHYSL BETHESD, DOI [10.1152/japplphysiol.01266, DOI 10.1152/JAPPLPHYSI0L.01266.2013]; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STRANDGAARD S, 1973, BMJ-BRIT MED J, V1, P507, DOI 10.1136/bmj.1.5852.507; Strebel S, 1995, ANESTHESIOLOGY, DOI [10.1097/00132586-199610000-00054, DOI 10.1097/00132586-199610000-00054]; Tan CO, 2012, J APPL PHYSIOL, V113, P1194, DOI 10.1152/japplphysiol.00783.2012; Tiecks FP, 1996, STROKE, V27, P1177, DOI 10.1161/01.STR.27.7.1177; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Young AMH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148817; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	54	6	6	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1735	1744		10.1007/s00381-017-3523-x			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900017	29149389				2022-02-06	
J	Harwayne-Gidansky, I; Bellis, JM; McLaren, SH; Critelli, K; Clark, S; Chen, ZM; Gerber, LM; Ching, K				Harwayne-Gidansky, Ilana; Bellis, Jennifer M.; McLaren, Son H.; Critelli, Kristen; Clark, Sunday; Chen, Zhengming; Gerber, Linda M.; Ching, Kevin			Mannequin-Based Immersive Simulation Improves Resident Understanding of a Clinical Decision Rule	SIMULATION & GAMING			English	Article						clinical decision-making; clinical performance; debriefing; emergency medicine; highfidelity simulation; medical decision-making; medical education; PECARN; pediatric interns; pediatrics; resident education; simulation; structured clinical observation; structured debriefing	BLUNT HEAD TRAUMA; HIGH-FIDELITY; RETENTION; MANAGEMENT; EDUCATION; CHILDREN; SUPPORT; IMPACT; SKILLS	Objective. Simulation-based medical education may aid to standardize clinical performance measures, though there is little evidence for using an immersive, mannequin-based simulation for knowledge acquisition. We predicted that residents who had participated in an immersive simulation exercise illustrating the use of a clinical decision rule plus routine instructional methods (experimental group) would understand and implement this tool better than interns who participated in an immersive simulation focused on traumatic brain injury with intracranial hypertension plus routine instructional methods (control group 1). We further predicted that interns in the experimental group would understand and implement this tool as well as senior residents with more clinical experience (control group 2). Methods. This was a single center, prospective, simulation-based, randomized controlled trial. Pediatric interns were randomly assigned to clinically integrated teaching, plus a single, immersive simulation and structured debrief aimed at teaching this tool in minor head trauma (intervention), or clinically integrated teaching plus a related simulation on intracranial hypertension. Senior residents were used as an historical control arm and did not participate in a simulated encounter. Results. 20 interns (ten per group) participated in the study. Senior residents (n= 40) served as historical comparisons. Interns in the intervention group scored similar to senior residents on a structured clinical observation score (median 64% vs. 57%), and better than interns in the placebo group (median 64% vs. 43%). Conclusions. In this study, a single immersive simulation improved resident learning and application of a clinical prediction rule when compared to standard resident education.	[Harwayne-Gidansky, Ilana] Stony Brook Childrens Hosp, Pediat Clin, Div Pediat Crit Care Med, Stony Brook, NY USA; [Bellis, Jennifer M.] Mt Sinai Kravis Childrens Hosp, New York, NY USA; [McLaren, Son H.] Morgan Stanley Childrens Hosp, New York, NY USA; [Critelli, Kristen] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Clark, Sunday] Weill Cornell Med Coll, Div Emergency Med, Res, New York, NY 10065 USA; [Clark, Sunday] Weill Cornell Med Coll, Epidemiol Med & Healthcare Policy & Res, New York, NY 10065 USA; [Chen, Zhengming; Gerber, Linda M.] Weill Cornell Med Coll, Healthcare Policy & Res, New York, NY 10065 USA; [Gerber, Linda M.] Weill Cornell Med Coll, Epidemiol Med, New York, NY 10065 USA; [Ching, Kevin] NewYork Presbyterian Hosp, Div Pediat Emergency Med, Pediat, Weill Cornell Med Coll, New York, NY 10065 USA		Ching, K (corresponding author), Weill Cornell Med Coll, Div Pediat Emergency Med, 525 E 68th St,Box 179, New York, NY 10065 USA.	Ilana.Harwayne-Gidansky@stonybrookmedicine.edu; jennifer.garnett@mountsinai.org; shm2108@cumc.columbia.edu; critellik@gmail.com; suc2010@med.cornell.edu; zhc2006@med.cornell.edu; lig2002@med.cornell.edu; kec9012@med.cornell.edu	Clark, Sunday/AAA-5458-2021; Harwayne-Gidansky, Ilana/I-9528-2019	Harwayne-Gidansky, Ilana/0000-0001-7987-6440			[Anonymous], 2013, CHOOS WIS 5 THINGS P; Braun L, 2015, PEDIATR CRIT CARE ME, V16, P131, DOI 10.1097/PCC.0000000000000315; Cato DL, 2010, CRIT CARE NURS Q, V33, P44, DOI 10.1097/CNQ.0b013e3181c8dfd4; Donoghue A, 2015, RESUSCITATION, V93, pA3, DOI 10.1016/j.resuscitation.2015.05.004; Donoghue AJ, 2010, SIMUL HEALTHC, V5, P16, DOI 10.1097/SIH.0b013e3181a46aa1; Garnett J, 2015, CRIT CARE MED, V43; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kuduvalli PM, 2009, EUR J ANAESTH, V26, P17, DOI 10.1097/EJA.0b013e32831bc665; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lammers RL, 2008, ACAD EMERG MED, V15, P1181, DOI 10.1111/j.1553-2712.2008.00220.x; McGaghie WC, 2010, MED EDUC, V44, P50, DOI 10.1111/j.1365-2923.2009.03547.x; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Obeid JS, 2013, J BIOMED INFORM, V46, P259, DOI 10.1016/j.jbi.2012.10.006; Scerbo MW, 2016, SIMUL HEALTHC, V11, P232, DOI 10.1097/SIH.0000000000000190; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Sutton RM, 2011, PEDIATRICS, V128, pE145, DOI 10.1542/peds.2010-2105; Tavarez MM, 2012, CURR OPIN PEDIATR, V24, P307, DOI 10.1097/MOP.0b013e3283531ce6; Wayne DB, 2006, ACAD MED, V81, pS9, DOI 10.1097/00001888-200610001-00004	19	6	6	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1046-8781	1552-826X		SIMULAT GAMING	Simul. Gaming	OCT	2017	48	5					657	669		10.1177/1046878117719483			13	Education & Educational Research; Psychology, Social; Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Education & Educational Research; Psychology; Social Sciences - Other Topics	FH3ZY	WOS:000411090600005					2022-02-06	
J	Johnson, SS; Levesque, DA; Broderick, LE; Bailey, DG; Kerns, RD				Johnson, Sara S.; Levesque, Deborah A.; Broderick, Lynne E.; Bailey, Dustin G.; Kerns, Robert D.			Pain Self-Management for Veterans: Development and Pilot Test of a Stage-Based Mobile-Optimized Intervention	JMIR MEDICAL INFORMATICS			English	Article						pain management; self-management; mobile health; mhealth	POSTTRAUMATIC-STRESS-DISORDER; CHRONIC BACK-PAIN; PRIMARY-CARE; OPIOID USE; SMARTPHONE APPLICATIONS; CHANGE QUESTIONNAIRE; SMOKING-CESSATION; READINESS; BEHAVIOR; IMPACT	Background: Chronic pain is a significant public health burden affecting more Americans than cardiovascular disease, diabetes, and cancer combined. Veterans are disproportionately affected by chronic pain. Among previously deployed soldiers and veterans, the prevalence of chronic pain is estimated between 44% and 60%. Objective: The objective of this research was to develop and pilot-test Health eRide: Your Journey to Managing Pain, a mobile pain self-management program for chronic musculoskeletal pain for veterans. Based on the transtheoretical model of behavior change, the intervention is tailored to veterans' stage of change for adopting healthy strategies for pain self-management and their preferred strategies. It also addresses stress management and healthy sleep, two components of promising integrated treatments for veterans with pain and co-occurring conditions, including posttraumatic stress disorder (PTSD) and traumatic brain injury. In addition, Health eRide leverages gaming principles, text messaging (short message service, SMS), and social networking to increase engagement and retention. Methods: Pilot test participants were 69 veterans recruited in-person and by mail at a Veterans Health Administration facility, by community outreach, and by a Web-based survey company. Participants completed a mobile-delivered baseline assessment and Health eRide intervention session. During the next 30 days, they had access to a Personal Activity Center with additional stage-matched activities and information and had the option of receiving tailored text messages. Pre-post assessments, administered at baseline and the 30-day follow-up, included measures of pain, pain impact, use of pain self-management strategies, PTSD, and percentage in the Action or Maintenance stage for adopting pain self-management, managing stress, and practicing healthy sleep habits. Global impressions of change and program acceptability and usability were also assessed at follow-up. Results: Among the 44 veterans who completed the 30-day post assessment, there were statistically significant pre-post reductions in pain (P <.001) and pain impact (P <.001); there was some reduction in symptoms of PTSD (P=.05). There were significant pre-post increases in the percentage of participants in the Action or Maintenance stage for adopting pain self-management (P=.01) and for managing stress (P <.001) but not for practicing healthy sleep habits (P=.11). The global impressions of change measure showed that a majority had experienced some level of improvement. User ratings of acceptability were quite high; ratings of usability fell slightly below the mean for digital programs. Conclusions: Preliminary data demonstrate the potential impact of the Health eRide program for chronic musculoskeletal pain for veterans. The results underscore that simultaneously addressing other behaviors may be a promising approach to managing pain and comorbid conditions. Additional formative research is required to complete development of the Health eRide program and to address areas of usability requiring improvement. A randomized trial with longer follow-up is needed to demonstrate the program's long-term effects on pain and pain self-management.	[Johnson, Sara S.; Levesque, Deborah A.; Broderick, Lynne E.; Bailey, Dustin G.] Prochange Behav Syst Inc, 1174 Kingstown Rd,Suite 101, South Kingstown, RI 02879 USA; [Kerns, Robert D.] Yale Univ, VA Connecticut Healthcare Syst, West Haven, CT USA; [Kerns, Robert D.] PRIME Ctr, West Haven, CT USA		Johnson, SS (corresponding author), Prochange Behav Syst Inc, 1174 Kingstown Rd,Suite 101, South Kingstown, RI 02879 USA.	sjohnson@prochange.com		Broderick, Lynne/0000-0001-8783-9877; Kerns, Robert/0000-0001-7609-2771	National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [R43TR000362]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [R43TR000362, UL1TR001863] Funding Source: NIH RePORTER	We gratefully acknowledge funding from the National Center for Advancing Translational Sciences (Grant R43TR000362).	Alexander JC, 2016, J PAIN RES, V9, P731, DOI 10.2147/JPR.S119966; Baranowski T, 2008, AM J PREV MED, V34, P74, DOI 10.1016/j.amepre.2007.09.027; Becker J, 2007, PAIN MED, V8, pS129, DOI 10.1111/j.1526-4637.2007.00377.x; Briggs JP, 2014, EXPLORING NONDRUG AP; Brooke J., 1996, USABILITY EVALUATION, P189, DOI DOI 10.1002/HBM.20701; Brooke J, 2013, J USABILITY STUD, V8, P29; Brug J, 1998, HEALTH EDUC BEHAV, V25, P517, DOI 10.1177/109019819802500409; CAMPBELL MK, 1994, AM J PUBLIC HEALTH, V84, P783, DOI 10.2105/AJPH.84.5.783; Cantril H., 1965, PATTERN HUMAN CONCER; Carpenter KM, 2012, CLIN J PAIN, V28, P14, DOI 10.1097/AJP.0b013e31822363db; Childress S, VETERANS FACE GREATE; comScore, COMSCORE REP JAN 201; DICLEMENTE CC, 1991, J CONSULT CLIN PSYCH, V59, P295, DOI 10.1037/0022-006X.59.2.295; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Dunn AS, 2011, J REHABIL RES DEV, V48, P493, DOI 10.1682/JRRD.2010.05.0104; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Evers KE, 2006, HEALTH PSYCHOL, V25, P521, DOI 10.1037/0278-6133.25.4.521; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hall KL, 2008, PREV MED, V46, P266, DOI 10.1016/j.ypmed.2007.11.006; Heapy AA, 2017, JAMA INTERN MED, V177, P765, DOI 10.1001/jamainternmed.2017.0223; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Iprcc.nih, NAT PAIN STRAT; Jamison RN, 2010, ANESTHESIOLOGY, V112, P777, DOI 10.1097/ALN.0b013e3181cdefb4; Jensen MP., 2011, HYPNOSIS CHRONIC PAI; Johnson S.S., 2006, DIS MANAG, V9, P102, DOI DOI 10.1089/DIS.2006.9.102; Johnson SS, 2008, PREV MED, V46, P238, DOI 10.1016/j.ypmed.2007.09.010; Johnson SS, 2015, AM J HEALTH PROMOT, V29, pTAHP4; Jonas WB, 2014, JAMA INTERN MED, V174, P1402, DOI 10.1001/jamainternmed.2014.2114; Kerns RD, 2011, TRANSL BEHAV MED, V1, P635, DOI 10.1007/s13142-011-0094-3; Kreuter MW, 1999, ANN BEHAV MED, V21, P276, DOI 10.1007/BF02895958; Kroenke K, 2009, JAMA-J AM MED ASSOC, V301, P2099, DOI 10.1001/jama.2009.723; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Levesque D, 2013, 2013 INT CYST FDN 20; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Luger Tana M, 2016, J Med Internet Res, V18, pe296; Macea DD, 2010, J PAIN, V11, P917, DOI 10.1016/j.jpain.2010.06.005; Mailloux J, 2006, AM J PHYS MED REHAB, V85, P120, DOI 10.1097/01.phm.0000197580.64079.3d; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P35; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; McGonigal J., 2011, REALITY IS BROKEN WH; National Cancer Institute, 1989, MAK HLTH COMM PROGR; Nicholas MK, 2012, EUR J PAIN, V16, P93, DOI 10.1016/j.ejpain.2011.06.005; Nielson WR, 2008, J PAIN, V9, P552, DOI 10.1016/j.jpain.2008.01.327; Nielson WR, 2009, CLIN J PAIN, V25, P48, DOI 10.1097/AJP.0b013e3181817ab4; Nielson WR, 2003, J PAIN, V4, P148, DOI 10.1054/jpai.2003.436; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Palermo TM, 2010, PAIN, V148, P387, DOI 10.1016/j.pain.2009.10.004; Park ER, 2015, JAMA INTERN MED, V175, P1509, DOI 10.1001/jamainternmed.2015.2391; Portelli P, 2016, BRIT J PAIN, V10, P135, DOI 10.1177/2049463716638700; Poushter J, PEWGLOBAL SMARTPHONE; Prochaska J O, 1992, Prog Behav Modif, V28, P183; PROCHASKA JO, 1988, J CONSULT CLIN PSYCH, V56, P520, DOI 10.1037/0022-006X.56.4.520; Prochaska JO, 2003, HOMEOST HLTH DIS, V42, P1, DOI DOI 10.1037/0278-6133.25.4.521; Reynoldson C, 2014, PAIN MED, V15, P898, DOI 10.1111/pme.12327; Ruehlman LS, 2012, PAIN, V153, P319, DOI 10.1016/j.pain.2011.10.025; Sauro J., 2011, MEASURINGU MEASURING; Schneiderhan J, 2017, JAMA-J AM MED ASSOC, V317, P2367, DOI 10.1001/jama.2017.5787; Schwab KA, INSIGHTS OVID BRIEF; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Sherman KJ, 2011, ARCH INTERN MED, V171, P2019, DOI 10.1001/archinternmed.2011.524; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Singer E, 2008, J EMPIR RES HUM RES, V3, P49, DOI 10.1525/jer.2008.3.3.49; Sinnott P, 2009, ARCH INTERN MED, V169, P1338, DOI 10.1001/archinternmed.2009.201; Skinner CS, 1999, ANN BEHAV MED, V21, P290, DOI 10.1007/BF02895960; Smeets RJ, 2006, BMC MUSCULOSKELET DI; Stein C, 2010, CURR OPIN ANESTHESIO, V23, P598, DOI 10.1097/ACO.0b013e32833c57a8; Toblin RL, 2014, JAMA INTERN MED, V174, P1400, DOI 10.1001/jamainternmed.2014.2726; Toblin RL, 2011, PAIN, V152, P1249, DOI 10.1016/j.pain.2010.12.036; Trompetter HR, 2015, J BEHAV MED, V38, P66, DOI 10.1007/s10865-014-9579-0; Usability.gov, 2013, SYST US SCAL SUS; Velicer W, 1998, HOMEOSTASIS HLTH DIS, V38, P216; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Weathers F.W., 1993, ANN CONV INT SOC TRA; Williams DA, 2010, PAIN, V151, P694, DOI 10.1016/j.pain.2010.08.034; Woodcock J, 2009, NEW ENGL J MED, V361, P2105, DOI 10.1056/NEJMp0908913; Wu Phipson C, 2010, J Opioid Manag, V6, P133; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004	80	6	6	1	17	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA		2291-9694		JMIR MED INF	JMIR Med. Inf.	OCT-DEC	2017	5	4							e40	10.2196/medinform.7117			15	Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics	FR6EO	WOS:000419158400017	29042341	Green Published, gold			2022-02-06	
J	Oyesanya, TO; Bowers, B				Oyesanya, Tolu O.; Bowers, Barbara			"I'm Trying To Be the Safety Net": Family Protection of Patients With Moderate-To-Severe TBI During the Hospital Stay	QUALITATIVE HEALTH RESEARCH			English	Article						brain injury; patients; families; grounded theory; qualitative; Midwest, USA	TRAUMATIC BRAIN-INJURY; GROUNDED THEORY; CARE; REHABILITATION; PERSPECTIVES; EXPERIENCES; CAREGIVERS; MEMBERS; NEEDS	Research has shown that during hospital stay, family caregivers of patients with traumatic brain injury (TBI) perceive that their role is to protect the patient; however, research on this topic is limited. The purpose of this article is to describe family caregivers' experience of protecting patients with TBI during the hospital stay. Grounded theory was used to conduct 24 interviews with 16 family caregivers. Findings showed family caregivers worked to protect the patient's physical and emotional safety, using the following strategies: (a) influencing the selection of staff, (b) breaking the patient's bad habits, (c) anticipating how to orchestrate the home environment; (d) connecting on an emotional level, (e) managing visitors, and (f) connecting on an emtoional level. The findings have practice implications for educating interdisciplinary health care providers about the experience of family caregivers and for developing an adversarial alliance between health care providers and family caregivers during the hospital stay to improve support provided to them.	[Oyesanya, Tolu O.] Univ Wisconsin Madison, Madison, WI USA; [Bowers, Barbara] Univ Wisconsin Madison, Sch Nursing, Nursing, Madison, WI USA; [Bowers, Barbara] Univ Wisconsin Madison, Sch Nursing, Res, Madison, WI USA		Oyesanya, TO (corresponding author), Shepherd Ctr, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.	toyesanya@wisc.edu		Oyesanya, Tolu/0000-0001-8821-4510	National Institute of Nursing Research (NINR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F31NR015398]; University of Wisconsin-Madison, School of Nursing; NIH/NIGMS Initiative for Maximizing Student Development [R25GM083252]; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR015398] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the National Institute of Nursing Research (NINR) and the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) (PI, T. Oyesanya), Grant F31NR015398, and by the University of Wisconsin-Madison, School of Nursing. This project was partially supported by the NIH/NIGMS Initiative for Maximizing Student Development (PI, M. Carnes) Grant R25GM083252 and by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS) (PI B. Bowers), Grant UL1TR000427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Beaulieu M., 2004, J NEUROSCIENCE NURSI, V36, P142; Bischofberger Iren, 2004, Pflege, V17, P176, DOI 10.1024/1012-5302.17.3.176; Blumer H., 1969, SYMB INTERACT, P1; Bowers B.J., 1990, PATHS KNOWLEDGE; BOWERS BJ, 1987, ADV NURS SCI, V9, P20, DOI 10.1097/00012272-198701000-00006; BOWERS BJ, 1988, GERONTOLOGIST, V28, P361, DOI 10.1093/geront/28.3.361; Brain Injury Association of America, 2015, LIV BRAIN INJ; Brain Injury Association of America, 2015, FAM CAR; Brereton L, 2002, J CLIN NURS, V11, P22, DOI 10.1046/j.1365-2702.2002.00564.x; Carr Jeanine M, 2014, Medsurg Nurs, V23, P251; Carr JM, 1999, J FAM PRACTICE, V48, P433; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chan TMS, 2017, QUAL HEALTH RES, V27, P260, DOI 10.1177/1049732315605272; Charmaz, 2014, CONSTRUCTING GROUNDE; Choi H., 2016, ENCY ADULTHOOD AGING, V1-3, P1; Duff Diane, 2002, Axone, V24, P14; Family Caregiver Alliance, 2009, CAR; Handberg C, 2015, QUAL HEALTH RES, V25, P1023, DOI 10.1177/1049732314554231; HASSELKUS BR, 1988, GERONTOLOGIST, V28, P686, DOI 10.1093/geront/28.5.686; Hupcey JE, 1999, J CLIN NURS, V8, P253, DOI 10.1046/j.1365-2702.1999.00244.x; Jamerson PA, 1996, HEART LUNG, V25, P467, DOI 10.1016/S0147-9563(96)80049-5; Kahler DM, 2001, J BONE JOINT SURG AM, V83A, P142, DOI 10.2106/00004623-200101000-00021; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kosny A, 2014, QUAL HEALTH RES, V24, P837, DOI 10.1177/1049732314535666; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; Leahey, 2012, NURSES FAMILIES GUID; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Levack WMM, 2009, BRAIN INJURY, V23, P192, DOI 10.1080/02699050802695582; Lor M, 2016, NURS OUTLOOK, V64, P352, DOI 10.1016/j.outlook.2016.02.006; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; MIRR MP, 1991, HEART LUNG, V20, P228; Mukherjee D, 2006, TOP STROKE REHABIL, V13, P75, DOI 10.1310/2M1U-71FQ-QV33-56PX; Norcross J.C., 2010, HEART SOUL CHANGE DE, DOI [10.1037/12075004, DOI 10.1037/12075004, DOI 10.1037/12075-004]; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rivera-Rodriguez AJ, 2010, QUAL SAF HEALTH CARE, V19, P304, DOI 10.1136/qshc.2009.033282; ROSENBLATT PC, 1994, METAPHORS FAMILY SYS; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Salmond Susan W, 2011, Intensive Crit Care Nurs, V27, P10, DOI 10.1016/j.iccn.2010.09.002; Sapountzi-Krepia D, 2008, J CLIN NURS, V17, P1287, DOI 10.1111/j.1365-2702.2007.02033.x; Silva-Smith AL, 2007, J FAM NURS, V13, P99, DOI 10.1177/1074840706297425; Stavrou V., 2014, INT J, V7, P553; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Strauss AL, 1987, QUALITATIVE ANAL SOC, DOI DOI 10.1017/CBO9780511557842; Vandall-Walker V, 2011, J FAM NURS, V17, P148, DOI 10.1177/1074840711406728; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; WILSON HS, 1989, NURS RES, V38, P94	47	6	7	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	OCT	2017	27	12					1804	1815		10.1177/1049732317697098			12	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	FY0AH	WOS:000426471800005	28936928	Green Accepted			2022-02-06	
J	Patel, Y; Goljan, P; Pierce, TP; Scillia, A; Issa, K; McInerney, VK; Festa, A				Patel, Yashika; Goljan, Peter; Pierce, Todd P.; Scillia, Anthony; Issa, Kimona; McInerney, Vincent K.; Festa, Anthony			Management of Nasal Fractures in Sports	SPORTS MEDICINE			English	Article							CONVENTIONAL RADIOGRAPHY; FACIAL FRACTURES; TRAUMA; INJURIES; SPLINT; HEAD	Nasal fractures represent approximately 60% of all maxillofacial injuries that occur in athletic activities; however, there are no current guidelines regarding immediate sideline management of these injuries. Therefore, the purpose of this article was to (1) summarize the anatomy, etiology, and incidence of nasal fractures, and (2) evaluate the current body of literature regarding immediate on-field and subsequent outpatient management. It is imperative to establish that the athlete's airway is not compromised and there are no other severe concomitant injuries, such as a concussion, ocular injury, or leakage of cerebrospinal fluid. Immediate closed reduction should not be attempted unless there is airway compromise or the practitioner has experience in performing it. The majority of athletes with these injuries in isolation may return to play; however, in our practice, we recommend they wear a face mask for 6 weeks after their injury. Despite our recommendations, we know there is a paucity of clinical studies on immediate sideline and longer-term management. Future studies should focus on establishing therapeutic algorithms that will allow physicians to make treatment recommendations to patients with strong evidence to support their decision.	[Patel, Yashika; Goljan, Peter; Pierce, Todd P.; Scillia, Anthony; Issa, Kimona; McInerney, Vincent K.; Festa, Anthony] Seton Hall Univ, Sch Hlth & Med Sci, Dept Orthopaed, 400 S Orange Ave, S Orange, NJ 07079 USA		Festa, A (corresponding author), Seton Hall Univ, Sch Hlth & Med Sci, Dept Orthopaed, 400 S Orange Ave, S Orange, NJ 07079 USA.	anthonyfestamd@gmail.com					Antoun JS, 2008, J ORAL MAXIL SURG, V66, P504, DOI 10.1016/j.joms.2007.08.018; Baek HJ, 2013, IRAN J RADIOL, V10, P140, DOI 10.5812/iranjradiol.6353; Baliarsing A, 2000, BRIT J PLAST SURG, V53, P450, DOI 10.1054/bjps.2000.3354; Bartkiw T P, 1995, Int J Trauma Nurs, V1, P11, DOI 10.1016/S1079-2104(05)80405-6; Butler JSCF, 2010, FACIAL INJURIES; Cannon C Ron, 2011, Ear Nose Throat J, V90, pE8; CARROLL SM, 1995, BRIT J SPORT MED, V29, P194, DOI 10.1136/bjsm.29.3.194; Daniel RK, 2006, FACIAL PLAST SURG CL, V14, pvi; Daniel Rollin K, 2006, Facial Plast Surg Clin North Am, V14, P301, DOI 10.1016/j.fsc.2006.06.008; Exadaktylos AK, 2004, BRIT J SPORT MED, V38, P750, DOI 10.1136/bjsm.2003.008581; Fernandes SV, 2004, LARYNGOSCOPE, V114, P587, DOI 10.1097/00005537-200403000-00038; FRENGUELLI A, 1991, J CRANIO MAXILL SURG, V19, P178, DOI 10.1016/S1010-5182(05)80309-9; Gilpin T, 2000, J ACCID EMERG MED, V17, P286; Hester T O, 1997, J Ky Med Assoc, V95, P386; Iida S, 2001, INT J ORAL MAX SURG, V30, P286, DOI 10.1054/ijom.2001.0056; JACOBSON JA, 1986, ARCH OTOLARYNGOL, V112, P329; LIM TC, 1993, BRIT J PLAST SURG, V46, P714, DOI 10.1016/0007-1226(93)90206-Q; LINN EW, 1986, J MAXILLOFAC SURG, V14, P83, DOI 10.1016/S0301-0503(86)80266-1; LOGAN M, 1994, CLIN RADIOL, V49, P192, DOI 10.1016/S0009-9260(05)81775-1; NIGAM A, 1993, ARCH EMERG MED, V10, P293; Perkins S W, 2000, Ear Nose Throat J, V79, P632; Perkins SW, 2000, ENT-EAR NOSE THROAT, V79, P8; Perkins SW, 2000, ENT-EAR NOSE THROAT, V79, P6; Rhee SC, 2004, PLAST RECONSTR SURG, V113, P45, DOI 10.1097/01.PRS.0000096705.64545.69; Romeo Sam J, 2007, Curr Sports Med Rep, V6, P155, DOI 10.1007/s11932-007-0022-y; Sargent L A, 1999, J Craniomaxillofac Trauma, V5, P19; Stackhouse T, 1998, PHYSICIAN SPORTSMED, V26, P69, DOI 10.3810/psm.1998.08.1119; Thiede O, 2005, ARCH OTOLARYNGOL, V131, P434, DOI 10.1001/archotol.131.5.434; Yabe T, 2004, ANN PLAS SURG, V53, P547, DOI 10.1097/01.sap.0000139567.23921.2a; Yilmaz MS, 2013, BRIT J ORAL MAX SURG, V51, pE256, DOI 10.1016/j.bjoms.2013.07.008; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	31	6	6	0	10	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	OCT	2017	47	10					1919	1923		10.1007/s40279-017-0729-8			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FH1FQ	WOS:000410885700002	28417330				2022-02-06	
J	Tamplin, J; Baker, FA				Tamplin, Jeanette; Baker, Felicity A.			Therapeutic Singing Protocols for Addressing Acquired and Degenerative Speech Disorders in Adults	MUSIC THERAPY PERSPECTIVES			English	Article						music therapy; singing; protocol; speech disorder; neurorehabilitation	GROUP MUSIC-THERAPY; PARKINSONS-DISEASE; VOICE PROTOCOL; INDIVIDUALS; MOOD; INTELLIGIBILITY; COMMUNICATION; INSTRUCTION; RHYTHM	The ability to communicate and make oneself understood is integral to a person's quality of life. It affects social interaction, educational and vocational opportunities, and ultimately independence and sense of self. Unfortunately, speech production is often impaired as a result of neurological damage (e.g., traumatic brain injury, stroke) or disorders (e.g., Parkinson's disease). There are many similarities and shared neural mechanisms between speech and singing. For example, both singing and speech utilize rhythm, pitch variation, tempo, dynamics, articulation, and respiratory support. Music therapists manipulate these elements of music when addressing therapeutic goals for people with neurogenic speech disorders. Many clinical protocols to address speech disorders in adults have now been published to guide clinical practice in music therapy. This paper summarizes existing music therapy and singing-based protocols used to address commonly occurring acquired or degenerative speech disorders, namely dysarthria, dysphonia, dysprosody, and apraxia of speech. We examine individual and group therapy protocols used in medical and community settings for people with neurogenic speech disorders caused by traumatic brain injury, stroke, spinal cord injury, and Parkinson's disease. We highlight the strengths and limitations of these protocols and make recommendations for clinical practice.	[Tamplin, Jeanette] Univ Melbourne, Melbourne, Vic, Australia; [Baker, Felicity A.] Univ Melbourne, Melbourne Conservatorium Mus, Melbourne, Vic, Australia		Tamplin, J (corresponding author), Univ Melbourne, Mus Therapy, 234 St Kilda Rd, Southbank, Vic 3006, Australia.	jeanette.tamplin@unimelb.edu.au	Tamplin, Jeanette/AAR-2855-2021	Tamplin, Jeanette/0000-0002-3623-033X			Altenmuller E., 2013, MUSIC MED, V5, P210, DOI [10.1177/1943862113505328, DOI 10.1177/1943862113505328]; Azekawa M., 2011, THESIS; Baker F, 2005, BRAIN INJURY, V19, P519, DOI 10.1080/02699050400005150; Baker F, 2004, BRIT J MUSIC THERAPY, V2, P55; Baker F, 2011, VOICEWORK MUSIC THER, P189; Baker F., 2004, NORD J MUSIC THER, V13, P20, DOI DOI 10.1080/08098130409478095; Baker F. A., 2011, DEV MUSIC THERAPY PR, P281; Baker F. A., 2011, VOICEWORK MUSIC THER, P171; Baker F.A., 2000, MUSIC THER PERSPECT, V18, P110, DOI [10.1093/mtp/18.2.110, DOI 10.1093/MTP/18.2.110]; Baker FA, 2006, MUSIC THERAPY METHOD; Brown S., 2000, ORIGINS MUSIC; Cohen N., 1995, MUSIC THERAPY PERSPE, V13, P69; COHEN NS, 1995, J MUSIC THER, V32, P46, DOI 10.1093/jmt/32.1.46; COHEN NS, 1988, J MUSIC THER, V25, P85, DOI 10.1093/jmt/25.2.85; COHEN NS, 1992, J MUSIC THER, V29, P87, DOI 10.1093/jmt/29.2.102; COHEN NS, 1993, J MUSIC THER, V30, P81, DOI 10.1093/jmt/30.2.81; de Bruijn M., 2011, VOICEWORK MUSIC THER; Di Benedetto P, 2009, EUR J PHYS REHAB MED, V45, P13; Duffy JR., 2013, MOTOR SPEECH DISORDE; Elefant C, 2012, J MUSIC THER, V49, P278, DOI 10.1093/jmt/49.3.278; Evans Caroline., 2012, ARTS HEALTH, V4, P83, DOI DOI 10.1080/17533015.2011.584883; Fairbanks G., 1960, VOICE ARTICULATION D; Freeman W, 2000, ORIGINS OF MUSIC, P411; Haneishi E, 2001, J MUSIC THER, V38, P273, DOI 10.1093/jmt/38.4.273; Hurkmans J, 2015, APHASIOLOGY, V29, P939, DOI 10.1080/02687038.2015.1006565; Kent RD, 1994, REFERENCE MANUAL COM; Kim SJ, 2013, NEUROREHABILITATION, V32, P185, DOI 10.3233/NRE-130835; KOTBY MN, 1995, ACCENT METHOD VOICE; Magee WL, 2006, DISABIL REHABIL, V28, P1221, DOI 10.1080/09638280600630999; Magee WL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub3; Onofre F, 2013, ACTA CIR BRAS, V28, P119, DOI 10.1590/S0102-86502013000200006; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Perez-Delgado F., 2007, THESIS; Pilon MA, 1998, BRAIN INJURY, V12, P793, DOI 10.1080/026990598122188; Ramig Lorraine Olson, 2004, Seminars in Speech and Language, V25, P169; Sanches VS, 2014, RESP CARE, V59, P1838, DOI 10.4187/respcare.03063; Sapir S, 2008, CURR OPIN OTOLARYNGO, V16, P205, DOI 10.1097/MOO.0b013e3282febd3a; Sellars C., 2009, COCHRANE DATABASE SY; Shih LC, 2012, PARKINSONISM RELAT D, V18, P548, DOI 10.1016/j.parkreldis.2012.02.009; Stahl B, 2011, BRAIN, V134, P3083, DOI 10.1093/brain/awr240; Stegemoller EL, 2017, DISABIL REHABIL, V39, P594, DOI 10.3109/09638288.2016.1152610; Tamplin J., 2012, THESIS; Tamplin J, 2008, NEUROREHABILITATION, V23, P207; Tamplin J, 2008, MUSIC THER PERSPECT, V26, P23, DOI 10.1093/mtp/26.1.23; Tamplin J, 2013, ARCH PHYS MED REHAB, V94, P426, DOI 10.1016/j.apmr.2012.10.006; Thaut M. H., 2014, HDB NEUROLOGIC MUSIC; Thaut MH, 2001, FUNCT NEUROL, V16, P163; van der Merwe A, 1997, COMSIG '97 - PROCEEDINGS OF THE 1997 SOUTH AFRICAN SYMPOSIUM ON COMMUNICATIONS AND SIGNAL PROCESSING, P1, DOI 10.1109/COMSIG.1997.629970; Yinger OS, 2012, MUSIC THER PERSPECT, V30, P25, DOI 10.1093/mtp/30.1.25	49	6	7	3	25	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0734-6875	2053-7387		MUSIC THER PERSPECT	Music Ther. Perspect.	OCT	2017	35	2					113	123		10.1093/mtp/mix006			11	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FY6SC	WOS:000426989200004					2022-02-06	
J	Wackym, PA; Mackay-Promitas, HT; Demirel, S; Gianoli, GJ; Gizzi, MS; Carter, DM; Siker, DA				Wackym, P. Ashley; Mackay-Promitas, Heather T.; Demirel, Shaban; Gianoli, Gerard J.; Gizzi, Martin S.; Carter, Dale M.; Siker, David A.			Comorbidities Confounding the Outcomes of Surgery for Third Window Syndrome: Outlier Analysis	LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY			English	Article						Cognitive dysfunction; conversion disorder; CSF; depression; factitious disorder; functional neurological symptom disorder; memory; migraine; otic capsule dehiscence syndrome; perilymph fistula; somatic symptom disorder; superior semicircular canal dehiscence syndrome; third window syndrome; traumatic brain injury	SEMICIRCULAR CANAL DEHISCENCE; TRAUMATIC BRAIN-INJURY; GENERALIZED ANXIETY DISORDER; COCHLEAR-FACIAL DEHISCENCE; OBSTRUCTIVE SLEEP-APNEA; MINOR HEAD-INJURY; SURGICAL-MANAGEMENT; PERILYMPH FISTULAS; INTRACRANIAL HYPERTENSION; PSYCHIATRIC-DISORDERS	Objective: Patients with third window syndrome and superior semicircular canal dehiscence (SSCD) symptoms whose surgical outcomes placed them as outliers were systematically studied to determine comorbidities that were responsible for their poor outcomes due to these confounding factors. Study Design: Observational analytic case-control study in a tertiary referral center. Methods: Twelve adult patients with clinical SSCD syndrome underwent surgical management and had outcomes that did not resolve all of their subjective symptoms. In addition to one of the neurotologists, 2 neurologists (one specializing in migraine and the other a neuro-ophthalmologist), and a psychologist clinician-investigator completed comprehensive evaluations. Neuropsychology test batteries included: the Millon Behavioral Medicine Diagnostic; Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Screener (GAD-7); Adverse Childhood Experiences Scale; the Wide Range Assessment of Memory and Learning, including the 3 domains of verbal memory, visual memory, and attention/concentration; Wechsler Adult Intelligence Scale; and the Delis-Kaplan Executive Function System. The control cohort was comprised of 17 participants who previously underwent surgery for third window syndrome that resulted in the expected outcomes of resolution of their third window syndrome symptoms and cognitive dysfunction. Results: There was a high rate of psychological comorbidity (n = 6) in the outlier cohort; multiple traumatic brain injuries were also a confounding element (n = 10). One patient had elevated cerebrospinal fluid (CSF) pressure requiring ventriculoperitoneal shunting to control the recurrence of dehiscence and one patient with a drug-induced Parkinson-like syndrome and idiopathic progressive neurological degenerative process. Conclusions: Components of the Millon Behavioral Medicine Diagnostic, PHQ-9 and GAD-7 results suggest that these instruments would be useful as screening tools preoperatively to identify psychological comorbidities that could confound outcomes. The identification of these comorbid psychological as well as other neurological degenerative disease processes led to alternate clinical management pathways for these patients.	[Wackym, P. Ashley] Rutgers Robert Wood Johnson Med Sch, Dept Otolaryngol Head & Neck Surg, 10 Plum St,Room 543, New Brunswick, NJ 08901 USA; [Wackym, P. Ashley] Ear & Skull Base Ctr, New Brunswick, NJ USA; [Mackay-Promitas, Heather T.; Demirel, Shaban; Gizzi, Martin S.] Legacy Res Inst, Portland, OR USA; [Gianoli, Gerard J.] Ear & Balance Inst, Covington, LA USA; [Carter, Dale M.] NW Headache & Wellness Ctr, Portland, OR USA; [Siker, David A.] Siker Med Imaging & Intervent, Portland, OR USA		Wackym, PA (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Otolaryngol Head & Neck Surg, 10 Plum St,Room 543, New Brunswick, NJ 08901 USA.	wackym@neurotology.org	Wackym, P. Ashley/I-5879-2019	Wackym, P. Ashley/0000-0002-2904-5072; Demirel, Shaban/0000-0003-3855-6461	Legacy Good Samaritan Foundation; Ear and Skull Base Center	The Legacy Good Samaritan Foundation and the Ear and Skull Base Center provided funding to help support this work.	Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Barber SJ, 2012, MEM COGNITION, V40, P874, DOI 10.3758/s13421-012-0202-8; Barber SJ, 2012, SOC COGNITION, V30, P121, DOI 10.1521/soco.2012.30.1.121; Barber SJ, 2011, MEMORY, V19, P462, DOI 10.1080/09658211.2011.584389; Barber SJ, 2011, MEMORY, V19, P378, DOI 10.1080/09658211.2011.575787; Bear ZW, 2015, ACTA OTO-LARYNGOL, V135, P974, DOI 10.3109/00016489.2015.1060630; Beck KD, 2008, PERSONALITY PREDICTI; Beck KD, 2010, PM&R, V2, P195, DOI 10.1016/j.pmrj.2009.12.007; Bigelow RT, 2016, J NEUROL NEUROSUR PS, V87, P367, DOI 10.1136/jnnp-2015-310319; Bigelow RT, 2015, J AM GERIATR SOC, V63, P1837, DOI 10.1111/jgs.13609; Bigelow RT, 2015, J VESTIBUL RES-EQUIL, V25, P73, DOI 10.3233/VES-150544; Bilgrei R, PSYCHOL VESTIBULAR 1; BLACK FO, 1990, NEUROL CLIN, V8, P361, DOI 10.1016/S0733-8619(18)30361-X; BLACK FO, 1991, ARCH OTOLARYNGOL, V117, P641; BLACK FO, 1987, OTOLARYNG HEAD NECK, V96, P125, DOI 10.1177/019459988709600203; BLACK FO, 1992, AM J OTOL, V13, P254; Blake DM, 2014, LARYNGOSCOPE, V124, P283, DOI 10.1002/lary.24223; Coalson D, 2008, WECHSLER ADULT INTEL; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P167; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Delis DC., 2001, DELIS KAPLAN EXECUTI; DoD Worldwide Numbers for TBI, DOD WORLDW NUMB TBI; Elmali M, 2013, EUR J RADIOL, V82, pE606, DOI 10.1016/j.ejrad.2013.06.022; Fang CH, 2016, OTOL NEUROTOL, V37, P967, DOI 10.1097/MAO.0000000000001057; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Gizzi M, 2003, J HEAD TRAUMA REHAB, V18, P398, DOI 10.1097/00001199-200309000-00002; Glutting J, 2000, WIDE RANGE INTELLIGE; Gopen Q, 2010, OTOL NEUROTOL, V31, P339, DOI 10.1097/MAO.0b013e3181be65a4; Goto F, 2014, PSYCHIAT INVEST, V11, P499, DOI 10.4306/pi.2014.11.4.499; GRIMM RJ, 1989, ACTA OTO-LARYNGOL, P1, DOI 10.3109/00016488909138632; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Hathaway SR, 1940, J PSYCHOL, V10, P249, DOI 10.1080/00223980.1940.9917000; Hoffer ME, 2016, J NEUROSCI METH, V272, P77, DOI 10.1016/j.jneumeth.2016.04.021; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; James W., 1890, PRINCIPLES PSYCHOL; JENNUM P, 1989, CHEST, V95, P279, DOI 10.1378/chest.95.2.279; Kondo K, 2010, BIO MED CENTRAL NEUR, V11, P1; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larkin H, 2014, SOC WORK PUBLIC HLTH, V29, P1, DOI 10.1080/19371918.2011.619433; Lashley K., 1929, BRAIN MECH INTELLIGE; Lee AG, 2002, OPHTHALMOLOGY, V109, P482, DOI 10.1016/S0161-6420(01)00987-3; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Manzari L, 2013, ENT-EAR NOSE THROAT, V92, P25, DOI 10.1177/014556131309200109; MARGOLIS RH, 1995, ARCH OTOLARYNGOL, V121, P44; Martin PK, 2015, PSYCHIAT TIMES, V32, P1; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Meiklejohn DA, 2015, OTOL NEUROTOL, V36, P1383, DOI 10.1097/MAO.0000000000000811; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Millon Behavioral Medicine Diagnostic (MBMD), PEARS CLIN ASS; MILLON T, 1979, PROF PSYCHOL, V10, P529, DOI 10.1037/0735-7028.10.4.529; Millon T, 2006, MILLON BEHAV MED DIA; Millon T, 2008, SAGE HDB PERSONALITY, V2; Minor LB, 2005, LARYNGOSCOPE, V115, P1717, DOI 10.1097/01.mlg.0000178324.55729.b7; Minor LB, 1998, ARCH OTOLARYNGOL, V124, P249, DOI 10.1001/archotol.124.3.249; Moran M, 2013, PATIENT HLTH QUESTIO; Morey, 1991, PERSONALITY ASSESSME; Naveh-Benjamin M, 2014, Q J EXP PSYCHOL, V67, P1682, DOI 10.1080/17470218.2013.867517; Park JJH, 2015, AM J OTOLARYNG, V36, P347, DOI 10.1016/j.amjoto.2014.12.006; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Poldrack RA, 2015, DEV COGN NEUROS-NETH, V11, P12, DOI 10.1016/j.dcn.2014.06.001; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Revlin R., 2013, COGNITION THEORY PRA; Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405; Schutt CA, 2015, OTOL NEUROTOL, V36, P551, DOI 10.1097/MAO.0000000000000555; Semenov YR, 2016, J GERONTOL A-BIOL, V71, P243, DOI 10.1093/gerona/glv069; Sharon JD, 2016, OTOL NEUROTOL, V37, P1096, DOI 10.1097/MAO.0000000000001113; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Silverstein H, 2014, AM J OTOLARYNG, V35, P286, DOI 10.1016/j.amjoto.2014.02.016; SISMANIS A, 1987, LARYNGOSCOPE, V97, P1, DOI 10.1288/00005537-198708001-00001; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Spreen O, 2006, COMPENDIUM NEUROPSYC; SUGITA Y, 1985, ELECTROEN CLIN NEURO, V60, P214, DOI 10.1016/0013-4694(85)90033-1; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Tromp DPM, 2012, ARCH GEN PSYCHIAT, V69, P925, DOI 10.1001/archgenpsychiatry.2011.2178; Trull Timothy J, 2013, Dialogues Clin Neurosci, V15, P135; TULVING E, 1966, J VERB LEARN VERB BE, V5, P381, DOI 10.1016/S0022-5371(66)80048-8; Van dersHart O, 2006, HAUNTED SELF STRUCTU; Vlastarakos PV, 2009, EUR ARCH OTO-RHINO-L, V266, P177, DOI 10.1007/s00405-008-0840-4; Wackym PA, 2016, OTOL NEUROTOL, V37, P70, DOI 10.1097/MAO.0000000000000928; Wackym P Ashley, 2015, Ear Nose Throat J, V94, pE8; Wackym PA, 2012, OTOL NEUROTOL, V33, P1392, DOI 10.1097/MAO.0b013e318268d234; Wackym PA, TRAUMATIC OTIC CAPSU; Wackym PA, RIGHT COMPUTED TOMOG; Wackym PA, TUNING FORK TESTING; Wackym PA, COGNITIVE DYSFUNCTIO; Wackym PA, RECURRENT 3 WINDOW S; Wackym PA, LEFT COMPUTED TOMOGR; Wackym PA, COMPUTED TOMOGRAPHY; Wackym PA, VESTIBULAR MIGRAINE; Ward BK, 2013, OTOL NEUROTOL, V34, P1421, DOI 10.1097/MAO.0b013e318287efe6; Weiss LG, 2010, PRACT RESOUR MENT, P1; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Young L, 2010, OTOL NEUROTOL, V31, P697, DOI 10.1097/MAO.0b013e31819bd803; Zhai F, 2016, OTOL NEUROTOL, V37, P539, DOI 10.1097/MAO.0000000000001002; Zhou GW, 2007, OTOL NEUROTOL, V28, P920, DOI 10.1097/MAO.0b013e31814b25f2; Ziylan F, 2017, OTOL NEUROTOL, V38, P1, DOI 10.1097/MAO.0000000000001277	105	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2378-8038			LARYNGOSCOPE INVEST	Laryngoscope Investig. Otol.	OCT	2017	2	5					225	253		10.1002/lio2.89			29	Otorhinolaryngology	Emerging Sources Citation Index (ESCI)	Otorhinolaryngology	FK7FP	WOS:000413670900004	29094067	Green Published, gold			2022-02-06	
J	Zander, NE; Piehler, T; Hogberg, H; Pamies, D				Zander, Nicole E.; Piehler, Thuvan; Hogberg, Helena; Pamies, David			Explosive Blast Loading on Human 3D Aggregate Minibrains	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Primary blast; Traumatic brain injury; In vitro model; Induced pluripotent stem cells; Minibrain; Explosives	IN-VITRO; CULTURES; NEURONS	The effects of primary explosive blast on brain tissue still remain mostly unknown. There are few in vitro models that use real explosives to probe the mechanisms of injury at the cellular level. In this work, 3D aggregates of human brain cells or brain microphysiological system were exposed to military explosives at two different pressures (50 and 100 psi). Results indicate that membrane damage and oxidative stress increased with blast pressure, but cell death remained minimal.	[Zander, Nicole E.; Piehler, Thuvan] US Army, Res Lab, Dept Army, Weap & Mat Res Directorate,RDRL WMM G, Bldg 4600, Aberdeen Proving Ground, MD 21005 USA; [Hogberg, Helena; Pamies, David] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, 615N Wolfe St, Baltimore, MD 21205 USA		Zander, NE (corresponding author), US Army, Res Lab, Dept Army, Weap & Mat Res Directorate,RDRL WMM G, Bldg 4600, Aberdeen Proving Ground, MD 21005 USA.	nicole.e.zander.civ@mail.mil		Pamies, David/0000-0002-1224-573X; Hogberg, Helena/0000-0001-8034-6818	Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [DSI-13-WMR-2D-005] Funding Source: Medline		Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Hogberg HT, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt365; Pamies D., 2016, ALTEX; Pamies D, 2014, EXP BIOL MED, V239, P1096, DOI 10.1177/1535370214537738; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Zander NE, 2016, J NEUROSCI RES, V94, P827, DOI 10.1002/jnr.23786; Zander NE, 2016, ANAL BIOCHEM, V504, P4, DOI 10.1016/j.ab.2016.03.009; Zander NE, 2015, J NEUROSCI RES, V93, P1353, DOI 10.1002/jnr.23594	9	6	6	0	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	OCT	2017	37	7					1331	1334		10.1007/s10571-017-0463-7			4	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	FF9QQ	WOS:000409352200018	28110483				2022-02-06	
J	Gerstenecker, A; Lowry, K; Myers, T; Bashir, K; Triebel, KL; Martin, RC; Marson, DC				Gerstenecker, Adam; Lowry, Kathleen; Myers, Terina; Bashir, Khurram; Triebel, Kristen L.; Martin, Roy C.; Marson, Daniel C.			Medical decision-making capacity and its cognitive predictors in progressive MS: Preliminary evidence	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Progressive multiple sclerosis; Multiple sclerosis; Cognition; IADL; Medical decision-making capacity; Assessment	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; IMPAIRMENT; CONSENT; COMPETENCE; RECOVERY; DISEASE; MEMORY	Background: Medical decision-making capacity (MDC) refers to the ability to make informed decisions about treatment and declines in cognition are associated with declines in MDC across multiple disease entities. However, although it is well known that cognitive impairment is prevalent in multiple sclerosis (MS), little is known about MDC in the disease. Methods: Data from 22 persons with progressive MS and 18 healthy controls were analyzed. All diagnoses were made by a board-certified neurologist with experience in MS. All study participants were administered a vignette-based measure of MDC and also a neuropsychological battery. Results: Performance on three MDC consent standards (i.e., Appreciation, Reasoning, Understanding) was significantly lower for people with progressive MS as compared to healthy controls. In the progressive MS group, verbal fluency was the primary cognitive predictor for both Reasoning and Understanding consent standards. Verbal learning and memory was the primary cognitive predictor for Appreciation. MS severity was not significantly correlated with any MDC variable. Conclusion: MDC is a complex and cognitively mediated functional ability that is impaired in many people with progressive MS. Verbal measures of fluency and memory are strongly associated with MDC performances in the current sample of people with MS and could potentially be utilized to quickly screen for MDC impairment in MS. (C) 2017 Elsevier B.V. All rights reserved.	[Gerstenecker, Adam; Lowry, Kathleen; Myers, Terina; Bashir, Khurram; Triebel, Kristen L.; Martin, Roy C.; Marson, Daniel C.] Univ Alabama Birmingham, Dept Neurol, Sparks Ctr 650,1720 7th Ave South, Birmingham, AL 35294 USA		Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, Sparks Ctr 650,1720 7th Ave South, Birmingham, AL 35294 USA.	dmarson@uab.edu	triebel, kristen/A-6569-2019	triebel, kristen/0000-0001-9161-7847; Martin, Roy/0000-0001-9328-0846	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [PP0582]	This work was supported by the National Multiple Sclerosis Society [PP0582 to D. M.].	APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Bambara JK, 2007, EPILEPSY BEHAV, V10, P63, DOI 10.1016/j.yebeh.2006.10.003; Basso MR, 2010, J CLIN EXP NEUROPSYC, V32, P1050, DOI 10.1080/13803391003683062; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; DeSousa Eduardo Adonias, 2002, Am J Alzheimers Dis Other Demen, V17, P23, DOI 10.1177/153331750201700104; Dymek MP, 2001, NEUROLOGY, V56, P17, DOI 10.1212/WNL.56.1.17; Dymek MP, 1999, J FORENSIC NEUROPSYC, V1, P27, DOI DOI 10.1300/J151V01N01_; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Gerstenecker A, 2016, ASSESSMENT, V23, P232, DOI 10.1177/1073191115599053; Gerstenecker A, 2015, J INT NEUROPSYCH SOC, V21, P412, DOI 10.1017/S1355617715000478; Gerstenecker A, 2015, CANCER-AM CANCER SOC, V121, P2013, DOI 10.1002/cncr.29326; Gerstenecker A, 2014, J NEURO-ONCOL, V120, P179, DOI 10.1007/s11060-014-1543-x; Grisso T., 1998, ASSESSING COMPETENCE; GRISSO T, 1986, EVALUATING COMPETENC; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Huijbregts SCJ, 2006, J NEUROL SCI, V245, P187, DOI 10.1016/j.jns.2005.07.018; Huthwaite JS, 2006, BEHAV SCI LAW, V24, P453, DOI 10.1002/bsl.701; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; Martin RC, 2008, MOVEMENT DISORD, V23, P1867, DOI 10.1002/mds.22170; Martin RC, 2015, NEURO-ONCOL PRACT, V2, P13, DOI 10.1093/nop/npu030; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Morgante L., 2006, INT J MULTIPLE SCLER, V8, P113; Niccolai LM, 2017, CLIN GERONTOLOGIST, V40, P14, DOI 10.1080/07317115.2016.1228022; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Okonkwo OC, 2008, J INT NEUROPSYCH SOC, V14, P297, DOI 10.1017/S1355617708080338; Potagas C, 2008, J NEUROL SCI, V267, P100, DOI 10.1016/j.jns.2007.10.002; Rao S., 1990, MANUAL BRIEF REPEATA; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; Ruet A, 2013, NEUROLOGY, V80, P1501, DOI 10.1212/WNL.0b013e31828cf82f; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Steward KA, 2016, NEUROLOGY, V87, P1052, DOI 10.1212/WNL.0000000000003079; TEPPER AM, 1984, LAW HUMAN BEHAV, V8, P205, DOI 10.1007/BF01044693; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Triebel KL, 2015, PSYCHO-ONCOLOGY, V24, P1448, DOI 10.1002/pon.3753; Triebel KL, 2009, NEUROLOGY, V73, P2086, DOI 10.1212/WNL.0b013e3181c67bce; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	46	6	7	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	SEP 15	2017	380						38	43		10.1016/j.jns.2017.06.047			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FI5OJ	WOS:000412033400009	28870585				2022-02-06	
J	Luo, YW; Zou, HY; Wu, YL; Cai, F; Zhang, S; Song, W				Luo, Yawen; Zou, Haiyan; Wu, Yili; Cai, Fang; Zhang, Si; Song, Weihong			Mild traumatic brain injury induces memory deficits with alteration of gene expression profile	SCIENTIFIC REPORTS			English	Article							UBIQUITIN-PROTEASOME PATHWAY; CENTRAL-NERVOUS-SYSTEM; PROFESSIONAL FOOTBALL; FUNCTIONAL RECOVERY; SPINAL-CORD; CONCUSSION; MICE; BIOMECHANICS; DEGRADATION; PROTEIN	Repeated mild traumatic brain injury (rmTBI), the most common type of traumatic brain injuries, can result in neurological dysfunction and cognitive deficits. However, the molecular mechanisms and the long-term consequence of rmTBI remain elusive. In this study, we developed a modified rmTBI mouse model and found that rmTBI-induced transient neurological deficits and persistent impairments of spatial memory function. Furthermore, rmTBI mice had long-lasting detrimental effect on cognitive function, exhibiting memory deficits even 12 weeks after rmTBI. Microarray analysis of whole genome gene expression showed that rmTBI significantly altered the expression level of 87 genes which are involved in apoptosis, stress response, metabolism, and synaptic plasticity. The results indicate the potential mechanism underlying rmTBI-induced acute neurological deficits and its chronic effect on memory impairments. This study suggests that long-term monitoring and interventions for rmTBI individuals are essential for memory function recovery and reducing the risk of developing neurodegenerative diseases.	[Luo, Yawen; Zou, Haiyan; Wu, Yili; Cai, Fang; Zhang, Si; Song, Weihong] Univ British Columbia, Dept Psychiat, Townsend Family Labs, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada		Song, W (corresponding author), Univ British Columbia, Dept Psychiat, Townsend Family Labs, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	weihong@mail.ubc.ca	Song, Weihong/O-7623-2017	Song, Weihong/0000-0001-9928-889X; wu, yili/0000-0002-2369-6974	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [CEN-132387, MOP-142487]; Chinese Scholarship CouncilChina Scholarship Council	This work was supported by the Canadian Institutes of Health Research (CIHR) Grant CEN-132387 and MOP-142487 (W.S.). and W.S. is the holder of the Tier 1 Canada Research Chair in Alzheimer's Disease. Y.L. was the recipient of the Chinese Scholarship Council award.	Amith SR, 2009, GLYCOCONJUGATE J, V26, P1197, DOI 10.1007/s10719-009-9239-8; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; FERKO AP, 1986, PHARMACOL BIOCHEM BE, V24, P543, DOI 10.1016/0091-3057(86)90555-1; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Fraser PE, 1998, NEUROBIOL AGING, V19, pS19, DOI 10.1016/S0197-4580(98)00029-3; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harmon KG, 1999, AM FAM PHYSICIAN, V60, P887; He GQ, 2007, J NEUROCHEM, V101, P982, DOI 10.1111/j.1471-4159.2007.04449.x; He GQ, 2006, J NEUROCHEM, V99, P1403, DOI 10.1111/j.1471-4159.2006.04184.x; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Liu SC, 2008, EUR J NEUROSCI, V28, P1980, DOI 10.1111/j.1460-9568.2008.06497.x; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Mao Z, 2008, NEUROSCI LETT, V439, P147, DOI 10.1016/j.neulet.2008.05.006; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon JC, 2000, NEUROSURGERY, V47, P669; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Okubo Shuichi, 2013, Acta Neurochir Suppl, V118, P83, DOI 10.1007/978-3-7091-1434-6_14; Ou S, 2014, EUR REV MED PHARMACO, V18, P101; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Silverstone Peter H, 2008, Ann Gen Psychiatry, V7, P19, DOI 10.1186/1744-859X-7-19; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wang W, 2013, J NEUROSCI RES, V91, P726, DOI 10.1002/jnr.23195; Zhang DH, 2011, INT J BIOCHEM CELL B, V43, P33, DOI 10.1016/j.biocel.2010.09.019; Zhang GR, 2008, NEUROSCI LETT, V438, P371, DOI 10.1016/j.neulet.2008.04.075	46	6	6	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 7	2017	7								10846	10.1038/s41598-017-11458-9			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG1NC	WOS:000409561800097	28883638	gold, Green Published			2022-02-06	
J	Bambakidis, T; Dekker, SE; Halaweish, I; Liu, BL; Nikolian, VC; Georgoff, PE; Piascik, P; Li, YQ; Sillesen, M; Alam, HB				Bambakidis, Ted; Dekker, Simone E.; Halaweish, Ihab; Liu, Baoling; Nikolian, Vahagn C.; Georgoff, Patrick E.; Piascik, Patryk; Li, Yongqing; Sillesen, Martin; Alam, Hasan B.			Valproic acid modulates platelet and coagulation function ex vivo	BLOOD COAGULATION & FIBRINOLYSIS			English	Article; Proceedings Paper	11th Annual American Academic Surgical Congress (ASC) of the Society-of-University-Surgeons / Association-for-Academic-Surgery	JAN 18-FEB 05, 2016	Jacksonville, FL	Soc Univ Surg, Assoc Acad Surg		coagulopathy; histone deacetylase inhibitors; platelets; shock; traumatic brain injury; valproic acid	TRAUMATIC BRAIN-INJURY; LARGE-ANIMAL-MODEL; DYSFUNCTION; ACTIVATION; RESUSCITATION; PLASMA	Trauma-induced coagulopathy is associated with adverse patient outcome. Animal models demonstrate that histone deacetylase inhibitors, such as valproic acid (VPA), improve survival following injury. While in-vivo data suggest that improved survival may in part be because of an attenuation of coagulopathy, it remains unknown whether this is a direct effect of the drug, or the establishment of an overall prosurvival phenotype. We thus conducted an ex-vivo experiment to determine if VPA has an effect on coagulation and platelet function. Ten swine were subjected to traumatic brain injury (TBI) and hemorrhagic shock (HS). Blood samples were drawn prior to TBI +/- HS insult (Healthy group) and 2 h following TBI +/- HS (Shock group). Samples were incubated with VPA or vehicle controls for 1 h. Platelet aggregation was analyzed via impedance aggregometry and coagulation was measured using thromboelastography. Addition of VPA to the healthy blood did not affect platelet aggregation or coagulation parameters. In shock blood, incubation with VPA significantly reduced collagen-(P=0.050), arachidonic acid (P=0.005), and adenosine diphosphate-(P=0.023) induced platelet aggregation. VPA also significantly increased the clot strength (P=0.002) and clot formation rate (P=0.011). This is the first study to investigate the effect of VPA on platelet function ex vivo. Our results suggest that VPA has no effect on normal blood, but it decreases platelet activation and improves clot dynamics (strength and rate of formation) in blood from shocked animals. This suggests that VPA is capable of exerting a selective platelet sparing effect while enhancing the clot integrity. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Bambakidis, Ted; Dekker, Simone E.; Halaweish, Ihab; Liu, Baoling; Nikolian, Vahagn C.; Georgoff, Patrick E.; Piascik, Patryk; Li, Yongqing; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA; [Dekker, Simone E.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Sillesen, Martin] Rigshosp, Copenhagen Univ Hosp, Dept Surg Gastroenterol, Copenhagen, Denmark; [Sillesen, Martin] Rigshosp, Copenhagen Univ Hosp, Inst Inflammat Res, Copenhagen, Denmark		Alam, HB (corresponding author), Univ Michigan Hosp, Dept Surg, Taubman Ctr 2920, Gen Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Sillesen, Martin/0000-0001-9494-5475	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [GRANTT00521959]; Joyce and Don Massey Family Foundation	This research was funded by a grant from the US Army Medical Research and Materiel Command (GRANTT00521959) to HBA, and supported by a financial gift from the Joyce and Don Massey Family Foundation.	Alam HB, 2009, J TRAUMA, V67, P856, DOI 10.1097/TA.0b013e3181b5ae75; Aslan JE, 2013, AM J PHYSIOL-CELL PH, V305, pC1230, DOI 10.1152/ajpcell.00053.2013; Bambakidis T, 2016, TRAUMA INDUCED COAGU, P545, DOI DOI 10.1007/978-3-319-28308-1_34; Branco BC, 2014, SHOCK, V41, P200, DOI 10.1097/SHK.0000000000000109; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P358, DOI 10.1097/TA.0b013e31825889ba; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, GLOB TRAUM CAR; Cohen MJ, 2016, INT J SURG, V33, P242, DOI 10.1016/j.ijsu.2016.05.037; Darlington DN, 2013, SHOCK, V39, P440, DOI 10.1097/SHK.0b013e31829040e3; Davenport RA, 2016, CURR OPIN ANESTHESIO, V29, P212, DOI 10.1097/ACO.0000000000000295; Dekker SE, 2014, J SURG RES, V190, P312, DOI 10.1016/j.jss.2014.02.049; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; Gonzalez E., 2016, TRAUMA INDUCED COAGU; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Hess JR, 2005, CRIT CARE, V9, pS10, DOI 10.1186/cc3780; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Larsson P, 2016, J THROMB HAEMOST, V14, P2496, DOI 10.1111/jth.13527; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; Rivera FJ, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00511; Sadoul K, 2012, BLOOD, V120, P4215, DOI 10.1182/blood-2012-05-428011; Saluveer O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107582; Sillesen M, 2013, J TRAUMA ACUTE CARE, V76, P12; Sillesen M, 2013, J AM COLL SURGEONS, V217, pS51, DOI 10.1016/j.jamcollsurg.2013.07.104; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Zink KA, 2009, AM J SURG, V197, P565, DOI 10.1016/j.amjsurg.2008.12.014	28	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0957-5235	1473-5733		BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	SEP	2017	28	6					479	484		10.1097/MBC.0000000000000626			6	Hematology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Hematology	FF1XU	WOS:000408693300009	28230635				2022-02-06	
J	Bosche, KV; Mosleh, Y; Depreitere, B; Sloten, JV; Verpoest, I; Ivens, J				Bosche, Kelly Vanden; Mosleh, Yasmine; Depreitere, Bart; Sloten, Jos Vander; Verpoest, Ignaas; Ivens, Jan			Anisotropic polyethersulfone foam for bicycle helmet liners to reduce rotational acceleration during oblique impact	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Bicycle helmet; rotational acceleration; traumatic brain injury; oblique impact; anisotropic foam	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL; HEAD-INJURY; SUBDURAL-HEMATOMA; RESPONSES; PRIMATE; INERTIA; TESTS	Although current standard bicycle helmets protect cyclists against linear acceleration, they still lack sufficient protection against rotational acceleration during oblique impact events. Rotational acceleration is correlated with serious traumatic brain injuries such as acute subdural haematoma and thus should be minimized. This study proposes using highly anisotropic polyethersulfone foam for bicycle helmet liners in order to limit the rotational acceleration. Helmet prototypes, made of polyethersulfone foam with cell anisotropy direction perpendicular to the head, have been produced and compared to a standard commercial helmet. Standard helmets consist of expanded polystyrene foam. Oblique impact tests were performed to measure both linear and rotational accelerations and impact pulse duration. Results demonstrate that the peak rotational acceleration of the polyethersulfone prototype helmet showed a decrease of around 40% compared to the reference expanded polystyrene helmet. Moreover, the peak linear acceleration showed an average decrease of about 37%. Upon impact, the polyethersulfone helmet showed improved head injury protection when analysed based on global biomechanical head injury criteria such as HIC15 and HICrot as well as generalized acceleration model for brain injury threshold, brain injury criterion and head impact power, with a predicted sixfold decrease in likelihood of concussion.	[Bosche, Kelly Vanden; Mosleh, Yasmine; Verpoest, Ignaas; Ivens, Jan] Katholieke Univ Leuven, Dept Mat Engn, Scalint Sect, Kasteelpk Arenberg 44, B-3001 Leuven, Belgium; [Depreitere, Bart] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Neurosurg, Leuven, Belgium; [Sloten, Jos Vander] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Leuven, Belgium		Mosleh, Y (corresponding author), Katholieke Univ Leuven, Dept Mat Engn, Scalint Sect, Kasteelpk Arenberg 44, B-3001 Leuven, Belgium.	Yasi.mosleh@kuleuven.be	Ivens, Jan/A-7922-2015; Depreitere, Bart/AAA-9846-2020; Ivens, Jan ID/I-4339-2016	Depreitere, Bart/0000-0002-7458-0648; Ivens, Jan ID/0000-0002-2766-1381	Flemish research funding agency FWO [G.0C67.13]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors thank Flemish research funding agency FWO for supporting this research through the project Levenslijn (G.0C67.13).	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; [Anonymous], 10782012 EN; BENZ G, 1993, EUR J PEDIATR SURG, V3, P259, DOI 10.1055/s-2008-1063555; Bottlang M, 2007, J NEUROTRAUM, V24, P1068, DOI 10.1089/neu.2006.3772; Deck C, 2012, P INT CRASHW C MIL 1; Deck C., 2007, P IRCOBI C MAASTR NE, P185; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Depreitere B, 2004, THESIS; Depreitere B, 2008, PROTECTIVE HELMET; Eppinger R., 2000, SUPPLEMENT DEV IMPRO; Finan JD, 2008, TRAFFIC INJ PREV, V9, P483, DOI 10.1080/15389580802272427; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harrison TI, 1996, P INT RES COUNC BIOM; Hodgson VR., 1990, IMPACT SKID RETENTIO; Holbourn AHS, 1943, LANCET, V2, P438; Ivarsson J, 2003, J BIOMECH ENG-T ASME, V125, P523, DOI 10.1115/1.1590360; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Mattei TA, 2012, J NEUROSURG-PEDIATR, V10, P490, DOI 10.3171/2012.8.PEDS12116; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; Newman J A, 2000, Stapp Car Crash J, V44, P215; Otte D., 1999, CONTRIBUTION FINAL R; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pang TY, 2011, INT J CRASHWORTHINES, V16, P297, DOI 10.1080/13588265.2011.559799; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Scher IS, 2009, 010248 SAE; St Clair VJ, 2007, PPR213 TRL; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thibault L., 1971, P 15 STAPP CAR CRASH; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Van Lierde C, 2005, THESIS; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; Verschueren P., 2009, BIOMECHANICAL ANAL H; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Willinger R, 2014, P INT CYCL SAF C GOT; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	47	6	6	0	28	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	SEP	2017	231	9					851	861		10.1177/0954411917711201			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FD8WE	WOS:000407804000006	28535722				2022-02-06	
J	Gonzalez-Robledo, J; Martin-Gonzalez, F; Sanchez-Barba, M; Sanchez-Hernandez, F; Moreno-Garcia, MN				Gonzalez-Robledo, Javier; Martin-Gonzalez, Felix; Sanchez-Barba, Mercedes; Sanchez-Hernandez, Fernando; Moreno-Garcia, Maria N.			Multiclassifier Systems for Predicting Neurological Outcome of Patients with Severe Trauma and Polytrauma in Intensive Care Units	JOURNAL OF MEDICAL SYSTEMS			English	Article						Severe trauma; Polytrauma; Mortality; Data mining; Ensemble classifiers; Multiclassifiers	GLASGOW COMA SCALE; BRAIN-INJURY; NETWORKS	This paper presents an ensemble based classification proposal for predicting neurological outcome of severely traumatized patients. The study comprises both the whole group of patients and a subgroup containing those patients suffering traumatic brain injury (TBI). Data was gathered from patients hospitalized in the Intensive Care Unit (ICU) of the University Hospital in Salamanca. Predictive models were induced from both epidemiologic and clinical variables taken at the emergency room and along the stay in the ICU. The large number of variables leads to a low accuracy in the classifiers even when feature selection methods are used. In addition, the presence of a much larger number of instances of one of the classes in the subgroup of TBI patients produces a significantly lesser precision for the minority class. Usual ways of dealing with the last problem is to use undersampling and oversampling strategies, which can lead to the loss of valuable data and overfitting problems respectively. Our proposal for dealing with these problems is based in the use of ensemble multiclassifiers as well as in the use of an ensemble playing the role of base classifier in multiclassifiers. The proposed strategy gave the best values of the selected quality measures (accuracy, precision, sensitivity, specificity, F-measure and area under the Receiver Operator Characteristic curve) as well as the closest values of precision for the two classes under study in the case of the classification from imbalanced data.	[Gonzalez-Robledo, Javier; Martin-Gonzalez, Felix] Univ Hosp Salamanca, Intens Care Unit, Salamanca, Spain; [Sanchez-Barba, Mercedes] Univ Salamanca, Dept Stat, Salamanca, Spain; [Sanchez-Hernandez, Fernando] Univ Salamanca, Prehospital Emergency Serv, Sch Nursing & Physiotherapy, Salamanca, Spain; [Moreno-Garcia, Maria N.] Univ Salamanca, Dept Comp & Automat, Salamanca, Spain		Moreno-Garcia, MN (corresponding author), Univ Salamanca, Dept Comp & Automat, Salamanca, Spain.	mmg@usal.es	Sanchez-Barba, Mercedes/AAE-7338-2020; Martin-Gonzalez, Felix/AAS-8943-2021; Garcia, Maria N Moreno/P-4608-2014	Martin-Gonzalez, Felix/0000-0002-9365-3603; Garcia, Maria N Moreno/0000-0003-2809-3707; Sanchez, Fernando/0000-0002-8662-1443; Sanchez-Barba, Mercedes/0000-0002-3324-5798			Berikol GB, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0432-6; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Chen DC, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0518-1; Chen H, 2014, COMPUT BIOL MED, V50, P70, DOI 10.1016/j.compbiomed.2014.04.012; Cohen NH, 2010, CRIT CARE MED, V38, P334, DOI 10.1097/CCM.0b013e3181b9d3e4; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1023/A:1022649401552; Dossett LA, 2009, INJURY, V40, P993, DOI 10.1016/j.injury.2009.03.004; Freund Y., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P148; Gama J, 2000, MACH LEARN, V41, P315, DOI 10.1023/A:1007652114878; Hall M. A., 1999, CORRELATION BASED FE; Hemmila MR, 2008, SURGERY, V144, P307, DOI 10.1016/j.surg.2008.05.003; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hunter A, 2000, COMPUT METH PROG BIO, V62, P11, DOI 10.1016/S0169-2607(99)00046-2; Kuncheva L. I.=, 2004, COMBINING PATTERN CL; Li S, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0517-2; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Martin-Gonzalez F, 2016, METHOD INFORM MED, V55, P234, DOI 10.3414/ME14-01-0015; NAEMT, 2010, PHTLS PREH TRAUM LIF; Ozcift A, 2011, COMPUT BIOL MED, V41, P265, DOI 10.1016/j.compbiomed.2011.03.001; Platt J, 1998, ADV KERNEL METHODS; Quinlan J.R., 2014, C4 5 PROGRAMS MACHIN; Schetinin V, 2013, COMPUT METH PROG BIO, V111, P602, DOI 10.1016/j.cmpb.2013.05.015; Van Hulse J., 2007, P 24 INT C MACH LEAR, P935, DOI 10.1145/1273496.1273614; Wagholikar KB, 2012, J MED SYST, V36, P3029, DOI 10.1007/s10916-011-9780-4; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1	28	6	7	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0148-5598	1573-689X		J MED SYST	J. Med. Syst.	SEP	2017	41	9							136	10.1007/s10916-017-0789-1			8	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; Medical Informatics	FD6XA	WOS:000407670000010	28755271				2022-02-06	
J	Hassan, MH; Hassan, WMNW; Zaini, RHM; Shukeri, WFWM; Abidin, HZ; Eu, CS				Hassan, Mohamad Hasyizan; Hassan, Wan Mohd Nazaruddin Wan; Zaini, Rhendra Hardy Mohd; Shukeri, Wan Fadzlina Wan Muhd; Abidin, Huda Zainal; Eu, Chong Soon			Balanced Fluid Versus Saline-Based Fluid in Post-operative Severe Traumatic Brain Injury Patients: Acid-Base and Electrolytes Assessment	MALAYSIAN JOURNAL OF MEDICAL SCIENCES			English	Article						balanced solution; sodium chloride; severe traumatic brain injury; critical care; electrolytes; acid-base balance	LACTATED RINGERS SOLUTION; CRYSTALLOID SOLUTIONS; MAJOR SURGERY; REPLACEMENT; HETASTARCH; VOLUNTEERS; CHLORIDE; CARE	Background: Normal saline (NS) is a common fluid of choice in neurosurgery and neurointensive care unit (ICU), but it does not contain other electrolytes and has the potential to cause hyperchloremic metabolic acidosis with prolonged infusion. These problems may be reduced with the availability of balanced fluid (BF), which becomes a more physiological isotonic solution with the presence of complete electrolyte content. This study aimed to compare the changes in electrolytes and acid-base between NS and BF (Sterofundin r ISO) therapy for post-operative severe traumatic brain injury (TBI) patients in neuro-ICU. Methods: Sixty-six severe TBI patients who required emergency craniotomy or craniectomy and were planned for post-operative ventilation were randomised into NS (n = 33) and BF therapy groups (n = 33). The calculation of maintenance fluid given was based on the Holliday-Segar method. The electrolytes and acid-base parameters were assessed at an 8 h interval for 24 h. The data were analysed using repeated measures ANOVA. Results: The NS group showed a significant lower base excess (-3.20 versus -1.35, P = 0.049), lower bicarbonate level (22.03 versus 23.48 mmol/L, P = 0.031), and more hyperchloremia (115.12 versus 111.74 mmol/L, P < 0.001) and hypokalemia (3.36 versus 3.70 mmol/L, P < 0.001) than the BF group at 24 h of therapy. The BF group showed a significantly higher level of calcium (1.97 versus 1.79 mmol/L, P = 0.003) and magnesium (0.94 versus 0.80 mmol/L, P < 0.001) than the NS group at 24 h of fluid therapy. No significant differences were found in pH, pCO(2), lactate, and sodium level. Conclusion: BF therapy showed better effects in maintaining higher electrolyte parameters and reducing the trend toward hyperchloremic metabolic acidosis than the NS therapy during prolonged fluid therapy for postoperative TBI patients.	[Hassan, Mohamad Hasyizan] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia; [Hassan, Mohamad Hasyizan; Hassan, Wan Mohd Nazaruddin Wan; Zaini, Rhendra Hardy Mohd; Shukeri, Wan Fadzlina Wan Muhd; Abidin, Huda Zainal; Eu, Chong Soon] Univ Sains Malaysia, Sch Med Sci, Dept Anaesthesiol & Intens Care, Kubang Kerian 16150, Kelantan, Malaysia; [Eu, Chong Soon] Univ Sains Malaysia, Adv Med & Dent Inst, Regenerat Med Cluster, Bertam 13200, Pulau Pinang, Malaysia		Hassan, MH (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	hasyizan@usm.my	Shukeri, Wan Fadzlina Wan Muhd/T-8037-2019; Chong, Soon Eu/H-3946-2016; Hassan, Wan Mohd Nazaruddin Wan/F-1124-2019	Chong, Soon Eu/0000-0002-3248-4519; hassan, mohamad hasyizan/0000-0001-7264-7549; Ibrahim, Kamaruddin/0000-0001-9904-2419; Hassan, Nazaruddin/0000-0002-3771-0327	Short Term Grant of Universiti Sains Malaysia [304.PPSP.61312128]	This study was financially supported by the Short Term Grant of Universiti Sains Malaysia [304.PPSP.61312128].	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Boldt J, 2007, BRIT J ANAESTH, V99, P312, DOI 10.1093/bja/aem219; Boldt J, 2006, J CARDIOTHOR VASC AN, V20, P98, DOI 10.1053/j.jvca.2005.07.023; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P27, DOI 10.4103/2229-5151.79279; Disma N, 2014, PEDIATR ANESTH, V24, P980, DOI 10.1111/pan.12439; Drueke T, 2007, MAGNESIUM HOMEOSTASI, V3rd, P136; Guidet B, 2010, CRIT CARE, V14, DOI 10.1186/cc9230; Hadimioglu N, 2008, ANESTH ANALG, V107, P264, DOI 10.1213/ane.0b013e3181732d64; Hofmann-Kiefer KF, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-21; Kellum JA, 2002, CRIT CARE MED, V30, P259, DOI 10.1097/00003246-200201000-00046; Martin G, 2002, J CARDIOTHOR VASC AN, V16, P441, DOI 10.1053/jcan.2002.125146; Mathes DD, 1997, ANESTHESIOLOGY, V86, P501, DOI 10.1097/00000542-199702000-00028; MCFARLANE C, 1994, ANAESTHESIA, V49, P779; Morgan T J, 2003, Crit Care Resusc, V5, P284; MYTHEN MG, 2001, TRANSFUS ALTERN TRAN, V3, P15; Roche AM, 2006, ANESTH ANALG, V102, P1274, DOI 10.1213/01.ane.0000197694.48429.94; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; Smith I, 2001, INTENS CARE MED, V27, P74, DOI 10.1007/s001340051352; Zunini GS, 2011, J CRANIOFAC SURG, V22, P1370, DOI 10.1097/SCS.0b013e31821c94db; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Wilkes NJ, 2002, ANESTH ANALG, V94, P538, DOI 10.1097/00000539-200203000-00011; Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006	25	6	8	0	2	UNIV SAINS MALAYSIA, SCH MEDICAL SCIENCES	KELANTAN	HEALTH CAMPUS, 16150 KUBANG KERIAN, KELANTAN, 00000, MALAYSIA	1394-195X	2180-4303		MALAYS J MED SCI	Malays. J. Med. Sci.	SEP-OCT	2017	24	5					83	93		10.21315/mjms2017.24.5.9			11	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	FP1JA	WOS:000417367100009	29386975	Green Published, gold			2022-02-06	
J	Huang, XT; Wan, DH; Lin, YP; Xue, NZ; Hao, JH; Ma, N; Pei, XL; Li, RL; Zhang, WJ				Huang, Xintao; Wan, Dahai; Lin, Yunpeng; Xue, Naizhao; Hao, Jiehe; Ma, Ning; Pei, Xile; Li, Ruilong; Zhang, Wenju			Endothelial Progenitor Cells Correlated with Oxidative Stress after Mild Traumatic Brain Injury	YONSEI MEDICAL JOURNAL			English	Article						Traumatic brain injury; endothelial progenitor cells; superoxide dismutase; malonyldialdehyde	ISCHEMIC-STROKE; STEM-CELLS; TRANSPLANTATION; ANGIOGENESIS; MODEL; NEUROPROTECTION; INFLAMMATION; THERAPIES; RATS; MICE	Purpose: Endothelial progenitor cells (EPCs) play a key role in tissue repair and regeneration. Previous studies have shown that infusion of human umbilical cord blood-derived endothelial colony-forming cells improves outcomes in mice subjected to experimental traumatic brain injury (TBI). However, the efficiency of cell transplantation is not satisfactory. Oxidative stress plays a significant role in the survival of transplanted cells following ischemic reperfusion injury. This observational clinical study investigated the correlation between the number of circulating EPCs and plasma levels of superoxide dismutase (SOD) and malonyldialdehyde (MDA). Materials and Methods: Peripheral blood samples were collected from 20 patients with mild TBI at day-1, day-2, day-3, day-4, and day-7 post TBI. The number of circulating EPCs and the plasma levels of SOD and MDA were measured. Results: The average of circulating EPCs in TBI patients decreased initially, but increased thereafter, compared with healthy controls. Plasma levels of SOD in TBI patients were significantly lower than those in healthy controls at day-4 post-TBI. MDA levels showed no difference between the two groups. Furthermore, when assessed on day-7 post-TBI, the circulating EPC number were correlated with the plasma levels of SOD and MDA. Conclusion: These results suggest that the number of circulating EPCs is weakly to moderately correlated with plasma levels of SOD and MDA at day-7 post-TBI, which may offer a novel antioxidant strategy for EPCs transplantation after TBI.	[Huang, Xintao; Wan, Dahai; Xue, Naizhao; Hao, Jiehe; Ma, Ning; Pei, Xile; Li, Ruilong; Zhang, Wenju] Shanxi Med Univ, Affiliated Hosp 1, Dept Neurosurg, 85 Jiefangnan Rd, Taiyuan 030001, Shanxi, Peoples R China; [Lin, Yunpeng] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China		Huang, XT (corresponding author), Shanxi Med Univ, Affiliated Hosp 1, Dept Neurosurg, 85 Jiefangnan Rd, Taiyuan 030001, Shanxi, Peoples R China.	xintaoh@hotmail.com		Huang, Xintao/0000-0002-9683-9518	Shanxi Health and Family Planning Commission [2015023]; Shanxi Science and Technology Fund [2016D202097]	The present work was supported by the Shanxi Health and Family Planning Commission Research Fund (grant no.: 2015023) and the Shanxi Science and Technology Fund for Young Scholars (grant no.: 2016D202097).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Briasoulis A, 2011, CARDIOVASC THER, V29, P125, DOI 10.1111/j.1755-5922.2009.00131.x; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Fukui M, 2010, FREE RADICAL BIO MED, V48, P821, DOI 10.1016/j.freeradbiomed.2009.12.024; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Mojtahedzadeh M, 2014, J RES MED SCI, V19, P867; Monsel A, 2014, ANESTHESIOLOGY, V121, P1099, DOI 10.1097/ALN.0000000000000446; Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sakata H, 2012, STROKE, V43, P2423, DOI 10.1161/STROKEAHA.112.656900; Sakata H, 2012, J NEUROSCI, V32, P3462, DOI 10.1523/JNEUROSCI.5686-11.2012; Shen LH, 2012, NEUROSCIENCE, V223, P315, DOI 10.1016/j.neuroscience.2012.08.001; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yu P, 2016, CELL PROLIFERAT, V49, P48, DOI 10.1111/cpr.12231; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073	28	6	6	0	6	YONSEI UNIV COLL MEDICINE	SEOUL	50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA	0513-5796	1976-2437		YONSEI MED J	Yonsei Med. J.	SEP	2017	58	5					1012	1017		10.3349/ymj.2017.58.5.1012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH1JT	WOS:000410897000017	28792147	Green Published, Green Submitted, gold			2022-02-06	
J	Lam, C; Chen, PL; Kang, JH; Cheng, KF; Chen, RJ; Hung, KS				Lam, Carlos; Chen, Ping-Ling; Kang, Jiunn-Horng; Cheng, Kuang-Fu; Chen, Ray-Jade; Hung, Kuo-Sheng			Risk factors for 14-day rehospitalization following trauma with new traumatic spinal cord injury diagnosis: A 10-year nationwide study in Taiwan	PLOS ONE			English	Article							CERVICAL-SPINE; BLUNT TRAUMA; NEUROLOGICAL DETERIORATION; ASSOCIATION; SURGERY; MANAGEMENT; INSTABILITY; CLEARANCE; SECONDARY; ETIOLOGY	Objectives Fourteen-day rehospitalization with new traumatic spinal cord injury (tSCI) diagnosis is used as an indicator for the diagnostic quality of the first hospitalization. In this nationwide population-based cohort study, we identified risk factors for this indicator. Methods We conducted a nested case-control study by using the data of patients who received a first hospitalization for trauma between 2001 and 2011. The data were retrieved from Taiwan's National Health Insurance Research Database. Variables including demographic and trauma characteristics were compared between patients diagnosed with tSCI at the first hospitalization and those receiving a 14-day rehospitalization with new tSCI diagnosis. Results Of the 23 617 tSCI patients, 997 had 14-day rehospitalization with new tSCI diagnosis (incidence rate, 4.22%). The risk of 14-day rehospitalization with new tSCI diagnosis was significantly lower in patients with severe (injury severity score [ISS] = 16-24; odds ratio [OR], 0.17; 95% confidence interval [CI], 0.13-0.21) and profound (ISS > 24; OR, 0.11; 95% CI, 0.07-0.18) injuries. Interhospital transfer (OR, 8.20; 95% CI, 6.48-10.38) was a significant risk factor, along with injuries at the thoracic (OR, 1.62; 95% CI, 1.21-2.18), lumbar (OR, 1.30; 95% CI, 1.02-1.65), and multiple (OR, 3.23; 95% CI, 1.86-5.61) levels. Brain (OR, 2.82), chest (OR, 2.99), and abdominal (OR, 2.74) injuries were also identified as risk factors. In addition, the risk was higher in patients treated at the orthopedic department (OR, 2.26; 95% CI, 1.78-2.87) and those of other surgical disciplines (OR, 1.89; 95% CI, 1.57-2.28) than in those treated at the neurosurgery department. Conclusions Delayed tSCI diagnoses are not uncommon, particularly among trauma patients with ISSs < 16 or those who are transferred from lower-level hospitals. Further validation and implementation of evidence-based decision rules is essential for improving the diagnostic quality of traumatic thoracolumbar SCI.	[Lam, Carlos] Taipei Med Univ, Wan Fang Hosp, Dept Emergency & Crit Care Med, Emergency Dept, Taipei, Taiwan; [Lam, Carlos; Chen, Ping-Ling; Hung, Kuo-Sheng] Taipei Med Univ, Coll Publ Hlth, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Lam, Carlos] Taipei Med Univ, Coll Med, Sch Med, Dept Emergency Med, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan; [Cheng, Kuang-Fu] Taipei Med Univ, Coll Management, Biostat Ctr, Taipei, Taiwan; [Chen, Ray-Jade] Taipei Med Univ, Sch Med, Dept Surg, Coll Med, Taipei, Taiwan; [Chen, Ray-Jade] Taipei Med Univ Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan		Hung, KS (corresponding author), Taipei Med Univ, Coll Publ Hlth, Grad Inst Injury Prevent & Control, Taipei, Taiwan.; Chen, RJ (corresponding author), Taipei Med Univ, Sch Med, Dept Surg, Coll Med, Taipei, Taiwan.; Chen, RJ (corresponding author), Taipei Med Univ Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.; Hung, KS (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan.	rayjchen@tmu.edu.tw; kshung25@gmail.com		Lam, Carlos/0000-0002-8051-7485	Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan [E1020766]	This research was supported by grants from the Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan (Grant number E1020766). PLC received the funding. The funder's website is http://www.hpa.gov.tw/Bhpnet/Web/Index/Index.aspx. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 1996, ACAD EMERG MED, V3, P832, DOI 10.1111/j.1553-2712.1996.tb03527.x; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; BICKNELL JM, 1992, AM J EMERG MED, V10, P336, DOI 10.1016/0735-6757(92)90015-P; Carlson GD, 2003, J BONE JOINT SURG AM, V85A, P86, DOI 10.2106/00004623-200301000-00014; Cason B, 2016, J TRAUMA ACUTE CARE, V80, P125, DOI 10.1097/TA.0000000000000884; Cirera E, 2014, INJURY PREV, V20, P401, DOI 10.1136/injuryprev-2014-041199; DAVIS JW, 1993, J TRAUMA, V34, P342, DOI 10.1097/00005373-199303000-00006; Delfini R, 1999, SURG NEUROL, V51, P588, DOI 10.1016/S0090-3019(99)00020-8; Diaz JJ, 2007, J TRAUMA, V63, P709, DOI 10.1097/TA.0b013e318142d2db; Dvorak MF, 2015, J NEUROTRAUM, V32, P645, DOI 10.1089/neu.2014.3632; Flabouris A, 2001, INJURY, V32, P569, DOI 10.1016/S0020-1383(01)00071-7; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Goldfield NI, 2008, HEALTH CARE FINANC R, V30, P75; Graves, 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Grossman MD, 1999, J TRAUMA, V47, P684, DOI 10.1097/00005373-199910000-00012; Harris JH, 2002, J TRAUMA, V53, P392, DOI 10.1097/00005373-200208000-00041; Hicks CW, 2014, JAMA SURG, V149, P642, DOI 10.1001/jamasurg.2014.166; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Inaba K, 2015, J TRAUMA ACUTE CARE, V78, P459, DOI 10.1097/TA.0000000000000560; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lekovic GP, 2007, NEUROSURGERY, V60, P516, DOI 10.1227/01.NEU.0000255337.80285.39; Levi AD, 2006, SPINE, V31, P451, DOI 10.1097/01.brs.0000199927.78531.b5; McCormack RA, 2012, SPINE, V37, P1260, DOI 10.1097/BRS.0b013e318245f561; Middleton PM, 2012, INJURY, V43, P480, DOI 10.1016/j.injury.2011.12.010; Nance Michael L, NATL TRAUMA DATA BAN; National Health Insurance Administration Ministry of Health and Welfare, HEALTHC QUAL IND GLO; National Health Insurance Administration Ministry of Health and Welfare, NHIA ORG CHART; O'Connor E, 2009, EMERG MED AUSTRALAS, V21, P94, DOI 10.1111/j.1742-6723.2009.01164.x; Poonnoose PM, 2002, J TRAUMA, V53, P314, DOI 10.1097/00005373-200208000-00021; Quigley RS, 2015, SPINE, V40, P851, DOI 10.1097/BRS.0000000000000878; RAVICHANDRAN G, 1982, BRIT MED J, V284, P953, DOI 10.1136/bmj.284.6320.953; REID DC, 1987, J TRAUMA, V27, P980, DOI 10.1097/00005373-198709000-00005; Sasser SM, 2011, MMWR-MORBID MORTAL W, V61, P1; SCHNEIDER RC, 1954, J NEUROSURG, V11, P546, DOI 10.3171/jns.1954.11.6.0546; Sears JM, 2014, INJURY, V45, P16, DOI 10.1016/j.injury.2012.12.024; Shah VM, 2007, SPINE, V32, pE168, DOI 10.1097/01.brs.0000257355.27053.4c; Sixta S, 2012, J TRAUMA ACUTE CARE, V73, pS326, DOI 10.1097/TA.0b013e31827559b8; Stein DM, 2012, NEUROCRIT CARE, V17, P102, DOI 10.1007/s12028-012-9759-0; Stephan K, 2015, SPINE J, V15, P1994, DOI 10.1016/j.spinee.2015.04.041; Todd NV, 2015, BONE JOINT J, V97B, P527, DOI 10.1302/0301-620X.97B4.34328; TOSCANO J, 1988, PARAPLEGIA, V26, P143, DOI 10.1038/sc.1988.23; Wu JC, 2012, J NEUROTRAUM, V29, P889, DOI 10.1089/neu.2011.1777; Yang NP, 2008, INJURY, V39, P443, DOI 10.1016/j.injury.2007.12.007; Yang TY, 2015, SPINE, V40, P147, DOI 10.1097/BRS.0000000000000704	45	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2017	12	9							e0184253	10.1371/journal.pone.0184253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FF3ON	WOS:000408816900043	28863195	Green Published, Green Submitted, gold			2022-02-06	
J	Lang, GE; Vella, D; Waters, SL; Goriely, A				Lang, Georgina E.; Vella, Dominic; Waters, Sarah L.; Goriely, Alain			Mathematical modelling of blood-brain barrier failure and oedema	MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA			English	Article						Blood-brain barrier; biphasic model; brain mechanics; vasogenic oedema; mathematical modelling	BIPHASIC HYPERELASTIC MODEL; BULK FLOW; TRANSPORT; TISSUE; HYDROCEPHALUS; FLUID; INFUSION; INJURY; ELASTICITY; PRESSURE	Injuries such as traumatic brain injury and stroke can result in increased blood-brain barrier (BBB) permeability. This increase may lead to water accumulation in the brain tissue resulting in vasogenic oedema. Although the initial injury may be localized, the resulting oedema causes mechanical damage and compression of the vasculature beyond the original injury site. We employ a biphasic mixture model to investigate the consequences of BBB permeability changes within a region of brain tissue and the onset of vasogenic oedema. We find that such localized changes can indeed result in brain tissue swelling and suggest that the type of damage that results (stress damage or strain damage) depends on the ability of the brain to clear oedema fluid.	[Lang, Georgina E.; Vella, Dominic; Waters, Sarah L.; Goriely, Alain] Univ Oxford, Math Inst, Oxford OX2 6GG, England		Goriely, A (corresponding author), Univ Oxford, Math Inst, Oxford OX2 6GG, England.	goriely@maths.ox.ac.uk	Vella, Dominic/A-9070-2008	Vella, Dominic/0000-0003-1341-8863			Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Bakker ENTP, 2016, CELL MOL NEUROBIOL, V36, P181, DOI 10.1007/s10571-015-0273-8; BRADBURY MWB, 1985, CIRC RES, V57, P213, DOI 10.1161/01.RES.57.2.213; Chen XM, 2007, ANN BIOMED ENG, V35, P2145, DOI 10.1007/s10439-007-9371-1; Conn, 2008, NEUROSCIENCE MED, P173, DOI [10.1007/978-1-60327-455-5_11, DOI 10.1007/978-1-60327-455-5_11]; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Ek CJ, 2005, BLOOD-CEREBROSPINAL FLUID BARRIER, P3; Elkin BS, 2010, PHILOS T R SOC A, V368, P585, DOI 10.1098/rsta.2009.0223; Flechsenhar J, 2013, J CLIN NEUROSCI, V20, P6, DOI 10.1016/j.jocn.2012.02.019; Garcia JJ, 2010, LAT AM APPL RES, V40, P295; Garcia JJ, 2009, ANN BIOMED ENG, V37, P375, DOI 10.1007/s10439-008-9610-0; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; HOLMES MH, 1985, B MATH BIOL, V47, P669, DOI 10.1007/BF02460132; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; KAWAMATA T., 2008, NEUROSURG FOCUS, V22, P1; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KORTHUIS R., 2010, CAPILLARY FLUID EXCH; LANG G. E., 2014, THESIS; Lang GE, 2015, BIOMECH MODEL MECHAN, V14, P1197, DOI 10.1007/s10237-015-0665-1; Lang GE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0123; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; MAK AF, 1987, J BIOMECH, V20, P703, DOI 10.1016/0021-9290(87)90036-4; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Moran R, 2014, J BIOMECH, V47, P3762, DOI 10.1016/j.jbiomech.2014.09.030; NAGASHIMA T, 1990, Neurologia Medico-Chirurgica, V30, P1, DOI 10.2176/nmc.30.1; NAGASHIMA T., 1990, ADV NEUROL, V52, P327; Neal J, 2007, J ANAT, V210, P66, DOI 10.1111/j.1469-7580.2006.00674.x; Ogden, 1984, NONLINEAR ELASTIC DE; RAPOPORT SI, 1978, J THEOR BIOL, V74, P439, DOI 10.1016/0022-5193(78)90224-2; RAPOPORT SI, 1997, PRIMER CEREBROVASCUL, P25; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Smillie A, 2005, J FLUID MECH, V539, P417, DOI 10.1017/S0022112005005707; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith JH, 2007, MICROVASC RES, V73, P58, DOI 10.1016/j.mvr.2006.07.001; Smith Quentin R, 2003, Methods Mol Med, V89, P193; Sobey Ian, 2012, INT J NUMER ANAL M B, V3, P52; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; STRANDGAS, 1973, BMJ-BRIT MED J, V1, P507, DOI DOI 10.1007/S00134-016-4249-Z; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Tully B, 2011, J FLUID MECH, V667, P188, DOI 10.1017/S0022112010004428; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walberer M, 2008, J NEUROSURG, V109, P287, DOI 10.3171/JNS/2008/109/8/0287; Wilson W, 2005, J BIOMECH ENG-T ASME, V127, P158, DOI 10.1115/1.1835361; Wirth B, 2006, MATH MED BIOL, V23, P363, DOI 10.1093/imammb/dql014; Wirth B, 2009, MATH MED BIOL, V26, P25, DOI 10.1093/imammb/dqn021; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	52	6	6	3	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1477-8599	1477-8602		MATH MED BIOL	Math. Med. Biol.	SEP	2017	34	3					391	414		10.1093/imammb/dqw009			24	Biology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	FJ4JG	WOS:000412702300004	27305934	Green Published			2022-02-06	
J	Ma, YB; Matsuwaki, T; Yamanouchi, K; Nishihara, M				Ma, Yanbo; Matsuwaki, Takashi; Yamanouchi, Keitaro; Nishihara, Masugi			Involvement of progranulin in modulating neuroinflammatory responses but not neurogenesis in the hippocampus of aged mice	EXPERIMENTAL GERONTOLOGY			English	Article						Aging; Hippocampus; Neurogenesis; Neuroinflammation; Progranulin	TRAUMATIC BRAIN-INJURY; ADULT NEUROGENESIS; MICROGLIAL ACTIVATION; GENETIC-VARIABILITY; HUNTINGTONS-DISEASE; CELL-PROLIFERATION; MUTATIONS; INFLAMMATION; CONTRIBUTES; EXPRESSION	It is well established that adult neurogenesis in the hippocampus declines with age. Our previous studies have suggested that progranulin (PGRN) has a facilitative effect on hippocampal neurogenesis. We have also shown that PGRN plays a role in suppressing excessive neuroinflammatory responses in the cortex and thalamus after brain injury and aging, respectively. However, the roles of PGRN in modulating neurogenesis and neuroinflammatory responses in the hippocampus of aged animals are not yet understood. In the present study, we investigated neurogenesis and neuroinflammation-related responses in the hippocampus of young (15-week-old) and old (135-week-old) wild-type and PGRN-deficient male mice. Neurogenesis in the dentate gyrus of the hippocampus markedly declined with age, and there was no significant difference between the genotype. The number of CD68-positive activated microglia and the expression of lysosomal genes in the hippo campus were significantly increased with age, and PGRN deficiency further increased them. The expression of pro-inflammatory genes was also increased with age, and PGRN deficiency significantly enhanced some of them. These results suggest that PGRN deficiency exacerbates neuroinflammatory responses related to activated microglia in aged animals, while PGRN may not counteract the decline of hippocampal neurogenesis with age. (C) 2017 Elsevier Inc. All rights reserved.	[Ma, Yanbo; Matsuwaki, Takashi; Yamanouchi, Keitaro; Nishihara, Masugi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Physiol, Tokyo 1138657, Japan; [Ma, Yanbo] Henan Univ Sci & Technol, Coll Anim Sci, Dept Anim Physiol, Luoyang 471003, Peoples R China		Nishihara, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Physiol, Tokyo 1138657, Japan.	amnishi@mail.ecc.u-tokyo.ac.jp	Yamanouchi, Keitaro/R-5003-2019		JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23228004, 17H03930]; JSPS Postdoctoral Fellowship for Foreign ResearchersMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [26.04906]	This work was partly supported by JSPS KAKENHI (Grant Number 23228004 and 17H03930 to MN) and a JSPS Postdoctoral Fellowship for Foreign Researchers (Grant Number 26.04906 to YM).	Asakura R, 2011, NEUROREPORT, V22, P881, DOI 10.1097/WNR.0b013e32834bf4ca; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Ben Menachem-Zidon O, 2008, NEUROPSYCHOPHARMACOL, V33, P2251, DOI 10.1038/sj.npp.1301606; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Chiba S, 2007, J REPROD DEVELOP, V53, P297, DOI 10.1262/jrd.18108; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Conover J. C., 2016, EXP GERONTOL S, VS0531-5565, P30398; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; De Muynck L, 2011, J MOL NEUROSCI, V45, P549, DOI 10.1007/s12031-011-9553-z; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Ghidoni R, 2012, NEURODEGENER DIS, V9, P121, DOI 10.1159/000333132; Gil-Mohapel J, 2011, BRAIN RES, V1406, P84, DOI 10.1016/j.brainres.2011.06.040; Goshen I, 2009, J NEUROSCI, V29, P3395, DOI 10.1523/JNEUROSCI.5352-08.2009; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuzumaki N, 2010, SYNAPSE, V64, P721, DOI 10.1002/syn.20800; Le WD, 2001, J NEUROSCI, V21, P8447, DOI 10.1523/JNEUROSCI.21-21-08447.2001; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Ma Y., 2016, MOL NEUROBIOL, V56, P1; Ma YB, 2013, BRAIN RES, V1508, P23, DOI 10.1016/j.brainres.2013.02.042; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Marxreiter F, 2013, CELL MOL LIFE SCI, V70, P459, DOI 10.1007/s00018-012-1062-x; Matsuwaki T, 2011, J REPROD DEVELOP, V57, P113, DOI 10.1262/jrd.10-116S; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nedachi T, 2011, NEUROSCIENCE, V185, P106, DOI 10.1016/j.neuroscience.2011.04.037; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Regensburger M, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/454696; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Tanaka Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0078-x; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568	53	6	8	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	SEP	2017	95						1	8		10.1016/j.exger.2017.05.003			8	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	EZ1TK	WOS:000404493500001	28479389				2022-02-06	
J	Moyron, RB; Gonda, A; Selleck, MJ; Luo-Owen, X; Catalano, RD; O'Callahan, T; Garberoglio, C; Turay, D; Wall, NR				Moyron, Ron B.; Gonda, Amber; Selleck, Matthew J.; Luo-Owen, Xian; Catalano, Richard D.; O'Callahan, Thomas; Garberoglio, Carlos; Turay, David; Wall, Nathan R.			Differential protein expression in exosomal samples taken from trauma patients	PROTEOMICS CLINICAL APPLICATIONS			English	Article						Exosome; Exo-Proteomics; TBI; Trauma biomarker discovery	BRAIN-INJURY; DISEASE; ENCEPHALOPATHY	Traumatic brain injuries (TBI) are among the most misdiagnosed and underreported types of head trauma. The potential long-term impact of undiagnosed or incorrectly identified concussions and other head injuries are potentially devastating, as evidenced by the increasing societal burden exhibited by soldiers returning from combat and athletes in contact sports. Concussions and TBI are notoriously difficult to correctly diagnose and prognosis for these injuries is poorly understood. In order to increase the likelihood of successful diagnosis, treatment, and prediction of outcomes, a definitive differential diagnosis will need to be established. The establishment of a "trauma-specific profile" or a panel of known trauma markers will significantly aid in this goal. Small membrane vesicles called exosomes have been shown to contain proteins and injury-specific biomarkers. In the future it is possible that they could become an important tool, utilized for their diagnostic and therapeutic potential.	[Moyron, Ron B.; Gonda, Amber; Wall, Nathan R.] Loma Linda Univ, Ctr Hlth Dispar Res & Mol Med, Loma Linda, CA 92350 USA; [Moyron, Ron B.; Wall, Nathan R.] Loma Linda Univ, Div Biochem, Dept Basic Sci, Loma Linda, CA 92350 USA; [Gonda, Amber] Loma Linda Univ, Div Anat, Dept Basic Sci, Loma Linda, CA 92350 USA; [Selleck, Matthew J.; Garberoglio, Carlos] Loma Linda Univ, Div Surg Oncol, Dept Surg, Loma Linda, CA 92350 USA; [Luo-Owen, Xian; Catalano, Richard D.; O'Callahan, Thomas; Garberoglio, Carlos; Turay, David] Loma Linda Univ, Dept Surg, Div Trauma, Loma Linda, CA 92350 USA		Wall, NR (corresponding author), Loma Linda Univ, Dept Basic Sci, Ctr Hlth Dispar Res & Mol Med, 11085 Campus St,Mortensen Hall Room 162, Loma Linda, CA 92350 USA.	nwall@llu.edu	Wall, Nathan R./H-7368-2015	Wall, Nathan R./0000-0002-3235-4386	Loma Linda University; Loma Linda University School of Medicine; Center for Health Disparities and Molecular Medicine	Research reported in this publication was supported by a Loma Linda University internal grant to promote collaborative & translational research (GCAT) mechanism. The authors thank Loma Linda University School of Medicine and the Center for Health Disparities and Molecular Medicine for supporting this work.	Broglio SP, 2017, SPORTS MED, DOI 10.1007/s40279-017-0707-1; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kalani A, 2014, MOL NEUROBIOL, V49, P590, DOI 10.1007/s12035-013-8544-1; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; National Collegiate Athletic Association, 2014, NCAA DOD LAUNCH MIND; TEASDALE G, 1974, LANCET, V2, P81; Turay D, 2016, CANCER INVEST, V34, P1, DOI 10.3109/07357907.2015.1081921; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Yang YX, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00055	14	6	6	0	4	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1862-8346	1862-8354		PROTEOM CLIN APPL	Proteom. Clin. Appl.	SEP	2017	11	9-10							1700061	10.1002/prca.201700061			7	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH8XJ	WOS:000411488300008	28544811				2022-02-06	
J	O'Brien, A; O'Brien, M; Schlosser, RW; Yu, C; Allen, AA; Flynn, S; Costello, J; Shane, HC				O'Brien, Amanda; O'Brien, Meghan; Schlosser, Ralf W.; Yu, Christina; Allen, Anna A.; Flynn, Suzanne; Costello, John; Shane, Howard C.			Repurposing Consumer Products as a Gateway to Just-in-Time Communication	SEMINARS IN SPEECH AND LANGUAGE			English	Article						Just-in-time; augmentative and alternative communication; ASD; acquired brain injury; amyotrophic lateral; sclerosis	AUTISM SPECTRUM DISORDERS; TRAUMATIC BRAIN-INJURY; MOBILE TECHNOLOGY; LEAST PROMPTS; CHILDREN; MEMORY; INDIVIDUALS; STUDENTS; INDEPENDENCE; SMARTPHONES	The rich feature set and flexibility of mobile technology offers a host of novel opportunities to provide specific and timely supports to individuals with communication and memory disorders. These "just-in time" (JIT) supports can be used as prompts, reminders, rewards, strategies to increase independence, and expressive language supports for children and adults with communication and memory disorders. The purpose of this article is to examine current research on, and propose future directions for, repurposing consumer products to enhance JIT communication within the field of augmentative and alternative communication. Initially, a brief history of JIT supports will be reviewed, including a timeline and history of JIT-enabling technology. Next, the taxonomy of JIT supports will be applied to current research in both individuals with autism spectrum disorder and individuals with acquired communication disorders (e.g., acquired brain injury, amyotrophic lateral sclerosis) to illustrate current clinical implications and evaluate current limitations of JIT supports. Finally, future directions for research and expanded use of consumer products to provide JIT supports will be discussed.	[O'Brien, Amanda; Yu, Christina] Boston Childrens Hosp, Boston, MA USA; [O'Brien, Meghan; Allen, Anna A.] Boston Childrens Hosp, MGH Inst Hlth Profess, Boston, MA USA; [Schlosser, Ralf W.] Northeastern Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [Flynn, Suzanne] MIT, Boston Childrens Hosp, Boston, MA USA; [Costello, John] Boston Univ, Boston Childrens Hosp, MGH Inst Hlth Profess, Boston, MA 02215 USA; [Shane, Howard C.] Harvard Med Sch, Boston Childrens Hosp, MGH Inst Hlth Profess, Boston, MA USA		O'Brien, A (corresponding author), Boston Childrens Hosp, 9 Hope Ave, Waltham, MA 02453 USA.	Amanda.obrien@childrens.harvard.edu	O'Brien, Amanda/AAN-4048-2020; Allen, Anna A./AAU-9942-2021	Flynn, Suzanne/0000-0002-0610-6725; Schlosser, Ralf/0000-0002-2069-3911			Ayres W., 1989, GOOD PRESCHOOL TEACH; Baddeley A.D., 2007, COMMUNICATION 0913; Barsalou LW, 1999, DISCOURSE PROCESS, V28, P61, DOI 10.1080/01638539909545069; Bereznak S, 2012, J DEV PHYS DISABIL, V24, P269, DOI 10.1007/s10882-012-9270-8; Beukelman D, 2016, INT SOC AUGM ALT COM; Brady N., 2016, PERSPECTIVES ASHA SP, V1, P12, DOI [10.1044/persp1.SIG1.12, DOI 10.1044/PERSP1.SIG1.12]; Brooks PJ, 2015, J SPEECH LANG HEAR R, V58, P1210, DOI 10.1044/2015_JSLHR-L-14-0212; Brown JS., 1989, EDUC RESEARCHER, V18, P32, DOI DOI 10.3102/0013189X018001032; Burke RV, 2010, RES DEV DISABIL, V31, P1223, DOI 10.1016/j.ridd.2010.07.023; Cannella-Malone H, 2006, EDUC TRAIN DEV DISAB, V41, P344; Caron J, 2016, AUGMENT ALTERN COMM, V32, P12, DOI 10.3109/07434618.2015.1126636; Charters E, 2015, NEUROPSYCHOL REHABIL, V25, P82, DOI 10.1080/09602011.2014.942672; Cheng TCE, 1996, JUST TIME MANUFACTUR; Cihak D, 2010, J POSIT BEHAV INTERV, V12, P103, DOI 10.1177/1098300709332346; Cihak DF, 2007, RES DEV DISABIL, V28, P397, DOI 10.1016/j.ridd.2006.05.003; Evald L, 2015, NEUROPSYCHOL REHABIL, V25, P283, DOI 10.1080/09602011.2014.970557; Goddard WE, 1986, JUST IN TIME; Hyun E, 2003, J CURRICULUM STUD, V35, P111, DOI 10.1080/00220270210125583; Jamieson M, 2017, NEUROPSYCHOL REHABIL, V27, P919, DOI 10.1080/09602011.2015.1103760; Kagohara DM, 2013, RES DEV DISABIL, V34, P147, DOI 10.1016/j.ridd.2012.07.027; Kagohara DM, 2012, RES AUTISM SPECT DIS, V6, P304, DOI 10.1016/j.rasd.2011.05.012; Kinas Jerome M, 2017, ASS TECHN IND ASS C; LIGHT J, 1991, AUGMENT ALTERN COMM, V7, P186, DOI DOI 10.1080/07434619112331275893; Linden M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011020.pub2; Lorah ER, 2015, J AUTISM DEV DISORD, V45, P3792, DOI 10.1007/s10803-014-2314-4; McNaughton D, 2013, AUGMENT ALTERN COMM, V29, P107, DOI 10.3109/07434618.2013.784930; Mechling LC, 2008, J SPEC EDUC, V42, P179, DOI 10.1177/0022466907313348; Muench F, 2013, PSYCHOL ADDICT BEHAV, V27, P315, DOI 10.1037/a0029963; Novak GM, 2011, NEW DIRECTION TEACHI, V2011, P63, DOI [10.1002/tl.469, DOI 10.1002/TL.469]; O'Brien A, 2016, J AUTISM DEV DISORD, V46, P3818, DOI 10.1007/s10803-016-2891-5; O'Brien M., 2015, PERSPECT AUGMENT ALT, V24, P45; Pierno AC, 2008, NEUROPSYCHOLOGIA, V46, P448, DOI 10.1016/j.neuropsychologia.2007.08.020; Plackett R, 2017, DISABIL REHABIL-ASSI, V12, P236, DOI 10.3109/17483107.2015.1127436; Radhakrishnan R., 2007, ASSIST TECHNOL, V4, P99; Robins B, 2006, INTERACT STUD, V7, P479; Schlosser R.W., 1999, AUGMENT ALTERN COMM, V15, P234, DOI [DOI 10.1080/07434619912331278775, 10.1080/07434619912331278775]; Schlosser RW, 2016, J DEV PHYS DISABIL, V28, P177, DOI 10.1007/s10882-015-9452-2; Schlosser RW, 2017, INT J DEV D IN PRESS; Shane HC, 2015, VISUAL IMMERSION PRO; Shane HC, 2007, ANN M CURR TRENDS AU; Spriggs AD, 2015, J AUTISM DEV DISORD, V45, P3846, DOI 10.1007/s10803-014-2315-3; Thistle JJ, 2013, AUGMENT ALTERN COMM, V29, P235, DOI 10.3109/07434618.2013.815800; Van Laarhoven T, 2009, J BEHAV EDUC, V18, P119, DOI 10.1007/s10864-009-9077-6; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Wang V, 2016, CLIN TEACH, V13, P183, DOI 10.1111/tct.12394; Warren Z, 2015, J AUTISM DEV DISORD, V45, P3870, DOI 10.1007/s10803-014-2334-0; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434	47	6	6	0	17	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	SEP	2017	38	4					297	312		10.1055/s-0037-1604277			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FG1OA	WOS:000409564300006	28892836				2022-02-06	
J	Omar, MTA; Abd El Baky, AM; Ebid, AA				Omar, Mohammed T. A.; Abd El Baky, Amal M.; Ebid, Anwar A.			Lower-Limb Muscular Strength, Balance, and Mobility Levels in Adults Following Severe Thermal Burn Injuries	JOURNAL OF BURN CARE & RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; ASSESSMENT-TOOL HIMAT; QUALITY-OF-LIFE; MUSCLE STRENGTH; SKELETAL-MUSCLE; HEALED BURNS; LEAN MASS; CHILDREN; EXERCISE; REHABILITATION	Severe burn injuries are associated with hypermetabolic response and increased catabolism. These lead to a vast loss of muscle mass and reduced muscle strength and function. Therefore, the aim of this study is to determine the impact of severe burn injuries on lower-limb muscular strength, balance, and mobility level in adults. Forty burned adults with burned TBSA (burned TBSA) >= 40% participated in this study. The peak torque and total work of quadriceps and knee flexors were calculated at 150 degrees/sec using Biodex isokinetic dynamometer. Balance and mobility were tested via the Biodex balance device and the high mobility assessment tool, respectively. Twenty-three matched nonburned healthy adults were evaluated and served as a control group. Severely burned adults exhibited significantly lower peak torque and total work in their quadriceps (27.50 and 22.58%, P < .05) and knee flexors (23.72, and 21.65%, P < .05) relative to the nonburned adults. Burned adults had a significant decrease in stability index and balance including the dynamic limits of stability (P < .05). The high mobility assessment tool scores were significantly lower (42 +/- 7.64, P < .05) when compared with control subjects (51 +/- 1.62). Patients who had severe burns (burned TBSA >= 40%) showed muscular weakness, limited balance, and mobility levels between 16 and 24 weeks after discharge from the hospital compared with matched nonburned control subjects. These results can guide therapists in creating rehabilitation programs that focus on the specific difficulties faced by burned patients.	[Omar, Mohammed T. A.; Abd El Baky, Amal M.; Ebid, Anwar A.] Cairo Univ, Fac Phys Therapy, Phys Therapy Dept Surg, 7 Ahmad Alzayat St, Giza 12612, Egypt; [Abd El Baky, Amal M.] Majmaah Univ, CAMS, Al Majmaah, Saudi Arabia		Omar, MTA (corresponding author), Cairo Univ, Fac Phys Therapy, Phys Therapy Dept Surg, 7 Ahmad Alzayat St, Giza 12612, Egypt.	dr.Taher_m@yahoo.com	Omar, Mohammed/AAC-1938-2021				Alloju SM, 2008, BURNS, V34, P452, DOI 10.1016/j.burns.2007.10.006; Baker CP, 2007, ARCH PHYS MED REHAB, V88, pS57, DOI 10.1016/j.apmr.2007.09.014; Benjamin NC, 2015, BURNS, V41, P1653, DOI 10.1016/j.burns.2015.05.020; CRONAN T, 1990, Journal of Burn Care and Rehabilitation, V11, P224, DOI 10.1097/00004630-199005000-00008; Diaz EC, 2015, BURNS, V41, P649, DOI 10.1016/j.burns.2014.10.010; Diego AM, 2013, J BURN CARE RES, V34, pE311, DOI 10.1097/BCR.0b013e3182839ae9; Disseldorp LM, 2015, BURNS, V41, P1839, DOI 10.1016/j.burns.2015.08.025; Ebid AA, 2015, INT J PHYSIOTHER RES, V3, P1024; Ebid AA, 2012, BURNS, V38, P61, DOI 10.1016/j.burns.2011.05.007; Ebid AA, 2012, BURNS, V38, P1019, DOI 10.1016/j.burns.2012.02.006; Finlay V, 2010, BURNS, V36, P780, DOI 10.1016/j.burns.2009.10.019; Grisbrook TL, 2013, BURNS, V39, P680, DOI 10.1016/j.burns.2012.09.005; Grisbrook TL, 2012, BURNS, V38, P1165, DOI 10.1016/j.burns.2012.03.007; Grisbrook TL, 2010, BURNS, V36, pE24, DOI 10.1016/j.burns.2009.01.006; Hart DW, 2000, SURGERY, V128, P312, DOI 10.1067/msy.2000.108059; Hinman MR, 2000, J SPORT REHABIL, V9, P240, DOI 10.1123/jsr.9.3.240; Huang MH, 2003, SEMIN ARTHRITIS RHEU, V32, P398, DOI 10.1053/sarh.2003.50021; Ibebunjo C, 2001, MUSCLE NERVE, V24, P1283, DOI 10.1002/mus.1146; Kaufman T., 1997, ORTHOP PHYS THER CLI, V6, P43; Kowalske K, 2001, J BURN CARE REHABIL, V22, P353, DOI 10.1097/00004630-200109000-00013; Leblebici B, 2006, J BURN CARE RES, V27, P864, DOI 10.1097/01.BCR.0000245652.26648.36; Melenfant A, 1998, PAIN, V77, P241, DOI 10.1016/S0304-3959(98)00096-7; Merritt EK, 2013, J BURN CARE RES, V34, pE297, DOI 10.1097/BCR.0b013e31827a2a9c; Nashner LM., 1998, BALANCE MASTER SYSTE; Nedelec B, 2005, BURNS, V31, P817, DOI 10.1016/j.burns.2005.06.007; Pereira C, 2005, INT J BIOCHEM CELL B, V37, P1948, DOI 10.1016/j.biocel.2005.05.009; Porter C, 2013, BURNS, V39, P1039, DOI 10.1016/j.burns.2013.03.018; Schneider JC, 2006, J BURN CARE RES, V27, P508, DOI 10.1097/01.BCR.0000225994.75744.9D; Schneider JC, 2011, PHYS MED REH CLIN N, V22, P261, DOI 10.1016/j.pmr.2011.01.003; Schneider JC, 2012, BURNS, V38, P164, DOI 10.1016/j.burns.2011.11.002; St-Pierre DMM, 1998, ARCH PHYS MED REHAB, V79, P155, DOI 10.1016/S0003-9993(98)90292-1; Suman OE, 2003, J APPL PHYSIOL, V94, P2273, DOI 10.1152/japplphysiol.00849.2002; Suman OE, 2007, ARCH PHYS MED REHAB, V88, pS24, DOI 10.1016/j.apmr.2007.09.002; van Baar ME, 2006, BURNS, V32, P1, DOI 10.1016/j.burns.2005.08.007; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	37	6	7	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1559-047X	1559-0488		J BURN CARE RES	J. Burn Care Res.	SEP-OCT	2017	38	5					327	333		10.1097/BCR.0000000000000495			7	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	FF0HP	WOS:000408583100025	28099237				2022-02-06	
J	Sherer, M; Ponsford, J; Hicks, A; Leon-Novelo, L; Ngan, E; Sander, AM				Sherer, Mark; Ponsford, Jennie; Hicks, Amelia; Leon-Novelo, Luis; Ngan, Esther; Sander, Angelle M.			Cross-Validation of a Classification System for Persons With Traumatic Brain Injury in the Posthospital Period	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						classification; cross-validation; traumatic brain injury	SEQUELAE	Objective: To (1) identify groupings of persons with traumatic brain injury (TBI) in the posthospital period in a cohort recruited in Australia; (2) compare groupings from the Australian cohort to groupings previously developed for a US cohort. Setting: Rehabilitation centers in the US and Australia. Participants: A total of 170 persons with TBI from Australia and 504 persons with TBI from the United States. Participants were aged 18 to 64 years, greater than 6 months postinjury, had capacity to give consent, and had definitive contemporaneous medical evidence of TBI. Design: Observational study. Main Measures: Cognitive tests-Wechsler Letter-Number Sequencing and Coding, Rey Auditory Verbal Learning Test, Trail Making Test, Verbal Fluency. Questionnaires-9 scales from the Traumatic Brain Injury Quality-of-Life system; Neurobehavioral Symptom Inventory; Economic Quality of Life, Family Assessment Device-General Functioning. Performance validity-Word Memory Test. Results: Agreement in classification for the 2 samples was only moderate with 63.5% correctly classified and Cohen's kappa = 0.53. A post hoc analysis placing all persons showing poor performance validity in the same group improved classification to 73% and Cohen's kappa= 0.65 indicating substantial agreement. Conclusion: Results provided support for the patient groups developed for the US sample and indicate that these groupings largely replicated in a new cohort.	[Sherer, Mark; Sander, Angelle M.] TIRR Mem Hermann, 1333 Moursund, Houston, TX 77030 USA; [Sherer, Mark; Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Ponsford, Jennie; Hicks, Amelia] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Ponsford, Jennie; Hicks, Amelia] Epworth Med Fdn, Melbourne, Vic, Australia; [Leon-Novelo, Luis; Ngan, Esther] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Dept Psychiat, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Phys Med & Rehabil, Houston, TX USA		Sherer, M (corresponding author), TIRR Mem Hermann, 1333 Moursund, Houston, TX 77030 USA.	Mark.Sherer@memorialhermann.org	Hicks, Amelia/AAQ-7743-2020	Hicks, Amelia/0000-0002-1152-0576	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90RT5007, 90DP0028, 90DP0060]	The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (grant numbers 90RT5007 [PI: Sander], 90DP0028 [PI: Sherer], and 90DP0060 [PI: Arciniegas]). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Bergquist TF, 2014, HDB NEUROPSYCHOLOGY, P3; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; FORGY EW, 1965, BIOMETRICS, V21, P768; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Green P., 1996, WORD MEMORY TEST USE; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1958, EXAMIN CLIN PSYCHOL; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Roebuck-Spencer T., 2014, HDB NEUROPSYCHOLOGY, P3; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tulsky DS, 2015, ARCH PHYS MED REHAB, V96, P604, DOI 10.1016/j.apmr.2014.02.030; Wechsler D., 2008, WECHSLER ADULT INTEL	26	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					E17	E25		10.1097/HTR.0000000000000290			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800002	28195953				2022-02-06	
J	van Delft-Schreurs, CCHM; van Son, MAC; de Jongh, MAC; Lansink, KWW; de Vries, J; Verhofstad, MHJ				van Delft-Schreurs, C. C. H. M.; van Son, M. A. C.; de Jongh, M. A. C.; Lansink, K. W. W.; de Vries, J.; Verhofstad, M. H. J.			The relationship between physical and psychological complaints and quality of life in severely injured patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Quality of life; injury; Trauma; Psychopathology; Psychological problems; Physical limitations	POSTTRAUMATIC-STRESS-DISORDER; ASSESSMENT SMFA QUESTIONNAIRE; MAJOR TRAUMATIC INJURY; FUNCTIONAL CONSEQUENCES; PSYCHOMETRIC PROPERTIES; MULTIPLE INJURIES; MENTAL-HEALTH; BRAIN-INJURY; DISABILITY; RECOVERY	Purpose: The purpose of this study was two-fold. The first goal was to investigate which variables were associated with the remaining physical limitations of severely injured patients after the initial rehabilitation phase. Second, we investigated whether physical limitations were attributable to the association between psychological complaints and quality of life in this patient group. Methods: Patients who were 18 years or older and who had an injury severity score (ISS) > 15 completed a set of questionnaires at one time-point after their rehabilitation phase (15-53 months after their trauma). The Short Musculoskeletal Function Assessment (SMFA) questionnaire was used to determine physical limitations. The Hospital Anxiety and Depression Scale, the Dutch Impact of Event Scale and the Cognitive Failure Questionnaire were used to determine psychological complaints, and the World Health Organization Quality of Life assessment instrument-BREF was used to measure general Quality of Life (QOL). Differences in physical limitations were investigated for several trauma-and patient-related variables using non-parametric independent-sample Mann-Whitney U tests. Multiple linear regression was performed to investigate whether the decreased QOL of severely injured patients with psychological complaints could be explained by their physical limitations. Results: Older patients, patients with physical complaints before the injury, patients with higher ISS scores, and patients who had an injury of the spine or of the lower extremities reported significantly more physical problems. Additionally, patients with a low education level, patients who were living alone, and those who were unemployed reported significantly more long-term physical problems. Severely injured patients without psychological complaints reported significantly less physical limitations than those with psychological complaints. The SMFA factor of Lower extremity dysfunction was a confounder of the association between psychological complaints and QOL in all QOL domains. Conclusions: Long-term physical limitations were mainly reported by patients with psychological complaints. The decreased QOL of severely injured patients with psychological complaints can partially be explained by physical limitations, particularly those involving lower extremity function. Experienced physical limitations were significantly different for some trauma and patient characteristics. These characteristics may be used to select patients for whom a rehabilitation programme would be useful. (C) 2017 Published by Elsevier Ltd.	[van Delft-Schreurs, C. C. H. M.; de Jongh, M. A. C.; Lansink, K. W. W.] Elisabeth TweeSteden Hosp, Network Emergency Care Brabant, POB 90151, NL-5000 LC Tilburg, Netherlands; [van Son, M. A. C.] Netherlands Soc Occupat Med Ctr Excellence, Utrecht, Netherlands; [Lansink, K. W. W.] Elisabeth TweeSteden Hosp, Dept Surg, Tilburg, Netherlands; [de Vries, J.] Elisabeth TweeSteden Hosp, Dept Med Psychol, Tilburg, Netherlands; [de Vries, J.] Tilburg Univ, CoRPS, Dept Med & Clin Psychol, Tilburg, Netherlands; [Verhofstad, M. H. J.] Erasmus MC, Dept Trauma Surg, Rotterdam, Netherlands		van Delft-Schreurs, CCHM (corresponding author), Elisabeth TweeSteden Hosp, Network Emergency Care Brabant, POB 90151, NL-5000 LC Tilburg, Netherlands.	k.v.delft@nazb.nl; m.vanson@nvab-online.nl; m.d.jongh@nazb.nl; k.lansink@etz.nl; j.devries@etz.nl; m.verhofstad@erasmusmc.nl					Airey CM, 2001, DISABIL REHABIL, V23, P509; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brom D., 1985, NEDERLANDS TIJDSCHRI, V40, P164; Christensen MC, 2011, J TRAUMA, V70, P1524, DOI 10.1097/TA.0b013e3181f053c2; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Gabbe BJ, 2013, ANN SURG, V257, P166, DOI 10.1097/SLA.0b013e31825d7422; Haagsma JA, 2011, INJURY PREV, V17, P21, DOI 10.1136/ip.2010.026419; HOLBROOK TL, 1994, J TRAUMA, V36, P74, DOI 10.1097/00005373-199401000-00011; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holtslag HR, 2007, INJURY, V38, P280, DOI 10.1016/j.injury.2006.10.026; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Kaske S, 2016, SCHMERZ, V30, P273, DOI 10.1007/s00482-016-0112-y; Kaske S, 2014, INJURY, V45, pS100, DOI 10.1016/j.injury.2014.08.028; Kiely JM, 2006, J TRAUMA, V61, P791, DOI 10.1097/01.ta.0000239360.29852.1d; MACKENZIE EJ, 1986, MED CARE, V24, P377, DOI 10.1097/00005650-198605000-00001; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; NEAL LA, 1994, J TRAUMA STRESS, V7, P447, DOI 10.1007/BF02102789; O'Donnell ML, 2013, J CLIN PSYCHIAT, V74, pE137, DOI 10.4088/JCP.12m08011; O'Donnell ML, 2009, MED J AUSTRALIA, V190, pS71; O'Donnell ML, 2005, J TRAUMA, V59, P1328, DOI 10.1097/01.ta.0000197621.94561.4e; Orwelius L, 2011, J TRAUMA; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Ponds R., 2006, TIJDSCHR NEUROPSYCHO, V2, P37; REGEL G, 1993, UNFALLCHIRURG, V96, P341; Ringburg AN, 2010, J TRAUMA; Sampalis JS, 2006, J TRAUMA, V60, P806, DOI 10.1097/01.ta.0000215103.62783.4d; Soberg HL, 2010, ARCH PHYS MED REHAB, V91, P481, DOI 10.1016/j.apmr.2009.11.007; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Stalp M, 2002, J TRAUMA, V52, P1160, DOI 10.1097/00005373-200206000-00023; Sutherland AG, 2006, J TRAUMA, V61, P1408, DOI 10.1097/01.ta.0000197562.34651.df; Swiontkowski MF, 1999, J BONE JOINT SURG AM, V81A, P1245, DOI 10.2106/00004623-199909000-00006; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; van Beeck EF, 1998, PUBLIC HEALTH REP, V113, P427; van Delft-Schreurs CCHM, 2016, INJURY, V47, P2034, DOI 10.1016/j.injury.2016.03.006; van Delft-Schreurs CCHM, 2014, QUAL LIFE RES, V23, P1353, DOI 10.1007/s11136-013-0546-y; van Delft-Schreurs CCHM, 2014, INJURY, V45, P320, DOI 10.1016/j.injury.2013.02.025; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; Van Son MAC, 2014, QUAL LIFE RES, V23, P917, DOI 10.1007/s11136-013-0529-z; Vries de J, 1996, NEDERLANDSE VERSIE W; WHOQOL Group, 1996, WHOQOL BREF; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zigmond AS, HOSP ANXIETY DEPRESS, P1994	42	6	6	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2017	48	9					1978	1984		10.1016/j.injury.2017.05.007			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FE2LA	WOS:000408046600020	28551050	Green Submitted			2022-02-06	
J	Yerramsetti, AP; Simons, DD; Coonan, L; Stolar, A				Yerramsetti, Ashok Paparao; Simons, Daniel David; Coonan, Loretta; Stolar, Andrea			Veteran treatment courts: A promising solution	BEHAVIORAL SCIENCES & THE LAW			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COMBAT VETERANS; RISK-FACTORS; HEALTH-CARE; JUSTICE; PROGRAMS; RECIDIVISM; PREVALENCE; DIAGNOSES	The high prevalence of substance use, traumatic brain injury, post-traumatic stress disorder, and other mental illness in the veteran population presents unique public health and social justice challenges. Veteran involvement in the justice system has been identified as a national concern. Criminal justice involvement compounds pre-existing socioeconomic stressors and further strains support systems. The point of contact with the criminal justice system, however, presents an opportunity to establish mental health treatment. This is consistent with the concept of the sequential intercept model that seeks to divert offenders with mental illness from the criminal justice system into treatment. In recent years, many jurisdictions have established veterans treatment courts (VTCs), a type of problem-solving court serving this diversion function for military veterans. This article presents an overview of the problem, the ethical basis for their development, a brief history of the courts, and their potential for success. The Harris County Veterans Court is presented as an example.	[Yerramsetti, Ashok Paparao; Simons, Daniel David; Coonan, Loretta; Stolar, Andrea] Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA; [Coonan, Loretta] Michael E DeBakey VA Med Ctr, Houston, TX USA		Stolar, A (corresponding author), Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA.	stolar@bcm.edu					Blue-Howells JH, 2013, PSYCHOL SERV, V10, P48, DOI 10.1037/a0029652; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Bucher J, 2012, J DRUG EDUC, V42, P267, DOI 10.2190/DE.42.3.b; Cartwright T, 2011, STANFORD LAW AND POL, V22, P295; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; Deen TL, 2012, PSYCHIAT SERV, V63, P1131, DOI 10.1176/appi.ps.201100458; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Grey BJ, 2012, CARDOZO L REV, V34, P53; Hamblen J. L., 2016, PTSD SUBSTANCE USE D; Hartwell SW, 2014, PROF PSYCHOL-RES PR, V45, P425, DOI 10.1037/a0037725; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Holbrook JG, 2011, WIDENER LAW SCH LEGA, V25, P1; Johnson RS, 2016, COMMUNITY MENT HLT J, V52, P180, DOI 10.1007/s10597-015-9972-3; Johnson RS, 2015, J AM ACAD PSYCHIATRY, V43, P171; Johnson RS, 2015, B MENNINGER CLIN, V79, P166, DOI 10.1521/bumc.2015.79.2.166; Justice for Vets, VOL VET MENT; Justice for Vets, VET TREATM COURT LOC; Justice for Vets, VET TREATM COURT STU; Justice for Vets, VET TREATM COURT PLA; Knudsen KJ, 2016, COMMUNITY MENT HLT J, V52, P127, DOI 10.1007/s10597-015-9845-9; Little G., 2013, WINN INV WAR MRT WOR; McCormick-Goodhart Mark A., 2012, PENN STATE LAW REV, V117, P895; Miller MW, 2013, J ANXIETY DISORD, V27, P240, DOI 10.1016/j.janxdis.2013.02.005; Mitchell O, 2012, J CRIM JUST, V40, P60, DOI 10.1016/j.jcrimjus.2011.11.009; Najavits L., 2002, SEEKING SAFETY TREAT; National Institute of Justice, 2017, DRUGS CRIME RES PROJ; National Institute of Justice, 2017, DURG COURTS; Oh H, 2017, PSYCHIAT SERV, V68, P424, DOI 10.1176/appi.ps.201600564; Pietrzak RH, 2011, J ANXIETY DISORD, V25, P456, DOI 10.1016/j.janxdis.2010.11.010; Pinals DA, 2010, J AM ACAD PSYCHIATRY, V38, P163; Prins SJ, 2014, PSYCHIAT SERV, V65, P862, DOI 10.1176/appi.ps.201300166; Russell R. T., 2009, N E J CRIM CIV CONF, V35, P357; Sarteschi CM, 2011, J CRIM JUST, V39, P12, DOI 10.1016/j.jcrimjus.2010.11.003; SCHLENGER WE, 1992, J TRAUMA STRESS, V5, P333, DOI 10.1002/jts.2490050303; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Seamone CER, 2009, MIL LAW REV, V202, P144; Shevory K., 2011, ATLANTIC WHY VETERAN; Sirotich F, 2009, J AM ACAD PSYCHIATRY, V37, P461; Snell C. D., 2015, J FAMILY STRENGTHS, V15; Swartz Mimi, 2010, TEXAS MONTHLY; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Timko C, 2014, J OFFENDER REHABIL, V53, P620, DOI 10.1080/10509674.2014.956964; Tsai J, 2017, PSYCHIAT SERV, V68, P375, DOI 10.1176/appi.ps.201600233; Tsai J, 2017, PSYCHIAT SERV, V68, P321, DOI 10.1176/appi.ps.201600486; Tsai J, 2015, EPIDEMIOL REV, V37, P177, DOI 10.1093/epirev/mxu004; Wan CR, 2014, PSYCHIAT SERV, V65, P758, DOI 10.1176/appi.ps.201300206; Weiss D. C., 2009, AM BAR ASS J; Williamson V., 2009, IRAQ AFGHANISTAN VET; Wolff N, 2012, INT J ENV RES PUB HE, V9, P1908, DOI 10.3390/ijerph9051908; Wortzel HS, 2013, BEHAV SCI LAW, V31, P721, DOI 10.1002/bsl.2079; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Wortzel HS, 2010, J AM ACAD PSYCHIATRY, V38, P407	53	6	6	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	SEP-DEC	2017	35	5-6			SI		512	522		10.1002/bsl.2308			11	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	FQ9BU	WOS:000418658200013	28913894				2022-02-06	
J	Zhang, J; Huang, P; Wang, ZY; Dong, HM				Zhang, Ji; Huang, Ping; Wang, Zhenyuan; Dong, Hongmei			Application of FTIR spectroscopy for traumatic axonal injury: a possible tool for estimating injury interval	BIOSCIENCE REPORTS			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSFORM INFRARED MICROSPECTROSCOPY; MEDIATED CYTOSKELETAL DEGRADATION; DIFFUSE BRAIN INJURY; CLOSED-HEAD-INJURY; IR SPECTROSCOPY; BIOCHEMICAL-CHANGES; UNMYELINATED AXONS; CORPUS-CALLOSUM; RATS	Traumatic axonal injury (TAI) is a progressive and secondary injury following traumatic brain injury (TBI). Despite extensive investigations in the field of forensic science and neurology, no effective methods are available to estimate TAI interval between injury and death. In the present study, Fourier transform IR (FTIR) spectroscopy with IR microscopy was applied to collect IR spectra in the corpus callosum (CC) of rats subjected to TAI at 12, 24, and 72 h post-injury compared with control animals. The classification amongst different groups was visualized based on the acquired dataset using hierarchical cluster analysis (HCA) and partial least square (PLS). Furthermore, the established PLS models were used to predict injury interval of TAI in the unknown sample dataset. The results showed that samples at different time points post-injury were distinguishable from each other, and biochemical changes in protein, lipid, and carbohydrate contributed to the differences. Then, the established PLS models provided a satisfactory prediction of injury periods between different sample groups in the external validation. The present study demonstrated the great potential of FTIR-based PLS algorithm as an objective tool for estimating injury intervals of TAI in the field of forensic science and neurology.	[Zhang, Ji; Huang, Ping] Minist Justice, Shanghai Key Lab Forens Med, Inst Forens Sci, Shanghai 200063, Peoples R China; [Zhang, Ji; Wang, Zhenyuan] Xi An Jiao Tong Univ, Dept Forens Pathol, Coll Forens Med, Xian 710061, Shaanxi, Peoples R China; [Dong, Hongmei] Huazhong Univ Sci & Technol, Dept Forens Med, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China		Wang, ZY (corresponding author), Xi An Jiao Tong Univ, Dept Forens Pathol, Coll Forens Med, Xian 710061, Shaanxi, Peoples R China.; Dong, HM (corresponding author), Huazhong Univ Sci & Technol, Dept Forens Med, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.	wzy218@xjtu.edu.cn; hongmeidong1@hotmail.com	Huang, Ping/L-1193-2019; wang, zhenyuan/AAB-4874-2021		National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273335, 81471819, 81471821, 81671869, 81273339]; China Postdoctoral Science Foundation GrantChina Postdoctoral Science Foundation [2016M592801]	This work was supported by the National Science Foundation of China [grant numbers 81273335, 81471819, 81471821,81671869,81273339]; and the China Postdoctoral Science Foundation Grant [grant number 2016M592801].	Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Beljebbar A, 2008, ANAL CHEM, V80, P8406, DOI 10.1021/ac800990y; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Caine S, 2012, NEUROIMAGE, V59, P3624, DOI 10.1016/j.neuroimage.2011.11.033; Cakmak G, 2012, ARCH BIOCHEM BIOPHYS, V520, P67, DOI 10.1016/j.abb.2012.02.012; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dudala J, 2016, POL J PATHOL, V67, P60, DOI 10.5114/PJP.2016.59221; Faolain EO, 2005, J HISTOCHEM CYTOCHEM, V53, P121, DOI 10.1177/002215540505300114; Finnie JW, 2016, VET PATHOL, V53, P962, DOI 10.1177/0300985815612155; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Gajjar K, 2013, ANALYST, V138, P3917, DOI 10.1039/c3an36654e; Gasper R, 2009, BBA-BIOMEMBRANES, V1788, P1263, DOI 10.1016/j.bbamem.2009.02.016; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Hackett MJ, 2016, ANAL CHEM, V88, P10949, DOI 10.1021/acs.analchem.6b02588; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Heraud P, 2010, NEUROIMAGE, V49, P1180, DOI 10.1016/j.neuroimage.2009.09.053; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Khoshmanesh A, 2014, ANAL CHEM, V86, P4379, DOI 10.1021/ac500199x; Kneipp J, 2000, BBA-MOL BASIS DIS, V1501, P189, DOI 10.1016/S0925-4439(00)00021-1; Kos G, 2004, ANAL BIOANAL CHEM, V378, P159, DOI 10.1007/s00216-003-2245-y; Leskovjan AC, 2010, ANAL CHEM, V82, P2711, DOI 10.1021/ac1002728; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Lou M, 2007, NEUROSCIENCE, V146, P555, DOI 10.1016/j.neuroscience.2007.01.046; Lu R, 2015, ANALYST, V140, P765, DOI 10.1039/c4an01495b; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Mistek E, 2015, ANAL BIOANAL CHEM, V407, P7435, DOI 10.1007/s00216-015-8909-6; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Muehlethaler C, 2014, FORENSIC SCI INT, V244, P170, DOI 10.1016/j.forsciint.2014.08.038; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Peng CY, 2015, ANALYST, V140, P1107, DOI 10.1039/c4an01679c; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Stone N, 2004, FARADAY DISCUSS, V126, P141, DOI 10.1039/b304992b; Yang TT, 2014, J FORENSIC SCI, V59, P231, DOI 10.1111/1556-4029.12290; Zhang J, 2017, SPECTROCHIM ACTA A, V173, P733, DOI 10.1016/j.saa.2016.10.041; Zhang J, 2015, J FORENSIC SCI, V60, P1488, DOI 10.1111/1556-4029.12871; Zhang J, 2015, J FORENSIC SCI, V60, P759, DOI 10.1111/1556-4029.12743	49	6	6	0	3	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0144-8463	1573-4935		BIOSCIENCE REP	Biosci. Rep.	AUG 31	2017	37		4						BSR20170720	10.1042/BSR20170720			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FH6WU	WOS:000411322000042		Green Published, gold			2022-02-06	
J	Sick, T; Wasserman, J; Bregy, A; Sick, J; Dietrich, WD; Bramlett, HM				Sick, Thomas; Wasserman, Joseph; Bregy, Amade; Sick, Justin; Dietrich, W. Dalton; Bramlett, Helen M.			Increased Expression of Epileptiform Spike/Wave Discharges One Year after Mild, Moderate, or Severe Fluid Percussion Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						electrocorticogram; electroencephalogram; epilepsy; fluid percussion; nonconvulsive seizures; spike wave discharges; traumatic brain injury	SPRAGUE-DAWLEY RATS; POSTTRAUMATIC EPILEPSY; ANIMAL-MODELS; ABSENCE EPILEPSY; WAVE DISCHARGES; SEIZURES; EPILEPTOGENESIS; IMPACT; COMMON	In this study, we describe increased expression of cortical epileptiform spike/wave discharges (SWD) in rats one year after mild, moderate, or severe fluid percussion traumatic brain injury (fpTBI). Groups of rats consisted of animals that had received mild, moderate, or severe fpTBI, or sham operation one year earlier than electrocorticography (ECoG) recordings. In addition, we included a group of age-matched naive animals. ECoG was recorded from awake animals using epidural electrodes implanted on the injured hemisphere (right), sham-operated hemisphere (right), or right hemisphere in naive animals. The SWDs were detected automatically using Fast Fourier Transformation and a novel algorithm for comparing changes in spectral power to control (nonepileptical) ECoG. The fpTBI resulted in increased expression of SWDs one year after injury compared with sham-operated or naive animals. The number of SWD-containing ECoG epochs recorded in a 1 h recording session were: naive 12.9 - 10.3, n = 8, sham 23.6 - 8.2, n = 10, mild TBI 78.9 - 23.9, n = 10, moderate TBI 61.3 - 32.5, n = 12, severe TBI 72.5 - 28.3, n = 11 (mean - standard error of the mean). Increased expression of SWDs was not related to injury severity. SWDs were observed to a lesser extent even in sham-operated and naive animals. The data indicate that fpTBI exacerbates expression of SWDs in the rat and that this increase may be observed at least one year after injury. As others have discussed, the spontaneous occurrence of these epileptiform events in rodents limits the use of this model for investigations of acquired epilepsy, at least of the nonconvulsive type, after TBI.	[Sick, Thomas; Wasserman, Joseph; Bregy, Amade; Sick, Justin; Dietrich, W. Dalton; Bramlett, Helen M.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Sick, Thomas; Dietrich, W. Dalton; Bramlett, Helen M.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Sick, Thomas; Bramlett, Helen M.] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA; [Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL USA; [Bramlett, Helen M.] Univ Miami, Ctr Computat Sci, Miami, FL USA		Sick, T (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA.	TSick@med.miami.edu			American Heart AssociationAmerican Heart Association [16PRE27050003]; DODUnited States Department of Defense [W81XWH-12-1-0618]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS042133]; Veterans Affairs grantUS Department of Veterans Affairs [BX000521-01]; Miami Project to Cure Paralysis	The authors would like to thank Maura Lapoff for help quantifying behavioral movements and Maria Navarro for help with histological analysis. This work was funded with the support of the American Heart Association Grant # 16PRE27050003, DOD W81XWH-12-1-0618, NIH NS042133, Veterans Affairs grant BX000521-01, and The Miami Project to Cure Paralysis.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; CAVENESS WF, 1976, EPILEPSIA, V17, P207, DOI 10.1111/j.1528-1157.1976.tb03398.x; COENEN AML, 1987, EPILEPSY RES, V1, P297, DOI 10.1016/0920-1211(87)90005-2; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Ding MC, 2008, NEUROSCIENCE, V154, P551, DOI 10.1016/j.neuroscience.2008.03.088; Eslami M, 2016, NEUROL RES, V38, P269, DOI 10.1179/1743132815Y.0000000086; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Kelly KM, 2006, EXP NEUROL, V201, P495, DOI 10.1016/j.expneurol.2006.05.006; Kelly Kevin M, 2004, Epilepsy Curr, V4, P176, DOI 10.1111/j.1535-7597.2004.04503.x; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; Lu XCM, 2013, J NEUROTRAUM, V30, P580, DOI 10.1089/neu.2012.2641; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; McGuire L.S., 2015, BRAIN NEUROTRAUMA MO; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Sick J, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-12; Sitnikova E, 2010, EPILEPSY RES, V89, P17, DOI 10.1016/j.eplepsyres.2009.09.005; van Luijtelaar G, 2006, NEUROSCI BIOBEHAV R, V30, P983, DOI 10.1016/j.neubiorev.2006.03.002; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wilson DA, 2014, EPILEPSY BEHAV, V32, P42, DOI 10.1016/j.yebeh.2013.12.035	32	6	6	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2467	2474		10.1089/neu.2016.4826			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400009	28388862	Green Published			2022-02-06	
J	Del Rossi, G				Del Rossi, Gianluca			Evaluating the Recovery Curve for Clinically Assessed Reaction Time After Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						ruler-drop test; mild traumatic brain injuries; neurocognitive function	HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; SPORTS CONCUSSION; RELIABILITY; MOTIVATION; MANAGEMENT; STATEMENT	Context: A change in reaction time is one of various clinical measures of neurocognitive function that can be monitored after concussion and has been reported to be among the most sensitive indicators of cognitive impairment. Objective: To determine the timeline for clinically assessed simple reaction time to return to baseline after a concussion in high school athletes. Design: Observational study. Setting: Athletic training room. Patients or Other Participants: Twenty-one high school-aged volunteers. Intervention(s): Participants completed 8 trials of the ruler-drop test during each session. Along with baseline measures, a total of 6 additional test sessions were completed over the course of 4 weeks after a concussion (days 3, 7, 10, 14, 21, and 28). Main Outcome Measure(s): The mean reaction times calculated for all participants from each of the 7 test sessions were analyzed to assess the change in reaction time over the 7 time intervals. Results: After a concussion and compared with baseline, simple reaction time was, on average, 26 milliseconds slower at 48 to 72 hours postinjury (P < .001), almost 18 milliseconds slower on day 7 (P < .001), and about 9 milliseconds slower on day 10 (P < .001). Simple reaction time did not return to baseline levels until day 14 postinjury. Conclusions: Clinically assessed simple reaction time appeared to return to baseline levels within a timeframe that mirrors other measures of cognitive performance (approximately 14 days).	[Del Rossi, Gianluca] Univ S Florida, 13220 USF Laurel Dr MDF 5117,Mail Code MDC 106, Tampa, FL 33612 USA		Del Rossi, G (corresponding author), Univ S Florida, 13220 USF Laurel Dr MDF 5117,Mail Code MDC 106, Tampa, FL 33612 USA.	gdelross@health.usf.edu	Del Rossi, Gianluca/AAR-5000-2020				Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Del Rossi G, 2014, J ATHL TRAINING, V49, P356, DOI 10.4085/1062-6059-49.2.04; Eckner JT, 2015, PERCEPT MOTOR SKILL, V120, P841, DOI 10.2466/25.15.PMS.120v19x6; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; MacDonald J, 2015, CLIN J SPORT MED, V25, P43, DOI 10.1097/JSM.0000000000000096; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Udermann BE, 2004, PERCEPT MOTOR SKILL, V98, P409; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Zuckerman SL, 2012, NEUROSURG FOCUS, V33	24	6	6	4	19	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2017	52	8					766	770		10.4085/1062-6050-52.6.02			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FF5ZN	WOS:000409081500006	28722468	Green Published, Bronze			2022-02-06	
J	Gunia-Krzyzak, A; Zeslawska, E; Bareyre, FM; Nitek, W; Waszkielewicz, AM; Marona, H				Gunia-Krzyzak, Agnieszka; Zeslawska, Ewa; Bareyre, Florence M.; Nitek, Wojciech; Waszkielewicz, Anna M.; Marona, Henryk			Physicochemical and biological evaluation of a cinnamamide derivative R,S-(2E)-1-(3-hydroxypiperidin-1-yl)-3-phenylprop-2-en-1-one (KM-608) for nervous system disorders	CHEMICAL BIOLOGY & DRUG DESIGN			English	Article						anticonvulsant; antiepileptogenic; cinnamamide; traumatic brain injury	SEIZURES; EPILEPSY; MODEL; ANTICONVULSANTS; POLYMORPHISM; DISCOVERY; VALPROATE; MICE	A cinnamamide scaffold has been successfully incorporated in several compounds possessing desirable pharmacological activities in central and peripheral nervous system such as anticonvulsant, antidepressant, neuroprotective, analgesic, anti-inflammatory, muscle relaxant, and sedative/hypnotic properties. R,S-(2E)-1-(3-hydroxypiperidin-1-yl)-3-phenylprop-2-en-1-one (KM-608), a cinnamamide derivative, was synthesized, its chemical structure was confirmed by means of spectroscopy and crystallography, and additionally, thermal analysis showed that it exists in one crystalline form. The compound was evaluated in vivo in rodents as anticonvulsant, antiepileptogenic, analgesic, and neuroprotective agent. The beneficial properties of the compound were found in animal models of seizures evoked electrically (maximal electroshock test, 6-Hz) and chemically (subcutaneous pentylenetetrazole seizure test) as well as in three animal models of epileptogenesis: corneal-kindled mice, hippocampal-kindled rats, and lamotrigine-resistant amygdala-kindled rats. Quantitative pharmacological parameters calculated for the tested compound were comparable to those of currently used antiepileptic drugs. In vivo pharmacological profile of KM-608 corresponds with the activity of valproic acid.	[Gunia-Krzyzak, Agnieszka; Waszkielewicz, Anna M.; Marona, Henryk] Jagiellonian Univ, Coll Med, Fac Pharm, Chair Organ Chem,Dept Bioorgan Chem, Krakow, Poland; [Zeslawska, Ewa] Pedag Univ, Inst Biol, Dept Chem, Krakow, Poland; [Bareyre, Florence M.] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, Hosp & Biomed Ctr BMC, Munich, Germany; [Bareyre, Florence M.] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Nitek, Wojciech] Jagiellonian Univ, Fac Chem, Krakow, Poland		Gunia-Krzyzak, A (corresponding author), Jagiellonian Univ, Coll Med, Fac Pharm, Chair Organ Chem,Dept Bioorgan Chem, Krakow, Poland.	agnieszka.gunia@uj.edu.pl	Nitek, Wojciech/D-7317-2014	Nitek, Wojciech/0000-0002-0276-9003; Waszkielewicz, Anna/0000-0002-2871-9418; Marona, Henryk/0000-0002-3815-4174; Gunia-Krzyzak, Agnieszka/0000-0003-4162-4760	Jagiellonian University Medical College [K/ZDS/005487, K/DSC/001954]; European Regional Development Fund through the Innovative Economy Operational Program [POIG.01.01.02-12-012/09-00, POIG.02.01.00-12-023/08]; Pedagogical University in Krakow; Foundation for Polish ScienceFoundation for Polish ScienceEuropean Commission; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [SFB 870]; Munich Center for Neurosciences (MCN); Wings for Life foundation; Munich Center for Systems Neurology (DFG)German Research Foundation (DFG) [EXC 1010]	Jagiellonian University Medical College, Grant Number: K/ZDS/005487 and K/DSC/001954; European Regional Development Fund through the Innovative Economy Operational Program, Grant Number: POIG.01.01.02-12-012/09-00 and POIG.02.01.00-12-023/08; Pedagogical University in Krakow; Foundation for Polish Science; Deutsche Forschungsgemeinschaft (DFG, SFB 870); Munich Center for Neurosciences (MCN); Wings for Life foundation; Munich Center for Systems Neurology (DFG, SyNergy; EXC 1010)	Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Beczkowicz H, 2006, PRZEM CHEM, V85, P354; Bialer M, 2010, NAT REV DRUG DISCOV, V9, P68, DOI 10.1038/nrd2997; Brodie MJ, 2001, EPILEPSIA, V42, P27, DOI 10.1046/j.1528-1157.2001.042suppl.3027.x; Capone Francesca, 2004, Ann Ist Super Sanita, V40, P223; Chen S, 2014, NEUROCHEM RES, V39, P1621, DOI 10.1007/s11064-014-1241-2; Dimmock JR, 2004, J ENZYM INHIB MED CH, V19, P303, DOI 10.1080/14756360409162442; Farrugia LJ, 2012, J APPL CRYSTALLOGR, V45, P849, DOI 10.1107/S0021889812029111; Giron D, 2001, J THERM ANAL CALORIM, V64, P37, DOI 10.1023/A:1011572610005; Gunia-Krzyzak A, 2016, EUR J MED CHEM, V107, P26, DOI 10.1016/j.ejmech.2015.10.051; Gunia-Krzyzak A, 2015, CHEMMEDCHEM, V10, P1302, DOI 10.1002/cmdc.201500153; Holmes GL, 2007, NEUROLOGY, V69, pS28, DOI 10.1212/01.wnl.0000302369.24230.c6; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Li R.-l., 1995, QSAR DRUG DESIGN NEW, P321; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; LOTHMAN EW, 1988, EPILEPSY RES, V2, P367, DOI 10.1016/0920-1211(88)90048-4; Macrae CF, 2006, J APPL CRYSTALLOGR, V39, P453, DOI 10.1107/S0021 88980600731X; Matagne A, 1998, EPILEPSY RES, V31, P59, DOI 10.1016/S0920-1211(98)00016-3; Meldrum BS., 2002, ANTIEPILEPTIC DRUGS, P36; Perucca E, 2007, LANCET NEUROL, V6, P793, DOI 10.1016/S1474-4422(07)70215-6; Postma T, 2000, EPILEPSIA, V41, P1514; Purohit R, 2009, RESONANCE, V14, P882, DOI 10.1007/s12045-009-0084-7; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rowley NM, 2010, EPILEPSY RES, V92, P163, DOI 10.1016/j.eplepsyres.2010.09.002; Schnitzler E., 2002, EXACT SOIL SCI AGRAR, V8, P91; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Srivastava AK, 2013, EPILEPSY RES, V104, P26, DOI 10.1016/j.eplepsyres.2012.10.003; Stables JP, 1997, CURR PROB E, V12, P191; WANG L, 1993, EPILEPSY RES, V15, P1, DOI 10.1016/0920-1211(93)90002-O; Waszkielewicz AM, 2011, CURR MED CHEM, V18, P4344; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135	35	6	6	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-0277	1747-0285		CHEM BIOL DRUG DES	Chem. Biol. Drug Des.	AUG	2017	90	2					244	253		10.1111/cbdd.12943			10	Biochemistry & Molecular Biology; Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	FA0EA	WOS:000405102900008	28097810				2022-02-06	
J	Khan, AD; Elseth, AJ; Head, B; Rostas, J; Dunn, JA; Schroeppel, TJ; Gonzalez, RP				Khan, Abid D.; Elseth, Anna J.; Head, Brian; Rostas, Jack; Dunn, Julie A.; Schroeppel, Thomas J.; Gonzalez, Richard P.			Indicators of Survival and Favorable Functional Outcomes after Decompressive Craniectomy: A Multi-Institutional Retrospective Study	AMERICAN SURGEON			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; IMPACT	The role of decompressive craniectomy (DC) for severe traumatic brain injury (STBI) remains controversial. The purpose of this study was to identify factors that are indicators of survival and improved functional outcome in patients who undergo DC for STBI. A retrospective review of STBI patients who underwent DC was performed at four trauma centers during a 45-month period. Data collected included age, gender, mechanism of injury, Injury Severity Score (ISS), admission Glasgow Coma Scale (GCS), time from admission to DC, mortality, and extended Glasgow Outcome Score before discharge. Sixty-nine STBI patients were treated with DC during the study period. A higher initial GCS, lower ISS, and longer time to DC were all statistically significant for improved survival after DC. A younger age, higher initial GCS, and lower ISS were all statistically significant for a favorable functional outcome after DC. Patients with a higher initial GCS and lower ISS are more likely to survive DC and have a favorable functional outcome, whereas a longer time to DC was indicative of improved survival after DC.	[Khan, Abid D.; Elseth, Anna J.; Schroeppel, Thomas J.] Univ Colorado Hlth, Mem Hosp, Dept Trauma & Acute Care Surg, Colorado Springs, CO 80909 USA; [Head, Brian; Rostas, Jack] Univ S Alabama, Dept Surg, Div Trauma Burn Surg Crit Care & Acute Care Surg, Mobile, AL USA; [Dunn, Julie A.] Med Ctr Rockies, Dept Trauma & Acute Care Surg, Ft Collins, CO USA; [Gonzalez, Richard P.] Loyola Univ, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, Maywood, IL 60153 USA		Khan, AD (corresponding author), Univ Colorado Hlth, 1400 E Boulder Suite 600, Colorado Springs, CO 80909 USA.	adkhan@gmail.com	Elseth, Anna/AAW-4542-2020	Schroeppel, Thomas/0000-0001-9164-5004; Khan, Abid/0000-0002-1533-4578; Elseth, Anna/0000-0002-2344-7468			Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS55, DOI DOI 10.1089/NEU.2007.9988; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2011, BRIT J NEUROSURG, V25, P441, DOI 10.3109/02688697.2011.583366; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wen L, 2011, BRAIN INJURY, V25, P1318, DOI 10.3109/02699052.2011.608214; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4	26	6	6	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	AUG	2017	83	8					836	841					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FE5PH	WOS:000408262900032	28822387				2022-02-06	
J	O'Connor, KL; Peeters, T; Szymanski, S; Broglio, SP				O'Connor, Kathryn L.; Peeters, Thomas; Szymanski, Stefan; Broglio, Steven P.			Individual Impact Magnitude vs. Cumulative Magnitude for Estimating Concussion Odds	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Head impact; Concussion; Biomechanics	HIGH-SCHOOL; FOOTBALL PLAYERS; EXPOSURE; COLLEGIATE; SPORT	Helmeted impact devices have allowed researchers to investigate the biomechanics of head impacts in vivo. While increased impact magnitude has been associated with greater concussion risk, a definitive concussive threshold has not been established. It is likely that concussion risk is not determined by a single impact itself, but a host of predisposing factors. These factors may include genetics, fatigue, and/or prior head impact exposure. The objective of the current paper is to investigate the association between cumulative head impact magnitude and concussion risk. It is hypothesized that increased cumulative magnitudes will be associated with greater concussion risk. This retrospective analysis included participants that were recruited from regional high-schools in Illinois and Michigan from 2007 to 2014 as part of an ongoing study on concussion biomechanics. Across seven seasons, 185 high school football athletes were instrumented with the Head Impact Telemetry system. Out of 185 athletes, 31 (17%) sustained a concussion, with two athletes sustaining two concussions over the study period, yielding 33 concussive events. The system recorded 78,204 impacts for all concussed players. Linear acceleration, rotational acceleration, and head impact telemetry severity profile (HITsp) magnitudes were summed within five timeframes: the day of injury, three days prior to injury, seven days prior to injury, 30 days prior to injury, and prior in-season exposure. Logistic regressions were modeled to explain concussive events based on the singular linear acceleration, rotational acceleration, and HITsp event along with the calculated summations over time. Linear acceleration, rotational acceleration, and HITsp all produced significant models estimating concussion (p < 0.05). The strongest estimators of a concussive impact were the linear acceleration (OR = 1.040, p < 0.05), rotational acceleration (OR = 1.001, p < 0.05), and HITsp (OR = 1.003, p < 0.05) for the singular impact rather than any of the cumulative magnitude calculations. Moreover, no cumulative count measure was significant for linear or rotational acceleration. Results from this investigation support the growing literature indicating cumulative magnitude is not related to concussion likelihood. Cumulative magnitude is a simplistic measure of the total exposure sustained by a player over a given period. However, this measure is limited as it assumes the brain is a static structure unable to undergo self-repair. Future research should consider how biological recovery between impacts may influence concussion risk.	[O'Connor, Kathryn L.] Univ Michigan, Sch Kinesiol, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Peeters, Thomas] Erasmus Sch Econ, Postbus 1738, NL-3000 DR Rotterdam, Netherlands; [Szymanski, Stefan] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Injury Ctr, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA		O'Connor, KL (corresponding author), Univ Michigan, Sch Kinesiol, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA.	kloconn@umich.edu; peeters@ese.eur.nl; stefansz@umich.edu; broglio@umich.edu	Peeters, Thomas/AAS-4510-2021	Peeters, Thomas/0000-0001-8507-5164; Van Pelt, Kathryn/0000-0002-5494-2357	National Institutes of Health: National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS081691-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS081691] Funding Source: NIH RePORTER	The authors would like to acknowledge the assistance of Dr's Douglas Martini and Richelle Williams along with the coaches, players, and staff of Unity High School (Tolono, IL), Skyline High School (Ann Arbor, MI), and Father Gabriel Richard High School (Ann Arbor, MI). This investigation was funded by the National Institutes of Health: National Institute of Neurological Disorders and Stroke (1R15NS081691-01).	Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Funk J. R., 2007, BIOMECHANICAL RISK E; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kelly JP, 1997, NEUROLOGY, V48, P581; King A. I, 2003, IS HEAD INJURY CAUSE; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; National Federation of State High School Associations, 2015, NFHS HDB; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z	27	6	6	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	AUG	2017	45	8					1985	1992		10.1007/s10439-017-1843-3			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FB7VW	WOS:000406349100014	28455786				2022-02-06	
J	Orinx, C; Legros, B; Gaspard, N				Orinx, Cindy; Legros, Benjamin; Gaspard, Nicolas			Recent antiseizure medications in the Intensive Care Unit	MINERVA ANESTESIOLOGICA			English	Article						Seizures; Status epilepticus; Pharmacokinetics; Critical care; Intensive Care Units; Lacosamide	AUGMENTED RENAL CLEARANCE; CONTINUOUS VENOVENOUS HEMOFILTRATION; REFRACTORY STATUS EPILEPTICUS; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; LEVETIRACETAM PHARMACOKINETICS; ANTIEPILEPTIC DRUGS; REPLACEMENT THERAPY; PHENYTOIN; BRIVARACETAM	BACKGROUND: Seizures and status epilepticus (SE), both clinical and subclinical, are frequent in critically ill patients. The list of available antiseizure medications (ASMs) is expanding and now includes older and widely used drugs as well as more recent medications with a better safety and pharmacokinetics profile. METHODS: We review a selection of recent publications about the indications and administration of ASMs in critical care for the prophylaxis and treatment of seizures and SE, focusing on recent ASMs available as intravenous formulation and emphasizing pharmacokinetics and safety issues in relation to several aspects of critical illness. RESULTS : Levetiracetam, lacosamide and more recently brivaracetam, represent interesting alternatives to older ASMs, mostly due to a more favorable safety and pharmacokinetic profile. Low-quality studies suggest that this profile results in better tolerability in treated patients. Ketamine might represent a useful addition in our anesthetic armamentarium for refractory SE, due to its different mechanism of action and cardiovascular properties. Little evidence is available however to support the prophylactic use of ASMs in critically ill patients, except in specific settings (traumatic brain injury and subarachnoid hemorrhage). Head-to-head studies comparing recent and older ASMs in the treatment of acute seizures and SE are ongoing or awaiting publication. Administration of ASMs to critically ill patients needs to be adapted to organ dysfunction, and especially to renal dysfunction for recent drugs. CONCLUSIONS: Recent ASMs and could represent better treatment choices in critically ill patients than older ones but this needs to be confirmed in randomized controlled studies. In general, further studies are required to clarify the indications and optimal use of ASMs in the critical care setting.	[Orinx, Cindy; Legros, Benjamin; Gaspard, Nicolas] Univ Libre Bruxelles, Dept Neurol, Erasme Hosp, Route Lennik 808, B-1070 Brussels, Belgium		Gaspard, N (corresponding author), Univ Libre Bruxelles, Dept Neurol, Erasme Hosp, Route Lennik 808, B-1070 Brussels, Belgium.	nicolas.gaspard@erasme.ulb.ac.be					Bansal S, 2014, J NEUROSURG-PEDIATR, V13, P209, DOI 10.3171/2013.10.PEDS13256; Bellante F, 2016, J NEUROL, V1, P1; Beydoun A, 2009, EXPERT REV NEUROTHER, V9, P33, DOI 10.1586/14737175.9.1.33; Bleck T, 2013, EPILEPSIA, V54, P89, DOI 10.1111/epi.12288; BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; Brandt C, 2016, THER ADV NEUROL DISO, V9, P474, DOI 10.1177/1756285616665564; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Cawello W, 2013, CLIN PHARMACOKINET, V52, P897, DOI 10.1007/s40262-013-0080-7; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cook AM, 2013, NEUROCRIT CARE, V19, P210, DOI 10.1007/s12028-013-9837-y; De Paepe P, 2002, CLIN PHARMACOKINET, V41, P1135, DOI 10.2165/00003088-200241140-00002; DeWolfe JL, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00121; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Erstad BL, 2016, J CRIT CARE, V35, P145, DOI 10.1016/j.jcrc.2016.05.016; Fernandez A, 2014, NEUROLOGY, V82, P359, DOI 10.1212/WNL.0000000000000054; French J, 2001, EPILEPSIA, V42, P40, DOI 10.1046/j.1528-1157.2001.0420s4040.x; Gaspard N, 2013, EPILEPSIA, V54, P1498, DOI 10.1111/epi.12247; Gilmore EJ, 2015, INTENS CARE MED, V41, P686, DOI 10.1007/s00134-015-3709-1; Hobbs ALV, 2015, PHARMACOTHERAPY, V35, P1063, DOI 10.1002/phar.1653; Hofler J, 2016, CNS DRUGS, V30, P869, DOI 10.1007/s40263-016-0371-2; Hofler J, 2013, EPILEPSIA, V54, P393, DOI 10.1111/epi.12058; Hovinga CA, 2001, PHARMACOTHERAPY, V21, P1375, DOI 10.1592/phco.21.17.1375.34432; Husain AM, 2015, EPILEPSY BEHAV, V49, P337, DOI 10.1016/j.yebeh.2015.06.018; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Johannessen SI, 2006, CLIN PHARMACOKINET, V45, P1061, DOI 10.2165/00003088-200645110-00002; Karamchandani RR, 2014, J CLIN NEUROSCI, V21, P1507, DOI 10.1016/j.jocn.2014.03.009; Kiang TKL, 2016, ANN PHARMACOTHER, V50, P311, DOI 10.1177/1060028016628166; Klein P, 2016, EPILEPSIA, V57, P1130, DOI 10.1111/epi.13409; KNAUS WA, 1981, NEUROSURGERY, V8, P438, DOI 10.1227/00006123-198104000-00006; Loh GW, 2010, CURR OPIN CRIT CARE, V16, P128, DOI 10.1097/MCC.0b013e3283374e3c; Louie JM, 2015, ANN PHARMACOTHER, V49, P1079, DOI 10.1177/1060028015591845; Mahmoud SH, 2017, CLIN DRUG INVEST, V37, P7, DOI 10.1007/s40261-016-0457-0; May CC, 2015, NEUROCRIT CARE, V23, P374, DOI 10.1007/s12028-015-0127-8; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Naylor DE, 2013, NEUROBIOL DIS, V54, P225, DOI 10.1016/j.nbd.2012.12.015; Naylor DE, 2005, EPILEPSIA, V46, P142, DOI 10.1111/j.1528-1167.2005.01022.x; Nei SD, 2015, PHARMACOTHERAPY, V35, pe127, DOI 10.1002/phar.1615; New AM, 2016, NEUROCRIT CARE, V25, P141, DOI 10.1007/s12028-016-0242-1; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Radic JAE, 2014, NEUROCRIT CARE, V21, P228, DOI 10.1007/s12028-013-9951-x; Rudd GD, 2015, ACTA NEUROL SCAND, V132, P355, DOI 10.1111/ane.12414; Sargentini-Maier ML, 2012, J CLIN PHARMACOL, V52, P1927, DOI 10.1177/0091270011431457; Schulze-Bonhage A, 2011, EXPERT OPIN PHARMACO, V12, P1959, DOI 10.1517/14656566.2011.591380; Sen S, 2005, AM J GASTROENTEROL, V100, P468, DOI 10.1111/j.1572-0241.2005.40864.x; Sen S, 2004, INTENS CARE MED, V30, P496, DOI 10.1007/s00134-003-2141-0; Sen S, 2003, EPILEPSIA, V44, P265, DOI 10.1046/j.1528-1157.2003.31402.x; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Smetana KS, 2016, J CRIT CARE, V36, P116, DOI 10.1016/j.jcrc.2016.06.023; Smith Katherine, 2012, Nat Rev Nephrol, V8, P314, DOI 10.1038/nrneph.2012.78; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Thomson SJ, 2009, INTENS CARE MED, V35, P1406, DOI 10.1007/s00134-009-1511-7; Tolwani A, 2012, NEW ENGL J MED, V367, P2505, DOI 10.1056/NEJMct1206045; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Verbeeck RK, 2008, EUR J CLIN PHARMACOL, V64, P1147, DOI 10.1007/s00228-008-0553-z; Wong Gloria, 2014, BMC Infect Dis, V14, P288, DOI 10.1186/1471-2334-14-288; Zimmerman JE, 1998, NEUROSURGERY, V42, P91, DOI 10.1097/00006123-199801000-00019	58	6	6	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	AUG	2017	83	8					878	887		10.23736/S0375-9393.17.11884-5			10	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	FK1KD	WOS:000413238800014	28492297				2022-02-06	
J	Rosi, J; Welling, LC; Schafranski, M; Yeng, LT; do Prado, RR; Koterba, E; de Andrade, AF; Teixeira, MJ; Figueiredo, EG				Rosi Junior, Jefferson; Welling, Leonardo C.; Schafranski, Marcelo; Yeng, Lin Tchia; do Prado, Rogerio Ruscito; Koterba, Edwin; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Figueiredo, Eberval Gadelha			Prognostic model for patients with traumatic brain injuries and abnormal computed tomography scans	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Brain injury; Prognostic; Survival	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; MOTOR SCORE; OUTCOME PREDICTION; CLASSIFICATION; VALIDATION; DISABILITY; MORTALITY; MODERATE; DEATH	Traumatic brain injury (TBI) is an important cause of death and disability worldwide. The prognosis evaluation is a challenge when many variables are involved. The authors aimed to develop prognostic model for assessment of survival chances after TBI based on admission characteristics, including extracranial injuries, which would allow application of the model before in-hospital therapeutic interventions. A cohort study evaluated 1275 patients with TBI and abnormal CT scans upon admission to the emergency unit of Hospital das Clinicas of University of Sao Paulo and analyzed the final outcome on mortality. A logistic regression analysis was undertaken to determine the adjusted weigh of each independent variable in the outcome. Four variables were found to be significant in the model: age (years), Glasgow Coma Scale (3-15), Marshall Scale (MS, stratified into 2,3 or 4,5,6; according to the best group positive predictive value) and anysochoria (yes/no). The following formula is in a logistic model (USP index to head injury) estimates the probability of death of patients according to characteristics that influence on mortality. We consider that our mathematical probability model (USP Index) may be applied to clinical prognosis in patients with abnormal CT scans after severe traumatic brain injury. (C) 2017 Elsevier Ltd. All rights reserved.	[Rosi Junior, Jefferson; Yeng, Lin Tchia; do Prado, Rogerio Ruscito; Koterba, Edwin; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Figueiredo, Eberval Gadelha] Univ Sao Paulo, Div Neurol Surg, Sao Paulo, Brazil; [Welling, Leonardo C.; Schafranski, Marcelo] Univ Estadual Ponta Grossa, Div Neurol Surg, Rua Tiradentes 976, BR-84010190 Ponta Grossa, Brazil		Welling, LC (corresponding author), Univ Estadual Ponta Grossa, Div Neurol Surg, Rua Tiradentes 976, BR-84010190 Ponta Grossa, Brazil.	jefrosijr@gmail.com; leonardowelling@yahoo.com.br; marceloschafranski@yahoo.com.br; linyeng@gmail.com; ruscittousp@yahoo.com.br; koterba@uol.com.br; lcwelling9@gmail.com; manoeljacobsen@gmail.com; ebgadelha@yahoo.com	Figueiredo, Eberval Gadelha/H-3488-2012; Welling, Leonardo/E-4715-2018	Welling, Leonardo/0000-0001-9987-6819; Schafranski, Marcelo/0000-0002-6731-9564			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caterino JM, 2012, EMERG MED J, V29, P492, DOI 10.1136/emj.2010.110437; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Emami P, 2016, J NEUROSURG, P1; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; JENNETT B, 1976, LANCET, V1, P1031; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mauritz W, 2009, EUR J EMERG MED, V16, P153, DOI 10.1097/MEJ.0b013e32832a0864; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640	40	6	7	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2017	42						122	128		10.1016/j.jocn.2017.03.012			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA6EJ	WOS:000405535800027	28347684				2022-02-06	
J	Shepherd, DJ; Tsai, SY; Cappucci, SP; Wu, JY; Farrer, RG; Kartje, GL				Shepherd, Daniel J.; Tsai, Shih-Yen; Cappucci, Stefanie P.; Wu, Joanna Y.; Farrer, Robert G.; Kartje, Gwendolyn L.			The Subventricular Zone Response to Stroke Is Not a Therapeutic Target of Anti-Nogo-A Immunotherapy	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Immunotherapy; Migration; Neurogenesis; Nogo-A; Proliferation; Stroke; Subventricular zone	CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; CORTICOSPINAL TRACT; ADULT RATS; RECEPTOR 1; NEUROGENESIS; PLASTICITY; MIGRATION; INHIBITION	Ischemic stroke is a leading cause of adult disability with no pharmacological treatments to promote the recovery of lost function. Neutralizing antibodies against the neurite outgrowth inhibitor Nogo-A have emerged as a promising treatment for subacute and chronic stroke in animal models; however, whether anti-Nogo-A treatment affects poststroke neurogenesis remains poorly understood. In this study, we confirmed expression of Nogo-A by neuroblasts in the adult rat subventricular zone (SVZ), a major neurogenic niche; however, we found no evidence that Nogo-A was expressed at the surface of these cells. In vitro migration assays demonstrated that Nogo-A signaling induced a modest reduction in neuroblast migration speed, while anti-Nogo-A antibodies had no effect on motility properties. Using a permanent distal middle cerebral artery occlusion model of cortical stroke, we found that the number of proliferating cells in the SVZ was unaffected in response to stroke, while neuroblast mobilization from the SVZ toward the stroke lesion correlated positively with lesion size. However, we found no evidence that proliferation or neuroblast mobilization were affected by anti-Nogo-A antibody treatment. Our results suggest that the SVZ is not a therapeutic target of anti-Nogo-A immunotherapy, and contribute to our understanding of the SVZ response to cortical stroke.	[Shepherd, Daniel J.; Cappucci, Stefanie P.; Kartje, Gwendolyn L.] Loyola Univ, Div Hlth Sci, Maywood, IL 60153 USA; [Shepherd, Daniel J.; Tsai, Shih-Yen; Cappucci, Stefanie P.; Wu, Joanna Y.; Farrer, Robert G.; Kartje, Gwendolyn L.] Edward Hines Jr Vet Affairs Hosp, Res Serv, Hines, IL USA		Shepherd, DJ (corresponding author), Loyola Univ Chicago, Div Hlth Sci, 2160 S First Ave, Maywood, IL 60161 USA.	djshepherd@luc.edu			US Department of Veterans Affairs Rehabilitation Research and Development serviceUS Department of Veterans Affairs [5I01RX000828]; American Heart AssociationAmerican Heart Association [15PRE24470136]	This study was supported by grant 5I01RX000828 from the US Department of Veterans Affairs Rehabilitation Research and Development service to GLK, and American Heart Association 15PRE24470136 to DJS.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Baldwin KT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00023; Belvindrah R, 2011, J NEUROSCI, V31, P7551, DOI 10.1523/JNEUROSCI.6716-10.2011; Bravo-Ferrer I, 2017, STROKE, V48, P204, DOI 10.1161/STROKEAHA.116.014793; Bye N, 2016, EXP NEUROL, V279, P86, DOI 10.1016/j.expneurol.2016.02.012; Craveiro LM, 2013, EXP NEUROL, V250, P52, DOI 10.1016/j.expneurol.2013.09.015; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gillani RL, 2010, BEHAV BRAIN RES, V208, P415, DOI 10.1016/j.bbr.2009.12.015; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hatakeyama J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1604; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Iketani M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39586; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kimura A, 2008, STROKE, V39, P3411, DOI 10.1161/STROKEAHA.108.514612; Kumar P, 2013, CNS NEUROL DISORD-DR, V12, P200; Kurowska Z, 2014, NEUROSCIENCE, V256, P456, DOI 10.1016/j.neuroscience.2013.10.029; Leong SY, 2011, STEM CELLS, V29, P332, DOI 10.1002/stem.577; Lim D.A, 2016, COLD SPRING HARB PER, V8; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Marlier Q, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00458; Mathis C, 2010, CEREB CORTEX, V20, P2380, DOI 10.1093/cercor/bhp307; Meur AML, 2007, CEREB CORTEX, V17, P2375, DOI 10.1093/cercor/bhl146; Mokin M, 2016, NAT REV NEUROL, V12, P86, DOI 10.1038/nrneurol.2015.240; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Oertle T, 2003, J NEUROSCI, V23, P5393; Ota H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5532; Papadopoulos CM, 2006, CEREB CORTEX, V16, P529, DOI 10.1093/cercor/bhi132; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Petrinovic MM, 2013, P NATL ACAD SCI USA, V110, P1083, DOI 10.1073/pnas.1214255110; Petrinovic MM, 2010, DEVELOPMENT, V137, P2539, DOI 10.1242/dev.048371; Ramo O, 2016, SCI REP-UK, V6, DOI 10.1038/srep35969; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmandke A, 2014, NEUROSCIENTIST, V20, P372, DOI 10.1177/1073858413516800; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Shepherd DJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00467; Shinohara R, 2012, NAT NEUROSCI, V15, P373, DOI 10.1038/nn.3020; Sozmen EG, 2016, P NATL ACAD SCI USA, V113, pE8453, DOI 10.1073/pnas.1615322113; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Thiede-Stan NK, 2015, J CELL SCI, V128, P2403, DOI 10.1242/jcs.165555; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; Vajda F, 2015, CELL DEATH DIFFER, V22, P323, DOI 10.1038/cdd.2014.147; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Walchli T, 2013, P NATL ACAD SCI USA, V110, pE1943, DOI 10.1073/pnas.1216203110; Wahl AS, 2014, SCIENCE, V344, P1250, DOI 10.1126/science.1253050; Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0040084]; Weinmann O, 2006, MOL CELL NEUROSCI, V32, P161, DOI 10.1016/j.mcn.2006.03.007; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Young CC, 2011, ANTIOXID REDOX SIGN, V14, P1877, DOI 10.1089/ars.2010.3435; Zemmar A, 2018, CEREB CORTEX, V28, P2109, DOI 10.1093/cercor/bhx116	66	6	6	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	AUG	2017	76	8					683	696		10.1093/jnen/nlx050			14	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	FD2IQ	WOS:000407359000005	28789474	hybrid			2022-02-06	
J	Taipale, H; Koponen, M; Tanskanen, A; Lavikainen, P; Sund, R; Tiihonen, J; Hartikainen, S; Tolppanen, AM				Taipale, Heidi; Koponen, Marjaana; Tanskanen, Antti; Lavikainen, Piia; Sund, Reijo; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija			Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study	ALZHEIMERS RESEARCH & THERAPY			English	Article						Antidepressant; Head trauma; Traumatic brain injury; Older person; Alzheimer's disease	AGED 75 YEARS; DRUG-USE; SEDATIVE LOAD; OLDER; FALLS; DEMENTIA; REGISTER; HYPONATREMIA	Background: Antidepressant use has been associated with an increased risk of falling, but no studies have been conducted on whether antidepressant use is associated with an increased risk of head injuries which often result from falling among older persons. The objective of this study was to investigate the risk of head and brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease. Methods: A matched cohort study was conducted by comparing new antidepressant users (n = 10,910) with two matched nonusers (n = 21,820) in the MEDALZ study cohort. The MEDALZ cohort includes all community-dwelling persons newly diagnosed with Alzheimer's disease between 2005 and 2011 in Finland. Incident antidepressant users were identified based on register-based dispensing data from the Prescription register with a 1-year washout period for antidepressant use. Nonusers were matched with users based on age, gender, and time since Alzheimer's disease diagnosis. The outcome events were defined as any head injuries and traumatic brain injuries based on diagnoses in Hospital Discharge and Causes of Death registers. Propensity score adjusted Cox proportional hazard models were utilized. Sensitivity analyses with case-crossover design were conducted. All registers are linkable with unique personal identification numbers assigned for each resident. Results: Antidepressant use was associated with an increased risk of head injuries (age-adjusted event rate per 100 person-years 2.98 (95% confidence interval (CI) 2.49-3.06) during use and 2.43 (95% CI 2.06-2.35) during nonuse, adjusted hazard ratio (HR) 1.35, 95% CI 1.20-1.52) and traumatic brain injuries (age-adjusted event rate per 100 person-years 1.33 (95% CI 1.13-1.53) during use and 1.10 (95% CI 1.00-1.20) during nonuse, adjusted HR 1.26, 95% CI 1.06-1.50). The risk was highest during the first 30 days of use (HR 1.71, 95% CI 1.10-2.66 for head injuries; HR 2. 06, 95% CI 1.12-3.82 for traumatic brain injuries) and remained at an elevated level for head injuries for over 2 years of use. In case-crossover analyses, antidepressant use was consistently associated with a higher risk of head injuries. Conclusions: Antidepressant use was associated with an increased risk of the most severe outcomes, head and brain injuries, in persons with Alzheimer's disease. Antidepressant use should be carefully considered and the association confirmed in future studies.	[Taipale, Heidi; Koponen, Marjaana; Lavikainen, Piia; Hartikainen, Sirpa] Univ Eastern Finland, Kuopio Res Ctr Geriatr Care, POB 1627, Kuopio 70211, Finland; [Taipale, Heidi; Koponen, Marjaana; Hartikainen, Sirpa; Tolppanen, Anna-Maija] Univ Eastern Finland, Sch Pharm, POB 1627, Kuopio 70211, Finland; [Taipale, Heidi; Tanskanen, Antti; Tiihonen, Jari] Univ Eastern Finland, Dept Forens Psychiat, Niuvanniemi Hosp, Kuopio, Finland; [Tolppanen, Anna-Maija] Univ Eastern Finland, Res Ctr Comparat Effectiveness & Patient Safety R, POB 1627, Kuopio 70211, Finland; [Tanskanen, Antti; Tiihonen, Jari] Karolinska Inst, Dept Clin Neurosci, Tomtebodavagen 18A,5th Floor, S-17177 Stockholm, Sweden; [Tanskanen, Antti] Natl Inst Hlth & Welf, Impact Assessment Unit, POB 30, Helsinki 00271, Finland; [Lavikainen, Piia] Univ Helsinki, Dept Social Res, Ctr Res Methods, POB 54, Helsinki 00014, Finland; [Sund, Reijo] Kuopio Univ Hosp, Dept Psychiat, POB 100, Kuopio 70029, Finland		Taipale, H (corresponding author), Univ Eastern Finland, Kuopio Res Ctr Geriatr Care, POB 1627, Kuopio 70211, Finland.; Taipale, H (corresponding author), Univ Eastern Finland, Sch Pharm, POB 1627, Kuopio 70211, Finland.	heidi.taipale@uef.fi	Tiihonen, Jari/G-3078-2012; Sund, Reijo/N-5471-2016	Tiihonen, Jari/0000-0002-0400-6798; Sund, Reijo/0000-0002-6268-8117; Taipale, Heidi/0000-0002-3281-934X; Lavikainen, Piia/0000-0003-3560-8860			Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Baker NL, 2011, AGE AGEING, V40, P49, DOI 10.1093/ageing/afq146; Bourin M, 2004, HUM PSYCHOPHARM CLIN, V19, P135, DOI 10.1002/hup.561; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; De Picker L, 2014, PSYCHOSOMATICS, V55, P536, DOI 10.1016/j.psym.2014.01.010; Finnish Medical Society Duodecim Helsinki, 2010, CURR CAR MEM DIS; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172, DOI 10.1093/gerona/62.10.1172; Hindmarch I, 2009, INT J CLIN PRACT, V63, P1085, DOI 10.1111/j.1742-1241.2009.02085.x; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Laitinen ML, 2015, INT PSYCHOGERIATR, V27, P669, DOI 10.1017/S1041610214002427; Lehtola S, 2006, ARCH GERONTOL GERIAT, V42, P217, DOI 10.1016/j.archger.2005.07.002; Martinez C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002080; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mittal V, 2011, AM J ALZHEIMERS DIS, V26, P10, DOI 10.1177/1533317510390351; Norgaard A, 2016, J ALZHEIMERS DIS, V49, P211, DOI 10.3233/JAD-150481; Oderda LH, 2012, ANN PHARMACOTHER, V46, P917, DOI 10.1345/aph.1Q589; Puranen A, 2017, INT J GERIATR PSYCH, V32, P94, DOI 10.1002/gps.4450; Rikala M, 2010, DRUG AGING, V27, P337, DOI 10.2165/11315960-000000000-00000; Tachi T, 2015, EUR J CLIN NUTR, V69, P205, DOI 10.1038/ejcn.2014.195; Taipale H, 2016, CLIN EPIDEMIOL, V8, P363, DOI 10.2147/CLEP.S116160; Taipale H, 2014, EUR NEUROPSYCHOPHARM, V24, P1729, DOI 10.1016/j.euroneuro.2014.10.004; Taipale HT, 2012, J CLIN PSYCHOPHARM, V32, P218, DOI 10.1097/JCP.0b013e3182485802; Taipale HT, 2011, J GERONTOL A-BIOL, V66, P1384, DOI 10.1093/gerona/glr170; Tanskanen A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0140-z; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tiligada E, 2011, CNS NEUROSCI THER, V17, P620, DOI 10.1111/j.1755-5949.2010.00212.x; Tolppanen Anna-Maija, 2013, Clin Epidemiol, V5, P277, DOI 10.2147/CLEP.S46622; Tolppanen AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059124; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; WHO Collaborating Center for Drug Statistics Methodology. Norwegian Institute of Public Health, AN THER CHEM CLASS S AN THER CHEM CLASS S; World Health Organization and Alzheimer's Disease, 2012, DEM PUBL HLTH PRIOR	33	6	7	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-9193			ALZHEIMERS RES THER	Alzheimers Res. Ther.	AUG 1	2017	9								59	10.1186/s13195-017-0285-3			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FC6IB	WOS:000406942500003	28764750	Green Published, gold			2022-02-06	
J	Unterhofer, C; Ho, WM; Wittlinger, K; Thome, C; Ortler, M				Unterhofer, Claudia; Ho, Wing Mann; Wittlinger, Katrin; Thome, Claudius; Ortler, Martin			"I am not afraid of death"-a survey on preferences concerning neurosurgical interventions among patients over 75 years	ACTA NEUROCHIRURGICA			English	Article						Acute subdural hematoma; Decision-making process; Elderly; End-of-life decision	TRAUMATIC BRAIN-INJURY; ACUTE SUBDURAL-HEMATOMA; ELDERLY-PATIENTS; SURGICAL-MANAGEMENT; PROGNOSTIC MODELS; MORTALITY; VALIDATION; COHORT; TRIAL	Introduction Treatment decisions in elderly patients with traumatic brain injury (TBI) are mainly determined by trauma severity and patient age. The aim of this study was to explore personal preferences of potential patients regarding life-prolonging neurosurgical interventions by interviewing ambulatory, autonomous elderly people. Methods One hundred consecutive patients older than 75 years frequenting the outpatient clinic of the Department of Neurosurgery were interviewed about their attitudes regarding the hypothetical case of an 81-year-old patient with TBI and a space-occupying acute subdural hematoma (aSDH) using a 21-point questionnaire. Results Fifty-one percent of the consulted persons declined life-prolonging surgical measures. If surgery was associated with physical disability, 68% of the people wished no surgery. In case of cognitive impairment after surgery, 91% were against any surgical intervention. The majority feared being a burden to relatives (76%) and becoming unable to master an independent life (75%). Four-fifths of the interviewed patients (82%) were not afraid of death. Conclusions The majority of elderly patients only consent to surgical measures if no relevant disabilities are involved and if they can return to their previous life. These findings need consideration in case of life-threatening neurosurgical emergencies as well as in the surgical treatment of elderly patients in general.	[Unterhofer, Claudia; Ho, Wing Mann; Wittlinger, Katrin; Thome, Claudius; Ortler, Martin] Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria		Unterhofer, C (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria.	claudia.unterhofer@tirol-kliniken.at; wing.ho@tirol-kliniken.at; katrin.wittlinger@student.i-med.ac.at; claudius.thome@tirol-kliniken.at; martin.ortler@i-med.ac.at					BOURGEOIS M, 1975, ANN MED-PSYCHOL, V133, P706; Burla C, 2014, MED HEALTH CARE PHIL, V17, P389, DOI 10.1007/s11019-014-9559-8; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Heyland DK, 2015, INTENS CARE MED, V41, P1911, DOI 10.1007/s00134-015-4028-2; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Klein A, 2012, NEUROCRIT CARE, V16, P456, DOI 10.1007/s12028-012-9677-1; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; MAHONEY F I, 1965, Md State Med J, V14, P61; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Mulligan P, 2013, J NEUROSCI RURAL PRA, V4, P250, DOI 10.4103/0976-3147.118760; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pilitsis AB, 2013, JCLIN NEUROL NEUROSU, V115, P1429; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rosenfeld JV, 2015, INJURY, V46, P1703, DOI 10.1016/j.injury.2015.07.037; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sulzgruber P, 2016, EUR HEART J ACUTE CA; Unterhofer C, 2018, NEUROSURG REV, V41, P183, DOI 10.1007/s10143-017-0833-0; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014	24	6	6	1	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	AUG	2017	159	8					1547	1552		10.1007/s00701-017-3240-y			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FA6CM	WOS:000405530900027	28623411				2022-02-06	
J	Zarshenas, S; Tam, L; Colantonio, A; Alavinia, SM; Cullen, N				Zarshenas, Sareh; Tam, Laetitia; Colantonio, Angela; Alavinia, Seyed Mohammad; Cullen, Nora			Predictors of discharge destination from acute care in patients with traumatic brain injury	BMJ OPEN			English	Article							MORTALITY; REHABILITATION; MODERATE	Introduction Many studies have assessed the predictors of morbidity/mortality of patients with traumatic brain injury (TBI) in acute care. However, with the increasing rate of survival after TBI, more attention has been given to discharge destinations from acute care as an important measure of clinical priorities. This study describes the design of a systematic review compiling and synthesising studies on the prognostic factors of discharge settings from acute care in patients with TBI. Methods and analysis This systematic review will be conducted on peer-reviewed studies using seven databases including Medline/Medline in-Process, Embase, Cochrane Database of Systematic Reviews, Cochrane CENTRAL, PsycINFO, CINAHL and Supplemental PubMed. The reference list of selected articles and Google Scholar will also be reviewed to determine other relevant articles. This study will include all English language observational studies that focus on adult patients with TBI in acute care settings. The quality of articles will be assessed by the Quality in Prognostic Studies tool. Ethics and dissemination The results of this review will provide evidence that may guide healthcare providers in making more informed and timely discharge decisions to the next level of care for patient with TBI. Also, this study will provide valuable information to address the gaps in knowledge for future research.	[Zarshenas, Sareh; Colantonio, Angela; Cullen, Nora] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Zarshenas, Sareh; Tam, Laetitia; Colantonio, Angela; Cullen, Nora] Univ Hlth Network, Toronto Rehabil Inst, Univ Ctr, Toronto, ON, Canada; [Alavinia, Seyed Mohammad] Univ Hlth Network, Toronto Rehabil Inst, Lyndhurst Ctr, Toronto, ON, Canada		Zarshenas, S (corresponding author), Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada.; Zarshenas, S (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Univ Ctr, Toronto, ON, Canada.	sareh.zarshenas@mail.utoronto.ca	Alavinia, Mohammad/F-9195-2017; zarshenas, sareh/W-1888-2017; Alavinia, Mohammad/AAF-5335-2020	Alavinia, Mohammad/0000-0002-5503-9362; Alavinia, Mohammad/0000-0002-5503-9362; Colantonio, Angela/0000-0003-2094-4765; Cullen, Nora/0000-0001-6359-9418	Toronto Rehabilitation Institute Scholarship; Canadian Institutes of Health Research Research Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. SZ was supported by a Toronto Rehabilitation Institute Scholarship for graduate students (2016/17), and AC was supported by a Canadian Institutes of Health Research Research Chair in Gender, Work and Health (#CGW-126580).	Amador LF, 2007, CLIN INTERV AGING, V2, P395; [Anonymous], 2014, NAT POP HLTH STUD NE; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; Brain Injury Association of America, 2016, TRAUM BRAIN INJ CONT; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Chen AY, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-16; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Cotera-Perez-Perez O, 2005, J LEGAL MED, V26, P85, DOI 10.1080/01947640590917990; Cullen N, 2013, EVIDENCE BASED REV M; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Frieden TR, 2015, TRAUMATIC BRAIN INJU; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Hayden JA, 2008, J CLIN EPIDEMIOL, V61, P552, DOI 10.1016/j.jclinepi.2007.08.005; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; Hirshon JM, 2013, B WORLD HEALTH ORGAN, V91, P386, DOI 10.2471/BLT.12.112664; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jette DU, 2014, PHYS THER, V94, P1252, DOI 10.2522/ptj.20130359; Jette DU, 2003, PHYS THER, V83, P224, DOI 10.1093/ptj/83.3.224; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim H, 2006, CAN J NEUROL SCI, V33, P48, DOI 10.1017/S0317167100004686; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Peck KA, 2014, J TRAUMA ACUTE CARE, V77, P978, DOI 10.1097/TA.0000000000000356; Rogers S, 2015, ARCH PHYS MED REHAB, V96, P276, DOI 10.1016/j.apmr.2014.09.018; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; SLAVIN RE, 1995, J CLIN EPIDEMIOL, V48, P9, DOI 10.1016/0895-4356(94)00097-A; Wong ELY, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-242; World Health Organization, 2006, NEUR DIS PUBL HLTH C	33	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	AUG	2017	7	8							e016694	10.1136/bmjopen-2017-016694			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FI2UT	WOS:000411802700193	28860230	gold, Green Published			2022-02-06	
J	Zhang, L; Chopp, M; Lu, M; Zhang, T; Li, C; Winter, S; Brandstaetter, H; Doppler, E; Meier, D; Pabla, P; Zhang, ZG				Zhang, Li; Chopp, Michael; Lu, Mei; Zhang, Talan; Li, Chao; Winter, Stefan; Brandstaetter, Hemma; Doppler, Edith; Meier, Dieter; Pabla, Pardeep; Zhang, Zheng G.			Demonstration of therapeutic window of Cerebrolysin in embolic stroke: A prospective, randomized, blinded, and placebo-controlled study	INTERNATIONAL JOURNAL OF STROKE			English	Article						Cerebrolysin; ischemic stroke; treatment; middle cerebral artery occlusion; neurological outcome; recovery; brain infarction; therapeutic window; embolic stroke	NEUROTROPHIC AGENT CEREBROLYSIN(R); TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; GLOBAL FUNCTION; HEAD-INJURY; RATS; NEUROGENESIS; IMPROVEMENT; OUTCOMES; TRIALS	Background and aims: In an effort to characterize the effects of Cerebrolysin for treatment of stroke that are essential for successful clinical translation, we have demonstrated that Cerebrolysin dose dependently enhanced neurological functional recovery in experimental stroke. Here, we conduct a prospective, randomized, placebo-controlled, blinded study to examine the therapeutic window of Cerebrolysin treatment of rats subjected to embolic stroke. Methods: Male Wistar rats age 3-4 months (n = 100) were subjected to embolic middle cerebral artery occlusion. Animals were randomized to receive saline or Cerebrolysin daily for 10 consecutive days starting 4, 24, 48, and 72 h after middle cerebral artery occlusion. Neurological outcome was measured weekly with a battery of behavioral tests (adhesive removal test, modified neurological severity score (mNSS), and foot-fault test). Global test was employed to assess Cerebrolysin effect on neurological recovery with estimation of mean difference between Cerebrolysin and control-treated groups and its 95% confidence interval in the intent-to-treat population, where a negative value of the mean difference and 95% confidence interval < 0 indicated a significant treatment effect. All rats were sacrificed 28 days after middle cerebral artery occlusion and infarct volume was measured. Results: Cerebrolysin treatment initiated within 48 h after middle cerebral artery occlusion onset significantly improved functional outcome; mean differences and 95% confidence interval were -11.6 (-17.7, -5.4) at 4 h, -7.1 (-13.5, -0.8) at 24 h, -8.4 (-14.2, -8.6) at 48 h, and -4.9 (-11.4, 1.5) at 72 h. There were no differences on infarct volume and mortality rate among groups. Conclusions: With a clinically relevant rigorous experimental design, our data demonstrate that Cerebrolysin treatment effectively improves stroke recovery when administered up to 48 h after middle cerebral artery occlusion.	[Zhang, Li; Chopp, Michael; Li, Chao; Zhang, Zheng G.] Oakland Univ, Dept Neurol, Rochester, MI 48063 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Lu, Mei; Zhang, Talan] Oakland Univ, Dept Biostat & Res Epidemiol, Rochester, MI 48063 USA; [Winter, Stefan; Brandstaetter, Hemma; Doppler, Edith; Meier, Dieter] EVER Pharma GmbH, Unterach, Austria; [Pabla, Pardeep] Henry Ford Hosp, Dept Pharmacol, Detroit, MI 48202 USA		Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA.	zzhang1@hfhs.org			EVER Pharma GmbH	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by EVER Pharma GmbH.	Adeoye O, 2011, STROKE, V42, P1952, DOI 10.1161/STROKEAHA.110.612358; Chang WH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0553-z; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Feng ZD, 2001, ANNU REV PUBL HEALTH, V22, P167, DOI 10.1146/annurev.publhealth.22.1.167; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Kleindorfer D, 2013, STROKE, V44, pS129, DOI 10.1161/STROKEAHA.113.001457; Ladurner G, 2005, J NEURAL TRANSM, V112, P415, DOI 10.1007/s00702-004-0248-2; LEGLER JM, 1995, J AM STAT ASSOC, V90, P680; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Martus P, 2004, STAT MED, V23, P1377, DOI 10.1002/sim.1745; Muresanu DF, 2002, J NEURAL TRANSM-SUPP, P277; OBRIEN RG, 1993, APPL ANAL VARIANCE B, P297; Ren J, 2007, RESTOR NEUROL NEUROS, V25, P25; Ruether E, 2002, J NEURAL TRANSM-SUPP, P265; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136; Wong GKC, 2005, ACTA NEUROCHIR SUPPL, V95, P59; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang L, 2016, INT J STROKE, V11, P347, DOI 10.1177/1747493015625645; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang YL, 2013, J NEUROSURG, V118, P1343, DOI 10.3171/2013.3.JNS122061	25	6	8	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	AUG	2017	12	6					628	635		10.1177/1747493017702665			8	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	FB3UT	WOS:000406069000009	28382851				2022-02-06	
J	Rizzo, JR; Fung, JK; Hosseini, M; Shafieesabet, A; Ahdoot, E; Pasculli, RM; Rucker, JC; Raghavan, P; Landy, MS; Hudson, TE				Rizzo, John-Ross; Fung, James K.; Hosseini, Maryam; Shafieesabet, Azadeh; Ahdoot, Edmond; Pasculli, Rosa M.; Rucker, Janet C.; Raghavan, Preeti; Landy, Michael S.; Hudson, Todd E.			Eye Control Deficits Coupled to Hand Control Deficits: Eye-Hand Incoordination in Chronic Cerebral Injury	FRONTIERS IN NEUROLOGY			English	Article						brain injuries; eye; hand; eye movements; stroke	TRAUMATIC BRAIN-INJURY; FRONTOTEMPORAL LOBAR DEGENERATION; SCLERAL SEARCH COILS; OCULAR MOTOR SYSTEM; CLOSED-HEAD INJURY; KING-DEVICK TEST; VIDEO-OCULOGRAPHY; ARM MOVEMENTS; SUPERIOR COLLICULUS; ALZHEIMERS-DISEASE	It is widely accepted that cerebral pathology can impair ocular motor and manual motor control. This is true in indolent and chronic processes, such as neurodegeneration and in acute processes such as stroke or those secondary to neurotrauma. More recently, it has been suggested that disruptions in these control systems are useful markers for prognostication and longitudinal monitoring. The utility of examining the relationship or the coupling between these systems has yet to be determined. We measured eye and hand-movement control in chronic, middle cerebral artery stroke, relative to healthy controls, in saccade-to-reach paradigms to assess eye-hand coordination. Primary saccades were initiated significantly earlier by stroke participants relative to control participants. However, despite these extremely early initial saccades to the target, reaches were nevertheless initiated at approximately the same time as those of control participants. Control participants minimized the time period between primary saccade onset and reach initiation, demonstrating temporal coupling between eye and hand. In about 90% of all trials, control participants produced no secondary, or corrective, saccades, instead maintaining fixation in the terminal position of the primary saccade until the end of the reach. In contrast, participants with stroke increased the time period between primary saccade onset and reach initiation. During this temporal decoupling, multiple saccades were produced in about 50% of the trials with stroke participants making between one and five additional saccades. Reaches made by participants with stroke were both longer in duration and less accurate. In addition to these increases in spatial reach errors, there were significant increases in saccade endpoint errors. Overall, the magnitude of the endpoint errors for reaches and saccades were correlated across participants. These findings suggest that in individuals with otherwise intact visual function, the spatial and temporal relationships between the eye and hand are disrupted poststroke, and may need to be specifically targeted during neurorehabilitation. Eye-hand coupling may be a useful biomarker in individuals with cerebral pathology in the setting of neurovascular, neurotraumatic, and neurodegenerative pathology.	[Rizzo, John-Ross; Fung, James K.; Hosseini, Maryam; Shafieesabet, Azadeh; Ahdoot, Edmond; Pasculli, Rosa M.; Raghavan, Preeti; Hudson, Todd E.] NYU, Dept Rehabil Med, Langone Med Ctr, New York, NY 10003 USA; [Rizzo, John-Ross; Rucker, Janet C.; Hudson, Todd E.] NYU, Dept Neurol, Langone Med Ctr, New York, NY 10016 USA; [Rucker, Janet C.] NYU, Dept Ophthalmol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Landy, Michael S.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Landy, Michael S.] NYU, Ctr Neural Sci, New York, NY 10003 USA		Rizzo, JR (corresponding author), NYU, Dept Rehabil Med, Langone Med Ctr, New York, NY 10003 USA.; Rizzo, JR (corresponding author), NYU, Dept Neurol, Langone Med Ctr, New York, NY 10016 USA.	johnross.rizzo@nyumc.org	Shafieesabet, Azadeh/AAE-6860-2019	Rucker, Janet/0000-0002-0397-0999; Rizzo, John-Ross/0000-0002-4084-0085; Raghavan, Preeti/0000-0002-7852-5005	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY08266, HD071978, TR000038, UL1TR001445, 5K12 HD001097]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071978, K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY013079, R01EY008266] Funding Source: NIH RePORTER	We would like to thank Dr. Tamara Bushnik and the NYULMC Rusk Research Team for their thoughts, suggestions, and contributions. This research was supported in part by National Institutes of Health Grants EY08266 (to ML), HD071978 (to PR), TR000038 (to J-RR), UL1TR001445 (to J-RR, ML, and PR), and 5K12 HD001097 (to J-RR, ML, and PR).	Agrawal Y, 2014, OTOL NEUROTOL, V35, P283, DOI 10.1097/MAO.0b013e3182995227; Anderson T, 2013, J NEUROL NEUROSUR PS, V84, P242, DOI 10.1136/jnnp-2012-304481; BALLARD DH, 1995, J COGNITIVE NEUROSCI, V7, P66, DOI 10.1162/jocn.1995.7.1.66; BALLARD DH, 1991, ARTIF INTELL, V48, P57, DOI 10.1016/0004-3702(91)90080-4; Bard C., 1990, DEV EYE HAND COORDIN; Battaglia-Mayer A, 2006, NEUROPSYCHOLOGIA, V44, P2607, DOI 10.1016/j.neuropsychologia.2005.11.021; BECK RW, 1985, OPHTHALMOLOGY, V92, P77; Beer R, 1999, PROG BRAIN RES, V123, P455, DOI 10.1016/S0079-6123(08)62881-2; Beer RF, 2000, EXP BRAIN RES, V131, P305, DOI 10.1007/s002219900275; Belardinelli A, 2016, J VISION, V16, DOI 10.1167/16.1.18; Binsted G, 1999, EXP BRAIN RES, V127, P193, DOI 10.1007/s002210050789; BOGOUSSLAVSKY J, 1987, ARCH NEUROL-CHICAGO, V44, P141, DOI 10.1001/archneur.1987.00520140013011; BOGOUSSLAVSKY J, 1987, J NEUROL, V234, P160, DOI 10.1007/BF00314136; Boxer AL, 2012, ARCH NEUROL-CHICAGO, V69, P509, DOI 10.1001/archneurol.2011.1021; Brouwer AM, 2009, J VISION, V9, DOI 10.1167/9.1.18; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2009, J HEAD TRAUMA REHAB, V24, P363, DOI 10.1097/HTR.0b013e3181af0810; Carlson RV, 2004, BRIT J CLIN PHARMACO, V57, P695, DOI 10.1111/j.1365-2125.2004.02103.x; CARLTON LG, 1981, Q J EXP PSYCHOL-A, V33, P87, DOI 10.1080/14640748108400771; Catz A, 1997, J NEUROL REHABIL, V11, P175; Cavina-Pratesi C, 2013, J VISION, V13, DOI 10.1167/13.5.15; Cilo M, 2010, NEUROREHABILITATION, V27, P237, DOI 10.3233/NRE-2010-0603; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Colombo A, 1981, Riv Patol Nerv Ment, V102, P38; Contreras R, 2011, BRAIN RES, V1398, P55, DOI 10.1016/j.brainres.2011.05.004; Coutte A, 2014, COGN PROCESS, V15, P415, DOI 10.1007/s10339-014-0612-6; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; DESROSIERS J, 1995, AGE AGEING, V24, P108, DOI 10.1093/ageing/24.2.108; Dong W, 2013, J NEUROL NEUROSUR PS, V84, P337, DOI 10.1136/jnnp-2012-303926; Eckenwiler LA, 2008, J MED ETHICS, V34, P765, DOI 10.1136/jme.2007.023481; Edlin JM, 2015, BRAIN COGNITION, V94, P44, DOI 10.1016/j.bandc.2015.01.003; Eggert Thomas, 2007, Dev Ophthalmol, V40, P15; Farber S. D., 1991, ASSESSING NEUROMOTOR; Fisher BE, 2000, EXP BRAIN RES, V132, P328, DOI 10.1007/s002219900316; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Galetta KM, 2017, ALZ DIS ASSOC DIS, V31, P152, DOI 10.1097/WAD.0000000000000157; Gao KL, 2010, J REHABIL MED, V42, P368, DOI 10.2340/16501977-0520; Garbutt S, 2008, BRAIN, V131, P1268, DOI 10.1093/brain/awn047; Gaveau V, 2014, NEUROPSYCHOLOGIA, V55, P25, DOI 10.1016/j.neuropsychologia.2013.12.005; Gaymard B, 2012, REV NEUROL-FRANCE, V168, P734, DOI 10.1016/j.neurol.2012.07.016; Gaymard B, 1998, EXP BRAIN RES, V120, P173, DOI 10.1007/s002210050391; Gorbet DJ, 2009, BRAIN RES, V1284, P77, DOI 10.1016/j.brainres.2009.05.057; Hall J, 2005, TXB MED PHYSL; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Helsen WF, 1998, J MOTOR BEHAV, V30, P249, DOI 10.1080/00222899809601340; Helsen WF, 2000, J MOTOR BEHAV, V32, P241, DOI 10.1080/00222890009601375; Heuer HW, 2013, NEUROLOGY, V81, P1235, DOI 10.1212/WNL.0b013e3182a6cbfe; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Histed MH, 2009, NEURON, V63, P244, DOI 10.1016/j.neuron.2009.06.019; Houben MMJ, 2006, INVEST OPHTH VIS SCI, V47, P179, DOI 10.1167/iovs.05-0234; Hudson TE, 2007, J NEUROPHYSIOL, V98, P3034, DOI 10.1152/jn.00858.2007; Hudson TE, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000130; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Imai T, 2005, AURIS NASUS LARYNX, V32, P3, DOI 10.1016/j.anl.2004.11.009; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; Irwin DE, 1996, CURR DIR PSYCHOL SCI, V5, P94, DOI 10.1111/1467-8721.ep10772833; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; JOHNSTON CW, 1986, J CLIN EXP NEUROPSYC, V8, P93, DOI 10.1080/01688638608401299; KAPLAN J, 1982, AM J OCCUP THER, V36, P314, DOI 10.5014/ajot.36.5.314; KEATING EG, 1986, BEHAV BRAIN RES, V22, P191, DOI 10.1016/0166-4328(86)90064-1; Ketcham CJ, 2007, NEUROREHAB NEURAL RE, V21, P388, DOI 10.1177/1545968306297872; Khan AZ, 2011, J VISION, V11, DOI 10.1167/11.1.9; Kimmel DL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00049; Kusoffsky A, 2001, ARCH PHYS MED REHAB, V82, P650, DOI 10.1053/apmr.2001.22611; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; Lee D, 2014, EXP BRAIN RES, V232, P211, DOI 10.1007/s00221-013-3732-9; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Lekwuwa GU, 1996, BRAIN, V119, P491, DOI 10.1093/brain/119.2.491; LeVasseur AL, 2001, BRAIN, V124, P2045, DOI 10.1093/brain/124.10.2045; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Machado L, 2004, NEUROPSYCHOLOGY, V18, P115, DOI 10.1037/0894-4105.18.1.115; Mahamed S, 2014, J NEUROPHYSIOL, V111, P804, DOI 10.1152/jn.00002.2013; Malloy P, 2003, CLIN NEUROPSYCHOL, V17, P544, DOI 10.1076/clin.17.4.544.27947; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCamy MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128428; McCrea P, 2005, EXP BRAIN RES, V162, P70, DOI 10.1007/s00221-004-2106-8; McRobert AP, 2009, ERGONOMICS, V52, P474, DOI 10.1080/00140130802707824; Noudoost B, 2014, J NEUROSCI, V34, P3687, DOI 10.1523/JNEUROSCI.3824-13.2014; O'Dell MW, 2009, ANNU REV MED, V60, P55, DOI 10.1146/annurev.med.60.042707.104248; OHTSUKA K, 1991, NEUROSCI RES, V10, P290, DOI 10.1016/0168-0102(91)90086-E; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pierrot-Deseilligny C, 2002, ANN NY ACAD SCI, V956, P216, DOI 10.1111/j.1749-6632.2002.tb02821.x; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; PIERROTDESEILLIGNY C, 1991, J NEUROL NEUROSUR PS, V54, P1106, DOI 10.1136/jnnp.54.12.1106; Piras A, 2010, J SPORT MED PHYS FIT, V50, P99; PRABLANC C, 1979, BIOL CYBERN, V35, P183, DOI 10.1007/BF00337063; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Procacci NM, 2009, NEUROCASE, V15, P73, DOI 10.1080/13554790802620558; Raghavan P, 2006, BRAIN, V129, P1415, DOI 10.1093/brain/awl070; Raghavan P, 2010, J NEUROPHYSIOL, V103, P3034, DOI 10.1152/jn.00936.2009; Rand MK, 2011, BEHAV BRAIN RES, V219, P39, DOI 10.1016/j.bbr.2010.12.008; RANKIN J, 1957, Scott Med J, V2, P127; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Rizzo JR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00227; Rizzo JR, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12650; Rizzo JR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00012; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Savelsbergh GJP, 2005, ERGONOMICS, V48, P1686, DOI 10.1080/00140130500101346; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; Schall S, 1991, Quintessenz J, V21, P611; SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509; Schmidt H, 2010, MED LAW, V29, P565; Shires J, 2010, CURR OPIN NEUROBIOL, V20, P717, DOI 10.1016/j.conb.2010.08.008; Song JH, 2009, J NEUROPHYSIOL, V102, P2681, DOI 10.1152/jn.91352.2008; Srivastava A, 2006, BRAIN INJURY, V20, P1377, DOI 10.1080/02699050601111385; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Starkes J, 2002, J SPORT SCI, V20, P217, DOI 10.1080/026404102317284772; Stuphorn V, 2000, J NEUROPHYSIOL, V83, P1283, DOI 10.1152/jn.2000.83.3.1283; Stuphorn V, 2010, J NEUROPHYSIOL, V103, P801, DOI 10.1152/jn.00221.2009; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Takahashi CD, 2003, EXP BRAIN RES, V149, P131, DOI 10.1007/s00221-002-1340-1; Tannenbaum S, 1971, J Am Optom Assoc, V42, P89; Temple V, 2010, J INTELL DISABIL RES, V54, P573, DOI 10.1111/j.1365-2788.2010.01282.x; Thakkar KN, 2014, J NEUROSCI, V34, P8918, DOI 10.1523/JNEUROSCI.0732-14.2014; Tippett WJ, 2007, EUR NEUROL, V58, P1, DOI 10.1159/000102160; Tsang WWN, 2013, AM J PHYS MED REHAB, V92, P781, DOI 10.1097/PHM.0b013e3182876adb; van Boxtel JJA, 2013, J VISION, V13, DOI 10.1167/13.12.7; van der Geest JN, 2002, J NEUROSCI METH, V114, P185, DOI 10.1016/S0165-0270(01)00527-1; van Donkelaar P, 2004, J MOTOR BEHAV, V36, P245, DOI 10.3200/JMBR.36.3.245-252; Velicki MR, 2000, EXP BRAIN RES, V130, P362, DOI 10.1007/s002219900262; Verheij S, 2012, J ALZHEIMERS DIS, V30, P131, DOI 10.3233/JAD-2012-111883; Volz M, 2016, J AFFECT DISORDERS, V206, P252, DOI 10.1016/j.jad.2016.07.041; WAESPE W, 1992, BRAIN, V115, P1125, DOI 10.1093/brain/115.4.1125; Watanabe M, 2013, J NEUROPHYSIOL, V110, P334, DOI 10.1152/jn.00046.2013; Wenzelburger R, 2005, BRAIN, V128, P64, DOI 10.1093/brain/awh317; White OB, 2012, J NEURO-OPHTHALMOL, V32, P266, DOI 10.1097/WNO.0b013e3182688230; Williams AM, 2000, J SPORT SCI, V18, P737, DOI 10.1080/02640410050120113; Williams AM, 2006, PERCEPTION, V35, P317, DOI 10.1068/p5310; YEE RD, 1985, INVEST OPHTH VIS SCI, V26, P938; Zackowski KM, 2004, BRAIN, V127, P1035, DOI 10.1093/brain/awh116; ZAGAR R, 1983, J CLIN PSYCHOL, V39, P590, DOI 10.1002/1097-4679(198307)39:4<590::AID-JCLP2270390422>3.0.CO;2-B; Zoltan B, 1990, EVALUATION MUSCLE TO	144	6	6	3	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 17	2017	8								330	10.3389/fneur.2017.00330			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB9TQ	WOS:000406482300001	28769866	Green Published, gold			2022-02-06	
J	Knowles, BM; MacGillivray, SR; Newman, JA; Dennison, CR				Knowles, Brooklynn M.; MacGillivray, Samantha R.; Newman, James A.; Dennison, Christopher R.			Influence of rapidly successive head impacts on brain strain in the vicinity of bridging veins	JOURNAL OF BIOMECHANICS			English	Article						Head injury; Brain injury; Injury biomechanics; Subdural hematoma; Diffuse axon injury; Finite element model	ACUTE SUBDURAL-HEMATOMA; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; BIOMECHANICS; CONCUSSION; INJURY; PLAYER; ACCELERATION; MECHANICS; TRAUMA	Acute subdural hematoma due to a bridging vein rupture is a devastating but rare injury. There has to date been no satisfactory biomechanical explanation for this infrequent but costly injury. We surmise that it may be associated with multiple head impacts. Though numerical models have been used to estimate vein strains in single impact events, none to date have examined the influence on localized brain strain of rapidly consecutive impacts. Using the Simulated Injury Monitor, we investigated the hypothesis that such double impacts can increase strain beyond that created by any single impact. Input to our parametric study comprised hypothetical biphasic rotational head accelerations producing a maximum angular velocity of 40 rad./s. In each of 19 simulations, two identical angular inputs are applied at right angles to each other but with time separations varying from 0 to 40 ms. For these double impacts, it has been generally found that strain in the region of the bridging veins is different, than what would be associated with any corresponding single impact. In some cases, the effect is to actually reduce the tissue strain. In others, the strain in the region of the bridging veins is increased markedly. The mechanistic explanation for the strain increase is that the tissue strain from the first impact has not diminished fully when strain from the second impact is initiated. Rapidly consecutive impacts could be a potential mechanism leading to vein rupture that warrants further investigation. (C) 2017 Elsevier Ltd. All rights reserved.	[Knowles, Brooklynn M.; MacGillivray, Samantha R.; Dennison, Christopher R.] Univ Alberta, Biomed Instrumentat Lab, Edmonton, AB, Canada; [Knowles, Brooklynn M.; MacGillivray, Samantha R.; Newman, James A.; Dennison, Christopher R.] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada		Dennison, CR (corresponding author), Univ Alberta, Biomed Instrumentat Lab, Edmonton, AB, Canada.	cdenniso@ualberta.ca			Natural Sciences and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC) [435921]; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR [CFI JELF 32642]; Pashby Sport Safety Fund [2016: RES0028760]; Banting Research Foundation [31214]; Faculty of Engineering and Department of Mechanical Engineering at the University of Alberta	We gratefully acknowledge funding from the Natural Sciences and Engineering Research Council (NSERC) of Canada (Discovery Grants 435921), the Canada Foundation for Innovation (CFI JELF 32642), The Pashby Sport Safety Fund (2016: RES0028760), The Banting Research Foundation (Discovery Award 31214), the Faculty of Engineering and Department of Mechanical Engineering at the University of Alberta.	Abel JM, 1978, 780886 SAE; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Bradshaw DRS, 2001, J BIOMECH, V34, P85, DOI 10.1016/S0021-9290(00)00135-4; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Forbes JA, 2013, PEDIATR NEUROSURG, V49, P43, DOI 10.1159/000355121; Gennarelli T, 1971, P 15 STAPP CAR CRASH; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gennarelli TA, 1972, P 16 STAPP CAR CRASH, P296; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Holbourn AHS, 1943, LANCET, V2, P438; Huang H.-M., 1999, J TRAUMA ACUTE CARE, V47; Ivarsson J, 2000, J BIOMECH, V33, P181, DOI 10.1016/S0021-9290(99)00144-X; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Logan SM, 2001, J ATHL TRAINING, V36, P433; Lowenhielm P., 1974, DYNAMIC PROPERTIES P; Margulies S.S., 1985, P 1985 INT IRCOBIAAA; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Ommaya A.K., 1966, 660804 SAE; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; OMMAYA AK, 1969, LANCET, V294, P237; Ratajczak M, 2016, ACTA BIOENG BIOMECH, V18, P21, DOI 10.5277/ABB-00552-2016-02; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Yokota H., 2016, ACUTE SUBDURAL HEMAT; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	39	6	7	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUL 5	2017	59						59	70		10.1016/j.jbiomech.2017.05.016			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FA9KB	WOS:000405763400008	28577905				2022-02-06	
J	Ameliorate, JL; Ghabriel, MN; Vink, R				Ameliorate, Joshua L.; Ghabriel, Mounir N.; Vink, Robert			Magnesium enhances the beneficial effects of NK1 antagonist administration on blood-brain barrier permeability and motor outcome after traumatic brain injury	MAGNESIUM RESEARCH			English	Article						neurotrauma; magnesium; substance P; blood-brain barrier; brain injury	SUBSTANCE-P; KNOCKOUT MICE; RATS; EDEMA; IMPACT; PATHOPHYSIOLOGY; NEUROPEPTIDES; INFLAMMATION; ACTIVATION; RECEPTORS	The current study investigated whether adding magnesium to an NK1 tachykinin receptor antagonist after traumatic brain injury would enhance efficacy to further reduce blood-brain barrier permeability and improve functional recovery compared to either treatment alone. Sprague-Dawley rats were injured using the impact acceleration model of diffuse brain injury, and received either no treatment, MgSO4 (30 mg/kg IV), the NK1 antagonist n-acetyl L tryptophan (2.5 mg/kg IP), or both agents combined. Animals were then killed at either 1, 5, or 24 h postinjury for determination of blood-brain barrier permeability using previously administered Evans blue dye or assessed for functional outcome over a 1-week period using the rotarod motor test. As expected, both MgSO4 and n-acetyl L tryptophan significantly reduced blood-brain barrier permeability and improved functional outcome. However, combined n-acetyl L tryptophan and MgSO4 was more effective at reducing blood-brain barrier permeability (P < 0.05) and improving functional outcome (P < 0.001) compared to the individual compounds. Our results demonstrate that combination therapy with magnesium and an NK1 antagonist may be a more effective therapy for TBI than either compound administered alone.	[Ameliorate, Joshua L.; Ghabriel, Mounir N.] Univ Adelaide, Sch Med, Discipline Anat & Pathol, Adelaide, SA, Australia; [Vink, Robert] Univ South Australia, Sansom Inst Hlth Res, Div Hlth Sci, Adelaide, SA, Australia		Vink, R (corresponding author), Univ South Australia, Div Hlth Sci, North Terrace, Adelaide, SA 5001, Australia.	robert.vink@unisa.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012; Ameliorate, Joshua Luke/F-7820-2016	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ameliorate, Joshua Luke/0000-0002-9125-5695	Neurosurgical Research Foundation, Australia	This study was supported, in part, by the Neurosurgical Research Foundation, Australia. Conflict of interest: none.	Annunziata P, 2002, J NEUROIMMUNOL, V131, P41, DOI 10.1016/S0165-5728(02)00262-X; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Bloch Orin, 2007, Neurosurg Focus, V22, pE3; Busingye DS, 2016, CNS NEUROSCI THER, V22, P854, DOI 10.1111/cns.12591; Cao T, 2000, J IMMUNOL, V164, P5424, DOI 10.4049/jimmunol.164.10.5424; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gabrielian Levon, 2013, Acta Neurochir Suppl, V118, P201, DOI 10.1007/978-3-7091-1434-6_37; GEPPETTI P, 1995, CAN J PHYSIOL PHARM, V73, P843, DOI 10.1139/y95-115; Ghabriel MN, 2006, ACTA NEUROCHIR SUPPL, V96, P402; Hamm RJ, 1994, NEUROBIOLOGY CENTRAL, P86; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Palma C, 1997, GLIA, V21, P183, DOI 10.1002/(SICI)1098-1136(199710)21:2<183::AID-GLIA2>3.0.CO;2-8; Schratzberger P, 1997, J IMMUNOL, V158, P3895; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Shimosawa T, 2004, HYPERTENSION, V44, P897, DOI 10.1161/01.HYP.0000146536.68208.84; Souza DG, 2002, BRIT J PHARMACOL, V135, P303, DOI 10.1038/sj.bjp.0704464; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Vink R, 2004, J AM COLL NUTR, V23, p538S, DOI 10.1080/07315724.2004.10719398; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1988, J BIOL CHEM, V263, P757; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Vink R, 2016, MAGNESIUM RES, V29, P95, DOI 10.1684/mrh.2016.0408; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Vink R, 2009, MAGNESIUM RES, V22, p158S; Weglicki WB, 2010, MAGNESIUM RES, V23, pS199, DOI 10.1684/mrh.2010.0218; Xu Minhui, 2002, Chin J Traumatol, V5, P361; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Zhu J, 2014, CELL PHYSIOL BIOCHEM, V34, P768, DOI 10.1159/000363041	39	6	6	0	3	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	0953-1424	1952-4021		MAGNESIUM RES	Magnes. Res.	JUL-SEP	2017	30	3					88	97		10.1684/mrh.2017.0427			10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	FW3UF	WOS:000425235500003	29256408				2022-02-06	
J	Benedict, SE; Hinshaw, JW; Byron-Fields, R; Baweja, HS; Goble, DJ				Benedict, Scott E.; Hinshaw, Jeffrey W.; Byron-Fields, Ryan; Baweja, Harsimran S.; Goble, Daniel J.			Effects of Fatigue on the BTrackS Balance Test for Concussion Management	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						force plate; postural sway; exercise; reliability	ERROR SCORING SYSTEM; POSTURAL STABILITY; SPORTS; STATEMENT; EXERTION; RECOVERY; SCORES	Fatigue has been shown to adversely affect balance results, as measured by the Balance Error Scoring System (BESS). The present study aimed to determine whether a new low-cost force plate for concussion balance assessment, the Balance Tracking System (BTrackS), is subject to similar fatigue effects. Significant fatigue effects were only evident immediately following a fatigue protocol (p >.05), and were fully resolved within 5 min postfatigue. These results suggest that the BTrackS Balance Test (BBT) is more fatigue resistant than the BESS, and support use of the BBT as a potentially more reliable alternative to the BESS during immediate sideline balance testing.	[Benedict, Scott E.] San Diego State Univ, Appl Movement Sci Concentrat, San Diego, CA 92182 USA; [Hinshaw, Jeffrey W.; Byron-Fields, Ryan] San Diego State Univ, Kinesiol Program, San Diego, CA 92182 USA; [Baweja, Harsimran S.] San Diego State Univ, Doctoral Phys Therapy Program, San Diego, CA 92182 USA; [Goble, Daniel J.] San Diego State Univ, Kinesiol, San Diego, CA 92182 USA; [Goble, Daniel J.] San Diego State Univ, Appl Movement Sci Masters Program, San Diego, CA 92182 USA		Benedict, SE (corresponding author), San Diego State Univ, Appl Movement Sci Concentrat, San Diego, CA 92182 USA.		Goble, Daniel/A-1317-2007	Goble, Daniel/0000-0002-8027-6722			BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Goble DJ, 2016, INT J SPORTS PHYS TH, V11, P149; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MCARDLE WD, 1972, MED SCI SPORT EXER, V4, P182; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; O'Connor SM, 2016, J BIOMECH, V49, P4142, DOI 10.1016/j.jbiomech.2016.10.020; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robertson RJ, 2000, MED SCI SPORT EXER, V32, P2120, DOI 10.1097/00005768-200012000-00024; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Williams DSB, 2016, J SPORT HEALTH SCI, V5, P70, DOI 10.1016/j.jshs.2016.01.010	20	6	6	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	JUL	2017	22	4					23	28		10.1123/ijatt.2016-0086			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	FC2QJ	WOS:000406682800004					2022-02-06	
J	Cai, SS; Mossop, C; Diaconu, SC; Hersh, DS; AlFadil, S; Rasko, YM; Christy, MR; Granta, MP; Nam, AJ				Cai, Stephen S.; Mossop, Corey; Diaconu, Silviu C.; Hersh, David S.; AlFadil, Sara; Rasko, Yvonne M.; Christy, Michael R.; Granta, Michael P.; Nam, Arthur J.			The "Crumple Zone" hypothesis: Association of frontal sinus volume and cerebral injury after craniofacial trauma	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Paranasal sinuses; Frontal sinus volume; Marshall Score; Cranial injury; Craniofacial trauma; Crumple zone	PARANASAL SINUSES; GENDER DETERMINATION; TOMOGRAPHY; DIMENSIONS	Purpose: The paranasal sinuses are complex anatomical structures of unknown significance. One hypothesis theorizes that the sinuses, in the event of a traumatic injury, function as a crumple zone to distribute and absorb energy to protect the brain and other critical structures. The current study investigates the association between frontal sinus (FS) volume and the severity of cerebral insults following craniofacial trauma. Methods: All patients with FS fracture admitted to a level 1 trauma center from 2011 to 2014 were retrospectively reviewed. FS volumes were measured from computed tomography (CT) on admission using a proprietary region growing segmentation tool. Head injuries were classified based on the presence of specific types of intracranial pathology and their corresponding Marshall Score. Results: FS fracture was identified on the admission CT in 165 patients. Male patients had significantly larger FS volume compared to females (8.4 +/- 6.3 vs. 4.0 +/- 2.9 cm(3), p < 0.001). Smaller FS volume was significantly associated with a worse Marshall Score (p = 0.041) and a higher incidence of cerebral contusion (p = 0.016) independent of age, gender, mechanism, ISS, and admission GCS. The inverse correlation between FS volume and the Marshall Score was also statistically significant (Spearman correlation coefficient r = -0.19, p = 0.015). Smaller FS volume was observed in patients who suffered intracranial insults, underwent neurosurgical interventions, and had worse clinical outcomes and trended towards significance with respect to an association with subarachnoid hemorrhage (p = 0.074) and subdural hematoma (p = 0.080), and had a statistically significant association with longer length of stay (p < 0.001). Conclusion: FS volume is inversely correlated with the severity of intracranial pathology following craniofacial trauma. Our findings are consistent with the "crumple zone" hypothesis and suggest that the FS likely plays a role in mitigating intracranial injury. Furthermore, FS volume is significantly different between male and female patients. This is a novel finding that warrants further validation. (C) 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Cai, Stephen S.; Mossop, Corey; Diaconu, Silviu C.; AlFadil, Sara; Christy, Michael R.; Granta, Michael P.; Nam, Arthur J.] Univ Maryland, Div Plast Reconstruct & Maxillofacial Surg, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Hersh, David S.] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Rasko, Yvonne M.] Univ Maryland, Sch Med, Dept Surg, Div Plast Surg, Baltimore, MD 21201 USA		Nam, AJ (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Plast Reconstruct & Maxillofacial Surg, 110 South Paca St 3N-149, Baltimore, MD 21201 USA.	anam@umm.edu		Hersh, David/0000-0003-1177-2201			BLANTON PL, 1969, AM J ANAT, V124, P135, DOI 10.1002/aja.1001240202; Ekizoglu O, 2014, J CRANIOFAC SURG, V25, P957, DOI 10.1097/SCS.0000000000000734; Fernandes CL, 2004, AM J FOREN MED PATH, V25, P302, DOI 10.1097/01.paf.0000146379.85804.da; Keir J, 2009, J LARYNGOL OTOL, V123, P4, DOI 10.1017/S0022215108003976; Kellman RM, 2009, LARYNGOSCOPE, V119, P1682, DOI 10.1002/lary.20583; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; NEGUS VE, 1954, ANN ROY COLL SURG, V15, P141; Teke HY, 2007, SURG RADIOL ANAT, V29, P9, DOI 10.1007/s00276-006-0157-1; Uthman AT, 2011, J FORENSIC SCI, V56, P403, DOI 10.1111/j.1556-4029.2010.01642.x; Yu JL, 2014, J TRAUMA ACUTE CARE, V76, P488, DOI 10.1097/TA.0b013e3182aaa4bd	11	6	6	0	4	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	JUL	2017	45	7					1094	1098		10.1016/j.jcms.2017.04.005			5	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	EY7XM	WOS:000404205500009	28551409				2022-02-06	
J	Case, RJL; Starkey, NJ; Jones, K; Barker-Collo, S; Feigin, V				Case, Rosalind Jane Leamy; Starkey, Nicola J.; Jones, Kelly; Barker-Collo, Suzanne; Feigin, Valery			New Zealand Teachers' Understanding of Childhood Mild Traumatic Brain Injury: Investigating and Enhancing Teacher Knowledge and Practice	NEW ZEALAND JOURNAL OF EDUCATIONAL STUDIES			English	Article						Disability; Concussion; Teacher professional development; Intervention	SYMPTOMS; CHILDREN; ADOLESCENTS	This two-phase study investigated New Zealand primary school teachers' knowledge and perceptions of childhood mild Traumatic Brain Injury (mTBI), and evaluated the effectiveness of a professional development workshop for enhancing teacher knowledge regarding mTBI. In phase one, 19 teachers from schools in the Waikato and Bay of Plenty engaged in interviews regarding their understanding of mTBI and their experiences of learning and professional development in regards to this topic. In phase two, 38 teachers across three schools participated in and evaluated a workshop that focused on increasing knowledge of possible mTBI effects and intervention strategies. The results of phase one found that teachers had a limited understanding of mTBI, its implications in childhood and how to manage its effects at school. Few had engaged in formal learning opportunities related to childhood TBI. In phase two, the brief professional development workshop resulted in a significant increase in TBI knowledge, with teachers identifying the need for practice adaptation. The findings enrich what is known regarding New Zealand teachers' knowledge of mTBI and demonstrates the potential usefulness of brief professional development approaches to inform classroom practice and enhance functional outcomes for children who have experienced mTBI.	[Case, Rosalind Jane Leamy] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Starkey, Nicola J.] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Jones, Kelly; Feigin, Valery] AUT Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand		Case, RJL (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	rosalind.case@monash.edu	Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019; Starkey, Nicola/AAJ-3795-2020	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740; Case, Rosalind/0000-0003-3182-9930			Adams N. J., 2012, NATL SOCIAL SCI J, V37, P1; Babbie ER, 2011, BASICS SOCIAL RES; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bickerstaff L, 2010, FREQUENTLY ASKED QUE; Borse NN, 2008, CDC CHILDHOOD INJURY; Brady F., 2011, SPORT RELATED CONCUS; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Dise-Lewis JE, 2009, J HEAD TRAUMA REHAB, V24, P166, DOI 10.1097/HTR.0b013e3181a7ecb0; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Feigin V. L., 2010, BEST PRACTICE RES CL, V24, P733; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; FULLAN MG, 1992, PHI DELTA KAPPAN, V73, P745; Garet MS, 2001, AM EDUC RES J, V38, P915, DOI 10.3102/00028312038004915; Gersten R, 1997, J LEARN DISABIL, V30, P466, DOI 10.1177/002221949703000501; Guskey TR., 2000, EVALUATING PROFESSIO; Iverson GL, 2012, MILD TRAUMATIC BRAIN, P281; Keyser-Marcus L., 2002, TEACHING EXCEPTIONAL, V34, P62; Kirk JW, 2012, MILD TRAUMATIC BRAIN, P321; Kirkwood M. W., 2010, EDIATRIC TRAUMATIC B, P94; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; Molnar S. B., 2010, THESIS; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Olsson K. A., 2013, BRAIN INJURY, V18, P1135; Swaine BR, 2008, BRAIN INJURY, V22, P581, DOI 10.1080/02699050802189701; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	32	6	6	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0028-8276	2199-4714		NEW ZEAL J EDUC STUD	N. Z. J. Educ. Stud.	JUL	2017	52	1					159	176		10.1007/s40841-017-0080-5			18	Education & Educational Research	Emerging Sources Citation Index (ESCI)	Education & Educational Research	FJ1WB	WOS:000412510100011					2022-02-06	
J	DeBeer, BB; Kimbrel, NA; Mendoza, C; Davidson, D; Meyer, EC; La Bash, H; Gulliver, SB; Morissette, SB				DeBeer, Bryann B.; Kimbrel, Nathan A.; Mendoza, Corina; Davidson, Dena; Meyer, Eric C.; La Bash, Heidi; Gulliver, Suzy Bird; Morissette, Sandra B.			Traumatic Brain Injury, Sleep Quality, and Suicidal Ideation in Iraq/Afghanistan Era Veterans	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Sleep; suicide; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; OEF/OIF VETERANS; RISK-FACTORS; FOLLOW-UP; POPULATION; SYMPTOMS; INSOMNIA; IRAQ; AFGHANISTAN	The objective of this study was to test the hypothesis that sleep quality mediates the association between traumatic brain injury (TBI) history and current suicidal ideation. Measures of TBI history, sleep quality, and suicidal ideation were administered to 130 Iraq/Afghanistan veterans. As expected, sleep qualitymediated the effect of TBI history on current suicidal ideation (indirect effect, 0.0082; 95% confidence interval, 0.0019-0.0196), such that history of TBI was associated with worse sleep quality, which was, in turn, associated with increased suicidal ideation. These findings highlight the importance of assessing TBI history and sleep quality during suicide risk assessments for veterans.	[DeBeer, Bryann B.; Mendoza, Corina; Davidson, Dena; Meyer, Eric C.; La Bash, Heidi] VISN 17 Ctr Excellence Res Returning War Vet, Dept Vet Affairs, Waco, TX USA; [DeBeer, Bryann B.; Mendoza, Corina; Davidson, Dena; Meyer, Eric C.; La Bash, Heidi] Cent Texas Vet Healthcare Syst, Temple, TX USA; [DeBeer, Bryann B.; Davidson, Dena; Meyer, Eric C.; La Bash, Heidi; Gulliver, Suzy Bird] Texas A&M Univ, Coll Med, Temple, TX 76508 USA; [Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Kimbrel, Nathan A.] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Durham, NC USA; [La Bash, Heidi] US Dept Vet Affairs, Adv Fellowship Program Mental Illness Res & Treat, Off Acad Affiliat, Washington, DC USA; [Gulliver, Suzy Bird] Baylor Scott & White Healthcare Syst, Warriors Res Inst, Waco, TX USA; [Morissette, Sandra B.] Univ Texas San Antonio, San Antonio, TX USA		DeBeer, BB (corresponding author), VA VISN 17 Ctr Excellence Res Returning War Vet, 4800 Vet Mem Dr,151-C, Waco, TX 76711 USA.	bryann.debeer@va.gov	Gulliver, Suzy/X-9776-2019	Gulliver, Suzy Bird/0000-0002-6476-9447	Department of Veterans Affairs VISN 17 Center of Excellence for Research on Returning War VeteransUS Department of Veterans Affairs; CTVHCS; Department of Veterans Affairs Office of Academic AffiliationsUS Department of Veterans Affairs; Advanced Fellowship Program in Mental Illness Research and Treatment; VA Merit AwardUS Department of Veterans Affairs [I01RX000304]; Career Development Award [IK2 CX000525]; Veterans AffairsUS Department of Veterans Affairs [I01RX000304, IK2CX000525] Funding Source: NIH RePORTER	This research was supported by the Department of Veterans Affairs VISN 17 Center of Excellence for Research on Returning War Veterans, CTVHCS, the Department of Veterans Affairs Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, a VA Merit Award #I01RX000304 to Dr Morissette from the Rehabilitation Research and Development Service of the VA Office of Research and Development (ORD), and a Career Development Award (IK2 CX000525) to Dr Kimbrel from Clinical Sciences Research and Development Service of VA ORD. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the VA, the US government, Texas A&M University, Duke University Medical Center, or other affiliates.	Angst F, 2002, J AFFECT DISORDERS, V68, P167, DOI 10.1016/S0165-0327(01)00377-9; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Balkrishnan R, 2005, SLEEP, V28, P715, DOI 10.1093/sleep/28.6.715; Batterham PJ, 2015, PSYCHOL ASSESSMENT, V27, P501, DOI 10.1037/pas0000053; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; Beck AT., 1991, MANUAL BECK SCALE SU; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brower KJ, 2011, J CLIN PSYCHIAT, V72, P515, DOI 10.4088/JCP.09m05484gry; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cukrowicz KC, 2006, DREAMING, V16, P1, DOI DOI 10.1037/1053-0797.16.1.1; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Hayes, 2018, INTRO MEDIATION MODE; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; Karlin BE, 2013, J CONSULT CLIN PSYCH, V81, P912, DOI 10.1037/a0032554; Kimbrel NA, 2014, PSYCHIAT RES, V220, P397, DOI 10.1016/j.psychres.2014.07.064; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Pigeon WR, 2012, AM J PUBLIC HEALTH, V102, pS93, DOI 10.2105/AJPH.2011.300470; Pompili M, 2013, J AFFECT DISORDERS, V147, P437, DOI 10.1016/j.jad.2012.08.046; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Rapoport M, 2010, PSYCHIAT ANN, V40, P581, DOI 10.3928/00485713-20101015-08; Rosipal R, 2013, BIOL PSYCHOL, V94, P210, DOI 10.1016/j.biopsycho.2013.05.014; Schneider B, 2001, EUR PSYCHIAT, V16, P283, DOI 10.1016/S0924-9338(01)00579-X; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Singareddy R K, 2001, Ann Clin Psychiatry, V13, P93, DOI 10.3109/10401230109148954; Starkstein SE, 2014, PSYCHIAT CLIN N AM, V37, P103, DOI 10.1016/j.psc.2013.10.002; STEER RA, 1993, J CONSULT CLIN PSYCH, V61, P1096, DOI 10.1037/0022-006X.61.6.1096; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trockel M, 2015, SLEEP, V38, P259, DOI 10.5665/sleep.4410; Troxel WM, 2010, PSYCHOSOM MED, V72, P578, DOI 10.1097/PSY.0b013e3181de7ff8; US Department of Veterans Affairs, 2013, SUICIDE DATA REPORT; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Weber M, 2013, J SLEEP DISORD THER, V2, P110, DOI DOI 10.4172/2167-0277.1000110; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	58	6	6	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	JUL	2017	205	7					512	516		10.1097/NMD.0000000000000695			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	EZ4CH	WOS:000404658200002	28590264	Green Accepted			2022-02-06	
J	Herrold, AA; Pape, TLB; Li, X; Jordan, N				Herrold, Amy A.; Pape, Theresa L-B; Li, Xue; Jordan, Neil			Association Between Alcohol Craving and Health-Related Quality of Life Among Veterans With Co-occurring Conditions	MILITARY MEDICINE			English	Article							DISORDERS IDENTIFICATION TEST; POSTTRAUMATIC-STRESS; SUBSTANCE USE; DEPENDENCE; INVENTORY; UPDATE; INJURY; AUDIT; IRAQ	Background: Probable alcohol use disorder (AUD), mental health disorders (MHDs), and mild traumatic brain injury (mTBI) are endemic among U.S. Veterans of the recent conflicts in Iraq and Afghanistan. Previous research demonstrates that recent Veterans with AUD and MHD both with and without mTBI (MHD +/- mTBI) self-report higher alcohol craving levels relative to Veterans with AUD only. Since it is unknown if alcohol craving negatively impacts health-related quality of life (HRQOL), the purpose of this study is to identify and describe the relationship between alcohol craving and HRQOL for recent Veterans with AUD alone and those with AUD and co-occurring conditions. Methods: This cross-sectional study included Penn Alcohol Craving Scale (PACS) and Veterans RAND 36 Item Health Survey mental and physical component score data collected among recent Veterans with AUD (N = 29, n = 27 males): 14 combat controls, 15 MHD +/- mTBI. The Alcohol Use Disorder Identification Test, consumption questions determined AUD classification. That is only Veterans scoring a 4 or above for males and a 3 or above for females on the Alcohol Use Disorder Identification Test, consumption questions were included in this study. Associations between alcohol craving and HRQOL were examined using correlations and regression models. Results: There was a significant negative linear relationship between PACS and mental component score (p < 0.05) that did not significantly differ between groups. There was a significant negative curvilinear relationship between PACS and physical component score with a significant group effect. Discussion: Greater alcohol craving was associated with poorer mental HRQOL. Physical HRQOL was also significantly associated with alcohol craving. These relationships have important implications for clinical assessment and treatment among people with AUD. These findings suggest that alcohol craving is an important symptom of AUD for clinicians to assess and focus their treatment upon because it may negatively impact HRQOL.	[Herrold, Amy A.; Pape, Theresa L-B; Jordan, Neil] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare & Res Serv, 5000 South 5th Ave, Hines, IL 60141 USA; [Herrold, Amy A.; Jordan, Neil] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, 710 North Lake Shore Dr, Chicago, IL 60611 USA; [Pape, Theresa L-B] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, 710 North Lake Shore Dr, Chicago, IL 60611 USA; [Li, Xue] Edward Hines Jr VA Hosp, Cooperat Studies Program Coordinating Ctr, 5000 South 5th Ave, Hines, IL 60141 USA		Herrold, AA (corresponding author), Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare & Res Serv, 5000 South 5th Ave, Hines, IL 60141 USA.; Herrold, AA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, 710 North Lake Shore Dr, Chicago, IL 60611 USA.			Bender Pape, Theresa/0000-0001-7738-5963	Veterans Health Administration, Health Services Research and Development Service (VHA-HSRD); Centers for Medicare and Medicaid Services (CMS)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL; Department of Veterans Affairs (VA), Office of Research and Development (ORD), Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [RX000949-01A2]; VA, ORD, Health Services Research and Development Service [08-377]; Edward Hines, Jr. VA Hospital, Center of Innovation for Complex Chronic Healthcare [42-130]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDIHLRR) Merit Switzer Research Fellowship [H133F130011]; Veterans AffairsUS Department of Veterans Affairs [IK2RX000949] Funding Source: NIH RePORTER	We would like to acknowledge the developers of the Veterans RAND 36 Item Health Survey (VR-36): Dr. Lewis Kazis, Dr. Alfredo Selim, Dr. William Rogers, Dr. Austin Lee, Dr. Xinhua S. Ren, Dr. James Rothendler, Dr. Donald Miller, Dr. Katherine Skinner, Dr. Jack Clark, Dr. Avron Spiro III., Dr. Graeme Fincke, and Ms. Shirley Qian. The VR-36 is in the public domain as the development of the instrument was supported by federal funds from the Veterans Health Administration, Health Services Research and Development Service (VHA-HSR&D), and the Centers for Medicare and Medicaid Services (CMS). We would like to thank Brendan Sullivan for assistance with data collection, Francis Sesso Osburn for assistance with data entry and cleaning, and Melissa London for assistance with manuscript preparation. We have obtained written permission from all persons named in the Acknowledgment. This work was funded by Department of Veterans Affairs (VA), Office of Research and Development (ORD), Rehabilitation Research and Development Service, Career Development, Level II Award number RX000949-01A2; VA, ORD, Health Services Research and Development Service, Service Directed Research Project number 08-377; Edward Hines, Jr. VA Hospital, Center of Innovation for Complex Chronic Healthcare, Locally Initiated Project number 42-130; and National Institute on Disability, Independent Living, and Rehabilitation Research (NIDIHLRR) Merit Switzer Research Fellowship number H133F130011.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, STEER RA BROWN GK MA; Beck AT, 1988, STEER RA MANUAL BECK; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bottlender M, 2004, ALCOHOL ALCOHOLISM, V39, P357, DOI 10.1093/alcalc/agh073; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Burnett-Zeigler I, 2011, ADDICT BEHAV, V36, P801, DOI 10.1016/j.addbeh.2010.12.032; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chakravorty S, 2010, AM J ADDICTION, V19, P450, DOI 10.1111/j.1521-0391.2010.00067.x; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Daeppen JB, 1998, AM J DRUG ALCOHOL AB, V24, P685, DOI 10.3109/00952999809019617; De TP, 2013, PLOS ONE, V8; Donovan D, 2005, J STUD ALCOHOL, P119, DOI 10.15288/jsas.2005.s15.119; Falk D, 2008, ALCOHOL RES HEALTH, V31, P100; Flannery BA, 1999, ALCOHOL CLIN EXP RES, V23, P1289, DOI 10.1111/j.1530-0277.1999.tb04349.x; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Heinz AJ, 2016, MIL MED, V181, P663, DOI 10.7205/MILMED-D-15-00228; Herrold AA., 2015, CURR ADDICT REP, V2, P273, DOI [10.1007/S40429-015-0078-3, DOI 10.1007/S40429-015-0078-3, 10.1007/s40429-015-0078-3, DOI 10.1007/s40429-015-0078-3]; Herrold AA, 2014, J REHABIL RES DEV, V51, P1397, DOI 10.1682/JRRD.2013.07.0170; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kazis LE., 2000, MED OUTCOMES TRUST M, V5, P1; Law B, 2016, ALCOHOL CLIN EXP RES, V40, P1058, DOI 10.1111/acer.13034; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Morgan MY, 2004, ALCOHOL CLIN EXP RES, V28, P64, DOI 10.1097/01.ALC.0000108652.73143.4B; Pape TLB, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000220; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Pombo S, 2016, PSYCHIAT RES, V243, P53, DOI 10.1016/j.psychres.2016.02.064; Ralevski E, 2016, ALCOHOL CLIN EXP RES, V40, P1752, DOI 10.1111/acer.13120; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Simpson TL, 2005, DRUG ALCOHOL DEPEN, V79, P241, DOI 10.1016/j.drugalcdep.2005.02.001; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wiers CE, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.141	38	6	6	1	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL-AUG	2017	182	7					E1712	E1717		10.7205/MILMED-D-16-00360			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2MZ	WOS:000408732800011	28810962				2022-02-06	
J	Higgins, GA; Allyn-Feuer, A; Georgoff, P; Nikolian, V; Alam, HB; Athey, BD				Higgins, Gerald A.; Allyn-Feuer, Ari; Georgoff, Patrick; Nikolian, Vahagn; Alam, Hasan B.; Athey, Brian D.			Mining the topography and dynamics of the 4D Nucleome to identify novel CNS drug pathways	METHODS			English	Article						Pharmacoepigenomics; Gene regulation; Circadian rhythmicity; Mechanogenomics; Transcription; Non-coding genome	GENOME-WIDE ASSOCIATION; TRAUMATIC BRAIN-INJURY; VALPROIC ACID; BIPOLAR DISORDER; CHROMATIN DOMAINS; GENE-EXPRESSION; FUNCTIONAL-ORGANIZATION; SPATIAL-ORGANIZATION; LITHIUM RESPONSE; CIRCADIAN CLOCK	The pharmacoepigenome can be defined as the active, noncoding province of the genome including canonical spatial and temporal regulatory mechanisms of gene regulation that respond to xenobiotic stimuli. Many psychotropic drugs that have been in clinical use for decades have ill-defined mechanisms of action that are beginning to be resolved as we understand the transcriptional hierarchy and dynamics of the nucleus. In this review, we describe spatial, temporal and biomechanical mechanisms mediated by psychotropic medications. Focus is placed on a bioinformatics pipeline that can be used both for detection of pharmacoepigenomic variants that discretize drug response and adverse events to improve pharmacogenomic testing, and for the discovery of novel CNS therapeutics. This approach integrates the functional topology and dynamics of the transcriptional hierarchy of the pharmacoepigenome, gene variant-driven identification of pharmacogenomic regulatory domains, and mesoscale mapping for the discovery of novel CNS pharmacodynamic pathways in human brain. Examples of the application of this pipeline are provided, including the discovery of valproic acid (VPA) mediated transcriptional reprogramming of neuronal cell fate following injury, and mapping of a CNS pathway glutamatergic pathway for the mood stabilizer lithium. These examples in regulatory pharmacoepigenomics illustrate how ongoing research using the 4D nucleome provides a foundation to further insight into previously unrecognized psychotropic drug pharmacodynamic pathways in the human CNS. (C) 2017 Published by Elsevier Inc.	[Higgins, Gerald A.; Allyn-Feuer, Ari; Athey, Brian D.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Georgoff, Patrick; Nikolian, Vahagn; Alam, Hasan B.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Athey, Brian D.] Michigan Inst Data Sci MIDAS, Ann Arbor, MI USA		Athey, BD (corresponding author), Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	bleu@med.umich.edu		Higgins, Gerry/0000-0002-0434-1465; Athey, Brian/0000-0002-9793-535X	Office of Naval ResearchOffice of Naval Research [N000141310071]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Massey Foundation	This work was supported by the Office of Naval Research (N000141310071) to H.A., National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000433 to the Michigan Institute for Clinical & Health Research, and the Massey Foundation to H.A. and B.A.	ANDERSON IM, 1994, J PSYCHOPHARMACOL, V8, P238, DOI 10.1177/026988119400800407; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bai JPF, 2013, ANNU REV PHARMACOL, V53, P451, DOI 10.1146/annurev-pharmtox-011112-140248; Banigan E., 2016, APS M; Benedetti F, 2013, NEUROPSYCHOPHARMACOL, V38, P313, DOI 10.1038/npp.2012.172; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Bonev B, 2016, NAT REV GENET, V17, P661, DOI 10.1038/nrg.2016.112; Borglum AD, 2014, MOL PSYCHIATR, V19, P325, DOI 10.1038/mp.2013.2; Bunney BG, 2015, MOL PSYCHIATR, V20, P48, DOI 10.1038/mp.2014.138; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Byrne EM, 2013, AM J MED GENET B, V162B, P439, DOI 10.1002/ajmg.b.32168; Calati R., 2013, BIOL PSYCHIAT, V1, P271; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chen HM, 2015, P NATL ACAD SCI USA, V112, P8002, DOI 10.1073/pnas.1505822112; Chiang AP, 2009, CLIN PHARMACOL THER, V86, P507, DOI 10.1038/clpt.2009.103; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cloney R, 2016, NAT REV GENET, V17, P437, DOI 10.1038/nrg.2016.81; Crawford RR, 2015, CLIN CASE REP, V3, P14, DOI 10.1002/ccr3.136; Cremer T, 2015, FEBS LETT, V589, P2931, DOI 10.1016/j.febslet.2015.05.037; Crisafulli C, 2012, PSYCHIAT RES, V198, P39, DOI 10.1016/j.psychres.2011.08.022; Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2; Dai C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11549; Dallaspezia S, 2012, MOL DIAGN THER, V16, P303, DOI 10.1007/s40291-012-0004-5; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; del Rosario RCH, 2015, NAT METHODS, V12, P458, DOI [10.1038/NMETH.3326, 10.1038/nmeth.3326]; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Eriksson P.S., NAT MED, V4; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fagny M., 2016, BIORXIV; Fanucchi S, 2013, CELL, V155, P606, DOI 10.1016/j.cell.2013.09.051; Felisbino M. B., J CELL BIOCH, V115; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Gibson CL, 2010, J NEUROCHEM, V115, P806, DOI 10.1111/j.1471-4159.2010.06993.x; Giorgio E., 2015, HUM MOL GENET; Goel N, 2009, J BIOL RHYTHM, V24, P85, DOI 10.1177/0748730408328914; Gomez-Diaz E, 2014, TRENDS CELL BIOL, V24, P703, DOI 10.1016/j.tcb.2014.08.003; Gonzalez-Sandoval A, 2016, TRENDS GENET, V32, P485, DOI 10.1016/j.tig.2016.05.004; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Haase K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21300; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halsall JA, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0021-9; Halverson JD, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/022601; Hampton LM, 2014, JAMA PSYCHIAT, V71, P1006, DOI 10.1001/jamapsychiatry.2014.436; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hayashi A, 2015, MOL PSYCHIATR, V20, P931, DOI 10.1038/mp.2014.104; Hebbring SJ, 2015, BIOINFORMATICS, V31, P1981, DOI 10.1093/bioinformatics/btv076; Higgins GA, 2017, PHARM RES-DORDR, V34, P1658, DOI 10.1007/s11095-017-2130-6; Higgins GA, 2015, PHARMACOGENOMICS, V16, P1649, DOI 10.2217/pgs.15.111; Higgins GA, 2015, PHARMACOGENOMICS, V16, P1565, DOI 10.2217/pgs.15.105; Higgins GA, 2015, PHARMACOGENOMICS, V16, P1547, DOI 10.2217/pgs.15.106; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hu JX, 2016, NAT REV GENET, V17, P615, DOI 10.1038/nrg.2016.87; Hung CC, 2011, PHARMACOGENOMICS, V12, P1107, DOI [10.2217/PGS.11.64, 10.2217/pgs.11.64]; Le HQ, 2016, NAT CELL BIOL, V18, P864, DOI 10.1038/ncb3387; Hyman SE, 2014, NEUROPSYCHOPHARMACOL, V39, P220, DOI 10.1038/npp.2013.181; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Kino T, 2011, ENDOCR DEV, V20, P116, DOI 10.1159/000321232; Kishi T, 2013, EUR ARCH PSY CLIN N, V263, P105, DOI 10.1007/s00406-012-0337-4; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YF, 2013, J AFFECT DISORDERS, V147, P401, DOI 10.1016/j.jad.2012.08.025; Liu XS, 2012, NEUROSCIENCE, V220, P313, DOI 10.1016/j.neuroscience.2012.06.012; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Lv L, 2011, BRAIN RES, V1396, P60, DOI 10.1016/j.brainres.2011.03.040; MANN DMA, 1973, J NEUROL SCI, V18, P183, DOI 10.1016/0022-510X(73)90005-1; Marx V, 2016, NAT METHODS, V13, P829, DOI 10.1038/nmeth.4001; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Matharu N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005640; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy MJ, 2011, GENES BRAIN BEHAV, V10, P852, DOI 10.1111/j.1601-183X.2011.00725.x; McCarthy MJ, 2016, NEUROPHARMACOLOGY, V101, P439, DOI 10.1016/j.neuropharm.2015.10.017; McCarthy MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032091; Monlong J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5698; Narayanan R, 2014, CELL TISSUE RES, V356, P575, DOI 10.1007/s00441-013-1791-7; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nowrouzi B, 2013, EUR NEUROPSYCHOPHARM, V23, P224, DOI 10.1016/j.euroneuro.2012.05.008; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Perlis RH, 2009, AM J PSYCHIAT, V166, P718, DOI 10.1176/appi.ajp.2009.08111633; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Sanjana N. E., 2016, BIORXIV; Sapolsky R. M., 1994, WHY ZEBRAS DONT GET; Scott D. F., 1993, HIST EPILEPTIC THERA; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Severino G, 2009, BIPOLAR DISORD, V11, P215, DOI 10.1111/j.1399-5618.2009.00667.x; Seyfarth RM, 2013, P NATL ACAD SCI USA, V110, P10349, DOI 10.1073/pnas.1301223110; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Silberberg G, 2008, PHARMACOGENET GENOM, V18, P403, DOI 10.1097/FPC.0b013e3282f974ca; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Sneader W, 2005, DRUG DISCOVERY: A HISTORY, P1, DOI 10.1002/0470015535; Son EY, 2014, AM J MED GENET C, V166, P333, DOI 10.1002/ajmg.c.31416; Song J, 2016, MOL PSYCHIATR, V21, P1290, DOI 10.1038/mp.2015.165; Thakurela S, 2015, GENOME RES, V25, P1309, DOI 10.1101/gr.190926.115; Thier S, 2012, NEUROLOGY, V79, P243, DOI 10.1212/WNL.0b013e31825fdeed; Tjong H, 2016, P NATL ACAD SCI USA, V113, pE1663, DOI 10.1073/pnas.1512577113; Tsuchihashi T, 2014, CLIN OPHTHALMOL, V8, P2471, DOI 10.2147/OPTH.S71305; Uhler Caroline, 2016, Bioarchitecture, V6, P76, DOI 10.1080/19490992.2016.1201620; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Wadi L, 2016, NAT METHODS, V13, P705, DOI 10.1038/nmeth.3963; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; Wang YJ, 2016, PHYSIOL HEALTH DIS, P197, DOI 10.1007/978-1-4939-5617-3_10; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Weideman R., THESIS; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wiley JW, 2016, NEUROGASTROENT MOTIL, V28, P12, DOI 10.1111/nmo.12706; Yan Q, 2015, CELLULAR RHYTHMS NET, P61; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yi J., BIOPHYS J, V109; Zhang C, 2014, PSYCHOPHARMACOLOGY, V231, P685, DOI 10.1007/s00213-013-3297-0; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zlotorynski E, 2015, NAT REV MOL CELL BIO, V16, P640, DOI 10.1038/nrm4071; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	143	6	6	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	JUL 1	2017	123						102	118		10.1016/j.ymeth.2017.03.012			17	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC3JW	WOS:000406735900010	28385536				2022-02-06	
J	Lawrence, KA; Matthieu, MM; Robertson-Blackmore, E				Lawrence, Karen A.; Matthieu, Monica M.; Robertson-Blackmore, Emma			Completion of a Veteran-Focused Civic Service Program Improves Health and Psychosocial Outcomes in Iraq and Afghanistan Veterans With a History of Traumatic Brain Injury	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SOCIAL SUPPORT; COPING STRATEGIES; RISK-FACTORS; MILD; LONELINESS; DEPRESSION; MILITARY; SUICIDE; EPIDEMIOLOGY	Introduction: Volunteering as a health promotion intervention is positively related to improved health and well-being in civilians and older adults. Yet, the impacts of participating in a community-based volunteering program on returning military veterans have not been studied, nor have the outcomes for veterans who have experienced a traumatic brain injury (TBI). Materials and Methods: This observational, pre-post survey examines health, psychological, and social outcomes from a cohort of post-9/11/01 veterans with (N = 67) and without a reported TBI history (N = 273) who completed a 6-month, 20-hour per week veteran-focused civic service program. This study was approved by the Saint Louis University Institutional Review Board. Results: Veterans with a TBI history who completed the 6-month civic service program conducted by a veteran-focused national nonprofit organization showed significant pre-post improvement (p < 0.05) in overall health, decreased post-traumatic stress disorder (PTSD) symptoms, increased perceived self-efficacy, decreased feelings of isolation and loneliness, and increased perceived availability of social support. These significant findings were not due to participants seeking external help for emotional problems. Out of four aspects of PTSD symptomatology assessed, "feeling numb or detached from others, activities, or surroundings" most accounted for the decrease in PTSD scores. Given this and taken together with the significant decrease in social isolation and loneliness and the social nature of the program, we posit that decreased social isolation and loneliness is the primary driver of the improved psychological and social outcomes documented here. Finally, pre-post change scores did not differ significantly between veterans with and without a TBI, indicating that TBI history did not hinder the ability to benefit from this program. Conclusion: Completion of this civic service program positively impacted veterans with TBI, especially on psychological and social outcomes important to recovery and life satisfaction after TBI. Civic service may provide an innovative approach to promoting wellness in returning veterans with a TBI. Results of this study provide preliminary evidence that civic service decreases social isolation and loneliness in veterans with a reported TBI history. Given our findings, volunteering may prevent against social isolation and be promotional of perceived social support in veterans with TBI.	[Lawrence, Karen A.] Univ Kentucky, Coll Social Work, 669 Patterson Off Tower, Lexington, KY 40506 USA; [Matthieu, Monica M.] St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, Tegeler Hall,3550 Lindell Blvd, St Louis, MO 63106 USA; [Robertson-Blackmore, Emma] Halifax Hlth, 201 North Clyde Morris Blvd,Suite 200, Daytona Beach, FL 32114 USA		Lawrence, KA (corresponding author), Univ Kentucky, Coll Social Work, 669 Patterson Off Tower, Lexington, KY 40506 USA.			Lawrence, Karen/0000-0002-7235-5594	National Institute of Mental Health of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [NRSA MHI9960]	We would like to acknowledge Aaron Scheinberg, Oliver Gould, and Olivia Obicheta at The Mission Continues for helping with data collection, cleaning, editing, and encouragement. Lawrence's work was supported by the National Institute of Mental Health of the National Institutes of Health, grant number: NRSA MHI9960 (to Enola Proctor).	BECK AT, 1990, AM J PSYCHIAT, V147, P190; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Denning LA., 2014, PREVENTING PSYCHOL D; Department of Defense U. S, 2008, POSTD HLTH REASS DD; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Gubata ME, 2013, MIL MED, V178, P708, DOI 10.7205/MILMED-D-12-00542; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Izaute M, 2008, BRAIN INJURY, V22, P758, DOI 10.1080/02699050802366002; Jenkinson CE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-773; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Matthieu MM, 2017, PSYCHIAT RES, V248, P111, DOI 10.1016/j.psychres.2016.12.028; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Savitsky L, 2009, SOC WORK, V54, P327, DOI 10.1093/sw/54.4.327; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Sherman MD, 2015, PROF PSYCHOL-RES PR, V46, P355, DOI 10.1037/pro0000043; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	43	6	6	1	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL-AUG	2017	182	7					E1763	E1770		10.7205/MILMED-D-16-00150			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2MZ	WOS:000408732800019	28810970	Green Accepted			2022-02-06	
J	Leibu, S; Rosenthal, G; Shoshan, Y; Benifla, M				Leibu, Sharon; Rosenthal, Guy; Shoshan, Yigal; Benifla, Mony			Clinical Significance of Long-Term Follow-Up of Children with Posttraumatic Skull Base Fracture	WORLD NEUROSURGERY			English	Article						Meningitis; Prophylactic antibiotics; Skull base fracture; Traumatic brain injury; Vaccination	CEREBROSPINAL-FLUID FISTULAS; MANAGEMENT; COMPLICATIONS; MENINGITIS; OUTCOMES	OBJECTIVE: To assess the incidence of cerebrospinal fluid (CSF) leak and meningitis, and the need for prophylactic antibiotics, antipneumococcal vaccination, and surgical interventions, in children with a skull base fracture. - METHODS: We reviewed the records of children with a skull base fracture who were admitted to our tertiary care center between 2009 and 2014. RESULTS: A total of 196 children (153 males), age 1 month to 18 years (mean age, 6 +/- 4 years), were hospitalized with skull base fracture. Causes of injury were falls (n = 143), motor vehicle accidents (n = 34), and other (n = 19). Fracture locations were the middle skull base in 112 patients, frontal base in 62, and occipital base in 13. Fifty-four children (28%) had a CSF leak. In 34 of these children (63%), spontaneous resolution occurred within 3 days. Three children underwent surgery on admission owing to a CSF leak from an open wound, 3 underwent CSF diversion by spinal drainage, and 4 (2%) required surgery to repair a dural tear after failure of continuous spinal drainage and acetazolamide treatment. Twenty-eight children (14%) received prophylactic antibiotic therapy, usually due to other injuries, and 11 received pneumococcal vaccination. Two children developed meningitis, and 3 children died. Long-term follow up in 124 children revealed 12 children with delayed hearing loss and 3 with delayed facial paralysis. CONCLUSIONS: This is the largest pediatric series of skull base fractures reporting rates of morbidity and longterm outcomes published to date. The rate of meningitis following skull base fracture in children is low, supporting a policy of not administering prophylactic antibiotics or pneumococcal vaccine. Long-term follow up is important to identify delayed complications.	[Leibu, Sharon; Benifla, Mony] Hadassah Kerem Med Ctr, Neurosurg Pediat Unit, Jerusalem, Israel; [Rosenthal, Guy; Shoshan, Yigal; Benifla, Mony] Hadassah Kerem Med Ctr, Neurosurg Dept, Jerusalem, Israel		Benifla, M (corresponding author), Hadassah Kerem Med Ctr, Neurosurg Pediat Unit, Jerusalem, Israel.; Benifla, M (corresponding author), Hadassah Kerem Med Ctr, Neurosurg Dept, Jerusalem, Israel.	beniflam@yahoo.com					Abuabara Allan, 2007, Med Oral Patol Oral Cir Bucal, V12, pE397; Alhelali I, 2015, J TRAUMA ACUTE CARE, V78, P1155, DOI 10.1097/TA.0000000000000662; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Bell R Bryan, 2010, Atlas Oral Maxillofac Surg Clin North Am, V18, P181, DOI 10.1016/j.cxom.2010.08.003; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Brodie HA, 1997, AM J OTOL, V18, P188; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Clauser L, 2004, CHILD NERV SYST, V20, P168, DOI 10.1007/s00381-003-0868-0; Coon D, 2014, PLAST RECONSTR SURG, V134, p442E, DOI 10.1097/PRS.0000000000000421; Dalgic A, 2008, MINIM INVAS NEUROSUR, V51, P154, DOI 10.1055/s-2008-1042437; Friedman J A, 2000, Neurosurg Focus, V9, pe1, DOI 10.3171/foc.2000.9.1.1; GLARNER H, 1994, J TRAUMA, V36, P198, DOI 10.1097/00005373-199402000-00009; Iacob G, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P643; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; Katzen JT, 2003, J TRAUMA, V54, P1026, DOI 10.1097/01.TA.0000066180.14666.8B; Kerman M, 2002, NEUROSURG QUART, V12, P23, DOI 10.1097/00013414-200203000-00003; KITCHENS JL, 1991, J PEDIATR SURG, V26, P992, DOI 10.1016/0022-3468(91)90849-O; McCutcheon BA, 2013, OTOLARYNG HEAD NECK, V149, P931, DOI 10.1177/0194599813508539; MCGUIRT WF, 1995, LARYNGOSCOPE, V105, P359, DOI 10.1288/00005537-199504000-00003; Pebody R G, 2005, Euro Surveill, V10, P174, DOI 10.2807/esm.10.09.00564-en; Perheentupa U, 2010, INT J PEDIATR OTORHI, V74, P1245, DOI 10.1016/j.ijporl.2010.07.023; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Sirichai P, 2015, BRIT J ORAL MAX SURG, V53, P938, DOI 10.1016/j.bjoms.2015.06.007; Tasdemiroglu E, 2002, NEUROSURG QUART, V12, P42; Tunik MG, 2016, ANN EMERG MED, V68, P431, DOI 10.1016/j.annemergmed.2016.04.058; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Yellinek S, 2016, J CLIN NEUROSCI, V25, P111, DOI 10.1016/j.jocn.2015.10.012; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3; Ziu M, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.4.FOCUS1244	31	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2017	103						315	321		10.1016/j.wneu.2017.04.068			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FA5JR	WOS:000405479900041	28433849				2022-02-06	
J	Su, JH; Wu, YH; Guo, NW; Huang, CF; Li, CF; Chen, CH; Huang, MH				Su, Jyong-Huei; Wu, Yu-Hsin; Guo, Nai-Wen; Huang, Ching-Fen; Li, Cyuan-Fong; Chen, Chia-Hsin; Huang, Mao-Hsiung			The effect of cranioplasty in cognitive and functional improvement: Experience of post traumatic brain injury inpatient rehabilitation	KAOHSIUNG JOURNAL OF MEDICAL SCIENCES			English	Article						Traumatic brain injury; Cranioplasty; Rehabilitation; Cognitive function	CEREBRAL-BLOOD-FLOW; SINKING SKIN FLAP; RECOVERY	To investigate the effect of cranioplasty on rehabilitation of post-traumatic brain injury (TBI) patients, 37 patients with TBI were arranged by retrospectively assessment study. Those TBI patients receiving in-hospital rehabilitation in the Department of Rehabilitation in a medical center of South Taiwan from 2010 to 2015 were assigned into two groups: A and B. All patients entered the multidisciplinary holistic in-patient rehabilitation training for about 1 month. Patients in Group A received decompressive craniectomy (DC), patients in Group B received DC and cranioplasty. All assessments were arranged right on admission and before discharge. The functional activity evaluation included muscle power and Barthel index (BI), and cognitive function evaluation, including the Rancho Los Amigo Scale, Mini Mental State Examination (MMSE), Community Mental State Examination (CMSE), and the Luria-Nebraska Neuropsychological Battery-Screening Test Short Form (LNNBS). The results showed that there were synergetic effects of cranioplasty on post-TBI patients with rehabilitation training, especially in the BI score, and cognitive improvement in CMSE and LNNBS. Copyright (C) 2017, Kaohsiung Medical University. Published by Elsevier Taiwan LLC.	[Su, Jyong-Huei; Wu, Yu-Hsin; Huang, Ching-Fen; Li, Cyuan-Fong; Chen, Chia-Hsin; Huang, Mao-Hsiung] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Guo, Nai-Wen] Natl Cheng Kung Univ, Coll Med, Inst Behav Med, Tainan, Taiwan; [Chen, Chia-Hsin; Huang, Mao-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan		Huang, MH (corresponding author), Kaohsiung Med Univ Hosp, 100 Tzyou 1st Rd, Kaohsiung, Taiwan.	maohuang@ms24.hinet.net					Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Coelho F, 2014, NEUROPSYCH DIS TREAT, V10, P695, DOI 10.2147/NDT.S52875; Corallo F, 2014, FUNCT NEUROL, V29, P273, DOI 10.11138/FNeur/2014.29.4.273; Corallo F, 2015, TURK NEUROSURG, V25, P193, DOI 10.5137/1019-5149.JTN.10618-14.2; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; Di Stefano C, 2016, BRAIN INJURY, V30, P164, DOI 10.3109/02699052.2015.1090013; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Erdogan E, 2003, NEUROL INDIA, V51, P479; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Golden CJ, 1985, LURIA NEBRASKA NEURO; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Janzen C, 2012, BRAIN INJURY, V26, P101, DOI 10.3109/02699052.2011.635357; Jelcic N, 2013, ACTA NEUROCHIR, V155, P1597, DOI 10.1007/s00701-012-1519-6; Krishnan P, 2006, NEUROL INDIA, V54, P291; Kuo JR, 2004, J CLIN NEUROSCI, V11, P486, DOI 10.1016/j.jocn.2003.06.005; Leon-Carrion J, 2012, J REHABIL MED, V44, P505, DOI 10.2340/16501977-0982; Maekawa M, 1999, NEUROL SURG TOKYO, V27, P717; MAHONEY F I, 1965, Md State Med J, V14, P61; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Sivaramakrishnan A, 2004, NEUROSURGERY, V55, P1344, DOI 10.1227/01.NEU.0000143612.60114.2D; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Winkler PA., 2000, NEUROSURG FOCUS, V8, DOI [10.3171/foc.2000.8.1.1920, DOI 10.3171/FOC.2000.8.1.1920, DOI 10.3171/INS.2000.93.1.0053]; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yu Lifa, 1998, Kaohsiung Journal of Medical Sciences, V14, P779	33	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1607-551X	2410-8650		KAOHSIUNG J MED SCI	Kaohsiung J. Med. Sci.	JUL	2017	33	7					344	350		10.1016/j.kjms.2017.05.002			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FC2UX	WOS:000406695200005	28738975	gold			2022-02-06	
J	Sun, MK; Chen, LL				Sun, Mingkuan; Chen, Liam L.			A Novel Method to Model Chronic Traumatic Encephalopathy in Drosophila	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 125; Mild traumatic brain injury; chronic traumatic encephalopathy; Drosophila; concussion; neurodegeneration; animal model	BRAIN-INJURY; MELANOGASTER; SPECTRUM	Chronic Traumatic Encephalopathy (CTE) is an established neurodegenerative disease that is closely associated with exposure to repetitive mild Traumatic Brain Injury (mTBI). The mechanisms responsible for its complex pathological changes remain largely elusive, despite a recent consensus to define the neuropathological criteria. Here, we describe a novel method to develop a model of CTE in Drosophila melanogaster (Drosophila) in an attempt to identify the key genes and pathways that lead to the characteristic hyperphosphorylated tau accumulation and neuronal death in the brain. Adjustable-strength impacts to inflict mild closed injury are delivered directly to the fly head, subjecting the head to rapid acceleration and deceleration. Our method eliminates the potential problems inherent with other Drosophila mTBI models (e.g., animal death might be induced by damage to other parts of the body or to internal organs). The less labor- and cost-intensive animal care, short life span, and extensive genetic tools make the fruit fly ideal to study CTE pathogenesis and make it possible to perform large-scale, genome-wide forward genetic and pharmacological screens. We anticipate that the ongoing characterization of the model will generate important mechanistic insights on disease prevention and therapeutic approaches.	[Sun, Mingkuan; Chen, Liam L.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21218 USA		Chen, LL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21218 USA.	lchen99@jhmi.edu	Sun, Mingkuan/H-6191-2019	Sun, Mingkuan/0000-0002-4511-5894	Johns Hopkins University School of MedicineJohns Hopkins University	This work was supported by the Johns Hopkins University School of Medicine faculty startup fund to L.C.	APPEL LF, 1993, P NATL ACAD SCI USA, V90, P4937, DOI 10.1073/pnas.90.11.4937; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Drobysheva D, 2008, J HISTOCHEM CYTOCHEM, V56, P1049, DOI 10.1369/jhc.2008.951137; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Katzenberger RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52905; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Piyankarage SC, 2012, ANAL CHEM, V84, P4460, DOI 10.1021/ac3002319; Straw AD, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-5; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579	20	6	6	0	12	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUL	2017		125							e55602	10.3791/55602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3TS	WOS:000407455900021	28715400	Green Published			2022-02-06	
J	Hong, CK; Shim, YS; Sim, SY; Joo, JY; Kwon, MA; Kim, YB; Chung, J				Hong, Chang-Ki; Shim, Yu Shik; Sim, Sook Young; Joo, Jin-Yang; Kwon, Min A.; Kim, Yong Bae; Chung, Joonho			Post-traumatic headache in patients with minimal traumatic intracranial hemorrhage after traumatic brain injury: a retrospective matched case-control study	JOURNAL OF HEADACHE AND PAIN			English	Article						Head trauma; Post-traumatic headache; Traumatic brain injury; Traumatic intracranial hemorrhage	CHRONIC PAIN; SEIZURES; PREVALENCE; SLEEP	Background: No evidence is available on the risks of neurologically asymptomatic minimal traumatic intracranial hemorrhage (mTIH) in patients with traumatic brain injury (TBI) for post-traumatic headache (PTH). The purpose of this study was to investigate whether mTIH in patients with TBI was associated with PTH and to evaluate its risk factors. Methods: Between September 2009 and December 2014, 1484 patients with TBI were treated at our institution, 57 of whom had mTIH after TBI and were include in this study. We performed propensity score matching to establish a control group among the 823 patients with TBI treated during the same period. Patients with TBI rated their headaches prospectively using a numeric rating scale (NRS). We compared NRS scores between mTIH group (n = 57) and non-mTIH group (n = 57) and evaluated risk factors of moderate-to-severe PTH (NRS = 4) at the 12-month follow-up. Results: Moderate-to-severe PTH was reported by 21.9% of patients (29.8% in mTIH group and 14.0% in non-mTIH group B, p = 0.012) at the 12-month follow-up. The mean NRS was higher in mTIH group than in non-mTIH group throughout the follow-up period (95% confidence interval [CI], 0.11 to 1.14; p < 0.05, ANCOVA). Logistic regression analysis showed that post-traumatic seizure (odds ratio, 1.520; 95% CI, 1.128-6.785; p = 0.047) and mTIH (odds ratio, 2.194; 95% CI, 1.285-8.475; p = 0.039) were independently associated with moderate-to-severe PTH at the 12-month follow-up. Conclusions: Moderate-to-severe PTH can be expected after TBI in patients with mTIH and post-traumatic seizure. PTH occurs more frequently in patients with mTIH than in those without mTIH.	[Hong, Chang-Ki; Joo, Jin-Yang; Kwon, Min A.; Kim, Yong Bae; Chung, Joonho] Yonsei Univ, Dept Neurosurg, Gangnam Severance Hosp, Coll Med, 211 Eonjuro, Seoul 06273, South Korea; [Hong, Chang-Ki; Chung, Joonho] Yonsei Univ, Severance Inst Vasc & Metab Res, Seoul, South Korea; [Shim, Yu Shik] Inha Univ, Dept Neurosurg, Sch Med & Hosp, Incheon, South Korea; [Sim, Sook Young] Inje Univ, Dept Neurosurg, Seoul Paik Hosp, Seoul, South Korea; [Chung, Joonho] Rush Univ, Dept Neurol Surg, Med Ctr, 1725 W Harrison St,Profess Bldg Suite 855, Chicago, IL 60612 USA		Chung, J (corresponding author), Yonsei Univ, Dept Neurosurg, Gangnam Severance Hosp, Coll Med, 211 Eonjuro, Seoul 06273, South Korea.; Chung, J (corresponding author), Yonsei Univ, Severance Inst Vasc & Metab Res, Seoul, South Korea.	ns.joonho.chung@gmail.com		Kim, Yong Bae/0000-0003-2262-7157; Hong, Changki/0000-0002-2761-0373			Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Gu DQ, 2013, AM J NEURORADIOL, V34, P1227, DOI 10.3174/ajnr.A3353; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hong CK, 2015, HEADACHE, V55, P992, DOI 10.1111/head.12612; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kwong WJ, 2007, CEPHALALGIA, V27, P336, DOI 10.1111/j.1468-2982.2007.01283.x; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Piovesan Elcio J, 2003, Curr Pain Headache Rep, V7, P377, DOI 10.1007/s11916-003-0037-x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61	24	6	6	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	JUN 26	2017	18								64	10.1186/s10194-017-0774-6			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB3HU	WOS:000406034300001	28653247	gold, Green Published			2022-02-06	
J	Thomschewski, A; Holler, Y; Holler, P; Leis, S; Trinka, E				Thomschewski, Aljoscha; Hoeller, Yvonne; Hoeller, Peter; Leis, Stefan; Trinka, Eugen			High Amplitude EEG Motor Potential during Repetitive Foot Movement: Possible Use and Challenges for Futuristic BCIs That Restore Mobility after Spinal Cord Injury	FRONTIERS IN NEUROSCIENCE			English	Article						spinal cord injury; neuroplasticity; brain plasticity; motor evoked potential; electroencephalography; neuroprosthetics	ISCHEMIC NERVE BLOCK; HAND MOVEMENTS; CORTEX REPRESENTATION; CORTICAL POTENTIALS; BRAIN POTENTIALS; PLASTICITY; REORGANIZATION; ADULT; MODULATION; VOLUNTARY	Recent advances in neuroprostheses provide us with promising ideas of how to improve the quality of life in people suffering from impaired motor functioning of upper and lower limbs. Especially for patients after spinal cord injury (SCI), futuristic devices that are controlled by thought via brain-computer interfaces (BCIs) might be of tremendous help in managing daily tasks and restoring at least some mobility. However, there are certain problems arising when trying to implement BCI technology especially in such a heterogenous patient group. A plethora of processes occurring after the injuries change the brain's structure as well as its functionality collectively referred to as neuroplasticity. These changes are very different between individuals, leading to an increasing interest to reveal the exact changes occurring after SCI. In this study we investigated event-related potentials (ERPs) derived fromelectroencephalography (EEG) signals recorded during the (attempted) execution and imagination of hand and foot movements in healthy subjects and patients with SCI. As ERPs and especially early components are of interest for BCI research we aimed to investigate differences between 22 healthy volunteers and 7 patients (mean age = 51.86, SD = 15.49) suffering from traumatic or non-traumatic SCI since 2-314 months (mean = 116,57, SD = 125,55). We aimed to explore differences in ERP responses as well as the general presence of component that might be of interest to further consider for incorporation into BCI research. In order to match the real-life situation of BCIs for controlling neuroprostheses, we worked on small trial numbers (< 25), only. We obtained a focal potential over Pz in ten healthy participants but in none of the patients after lenient artifact rejection. The potential was characterized by a high amplitude, it correlated with the repeated movements (6 times in 6 s) and in nine subjects it significantly differed from a resting condition. Furthermore, there are strong arguments against possible confounding factors leading to the potential's appearance. This phenomenon, occurring when movements are repeatedly conducted, might represent a possible potential to be used in futuristic BCIs and further studies should try to investigate the replicability of its appearance.	[Thomschewski, Aljoscha; Hoeller, Yvonne; Hoeller, Peter; Leis, Stefan; Trinka, Eugen] Paracelsus Med Univ, Christian Doppler Med Ctr, Dept Neurol, Salzburg, Austria; [Thomschewski, Aljoscha; Hoeller, Peter; Leis, Stefan; Trinka, Eugen] Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Thomschewski, Aljoscha; Hoeller, Yvonne] Paris London Univ Salzburg, Dept Psychol, Salzburg, Austria; [Hoeller, Yvonne; Trinka, Eugen] Ctr Cognit Neurosci Salzburg, Salzburg, Austria		Thomschewski, A (corresponding author), Paracelsus Med Univ, Christian Doppler Med Ctr, Dept Neurol, Salzburg, Austria.; Thomschewski, A (corresponding author), Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria.; Thomschewski, A (corresponding author), Paris London Univ Salzburg, Dept Psychol, Salzburg, Austria.	a.thomschewski@salk.at	cohorts, Doctoral College Imaging the Mind - all/I-4689-2018; delete, Doctoral College Imaging the Mind - to/E-5040-2018; Holler, Yvonne/I-8928-2017	Holler, Yvonne/0000-0002-1727-8557; Trinka, Eugen/0000-0002-5950-2692; Thomschewski, Aljoscha/0000-0002-1811-5469	Spinal Cord Injury and Tissue Regeneration Center Salzburg within the Paracelsus Medical University Salzburg	The study at hand was funded by the Spinal Cord Injury and Tissue Regeneration Center Salzburg, which is a non-commercial research organization within the Paracelsus Medical University Salzburg. There was no additional funding regarding the conduct of the manuscript submitted.	Aeschbach D, 1997, NEUROSCI LETT, V239, P121, DOI 10.1016/S0304-3940(97)00904-X; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; BEISTEINER R, 1995, EVOKED POTENTIAL, V96, P183, DOI 10.1016/0168-5597(94)00226-5; BOSCHERT J, 1983, EXP BRAIN RES, V52, P73; BRASILNETO JP, 1993, BRAIN, V116, P511, DOI 10.1093/brain/116.3.511; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Casanova MF, 2012, TRANSL NEUROSCI, V3, P170, DOI 10.2478/s13380-012-0022-0; Castro A, 2007, EUR J NEUROSCI, V25, P2927, DOI 10.1111/j.1460-9568.2007.05532.x; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Cui RQ, 1999, NEUROIMAGE, V9, P124, DOI 10.1006/nimg.1998.0388; CUNNINGTON R, 1995, BRAIN, V118, P935, DOI 10.1093/brain/118.4.935; Curio G., 2009, INT J BIOELECTROMAGN, V11, P65, DOI DOI 10.1007/s11042-013-1612-8; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; DEECKE L, 1987, CIBA F SYMP, V132, P231; Dietz V, 2012, EXP NEUROL, V235, P110, DOI 10.1016/j.expneurol.2011.04.007; Ding YM, 2005, CURR PHARM DESIGN, V11, P1441, DOI 10.2174/1381612053507855; Dirnberger G, 2004, CLIN NEUROPHYSIOL, V115, P378, DOI 10.1016/S1388-2457(03)00328-6; DONOGHUE JP, 1988, J NEUROSCI, V8, P3221; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Espinet SD, 2012, DEV COGN NEUROS-NETH, V2, pS49, DOI 10.1016/j.dcn.2011.12.002; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; FREUDE G, 1987, EUR J APPL PHYSIOL, V56, P105, DOI 10.1007/BF00696384; Geodesics E., 2007, GEODESIC SENSOR NET; Gourab K, 2010, CLIN NEUROPHYSIOL, V121, P2017, DOI 10.1016/j.clinph.2010.05.012; Green JB, 1998, NEUROLOGY, V50, P1115, DOI 10.1212/WNL.50.4.1115; Green JB, 2003, J REHABIL RES DEV, V40, P225; Green JB, 1999, NEUROLOGY, V53, P736, DOI 10.1212/WNL.53.4.736; Hamer H., 2010, EEG POCKETFLYER; Harvey LA, 2016, SPINAL CORD, V54, P914, DOI 10.1038/sc.2016.95; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Jackson A, 2012, NAT REV NEUROL, V8, P690, DOI 10.1038/nrneurol.2012.219; Jain N, 2008, J NEUROSCI, V28, P11042, DOI 10.1523/JNEUROSCI.2334-08.2008; James W., 1890, PRINCIPLES PSYCHOL; Jeong JH, 2017, INT WINT WORKSH BR, P50, DOI [10.1109/IWW-BCI.2017.7858156, 10.1145/3130265.3130323]; KARNI A, 1995, NATURE, V377, P155; Keil A, 2014, PSYCHOPHYSIOLOGY, V51, P1, DOI 10.1111/psyp.12147; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kornhuber HH, 2016, PFLUG ARCH EUR J PHY, V468, P1115, DOI 10.1007/s00424-016-1852-3; Krauledat M, 2004, P ANN INT IEEE EMBS, V26, P4511; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Lippert H., 2006, LEHRBUCH ANATOMIE; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Luft AR, 2002, HUM BRAIN MAPP, V17, P131, DOI 10.1002/hbm.10058; Luu P., 2005, DETERMINATION HYDROC; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Merzenich M M, 1993, Curr Opin Neurobiol, V3, P187, DOI 10.1016/0959-4388(93)90209-H; Nash Mark S, 2005, J Neurol Phys Ther, V29, P87; Noachtar S, 1999, ELECTROENCEPHALOGR S, V52, P21; Ouzky M., 2002, CONCIL EUR DOC, V9401, P27; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Penfield W., 1954, AM J PHYS MED REHABI, V33, P126; Perani D, 2001, NEUROSCI LETT, V303, P62, DOI 10.1016/S0304-3940(01)01649-4; Pfurtscheller G, 2006, BRAIN RES, V1071, P145, DOI 10.1016/j.brainres.2005.11.083; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2005, EURASIP J APPL SIG P, V2005, P3152, DOI 10.1155/ASP.2005.3152; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Pineda JA, 2000, IEEE T REHABIL ENG, V8, P219, DOI 10.1109/86.847822; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Popovic DB, 2002, NEUROMODULATION, V5, P54, DOI 10.1046/j.1525-1403.2002._2009.x; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rossi S, 1998, NEUROIMAGE, V8, P163, DOI 10.1006/nimg.1998.0352; Rupp R, 2013, BIOMED ENG-BIOMED TE, V58, DOI 10.1515/bmt-2013-4440; Rupp Rudiger, 2014, Front Neuroeng, V7, P38, DOI 10.3389/fneng.2014.00038; SANES JN, 1990, EXP BRAIN RES, V79, P479; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; TAMAS LB, 1985, J CLIN NEUROPHYSIOL, V2, P157, DOI 10.1097/00004691-198504000-00003; Tatum W. O, 2008, HDB EEG INTERPRETATI; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; WHO, 2013, INTERNATIONAL PERSPECTIVES ON SPINAL CORD INJURY, P1; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Ziemann U, 1998, J NEUROSCI, V18, P1115	77	6	6	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUN 23	2017	11						3	14	362	10.3389/fnins.2017.00362			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC0TM	WOS:000406551600002	28690497	Green Published, gold			2022-02-06	
J	Mi, YJ; Chen, H; Guo, N; Sun, MY; Zhao, ZH; Gao, XC; Wang, XL; Zhang, RS; Zhou, JB; Gou, XC				Mi, Ya-Jing; Chen, Hai; Guo, Na; Sun, Meng-Yi; Zhao, Zhao-Hua; Gao, Xing-Chun; Wang, Xiao-Long; Zhang, Rui-San; Zhou, Jiang-Bing; Gou, Xing-Chun			Inhibition of PirB Activity by TAT-PEP Improves Mouse Motor Ability and Cognitive Behavior	FRONTIERS IN AGING NEUROSCIENCE			English	Article						PirB; motor capacity; cognitive behavior; TAT-PEP; BDNF	CEREBRAL ISCHEMIC-INJURY; TRAUMATIC BRAIN-INJURY; SYNAPTIC PLASTICITY; RECEPTOR B; EXPRESSION; PROTEIN; MICE; REGENERATION; BDNF; MHCI	Paired immunoglobulin-like receptor B (PirB), a functional receptor for myelin-associated inhibitory proteins, plays an important role in axon regeneration in injured brains. However, its role in normal brain function with age has not been previously investigated. Therefore in this study, we examined the expression level of PirB in the cerebral cortex, hippocampus and cerebellum of mice at 1 month, 3 months and 18 months of age. The results showed that the expression of PirB increased with age. We further demonstrated that overexpression of PirB inhibited neurite outgrowth in PC12 cells, and this inhibitory activity of PirB could be reversed by TAT-PEP, which is a recombinant soluble PirB ectodomain fused with TAT domain for blood-brain barrier penetration. In vivo study, intraperitoneal administration of TAT-PEP was capable of enhancing motor capacity and spatial learning and memory in mice, which appeared to be mediated through regulation of brain-derived neurotrophic factor (BDNF) secretion. Our study suggests that PirB is associated with aging and TAT-PEP may be a promising therapeutic agent for modulation of age-related motor and cognitive dysfunctions.	[Mi, Ya-Jing; Chen, Hai; Guo, Na; Zhao, Zhao-Hua; Gao, Xing-Chun; Wang, Xiao-Long; Zhang, Rui-San; Gou, Xing-Chun] Xian Med Univ, Inst Basic & Translat Med, Xian, Peoples R China; [Mi, Ya-Jing; Chen, Hai; Guo, Na; Zhao, Zhao-Hua; Gao, Xing-Chun; Wang, Xiao-Long; Zhang, Rui-San; Gou, Xing-Chun] Xian Med Univ, Sch Basic Med Sci, Xian, Peoples R China; [Mi, Ya-Jing; Chen, Hai; Guo, Na; Zhao, Zhao-Hua; Gao, Xing-Chun; Wang, Xiao-Long; Zhang, Rui-San; Gou, Xing-Chun] Xian Med Univ, Shaanxi Key Lab Brain Disorders, Xian, Peoples R China; [Chen, Hai] Fourth Mil Med Univ, Tangdu Hosp, Dept Anesthesiol, Xian, Peoples R China; [Sun, Meng-Yi; Zhou, Jiang-Bing; Gou, Xing-Chun] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA		Gou, XC (corresponding author), Xian Med Univ, Inst Basic & Translat Med, Xian, Peoples R China.; Gou, XC (corresponding author), Xian Med Univ, Sch Basic Med Sci, Xian, Peoples R China.; Gou, XC (corresponding author), Xian Med Univ, Shaanxi Key Lab Brain Disorders, Xian, Peoples R China.; Zhou, JB; Gou, XC (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA.	jiangbing.zhou@yale.edu; gouxingchun@189.cn			NSFCNational Natural Science Foundation of China (NSFC) [81471415, 31400913, 81402063, 81271290]; Shaanxi Scientific Research Program fund [16JK1655, 16JK1645]; Shaanxi Natural Science Basic Research Plan fund [2016JQ8022]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS095817, NS095147]	This work was supported by NSFC grant, 81471415, 31400913, 81402063 and 81271290. Shaanxi Scientific Research Program fund 16JK1655 and 16JK1645, Shaanxi Natural Science Basic Research Plan fund 2016JQ8022, NIH Grants NS095817 and NS095147, and the Leading Disciplines Development Government Foundation of Shaanxi. University's Key Disciplines of Molecular Immunology.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Bochner DN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010157; Cai XF, 2012, NEUROCHEM RES, V37, P647, DOI 10.1007/s11064-011-0656-2; Chen YK, 2015, ONCOTARGET, V6, P32575, DOI 10.18632/oncotarget.5331; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Deng B, 2018, MOL NEUROBIOL, V55, P652, DOI 10.1007/s12035-016-0301-9; Deng X, 2012, NEUROSCIENCE, V209, P161, DOI 10.1016/j.neuroscience.2012.02.022; Gou ZY, 2014, J DRUG TARGET, V22, P365, DOI 10.3109/1061186X.2013.878939; Guo F, 2013, CNS NEUROSCI THER, V19, P319, DOI 10.1111/cns.12083; Han L, 2016, NANOMED-NANOTECHNOL, V12, P1833, DOI 10.1016/j.nano.2016.03.005; Karim F, 2001, BRAIN RES REV, V36, P204, DOI 10.1016/S0165-0173(01)00096-0; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014; Li LY, 2017, BEHAV BRAIN RES, V326, P322, DOI 10.1016/j.bbr.2017.03.021; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; Liu J, 2015, NEURAL REGEN RES, V10, P1338, DOI 10.4103/1673-5374.162771; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Matsushita H, 2011, J BIOL CHEM, V286, P25739, DOI 10.1074/jbc.M110.157859; Nakamura Y, 2011, J BIOL CHEM, V286, P1876, DOI 10.1074/jbc.M110.163493; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008; Starkey HDV, 2012, J MOL NEUROSCI, V48, P111, DOI 10.1007/s12031-012-9783-8; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Tong Chuan-Wang, 2015, Zoological Research, V36, P48, DOI 10.13918/j.issn.2095-8137.2015.1.48; Torres LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136399; Wang H, 2012, MOL MED REP, V6, P339, DOI 10.3892/mmr.2012.907; Wang Q, 2008, ANESTHESIOLOGY, V108, P1071, DOI 10.1097/ALN.0b013e318173f66b; Wu YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep15032; You Y, 2015, J NUTR SCI VITAMINOL, V61, P488, DOI 10.3177/jnsv.61.488; Zhou YC, 2010, J HUAZHONG U SCI-MED, V30, P482, DOI 10.1007/s11596-010-0453-1	32	6	7	1	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	JUN 20	2017	9								199	10.3389/fnagi.2017.00199			8	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	EY2AF	WOS:000403769800002	28676756	Green Published, gold			2022-02-06	
J	Wyrick, JM; Kalosza, BA; Coritsidis, GN; Tse, R; Agriantonis, G				Wyrick, Jonathan M.; Kalosza, Brittany A.; Coritsidis, George N.; Tse, Raymond; Agriantonis, George			Trauma care in a multiethnic population: effects of being undocumented	JOURNAL OF SURGICAL RESEARCH			English	Article						Undocumented immigrants; Socioeconomic disparities; Trauma; Social determinants of health	LENGTH-OF-STAY; INSURANCE STATUS; BRAIN-INJURY; LATINO IMMIGRANTS; UNITED-STATES; HEALTH-CARE; OUTCOMES; MORTALITY; DISPARITIES; RISK	Background: Epidemiologic studies have shown that undocumented immigrants (UIs) display characteristics of having a low socioeconomic status and are primarily of ethnic minorities. These social determinants of health are known to be associated with diminished health care access and poor clinical outcomes. We therefore investigated the impact of documentation status on the clinical outcomes of patients with traumatic injuries. Materials and methods: We conducted a retrospective review of the trauma registry at our safety net institution for all adult patients who were admitted from 2010 to 2014. UIs were identified by the absence of a valid social security number within their medical records. Multivariate regression analysis was used to determine the impact of documentation status on in-hospital mortality, length of stay (LOS), and the odds of rehab placement. Results: 4924 trauma patients met the study criteria, of which 1050 (21.3%) were UIs. There was no significant difference in mortality rates between the two populations. Multivariate regression analyses revealed a longer average LOS and a decreased likelihood for placement in an in-patient rehabilitation facility following hospitalization for UIs, even after accounting for insurance, age, injury severity, and other possible confounders known to affect these outcomes. Conclusions: There was no association between in-hospital mortality and documentation status; however, UIs had a longer average LOS and were less likely to be placed into rehab following their hospitalization. A longer LOS and a decreased likelihood for rehabilitation placement suggest that disparities in trauma care exist for UIs, putting them at risk for worse clinical and functional outcomes. (C) 2017 Elsevier Inc. All rights reserved.	[Wyrick, Jonathan M.; Kalosza, Brittany A.; Coritsidis, George N.; Tse, Raymond; Agriantonis, George] Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Surg, 79-01 Broadway,Main Bldg E2-27, Elmhurst, NY 11373 USA		Coritsidis, GN (corresponding author), Icahn Sch Med Mt Sinai, Elmhurst Hosp Ctr, Dept Surg, 79-01 Broadway,Main Bldg E2-27, Elmhurst, NY 11373 USA.	CoritsG@nychhc.org					Bachmeier JD., 2013, DEMOGRAPHIC SOCIOECO; Berk M L, 2001, J Immigr Health, V3, P151; Berk ML, 2000, HEALTH AFFAIR, V19, P51, DOI 10.1377/hlthaff.19.4.51; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Brasel KJ, 2007, ARCH SURG-CHICAGO, V142, P461, DOI 10.1001/archsurg.142.5.461; Carr DD, 2006, PROF CASE MANAG, V11, P195; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chavez LR, 2012, SOC SCI MED, V74, P887, DOI 10.1016/j.socscimed.2011.05.023; Chong VE, 2014, J SURG RES, V191, P251, DOI 10.1016/j.jss.2014.05.008; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Coritsidis GN, 2004, AM J KIDNEY DIS, V43, P424, DOI 10.1053/j.ajkd.2003.11.004; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Kaboli PJ, 2012, ANN INTERN MED, V157, P837, DOI 10.7326/0003-4819-157-12-201212180-00003; Linden EA, 2012, AM J KIDNEY DIS, V60, P354, DOI 10.1053/j.ajkd.2012.05.016; Maldonado CZ, 2013, ACAD EMERG MED, V20, P155, DOI 10.1111/acem.12079; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Migration Policy Institute, 2015, UN IMM POP PROF UN P; Mitchell CD, 2012, J TRAUMA ACUTE CARE, V72, P609, DOI 10.1097/TA.0b013e31824765de; Newest New Yorkers, 2013, NEW NEW YORK CHAR CI; Newgard CD, 2011, AM J PUBLIC HEALTH, V101, P669, DOI 10.2105/AJPH.2010.300063; Nichols H., MED NEWS TODAY; O'Keefe GE, 1999, J TRAUMA, V46, P473, DOI 10.1097/00005373-199903000-00023; Ortega AN, 2007, ARCH INTERN MED, V167, P2354, DOI 10.1001/archinte.167.21.2354; Passel J, 2011, UNAUTHORIZED IMMIGRA; Passel J. S., 2009, PORTRAIT UNDOCUMENTE; Passel Jeffrey S, 2014, UNAUTHORIZED IMMIGRA; SAVITEER SM, 1988, AM J MED, V84, P661, DOI 10.1016/0002-9343(88)90101-5; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Watkins JR, 2014, AM J SURG, V208, P969, DOI 10.1016/j.amjsurg.2014.07.002; Weiner B, 2008, COMMUNITY MIGRANT HO	35	6	6	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 15	2017	214						145	153		10.1016/j.jss.2017.02.006			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	FA3RX	WOS:000405363200020	28624037				2022-02-06	
J	Maclean, FL; Lau, CL; Ozergun, S; O'Shea, RD; Cederfur, C; Wang, J; Healy, KE; Walker, FR; Tomas, D; Horne, MK; Beart, PM; Nisbet, DR				Maclean, Francesca L.; Lau, Chew L.; Ozergun, Sam; O'Shea, Ross D.; Cederfur, Cecilia; Wang, Jason; Healy, Kevin E.; Walker, Frederick R.; Tomas, Doris; Horne, Malcolm K.; Beart, Philip M.; Nisbet, David R.			Galactose-functionalised PCL nanofibre scaffolds to attenuate inflammatory action of astrocytes in vitro and in vivo	JOURNAL OF MATERIALS CHEMISTRY B			English	Article							REACTIVE ASTROCYTES; NEURITE INFILTRATION; GLIAL SCAR; TISSUE; GALECTINS; MICROGLIA; ELECTRO	Astrocytes represent an attractive therapeutic target for the treatment of traumatic brain injury in the glial scar, which inhibits functional repair and recovery if persistent. Many biomaterial systems have been investigated for neural tissue engineering applications, including electrospun nanofibres, which are a favourable biomaterial as they can mimic the fibrous architecture of the extracellular matrix, and are conveniently modified to present biologically relevant cues to aid in regeneration. Here, we synthesised a novel galactose-presenting polymer, poly(L-lysine)-lactobionic acid (PLL-LBA), for use in layer-bylayer (LbL) functionalisation of poly(e-caprolactone) (PCL) nanofibres, to covalently attach galactose moieties to the nanofibre scaffold surface. We have assessed the use of this novel biomaterial system in vitro and in vivo, and have shown, for the first time, the ability of galactose to maintain an attenuated inflammatory profile of astrocytes in culture, and to increase the survival of neurons after traumatic injury, as compared to control PCL nanofibres. This study highlights the importance of galactose in controlling the astrocytic response, and provides a promising biomaterial system to deliver the essential morphological and biological cues to achieve functional repair after traumatic brain injury.	[Maclean, Francesca L.; Nisbet, David R.] Australian Natl Univ, Res Sch Engn, Canberra, ACT, Australia; [Lau, Chew L.; Ozergun, Sam; Cederfur, Cecilia; Tomas, Doris; Horne, Malcolm K.; Beart, Philip M.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Ozergun, Sam; O'Shea, Ross D.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Wang, Jason; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Walker, Frederick R.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Horne, Malcolm K.] St Vincents Hosp, Dept Neurol, Fitzroy, Vic, Australia		Nisbet, DR (corresponding author), Australian Natl Univ, Res Sch Engn, Canberra, ACT, Australia.	david.nisbet@anu.edu.au	O'Shea, Ross D/B-5426-2012; Horne, Malcolm/AAL-5214-2020	O'Shea, Ross D/0000-0002-8178-8797; Horne, Malcolm/0000-0001-9427-2100; Nisbet, David/0000-0002-1343-0769	NHMRCNational Health and Medical Research Council of Australia [APP1020332, APP1020401, APP1019833, APP1050684]; Australian Postgraduate AwardAustralian Government; Australian National University Centre for Advanced Microscopy (CAM); Australian Microscopy and Microanalysis Research Facility (AMMRF); Victorian State Government (Australia)	This research was supported by funding from an NHMRC project grant (APP1020332). FLM was supported by an Australian Postgraduate Award; MKH and PMB were supported by NHMRC Research Fellowships APP1020401 and APP1019833, respectively; DRN was supported by a NHMRC Career Development Fellowship (APP1050684). Access to the facilities of the Australian National University Centre for Advanced Microscopy (CAM) with funding through the Australian Microscopy and Microanalysis Research Facility (AMMRF) is gratefully acknowledged. The Florey Institute of Neuroscience and Mental Health receives infrastructure support from the Victorian State Government (Australia).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Bruggeman KF, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/38/385102; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cheng ZQ, 2016, JOURNAL PRACT, V10, P744, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Collier CP, 2015, CHEM PHYS LIPIDS, V192, P75, DOI 10.1016/j.chemphyslip.2015.07.013; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FEDOROFF S, 1987, NEUROSCIENCE, V22, P255, DOI 10.1016/0306-4522(87)90216-8; Gentile P, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/42/422001; Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646; Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7; Hughes RC, 2001, BIOCHIMIE, V83, P667; Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002; Lau CL, 2011, BRIT J PHARMACOL, V163, P533, DOI 10.1111/j.1476-5381.2011.01259.x; Lau CL, 2014, J NEUROCHEM, V130, P215, DOI 10.1111/jnc.12702; Liddelow S, 2015, CELL, V162, P1170, DOI 10.1016/j.cell.2015.08.029; Maclean F., 2015, NEUROCHEM RES, P1; Maclean FL, 2016, STEM CELLS DEV, V25, P214, DOI 10.1089/scd.2015.0314; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Nisbet DR, 2010, TISSUE ENG PT A, V16, P2833, DOI [10.1089/ten.tea.2009.0677, 10.1089/ten.TEA.2009.0677]; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; O'Shea RD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00050; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pettikiriarachchi JTS, 2010, AUST J CHEM, V63, P1143, DOI 10.1071/CH10159; Poras JR, 2015, J IMMUNOL METHODS, V420, P38, DOI 10.1016/j.jim.2015.03.013; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Qu WS, 2011, J NEUROCHEM, V116, P217, DOI 10.1111/j.1471-4159.2010.07095.x; Qu WS, 2010, NEUROCHEM RES, V35, P1716, DOI 10.1007/s11064-010-0234-z; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rodriguez AL, 2016, NANO RES, V9, P674, DOI 10.1007/s12274-015-0946-0; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Wang TY, 2016, BIOMATERIALS, V74, P89, DOI 10.1016/j.biomaterials.2015.09.039; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhou K, 2012, ACS APPL MATER INTER, V4, P4524, DOI 10.1021/am3007565; Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079	45	6	6	1	15	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-750X	2050-7518		J MATER CHEM B	J. Mat. Chem. B	JUN 14	2017	5	22					4073	4083		10.1039/c7tb00651a			11	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	EX1ZX	WOS:000403026400009	32264140				2022-02-06	
J	Berisha, V; Wang, S; LaCross, A; Liss, J; Garcia-Filion, P				Berisha, Visar; Wang, Shuai; LaCross, Amy; Liss, Julie; Garcia-Filion, Pamela			Longitudinal changes in linguistic complexity among professional football players	BRAIN AND LANGUAGE			English	Article						Chronic traumatic encephalopathy; Linguistic complexity; Natural language processing; Type-to-token ratio; Lexical density	TRAUMATIC BRAIN-INJURY; CONVERSATIONAL SPEECH; ALZHEIMERS-DISEASE; DEMENTIA; MILD; DISCOURSE; LANGUAGE; LIFE	Reductions in spoken language complexity have been associated with the onset of various neurological disorders. The objective of this study is to analyze whether similar trends are found in professional football players who are at risk for chronic traumatic encephalopathy. We compare changes in linguistic complexity (as indexed by the type-to-token ratio and lexical density) measured from the interview transcripts of players in the National Football League (NFL) to those measured from interview transcripts of coaches and/or front-office NFL executives who have never played professional football. A multilevel mixed model analysis reveals that exposure to the high-impact sport (vs no exposure) was associated with an overall decline in language complexity scores over time. This trend persists even after controlling for age as a potential confound. The results set the stage for a prospective study to test the hypothesis that language complexity decline is a harbinger of chronic traumatic encephalopathy. (C) 2017 Elsevier Inc. All rights reserved.	[Berisha, Visar; Wang, Shuai; LaCross, Amy; Liss, Julie] Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85284 USA; [Berisha, Visar] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ 85284 USA; [Garcia-Filion, Pamela] Univ Arizona, Coll Med Phoenix, Dept Biomed Informat, Tucson, AZ 85721 USA		Berisha, V (corresponding author), Arizona State Univ, Dept Speech & Hearing Sci, Tempe, AZ 85284 USA.; Berisha, V (corresponding author), Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ 85284 USA.	visar@asu.edu		Berisha, Visar/0000-0001-8804-8874	NIH-NIDCD R21 Research Grant [1R21DC013812]; Arizona State University Athletics Research Grant; NSF STTR Phase I GrantNational Science Foundation (NSF)NSF - Directorate for Engineering (ENG) [1448184]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC006859, R21DC013812] Funding Source: NIH RePORTER	The authors gratefully acknowledge partial support of this work by NIH-NIDCD R21 Research Grant 1R21DC013812, NSF STTR Phase I Grant 1448184 awarded to Aural Analytics, LLC, and an Arizona State University Athletics Research Grant.	ANDREASEN NJC, 1976, ARCH GEN PSYCHIAT, V33, P1361; Berisha V, 2015, J ALZHEIMERS DIS, V45, P959, DOI 10.3233/JAD-142763; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Borovsky A, 2007, NEUROPSYCHOLOGIA, V45, P2525, DOI 10.1016/j.neuropsychologia.2007.03.023; Bucks RS, 2000, APHASIOLOGY, V14, P71, DOI 10.1080/026870300401603; Coupland N, 2007, KEY T SOCIOLINGUIST, P1, DOI 10.1017/CBO9780511755064; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Fergadiotis G, 2013, AM J SPEECH-LANG PAT, V22, pS397, DOI 10.1044/1058-0360(2013/12-0083); Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; KEMPER S, 1990, DISCOURSE PROCESS, V13, P207, DOI 10.1080/01638539009544754; Kemper S, 2001, PSYCHOL AGING, V16, P600, DOI 10.1037//0882-7974.16.4.600; Kemper S, 2001, PSYCHOL AGING, V16, P312, DOI 10.1037//0882-7974.16.2.312; Kemper S, 2001, PSYCHOL AGING, V16, P227, DOI 10.1037/0882-7974.16.2.227; Kempler D., 1995, DEMENTIA COMMUNICATI, P98; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Le X, 2011, LIT LINGUIST COMPUT, V26, P435, DOI 10.1093/llc/fqr013; Lenihan M. W., 2015, CURRENT NEUROLOGY NE, V15, P1; Levin H.S., 1989, MILD HEAD INJURY; Lu XF, 2012, MOD LANG J, V96, P190, DOI 10.1111/j.1540-4781.2011.01232.x; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Rabaglia CD, 2011, LANG COGNITIVE PROC, V26, P1505, DOI 10.1080/01690965.2010.507489; RICHARDS B, 1987, J CHILD LANG, V14, P201, DOI 10.1017/S0305000900012885; RIPICH DN, 1991, BRAIN LANG, V40, P330, DOI 10.1016/0093-934X(91)90133-L; Roark B, 2011, IEEE T AUDIO SPEECH, V19, P2081, DOI 10.1109/TASL.2011.2112351; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Schilling N, 2013, BLACKW HBK LINGUIST, P327; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Vas A. K., 2015, HDB CLIN NEUROLOGY, P128; Wechsler D., 2014, WECHSLER ADULT INTEL, Vfourth	31	6	6	1	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	JUN	2017	169						57	63		10.1016/j.bandl.2017.02.003			7	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	EU9YR	WOS:000401396100007	28327371	Green Accepted			2022-02-06	
J	Beynon, C; Wessels, L; Unterberg, AW				Beynon, Christopher; Wessels, Lars; Unterberg, Andreas W.			Point-of-Care Testing in Neurosurgery	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						intracranial hemorrhage; coagulation; antithrombotic medication; craniotomy; bedside testing	TRAUMATIC BRAIN-INJURY; GOAL-DIRECTED THERAPY; INTRACEREBRAL HEMORRHAGE; ROTATIONAL THROMBOELASTOMETRY; SUBARACHNOID HEMORRHAGE; ORAL ANTICOAGULANTS; PLATELET DYSFUNCTION; ANTIPLATELET THERAPY; INDUCED COAGULOPATHY; PROGNOSTIC VALUE	Coagulation disorders can have a major impact on the outcome of neurosurgical patients. The central nervous system is located within the closed space of the skull, and therefore, intracranial hemorrhage can lead to intracranial hypertension. Acute brain injury has been associated with alterations of various hemostatic parameters. Point-of-care (POC) techniques such as rotational thromboelastometry are able to identify markers of coagulopathy which are not reflected by standard assessment of hemostasis (e.g., hyperfibrinolysis). In patients with acute brain injury, POC test results have been associated with important outcome parameters such as mortality and need for neurosurgical intervention. POC devices have also been used to rapidly identify and quantify the effects of antithrombotic medication. In cases of life-threatening intracranial hemorrhage, this information can be valuable when deciding over administration of prohemostatic substances or immediate neurosurgical intervention. In elective neurosurgical procedures, POC devices can provide important information when unexpected bleeding occurs or in cases of prolonged operative time with subsequent blood loss. Initial experiences with POC devices in neurosurgical care have shown promising results but further studies are needed to characterize their full potential and limitations.	[Beynon, Christopher; Wessels, Lars; Unterberg, Andreas W.] Heidelberg Univ Hosp, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany		Beynon, C (corresponding author), Heidelberg Univ Hosp, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	christopher.beynon@med.uni-heidelberg.de		Wessels, lars/0000-0001-8056-9659	Bayer HealthcareBayer AGBayer Healthcare Pharmaceuticals; Boehringer IngelheimBoehringer Ingelheim; CSL Behring; Roche Diagnostics	C.B. has received speaker honoraria and/or consulting fees from Bayer Healthcare, Boehringer Ingelheim, CSL Behring and research support from Roche Diagnostics. L.W. and A.W.U. declare that they have no conflict of interest.	Abdelmalik PA, 2016, NEUROCRIT CARE, V24, P361, DOI 10.1007/s12028-015-0191-0; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Becattini C, 2017, INT J CARDIOL, V227, P261, DOI 10.1016/j.ijcard.2016.11.117; Beynon C, 2015, THROMB RES, V135, P1218, DOI 10.1016/j.thromres.2015.03.016; Beynon C, 2014, BRIT J NEUROSURG, V28, P29, DOI 10.3109/02688697.2013.869549; Beynon C, 2013, CLIN NEUROL NEUROSUR, V115, P2003, DOI 10.1016/j.clineuro.2013.06.002; Cervera A, 2012, J NEUROL, V259, P212, DOI 10.1007/s00415-011-6153-3; Combescure C, 2010, J THROMB HAEMOST, V8, P923, DOI 10.1111/j.1538-7836.2010.03809.x; Da Luz LT, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0518-9; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Ebner M, 2015, STROKE, V46, P2741, DOI 10.1161/STROKEAHA.115.010148; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Franchini M, 2015, SEMIN THROMB HEMOST, V41, P788, DOI 10.1055/s-0035-1556046; Frontera JA, 2017, NEUROCRIT CARE, V26, P48, DOI 10.1007/s12028-016-0292-4; Gorlinger K, 2012, TRANSFUS MED HEMOTH, V39, P104, DOI 10.1159/000337186; Goh C, 2013, AM J NEURORADIOL, V34, P721, DOI 10.3174/ajnr.A3418; Haas T, 2014, PEDIATR ANESTH, V24, P774, DOI 10.1111/pan.12341; Harenberg J, 2013, SEMIN THROMB HEMOST, V39, P66, DOI 10.1055/s-0032-1331155; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Karger R, 2012, ISRN HEMATOL, V2012; Karni A, 2001, AM SURGEON, V67, P1098; Kass-Hout T, 2014, INTERV NEUROL, V3, P184, DOI 10.1159/000431261; Kawano-Castillo J, 2014, STROKE, V45, P683, DOI 10.1161/STROKEAHA.113.003826; Khorsand N, 2015, THROMB RES, V135, P9, DOI 10.1016/j.thromres.2014.11.019; Kreitzer NP, 2015, NEUROCRIT CARE, V23, P427, DOI 10.1007/s12028-015-0187-9; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Levi M, 2012, SEMIN THROMB HEMOST, V38, P292, DOI 10.1055/s-0032-1302444; Naidech AM, 2014, NEUROCRIT CARE, V21, P168, DOI 10.1007/s12028-014-0023-7; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naik BI, 2016, ANESTH ANALG, V123, P1380, DOI 10.1213/ANE.0000000000001509; Naik BI, 2015, J NEUROSURG-SPINE, V23, P239, DOI 10.3171/2014.12.SPINE14620; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; PALMER JD, 1994, NEUROSURGERY, V35, P1061, DOI 10.1227/00006123-199412000-00007; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Prinz V, 2016, ACTA NEUROCHIR, V158, P117, DOI 10.1007/s00701-015-2645-8; Ramchand P, 2016, WORLD NEUROSURG, V96, P215, DOI 10.1016/j.wneu.2016.04.002; Rizos T, 2010, ANN NEUROL, V67, P788, DOI 10.1002/ana.21965; Rolston JD, 2014, J NEUROSURG, V120, P736, DOI 10.3171/2013.10.JNS122419; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schochl H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-15; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; van den Bergh WM, 2006, STROKE, V37, P2326, DOI 10.1161/01.STR.0000236841.16055.0f; Wikkelso A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub3; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53	51	6	7	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	JUN	2017	43	4					416	422		10.1055/s-0037-1599159			7	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	EY5WF	WOS:000404050900008	28346963				2022-02-06	
J	Chieregato, A; Malacarne, P; Cocciolo, F; Ravaldini, M; Russo, E; Viaggi, B; Giardino, M; Rossi, C; Simini, B; Bertolini, G				Chieregato, Arturo; Malacarne, Paolo; Cocciolo, Francesco; Ravaldini, Maurizio; Russo, Emanuele; Viaggi, Bruno; Giardino, Michele; Rossi, Carlotta; Simini, Bruno; Bertolini, Guido			Aggressive versus conservative antibiotic use to prevent and treat ventilator-associated pneumonia in patients with severe traumatic brain injury: comparison of two case series	MINERVA ANESTESIOLOGICA			English	Article						Antibiotic prophylaxis; Brain injuries; Drug resistance; bacterial; Intensive care units; Pneumonia; ventilator-associated	INTENSIVE-CARE-UNIT; SEVERE SEPSIS; SEPTIC SHOCK; INFECTION; SURVEILLANCE; IMPROVEMENT; INITIATION; MORTALITY; DIAGNOSIS; VAP	BACKGROUND: In patients with traumatic brain injury (TBI), ventilator-associated pneumonia (VAP) is considered a dangerous complication, prompting early aggressive antibiotic treatment and prophylaxis. While this approach increases the selection of multidrug-resistant bacteria (MDR), its clinical benefit has not been demonstrated. METHODS: One-year incidence of VAP in severe TBI patients (ICU stay >48 hours, with either Glasgow Coma Scale <= 8 or receiving intracranial pressure monitoring, or having undergone emergency surgery) and the prevalence of MDR among those who eventually developed it, were compared in two Italian intensive care units (ICUs) adopting different antibiotic approaches. Antibiotic use was guideline-driven and aggressive in the Pisa-based unit (165 eligible patients), and very conservative and coupled with non-pharmacological prevention measures in Cesena (262 patients). Data were also compared with those of 208 Italian ICUs participating in the same infection surveillance program. RESULTS: Patient case mix and general care were similar in the two units. Overall antibiotic pressure was higher in Pisa (58.9% vs. 26.1% of beds occupied by patients receiving antibiotics, P<0.0001), as was antibiotic prophylaxis in eligible patients (87.3% vs. 7.6%, P<0.0001; Italian ICUs, 69.2%) and empirical therapy in those who developed VAP (60.8% vs. 25.2%, P<0.0001; Italian ICUs, 51.6%). The incidence rate of VAP did not significantly differ (39.8 per 1000 days of mechanical ventilation in Pisa, 49.3 in Cesena, P=0.16), although it occurred earlier in Cesena (23.0% early VAP in Pisa vs. 61.2% in Cesena, P<0.0001). Mortality was higher in Pisa but Cesena transferred more patients to other hospitals, precluding comparison of the two rates. The prevalence of MDR was higher in Pisa (38.2% vs. 9.9%, P<0.0001; Italian ICUs, 30.2%). CONCLUSIONS: Although not conclusive, these results call into question the prevalent aggressive use of antibiotics in TBI patients and urge the scientific community to produce better evidence for clinical recommendations.	[Chieregato, Arturo] ASST Grande Osped Metropolitano Niguarda, Dept Anesthesia, Unit Neuororesuscitat, Milan, Italy; [Malacarne, Paolo] AOU Pisa, Unit Anesthesia & Resuscitat, Pisa, Italy; [Cocciolo, Francesco; Ravaldini, Maurizio; Russo, Emanuele] AUSL Romagna, Unit Anesthesia & Resuscitat, Cesena, Forli Cesena, Italy; [Viaggi, Bruno] AOU Careggi, Unit Neuroanesthesia & Intens Therapy, Florence, Italy; [Giardino, Michele; Rossi, Carlotta; Bertolini, Guido] IRCCS, Ist Ric Farmacol Mario Negri, Ctr Ric Clin Malattie Rare Aldo & Cele Dacco, GiViTI Coordinating Ctr, Bergamo, Italy; [Simini, Bruno] Lucca Prov Hosp, ASL Lucca, Lucca, Italy		Malacarne, P (corresponding author), Osped Santa Chiara, Pronto Soccorso, Serv Anestesia & Rianimaz, Pisa, Italy.	pmalacarne@hotmail.com	Viaggi, Bruno/X-5074-2018; Bertolini, Guido/AAA-8005-2020; Russo, Emanuele/AAP-5645-2020	Viaggi, Bruno/0000-0001-5710-2479; Bertolini, Guido/0000-0002-3101-4259; Russo, Emanuele/0000-0002-6531-5527	GiViTI, Italian Group for the Evaluation of Interventions in Intensive Care Medicine	The study was funded by GiViTI, Italian Group for the Evaluation of Interventions in Intensive Care Medicine.	Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; Boffelli S, 2006, MINERVA ANESTESIOL, V72, P419; Borgatta B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-211; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS26; Chieregato A, 2007, INTENS CARE MED, V33, P856, DOI 10.1007/s00134-007-0604-4; Cormio M, 2007, NEUROCRIT CARE, V6, P82, DOI 10.1007/s12028-007-0002-3; Corona A, 2010, J ANTIMICROB CHEMOTH, V65, P1276, DOI 10.1093/jac/dkq088; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; ECDC, 2013, POINT PREV SURV HEAL; Fabregas N, 2002, Minerva Anestesiol, V68, P285; Fan E, 2008, AM J RESP CRIT CARE, V178, P1156, DOI 10.1164/rccm.200802-335OC; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hranjec T, 2013, LANCET INFECT DIS, V13, P390, DOI 10.1016/S1473-3099(13)70083-5; Hranjec T, 2012, LANCET INFECT DIS, V12, P774, DOI 10.1016/S1473-3099(12)70151-2; Jung B, 2009, INTENS CARE MED, V35, P101, DOI 10.1007/s00134-008-1248-8; Langer M, 2009, MINERVA ANESTESIOL, V75, P584; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; LEVY MM, 2003, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Magill SS, 2013, AM J INFECT CONTROL, V41, P1096, DOI 10.1016/j.ajic.2013.07.001; Malacarne P, 2010, MINERVA ANESTESIOL, V76, P13; Malacarne P, 2008, CRIT CARE MED, V36, P1105, DOI 10.1097/CCM.0b013e318169ed30; Martin-Loeches I, 2014, CURR OPIN CRIT CARE, V20, P516, DOI 10.1097/MCC.0000000000000124; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Nathan C, 2014, NEW ENGL J MED, V371, P1761, DOI 10.1056/NEJMp1408040; O'Grady NP, 2012, JAMA-J AM MED ASSOC, V307, P2534, DOI 10.1001/jama.2012.6445; Poole D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113676; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; TEASDALE G, 1974, LANCET, V2, P81; Yokota PKO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104475	33	6	7	1	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	JUN	2017	83	6					553	+		10.23736/S0375-9393.17.11068-0			15	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	FF4QL	WOS:000408938800006	28275224				2022-02-06	
J	Esquivel, AO; Sherman, SS; Bir, CA; Lemos, SE				Esquivel, Amanda O.; Sherman, Sarah S.; Bir, Cynthia A.; Lemos, Stephen E.			The Interaction of Intramuscular Ketorolac (Toradol) and Concussion in a Rat Model	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Head impact; Mild traumatic brain injury; Sport related concussion	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HEAD IMPACT EXPOSURE; MORRIS WATER MAZE; ANIMAL-MODEL; BEHAVIORAL IMPAIRMENTS; PROFESSIONAL FOOTBALL; DAMAGE; PROTEIN; S100B	The purpose of this study was to examine the interaction of a single dose of Toradol and head impact in an in vivo rat model for sport-related concussion using a validated rat concussion model. Thirty-five Sprague-Dawley rats were placed into one of four groups: (1) Control, (2) Impact Only, (3) Toradol Only, (4) Impact and Toradol. Animals in the impact groups were subjected to a single head impact. Animals in the Toradol group received a single intramuscular injection of Toradol prior to impact. We examined magnetic resonance imaging, serum S100-B and cognitive function using a Morris Water Maze. In the control group, latency decreased significantly from day 0 (74.9 s) to 24 h (57.4 s) after anesthesia. There was no statistically significant difference between time zero and 24 h after impact in the Impact only or Impact and Toradol group. Our findings indicate that there were no differences between cognitive ability, MRI findings or S100B in rats that were administered a single dose of Toradol and subjected to a single impact and rats that were subjected to a single impact only. In both impact groups there were transient changes in cognitive ability as measured by the Morris Water Maze.	[Esquivel, Amanda O.] Univ Michigan Dearborn, Dept Mech Engn, Coll Engn & Comp Sci, 4901 Evergreen Rd,2074 IAVS, Dearborn, MI 48128 USA; [Sherman, Sarah S.; Lemos, Stephen E.] Wayne State Univ, 818 W Hancock, Detroit, MI USA; [Bir, Cynthia A.] Univ Southern Calif, Keck Sch Med, Mudd Mem Res Bldg,1333 San Pablo St,Room 116, Los Angeles, CA 90033 USA; [Lemos, Stephen E.] Detroit Med Ctr, Dept Sports Med, 28800 Ryan Rd, Warren, MI 48092 USA		Esquivel, AO (corresponding author), Univ Michigan Dearborn, Dept Mech Engn, Coll Engn & Comp Sci, 4901 Evergreen Rd,2074 IAVS, Dearborn, MI 48128 USA.	aoe@umich.edu		Bir, Cynthia/0000-0002-0777-0951; Esquivel, Amanda/0000-0002-0793-4581			Ali MS, 2000, BRIT J ANAESTH, V85, P287, DOI 10.1093/bja/85.2.287; Bolouri H, 2012, ACTA NEUROL SCAND, V125, P241, DOI 10.1111/j.1600-0404.2011.01614.x; Bouvier D, 2017, SPORTS MED, V47, P781, DOI 10.1007/s40279-016-0579-9; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Buckley EM, 2015, J CEREBR BLOOD F MET, V35, P1995, DOI 10.1038/jcbfm.2015.161; Connolly ES, 2001, NEUROSURGERY, V49, P1076, DOI 10.1097/00006123-200111000-00010; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Dietzel Douglas P, 2004, Curr Sports Med Rep, V3, P310; Dobre MC, 2007, MAGN RESON IMAGING, V25, P733, DOI 10.1016/j.mri.2006.10.020; Havnes MB, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12546; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Kallakuri S, 2015, J CLIN IMAG SCI, V5, DOI 10.4103/2156-7514.166354; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; Lalonde R, 2003, CEREBELLUM, V2, P300, DOI 10.1080/14734220310017456; Luh WM, 1999, MAGNET RESON MED, V41, P1246, DOI 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matava M, 2012, SPORTS HEALTH, V4, P377, DOI 10.1177/1941738112457154; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nepple JJ, 2009, SPORTS HEALTH, V1, P396, DOI 10.1177/1941738109343159; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Powell Elisha T, 2002, Curr Sports Med Rep, V1, P191; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; Sawyer GA, 2012, SPORTS HEALTH, V4, P319, DOI 10.1177/1941738112439686; Schulte S, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0050-x; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Shaikh H, 2015, TRANSL STROKE RES, V6, P224, DOI 10.1007/s12975-015-0387-9; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Tokish JM, 2002, PHYSICIAN SPORTSMED, V30, P19, DOI 10.3810/psm.2002.09.428; Veilleux-Lemieux D, 2013, J AM ASSOC LAB ANIM, V52, P567; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Vonder Haar C, 2013, BEHAV BRAIN RES, V240, P153, DOI 10.1016/j.bbr.2012.11.029; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Warner DC, 2002, J ADOLESCENT HEALTH, V30, P150, DOI 10.1016/S1054-139X(01)00325-1; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036	40	6	6	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JUN	2017	45	6					1581	1588		10.1007/s10439-017-1809-5			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	EU0DB	WOS:000400678200018	28194658				2022-02-06	
J	Hoshizaki, TB; Karton, C; Oeur, RA; Kendall, M; Dawson, L; Post, A				Hoshizaki, Thomas Blaine; Karton, Clara; Oeur, R. Anna; Kendall, Marshall; Dawson, Lauren; Post, Andrew			An examination of the current National Operating Committee on Standards for Athletic Equipment system and a new pneumatic ram method for evaluating American football helmet performance to reduce risk of concussion	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Biomechanics; head protection; design; brain injury; mechanism of injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; ACCELERATION; PLAYERS; IMPACTS	Brain injuries are prevalent in the sport of American football. Helmets have been used which effectively have reduced the incidence of traumatic brain injury, but have had a limited effect on concussion rates. In an effort to improve the protective capacity of American football helmets, a standard has been proposed by National Operating Committee on Standards for Athletic Equipment that may better represent helmet-to-helmet impacts common to football concussions. The purpose of this research was to examine the National Operating Committee on Standards for Athletic Equipment standard and a new impact method similar to the proposed National Operating Committee on Standards for Athletic Equipment standard to examine the information these methods provide on helmet performance. Five National Operating Committee on Standards for Athletic Equipment-certified American football helmets were impacted according to the National Operating Committee on Standards for Athletic Equipment standard test and a new method based on the proposed standard test. The results demonstrated that the National Operating Committee on Standards for Athletic Equipment test produced larger linear accelerations than the new method, which were a reflection of the stiffer compliance of the standard meant to replicate traumatic brain injury mechanisms of injury. When the helmets were impacted using a new helmet-to-helmet method, the results reflected significant risk of concussive injury but showed differences in rotational acceleration responses between different helmet models. This suggests that the new system is sensitive enough to detect the effect of different design changes on rotational acceleration, a metric more closely associated with risk of concussion. As only one helmet produced magnitudes of response lower than the National Operating Committee on Standards for Athletic Equipment pass/fail using the new system, and all helmets passed the National Operating Committee on Standards for Athletic Equipment standard, these results suggest that further development of helmet technologies must be undertaken to reduce this risk in the future. Finally, these results show that it would be prudent to use both standards together to address risk of injury from traumatic brain injury and concussion.	[Hoshizaki, Thomas Blaine; Karton, Clara; Oeur, R. Anna; Kendall, Marshall; Dawson, Lauren; Post, Andrew] Univ Ottawa, Sch Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada		Post, A (corresponding author), Univ Ottawa, Sch Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca			National Operating Committee on Standards for Athletic Equipment	This research was funded by the National Operating Committee on Standards for Athletic Equipment.	BANDAK FA, 1994, P 38 STAPP CAR CRASH, P145; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; National Operating Committee on Standards for Athletic Equipment (NOCSAE), ND00213M13 NOCSAE; National Operating Committee on Standards for Athletic Equipment (NOCSAE), ND002D014 NOCSAE; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	20	6	6	0	15	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	JUN	2017	231	2					83	90		10.1177/1754337116633376			8	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	EX5JE	WOS:000403276400002					2022-02-06	
J	Hu, GW; Lang, HL; Guo, H; Wu, L; Zhang, P; Kuang, W; Zhu, XG				Hu, Guo-wen; Lang, Hai-li; Guo, Hua; Wu, Lei; Zhang, Pei; Kuang, Wei; Zhu, Xin-gen			A risk score based on admission characteristics to predict progressive hemorrhagic injury from traumatic brain injury in children	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						Prognostic model; Progressive hemorrhagic injury; Traumatic brain injury; Risk score; Children	HEAD TRAUMA; INTRACRANIAL HEMORRHAGE; COAGULOPATHY; COAGULATION; MORTALITY; SEVERITY; TESTS	Traumatic brain injury (TBI) is one of the leading causes of death and disability in children, and progressive hemorrhagic injury (PHI) post TBI is associated with poor outcomes. Therefore, the objective of this study was to develop and validate a prognostic model that uses the information available at admission to determine the likelihood of PHI occurrence after TBI in children. The identified demographic data, cause of injury, clinical predictors on admission, computed tomography scan characteristics, and routine laboratory parameters were collected and used to develop a PHI prognostic model with logistic regression analysis, and the prediction model was validated in 68 children. Eight independent prognostic factors were identified: lower Glasgow coma scale score (3 similar to 8) (6 points), intra-axial bleeding/brain contusion (4 points), midline shift >= 5 mm (9 points), platelets < 100 x 10(9)/L (11 points), prothrombin time > 14 s (6 points), international normalized ratio > 1.25 (7 points), D-dimer >= 5 mg/L (14 points), and glucose >= 10 mmol/L (11 points). We calculated risk scores for each child and defined three risk groups: low risk (0-16 points), intermediate risk (17-36 points), and high risk (37-68 points). In the development cohort, the PHI rates after TBI for the low-, intermediate-, and high-risk groups were 10.1, 47.9, and 84.2%, respectively. In the validation cohort, the corresponding PHI rates were 10.9, 47.5, and 85.4%, respectively. The C-statistic for the point system was 0.873 (p = 0.586 by the Hosmer-Lemeshow test) in the development cohort and 0.877 (p = 0.524 by the Hosmer-Lemeshow test) in the validation cohort. Conclusion: Using admission predictors, we developed a relatively simple risk score that accurately predicted the risk of PHI after TBI in children.	[Hu, Guo-wen; Guo, Hua; Wu, Lei; Zhang, Pei; Kuang, Wei; Zhu, Xin-gen] Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, Nanchang 330006, Jiangxi, Peoples R China; [Lang, Hai-li] Nanchang Univ, Dept Anesthesiol, Affiliated Hosp 2, Nanchang 330006, Jiangxi, Peoples R China		Zhu, XG (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, Nanchang 330006, Jiangxi, Peoples R China.	hugw0625@163.com; langhaili1989@163.com; chiefGHndefy@aliyun.com; doctorwundefy@aliyun.com; luyimei84036@163.com; chenmingjunndxb@163.com; doctorzxgndefy@126.com			Jiangxi Province's Department of Education Project [GJJ14079]; Jiangxi Province's Science and Technology Agency Support Program [20161BBI90054]	The study was funded by the financial support of Jiangxi Province's Department of Education Project (GJJ14079) and Jiangxi Province's Science and Technology Agency Support Program (No. 20161BBI90054).	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; *CDCP, 2005, WEB BAS INJ STAT QUE; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; FIFE D, 1984, J NEUROSURG, V60, P697, DOI 10.3171/jns.1984.60.4.0697; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Joseph B, 2014, AM SURGEON, V80, P335; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; MAYER T, 1981, JAMA-J AM MED ASSOC, V245, P719; Melhem S, 2014, CRIT CARE, V18, DOI 10.1186/cc13713; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Seifman MA, 2011, NEUROSURG REV, V34, P393, DOI 10.1007/s10143-010-0304-3; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Vedantam A, 2015, NEUROSURGERY, V62, P203; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yuan Q, 2015, J CRIT CARE, V30, P116, DOI 10.1016/j.jcrc.2014.07.009	28	6	8	1	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-6199	1432-1076		EUR J PEDIATR	Eur. J. Pediatr.	JUN	2017	176	6					689	696		10.1007/s00431-017-2897-9			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EV0ML	WOS:000401434200002	28343321				2022-02-06	
J	Liang, DY; Sahbaie, P; Sun, Y; Irvine, KA; Shi, XY; Meidahl, A; Liu, P; Guo, TZ; Yeomans, DC; Clark, JD				Liang, De-Yong; Sahbaie, Peyman; Sun, Yuan; Irvine, Karen-Amanda; Shi, Xiaoyou; Meidahl, Anders; Liu, Peng; Guo, Tian-Zhi; Yeomans, David C.; Clark, J. David			TBI-induced nociceptive sensitization is regulated by histone acetylation	IBRO REPORTS			English	Article						Traumatic brain injury; Epigenetic regulation; Biomarker; Curcumin; Histone acetyltransferase; Histone deacetylase		Chronic pain after traumatic brain injury (TBI) is very common, but the mechanisms linking TBI to pain and the pain-related interactions of TBI with peripheral injuries are poorly understood. In these studies we pursued the hypothesis that TBI pain sensitization is associated with histone acetylation in the rat lateral fluid percussion model. Some animals received hindpaw incisions in addition to TBI to mimic polytrauma. Neuropathological analysis of brain tissue from sham and TBI animals revealed evidence of bleeding, breakdown of the blood brain barrier, in the cortex, hippocampus, thalamus and other structures related to pain signal processing. Mechanical allodynia was measured in these animals for up to eight weeks post-injury. Inhibitors of histone acetyltransferase (HAT) and histone deacetylase (HDAC) were used to probe the role of histone acetylation in such pain processing. We followed serum markers including glial fibrillary acidic protein (GFAP), neuron-specific enolase 2 (NSE) myelin basic protein (MBP) and sloop to gauge TBI injury severity. Our results showed that TBI caused mechanical allodynia in the hindpaws of the rats lasting several weeks. Hindpaws contralateral to TBI showed more rapid and profound sensitization than ipsilateral hindpaws. The inhibition of HAT using curcumin 50 mg/kg s.c reduced mechanical sensitization while the HDAC inhibitor suberoylanilide hydroxamic acid 50 mg/kg i.p. prolonged sensitization in the TBI rats. Immunohistochemical analyses of spinal cord tissue localized changes in the level of acetylation of the H3K9 histone mark to dorsal horn neurons. Taken together, these findings demonstrate that TBI induces sustained nociceptive sensitization, and changes in spinal neuronal histone proteins may play an important role. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of International Brain Research Organization.	[Liang, De-Yong; Sahbaie, Peyman; Sun, Yuan; Irvine, Karen-Amanda; Shi, Xiaoyou; Liu, Peng; Guo, Tian-Zhi; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Dept Anesthesiol, 3801 Miranda Ave, Palo Alto, CA 94304 USA; [Liang, De-Yong; Sahbaie, Peyman; Sun, Yuan; Irvine, Karen-Amanda; Shi, Xiaoyou; Meidahl, Anders; Yeomans, David C.; Clark, J. David] Stanford Univ, Sch Med, Dept Anesthesiol Pain & Perioperat Med, Stanford, CA 94305 USA		Liang, DY; Clark, JD (corresponding author), Stanford Univ, Sch Med, Dept Anesthesiol Pain & Perioperat Med, Stanford, CA 94305 USA.	dyliang@stanford.edu; psahbaie@stanford.edu; yuansun@gmail.com; karen.amanda.irvine@gmail.com; xshi@stanford.edu; anders@meidahl.dk; tianmittmm66@163.com; wxtguo@yahoo.com; dcyeomans@stanford.edu; djclark@stanford.edu		Meidahl, Anders Christian/0000-0002-8404-4742	DOD CDMRPUnited States Department of Defense [MR130295]	This work was supported by the DOD CDMRP award MR130295	Andruszkow H, 2013, CLIN ORTHOP RELAT R, V471, P2899, DOI 10.1007/s11999-013-3031-6; Bai GA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-51; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Chen JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10278; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Doehring A, 2011, EUR J PAIN, V15, P11, DOI 10.1016/j.ejpain.2010.06.004; Douglass BJ, 2015, J AM COLL NUTR, V34, P347, DOI 10.1080/07315724.2014.950392; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Guo TZ, 2004, PAIN, V108, P95, DOI 10.1016/j.pain.2003.12.010; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jantan I, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00655; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kadota E, 2000, ACT NEUR S, V76, P69; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Latimer B, 2015, ANTICANCER RES, V35, P6411; Li CQ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-27; Li D, 2015, ANESTHESIOLOGY, V122, P1142, DOI 10.1097/ALN.0000000000000560; Li K, 2014, NEUROREPORT, V25, P1116, DOI 10.1097/WNR.0000000000000237; Li XQ, 2001, ANESTH ANALG, V93, P204; Liang DY, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-59; Liang DY, 2013, J PAIN, V14, P36, DOI 10.1016/j.jpain.2012.10.005; Liang LL, 2015, EPIGENOMICS-UK, V7, P235, DOI [10.2217/EPI.14.75, 10.2217/epi.14.75]; Ling G.S., 2004, CURR PROTOC NEUROSCI; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMahon CG, 2010, J TRAUMA, V69, P1169, DOI 10.1097/TA.0b013e3181cc8889; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Oliveira AS, 2015, CURR MED CHEM, V22, P4196, DOI 10.2174/0929867322666151029104611; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Patil S, 2015, PHYTOMEDICINE, V22, P1103, DOI 10.1016/j.phymed.2015.08.006; Peddada KV, 2015, ORTHOP SURG, V7, P222, DOI 10.1111/os.12183; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schroeter ML, 2015, J NEUROTRAUM, V32, P1380, DOI 10.1089/neu.2013.3163; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; Sun Y, 2014, J PAIN, V15, P856, DOI 10.1016/j.jpain.2014.05.003; Sun Y, 2013, ANESTHESIOLOGY, V119, P1198, DOI 10.1097/ALN.0b013e31829ce340; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Zammataro M, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-68; Zheng ZL, 2015, DRUG DES DEV THER, V9, P4931, DOI 10.2147/DDDT.S90147; Zhu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091303	56	6	6	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-8301			IBRO REP	IBRO Rep.	JUN	2017	2						14	23		10.1016/j.ibror.2016.12.001			10	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VJ5SD	WOS:000608621000002	30135929	gold, Green Published			2022-02-06	
J	O'Sullivan, DM; Fife, GP				O'Sullivan, David M.; Fife, Gabriel P.			Biomechanical head impact characteristics during sparring practice sessions in high school taekwondo athletes	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						biomechanics; injury and prevention; acceleration; trauma	SPORTS INJURIES; ACCELERATION; PERFORMANCE; ATTENUATION; CONCUSSION; PLAYERS; MATCHES	OBJECTIVE The purpose of this study was to monitor head impact magnitude and characteristics, such as impact location and frequency, at high school taekwondo sparring sessions. METHODS Eight male high school taekwondo athletes participated in this study. The head impact characteristics were recorded by X-Patch, a wireless accelerometer and gyroscope, during 6 taekwondo sparring sessions. The outcome measures were the peak linear acceleration (g = 9.81 msec(2)), peak rotational acceleration, rotational velocity, and Head Injury Criterion. RESULTS A total of 689 impacts occurred over 6 sessions involving the 8 athletes. There was an average of 24 impacts per 100 minutes, and there were significant differences in the frequency of impacts among both the sessions and individual athletes. In order of frequency, the most commonly hit locations were the side (38.2%), back (35.7%), and front (23.8%) of the head. CONCLUSIONS The data indicate that there is a relatively high number of head impacts experienced by taekwondo athletes during sparring practice. According to the rotational acceleration predicting impact severity published in previous research, 17.1% of the impacts were deemed to be a moderate and 15.5% were deemed to be severe.	[O'Sullivan, David M.] Pusan Natl Univ, Dept Sports Sci, Busan, South Korea; [Fife, Gabriel P.] Texas State Univ, Dept Hlth & Human Performance, San Marcos, TX 78666 USA		Fife, GP (corresponding author), Texas State Univ, Dept Hlth & Human Performance, San Marcos, TX 78666 USA.	gabefife@txstate.edu			National Research Foundation of Korea - Korean governmentNational Research Foundation of KoreaKorean Government [2014S1A5A8013953]	This work was supported by the National Research Foundation of Korea grant funded by the Korean government (2014S1A5A8013953).	Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Fife GP, 2013, BIOL SPORT, V30, P263, DOI 10.5604/20831862.1077551; Fife GP, 2013, BRIT J SPORT MED, V47, P1161, DOI 10.1136/bjsports-2012-090979; Fife GP, 2012, ARCH BUDO, V8; Fife GP, 2013, INT SPORTMED J, V14, P53; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Koh JO, 2002, CROSSING BOUNDARIES, V1, P1; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Lennon A., 2015, THESIS; Lystad RP, 2013, J SPORT MED PHYS FIT, V53, P655; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; Moffitt M, 1995, THESIS; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; O'Sullivan D, 2009, J SPORT SCI MED, V8, P13; O'Sullivan DM, 2016, EUR J SPORT SCI, V16, P1219, DOI 10.1080/17461391.2016.1161073; O'Sullivan DM, 2013, BRIT J SPORT MED, V47, P447, DOI 10.1136/bjsports-2012-091416; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Siana J E, 1986, Br J Sports Med, V20, P165; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	26	6	6	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2017	19	6					662	667		10.3171/2017.1.PEDS16432			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EV6OW	WOS:000401889700007	28387642	Bronze			2022-02-06	
J	Shih, CC; Yeh, CC; Hu, CJ; Lane, HL; Tsai, CC; Chen, TL; Liao, CC				Shih, Chun-Chuan; Yeh, Chun-Chieh; Hu, Chaur-Jong; Lane, Hsin-Long; Tsai, Chin-Chuan; Chen, Ta-Liang; Liao, Chien-Chang			Risk of dementia in patients with non-haemorrhagic stroke receiving acupuncture treatment: a nationwide matched cohort study from Taiwan's National Health Insurance Research Database	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; REHABILITATION; MORTALITY; MIGRAINE; EFFICACY; OUTCOMES; DISEASE; SURGERY; OBESITY; SAFETY	Objective To investigate the risk of dementia in patients with stroke who did and did not receive acupuncture treatment. Design Retrospective cohort study. Setting This study was based on Taiwan's National Health Insurance Research Database that included patients with stroke hospitalised between 1 January 2000 and 31 December 2004. Participants We identified 11 220 patients aged 50 years and older with newly diagnosed stroke hospitalisation. Primary and secondary outcome measures We compared the incident dementia during the follow-up period until the end of 2009 in patients with stroke who did and did not receive acupuncture. The adjusted HRs and 95% CIs of dementia associated with acupuncture were calculated in multivariate Cox proportional hazard regressions. Results Acupuncture treatment was associated with a decreased risk of dementia with multivariate adjustment (HR, 0.73; 95% CI 0.66 to 0.80), and the association was significant in both sexes and every age group, as well as in groups with ischaemic stroke, with fewer medical conditions and those hospitalised after stroke. Patients with stroke received acupuncture treatment, and conventional rehabilitation was associated with a significantly reduced risk of poststroke dementia (HR, 0.64; 95% CI 0.56 to 0.74). Conclusions This study raises the possibility that patients with non-haemorrhagic stroke who received acupuncture had a reduced risk of dementia. The results suggest the need for prospective sham-controlled and randomised trials to establish the efficacy of acupuncture in preventing dementia.	[Shih, Chun-Chuan; Lane, Hsin-Long; Tsai, Chin-Chuan] I Shou Univ, Coll Med, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan; [Shih, Chun-Chuan] Taipei Med Univ, Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan; [Shih, Chun-Chuan] Taipei Chinese Med Assoc, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Hlth Policy Res Ctr, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Liao, Chien-Chang] Taipei Med Univ, Shuang Ho Hosp, Dept Anesthesiol, Taipei, Taiwan		Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ Hosp, Hlth Policy Res Ctr, Taipei, Taiwan.; Liao, CC (corresponding author), China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Anesthesiol, Taipei, Taiwan.	jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	Taiwan's National Union of Chinese Medical Doctors' Association [UNCMA104-H-001]; Shuan Ho Hospital and Taipei Medical University [104TMU-SHH-23]; Ministry of Science and Technology [MOST105-2629-B-038-001, MOST105-2314-B-038-025, MOST104-2314-B-038-027-MY2, MOST103-2320-B-214-010-MY2, NSC102-2314-B-038-021-MY3]; Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP98-RD-038, CCMP99-RD-035]; Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]	This research was supported in part by Taiwan's National Union of Chinese Medical Doctors' Association (UNCMA104-H-001), Shuan Ho Hospital and Taipei Medical University (104TMU-SHH-23), Ministry of Science and Technology (MOST105-2629-B-038-001; MOST105-2314-B-038-025; MOST104-2314-B-038-027-MY2; MOST103-2320-B-214-010-MY2; NSC102-2314-B-038-021-MY3), the Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan (Grants nos. CCMP98-RD-038 and CCMP99-RD-035), and Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004).	Barnes Patricia M, 2008, Natl Health Stat Report, P1; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Chan YY, 2015, J AFFECT DISORDERS, V176, P106, DOI 10.1016/j.jad.2015.01.048; Chang KC, 2012, J NEUROL SCI, V323, P205, DOI 10.1016/j.jns.2012.09.018; Cho SH, 2009, INT J OBESITY, V33, P183, DOI 10.1038/ijo.2008.269; Cho SY, 2012, PARKINSONISM RELAT D, V18, P948, DOI 10.1016/j.parkreldis.2012.04.030; Chon TY, 2013, MAYO CLIN PROC, V88, P1141, DOI 10.1016/j.mayocp.2013.06.009; Chou YC, 2014, J HEAD TRAUMA REHAB, V29, P514, DOI 10.1097/HTR.0000000000000007; Chou YC, 2012, J REHABIL MED, V44, P319, DOI 10.2340/16501977-0935; Chuang CS, 2013, NEUROEPIDEMIOLOGY, V41, P139, DOI 10.1159/000353559; Chuang SF, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0828-8; Devanand DP, 1996, ARCH GEN PSYCHIAT, V53, P175; Flachskampf FA, 2007, CIRCULATION, V115, P3121, DOI 10.1161/CIRCULATIONAHA.106.661140; Gallacher J, 2009, PSYCHOSOM MED, V71, P659, DOI 10.1097/PSY.0b013e3181a6177c; Hanon Olivier, 2005, Alzheimers Dement, V1, P30, DOI 10.1016/j.jalz.2005.06.022; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Lee HC, 2013, J CHIN MED ASSOC, V76, P703, DOI 10.1016/j.jcma.2013.08.003; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114057; Liao CC, 2014, BRIT J SURG, V101, P1616, DOI 10.1002/bjs.9639; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; MacPherson H, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001518; Mukherjee M, 2007, ARCH PHYS MED REHAB, V88, P159, DOI 10.1016/j.apmr.2006.10.034; Park J, 2005, ARCH INTERN MED, V165, P2026, DOI 10.1001/archinte.165.17.2026; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Prince M, 2015, EPIDEMIOLOGY IMPACT; Ritchie K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3885; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Sibolt G, 2013, J NEUROL NEUROSUR PS, V84, P722, DOI 10.1136/jnnp-2012-304084; Wang LP, 2011, PAIN, V152, P1864, DOI 10.1016/j.pain.2011.04.006; Wang SM, 2001, ANESTH ANALG, V92, P548, DOI 10.1213/00000539-200102000-00049; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042730; Wei JW, 2010, STROKE, V41, P1877, DOI 10.1161/STROKEAHA.110.586909; Weng SW, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010539; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Wu P, 2010, STROKE, V41, pE171, DOI 10.1161/STROKEAHA.109.573576; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Yang J, 2015, ALZHEIMERS DEMENT, V11, P16, DOI 10.1016/j.jalz.2014.01.003; Zhang JH, 2014, NEUROEPIDEMIOLOGY, V42, P50, DOI 10.1159/000355435; Zhang SH, 2015, STROKE, V46, P1301, DOI 10.1161/STROKEAHA.114.007659; Zhou J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000933	43	6	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2017	7	6							e013638	10.1136/bmjopen-2016-013638			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB8LT	WOS:000406391200025	28679673	Green Published, Green Submitted, gold			2022-02-06	
J	Silverberg, ND; Wojtowicz, M; Bui, E; Wershba, R; Zafonte, R; Laifer, LM; Simon, NM; Iverson, GL				Silverberg, Noah D.; Wojtowicz, Magdalena; Bui, Eric; Wershba, Rebecca; Zafonte, Ross; Laifer, Lauren M.; Simon, Naomi M.; Iverson, Grant L.			Contribution of Perceived Cognitive Functioning to Quality of Life in Service Members and Veterans With Posttraumatic Stress Disorder	JOURNAL OF TRAUMATIC STRESS			English	Article							TRAUMATIC BRAIN-INJURY; SATISFACTION; DEPRESSION; PTSD	Perceived cognitive impairment is a core clinical feature of posttraumatic stress disorder (PTSD) and may be an important determinant of quality of life (QOL) in those who suffer from this disorder. Using a clinical data repository, we evaluated this hypothesis in a cross-sectional sample of U.S. military service members and veterans who served after September 11, 2001, and were seeking mental health treatment at a tertiary outpatient clinic. A consecutive series of 117 patients with a clinical diagnosis of PTSD completed a battery of questionnaires at intake, including the PTSD Checklist (Weathers, Litz, Herman, Huska, & Keane, 1993), a 4-item Cognitive Symptom subscale of the Neurobehavioral Symptom Inventory (Cicerone & Kalmar, 1995), the Depression Anxiety Stress Scale-21 (Lovibond & Lovibond, 1995), and the Quality of Life Enjoyment and Satisfaction Questionnaire (Endicott, Nee, Harrison, & Blumenthal, 1993). Cognitive symptom reporting was very high, even in the subgroup without a history of traumatic brain injury. In a regression analysis, cognitive symptom severity was independently associated with QOL ( = -.204). This relationship was not explained by comorbid traumatic brain injury, but was restricted to patients with comorbid depression ( = -.278 in the subgroup with an elevated Depression Anxiety Stress Scale-21 Depression subscale; n = 91). In conclusion, perceived cognitive impairment was common in this PTSD sample and helped to explain impairments in QOL, especially in patients with comorbid depression.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.; Wojtowicz, Magdalena; Bui, Eric; Wershba, Rebecca; Zafonte, Ross; Laifer, Lauren M.; Simon, Naomi M.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Home Base, Boston, MA USA; [Wojtowicz, Magdalena; Bui, Eric; Wershba, Rebecca; Zafonte, Ross; Simon, Naomi M.; Iverson, Grant L.] Harvard Med Sch, Dept Psychiat, Boston, MA USA		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca	Bui, Eric/J-8347-2015; Laifer, Lauren/AAU-1704-2020	Bui, Eric/0000-0002-1413-6473; Laifer, Lauren/0000-0001-5473-7882; Iverson, Grant/0000-0001-7348-9570	Home Base, a philanthropic effort of the Red Sox Foundation; Massachusetts General HospitalGeneral Electric	This study was funded by Home Base, a philanthropic effort of the Red Sox Foundation and Massachusetts General Hospital.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Danckwerts A, 2003, NEUROPSYCHOL REV, V13, P221, DOI 10.1023/B:NERV.0000009485.76839.b7; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Olff M, 2014, NEUROBIOL LEARN MEM, V112, P114, DOI 10.1016/j.nlm.2014.01.003; Pineau H, 2015, BEHAV SCI-BASEL, V5, P43, DOI 10.3390/bs5010043; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Revicki DA, 2014, DIALOGUES CLIN NEURO, V16, P127; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vasterling JJ, 2009, J INT NEUROPSYCH SOC, V15, P826, DOI 10.1017/S1355617709990683; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wicksell Rikard K., 2008, Cognitive Behaviour Therapy, V37, P169, DOI 10.1080/16506070802078970	19	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	JUN	2017	30	3					318	322		10.1002/jts.22184			5	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	EY6YJ	WOS:000404130400014	28544024				2022-02-06	
J	Theodore, JE; Theodore, SG; Stockton, KA; Kimble, RM				Theodore, Jane E.; Theodore, Sigrid G.; Stockton, Kellie A.; Kimble, Roy M.			Paediatric horse-related trauma	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						equestrian; horse riding; injury; paediatric; trauma	GLASGOW COMA SCALE; EQUESTRIAN INJURIES; BRAIN-INJURY; SEVERITY; CLASSIFICATION; EPIDEMIOLOGY; PREVENTION; PATTERNS; HELMETS	Aim: This retrospective cohort study reported on the epidemiology of horse-related injuries for patients presenting to the only tertiary paediatric trauma hospital in Queensland. The secondary outcome was to examine the use of helmets and adult supervision. Traumatic brain injury (TBI) was examined in relation to helmet use. Morbidity and mortality were also recorded. Methods: Included were all patients presenting with any horse-related trauma to the Royal Children's Hospital in Brisbane from January 2008 to August 2014. Data were retrospectively collected on patient demographics, hospital length of stay (LOS), mechanism of injury (MOI), safety precautions taken, diagnoses and surgical procedures performed. Results: Included in the analysis were 187 incidents involving 171 patients. Most patients were aged 12-14 years (36.9%) and female (84.5%). The most common MOI were falls while riding horses (97.1%). Mild TBI (24.6%) and upper limb fractures (20.9%) were common injuries sustained. Patients who wore helmets had significantly reduced hospital LOS and severity of TBI when compared with those who did not wear helmets (P < 0.001 and P = 0.028, respectively). Morbidity was reported in 7.5% of patients. There were three deaths in Queensland. Conclusion: Helmet use is recommended for non-riders when handling horses, in addition to being a compulsory requirement whilst horse riding. Prompts in documentation may assist doctors to record the use of safety attire and adult supervision. This will allow future studies to further investigate these factors in relation to clinical outcomes.	[Theodore, Jane E.; Kimble, Roy M.] Univ Queensland, Child Hlth Res Ctr, Ctr Childrens Burns & Trauma Res, Brisbane, Qld, Australia; [Theodore, Jane E.; Kimble, Roy M.] Lady Cilento Childrens Hosp, Dept Paediat & Neonatal Surg Urol Burns & Traum, Brisbane, Qld, Australia; [Theodore, Sigrid G.] Lady Cilento Childrens Hosp, Dept Physiotherapy, Brisbane, Qld, Australia; [Stockton, Kellie A.] Townsville Hosp, Surg Serv Grp, Townsville, Qld, Australia; [Stockton, Kellie A.] Bond Univ, Bond Inst Hlth & Sport, Gold Coast, Qld, Australia		Theodore, JE (corresponding author), Redcliffe Hosp, Dept Surg, Anzac Ave, Redcliffe, Qld 4020, Australia.	jane.theodore@health.qld.gov.au		Stockton, Kellie/0000-0002-0756-5157			Abu-Kishk Ibrahim, 2013, Isr Med Assoc J, V15, P169; Abu-Zidan FM, 2003, INJURY, V34, P897, DOI 10.1016/S0020-1383(03)00054-8; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Australian Campdraft Association Inc, 2015, GEN INF COMP RUL GUI; Australian Centre for Agricultural Health and Safety, 2014, CHILD SAF FARMS; Australian Endurance Riders Association Inc, 2014, NAT RUL; Australian Sports Commission, PART HORS ACT AUSTR; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; BOND GR, 1995, PEDIATRICS, V95, P487; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassell E, 2002, PREVENTING INJURY SP, V51; Chieregato A, 2010, ACTA ANAESTH SCAND, V54, P696, DOI 10.1111/j.1399-6576.2010.02234.x; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; CONDIE C, 1993, PUBLIC HEALTH REP, V108, P121; Craven JA, 2008, EMERG MED AUSTRALAS, V20, P357, DOI 10.1111/j.1742-6723.2008.01107.x; CRIPPS RA, 2000, HORSE RELATED INJURY; Equestrian Australia Limited, 2015, GEN REG; Exadaktylos AK, 2002, EMERG MED J, V19, P573, DOI 10.1136/emj.19.6.573; Ghosh A, 2000, J PEDIATR SURG, V35, P1766, DOI 10.1053/jpsu.2000.19247; Hawson LA, 2010, J VET BEHAV, V5, P324, DOI 10.1016/j.jveb.2010.06.001; Hessler C, 2012, KLIN PADIATR, V224, P443, DOI 10.1055/s-0032-1327621; Holland AJA, 2001, MED J AUSTRALIA, V175, P609, DOI 10.5694/j.1326-5377.2001.tb143746.x; Horse Safety Australia Inc, 2008, STAND RID PROGR; Jagodzinski Tanya, 2005, WMJ, V104, P50; Lang J, 2014, J TRAUMA ACUTE CARE, V76, P205, DOI 10.1097/TA.0b013e3182a9007e; Lim J, 2003, ANZ J SURG, V73, P567, DOI 10.1046/j.1445-2197.2003.02707.x; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; NELSON DE, 1994, AM J PREV MED, V10, P15, DOI 10.1016/S0749-3797(18)30641-X; Pony Club Australia, 2014, GEAR UN REG; Riding for the Disabled Association of Australia Limited, 2015, STAND HELM RDA; Russell A, 2003, ARIA SCORES INDEX AC; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherry K., 1991, HORSE RELATED INJURI, V7; Smartt P, 2009, J SCI MED SPORT, V12, P376, DOI 10.1016/j.jsams.2008.04.001; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; The Heights Equestrian Vaulting Group, 2006, VAULT SAF; The Polocrosse Association of Australia Incorporated, 2014, POL RUL INF GAM; The University of Adelaide, 2015, ACC REM IND AUSTR AR; Williams F, 1995, HORSE RELATED INJURI, V23	40	6	6	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health	JUN	2017	53	6					543	550		10.1111/jpc.13471			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FH7OR	WOS:000411379800006	28268253				2022-02-06	
J	Xu, L; Tao, XG; Liu, WM; Li, YN; Ma, J; Lu, T; Han, B; Liu, BY; Zhao, YL; Li, JS; Zhao, JZ				Xu, Long; Tao, Xiaogang; Liu, Weiming; Li, Yanong; Ma, Jun; Lu, Te; Han, Bo; Liu, Baiyun; Zhao, Yuanli; Li, Jingsheng; Zhao, Jizong			Portable near-infrared rapid detection of intracranial hemorrhage in Chinese population	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Intracranial hemorrhage; Traumatic brain injury; Near infrared; TBI; NIR	TRAUMATIC BRAIN-INJURY; CHILDREN; DEVICE; SPECTROSCOPY; INFRASCANNER; HEMATOMAS	Background: Secondary brain injury is the main cause of mortality from traumatic brain injury (TBI). One hallmark of TBI is intracranial hemorrhage, which occurs in 40-50% of severe TBI cases. Early identification of intracranial hematomas in TBI patients allows early surgical evacuation, and can reduce the case fatality rate of TBI. Since pre-hospital care is the weakest part of Chinese emergency care, there is an urgent need for a capability to detect brain hematomas early. The purpose of this observational study was to evaluate the performance of a near infrared (NIR) based, device to screen for traumatic intracranial hematomas in Chinese population. Methods: Data was collected using the NIR device at the time of a computed tomography (CT) or magnetic resonance imaging (MRI) scan was performed to evaluate a suspected TBI. 85 patients were included in the per protocol population. Of the 85 patients, 45 were determined by CT scan to have intracranial hemorrhage. The CT and MRI scans were read by an independent neuroradiologist who was blinded to the NIR measurements. Results: The NIR device demonstrated sensitivity of 95.6% (95% confidence intervals [CI] 83.6-99.2%) and specificity of 92.5% (CI 78.5-98%) in detecting intracranial hematomas larger than 3.5 ml in volume, and that were less than 2.5 cm from the surface of the brain. Conclusion: These results confirm in Chinese population the results of previous studies that demonstrated a NIR based device can reliably screen for intracranial hematomas that are likely to be of clinical importance. (C) 2017 Elsevier Ltd. All rights reserved.	[Xu, Long; Tao, Xiaogang; Liu, Weiming; Lu, Te; Han, Bo; Liu, Baiyun; Zhao, Yuanli; Li, Jingsheng; Zhao, Jizong] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, 6 Tiantan Xili, Beijing 100050, Peoples R China; [Zhao, Jizong] China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing 100050, Peoples R China; [Li, Yanong; Ma, Jun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China		Zhao, JZ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, 6 Tiantan Xili, Beijing 100050, Peoples R China.	zhaojz205@163.com	Liu, Weiming/O-7968-2019; Liu, Weiming/E-7512-2015	Liu, Weiming/0000-0002-6245-6287; Liu, Weiming/0000-0002-6245-6287			Ayaz Hasan, 2011, Journal of Medical Devices, V5, DOI 10.1115/1.3591407; Bressan S, 2014, CHILD NERV SYST, V30, P477, DOI [10.1007/s00381-014-2368-9, 10.1007/s00381-013-2314-2]; Cope M, 1991, THESIS; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kou K, 2014, WORLD J EMERG MED, V5, P245, DOI 10.5847/wjem.j.issn.1920-8642.2014.04.001; Leon-Carrion J, 2010, BRAIN INJURY, V24, P1193, DOI 10.3109/02699052.2010.506636; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; Liu BY, 2015, CHIN J TRAUMATOL, V18, P135, DOI 10.1016/j.cjtee.2015.04.002; Marion DW, 2006, NEUROSURGERY, V58, P655; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Rolfe P, 2000, ANNU REV BIOMED ENG, V2, P715, DOI 10.1146/annurev.bioeng.2.1.715; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Santalucia P, 2008, NEUROL SCI, V29, pS271, DOI 10.1007/s10072-008-0961-y; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Semenova ZB, 2016, BRAIN INJURY, V30, P18, DOI 10.3109/02699052.2014.989401; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Skotnicka-Klonowicz G, 2014, STANDARDY MED PROBLE, V4, P42; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Tyzo B, 2014, NEUROL PRAKTYCZNA, V2, P13; Zhao YD, 2001, WORLD J SURG, V25, P1202	22	6	6	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2017	40						136	146		10.1016/j.jocn.2017.02.056			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB1DR	WOS:000405884400032	28279553				2022-02-06	
J	Lent, MR; Hoffman, SN; Kirchner, HL; Urosevich, TG; Boscarino, JJ; Boscarino, JA				Lent, Michelle R.; Hoffman, Stuart N.; Kirchner, H. Lester; Urosevich, Thomas G.; Boscarino, Joseph J.; Boscarino, Joseph A.			Attitudes about Future Genetic Testing for Posttraumatic Stress Disorder and Addiction among Community-Based Veterans	FRONTIERS IN PSYCHIATRY			English	Article						genetic testing; posttraumatic stress disorder; addiction; veterans; psychiatric genetics	SERIOUS MENTAL-ILLNESS; TRADE-CENTER DISASTER; PTSD RISK SCORE; NEW-YORK-CITY; PSYCHIATRIC-DISORDERS; PSYCHOTIC DISORDERS; HEALTH-SERVICE; GENOMIC ERA; ALCOHOL-USE; FAMILIES	This study explored attitudes toward hypothetical genetic testing for posttraumatic stress disorder (PTSD) and addiction among veterans. We surveyed a random sample of community-based veterans (n = 700) by telephone. One year later, we asked the veterans to provide a DNA sample for analysis and 41.9% of them returned the DNA samples. Overall, most veterans were not interested in genetic testing neither for PTSD (61.7%) nor for addiction (68.7%). However, bivariate analyses suggested there was an association between having the condition of interest and the likelihood of genetic testing on a 5-point scale (p < 0.001 for PTSD; p = 0.001 for alcohol dependence). While ordinal regressions confirmed these associations, the models with the best statistical fit were bivariate models of whether the veteran would likely test or not. Using logistic regressions, significant predictors for PTSD testing were receiving recent mental health treatment, history of a concussion, younger age, having PTSD, having alcohol dependence, currently taking opioids for pain, and returning the DNA sample during the follow-up. For addiction testing, significant predictors were history of concussion, younger age, psychotropic medication use, having alcohol dependence, and currently taking opioids for pain. Altogether, 25.9% of veterans reported that they would have liked to have known their genetic results before deployment, 15.6% reported after deployment, and 58.6% reported they did not want to know neither before nor after deployment. As advancements in genetic testing continue to evolve, our study suggests that consumer attitudes toward genetic testing for mental disorders are complex and better understanding of these attitudes and beliefs will be crucial to successfully promote utilization.	[Lent, Michelle R.; Boscarino, Joseph A.] Geisinger Med Clin, Dept Epidemiol & Hlth Serv Res, Danville, PA 17822 USA; [Hoffman, Stuart N.; Urosevich, Thomas G.] Geisinger Med Clin, Danville, PA USA; [Kirchner, H. Lester] Geisinger Med Clin, Dept Biomed & Translat Informat, Danville, PA USA; [Boscarino, Joseph J.] William James Coll, Newton, MA USA		Boscarino, JA (corresponding author), Geisinger Med Clin, Dept Epidemiol & Hlth Serv Res, Danville, PA 17822 USA.	jaboscarino@geisinger.edu		Lent, Michelle/0000-0001-7892-1879	Geisinger Auxiliary Fund; Kline & Ditty Health Fund; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21-MH-086317]; Wounded Warrior Project Organization; Department of DefenseUnited States Department of Defense [W81XWH-15-1-0506]	Support for this study was provided in part by the Geisinger Auxiliary Fund, the Kline & Ditty Health Fund, the National Institute of Mental Health (Grant No. R21-MH-086317), the Wounded Warrior Project Organization, and Department of Defense (Contract No. W81XWH-15-1-0506 to JAB).	Adams RE, 2006, J NERV MENT DIS, V194, P485, DOI 10.1097/01.nmd.0000228503.95503.e9; Austin J, 2013, PSYCHIAT TIMES, V30, P15; Austin JC, 2007, PSYCHIAT SERV, V58, P254, DOI 10.1176/appi.ps.58.2.254; Austin JC, 2006, AM J MED GENET B, V141B, P926, DOI 10.1002/ajmg.b.30372; Austin JC, 2008, EARLY INTERV PSYCHIA, V2, P80, DOI 10.1111/j.1751-7893.2008.00062.x; Benedek D.M., 2011, CLIN MANUAL MANAGEME; Bortolotti L, 2011, J MED ETHICS, V37, P673, DOI 10.1136/jme.2010.041111; Boscarino JA, 2005, J TRAUMA STRESS, V18, P287, DOI 10.1002/jts.20039; Boscarino JA, 2004, PSYCHIAT SERV, V55, P274, DOI 10.1176/appi.ps.55.3.274; BOSCARINO JA, 1995, J TRAUMA STRESS, V8, P317, DOI 10.1007/BF02109567; Boscarino JA, 2007, ENCY STRESS, V3, P830; Boscarino Joseph A, 2015, Mil Behav Health, V3, P244; Boscarino Joseph A, 2014, Am J Disaster Med, V9, P107, DOI 10.5055/ajdm.2014.0147; Boscarino JA, 2013, NEUROPSYCH DIS TREAT, V9, P517, DOI 10.2147/NDT.S42422; Boscarino JA, 2012, PSYCHIAT RES, V200, P827, DOI 10.1016/j.psychres.2012.04.022; Boscarino JA, 2012, GEN HOSP PSYCHIAT, V34, P317, DOI 10.1016/j.genhosppsych.2012.01.005; Boscarino JA, 2011, J NERV MENT DIS, V199, P91, DOI 10.1097/NMD.0b013e3182043b39; Breslau N, 2004, PSYCHOL MED, V34, P1205, DOI 10.1017/S0033291704002594; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Costain G, 2014, SCHIZOPHRENIA BULL, V40, P88, DOI 10.1093/schbul/sbs124; Dedert EA, 2012, GENET TEST MOL BIOMA, V16, P1122, DOI 10.1089/gtmb.2012.0048; DeLisi LE, 2006, AM J MED GENET B, V141B, P110, DOI 10.1002/ajmg.b.30249; Department of Veterans Affairs, 2015, PTSD SUBST AB VET; Erlich PM, 2010, HUM GENET, V128, P491, DOI 10.1007/s00439-010-0876-6; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Groves R. M., 2009, SURVEY METHODOLOGY, V561; Hippman C, 2016, J CLIN PSYCHIAT, V77, pE190, DOI 10.4088/JCP.14m09710; Hippman C, 2013, J GENET COUNS, V22, P625, DOI 10.1007/s10897-013-9594-2; Hoffman SN, 2012, PSYCHOSOM MED, V74, P912, DOI 10.1097/PSY.0b013e3182731007; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KING M, 1986, PSYCHOL MED, V16, P213, DOI 10.1017/S0033291700002658; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Laegsgaard MM, 2009, GENET TEST MOL BIOMA, V13, P57, DOI 10.1089/gtmb.2008.0022; Lawrence RE, 2011, PSYCHIATRY, V74, P315, DOI 10.1521/psyc.2011.74.4.315; Lee DJ, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0467-7; Lemeshow S, 2000, APPL LOGISTIC REGRES; Long J.S., 2014, REGRESSION MODELS CA; Meiser B, 2008, GENET TEST, V12, P233, DOI 10.1089/gte.2007.0100; PAULSEN AS, 1988, ARCH GEN PSYCHIAT, V45, P62; Strobel B, 2013, ALCOHOL ALCOHOLISM, V48, P700, DOI 10.1093/alcalc/agt130; WEEKS MF, 1983, AM J PUBLIC HEALTH, V73, P1389, DOI 10.2105/AJPH.73.12.1389; Williams EC, 2014, ADDICTION, V109, P1472, DOI 10.1111/add.12600	45	6	7	0	10	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	MAY 15	2017	8								76	10.3389/fpsyt.2017.00076			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EV3JO	WOS:000401655300001	28555114	Green Published, gold			2022-02-06	
J	Andrews, PJD; Rodriguez, A; Suter, P; Battison, CG; Rhodes, JKJ; Puddu, I; Harris, BA				Andrews, Peter J. D.; Rodriguez, Aryelly; Suter, Peter; Battison, Claire G.; Rhodes, Jonathan K. J.; Puddu, Irene; Harris, Bridget A.			Mortality Risk Stratification After Traumatic Brain Injury and Hazard of Death With Titrated Hypothermia in the Eurotherm3235Trial	CRITICAL CARE MEDICINE			English	Article						IMPACT extended prediction model; randomized controlled trial; therapeutic hypothermia; traumatic brain injury	INTRACRANIAL-PRESSURE REDUCTION; THERAPEUTIC HYPOTHERMIA; DECOMPRESSIVE CRANIECTOMY; EXTERNAL VALIDATION; INTENSIVE-CARE; HEAD-INJURY; IMPACT; MODELS; MODERATE; TRIAL	Objectives: Hypothermia reduces intracranial hypertension in patients with traumatic brain injury but was associated with harm in the Eurotherm3235Trial. We stratified trial patients by International Mission for Prognosis and Analysis of Clinical Trials in [Traumatic Brain Injury] (IMPACT) extended model sum scores to determine where the balance of risks lay with the intervention. Design: The Eurotherm3235Trial was a randomized controlled trial, with standardized and blinded outcome assessment. Patients in the trial were split into risk tertiles by IMPACT extended model sum scores. A proportional hazard analysis for death between randomization and 6 months was performed by intervention and IMPACT extended model sum scores tertiles in both the intention-to-treat and the per-protocol populations of the Eurotherm3235Trial. Setting: Forty-seven neurologic critical care units in 18 countries. Patients: Adult traumatic brain injury patients admitted to intensive care who had suffered a primary, closed traumatic brain injury; increased intracranial pressure; an initial head injury less than 10 days earlier; a core temperature at least 36 degrees C; and an abnormal brain CT. Intervention: Titrated Hypothermia in the range 32-35 degrees C as the primary intervention to reduce raised intracranial pressure. Measurements and Main Results: Three hundred eighty-six patients were available for analysis in the intention-to-treat and 257 in the per-protocol population. The proportional hazard analysis (intention-to-treat and per-protocol populations) showed that the treatment effect behaves similarly across all risk stratums. However, there is a trend that indicates that patients in the low-risk group could be at greater risk of suffering harm due to hypothermia. Conclusions: Hypothermia as a first line measure to reduce intracranial pressure to less than 20 mm Hg is harmful in patients with a lower severity of injury and no clear benefit exists in patients with more severe injuries.	[Andrews, Peter J. D.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Rodriguez, Aryelly] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Suter, Peter] Univ Geneva, Dept Anaesthesiol Pharmacol & Surg Intens Care, Geneva, Switzerland; [Battison, Claire G.; Rhodes, Jonathan K. J.; Harris, Bridget A.] Univ Edinburgh, Dept Anaesthesia Crit Care & Pain Med, Edingburgh, England; [Puddu, Irene] Univ Turin, Dept Anaesthesia & Crit Care, Turin, Italy		Andrews, PJD (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	p.andrews@ed.ac.uk		Battison, Claire/0000-0001-9549-4522	National Institute for Health Research Health Technology Assessment program [11/01/30]; European Society of Intensive Care Medicine (ESICM); BARD; Integra Neuroscience; National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programNational Institute for Health Research (NIHR); University of Edinburgh; National Health Service Lothian; NIHR HTA research grant; NIHRNational Institute for Health Research (NIHR); NIHR HTA; ESICM; National Health Service Research Scotland; Integra; NIHR HTA (U.K. Government); Edinburgh and Lothians Health Foundation; NHS Research Scotland; National Institute for Health ResearchNational Institute for Health Research (NIHR) [11/01/30] Funding Source: researchfish	This project was funded by the National Institute for Health Research Health Technology Assessment program (project number 11/01/30). The European Society of Intensive Care Medicine funded the pilot phase (11).; Professor Andrews (Chief Investigator) disclosed that the European Society of Intensive Care Medicine (ESICM) funded the pilot phase; he received funding from lecturing fees for BARD and Integra Neuroscience, and he received support for article research from the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) program. Sponsored by The University of Edinburgh and National Health Service Lothian. Dr. Rodriguez's institution received funding from NIHR HTA research grant, and she received support for article research from the NIHR. Ms. Battison received support for article research from the NIHR HTA and ESICM. Dr. Rhodes disclosed fellowship support from National Health Service Research Scotland; he received funding from BARD (speakers fees for educational meetings) and Integra (speakers bureau). Dr. Puddu received support for article research from the NIHR HTA. Dr. Harris received support for article research from the NIHR HTA (U.K. Government funding) and from ESICM; her institution received funding from Edinburgh and Lothians Health Foundation, NHS Research Scotland, and from NIHR HTA. Dr. Suter has disclosed that he does not have any potential conflicts of interest.	Andrews PJD, 2016, NEW ENGL J MED, V374, P1385, DOI 10.1056/NEJMc1600339; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-277; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083	24	6	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAY	2017	45	5					883	890		10.1097/CCM.0000000000002376			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES4RK	WOS:000399522200018	28277415	Green Published			2022-02-06	
J	Bauman, WA; Wecht, JM; Biering-Sorensen, F				Bauman, W. A.; Wecht, J. M.; Biering-Sorensen, F.			International spinal cord injury endocrine and metabolic extended data set	SPINAL CORD			English	Article							ACUTE ADRENAL INSUFFICIENCY; TRAUMATIC BRAIN-INJURY; CORONARY-HEART-DISEASE; BONE-MINERAL CONTENT; VITAMIN-D DEFICIENCY; MIDDLE-AGED MEN; BODY-COMPOSITION; RISK-FACTORS; CARDIOVASCULAR-DISEASE; URINARY CALCIUM	Objective: The objective of this study was to develop the International Spinal Cord Injury (SCI) Endocrine and Metabolic Extended Data Set (ISCIEMEDS) within the framework of the International SCI Data Sets that would facilitate consistent collection and reporting of endocrine and metabolic findings in the SCI population. Setting: This study was conducted in an international setting. Methods: The ISCIEMEDS was developed by a working group. The initial ISCIEMEDS was revised based on suggestions from members of the International SCI Data Sets Committee, the International Spinal Cord Society (ISCoS) Executive and Scientific Committees, American Spinal Injury Association (ASIA) Board, other interested organizations, societies and individual reviewers. The data set was posted for two months on ISCoS and ASIA websites for comments. Variable names were standardized, and a suggested database structure for the ISCIEMEDS was provided by the Common Data Elements (CDEs) project at the National Institute on Neurological Disorders and Stroke (NINDS) of the US National Institute of Health (NIH), and are available at https://commondataelements.ninds.nih.gov/SCI.aspx#tab=Data_Standards. Results: The final ISCIEMEDS contains questions on the endocrine and metabolic conditions related to SCI. Because the information may be collected at any time, the date of data collection is important to determine the time after SCI. ISCIEMEDS includes information on carbohydrate metabolism (6 variables), calcium and bone metabolism (12 variables), thyroid function (9 variables), adrenal function (2 variables), gonadal function (7 variables), pituitary function (6 variables), sympathetic nervous system function (1 variable) and renin-aldosterone axis function (2 variables). Conclusion: The complete instructions for data collection and the data sheet itself are freely available on the website of ISCoS (http://www.iscos.org.uk/international-sci-data-sets).	[Bauman, W. A.; Wecht, J. M.] James J Peters Vet Affairs Med Ctr, Dept Vet Affairs Rehabil Res & Dev, Natl Ctr Med Consequences Spinal Cord Injury, New York, NY USA; [Bauman, W. A.; Wecht, J. M.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Bauman, W. A.; Wecht, J. M.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Biering-Sorensen, F.] Univ Copenhagen, Rigshosp, NeuroSci Ctr, Clin Spinal Cord Injuries, Copenhagen, Denmark		Bauman, WA (corresponding author), James J Peters Vet Affairs Med Ctr, Dept Vet Affairs Rehabil Res & Dev, Natl Ctr Med Consequences Spinal Cord Injury, Bronx, NY 10468 USA.	william.bauman@va.gov		Biering-Sorensen, Fin/0000-0002-2186-0144	Department of Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B9212-C]	We are thankful for the comments and suggestions received from Lawrence Vogel, Eva Widerstrom-Noga, Susan Charlifue, Marcel Post, Peter New, Marcalee Sipski Alexander, Leslie Morse, Bill Leslie and Niklas Rye Jorgensen. We thank the Department of Veterans Affairs Rehabilitation Research and Development Service for their support (Grant B9212-C).	Alconcher LF, 1997, PEDIATR NEPHROL, V11, P186, DOI 10.1007/s004670050256; Allan CA, 2004, CLIN ENDOCRINOL, V60, P653, DOI 10.1111/j.1365-2265.2004.02002.x; Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Apstein MD, 1998, METABOLISM, V47, P367, DOI 10.1016/S0026-0495(98)90044-0; Baird GS, 2011, CLIN CHIM ACTA, V412, P696, DOI 10.1016/j.cca.2011.01.004; Bauman WA, 2008, SPINAL CORD, V46, P466, DOI 10.1038/sj.sc.3102161; Bauman WA, 2012, SPINAL CORD, V50, P567, DOI 10.1038/sc.2012.37; Bauman WA, 2011, SPINAL CORD, V49, P1068, DOI 10.1038/sc.2011.51; Bauman W A, 2001, J Spinal Cord Med, V24, P266; BAUMAN WA, 1994, HORM METAB RES, V26, P152, DOI 10.1055/s-2007-1000798; Bauman WA, 1999, OSTEOPOROSIS INT, V10, P123, DOI 10.1007/s001980050206; Bauman WA, 1995, METABOLISM, V44, P1612, DOI 10.1016/0026-0495(95)90083-7; Bauman WA, 2002, SPINAL CORD MED, P164; Bauman WA, 2014, J SPINAL CORD MED, V37, P32, DOI 10.1179/2045772313Y.0000000122; Bhasin S, 2009, FRONT HORM RES, V37, P163, DOI 10.1159/000176052; Biering-Sorensen F, 2006, SPINAL CORD, V44, P530, DOI 10.1038/sj.sc.3101930; Biering-Sorensen F, 2012, SPINAL CORD, V50, P797, DOI 10.1038/sc.2012.102; BIERINGSORENSEN F, 1990, EUR J CLIN INVEST, V20, P330, DOI 10.1111/j.1365-2362.1990.tb01865.x; Binkley Neil, 2008, Curr Osteoporos Rep, V6, P95, DOI 10.1007/s11914-008-0017-5; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Bringhurst FR, 1998, WILLIAMS TXB ENDOCRI, P1152; CHANTRAINE A, 1986, CALCIFIED TISSUE INT, V38, P323, DOI 10.1007/BF02555744; Chen Y, 2000, SPINAL CORD, V38, P346, DOI 10.1038/sj.sc.3101008; CLAUSWALKER J, 1971, J CHRON DIS, V24, P193, DOI 10.1016/0021-9681(71)90110-X; Claydon VE, 2006, SPINAL CORD, V44, P341, DOI 10.1038/sj.sc.3101855; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Closson B L, 1993, Rehabil Nurs, V18, P368; Cragg Jacquelyn J, 2013, Neurology, V81, P723, DOI 10.1212/WNL.0b013e3182a1aa68; Cragg JJ, 2013, NEUROLOGY, V81, P1864, DOI 10.1212/01.wnl.0000436074.98534.6e; CRYER PE, 1976, ARCH NEUROL-CHICAGO, V33, P275, DOI 10.1001/archneur.1976.00500040059009; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Delmas Pierre D., 1993, P108; DeVivo M, 2006, SPINAL CORD, V44, P535, DOI 10.1038/sj.sc.3101958; Dobsa L, 2013, BIOCHEM MEDICA, V23, P172, DOI 10.11613/BM.2013.021; Doty S B, 1995, Curr Opin Orthop, V6, P45; Eser P, 2004, BONE, V34, P869, DOI 10.1016/j.bone.2004.01.001; *EXP COMM DIAGN CL, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; FARRELL CA, 1986, ARCH PHYS MED REHAB, V67, P132, DOI 10.1016/0003-9993(86)90126-7; Fonseca H, 2014, SPORTS MED, V44, P37, DOI 10.1007/s40279-013-0100-7; Freeman R, 2008, NEW ENGL J MED, V358, P615, DOI 10.1056/NEJMcp074189; Garshick E, 2005, SPINAL CORD, V43, P408, DOI 10.1038/sj.sc.3101729; Genuth S, 2003, DIABETES CARE, V26, P3160; GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016, DOI 10.1210/jcem-73-5-1016; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; Heaney RP, 2003, J AM COLL NUTR, V22, P142, DOI 10.1080/07315724.2003.10719287; Holick MF, 1989, VITAMIN D BIOSYNTHES; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Huang TS, 1996, METABOLISM, V45, P718, DOI 10.1016/S0026-0495(96)90137-7; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kostovski E, 2008, SPINAL CORD, V46, P559, DOI 10.1038/sc.2008.3; Koyun M, 2007, PEDIATR NEPHROL, V22, P1297, DOI 10.1007/s00467-007-0528-9; Krassioukov A, 2006, PROG BRAIN RES, V152, P223, DOI 10.1016/S0079-6123(05)52014-4; Kuzeyli K, 2001, Spine (Phila Pa 1976), V26, pE510, DOI 10.1097/00007632-200111010-00023; Ladenson PW, 2000, ARCH INTERN MED, V160, P1573, DOI 10.1001/archinte.160.11.1573; Lecamwasam HS, 2004, ANESTH ANALG, V99, P1813, DOI 10.1213/01.ANE.0000138058.08094.A4; Leroy C, 2013, ANN ENDOCRINOL-PARIS, V74, P496, DOI 10.1016/j.ando.2013.10.002; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; MATHIAS CJ, 1981, CLIN SCI, V60, P399, DOI 10.1042/cs0600399; MATHIAS CJ, 1980, CLIN SCI, V59, P251, DOI 10.1042/cs0590251; MATHIAS CJ, 1975, CLIN SCI MOL MED, V49, P291, DOI 10.1042/cs0490291; MAYNARD FM, 1977, ARCH PHYS MED REHAB, V58, P16; McIver B, 1997, THYROID, V7, P125, DOI 10.1089/thy.1997.7.125; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Ng E, 2004, ULTRASOUND MED BIOL, V30, P1427, DOI 10.1016/j.ultrasmedbio.2004.09.004; Norman AW, 2007, J STEROID BIOCHEM, V103, P204, DOI 10.1016/j.jsbmb.2006.12.071; O'Connell MDL, 2011, J CLIN ENDOCR METAB, V96, P454, DOI 10.1210/jc.2010-1167; OLEFSKY J, 1973, DIABETES, V22, P507, DOI 10.2337/diab.22.7.507; Pastrana EA, 2012, WORLD NEUROSURG, V77, P561, DOI 10.1016/j.wneu.2011.06.041; PIETSCHMANN P, 1992, PARAPLEGIA, V30, P204, DOI 10.1038/sc.1992.56; REUSZ GS, 1995, PEDIATR NEPHROL, V9, P39, DOI 10.1007/BF00858966; Roberts D, 1998, J CLIN ENDOCR METAB, V83, P415, DOI 10.1210/jc.83.2.415; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P345; Sahota IS, 2012, J NEUROTRAUM, V29, P2446, DOI 10.1089/neu.2012.2379; Schopp LH, 2006, AM J PHYS MED REHAB, V85, P678, DOI 10.1097/01.phm.0000228617.94079.4a; Sinelnikov AO, 2007, EMERG RADIOL, V13, P313, DOI 10.1007/s10140-006-0563-z; Sipski M L, 1991, J Am Paraplegia Soc, V14, P122; SIU SCB, 1990, MAYO CLIN PROC, V65, P664, DOI 10.1016/S0025-6196(12)65129-5; SONINO N, 1993, ACTA ENDOCRINOL-COP, V128, P293, DOI 10.1530/acta.0.1280293; Spungen AM, 2003, J APPL PHYSIOL, V95, P2398, DOI 10.1152/japplphysiol.00729.2002; Spungen AM, 2000, J APPL PHYSIOL, V88, P1310, DOI 10.1152/jappl.2000.88.4.1310; STEWART AF, 1982, NEW ENGL J MED, V306, P1136, DOI 10.1056/NEJM198205133061903; Taskinen S, 1996, J UROLOGY, V155, P930, DOI 10.1016/S0022-5347(01)66349-3; Traish AM, 2009, J ANDROL, V30, P23, DOI 10.2164/jandrol.108.005751; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Wang C, 1997, ENDOCRIN METAB CLIN, V26, P189, DOI 10.1016/S0889-8529(05)70240-1; Wang YH, 1999, ARCH PHYS MED REHAB, V80, P863, DOI 10.1016/S0003-9993(99)90075-8; Weaver FM, 2007, AM J PHYS MED REHAB, V86, P22, DOI 10.1097/PHM.0b013e31802b8937; Wecht JM, 2011, ARCH PHYS MED REHAB, V92, P1789, DOI 10.1016/j.apmr.2011.03.022; WILMET E, 1995, PARAPLEGIA, V33, P674, DOI 10.1038/sc.1995.141; Zeitzer JM, 2000, J CLIN ENDOCR METAB, V85, P2189, DOI 10.1210/jc.85.6.2189; Zmuda JM, 1997, AM J EPIDEMIOL, V146, P609, DOI 10.1093/oxfordjournals.aje.a009326	94	6	6	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAY	2017	55	5					466	477		10.1038/sc.2016.164			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EU2JD	WOS:000400854100008	28322240	Bronze			2022-02-06	
J	Corbin-Berrigan, LA; Gagnon, I				Corbin-Berrigan, Laurie-Ann; Gagnon, Isabelle			Postconcussion Symptoms as a Marker of Delayed Recovery in Children and Youth Who Recently Sustained a Concussion: A Brief Report	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mild traumatic brain injury; children; pediatrics; postconcussion symptoms; delayed recovery; slow to recover	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; SEVERITY	Objective: To identify predictors of delayed recovery in children who sustained a concussion and sought care in a pediatric hospital. Design: Retrospective cohort study design. Setting: Montreal Children's Hospital Concussion Clinic database. Patients: Children who sustained a concussion and sought care within 10 days of the injury, with complete medical history and Postconcussion Symptom Scale (PCSS) score available. Independent Variables: Total symptom score on the PCSS, sex, age, history of concussion, sleep disturbances, anxiety, learning disabilities, attention problems, and depression. Main Outcome Measure: Delayed recovery (28 days or more). Results: A total of 213 children (F = 76, M = 138) with a mean age of 13.89 +/- 2.55 years were included. Only total PCSS score at 10 days postinjury was identified as a significant predictor of delayed recovery (odds ratio: 1.019, P = 0.01). Conclusions: This study demonstrates the potential for clinicians to identify, with the sole use of the PCSS, children at risk of experiencing symptoms for longer periods of time.	Trauma Child Dev Montreal Childrens Hosp, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, 3634 Promenade Sir William Osler, Montreal, PQ H3G 1Y5, Canada		Gagnon, I (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, 3634 Promenade Sir William Osler, Montreal, PQ H3G 1Y5, Canada.			Gagnon, Isabelle/0000-0003-2043-1644			Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; World Health Organization, 2004, ICD10 WHO	12	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2017	27	3					325	327		10.1097/JSM.0000000000000355			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	ET9NV	WOS:000400635100014	27347856				2022-02-06	
J	Gabriel, N; Samuel, R; Jayandharan, GR				Gabriel, Nishanth; Samuel, Rekha; Jayandharan, Giridhara R.			Targeted delivery of AAV-transduced mesenchymal stromal cells to hepatic tissue for ex vivo gene therapy	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						mesenchymal stromal cell; gene therapy; adeno-associated virus; liver injury model; hepatocyte; viral vectors	TRAUMATIC BRAIN-INJURY; STEM-CELLS; ADENOASSOCIATED VIRUS; COVALENT BINDING; MOUSE MODEL; MYOCARDIAL-INFARCTION; HUMAN HEPATOCYTES; SKELETAL-MUSCLE; IMMUNE-SYSTEM; MURINE LIVER	Adeno-associated virus (AAV)-mediated gene therapy holds great promise if challenges related to vector neutralization by pre-existing antibodies are circumvented. The use of autologous or allogeneic cells to shield the vector might offer the possibility of successful gene transfer in such a situation. In the present study, we evaluated the feasibility of AAV-transducedmesenchymal stromal cells (MSCs) as a vehicle for hepatic gene transfer in a murine liver injury model. In our initial studies to determine the most suitable vector, we observed that AAV1 (91%) and AAV6 (72%) serotypes are highly efficient in transducing MSCs. Subsequently, we generated a transient liver injury model to analyse the efficacy of MSCs homing to the liver, as well as their hepatic gene transfer efficiency; our data show that administration of acetaminophen (500mg/kg) served as a cue for the homing of MSCs to the liver. Furthermore, sex-mismatched transplantation of AAV1-infected MSCs demonstrated a 3.5-fold (day 7) and 2.2-fold (day 28) higher hepatic gene transfer efficiency. To further corroborate this, we estimated the donor cell Y chromosome copies in the liver of recipient female mice. Our data revealed a 12.7-fold increase in average genome copies of male MSCs in the livers of recipient mice with injury compared to control, 60 days after transplantation. However, in vivo administration of AAV-transduced MSCs in the presence of neutralization antibodies (intravenous immunoglobulin, IVIG) was not beneficial. This is possibly due to the clearance of transplanted MSCs by circulating IVIG and underscores the need to develop suitable in vivo models to study such a mode of gene transfer. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Gabriel, Nishanth; Jayandharan, Giridhara R.] Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India; [Samuel, Rekha] Christian Med Coll & Hosp, Ctr Stem Cell Res, Vellore, Tamil Nadu, India; [Jayandharan, Giridhara R.] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India		Jayandharan, GR (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	jayrao@iitk.ac.in			Department of Science of Technology, Government of India [2011]; Department of Biotechnology (DBT), the Government of India [BT/03/IYBA/2010, BT/PR14748/MED/12/491/2010, BT/PR5021/MED/30/757/2012]; IIT-Kanpur [IIK-BSBE-2014256]	G.R.J. was supported by research grants from the Department of Science of Technology, Government of India (Swarnajayanti Fellowship No. 2011), the Department of Biotechnology (DBT), the Government of India (Senior Innovative Young Biotechnologist Award 2014, Grant Nos BT/03/IYBA/2010, BT/PR14748/MED/12/491/2010 and BT/PR5021/MED/30/757/2012) and an Initiation Grant (IIK-BSBE-2014256) from IIT-Kanpur. We thank Ms Sangeetha Hareendran and Dr Ruchita Selot for technical assistance during the course of this study.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Arbetman AE, 2005, J VIROL, V79, P15238, DOI 10.1128/JVI.79.24.15238-15245.2005; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Bortolussi G, 2014, HUM GENE THER, V25, P844, DOI 10.1089/hum.2013.233; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Chang YK, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-54; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chirmule N, 2000, J VIROL, V74, P2420, DOI 10.1128/JVI.74.5.2420-2425.2000; Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471; Colletti EJ, 2009, STEM CELL RES, V2, P125, DOI 10.1016/j.scr.2008.08.002; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; CORCORAN GB, 1985, J PHARMACOL EXP THER, V232, P864; Doria M, 2013, HUM GENE THER METHOD, V24, P392, DOI 10.1089/hgtb.2013.155; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Forbes SC, 2014, GENE THER, V21, P387, DOI 10.1038/gt.2014.9; Francois S, 2007, ANN HEMATOL, V86, P1, DOI 10.1007/s00277-006-0166-5; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Harkness J. E., 1989, BIOL MED RABBITS ROD; Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040; Ji R, 2012, BIOMATERIALS, V33, P8995, DOI 10.1016/j.biomaterials.2012.08.058; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Karman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034684; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Komada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046436; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kube DM, 1997, NUCLEIC ACIDS RES, V25, P3375, DOI 10.1093/nar/25.16.3375; Kumar S, 2010, MOL THER, V18, P1026, DOI 10.1038/mt.2009.315; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2004, SCAND J IMMUNOL, V60, P307, DOI 10.1111/j.0300-9475.2004.01483.x; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lin ZQ, 2014, CIRC RES, V115, P354, DOI 10.1161/CIRCRESAHA.115.303632; Liu WH, 2015, J CELL MOL MED, V19, P511, DOI 10.1111/jcmm.12482; Lochrie MA, 2006, J VIROL, V80, P821, DOI 10.1128/JVI.80.2.821-834.2006; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Malinowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050709; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mingozzi F, 2009, BLOOD, V114, P2077, DOI 10.1182/blood-2008-07-167510; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; Mitruka B., 1981, CLIN BIOCH HEMATOLOG, VSecond Edition; Mouiseddine M, 2007, BRIT J RADIOL, V80, pS49, DOI 10.1259/bjr/25927054; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakatani K, 2002, CLIN EXP IMMUNOL, V127, P445, DOI 10.1046/j.1365-2249.2002.01769.x; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Pagnotto MR, 2007, GENE THER, V14, P804, DOI 10.1038/sj.gt.3302938; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POTTER WZ, 1973, J PHARMACOL EXP THER, V187, P203; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rabani V, 2010, CELL BIOL INT, V34, P601, DOI 10.1042/CBI20090386; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Scallan CD, 2006, BLOOD, V107, P1810, DOI 10.1182/blood-2005-08-3229; Selot RS, 2013, CURR PHARM BIOTECHNO, V14, P1072, DOI 10.2174/1389201015666140327141710; Seo SH, 2011, GENE THER, V18, P488, DOI 10.1038/gt.2010.170; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Stender S, 2007, EUR CELLS MATER, V13, P93, DOI 10.22203/eCM.v013a10; Stock P, 2010, NAT PROTOC, V5, P617, DOI 10.1038/nprot.2010.7; STOOP JW, 1969, CLIN EXP IMMUNOL, V4, P101; Sundin M, 2009, J IMMUNOTHER, V32, P755, DOI 10.1097/CJI.0b013e3181ab1807; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xia X, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-134; Yadav N, 2009, BLOOD, V114, P4552, DOI 10.1182/blood-2009-02-202788; Yannarelli G, 2014, STEM CELL REV REP, V10, P304, DOI 10.1007/s12015-013-9483-y; Zhao QJ, 2009, BIOL CELL, V101, P557, DOI 10.1042/BC20080105; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	75	6	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	MAY	2017	11	5					1354	1364		10.1002/term.2034			11	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Engineering	EX1MJ	WOS:000402987500004	26053555				2022-02-06	
J	Keskin, I; Gunal, MY; Ayturk, N; Kilic, U; Ozansoy, M; Kilic, E				Keskin, Ilknur; Gunal, M. Yalcin; Ayturk, Nilufer; Kilic, Ulkan; Ozansoy, Mehmet; Kilic, Ertugrul			Dose-dependent neuroprotective effect of enoxaparin on cold-induced traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; neuroprotection; traumatic brain injury; cold-induced brain injury; enoxaparin; anti-oxidative; apoptosis; neural regeneration	MOLECULAR-WEIGHT HEPARIN; NEUROLOGIC RECOVERY; CEREBRAL EDEMA; CELL-DEATH; IN-VIVO; RATS; MECHANISMS; APOPTOSIS; ERYTHROPOIETIN; MELATONIN	Recent evidence exists that enoxaparin can reduce brain injury because of its anticoagulant activity. To investigate the potential therapeutic effect of enoxaparin on cold-induced traumatic brain injury, at 20 minutes after modeling, male BALB/c mouse models of cold-induced traumatic brain injury were intra-peritoneally administered 3 and 10 mg/kg enoxaparin or isotonic saline solution. Twenty-four hours later, enoxaparin at 10 mg/kg greatly reduced infarct volume, decreased cell apoptosis in the cortex and obviously increased serum level of total antioxidant status. By contrast, administration of enoxaparin at 3 mg/kg did not lead to these changes. These findings suggest that enoxaparin exhibits neuroprotective effect on cold-induced traumatic brain injury in a dose-dependent manner.	[Keskin, Ilknur; Ayturk, Nilufer] Medipol Univ, Dept Histol & Embryol, Istanbul, Turkey; [Gunal, M. Yalcin; Ozansoy, Mehmet; Kilic, Ertugrul] Medipol Univ, Dept Physiol, Istanbul, Turkey; [Keskin, Ilknur; Gunal, M. Yalcin; Ayturk, Nilufer; Kilic, Ulkan; Ozansoy, Mehmet; Kilic, Ertugrul] Medipol Univ, Regenerat & Restorat Med Res Ctr REMER, Istanbul, Turkey; [Kilic, Ulkan] Medipol Univ, Dept Med Biol, Istanbul, Turkey		Keskin, I (corresponding author), Medipol Univ, Dept Histol & Embryol, Istanbul, Turkey.; Keskin, I (corresponding author), Medipol Univ, Regenerat & Restorat Med Res Ctr REMER, Istanbul, Turkey.	ilknurkeskin@medipol.edu.tr	Gunal, Mehmet Yalcin/AAT-9806-2021; Kilic, Ertugrul/W-4563-2018; Gunal, Mehmet/AAT-2910-2020; keskin, ilknur/A-6521-2018; Ozansoy, Mehmet/AAG-4970-2019	Kilic, Ertugrul/0000-0001-6494-8923; Gunal, Mehmet/0000-0001-7702-2441; keskin, ilknur/0000-0002-7059-1884; Ozansoy, Mehmet/0000-0002-1079-8832			Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Babaee A, 2015, IRAN J BASIC MED SCI, V18, P867; Gikakis N, 1996, CIRCULATION, V94, P341; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Jonas S, 1997, ANN NY ACAD SCI, V825, P389, DOI 10.1111/j.1749-6632.1997.tb48449.x; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Kobbi Z, 2017, REGUL TOXICOL PHARM, V84, P9, DOI 10.1016/j.yrtph.2016.12.003; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Mary V, 2001, STROKE, V32, P993, DOI 10.1161/01.STR.32.4.993; Michinaga S, 2015, EUR J NEUROSCI, V42, P2356, DOI 10.1111/ejn.13020; Michinaga S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102009; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Pratt J, 1998, HAEMOSTASIS, V28, P78; Quartermain D, 2003, CEREBROVASC DIS, V16, P346, DOI 10.1159/000072556; Schwarzmaier SM, 2016, J NEUROTRAUM, V33, P1634, DOI 10.1089/neu.2015.4173; Sen O, 2011, TURK NEUROSURG, V21, P203, DOI 10.5137/1019-5149.JTN.3646-10.1; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zupan Z, 2011, PROG NEURO-PSYCHOPH, V35, P1846, DOI 10.1016/j.pnpbp.2011.08.005	23	6	6	0	5	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2017	12	5					761	764		10.4103/1673-5374.206646			4	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	EX6UY	WOS:000403378800018	28616032	gold, Green Published			2022-02-06	
J	Kramer, JLK; Geisler, F; Ramer, L; Plunet, W; Cragg, JJ				Kramer, John L. K.; Geisler, Fred; Ramer, Leanne; Plunet, Ward; Cragg, Jacquelyn J.			Open Access Platforms in Spinal Cord Injury: Existing Clinical Trial Data to Predict and Improve Outcomes	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						spinal cord injury; disease progression; heterogeneity; clinical trials; open access; crowdsourcing; SCI; recovery profile	RECOVERY	Recovery from acute spinal cord injury (SCI) is characterized by extensive heterogeneity, resulting in uncertain prognosis. Reliable prediction of recovery in the acute phase benefits patients and their families directly, as well as improves the likelihood of detecting efficacy in clinical trials. This issue of heterogeneity is not unique to SCI. In fields such as traumatic brain injury, Parkinson's disease, and amyotrophic lateral sclerosis, one approach to understand variability in recovery has been to make clinical trial data widely available to the greater research community. We contend that the SCI community should adopt a similar approach in providing open access clinical trial data.	[Kramer, John L. K.; Plunet, Ward; Cragg, Jacquelyn J.] Univ British Columbia, Vancouver, BC, Canada; [Geisler, Fred] Rhausler Inc, Can Carlos, CA USA; [Ramer, Leanne] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada		Kramer, JLK (corresponding author), Univ British Columbia, Vancouver, BC, Canada.; Kramer, JLK (corresponding author), Univ British Columbia, Sch Kinesiol, ICORD, Vancouver, BC, Canada.	kramer@icord.org			Wings for Life Spinal Cord Research Foundation; Rick Hansen Institute; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr Kramer's laboratory is supported by the Wings for Life Spinal Cord Research Foundation, the Rick Hansen Institute, and the Michael Smith Foundation for Health Research. Dr Cragg is a Society in Science Branco Weiss Postdoctoral Fellow and is also supported by the Michael Smith Foundation for Health Research.	Atassi N, 2014, NEUROLOGY, V83, P1719, DOI 10.1212/WNL.0000000000000951; Bedlack RS, 2016, NEUROLOGY, V86, P808, DOI 10.1212/WNL.0000000000002251; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; GEISLER FH, 1991, NEW ENGL J MED, V324, P1829, DOI 10.1056/NEJM199106273242601; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Golle P., 2006, P 5 ACM WORKSH PRIV, P77, DOI DOI 10.1145/1179601.1179615; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hothorn T, 2014, AMYOTROPH LAT SCL FR, V15, P444, DOI 10.3109/21678421.2014.893361; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kuffner R, 2015, NAT BIOTECHNOL, V33, P51, DOI 10.1038/nbt.3051; Lo B, 2015, JAMA-J AM MED ASSOC, V313, P793, DOI 10.1001/jama.2015.292; Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564; Lunetta C, 2016, AMYOTROPH LAT SCL FR, V17, P93, DOI 10.3109/21678421.2015.1083585; MCCARTHY M, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G1135; Navarro Robert, 2008, Inform Prim Care, V16, P257; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Steeves JD, 2011, SPINAL CORD, V49, P257, DOI 10.1038/sc.2010.99; Sweeney L., 2000, HEALTH, V671, P1; Taichman DB, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001950; Wu X, 2015, SPINAL CORD, V53, P84, DOI 10.1038/sc.2014.232	20	6	6	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	MAY	2017	31	5					399	401		10.1177/1545968316688801			3	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ES7EE	WOS:000399711600001	28107789	Bronze			2022-02-06	
J	Lane, AD; Berkman, MR; Verbunker, D; Shekell, T; Bouska, M; Barnett, L; Keogh, A; Nuno, T; Stolz, U; Waterbrook, AL				Lane, Allison D.; Berkman, Matthew R.; Verbunker, David; Shekell, Taylor; Bouska, Michael; Barnett, Lauren; Keogh, Allie; Nuno, Tomas; Stolz, Uwe; Waterbrook, Anna L.			RETROSPECTIVE CHART ANALYSIS OF CONCUSSION DISCHARGE INSTRUCTIONS IN THE EMERGENCY DEPARTMENT	JOURNAL OF EMERGENCY MEDICINE			English	Article						sports medicine; concussion; closed head injury	TRAUMATIC BRAIN-INJURY; IMPACT	Background: Recognition and diagnosis of concussion is increasing, but current research shows these patients are discharged from the emergency department (ED) with a wide variability of recommendations and instructions. Objective: To assess the adequacy of documentation of discharge instructions given to patients discharged from the ED with concussions. Methods: This was a quality-improvement study conducted at a University-based Level I trauma center. A chart review was performed on all patients discharged with closed head injury or concussion over a 1-year period. Chi-squared measures of association and Fisher's exact testwere used to compare the proportion of patients receiving discharge instructions (printed or documented in the chart as discussed by the physician). Multivariable logistic regression was used to assess the relationship between whether the concussion was sport-related in relation to our primary outcomes. Results: There were 1855 charts that met inclusion criteria. The physician documented discussion of concussion discharge instructions in 41%(95% confidence interval [CI] 39.2-43.7) and printed instructions were given in 71% (95% CI 69.1-73.2). Physicians documented discussion of instructions more often for sport-related vs. non-sport-related concussion (58% vs. 39%, p = 0.008) with an odds ratio (OR) of 2.1 (95% CI 1.6-2.8). Discharge instructions were given more often for sport-related injuries than those without sport-related injuries (85% vs. 69%, p = 0.047), with an OR of 2.2 (95% CI 1.6-3.1). Children were more likely to have had physician-documented discussion of instructions (56%, 95% CI 52.3-59.1 vs. 31%, 95% CI 28.0-33.6), printed dischargeinstructions (86%, 95% CI 83.2-88.1 vs. 61%, 95% CI 57.6-63.4), and return-to-play precautions given (11.2%, 95% CI 9.2-13.6 vs. 4.5%, 95% CI 3.4-5.9) compared with adults. Conclusions: Documentation of discharge instructions given to ED patients with concussions was inadequate, overall. (C) 2017 Elsevier Inc. All rights reserved.	[Lane, Allison D.; Berkman, Matthew R.; Verbunker, David; Shekell, Taylor; Bouska, Michael; Barnett, Lauren; Keogh, Allie; Nuno, Tomas; Stolz, Uwe; Waterbrook, Anna L.] Univ Arizona, Dept Emergency Med, 1501 N Campbell Ave,POB 245057, Tucson, AZ 85724 USA		Lane, AD (corresponding author), Univ Arizona, Dept Emergency Med, 1501 N Campbell Ave,POB 245057, Tucson, AZ 85724 USA.						Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention (CDC), HEADS UP YOUTH SPORT; De Maio VJ, 2014, PEDIATR EMERG CARE, V30, P20, DOI 10.1097/PEC.0000000000000058; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2012, J SCI MED SPORT, P178; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Stern RA, 2016, J NEUROTRAUMA; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38	20	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAY	2017	52	5					690	698		10.1016/j.jemermed.2016.12.017			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EX9HC	WOS:000403567400027	28202206				2022-02-06	
J	Moghadam, HS; Nazari, MA; Jahan, A; Mahmoudi, J; Salimi, MM				Moghadam, Hasan Sabouri; Nazari, Mohamad Ali; Jahan, Ali; Mahmoudi, Javad; Salimi, Maryam Moghadam			Beneficial Effects of Transcranial Light Emitting Diode (LED) Therapy on Attentional Performance: An Experimental Design	IRANIAN RED CRESCENT MEDICAL JOURNAL			English	Article						Low-Level Light Therapy; Light-Emitting Diode; Attention; Cytochrome Oxidase	TRAUMATIC BRAIN-INJURY; NEAR-INFRARED LIGHT; LEVEL LASER THERAPY; SUSTAINED ATTENTION; STIMULATION; CORTEX; MICE; PHOTOBIOMODULATION; IMPROVEMENTS; IRRADIATION	Background: Transcranial light therapy (TCLT) is a new noninvasive interventional method, which applies red to near infrared spectrum laser or light emitting diode (LED) source on the head, transcranially. This spectrum can penetrate the skull and could improve the brain pathological conditions and cognitive functions. Despite relative advantages of the LED upon laser sources, TCLT research has been limited on the beneficial effects of LED source on human cognitive performances. Objectives: This study aimed at investigating the effectiveness of the TCLT with LED source on brain attentional performance as an important cognitive ability. Methods: This experimental intervention study was conducted in Tabriz, Iran, from September to October 2016. The study samples were selected by the convenience sampling method. Thirty-four healthy individuals (age: 18 to 24; 17 males and 17 females) were randomly assigned to sham (n = 17) or real intervention (n = 17) groups. We applied 850 nm LED with irradiation energy density 60 J/cm(2) upon the frontal cortex, the brain region involved in attentional activities. Before and after TCLT, participants completed a cognitive task (Level-1 of parametric Go/No-task), which measures attentional performance. Results: Our results revealed improvement of efficiency score as the main parameter of attentional performance in the real intervention group versus sham-TCLT group. The interaction of group x time was significant (P = 0.004). Mean change of the efficiency score was higher in the real intervention group (mean = 4.6 +/- 3) than the sham group (mean = 0.8 +/- 3) after TCLT (P = 0.001). Conclusions: Applying the TCLT by LED source over the PFC, promotes attentional performance as an important cognitive function.	[Moghadam, Hasan Sabouri; Nazari, Mohamad Ali; Salimi, Maryam Moghadam] Univ Tabriz, Fac Psychol, Dept Psychol, Tabriz, Iran; [Jahan, Ali] Tabriz Univ Med Sci, Fac Rehabil, Dept Commun Disorders, Tabriz, Iran; [Mahmoudi, Javad] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran		Salimi, MM (corresponding author), Univ Tabriz, Fac Psychol, Dept Psychol, Tabriz, Iran.	m.salimi.ns@gmail.com	Jahan, Ali/L-8744-2017; Mahmoudi, Javad/K-5577-2019; Mahmoudi, Javad/M-4680-2017; Nazari, Mohammad Ali/AAV-4618-2021	Mahmoudi, Javad/0000-0001-9755-9422; Nazari, Mohammad Ali/0000-0002-0340-994X	University of Tabriz	This study was supported in part by the University of Tabriz.	Averbukh LD, 2013, SUSTAINED ATTENTION, P7; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Behl C, 1998, FORTSCHR NEUROL PSYC, V66, P113, DOI 10.1055/s-2007-995246; Blanco NJ, 2017, J NEUROPSYCHOL, V11, P14, DOI 10.1111/jnp.12074; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Clark L, 2002, BRIT J PSYCHIAT, V180, P313, DOI 10.1192/bjp.180.4.313; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; dos Santos JGR Peixoto, 2016, J NEUROL DISORD, V4, DOI [10.4172/2329-6895.1000294, DOI 10.4172/2329-6895.1000294]; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gunzelmann G, 2009, FLUCTUATIONS ALERTNE; Hanczyc P, 2013, NAT PHOTONICS, V7, P969, DOI [10.1038/NPHOTON.2013.282, 10.1038/nphoton.2013.282]; Hwang J, 2016, LASER MED SCI, V31, P1151, DOI 10.1007/s10103-016-1962-3; Johannsen P, 1999, NEUROIMAGE, V10, P269, DOI 10.1006/nimg.1999.0475; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Liu SK, 2002, AM J PSYCHIAT, V159, P975, DOI 10.1176/appi.ajp.159.6.975; Marklund P, 2007, CORTEX, V43, P22, DOI 10.1016/S0010-9452(08)70443-X; McCarthy T, 2011, SPIE BIOS; Moreira MS, 2009, J PHOTOCH PHOTOBIO B, V97, P145, DOI 10.1016/j.jphotobiol.2009.09.002; Moro C, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-40; Naeser MA, 2015, SPIE DEFENSE SECURIT; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Nelson JT, 2014, NEUROIMAGE, V85, P909, DOI 10.1016/j.neuroimage.2012.11.061; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron U, 2007, PHOTOMED LASER SURG, V25, P180, DOI 10.1089/pho.2007.2064; Petrides M, 1995, ANN NY ACAD SCI, V769, P85, DOI 10.1111/j.1749-6632.1995.tb38133.x; Quirk BJ, 2012, PHOTOMED LASER SURG, V30, P523, DOI 10.1089/pho.2012.3261; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Rojas JC, 2012, J ALZHEIMERS DIS, V32, P741, DOI 10.3233/JAD-2012-120817; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Salgado SIA, 2015, J BIOENG BIOMED SCI, V5, P1; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Shaw VE, 2010, J COMP NEUROL, V518, P25, DOI 10.1002/cne.22207; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Uozumi Y, 2010, LASER SURG MED, V42, P566, DOI 10.1002/lsm.20938; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Votruba KL, 2013, J CLIN EXP NEUROPSYC, V35, P132, DOI 10.1080/13803395.2012.758239; Wong-Riley MTT, 2001, NEUROREPORT, V12, P3033, DOI 10.1097/00001756-200110080-00011; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Xuan WJ, 2016, J BIOPHOTONICS, V9, P1263, DOI 10.1002/jbio.201500336; Yip KK, 2011, NEUROSCIENCE, V190, P301, DOI 10.1016/j.neuroscience.2011.06.022; Yue L, 2015, SPIE BIOS	47	6	6	0	8	KOWSAR PUBL	HOENSBROEK	PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS	2074-1804	2074-1812		IRAN RED CRESCENT ME	Iran. Red Crescent Med. J.	MAY	2017	19	5							e44513	10.5812/ircmj.44513			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF0KW	WOS:000408591600007					2022-02-06	
J	Neumann, D; Malec, JF; Hammond, FM				Neumann, Dawn; Malec, James F.; Hammond, Flora M.			Negative Attribution Bias and Anger After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aggression; anger; attributions; brain injury; emotion	AGGRESSIVE-BEHAVIOR; SOCIAL-PERCEPTION; MANAGEMENT; ASSOCIATION; MARRIAGE; THERAPY; STYLE	Objectives: Negative attributions pertain to judgments of intent, hostility, and blame regarding others' behaviors. This study compared negative attributions made by people with and without traumatic brain injury (TBI) and examined the degree to which these negative attributions predicted angry ratings in response to situations. Setting: Outpatient rehabilitation hospital. Participants: Forty-six adults with moderate to severe TBI and 49 healthy controls. Design: Cross-sectional study using a quasi-experimental research design. Main Measures: In response to hypothetical scenarios, participants rated how irritated and angry they would be, and how intentional, hostile, and blameworthy they perceived characters' behaviors. There were 3 scenario types differentiated by the portrayal of characters' actions: benign, ambiguous, or hostile. All scenarios theoretically resulted in unpleasant outcomes for participants. Results: Participants with TBI had significantly higher ratings for feeling irritated and angry and attributions of intent, hostility, and blame compared with healthy controls for all scenario types. Negative attribution ratings accounted for 72.4% and 65.3% of the anger rating variance for participants with and without TBI, respectively. Conclusion: People with TBI may have negative attribution bias, in which they disproportionately judge the intent, hostility, and blameworthiness of others' behaviors. These attributions contributed to their ratings of feeling angry. This suggests that participants with TBI who have anger problems should be evaluated for this bias, and anger treatments should possibly aim to alter negative attributions. However, before implementing clinical practice changes, there is a need for replication with larger samples, and further investigation of the characteristics associated with negative attribution bias.	[Neumann, Dawn; Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA		Neumann, D (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) Switzer Research Fellowships Program Priority (CFDA) [84.133F-1]; Indiana Spinal Cord and Brain Injury Research Fund; Indiana University Brain Rehabilitation, Advanced Imaging, and Neuroscience (BRAIN) Signature Center Initiative; National Institutes of Health, NICHD STTR [1R41HD077967-01A1]	This research was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) Switzer Research Fellowships Program Priority (CFDA No. 84.133F-1); the Indiana Spinal Cord and Brain Injury Research Fund; and the Indiana University Brain Rehabilitation, Advanced Imaging, and Neuroscience (BRAIN) Signature Center Initiative.; Dr Dawn Neumann is a small business owner that currently receives federal grant funding from the National Institutes of Health, NICHD STTR (grant# 1R41HD077967-01A1), to develop and investigate an intervention to improve emotional processing after brain. For the remaining authors, no other conflicts of interest are declared.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; An SK, 2010, SCHIZOPHR RES, V118, P54, DOI 10.1016/j.schres.2010.01.025; AVERILL JR, 1983, AM PSYCHOL, V38, P1145, DOI 10.1037/0003-066X.38.11.1145; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bailey CA, 2008, J YOUTH ADOLESCENCE, V37, P713, DOI 10.1007/s10964-007-9211-5; Beck AT., 1979, COGNITIVE THERAPY DE; Beck R, 1998, COGNITIVE THER RES, V22, P63, DOI 10.1023/A:1018763902991; Bierman KL, 2002, DEV PSYCHOPATHOL, V14, P925, DOI 10.1017/S0954579402004133; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brookshire R, 1993, DISCOURSE COMPREHENS, P105; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; DODGE KA, 1980, CHILD DEV, V51, P162, DOI 10.2307/1129603; Dodge KA, 2006, DEV PSYCHOPATHOL, V18, P791, DOI 10.1017/S0954579406060391; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; EPPS J, 1995, COGNITIVE THER RES, V19, P159, DOI 10.1007/BF02229692; FINCHAM FD, 1992, J PERS SOC PSYCHOL, V62, P457, DOI 10.1037/0022-3514.62.3.457; Gilbert P, 1998, BRIT J MED PSYCHOL, V71, P447, DOI 10.1111/j.2044-8341.1998.tb01002.x; GUERRA NG, 1990, DEV PSYCHOL, V26, P269, DOI 10.1037/0012-1649.26.2.269; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; HOLM S, 1979, SCAND J STAT, V6, P65; Holtzworth-Munroe A, 2001, BEHAV THER, V31, P603; Holtzworth-Munroe A, 1996, Violence Vict, V11, P319; Jeon IH, 2013, PSYCHIAT INVEST, V10, P34, DOI 10.4306/pi.2013.10.1.34; Kassinove H, 1995, Issues Compr Pediatr Nurs, V18, P173, DOI 10.3109/01460869509087270; KELLEY HH, 1980, ANNU REV PSYCHOL, V31, P457, DOI 10.1146/annurev.ps.31.020180.002325; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Neumann D, 2015, J HEAD TRAUMA REHAB, DOI [10.3233/NRE-161347, DOI 10.3233/NRE-161347]; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Salkovskis PM., 1997, FRONTIERS COGNITIVE; Sanford K, 2005, J FAM PSYCHOL, V19, P180, DOI 10.1037/0893-3200.19.2.180; Scherer KR., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/J.PHYSBEH.2006.11.008; Smith CA, 2004, EMOTION, V4, P133, DOI 10.1037/1528-3542.4.2.133; Steinberg M. S., 1983, J SOC CLIN PSYCHOL, V1, P312, DOI [10.1521/jscp.1983.1.4.312, DOI 10.1521/JSCP.1983.1.4.312]; Sukhodolsky DG, 2005, BEHAV THER, V36, P15, DOI 10.1016/S0005-7894(05)80050-4; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721; Winegardner J, 2016, NEUROREHABILITATION, V39, P153, DOI 10.3233/NRE-161347; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778	41	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					197	204		10.1097/HTR.0000000000000259			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900006	28476058	Green Submitted			2022-02-06	
J	Ogami, K; Dofredo, M; Moheet, AM; Lahiri, S				Ogami, Kyle; Dofredo, Melissa; Moheet, Asma M.; Lahiri, Shouri			Early and Severe Symptomatic Cerebral Vasospasm After Mild Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Cerebral infarction; Intracranial vasospasm; Subarachnoid hemorrhage; Traumatic brain injury	SUBARACHNOID HEMORRHAGE	BACKGROUND: Symptomatic cerebral vasospasm has been reported in a low percentage of patients with moderate or severe traumatic brain injury (TBI) as defined by Glasgow Coma Scale (GCS) score. We present a case of mild TBI (GCS score 14) complicated by early and severe symptomatic cerebral vasospasm. CASE DESCRIPTION: A 63-year-old woman was admitted following mild TBI with a GCS score of 14. Concurrent with the onset of sonographic vasospasm, the patient developed severe neurologic symptoms consistent with ischemia of the left middle cerebral artery territory. Confounding causes of these symptoms were excluded. Each occurrence of these symptoms resolved with intra-arterial calcium channel blocker therapy. CONCLUSIONS: Early and severe symptomatic vasospasm may occur as a complication of mild TBI. GCS score alone may be an inadequate risk predictor of symptomatic cerebral vasospasm. Aggressive interventional management may be justified, such as with intra-arterial calcium channel blockers, to optimize the likelihood of a favorable outcome.	[Ogami, Kyle; Dofredo, Melissa; Moheet, Asma M.; Lahiri, Shouri] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Dofredo, Melissa; Moheet, Asma M.; Lahiri, Shouri] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA		Ogami, K (corresponding author), Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA.	kyle.ogami@cshs.org	Moheet, Asma/AAR-3235-2020; Lahiri, Shouri/AAG-8724-2021	Moheet, Asma/0000-0001-9133-4660; 			Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Connolly Jr ES, 2012, STROKE, V43, P1; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Stuart RM, 2011, NEUROSURGERY, V68, P337, DOI 10.1227/NEU.0b013e318201be47; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Zubkov ZY, 2000, SURG NEUROL, V53, P126	7	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2017	101								81300000000000	10.1016/j.wneu.2017.03.039			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7CR	WOS:000401932500134	28323180				2022-02-06	
J	Pretz, CR; Graham, JE; Middleton, A; Karmarkar, AM; Ottenbacher, KJ				Pretz, Christopher R.; Graham, James E.; Middleton, Addie; Karmarkar, Amol M.; Ottenbacher, Kenneth J.			Longitudinal Investigation of Rehospitalization Patterns in Spinal Cord Injury and Traumatic Brain Injury Among Medicare Beneficiaries	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Longitudinal studies; Patient readmission; Rehabilitation; Spinal cord injuries	UNIFORM DATA SYSTEM; MODEL SYSTEMS; NATIONAL INSTITUTE; REHABILITATION PROGRAMS; HOSPITAL READMISSION; DISABILITY; MORTALITY	Objectives: To model 12-month rehospitalization risk among Medicare beneficiaries receiving inpatient rehabilitation for spinal cord injury (SCI) or traumatic brain injury (TBI) and to create 2 (SCI- and TBI-specific) interactive tools enabling users to generate monthly projected probabilities of rehospitalization on the basis of an individual patient's clinical profile at discharge from inpatient rehabilitation. Design: Secondary data analysis. Setting: Inpatient rehabilitation facilities. Participants: Medicare beneficiaries receiving inpatient rehabilitation for SCI (n=2587) or TBI (n=10,864). Interventions: Not applicable. Main Outcome Measures: Monthly rehospitalization (yes/no) based on Medicare claims. Results: Results are summarized through computer-generated interactive tools, which plot individual level trajectories of rehospitalization probabilities over time. Factors associated with the probability of rehospitalization over time are also provided, with different combinations of these factors generating different individual level trajectories. Four case studies are presented to demonstrate the variability in individual risk trajectories. Monthly rehospitalization probabilities for the individual high-risk TBI and SCI cases declined from 33% to 15% and from 41% to 18%, respectively, over time, whereas the probabilities for the individual low-risk cases were much lower and stable over time: 5% to 2% and 6% to 2%, respectively. Conclusions: Rehospitalization is an undesirable and multifaceted health outcome. Classifying patients into meaningful risk strata at different stages of their recovery is a positive step forward in anticipating and managing their unique health care needs over time.	[Pretz, Christopher R.] Craig Hosp, Res Dept, Englewood, CO USA; [Graham, James E.; Middleton, Addie; Karmarkar, Amol M.; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, 301 Univ Blvd,Mail Route 1137, Galveston, TX 77555 USA		Graham, JE (corresponding author), Univ Texas Med Branch, Div Rehabil Sci, 301 Univ Blvd,Mail Route 1137, Galveston, TX 77555 USA.	jegraham@utmb.edu		Middleton, Addie/0000-0001-8970-3703; Ottenbacher, Kenneth/0000-0001-5990-3982	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24-HS022134, P2C-HD065702, K12-HD055929, K01-HD086290, R01-HD069443]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90IF0071]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R24HS022134] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD086290, R24HD065702, R01HD069443, P2CHD065702, K12HD055929] Funding Source: NIH RePORTER	Supported in part by the National Institutes of Health (grant nos. R24-HS022134, P2C-HD065702, K12-HD055929, K01-HD086290, and R01-HD069443) and the National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. 90IF0071).	Chen LM, 2015, AM J MANAG CARE, V21, P814; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Dams-O'Connor K, J HEAD TRAU IN PRESS; DAVIDOFF G, 1990, ARCH PHYS MED REHAB, V71, P121; Ditunno John F, 2012, Handb Clin Neurol, V109, P181, DOI 10.1016/B978-0-444-52137-8.00011-5; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Granger CV, 2012, AM J PHYS MED REHAB, V91, P289, DOI 10.1097/PHM.0b013e31824ad2fd; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Greenwald JL, 2009, PROF CASE MANAG, V14, P135, DOI 10.1097/NCM.0b013e318198d4e1; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; Kripalani S, 2014, ANNU REV MED, V65, P471, DOI 10.1146/annurev-med-022613-090415; Mahmoudi E, 2014, ARCH PHYS MED REHAB, V95, P2158, DOI 10.1016/j.apmr.2014.07.399; Medicare Payment Advisory Commission, 2015, C MED PAYM POL; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Pretz CR, 2014, J HEAD TRAUMA REHAB, V29, pE65, DOI 10.1097/HTR.0000000000000025; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Pretz CR, 2015, 2015 JOINT STAT M AU; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Shortell SM, 2015, MED CARE RES REV, V72, P580, DOI 10.1177/1077558715588874; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Strauss DJ, 2006, ARCH PHYS MED REHAB, V87, P1079, DOI 10.1016/j.apmr.2006.04.022; UB Foundation Activities Inc, 2004, INP REH FAC PAT ASS; US. Department of Health and Human Services, 2013, FED REGISTER, V78, P47906	28	6	6	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2017	98	5					997	1003		10.1016/j.apmr.2016.12.012			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ET5GY	WOS:000400313400023	28115070	Green Accepted			2022-02-06	
J	Sahyouni, R; Mahmoodi, A; Mahmoodi, A; Huang, M; Tran, DK; Chen, JW				Sahyouni, Ronald; Mahmoodi, Amin; Mahmoodi, Amir; Huang, Melissa; Tran, Diem Kieu; Chen, Jefferson W.			Interactive eBooks in educating patients and their families about head injury regardless of age	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Concussion; TBI; Traumatic brain injury; iBook; Education; Neurosurgery; Age; Elderly	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; RISK-FACTOR	Objectives: Traumatic Brain Injury (TBI) is a common and debilitating injury that is particularly prevalent in patients over 60. Given the influence of head injury on dementia (and vice versa), and the increased likelihood of ground-level falls, elderly patients are vulnerable to TBI. Educational interventions can increase knowledge and influence preventative activity to decrease the likelihood of further TBI. We sought to determine the efficacy of interactive tablet-based educational interventions in elderly patients on self-reported knowledge. Patients and methods: Patients and family members, ages 20-90, presenting to a NeuroTrauma clinic completed a pre-survey to assess baseline TBI or concussion knowledge, depending on their diagnosis. Participants then received an interactive electronic book (eBook), or a text-based pamphlet with identical information, and completed a post-survey to test interim knowledge improvement. Results: All participants (n=180), regardless of age, had significantly higher post-survey scores (p < 0.01, 95% CI). Elderly participants who received the eBook (n = 39) scored lower than their younger counterparts despite higher pre-survey scores (p<0.01, 95% CI). All participants who received the eBook (n= 20, 90) significantly improved on the post-survey (p <0.01, 95% CI) when compared to participants who received the paper pamphlets (n=10, 31). All participants significantly preferred the eBook (p < 0.01, 95% CI). Conclusions: We demonstrated that interactive educational interventions are effective in the elderly TBI population. Enhanced educational awareness in the elderly population, especially patients at risk or with prior TBI, may prevent further head injury by educating patients on the importance of avoiding further head injury and taking precautionary measures to decrease the likelihood of further injury. (C) 2017 Elsevier B.V. All rights reserved.	[Sahyouni, Ronald] UC Irvine Sch Med MSTP, Irvine, CA USA; [Mahmoodi, Amin] UC Irvine Dept Biomed Engn, Irvine, CA USA; [Mahmoodi, Amir; Huang, Melissa; Tran, Diem Kieu; Chen, Jefferson W.] UC Irvine Dept Neurol Surg, Irvine, CA USA		Chen, JW (corresponding author), UC Irvine Med Ctr, 101 City Dr South, Orange, CA 92868 USA.	rsahyoun@uci.edu; mahmooa1@uci.edu; amahmoo1@uci.edu; mhuang96@gmail.com; diemkt@uci.edu; jeffewc1@uci.edu	chen, jeff/AAR-7375-2020	chen, jeff/0000-0003-0624-6864; Sahyouni, Ronald/0000-0002-2124-0535; Mahmoodi, Amin/0000-0003-0012-9245	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008620] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008620] Funding Source: Medline		Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen, 2017, TRAUMA ACUTE CARE, V2, P32; Chen JW, 2015, CONCUSSION; Chen JW, 2015, TRAUMATIC BRAIN INJU; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Cusea J., 1992, COOPERATIVE LEARNING, V2, P2; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gliem J. A., 2003, MIDW RES TO PRACT C; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jossey-Bass Bonwell C. C., 1991, 1 ASHEERIC G WASH U; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; MARTIN A, 1987, J CLIN EXP NEUROPSYC, V9, P191, DOI 10.1080/01688638708405361; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; RAKIER A, 1995, BRAIN INJURY, V9, P187, DOI 10.3109/02699059509008191; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633	25	6	6	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAY	2017	156						41	47		10.1016/j.clineuro.2017.03.003			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV6LC	WOS:000401879900008	28324787	Green Accepted			2022-02-06	
J	Schmidtmann, G; Ruiz, T; Reynaud, A; Spiegel, DP; Lague-Beauvais, M; Hess, RF; Farivar, R				Schmidtmann, Gunnar; Ruiz, Tatiana; Reynaud, Alexandre; Spiegel, Daniel P.; lague-Beauvais, Maude; Hess, Robert F.; Farivar, Reza			Sensitivity to Binocular Disparity is Reduced by Mild Traumatic Brain Injury	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						traumatic brain injury; stereopsis; disparity sensitivity	DEPTH-PERCEPTION; PARKINSONS-DISEASE; GLOBAL STEREOPSIS; 1ST; EPIDEMIOLOGY; SYMPTOMS	PURPOSE. The impairment of visual functions is one of the most common complaints following mild traumatic brain injury (mTBI). Traumatic brain injury-associated visual deficits include blurred vision, reading problems, and eye strain. In addition, previous studies have found evidence that TBI can diminish early cortical visual processing, particularly for second-order stimuli. We investigated whether cortical processing of binocular disparity is also affected by mTBI. METHODS. In order to investigate the influence of mTBI on global stereopsis, we measured the quick Disparity Sensitivity Function (qDSF) in 22 patients with mTBI. Patients with manifest strabismus and double vision were excluded. Compared with standard clinical tests, the qDSF is unique in that it offers a quick and accurate estimate of thresholds across the whole spatial frequency range. RESULTS. Results show that disparity sensitivity in the mTBI patients were significantly reduced compared with the normative dataset (n = 61). The peak spatial frequency was not affected. CONCLUSIONS. Our results suggest that the reduced disparity sensitivity in patients with mTBI is more likely caused by cortical changes (e.g., axonal shearing, or reduced interhemispheric communication) rather than oculomotor dysfunction.	[Schmidtmann, Gunnar; Ruiz, Tatiana; Spiegel, Daniel P.; lague-Beauvais, Maude; Farivar, Reza] McGill Univ, Ctr Hlth, Res Inst, Traumat Brain Injury Program, Montreal, PQ, Canada; [Schmidtmann, Gunnar; Ruiz, Tatiana; Reynaud, Alexandre; Spiegel, Daniel P.; Hess, Robert F.; Farivar, Reza] McGill Univ, Dept Ophthalmol, McGill Vis Res Unit, Montreal, PQ, Canada; [lague-Beauvais, Maude] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada		Schmidtmann, G; Farivar, R (corresponding author), Montreal Gen Hosp, McGill Vis Res Unit, Dept Ophthalmol, L7-213, Montreal, PQ H3G 1A4, Canada.	gunnar.schmidtmann@mail.mcgill.ca; reza.farivar@mcgill.ca	Schmidtmann, Gunnar/V-3839-2019; Farivar, Reza/AAA-5762-2020	Schmidtmann, Gunnar/0000-0001-8180-7751; 	Psychological Health and Traumatic Brain Injury Research Program of the U.S. Department of Defense (Arlington, VA, USA) [W81XWH-14-1-0320]	Supported by grants from the Psychological Health and Traumatic Brain Injury Research Program of the U.S. Department of Defense under award W81XWH-14-1-0320 (Arlington, VA, USA).	Ahumada Jr AJ, 1992, HUMAN VISION VISUAL, DOI [DOI 10.1117/12.135982, 10.1117/12.135982]; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; COWEY A, 1979, PROC R SOC SER B-BIO, V204, P399, DOI 10.1098/rspb.1979.0035; Cowey A., 1985, BRAIN MECHANISMS SPA, P259; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Fricke T. R., 1997, CLIN EXP OPTOMETRY, V80, P165, DOI DOI 10.1111/J.1444-0938.1997.TB04876.X; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Hou F, 2010, INVEST OPHTH VIS SCI, V51, P5365, DOI 10.1167/iovs.10-5468; HOWARD IP, 2002, SEEING DEPTH, V2; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; ISHIAI S, 1993, NEUROLOGY, V43, P106, DOI 10.1212/WNL.43.1_Part_1.106; JULESZ B, 1960, AT&T TECH J, V39, P1125, DOI 10.1002/j.1538-7305.1960.tb03954.x; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kim SH, 2011, CAN J NEUROL SCI, V38, P299, DOI 10.1017/S0317167100011501; Koh SB, 2013, NEUROREPORT, V24, P229, DOI 10.1097/WNR.0b013e32835edbc5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee CN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123229; Lesmes LA, 2010, J VISION, V10, DOI 10.1167/10.3.17; Mendez MF, 1996, PERCEPT MOTOR SKILL, V83, P987, DOI 10.2466/pms.1996.83.3.987; Miller LJ, 1999, ARCH CLIN NEUROPSYCH, V14, P537; Neri P, 2005, J NEUROPHYSIOL, V93, P1823, DOI 10.1152/jn.01068.2004; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Piponnier JC, 2016, J NEUROTRAUM, V33, P242, DOI 10.1089/neu.2014.3832; PTITO A, 1991, BRAIN, V114, P1323, DOI 10.1093/brain/114.3.1323; PTITO A, 1993, NEUROREPORT, V4, P1155; Reynaud A, 2015, VISION RES, V113, P97, DOI 10.1016/j.visres.2015.04.021; Spiegel DP, 2016, VISION RES, V122, P43, DOI 10.1016/j.visres.2016.03.004; Spiegel DP, 2015, VISION RES, V109, P38, DOI 10.1016/j.visres.2015.02.020; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; TYLER CW, 1974, NATURE, V251, P140, DOI 10.1038/251140a0; Verhoef BE, 2016, CORTEX, V82, P63, DOI 10.1016/j.cortex.2016.05.020; Watson AB, 2005, J VISION, V5, P717, DOI 10.1167/5.9.6; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; Witz N, 2013, VISION RES, V87, P10, DOI 10.1016/j.visres.2013.05.003	41	6	6	2	5	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	MAY	2017	58	5					2630	2635		10.1167/iovs.17-21845			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EZ3DV	WOS:000404591500023	28494496	Green Published, Green Submitted, gold			2022-02-06	
J	Tapia, RN; Eapen, BC				Tapia, Rebecca N.; Eapen, Blessen C.			Rehabilitation of Persistent Symptoms After Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Postconcussion syndrome; Rehabilitation; Concussion; Treatment; Chronic	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; POSTCONCUSSION SYMPTOMS; CHRONIC PAIN; PHARMACOTHERAPY; PREDICTORS; PREVALENCE; FATIGUE; QUALITY; STRESS	One of the more challenging aspects beyond acute concussion management occurs when symptoms do not resolve as anticipated over time. The term postconcussion syndrome generally refers to a presentation of multiple ongoing symptoms months to years from injury, typically comprised of physical, cognitive, and emotional complaints such as headaches, poor sleep, poor concentration, dizziness, and irritability. Although individual factors vary, the condition is often regarded as multifactorial. Persistent issues can pose a threat to full community reintegration following concussion and reduce overall quality of life; thus early recognition and treatment are essential to optimize long-term outcomes.	[Tapia, Rebecca N.] South Texas Vet Healthcare Syst, Polytrauma Serv, Polytrauma Network Site, 7400 Merton Minter, San Antonio, TX 78229 USA; [Eapen, Blessen C.] South Texas Vet Healthcare Syst, Polytrauma Serv, Polytrauma Rehabil Ctr, 7400 Merton Minter, San Antonio, TX 78229 USA		Tapia, RN (corresponding author), South Texas Vet Healthcare Syst, Polytrauma Serv, Polytrauma Network Site, 7400 Merton Minter, San Antonio, TX 78229 USA.	rebecca.tapia@va.gov					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Berger S, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020875; Bhatnagar S, 2016, BRAIN RES, V1640, P164, DOI 10.1016/j.brainres.2016.01.021; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Diener H C, 2001, Curr Med Res Opin, V17 Suppl 1, ps17, DOI 10.1185/0300799039117003; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lipton RB, 2000, NEUROLOGY, V55, P629, DOI 10.1212/WNL.55.5.629; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meyers JE, 2015, APPL NEUROPSYCH-ADUL, V22, P427, DOI 10.1080/23279095.2014.968919; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Obermann M, 2015, THER ADV NEUROL DISO, V8, P311, DOI 10.1177/1756285615605699; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P1; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Zasler ND, 2011, J HEAD TRAUMA REHAB, V26, P397, DOI 10.1097/HTR.0b013e31822721f8	47	6	6	1	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					287	+		10.1016/j.pmr.2016.12.006			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU5AJ	WOS:000401043700008	28390514				2022-02-06	
J	Hong, CK; Joo, JY; Shim, YS; Sim, SY; Kwon, MA; Kim, YB; Chung, J				Hong, Chang-Ki; Joo, Jin-Yang; Shim, Yu Shik; Sim, Sook Young; Kwon, Min A.; Kim, Yong Bae; Chung, Joonho			The course of headache in patients with moderate-to-severe headache due to mild traumatic brain injury: a retrospective cross-sectional study	JOURNAL OF HEADACHE AND PAIN			English	Article						Headache; Head injury; Post-traumatic headache; Traumatic brain injury	CHRONIC PAIN; PREVALENCE; MIGRAINE; RATES	Background: Little is known about the long-term course of headache in patients with moderate-to-severe headache due to traumatic brain injury (TBI). We evaluated the course of headache in patients with moderate-to-severe headache due to mild TBI. Methods: Since September 2009, patients with TBI prospectively rated their headache using a numeric rating scale (NRS). From the database containing 935 patients with TBI between September 2009 and December 2013, 259 patients were included according to following criteria: (1) newly onset moderate-to-severe headache (NRS >= 4) due to head trauma; (2) age >= 15 years; (3) Glasgow Coma Scale >= 13; (4) transient loss of consciousness <= 30 min; and (5) radiographic evaluation, such as computed tomography or magnetic resonance image. We evaluated initial and follow-up NRS scores to determine the significance of NRS changes and identified risk factors for moderate-to-severe headache at 36-month follow-up. Results: At 36-month follow-up, 225 patients (86.9%) reported improved headache (NRS <= 3) while 34 (13.1%) reported no improvement. The NRS scores were significantly decreased within a month (P < 0.001). The follow-up NRS scores at 12-, 24-, and 36-months were lower than those at one month (P < 0.001). Multiple logistic regression analysis showed that post-traumatic seizure (odds ratio, 2.162; 95% CI, 1.095-6.542; P = 0.041) and traumatic intracranial hemorrhage (odds ratio, 2.854; 95% CI, 1.241-10.372; P = 0.024) were independent risk factors for moderate-to-severe headache at 36-month follow-up. Conclusions: The course of headache in patients with mild TBI continuously improved until 36-month follow-up. However, 13.1% of patients still suffered from moderate-to-severe headache at 36-month follow-up, for whom post-traumatic seizure and traumatic intracranial hemorrhage might be risk factors.	[Hong, Chang-Ki; Joo, Jin-Yang; Kwon, Min A.; Kim, Yong Bae; Chung, Joonho] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Neurosurg, 211 Eonjuro, Seoul 135720, South Korea; [Hong, Chang-Ki; Chung, Joonho] Yonsei Univ, Severance Inst Vasc & Metab Res, Seoul, South Korea; [Shim, Yu Shik] Inha Univ, Sch Med & Hosp, Dept Neurosurg, Incheon, South Korea; [Sim, Sook Young] Inje Univ, Seoul Paik Hosp, Dept Neurosurg, Seoul, South Korea; [Chung, Joonho] Rush Univ, Med Ctr, Dept Neurol Surg, 1725 W Harrison St,Profess Bldg Suite 855, Chicago, IL 60612 USA		Chung, J (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Neurosurg, 211 Eonjuro, Seoul 135720, South Korea.; Chung, J (corresponding author), Yonsei Univ, Severance Inst Vasc & Metab Res, Seoul, South Korea.	ns.joonho.chung@gmail.com		Kim, Yong Bae/0000-0003-2262-7157; Hong, Changki/0000-0002-2761-0373			Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bekkelund SI, 2003, HEADACHE, V43, P59, DOI 10.1046/j.1526-4610.2003.03010.x; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Finkel AG, 2016, CEPHALALGIA; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Gu DQ, 2013, AM J NEURORADIOL, V34, P1227, DOI 10.3174/ajnr.A3353; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hong CK, 2015, HEADACHE, V55, P992, DOI 10.1111/head.12612; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kwong WJ, 2007, CEPHALALGIA, V27, P336, DOI 10.1111/j.1468-2982.2007.01283.x; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sakai F, 1997, CEPHALALGIA, V17, P15, DOI 10.1046/j.1468-2982.1997.1701015.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042	27	6	6	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	APR 20	2017	18								48	10.1186/s10194-017-0755-9			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC9GR	WOS:000407149700001	28429236	Green Published, gold			2022-02-06	
J	Brockman, EC; Jackson, TC; Dixon, CE; Bayir, H; Clark, RSB; Vagni, V; Feldman, K; Byrd, C; Ma, L; Hsia, C; Kochanek, PM				Brockman, Erik C.; Jackson, Travis C.; Dixon, C. Edward; Bayir, Hulya; Clark, Robert S. B.; Vagni, Vincent; Feldman, Keri; Byrd, Catherine; Ma, Li; Hsia, Carleton; Kochanek, Patrick M.			Polynitroxylated Pegylated Hemoglobin-A Novel, Small Volume Therapeutic for Traumatic Brain Injury Resuscitation: Comparison to Whole Blood and Dose Response Evaluation	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; intracranial pressure; secondary insult; traumatic brain injury	POSITIVE FLUID BALANCE; DRAG-REDUCING POLYMERS; HEMORRHAGIC-SHOCK; INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; CEREBROVASCULAR RESPONSE; SECONDARY INSULTS; TRANSFUSION; HYPERTENSION; SUBSTITUTES	Resuscitation with polynitroxylated pegylated hemoglobin (PNPH), a pegylated bovine hemoglobin decorated with nitroxides, eliminated the need for fluid administration, reduced intracranial pressure (ICP) and brain edema, and produced neuroprotection in vitro and in vivo versus Lactated Ringer's solution (LR) in experimental traumatic brain injury (TBI) plus hemorrhagic shock (HS). We hypothesized that resuscitation with PNPH would improve acute physiology versus whole blood after TBI+HS and would be safe and effective across a wide dosage range. Anesthetized mice underwent controlled cortical impact and severe HS to mean arterial pressure (MAP) of 25-27mm Hg for 35 min, then were resuscitated with PNPH, autologous whole blood, or LR. Markers of acute physiology, including mean arterial blood pressure (MAP), heart rate (HR), blood gases/chemistries, and brain oxygenation (PbtO(2)), were monitored for 90 min on room air followed by 15 min on 100% oxygen. In a second experiment, the protocol was repeated, except mice were resuscitated with PNPH with doses between 2 and 100 mL/kg. ICP and 24 h %-brain water were evaluated. PNPH-resuscitated mice had higher MAP and lower HR post-resuscitation versus blood or LR (p < 0.01). PNPH-resuscitated mice, versus those resuscitated with blood or LR, also had higher pH and lower serum potassium (p < 0.05). Blood-resuscitated mice, however, had higher PbtO2 versus those resuscitated with LR and PNPH, although PNPH had higher PbtO(2) versus LR (p < 0.05). PNPH was well tolerated across the dosing range and dramatically reduced fluid requirements in all doses-even 2 or 5 mL/kg (p < 0.001). ICP was significantly lower in PNPH-treated mice for most doses tested versus in LR-treated mice, although %-brain water did not differ between groups. Resuscitation with PNPH, versus resuscitation with LR or blood, improved MAP, HR, and ICP, reduced acidosis and hyperkalemia, and was well tolerated and effective across a wide dosing range, supporting ongoing pre-clinical development of PNPH for TBI resuscitation.	[Brockman, Erik C.; Jackson, Travis C.; Bayir, Hulya; Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Brockman, Erik C.; Jackson, Travis C.; Dixon, C. Edward; Bayir, Hulya; Clark, Robert S. B.; Vagni, Vincent; Feldman, Keri; Byrd, Catherine; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Brockman, Erik C.; Bayir, Hulya; Clark, Robert S. B.; Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Bayir, Hulya] Pittsburgh Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA USA; [Ma, Li] Georgia Southern Univ, Dept Phys, Statesboro, GA USA; [Hsia, Carleton] SynZyme Technol LLC, Irvine, CA USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U44 NS070324]; U.S. Department of DefenseUnited States Department of Defense [WH81XWH-10-1-0623, WH81XWH-14-2-0018]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040686]; Career Education and Enhancement for Health Care Research Diversity (CEED) Program at the University of Pittsburgh School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER	This study was supported in part by U44 NS070324 (CH, LM, PMK) from the National Institute of Neurological Disorders and Stroke. Drs. Kochanek and Dixon were also supported by grants WH81XWH-10-1-0623 and WH81XWH-14-2-0018 from the U.S. Department of Defense. Dr. Brockman was supported by T32 HD040686 from NICHD. Catherine Byrd was supported by the Career Education and Enhancement for Health Care Research Diversity (CEED) Program at the University of Pittsburgh School of Medicine.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Alayash AI, 1999, NAT BIOTECHNOL, V17, P545, DOI 10.1038/9849; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; ATLS Subcommittee American College of Surgeons' Committee on Trauma and International ATLS Working Group, 2013, J CEREB BLOOD FLOW M, V33, P1457; Bragin DE, 2014, BRAIN INJURY, V28, P750; Brands J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077252; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BUNKER JP, 1962, NEW ENGL J MED, V266, P372, DOI 10.1056/NEJM196202222660802; Chesnut R M, 1995, New Horiz, V3, P366; CHURCHIL.HC, 1968, P ROY SOC MED, V61, P681, DOI 10.1177/003591576806100731; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Flori HR, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/854142; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Gurney J, 2004, J TRAUMA, V57, P726, DOI 10.1097/01.TA.0000147520.84792.B4; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Hsia Carleton Jen Chang, 2012, Artif Organs, V36, P215, DOI 10.1111/j.1525-1594.2011.01307.x; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Kameneva MV, 2012, INT J ENG SCI, V59, P168, DOI 10.1016/j.ijengsci.2012.03.014; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; Marik PE, 2008, CRIT CARE MED, V36, P3080, DOI 10.1097/CCM.0b013e31818c3801; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Pacella J, 2010, CIRCULATION, V122; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Reid TJ, 2003, TRANSFUSION, V43, P280, DOI 10.1046/j.1537-2995.2003.00314.x; RICHES AC, 1973, J PHYSIOL-LONDON, V228, P279, DOI 10.1113/jphysiol.1973.sp010086; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sakr Y, 2005, CHEST, V128, P3098, DOI 10.1378/chest.128.5.3098; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Zhang J., 1985, J APPL PHYSL BETHESD, V113, P1709	45	6	6	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1337	1350		10.1089/neu.2016.4656			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600005	27869558	Green Published			2022-02-06	
J	Buonaguro, EF; Tomasetti, C; Chiodini, P; Marmo, F; Latte, G; Rossi, R; Avvisati, L; Iasevoli, F; de Bartolomeis, A				Buonaguro, Elisabetta F.; Tomasetti, Carmine; Chiodini, Paolo; Marmo, Federica; Latte, Gianmarco; Rossi, Rodolfo; Avvisati, Livia; Iasevoli, Felice; de Bartolomeis, Andrea			Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia	JOURNAL OF PSYCHOPHARMACOLOGY			English	Article						Antipsychotics; treatment resistant schizophrenia; Homer1; Arc; N-methyl-D-aspartate receptor	NMDA RECEPTOR ANTAGONISTS; EARLY-PHASE SCHIZOPHRENIA; TRAUMATIC BRAIN-INJURY; NEGATIVE SYMPTOMS; DOUBLE-BLIND; MICROGLIAL ACTIVATION; SCAFFOLDING PROTEINS; GENE-EXPRESSION; MOUSE MODEL; DOPAMINERGIC-NEURONS	In this study, we investigated whether minocycline, a second-generation tetracycline proposed as an add-on to antipsychotics in treatment-resistant schizophrenia (TRS), may affect the expression of Homer and Arc postsynaptic density (PSD) transcripts, implicated in synaptic regulation. Minocycline was administered alone or with haloperidol in rats exposed or not to ketamine, mimicking acute glutamatergic psychosis or naturalistic conditions, respectively. Arc expression was significantly reduced by minocycline compared with controls. Minocycline in combination with haloperidol also significantly reduced Arc expression compared with both controls and haloperidol alone. Moreover, haloperidol/minocycline combination significantly affected Arc expression in cortical regions, while haloperidol alone was ineffective on cortical gene expression. These results suggest that minocycline may strongly affect the expression of Arc as mediated by haloperidol, both in terms of quantitative levels and of topography of haloperidol-related expression. It is noteworthy that no significant pre-treatment effect was found, suggesting that pre-exposure to ketamine did not grossly affect gene expression. Minocycline was not found to significantly affect haloperidol-related Homer1a expression. No significant changes in Homer1b/c expression were observed. These results are consistent with previous observations that minocycline may modulate postsynaptic glutamatergic transmission, affecting distinct downstream pathways initiated by N-methyl-D-aspartate (NMDA) receptor modulation, i.e. Arc-mediated but not Homer1a-mediated pathways.	[Buonaguro, Elisabetta F.; Tomasetti, Carmine; Marmo, Federica; Latte, Gianmarco; Rossi, Rodolfo; Avvisati, Livia; Iasevoli, Felice; de Bartolomeis, Andrea] Univ Sch Med Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy; [Chiodini, Paolo] Univ Naples 2, Med Stat Unit, Naples, Italy		de Bartolomeis, A (corresponding author), Univ Sch Med Napoli Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Bldg 18,3rd Floor, I-80131 Naples, Italy.	adebarto@unina.it	Chiodini, Paolo/E-7290-2014; Iasevoli, Felice/Q-1430-2019; Rossi, Rodolfo/P-9228-2019	Chiodini, Paolo/0000-0003-0139-2264; Iasevoli, Felice/0000-0002-7051-5013; Rossi, Rodolfo/0000-0002-6857-898X			Adembri C, 2014, CRIT CARE MED, V42, pE570, DOI 10.1097/CCM.0000000000000414; Ahuja N, 2007, PROG NEURO-PSYCHOPH, V31, P968, DOI 10.1016/j.pnpbp.2007.01.018; Ambesi-Impiombato A, 2003, BRAIN RES PROTOC, V11, P189, DOI 10.1016/S1385-299X(03)00056-4; Ambesi-Impiombato A, 2007, SYNAPSE, V61, P429, DOI 10.1002/syn.20385; Amin AR, 1996, P NATL ACAD SCI USA, V93, P14014, DOI 10.1073/pnas.93.24.14014; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chaudhry IB, 2012, J PSYCHOPHARMACOL, V26, P1185, DOI 10.1177/0269881112444941; Chaves C, 2015, SCHIZOPHR RES, V161, P439, DOI 10.1016/j.schres.2014.11.031; Chaves C, 2010, PROG NEURO-PSYCHOPH, V34, P550, DOI 10.1016/j.pnpbp.2010.01.020; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; de Bartolomeis A, 2013, EUR J PHARMACOL, V718, P502, DOI 10.1016/j.ejphar.2013.06.034; de Bartolomeis A, 2013, EUR NEUROPSYCHOPHARM, V23, P1516, DOI 10.1016/j.euroneuro.2012.11.014; de Bartolomeis A, 2013, PROG NEURO-PSYCHOPH, V46, P1, DOI 10.1016/j.pnpbp.2013.06.010; de Bartolomeis A, 2012, MOL NEUROBIOL, V46, P275, DOI 10.1007/s12035-012-8293-6; de Bartolomeis A, 2012, EUR J PHARMACOL, V682, P1, DOI 10.1016/j.ejphar.2012.02.033; Deakin JFW, 2008, ARCH GEN PSYCHIAT, V65, P154, DOI 10.1001/archgenpsychiatry.2007.37; Drouin-Ouellet J, 2011, GLIA, V59, P188, DOI 10.1002/glia.21086; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Gallo EF, 2011, J NEUROSCI, V31, P6947, DOI 10.1523/JNEUROSCI.0374-11.2011; Gao C, 2013, NEUROBIOL LEARN MEM, V105, P3, DOI 10.1016/j.nlm.2013.04.014; Ghanizadeh A, 2014, RECENT PATENTS INFLA, V8, P211, DOI 10.2174/1872213X08666141029123524; Gonzalez JC, 2007, EUR J NEUROSCI, V26, P2481, DOI 10.1111/j.1460-9568.2007.05873.x; Hashimoto K, 2007, BIOL PSYCHIAT, V61, P577, DOI 10.1016/j.biopsych.2006.03.019; Hodkinson Duncan J, 2012, Br J Med Med Res, V2, P373; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Iasevoli F, 2014, PROG NEURO-PSYCHOPH, V54, P299, DOI 10.1016/j.pnpbp.2014.07.003; Iasevoli F, 2014, CURR NEUROPHARMACOL, V12, P219, DOI 10.2174/1570159X12666140324183406; Iasevoli F, 2013, NEUROCHEM RES, V38, P1, DOI 10.1007/s11064-012-0886-y; Iasevoli F, 2009, PROG NEURO-PSYCHOPH, V33, P813, DOI 10.1016/j.pnpbp.2009.02.009; Imbesi M, 2008, NEUROSCI LETT, V447, P134, DOI 10.1016/j.neulet.2008.10.006; Kelly DL, 2015, J CLIN PSYCHOPHARM, V35, P374, DOI 10.1097/JCP.0000000000000345; Kelly DL, 2011, SCHIZOPHR RES, V133, P257, DOI 10.1016/j.schres.2011.08.005; Khodaie-Ardakani MR, 2014, PSYCHIAT RES, V215, P540, DOI 10.1016/j.psychres.2013.12.051; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; KLEIN NC, 1995, MED CLIN N AM, V79, P789, DOI 10.1016/S0025-7125(16)30039-6; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lees J, 2004, J PSYCHOPHARMACOL, V18, P337, DOI 10.1177/026988110401800302; Levkovitz Y, 2007, BRAIN RES, V1154, P154, DOI 10.1016/j.brainres.2007.03.080; Levkovitz Y, 2010, J CLIN PSYCHIAT, V71, P138, DOI 10.4088/JCP.08m04666yel; Li Y, 2013, J NEUROPHYSIOL, V109, P1494, DOI 10.1152/jn.00580.2012; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Liu F, 2014, SCHIZOPHR RES, V153, P169, DOI 10.1016/j.schres.2014.01.011; Liu T, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-16; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Miyaoka T, 2007, PROG NEURO-PSYCHOPH, V31, P304, DOI 10.1016/j.pnpbp.2006.08.013; Mizoguchi H, 2008, PSYCHOPHARMACOLOGY, V196, P233, DOI 10.1007/s00213-007-0955-0; Moghaddam B, 2012, SCHIZOPHRENIA BULL, V38, P942, DOI 10.1093/schbul/sbs075; Murphy BP, 2006, SCHIZOPHR RES, V88, P5, DOI 10.1016/j.schres.2006.07.002; Nam JH, 2014, NEUROREPORT, V25, P489, DOI 10.1097/WNR.0000000000000122; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; *NIH, 1996, NIH PUBL; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; Oya K, 2014, HUM PSYCHOPHARM CLIN, V29, P483, DOI 10.1002/hup.2426; Papaleo F, 2012, MOL PSYCHIATR, V17, P85, DOI 10.1038/mp.2010.106; Papaleo F, 2012, NEUROPHARMACOLOGY, V62, P1204, DOI 10.1016/j.neuropharm.2011.04.025; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; POGUN S, 1994, SYNAPSE, V18, P21, DOI 10.1002/syn.890180104; Polese D, 2002, NEUROPSYCHOPHARMACOL, V27, P906, DOI 10.1016/S0893-133X(02)00371-8; Qurashi I, 2014, J PSYCHOPHARMACOL, V28, P707, DOI 10.1177/0269881114527358; ROBERTSON GS, 1992, NEUROSCIENCE, V46, P315, DOI 10.1016/0306-4522(92)90054-6; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Siddoway B, 2014, NEUROPHARMACOLOGY, V78, P38, DOI 10.1016/j.neuropharm.2013.07.009; Tan HY, 2007, CEREB CORTEX, V17, pI171, DOI [10.1093/cercor/bhm069, 10.1093/cercor/hhm069]; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tomasetti C, 2007, NEUROSCIENCE, V150, P144, DOI 10.1016/j.neuroscience.2007.08.022; Tomasetti C, 2011, PROG NEURO-PSYCHOPH, V35, P184, DOI 10.1016/j.pnpbp.2010.10.025; Trotti D, 1996, J BIOL CHEM, V271, P5976, DOI 10.1074/jbc.271.11.5976; Tuominen HJ, 2005, SCHIZOPHR RES, V72, P225, DOI 10.1016/j.schres.2004.05.005; Wang JQ, 2005, MOL NEUROBIOL, V32, P237, DOI 10.1385/MN:32:3:237; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wiedholz LM, 2008, MOL PSYCHIATR, V13, P631, DOI 10.1038/sj.mp.4002056; Woolley ML, 2009, PSYCHOPHARMACOLOGY, V202, P343, DOI 10.1007/s00213-008-1325-2; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zhang L, 2006, EUR J PHARMACOL, V544, P1, DOI 10.1016/j.ejphar.2006.05.047; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	82	6	6	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-8811	1461-7285		J PSYCHOPHARMACOL	J. Psychopharmacol.	APR	2017	31	4					406	417		10.1177/0269881116658987			12	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	ET3LE	WOS:000400179400002	27443599				2022-02-06	
J	Gaw, CE; Chounthirath, T; Smith, GA				Gaw, Christopher E.; Chounthirath, Thiphalak; Smith, Gary A.			Nursery Product-Related Injuries Treated in United States Emergency Departments	PEDIATRICS			English	Article							YOUNG-CHILDREN; US; SUFFOCATION; DEATHS; FALL	OBJECTIVE: The goal of this study was to determine the epidemiology of injuries associated abstract with nursery products among young children treated in US emergency departments. METHODS: Data from the National Electronic Injury Surveillance System were retrospectively analyzed for patients aged < 3 years who sustained an injury associated with a nursery product from 1991 through 2011. RESULTS: An estimated 1 391 844 (95% confidence interval, 1 169 489-1 614 199) nursery product-related injuries among children aged < 3 years were treated in US emergency departments during the 21-year study period, averaging 56.29 injuries per 10 000 children. The annual injury rate decreased significantly by 33.9% from 1991 to 2003, followed by a significant increase of 23.7% from 2003 to 2011. The decrease was driven by a significant decline in baby walker/jumper/exerciser-related injuries; the increase was driven by a significant increase in concussions and closed head injuries. Nursery product-related injuries were most commonly associated with baby carriers (19.5%), cribs/mattresses (18.6%), strollers/carriages (16.5%), or baby walkers/jumpers/exercisers (16.2%). The most common mechanism of injury was a self-precipitated fall (80.0%), and the most frequently injured body region was the head or neck (47.1%). CONCLUSIONS: Although successful injury prevention efforts with baby walkers led to a decline in nursery product-related injuries from 1991 to 2003, the number and rate of these injuries have been increasing since 2003. Greater efforts are warranted to prevent injuries associated with other nursery products, especially baby carriers, cribs, and strollers. Prevention of falls and concussions/closed head injuries associated with nursery products also deserves special attention.	[Gaw, Christopher E.; Chounthirath, Thiphalak; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA; [Gaw, Christopher E.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org	Gaw, Christopher/ABI-2314-2020	Gaw, Christopher/0000-0002-2847-6372			Byard RW, 2009, J FORENSIC LEG MED, V16, P340, DOI 10.1016/j.jflm.2009.01.003; Center for Injury Research and Policy, GUID NEW PAR GETT YO; CHIAVIELLO CT, 1994, PEDIATRICS, V93, P974; Chowdhury RT, INJURIES DEATHS ASS; Division of State Documents, COD MAR 10 11 07 PRO; Durrett J., RECALL DANGEROUS PRO; Durrett J., DECADE DATA IN DEPTH; FAZEN LE, 1982, PEDIATRICS, V70, P106; Greenberg RA, 2009, PEDIATR EMERG CARE, V25, P66, DOI 10.1097/PEC.0b013e318196e9dc; Inoue N, PRAM STROLLER RELATE; Juvenile Products Manufacturers Association, JPMA BUMP STAT; Kamboj A, 2017, CLIN PEDIATR, V56, P545, DOI 10.1177/0009922816664064; Keim SA, 2012, PEDIATRICS, V129, P1104, DOI 10.1542/peds.2011-3348; Kids in Danger, SAF SLEEP SAF PLAY C; Kids In Danger, MOV SAF LOOK PROD RE; Kids In Danger, YEAR NURS PROD REC L; Kids In Danger, MEAS SAF CHILDR PROD; Kids In Danger, CHECK UP CHIC BAN CR; Lawrence Brenda, 2012, Morbidity and Mortality Weekly Report, V61, P933; Mack KA, 2008, PEDIATRICS, V121, P930, DOI 10.1542/peds.2007-1731; Moon RY, 2011, PEDIATRICS, V128, P1030, DOI 10.1542/peds.2011-2284; Moon RY, 2011, PEDIATRICS, V128; Pollack-Nelson C, 2000, PEDIATR EMERG CARE, V16, P77, DOI 10.1097/00006565-200004000-00002; Pollack-Nelson C, 2012, INJURY PREVENTION CH; Powell EC, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e62; Rodgers GB, 2005, J SAFETY RES, V36, P327, DOI 10.1016/j.jsr.2005.06.010; Scheers NJ, 2016, J PEDIATR-US, V169, P93, DOI 10.1016/j.jpeds.2015.10.050; Schroeder T., NEISS SAMPLE DESIGN; Shapiro-Mendoza CK, 2009, PEDIATRICS, V123, P533, DOI 10.1542/peds.2007-3746; Shields BJ, 2006, PEDIATRICS, V117; Smith GA, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.2.e1; Thach BT, 2007, J PEDIATR-US, V151, P271, DOI 10.1016/j.jpeds.2007.04.028; Thach BT, 2007, J PEDIAT, V151, pe1; Tripathi M, 2017, INJURY PREV, V23, P60, DOI 10.1136/injuryprev-2015-041805; United States Consumer Product Safety Commission, NAT EL INJ SURV SYST; US Census Bureau, INT EST US POP AG SE; US Census Bureau, ANN EST RES POP SING ANN EST RES POP SING; US Census Bureau, INT EST RES POP SING; US Consumer Product Safety Commission, THE SAF NURS; Vilke GM, 2004, PEDIATR EMERG CARE, V20, P660, DOI 10.1097/01.pec.0000142949.81135.3d; Watson W, INJURIES ASS NURSERY; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x; Yeh ES, 2011, PEDIATRICS, V127, P479, DOI 10.1542/peds.2010-1537; Zielinski AE, 2012, PEDIATRICS, V129, P721, DOI 10.1542/peds.2011-2314	44	6	7	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2017	139	4							e20162503	10.1542/peds.2016-2503			11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	ER2CU	WOS:000398602400018	28289137	Bronze			2022-02-06	
J	Gupta, S; Iv, V; Sam, N; Vuthy, D; Klaric, K; Shrime, MG; Park, KB				Gupta, Saksham; Iv, Vycheth; Sam, Nang; Vuthy, Din; Klaric, Katherine; Shrime, Mark G.; Park, Kee B.			Impact of Helmet Use on Severity of Epidural Hematomas in Cambodia	WORLD NEUROSURGERY			English	Article						Cambodia; Epidural hematoma; Helmet usage; Low-income countries; Road traffic accidents; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MOTORCYCLE CRASHES; INCOME COUNTRIES; PREVALENCE; BEHAVIORS; ATTITUDES; MORTALITY; OUTCOMES	BACKGROUND: Traumatic brain injury is a major cause of morbidity and mortality worldwide, often necessitating neurosurgical intervention to evacuate intracranial bleeding. Since the early 2000s, Cambodia has been undergoing a rapid increase in motorcycle transit and in road traffic accidents, but the prevalence of helmet usage remains low. Epidural hematomas are severe traumatic brain injuries that can necessitate neurosurgical intervention. METHODS: This is a retrospective cohort study of patients with epidural hematoma secondary to motorcycle accidents who presented to a major national tertiary care center in Phnom Penh, Cambodia, between November 2013 and March 2016. All patients were diagnosed with computed tomography of the head. RESULTS: In this cohort, 21.6% of patients in motorcycle accidents presented with epidural hematoma and 89.1% of patients were men, 47.6% were intoxicated, and were 87.8% were not wearing helmets at the moment of impact. Not wearing a helmet was associated with a 6.90-fold increase in odds of presenting with a moderate-to-severe Glasgow coma scale score and a 3.76-fold increase in odds of requiring craniotomy or craniectomy for evacuation of hematoma. Male sex was also associated with increased odds of higher clinical severity at presentation and indication for craniotomy or craniectomy, and alcohol intoxication at the time of accident was not associated with either. CONCLUSIONS: Helmet usage is protective in reducing the severity of presentation and need for neurosurgical intervention for patients with epidural hematoma secondary to motorcycle accidents.	[Gupta, Saksham] Harvard Med Sch, Boston, MA USA; [Shrime, Mark G.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, 243 Charles St, Boston, MA 02114 USA; [Shrime, Mark G.; Park, Kee B.] Harvard Med Sch, Program Global Surg & Social Change, Boston, MA 02115 USA; [Iv, Vycheth; Sam, Nang; Vuthy, Din; Park, Kee B.] Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia; [Klaric, Katherine] Asia Injury Prevent Fdn, Toul Svay Prey Commune, Chamka Mom Dist, Phnom Penh, Cambodia		Park, KB (corresponding author), Harvard Med Sch, Program Global Surg & Social Change, Boston, MA 02115 USA.; Park, KB (corresponding author), Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia.	keebpark@gmail.com			Korean American Medical Foundation; Foundation of the World Federation of Neurosurgical Societies	This study was partially funded by support from the Korean American Medical Foundation and the Foundation of the World Federation of Neurosurgical Societies.	Ackaah W, 2013, INJURY PREV, V19, P158, DOI 10.1136/injuryprev-2012-040348; Bachani AM, 2013, INJURY, V44, pS31, DOI [10.1016/S0020-1383(13)70210-9, 10.1016/S0020-1383(13)70209-2]; Bilgin S, 2012, NEURAL REGEN RES, V7, P1978, DOI 10.3969/j.issn.1673-5374.2012.25.009; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Dagher JH, 2016, CAN J NEUROL SCI, V43, P56, DOI 10.1017/cjn.2015.281; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Emejulu JKC, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.09.002; Erhardt T, 2016, ACCIDENT ANAL PREV, V86, P23, DOI 10.1016/j.aap.2015.10.004; Fong MC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2304-2; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Hooten Kristopher G, 2012, Clin Neurosurg, V59, P126; Hung DV, 2006, INJURY PREV, V12, P409, DOI 10.1136/ip.2006.012724; Karuppanagounder K, 2016, TRAFFIC INJ PREV, V17, P292, DOI 10.1080/15389588.2015.1055736; Khan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132229; Kraemer JD, 2012, INT J INJ CONTROL SA, V19, P373, DOI 10.1080/17457300.2012.663762; Lam C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/487985; Lee HY, 2010, AM J PUBLIC HEALTH, V100, P165, DOI 10.2105/AJPH.2008.159004; Lin HL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619231; Liu B. C., 2004, COCHRANE DB SYST REV; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; National Road Safety Committee HI, 2013, 2013 ANN REP ROAD CR; Norvell DC, 2002, AM J EPIDEMIOL, V156, P483, DOI 10.1093/aje/kwf081; Olsen Cody S, 2016, Inj Epidemiol, V3, P8; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ramli R, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-17; Roehler DR, 2015, INT J INJ CONTROL SA, V22, P165, DOI 10.1080/17457300.2013.876050; Roehler DR, 2013, GLOB HEALTH PROMOT, V20, P37, DOI 10.1177/1757975913509657; Roehler DR, 2013, INT J INJ CONTROL SA, V20, P179, DOI 10.1080/17457300.2012.759594; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubiano AM, 2013, BRAIN INJURY, V27, P262, DOI 10.3109/02699052.2012.750742; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5	34	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2017	100						267	270		10.1016/j.wneu.2016.12.104			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7BT	WOS:000401930000036	28049032				2022-02-06	
J	Patrick, MM; Grillot, JM; Derden, ZM; Paul, DW				Patrick, Marlena M.; Grillot, Julianna M.; Derden, Zayne M.; Paul, David W.			Long-term Drifts in Sensitivity Caused by Biofouling of an Amperometric Oxygen Sensor	ELECTROANALYSIS			English	Article						Oxygen sensor; Poly-o-phenylenediamine; Electropolymerization; Biofouling	CARBON-FIBER MICROELECTRODES; TRAUMATIC BRAIN-INJURY; IN-VIVO; PROTEIN ADSORPTION; SERUM-ALBUMIN; GOLD ELECTRODES; TISSUE OXYGEN; BIOSENSORS; COATINGS; GLUCOSE	Changes in oxygen sensitivity of an poly(o-phenylenediamine) (PoPD) coated gold electrode was determined by constructing calibration curves invitro. Oxygen sensitivities recorded in the presence of biofoulants were significantly different from those recorded in buffer; however, PoPD demonstrated its effectiveness in providing some resistance to changes in oxygen sensitivity over time compared to a bare electrode. Three sets of PoPD-coated electrodes were calibrated in simple electrolyte of phosphate buffered saline; each set yielding an average oxygen sensitivity of 0.58 +/- 0.03A/ppm, 0.68 +/- 0.01A/ppm, and 0.48 +/- 0.01A/ppm (n=4), which shows the electrode to electrode variation in the PoPD-coating/electrode. These sets were correspondingly exposed to bovine serum albumin, fibrinogen, rat brain homogenate. Exposure to these biofoulants resulted in decreases in sensitivity ranging from 26-35% after immediate exposure. Furthermore, long-term exposure to some biofoulants causes significant decreases in sensitivity over a time period of 14 days. We also estimated through invitro exposure to rat brain homogenate the errors that might be associated with current methods of calibration. Sensitivities to oxygen determined by precalibration resulted in a 50% error from the sensitivity found invitro; the error from postcalibration after rinsing resulted in 25% error.	[Patrick, Marlena M.; Grillot, Julianna M.; Derden, Zayne M.; Paul, David W.] Univ Arkansas, Fayetteville, AR 72701 USA		Patrick, MM; Paul, DW (corresponding author), Univ Arkansas, Fayetteville, AR 72701 USA.	mxp031@uark.edu; dpaul@uark.edu			Arkansas Biosciences Institute; major research component of the Arkansas Tobacco Settlement Proceeds Act	The authors acknowledge financial support from the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000. We are also thankful for the collaborative support of Dr. Julie Stenken's research group, especially Tina Poseno.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Andrade J D, 1973, Med Instrum, V7, P110; AUSTINHARRISON DS, 1989, ELECTROANAL, V1, P189, DOI 10.1002/elan.1140010302; Barfidokht A, 2014, ELECTROANAL, V26, P1182, DOI 10.1002/elan.201400097; Bazzu G, 2009, ANAL CHEM, V81, P2235, DOI 10.1021/ac802390f; Bolger FB, 2011, ANALYST, V136, P4028, DOI 10.1039/c1an15324b; Brown FO, 2009, ANALYST, V134, P2012, DOI 10.1039/b909005c; Brown J. R, 1977, ALBUMIN STRUCTURE FU, P27; Bucur B, 2012, CURR NEUROPHARMACOL, V10, P197, DOI 10.2174/157015912803217350; Burmeister JJ, 2003, TRAC-TREND ANAL CHEM, V22, P498, DOI 10.1016/S0165-9936(03)00904-X; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058; CLARK LC, 1953, J APPL PHYSIOL, V6, P189, DOI 10.1152/jappl.1953.6.3.189; Collyer S, 2004, ELECTROANAL, V16, P275, DOI 10.1002/elan.200402829; Dai YQ, 2006, ELECTROCHIM ACTA, V52, P297, DOI 10.1016/j.electacta.2006.05.010; Dargahi M, 2015, ELECTROCHIM ACTA, V174, P1009, DOI 10.1016/j.electacta.2015.06.065; Dengler J, 2011, INTENS CARE MED, V37, P1809, DOI 10.1007/s00134-011-2316-z; Feng L, 1995, ACS SYM SER, V602, P66; Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8; Gifford R, 2006, BIOMATERIALS, V27, P2587, DOI 10.1016/j.biomaterials.2005.11.033; Glomm WR, 2007, J PHYS CHEM B, V111, P14329, DOI 10.1021/jp074839d; Gui AL, 2013, ACS APPL MATER INTER, V5, P4827, DOI 10.1021/am400519m; Hanssen BL, 2016, REV ANAL CHEM, V35, P1, DOI 10.1515/revac-2015-0008; HIGSON SPJ, 1993, J CHEM SOC FARADAY T, V89, P2847, DOI 10.1039/ft9938902847; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Hu YB, 1997, J NEUROCHEM, V68, P1745; JOHNSON DC, 1993, J CHROMATOGR, V640, P79, DOI 10.1016/0021-9673(93)80171-4; Kealy J, 2013, J NEUROSCI METH, V215, P110, DOI 10.1016/j.jneumeth.2013.02.016; Keddie S, 2012, NURS CRIT CARE, V17, P204, DOI 10.1111/j.1478-5153.2012.00499.x; Khubutiya MS, 2010, RUSS J ELECTROCHEM+, V46, P537, DOI 10.1134/S1023193510050071; Killoran SJ, 2008, ELECTROCHIM ACTA, V53, P7303, DOI 10.1016/j.electacta.2008.03.076; Klueh Ulrike, 2013, J Diabetes Sci Technol, V7, P452; Klueh Ulrike, 2007, J Diabetes Sci Technol, V1, P842; Kong L, 2013, SENSOR ACTUAT B-CHEM, V185, P424, DOI 10.1016/j.snb.2013.05.033; KUHR WG, 1984, J NEUROCHEM, V43, P560, DOI 10.1111/j.1471-4159.1984.tb00935.x; Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s; Liu XM, 2016, ANAL CHEM, V88, P7238, DOI 10.1021/acs.analchem.6b01476; Logman MJ, 2000, J NEUROSCI METH, V95, P95, DOI 10.1016/S0165-0270(99)00155-7; MEYERHOFF ME, 1993, TRAC-TREND ANAL CHEM, V12, P257, DOI 10.1016/0165-9936(93)87065-6; Moghadas SM, 2006, MATH MED BIOL, V23, P231, DOI 10.1093/imammb/dql011; Moulton SE, 2004, ELECTROCHIM ACTA, V49, P4223, DOI 10.1016/j.electacta.2004.03.034; Moulton SE, 2003, J COLLOID INTERF SCI, V261, P312, DOI 10.1016/S0021-9797(03)00073-0; Nozue M, 1997, J SURG ONCOL, V66, P30, DOI 10.1002/(SICI)1096-9098(199709)66:1<30::AID-JSO7>3.0.CO;2-O; Patel J, 2013, ANAL CHEM, V85, P11610, DOI 10.1021/ac403013r; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; Ren H, 2015, ANAL CHEM, V87, P8067, DOI 10.1021/acs.analchem.5b01590; Rothwell SA, 2010, SENSORS-BASEL, V10, P6439, DOI 10.3390/s100706439; SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Severinghaus J W, 1986, J Clin Monit, V2, P174, DOI 10.1007/BF01620550; Singh YS, 2011, ANAL CHEM, V83, P6658, DOI 10.1021/ac2011729; Stephen B. McHugh, 2011, EUR J NEUROSCI, V33, P322; Szott LM, 2012, ACS SYM SER, V1120, P321; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Vreeland RF, 2015, ANAL CHEM, V87, P2600, DOI 10.1021/ac502165f; Wahono N, 2012, BIOSENS BIOELECTRON, V33, P260, DOI 10.1016/j.bios.2012.01.019; Wasilewska M, 2009, LANGMUIR, V25, P3698, DOI 10.1021/la803662a; Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556; Xiang L, 2014, ANAL CHEM, V86, P5017, DOI 10.1021/ac500622m; Yang W, 2011, BIOSENS BIOELECTRON, V26, P2454, DOI 10.1016/j.bios.2010.10.031; Ying PQ, 2004, J COLLOID INTERF SCI, V279, P95, DOI 10.1016/j.jcis.2004.06.048; Zhai WY, 2013, CAN J CHEM, V91, P1077, DOI 10.1139/cjc-2013-0141	63	6	6	2	25	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1040-0397	1521-4109		ELECTROANAL	Electroanalysis	APR	2017	29	4					998	1005		10.1002/elan.201600653			8	Chemistry, Analytical; Electrochemistry	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Electrochemistry	ER5OE	WOS:000398850400011					2022-02-06	
J	Williams, JZ; Singichetti, B; Li, HM; Xiang, H; Klingele, KE; Yang, JZ				Williams, Jacob Z.; Singichetti, Bhavna; Li, Hongmei; Xiang, Henry; Klingele, Kevin E.; Yang, Jingzhen			Epidemiological Patterns of Initial and Subsequent Injuries in Collegiate Football Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						football (American); epidemiology; collegiate athletics; subsequent injury; recurrent injury	HIGH-SCHOOL; SURVEILLANCE SYSTEM; RISK-FACTOR; SPORTS; CONCUSSION; PLAYERS; DEPRESSION; INCREASES	Background: A body of epidemiological studies has examined football injuries and associated risk factors among collegiate athletes. However, few existing studies specifically analyzed injury risk in terms of initial or subsequent injuries. Purpose: To determine athlete-exposures (AEs) and rates of initial and subsequent injury among collegiate football athletes. Study Design: Descriptive epidemiological study. Methods: Injury and exposure data collected from collegiate football players from two Division I universities (2007-2011) were analyzed. Rate of initial injury was calculated as the number of initial injuries divided by the total number of AEs for initial injuries, while the rate for subsequent injury was calculated as the number of subsequent injuries divided by the total number of AEs for subsequent injury. Poisson regression was used to determine injury rate ratio (subsequent vs initial injury), with adjustment for other covariates. Results: The total AEs during the study period were 67,564, resulting in an overall injury rate of 35.2 per 10,000 AEs. Rates for initial and subsequent injuries were 31.7 and 45.3 per 10,000 AEs, respectively, with a rate ratio (RR) of 1.4 for rate of subsequent injury vs rate of initial injury (95% CI, 1.1-1.9). Rate of injury appeared to increase with each successive injury. RR during games was 1.8 (95% CI, 1.1-3.0). The rate of subsequent injuries to the head, neck, and face was 10.9 per 10,000 AEs, nearly double the rate of initial injuries to the same sites (RR = 2.0; 95% CI, 1.1-3.5). For wide receivers, the rate of subsequent injuries was 2.2 times the rate of initial injuries (95% CI, 1.3-3.8), and for defensive linemen, the rate of subsequent injuries was 2.1 times the rate of initial injuries (95% CI, 1.1-3.9). Conclusion: The method used in this study allows for a more accurate determination of injury risk among football players who have already been injured at least once. Further research is warranted to better identify which specific factors contribute to this increased risk for subsequent injury.	[Williams, Jacob Z.; Singichetti, Bhavna; Li, Hongmei; Xiang, Henry; Yang, Jingzhen] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH USA; [Yang, Jingzhen] Ohio State Univ, Nationwide Childrens Hosp, Ctr Injury Res & Prevent, Res Inst,Dept Pediat, Columbus, OH 43205 USA; [Williams, Jacob Z.] Ohio State Univ, Coll Med, Med Student Res Program, 700 Childrens Dr,WB5403, Columbus, OH 43205 USA; [Li, Hongmei] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol & Biostat, Suzhou, Jiangsu, Peoples R China; [Xiang, Henry; Klingele, Kevin E.; Yang, Jingzhen] Ohio State Univ, Coll Med, Dept Pediat, 700 Childrens Dr,WB5403, Columbus, OH 43205 USA; [Yang, Jingzhen] Ohio State Univ, Coll Publ Hlth, Dept Epidemiol, 700 Childrens Dr,WB5403, Columbus, OH 43205 USA; [Klingele, Kevin E.] Nationwide Childrens Hosp, Sports Med & Orthoped, Columbus, OH USA		Yang, JZ (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Ctr Injury Res & Prevent, Res Inst,Dept Pediat, Columbus, OH 43205 USA.	ginger.yang@nationwidechildrens.org		Singichetti, Bhavna/0000-0002-2188-3979	University of Iowa Injury Prevention Research Center; Centers for Disease Control and Prevention (CDC)/National Center for Injury Prevention and Control [R49 CD001167-01]; Ohio State University College of Medicine Barnes & Bennett Memorial Research Scholarship	This work was supported by the University of Iowa Injury Prevention Research Center and was funded by grant R49 CD001167-01 from the Centers for Disease Control and Prevention (CDC)/National Center for Injury Prevention and Control, and in part by the Ohio State University College of Medicine Barnes & Bennett Memorial Research Scholarship.	Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Dvorak J, 2000, AM J SPORT MED, V28, pS69; Greene HS, 2001, AM J SPORT MED, V29, P795, DOI 10.1177/03635465010290062001; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hamilton GM, 2011, CLIN J SPORT MED, V21, P508, DOI 10.1097/JSM.0b013e31822e8619; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Knowles SB, 2006, AM J EPIDEMIOL, V164, P1209, DOI 10.1093/aje/kwj337; Lehr ME, 2013, SCAND J MED SCI SPOR, V23, pe225, DOI 10.1111/sms.12062; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Rauh MJ, 2007, J ATHL TRAINING, V42, P486; Rugg CM, 2014, AM J SPORT MED, V42, P959, DOI 10.1177/0363546513519951; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b; Yang JZ, 2012, J ATHL TRAINING, V47, P198; Yang JZ, 2010, J ATHL TRAINING, V45, P372, DOI 10.4085/1062-6050-45.4.372; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	27	6	6	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	APR	2017	45	5					1171	1178		10.1177/0363546516685317			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	ET4HK	WOS:000400239900024	28171736				2022-02-06	
J	Zhang, HR; Jiang, L; Guo, ZD; Zhong, JJ; Wu, JC; He, JC; Liu, H; He, ZH; Wu, HT; Cheng, CJ; Sun, XC				Zhang, Hongrong; Jiang, Li; Guo, Zongduo; Zhong, Jianjun; Wu, Jingchuan; He, Junchi; Liu, Han; He, Zhaohui; Wu, Haitao; Cheng, Chongjie; Sun, Xiaochuan			PPAR beta/delta, a Novel Regulator for Vascular Smooth Muscle Cells Phenotypic Modulation and Vascular Remodeling after Subarachnoid Hemorrhage in Rats	SCIENTIFIC REPORTS			English	Article							ACTIVATED-RECEPTOR-DELTA; TRAUMATIC BRAIN-INJURY; SERUM RESPONSE FACTOR; CEREBRAL AUTOREGULATION; GENE-EXPRESSION; BASILAR ARTERY; MYOCARDIN; PATHWAY; DIFFERENTIATION; MODEL	Cerebral vascular smooth muscle cell (VSMC) phenotypic switch is involved in the pathophysiology of vascular injury after aneurysmal subarachnoid hemorrhage (aSAH), whereas the molecular mechanism underlying it remains largely speculative. Peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) has been implicated to modulate the vascular cells proliferation and vascular homeostasis. In the present study, we investigated the potential role of PPAR beta/delta in VSMC phenotypic switch following SAH. Activation of PPAR beta/delta by GW0742 and adenoviruses PPAR beta/delta (Ad-PPAR beta/delta) significantly inhibited hemoglobin-induced VSMC phenotypic switch. However, the effects of PPAR beta/delta on VSMC phenotypic switch were partly obstacled in the presence of LY294002, a potent inhibitor of Phosphatidyl-Inositol-3 Kinase-AKT (PI3K/AKT). Furthermore, following study demonstrated that PPAR beta/delta-induced PI3K/AKT activation can also contribute to Serum Response Factor (SRF) nucleus localization and Myocardin expression, which was highly associated with VSMC phenotypic switch. Finally, we found that AdPPAR beta/delta positively modulated vascular remodeling in SAH rats, i.e. the diameter of basilar artery and the thickness of vessel wall. In addition, overexpression of PPAR beta/delta by adenoviruses significantly improved neurological outcome. Taken together, this study identified PPAR beta/delta as a useful regulator for VSMC phenotypic switch and vascular remodeling following SAH, providing novel insights into the therapeutic strategies of delayed cerebral ischemia.	[Zhang, Hongrong; Jiang, Li; Guo, Zongduo; Zhong, Jianjun; Wu, Jingchuan; He, Junchi; Liu, Han; He, Zhaohui; Cheng, Chongjie; Sun, Xiaochuan] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 1 Youyi Rd, Chongqing, Peoples R China; [Wu, Haitao] Zunyi Med Coll, Affiliated Hosp, Dept Neurosurg, 149 Dalian Rd, Zunyi, Guizhou, Peoples R China		Cheng, CJ; Sun, XC (corresponding author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 1 Youyi Rd, Chongqing, Peoples R China.	358187887@qq.com; sunxch1445@qq.com	He, Junchi/AAD-8482-2019; Wu, Jingchuan/AAV-7799-2020	Wu, Jingchuan/0000-0002-1213-4888	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159, 81371309]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81601072]; National Construction Project for Clinical Key Specialty [(2011)170]; Guizhou Science and Technology Department [(2013) 2332]	The authors thank the following funding agencies for their support: National Natural Science Foundation of China (No. 81571159), National Natural Science Foundation for Youth of China (No. 81601072), National Natural Science Foundation of China (No. 81371309), National Construction Project for Clinical Key Specialty (No. (2011)170), and Guizhou Science and Technology Department (No. (2013) 2332). We acknowledge the service provided by Chongqing Key Laboratory of Ophthalmology and Laboratory Research Central, the First Affiliated Hospital of Chongqing Medical University.	Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; Boerth NJ, 1997, J VASC RES, V34, P245, DOI 10.1159/000159231; Brophy CM, 2002, J VASC RES, V39, P95, DOI 10.1159/000057758; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Carpenter RC, 2001, STROKE, V32, P516, DOI 10.1161/01.STR.32.2.516; Chen D, 2011, J PHARMACOL EXP THER, V337, P663, DOI 10.1124/jpet.110.177055; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Chen YJ, 2015, STROKE, V46, P529, DOI 10.1161/STROKEAHA.114.007265; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Diringer MN, 2009, CRIT CARE MED, V37, P432, DOI 10.1097/CCM.0b013e318195865a; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Edvinsson L, 2014, TRANSL STROKE RES, V5, P365, DOI 10.1007/s12975-014-0331-4; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Guo X, 2015, CIRC RES, V116, pE71, DOI 10.1161/CIRCRESAHA.116.305863; Guo ZN, 2016, MOL NEUROBIOL, V53, P3606, DOI 10.1007/s12035-015-9308-x; Hamaya R, 2013, EXPERT OPIN INV DRUG, V22, P1095, DOI 10.1517/13543784.2013.820702; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Jimenez R, 2010, J PHARMACOL EXP THER, V332, P554, DOI 10.1124/jpet.109.159806; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kim HJ, 2008, CIRC RES, V102, P193, DOI 10.1161/CIRCRESAHA.107.158477; Lai CF, 2006, CIRC RES, V98, P1479, DOI 10.1161/01.RES.0000227550.00426.60; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Li J, 2011, CLIN SCI, V120, P451, DOI 10.1042/CS20100466; Link TE, 2008, STROKE, V39, P2122, DOI 10.1161/STROKEAHA.107.508754; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Maddahi A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-274; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Muroi C, 2014, BRIT J NEUROSURG, V28, P722, DOI 10.3109/02688697.2014.918579; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Ohkuma H, 2003, NEUROSCI LETT, V344, P193, DOI 10.1016/S0304-3940(03)00464-6; Ohkuma H, 2001, NEUROSCI LETT, V311, P9, DOI 10.1016/S0304-3940(01)02101-2; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Piqueras L, 2007, ARTERIOSCL THROM VAS, V27, P63, DOI 10.1161/01.ATV.0000250972.83623.61; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rodriguez AI, 2015, ARTERIOSCL THROM VAS, V35, P430, DOI 10.1161/ATVBAHA.114.304936; Rossi F, 2006, PEPTIDES, V27, P2935, DOI 10.1016/j.peptides.2006.05.003; Shimamura N, 2014, TRANSL STROKE RES, V5, P357, DOI 10.1007/s12975-013-0310-1; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Teng ZP, 2016, STROKE, V47, P196, DOI 10.1161/STROKEAHA.115.011701; Tsai MC, 2009, CIRC RES, V105, P471, DOI 10.1161/CIRCRESAHA.109.193656; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wu J, 2016, STROKE, V47, P1319, DOI 10.1161/STROKEAHA.115.011552; Yang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058746; Yoshida T, 2012, J BIOL CHEM, V287, P25706, DOI 10.1074/jbc.M112.361360; Zhang J, 2013, J CARDIOVASC SURG, V54, P511; Zhang JH, 2012, NAT REV NEUROL, V8, P711, DOI 10.1038/nrneurol.2012.210	52	6	7	3	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 22	2017	7								45234	10.1038/srep45234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9EU	WOS:000396992800001	28327554	gold, Green Published			2022-02-06	
J	Schroeder, DC; Guschlbauer, M; Maul, AC; Cremer, DA; Becker, I; Bethencourt, DD; Paal, P; Padosch, SA; Wetsch, WA; Annecke, T; Boettiger, BW; Sterner-Kock, A; Herff, H				Schroeder, Daniel C.; Guschlbauer, Maria; Maul, Alexandra C.; Cremer, Daniel A.; Becker, Ingrid; Bethencourt, David de la Puente; Paal, Peter; Padosch, Stephan A.; Wetsch, Wolfgang A.; Annecke, Thorsten; Boettiger, Bernd W.; Sterner-Kock, Anja; Herff, Holger			Oesophageal heat exchangers with a diameter of 11mm or 14.7mm are equally effective and safe for targeted temperature management	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; INTRACRANIAL HYPERTENSION; TRANSFER DEVICE; RESUSCITATION; ASSOCIATION; PREVENTION; GUIDELINES; INDUCTION	Background Targeted temperature management (TTM) is widely used in critical care settings for conditions including hepatic encephalopathy, hypoxic ischemic encephalopathy, meningitis, myocardial infarction, paediatric cardiac arrest, spinal cord injury, traumatic brain injury, ischemic stroke and sepsis. Furthermore, TTM is a key treatment for patients after out-of-hospital cardiac-arrest (OHCA). However, the optimal cooling method, which is quick, safe and cost-effective still remains controversial. Since the oesophagus is adjacent to heart and aorta, fast heat-convection to the central blood-stream could be achieved with a minimally invasive oesophageal heat exchanger (OHE). To date, the optimal diameter of an OHE is still unknown. While larger diameters may cause thermal-or pressure-related tissue damage after long-term exposure to the oesophageal wall, smaller diameter (e.g., gastric tubes, up to 11mm) may not provide effective cooling rates. Thus, the objective of the study was to compare OHE-diameters of 11mm (OHE11) and 14.7mm (OHE14.7) and their effects on tissue and cooling capability. Methods Pigs were randomized to OHE11 (N = 8) or OHE14.7 (N = 8). After cooling, pigs were maintained at 33 degrees C for 1 hour. After 10h rewarming, oesophagi were analyzed by means of histopathology. The oesophagus of four animals from a separate study that underwent exactly the identical preparation and cooling protocol described above but received a maintenance period of 24h were used as histopathological controls. Results Mean cooling rates were 2.8 +/- 0.4 degrees C degrees C/h (OHE11) and 3.0 +/- 0.3 degrees C degrees C/h (OHE14.7; p = 0.20). Occasional mild acute inflammatory transepithelial infiltrates were found in the cranial segment of the oesophagus in all groups including controls. Deviations from target temperature were 0.1 +/- 0.4 degrees C (OHE11) and 0 +/- 0.1 degrees C (OHE14.7; p = 0.91). Rewarming rates were 0.19 +/- 0.07 degrees C degrees C/h (OHE11) and 0.20 +/- 0.05 degrees C degrees C/h (OHE14.7; p = 0.75). Conclusions OHE with diameters of 11 mm and 14.7 mm achieve effective cooling rates for TTM and did not cause any relevant oesophageal tissue damage. Both OHE demonstrated acceptable deviations from target temperature and allowed for an intended rewarming rate (0.25 degrees C/h).	[Schroeder, Daniel C.; Cremer, Daniel A.; Bethencourt, David de la Puente; Padosch, Stephan A.; Wetsch, Wolfgang A.; Annecke, Thorsten; Boettiger, Bernd W.; Herff, Holger] Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Kerpener Str 62, Cologne, Germany; [Guschlbauer, Maria; Maul, Alexandra C.; Sterner-Kock, Anja] Univ Hosp Cologne, Dept Expt Med, Cologne, Germany; [Becker, Ingrid] Univ Hosp Cologne, Inst Med Stat Informat & Epidemiol, Kerpener Str 62, Cologne, Germany; [Paal, Peter] Queen Mary Univ London, Barts Heart Ctr, St Bartholomews Hosp, Barts Hlth NHS Trust, London, England; [Paal, Peter] Barmherzige Bruder Salzburg Hosp, Dept Anaesthesiol & Crit Care Med, Kajetanerpl 2, Salzburg, Austria		Schroeder, DC (corresponding author), Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Kerpener Str 62, Cologne, Germany.	Daniel.Schroeder@uk-koeln.de	Annecke, Thorsten/AAG-3909-2020	Annecke, Thorsten/0000-0002-2496-4432; Schroeder, Daniel/0000-0002-0104-5986; Guschlbauer, Maria/0000-0002-5401-4542; Paal, Peter/0000-0002-2939-4782; Becker, Ingrid/0000-0001-5829-3553	"The Central Innovation Program for Small and Medium-sized enterprises", German Federal Ministry for Economic affairs and Energy [KF2429611AK3]	This work was supported by "The Central Innovation Program for Small and Medium-sized enterprises", German Federal Ministry for Economic affairs and Energy (KF2429611AK3) (HH). Equipment was provided by Hirtz & Co. KG, Cologne, Germany.	BUGGY D, 1994, BRIT J ANAESTH, V72, P393, DOI 10.1093/bja/72.4.393; Desai TK, 2005, GASTROINTEST ENDOSC, V61, P795, DOI 10.1016/S0016-5107(05)00313-5; Gotberg M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-7; Guluma KZ, 2006, ACAD EMERG MED, V13, P820, DOI 10.1197/j.aem.2006.03.559; He Xiaoming, 2003, Crit Rev Biomed Eng, V31, P355, DOI 10.1615/CritRevBiomedEng.v31.i56.10; HENRIQUES FC, 1947, AM J PATHOL, V23, P531; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; HUDACK STEPHEN, 1932, JOUR EXP MED, V55, P431, DOI 10.1084/jem.55.3.431; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; KOKATE JY, 1995, ARCH PHYS MED REHAB, V76, P666, DOI 10.1016/S0003-9993(95)80637-7; KULKARNI P, 1993, BRIT J ANAESTH, V70, P216, DOI 10.1093/bja/70.2.216; Kulstad E, 2013, RESUSCITATION, V84, P1619, DOI 10.1016/j.resuscitation.2013.06.019; Kulstad EB, 2012, WORLD J EMERG MED, V3, P118, DOI [10.5847/wjem.j.1920-8642.2012.02.007, 10.5847/wjem.j.issn.1920-8642.2012.02.007]; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; Lequerica JL, 2009, INT J HYPERTHER, V25, P150, DOI 10.1080/02656730802537626; LI DJ, 1987, INT J HYPERTHER, V3, P143, DOI 10.3109/02656738709140382; Markota A, 2016, J EMERGENCY MED; Markota A, 2016, AM J EMERG MED, V34, P741, DOI 10.1016/j.ajem.2016.01.028; Markota A, 2015, RESUSCITATION, V89, pE1, DOI 10.1016/j.resuscitation.2015.01.032; McMaster PD, 1934, J EXP MED, V60, P479, DOI 10.1084/jem.60.4.479; Naiman M, 2016, EXPERT REV MED DEVIC, V13, P423, DOI 10.1080/17434440.2016.1174573; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Pehbock D, 2014, ANAESTHESIST; Piercy M, 2009, J CARDIOTHOR VASC AN, V23, P62, DOI 10.1053/j.jvca.2008.09.014; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Popugaev KA, 2014, J NEUROL SURG REP, V75, pE224, DOI 10.1055/s-0034-1387188; Ran ZG, 2015, J VIROL, V89, P4818, DOI 10.1128/JVI.00059-15; Rasmussen YH, 1998, ACTA ANAESTH SCAND, V42, P348; Saito T, 2013, J VASC SURG, V57, P173, DOI 10.1016/j.jvs.2012.05.101; Sause A, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-52; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Sessler DI, 2013, ANESTHESIOLOGY, V118, P181, DOI 10.1097/ALN.0b013e3182784df3; SESSLER DI, 1988, ANESTHESIOLOGY, V68, P836, DOI 10.1097/00000542-198806000-00002; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sleisenger M.H., 2002, GASTROINTESTINAL LIV, P551; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Tobey NA, 1999, AM J PHYSIOL-GASTR L, V276, pG1322, DOI 10.1152/ajpgi.1999.276.6.G1322	40	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2017	12	3							e0173229	10.1371/journal.pone.0173229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6DM	WOS:000396094700016	28291783	Green Published, Green Submitted, gold			2022-02-06	
J	Shavit-Stein, E; Artan-Furman, A; Feingold, E; Ben Shimon, M; Itzekson-Hayosh, Z; Chapman, J; Vlachos, A; Maggio, N				Shavit-Stein, Efrat; Artan-Furman, Avital; Feingold, Ekaterina; Ben Shimon, Marina; Itzekson-Hayosh, Zeev; Chapman, Joab; Vlachos, Andreas; Maggio, Nicola			Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4)	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						PAR2; TRPV4; synaptic plasticity; hippocampus; LTD	TRAUMATIC BRAIN-INJURY; SYNAPTIC PLASTICITY; THROMBIN REGULATION; SIGNALING PATHWAYS; TRANSMISSION; SEIZURES; MICE; LTD; METAPLASTICITY; INFLAMMATION	Protease activated receptors (PARs) are involved in regulating synaptic transmission and plasticity in the brain. While it is well-accepted that PAR1 mediates long-term potentiation (LTP) of excitatory synaptic strength, the role of PAR2 in synaptic plasticity remains not well-understood. In this study, we assessed the role of PAR2-signaling in plasticity at hippocampal Schaffer collateral-CA1 synapses. Using field potential recordings, we report that PAR2-activation leads to long-term depression (LTD) of synaptic transmission through a protein kinase A -dependent, Transient Receptor Potential Vanilloid 4 -mediated mechanism, which requires the activation of N-methylD- aspartate receptors. These results demonstrate that the effects of PAR2 on synaptic plasticity are distinct from what is observed upon PAR1-activation. Thus, we propose that the activation of different classes of PARs, i. e., PAR1 and PAR2, may set the threshold of synaptic plasticity in the hippocampal network by balancing LTP and LTD.	[Shavit-Stein, Efrat; Artan-Furman, Avital; Feingold, Ekaterina; Ben Shimon, Marina; Itzekson-Hayosh, Zeev; Chapman, Joab; Maggio, Nicola] Chaim Sheba Med Ctr, Dept Neurol, Tel Hashomer, Israel; [Ben Shimon, Marina; Chapman, Joab; Maggio, Nicola] Tel Aviv Univ, Dept Neurol & Neurosurg, Sackler Fac Med, Tel Aviv, Israel; [Chapman, Joab; Maggio, Nicola] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Vlachos, Andreas] Heinrich Heine Univ, Inst Anat 2, Fac Med, Dusseldorf, Germany; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Tel Hashomer, Israel		Maggio, N (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, Tel Hashomer, Israel.; Maggio, N (corresponding author), Tel Aviv Univ, Dept Neurol & Neurosurg, Sackler Fac Med, Tel Aviv, Israel.; Maggio, N (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.; Maggio, N (corresponding author), Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Tel Hashomer, Israel.	nicola.maggio@sheba.health.gov.il	Chapman, Joab/E-4598-2010	Mindel, Kate/0000-0002-0242-8647	Talpiot Medical Leadership Program grant from the Chaim Sheba Medical Center; German Israeli Foundation grant [GIF G-1317-418.13/2015]	This study was supported by a Talpiot Medical Leadership Program grant from the Chaim Sheba Medical Center to NM and a German Israeli Foundation grant (GIF G-1317-418.13/2015) to AV and NM.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Almonte AG, 2007, NEUROBIOL LEARN MEM, V88, P295, DOI 10.1016/j.nlm.2007.04.004; Almonte AG, 2013, J NEUROCHEM, V124, P109, DOI 10.1111/jnc.12075; Alter BJ, 2008, NEURON, V57, P629, DOI 10.1016/j.neuron.2008.02.023; Bao YJ, 2014, EXPERT OPIN THER TAR, V18, P15, DOI 10.1517/14728222.2014.844792; Becker D, 2014, NEUROPHARMACOLOGY, V86, P212, DOI 10.1016/j.neuropharm.2014.07.013; Ben Shimon M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00151; Brown TE, 2013, HIPPOCAMPUS, V23, P662, DOI 10.1002/hipo.22125; Bushell TJ, 2006, NEUROPHARMACOLOGY, V50, P714, DOI 10.1016/j.neuropharm.2005.11.024; Bushell TJ, 2016, CURR DRUG TARGETS, V17, P1861, DOI 10.2174/1389450117666151209115232; Bushi D, 2015, J NEUROCHEM, V135, P1140, DOI 10.1111/jnc.13372; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Chen Y, 2011, NEUROSCIENCE, V193, P440, DOI 10.1016/j.neuroscience.2011.06.085; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Coughlin SR, 2001, THROMB HAEMOSTASIS, V86, P298; Deselms H, 2016, J NEUROSCI METH, V272, P69, DOI 10.1016/j.jneumeth.2016.02.002; Edwards JG, 2012, HIPPOCAMPUS, V22, P209, DOI 10.1002/hipo.20884; Fitzjohn S, 2016, CURR NEUROPHARMACOL, V14, P435, DOI 10.2174/1570159X13666150615221502; Gan J, 2011, BRIT J PHARMACOL, V163, P984, DOI 10.1111/j.1476-5381.2011.01293.x; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Grimsey N, 2011, IUBMB LIFE, V63, P403, DOI 10.1002/iub.442; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Hell JW, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7067; Hulme SR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0148; Hunt RF, 2012, EXP NEUROL, V237, P199, DOI 10.1016/j.expneurol.2012.06.013; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lohman RJ, 2009, NEUROBIOL LEARN MEM, V92, P301, DOI 10.1016/j.nlm.2009.03.010; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Maggio N, 2014, NEUROSCIENCE, V281, P135, DOI 10.1016/j.neuroscience.2014.09.041; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maggio N, 2007, HIPPOCAMPUS, V17, P10, DOI 10.1002/hipo.20237; Maggio N, 2014, HIPPOCAMPUS, V24, P1030, DOI 10.1002/hipo.22288; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Maggio N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00019; Maggio N, 2009, J NEUROSCI, V29, P8633, DOI 10.1523/JNEUROSCI.1901-09.2009; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Nieman MT, 2016, BLOOD, V128, P169, DOI 10.1182/blood-2015-11-636472; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Oikonomopoulou K, 2006, BIOL CHEM, V387, P677, DOI 10.1515/BC.2006.086; Olianas MC, 2007, NEUROSCIENCE, V146, P1289, DOI 10.1016/j.neuroscience.2007.02.059; Poole DP, 2013, J BIOL CHEM, V288, P5790, DOI 10.1074/jbc.M112.438184; Rezaie AR, 2014, THROMB HAEMOSTASIS, V112, P876, DOI 10.1160/TH14-02-0167; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Sanderson JL, 2016, NEURON, V89, P1000, DOI 10.1016/j.neuron.2016.01.043; Schuldt G, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00064; Shibasaki K, 2015, PFLUG ARCH EUR J PHY, V467, P2495, DOI 10.1007/s00424-015-1726-0; Stein ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep07912; Tillu DV, 2015, PAIN, V156, P859, DOI 10.1097/j.pain.0000000000000125; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Tsilibary E, 2014, PROG BRAIN RES, V214, P135, DOI 10.1016/B978-0-444-63486-3.00006-2; Vance KM, 2015, J NEUROSCI, V35, P776, DOI 10.1523/JNEUROSCI.3105-14.2015; Wlodarczyk J, 2011, DEV NEUROBIOL, V71, P1040, DOI 10.1002/dneu.20958; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736	60	6	6	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	MAR 2	2017	10								42	10.3389/fnmol.2017.00042			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EM1XX	WOS:000395111700001	28303089	Green Published, gold			2022-02-06	
J	Hecimovich, MD; King, D				Hecimovich, Mark D.; King, Doug			Prevalence of head injury and medically diagnosed concussion in junior-level community-based Australian Rules Football	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						football; head injuries; incidence; surveillance; youth	SPORTS-RELATED CONCUSSION; RUGBY UNION FOOTBALL; HIGH-SCHOOL; YOUTH; POPULATION; MANAGEMENT; STATEMENT; PLAYERS; IMPACT; AGE	Aim: For junior-level Australian Rules Football there is a paucity of head injury and concussion surveillance data; thus, the primary aim was to document head injury and concussion incidence in participants aged 9-17 years with a secondary aim to identify the mechanism-of-injury. Methods: A prospective cohort study in which a designated representative for each of the 41 teams recorded on a weekly basis the number of head injuries suspected of being a concussion, diagnosed concussions and the mechanism-of-injury during competition games over the course of a 12-game season. For analysis three groups were formed - number of Player-Seasons, Athlete-Exposures, head injury and concussion incidence per 1000 Athlete-Exposures - and were calculated. Narrative data was categorised. Results: There was 13 reported head injuries resulting in seven concussions in the sample population (n = 976). The incidence rates for head injury and concussion were 1.1 (95% confidence interval: 0.5-1.7) and 0.59 (95% confidence interval: 0.2-1.0) per 1000 Athlete-Exposures. There were four head injuries resulting in two concussions in the 12-13-year-old group and nine head injuries and five concussions in the 14-17-year-old group. Two categories emerged for mechanism-of-injury: player-to-surface and player-to-player, with 9 of the 13 head injuries resulting from player-to-player contact. Conclusions: The incidence rates were similar in the two older groups and lower in comparison with American football and rugby. The data collected have advanced our knowledge of head injury incidence and established baseline data which to compare in future years and may assist in development of preventative measures.	[Hecimovich, Mark D.] Univ Northern Iowa, Div Athlet Training, Cedar Falls, IA 50614 USA; [Hecimovich, Mark D.] Murdoch Univ, Sch Psychol & Exercise Sci, Perth, WA, Australia; [King, Doug] Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Sport & Recreat, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [King, Doug] Hutt Valley Dist Hlth Board, Emergency Dept, Wellington, New Zealand		Hecimovich, MD (corresponding author), Univ Northern Iowa, Div Athlet Training, Human Performance Ctr 003C, Cedar Falls, IA 50613 USA.	mark.hecimovich@uni.edu			West Australian Football Commission; South West Regional Football Development Council	We thank the West Australian Football Commission and South West Regional Football Development Council for their support and cooperation of this research project.	Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Australian Football League, 2016, LAWS AUSTR FOOTB 201; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Braham R, 2004, J SCI MED SPORT, V7, P96, DOI 10.1016/S1440-2440(04)80048-3; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fortington Lauren V, 2015, Inj Epidemiol, V2, P20; Fuller CW, 2015, BRIT J SPORT MED, V49, P1; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hrysomallis C, 2007, INT J SPORTS MED, V28, P844, DOI 10.1055/s-2007-964897; Hrysomallis C., 2006, WEIGHT TRAINING AUST; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Manoogian SJ, 2015, CURR SPORT MED REP, V5, P23; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Moon D W, 1971, Med Sci Sports, V3, P44; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pellman EJ, 2007, NEUROSURGERY, V60, P1050; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; REID SE, 1971, SURG GYNECOL OBSTETR, V133, P929; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036	38	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health	MAR	2017	53	3					246	251		10.1111/jpc.13405			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	ER4PD	WOS:000398781600008	27862527				2022-02-06	
J	Ji, WY; Wang, J; Xu, J; Zhao, XD; Xu, X; Lu, XJ				Ji, Weiyang; Wang, Jing; Xu, Jie; Zhao, Xudong; Xu, Xing; Lu, Xiaojie			Lack of Aquaporin 9 Reduces Brain Angiogenesis and Exaggerates Neuronal Loss in the Hippocampus Following Intracranial Hemorrhage in Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Intracranial hemorrhage; Angiogenesis; Aquaporin 9; Hippocampus; Neuronal loss	BONE-MARROW ANGIOGENESIS; FOCAL CEREBRAL-ISCHEMIA; ACTIVE MULTIPLE-MYELOMA; CENTRAL-NERVOUS-SYSTEM; INTRACEREBRAL HEMORRHAGE; RAT ASTROCYTES; EXPRESSION; EDEMA; INJURY; CELLS	Intracranial hemorrhage (ICH) is a common subtype of stroke with high morbidity and mortality. However, few clinical therapies that can reduce ICH-induced brain injury and promote the recovery outcome in ICH patients are available to improve the recovery from ICH. Given that aquaporin 9 (AQP9) plays a critical role in brain edema after ischemic stroke and traumatic brain injury and is involved in the regulation of angiogenesis, we examined the role of AQP9 in preventing neuronal loss and in neovascularization in the dorsal hippocampus (DH) after ICH. We found that intra-DH collagenase-induced ICH increased AQP9 protein levels in the hippocampus, which was associated with behavioral deficits in wild-type mice. However, ICH robustly enhanced behavioral deficits in the AQP9-null mice, as compared with the wild-type mice. Furthermore, neovascularization and proliferation of brain microvascular endothelial cells following ICH were severely impaired in the AQP9-null mice, as compared with the wild-type mice. Finally, hippocampal neuronal loss following ICH became severer in the AQP9-null mice, relative to the wild-type mice. Taken together, our findings indicated that AQP9 in the brain may play a compensatory role in response to ICH, promote brain angiogenesis, and prevent subsequent neuronal death, thus preventing the deterioration of neurological outcome of ICH.	[Ji, Weiyang; Wang, Jing; Xu, Jie; Zhao, Xudong; Xu, Xing; Lu, Xiaojie] Nanjing Med Univ, Dept Neurosurg, Wuxi Hosp 2, 68 Zhongshan Rd, Wuxi 214002, Peoples R China		Lu, XJ (corresponding author), Nanjing Med Univ, Dept Neurosurg, Wuxi Hosp 2, 68 Zhongshan Rd, Wuxi 214002, Peoples R China.	luxiaojie2111@163.com					Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Camerino GM, 2006, CELL MOL BIOL, V52, P51, DOI 10.1170/T750; El Hindy N, 2013, ANTICANCER RES, V33, P609; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Fu XM, 2007, GLIA, V55, P935, DOI 10.1002/glia.20515; Griesdale DEG, 2004, SURG NEUROL, V61, P418, DOI 10.1016/j.surneu.2003.10.047; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Huebert RC, 2010, HEPATOLOGY, V52, P238, DOI 10.1002/hep.23628; Hwang IK, 2007, J NEUROSCI RES, V85, P2470, DOI 10.1002/jnr.21381; Kaneko K, 2008, MICROVASC RES, V75, P297, DOI 10.1016/j.mvr.2007.12.003; Kleffner I, 2008, STROKE, V39, P1333, DOI 10.1161/STROKEAHA.107.500785; Liu H, 2012, ARQ NEURO-PSIQUIAT, V70, P214, DOI 10.1590/S0004-282X2012000300012; National-Research-Council, 2010, GUIDE CARE USE LAB A, P1; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Qureshi Adnan I, 2005, J Intensive Care Med, V20, P34, DOI 10.1177/0885066604271619; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Sobue Kazuya, 2006, Nihon Rinsho, V64, P1181; Sulyok E, 2004, ACTA NEUROCHIR, V146, P955, DOI 10.1007/s00701-004-0319-z; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vacca A, 2001, ACTA HAEMATOL-BASEL, V106, P162, DOI 10.1159/000046612; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; Vacca A, 2001, SEMIN ONCOL, V28, P543, DOI 10.1053/sonc.2001.28604; Venero JL, 2004, CURR PHARM DESIGN, V10, P2153, DOI 10.2174/1381612043384150; Venero JL, 2001, PROG NEUROBIOL, V63, P321, DOI 10.1016/S0301-0082(00)00035-6; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wang BF, 2015, ACTA PHARMACOL SIN, V36, P939, DOI 10.1038/aps.2015.47; Wei XY, 2015, J MOL HISTOL, V46, P273, DOI 10.1007/s10735-015-9618-3; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yang M, 2013, J CELL BIOCHEM, V114, P111, DOI 10.1002/jcb.24308; Yool AJ, 2007, NEUROSCIENTIST, V13, P470, DOI 10.1177/1073858407303081	39	6	7	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAR	2017	61	3					351	358		10.1007/s12031-016-0862-0			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EN8QK	WOS:000396264700007	27885529				2022-02-06	
J	Kobata, H; Sugie, A; Suehiro, E; Dohi, K; Kaneko, T; Fujita, M; Oda, Y; Kuroda, Y; Yamashita, S; Maekawa, T				Kobata, Hitoshi; Sugie, Akira; Suehiro, Eiichi; Dohi, Kenji; Kaneko, Tadashi; Fujita, Motoki; Oda, Yasutaka; Kuroda, Yasuhiro; Yamashita, Susumu; Maekawa, Takeshi		B-HYPO Study Grp	Association between Blood Glucose Levels the Day after Targeted Temperature Initiation and Outcome in Traumatic Brain Injury: A Post-Hoc Analysis of the B-HYPO Study	JOURNAL OF NEUROTRAUMA			English	Article						hyperglycemia; outcome; targeted temperature management; therapeutic hypothermia; traumatic brain injury	CRITICALLY-ILL PATIENTS; RANDOMIZED CONTROLLED-TRIAL; INTENSIVE INSULIN THERAPY; CARDIAC-ARREST; INTRACEREBRAL HEMORRHAGE; PERSISTENT HYPERGLYCEMIA; STRESS HYPERGLYCEMIA; HYPOTHERMIA THERAPY; GLYCEMIC CONTROL; NICE-SUGAR	We investigated associations between blood glucose levels and clinical outcomes in participants of the multi-center randomized controlled Brain-Hypothermia (B-HYPO) study. Patients with severe traumatic brain injury (TBI, Glasgow Coma Scale 4-8) were assigned to therapeutic hypothermia (TH, 32-34 degrees C, n=98) or fever control (35.5-37.0 degrees C, n=50) groups. TH patients were cooled as soon as possible for 72h and rewarmed at a rate of <1 degrees C/d. We recorded blood glucose (BG) levels on days 0, 1, and 3 after treatment initiation, and day 1 after rewarming. The Glasgow Outcome Scale was assessed at 6 months. Median BG levels decreased from day 0 to day 1 (163 vs. 132mg/dL, p=0.0062) in the fever control group. In contrast, a decrease was observed from day 1 to day 3 (157.5 vs. 126mg/dL, p<0.001) in the TH group. Day 1 BG was higher in the TH group compared with the fever control group (p=0.0252). At day 0, BG levels were higher in non-survivors compared with survivors across all patients (p=0.0035), the TH group (p=0.0125), and the non-surgical group (p=0.0236). Higher day 1 BG levels were observed in non-survivors compared with survivors across all patients (p=0.0071), the fever control group (p=0.0495), and the surgical group (p=0.0364). In the TH group, the initial stress hyperglycemia was sustained the next day after TH induction. Day 1 BG predicted outcome in TBI patients with TH and fever control. Our findings indicate the significance of BG control particularly during TH treatment.	[Kobata, Hitoshi; Sugie, Akira] Osaka Mishima Emergency Crit Care Ctr, Osaka, Japan; [Suehiro, Eiichi] Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi, Japan; [Dohi, Kenji] Jikei Univ, Dept Emergency Med, Tokyo, Japan; [Kaneko, Tadashi] Kumamoto Univ Hosp, Emergency & Gen Med, Kumamoto, Japan; [Fujita, Motoki; Oda, Yasutaka] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan; [Kuroda, Yasuhiro] Kagawa Univ, Sch Med, Dept Emergency Med, Takamatsu, Kagawa, Japan; [Yamashita, Susumu] Tokuyama Cent Hosp, Emergency & Crit Care Ctr, Yamaguchi, Japan; [Maekawa, Takeshi] Yamaguchi Prefectural Grand Med Ctr, Yamaguchi, Japan		Kobata, H (corresponding author), Osaka Mishima Emergency Crit Care Ctr, 11-1 Minamiakutagawa Cho, Takatsuki, Osaka 5691124, Japan.	neu035@osaka-med.ac.jp	Suehiro, Eiichi/I-5852-2019; Kaneko, Tadashi/AAD-1516-2022	Kaneko, Tadashi/0000-0002-7171-7231; dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by research project grants from the Japanese Ministry of Health, Labor and Welfare (H-14-shinkin-005; H-15-shinkin-001; H-16-shinkin-001), and by the Japanese Human Science Association, 2002-2004.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cueni-Villoz N, 2011, CRIT CARE MED, V39, P2225, DOI 10.1097/CCM.0b013e31822572c9; Daviaud F, 2014, INTENS CARE MED, V40, P855, DOI 10.1007/s00134-014-3269-9; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Fuentes B, 2010, STROKE, V41, P2362, DOI 10.1161/STROKEAHA.110.591529; Godoy DA, 2008, NEUROCRIT CARE, V9, P217, DOI 10.1007/s12028-008-9063-1; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; HAYASHI N, 2004, BRAIN HYPOTHERMIA TR, P37; Hayashi N, 2009, J NEUROTRAUM, V26, P445, DOI 10.1089/neu.2008.0648; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kim JT, 2016, STROKE, V47, P120, DOI 10.1161/STROKEAHA.115.010753; Kim SH, 2015, J CRIT CARE, V30, P1204, DOI 10.1016/j.jcrc.2015.08.011; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Kutcher ME, 2011, J TRAUMA, V71, P1108, DOI 10.1097/TA.0b013e318232e35b; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Mesotten D, 2015, LANCET DIABETES ENDO, V3, P723, DOI 10.1016/S2213-8587(15)00223-5; Mullner M, 1997, J CEREBR BLOOD F MET, V17, P430; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Pri AS, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0586-x; Qureshi AI, 2011, NEUROCRIT CARE, V15, P428, DOI 10.1007/s12028-011-9541-8; Saadat SMS, 2012, CHILD NERV SYST, V28, P1773, DOI 10.1007/s00381-012-1753-5; Saxena A, 2016, STROKE, V47, P682, DOI 10.1161/STROKEAHA.115.011627; Schmutzhard E, 2011, NEUROCRIT CARE, V15, P281, DOI 10.1007/s12028-011-9601-0; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Sonneville R, 2015, INTENS CARE MED, V41, P192, DOI 10.1007/s00134-014-3577-0; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Suehiro E, 2015, J NEUROTRAUM, V32, P353, DOI 10.1089/neu.2014.3584; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Yuan Q, 2014, NEUROCRIT CARE, V20, P69, DOI 10.1007/s12028-012-9730-0	45	6	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					987	995		10.1089/neu.2016.4662			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200003	27673360				2022-02-06	
J	Le Prieult, F; Thal, SC; Engelhard, K; Imbrosci, B; Mittmann, T				Le Prieult, Florie; Thal, Serge C.; Engelhard, Kristin; Imbrosci, Barbara; Mittmann, Thomas			Acute Cortical Transhemispheric Diaschisis after Unilateral Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; neuroplasticity; traumatic brain injury	CEREBRAL-ARTERY OCCLUSION; ELECTROPHYSIOLOGICAL TRANSCORTICAL DIASCHISIS; SOMATOSENSORY EVOKED-POTENTIALS; RAT VISUAL-CORTEX; MOTOR RECOVERY; FUNCTIONAL CONNECTIVITY; POSTTRAUMATIC EPILEPSY; RECEPTOR SUBUNITS; GABA(A) RECEPTORS; TONIC INHIBITION	Focal neocortical brain injuries lead to functional alterations, which can spread beyond lesion-neighboring brain areas. The undamaged hemisphere and its associated disturbances after a unilateral lesion, so-called transhemispheric diaschisis, have been progressively disclosed over the last decades; they are strongly involved in the pathophysiology and, potentially, recovery of brain injuries. Understanding the temporal dynamics of these transhemispheric functional changes is crucial to decipher the role of the undamaged cortex in the processes of functional reorganization at different stages post-lesion. In this regard, little is known about the acute-subacute processes after 24-48h in the brain hemisphere contralateral to injury. In the present study, we performed a controlled cortical impact to produce a unilateral traumatic brain injury (TBI) in the motor and somatosensory cortex of mice. In vitro extracellular multi-unit recordings from large neuronal populations, together with single-cell patch-clamp recordings in the cortical network contralateral to the lesion, revealed a strong, but transient, neuronal hyperactivity as early as 24-48h post-TBI. This abnormal excitable state in the intact hemisphere was not accompanied by alterations in neuronal intrinsic properties, but it was associated with an impairment of the phasic gamma aminobutyric acid (GABA)ergic transmission and an increased expression of GABA(A) receptor subunits related to tonic inhibition exclusively in the contralateral hemisphere. These data unravel a series of early transhemispheric functional alterations after diffuse unilateral cortical injury, which may compensate and stabilize the disrupted brain functions. Therefore, our findings support the hypothesis that the undamaged hemisphere could play a significant role in early functional reorganization processes after a TBI.	[Le Prieult, Florie; Imbrosci, Barbara; Mittmann, Thomas] Johannes Gutenberg Univ Mainz, UMC, Inst Physiol, Duesbergweg 6, D-55128 Mainz, Germany; [Thal, Serge C.; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Imbrosci, Barbara] Campus Charite Mitte, Charite Berlin, Univ Med Ctr, Neurowissensch Forschungszentrum, Berlin, Germany		Mittmann, T (corresponding author), Johannes Gutenberg Univ Mainz, UMC, Inst Physiol, Duesbergweg 6, D-55128 Mainz, Germany.	mittmann@uni-mainz.de	Mittmann, Thomas/AAM-9047-2020; Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	German Research Foundation (DFG)German Research Foundation (DFG) [CRC 1080, TP A7 CO2]	We thank Tobias Hirnet for performing part of the CCI, Simone Dahms-Pratorius for the help with molecular biology, and the support of the Microscopy Core Facility of the IMB, Mainz. This work is supported by the German Research Foundation (DFG, CRC 1080, TP A7 CO2 to K.E. and T.M.).	Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Andres FG, 1999, BRAIN, V122, P855, DOI 10.1093/brain/122.5.855; ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; BuchkremerRatzmann I, 1996, STROKE, V27, P1105, DOI 10.1161/01.STR.27.6.1105; Butefisch CM, 2006, J PHYSIOL-PARIS, V99, P437, DOI 10.1016/j.jphysparis.2006.03.001; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Grigorovsky V, 2014, IEEE ENG MED BIO, P4880, DOI 10.1109/EMBC.2014.6944717; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; HOSSMANN KA, 1985, J CEREBR BLOOD F MET, V5, P97, DOI 10.1038/jcbfm.1985.13; Huang SY, 2015, J NEUROSCI, V35, P15916, DOI 10.1523/JNEUROSCI.1813-15.2015; Imbrosci B, 2013, NEUROSCIENCE, V250, P208, DOI 10.1016/j.neuroscience.2013.06.063; Imbrosci B, 2015, BRAIN STRUCT FUNCT, V220, P1649, DOI 10.1007/s00429-014-0750-8; Imbrosci B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111105; Imbrosci B, 2013, PFLUG ARCH EUR J PHY, V465, P879, DOI 10.1007/s00424-012-1191-y; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Jacobs KM, 2000, EPILEPSIA, V41, pS153, DOI 10.1111/j.1528-1157.2000.tb01574.x; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kohl MM, 2011, NAT NEUROSCI, V14, P1413, DOI 10.1038/nn.2915; KOLB B, 1989, PROG NEUROBIOL, V32, P235, DOI 10.1016/0301-0082(89)90023-3; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; MEYER KL, 1985, J NEUROSURG, V62, P269, DOI 10.3171/jns.1985.62.2.0269; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; NAKASHIMA K, 1985, J NEUROL SCI, V70, P117, DOI 10.1016/0022-510X(85)90081-4; Neumann-Haefelin T, 2000, J CEREBR BLOOD F MET, V20, P45, DOI 10.1097/00004647-200001000-00008; Nudo RJ, 1999, CURR OPIN NEUROBIOL, V9, P740, DOI 10.1016/S0959-4388(99)00027-6; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pavlov I, 2013, NEUROPHARMACOLOGY, V69, P55, DOI 10.1016/j.neuropharm.2012.04.003; Redecker C, 2002, J CEREBR BLOOD F MET, V22, P1463, DOI 10.1097/01.WCB.0000034149.72481.BD; Reinecke S, 1999, NEUROSCI LETT, V261, P85, DOI 10.1016/S0304-3940(99)00014-2; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schaechter JD, 2008, CEREB CORTEX, V18, P638, DOI 10.1093/cercor/bhm096; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; Seitz RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1081, DOI 10.1001/archneur.55.8.1081; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takatsuru Y, 2009, J NEUROSCI, V29, P10081, DOI 10.1523/JNEUROSCI.1638-09.2009; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thompson GJ, 2013, NEUROIMAGE, V83, P826, DOI 10.1016/j.neuroimage.2013.07.036; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; von Monakow C, 1914, JAMA-J AM MED ASSOC, V63, P797; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Walmsley B, 1998, IMMUNOL CELL BIOL, V76, P430, DOI 10.1046/j.1440-1711.1998.00764.x; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282	65	6	6	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1097	1110		10.1089/neu.2016.4575			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200014	27650335				2022-02-06	
J	Lindberg, DM; Wood, JN; Campbell, KA; Scribano, PV; Laskey, A; Leventhal, JM; Pierce, MC; Runyan, DK				Lindberg, Daniel M.; Wood, Joanne N.; Campbell, Kristine A.; Scribano, Philip V.; Laskey, Antoinette; Leventhal, John M.; Pierce, Mary Clyde; Runyan, Desmond K.			Research priorities for a multi-center child abuse pediatrics network - CAPNET	CHILD ABUSE & NEGLECT			English	Article						Physical abuse; Multi-center research; Delphi method; Research; Priorities	TRAUMATIC BRAIN-INJURY; HEAD TRAUMA; EMERGENCY-DEPARTMENTS; SKELETAL SURVEYS; SUSPECTED ABUSE; PHYSICAL ABUSE; FRACTURES; INFANTS; PREVALENCE; HOUSEHOLD	Although child maltreatment medical research has benefited from several multi-center studies, the new specialty of child abuse pediatrics has not had a sustainable network capable of pursuing multiple, prospective, clinically-oriented studies. The Child Abuse Pediatrics NetWork (CAPNET) is a new multi-center research network dedicated to child maltreatment medical research. In order to establish a relevant, practical research agenda, we conducted a modified Delphi process to determine the topic areas with highest priority for such a. network. Research questions were solicited from members of the Ray E. Helfer Society and study authors and were sorted into topic areas. These topic areas were rated for priority using iterative rounds of ratings and in-person meetings. The topics rated with the highest priority were missed diagnosis and selected/indicated prevention. This agenda can be used to target future multi-center child maltreatment medical research. (C) 2017 Elsevier Ltd. All rights reserved.	[Lindberg, Daniel M.; Runyan, Desmond K.] Univ Colorado, Sch Med, Kempe Ctr Prevent, 12401 E 17th Ave Mailstop B-215, Aurora, CO 80045 USA; [Lindberg, Daniel M.; Runyan, Desmond K.] Univ Colorado, Sch Med, Treatment Child Abuse & Neglect, 12401 E 17th Ave Mailstop B-215, Aurora, CO 80045 USA; [Wood, Joanne N.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Div Gen Pediat & PolicyLab, Philadelphia, PA 19104 USA; [Wood, Joanne N.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Campbell, Kristine A.; Laskey, Antoinette] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Wood, Joanne N.; Scribano, Philip V.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Ctr Child Protect & Hlth, Philadelphia, PA 19104 USA; [Leventhal, John M.] Yale Sch Med, Dept Pediat, New Haven, CT USA; [Pierce, Mary Clyde] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Evanston, IL 60208 USA		Lindberg, DM (corresponding author), Univ Colorado, Sch Med, Kempe Ctr Prevent, 12401 E 17th Ave Mailstop B-215, Aurora, CO 80045 USA.; Lindberg, DM (corresponding author), Univ Colorado, Sch Med, Treatment Child Abuse & Neglect, 12401 E 17th Ave Mailstop B-215, Aurora, CO 80045 USA.	Daniel.lindberg@ucdenver.edu; woodjo@email.chop.edu; Kristine.campbell@hsc.utah.edu; scribanop@email.chop.edu; Antoinette.laskey@hsc.utah.edu; John.leventhal@yale.edu; Mpierce@luriechildrens.org; Desmond.runyan@childrenscolorado.org	Pierce, Mary Clyde/AAQ-3509-2021; Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD083559, K23HD071967]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD083559, K23HD071967] Funding Source: NIH RePORTER	Dr. Lindberg and Dr. Wood received salary funding from the National Institute of Child Health and Human Development grants K23HD083559 and K23HD071967, respectively. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alpern ER, 2006, PEDIATR EMERG CARE, V22, P689, DOI 10.1097/01.pec.0000236830.39194.c0; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Berger RP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3756; Block RW, 2006, J PEDIATR-US, V148, P711, DOI 10.1016/j.jpeds.2006.01.033; Bourgeois F. T., 2013, PEDIATRICS; Bradford R, 2013, J NEUROSURG-PEDIATR, V12, P110, DOI 10.3171/2013.4.PEDS12596; Campbell KA, 2010, ARCH PEDIAT ADOL MED, V164, P943, DOI 10.1001/archpediatrics.2010.166; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P161, DOI 10.1097/TA.0b013e3182984831; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; Greiner M. V., 2015, J CHILD NEUROLOGY; Hewes HA, 2011, ARCH PEDIAT ADOL MED, V165, P918, DOI 10.1001/archpediatrics.2011.151; Hooft AM, 2015, ACAD PEDIATR, V15, P444, DOI 10.1016/j.acap.2015.01.008; Hymel K. P., 2014, PEDIATRICS, P2014; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Karmazyn B, 2011, AM J ROENTGENOL, V197, pW159, DOI 10.2214/AJR.10.5733; Keenan HT, 2008, AM J PREV MED, V34, pS120, DOI 10.1016/j.amepre.2007.11.001; Kleinman PK, 2013, AM J ROENTGENOL, V200, P641, DOI 10.2214/AJR.12.8878; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Laskey AL, 2012, J PEDIATR-US, V160, P1003, DOI 10.1016/j.jpeds.2011.11.042; Lindberg D, 2009, PEDIATRICS, V124, P509, DOI 10.1542/peds.2008-2348; Lindberg DM, 2015, PEDIATRICS, V136, P831, DOI 10.1542/peds.2015-1487; Lindberg DM, 2013, PEDIATR EMERG CARE, V29, P26, DOI 10.1097/PEC.0b013e31827b475e; Lindberg DM, 2012, PEDIATRICS, V130, P193, DOI 10.1542/peds.2012-0085; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Louwers ECFM, 2012, PEDIATRICS, V130, P457, DOI 10.1542/peds.2011-3527; Ludwig S., 2010, HELF SOC PHIL PA; Maguire S, 2007, ARCH DIS CHILD, V92, P1113, DOI 10.1136/adc.2006.113001; Paine CW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3024; Pierce MC, 2016, ANN EMERG MED, V67, P1, DOI 10.1016/j.annemergmed.2015.06.021; Postema FAM, 2014, EMERG RADIOL, V21, P349, DOI 10.1007/s10140-014-1196-2; Putnam-Hornstein E., 2014, CHILD MALTREATMENT; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Runyan DK, 2001, CHILD ABUSE NEGLECT, V25, P199, DOI 10.1016/S0145-2134(00)00245-3; Sieswerda-Hoogendoorn T, 2014, EUR J RADIOL, V83, P1257, DOI 10.1016/j.ejrad.2014.03.015; U. S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2015, CHILD MALTR 2013; Willson DF, 2006, PEDIATR CRIT CARE ME, V7, P301, DOI 10.1097/01.PCC.0000227106.66902.4F; Wood J., 2014, HELF SOC ANN M ANN M; Wood J. N., 2012, PEDIATRICS; Wood J. N., 2015, PEDIATRICS; Wood JN, 2015, PEDIATRICS, V136, P232, DOI 10.1542/peds.2014-3977; Wood JN, 2015, PEDIATRICS, V135, pE312, DOI 10.1542/peds.2014-2169; Wood JN, 2012, PEDIATRICS, V130, P853, DOI 10.1542/peds.2012-0244; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031	44	6	6	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	MAR	2017	65						152	157		10.1016/j.chiabu.2017.01.015			6	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	ER4CU	WOS:000398747500015	28161656	Green Accepted			2022-02-06	
J	Mahoney, JJ; Kalechstein, AD; De Marco, AP; Newton, TF; De La Garza, R				Mahoney, James J., III; Kalechstein, Ari D.; De Marco, Anthony P.; Newton, Thomas F.; De La Garza, Richard, II			The Relationship Between Premorbid IQ and Neurocognitive Functioning in Individuals With Cocaine Use Disorders	NEUROPSYCHOLOGY			English	Article						cocaine; intellectual functioning; cognitive reserve; verbal learning; working memory	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; NICOTINE-DEPENDENT VOLUNTEERS; TRAUMATIC BRAIN-INJURY; COGNITIVE RESERVE; WORKING-MEMORY; D-CYCLOSERINE; SHORT-TERM; EDUCATION; INTELLIGENCE; DEFICITS	Objective: To determine whether premorbid IQ mediates performance on neurocognitive tests in individuals diagnosed with cocaine use disorder (CUD). Method: Recently abstinent cocaine users (N = 113) completed measures sensitive to the effects of cocaine on cognition: Conners' Continuous Performance Task-II (CPT-II), n-back working memory test, and Hopkins Verbal Learning Task-Revised (HVLT-R). Premorbid IQ was calculated using the Oklahoma Premorbid Intelligence Estimate, which integrates scores from the Wechsler Adult Intelligence Scale-III and demographic variables. Participants were grouped according to their premorbid IQ using commonly accepted classifications of ability level (above average [> 110], average [90 -109], and below average [< 90]) and comparisons in neurocognitive performance were performed using one-way analysis of variance. Results: Significant differences were detected between groups on the HVLT-R including Trial 1 (p =.002), total word recall across the 3 list-learning trials (p =.001), and recall following a delay (p =.001). Significant differences were also detected on the N-back, including auditory and visual accuracy (p =.022 and p =.001, respectively) and mean and maximum block length (p =.001). Although significant differences were observed between the above average and average groups (mean effect size =.418 [Cohen's d]), the magnitude of group differences was greatest between the average and below average groups (mean effect size =.716). Conclusions: These results raise questions as to whether the neurocognitive impairment observed in individuals diagnosed with CUD predated the onset of cocaine use or whether the impairments were caused by cocaine use. Because these impairments are potential risk factors for poor treatment outcomes, it is important to consider the need to modify treatment programs to account for lower premorbid IQ.	[Mahoney, James J., III] West Virginia Univ, Sch Med, Dept Behav Med & Psychiat, Morgantown, WV 26505 USA; [Kalechstein, Ari D.; Newton, Thomas F.; De La Garza, Richard, II] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [De Marco, Anthony P.] St Lukes Univ Hlth Network, Ctr Neurosci, Bethlehem, PA USA		Mahoney, JJ (corresponding author), West Virginia Univ, Sch Med, Dept Behav Med & Psychiat, Morgantown, WV 26505 USA.	james.mahoney@hsc.wvu.edu	Mahoney, James/ABB-9284-2021; De La Garza, Richard/B-2489-2014	Mahoney, James/0000-0003-0824-1776; De La Garza, Richard/0000-0003-1943-4469	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA023624, DA028387, DA023588, DA018197]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA023588, R01DA035513, P50DA018197, RC1DA028387, R01DA023624] Funding Source: NIH RePORTER	This material is the result of work supported by National Institutes of Health Grants DA023624, DA028387, and DA023588 to Richard De La Garza II and DA018197 to Thomas F. Newton, as well as resources from, and the use of facilities at, the Michael E. DeBakey VA Medical Center, Houston, Texas.	ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; Aharonovich E, 2006, DRUG ALCOHOL DEPEN, V81, P313, DOI 10.1016/j.drugalcdep.2005.08.003; Aharonovich E, 2003, DRUG ALCOHOL DEPEN, V71, P207, DOI 10.1016/S0376-8716(03)00092-9; Aharonovich E, 2008, DRUG ALCOHOL DEPEN, V95, P279, DOI 10.1016/j.drugalcdep.2008.01.009; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barnett JH, 2006, PSYCHOL MED, V36, P1053, DOI 10.1017/S0033291706007501; Basso MR, 2000, J CLIN EXP NEUROPSYC, V22, P208, DOI 10.1076/1380-3395(200004)22:2;1-1;FT208; Benedict, 2001, HOPKINS VERBAL LEARN; Bolla KI, 2007, STUD NEUROPSYCH DEV, P111; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Bolla KI, 1998, NEUROLOGY, V51, P1532, DOI 10.1212/WNL.51.6.1532; Cohen J., 2013, STAT POWER ANAL BEHA; Conners C. K., 2002, CONNERS CONTINUOUS P; De La Garza R, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv098; Diaz-Asper CM, 2004, J INT NEUROPSYCH SOC, V10, P82; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Dufouil C, 2003, NEUROLOGY, V60, P831, DOI 10.1212/01.WNL.0000049456.33231.96; Elkins JS, 2006, NEUROLOGY, V67, P435, DOI 10.1212/01.wnl.0000228246.89109.98; Glatt SL, 1996, NEUROEPIDEMIOLOGY, V15, P20, DOI 10.1159/000109885; Gonzalez-Blanch C, 2010, SCHIZOPHR RES, V119, P18, DOI 10.1016/j.schres.2010.02.1072; Gooding DC, 2008, PSYCHIAT RES, V160, P145, DOI 10.1016/j.psychres.2007.11.019; Horner MD, 1999, DRUG ALCOHOL DEPEN, V54, P19, DOI 10.1016/S0376-8716(98)00141-0; Horton AM, 1999, INT J NEUROSCI, V99, P221, DOI 10.3109/00207459908994326; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; Kalechstein AD, 2012, PHARMACOL BIOCHEM BE, V103, P403, DOI 10.1016/j.pbb.2012.08.011; Kalechstein AD, 2013, NEUROPHARMACOLOGY, V64, P472, DOI 10.1016/j.neuropharm.2012.06.064; Kalechstein AD, 2014, NEUROPHARMACOLOGY, V85, P493, DOI 10.1016/j.neuropharm.2014.05.045; Kalechstein AD, 2011, PHARMACOL BIOCHEM BE, V99, P423, DOI 10.1016/j.pbb.2011.05.013; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Le Carret Nicolas, 2005, Brain Cogn, V57, P120; LORD FM, 1967, PSYCHOL BULL, V68, P304, DOI 10.1037/h0025105; Mahoney JJ, 2014, PROG NEURO-PSYCHOPH, V50, P137, DOI 10.1016/j.pnpbp.2013.11.001; McKellar JD, 2006, J STUD ALCOHOL, V67, P685, DOI 10.15288/jsa.2006.67.685; Milanini B, 2016, J NEUROVIROL, V22, P575, DOI 10.1007/s13365-016-0426-7; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Newton TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030854; Roldan-Tapia L, 2012, APPL NEUROPSYCH-ADUL, V19, P2, DOI 10.1080/09084282.2011.595458; SATZ P, 1993, J ACQ IMMUN DEF SYND, V6, P503; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Schoenberg MR, 2006, ARCH CLIN NEUROPSYCH, V21, P469, DOI 10.1016/j.acn.2006.06.006; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Sofuoglu M, 2013, NEUROPHARMACOLOGY, V64, P452, DOI 10.1016/j.neuropharm.2012.06.021; Sofuoglu M, 2010, EXP CLIN PSYCHOPHARM, V18, P109, DOI 10.1037/a0019295; Sofuoglu M, 2010, ADDICTION, V105, P38, DOI 10.1111/j.1360-0443.2009.02791.x; Spronk DB, 2013, NEUROSCI BIOBEHAV R, V37, P1838, DOI 10.1016/j.neubiorev.2013.07.003; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2011, J INT NEUROPSYCH SOC, V17, P639, DOI 10.1017/S1355617711000579; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307; Thames AD, 2014, ADDICT BEHAV, V39, P994, DOI 10.1016/j.addbeh.2014.01.019; Tremont G, 1998, CLIN NEUROPSYCHOL, V12, P560, DOI 10.1076/clin.12.4.560.7238; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P90, DOI 10.1017/S1355617706060127; Verrico CD, 2014, DRUG ALCOHOL DEPEN, V141, P72, DOI 10.1016/j.drugalcdep.2014.05.008; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Yoon JH, 2013, ADDICT BEHAV, V38, P1518, DOI 10.1016/j.addbeh.2012.03.022	56	6	6	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2017	31	3					311	318		10.1037/neu0000344			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EN4UY	WOS:000396003600008	28054825	Bronze			2022-02-06	
J	Ryan, NP; Mihaljevic, K; Beauchamp, MH; Catroppa, C; Crossley, L; Hearps, S; Silk, T; Godfrey, C; Yeates, KO; Anderson, VA				Ryan, Nicholas P.; Mihaljevic, Kim; Beauchamp, Miriam H.; Catroppa, Cathy; Crossley, Louise; Hearps, Stephen; Silk, Timothy; Godfrey, Celia; Yeates, Keith Owen; Anderson, Vicki A.			Examining the Prospective Relationship between Family Affective Responsiveness and Theory of Mind in Chronic Paediatric Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						child; brain injuries; theory of mind; social cognition; family environment	WEIGHTED IMAGING SWI; BEHAVIOR PROBLEMS; SOCIAL BRAIN; EMOTION RECOGNITION; YOUNG-CHILDREN; NEURAL BASIS; SHORT-TERM; ADOLESCENCE; CHILDHOOD; OUTCOMES	Childhood and adolescence coincide with rapid structural and functional maturation of brain networks implicated in Theory of Mind (ToM); however, the impact of paediatric traumatic brain injury (TBI) on the development of these higher order skills is not well understood. ToM can be partitioned into conative ToM, defined as the ability to understand how indirect speech acts involving irony and empathy are used to influence the mental or affective state of the listener; and affective ToM, concerned with understanding that facial expressions are often used for social purposes to convey emotions that we want people to think we feel. In a sample of 84 children with mild-severe TBI and 40 typically developing controls, this study examined the effect of paediatric TBI on affective and conative ToM; and evaluated the respective contributions of injury-related factors (injury severity/lesion location) and non-injury-related environmental variables (socio-economic status (SES)/family functioning) to long-term ToM outcomes. Results showed that the poorest ToM outcomes were documented in association with mild-complicated and moderate TBI, rather than severe TBI. Lesion location and SES did not significantly contribute to conative or affective ToM. Post-injury family affective responsiveness was the strongest and most significant predictor of conative ToM. Results suggest that clinicians should exercise caution when prognosticating based on early clinical indicators, and that group and individual-level outcome prediction should incorporate assessment of a range of injury-and non-injury-related factors. Moreover, the affective quality of post-injury family interactions represents a potentially modifiable risk factor, and might be a useful target for family-centred interventions designed to optimise social cognitive outcomes after paediatric TBI.	[Ryan, Nicholas P.; Mihaljevic, Kim; Beauchamp, Miriam H.; Catroppa, Cathy; Crossley, Louise; Hearps, Stephen; Silk, Timothy; Godfrey, Celia; Anderson, Vicki A.] Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Res Inst, Flemington Rd,Parkville, Melbourne, Vic 3052, Australia; [Ryan, Nicholas P.; Mihaljevic, Kim; Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Resarch Ctr, Montreal, PQ, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada		Ryan, NP (corresponding author), Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Res Inst, Flemington Rd,Parkville, Melbourne, Vic 3052, Australia.; Ryan, NP (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.; Ryan, NP (corresponding author), Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia.	nicholas.ryan@mcri.edu.au	Yeates, Keith/AAJ-4223-2020; Silk, Tim/K-4295-2019; Catroppa, Cathy/AAX-9458-2021; Ryan, Nicholas/K-5445-2019; Hearps, Stephen/L-6853-2016	Catroppa, Cathy/0000-0002-9750-0436; Ryan, Nicholas/0000-0002-0878-8889; Yeates, Keith/0000-0001-7680-2892; Silk, Tim/0000-0002-7290-512X; Hearps, Stephen/0000-0003-2984-1172	Victorian Neurotrauma Initiative [CO6E1]; Victorian Government Operational Infrastructure Support Program; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; NHMRC Centre for Research Excellence in Brain Injury Seed GrantNational Health and Medical Research Council of Australia	This work was supported by a grant from the Victorian Neurotrauma Initiative (No. CO6E1); the Victorian Government Operational Infrastructure Support Program; a NHMRC Practitioner Fellowship (V. A.); and a NHMRC Centre for Research Excellence in Brain Injury Seed Grant (N.R.).	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2007, SOC COGN AFFECT NEUR, V2, P130, DOI 10.1093/scan/nsm009; Blakemore SJ, 2011, CHILD PSYCHOLOGY AND PSYCHIATRY: FRAMEWORKS FOR PRACTICE, 2ND EDITION, P62; Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202; Burnett S, 2011, NEUROSCI BIOBEHAV R, V35, P1654, DOI 10.1016/j.neubiorev.2010.10.011; Burnett S, 2009, ANN NY ACAD SCI, V1167, P51, DOI 10.1111/j.1749-6632.2009.04509.x; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Coffey CE, 1991, PSYCHOPATHOL BRAIN, P243; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Herbet G, 2013, CORTEX, V49, P2711, DOI 10.1016/j.cortex.2013.08.003; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Levan A, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000040; Molenberghs P, 2016, NEUROSCI BIOBEHAV R, V65, P276, DOI 10.1016/j.neubiorev.2016.03.020; Robinson L, 2007, SOCIAL DEV, V16, P361; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Schmidt AT, 2010, BRAIN INJURY, V24, P1550, DOI 10.3109/02699052.2010.523047; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Schwartz OS, 2012, J ABNORM CHILD PSYCH, V40, P59, DOI 10.1007/s10802-011-9542-2; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Sodian B, 2007, DEVELOPMENTAL SCI, V10, P199, DOI 10.1111/j.1467-7687.2007.00580.x; Steinberg L, 2001, ANNU REV PSYCHOL, V52, P83, DOI 10.1146/annurev.psych.52.1.83; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Trewin D, 2006, ANZSCO AUSTR NZ STAN; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	53	6	6	2	21	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2017	18	1					88	101		10.1017/BrImp.2016.20			14	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EQ3SZ	WOS:000397994400008					2022-02-06	
J	Steingrimsson, JA; Hanley, DF; Rosenblum, M				Steingrimsson, Jon Arni; Hanley, Daniel F.; Rosenblum, Michael			Improving precision by adjusting for prognostic baseline variables in randomized trials with binary outcomes, without regression model assumptions	CONTEMPORARY CLINICAL TRIALS			English	Article						Covariate adjustment; Post-stratification	TRAUMATIC BRAIN-INJURY; SAMPLE-SIZE REQUIREMENTS; COVARIATE ADJUSTMENT; CLINICAL-TRIALS; SUBGROUP ANALYSIS; POWER	In randomized clinical trials with baseline variables that are prognostic for the primary outcome, there is potential to improve precision and reduce sample size by appropriately adjusting for these variables. A major challenge is that there are multiple statistical methods to adjust for baseline variables, but little guidance on which is best to use in a given context. The choice of method can have important consequences. For example, one commonly used method leads to uninterpretable estimates if there is any treatment effect heterogeneity, which would jeopardize the validity of trial conclusions. We give practical guidance on how to avoid this problem, while retaining the advantages of covariate adjustment. This can be achieved by using simple (but less well-known) standardization methods from the recent statistics literature. We discuss these methods and give software in R and Stata implementing them. A data example from a recent stroke trial is used to illustrate these methods. (C) 2017 Elsevier Inc. All rights reserved.	[Steingrimsson, Jon Arni; Rosenblum, Michael] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Hanley, Daniel F.] Johns Hopkins Univ, Brain Injury Outcomes Coordinating Ctr, Dept Neurol, Baltimore, MD 21231 USA; [Rosenblum, Michael] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA		Rosenblum, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.; Rosenblum, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.	jsteing5@jhu.edu; dhanley@jhmi.edu; mrosen@jhu.edu		Hanley, Daniel/0000-0002-9536-4258	Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [ME-1306-03198]; U.S. Food and Drug Administration [HHSF223201400113C]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	This work was supported by the Patient-Centered Outcomes Research Institute [ME-1306-03198], the U.S. Food and Drug Administration [HHSF223201400113C]. The CLEAR III trial was supported by the grant 5U01 NS062851-05, awarded to DFH from the National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS); this study is registered with ClinicalTrials.gov, NCT00222573. This work is solely the responsibility of the authors and does not represent the views of the above people and agencies.	Austin PC, 2010, J CLIN EPIDEMIOL, V63, P142, DOI 10.1016/j.jclinepi.2009.06.002; Bath P, 2009, STROKE, V40, P888, DOI 10.1161/STROKEAHA.108.519207; Choi S C, 1998, J Biopharm Stat, V8, P367, DOI 10.1080/10543409808835246; Colantuoni E, 2015, STAT MED, V34, P2602, DOI 10.1002/sim.6507; Diaz I, 2015, BIOMETRICS; Diggle P, 2013, ANAL LONGITUDINAL DA, V2nd; Freedman DA, 2008, STAT SCI, V23, P237, DOI 10.1214/08-STS262; Garofolo KM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-98; Hanley DF, 2016, LANCET; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Hernandez AV, 2004, J CLIN EPIDEMIOL, V57, P454, DOI 10.1016/j.jclinepi.2003.09.014; Moore KL, 2009, STAT MED, V28, P39, DOI 10.1002/sim.3445; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; ROBINSON LD, 1991, INT STAT REV, V59, P227, DOI 10.2307/1403444; Rose S, 2011, SPRINGER SER STAT, P3, DOI 10.1007/978-1-4419-9782-1; Rosenblum M, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1138; Scharfstein DO, 1999, J AM STAT ASSOC, V94, P1096, DOI 10.2307/2669923; Steyerberg EW, 2000, AM HEART J, V139, P745, DOI 10.1016/S0002-8703(00)90001-2; Turnbull C.W., 1999, GROUP SEQUENTIAL MET; Turner EL, 2012, J CLIN EPIDEMIOL, V65, P474, DOI 10.1016/j.jclinepi.2011.08.012; Van der Vaart A.W., 1998, ASYMPTOTIC STAT, V3; Ziai WC, 2014, INT J STROKE, V9, P536, DOI 10.1111/ijs.12097	23	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	MAR	2017	54						18	24		10.1016/j.cct.2016.12.026			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	EL3YV	WOS:000394557500003	28064029				2022-02-06	
J	Sussman, WI; Mautner, K; Mason, RA; Bonecutter, K; Shealy, AK				Sussman, Walter I.; Mautner, Ken; Mason, R. Amadeus; Bonecutter, Kathryn; Shealy, Anna K.			Sphenopalatine Ganglion Block for Management of Refractory Chronic Posttraumatic Headaches After a Sport-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						posttraumatic headaches; sport-related concussion; postconcussion syndrome; sphenopalatine ganglion block	HIGH-SCHOOL; EPIDEMIOLOGY; COLLEGIATE	Posttraumatic headaches (PTHs) are one of the most frequently reported symptoms after a sport concussion, and treatment options for chronic PTH are limited. In this report, we present a case of a 17-year-old boy with persistent PTH after a sport concussion successfully treated with an intranasal sphenopalatine block.	[Sussman, Walter I.; Mautner, Ken; Mason, R. Amadeus; Bonecutter, Kathryn; Shealy, Anna K.] Emory Univ, Dept Orthoped, Atlanta, GA 30322 USA; [Sussman, Walter I.; Mautner, Ken; Mason, R. Amadeus] Emory Univ, Dept Phys Med & Rehabil, Atlanta, GA 30322 USA		Sussman, WI (corresponding author), Emory Univ, Ctr Sports Med, 59 Execut Pk South, Atlanta, GA 30329 USA.	walter.sussman@emory.edu	sussman, walter/V-5191-2019	sussman, walter/0000-0002-3279-6029			Candido KD, 2013, PAIN PHYSICIAN, V16, pE769; Edvinsson L, 2001, CEPHALALGIA, V21, P761, DOI 10.1046/j.1468-2982.2001.00245.x; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Shah RV, 2004, ARCH PHYS MED REHAB, V85, P1013, DOI 10.1016/j.apmr.2003.07.017; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8	9	6	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2017	27	2					e6	e8		10.1097/JSM.0000000000000325			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	EM8PJ	WOS:000395573100017	27177204				2022-02-06	
J	Turkstra, LS; Kraning, SG; Riedeman, SK; Mutlu, B; Duff, M; VanDenHeuvel, S				Turkstra, Lyn S.; Kraning, Sarah G.; Riedeman, Sarah K.; Mutlu, Bilge; Duff, Melissa; VanDenHeuvel, Sara			Labelling Facial Affect in Context in Adults with and without TBI	BRAIN IMPAIRMENT			English	Article						Emotions; facial expression; adult; humans; social cognition; reproducibility of results; social perception	TRAUMATIC BRAIN-INJURY; EMOTION RECOGNITION TASK; SOCIAL COGNITION; HEAD-INJURY; PERCEPTION DEFICITS; PRAGMATIC LANGUAGE; DIFFERENT MEDIA; NORMATIVE DATA; EXPRESSIONS; MIND	Recognition of facial affect has been studied extensively in adults with and without traumatic brain injury (TBI), mostly by asking examinees to match basic emotion words to isolated faces. This method may not capture affect labelling in everyday life when faces are in context and choices are open-ended. To examine effects of context and response format, we asked 148 undergraduate students to label emotions shown on faces either in isolation or in natural visual scenes. Responses were categorised as representing basic emotions, social emotions, cognitive state terms, or appraisals. We used students' responses to create a scoring system that was applied prospectively to five men with TBI. In both groups, over 50% of responses were neither basic emotion words nor synonyms, and there was no significant difference in response types between faces alone vs. in scenes. Adults with TBI used labels not seen in students' responses, talked more overall, and often gave multiple labels for one photo. Results suggest benefits of moving beyond forced-choice tests of faces in isolation to fully characterise affect recognition in adults with and without TBI.	[Turkstra, Lyn S.; Kraning, Sarah G.; Riedeman, Sarah K.; Mutlu, Bilge] Univ Wisconsin Madison, Dept Commun Sci & Disorders, 1975 Willow Dr, Madison, WI 53562 USA; [Duff, Melissa] Univ Iowa, Iowa City, IA 52242 USA; [VanDenHeuvel, Sara] Amer Speech Language Hearing Assoc, Rockville, MD USA		Turkstra, LS (corresponding author), Univ Wisconsin Madison, Dept Commun Sci & Disorders, 1975 Willow Dr, Madison, WI 53562 USA.	lyn.turkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	National Center for Medical Rehabilitation Research/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD071089]; Walker Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	This work was supported by the National Center for Medical Rehabilitation Research/National Institutes of Health grant number R01 HD071089, and the Walker Foundation (L.T.).	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adrian JE, 2005, J CHILD LANG, V32, P673, DOI 10.1017/S0305000905006963; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Barrett L, 2007, PHILOS T R SOC B, V362, P561, DOI 10.1098/rstb.2006.1995; Bora E, 2006, PSYCHIAT RES, V145, P95, DOI 10.1016/j.psychres.2005.11.003; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BRETHERTON I, 1982, DEV PSYCHOL, V18, P906, DOI 10.1037/0012-1649.18.6.906; Broicher SD, 2012, NEUROPSYCHOLOGIA, V50, P118, DOI 10.1016/j.neuropsychologia.2011.11.005; Brune M, 2001, PSYCHOPATHOLOGY, V34, P85, DOI 10.1159/000049286; Buck, 1988, HUMAN MOTIVATION EMO; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Charvet LE, 2014, MULT SCLER J, V20, P1478, DOI 10.1177/1352458514526942; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; de Gelder B, 2006, PROG BRAIN RES, V155, P37, DOI 10.1016/S0079-6123(06)55003-4; Delis D.C., 2000, CALIFORNIA VERBAL LE; Du SC, 2014, P NATL ACAD SCI USA, V111, pE1454, DOI 10.1073/pnas.1322355111; Eddy CM, 2012, ACTA NEUROL SCAND, V126, P376, DOI 10.1111/j.1600-0404.2012.01659.x; EKMAN P, 1969, PSYCHIATR, V32, P88, DOI 10.1080/00332747.1969.11023575; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; EKMAN PAUL, 2003, EMOTIONS REVEALED; Fernandez-Dols JM, 2008, EMOTION, V8, P530, DOI 10.1037/a0012724; Hansen G, 2005, META, V50, P511, DOI 10.7202/010997ar; Heller J, 2014, AGING DIS, V5, P63, DOI 10.14366/AD.2014.050063; Henry JD, 2009, J INT NEUROPSYCH SOC, V15, P277, DOI 10.1017/S1355617709090195; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Kertesz A., 2006, W APHASIA BATTERY; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Kipps CM, 2007, J COGNITIVE NEUROSCI, V19, P1206, DOI 10.1162/jocn.2007.19.7.1206; Klapwijk ET, 2013, HORM BEHAV, V64, P314, DOI 10.1016/j.yhbeh.2013.03.012; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; Lee TMC, 2005, MOL PSYCHIATR, V10, P450, DOI 10.1038/sj.mp.4001595; Limbrecht-Ecklundt Kerstin, 2013, Psychosoc Med, V10, pDoc04, DOI 10.3205/psm000094; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; MATSUMOTO D, 1994, AUST J PSYCHOL, V46, P58, DOI 10.1080/00049539408259471; McCade D, 2011, DEMENT GERIATR COGN, V32, P257, DOI 10.1159/000335009; McDonald, 2000, METAPHOR SYMBOL, V15, P85, DOI DOI 10.1080/10926488.2000.9678866; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Moran C, 2012, LANG SPEECH HEAR SER, V43, P264, DOI 10.1044/0161-1461(2011/10-0114); Mu YG, 2012, NEURO-ONCOLOGY, V14, P81, DOI 10.1093/neuonc/nos215; Mumenthaler C, 2012, J PERS SOC PSYCHOL, V102, P1118, DOI 10.1037/a0026885; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Rakoczy H, 2012, BRIT J PSYCHOL, V103, P58, DOI 10.1111/j.2044-8295.2011.02040.x; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rollins, 1998, AWARENESS SOCIAL INF; Rosenberg H., 2016, J NEUROPSYCHOLOGY; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; RUSSELL JA, 1993, MOTIV EMOTION, V17, P41, DOI 10.1007/BF00995206; Schlegel K, 2016, BEHAV RES METHODS, V48, P1383, DOI 10.3758/s13428-015-0646-4; Schlegel K, 2014, PSYCHOL ASSESSMENT, V26, P666, DOI 10.1037/a0035246; SCHLOSBERG H, 1952, J EXP PSYCHOL, V44, P229, DOI 10.1037/h0055778; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schwarz KA, 2013, SOC COGN AFFECT NEUR, V8, P438, DOI 10.1093/scan/nss013; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037/0022-3514.52.6.1061; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Statucka M, 2013, PSYCHIAT RES, V206, P125, DOI 10.1016/j.psychres.2012.12.005; Tamietto M, 2007, NEUROPSYCHOLOGIA, V45, P836, DOI 10.1016/j.neuropsychologia.2006.08.012; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Yan WJ, 2013, J NONVERBAL BEHAV, V37, P217, DOI 10.1007/s10919-013-0159-8; Yuvaraj R, 2013, DEMENT GERIATR COGN, V36, P179, DOI 10.1159/000353440; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	81	6	6	1	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2017	18	1					49	61		10.1017/BrImp.2016.29			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EQ3SZ	WOS:000397994400005	29093643	Bronze, Green Accepted			2022-02-06	
J	Wilson, ML; Tenovuo, O; Mattila, VM; Gisler, M; Celedonia, KL; Impinen, A; Saarijarvi, S				Wilson, Michael L.; Tenovuo, Olli; Mattila, Vile M.; Gisler, Mika; Celedonia, Karen L.; Impinen, Antti; Saarijarvi, Simo			Pediatric TBI in Finland: An examination of hospital discharges (1998-2012)	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						TBI; Epidemiology; Surveillance; Pediatric; Adolescent	TRAUMATIC BRAIN-INJURY; RESOURCE UTILIZATION; ALCOHOL PRICES; HEAD TRAUMA; RISK FACTOR; CHILDREN; EPIDEMIOLOGY; MORTALITY; REGISTER; TRENDS	Background: Traumatic brain injury constitutes a persistent health problem among pediatric populations worldwide and is often referred to as a silent epidemic. There remains a paucity of scientific exploration with regard to understanding the ecological risk profiles of well-defined populations. In Finland, the healthcare system covers all hospitals, provides uniform access to care and has a universal surveillance system that allows for epidemiological examination of a wide variety of health issues. The present study aims to clarify the incidence, type and geographical presentation of pediatric TBI in Finland. Methods: We utilized the National Hospital Discharge Register (NHDR) to prospectively identify all new cases of TBI among persons aged 18 years or younger between 1998 and 2012. Incidence rates were computed as average annual rates per 100,000 person years (py). Results: During the study period 1998-2012, 21,457 children and adolescents were hospitalized for TBI. The cumulative incidence rate for the entire period was 99/100,000. Males were approximatively 1.5 times more likely to have sustained a TBI and had consistently higher rates during each year under study. Concussions were the most common form of TBI (92.9/100,000 person years), with diffuse brain injuries being the second most common (8.7/100,000 py). Diagnostic trends differed markedly with southern Finland experiencing the lowest rates of TBI when adjusted for population size. Conclusions: TBI are serious and potentially disabling conditions. The elevated levels of pediatric TBI in Finland warrant increased attention. (C) 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Wilson, Michael L.; Saarijarvi, Simo] Univ Turku, Turku Univ Hosp, Dept Adolescent Psychiat, Kaivokatu 18A ,4th Floor, FIN-20520 Turku, Finland; [Wilson, Michael L.; Celedonia, Karen L.] Ctr Injury Prevent & Community Safety, PeerCorps Trust Fund, 352-64 Makunganya St,Co Architecture Bldg,4th Fl, Dar Es Salaam, Tanzania; [Tenovuo, Olli] Turku Univ, Turku Univ Hosp, Dept Rehabil & Brain Trauma, Div Clin Neurosci, Turku, Finland; [Mattila, Vile M.] Tampere Univ Hosp Tampere, Dept Orthopaed, Tampere, Finland; [Mattila, Vile M.] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Div Orthoped & Biotechnol, Stockholm, Sweden; [Gisler, Mika; Impinen, Antti] THL Natl Inst Hlth & Welf, POB 30, FIN-00271 Helsinki, Finland; [Gisler, Mika] Karolinska Dept Neurobiol Care Sci & Soc NVS, SE-17177 Stockholm, Sweden		Wilson, ML (corresponding author), Univ Turku, Turku Univ Hosp, Dept Adolescent Psychiat, Kaivokatu 18A ,4th Floor, FIN-20520 Turku, Finland.; Wilson, ML (corresponding author), Ctr Injury Prevent & Community Safety, PeerCorps Trust Fund, 352-64 Makunganya St,Co Architecture Bldg,4th Fl, Dar Es Salaam, Tanzania.	michael.l.wilson@utu.fi		Gissler, Mika/0000-0001-8254-7525	Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science	This study was supported by a grant from the Finnish Cultural Foundation.	Alaranta H, 2002, SUOM LAAKARILEHTI, V47, P4801; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; ARNARSON EO, 1995, ACTA PAEDIATR, V84, P96, DOI 10.1111/j.1651-2227.1995.tb13496.x; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cubbin C, 2000, AM J PUBLIC HEALTH, V90, P70, DOI 10.2105/AJPH.90.1.70; Dal Santo JA, 2004, J PEDIATR PSYCHOL, V29, P273, DOI 10.1093/jpepsy/jsh029; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Emerson Jane Anne, 2008, Mo Med, V105, P146; Granie MA, 2010, ACCIDENT ANAL PREV, V42, P726, DOI 10.1016/j.aap.2009.10.022; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HINGSON R, 1987, J STUD ALCOHOL, V48, P212, DOI 10.15288/jsa.1987.48.212; HOWLAND J, 1987, PUBLIC HEALTH REP, V102, P475; Huttunen TT, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-98; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Janssen F, 2004, B WORLD HEALTH ORGAN, V82, P904; Kemp A, 1997, J ACCID EMERG MED, V14, P316; Kimbler DE, 2011, J NEUROSCI NURS, V43, P286, DOI 10.1097/JNN.0b013e31823858a6; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Korhonen N, 2013, OSTEOPOROSIS INT, V24, P1599, DOI 10.1007/s00198-012-2190-8; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Kristiansen T, 2014, INJURY, V45, P23, DOI 10.1016/j.injury.2013.07.007; Lahti A, 2014, EUR CHILD ADOLES PSY, V23, P45, DOI 10.1007/s00787-013-0422-x; Lahti A, 2011, J CHILD PSYCHOL PSYC, V52, P984, DOI 10.1111/j.1469-7610.2011.02369.x; Lin CM, 2014, INJURY, V45, P690, DOI 10.1016/j.injury.2013.09.031; Lintonen T, 2000, ADDICTION, V95, P1255, DOI 10.1046/j.1360-0443.2000.958125512.x; Lunetta P, 1998, INT J EPIDEMIOL, V27, P1038, DOI 10.1093/ije/27.6.1038; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macpherson AK, 2004, ACCIDENT ANAL PREV, V36, P649, DOI 10.1016/S0001-4575(03)00086-1; Mattila VM, 2008, INJURY, V39, P1373, DOI 10.1016/j.injury.2008.05.007; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Michaud P A, 2001, Inj Prev, V7, P41, DOI 10.1136/ip.7.1.41; Naisaki A, 2012, J PAEDIAT CHILD HLTH; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; Parkkari J, 2015, INJ PREV; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Peden M., REPORTWORLD REPORT C; Puljula J, 2013, ACTA NEUROL SCAND, V127, P192, DOI 10.1111/j.1600-0404.2012.01697.x; Puljula J, 2013, SCAND J PUBLIC HEALT, V41, P524, DOI 10.1177/1403494813481644; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sorenson SB, 2011, AM J PUBLIC HEALTH, V101, pS353, DOI 10.2105/AJPH.2010.300029; Sourander A, 1999, SOC PSYCH PSYCH EPID, V34, P105, DOI 10.1007/s001270050119; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Terveyden ja Hyvinvoinnin Laitos Tapaturmat ja vakivalta - THL, TERV JA HYV LAIT TAP; Thygesen LC, 2014, EUR J EPIDEMIOL, V29, P551, DOI 10.1007/s10654-013-9873-0; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Vaaramo K, 2012, NEUROEPIDEMIOLOGY, V39, P156, DOI 10.1159/000341241; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	54	6	6	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	MAR	2017	21	2					374	381		10.1016/j.ejpn.2016.10.008			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	EN4CE	WOS:000395954600022	27840023				2022-02-06	
J	Clausen, F; Hansson, HA; Raud, J; Marklund, N				Clausen, Fredrik; Hansson, Hans-Arne; Raud, Johan; Marklund, Niklas			Intranasal Administration of the Antisecretory Peptide AF-16 Reduces Edema and Improves Cognitive Function Following Diffuse Traumatic Brain Injury in the Rat	FRONTIERS IN NEUROLOGY			English	Article						cerebral edema; traumatic brain injury; intranasal; neuroprotection; AF-16; cognition	FLUID PERCUSSION INJURY; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-I; AXONAL INJURY; WHITE-MATTER; INTRACRANIAL-PRESSURE; HEAD-INJURY; DELIVERY; BLOOD; CONTUSION	A synthetic peptide with antisecretory activity, antisecretory factor (AF)-16, improves injury-related deficits in water and ion transport and decreases intracranial pressure after experimental cold lesion injury and encephalitis although its role in traumatic brain injury (TBI) is unknown. AF-16 or an inactive reference peptide was administrated intranasally 30 min following midline fluid percussion injury (mFPI; n = 52), a model of diffuse mild-moderate TBI in rats. Sham-injured (n = 14) or naive (n = 24) animals were used as controls. The rats survived for either 48 h or 15 days post-injury. At 48 h, the animals were tested in the Morris water maze (MWM) for memory function and their brains analyzed for cerebral edema. Here, mFPI-induced brain edema compared to sham or naive controls that was significantly reduced by AF-16 treatment (p < 0.05) although MWM performance was not altered. In the 15-day survival groups, the MWM learning and memory abilities as well as histological changes were analyzed. AF-16-treated brain-injured animals shortened both MWM latency and swim path in the learning trials (p < 0.05) and improved probe trial performance compared to brain-injured controls treated with the inactive reference peptide. A modest decrease by AF-16 on TBI-induced changes in hippocampal glial acidic fibrillary protein (GFAP) staining (p = 0.11) was observed. AF-16 treatment did not alter any other immunohistochemical analyses (degenerating neurons, beta-amyloid precursor protein (beta-APP), and Olig2). In conclusion, intranasal AF-16-attenuated brain edema and enhanced visuospatial learning and memory following diffuse TBI in the rat. Intranasal administration early post-injury of a promising neuroprotective substance offers a novel treatment approach for TBI.	[Clausen, Fredrik; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Unit Neurosurg, Uppsala, Sweden; [Hansson, Hans-Arne] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden; [Raud, Johan] Lantmannen AS Faktor AB, Stockholm, Sweden		Marklund, N (corresponding author), Uppsala Univ, Dept Neurosci, Unit Neurosurg, Uppsala, Sweden.	niklas.marklund@neuro.uu.se		Marklund, Niklas/0000-0002-9797-5626; Clausen, Fredrik/0000-0003-3592-4417	Swedish Brain Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Uppsala University Hospital ALF funds	This work was financed by Swedish Brain Foundation, Swedish Research Council and Uppsala University Hospital ALF funds. The authors would like to thank Johanna Flygt, M.Sc. for performing the blinding of the investigators.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Al-Olama M, 2015, ACTA NEUROCHIR, V157, P129, DOI 10.1007/s00701-014-2221-7; Al-Olama M, 2011, ACTA ONCOL, V50, P1098, DOI 10.3109/0284186X.2011.562240; BALIN BJ, 1986, J COMP NEUROL, V251, P260, DOI 10.1002/cne.902510209; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Davidson TS, 2004, J LEUKOCYTE BIOL, V76, P835, DOI 10.1189/jlb.0204085; Davidson TS, 2004, LAB INVEST, V84, P307, DOI 10.1038/labinvest.3700036; Del Pizzo J, 2014, PEDIATR EMERG CARE, V30, P496, DOI 10.1097/PEC.0000000000000171; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Djupesland PG, 2014, THER DELIV, V5, P709, DOI [10.4155/TDE.14.41, 10.4155/tde.14.41]; Ekmark-Lewen S, 2016, EUR J NEUROSCI, V43, P1016, DOI 10.1111/ejn.13190; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hanell A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00252; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; Hansson Hans-Arne, 2012, Acta Neurochir Suppl, V114, P377, DOI 10.1007/978-3-7091-0956-4_73; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; Jennische E, 2008, BRAIN RES, V1227, P189, DOI 10.1016/j.brainres.2008.05.083; Jiang YJ, 2015, EXPERT OPIN DRUG DEL, V12, P1717, DOI 10.1517/17425247.2015.1065812; Jin HB, 2016, MED SCI MONITOR, V22, P678, DOI 10.12659/MSM.897201; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kim H, 2015, J NEUROTRAUM, V32, P1210, DOI 10.1089/neu.2014.3771; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Lange S, 2001, INT REV CYTOL, V210, P39; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Maas A, 2016, NEUROSURGERY, V78, P368; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Shiga H, 2014, CHEM SENSES, V39, P595, DOI 10.1093/chemse/bju032; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050; Ziebell JM, 2016, BRAIN INJURY, V30, P217, DOI 10.3109/02699052.2015.1090012; ZLOKOVIC BV, 1995, PHARM RES-DORDR, V12, P1395, DOI 10.1023/A:1016254514167; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	70	6	6	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 14	2017	8								39	10.3389/fneur.2017.00039			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK9ZK	WOS:000394282300001	28261150	Green Published, gold			2022-02-06	
J	Damiano, DL; Stanley, CJ; Bulea, TC; Park, HS				Damiano, Diane L.; Stanley, Christopher J.; Bulea, Thomas C.; Park, Hyung Soon			Motor Learning Abilities Are Similar in Hemiplegic Cerebral Palsy Compared to Controls as Assessed by Adaptation to Unilateral Leg-Weighting during Gait: Part I	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						asymmetry; aftereffects; cerebellar deficits; brain injury; children	SPLIT-BELT TREADMILL; LOCOMOTOR ADAPTATION; HUMAN WALKING; REHABILITATION; STROKE; POSTSTROKE; CHILDREN; LIMB	Introduction: Individuals with cerebral palsy (CP) demonstrate high response variability to motor training insufficiently accounted for by age or severity. We propose here that differences in the inherent ability to learn new motor tasks may explain some of this variability. Damage to motor pathways involving the cerebellum, which may be a direct or indirect effect of the brain injury for many with CP, has been shown to adversely affect the ability to learn new motor tasks and may be a potential explanation. Classic adaptation paradigms that evaluate cerebellar integrity have been utilized to assess adaptation to gait perturbations in adults with stroke, traumatic brain injury and other neurological injuries but not in children with CP. Materials and Methods: A case-control study of 10 participants with and 10 without hemiplegic CP within the age range of 5-20 years was conducted. Mean age of participants in the CP group was slightly but not significantly higher than controls. Step length and swing time adaptation, defined as gradual accommodation to a perturbation, and aftereffects, or maintenance of the accommodation upon removal of the perturbation, to unilateral leg weighing during treadmill gait were quantified to assess group differences in learning. Results: Adaptation and aftereffects were demonstrated in step length across groups with no main effect for group. In CP, the dominant leg had a greater response when either leg was weighted. Swing time accommodated immediately (no adaptation) in the weighted leg only, with the non-dominant leg instead showing a more pronounced response in CP. Discussion: This group of participants with unilateral CP did not demonstrate poorer learning or retention similar to reported results in adult stroke. Deficits, while not found here, may become evident in those with other etiologies or greater severity of CP. Our data further corroborate an observation from the stroke literature that repeated practice of exaggerating the asymmetry (error augmentation), in this case by weighting the more involved or shorter step leg, vs. minimizing it by weighting the less involved or longer step leg (error reduction) may be a useful training strategy to improve step symmetry in unilateral CP.	[Damiano, Diane L.; Stanley, Christopher J.; Bulea, Thomas C.] NIH, Funct & Appl Biomech Sect, Bldg 10, Bethesda, MD 20892 USA; [Park, Hyung Soon] Korea Adv Inst Sci & Technol, Dept Mech Engn, Daejeon, South Korea		Damiano, DL (corresponding author), NIH, Funct & Appl Biomech Sect, Bldg 10, Bethesda, MD 20892 USA.	damianod@cc.nih.gov	Park, Hyung-Soon/B-3334-2010	Park, Hyung-Soon/0000-0003-4274-7420; Bulea, Thomas/0000-0002-2732-8255	Intramural Research Program of the NIH Clinical CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; CLINICAL CENTER [ZIACL060017] Funding Source: NIH RePORTER	This work was funded by the Intramural Research Program of the NIH Clinical Center.	Bajaj S, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00173, 10.3389/fnhum.7015300173]; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Choi JT, 2009, BRAIN, V132, P722, DOI 10.1093/brain/awn333; Damiano DL, 2014, DEV MED CHILD NEUROL, V56, P1141, DOI 10.1111/dmcn.12505; Damiano DL, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-57; Earhart GM, 2002, EXP BRAIN RES, V146, P538, DOI 10.1007/s00221-002-1238-y; Fiori S, 2015, NEUROREHAB NEURAL RE, V29, P858, DOI 10.1177/1545968314568726; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; Malone LA, 2014, NEUROREHAB NEURAL RE, V28, P230, DOI 10.1177/1545968313505912; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Masia L, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-28; Musselman KE, 2011, J NEUROPHYSIOL, V105, P2195, DOI 10.1152/jn.01002.2010; Noble JW, 2006, EXP BRAIN RES, V169, P482, DOI 10.1007/s00221-005-0162-3; Regnaux JP, 2008, CLIN BIOMECH, V23, P762, DOI 10.1016/j.clinbiomech.2008.01.011; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2013, NEUROREHAB NEURAL RE, V27, P460, DOI 10.1177/1545968312474118; Reisman DS, 2010, PHYS THER, V90, P187, DOI 10.2522/ptj.20090073; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Savin DN, 2010, J NEUROPHYSIOL, V104, P3600, DOI 10.1152/jn.00633.2010; Vashista V, 2013, IEEE T NEUR SYS REH, V21, P969, DOI 10.1109/TNSRE.2013.2243917; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Vaswani PA, 2013, J NEUROSCI, V33, P7700, DOI 10.1523/JNEUROSCI.0124-13.2013	22	6	6	0	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 8	2017	11								49	10.3389/fnhum.2017.00049			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	EJ9LF	WOS:000393546900001	28228720	gold, Green Published			2022-02-06	
J	Li, X; Xu, HX; Lei, T; Yang, YF; Jing, D; Dai, SH; Luo, P; Xu, QL				Li, Xin; Xu, Haoxiang; Lei, Tao; Yang, Yuefan; Jing, Da; Dai, Shuhui; Luo, Peng; Xu, Qiaoling			A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by Modulating the Endocannabinoid System in HT22 Cells	Frontiers in Neuroscience			English	Article						pulsed electromagnetic field; excitotoxicity; endocannabinoid; glutamate; ERK	TRAUMATIC BRAIN-INJURY; IN-VIVO; NEURONS; STIMULATION; RECEPTORS; MICE; PEMF; RAT	Glutamate-induced excitotoxicity is common in the pathogenesis of many neurological diseases. A pulsed electromagnetic field (PEMF) exerts therapeutic effects on the nervous system, but its specific mechanism associated with excitotoxicity is still unknown. We investigated the role of PEMF exposure in regulating glutamate-induced excitotoxicity through the endocannabinoid (eCB) system. PEMF exposure improved viability of HT22 cells after excitotoxicity and reduced lactate dehydrogenase release and cell death. An eCB receptor 1 (CB1R) specific inhibitor suppressed the protective effects of PEMF exposure, even though changes in CB1R expression were not observed. Elevation of N-arachidonylethanolamide (AEA) and 2-arachidonylglycerol (2-AG) following PEMF exposure indicated that the neuroprotective effects of PEMF were related to modulation of the eCB metabolic system. Furthermore, CB1R/ERK signaling was shown to be an important downstream pathway of PEMF in regulating excitotoxicity. These results suggest that PEMF exposure leads to neuroprotective effects against excitotoxicity by facilitating the eCB/CB1R/ERK signaling pathway. Therefore, PEMF may be a potential physical therapeutic technique for preventing and treating neurological diseases.	[Li, Xin] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian, Peoples R China; [Xu, Haoxiang; Lei, Tao; Jing, Da; Luo, Peng; Xu, Qiaoling] Fourth Mil Med Univ, Dept Biomed Engn, Xian, Peoples R China; [Yang, Yuefan; Dai, Shuhui; Luo, Peng] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian, Peoples R China; [Xu, Qiaoling] Fourth Mil Med Univ, Dept Nursing, Xian, Peoples R China		Luo, P; Xu, QL (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian, Peoples R China.; Luo, P (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian, Peoples R China.; Xu, QL (corresponding author), Fourth Mil Med Univ, Dept Nursing, Xian, Peoples R China.	pengluo@fmmu.edu.cn; xqling@fmmu.edu.cn	Yang, Yuefan/AAJ-9136-2020	Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301037, 31270889, 81601149, 81471806]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M572683]	This work was supported by the National Natural Science Foundation of China (Nos. 81301037, 31270889, 81601149, and 81471806), and a China Postdoctoral Science Foundation funded project (No. 2015M572683).	Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Benyo Z, 2016, AM J PHYSIOL-HEART C, V310, pH785, DOI 10.1152/ajpheart.00571.2015; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Di Marzo V, 2015, NAT REV NEUROSCI, V16, P30, DOI 10.1038/nrn3876; Gramowski-Voss A, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00158, 10.3389/fneur2015.00158]; Hei WH, 2016, INT J NEUROSCI, V126, P739, DOI 10.3109/00207454.2015.1054032; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hug K, 2012, BIOELECTROMAGNETICS, V33, P95, DOI 10.1002/bem.20703; Kokona D, 2015, EXP EYE RES, V136, P45, DOI 10.1016/j.exer.2015.05.007; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lappin MS, 2003, ALTERN THER HEALTH M, V9, P38; Li X, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/195397; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mori F, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000048; Ortuno-Sahagun D, 2014, J MOL NEUROSCI, V52, P366, DOI 10.1007/s12031-013-0157-7; Parsons LH, 2015, NAT REV NEUROSCI, V16, P579, DOI 10.1038/nrn4004; Pena-Philippides JC, 2014, TRANSL STROKE RES, V5, P491, DOI 10.1007/s12975-014-0334-1; Rasouli J, 2012, NEUROSCI LETT, V519, P4, DOI 10.1016/j.neulet.2012.03.089; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Tantimonaco M, 2014, CELL MOL LIFE SCI, V71, P2681, DOI 10.1007/s00018-014-1575-6; Vadala M, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0070-z; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; Wang HN, 2014, J PSYCHIATR RES, V51, P79, DOI 10.1016/j.jpsychires.2014.01.004; Wang J, 2014, ACTA BIOMATER, V10, P975, DOI 10.1016/j.actbio.2013.10.008; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Xu JY, 2015, NEUROSCIENTIST, V21, P152, DOI 10.1177/1073858414524632; Yamaguchi-Sekino S, 2011, MAGN RESON MED SCI, V10, P1, DOI 10.2463/mrms.10.1	29	6	6	1	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	FEB 6	2017	11								42	10.3389/fnins.2017.00042			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ5CM	WOS:000393234100001	28220060	gold, Green Published			2022-02-06	
J	Amrhein, TJ; Mostertz, W; Matheus, MG; Maass-Bolles, G; Sharma, K; Collins, HR; Kranz, PG				Amrhein, Timothy J.; Mostertz, William; Matheus, Maria Gisele; Maass-Bolles, Genevieve; Sharma, Komal; Collins, Heather R.; Kranz, Peter G.			Reformatted images improve the detection rate of acute traumatic subdural hematomas on brain CT compared with axial images alone	EMERGENCY RADIOLOGY			English	Article						Subdural hematoma; Brain CT; Sensitivity; Specificity; Reformat	CORONAL REFORMATIONS; ISOTROPIC VOXELS; INJURY; RESIDENTS	Subdural hematomas (SDHs) comprise a significant percentage of missed intracranial hemorrhage on axial brain CT. SDH detection rates could be improved with the addition of reformatted images. Though performed at some centers, the potential additional diagnostic sensitivity of reformatted images has not yet been investigated. The purpose of our study is to determine if the addition of coronal and sagittal reformatted images to an axial brain CT increases the sensitivity and specificity for detection of acute traumatic SDH. We retrospectively reviewed consecutive brain CTs acquired for acute trauma that contained new SDHs. An equivalent number of normal brain CTs served as control. Paired sets of images were created for each case: (1) axial images only ("axial only") and (2) axial, coronal, sagittal images ("reformat added"). Three readers interpreted both the axial only and companion reformat added for each case, separated by 1 month. Reading times and SDH detection rates were compared. One hundred SDH and 100 negative examinations were collected. Sensitivity and specificity for the axial-only scans were 75.7 and 94.3 %, respectively, compared with 88.3 and 98.3 % for reformat added. There was a 24.3 % false negative (missed SDH) rate with axial-only scans versus 11.7 % with reformat added (p = < 0.001). Median reader interpretation times were longer with the addition of reformatted images (125 versus 89 s), but this difference was not significant (p = 0.23). The addition of coronal and sagittal images in trauma brain CT resulted in improved sensitivity and specificity as well as a reduction in SDH false negatives by greater than 50 %. Reformatted images substantially reduce the number of missed SDHs compared with axial images alone.	[Amrhein, Timothy J.; Kranz, Peter G.] Duke Univ, Med Ctr, Dept Radiol, Box 3808, Durham, NC 27710 USA; [Amrhein, Timothy J.; Mostertz, William; Matheus, Maria Gisele; Maass-Bolles, Genevieve; Sharma, Komal] Med Univ South Carolina, Dept Radiol & Radiol Sci, MSC 322 169 Ashley Ave, Charleston, SC 29425 USA; [Sharma, Komal] Quinnipiac Sch Med, St Vincents Med Ctr, Dept Radiol, 2800 Main St, Bridgeport, CT 06606 USA; [Collins, Heather R.] Med Univ South Carolina, Dept Radiol & Radiol Sci, Ctr Biomed Imaging, 96 Jonathan Lucas St,MSC 323, Charleston, SC 29425 USA		Amrhein, TJ (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Box 3808, Durham, NC 27710 USA.; Amrhein, TJ (corresponding author), Med Univ South Carolina, Dept Radiol & Radiol Sci, MSC 322 169 Ashley Ave, Charleston, SC 29425 USA.	timothy.amrhein@duke.edu; wmostert@wakehealth.edu; matheus@musc.edu; maass@musc.edu; drkomal_sharma@yahoo.in; collinshr@gmail.com; peter.kranz@duke.edu	Amrhein, Timothy J/R-7786-2016; Kranz, Peter G/B-2471-2016	Amrhein, Timothy J/0000-0002-9354-9486; Kranz, Peter G/0000-0001-5410-7135			Bhullar IS, 2011, AM SURG; Bordes J, 2012, J EMERG MED, V42, P459, DOI 10.1016/j.jemermed.2010.05.084; Caoili EM, 2002, RADIOLOGY, V222, P353, DOI 10.1148/radiol.2222010667; Cho SH, 2012, BRIT J RADIOL, V85, pE845, DOI 10.1259/bjr/28575455; Cooper P R, 1992, Neurosurg Clin N Am, V3, P659; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Gerard C, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0275-0; Hadjigeorgiou GE, 2014, J KOREAN NEUROSURG S, V55, P51, DOI 10.3340/jkns.2014.55.1.51; Jaffe TA, 2006, RADIOLOGY, V238, P135, DOI 10.1148/radiol.2381050489; Kim BJ, 2014, ACTA NEUROCHIR, V156, P1605, DOI 10.1007/s00701-014-2151-4; Kim ES, 2014, DIAGN INTERV RADIOL, V20, P277, DOI 10.5152/dir.2014.13401; Kung JW, 2014, EMERG RADIOL, V21, P359, DOI 10.1007/s10140-014-1201-9; Marin D, 2009, AM J ROENTGENOL, V192, P180, DOI 10.2214/AJR.07.3652; Matsuda W, 2008, J TRAUMA, V65, P461, DOI 10.1097/01.ta.0000202465.13784.2a; Paulson EK, 2004, AM J ROENTGENOLOGY; Son S, 2013, J KOREAN NEUROSURG S, V54, P211, DOI 10.3340/jkns.2013.54.3.211; Strub WM, 2007, AM J NEURORADIOL, V28, P1679, DOI 10.3174/ajnr.A0653; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; The ACR Task Force on Appropriateness Criteria, 2015, ACR ASNR SPR PRACT P, P1; Wei SC, 2010, AM J NEURORADIOL, V31, P334, DOI 10.3174/ajnr.A1824; Zacharia TT, 2010, EMERG RADIOL, V17, P97, DOI 10.1007/s10140-009-0842-6	21	6	6	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	FEB	2017	24	1					39	45		10.1007/s10140-016-1440-z			7	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	EI2GL	WOS:000392304800007	27620896				2022-02-06	
J	Armstrong, RA; Mckee, AC; Alvarez, VE; Cairns, NJ				Armstrong, Richard A.; McKee, Ann C.; Alvarez, Victor E.; Cairns, Nigel J.			Clustering of tau-immunoreactive pathology in chronic traumatic encephalopathy	JOURNAL OF NEURAL TRANSMISSION			English	Article						Chronic traumatic encephalopathy (CTE); Alzheimer's disease neuropathologic change (ADNC); Tauopathy; Neurofibrillary tangle; Spatial pattern; Spatial correlation	PROGRESSIVE SUPRANUCLEAR PALSY; CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; SPATIAL-PATTERNS; NEURODEGENERATIVE DISORDERS; BLOOD-VESSELS; BRAIN-TISSUE; CORTICOBASAL DEGENERATION; NEUROFIBRILLARY TANGLES; HISTOLOGICAL SECTIONS	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder which may result from repetitive brain injury. A variety of tau-immunoreactive pathologies are present, including neurofibrillary tangles (NFT), neuropil threads (NT), dot-like grains (DLG), astrocytic tangles (AT), and occasional neuritic plaques (NP). In tauopathies, cellular inclusions in the cortex are clustered within specific laminae, the clusters being regularly distributed parallel to the pia mater. To determine whether a similar spatial pattern is present in CTE, clustering of the tau-immunoreactive pathology was studied in the cortex, hippocampus, and dentate gyrus in 11 cases of CTE and 7 cases of Alzheimer's disease neuropathologic change (ADNC) without CTE. In CTE: (1) all aspects of tau-immunoreactive pathology were clustered and the clusters were frequently regularly distributed parallel to the tissue boundary, (2) clustering was similar in two CTE cases with minimal co-pathology compared with cases with associated ADNC or TDP-43 proteinopathy, (3) in a proportion of cortical gyri, estimated cluster size was similar to that of cell columns of the cortico-cortical pathways, and (4) clusters of the tau-immunoreactive pathology were infrequently spatially correlated with blood vessels. The NFT and NP in ADNC without CTE were less frequently randomly or uniformly distributed and more frequently in defined clusters than in CTE. Hence, the spatial pattern of the tau-immunoreactive pathology observed in CTE is typical of the tauopathies but with some distinct differences compared to ADNC alone. The spread of pathogenic tau along anatomical pathways could be a factor in the pathogenesis of the disease.	[Armstrong, Richard A.] Aston Univ, Vis Sci, Birmingham B4 7ET, W Midlands, England; [McKee, Ann C.; Alvarez, Victor E.] VA Boston, Boston, MA 02130 USA; [McKee, Ann C.; Alvarez, Victor E.] Vet Affairs Med Ctr, Bedford, MA 01730 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol & Pathol & Lab Med, Boston, MA 02118 USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA		Armstrong, RA (corresponding author), Aston Univ, Vis Sci, Birmingham B4 7ET, W Midlands, England.	R.A.Armstrong@aston.ac.uk	Armstrong, Richard A/H-4557-2012; Cairns, Nigel/AAB-9713-2020; Armstrong, Richard/AAU-4580-2020	Armstrong, Richard A/0000-0002-5046-3199; Cairns, Nigel/0000-0001-9858-3344; Armstrong, Richard/0000-0002-5046-3199	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086659-01]; Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Affairs Biorepository [CSP 501]; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS); Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA from the National Institute on Aging [P50 AG05681, P01 AG03991]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005681, P30AG013846, P01AG003991] Funding Source: NIH RePORTER	The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA, USA). We also gratefully acknowledge the help of all members of the Chronic Traumatic Encephalopathy Program at Boston University School of Medicine, VA Boston, and the Bedford VA, as well as the individuals and families whose participation and contributions made this work possible. This work was supported by the National Institute of Neurological Disorders and Stroke (1U01NS086659-01), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS), Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5). This work was supported by the Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA (P50 AG05681 and P01 AG03991 from the National Institute on Aging). This work was also supported by unrestricted gifts from the National Football League, Andlinger Foundation, and WWE.	Armstrong R, 1999, NEUROPATHOLOGY, V19, P64, DOI 10.1046/j.1440-1789.1999.00219.x; Armstrong RA, 2007, J NEURAL TRANSM, V114, P1569, DOI 10.1007/s00702-007-0796-3; Armstrong RA, 2017, NEUROPATH APPL NEURO, V43, P154, DOI 10.1111/nan.12323; Armstrong RA, 2009, J NEURAL TRANSM, V116, P1103, DOI 10.1007/s00702-009-0251-8; Armstrong RA, 1998, NEUROSCI LETT, V242, P81, DOI 10.1016/S0304-3940(98)00052-4; Armstrong RA, 2006, J MICROSC-OXFORD, V221, P153, DOI 10.1111/j.1365-2818.2006.01559.x; Armstrong RA, 2003, NEUROPATHOLOGY, V23, P245, DOI 10.1046/j.1440-1789.2003.00516.x; Armstrong RA, 2003, HISTOPATHOLOGY, V42, P521, DOI 10.1046/j.1365-2559.2003.01601.x; Armstrong RA, 1997, J NEUROSCI METH, V73, P141, DOI 10.1016/S0165-0270(96)02221-2; ARMSTRONG RA, 1993, NEUROSCI LETT, V160, P57, DOI 10.1016/0304-3940(93)90916-9; Armstrong RA, 1998, ALZ DIS ASSOC DIS, V12, P378, DOI 10.1097/00002093-199812000-00021; Armstrong RA, 2001, NEUROPATHOLOGY, V21, P1, DOI 10.1046/j.1440-1789.2001.00373.x; Armstrong RA, 2001, NEUROPATHOLOGY, V21, P19, DOI 10.1046/j.1440-1789.2001.00364.x; Armstrong RA, 2000, EXP NEUROL, V163, P348, DOI 10.1006/exnr.2000.7392; ARMSTRONG RA, 1993, NEURODEGENERATION, V2, P73; Armstrong RA, 2007, PARKINSONISM RELAT D, V13, P50, DOI 10.1016/j.parkreldis.2006.07.004; Armstrong RA, 2006, CURR NEUROVASC RES, V3, P289, DOI 10.2174/156720206778792948; Armstrong RA, 2012, J NEURAL TRANSM, V119, P1551, DOI 10.1007/s00702-012-0838-3; Armstrong RA, 2009, CURR NEUROVASC RES, V6, P239, DOI 10.2174/156720209789630339; BELL MA, 1990, NEUROBIOL AGING, V11, P359, DOI 10.1016/0197-4580(90)90001-G; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; DELACOSTE MC, 1993, NEUROBIOL AGING, V14, P1, DOI 10.1016/0197-4580(93)90015-4; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; HIORNS RW, 1991, P ROY SOC B-BIOL SCI, V246, P1, DOI 10.1098/rspb.1991.0117; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Josephs KA, 2006, ARCH NEUROL-CHICAGO, V63, P1632, DOI 10.1001/archneur.63.11.1632; KAWAI M, 1990, AM J PATHOL, V137, P1435; Kieman PT, 2015, SEMIN NEUROL, V35, P20; LUTHERT PJ, 1991, NEUROSCI LETT, V126, P110, DOI 10.1016/0304-3940(91)90531-W; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	45	6	6	0	13	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	FEB	2017	124	2					185	192		10.1007/s00702-016-1635-1			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EK8FX	WOS:000394160400003	27770214	Green Accepted			2022-02-06	
J	Chan, DYC; Woo, PYM; Mak, CHK; Chu, ACH; Li, CCH; Ko, NMW; Ng, SCP; Sun, TFD; Poon, WS				Chan, David Yuen Chung; Woo, Peter Yat Ming; Mak, Calvin Hoi Kwan; Chu, Alberto Chi Ho; Li, Charles Churk Hang; Ko, Natalie Man Wai; Ng, Stephanie Chi Ping; Sun, Tin Fung David; Poon, Wai Sang			Use of subdural drain for chronic subdural haematoma? A 4-year multi-centre observational study of 302 cases	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Burr hole; Chronic subdural haematoma; Elderly trauma; Head injury; Recurrence; Subdural drain	RANDOMIZED CONTROLLED-TRIAL; CLOSED-SYSTEM DRAINAGE; BURR-HOLE TREPANATION; RECURRENCE; METAANALYSIS; IRRIGATION; EVACUATION; MANAGEMENT; EFFICACY	Chronic subdural haematoma (CSDH) is a common neurosurgical condition and is more prevalent in the ageing population. Studies have suggested that placement of subdural drains after burr-hole drainage was associated with lower recurrence rates. However, a considerable proportion of surgeons remained unconvinced of the effectiveness of drain placement and concerns exist with the potential complications this additional manoeuvre entails such as infection or bleeding. The aim of the present study is to evaluate the impact of subdural drain on CSDH recurrence and its safety. This is a multicentre observational study. Data of consecutive patients with burr-hole drainage performed for CSDH in three hospitals in Hong Kong during a four-year period from January 2008 to December 2011 were prospectively collected and retrospectively analysed. The primary outcome was symptomatic recurrence requiring re-operation. Secondary outcomes included the modified Rankin scales (mRS), morbidity and mortality at six months. A total of 302 patients were identified. The recurrence rate was 8.72% (13/149) with drain placement versus 16.3% (25/153) with no drain (Odds Ratio = 0.489, 95%CI 0.240-0.998; p = 0.0463). Local wound infection, subdural empyema, acute subdural haematoma and other complications had no significant difference. Six-month mRS, 30-day mortality and six-month mortality were comparable in both groups. In conclusion, the use of subdural drain significantly reduced recurrence with no significant increase in complications. (C) 2016 Published by Elsevier Ltd.	[Chan, David Yuen Chung; Ng, Stephanie Chi Ping; Sun, Tin Fung David; Poon, Wai Sang] Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Prince Wales Hosp, 4-F Lui Che Woo Clin Sci Bldg,30-32 Ngan Shin St, Shatin, Hong Kong, Peoples R China; [Woo, Peter Yat Ming; Chu, Alberto Chi Ho; Ko, Natalie Man Wai] Kwong Wah Hosp, Dept Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Mak, Calvin Hoi Kwan] Queen Elizabeth Hosp, Dept Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Li, Charles Churk Hang] North Dist Hosp, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China		Poon, WS (corresponding author), Chinese Univ Hong Kong, Div Neurosurg, Dept Surg, Prince Wales Hosp, 4-F Lui Che Woo Clin Sci Bldg,30-32 Ngan Shin St, Shatin, Hong Kong, Peoples R China.	davidchan@surgery.cuhk.edu.hk; peterymwoo@gmail.com; calvinmakhk@yahoo.com; albertochu@hotmail.com; hanglsc@gmail.com; natalieko_@hotmail.com; stephanieng@surgery.cuhk.edu.hk; davidsun@surgery.cuhk.edu.hk; wpoon@surgery.cuhk.edu.hk	Mak, Calvin/ABA-5717-2021; Poon, Wai Sang/F-1558-2011	Mak, Calvin/0000-0002-1443-2109; CHAN, David Yuen Chung/0000-0002-9622-3799			Abouzari M, 2007, NEUROSURGERY, V61, P794, DOI 10.1227/01.NEU.0000298908.94129.67; Alcala-Cerra G, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.012; Bellut D, 2012, WORLD NEUROSURG, V77, P111, DOI 10.1016/j.wneu.2011.05.036; Cenic A, 2005, CAN J NEUROL SCI, V32, P501, DOI 10.1017/S0317167100004510; Chan DY, 2014, WORLD NEUROSURG, V82, P1007; Chan DYC., 2015, CHIN NEUROSURG J, V1, P1, DOI [10.1186/s41016-015-0005-4, DOI 10.1186/S41016-015-0005-4]; Drapkin A J, 1991, Br J Neurosurg, V5, P467, DOI 10.3109/02688699108998475; Erol FS, 2005, J CLIN NEUROSCI, V12, P261, DOI 10.1016/j.jocn.2003.09.012; Heula AL, 2013, NEUROSURGERY, V73, P317, DOI 10.1227/01.neu.0000430323.24623.de; Javadi A, 2011, WORLD NEUROSURG, V75, P731, DOI 10.1016/j.wneu.2010.11.042; KRUPP WF, 1995, BRIT J NEUROSURG, V9, P619, DOI 10.1080/02688699550040909; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Kwan MCL, 2012, WORLD NEUROSURG, V77, P51, DOI 10.1016/j.wneu.2011.08.036; LAUMER R, 1989, NEUROSURGERY, V25, P991, DOI 10.1227/00006123-198912000-00026; Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715; Nagatani K, 2012, NEUROSURGERY, V70, pE1334, DOI 10.1227/NEU.0b013e31824ae86a; Santarius T, 2008, BRIT J NEUROSURG, V22, P529, DOI 10.1080/02688690802195381; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f; Sun TFD, 2005, BRIT J NEUROSURG, V19, P327, DOI 10.1080/02688690500305332; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Tsutsumi K, 1997, J NEUROSURG, V87, P870, DOI 10.3171/jns.1997.87.6.0870; WAKAI S, 1990, NEUROSURGERY, V26, P771, DOI 10.1227/00006123-199005000-00006; Weigel R, 2007, NEUROSURGERY, V61, P788, DOI 10.1227/01.NEU.0000298907.56012.E8; Zumofen D, 2009, NEUROSURGERY, V64, P1116, DOI 10.1227/01.NEU.0000345633.45961.BB	25	6	6	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2017	36						27	30		10.1016/j.jocn.2016.10.039			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI5WN	WOS:000392567100005	27914805				2022-02-06	
J	Dusenberry, MW; Brown, CK; Brewer, KL				Dusenberry, Michael W.; Brown, Charles K.; Brewer, Kori L.			Artificial neural networks: Predicting head CT findings in elderly patients presenting with minor head injury after a fall	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Neural Network Models; Elderly; Head Injury; Minor; Falls	TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; EXTERNAL VALIDATION; MILD; RULE; PERFORMANCE; MANAGEMENT; RADIATION	Objectives: To construct an artificial neural network (ANN) model that can predict the presence of acute CT findings with both high sensitivity and high specificity when applied to the population of patients >= age 65 years who have incurred minor head injury after a fall. Methods: An ANN was created in the Python programming language using a population of 514 patients >= age 65 years presenting to the ED with minor head injury after a fall. The patient dataset was divided into three parts: 60% for "training", 20% for "cross validation", and 20% for "testing". Sensitivity, specificity, positive and negative predictive values, and accuracy were determined by comparing the model's predictions to the actual correct answers for each patient. Results: On the "cross validation" data, the model attained a sensitivity ("recall") of 100.00%, specificity of 78.95%, PPV ("precision") of 78.95%, NPV of 100.00%, and accuracy of 88.24% in detecting the presence of positive head CTs. On the "test" data, the model attained a sensitivity of 97.78%, specificity of 89.47%, PPV of 88.00%, NPV of 98.08%, and accuracy of 93.14% in detecting the presence of positive head CTs. Conclusions: ANNs show great potential for predicting CT findings in the population of patients >= 65 years of age presenting with minor head injury after a fall. As a good first step, the ANN showed comparable sensitivity, predictive values, and accuracy, with a much higher specificity than the existing decision rules in clinical usage for predicting head CTs with acute intracranial findings. (C) 2016 Elsevier Inc. All rights reserved.	[Dusenberry, Michael W.] East Carolina Univ, Brody Sch Med, 600 Moye Blvd, Greenville, NC 27834 USA; [Brown, Charles K.; Brewer, Kori L.] East Carolina Univ, Brody Sch Med, Dept Emergency Med, 600 Moye Blvd, Greenville, NC 27834 USA		Dusenberry, MW (corresponding author), East Carolina Univ, Brody Sch Med, 600 Moye Blvd, Greenville, NC 27834 USA.	dusenberrymw@gmail.com; browncha@ecu.edu; brewerk@ecu.edu					Bengio Yoshua, 2012, CORR; Bennett JM, 2014, BR J MED MED RES, V6, P342; Bergen GS., 2008, INJURY US 2007 CHART; Bishop CM., 2006, PATTERN RECOGN; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Centers for Disease Control, WISQARS WEB BAS INJ, VAccessed May 19, 2019; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; Goodfellow Ian, 2016, DEEP LEARNING UNPUB; Hastie T., 2009, ELEMENTS STAT LEARNI, V2; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; Hosek J, INTRO ESTIMATION CHO; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Kingma Diederik P., CORR; Korley FK, 2013, ACAD EMERG MED, V20, P463, DOI 10.1111/acem.12136; MacKay D. J, 2003, INFORM THEORY INFERE, V7; Martin DR, 2006, LANCET, V367, P1712, DOI 10.1016/S0140-6736(06)68748-5; Mazurowski MA, 2008, NEURAL NETWORKS, V21, P427, DOI 10.1016/j.neunet.2007.12.031; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Reynolds TA, 2013, ANN EMERG MED, V61, P528, DOI 10.1016/j.annemergmed.2012.12.006; Riccardi A, 2013, AM J EMERG MED, V31, P37, DOI 10.1016/j.ajem.2012.05.023; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sinha M, 2001, J TRAUMA, V50, P308, DOI 10.1097/00005373-200102000-00018; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Wolf H, 2014, J NEUROSURG, V120, P447, DOI 10.3171/2013.10.JNS13726	34	6	6	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	FEB	2017	35	2					260	267		10.1016/j.ajem.2016.10.065			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EL9FE	WOS:000394924600012	27876174				2022-02-06	
J	Geynisman-Tan, JM; Taylor, JS; Edersheim, T; Taubel, D				Geynisman-Tan, Julia M.; Taylor, Jolyn S.; Edersheim, Terri; Taubel, Debra			All the darkness we don't see	AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY			English	Article						sex trafficking; social justice; underserved care	TRAFFICKING; HEALTH	Trafficking of women and children for sexual exploitation is the fastest growing criminal enterprise in the world. This is a public health crisis; as physicians who have direct contact with victims, we have a unique opportunity to intervene. The authors developed a specialty clinic for survivors of sex trafficking in 2013 at an academic medical center in New York City. Twenty of the 24 women seen in the Survivor Clinic saw a physician while being trafficked. Sex trafficking violates basic human rights, which include the rights to bodily integrity, dignity, health, and freedom from violence and torture. The stories of the patients seen in the Survivor Clinic bear witness to the health consequences of commercial sexual exploitation and reinforce the previous literature on the rates of physical and psychologic harms of trafficking. Health consequences of trafficking include traumatic brain injuries, drug addiction, depression, and neglect of chronic health conditions. All physicians, but gynecologists especially, need more education about the prevalence and dynamics of trafficking and how to assess and intervene on behalf of survivors.	[Geynisman-Tan, Julia M.; Taylor, Jolyn S.; Edersheim, Terri] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY 10065 USA; [Taubel, Debra] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Clin Obstet & Gynecol, New York, NY 10065 USA; [Taylor, Jolyn S.] Univ Texas MD Anderson Canc Ctr, Div Gynecol Oncol, Houston, TX 77030 USA		Geynisman-Tan, JM (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY 10065 USA.			Taylor, Jolyn/0000-0003-1267-4371	American College of Obstetricians and Gynecologists Industry	Supported by the American College of Obstetricians and Gynecologists Industry-funded Research Fellowship in Contraceptive Access within Low-Resource Populations.	Baldwin SB, 2011, HEALTH HUM RIGHTS, V13, P36; Beck ME, 2015, PEDIATRICS, V135, pE895, DOI 10.1542/peds.2014-2814; Chaffee T, 2015, CURR OPIN OBSTET GYN, V27, P339, DOI 10.1097/GCO.0000000000000198; Family Violence Prevention Fund, 2005, TRAFF SURV PERSP EAR; Farley M, 1998, WOMEN HEALTH, V27, P37, DOI 10.1300/J013v27n03_03; Herman Lewis J, 1992, TRAUMA RECOVERY DOME; IOM/NRC Comm Commercial Sexual Exploitat & Sex Trafficking Minors US, 2013, CONFRONTING COMMERCIAL SEXUAL EXPLOITATION AND SEX TRAFFICKING OF MINORS IN THE UNITED STATES: A GUIDE FOR THE HEALTH CARE SECTOR, P1; Lederer L, 2014, ANN HLTH LAW, V23, P1; Office of Juvenile Justice and Delinquency Prevention: National Incidence Study of Missing, 2002, ABD RUN THROWN CHILD; Oram S, 2016, AM J PUBLIC HEALTH, V106, P1073, DOI 10.2105/AJPH.2016.303095; Rajaram SS, 2016, NEBRASKA SURVIVORS S; Raphael J., 2002, SISTERS SPEAK OUT LI; U.S. Department of State, 2012, TRAFF PERS REP 2012	13	6	6	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9378	1097-6868		AM J OBSTET GYNECOL	Am. J. Obstet. Gynecol.	FEB	2017	216	2					135	+	135.e1-e5	10.1016/j.ajog.2016.09.088			5	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	EO9YJ	WOS:000397043700008	27664496				2022-02-06	
J	Gooden, JR; Ponsford, JL; Charlton, JL; Ross, PE; Marshall, S; Gagnon, S; Bedard, M; Stolwyk, RJ				Gooden, James R.; Ponsford, Jennie L.; Charlton, Judith L.; Ross, Pamela E.; Marshall, Shawn; Gagnon, Sylvain; Bedard, Michel; Stolwyk, Renerus J.			The development and initial validation of a new tool to measure self-awareness of driving ability after brain injury	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						awareness; driving; rehabilitation; traumatic brain injury	COMMUNITY INTEGRATION; PERFORMANCE; REHABILITATION; VALIDITY; DEFICITS; RELIABILITY; DEMENTIA; PEOPLE	AimThe aim of this study was to develop and provide initial validation data for a self-awareness of on-road driving ability measure for individuals with brain injury. MethodThirty-nine individuals with Traumatic Brain Injury completed an on-road driving assessment, the Self-Regulation Skills Interview (SRSI) and the newly developed Brain Injury Driving Self-Awareness Measure (BIDSAM). ResultsBIDSAM self, clinician and discrepancy scales demonstrated high levels of internal consistency (=0.83-0.92). Criterion-related validity was established by demonstrating significantly higher correlations between clinician ratings and on-road performances, r(s)=0.82, P<0.01, compared to self-ratings, r(s)=0.45, P<0.05. Discrepancy scores were significantly correlated with the SRSI emergent, r(s)=0.52, P<0.01, and anticipatory awareness scores, r(s)=0.37, P<0.05, indicative of convergent validity. ConclusionsThese results provide initial support for the BIDSAM as a reliable and valid measure of self-awareness of on-road driving ability following TBI.	[Gooden, James R.; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Sch Psychol Sci, 18 Innovat Walk,Clayton Campus,Wellington Rd, Clayton, Vic 3800, Australia; [Gooden, James R.; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia; [Gooden, James R.; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Charlton, Judith L.] Monash Univ, Accid Res Ctr, Clayton, Vic, Australia; [Ross, Pamela E.] Epworth Rehabil, Richmond, Vic, Australia; [Marshall, Shawn] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Gagnon, Sylvain] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Bedard, Michel] Lakehead Univ, Ctr Res & Safe Driving, Thunder Bay, ON, Canada		Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol Sci, 18 Innovat Walk,Clayton Campus,Wellington Rd, Clayton, Vic 3800, Australia.	rene.stolwyk@monash.edu		Charlton, Judith/0000-0002-5990-2151; Gooden, James/0000-0001-6835-9528	Transport Accident Commission (Victoria, Australia); Ontario Neurotrauma Foundation (Ontario, Canada)	This research project was jointly funded by the Transport Accident Commission (Victoria, Australia) and the Ontario Neurotrauma Foundation (Ontario, Canada).	Abreu BC, 2001, ARCH PHYS MED REHAB, V82, P49, DOI 10.1053/apmr.2001.9167; Clare L, 2005, AGING MENT HEALTH, V9, P394, DOI 10.1080/13607860500142903; Clare L, 2010, AGING MENT HEALTH, V14, P20, DOI 10.1080/13607860903421029; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DeVellis RF., 2012, SCALE DEV THEORY APP, V34; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fleming JM, 1996, BRAIN INJURY, V10, P1; George Stacey, 2012, Aust Occup Ther J, V59, P105, DOI 10.1111/j.1440-1630.2011.00991.x; Griffen JA, 2011, CLIN NEUROPSYCHOL, V25, P1158, DOI 10.1080/13854046.2011.609841; Kay LG, 2009, ARCH PHYS MED REHAB, V90, P1514, DOI 10.1016/j.apmr.2009.03.011; Kay LG, 2009, DISABIL REHABIL, V31, P1074, DOI 10.1080/09638280802509553; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Mallon K, 2004, AM J OCCUP THER, V58, P279, DOI 10.5014/ajot.58.3.279; Markova IS, 2001, PSYCHOPATHOLOGY, V34, P245, DOI 10.1159/000049317; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; McCarthy DP, 2005, PHYS OCCUP THER GERI, V23, P25, DOI 10.1080/J148v23n02_02; Mihaljcic T, 2014, ARCH GERONTOL GERIAT, V59, P249, DOI 10.1016/j.archger.2014.06.001; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; ODENHEIMER GL, 1994, J GERONTOL, V49, pM153, DOI 10.1093/geronj/49.4.M153; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M., 1995, J INT NEUROPSYCH SOC, V1, P163; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Vlahodimitrakou Z, 2013, ACCIDENT ANAL PREV, V61, P253, DOI 10.1016/j.aap.2013.03.027	32	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	FEB	2017	64	1					33	40		10.1111/1440-1630.12306			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	EL8ZX	WOS:000394910000005	27488467				2022-02-06	
J	Guekht, A; Zharkinbekova, N; Shpak, A; Hauser, WA				Guekht, Alla; Zharkinbekova, Nazira; Shpak, Alexander; Hauser, W. Allen			Epilepsy and treatment gap in urban and rural areas of the Southern Kazakhstan in adults	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Kazakhstan; Prevalence; Etiology; Treatment gap	FACTOR SURVEILLANCE SYSTEM; PREVALENCE; EPIDEMIOLOGY; CONSANGUINITY; LAMOTRIGINE; TOPIRAMATE; SEIZURES; SANAD	Purpose: There are no data in the English literature about the epidemiology of epilepsy in the large countries in the Asian region of the former Soviet Union. This paper presents the results of epidemiological studies of active epilepsy in the population 14 years of age and older in the Province of South Kazakhstan. Methods: The study population consisted of 306.44 thousand persons: 139.42 in the urban Enbekshinsldy district of the city of Shymkent and 167.02 in the rural Sairam district. To collect patient's data, multiple medical sources were used. For each person with epilepsy (PWE), a questionnaire was completed by members of the research team. Clinical profiles, seizure type, clinical syndrome, etiology, seizure frequency, therapy, educational level, and social status were abstracted. Results: Overall, 1351 PWE were identified: 459 in the urban district and 892 in the rural district. The age adjusted prevalence of epilepsy was 3.14/1000 (CI95%: 2.86-3.45) in the urban district and 4.95/1000 (C195%: 4.62-5.30) in the rural district. Prevalence for men was higher than for women. Focal seizures predominated in both regions. Traumatic brain injury was the most frequently identified cause of epilepsy. The other important antecedents were pre/perinatal disorders, CNS infection, and cerebrovascular disease. Half of PWE experienced more than 12 seizures per year. Substantial social impacts of epilepsy were observed: 44% of PWE received disability pensions from the government; only 15.5% were employed. About a quarter of all PWE were not taldng AEDs at the time of the record review. For those on treatment, regimens were frequently suboptimal. Conclusion: In the first study performed according to the guidelines for epidemiologic studies on epilepsy of ILAE in the Asian part of the former Soviet Union, poor seizure control and a substantial treatment gap were identified. The need for improvement of epilepsy care was highlighted, especially in the rural regions. (C) 2016 Elsevier Inc. All rights reserved.	[Guekht, Alla] Healthcare Dept Moscow, Moscow Res & Clin Ctr Neuropsychiat, 43 Donskaya Ul, Moscow 115419, Russia; [Guekht, Alla; Zharkinbekova, Nazira] Russian Natl Res Med Univ, Dept Neurol Neurosurg & Med Genet, 8 Leninsky Prospekt,Bl 8, Moscow 119049, Russia; [Zharkinbekova, Nazira] Shymkent Reg Clin Hosp, 4 Mailykozha Str, Shymkent 160050, South Kazakhsta, Kazakhstan; [Shpak, Alexander] S Fyodorov Eye Microsurg Fed State Inst, 59A,Beskudnikovsky Blvd, Moscow 127486, Russia; [Hauser, W. Allen] Columbia Univ, Dept Neurol, Epidemiol & Sergievsky Ctr, 630,West 168 St, New York, NY 10032 USA		Guekht, A (corresponding author), 43 Donskaya Ul, Moscow 115419, Russia.	guekht@mail.ru; naziragar@rambler.ru; a_shpak@inbox.ru; wahauser@optonline.net	Guekht, Alla/N-3422-2019; Shpak, Alexander/K-5648-2019; Hauser, W Allen/AAB-5277-2020; Guekht, Alla B./Y-6725-2018	Guekht, Alla/0000-0002-1170-6127; Shpak, Alexander/0000-0003-0273-3307; Zharkinbekova, Nazira/0000-0002-5069-1562			Ablah E, 2014, EPILEPSY RES, V108, P792, DOI 10.1016/j.eplepsyres.2014.01.001; [Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Asadi-Pooya AA, 2005, EUR J PAEDIATR NEURO, V9, P383, DOI 10.1016/j.ejpn.2005.06.002; BALKHANOVA RB, 2006, THESIS; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Benamer HTS, 2009, EPILEPSIA, V50, P2301, DOI 10.1111/j.1528-1167.2009.02058.x; Bielen I, 2007, ACTA NEUROL SCAND, V116, P361, DOI 10.1111/j.1600-0404.2007.00881.x; Biryukbaeva GN, 2008, ZH NEVROL PSIKHIATR, P67; Boyle P, 1991, CANC REGISTRATION PR, V95; Chen CC, 2006, EPILEPSY RES, V72, P67, DOI 10.1016/j.eplepsyres.2006.07.007; Chentouf A, 2015, EPILEPSY RES, V111, P10, DOI 10.1016/j.eplepsyres.2014.12.014; Choueiri RN, 2001, PEDIATR NEUROL, V24, P37, DOI 10.1016/S0887-8994(00)00231-9; Covanis A, 2015, EPILEPSIA, V56, P1651, DOI 10.1111/epi.13192; Daoud AS, 2003, SEIZURE-EUR J EPILEP, V12, P171, DOI 10.1016/S1059-1311(02)00194-2; de Boer HM, 2010, SEIZURE-EUR J EPILEP, V19, P630, DOI 10.1016/j.seizure.2010.10.017; Djibuti M, 2003, J NEUROL NEUROSUR PS, V74, P570, DOI 10.1136/jnnp.74.5.570; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074; Gu L, 2013, EPILEPSY RES, V105, P195, DOI 10.1016/j.eplepsyres.2013.02.002; Guekht A, 2010, EPILEPSY RES, V92, P209, DOI 10.1016/j.eplepsyres.2010.09.011; Hara HS, 2015, NEUROEPIDEMIOLOGY, V45, P273, DOI 10.1159/000438509; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; KABAKOV RA, 2002, THESIS; Kale R, 2002, EPILEPSIA, V43, P31, DOI 10.1046/j.1528-1157.43.s.6.13.x; Khedr EM, 2013, EPILEPSY RES, V103, P294, DOI 10.1016/j.eplepsyres.2012.08.006; Kobau R, 2004, EPILEPSY BEHAV, V5, P358, DOI 10.1016/j.yebeh.2004.02.007; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Kuralbaev KB, 1998, THESIS; Mac TL, 2007, LANCET NEUROL, V6, P533, DOI 10.1016/S1474-4422(07)70127-8; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Meinardi H, 2001, EPILEPSIA, V42, P136, DOI 10.1046/j.1528-1157.2001.32800.x; Meyer ACL, 2012, EPILEPSIA, V53, P2178, DOI 10.1111/epi.12002; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Oun A, 2003, ACTA NEUROL SCAND, V108, P245, DOI 10.1034/j.1600-0404.2003.00121.x; Pi XR, 2014, SEIZURE-EUR J EPILEP, V23, P636, DOI 10.1016/j.seizure.2014.05.002; Robertson J, 2015, SEIZURE-EUR J EPILEP, V29, P46, DOI 10.1016/j.seizure.2015.03.016; Smailov AA, 2011, S KAZAKHSTAN PROVINC, V1-3; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Topbas M, 2012, IRAN J PEDIATR, V22, P344; WATERHOUSE J. A. H., 1976, CANC INCIDENCE 5 CON; WHO, 2005, ATL EP CAR WORLD; [Ярмухаметова Миляуша Рифхатовна Yarmukhametova Milyausha Rifhatovna], 2010, [Неврологический вестник, Nevrologicheskii vestnik], V42, P3	45	6	6	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	FEB	2017	67						98	104		10.1016/j.yebeh.2016.11.028			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	EN4HG	WOS:000395968000016	28142100				2022-02-06	
J	Konigs, M; Weeda, WD; van Heurn, LWE; Vermeulen, RJ; Goslings, JC; Luitse, JSK; Poll-The, BT; Beelen, A; van der Wees, M; Kemps, RJJK; Catsman-Berrevoets, CE; Oosterlaan, J				Konigs, Marsh; Weeda, Wouter D.; van Heurn, L. W. Ernest; Vermeulen, R. Jeroen; Goslings, J. Carel; Luitse, Jan S. K.; Poll-The, Bwee Tien; Beelen, Anita; van der Wees, Marleen; Kemps, Rachel J. J. K.; Catsman-Berrevoets, Coriene E.; Oosterlaan, Jaap			Pediatric Traumatic Brain Injury Affects Multisensory Integration	NEUROPSYCHOLOGY			English	Article						pediatrics; traumatic brain injury; multisensory integration; general neurocognitive functioning	TEMPORAL BINDING WINDOW; EXECUTIVE FUNCTIONS; DIFFUSION-MODEL; CHILDREN; OUTCOMES; TASK; TBI	Objective: To investigate the impact of pediatric traumatic brain injury (TBI) on multisensory integration in relation to general neurocognitive functioning. Method: Children with a hospital admission for TBI aged between 6 and 13 years (n = 94) were compared with children with trauma control (TC) injuries (n = 39), while differentiating between mild TBI without risk factors for complicated TBI (mild(RF-); n = 19), mild TBI with >= 1 risk factor (mild(RF+); n = 45), and moderate/severe TBI (n = 30). We measured set-shifting performance based on visual information (visual shift condition) and set-shifting performance based on audiovisual information, requiring multisensory integration (audiovisual shift condition). Effects of TBI on set-shifting performance were traced back to task strategy (i.e., boundary separation), processing efficiency (i.e., drift rate), or extradecisional processes (i.e., nondecision time) using diffusion model analysis. General neurocognitive functioning was measured using estimated full-scale IQ (FSIQ). Results: The TBI group showed selectively reduced performance in the audiovisual shift condition (p =.009, Cohen's d = -0.51). Follow-up analyses in the audiovisual shift condition revealed reduced performance in the mild(RF+) TBI group and moderate/severe TBI group (ps <= .025, ds <= -0.61). These effects were traced back to lower drift rate (ps <= .048, ds <= -0.44), reflecting reduced multisensory integration efficiency. Notably, accuracy and drift rate in the audiovisual shift condition partially mediated the relation between TBI and FSIQ. Conclusion: Children with mild(RF+) or moderate/severe TBI are at risk for reduced multisensory integration efficiency, possibly contributing to decreased general neurocognitive functioning.	[Konigs, Marsh; Oosterlaan, Jaap] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Boelelaan 1901, NL-1081 HV Amsterdam, Netherlands; [Weeda, Wouter D.] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Weeda, Wouter D.] Vrije Univ Amsterdam, Dept Methods, Amsterdam, Netherlands; [Weeda, Wouter D.] Leiden Univ, Inst Psychol, Dept Methodol & Stat, Leiden, Netherlands; [van Heurn, L. W. Ernest] Emma Childrens Hosp, Acad Med Ctr, Pediat Surg Ctr Amsterdam, Amsterdam, Netherlands; [van Heurn, L. W. Ernest] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Vermeulen, R. Jeroen] Vrije Univ Amsterdam, Dept Pediat Neurol, Amsterdam, Netherlands; [Vermeulen, R. Jeroen] Maastricht Univ, Med Ctr, Dept Pediat Neurol, Maastricht, Netherlands; [Goslings, J. Carel] Acad Med Ctr, Trauma Unit, Amsterdam, Netherlands; [Luitse, Jan S. K.] Acad Med Ctr, Dept Emergency Med, Amsterdam, Netherlands; [Poll-The, Bwee Tien] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Neurol, Amsterdam, Netherlands; [Beelen, Anita] Merem Rehabil Ctr Trappenberg, Huizen, Netherlands; [Beelen, Anita] Acad Med Ctr, Dept Rehabil, Amsterdam, Netherlands; [van der Wees, Marleen] Libra Rehabil Med & Audiol Blixembosch, Eindhoven, Netherlands; [Kemps, Rachel J. J. K.] Libra Rehabil Med & Audiol Leijpark, Tilburg, Netherlands; [Catsman-Berrevoets, Coriene E.] Erasmus MC, Dept Pediat Neurol, Rotterdam, Netherlands; [Oosterlaan, Jaap] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands		Konigs, M (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuropsychol, Boelelaan 1901, NL-1081 HV Amsterdam, Netherlands.	m.konigs@vu.nl		Vermeulen, R. Jeroen/0000-0002-3503-3625; Konigs, Marsh/0000-0003-0200-0445; Weeda, W. D./0000-0001-8619-2645; Poll-The, Bwee Tien/0000-0002-8118-5419	Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [022.003.010]	This work was supported by the Netherlands Organization for Scientific Research (NWO, http://www.nwo.nl) grant 022.003.010. We are grateful to J. A. van der Sluijs from the Department of Pediatric Orthopedics (VU Medical Center Amsterdam) and H. A. Heij from the Pediatric Surgical Center Amsterdam (VU University Medical Center and Academic Medical Center) for their assistance in the recruitment of participants for this study.	Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; American College of Surgeons Committee on Trauma, 2004, ADV TRAUM LIF SUPP P, V7; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barutchu A, 2011, DEV PSYCHOL, V47, P877, DOI 10.1037/a0021903; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buzy WM, 2009, CHILD NEUROPSYCHOL, V15, P441, DOI 10.1080/09297040802646991; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Dionne-Dostie E, 2015, BRAIN SCI, V5, P32, DOI 10.3390/brainsci5010032; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Faul M, 2010, TRAUMATIC BRAIN INJU; Galvin J, 2009, AM J OCCUP THER, V63, P701, DOI 10.5014/ajot.63.6.701; Hayes, 2018, INTRO MEDIATION MODE; Hillock-Dunn A, 2012, DEVELOPMENTAL SCI, V15, P688, DOI 10.1111/j.1467-7687.2012.01171.x; Kaufman AS, 1996, J CLIN CHILD PSYCHOL, V25, P97, DOI 10.1207/s15374424jccp2501_11; Konigs M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144395; Konigs M, 2015, PEDIATRICS, V136, P534, DOI 10.1542/peds.2015-0437; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Macaluso E, 2005, TRENDS NEUROSCI, V28, P264, DOI 10.1016/j.tins.2005.03.008; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2015, CURR DIR PSYCHOL SCI, V24, P458, DOI 10.1177/0963721415596228; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; ROSE SA, 1992, CHILD DEV, V63, P1126, DOI 10.2307/1131522; Rose SA, 1998, DEV PSYCHOL, V34, P435, DOI 10.1037/0012-1649.34.3.435; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Statistics Netherlands, 2006, STAND OND 2006; Tabachnick BG., 2012, USING MULTIVARIATE S; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; van den Brink RL, 2014, CEREB CORTEX, V24, P2169, DOI 10.1093/cercor/bht069; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Voss A, 2007, BEHAV RES METHODS, V39, P767, DOI 10.3758/BF03192967; Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wallace MT, 2014, NEUROPSYCHOLOGIA, V64, P105, DOI 10.1016/j.neuropsychologia.2014.08.005; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	45	6	6	1	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	FEB	2017	31	2					137	148		10.1037/neu0000302			12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EM0GU	WOS:000394997600003	27683950				2022-02-06	
J	Licona, NE; Chung, JS; Poole, JH; Salerno, RM; Laurenson, NM; Harris, OA				Licona, Nytzia E.; Chung, Joyce S.; Poole, John H.; Salerno, Rose M.; Laurenson, Nancy M.; Harris, Odette A.			Prospective Tracking and Analysis of Traumatic Brain Injury in Veterans and Military Personnel	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Blast injuries; Brain injuries; traumatic; Longitudinal studies; Multiple trauma; Prospective studies; Rehabilitation; Research	SERVICE MEMBERS; BLAST; CARE; TBI	Objective: To describe the ongoing Clinical Tracking Form (CTF) study of the Defense and Veterans Brain Injury Center (DVBIC). Design: Prospective longitudinal study. Data at baseline and postinjury are collected on participants through interview and questionnaire, review of medical records, and periodic follow-ups throughout their lifetime. Setting: A regional DVBIC site located at a Veterans Affairs Medical Center. Participants: Participants (N=211; age range, 18-75y) were enrolled between January 1,2005, and December 31,2012, at a regional DVBIC site. Intervention: Not applicable. Main Outcome Measures: Injury information, functioning, and psychological health. Results: Sixty percent of 211 participants were identified as having severe traumatic brain injuries (TBIs), 14% moderate TBIs, and 26% mild TBIs. Of these 211 participants, 79% sustained closed head injuries, 15% penetrating head injuries, and 6% were not reported. Comparing the severity of TBI in combat versus stateside situations, most of the mild injuries (71%) occurred in combat locations, while most of the severe injuries (62%) occurred in the United States. Among those injured in combat, blast-related TBIs (82%) greatly outnumbered non blast-related TBIs, regardless of severity. Conclusions: The CTF study serves as a significant resource of data to understand the effect and outcomes of TBI in the military population. The lifelong experience of military veterans across the full spectrum of TBI and recovery will be recorded through the CTF, and will translate into more informed clinical decisions and educational efforts to guide future research pathways. (C) 2016 by the American Congress of Rehabilitation Medicine	[Licona, Nytzia E.; Poole, John H.; Salerno, Rose M.; Laurenson, Nancy M.; Harris, Odette A.] Def & Vet Brain Injury Ctr, Palo Alto, CA USA; [Chung, Joyce S.; Harris, Odette A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Harris, Odette A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA		Licona, NE (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Def & Vet Brain Injury Ctr, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	Nytzia.licona@va.gov			Defense and Veterans Brain Injury Center, United States Army Medical Research and Materiel Command; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This material is based on work supported in part by the Defense and Veterans Brain Injury Center, United States Army Medical Research and Materiel Command. The parent study, Prospective Traumatic Injury Tracking Form Protocol, is funded by Defense and Veterans Brain Injury Center The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position, policy, or decision unless so designated by other official documentation.	Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Military One Source, PROF MIL COMM 2011 D; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Ommaya A K, 1999, Mil Med, V164, P1; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	10	6	6	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2017	98	2					391	394		10.1016/j.apmr.2016.09.131			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EK4XB	WOS:000393930100024	27794484				2022-02-06	
J	Lo, MH; Lin, CL; Chuang, E; Chuang, TY; Kao, CH				Lo, M. -H.; Lin, C. -L.; Chuang, E.; Chuang, T. -Y.; Kao, C. -H.			Association of dementia in patients with benign paroxysmal positional vertigo	ACTA NEUROLOGICA SCANDINAVICA			English	Article						dementia; benign paroxysmal positional vertigo; atherosclerosis	TRAUMATIC BRAIN-INJURY; VASCULAR RISK-FACTORS; AUTONOMIC DYSFUNCTION; ALZHEIMER-DISEASE; COHORT; FALLS; EPIDEMIOLOGY; POPULATION; PATTERNS; GLUCOSE	ObjectiveWe conducted a cohort study to investigate whether benign paroxysmal positional vertigo (BPPV) is correlated with an increased risk of dementia. MethodsWe established a case cohort comprising 7818 patients aged over 20 years who were diagnosed with BPPV from 2000 to 2010. In addition, we formed a control cohort by randomly selecting 31,272 people without BPPV and matched them with the BPPV patients according to gender, age, and index year. Cox proportional hazard regressions were performed to compute the hazard ratio (HR) of dementia after we adjusted for demographic characteristics and comorbidity. ResultsThe prevalence of comorbidity was higher among patients with BPPV than among those without BPPV. In addition, patients with BPPV exhibited a 1.24-fold (95% confidence interval, CI 1.09-1.40; P < 0.001) higher risk of dementia than those without BPPV after we adjusted for age, gender, and comorbidity. An analysis stratified according to demographic factors revealed that women with BPPV exhibited a 1.36-fold (95% CI 1.16-1.59; P < 0.001) higher risk of dementia. Patients with BPPV aged over 65 years exhibited a significantly higher risk of dementia (adjusted HR: 1.26; 95% CI 1.10-1.43; P < 0.001) than those without BPPV. ConclusionsPatients with BPPV exhibited a higher risk of dementia than those without BPPV.	[Lo, M. -H.; Chuang, T. -Y.] Taipei Vet Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lo, M. -H.; Chuang, T. -Y.] Natl Yang Ming Univ, Taipei, Taiwan; [Lin, C. -L.] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, C. -L.] China Med Univ, Coll Med, Taichung, Taiwan; [Chuang, E.] Univ Calif Berkeley, Intended BS Mol & Cell Biol, Berkeley, CA 94720 USA; [Kao, C. -H.] China Med Univ, Grad Inst Clin Med Sci, Coll Med, 2 Yuh Der Rd, Taichung 40447, Taiwan; [Kao, C. -H.] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, C. -H.] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, C. -H.] China Med Univ Hosp, PET Ctr, Taichung, Taiwan		Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, 2 Yuh Der Rd, Taichung 40447, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allan LM, 2007, J NEUROL NEUROSUR PS, V78, P671, DOI 10.1136/jnnp.2006.102343; Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Banerjee S, 2013, LANCET, V382, P1384, DOI 10.1016/S0140-6736(13)61579-2; Cattaneo D, 2016, ACTA NEUROL SCAND, V133, P346, DOI 10.1111/ane.12466; Celebisoy N, 2009, GAIT POSTURE, V29, P520, DOI 10.1016/j.gaitpost.2008.12.002; Cohen HS, 2004, ORL J OTO-RHINO-LARY, V66, P11, DOI 10.1159/000077227; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Dolan H, 2010, ANN NEUROL, V68, P231, DOI 10.1002/ana.22055; Erway L, 1985, SCAN ELECT MICROSC, V4, P1681; Feldman HH, 2005, ALZ DIS ASSOC DIS, V19, P29, DOI 10.1097/01.wad.0000157065.43282.bc; FERRARY E, 1987, AM J PHYSIOL, V253, pF59, DOI 10.1152/ajprenal.1987.253.1.F59; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; HEMENWAY W G, 1956, Ann Otol Rhinol Laryngol, V65, P692; HENNEBERG N, 1995, ARCH GERONTOL GERIAT, V21, P63, DOI 10.1016/0167-4943(95)00646-3; Horimoto Y, 2003, J NEUROL, V250, P530, DOI 10.1007/s00415-003-1029-9; Idiaquez J, 2011, J NEUROL SCI, V305, P22, DOI 10.1016/j.jns.2011.02.033; Ishiyama A, 2000, ANN OTO RHINOL LARYN, V109, P377, DOI 10.1177/000348940010900407; Kalmijn S, 2000, ARTERIOSCL THROM VAS, V20, P2255, DOI 10.1161/01.ATV.20.10.2255; Kao Chung-Lan, 2014, Front Aging Neurosci, V6, P108, DOI 10.3389/fnagi.2014.00108; Kato-Narita EM, 2011, ARQ NEURO-PSIQUIAT, V69, P202, DOI 10.1590/S0004-282X2011000200012; Kim HA, 2014, CLIN NEUROPHYSIOL, V125, P608, DOI 10.1016/j.clinph.2013.08.008; Lo MH, 2017, ACTA NEUROL SCAND, V135, P197, DOI 10.1111/ane.12581; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; Pezzoli M, 2010, CLIN AUTON RES, V20, P27, DOI 10.1007/s10286-009-0032-3; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith AD, 2014, J ALZHEIMERS DIS, V38, P699, DOI 10.3233/JAD-132372; Sonnen JA, 2009, ARCH NEUROL-CHICAGO, V66, P315, DOI 10.1001/archneurol.2008.579; Unverzagt FW, 2011, NEUROLOGY, V77, P1729, DOI 10.1212/WNL.0b013e318236ef23; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; van Oijen M, 2007, ANN NEUROL, V61, P403, DOI 10.1002/ana.21073; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Wada Masaoki, 2008, Int Tinnitus J, V14, P131; Yoda S, 2011, OTOLARYNG HEAD NECK, V145, P458, DOI 10.1177/0194599811407610	40	6	6	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	FEB	2017	135	2					197	203		10.1111/ane.12581			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI4XJ	WOS:000392496800007	26932875				2022-02-06	
J	Naghibi, T; Mohajeri, M; Dobakhti, F				Naghibi, Taraneh; Mohajeri, Mina; Dobakhti, Faramarz			Inflammation and Outcome in Traumatic Brain Injury: Does Gender Effect on Survival and Prognosis?	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Brain cells; C-reactive protein; Intracranial inflammatory response	C-REACTIVE PROTEIN; MORTALITY	Introduction: Traumatic Brain Injury (TBI) accounts for the majority of trauma deaths and there has been increased interest in the understanding the role of prognostic factors. C-Reactive Protein (CRP) level increases rapidly in response to trauma. Aim: Aim of the present study was to indicate the role of CRP as a predictor of outcome in TBI patients based on their gender category. Materials and Methods: A prospective cohort study in a surgical Intensive Care Unit (ICU) in one of the Zanjan University of Medical Science hospital was designed. Fifty nine head trauma patients were divided into two groups based on their gender. Serum CRP was measured 48 hours after trauma. All data including the length of ICU stay, the duration of mechanical ventilation, the Glasgow Coma Scale (GCS) at discharge, and mortality were collected. The relationship between the clinical features and serum CRP level was also studied. Results: In the male group, CRP level was not significantly correlated with the length of ICU stay, the duration of mechanical ventilation and GCS at discharge. In the female group, CRP level was positively correlated with the length of ICU stay and the duration of mechanical ventilation; however, CRP level was not significantly correlated with GCS at discharge. These results remain constant in female sub group with severe head injury contrast to female with mild injury. Conclusion: The GCS level can predict the outcome of females with severe head injury better than females with mild head injury and males.	[Naghibi, Taraneh; Mohajeri, Mina] Zanjan Univ Med Sci, Dept Anaesthesiol & Crit Care Med, Zanjan, Iran; [Dobakhti, Faramarz] Zanjan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Zanjan, Iran; [Naghibi, Taraneh] Mosavi Hosp, Gavazang St, Zanjan, Iran		Naghibi, T (corresponding author), Mosavi Hosp, Gavazang St, Zanjan, Iran.	tnaghibi@zums.ac.ir	Naghibi, Taraneh/M-5900-2016	Naghibi, Taraneh/0000-0001-6882-7598			Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Choudhry Mashkoor A., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P127; Doran B, 2013, AM HEART J, V166, P45, DOI 10.1016/j.ahj.2013.03.017; Garnacho-Montero J, 2014, CRIT CARE, V18, DOI 10.1186/cc13908; Gulcher SS, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0105-0; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hsieh YC, 2007, CRIT CARE MED, V35, pS621, DOI 10.1097/01.CCM.0000278603.18687.4F; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lee D.G., 2005, J KOREAN NEUROTRAUMA, V1, P57, DOI [10.13004/jknts.2005.1.1.57, DOI 10.13004/JKNTS.2005.1.1.57]; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Meisner M, 2006, CRIT CARE, V10, P1, DOI DOI 10.HTTP://WWW.NCBI.NLM.NIH.G0V/PUBMED/16356205; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Meyer KS, 2012, CRIT CARE, V16, DOI 10.1186/cc11311; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Raheja A, J NEUROSURGERY; Schoeneberg C, 2013, CRIT CARE, V17, DOI 10.1186/cc13132; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Sogut O, 2010, J INT MED RES, V38, P1708, DOI 10.1177/147323001003800516; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Zolin SJ, 2015, J TRAUMA ACUTE CARE, V78, P451, DOI 10.1097/TA.0000000000000550	24	6	6	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	FEB	2017	11	2					PC6	PC9		10.7860/JCDR/2017/19132.9198			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EQ3QX	WOS:000397988700084	28384927	gold, Green Published			2022-02-06	
J	Nicosia, G; Cicala, D; Mirone, G; Spennato, P; Trischitta, V; Ruggiero, C; Guarneri, G; Muto, M; Cinalli, G				Nicosia, Giancarlo; Cicala, Domenico; Mirone, Giuseppe; Spennato, Pietro; Trischitta, Vincenzo; Ruggiero, Claudio; Guarneri, Gianluigi; Muto, Mario; Cinalli, Giuseppe			Childhood acute basilar artery thrombosis successfully treated with mechanical thrombectomy using stent retrievers: case report and review of the literature	CHILDS NERVOUS SYSTEM			English	Article						Ischemic stroke; Paediatric stroke; Vertebral artery dissection; Endovascular treatment; Stent retrievers	ACUTE ISCHEMIC-STROKE; CHILDREN; OCCLUSION; DISSECTION; EMBOLECTOMY; MANAGEMENT; TRIAL	Introduction Acute basilar artery occlusion (ABAO) is an infrequent but potentially fatal cause of strokes in both adults and children, and it is usually due to vertebral artery dissection (VAD). VAD has been found to be usually a consequence of traumatic vertebral artery injury. ABAO usually presents with symptoms of acute ischemic stroke (AIS) of the posterior circulation or transient ischemic attack (TIA). It may lead to death or long-term disability if not promptly recanalized. Basilar artery recanalization in children can be achieved safely and with excellent clinical outcome using endovascular thrombectomy with the new generation self-expanding and retrievable stents. Clinical presentation We report the case of a 23-month old baby that came to the emergency room of our hospital for progressive impairment of consciousness associated with widespread stiffness and plaintive cry, appeared after accidental fall from stroller. An emergency brain CTscan was obtained showing multiple infarction lesions in the brainstem and left cerebellum suggestive of acute stroke in posterior circulation territories. An MR scan with angiography and diffusion-weighted sequences confirmed the multiple infarction lesions and demonstrated poor representation of the flow signal at the V3 segment of the left vertebral artery and absent representation of the flow signal at the distal segment of the basilar artery suggestive of acute thrombotic occlusion. The patient was immediately referred to interventional neuroradiology unit, and digital subtraction angiography showed complete basilar artery occlusion and left vertebral artery dissection at extracranial V2-V3 segment. The patient underwent intra-arterial thrombectomy using stent retrievers and occlusion of the V2-V3 segment of the left vertebral artery. The patient survived and long-term outcome was excellent. Conclusions To our knowledge, only nine cases of ABAO in children treated with intra-arterial thrombectomy have been previously reported in the literature. In only three cases, the Solitaire stent was applied. Our case is the first case of basilar artery occlusion treated with Solitaire stent, in a child under 24 months. The reports that are available so far indicate that basilar artery recanalization in children can be achieved safely and with excellent clinical outcome using endovascular thrombectomy with the new generation self-expanding and retrievable stents.	[Nicosia, Giancarlo; Mirone, Giuseppe; Spennato, Pietro; Trischitta, Vincenzo; Ruggiero, Claudio; Cinalli, Giuseppe] Santobono Pausillipon Childrens Hosp, Dept Neurosurg, Naples, Italy; [Nicosia, Giancarlo] Univ Aquila, Dept Hlth Sci, Laquila, Italy; [Cicala, Domenico] Santobono Pausillipon Childrens Hosp, Paediat Neuroradiol Unit, Naples, Italy; [Guarneri, Gianluigi; Muto, Mario] AORN Cardarelli Hosp, Diagnost & Intervent Neuroradiol Unit, Naples, Italy		Spennato, P (corresponding author), Santobono Pausillipon Childrens Hosp, Dept Neurosurg, Naples, Italy.	pierospen@gmail.com	cinalli, giuseppe/AAC-3889-2022	cinalli, giuseppe/0000-0002-7797-8483			Bodey C, 2014, EUR J PAEDIATR NEURO, V18, P730, DOI 10.1016/j.ejpn.2014.07.006; Broderick JP, 2015, STROKE, V46, P3416, DOI 10.1161/STROKEAHA.115.011397; Chen H, 2010, ACTA NEUROL TAIWAN, V19, P280; Chikkannaiah M, 2014, J CHILD NEUROL, V29, P633, DOI 10.1177/0883073813488826; Devue K, 2014, CASE REP EMERG MED, V2014; Dubedout S, 2013, PEDIATR NEUROL, V49, P379, DOI 10.1016/j.pediatrneurol.2013.06.008; Fan TW, 2003, HONG KONG J RADIOL, V6, P158; Fink J, 2013, J CHILD NEUROL, V28, P1521, DOI 10.1177/0883073812460334; Fransen PSS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-343; GARG BP, 1993, NEUROLOGY, V43, P2555, DOI 10.1212/WNL.43.12.2555; Sanchez CMG, 2016, NEUROLOGIA, V31, P347, DOI 10.1016/j.nrl.2014.05.003; Grunwald IQ, 2010, J INVASIVE CARDIOL, V22, P63; Hasan I, 2002, PEDIATR NEUROSURG, V37, P168, DOI 10.1159/000065391; Huded Vikram, 2015, J Vasc Interv Neurol, V8, P13; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Kuan CY, 2014, PEDIATR NEONATOL, V55, P316, DOI 10.1016/j.pedneo.2012.12.014; Mattle HP, 2011, LANCET NEUROL, V10, P1002, DOI 10.1016/S1474-4422(11)70229-0; Pfefferkorn T, 2010, STROKE, V41, P722, DOI 10.1161/STROKEAHA.109.567552; PROVENZALE JM, 1995, AM J ROENTGENOL, V165, P1099, DOI 10.2214/ajr.165.5.7572483; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Rosman NP, 2003, J CHILD NEUROL, V18, P450, DOI 10.1177/08830738030180070601; Savastano L, 2016, J NEUROINTERV SURG, V8, DOI 10.1136/neurintsurg-2015-011821.rep; SCHIEVINK WI, 1994, NEUROLOGY, V44, P1607, DOI 10.1212/WNL.44.9.1607; Sedney CL, 2011, J NEUROSURG-PEDIATR, V7, P272, DOI 10.3171/2010.12.PEDS10106; Simonetti BG, 2013, DEV MED CHILD NEUROL, V55, P65, DOI 10.1111/dmcn.12015; Stidd David A, 2014, Neurointervention, V9, P94, DOI 10.5469/neuroint.2014.9.2.94; Taneja SR, 2011, J PAEDIATR CHILD H, V47, P408, DOI 10.1111/j.1440-1754.2010.01974.x; Tatum J, 2013, J NEUROINTERV SURG, V5, P128, DOI 10.1136/neurintsurg-2011-010100; Toure A, 2009, NEUROPEDIATRICS, V40, P126, DOI 10.1055/s-0029-1238306	29	6	6	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2017	33	2					349	355		10.1007/s00381-016-3259-z			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EO7XT	WOS:000396904100023	27704247				2022-02-06	
J	Schleiger, E; Wong, A; Read, S; Rowland, T; Finnigan, S				Schleiger, Emma; Wong, Andrew; Read, Stephen; Rowland, Tennille; Finnigan, Simon			Poststroke QEEG informs early prognostication of cognitive impairment	PSYCHOPHYSIOLOGY			English	Article						QEEG; EEG; Cognitive impairment; Alpha slowing; Stroke	TRAUMATIC BRAIN-INJURY; PERCENT-ALPHA-VARIABILITY; ACUTE ISCHEMIC-STROKE; CONTINUOUS ELECTROENCEPHALOGRAPHY; THETA OSCILLATIONS; DELTA/ALPHA RATIO; QUANTITATIVE EEG; MILD; DEMENTIA; POWER	Cognitive impairment is a common consequence of stroke, but remains difficult to predict. We investigate the ability of early QEEG assessment to inform such prediction, using binary logistic regression. Thirty-five patients (12 female, ages 18-87) suffering middle cerebral artery, ischemic stroke were studied. Resting-state EEG was recorded 48-239 h after symptom onset. Relative power for delta, theta, alpha, and beta bands, delta:alpha ratio, and peak alpha frequency were analyzed. Montreal Cognitive Assessment (MoCA) was administered, where possible, on day of EEG and at median 99 days (range 69-138) poststroke. Eight patients could not complete the baseline MoCA, and four the follow-up MoCA, for varying reasons (most commonly, stroke symptoms). Fifteen patients (48%) had cognitive impairment (MoCA score 25) at follow-up. One QEEG index was able to correctly predict presence/absence of cognitive impairment in 24/31 patients (77.4%), whereas predischarge MoCA did so in 23 patients. This index, relative theta frequency (4-7.5 Hz) power, was computed from only three posterior electrodes over the stroke-affected hemisphere. Its predictive accuracy (three electrodes) was higher than that of any global QEEG measure (averaged over 19 electrodes). These results may signify association between poststroke alpha slowing and cognitive impairment, which may be mediated by attentional (dys)function, which warrants further investigation. Pending further studies, QEEG measure(s)from a few electrodescould inform early prognostication of poststroke cognitive outcomes (and clinical decisions), particularly when cognitive function cannot be adequately assessed (due to symptoms, language, or other issues) or when assessment is equivocal.	[Schleiger, Emma; Finnigan, Simon] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Schleiger, Emma; Wong, Andrew; Read, Stephen] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Wong, Andrew; Rowland, Tennille] Royal Brisbane & Womens Hosp, Dept Neurol, Acute Stroke Unit, Herston, Qld, Australia; [Rowland, Tennille] Royal Brisbane & Womens Hosp, Occupat Therapy Dept, Herston, Qld, Australia; [Finnigan, Simon] Royal Brisbane & Womens Hosp, Internal Med Res Unit, Herston, Qld, Australia		Finnigan, S (corresponding author), Royal Brisbane & Womens Hosp, UQ Ctr Clin Res, Herston, Qld 4029, Australia.	finnigan.simon@gmail.com	Schleiger, Emma/R-5599-2017; Finnigan, Simon/F-8034-2010; Read, Stephen J/H-7339-2013; Wong, Andrew/C-1569-2011	Schleiger, Emma/0000-0002-0360-3144; Finnigan, Simon/0000-0003-1291-0741; Read, Stephen J/0000-0001-7555-8461; Wong, Andrew/0000-0002-7272-8944	University of QueenslandUniversity of Queensland; Royal Brisbane and Women's Hospital Foundation; National Stroke Foundation (Australia); National Health and Medical Research Council (Australia)National Health and Medical Research Council of Australia; Royal Brisbane and Women's Hospital	This study was funded in part by the University of Queensland, the Royal Brisbane and Women's Hospital Foundation, and the National Stroke Foundation (Australia). SF was supported in part by a Career Development Award from the National Health and Medical Research Council (Australia). ES was supported by a Royal Brisbane and Women's Hospital Postgraduate Scholarship.	Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; Caviness JN, 2015, J PARKINSON DIS, V5, P117, DOI 10.3233/JPD-140480; Cummins TDR, 2008, INT J PSYCHOPHYSIOL, V70, P75, DOI 10.1016/j.ijpsycho.2008.06.002; Dong YH, 2014, INT PSYCHOGERIATR, V26, P787, DOI 10.1017/S1041610213002457; Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070; Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051; Finnigan S, 2016, CLIN NEUROPHYSIOL, V127, P1452, DOI 10.1016/j.clinph.2015.07.014; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P1083, DOI 10.1111/j.1469-8986.2010.01173.x; Freitas S, 2012, J INT NEUROPSYCH SOC, V18, P1031, DOI 10.1017/S135561771200077X; GUR AY, 1994, ACTA NEUROL SCAND, V90, P263; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Hurford R, 2013, J NEUROL, V260, P237, DOI 10.1007/s00415-012-6625-0; Juhasz C, 1997, ACTA NEUROL SCAND, V96, P397; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Mathewson KJ, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00177; Meerwijk EL, 2015, BIOL PSYCHOL, V105, P106, DOI 10.1016/j.biopsycho.2015.01.003; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Moretti DV, 2004, CLIN NEUROPHYSIOL, V115, P299, DOI 10.1016/S1388-2457(03)00345-6; Muresanu DF, 2008, J NEUROL SCI, V267, P112, DOI 10.1016/j.jns.2007.10.016; Narasimhalu K, 2009, NEUROLOGY, V73, P1866, DOI 10.1212/WNL.0b013e3181c3fcb7; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP; NOVAK P, 1992, NEUROSCI LETT, V136, P213, DOI 10.1016/0304-3940(92)90051-8; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; Schleiger E, 2014, INT J PSYCHOPHYSIOL, V94, P19, DOI 10.1016/j.ijpsycho.2014.06.012; Song Y, 2015, CLIN EEG NEUROSCI, V46, P142, DOI 10.1177/1550059413517492; Srikanth VK, 2003, STROKE, V34, P1136, DOI 10.1161/01.STR.0000069161.35736.39; van der Kooi AW, 2015, CHEST, V147, P94, DOI 10.1378/chest.13-3050; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Yuasa Takao, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P37, DOI 10.2114/jpa.20.37	36	6	6	1	16	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	FEB	2017	54	2					301	309		10.1111/psyp.12785			9	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	EJ9LT	WOS:000393548300014	28118690				2022-02-06	
J	Durham, WJ; Foreman, JP; Randolph, KM; Danesi, CP; Spratt, H; Masel, BD; Summons, JR; Singh, CK; Morrison, M; Robles, C; Wolfram, C; Kreber, LA; Urban, RJ; Sheffield-Moore, M; Masel, BE				Durham, William J.; Foreman, Jack P.; Randolph, Kathleen M.; Danesi, Christopher P.; Spratt, Heidi; Masel, Brian D.; Summons, Jennifer R.; Singh, Charan K.; Morrison, Melissa; Robles, Claudia; Wolfram, Cindy; Kreber, Lisa A.; Urban, Randall J.; Sheffield-Moore, Melinda; Masel, Brent E.			Hypoaminoacidemia Characterizes Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						head trauma; metabolism	RECOMMENDED DIETARY ALLOWANCE; CHAIN AMINO-ACIDS; NUTRITIONAL TREATMENT; PARKINSONS-DISEASE; ATROPHY; REHABILITATION; ENCEPHALOPATHY; DYSFUNCTION; MODULATION; PRECURSOR	Individuals with a history of traumatic brain injury (TBI) are at increased risk for a number of disorders, including Alzheimer's disease, Parkinson's disease, and chronic traumatic encephalopathy. However, mediators of the long-term morbidity are uncertain. We conducted a multi-site, prospective trial in chronic TBI patients (similar to 18 years post-TBI) living in long-term 24-h care environments and local controls without a history of head injury. Inability to give informed consent was exclusionary for participation. A total of 41 individuals (17 moderate-severe TBI, 24 controls) were studied before and after consumption of a standardized breakfast to determine if concentrations of amino acids, cytokines, C-reactive protein, and insulin are potential mediators of long-term TBI morbidity. Analyte concentrations were measured in serum drawn before (fasting) and 1 h after meal consumption. Mean ages were 44 +/- 15 and 49 +/- 11 years for controls and chronic TBI patients, respectively. Chronic TBI patients had significantly lower circulating concentrations of numerous individual amino acids, as well as essential amino acids (p = 0.03) and large neutral amino acids (p = 0.003) considered as groups, and displayed fundamentally altered cytokine-amino acid relationships. Many years after injury, TBI patients exhibit abnormal metabolic responses and altered relationships between circulating amino acids, cytokines, and hormones. This pattern is consistent with TBI, inducing a chronic disease state in patients. Understanding the mechanisms causing the chronic disease state could lead to new treatments for its prevention.	[Durham, William J.; Randolph, Kathleen M.; Danesi, Christopher P.; Urban, Randall J.; Sheffield-Moore, Melinda] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Spratt, Heidi] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Foreman, Jack P.; Wolfram, Cindy; Masel, Brent E.] Transit Learning Ctr Galveston, 1528 Post Off St, Galveston, TX 77550 USA; [Masel, Brian D.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Summons, Jennifer R.; Singh, Charan K.; Morrison, Melissa; Robles, Claudia; Kreber, Lisa A.] Ctr Neuro Skills, Bakersfield, CA USA; [Masel, Brent E.] Brain Injury Assoc Amer, Grapevine, TX USA		Masel, BE (corresponding author), Transit Learning Ctr Galveston, 1528 Post Off St, Galveston, TX 77550 USA.	bmasel@tlc-galveston.org		Randolph, Kathleen/0000-0003-4394-0978	Moody Endowment; Masel BE, Urban, Sheffield-Moore	Masel BE, Urban, Sheffield-Moore.	Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Borsheim E, 2007, ARCH PHYS MED REHAB, V88, P234, DOI 10.1016/j.apmr.2006.11.003; Burns JM, 2010, ARCH NEUROL-CHICAGO, V67, P428, DOI 10.1001/archneurol.2010.38; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Carbonell F, 2014, NEUROPHARMACOLOGY, V84, P90, DOI 10.1016/j.neuropharm.2013.12.021; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Curtis L, 2014, J NEUROSURG SCI, V58, P151; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Hase A, 2015, PHARMACOL BIOCHEM BE, V133, P1, DOI 10.1016/j.pbb.2015.03.008; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Leiser SC, 2015, ACS CHEM NEUROSCI, V6, P970, DOI 10.1021/cn500340j; Ma T, 2014, J NEUROSCI, V34, P12230, DOI 10.1523/JNEUROSCI.1694-14.2014; Masel BE, 2015, J NEUROTRAUM, V32, P1902, DOI 10.1089/neu.2014.3526; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Michely J, 2015, BRAIN, V138, P664, DOI 10.1093/brain/awu381; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Northrop NA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00069; Patrick RP, 2015, FASEB J, V29, P2207, DOI 10.1096/fj.14-268342; Schaefer A, 2014, CURR BIOL, V24, P2314, DOI 10.1016/j.cub.2014.08.024; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Varrone A, 2015, SYNAPSE, V69, P365, DOI 10.1002/syn.21823; Volpi E, 2013, J GERONTOL A-BIOL, V68, P677, DOI 10.1093/gerona/gls229; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Wolfe RR, 2008, JAMA-J AM MED ASSOC, V299, P2891, DOI 10.1001/jama.299.24.2891	41	6	6	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					385	390		10.1089/neu.2015.4350			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800014	27178787				2022-02-06	
J	Wang, X; Xie, H; Cotton, AS; Brickman, KR; Lewis, TJ; Wall, JT; Tamburrino, MB; Bauer, WR; Law, K; McLean, SA; Liberzon, I				Wang, Xin; Xie, Hong; Cotton, Andrew S.; Brickman, Kristopher R.; Lewis, Terrence J.; Wall, John T.; Tamburrino, Marijo B.; Bauer, William R.; Law, Kenny; McLean, Samuel A.; Liberzon, Israel			Early Changes in Cortical Emotion Processing Circuits after Mild Traumatic Brain Injury from Motor Vehicle Collision	JOURNAL OF NEUROTRAUMA			English	Article						human studies; MRI; TBI	SUSCEPTIBILITY-WEIGHTED MRI; HUMAN NEURAL SYSTEM; ORBITOFRONTAL CORTEX; FUNCTIONAL MRI; CONCUSSION; SYMPTOMS; ABNORMALITIES; RECRUITMENT; TIME; REPRESENTATIONS	Mild traumatic brain injury (mTBI) patients frequently experience emotion dysregulation symptoms, including post-traumatic stress. Although mTBI likely affects cortical activation and structure, resulting in cognitive symptoms after mTBI, early effects of mTBI on cortical emotion processing circuits have rarely been examined. To assess early mTBI effects on cortical functional and structural components of emotion processing, we assessed cortical activation to fearful faces within the first 2 weeks after motor vehicle collision (MVC) in survivors who did and did not experience mTBI. We also examined the thicknesses of cortical regions with altered activation. MVC survivors with mTBI (n = 21) had significantly less activation in left superior parietal gyrus (SPG) (-5.9, -81.8, 33.8; p = 10(-3.623)), left medial orbitofrontal gyrus (mOFG) (-4.7, 36.1, -19.3; p = 10(-3.231)), and left and right lateral orbitofrontal gyri (lOFG) (left: -16.0, 41.4, -16.6; p = 10(-2.573); right: 18.7, 22.7, -17.7; p = 10(-2.764)) than MVC survivors without mTBI (n = 23). SPG activation in mTBI survivors within 2 weeks after MVC was negatively correlated with subsequent post-traumatic stress symptom severity at 3 months (r=-0.68, p = 0.03). Finally, the SPG region was thinner in the mTBI survivors than in the non-mTBI survivors (F = 11.07, p = 0.002). These results suggest that early differences in activation and structure in cortical emotion processing circuits in trauma survivors who sustain mTBI may contribute to the development of emotion-related symptoms.	[Wang, Xin; Cotton, Andrew S.; Tamburrino, Marijo B.; Law, Kenny] Univ Toledo, Dept Psychiat, 3120 Glendale Ave, Toledo, OH 43614 USA; [Wang, Xin; Xie, Hong; Wall, John T.; Bauer, William R.] Univ Toledo, Dept Neurosci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Wang, Xin; Lewis, Terrence J.] Univ Toledo, Dept Radiol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Brickman, Kristopher R.] Univ Toledo, Dept Emergency Med, 2801 W Bancroft St, Toledo, OH 43606 USA; [McLean, Samuel A.] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC USA; [Liberzon, Israel] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA		Wang, X (corresponding author), Univ Toledo, Dept Psychiat, 3120 Glendale Ave, Toledo, OH 43614 USA.	Xin.Wang2@utoledo.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21MH098198-01]; ProMedica Translational Research Stimulation Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR060852] Funding Source: NIH RePORTER	The work is funded by NIH R21MH098198-01 and by a ProMedica Translational Research Stimulation Award to X.W. We thank Dr. Michael M. Dennis, Cindy Grey, Susan Yeager, Lindsey Katschke, Michelle Haunus, and the Department of Radiology at the University of Toledo for technical support; Dr. Joe Migliori Jr. for clinical support; Carol Brikmanis for editing the manuscript; and Karen Brenner of ProMedica Health System for survivor recruitment.	Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Caner B, 2012, J NEUROCHEM, V123, P12, DOI 10.1111/j.1471-4159.2012.07939.x; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Chossegros L, 2011, ACCIDENT ANAL PREV, V43, P471, DOI 10.1016/j.aap.2010.10.004; Cruz-Orive LM, 2014, J MICROSC-OXFORD, V253, P119, DOI 10.1111/jmi.12103; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Jackowski AP, 2012, REV BRAS PSIQUIATR, V34, P207, DOI 10.1590/S1516-44462012000200014; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kret ME, 2015, NEUROSCI BIOBEHAV R, V52, P153, DOI 10.1016/j.neubiorev.2015.02.011; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Liberzon I, 2015, SOC COGN AFFECT NEUR, V10, P1596, DOI 10.1093/scan/nsv045; Lieberman MD, 2011, EMOTION, V11, P468, DOI 10.1037/a0023503; Lillie Elizabeth M, 2013, Biomed Sci Instrum, V49, P297; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Neumann D, 2014, BRAIN IMAGING BEHAV, V8, P460, DOI 10.1007/s11682-013-9285-5; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Pallett PM, 2013, J VISION, V13, DOI 10.1167/13.14.13; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Rasser PE, 2005, NEUROIMAGE, V26, P941, DOI 10.1016/j.neuroimage.2004.11.054; Remy F, 2005, NEUROIMAGE, V25, P253, DOI 10.1016/j.neuroimage.2004.10.045; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Sripada RK, 2013, BIOL PSYCHIAT, V73, P1045, DOI 10.1016/j.biopsych.2012.12.008; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Tuor UI, 2001, EXP NEUROL, V167, P272, DOI 10.1006/exnr.2000.7565; Urban JE, 2012, J NEUROTRAUM, V29, P2774, DOI 10.1089/neu.2012.2373; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wang X, 2010, CEREB CORTEX, V20, P1513, DOI 10.1093/cercor/bhp226; Wang X, 2010, NEUROIMAGE, V49, P3075, DOI 10.1016/j.neuroimage.2009.11.018; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Zhang SR, 2009, J REHABIL MED, V41, P1062, DOI 10.2340/16501977-0462; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	73	6	7	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					273	280		10.1089/neu.2015.4392			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800002	27169480	Green Submitted, Green Published			2022-02-06	
J	Lewis, GN; Hume, PA; Stavric, V; Brown, SR; Taylor, D				Lewis, Gwyn N.; Hume, Patria A.; Stavric, Verna; Brown, Scott R.; Taylor, Denise			New Zealand rugby health study: motor cortex excitability in retired elite and community level rugby players	NEW ZEALAND MEDICAL JOURNAL			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SPORTS CONCUSSION; TRANSCALLOSAL INHIBITION; INTRACORTICAL INHIBITION; EVOKED-POTENTIALS; HEAD-INJURY; LONG-TERM; AGE; GABA; ABNORMALITIES	AIMS: Rugby union is a high contact sport in which players frequently experience brain injuries. Acute brain injury is associated with altered corticomotor function. However, it is uncertain if long-term exposure to rugby is associated with any alterations in corticomotor function. The aim of the study was to assess measures of corticomotor excitability and inhibition in retired rugby players in comparison to retired non-contact sport players. METHODS: The design was a cross-sectional study with three groups of retired athletes: elite rugby (n=23), community level rugby (n=28) and non-contact sport control (n=22). Assessments of corticomotor excitability were made using transcranial magnetic stimulation. RESULTS: Resting motor threshold was significantly higher and long-interval intracortical inhibition was greater in the elite rugby group compared to the control group. Participants in the two rugby groups had sustained significantly more concussions than the control group. CONCLUSIONS: We provide some evidence of altered corticomotor excitation and inhibition in retired elite rugby players in comparison to retired non-contact sport players. Given the absence of findings in the community rugby group, who had experienced a similar number of concussions, the association with previous brain injury is unclear.	[Lewis, Gwyn N.; Taylor, Denise] Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland, New Zealand; [Hume, Patria A.; Brown, Scott R.] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Stavric, Verna] Auckland Univ Technol, Physiotherapy Dept, Auckland, New Zealand		Lewis, GN (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Hlth & Rehabil Res Inst, Private Bag 92006, Auckland 1142, New Zealand.	gwyn.lewis@aut.ac.nz	Hume, Patria Anne/P-1084-2017; Taylor, Denise/AAP-4175-2020; Hume, Patria/AAN-5514-2021	Hume, Patria Anne/0000-0003-1847-8128; Taylor, Denise/0000-0002-0955-5702; Hume, Patria/0000-0003-1847-8128	World Rugby; New Zealand Rugby; Sport Performance Research Institute New Zealand (SPRINZ); Health and Rehabilitation Research Institute (HRRI) of Auckland University of Technology	Thanks are given to Dr Martin Raftery (World Rugby) and Dr Ken Quarrie (New Zealand Rugby) for initiating the RugbyHealth project and for providing feedback on the technical report that formed the basis of this manuscript. We would also like to thank Peter Griffiths and Serene Lorimer for providing administration for the project, and Dr Ian Murphy (NZ Rugby), Heath Mills (New Zealand Rugby Players Association) and Rob Nichol (New Zealand Cricket Players Association) for promoting the study and assisting with participant recruitment. The study was funded by World Rugby, New Zealand Rugby, and the Sport Performance Research Institute New Zealand (SPRINZ) and the Health and Rehabilitation Research Institute (HRRI) of Auckland University of Technology.	Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; Davidson T, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-62; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; De Boer HH, 2016, INT J LEGAL MED, P1; Debaere F, 2001, NEUROIMAGE, V14, P947, DOI 10.1006/nimg.2001.0892; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Florian J, 2008, J PHYSL; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hume PA, 2016, SPORTS MED; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; JEEVES MA, 1988, NEUROPSYCHOLOGIA, V26, P833, DOI 10.1016/0028-3932(88)90053-X; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Li JY, 2007, MOVEMENT DISORD, V22, P813, DOI 10.1002/mds.21386; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; McDonnell MN, 2007, EXP BRAIN RES, V180, P181, DOI 10.1007/s00221-006-0849-0; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Peinemann A, 2001, NEUROSCI LETT, V313, P33, DOI 10.1016/S0304-3940(01)02239-X; Pitcher JB, 2003, J PHYSIOL-LONDON, V546, P605, DOI 10.1113/jphysiol.2002.029454; ROSSINI PM, 1992, BRAIN RES, V593, P14, DOI 10.1016/0006-8993(92)91256-E; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Taubert M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00692; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, J NEUROPHYSIOL, V109, P1343, DOI 10.1152/jn.00704.2012; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Ziemann U, 1996, EXP BRAIN RES, V109, P127; Ziemann U., 2004, CLIN NEUROPHYSIOL	43	6	6	0	3	NEW ZEALAND MEDICAL ASSOC	CHRISTCHURCH	C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345, CHRISTCHURCH, 00000, NEW ZEALAND	0028-8446	1175-8716		NEW ZEAL MED J	N. Z. Med. J.	JAN 13	2017	130	1448					34	44					11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	FE3OZ	WOS:000408126700005	28081555				2022-02-06	
J	Alam, BK; Bukhari, AS; Assad, S; Siddique, PM; Ghazanfar, H; Niaz, MJ; Kundi, M; Shah, S; Siddiqui, M				Alam, Bilal Kamal; Bukhari, Ahmed S.; Assad, Salman; Siddique, Pir Muhammad; Ghazanfar, Haider; Niaz, Muhammad Junaid; Kundi, Maryam; Shah, Saima; Siddiqui, Maimoona			Functional Outcome After Decompressive Craniectomy in Patients with Dominant or Non-Dominant Malignant Middle Cerebral Infarcts	CUREUS			English	Article						decompressive craniectomy; functional outcome; ischemic stroke	ARTERY INFARCTION; HEMICRANIECTOMY; MULTICENTER; SURGERY; DISABILITY; TRIAL	Background: The use of decompressive craniectomy (DC) has been studied in the setting of different conditions, including traumatic brain injury, subarachnoid hemorrhage, and malignant middle cerebral artery (MCA) infarction. The rationale of this study is to determine the functional outcome after DC in patients with malignant MCA infarcts. Methods: A longitudinal cohort study was performed based on patients diagnosed with malignant MCA territory infarction admitted to the Neurosurgery Department of a tertiary care hospital in Islamabad, Pakistan between July 2015 and November 2016. All patients had a clinical diagnosis of stroke according to the World Health Organization (WHO) stroke criteria. Results: A total of 34 patients participated in this study, out of which 20/31 (64.5%) were males while 11/31 (35.5%) were females with a mean age of 51.61 +/- 13.96 years. The mean time from diagnosis to surgery was 60.61 +/- 49.83 hours. Out of 31 patients, 18 (58.1%) had a right middle cerebral artery infarct (RMCAI) and 13 (41.9%) had a left middle cerebral artery infarct (LCAI). Logistic regression was applied to assess the association between the type of MCA infarct with the National Institutes of Health Stroke Scale (NIHSS), modified Rankin Scale (mRS), modified Barthel Index (mBI) scores, and upper and lower limb motor power. However, the logistic regression model was not statistically significant chi(2 )(4) = 3.896, p = 0.866. There was a statistically significant mild improvement of neurological scores and upper and lower motor power over a course of six months, but the overall functional outcome was poor with mBI < 60 and mRS > 4(p < 0.001) with total mortality of 8.7%. Conclusion: Decompressive craniectomy is a life-saving surgery that appears to benefit patients with malignant MCA infarcts of either the dominant or non-dominant cerebral hemisphere. Decompressive craniectomy results in mild improvements in neurological scores but still poor functional outcome after six months.	[Alam, Bilal Kamal] Cleveland Clin, Fairview Hosp, Dept Internal Med, Cleveland, OH 44106 USA; [Bukhari, Ahmed S.; Ghazanfar, Haider; Siddiqui, Maimoona] Shifa Int Hosp, Dept Neurol, Islamabad, Pakistan; [Assad, Salman] Shifa Tameer E Millat Univ, Dept Med, Islamabad, Pakistan; [Siddique, Pir Muhammad] Shifa Int Hosp, Dept Internal Med, Islamabad, Pakistan; [Niaz, Muhammad Junaid] Cornell Univ, Weill Med Coll, Dept Genitourinary Oncol, Ithaca, NY 14853 USA; [Kundi, Maryam] Carthage Area Hosp, Dept Internal Med, New York, NY USA; [Shah, Saima] Hayatabad Med Complex, Dept Gen Med, Peshawar, Pakistan		Assad, S (corresponding author), Shifa Tameer E Millat Univ, Dept Med, Islamabad, Pakistan.	salmanassad91@gmail.com		Assad, Salman/0000-0002-5830-9997; Niaz, Muhammad Junaid/0000-0001-7995-2415			Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Chao SP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002781; Cheung A, 2005, NEUROCRIT CARE, V3, P216, DOI 10.1385/NCC:3:3:216; Cho DY, 2003, SURG NEUROL, V60, P227, DOI 10.1016/S0090-3019(03)00266-0; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Foerch C, 2004, J NEUROSURG, V101, P248, DOI 10.3171/jns.2004.101.2.0248; Hao ZL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001039; Heiss WD, 2016, CEREBROVASC DIS, V41, P1, DOI 10.1159/000441627; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kohrmann M, 2009, CURR OPIN CRIT CARE, V15, P125, DOI 10.1097/MCC.0b013e328321826e; Leonhardt G, 2002, J NEUROL, V249, P1433, DOI 10.1007/s00415-002-0875-1; Merenda A, 2010, CURR OPIN NEUROL, V23, P53, DOI 10.1097/WCO.0b013e328334bdf4; Neugebauer H, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-9956-0; Qureshi AI, 2003, CRIT CARE MED, V31, P272, DOI 10.1097/00003246-200301000-00043; Raffiq Mohammad Azman Mohammed, 2014, Surg Neurol Int, V5, P102, DOI 10.4103/2152-7806.135342; Subramaniam S, 2009, NEUROLOGIST, V15, P178, DOI 10.1097/NRL.0b013e3181963d19; Suyama K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.07.015; Thomalla GJ, 2003, STROKE, V34, P1892, DOI 10.1161/01.STR.0000081985.44625.B6; Tsai CL, 2012, NEUROL INDIA, V60, P608, DOI 10.4103/0028-3886.105195; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wartenberg KE, 2012, CURR OPIN CRIT CARE, V18, P152, DOI 10.1097/MCC.0b013e32835075c5; Yang MH, 2015, SURG-J R COLL SURG E, V13, P230, DOI 10.1016/j.surge.2014.12.002	25	6	7	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JAN	2017	9	1							e997	10.7759/cureus.997			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HE7LK	WOS:000453618700049	28286721	gold, Green Published			2022-02-06	
J	Allitt, BJ; Johnstone, VPA; Richards, KL; Yan, EB; Rajan, R				Allitt, Benjamin J.; Johnstone, Victoria P. A.; Richards, Katrina L.; Yan, Edwin B.; Rajan, Ramesh			Progesterone Sharpens Temporal Response Profiles of Sensory Cortical Neurons in Animals Exposed to Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						electrophysiology; sensory cortex; traumatic brain injury; cortical laminae; progesterone	DIFFUSE AXONAL INJURY; TIME-COURSE; CELL-DEATH; RAT; ALLOPREGNANOLONE; GABA; MECHANISMS; INHIBITION; DYSFUNCTION; EXPRESSION	Traumatic brain injury (TBI) initiates a cascade of pathophysiological changes that are both complex and difficult to treat. Progesterone (P4) is a neuroprotective treatment option that has shown excellent preclinical benefits in the treatment of TBI, but these benefits have not translated well in the clinic. We have previously shown that P4 exacerbates the already hypoactive upper cortical responses in the short-term post-TBI and does not reduce upper cortical hyperactivity in the long term, and we concluded that there is no tangible benefit to sensory cortex firing strength. Here we examined the effects of P4 treatment on temporal coding resolution in the rodent sensory cortex in both the short term (4 d) and long term (8 wk) following impact-acceleration- induced TBI. We show that in the short-term postinjury, TBI has no effect on sensory cortex temporal resolution and that P4 also sharpens the response profile in all cortical layers in the uninjured brain and all layers other than layer 2 (L2) in the injured brain. In the long term, TBI broadens the response profile in all cortical layers despite firing rate hyperactivity being localized to upper cortical layers and P4 sharpens the response profile in TBI animals in all layers other than L2 and has no long-term effect in the sham brain. These results indicate that P4 has long-term effects on sensory coding that may translate to beneficial perceptual outcomes. The effects seen here, combined with previous beneficial preclinical data, emphasize that P4 is still a potential treatment option in ameliorating TBI-induced disorders.	[Allitt, Benjamin J.; Johnstone, Victoria P. A.; Richards, Katrina L.; Yan, Edwin B.; Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Johnstone, Victoria P. A.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA, Australia		Rajan, R (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.	ramesh.rajan@monash.edu	rajan, ramesh/L-4842-2019	Rajan, Ramesh/0000-0001-9862-0520; Dell, Katrina/0000-0002-3552-6411	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP 1029311]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by the Australian National Health and Medical Research Council, Grant # APP 1029311.	Adelson PD, 1998, ACT NEUR S, V71, P104; Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Allitt BJ, 2016, J NEUROTRAUM, V33, P375, DOI 10.1089/neu.2015.3946; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; BUTCHER RL, 1974, ENDOCRINOLOGY, V94, P1704, DOI 10.1210/endo-94-6-1704; CALLACHAN H, 1987, PROC R SOC SER B-BIO, V231, P359, DOI 10.1098/rspb.1987.0049; Camp AJ, 2009, INT J BIOCHEM CELL B, V41, P2118, DOI 10.1016/j.biocel.2009.05.007; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Cook NL, 2010, J MOL NEUROSCI, V42, P192, DOI 10.1007/s12031-010-9347-8; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; El-Boustani S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6689; Follesa P, 2001, BRAIN RES REV, V37, P81, DOI 10.1016/S0165-0173(01)00125-4; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goldstein FC, 2017, J NEUROTRAUM, V34, P115, DOI 10.1089/neu.2015.4313; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kampa BM, 2006, NAT NEUROSCI, V9, P1472, DOI 10.1038/nn1798; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Lancel M, 1996, AM J PHYSIOL-ENDOC M, V271, pE763, DOI 10.1152/ajpendo.1996.271.4.E763; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Radnikow G, 2015, SENSORIMOTOR INTEGRA, P59, DOI [10.1007/978-1-4939-2975-7, DOI 10.1007/978-1-4939-2975-7]; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; SMITH SS, 1987, BRAIN RES, V400, P353, DOI 10.1016/0006-8993(87)90634-2; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Turkmen S, 2011, BRIT J PHARMACOL, V162, P311, DOI 10.1111/j.1476-5381.2010.01059.x; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656	76	6	6	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1202	1223		10.1177/0963689717714326			22	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800009	28933224	gold, Green Published			2022-02-06	
J	Atalay, T; Gulsen, I; Colcimen, N; Alp, HH; Sosuncu, E; Alaca, I; Ak, H; Ragbetli, MC				Atalay, Tugay; Gulsen, Ismail; Colcimen, Nese; Alp, Hamit Hakan; Sosuncu, Enver; Alaca, Ilker; Ak, Hakan; Ragbetli, Murat Cetin			Resveratrol Treatment Prevents Hippocampal Neurodegeneration in a Rodent Model of Traumatic Brain Injury	TURKISH NEUROSURGERY			English	Article						Resveratrol; Traumatic brain injury; Hippocampus; Malondialdehyde; Superoxide dismutase	OXIDATIVE STRESS; SCIATIC-NERVE; DNA; INHIBITION; GINSENG; MELATONIN; RECOVERY; DAMAGE; EDEMA; DEATH	AIM: Traumatic brain injury (TBI) is a complex process. Increasing evidence has demonstrated that reactive oxygen species contribute to brain injury. Resveratrol (RVT) which exhibits significant antioxidant properties, is neuroprotective against excitotoxicity, ischemia, and hypoxia. The aim of this study was to evaluate the neuroprotective effects of RVT on the hippocampus of a rat model of TBI. MATERIAL AND METHODS: Twenty eight rats were divided into four groups. A moderate degree of head trauma was induced using Feeney"s falling weight technique. Group 1 (control) underwent no intervention or treatment. Head trauma was induced in Group 2 (trauma) and no drug was administered. Head trauma was induced in Group 3 and low-dose RVT (50 mg/kg per day) was injected. In Group 4, high-dose RVT (100 mg/kg per day) was used after head trauma. Brain tissues were extracted immediately after perfusion without damaging the tissues. Histopathological and biochemistry parameters were studied. RESULTS: Brain tissue malondialdehyde (MDA) levels in the trauma group were significantly higher than those in the control, lowdose RVT-treated, and high-dose-RVT-treated groups. The superoxide dismutase (SOD) levels in the control group were significantly higher than those in the trauma, low-dose RVT-treated, and high-dose RVT-treated groups. Glutathione peroxidase (GSH-Px) levels in the control group were significantly higher than those in the trauma and low-dose RVT-treated groups. The level of oxidative deoxyribonucleic acid (DNA) damage (8-OHdG/106 dG) in the trauma group was higher than that in the control group, low-dose RVT-treated, and high-dose RVT-treated groups. CONCLUSION: Resveratrol has a healing effect on neurons after TBI.	[Atalay, Tugay; Ak, Hakan] Bozok Univ, Sch Med, Dept Neurosurg, Yozgat, Turkey; [Gulsen, Ismail] Yuzuncu Yil Univ, Dept Neurosurg, Van, Turkey; [Colcimen, Nese; Ragbetli, Murat Cetin] Yuzuncu Yil Univ, Dept Histol & Embryol, Van, Turkey; [Alp, Hamit Hakan] Yuzuncu Yil Univ, Dept Biochem, Van, Turkey; [Sosuncu, Enver] Ercis State Hosp, Dept Neurosurg, Van, Turkey; [Alaca, Ilker] Yuksekova State Hosp, Dept Neurosurg, Hakkari, Turkey		Atalay, T (corresponding author), Bozok Univ, Sch Med, Dept Neurosurg, Yozgat, Turkey.	atalaytugay1970@hotmail.com	Ragbetli, Murat Cetin/ABG-5631-2021; ALP, Hamit Hakan/U-2671-2018; Ragbetli, Murat/Q-5060-2017; Atalay, Tugay/AAY-2265-2020	Ragbetli, Murat Cetin/0000-0002-8189-264X; Ragbetli, Murat/0000-0002-8189-264X; Atalay, Tugay/0000-0003-0243-9132; alp, hamit hakan/0000-0002-9202-4944			AARABI B, 1979, J NEUROSURG, V51, P779, DOI 10.3171/jns.1979.51.6.0779; ADELI K, 1990, CLIN CHEM, V36, P261; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ak H, 2015, J NEUROL SCI-TURK, V32, P303; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Bagriyanik HA, 2014, NEUROSCI LETT, V561, P123, DOI 10.1016/j.neulet.2013.12.056; Bonnefont-Rousselot D, 2000, DIABETES METAB, V26, P163; Cankurt U, 2013, J NEUROL SCI-TURK, V30, P731; Choi SH, 2006, EMERG MED J, V23, P119, DOI 10.1136/emj.2004.020651; Demir I, 2013, ACTA NEUROCHIR, V155, P913, DOI 10.1007/s00701-013-1672-6; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Firuzi O, 2011, CURR MED CHEM, V18, P3871, DOI 10.2174/092986711803414368; FRANKEL EN, 1993, LANCET, V341, P1103, DOI 10.1016/0140-6736(93)92472-6; Gulsen I, 2016, WORLD NEUROSURG, V86, P243, DOI 10.1016/j.wneu.2015.09.052; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Howard V, 2004, UNBIASED STEREOLOGY; Jang JH, 2003, FREE RADICAL BIO MED, V34, P1100, DOI 10.1016/S0891-5849(03)00062-5; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kaur H, 1996, BIOCHEM J, V318, P21, DOI 10.1042/bj3180021; Khoschsorur GA, 2000, CHROMATOGRAPHIA, V52, P181, DOI 10.1007/BF02490453; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Naval MV, 2007, J ETHNOPHARMACOL, V112, P262, DOI 10.1016/j.jep.2007.03.010; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Rausch WD, 2006, ACTA NEUROBIOL EXP, V66, P369; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; SUN Y, 1988, CLIN CHEM, V34, P497; Takizawa Y, 2009, PEDIATR RES, V65, P636, DOI 10.1203/PDR.0b013e3181a16a9f; Tang QS, 2013, CANCER LETT, V336, P325, DOI 10.1016/j.canlet.2013.03.023; Tarng DG, 2000, AM J KIDNEY DIS, V36, P934, DOI 10.1053/ajkd.2000.19086; Wang XY, 2001, BIOL NEONATE, V79, P172; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254; Weissman L, 2007, NEUROSCIENCE, V145, P1318, DOI 10.1016/j.neuroscience.2006.08.061; Yao XF, 2005, MUTAT RES-GEN TOX EN, V587, P38, DOI 10.1016/j.mrgentox.2005.07.010; Zamin LL, 2006, NEUROBIOL DIS, V24, P170, DOI 10.1016/j.nbd.2006.06.002; Zhang F, 2010, EUR J PHARMACOL, V636, P1, DOI 10.1016/j.ejphar.2010.03.043	45	6	6	0	10	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2017	27	6					924	930		10.5137/1019-5149.JTN.17249-16.2			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FP4YT	WOS:000417623700010	27509464	Bronze			2022-02-06	
J	Attilio, PJ; Flora, M; Kamnaksh, A; Bradshaw, DJ; Agoston, D; Mueller, GP				Attilio, Peter J.; Flora, Michael; Kamnaksh, Alaa; Bradshaw, Donald J.; Agoston, Denes; Mueller, Gregory P.			The Effects of Blast Exposure on Protein Deimination in the Brain	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							MASS-SPECTROMETRIC IDENTIFICATION; CHRONIC TRAUMATIC ENCEPHALOPATHY; FIBRILLARY ACIDIC PROTEIN; TIME-DEPENDENT CHANGES; RHEUMATOID-ARTHRITIS; PEPTIDYLARGININE DEIMINASE; MULTIPLE-SCLEROSIS; CITRULLINATED PROTEINS; CEREBROSPINAL-FLUID; ARGININE DEIMINASES	Oxidative stress and calcium excitotoxicity are hallmarks of traumatic brain injury (TBI). While these early disruptions may be corrected over a relatively short period of time, long-lasting consequences of TBI including impaired cognition and mood imbalances can persist for years, even in the absence of any evidence of overt injury based on neuroimaging. This investigation examined the possibility that disordered protein deimination occurs as a result of TBI and may thus contribute to the long-term pathologies of TBI. Protein deimination is a calcium-activated, posttranslational modification implicated in the autoimmune diseases rheumatoid arthritis and multiple sclerosis, where aberrant deimination creates antigenic epitopes that elicit an autoimmune attack. The present study utilized proteomic analyses to show that blast TBI alters the deimination status of proteins in the porcine cerebral cortex. The affected proteins represent a small subset of the entire brain proteome and include glial fibrillary acidic protein and vimentin, proteins reported to be involved in autoimmune-based pathologies. The data also indicate that blast injury is associated with an increase in immunoglobulins in the brain, possibly representing autoantibodies directed against novel protein epitopes. These findings indicate that aberrant protein deimination is a biomarker for blast TBI and may therefore underlie chronic neuropathologies of head injury.	[Attilio, Peter J.; Bradshaw, Donald J.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA; [Flora, Michael; Kamnaksh, Alaa; Agoston, Denes; Mueller, Gregory P.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Mueller, GP (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	gregory.mueller@usuhs.edu			USUHS [92-447]; DMRDP [W81XWH-13-C-0196]; DARPA PREVENT	The authors would like to acknowledge Drs. G. Martinelli and G. Holstein for providing the 6B3 monoclonal antibody used here. They also wish to acknowledge funding by USUHS Intramural Grant no. 92-447 (to Gregory P. Mueller), DMRDP Grant W81XWH-13-C-0196 (to R. Diaz-Arrastia and Gregory P. Mueller), and DARPA PREVENT (to Denes Agoston).	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Bicker KL, 2013, BIOPOLYMERS, V99, P155, DOI 10.1002/bip.22127; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bradford CM, 2014, J NEUROIMMUNOL, V273, P85, DOI 10.1016/j.jneuroim.2014.05.007; Chatzidionysiou K, 2011, ANN RHEUM DIS, V70, P1575, DOI 10.1136/ard.2010.148759; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gottenberg JE, 2012, ANN RHEUM DIS, V71, P1815, DOI 10.1136/annrheumdis-2011-201109; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hao G, 2009, J AM SOC MASS SPECTR, V20, P723, DOI 10.1016/j.jasms.2008.12.012; Harauz G, 2007, NEUROCHEM RES, V32, P137, DOI 10.1007/s11064-006-9108-9; Hecker M, 2016, MOL CELL PROTEOMICS, V15, P1360, DOI 10.1074/mcp.M115.051664; Ishigami A, 2005, J NEUROSCI RES, V80, P120, DOI 10.1002/jnr.20431; Ishigami A, 2015, J NEUROSCI RES, V93, P1664, DOI 10.1002/jnr.23620; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jang B, 2013, PRION, V7, P42, DOI 10.4161/pri.22380; Jin ZC, 2013, PROTEOMICS, V13, P2682, DOI 10.1002/pmic.201300064; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Lal P, 2011, ARTHRITIS RHEUM-US, V63, P3681, DOI 10.1002/art.30596; Lazarus RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00204; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Louw C, 2007, J ENZYM INHIB MED CH, V22, P121, DOI 10.1080/14756360600990829; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martinelli GPT, 2002, NEUROSCIENCE, V114, P111, DOI 10.1016/S0306-4522(02)00238-5; Mastrangelo A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/712490; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Nicholas AP, 2004, J COMP NEUROL, V473, P128, DOI 10.1002/cne.20102; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Reyes-Castillo Z, 2015, CLIN EXP IMMUNOL, V182, P119, DOI 10.1111/cei.12677; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Yang L, 2016, NEUROCHEM RES, V41, P1845, DOI 10.1007/s11064-016-1920-2; Ytterberg AJ, 2015, ANN RHEUM DIS, V74, P1772, DOI 10.1136/annrheumdis-2013-204912; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	50	6	6	0	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.		2017	2017								8398072	10.1155/2017/8398072			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EW2YZ	WOS:000402363200001	28626499	Green Published, gold, Green Submitted			2022-02-06	
J	Bonanno, L; Marino, S; De Salvo, S; Ciurleo, R; Costa, A; Bruschetta, D; Milardi, D; Galletti, F; Bramanti, P; Caminiti, F				Bonanno, Lilla; Marino, Silvia; De Salvo, Simona; Ciurleo, Rosella; Costa, Antonio; Bruschetta, Daniele; Milardi, Demetrio; Galletti, Francesco; Bramanti, Placido; Caminiti, Fabrizia			Role of diffusion tensor imaging in the diagnosis and management of post-traumatic anosmia	BRAIN INJURY			English	Article						Diffusion tensor imaging; magnetic resonance imaging; olfactory event-related potentials; sniffin sticks test; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ORBITOFRONTAL CORTEX; ODOR DISCRIMINATION; PRACTICAL SCALE; OLFACTORY LOSS; IDENTIFICATION; RECOVERY; TESTS	Introduction: Anosmia is a possible complication of Traumatic Brain Injury (TBI). Psychometric and electrophysiological methods of olfaction measure and Magnetic Resonance imaging (MRI) are the tools to evaluate the post-traumatic olfactory loss. Diffusion Tensor Imaging (DTI) provides useful data for a better understanding of etiopathogenesis TBI-related anosmia, in particular the loss of neural connections and their eventual recovery over time.& para;& para;Materials and methods: This study describes a case of TBI-related anosmia. The olfactory function was evaluated by Sniffin' Sticks Test (SST), Olfactory Event-Related Potentials (OERPs), MRI and DTI at baseline (T0) and after one year (T1).& para;& para;Results: At baseline, SST highlighted a functional anosmia. The OERPs showed the presence of a small N1-P2 complex. MRI confirmed the presence of a scarring involved in the right orbitofrontal cortex (OFC). DTI detected a reduction in the average length and the number of neuronal fibre pathways of right OFC. At T1, a recovery of olfactory function was confirmed by SST and OERPs.& para;& para;Conclusion: While MRI images are unchanged from T0, DTI showed an increase in average length and number of fibre tracts in the right OFC. DTI could be a valid tool to display a post-traumatic loss of neural connections and to better understand TBI-recovery mechanisms.	[Bonanno, Lilla; Marino, Silvia; De Salvo, Simona; Ciurleo, Rosella; Costa, Antonio; Bramanti, Placido; Caminiti, Fabrizia] IRCCS Ctr Neurolesi Bonino Pulejo, SS 113,Via Palermo,Cda Casazza, I-98124 Messina, Italy; [Marino, Silvia; Bruschetta, Daniele; Milardi, Demetrio] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Galletti, Francesco] Dept Human Pathol Adult Evolutionary Age Gaetano B, Messina, Italy		Bonanno, L (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113,Via Palermo,Cda Casazza, I-98124 Messina, Italy.	lillabonanno@gmail.com	Ciurleo, Rosella/T-4590-2019; De Salvo, Simona/K-3180-2016; Milardi, Demetrio/J-6587-2016; MILARDI, DEMETRIO/AAD-7793-2019; Bramanti, Placido/K-5117-2016; Marino, Silvia/T-5118-2019; Caminiti, Fabrizia/B-9458-2017; Bonanno, Lilla/K-3937-2016	De Salvo, Simona/0000-0001-9501-3258; Milardi, Demetrio/0000-0001-7311-2757; MILARDI, DEMETRIO/0000-0001-7311-2757; Marino, Silvia/0000-0002-1088-6808; Caminiti, Fabrizia/0000-0002-2527-8063; Bonanno, Lilla/0000-0002-0282-405X; Ciurleo, Rosella/0000-0003-0709-5914; GALLETTI, Francesco/0000-0003-3073-9247			Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Caminiti F, 2014, BRAIN INJURY, V28, P1776, DOI 10.3109/02699052.2014.945960; Caminiti F, 2013, BRAIN INJURY, V27, P1715, DOI 10.3109/02699052.2013.823667; Costanzo RM, 2006, ADV OTO-RHINO-LARYNG, V63, P99, DOI 10.1159/000093753; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Hagen C., 1972, LEVELS COGNITIVE FUN; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; JENNETT B, 1975, LANCET, V1, P480; Li W, 2010, PSYCHOL SCI, V21, P1454, DOI 10.1177/0956797610382121; Mueller CA, 2009, J MED CASE REP, V3, P1; Papademetris Xenophon, 2006, Insight J, V2006, P209; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Rombaux P, 2006, NEUROPHYSIOL CLIN, V36, P53, DOI 10.1016/j.neucli.2006.03.005; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skorpil M, 2011, MAGN RESON IMAGING, V29, P289, DOI 10.1016/j.mri.2010.07.004; TEASDALE G, 1974, LANCET, V2, P81; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238	22	6	6	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1964	1968		10.1080/02699052.2017.1346293			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500031	28816545				2022-02-06	
J	Candy, S; Ma, I; McMahon, JM; Farrell, M; Mychasiuk, R				Candy, Sydney; Ma, Irene; McMahon, Jill M.; Farrell, Michael; Mychasiuk, Richelle			Staying in the game: a pilot study examining the efficacy of protective headgear in an animal model of mild traumatic brain injury (mTBI)	BRAIN INJURY			English	Article						Biomarker; concussion; ELISA; pathophysiology	TUMOR-NECROSIS-FACTOR; RUGBY UNION FOOTBALL; SEX-DIFFERENCES; TNF-ALPHA; PROFESSIONAL FOOTBALL; CONCUSSION SYMPTOMS; CEREBROSPINAL-FLUID; BIOMECHANICS; EXPRESSION; PLAYERS	Primary Objective: Rugby is one of the few contact sports that do not mandate protective headgear, possibly because studies have shown poor efficacy for protection related to concussion pathology with existing headguards.Research Design: Following innovative material technology utilization to produce headgear believed to have protective capabilities, this study examined the effects of a soft-shell headgear constructed from a novel viscoelastic material, on both behaviour and serum biomarkers after high and average impact force mild traumatic brain injuries (mTBI).Methods and Procedures: Seventy-five male Sprague Dawley rats were divided into five groups: control, average - 37G impact, with and without headgear, and high - 106G impact, with and without headgear. Rats were sacrificed at 3 or 48hours and serum samples were analyzed for levels of TNF-, NEF-L, and GFAP. Animals sacrificed at 48hours also underwent testing for balance and motor coordination, and exploratory/locomotor behaviour.Main Outcomes and Results: The novel headgear offered significant protection against mTBI symptomology and biomarkers in the group that experienced an average impact force, but only moderated protection for the animals in the high impact group.Conclusions: This innovative headgear may prevent some of the negative sequel associated with concussion pathology.	[Candy, Sydney; Mychasiuk, Richelle] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Candy, Sydney; Ma, Irene; Mychasiuk, Richelle] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Ma, Irene; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [McMahon, Jill M.] Natl Univ Ireland Galway, Sch Nat Sci, Galway Neurosci Ctr, Galway, Ireland; [Farrell, Michael] Beaumont Hosp, Dept Neuropathol, Dublin, Ireland		Mychasiuk, R (corresponding author), Univ Calgary, Dept Psychol, Alberta Childrens Hosp, Res Inst, Heritage Med Res Bldg,Room 274, Calgary, AB, Canada.	rmmychas@ucalgary.ca					Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; England Professional Rugby Injury Surveillance Project Steering Group, 2015, ENGL PROF RUGB INJ S; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Harmon KG, 2012, BRIT J SPORT MED, V46, P158, DOI 10.1136/bjsports-2012-090999; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Moriyama C, 2013, EPILEPSY BEHAV, V29, P19, DOI 10.1016/j.yebeh.2013.06.017; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Pettersen JA, 2002, BRIT J SPORT MED, V36, P19, DOI 10.1136/bjsm.36.1.19; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Sinclair M, 2009, BOKSMART WINNERS PLA; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Van Geel WJA, 2005, J IMMUNOL METHODS, V296, P179, DOI 10.1016/j.jim.2004.11.015; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang Z, 2010, METHODS MOL BIOL	50	6	6	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1521	1529		10.1080/02699052.2017.1363407			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200016	28972405				2022-02-06	
J	Caron, JG; Schaefer, L; Andre-Morin, D; Wilkinson, S				Caron, Jeffrey G.; Schaefer, Lee; Andre-Morin, Daphnee; Wilkinson, Shawn			A Narrative Inquiry into a Female Athlete's Experiences with Protracted Concussion Symptoms	JOURNAL OF LOSS & TRAUMA			English	Article						Athletic identity; concussion; female athletes; injury rehabilitation; qualitative research	SPORT; INJURIES; PLAYERS	This article explores a female university volleyball student-athlete's experience with protracted concussion symptoms. Through the methodology of narrative inquiry, four salient themes became apparent related to Daphnee's experiences: (a) I felt so alone, (b) I had to make one of the hardest decisions of my life, (c) I feel like I'm in prison, and (d) There's no light at the end of the tunnel. Overall, this study offers a rare look into the impact of concussion on an individual's athletic and academic identities, career progression, and in turn, her imagined stories of who she was and who she was becoming.	[Caron, Jeffrey G.; Schaefer, Lee; Andre-Morin, Daphnee] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ H2W 1S4, Canada; [Wilkinson, Shawn] Concordia Univ, Dept Appl Human Sci, Montreal, PQ, Canada		Caron, JG (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ H2W 1S4, Canada.	jeffrey.caron@mail.mcgill.ca					Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Butler-Kisber L., 2010, QUALITATIVE INQUIRY; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Carr, 1986, TIME NARRATIVE HIST; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Clandinin D.J., 2013, ENGAGING NARRATIVE I; Clinin, 2007, HDB NARRATIVE INQUIR, P35, DOI [DOI 10.4135/9781452226552, 10.4135/9781452226552]; Clinin D.J., 2000, NARRATIVE INQUIRY EX; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Dewey J., 1938, ED EXPERIENCE; Gordon S., 2012, NEW SPORT EXERCISE P, P567; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lal S, 2012, CAN J OCCUP THER, V79, P181, DOI 10.2182/cjot.2012.79.3.8; Lorenz LS, 2015, INTERD DISABIL STUD, P189; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Peshkin A., 1985, EXPLORING CLIN METHO, P267; Peshkin Alan, 2000, ED RES, V29, P5, DOI DOI 10.3102/0013189X029009005; Ristolainen L, 2012, EUR J SPORT SCI, V12, P274, DOI 10.1080/17461391.2011.566365; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; WERTHNER P, 1986, INT J SPORT PSYCHOL, V17, P337	24	6	6	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1532-5024	1532-5032		J LOSS TRAUMA	J. Loss Trauma		2017	22	6					501	513		10.1080/15325024.2017.1335150			13	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	FC4CH	WOS:000406785600004		Green Submitted			2022-02-06	
J	Cheever, KM; Myrer, JW; Johnson, AW; Fellingham, GW				Cheever, Kelly M.; Myrer, J. William; Johnson, A. Wayne; Fellingham, Gilbert W.			Understanding the complete pathophysiology of chronic mild to moderate neck pain: Implications for the inclusion of a comprehensive sensorimotor evaluation	JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION			English	Article						Tactile acuity; neck reposition error; isometric neck strength; range of motion; two-point discrimination; proprioception training	CERVICOCEPHALIC KINESTHETIC SENSIBILITY; TEST-RETEST RELIABILITY; MUSCLE STRENGTH; CERVICAL-SPINE; RANGE; MOTION; CONCUSSION; POSITION; WOMEN; HEAD	BACKGROUND: Inconsistencies in the literature concerning the effect of neck pain have led to a lack of understanding concerning the complete pathophysiology of neck pain. While the effect of neck pain on motor function as measured by active range of motion and isometric neck strength is well documented the effect of neck pain on sensory measures such as tactical acuity and neck reposition error (NRE) remain poorly understood. OBJECTIVE: The purpose of this study was to evaluate a combined sensorimotor evaluation to explore the potential benefits of incorporating both sensory and motor task into a physical evaluation of neck pain suffers to gain an added knowledge of the complete pathophysiology of their health status. METHODS: A cross-sectional study that measured neck joint reposition error, tactical acuity, neck isometric strength and range of motion in 40 volunteer participants (22 pain, 18 control). RESULTS: A statistically significant increase in NRE in flexion (2.75 degrees +/- 1.52 degrees +/- vs. 4.53 degrees +/- 1.74 degrees and in extension (3.78 degrees +/- 1.95 degrees +/- vs 5.77 degrees +/- 2.73 degrees in participants suffering from neck pain was observed. Additionally, the dermatome C5 was found to be the most affected. No differences were found in neck strength or neck range of motion between healthy controls and patients with chronic moderate neck pain.	[Cheever, Kelly M.] Temple Univ, Dept Kinesiol, 1800 N Broad St 230 Pearson Hall, Philadelphia, PA 19122 USA; [Myrer, J. William; Johnson, A. Wayne] Brigham Young Univ, Dept Exercise Sci, Provo, UT 84602 USA; [Fellingham, Gilbert W.] Brigham Young Univ, Stat Dept, Provo, UT 84602 USA		Cheever, KM (corresponding author), Temple Univ, Dept Kinesiol, 1800 N Broad St 230 Pearson Hall, Philadelphia, PA 19122 USA.	kellycheever@temple.edu		Cheever, Kelly/0000-0001-8381-3426; Johnson, A. Wayne/0000-0002-2207-5826			Andersen LL, 2008, PHYS THER, V88, P703, DOI 10.2522/ptj.20070304; Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; Cagnie B, 2007, ARCH PHYS MED REHAB, V88, P1441, DOI 10.1016/j.apmr.2007.06.776; Croft PR, 2001, PAIN, V93, P317, DOI 10.1016/S0304-3959(01)00334-7; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Hudes Karen, 2011, J Can Chiropr Assoc, V55, P222; Kato S, 2012, J ORTHOP SCI, V17, P687, DOI 10.1007/s00776-012-0276-y; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Law EYH, 2013, J BACK MUSCULOSKELET, V26, P141, DOI 10.3233/BMR-2012-00358; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lee H, 2005, J MANIP PHYSIOL THER, V28, P25, DOI 10.1016/j.jmpt.2004.12.005; Lee HJ, 2004, SPINE, V29, P33, DOI 10.1097/01.BRS.0000103944.10408.BA; Lee HY, 2006, MANUAL THER, V11, P61, DOI 10.1016/j.math.2005.03.008; Loudon JK, 1997, SPINE, V22, P865, DOI 10.1097/00007632-199704150-00008; Lundborg G, 2004, J HAND SURG-BRIT EUR, V29B, P418, DOI 10.1016/j.jhsb.2004.02.008; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; McPartland JM, 1997, J MANIP PHYSIOL THER, V20, P24; Panjabi MM, 1998, CLIN BIOMECH, V13, P11, DOI 10.1016/S0268-0033(97)00057-0; Pinsault Nicolas, 2008, Physiotherapy Theory and Practice, V24, P380, DOI 10.1080/09593980701884824; Pleger B, 2005, ANN NEUROL, V57, P425, DOI 10.1002/ana.20394; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Rezasoltani A, 2012, J BACK MUSCULOSKELET, V25, P67, DOI 10.3233/BMR-2012-0303; Rezasoltani A, 2010, MANUAL THER, V15, P400, DOI 10.1016/j.math.2010.02.010; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sjolander P, 2008, MANUAL THER, V13, P122, DOI 10.1016/j.math.2006.10.002; SONG ZK, 1993, PARAPLEGIA, V31, P485, DOI 10.1038/sc.1993.79; Sterling M, 2003, PAIN, V103, P65, DOI 10.1016/S0304-3959(02)00420-7; Tong J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00579; Treleaven J, 2006, MANUAL THER, V11, P99, DOI 10.1016/j.math.2005.04.003; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Cunha ACV, 2008, CLINICS, V63, P763, DOI 10.1590/S1807-59322008000600010; Voerman VF, 1999, AM J PHYS MED REHAB, V78, P24, DOI 10.1097/00002060-199901000-00007; Ylinen J, 2004, EUR J PAIN, V8, P473, DOI 10.1016/j.ejpain.2003.11.005	36	6	6	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8127	1878-6324		J BACK MUSCULOSKELET	J. Back Musculoskelet. Rehabil.		2017	30	5					991	997		10.3233/BMR-169535			7	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	FI5YJ	WOS:000412063800008	28505953				2022-02-06	
J	Choi, PA; Parry, PV; Bauer, JS; Zusman, BE; Panczykowski, DM; Puccio, AM; Okonkwo, DO				Choi, Phillip A.; Parry, Phillip V.; Bauer, Joshua S.; Zusman, Benjamin E.; Panczykowski, David M.; Puccio, Ava M.; Okonkwo, David O.			Use of Aspirin and P2Y(12) Response Assays in Detecting Reversal of Platelet Inhibition With Platelet Transfusion in Patients With Traumatic Brain Injury on Antiplatelet Therapy	NEUROSURGERY			English	Article						Antiplatelet therapy; Aspirin; Aspirin response unit; Clopidogrel; Platelet transfusion; P2Y(12) response unit; Traumatic brain injury	ACUTE LUNG INJURY; PERCUTANEOUS CORONARY INTERVENTION; CLOPIDOGREL; REACTIVITY; RISK; RESPONSIVENESS; RESISTANCE; BEDSIDE; SYSTEM	BACKGROUND: At present, guidelines are lacking on platelet transfusion in patients with a traumatic intracranial bleed and history of antiplatelet therapy. The aspirin and P2Y(12) response unit (ARU and PRU, respectively) assays detect the effect of aspirin and P2Y12 inhibitors in the cardiac population. OBJECTIVE: To describe the reversal of platelet inhibition after platelet transfusion using the ARU and PRU assays in patients with traumatic brain injury. METHODS: Between 2010 and 2015, we conducted a prospective comparative cohort study of patients presenting with a positive head computed tomography and a history of antiplatelet therapy. ARU and PRU assays were performed on admission and 6 hours after transfusion, with a primary end point of detection of disinhibition after platelet transfusion. RESULTS: One hundred seven patients were available for analysis. Seven percent of patients taking aspirin and 27% of patients taking clopidogrel were not therapeutic on admission per the ARU and PRU, respectively. After platelet transfusion, 51% of patients on any aspirin and 67% of patients on any clopidogrel failed to be reversed. ARU increased by 71 +/- 76 per unit of apheresis platelets for patients taking any aspirin, and PRU increased by 48 +/- 46 per unit of apheresis platelets for patients taking any clopidogrel. CONCLUSION: A significant percentage of patients taking aspirin or clopidogrel were not therapeutic and thus would be unlikely to benefit from a platelet transfusion. In patients with measured platelet inhibition, a single platelet transfusionwas not sufficient to reverse platelet inhibition in almost half.	[Choi, Phillip A.; Zusman, Benjamin E.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Parry, Phillip V.; Bauer, Joshua S.; Panczykowski, David M.; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Bauer, Joshua S.] St Georges Univ, Sch Med, Grand Anse, Grenada		Okonkwo, DO (corresponding author), Univ Pittsburgh, Med Ctr, Dept Neurol Surg, 200 Lothrop St,Ste B-400, Pittsburgh, PA 15213 USA.	okonkwodo@upmc.edu			Walter L. Copeland Fund of The Pittsburgh Foundation; University of Pittsburgh Clinical Scientist Training Program; Clinical and Translational Science Institute [UL1 TL1TR000005]	Support for this research was provided by the Walter L. Copeland Fund of The Pittsburgh Foundation and the University of Pittsburgh Clinical Scientist Training Program and Clinical and Translational Science Institute (UL1 TL1TR000005). The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Abaci A, 2005, THROMB RES, V116, P465, DOI 10.1016/j.thromres.2005.02.005; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, pE139, DOI 10.1016/j.jacc.2014.09.017; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Blais N, 2009, THROMB HAEMOSTASIS, V102, P404, DOI 10.1160/TH09-02-0126; Blumberg N, 2009, IMMUNOL RES, V45, P251, DOI 10.1007/s12026-009-8106-9; Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x; Cornet Alexander D, 2007, J Invasive Cardiol, V19, pE297; Eder AF, 2007, TRANSFUSION, V47, P599, DOI 10.1111/j.1537-2995.2007.01102.x; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC; Gilstad CW, 2003, CURR OPIN HEMATOL, V10, P419, DOI 10.1097/00062752-200311000-00004; GRATZ I, 1992, J THORAC CARDIOV SUR, V104, P1417; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Heddle NM, 2009, PRACTICAL TRANSFUSIO, P61; Hovens MMC, 2007, AM HEART J, V153, P175, DOI 10.1016/j.ahj.2006.10.040; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000142, 10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022]; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Kim DY, 2015, J NEUROTRAUM, V32, P1815, DOI 10.1089/neu.2014.3728; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Lee PY, 2005, AM J MED, V118, P723, DOI 10.1016/j.amjmed.2005.03.041; Lev EI, 2006, J AM COLL CARDIOL, V47, P27, DOI 10.1016/j.jacc.2005.08.058; Malinin A, 2006, METHOD FIND EXP CLIN, V28, P315, DOI 10.1358/mf.2006.28.5.990205; Malinin A, 2007, THROMB RES, V119, P277, DOI 10.1016/j.thromres.2006.01.019; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Michelson AD, 2009, AM J CARDIOL, V103, p20A, DOI 10.1016/j.amjcard.2008.11.019; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Nielsen HL, 2008, THROMB RES, V123, P267, DOI 10.1016/j.thromres.2008.03.023; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Price MJ, 2009, CIRCULATION, V119, P2625, DOI 10.1161/CIRCULATIONAHA.107.696732; Ranucci M, 2007, J CARDIOTHOR VASC AN, V21, P851, DOI 10.1053/j.jvca.2007.05.009; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Taylor G, 2013, J TRAUMA ACUTE CARE, V74, P1367, DOI 10.1097/TA.0b013e31828cca61; Vilahur G, 2007, J THROMB HAEMOST, V5, P82, DOI 10.1111/j.1538-7836.2006.02245.x; Vlaar APJ, 2010, CRIT CARE MED, V38, P771, DOI 10.1097/CCM.0b013e3181cc4d4b; Ziai WC, 2012, NEUROCRIT CARE, V17, P154, DOI 10.1007/s12028-012-9694-0	40	6	6	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2017	80	1					98	104		10.1227/NEU.0000000000001401			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EZ1ZT	WOS:000404510000017	28362883	Bronze, Green Published			2022-02-06	
J	de Guise, E; LeBlanc, J; Feyz, M; Lamoureux, J; Greffou, S				de Guise, E.; LeBlanc, J.; Feyz, M.; Lamoureux, J.; Greffou, S.			Prediction of behavioural and cognitive deficits in patients with traumatic brain injury at an acute rehabilitation setting	BRAIN INJURY			English	Article						Outcome; rehabilitation; neuropsychology; post-traumatic amnesia; memory; behaviour	CLOSED-HEAD INJURY; FUNCTIONAL RECOVERY; MODERATE; MORTALITY; OUTCOMES; RESERVE; SCALE; ORIENTATION; INTEGRATION; SEVERITY	Objective: The goal of this study was to identify factors that would predict short-term neuropsychological outcome in patients with traumatic brain injury (TBI) hospitalized in an acute rehabilitation setting. Methods: Data was collected in the context of an acute early rehabilitation setting of a trauma centre. A brief neuropsychological assessment was carried out for 348 patients within a month following their trauma. Results: Length of post-traumatic amnesia (PTA) was the best predictor of behavioural, memory and executive function variables within a month post TBI. The odds of being agitated, labile, irritable and disinhibited at one month post trauma were almost six times higher for those with PTA that lasted more than 7 days compared to those with a PTA of less than 24 hours. Also, the odds of having a higher mental manipulation score (less significant executive function impairment) were almost two times lower for those with frontal lesions, and three to six times lower for those with PTA of more than 24 hours. In addition, TBI severity, education and age were considered good predictors of some aspects of neuropsychological outcome. Conclusion: This model may help clinicians and administrators recognize the probable post-traumatic deficits as quickly as possible and to plan interventions as well as post-acute discharge orientation accordingly and early on.	[de Guise, E.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [de Guise, E.] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [de Guise, E.] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [LeBlanc, J.; Feyz, M.; Greffou, S.] McGill Univ, Hlth Ctr, Traumat Brain Injury Program, Montreal, PQ, Canada; [Lamoureux, J.] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Greffou, S.] McGill Univ, Neurol & Neurosurg Dept, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Dept Psychol, Ctr Ville, Pavillon Marie Victorin,CP 6128 Succ, Montreal, PQ H3C 3J7, Canada.				Centre de recherche interdisciplinaire en readaptation du Montreal metropolitain (CRIR); Research Institute of McGill University Health Center	The authors thank the Centre de recherche interdisciplinaire en readaptation du Montreal metropolitain (CRIR) and the Research Institute of the McGill University Health Center for their support as well as Mr Ricardo-Ruy Valle-Mena for his contribution to literature research and editing.	Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hanlon RE, 2005, BRAIN INJURY, V19, P257, DOI 10.1080/02699050400004955; Hawkins ML, 2003, AM SURGEON, V69, P497; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Lacy MG, 2006, SOCIOL METHOD RES, V34, P469, DOI 10.1177/0049124106286329; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Long CJ, 1992, HDB HEAD TRAUMA ACUT, P107; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Miller BA, BIOMED RES INT; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Novack TA, 2000, BRAIN INJURY, V14, P987; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Signoret JL, 1989, BEC 96; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thomas H, 2003, J HEAD TRAUMA REHAB, V18, P292, DOI 10.1097/00001199-200305000-00007; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wechsler D., 1997, WMS 3 MANUAL; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164	56	6	6	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	8					1061	1068		10.1080/02699052.2017.1297485			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FC3JI	WOS:000406734500005	28481672				2022-02-06	
J	Doknic, M; Pekic, S; Miljic, D; Soldatovic, I; Popovic, V; Stojanovic, M; Petakov, M				Doknic, M.; Pekic, S.; Miljic, D.; Soldatovic, I.; Popovic, V.; Stojanovic, M.; Petakov, M.			Etiology of Hypopituitarism in Adult Patients: The Experience of a Single Center Database in the Serbian Population	INTERNATIONAL JOURNAL OF ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GROWTH-HORMONE DEFICIENCY; PITUITARY DYSFUNCTION; NEUROENDOCRINE DISTURBANCES; CLINICAL CHARACTERISTICS; AUTOIMMUNE HYPOPHYSITIS; CRANIAL RADIOTHERAPY; FOLLOW-UP; DIAGNOSIS	There are only a few published studies related to the population-based etiology of hypopituitarism. New risks for developing hypopituitarism have been recognized in the last 10 years. Aim. To present data regarding the etiology of hypopituitarism collected in a tertiary center over the last decade. This is a cross-sectional database study. Patients and Methods. We included 512 patients (pts) with hypopituitarism, with a mean age of 45.9 +/- 1.7 yrs (range: 18-82; male: 57.9%). Results. Nonfunctional pituitary adenomas were presented in 205 pts (40.5%), congenital causes in 74 pts (14.6%), while acromegaly and prolactinomas were presented in 37 (7.2%) and 36 (7.0%) patients, respectively. Craniopharyngiomas were detected in 30 pts (5.9%), and head trauma due to trauma brain injury-TBI and subarachnoid hemorrhage-SAH in 27 pts (5.4%). Survivors of hemorrhagic fever with renal syndrome (HFRS) and those with previous cranial irradiation were presented in the same frequency (18 pts, 3.5% each). Conclusion. The most common causes of hypopituitarism in our database are pituitary adenomas. Increased awareness of the other causes of pituitary dysfunction, such as congenital, head trauma, extrapituitary cranial irradiation, and infections, is the reason for a higher frequency of these etiologies of hypopituitarism in the presented database.	[Doknic, M.; Pekic, S.; Miljic, D.; Stojanovic, M.; Petakov, M.] Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Dis, Neuroendocrine Dept, Belgrade, Serbia; [Doknic, M.; Pekic, S.; Miljic, D.; Soldatovic, I.; Popovic, V.; Stojanovic, M.; Petakov, M.] Univ Belgrade, Sch Med, Belgrade, Serbia; [Soldatovic, I.] Inst Med Stat & Informat, Belgrade, Serbia		Doknic, M (corresponding author), Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Dis, Neuroendocrine Dept, Belgrade, Serbia.; Doknic, M (corresponding author), Univ Belgrade, Sch Med, Belgrade, Serbia.	mirjanadoknic@gmail.com	Pekic, Sandra/S-7175-2016	Soldatovic, Ivan/0000-0003-4893-1683	Ministry of Science of the Republic of SerbiaMinistry of Education, Science & Technological Development, Serbia [175033]	This study was supported by the grants from the Ministry of Science of the Republic of Serbia (175033).	Abs R, 2005, GROWTH HORM IGF RES, V15, P349, DOI 10.1016/j.ghir.2005.06.018; Antonypillai CN, 2011, QJM-INT J MED, V104, P97, DOI 10.1093/qjmed/hcq214; Appelman-Dijkstra NM, 2011, J CLIN ENDOCR METAB, V96, P2330, DOI 10.1210/jc.2011-0306; Attanasio AF, 2002, J CLIN ENDOCR METAB, V87, P1600, DOI 10.1210/jc.87.4.1600; Beatrice Anne M, 2013, Indian J Endocrinol Metab, V17, pS608, DOI 10.4103/2230-8210.123546; Birla S, 2016, HORM METAB RES, V48, P822, DOI 10.1055/s-0042-117112; Brabant G., 2009, EUROPEAN J ENDOCRINO, V161, pS25; Chatterjee Purushottrram, 2008, J Indian Med Assoc, V106, P384; Cheer K, 2014, HAND CLINIC, V124, P141, DOI 10.1016/B978-0-444-59602-4.00010-1; Chiloiro S, 2017, NEUROENDOCRINOLOGY, V104, P280, DOI 10.1159/000446544; Dalan R, 2008, PITUITARY, V11, P299, DOI 10.1007/s11102-007-0057-3; Darzy KH, 2013, CURR OPIN ENDOCRINOL, V20, P342, DOI 10.1097/MED.0b013e3283631820; De Bellis A, 2011, CLIN ENDOCRINOL, V75, P361, DOI 10.1111/j.1365-2265.2011.04056.x; Doknic M, 2012, HORM-INT J ENDOCRINO, V11, P189, DOI 10.14310/horm.2002.1346; Fernandez-Rodriguez E, 2013, CLIN ENDOCRINOL, V78, P278, DOI 10.1111/j.1365-2265.2012.04516.x; Garrahy A, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0117-7; Gundgurthi Abhay, 2012, Indian J Endocrinol Metab, V16, P803, DOI 10.4103/2230-8210.100681; Gutierrez LP, 2008, PHARMACOEPIDEM DR S, V17, P90, DOI 10.1002/pds.1510; Harbeck B, 2011, EXP CLIN ENDOCR DIAB, V119, P633, DOI 10.1055/s-0031-1284366; Hoybye Charlotte, 2013, Clin Epidemiol, V5, P119, DOI 10.2147/CLEP.S42602; Jovanovic V, 2010, HORM-INT J ENDOCRINO, V9, P235, DOI 10.14310/horm.2002.1273; Juszczak A, 2012, EUR J ENDOCRINOL, V167, P1, DOI 10.1530/EJE-12-0167; Khajeh L, 2015, J NEUROL NEUROSUR PS, V86, P905, DOI 10.1136/jnnp-2014-307897; Klose M, 2015, J CLIN MED, V4, P1480, DOI 10.3390/jcm4071480; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Krewer C, 2016, J NEUROTRAUM, V33, P1544, DOI 10.1089/neu.2015.4109; Kyriakakis N, 2016, CLIN ENDOCRINOL, V84, P372, DOI 10.1111/cen.12969; LITTLEY MD, 1989, Q J MED, V70, P145; McCabe MJ, 2014, HAND CLINIC, V124, P3, DOI 10.1016/B978-0-444-59602-4.00001-0; Mehta A, 2009, CLIN ENDOCRINOL, V71, P376, DOI 10.1111/j.1365-2265.2009.03572.x; Melmed S, 2013, J CLIN ENDOCR METAB, V98, P2187, DOI 10.1210/jc.2012-4012; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Nystrom HF, 2011, PITUITARY, V14, P208, DOI 10.1007/s11102-010-0278-8; Pekic S, 2017, EUR J ENDOCRINOL, V176, pR269, DOI 10.1530/EJE-16-1065; Pekic S, 2014, HAND CLINIC, V124, P271, DOI 10.1016/B978-0-444-59602-4.00018-6; Pekic S, 2010, LANCET, V375, P432, DOI 10.1016/S0140-6736(09)61835-3; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Popovic V, 2002, J CLIN ENDOCR METAB, V87, P2095, DOI 10.1210/jc.87.5.2095; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sherlock M., 2013, ENDOCR REV, V1, P301; Shimatsu A, 2011, ENDOCR J, V58, P325, DOI 10.1507/endocrj.K10E-363; Stieg Mareike R, 2017, F1000Res, V6, P178, DOI 10.12688/f1000research.9436.1; Stojanovic M, 2008, J CLIN ENDOCR METAB, V93, P2722, DOI 10.1210/jc.2008-0311; Stojanovic M, 2012, EUR THYROID J, V1, P277, DOI 10.1159/000343910; Taku N, 2017, CLIN ONCOL-UK, V29, P34, DOI 10.1016/j.clon.2016.09.012; Tanriverdi F, 2014, ENDOCRINE, V47, P198, DOI 10.1007/s12020-013-0127-4; Tanriverdi F, 2015, J CLIN MED, V4, P847, DOI 10.3390/jcm4050847; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Tsiakalos A, 2010, J CLIN ENDOCR METAB, V95, P3277, DOI 10.1210/jc.2010-0144; van der Eerden AW, 2010, EUR J ENDOCRINOL, V162, P19, DOI 10.1530/EJE-09-0436; van Nieuwpoort IC, 2011, EUR J ENDOCRINOL, V164, P491, DOI 10.1530/EJE-10-0914; Vieira G, 2016, J STROKE CEREBROVASC, V25, P2405, DOI 10.1016/j.jstrokecerebrovasdis.2016.06.011; Webb SM, 2009, J CLIN ENDOCR METAB, V94, P392, DOI 10.1210/jc.2008-0713; Wilson V, 2014, QJM-INT J MED, V107, P21, DOI 10.1093/qjmed/hct193	54	6	7	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-8337	1687-8345		INT J ENDOCRINOL	Int. J. Endocrinol.		2017	2017								6969286	10.1155/2017/6969286			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	EY4KR	WOS:000403947400001	28702053	gold, Green Submitted, Green Published			2022-02-06	
J	Donders, J; DeWit, C				Donders, Jacobus; DeWit, Christin			Parental ratings of daily behavior and child cognitive test performance after pediatric mild traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article						Childhood brain insult; Everyday function; Head injuries; Learning and memory; Executive abilities; Emotion	VERBAL-LEARNING-TEST; EXECUTIVE FUNCTION; CVLT-C; PREDICTORS; MEMORY; IMPAIRMENT; INVENTORY; CONSTRUCT; SYMPTOMS; VALIDITY	This study aimed to evaluate the degree to which the Behavior Rating Inventory of Executive Function (BRIEF) and Child Behavior Checklist (CBCL) measure overlapping vs. distinct constructs in pediatric patients with mild traumatic brain injury (TBI), and to examine the demographic and injury correlates of such constructs as well as those of cognitive test performance. A total of 100 parents completed the BRIEF and the CBCL within 1 to 12months after the injury of their child. Groups were contrasted based on the presence vs. absence of impairment on, respectively, the BRIEF and the CBCL. Exploratory maximum likelihood factor analysis was used to evaluate latent constructs. Correlates of the various factor scores were evaluated through regression analysis and contrasted with those of a test of verbal learning and memory.The results revealed that the BRIEF and the CBCL disagree about the presence vs. absence of impairment in about one quarter of cases. A prior history of attention deficit/hyperactivity disorder (ADHD) was associated with an increased likelihood of impairment on both the BRIEF and the CBCL, whereas prior outpatient psychiatric treatment was associated with the increased likelihood of selective impairment on the CBCL. Latent constructs manifested themselves along cognitive regulation, emotional adjustment and behavioral regulation factors. Whereas premorbid characteristics were the exclusive correlates of these factors, performance on a test of verbal learning and memory was negatively affected by intracranial lesions on neuroimaging.It is concluded that the BRIEF and the CBCL offer complementary and non-redundant information about daily functioning after pediatric mild TBI. The correlates of cognitive test performance and parental behavior ratings after such injuries are different and reflect a divergence between premorbid and injury-related influences.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy St SE, Grand Rapids, MI 49503 USA; [DeWit, Christin] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Dept Psychol, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com			Mary Free Bed Fund [60]	This work was supported by the Mary Free Bed Fund, project [grant number #60].	Achenbach T. M., 2001, CHILD BEHAV CHECKLIS; Anderson V., 2014, UNDERSTANDING TRAUMA, P333; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Beauchamp MH, 2015, J INT NEUROPSYCH SOC, V21, P596, DOI 10.1017/S1355617715000636; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Byom L., 2014, BRAIN BEHAV COGNITIO, P190; Delis DC., 1994, CALIFORNIA VERBAL LE; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Familiar I, 2015, J DEV BEHAV PEDIATR, V36, P277, DOI 10.1097/DBP.0000000000000149; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gross D, 2006, PSYCHOL ASSESSMENT, V18, P313, DOI 10.1037/1040-3590.18.3.313; Gunther T, 2004, J AFFECT DISORDERS, V82, P265, DOI 10.1016/j.jad.2003.11.004; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Lande MB, 2010, J PEDIATR-US, V157, P114, DOI 10.1016/j.jpeds.2009.12.053; Lawson RA, 2015, NEUROPSYCHOLOGY, V29, P445, DOI 10.1037/neu0000145; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Mottram L, 2005, PSYCHOL ASSESSMENT, V17, P212, DOI 10.1037/1040-3590.17.2.212; Murphy KR, 2004, STAT POWER ANAL; O'Jile JR, 2005, ARCH CLIN NEUROPSYCH, V20, P547, DOI 10.1016/j.acn.2004.12.001; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Salorio CF, 2005, J INT NEUROPSYCH SOC, V11, P686, DOI 10.1017/S1355617705050885; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shultz E., NEUROPSYCHO IN PRESS; Studer M, 2015, BRAIN INJURY, V29, P1667, DOI 10.3109/02699052.2015.1075250; Tervo RC, 2006, ARCH PHYS MED REHAB, V87, P928, DOI 10.1016/j.apmr.2006.02.023; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; Vakil E, 2012, CHILD NEUROPSYCHOL, V18, P449, DOI 10.1080/09297049.2011.613816; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates K. O., 2012, MILD TRAUMATIC BRAIN, P124; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	41	6	6	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2017	23	5					554	570		10.1080/09297049.2016.1161015			17	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EU1AE	WOS:000400743600005	27002352				2022-02-06	
J	Dopheide, JA; Bostwick, JR; Goldstone, LW; Thomas, K; Nemire, R; Gable, KN; Cates, M; Caballero, J; Smith, T; Bainbridge, J				Dopheide, Julie A.; Bostwick, Jolene R.; Goldstone, Lisa W.; Thomas, Kelan; Nemire, Ruth; Gable, Kelly N.; Cates, Marshall; Caballero, Joshua; Smith, Tawny; Bainbridge, Jacquelyn			Curriculum in Psychiatry and Neurology for Pharmacy Programs	AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION			English	Article						curriculum; pharmacy; psychiatry; neurology; recommendations	MENTAL-HEALTH STIGMA; COLLEGES; STUDENTS; SCHOOLS	Objective. To describe pharmacy curricula in psychiatry and neurology and to report on neuropsychiatric pharmacy specialists' views on optimal curriculum. Methods. Design and administer one electronic survey to accredited pharmacy programs asking them to report information on curricula in psychiatry and neurology for the 2014-2015 academic year. Design and administer a separate electronic survey to board certified pharmacists with an academic affiliation who are members of the College of Psychiatric and Neurologic Pharmacists (CPNP) asking about their teaching activities and their opinion on optimal curricula. Results. Fifty-six percent of pharmacy programs and 65% of CPNP members responded to the surveys. The program survey revealed greater than 80% of topics were taught by full-time faculty. Didactic lecturing, team-based learning, and case studies were the most common teaching methods. Programs dedicated the most didactics (3 to 51 hours) to epilepsy, depression, schizophrenia, substance use disorders, and pain. Autism, traumatic brain injury, personality, and eating disorders were either not taught or given <= 1 hour of didactics in most programs. Inpatient psychiatry had themost APPE placements with a mean of 19.6, range 0-83. APPE electives in psychiatry outnumbered those in neurology 5 to 1. CPNP member survey results showed 2 out of 3 members agreed that curriculum could be improved with additional APPEs in psychiatry and neurology. Conclusion. Didactic hour distribution in psychiatry and neurology could be improved to better align with board certification in psychiatric pharmacy (BCPP) recommendations and disorder prevalence and complexity. Specialists recommend an experiential component in neurology and psychiatry to combat stigma and improve pharmacist knowledge and skills.	[Dopheide, Julie A.; Goldstone, Lisa W.] Univ Southern Calif, Sch Pharm, 1985 Zonal Ave, Los Angeles, CA 90089 USA; [Dopheide, Julie A.] Univ Southern Calif, Keck Sch Med, 1985 Zonal Ave, Los Angeles, CA 90089 USA; [Bostwick, Jolene R.] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA; [Thomas, Kelan] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Nemire, Ruth] Amer Assoc, Coll Pharm, Alexandria, VA USA; [Gable, Kelly N.] Southern Illinois Univ Edwardsville, Edwardsville, IL 62026 USA; [Cates, Marshall] Samford Univ, McWhorter Sch Pharm, Birmingham, AL USA; [Caballero, Joshua] Larkin Univ, Coll Pharm, Miami, FL USA; [Smith, Tawny] Univ Texas Austin, Austin Dell Med Sch, Austin, TX 78712 USA; [Bainbridge, Jacquelyn] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA; [Bainbridge, Jacquelyn] Univ Colorado, Sch Med, Anschutz Med Campus, Aurora, CO USA		Dopheide, JA (corresponding author), Univ Southern Calif, Sch Pharm, 1985 Zonal Ave, Los Angeles, CA 90089 USA.; Dopheide, JA (corresponding author), Univ Southern Calif, Keck Sch Med, 1985 Zonal Ave, Los Angeles, CA 90089 USA.	dopheide@usc.edu	Thomas, Kelan/AAZ-8575-2021	Thomas, Kelan/0000-0003-2818-270X; Smith, Tawny/0000-0002-7512-4919; Bostwick, Jolene/0000-0003-4587-7773			American Association of Colleges of Nursing, CURR GUID; American Association of Medical Colleges, COR ENTR PROF ACT EN; American College of Clinical Pharmacy, 2016 ACCP PHARM DID; American Society of Consultant Phannacists, 2015, GER PHARM CURR GUID; [Anonymous], 2013, DIAGN STAT MAN MENT; [Anonymous], AC PHARM VIT STAT; Association of American Medical Colleges, PERC MED SCH SEP REQ; Bell JS, 2010, INT J SOC PSYCHIATR, V56, P3, DOI 10.1177/0020764008097621; Caballero J, 2013, MENT HLTH CLIN, V2, P325; Cates ME, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710104; Chisholm D, 2016, LANCET PSYCHIAT, V3, P415, DOI 10.1016/S2215-0366(16)30024-4; Dipaula BA, 2011, AM J PHARM EDUC, V75, DOI 10.5688/ajpe75472; Nguyen E, 2012, SOC PSYCH PSYCH EPID, V47, P1087, DOI 10.1007/s00127-011-0413-5; Freeman A., 2016, NMC HORIZON REPORT 2; Gable KN, 2011, AM J PHARM EDUC, V75, DOI 10.5688/ajpe75234; Goetz CG, 2006, PSYCHIAT NEUROLOGIST; Goldstone L.W., 2015, MENT HLTH CLIN, V5, P1, DOI 10.9740/mhc.2015.01.001; Goldstone LW, 2013, AM J PHARM EDUC, V77, DOI 10.5688/ajpe776129; Grohol JM, CDC STAT MENTAL ILLN; Hawkins K, 2008, HEADACHE, V48, P553, DOI 10.1111/j.1526-4610.2007.00990.x; Insel T., 2013, ASSESSING STATE AM M; Jacoby A, 2005, LANCET NEUROL, V4, P171, DOI 10.1016/S1474-4422(05)01014-8; Jungnickel Paul W, 2010, Am J Pharm Educ, V74, pS11; Kwon J, 2015, CURR PHARM TEACH LEA, V7, P451, DOI 10.1016/j.cpd.2015.04.005; Medina MS, 2013, AM J PHARM EDUC, V77, DOI [10.5688/ajpe779189, 10.5688/ajpe778162]; Murphy JE, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj740107; Ofstad W, 2013, AM J PHARM EDUC, V77, DOI 10.5688/ajpe77470; Ott CA, 2013, MENT HLTH CLIN, V2, P319; Prescott WA, 2014, AM J PHARM EDUC, V78, DOI 10.5688/ajpe78351; Rutter P, 2013, AM J PHARM EDUC, V77, DOI 10.5688/ajpe777147; Siu AL, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-4467; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Stoner SC, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7409163; Ten Cate Olle, 2013, J Grad Med Educ, V5, P157, DOI 10.4300/JGME-D-12-00380.1; Tillery EE, 2014, MENT HLTH CLIN, V4, P265; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; White PD, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3454	37	6	7	0	4	AMER ASSOC COLL PHARMACY	ALEXANDRIA	1426 PRINCE STREET, ALEXANDRIA, VA 22314-2815 USA	0002-9459	1553-6467		AM J PHARM EDUC	Am. J. Pharm. Educ.		2017	81	7							5925				14	Education, Scientific Disciplines; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Pharmacology & Pharmacy	FJ9RA	WOS:000413116600003	29109559				2022-02-06	
J	Ferree, S; Hietbrink, F; van der Meijden, OAJ; Verleisdonk, EJMM; Leenen, LPH; Houwert, RM				Ferree, Steven; Hietbrink, Falco; van der Meijden, Olivier A. J.; Verleisdonk, Egbert Jan M. M.; Leenen, Luke P. H.; Houwert, Roderick M.			Comparing fracture healing disorders and long-term functional outcome of polytrauma patients and patients with an isolated displaced midshaft clavicle fracture	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Displaced; clavicle; fracture; delayed; fixation; functional; outcome; polytrauma	TRAUMATIC BRAIN-INJURY; NONOPERATIVE TREATMENT; ORTHOPEDIC-SURGEONS; CALLUS FORMATION; SHOULDER; QUICKDASH; FIXATION; EPIDEMIOLOGY; VALIDITY; PLATE	Background: Although clavicle fractures are a common injury in polytrauma patients, the functional outcome of displaced midshaft clavicle fractures (DMCFs) in this population is unknown. Our hypothesis was that there would be no differences in fracture healing disorders or functional outcome in polytrauma patients with a DMCF compared with patients with an isolated DMCF, regardless of the treatment modality. Methods: A retrospective cohort study of patients (treated at our level I trauma center) with a DMCF was performed and a follow-up questionnaire was administered. Polytrauma patients, defined as an Injury Severity Score >= 16, and those with an isolated clavicle fracture were compared. Fracture healing disorders (nonunion and delayed union) and delayed fixation rates were determined. Functional outcome was assessed by the Quick Disability of the Arm, Shoulder, and Hand questionnaire. Results: A total of 152 patients were analyzed, 71 polytrauma patients and 81 patients with an isolated DMCF. Questionnaire response of 121 patients (80%) was available (mean, 53 months; standard deviation, 22 months). No differences were found between polytrauma patients and those with an isolated DMCF with regard to nonunion (7% vs. 5%, respectively), delayed union (4% vs. 4%), and delayed fixation rate (13% vs. 13%). Polytrauma patients had an overall worse functional outcome, regardless of initial nonoperative treatment or delayed operative fixation. Conclusion: Polytrauma patients had a similar nonunion and delayed fixation rate but had an overall worse functional outcome compared with patients with an isolated DMCF. For polytrauma patients, a wait and see approach can be advocated without the risk of decreased upper extremity function after delayed fixation. (C) 2017 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights reserved.	[Ferree, Steven; Hietbrink, Falco; Leenen, Luke P. H.] Univ Med Ctr Utrecht, Dept Surg, NL-3584 CX Utrecht, Netherlands; [van der Meijden, Olivier A. J.] Spaarne Gasthuis, Dept Orthoped Surg, Hoofddorp, Netherlands; [Verleisdonk, Egbert Jan M. M.] Diakonessen Hosp, Dept Surg, Utrecht, Netherlands; [Houwert, Roderick M.] Utrecht Traumactr, Utrecht, Netherlands		Ferree, S (corresponding author), Univ Med Ctr Utrecht, Dept Surg, NL-3584 CX Utrecht, Netherlands.	s.ferree@umcutrecht.nl	Houwert, Roderick/K-7887-2019	Houwert, Roderick/0000-0003-3497-659X; Leenen, Luke/0000-0001-8385-1801			Althausen PL, 2013, J SHOULDER ELB SURG, V22, P608, DOI 10.1016/j.jse.2012.06.006; Banerjee M, 2013, INJURY, V44, P1015, DOI 10.1016/j.injury.2012.12.007; Beaton D E, 2001, J Hand Ther, V14, P128; Bhandari M, 2002, J ORTHOP TRAUMA, V16, P562, DOI 10.1097/00005131-200209000-00004; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Das A, 2014, J ORTHOP TRAUMA, V28, P119, DOI 10.1097/BOT.0b013e3182a2968e; Ferree S, 2016, INJURY, V47, P792, DOI 10.1016/j.injury.2015.11.040; Gallay SH, 1998, J ORTHOP TRAUMA, V12, P159, DOI 10.1097/00005131-199803000-00004; George DM, 2015, J SHOULDER ELB SURG, V24, P669, DOI 10.1016/j.jse.2014.09.037; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Gummesson C, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-44; Hill JM, 1997, J BONE JOINT SURG BR, V79B, P537, DOI 10.1302/0301-620X.79B4.7529; Hunsaker FG, 2002, J BONE JOINT SURG AM, V84A, P208, DOI 10.2106/00004623-200202000-00007; Lenza M, 2013, COCHRANE DB SYST REV, V6; London DA, 2014, J HAND SURG-AM, V39, P100, DOI 10.1016/j.jhsa.2013.09.041; Macdermid JC, 2015, J ORTHOP SPORT PHYS, V45, P25, DOI 10.2519/jospt.2015.5033; Mckee MD, 2007, J BONE JOINT SURG AM, V89A, P1, DOI 10.2106/JBJS.F.00020; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Murray IR, 2013, J BONE JOINT SURG AM, V95A, P1153, DOI 10.2106/JBJS.K.01275; Potter JM, 2007, J SHOULDER ELB SURG, V16, P514, DOI 10.1016/j.jse.2007.01.001; Robinson CM, 1998, J BONE JOINT SURG BR, V80B, P476, DOI 10.1302/0301-620X.80B3.8079; Robinson M, 2004, J BONE JOINT SURG AM, V86A, P1359, DOI 10.2106/00004623-200407000-00002; Stone ME, 2014, J TRAUMA ACUTE CARE, V76, P185, DOI 10.1097/TA.0b013e3182aafcd5; van der Meijden OA, 2015, J BONE JOINT SURG AM, V97A, P613, DOI 10.2106/JBJS.N.00449; van Laarhoven JJEM, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-36; Wijdicks FJG, 2012, ARCH ORTHOP TRAUM SU, V132, P617, DOI 10.1007/s00402-011-1456-5; Zlowodzki M, 2005, J ORTHOP TRAUMA, V19, P504, DOI 10.1097/01.bot.0000172287.44278.ef	29	6	6	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	JAN	2017	26	1					42	48		10.1016/j.jse.2016.05.023			7	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	EF0QB	WOS:000390029700011	27521136				2022-02-06	
J	Gokharman, FD; Aydin, S; Fatihoglu, E; Kosar, PN				Gokharman, Fatma Dilek; Aydin, Sonay; Fatihoglu, Erdem; Kosar, Pinar Nercis			Pediatric Emergency Care Applied Research Network head injury prediction rules: on the basis of cost and effectiveness	TURKISH JOURNAL OF MEDICAL SCIENCES			English	Article						Pediatric Emergency Care Applied Research Network; cost; effectiveness; computed tomography	RADIATION-EXPOSURE; COMPUTED-TOMOGRAPHY; CHILDREN; TRAUMA	Background/aim: Head injuries are commonly seen in the pediatric population. Noncontrast enhanced cranial CT is the method of choice to detect possible traumatic brain injury (TBI). Concerns about ionizing radiation exposure make the evaluation more challenging. The aim of this study was to evaluate the effectiveness of the Pediatric Emergency Care Applied Research Network (PECARN) rules in predicting clinically important TBI and to determine the amount of medical resource waste and unnecessary radiation exposure. Materials and methods: This retrospective study included 1041 pediatric patients presented to the emergency department. The patients were divided into subgroups of "appropriate for cranial CT", "not appropriate for cranial CT" and "cranial CT/observation of patient; both are appropriate". To determine the effectiveness of the PECARN rules, data were analyzed according to the presence of pathological findings Results: "Appropriate for cranial CT" results can predict pathology presence 118,056-fold compared to the "not appropriate for cranial CT" results. With " cranial CT/observation of patient; both are appropriate" results, pathology presence was predicted 11,457-fold compared to "not appropriate for cranial CT" results. Conclusion: PECARN rules can predict pathology presence successfully in pediatric TBI. Using PECARN can decrease resource waste and exposure to ionizing radiation.	[Gokharman, Fatma Dilek; Aydin, Sonay; Fatihoglu, Erdem; Kosar, Pinar Nercis] Ankara Numune Training & Res Hosp, Dept Radiol, Ankara, Turkey		Aydin, S (corresponding author), Ankara Numune Training & Res Hosp, Dept Radiol, Ankara, Turkey.	sonaydin89@hotmail.com	Aydin, Sonay/ABI-4569-2020	Aydin, Sonay/0000-0002-3812-6333			Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; Babl Franz E, 2015, Evid Based Med, V20, P33, DOI 10.1136/ebmed-2014-110090; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Forsyth R, 2013, ARCH DIS CHILD, V98, P925, DOI 10.1136/archdischild-2013-304436; Kamat AB, 2015, EMERG MED J, V32, P144, DOI 10.1136/emermed-2013-203136; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Levin DC, 2014, J AM COLL RADIOL, V11, P1044, DOI 10.1016/j.jacr.2014.07.008; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Nishijima DK, 2015, ANN EMERG MED, V65, P72, DOI 10.1016/j.annemergmed.2014.08.019; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Ringel JS, 2010, HEALTH SERV RES, V45, P1541, DOI 10.1111/j.1475-6773.2010.01146.x; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008	17	6	6	0	1	TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY	ANKARA	ATATURK BULVARI NO 221, KAVAKLIDERE, ANKARA, 00000, TURKEY	1300-0144	1303-6165		TURK J MED SCI	Turk. J. Med. Sci.		2017	47	6					1770	1777		10.3906/sag-1703-206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR2GD	WOS:000418884300016	29306237	Green Submitted, Bronze			2022-02-06	
J	Gorman, S; Barnes, MA; Swank, PR; Ewing-Cobbs, L				Gorman, Stephanie; Barnes, Marcia A.; Swank, Paul R.; Ewing-Cobbs, Linda			Recovery of Working Memory Following Pediatric Traumatic Brain Injury: A Longitudinal Analysis	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; PREFRONTAL CORTEX; SHORT-TERM; EXECUTIVE FUNCTION; MOTOR FUNCTION; CHILDREN; CHILDHOOD; AGE; MATHEMATICS; SEVERITY	In a prospective longitudinal study, the trajectory of verbal and visual-spatial working memory (WM) development was examined 2-, 6-, 12-, and 24-months following complicated-mild to severe pediatric traumatic brain injury (TBI; n=55) relative to an orthopedic injury comparison group (n=47). Individual growth curve modeling revealed an interaction of age, severity, and time for verbal, but not visual-spatial WM. The youngest children with severe TBI had the lowest scores and slowest verbal WM growth. WM outcome is best understood in light of age at injury and TBI severity. Findings support the early vulnerability hypothesis and highlight the need for long-term follow-up.	[Gorman, Stephanie] Univ Houston, Dept Psychol, Houston, TX USA; [Barnes, Marcia A.] Univ Texas Austin, Dept Special Educ, Austin, TX 78712 USA; [Swank, Paul R.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Dept Pediat, 7000 Fannin UCT 2401, Houston, TX 77030 USA		Ewing-Cobbs, L (corresponding author), Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Dept Pediat, 7000 Fannin UCT 2401, Houston, TX 77030 USA.	Linda.Ewing-Cobbs@uth.tmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This work was funded by the National Institutes of Health R01 NS046308 awarded to LEC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting institute. The authors report no financial or other conflict of interest.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; BADDELEY A, 1981, Q J EXP PSYCHOL-A, V33, P439, DOI 10.1080/14640748108400802; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnes M. A., 2010, PEDIAT NEUROPSYCHOLO, P297; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Catroppa C, 2015, BRAIN INJURY, V29, P1317, DOI 10.3109/02699052.2015.1043345; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chapman S.B, 1995, TRAUMATIC HEAD INJUR, P95; Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Cornoldi C, 2001, CHILD NEUROPSYCHOL, V7, P230, DOI 10.1076/chin.7.4.230.8735; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; de Abreu PMJE, 2011, MEMORY, V19, P529, DOI 10.1080/09658211.2011.590504; De Beni R, 1998, Q J EXP PSYCHOL-A, V51, P305, DOI 10.1080/713755761; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0029; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole VCM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00011; Geary DC, 2011, DEV PSYCHOL, V47, P1539, DOI 10.1037/a0025510; GOLDMAN PS, 1971, EXP NEUROL, V32, P366, DOI 10.1016/0014-4886(71)90005-7; GOLDMAN PS, 1977, NATURE, V267, P613, DOI 10.1038/267613a0; GOLDMAN PS, 1970, EXP NEUROL, V29, P221, DOI 10.1016/0014-4886(70)90053-1; Goldman PS, 1974, PLASTICITY RECOVERY; Gorman S, 2016, NEUROPSYCHOLOGY, V30, P263, DOI 10.1037/neu0000214; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Howell D.C., 2007, STAT METHODS PSYCHOL; ISAACS EB, 1989, BRIT J DEV PSYCHOL, V7, P377, DOI 10.1111/j.2044-835X.1989.tb00814.x; Jacob R, 2015, REV EDUC RES, V85, P512, DOI 10.3102/0034654314561338; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Kolb B., 2008, EXECUTIVE FUNCTION F, P81; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; Loe IM, 2016, J DEV BEHAV PEDIATR, V37, P548, DOI 10.1097/DBP.0000000000000318; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Nichelli F, 2001, NEUROL SCI, V22, P377, DOI 10.1007/s100720100068; Niedo J, 2014, LEARN INDIVID DIFFER, V32, P54, DOI 10.1016/j.lindif.2014.03.013; Peng P, 2016, J EDUC PSYCHOL, V108, P455, DOI 10.1037/edu0000079; Phillips NL, 2016, J NEUROTRAUM, V33, P2097, DOI 10.1089/neu.2015.4358; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Schneider M, 2005, EXP NEUROL, V195, P185, DOI 10.1016/j.expneurol.2005.04.014; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; Shah, 1999, MODELS WORKING MEMOR, DOI DOI 10.1017/CBO9781139174909.005; Sorge GB, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12408; Swanson HL, 2006, REV EDUC RES, V76, P249, DOI 10.3102/00346543076002249; Swanson HL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01099; Swanson HL, 1999, DEV PSYCHOL, V35, P986, DOI 10.1037/0012-1649.35.4.986; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Teuber H L, 1974, Neurosci Res Program Bull, V12, P197; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Veenstra AL, 2016, EPILEPSY BEHAV, V55, P6, DOI 10.1016/j.yebeh.2015.11.025; Wechsler D., 2011, WECHSLER ABBREVIATED; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; [No title captured]	95	6	6	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2017	42	3					127	145		10.1080/87565641.2017.1315581			19	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EW6FK	WOS:000402603900001	28497984	Green Accepted			2022-02-06	
J	Grabher, P; Blaiotta, C; Ashburner, J; Freund, P				Grabher, Patrick; Blaiotta, Claudia; Ashburner, John; Freund, Patrick			Relationship between brainstem neurodegeneration and clinical impairment in traumatic spinal cord injury	NEUROIMAGE-CLINICAL			English	Article						Spinal cord injuries; Brain stem; Atrophy; Periaqueductal grey; Pyramidal tracts; Red nucleus; Quantitative MRI; Structural MRI	IN-VIVO; UNIFIED SEGMENTATION; CORTICOSPINAL TRACT; RUBROSPINAL NEURONS; MRI CONTRAST; CORTEX; FIELD; PLASTICITY; ALGORITHM; HISTOLOGY	Background: Brainstem networks are pivotal in sensory and motor function and in recovery following experimental spinal cord injury (SCI). Objective: To quantify neurodegeneration and its relation to clinical impairment in major brainstem pathways and nuclei in traumatic SCI. Methods: Quantitative MRI data of 30 chronic traumatic SCI patients (15 with tetraplegia and 15 with paraplegia) and 23 controls were acquired. Patients underwent a full neurological examination. We calculated quantitative myelin-sensitive (magnetisation transfer saturation (MT) and longitudinal relaxation rate (R1)) and iron-sensitive (effective transverse relaxation rate (R2*)) maps. We constructed brainstem tissue templates using a multivariate Gaussian mixture model and assessed volume loss, myelin reductions, and iron accumulation across the brainstem pathways (e.g. corticospinal tracts (CSTs) and medial lemniscus), and nuclei (e.g. red nucleus and periaqueductal grey (PAG)). The relationship between structural changes and clinical impairment were assessed using regression analysis. Results: Volume loss was detected in the CSTs and in the medial lemniscus. Myelin-sensitive MT and R1 were reduced in the PAG, the CSTs, the dorsal medulla and pons. No iron-sensitive changes in R2* were detected. Lower pinprick score related to more myelin reductions in the PAG, whereas lower functional independence was related to more myelin reductions in the vestibular and pontine nuclei. Conclusion: Neurodegeneration, indicated by volume loss and myelin reductions, is evident in major brainstem pathways and nuclei following traumatic SCI; the magnitude of these changes relating to clinical impairment. Thus, quantitative MRI protocols offer new targets, which may be used as neuroimaging biomarkers in treatment trials.	[Grabher, Patrick; Freund, Patrick] Univ Zurich, Univ Zurich Hosp, Spinal Cord Injury Ctr Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland; [Blaiotta, Claudia; Ashburner, John; Freund, Patrick] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Freund, Patrick] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany; [Freund, Patrick] UCL, Inst Neurol, Dept Brain Repair & Rehabil, London, England		Freund, P (corresponding author), Univ Zurich, Univ Zurich Hosp, Spinal Cord Injury Ctr Balgrist, Forchstr 340, CH-8008 Zurich, Switzerland.	patrick.freund@balgrist.ch	Freund, Patrick/D-4193-2013	Freund, Patrick/0000-0002-4851-2246	Clinical Research Priority Program "NeuroRehab" of the University of Zurich and Wings for Life [WFL-CH-007/14]; Wellcome TrustWellcome TrustEuropean Commission [091593/Z/10/Z]	This study was funded by the Clinical Research Priority Program "NeuroRehab" of the University of Zurich and Wings for Life [WFL-CH-007/14]. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust [091593/Z/10/Z]. Open access of this publication was supported by the Wellcome Trust.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Beaud ML, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-5; Benarroch E. E., 2012, NEUROLOGY; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Blaiotta C, 2016, COMPUT VIS IMAGE UND, V151, P14, DOI 10.1016/j.cviu.2016.04.004; Callaghan MF, 2015, MAGN RESON MED, V73, P1309, DOI 10.1002/mrm.25210; Catz A, 2007, SPINAL CORD, V45, P275, DOI 10.1038/sj.sc.3101960; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Felix MS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00045; Freund P, 2016, BRAIN, V139, P1855, DOI 10.1093/brain/aww076; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Grabher P, 2015, ANN NEUROL, V78, P751, DOI 10.1002/ana.24508; Haefeli J, 2014, NEUROREHAB NEURAL RE, V28, P494, DOI 10.1177/1545968313517755; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; HASSELBLAD V, 1966, TECHNOMETRICS, V8, P431, DOI 10.2307/1266689; Jirjis M. B., 2015, J MAGN RESON IMAGING; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Jutzeler CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep18534; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Knerlich-Lukoschus F, 2011, J NEUROTRAUM, V28, P619, DOI 10.1089/neu.2010.1652; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lambert C, 2013, NEUROIMAGE-CLIN, V2, P684, DOI 10.1016/j.nicl.2013.04.017; Lambert C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00462; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Liao CC, 2015, J COMP NEUROL, V523, P2138, DOI 10.1002/cne.23783; Liechti M, 2008, CLIN NEUROPHYSIOL, V119, P2804, DOI 10.1016/j.clinph.2008.05.033; Moon TK, 1996, IEEE SIGNAL PROC MAG, V13, P47, DOI 10.1109/79.543975; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Naidich TP, 2009, DUVERNOYS ATLAS HUMA; NATHAN PW, 1982, BRAIN, V105, P223, DOI 10.1093/brain/105.2.223; Nichols TE, 2012, NEUROIMAGE, V62, P811, DOI 10.1016/j.neuroimage.2012.04.014; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; Sauerbeck A, 2013, EXP NEUROL, V248, P53, DOI 10.1016/j.expneurol.2013.05.011; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Turati L, 2015, NMR BIOMED, V28, P327, DOI 10.1002/nbm.3253; Villiger M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00254; Wannier-Morino P, 2008, BRAIN RES, V1217, P96, DOI 10.1016/j.brainres.2007.11.019; Weiskopf N, 2015, CURR OPIN NEUROL, V28, P313, DOI 10.1097/WCO.0000000000000222; Weiskopf N, 2011, NEUROIMAGE, V54, P2116, DOI 10.1016/j.neuroimage.2010.10.023; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115; Zorner B, 2014, BRAIN, V137, P1716, DOI 10.1093/brain/awu078	50	6	6	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	15						494	501		10.1016/j.nicl.2017.05.026			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FG3MN	WOS:000410067200053	28649492	Green Submitted, Green Published, gold, Green Accepted			2022-02-06	
J	Granata, RT; Castillo, EM; Vilke, GM				Granata, Robert T.; Castillo, Edward M.; Vilke, Gary M.			Safety of deferred CT imaging of intoxicated patients presenting with possible traumatic brain injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							ALCOHOL	Background: Patients presenting to the emergency department (ED) with altered mental status and alcohol intoxication can clinically resemble patients with an intracranial hemorrhage. Although intracranial hemorrhage is quickly excluded with a head computed tomographic (CT) scan, it is common practice to defer imaging and allow the patient to metabolize to spare ED resources and minimize radiation exposure to the patient. Although this reduces unnecessary scans, it may delay treatment in patients with occult intracranial hemorrhage, which some fear may increase morbidity and mortality. We sought to evaluate the safety of deferred CT imaging in these patients by evaluating whether time to scan significantly affects the rate of neurosurgical intervention. Methods: In this retrospective medical record review, all clinically alcohol-intoxicated patients presenting to 2 university EDs were included. Time to order CT imaging, findings on imaging, and outcomes of these patients were determined. Patients were assessed in 3 groups: CT ordered within 1 hour of triage, CT ordered 1-3 hours from triage, and CT ordered 3 or more hours from triage. Results: During the study period, 5943 patients were included in the study. Of these, 0 patients scanned in less than 3 hours had intracranial findings on imaging requiring neurosurgery, whereas 1 patient with a deferred CT scan required a neurosurgical intervention; however, it was not emergently performed. Conclusion: Routine CT scanning of alcohol-intoxicated patients with altered mental status is of low clinical value. Deferring CT imaging while monitoring improving clinical status appears to be a safe practice. (C) 2016 Elsevier Inc. All rights reserved.	[Granata, Robert T.; Castillo, Edward M.; Vilke, Gary M.] Univ Calif San Diego, Sch Med, San Diego, CA USA		Granata, RT (corresponding author), 9238 PiantinoWay, San Diego, CA 92108 USA.	rgranata@ucsd.edu			summer training grant from the National Heart, Lung, and Blood Institute [5T35HL007491-33]	This research was generously funded by a summer training grant from the National Heart, Lung, and Blood Institute (grant 5T35HL007491-33). We acknowledge and are grateful for their support of this study.	Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Easter JS, 2013, ACAD EMERG MED, V20, P753, DOI 10.1111/acem.12184; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Godbout BJ, 2011, EMERG RADIOL, V18, P381, DOI 10.1007/s10140-011-0966-3; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Vonghia L, 2008, EUR J INTERN MED, V19, P561, DOI 10.1016/j.ejim.2007.06.033	7	6	6	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JAN	2017	35	1					51	54		10.1016/j.ajem.2016.09.069			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EP5KE	WOS:000397416600010	27743625				2022-02-06	
J	Guo, XY; Edmed, SL; Anderson, V; Kenardy, J				Guo, Xiaoyuan; Edmed, Shannon L.; Anderson, Vicki; Kenardy, Justin			Neurocognitive Predictors of Posttraumatic Stress Disorder Symptoms in Children 6 Months After Traumatic Brain Injury: A Prospective Study	NEUROPSYCHOLOGY			English	Article						attention; children; memory; posttraumatic stress disorder; traumatic brain injury	RISK-FACTORS; EXECUTIVE FUNCTION; INTRUSIVE IMAGES; RECOVERY; MEMORY; PTSD; SYMPTOMATOLOGY; METAANALYSIS; IMPAIRMENTS; ADOLESCENTS	Objective: Various neurocognitive mechanisms have been proposed to explain the development of Posttraumatic Stress Disorder (PTSD) symptoms. However, the neurocognitive mechanisms underlying comorbid PTSD following Traumatic Brain Injury (TBI) have not been fully investigated, especially among children. This study prospectively examined the influence of theorized neurocognitive deficits at 3 months post pediatric TBI on the development of PTSD symptoms 6 months postinjury. Method: One hundred sixty-six children aged between 6 and 14 years were recruited after sustaining a TBI. Their demographic information and injury severity were assessed at 2 months postinjury, their neurocognitive outcomes in selective attention, sustained attention, verbal learning, working memory, and processing speed were assessed at 3 months postinjury, and PTSD symptoms were measured at 6 months postinjury. Results: Consistent with the Neurobiological Theory of PTSD, sustained attention deficits 3 months postinjury emerged as the key predictor for greater future PTSD severity at 6 months, especially following a mild TBI. However, contrary to the expectations of the Emotional Processing Theory and Dual Representation Theory, verbal learning and working memory deficits at 3 months postinjury protected children from the development of PTSD symptoms 6 months postinjury. Conclusions: PTSD involves a complex interplay between attention and memory functions post pediatric TBI. When trauma memory is relatively intact, difficulties disengaging from distractors contribute to the development of PTSD symptoms.	[Guo, Xiaoyuan; Kenardy, Justin] Univ Queensland, Sch Psychol, Level 7 UQ Oral Hlth Ctr, Brisbane, Qld 4029, Australia; [Edmed, Shannon L.; Kenardy, Justin] Univ Queensland, Recover Injury Res Ctr, Fac Hlth & Behav Sci, Level 7 UQ Oral Hlth Ctr, Brisbane, Qld 4029, Australia; [Anderson, Vicki] Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Australia; [Anderson, Vicki] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia		Kenardy, J (corresponding author), Univ Queensland, Sch Psychol, Level 7 UQ Oral Hlth Ctr, Brisbane, Qld 4029, Australia.; Kenardy, J (corresponding author), Univ Queensland, Recover Injury Res Ctr, Fac Hlth & Behav Sci, Level 7 UQ Oral Hlth Ctr, Brisbane, Qld 4029, Australia.	j.kenardy@uq.edu.au	Kenardy, Justin A/H-6603-2014; Kenardy, Justin/F-2085-2010	Kenardy, Justin A/0000-0001-9475-8450; 	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [301103]	Vicki Anderson is a co-author of the Test of Everyday Attention for Children which was a measure used in the study. This study was supported by the National Health and Medical Research Council grant 301103. We acknowledge the contribution to this study by Cathy Catroppa.	Amaya-Jackson L, 1995, CHILD PTSD CHECKLIST; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson PJ., 2000, CLIN NEUROPSYCHOL AS, V1, P247; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2012, J HEAD TRAUMA REHAB, V27, P199, DOI 10.1097/HTR.0b013e31821a9d2b; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Australian Centre for Posttraumatic Mental Health, 2013, AUSTR GUID TREATM AC; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BONTKE CF, 1996, J HEAD TRAUMA REHAB, V11, P95, DOI DOI 10.1097/00001199-199602000-00011; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brewin CR, 2002, BEHAV RES THER, V40, P923, DOI 10.1016/S0005-7967(01)00127-9; Bussone William R, 2010, Biomed Sci Instrum, V46, P166; Catroppa C, 2008, J CHILD NEUROL, V23, P486, DOI 10.1177/0883073807309773; Cohen JA, 1998, J AM ACAD CHILD PSY, V37, P997; Cowan N., 2008, DEV MEMORY INFANCY C, P303, DOI DOI 10.4324/9780203934654; Cox CM, 2010, J PEDIATR PSYCHOL, V35, P581, DOI 10.1093/jpepsy/jsp095; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; DiGangi JA, 2013, CLIN PSYCHOL REV, V33, P728, DOI 10.1016/j.cpr.2013.05.002; Foa E.B., 2007, PROLONGED EXPOSURE T; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Iselin G, 2010, J ANXIETY DISORD, V24, P774, DOI 10.1016/j.janxdis.2010.05.011; Johnsen GE, 2008, J ANXIETY DISORD, V22, P464, DOI 10.1016/j.janxdis.2007.04.007; Kenardy JA, 1996, J TRAUMA STRESS, V9, P37, DOI 10.1002/jts.2490090105; Kenardy J, 2012, J CLIN CHILD ADOLESC, V41, P5, DOI 10.1080/15374416.2012.632348; Kenardy JA, 2006, PEDIATRICS, V118, P1002, DOI 10.1542/peds.2006-0406; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Levy A., 1996, 2 WORLD C INT SOC TR; Lonigan CJ, 2003, CHILD ADOL PSYCH CL, V12, P171, DOI 10.1016/S1056-4993(02)00105-0; Malarbi S, 2016, J TRAUMA DISSOCIATIO, V17, P199, DOI 10.1080/15299732.2015.1094164; Manly T, 1999, TEA CH TEST EVERYDAY; March S, 2015, J TRAUMA STRESS, V28, P34, DOI 10.1002/jts.21981; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; McLennan W., 1997, AUSTR STANDARDS CLAS; Moradi AR, 1999, PSYCHOL MED, V29, P415, DOI 10.1017/S0033291798008009; Nader K., 1996, CLIN ADM PTSD SCALE; Orr SP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-8; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Rauch SL., 1998, CNS SPECTRUMS, V3, P30, DOI [10. 1017/S1092852900007306, DOI 10.1017/S1092852900007306, 10.1017/S1092852900007306]; Samuelson K. W., 2010, CHILD NEUROPSYCHOL, V45, P37; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Scheeringa M, 2003, J AM ACAD CHILD PSY, V42, P561, DOI 10.1097/01.CHI.0000046822.95464.14; Scheeringa MS, 2006, AM J PSYCHIAT, V163, P644, DOI 10.1176/appi.ajp.163.4.644; Schweizer S, 2011, BEHAV RES THER, V49, P498, DOI 10.1016/j.brat.2011.05.007; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P149, DOI 10.1007/978-0-387-76978-3_6; Stuart ADP, 2006, BEHAV RES THER, V44, P611, DOI 10.1016/j.brat.2005.04.004; Thomas MSC, 2008, CURR DIR PSYCHOL SCI, V17, P1, DOI 10.1111/j.1467-8721.2008.00537.x; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; Vasterling J. J., 2012, PTSD MILD TRAUMATIC, P37; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Verwoerd J, 2011, COGNITIVE THER RES, V35, P161, DOI 10.1007/s10608-010-9335-x; Verwoerd J, 2009, J BEHAV THER EXP PSY, V40, P189, DOI 10.1016/j.jbtep.2008.08.002; Walsh TM, 2004, J ANXIETY DISORD, V18, P695, DOI 10.1016/S0887-6185(03)00043-4; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 2003, WECHSLER ABBREVIATED; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson GS, 2005, J ADOLESCENCE, V28, P369, DOI 10.1016/j.adolescence.2004.08.004	66	6	6	0	12	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2017	31	1					84	92		10.1037/neu0000305			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EH3WI	WOS:000391702300008	27617636				2022-02-06	
J	Holster, JL; Bryan, CJ; Heron, EA; Seegmiller, RA				Holster, Jessica L.; Bryan, Craig J.; Heron, Elizabeth A.; Seegmiller, Robert A.			Traumatic Brain Injury, Sleep, and Mental Health: A Longitudinal Study of Air Force Personnel Pre- and Postdeployment to Iraq	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Air Force; concussion; depression; insomnia; Iraq; military; posttraumatic stress; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; RISK-FACTORS; MILITARY PERSONNEL; NCAA CONCUSSION; SYMPTOMS; AFGHANISTAN; INSOMNIA; SERVICE; DEPLOYMENT	Objective: We investigated the complex relationships between traumatic brain injury (TBI), sleep, and mental health problems longitudinally among US service members (SMs) pre- and postdeployment to Iraq. Participants: One hundred sixty-eight SMs enrolled in a 4-week Air Force Basic Combat Convoy Course predeployment. Design: Self-report data were collected at the beginning and end of training and then at 1, 3, 6, and 12 months postdeployment. Regression analyses were implemented, and participants were categorized into 4 groups based on TBI history for further statistical analysis. Results: Positive TBI history was associated with greater symptoms of insomnia and posttraumatic stress predeployment and persistence of insomnia symptoms, posttraumatic stress, and depression postdeployment. Positive TBI history and posttraumatic stress served as risk factors for head injury in Iraq, and SMs who reported a head injury during deployment also endorsed greater posttraumatic stress postdeployment than those without head injury. SMs with positive TBI history who also reported a new TBI in Iraq endorsed the greatest sleep and mental health problems across the study period. Conclusions: This study provides valuable information regarding temporal relationships between TBI, sleep, and mental health problems among a combat military population. Findings have important implications from both prevention and clinical perspectives.	[Holster, Jessica L.] Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, 920 Stanton L Young Blvd, Oklahoma City, OK 73104 USA; [Bryan, Craig J.] Natl Ctr Vet Studies, Salt Lake City, UT USA; [Bryan, Craig J.] Univ Utah, Salt Lake City, UT USA; [Heron, Elizabeth A.] US Air Force, Secur Forces Ctr, San Antonio, TX USA; [Heron, Elizabeth A.] CNI Adv, San Antonio, TX USA; [Seegmiller, Robert A.] Brooke Army Med Ctr, Neuropsychol Serv, Ft Sam Houston, TX 78234 USA		Holster, JL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Psychiat & Behav Sci, 920 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	jessica-holster@ouhsc.edu		Bryan, Craig/0000-0002-9714-0733	Department of the Air Force [09-198]; Department of DefenseUnited States Department of Defense; Department of the Air Force	This project was supported in part by an intramural grant from the Department of the Air Force awarded to Dr Heron (#09-198). Dr Bryan reports grant funding from the Department of Defense and the Department of the Air Force and contractual work with the Department of the Air Force.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; *ASS SECR DEF HLTH, 2007, TRAUM BRAIN INJ DEF; Baker DG, 2009, MIL MED, V174, P773; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Defense and Veterans Brain Injury Center, 2007, MIL AC CONC EV; Defense and Veterans Brain Injury Center, DOD NUMB TRAUM BRAIN; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leger D, 2014, J SLEEP RES, V23, P143, DOI 10.1111/jsr.12104; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; Maguen S, 2013, J NEUROTRAUM, V30, P1123, DOI 10.1089/neu.2012.2744; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2014, MIL MED, V179, P990, DOI 10.7205/MILMED-D-13-00349; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Morin CM, 2003, SLEEP MED REV, V7, P263, DOI 10.1053/smrv.2002.0274; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pang EW, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.63; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Weathers F., 1993, INT SOC TRAUM STRESS; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	46	6	6	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					25	33		10.1097/HTR.0000000000000237			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400003	27120293				2022-02-06	
J	Idowu, OE; Obafunwa, JO; Soyemi, SO				Idowu, Olufemi Emmanuel; Obafunwa, John O.; Soyemi, Sunday O.			Pituitary gland trauma in fatal nonsurgical closed traumatic brain injury	BRAIN INJURY			English	Article						Pituitary gland injury; pituitary stalk rupture; subdural haematoma	DIABETES-INSIPIDUS	Background: Traumatic injury to pituitary gland can lead to significant endocrine dysfunctions. The aim of this study is to define the frequency of pituitary gland injury in patients with fatal nonsurgical closed traumatic brain injury (TBI), and to correlate if any, the type of craniocerebral injury associated with the pituitary gland injury. Methods: The study is a prospective autopsy review of 30 adult patients with fatal closed TBI. Patients who had any form of neurosurgical intervention were excluded from the study. The harvested pituitary glands were assessed morphologically and histologically with haematoxylin-eosin stains. Results: There were 25 males and five females (median age: 35 years). Fatal closed TBI was associated with at least pituitary stalk rupture or pituitary gland haemorrhage in 13 patients (43.3%). There was significant relationship between subdural haemorrhage (SH) and either pituitary gland haemorrhage or pituitary stalk rupture. Odds ratio (OR) of a patient with SH having accompanying glandular pituitary haemorrhage was 21 while the OR of a patient with SH having pituitary stalk rupture was 12. Conclusion: Pituitary gland haemorrhage and stalk rupture frequency are fairly common in fatal closed TBI that do not require surgical intervention. Injury to both structures probably plays substantial roles in closed TBI outcome. We suggest routine assessment of pituitary gland function test in patients with closed TBI associated with SH.	[Idowu, Olufemi Emmanuel] Lagos State Univ, Coll Med, Dept Surg, Div Neurosurg, Lagos 234, Nigeria; [Obafunwa, John O.; Soyemi, Sunday O.] Lagos State Univ, Coll Med, Dep Pathol & Forens Med, Lagos, Nigeria; [Obafunwa, John O.; Soyemi, Sunday O.] Lagos State Univ Teaching Hosp, Lagos 234, Nigeria		Idowu, OE (corresponding author), Lagos State Univ, Coll Med, Dept Surg, Div Neurosurg, Lagos 234, Nigeria.; Idowu, OE (corresponding author), Lagos State Univ Teaching Hosp, Lagos 234, Nigeria.	oeidowu412@yahoo.com	Obafunwa, John/K-5244-2019; Soyemi, Sunday/AAA-2352-2021	Obafunwa, John/0000-0001-6014-168X; Idowu, Olufemi/0000-0001-9064-1562			Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Chaturvedi D, 2010, J TRAUMA, V69, P290, DOI 10.1097/TA.0b013e3181b403b5; Corneli Ginevra, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P301, DOI 10.1097/MED.0b013e3281e7e6e6; HADANI M, 1985, J NEUROSURG, V63, P456, DOI 10.3171/jns.1985.63.3.0456; Idowu OE, 2014, INJURY, V45, P1717, DOI 10.1016/j.injury.2014.05.028; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kibayashi K, 2012, AM J FOREN MED PATH, V33, P206, DOI 10.1097/PAF.0b013e3181fe33e8; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; LEVITT MA, 1984, J TRAUMA, V24, P532, DOI 10.1097/00005373-198406000-00012; Mesquita Joana, 2010, Endocrinol Nutr, V57, P492, DOI 10.1016/j.endonu.2010.06.012; Mitchell A, 1997, Crit Care Nurse, V17, P34; Powner DJ, 2008, CURR OPIN CRIT CARE, V14, P163, DOI 10.1097/MCC.0b013e3282f57528; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P540, DOI 10.1016/S0003-9993(97)90173-8	16	6	6	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					359	362		10.1080/02699052.2016.1257823			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900011	28156135				2022-02-06	
J	Johnstone, B; Hanks, R; Bhushan, B; Cohen, D; Roseberry, J; Yoon, DP				Johnstone, Brick; Hanks, Robin; Bhushan, Braj; Cohen, Daniel; Roseberry, Jarett; Yoon, Dong Pil			Selflessness as a universal neuropsychological foundation of spiritual transcendence: validation with Christian, Hindu, and Muslim traditions	MENTAL HEALTH RELIGION & CULTURE			English	Article						Selflessness; spirituality; right parietal lobe; Brief Multidimensional Measure of Religiousness; Spirituality; Christian; Hindu; Muslim	BRIEF MULTIDIMENSIONAL MEASURE; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SELF-TRANSCENDENCE; IMPLICIT RELIGIOUSNESS/SPIRITUALITY; HEALTH; PERSONALITY; MEDITATION; RELIGION; LESIONS	Research with US and European Christians has shown that increased spiritual transcendence is related to decreased right hemisphere/right parietal lobe (RH/RPL) functioning, which has been inferred as relating to increased selflessness. To determine if RH/RPL selflessness is a universal neuropsychological foundation for spiritual transcendence across cultures and religions, this study evaluated 109 individuals with traumatic brain injury from the US and India, including Christians, Hindus, and Muslims. Participants completed measures of spiritual transcendence and spatial perception as an index of the functional integrity of the RH/RPL. Spearman correlations indicated that decreased RH/RPL functioning is significantly associated with increased spiritual transcendence for the entire sample, but not for different cultures or religions, likely due to decreased statistical power. The results suggest that decreased RH/RPL-related selflessness is a universal neuropsychological foundation for spiritual transcendence across cultures and faith traditions, which is interpreted individually based on cultural and religious background (e.g., closeness to God, Allah, and Brahman).	[Johnstone, Brick] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65211 USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Bhushan, Braj] Indian Inst Technol, Kanpur, Uttar Pradesh, India; [Cohen, Daniel] Univ Missouri, Dept Religious Studies, Columbia, MO USA; [Roseberry, Jarett] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Yoon, Dong Pil] Univ Missouri, Sch Social Work, Columbia, MO USA		Johnstone, B (corresponding author), Univ Missouri, Dept Hlth Psychol, Columbia, MO 65211 USA.	johnstoneg@health.missouri.edu	Bhushan, Braj/B-1173-2008				Benton A, 1983, JUDGMENT LINE ORIENT; Brandstrom S, 1998, COMPR PSYCHIAT, V39, P122, DOI 10.1016/S0010-440X(98)90070-0; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Capanna C, 2013, PSYCHOL RELIG SPIRIT, V5, P316, DOI 10.1037/a0033642; Crescentini C, 2015, NEUROPSYCHOLOGIA, V70, P71, DOI 10.1016/j.neuropsychologia.2015.02.016; Crescentini C, 2014, CORTEX, V54, P1, DOI 10.1016/j.cortex.2014.01.023; d'Aquili E. G., 1993, ZYGON J RELIG SCI, V33, P177; d'Aquili EG, 2000, ZYGON, V35, P39, DOI 10.1111/0591-2385.00258; Feinberg T., 2005, LOST SELF PATHOLOGIE; Feinberg T. E., 2011, CONSCIOUSNESS COGNIT, V20; Feinberg TE, 2005, CONSCIOUS COGN, V14, P661, DOI 10.1016/j.concog.2005.01.002; Feinberg TE, 2001, ALTERED EGOS BRAIN C; Fetzer Institute/National Institute on Aging Working Group, 1999, MULT MEAREL SPIR U; Garcia-Romeu A., 2010, J TRANSPERSONAL PSY, V42; HERZOG H, 1991, NEUROPSYCHOBIOLOGY, V23, P182, DOI 10.1159/000119450; Idler EL, 2003, RES AGING, V25, P327, DOI 10.1177/0164027503025004001; Johnstone B, 2016, INT J PSYCHOL RELIG, V26, P287, DOI 10.1080/10508619.2015.1118328; Johnstone B, 2016, J RELIG HEALTH, V55, P572, DOI 10.1007/s10943-015-0170-y; Johnstone B, 2015, RELIG BRAIN BEHAV, V5, P24, DOI 10.1080/2153599X.2014.880069; Johnstone B, 2015, NEUROPSYCHOLOGY, V29, P463, DOI 10.1037/neu0000155; Johnstone B, 2012, INT J PSYCHOL RELIG, V22, P267, DOI 10.1080/10508619.2012.657524; Johnstone B, 2008, ZYGON, V43, P861, DOI 10.1111/j.1467-9744.2008.00964.x; Johnstone B, 2009, J RELIG HEALTH, V48, P146, DOI 10.1007/s10943-008-9179-9; KASS JD, 1991, J SCI STUD RELIG, V30, P203, DOI 10.2307/1387214; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Levenson MR, 2005, INT J AGING HUM DEV, V60, P127, DOI 10.2190/XRXM-FYRA-7U0X-GRC0; Lewis GJ, 2011, INTELLIGENCE, V39, P468, DOI 10.1016/j.intell.2011.08.002; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; MacDonald DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117701; Neff JA, 2006, J SCI STUD RELIG, V45, P449, DOI 10.1111/j.1468-5906.2006.00318.x; Newberg A, 2003, PERCEPT MOTOR SKILL, V97, P625, DOI 10.2466/PMS.97.5.625-630; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg A, 1997, J NUCL MED, V38, P77; Newberg Andrew I., 2005, HDB PSYCHOL RELIG SP, P199; Ng VWK, 2000, HUM BRAIN MAPP, V10, P80, DOI 10.1002/(SICI)1097-0193(200006)10:2<80::AID-HBM40>3.0.CO;2-2; *PEW RES CTR, 2012, NON RIS ON IN 5 AD H; Piedmont RL, 1999, J PERS, V67, P985, DOI 10.1111/1467-6494.00080; Piedmont RL., 2007, RES SOCIAL SCI STUDY, V17, P177; Przybeck TR, 1994, TEMPERAMENT CHARACTE; REED PG, 1991, NURS RES, V40, P5; Schjoedt U, 2009, METH THEORY STUD REL, V21, P310, DOI 10.1163/157006809X460347; Stewart C., 2006, INT J PSYCHOL RELIG, V16, P181, DOI [DOI 10.1207/S15327582IJPR1603_3, 10.1207/s15327582ijpr1603_3]; Tranel D., 2002, HDB MEMORY DISORDERS; Tranel D, 2009, J CLIN EXP NEUROPSYC, V31, P219, DOI 10.1080/13803390802317542; Urgesi C, 2010, NEURON, V65, P309, DOI 10.1016/j.neuron.2010.01.026; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Zahavi D, 2011, CONSCIOUS COGN, V20, P141, DOI 10.1016/j.concog.2010.10.011	49	6	6	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1367-4676	1469-9737		MENT HEALTH RELIG CU	Ment. Health Relig. Cult.		2017	20	2					175	187		10.1080/13674676.2017.1333090			13	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	FD0OV	WOS:000407239500007					2022-02-06	
J	Kozler, P; Maresova, D; Pokorny, J				Kozler, Petr; Maresova, Dana; Pokorny, Jaroslav			Study of locomotion, rearing and grooming activity after single and/or concomitant lesions of central and peripheral nervous system in rats	NEUROENDOCRINOLOGY LETTERS			English	Article						dual diagnosis; concomitant injury; locomotion; rearing; grooming; open field test; water intoxication; peripheral neuropathy; cellular brain edema	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; WATER-INTOXICATION; YOUNG-RATS; OPEN-FIELD; BEHAVIOR; EDEMA; HYPONATREMIA; ANXIETY; CORTEX	OBJECTIVE: Locomotion, rearing and grooming represent different forms of behaviour and motor activity in rats. In this study, changes in these activities were analysed in relation to impaired function of the nervous system by single and/or concomitant lesions representing an experimental model of the dual diagnosis. METHODS: 32 rats were divided into 4 groups of 8 rats: intact rats, rats with single lesion of peripheral nervous system (PNS) - Marcaine neuropathy, rats with single CNS lesion - cellular brain edema induced by water intoxication, and the concomitant lesions (combination of CNS and PNS lesion in one rat). Water intoxication was performed in a standard way by fractionated hyperhydration. The average time spent by locomotion, rearing and grooming was registered and analyzed using an open field test. RESULTS: All activities of the rats after water intoxication became inhibited due to the generally suppressive effect of brain edema. Lesion of PNS reduced activity in locomotion only, because for rearing and grooming activities, the function of the forelimb is not dominant. Combination of lesions (dual diagnosis) reduced locomotion and rearing activity more than single lesions, and enhances the stressogenic effect, which was manifested by a long periods of grooming. CONCLUSION: Results of our study confirmed the physiological and pathophysiological differences in the movement stereotype between locomotion, rearing and grooming caused by the characteristics and algorithms of the movements, which are inborn to rats - the dominant role of the forelimbs in locomotion, the dominant exploratory activity in rearing, and the precise syntactic movement pattern in grooming.	[Kozler, Petr; Maresova, Dana; Pokorny, Jaroslav] Charles Univ Prague, Inst Physiol, Fac Med 1, Albertov 5, Prague 12800 2, Czech Republic		Pokorny, J (corresponding author), Charles Univ Prague, Inst Physiol, Fac Med 1, Albertov 5, Prague 12800 2, Czech Republic.	jaroslav.pokorny@lf1.cuni.cz			Progres Q35	Supported with grant Progres Q35.	Alves R, 2005, BRAIN RES, V1058, P178, DOI 10.1016/j.brainres.2005.08.005; Aragao RD, 2011, J NEUROSCI METH, V195, P216, DOI 10.1016/j.jneumeth.2010.12.016; Arzaga Deborah, 2003, SCI Nurs, V20, P86; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; BERRIDGE KC, 1989, BEHAV BRAIN RES, V33, P241, DOI 10.1016/S0166-4328(89)80119-6; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Cromwell HC, 1996, J NEUROSCI, V16, P3444; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Jandova K, 2014, PHYSIOL RES, V63, pS521, DOI 10.33549/physiolres.932936; JOLLES J, 1979, BEHAV NEURAL BIOL, V25, P563, DOI 10.1016/S0163-1047(79)90362-5; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Kozler P, 2013, PHYSIOL RES, V62, pS75, DOI 10.33549/physiolres.932566; Kozler P, 2017, EXPT MODEL IN PRESS; Kozler P, 2012, NEUROENDOCRINOL LETT, V33, P782; Kruk MR, 1998, NEUROSCI BIOBEHAV R, V23, P163, DOI 10.1016/S0149-7634(98)00018-9; Levine JB, 2008, NEUROSCIENCE, V151, P589, DOI 10.1016/j.neuroscience.2007.10.014; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Maresova D, 2014, NEUROENDOCRINOL LETT, V35, P274; OLSON JE, 1994, ACTA NEUROCHIR, P571; Onaya M, 2002, NEUROPATHOLOGY, V22, P243, DOI 10.1046/j.1440-1789.2002.00456.x; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; RIDGELY MS, 1990, SCHIZOPHRENIA BULL, V16, P123, DOI 10.1093/schbul/16.1.123; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Schallert T, 2003, J REHABIL RES DEV, V40, P9, DOI 10.1682/JRRD.2003.08.0009; Silver SM, 1999, AM J PHYSIOL-REG I, V276, pR1595; Slamberova R, 2013, PHYSIOL RES, V62, pS99, DOI 10.33549/physiolres.932593; Sousa N, 2006, GENES BRAIN BEHAV, V5, P5, DOI 10.1111/j.1601-183X.2006.00228.x; Strong MK, 2009, EXP NEUROL, V217, P96, DOI 10.1016/j.expneurol.2009.01.020; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Vitalo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005523; Whishaw I. Q., 1999, MODERN TECHNIQUES NE; WHISHAW IQ, 1993, BEHAV BRAIN RES, V56, P59, DOI 10.1016/0166-4328(93)90022-I; Yamaguchi M, 1997, ACT NEUR S, V70, P152	37	6	6	0	2	MAGHIRA & MAAS PUBLICATIONS	MUNSBACH	MAGHIRA & MAAS S A R L, 6C, RUE GABRIEL LIPPMANN, L-5365 MUNSBACH, LUXEMBOURG	0172-780X			NEUROENDOCRINOL LETT	Neuroendocrinol. Lett.		2017	38	7					495	501	PMID 29369601				7	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	FU7ON	WOS:000424041900007	29369601				2022-02-06	
J	Liu, TT; Zeng, XW; Sun, FL; Hou, HL; Guan, YQ; Guo, DY; Ai, HX; Zhang, GJ; Wang, W				Liu, Tingting; Zeng, Xianwei; Sun, Fangling; Hou, Hongli; Guan, Yunqian; Guo, Deyu; Ai, Houxi; Zhang, Guojun; Wang, Wen			EphB4 Regulates Self-Renewal, Proliferation and Neuronal Differentiation of Human Embryonic Neural Stem Cells in Vitro	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						EphB4 signaling; Neural stem cells; Self-renewal; Proliferation; Differentiation; Neuron	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; EPHRIN-B; C-ABL; ADULT NEUROGENESIS; SIGNALING PATHWAYS; KINASE; CANCER; TRANSPLANTATION	Background/Aims: EphB4 belongs to the largest family of Eph receptor tyrosine kinases. It contributes to a variety of pathological progresses of cancer malignancy. However, little is known about its role in neural stem cells (NSCs). This study examined whether EphB4 is required for proliferation and differentiation of human embryonic neural stem cells (hNSCs) in vitro. Methods: We up-and down-regulated EphB4 expression in hNSCs using lentiviral over-expression and shRNA knockdown constructs and then investigated the influence of EphB4 on the properties of hNSCs. Results: Our results show that shRNA-mediated EphB4 reduction profoundly impaired hNSCs self-renewal and proliferation. Furthermore, detection of differentiation revealed that knockdown of EphB4 inhibited hNSCs differentiation towards a neuronal lineage and promoted hNSCs differentiation to glial cells. In contrast, EphB4 overexpression promoted hNSCs self-renewal and proliferation, further induced hNSCs differentiation towards a neuronal lineage and inhibited hNSCs differentiation to glial cells. Moreover, we found that EphB4 regulates cell proliferation mediated by the Abl-CyclinD1 pathway. Conclusion: These studies provide strong evidence that fine tuning of EphB4 expression is crucial for the proliferation and neuronal differentiation of hNSCs, suggesting that EphB4 might be an interesting target for overcoming some of the therapeutic limitations of neuronal loss in brain diseases. (C) 2017 The Author(s) Published by S. Karger AG, Basel	[Liu, Tingting; Sun, Fangling; Hou, Hongli; Guo, Deyu; Ai, Houxi; Wang, Wen] Capital Med Univ, Dept Expt Anim Ctr, Xuanwu Hosp, 45 Changchun Rd, Beijing 100053, Peoples R China; [Zeng, Xianwei] Weifang Med Coll, Dept Neurosurg, Affiliated Hosp, Weifang, Peoples R China; [Guan, Yunqian] Capital Med Univ, Xuanwu Hosp, Dept Cell Biol, Beijing, Peoples R China; [Zhang, Guojun] Capital Med Univ, Xuanwu Hosp, Beijing Inst Funct Neurosurg, 45 Changchun Rd, Beijing 100053, Peoples R China; [Wang, Wen] Beijing Inst Brain Disorders, Beijing, Peoples R China		Wang, W (corresponding author), Capital Med Univ, Dept Expt Anim Ctr, Xuanwu Hosp, 45 Changchun Rd, Beijing 100053, Peoples R China.; Zhang, GJ (corresponding author), Capital Med Univ, Xuanwu Hosp, Beijing Inst Funct Neurosurg, 45 Changchun Rd, Beijing 100053, Peoples R China.	zgj62051@163.com; lzwwang@163.com			National Science and Technology Major Project [2012ZX09102201-106]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81573633, 81503049, 81373994, 81173575]	We thank Professors Zhiguo Chen and Yumin Luo and their colleagues for excellent technical assistance. This work was supported by the National Science and Technology Major Project (2012ZX09102201-106) and the National Natural Science Foundation of China (81573633, 81503049, 81373994 and 81173575).	Alam SM, 2007, ANN ONCOL, V18, P485, DOI 10.1093/annonc/mdl414; Arien-Zakay H, 2010, INT J MOL SCI, V11, P3513, DOI 10.3390/ijms11093513; Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212; Casamassa A, 2016, GLIA, V64, P1124, DOI 10.1002/glia.22985; Cheng W, 2015, CELL PHYSIOL BIOCHEM, V35, P2019, DOI 10.1159/000374009; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Di CG, 2014, NEUROREPORT, V25, P782, DOI 10.1097/WNR.0000000000000177; Doeppner TR, 2011, ACTA NEUROPATHOL, V122, P429, DOI 10.1007/s00401-011-0856-5; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Ferguson BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067668; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Hara Y, 2010, STEM CELLS, V28, P974, DOI 10.1002/stem.427; Harbott LK, 2005, MOL CELL NEUROSCI, V30, P1, DOI 10.1016/j.mcn.2005.05.002; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Huang H, 2015, CELL PHYSIOL BIOCHEM, V35, P315, DOI 10.1159/000369698; Katakowski M, 2005, NEUROSCI LETT, V385, P204, DOI 10.1016/j.neulet.2005.05.060; Kaur S, 2016, INT J BIOCHEM CELL B, V81, P184, DOI 10.1016/j.biocel.2016.05.005; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Khodosevich K, 2011, J CELL SCI, V124, P1268, DOI 10.1242/jcs.076059; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Lee YC, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-119; Li M, 2011, DIGEST DIS SCI, V56, P698, DOI 10.1007/s10620-010-1346-7; Li MF, 2013, CELL PHYSIOL BIOCHEM, V32, P1776, DOI 10.1159/000356611; Madhavan L, 2010, NEUROPHARMACOLOGY, V58, P835, DOI 10.1016/j.neuropharm.2009.10.005; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nguyen TM, 2013, STEM CELLS DEV, V22, P2751, DOI 10.1089/scd.2012.0676; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Peixoto FO, 2015, CELL PHYSIOL BIOCHEM, V35, P104, DOI 10.1159/000369679; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Reekmans K, 2012, STEM CELL REV REP, V8, P262, DOI 10.1007/s12015-011-9266-2; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Rutkowski R, 2012, INT J CANCER, V131, pE614, DOI 10.1002/ijc.27392; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Schlatterer SD, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-208; Shu Y, 2016, MOL NEUROBIOL, V53, P561, DOI 10.1007/s12035-014-9020-2; Soni R, 2000, BIOCHEM BIOPH RES CO, V275, P877, DOI 10.1006/bbrc.2000.3349; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Torii MA, 1999, DEVELOPMENT, V126, P443; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; Xia GB, 2005, CLIN CANCER RES, V11, P4305, DOI 10.1158/1078-0432.CCR-04-2109; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP	48	6	6	3	7	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2017	41	2					819	834		10.1159/000459693			16	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	EU3EC	WOS:000400910400033	28214829	gold			2022-02-06	
J	Ljungqvist, J; Nilsson, D; Ljungberg, M; Esbjornsson, E; Eriksson-Ritzen, C; Skoglund, T				Ljungqvist, Johan; Nilsson, Daniel; Ljungberg, Maria; Esbjornsson, Eva; Eriksson-Ritzen, Catherine; Skoglund, Thomas			Longitudinal changes in diffusion tensor imaging parameters of the corpus callosum between 6 and 12 months after diffuse axonal injury	BRAIN INJURY			English	Article						Traumatic brain injury; axonal injury; MRI; outcome measures	TRAUMATIC BRAIN-INJURY; NEUROLOGICAL-INSTITUTE SCREEN; WHITE-MATTER INTEGRITY; HEAD-INJURY; COGNITIVE FUNCTION; SERIAL CHANGES; MODERATE; VALIDATION; SCALE; MILD	Background: resonance diffusion tensor imaging(MR-,DTI) is used increasingly to detect diffuse axonal injury (DAI) after traumatic brain injury (TBI). Primary objective: To investigate changes in the diffusion tensor imaging parameters of the corpus callosum 6 and 12 months after TBI, to optimize the timing of follow-up DTI investigations. A secondary goal was to study the relationship between DTI parameters and outcome. Research design: Longitudinal prospective study. Methods and procedures: MR-DTI was performed in 15 patients with suspected DAI, 6 and 12 months post-injury. Sixteen controls were also examined. Fractional anisotropy (FA) and diffusivity (trace) in the corpus callosum were analysed. The outcome measures were the extended Glasgow Outcome Scale and the Barrow Neurological Institute Screen for Higher Cerebral Functions, assessed at 6 and 12 months. Main outcomes and results: FA decreased and trace increased at 6 and 12 months compared to controls. Trace continued to increase even further between 6 and 12 months, while FA remained unchanged. Patients with the worst outcomes had lower FA and higher trace compared to patients with better outcomes. Conclusions: DTI parameters have not reached,a stable level at 6 months after DAI, but continue to change, probably reflecting an incessant microstructural alteration of the white matter.	[Ljungqvist, Johan; Nilsson, Daniel; Eriksson-Ritzen, Catherine; Skoglund, Thomas] Sahlgrens Univ Hosp, Dept Neurosurg, SE-41345 Gothenburg, Sweden; [Ljungberg, Maria] Sahlgrens Univ Hosp, Dept Med Phys & Biomed Engn, Gothenburg, Sweden; [Esbjornsson, Eva] Sahlgrens Univ Hosp, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden		Ljungqvist, J (corresponding author), Sahlgrens Univ Hosp, Dept Neurosurg, SE-41345 Gothenburg, Sweden.	johan.ljungqvist@vgregion.se	Nilsson, Daniel/AAF-3868-2020		Health and Medical Care Committee of Vastra Gotaland; Foundation for Medical Imaging in Memory of Erik Lysholm	The authors report no conflicts of interest. This work was supported by grants from the Health and Medical Care Committee of Vastra Gotaland, and the Foundation for Medical Imaging in Memory of Erik Lysholm.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bjorkdahl A, 2016, DISABIL REHABIL, V38, P1006, DOI 10.3109/09638288.2015.1076073; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Denvall V, 2002, J REHABIL MED, V34, P153, DOI 10.1080/16501970213231; Esbjornsson E, 2013, BRAIN INJURY, V27, P521, DOI 10.3109/02699052.2012.743179; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Good P., 2000, PERMUTATION TESTS PR; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hofgren C, 2007, J REHABIL MED, V39, P547, DOI 10.2340/16501977-0085; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moen KG, 2014, J NEUROTRAUM, V31, P56, DOI 10.1089/neu.2013.3000; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Prigatano G., 1991, BNI Q, V7, P2; Prigatano GP, 1995, 628487 TXU; Prigatano GP, 1993, BNI Q, V9, P2; Prigatano GP, 2008, BNI SCREEN HIGHER CE; Rosenstein LD, 1992, BNI Q, V8, P24; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Studerus-Germann AM, 2016, INT J NEUROSCI, V126, P289, DOI 10.3109/00207454.2015.1033620; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	44	6	8	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					344	350		10.1080/02699052.2016.1256500			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900009	28128655				2022-02-06	
J	Loosemore, MP; Butler, CF; Khadri, A; McDonagh, D; Patel, VA; Bailes, JE				Loosemore, Michael P.; Butler, Charles F.; Khadri, Abdelhamid; McDonagh, David; Patel, Vimal A.; Bailes, Julian E.			Use of Head Guards in AIBA Boxing Tournaments-A Cross-Sectional Observational Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						head protective devices; traumatic brain injury; concussion; acute brain injuries; boxing	PROFESSIONAL FOOTBALL PLAYERS; CONCUSSION; INJURY; BOXERS; RISK	Objective: This study looks at the changes in injuries after the implementation of a new rule by the International Boxing Association (AIBA) to remove head guards from its competitions. Design: A cross-sectional observational study performed prospectively. This brief report examines the removal of head guards in 2 different ways. The first was to examine the stoppages due to blows to the head by comparing World Series Boxing (WSB), without head guards, to other AIBA competitions with head guards. Secondly, we examined the last 3 world championships: 2009 and 2011 (with head guards) and 2013 (without head guards). Setting: World Series Boxing and AIBA world championship boxing. Participants: Boxers from WSB and AIBA world championships. Interventions: The information was recorded by ringside medical physicians. Main Outcome Measures: Stoppages per 10 000 rounds; stoppages per 1000 hours. Results: Both studies show that the number of stoppages due to head blows was significantly decreased without head guards. The studies also showed that there was a notable increase in cuts. Conclusions: Removing head guards may reduce the already small risk of acute brain injury in amateur boxing.	[Loosemore, Michael P.; Butler, Charles F.; Khadri, Abdelhamid; McDonagh, David] Int Boxing Assoc, AIBA Med Commiss, Lausanne, Switzerland; [Loosemore, Michael P.] Univ Coll London Hosp, Inst Sport Exercise & Hlth, London, England; [McDonagh, David] Int Boxing Assoc, AIBA Sci Commiss, Lausanne, Switzerland; [Patel, Vimal A.; Bailes, Julian E.] NorthShore Univ HealthSyst, NorthShore Neurol Inst, Evanston, IL USA		Bailes, JE (corresponding author), Evanston Hosp Corp, NorthShore Neurol Inst, 3rd Floor Kellogg Bldg,2650 Ridge Ave, Evanston, IL 60201 USA.	jbailes@northshore.org					Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Gennarelli TA, 1972, STAPP CAR CRASH J, V16, P296; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; McCrory P, 2002, BRIT J SPORT MED, V36, P314, DOI 10.1136/bjsm.36.5.314; Moriarity JM, 2012, BRIT J SPORT MED, V46, P1011, DOI 10.1136/bjsports-2011-090893; O'Sullivan D, 2014, BRIT J SPORT MED, V48, P648, DOI DOI 10.1136/BJSPORTS-2014-093494.233	11	6	6	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2017	27	1					86	88		10.1097/JSM.0000000000000322			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	EH9OP	WOS:000392101000015	27116592				2022-02-06	
J	Mbakile-Mahlanza, L; Manderson, L; Ponsford, J				Mbakile-Mahlanza, Lingani; Manderson, Lenore; Ponsford, Jennie			Cultural beliefs about TBI in Botswana	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						TBI; Culture; Beliefs	TRAUMATIC BRAIN-INJURY; PERCEPTION QUESTIONNAIRE; EXPERIENCES; FAMILIES; EDUCATION; OUTCOMES; ILLNESS; AFRICAN; RACE	Cultural differences have been shown to have an influence on outcome following traumatic brain injury (TBI). This study examined illness representations and the nature of beliefs about TBI in Botswana, a small middle income country in southern Africa. Participants included 26 people who had sustained moderate to severe TBI, 18 caregivers (all significant others) and 27 healthcare workers. A mixed-methods approach was utilised. Illness representations were assessed using the revised Illness Perception Questionnaire (IPQ-R), and beliefs and perceptions about cause of injury were established through semi-structured qualitative interviews. Results indicated that participants considered TBI to be chronic in nature and accompanied by serious consequences. Participants held positive attitudes about the manageability of symptoms despite having little understanding about TBI and its consequences. People with TBI tended to report fewer symptoms than did their caregivers. In addition, although some participants held concrete beliefs about the causes of injury, many participants attributed the injury to supernatural causes. Religious interpretations were also commonly held. Although age appeared to be associated with beliefs, no significant relationships existed between demographic factors and beliefs about the injury. This study highlights the importance of understanding the cultural perspectives of patients and their families in order to provide effective care.	[Mbakile-Mahlanza, Lingani; Manderson, Lenore; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Manderson, Lenore] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu		Mbakile-Mahlanza, Lingani/0000-0002-1285-3276; Manderson, Lenore/0000-0002-7883-1790			Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Beuster J., 1997, UNISA PSYCHOL, V24, P4; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chhabra S, 2010, J DISABIL POLICY STU, V20, P219, DOI 10.1177/1044207309344690; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Denbow J., 2006, CULTURE CUSTOMS BOTS, V1; DEVLIEGER P, 1995, DISABILITY CULTURE, P94; Farmer P., 1992, ETHNOPSYCHIATRY CULT, P251; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; INGSTAD B, 1988, INT J REHABIL RES, V11, P351, DOI 10.1097/00004356-198812000-00004; Ingstad B, 1990, Int J Rehabil Res, V13, P187, DOI 10.1097/00004356-199009000-00001; Ingstad B, 1995, DISABILITY CULTURE, P246; INGSTAD B, 1989, CULTURE EXPERIENCE P, P247; Ingstad B., 1997, COMMUNITY BASED REHA, V7; Ingstad Benedicte, 2007, DISABILITY LOCAL GLO, P237; Jackson H., 1988, Journal of Social Development in Africa, V3, P21; Khoury NM, 2012, CULT MED PSYCHIAT, V36, P514, DOI 10.1007/s11013-012-9270-2; Kleinman Arthur., 1980, PATIENTS HEALERS CON; Kobusingye O, 2001, Inj Prev, V7, P46, DOI 10.1136/ip.7.1.46; Leventhal H., 1997, PERCEPTIONS HLTH ILL, V2, P19; Lincoln Y., 2002, QUALITATIVE INQUIRY; Lopez-Jimenez H., 2011, BEHAV MODERATE SERER; Markovic M, 2006, FIELD METHOD, V18, P413, DOI 10.1177/1525822X06293126; Mokhosi MT, 2004, S AFR J PSYCHOL, V34, P301, DOI 10.1177/008124630403400208; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; MURREY GJ, 2000, FORENSIC EVALUATION; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Peden M., 2004, WORLD REPORT ROAD TR; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Schapera Isaac, 1952, AFR AFFAIRS, V51, P41; Schapera Isaac, 1958, J ROYAL ANTHR I GREA, V88, P1; Shek DTL, 2003, AM J FAM THER, V31, P427, DOI 10.1080/01926180390228955; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Shumba A, 2009, AFR EDUC RE, V6, P123, DOI 10.1080/18146620902857558; The PRS Group, 2010, BOTSW COUNTR REP; Tobin GA, 2004, J ADV NURS, V48, P388, DOI 10.1111/j.1365-2648.2004.03207.x; van Dyk AC, 2001, S AFR J PSYCHOL, V31, P60, DOI 10.1177/008124630103100208; Vonarx N, 2007, ANTHROPOL ACTION, V14, P18, DOI 10.3167/aia.2007.140304; Warren N, 2013, HEALTH-LONDON, V17, P323, DOI 10.1177/1363459312460699; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774	47	6	6	2	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	1					38	59		10.1080/09602011.2015.1053946			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EB0SL	WOS:000387055700004	26399782				2022-02-06	
J	Merz, ZC; Roskos, PT; Gfeller, JD; Bucholz, RD				Merz, Zachary C.; Roskos, P. Tyler; Gfeller, Jeffrey D.; Bucholz, Richard D.			Impact of psychiatric symptomatology on neuropsychological assessment performance in persons with TBI: A comparison of OEF/OIF veteran and civilian samples	BRAIN INJURY			English	Article						Traumatic brain injury; blast injury; post-traumatic stress disorder	TRAUMATIC BRAIN-INJURY; COMBAT VETERANS; MENTAL-HEALTH; RISK-FACTORS; IRAQ; AFGHANISTAN; DEPRESSION; DEFICITS; OUTCOMES; RBANS	Objective: To assess whether increased incidence of post-traumatic stress disorder and depressive symptomatology in veterans with combat-related traumatic brain injury might help account for neurocognitive impairment relative to civilians with traumatic brain injury.Participants: Neuropsychological assessment data of 53 Operation Enduring Freedom/Operation Iraqi Freedom veterans and 48 civilians with positive history of traumatic brain injury were analyzed to assess differences with respect to cognitive performance.Design: Retrospective analysis of data including neurocognitive test performance and self-reported symptoms of post-traumatic stress disorder and depression.Results: Results showed worse neurocognitive performance (i.e. RBANS Total Index score) in the veteran sample relative to the civilian sample [F(1,99) = 3.92, p = .05, ?2 = .04], particularly on tasks measuring attentional capabilities [F(1,99) = 9.18, p = .003, ?2 = .09]. Additional analyses found that after controlling for post-traumatic stress disorder symptomatology, differences were no longer significant. Broad correlations between measures also showcased attenuated relationships after controlling for both post-traumatic stress disorder and depressive symptomatology using partial correlationsConclusion: Findings suggest that the presence of post-traumatic stress disorder and depressive symptomatology negatively impacts cognitive performance across neuropsychological assessment above and beyond deficits related to traumatic brain injury.	[Merz, Zachary C.; Gfeller, Jeffrey D.] St Louis Univ, Dept Psychol, St Louis, MO 63108 USA; [Roskos, P. Tyler] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil Oakwood, Dearborn, MI USA; [Bucholz, Richard D.] St Louis Univ, Dept Neurosurg, St Louis, MO 63103 USA		Merz, ZC (corresponding author), St Louis Univ, Dept Psychol, St Louis, MO 63108 USA.	merzz@slu.edu		Merz, Zachary/0000-0001-7268-6265	Department of Defense: Evidence-Based Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder at SANICUnited States Department of Defense	This research was supported by the following grant from the Department of Defense: Evidence-Based Multimodal Neurodiagnostic Imaging of Traumatic Brain Injury and Post-Traumatic Stress Disorder at SANIC; Protocol Number PT075832 001-R004, Richard Bucholz, Principal Investigator.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beck AT, 1996, MANUAL FOR THE BDI 2; Bolzenius JD, 2015, APPL NEUROPSYCH-ADUL, V22, P79, DOI 10.1080/23279095.2013.845823; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Getz G. E., 2014, APPL BIOL PSYCHOL; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2003, MANUAL WORD MEMORY T; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Kroenke K, 1998, PSYCHOSOM MED, V60, P150, DOI 10.1097/00006842-199803000-00006; Larson E, 2013, REHABIL PSYCHOL, V58, P245, DOI 10.1037/a0032953; Lippa SM, 2013, BRAIN INJURY, V27, P689, DOI 10.3109/02699052.2013.771793; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Morey, 1991, PERSONALITY ASSESSME; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Oquendo MA, 2001, AM J PSYCHIAT, V158, P1652, DOI 10.1176/appi.ajp.158.10.1652; Porter RJ, 2005, AM J GERIAT PSYCHIAT, V13, P607; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Randolph C., 1998, RBANS MANUAL; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schuitevoerder S, 2013, J ANXIETY DISORD, V27, P550, DOI 10.1016/j.janxdis.2013.01.001; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SUTKER PB, 1991, AM J PSYCHIAT, V148, P67; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; WechslerD, 2001, WECHSLER TEST ADULT; Wolfe J, 1991, PSYCHOL ASSESSMENT J, V3, P573, DOI DOI 10.1037/1040-3590.3.4.573	39	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	11					1422	1428		10.1080/02699052.2017.1339124			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GB	WOS:000415961200003	28707957				2022-02-06	
J	Meyer, SRA; de Jonghe, JFM; Schmand, B; Ponds, RWHM				Meyer, Sascha R. A.; de Jonghe, Jos F. M.; Schmand, Ben; Ponds, Rudolf W. H. M.			The Visual Association Test-Extended: a cross-sectional study of the performance validity measures	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity test; simulating; malingering; memory; psychometrics	TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; CLASSIFICATION ACCURACY; ALZHEIMERS-DISEASE; HEAD-INJURY; COGNITIVE IMPAIRMENT; DISABILITY CLAIMANTS; LIKELIHOOD RATIOS; CHRONIC PAIN; DEMENTIA	Objective: Given the hazards of knowledge about performance validity tests (PVTs) being proliferated among the general public, there is a continuous need to develop new PVTs. The purpose of these studies was to validate the newly developed Visual Association Test-Extended (VAT-E). Method: The VAT-E consists of 24 pairs of line drawings; it is partly based on Green's Word Memory Test (WMT) paradigm. In study 1, we compared VAT-E total scores of healthy controls (n=226), patients with mild cognitive impairment (MCI) (n=76), patients with Alzheimer's disease (AD) (n=26), and persons instructed to feign memory deficit (n=29). In study 2, we compared litigating patients classified by Slick's criteria as Malingering of Neurocognitive Dysfunction (MND) (n=26) or non-MND (n=67). In addition, we compared the VAT-E to the Test of Memory Malingering (TOMM) (study 1) and the WMT (study 2). Results: Results showed that the VAT-E differentiated patients with MCI (specificity 93-100%) or patients with AD (specificity 92-100%) from persons instructed to feign (sensitivity 86-100%). The VAT-E also differentiated MND from non-MND (sensitivity 54%, specificity 97%). The VAT-E was in perfect agreement with the TOMM in classifying healthy controls and persons instructed to feign, and it was in moderate agreement with the WMT in classifying non-MND and MND. Conclusion: Preliminary evidence shows that the VAT-E may be a useful PVT based on the ability to differentiate between those with genuine memory impairment, persons instructed to feign memory impairment, and a group suspected of malingering cognitive deficits.	[Meyer, Sascha R. A.; de Jonghe, Jos F. M.; Ponds, Rudolf W. H. M.] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Meyer, Sascha R. A.; de Jonghe, Jos F. M.] Northwest Med Ctr, Dept Geriatr Med, Alkmaar, Netherlands; [Schmand, Ben] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Schmand, Ben] Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands		Meyer, SRA; de Jonghe, JFM (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Neuropsychol, Maastricht, Netherlands.; Meyer, SRA; de Jonghe, JFM (corresponding author), Northwest Med Ctr, Dept Geriatr Med, Alkmaar, Netherlands.	smeyer70@gmail.com; j.f.m.de.jonghe@nwz.nl		ponds, rudolf/0000-0002-9748-4659	Foreest Northwest Medical School [FIO1308]	This work was supported by the Foreest Northwest Medical School [grant number FIO1308].	Agresti A., 2007, STAT ART SCI LEARNIN, P244; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Bush, 2013, MILD TRAUMATIC BRAIN, P1; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; De Graaf A., 1991, COGNITIVE SCREENING; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green P., 2008, GREENS NONVERBAL MED; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Guilmette T.J., 2013, MILD TRAUMATIC BRAIN, P31; Guilmette TJ, 1996, PERCEPT MOTOR SKILL, V83, P1007, DOI 10.2466/pms.1996.83.3.1007; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Larrabee G. J., 2007, ASSESSMENT MALINGERE, P34; LARRABEE GJ, 2007, ASSESSMENT MALINGERE, P3; Larrabee GJ, 2007, ASSESSMENT MALINGERE, P44; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lindeboom J., 2014, VISUAL ASS TEST MANU; Lindeboom J, 2003, VISUAL ASS TEST MANU; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; PAIVIO A, 1968, PSYCHON SCI, V11, P137; PAIVIO A, 1969, PSYCHOL REV, V76, P241, DOI 10.1037/h0027272; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rogers R, 2008, CLIN ASSESSMENT MALI; Saan R. J., 1986, HDB NEUROPSYCHOLOGIS, P267; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Schmand B, 1996, Tijdschr Gerontol Geriatr, V27, P29; Schmand B., 2004, AMSTERDAM SHORT TERM; Schmidt M., 1996, REY AUDITORY VERBAL; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; SHEPARD RN, 1967, J VERB LEARN VERB BE, V6, P156, DOI 10.1016/S0022-5371(67)80067-7; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Tombaugh T.N., 1996, TEST MEMORY MALINGER; UNESCO, 2006, INT STAND CLASS ED I; Verhage F., 1964, THESIS; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	60	6	6	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	4					798	813		10.1080/13854046.2017.1280181			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ES6HB	WOS:000399646200204	28156190				2022-02-06	
J	Moreno, JA; McKerral, M				Moreno, Jhon Alexander; McKerral, Michelle			Towards a taxonomy of sexuality following traumatic brain injury: A pilot exploratory study using cluster analysis	NEUROREHABILITATION			English	Article						Neurosexuality; cluster analysis; traumatic brain injury; sexual quality of life; sexual desire; depression; anxiety	DYSEXECUTIVE QUESTIONNAIRE DEX; GENERALIZED ANXIETY DISORDER; QUALITY-OF-LIFE; DESIRE INVENTORY; PSYCHOMETRIC PROPERTIES; PREMATURE EJACULATION; ERECTILE DYSFUNCTION; NORMATIVE DATA; SYMPTOMS; VALIDATION	INTRODUCTION: Clinicians need to understand the heterogeneity of sexual problems following traumatic brain injury (TBI) for their adequate identification and treatment. OBJECTIVE: To systematically identify groups of individuals with TBI showing similar patterns of sexual functioning. METHODS: Forty-two individuals with TBI with a mean age of 37.9 years (SD = 9.7) and an average of 3.3 years post injury (SD = 4.3). We included four primary measures in the cluster analysis (sexual quality of life questionnaire, sexual desire inventory, generalized anxiety disorder scale, and the patient health questionnaire for depression) and two secondary measures for cluster validation (post-concussion symptom scale and dysexecutive questionnaire). RESULTS: A hierarchical cluster analysis using the Ward method revealed the existence of two groups of individuals with TBI: a) with sexual problems who were older, showed lower levels of sexual quality of life and sexual desire, with significant symptoms of anxiety and depression, and b) without sexual problems who were younger, showed high levels of sexual quality of life and sexual desire, as well as low complaints of anxiety and depression. CONCLUSIONS: Clinicians must be more proactive in assessing sexual concerns, mostly when emotional and cognitive difficulties are present in older individuals with TBI, regardless of gender, chronicity and injury severity.	[Moreno, Jhon Alexander] Univ Quebec Montreal, Fac Human Sci, Dept Sexol, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada; [Moreno, Jhon Alexander; McKerral, Michelle] CSMTL, Ctr Sud Ile Montreal, CIUSS, Ctr Interdisciplinary Res Rehabil CRIR,CRLB, Montreal, PQ, Canada; [McKerral, Michelle] Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada		Moreno, JA (corresponding author), Univ Quebec Montreal, Fac Human Sci, Dept Sexol, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada.	moreno.jhon_alexander@uqam.ca			CRIR; CERNEC; Faculte des etudes superieures et postdoctorales de l'Universite de Montreal; CRLB	The authors wish to thank the CRIR, CERNEC, and Faculte des etudes superieures et postdoctorales de l'Universite de Montreal (scholarships to J.A.M.), the CRLB for partial funding of this study (grant to M.M.), as well to the individuals with TBI who took part in the study.	Abraham L, 2008, J SEX MED, V5, P595, DOI 10.1111/j.1743-6109.2007.00749.x; Allen DN, 2013, CLUSTER ANAL NEUROPS; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barker LA, 2011, BRAIN INJURY, V25, P997, DOI 10.3109/02699052.2011.597046; Barthel D, 2014, J AFFECT DISORDERS, V169, P203, DOI 10.1016/j.jad.2014.08.004; Belanger D, 2009, SEXOLOGIES, V18, P83, DOI 10.1016/j.sexol.2009.01.008; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Bivona U, 2016, BRAIN INJURY, V30, P1082, DOI 10.3109/02699052.2016.1165867; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Corona G, 2015, J SEX MED, V12, P2291, DOI 10.1111/jsm.13041; DAVIS CM, 1998, HDB SEXUALITY RELATE; Delgadillo J, 2012, DRUG ALCOHOL DEPEN, V125, P37, DOI 10.1016/j.drugalcdep.2012.03.011; Diaz-Arrastia R., 2015, TRAUMATIC BRAIN INJU, P183; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Downing M, 2018, NEUROPSYCHOL REHABIL, V28, P1028, DOI 10.1080/09602011.2016.1236732; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Garcia-Campayo J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-8; Gouvernement du Quebec/Ministere de la Sante et des Services Sociaux & Societe de l'assurance automobile du Quebec, 2005, OR MIN TCCL; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; Henderson D J, 1995, Health Care Women Int, V16, P113; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; IBM, 2012, IBM SPSS ADV STAT 21; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; King BE, 2000, PSYCHOL REP, V86, P347, DOI 10.2466/pr0.2000.86.1.347; KRAMER TH, 1993, BRAIN INJURY, V7, P209, DOI 10.3109/02699059309029673; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Malary Mina, 2015, Mater Sociomed, V27, P383, DOI 10.5455/msm.2015.27.383-389; MALEC JF, 1993, CLIN NEUROPSYCHOL, V7, P48, DOI DOI 10.1080/13854049308401887; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Moreno A, 2015, NEUROREHABILITATION, V37, P99, DOI 10.3233/NRE-151243; Moreno JA, 2018, NEUROPSYCHOL REHABIL, V28, P34, DOI 10.1080/09602011.2015.1136222; Moreno JA, 2015, SEX DISABIL, V33, P483, DOI 10.1007/s11195-015-9414-8; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Mounce LTA, 2013, J HEAD TRAUMA REHAB, V28, P397, DOI 10.1097/HTR.0b013e318252dd75; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ortega V, 2006, PSYCHOL REP, V99, P147, DOI 10.2466/PR0.99.1.147-165; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pearce B, 2016, BRAIN INJURY, V30, P1708, DOI 10.1080/02699052.2016.1202450; Pedrero-Perez EJ, 2011, REV NEUROLOGIA, V52, P394, DOI 10.33588/rn.5207.2010731; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; RAPKIN BD, 1993, AM J COMMUN PSYCHOL, V21, P247, DOI 10.1007/BF00941623; Ruiz MA, 2011, J AFFECT DISORDERS, V128, P277, DOI 10.1016/j.jad.2010.07.010; Sander AM, 2016, ARCH PHYS MED REHAB, V97, P753, DOI 10.1016/j.apmr.2016.01.009; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Saxton ME, 2013, NEUROREHABILITATION, V33, P263, DOI 10.3233/NRE-130954; Shinagawa Y, 2007, INT J GERIATR PSYCH, V22, P951, DOI 10.1002/gps.1768; Sidik SM, 2012, J PRIM HEALTH CARE, V4, P5; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Spector IP, 1996, J SEX MARITAL THER, V22, P175; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Swinson Richard P, 2006, Evid Based Med, V11, P184, DOI 10.1136/ebm.11.6.184; Symonds T, 2005, J SEX MARITAL THER, V31, P385, DOI 10.1080/00926230591006502; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; van der Naalt J., 2015, TRAUMATIC BRAIN INJU, P211; Wild B, 2014, AM J GERIAT PSYCHIAT, V22, P1029, DOI 10.1016/j.jagp.2013.01.076	68	6	6	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2017	41	2					281	291		10.3233/NRE-172201			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK2DU	WOS:000413293600003	29060943				2022-02-06	
J	Nakhjavan-Shahraki, B; Yousefifard, M; Oraii, A; Sarveazad, A; Hajighanbari, MJ; Safari, S; Baratloo, A; Tafakhori, A; Hosseini, M				Nakhjavan-Shahraki, Babak; Yousefifard, Mahmoud; Oraii, Alireza; Sarveazad, Arash; Hajighanbari, Mohammad Javad; Safari, Saeed; Baratloo, Alireza; Tafakhori, Abbas; Hosseini, Mostafa			Prediction of Clinically Important Traumatic Brain Injury in Pediatric Minor Head Trauma; proposing Pediatric Traumatic Brain Injury (PTBI) Prognostic Rule	INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD			English	Article						Decision support systems; Emergency service; Sensitivity and Specificity; Pediatrics	COMPUTED-TOMOGRAPHY; CHILDREN; MILD; RISK; CT	Background: The present study assesses independent predictors of clinically important traumatic brain injury (ciTBI) in order to design a prognostic rule for identification of high risk children with mild head injury. Materials and Methods: In a retrospective cross-sectional study, 3,199 children with mild traumatic brain injury (TBI) brought to emergency ward of three hospitals in Tehran, Iran were gathered, from April 2014 to April 2016. The associations between probable predictors of ciTBI in children with mild TBI were assessed and a prediction rule for identification of high risk children in need of computed tomography (CT) scan was designed based on a stepwise multivariate logistic regression. Results: 592 (18.5%) children had ciTBI. History of loss of conciseness (odds ratio [ OR]=3.0; p<0.0001), underlying disease (OR=3.6; p=0.002), Glasgow coma scale (GCS) score equal to 14 (OR=40.6; p<0.0001), altered mental status (OR=19.1; p<0.0001), need for intubation (OR=27.4; p<0.0001), presence of vomiting (OR=7.3; p=0.001), and sign of basilar skull fracture (OR=25.9; p=0.007), were the most important prognostic factors of ciTBI in children. Pediatric traumatic brain injury prognostic rule (PTBI prognostic rule) was designed based on these predictors. PTBI prognostic rule had an area under the curve of 0.93, a sensitivity of 100.0%, a specificity of 73.0% and a proper calibration (slope=0.97 and intercept=0.006) in identification of ciTBI. Conclusion: The present study showed that a few of children with mild TBI have ciTBI. Therefore, CT scans are not necessary in all of these children. Using PTBI prognostic rule can reduce the number of unnecessary CT scans.	[Nakhjavan-Shahraki, Babak] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Yousefifard, Mahmoud] Iran Univ Med Sci, Fac Med, Physiol Res Ctr, Tehran, Iran; [Yousefifard, Mahmoud] Iran Univ Med Sci, Fac Med, Dept Physiol, Tehran, Iran; [Oraii, Alireza] Univ Tehran Med Sci, Sch Med, Dept Med, Tehran, Iran; [Sarveazad, Arash] Iran Univ Med Sci, Colorectal Res Ctr, Tehran, Iran; [Hajighanbari, Mohammad Javad] Iran Univ Med Sci, Hafte Tir Hosp, Dept Emergency Med, Tehran, Iran; [Safari, Saeed] Shahid Beheshti Univ Med Sci, Shohadaye Tajrish Hosp, Dept Emergency Med, Tehran, Iran; [Baratloo, Alireza] Univ Tehran Med Sci, Dept Emergency Med, Tehran, Iran; [Tafakhori, Abbas] Univ Tehran Med Sci, Imam Khomeini Hosp, Sch Med, Dept Neurol, Tehran, Iran; [Tafakhori, Abbas] Univ Tehran Med Sci, Iranian Ctr Neurol Res, Tehran, Iran; [Hosseini, Mostafa] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran		Hosseini, M (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran.	mhossein110@yahoo.com	Yousefifard, Mahmoud/P-1621-2018; Baratloo, Alireza/E-3293-2017; Sarveazad, Arash/L-2064-2018; Safari, Saeed/J-4604-2017; Oraii, Alireza/AAX-6455-2021	Yousefifard, Mahmoud/0000-0001-5181-4985; Baratloo, Alireza/0000-0002-4383-7738; Sarveazad, Arash/0000-0001-9273-1940; Safari, Saeed/0000-0002-7407-1739; Oraii, Alireza/0000-0002-2422-2930; hosseini, mostafa/0000-0002-1334-246X			Alexiou George A, 2011, J Emerg Trauma Shock, V4, P403, DOI 10.4103/0974-2700.83872; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Barzegari H, 2016, EMERGENCY, V4, P192; Barzegari H, 2015, EMERGENCY, V3, P109; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chabok SY, 2012, ARCH TRAUMA RES, V1, P19, DOI 10.5812/atr.5289; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Hashemi B, 2016, EMERGENCY, V4, P196; Ide K, 2016, ACAD EMERG MED; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Safari Saeed, 2016, J Clin Orthop Trauma, V7, P95, DOI 10.1016/j.jcot.2016.02.005; Salibi PN, 2014, AM J ROENTGENOL, V202, P397, DOI 10.2214/AJR.12.10294; Schonfeld D, 2015, POSTGRAD MED J, V91, P634, DOI 10.1136/postgradmedj-2013-305004rep; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033	20	6	6	0	2	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2345-5047	2345-5055		INT J PEDIATR-MASSHA	Int. J. Pediatr.-Masshad	JAN	2017	5	1					4127	4135		10.22038/ijp.2016.8017			9	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	EO3SC	WOS:000396613600001					2022-02-06	
J	Ostrowski, RP; Stepien, K; Pucko, E; Matyja, E				Ostrowski, Robert P.; Stepien, Katarzyna; Pucko, Emanuela; Matyja, Ewa			The efficacy of hyperbaric oxygen in hemorrhagic stroke: experimental and clinical implications	ARCHIVES OF MEDICAL SCIENCE			English	Article						intracerebral hemorrhage; subarachnoid hemorrhage; brain edema; preclinical research	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; RAT MODEL; THERAPY; NEUROPROTECTION; EDEMA; MECHANISMS; DIAGNOSIS; ISCHEMIA	Hemorrhagic stroke, accounting for 10-30% of stroke cases, carries high rates of morbidity and mortality. This review presents the current knowledge on the efficacy of hyperbaric oxygen (HBO)-based modalities in the preclinical research on hemorrhagic stroke. Both preconditioning and post-treatment with HBO are considered as prospective therapeutic options. High efficacy of HBO therapy (HBOT) for brain hemorrhage has been noted. We found that moderate hyperbaric pressures appear optimal for therapeutic effect, while the therapeutic window of opportunity is short. HBO preconditioning offers more modest neuroprotective benefit as compared to HBO post-treatment for experimental intracerebral hemorrhage. We advocate for mandatory calculations of percent changes in the experimentally investigated indexes of HBO effectiveness and stress the need to design new clinical trials on HBO for hemorrhagic stroke.	[Ostrowski, Robert P.; Stepien, Katarzyna; Pucko, Emanuela; Matyja, Ewa] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt & Clin Neuropathol, Warsaw, Poland		Matyja, E (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, 5 Pawinskiego St, PL-02106 Warsaw, Poland.	ematyja@imdik.pan.pl	Ostrowski, R./AAH-6756-2019	Matyja, Ewa/0000-0001-8137-7165; Ostrowski, Robert P./0000-0003-1373-4452			Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Boussi-Gross R, 2015, NEUROPSYCHOLOGY, V29, P610, DOI 10.1037/neu0000149; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brubakk AO, 2014, COMPR PHYSIOL, V4, P1229, DOI 10.1002/cphy.c130048; Chen LF, 2014, J FORMOS MED ASSOC, V113, P620, DOI 10.1016/j.jfma.2014.03.012; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Efrati S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127012; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; El-baz F., 2014, EGYPT J MED HUM GENE, V15, P155; Fang JY, 2015, EXP THER MED, V10, P699, DOI 10.3892/etm.2015.2539; Fewel ME, 2003, NEUROSURG FOCUS, V15, pE1, DOI DOI 10.3171/F0C.2003.15.4.0; Fiorella D, 2015, WORLD NEUROSURG, V84, P1136, DOI 10.1016/j.wneu.2015.05.063; Hanley D., 2016, INT STROK C LOS ANG, P02; Hu Qiang, 2014, Zhejiang Da Xue Xue Bao Yi Xue Ban, V43, P58; Hu Q, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0033-3; Hu Q, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-12; Huang ZX, 2007, BRAIN RES, V1153, P204, DOI 10.1016/j.brainres.2007.03.061; Jarus-Dziedzic K, 2003, ACT NEUR S, V86, P473; Jiang YJ, 2002, J CEREBR BLOOD F MET, V22, P689, DOI 10.1097/00004647-200206000-00007; Kanno T, 1996, MINIM INVAS NEUROSUR, V39, P56, DOI 10.1055/s-2008-1052217; Karlinski M, 2015, ARCH MED SCI, V11, P530, DOI 10.5114/aoms.2015.52355; Kellner CP, 2010, STROKE, V41, pS99, DOI 10.1161/STROKEAHA.110.597476; Kocaogullar Y, 2004, INTENS CARE MED, V30, P141, DOI 10.1007/s00134-003-1916-7; Kohshi Kiyotaka, 1993, Neurologia Medico-Chirurgica, V33, P92, DOI 10.2176/nmc.33.92; Kozba-Gosztyla M, 2015, ARCH MED SCI, V11, P536, DOI 10.5114/aoms.2013.37333; Krafft PR, 2014, BEHAV BRAIN RES, V264, P151, DOI 10.1016/j.bbr.2014.01.052; Krishnamurthi RV, 2014, GLOB HEART, V9, P101, DOI 10.1016/j.gheart.2014.01.003; Lacey DJ, 2012, ANN NEUROL, V72, P695, DOI 10.1002/ana.23681; Lee YS, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/512978; Lekic T, 2011, ACTA NEUROCHIR SUPPL, V111, P253, DOI 10.1007/978-3-7091-0693-8_42; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Liu JR, 2010, NEUROPATH APPL NEURO, V36, P211, DOI 10.1111/j.1365-2990.2009.01047.x; Liu WW, 2008, BRAIN RES, V1201, P128, DOI 10.1016/j.brainres.2008.01.068; MacDonald E, 1989, J Neurosci Nurs, V21, P313; MacLellan CL, 2010, STROKE, V41, pS95, DOI 10.1161/STROKEAHA.110.594457; Marois P, 2013, ANN NEUROL, V74, P149, DOI 10.1002/ana.23888; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Mychaskiw G, 2012, UNDERSEA HYPERBAR M, V39, P795; Ostrowski RP, 2016, MED GAS RES, V6, P39, DOI 10.4103/2045-9912.179344; Ostrowski RP, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-17; Ostrowski RP, 2006, STROKE, V37, P1314, DOI 10.1161/01.STR.0000217310.88450.c3; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Peng ZR, 2014, J NEUROL SCI, V342, P114, DOI 10.1016/j.jns.2014.04.037; Potts MB, 2014, WORLD NEUROSURG, V82, P549, DOI 10.1016/j.wneu.2014.08.046; Qin Z, 2008, ACTA NEUROCHIR SUPPL, V105, P113; Qin Zhiyong, 2007, Neurosurg Focus, V22, pE13, DOI 10.3171/foc.2007.22.5.14; Qureshi Adnan I, 2014, J Vasc Interv Neurol, V7, P34; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Rossignol DA, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-6; Rossignol DA, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-21; Sandu N, 2010, EXPERT REV CARDIOVAS, V8, P479, DOI [10.1586/erc.09.180, 10.1586/ERC.09.180]; Schaller B, 2003, LANCET, V362, P1007, DOI 10.1016/S0140-6736(03)14446-7; Snarska KK, 2017, ARCH MED SCI, V13, P100, DOI 10.5114/aoms.2016.61009; Soltani A, 2011, TRANSL STROKE RES, V2, P159, DOI 10.1007/s12975-011-0077-1; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; Szpecht D, 2015, FOLIA NEUROPATHOL, V53, P1, DOI 10.5114/fn.2015.49968; Thiex Ruth, 2007, Neurosurg Focus, V22, pE6; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; Wang J, 2016, J MOL NEUROSCI, V58, P424, DOI 10.1007/s12031-016-0724-9; Wiebers DO, 2006, HDB OF STROKE; Wu J, 2014, CELL BIOCHEM BIOPHYS, V70, P1579, DOI 10.1007/s12013-014-0098-y; Yang LM, 2015, BRAIN RES, V1627, P21, DOI 10.1016/j.brainres.2015.08.011; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhou W, 2015, NEUROCRIT CARE, V22, P121, DOI 10.1007/s12028-014-0013-9; Zhu HT, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0976-8	72	6	6	0	5	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1734-1922	1896-9151		ARCH MED SCI	Arch. Med. Sci.		2017	13	5					1217	1223		10.5114/aoms.2017.65081			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD1AQ	WOS:000407270200026	28883864	Green Published, gold, Green Submitted			2022-02-06	
J	Pandey, S; Singh, K; Sharma, V; Pandey, D; Jha, RP; Rai, SK; Chauhan, RS; Singh, R				Pandey, Sharad; Singh, Kulwant; Sharma, Vivek; Pandey, Deepa; Jha, Ravi Prakash; Rai, Sunil Kumar; Chauhan, Richa Singh; Singh, Royana			A prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Biochemical marker; cleaved-tau protein; severe TBI; Glasgow Coma Scale score; Glasgow outcome score	HEAD-INJURY; NEURONAL DAMAGE; BIOMARKER; DISEASE	Objective: Neurotrauma has been labelled as a "silent epidemic" affecting both the developed and the developing nations. To date, no single brain-specific biomarker has been unanimously accepted for routine clinical use in TBI. Our study aims to determine the correlation of "cleaved-tau protein" in severe traumatic brain injury (TBI) with Glasgow Coma Scale (GCS) at the time of admission, mode of injury, CT findings and outcome at discharge. Methods: The study has been approved by the institutional ethical committee. 40 cases with severe TBI and 40 randomly selected healthy controls were included in this prospective study. Venous blood samples were collected and serum cleaved tau protein levels were measured and correlated with gender, mode of injury, CT findings GCS score and GOS score at discharge. Results: In the severe TBI group, the mean serum cleaved tau protein levels in males were 91.65 +/- 41.34 pg/ml (mean +/- S. D.), and females were 104.43 +/- 53.08 pg/ml (mean +/- S. D.), (p = 0.27). Mean serum C-tau level in study group was 95.48 +/- 44.87 pg/ml (range 36.44-192.34), 95% C. I. (81.13-109.83) and in controls was 33.82 +/- 13.65 pg/ml (range 2.48-66.54), 95% C. I. (29.46-38.19) (p< 0.001). The distribution of serum C-tau was in severe TBI group varied in all categories of GCS at 0th day (p< 0.001). Serum cleaved tau protein levels in the good outcome group were 74.26 +/- 25.43 pg/ml (mean +/- S. D.), range 36.44-144.54, 95% C. I. (63.52-85.00) and the poor-outcome group were 127.32 +/- 49.40 pg/ml, range 66.65-192.34, 95% C. I. (100.99-153.64) (p = 0.001). Conclusion: In severe TBI, serum cleaved tau protein levels were significantly higher as compared to the controls in this prospective study. However, results of this study are preliminary in nature and there is a need to undertake larger prospective studies to reach a definitive conclusion.	[Pandey, Sharad; Singh, Kulwant; Sharma, Vivek] BHU, IMS, Sir Sunder Lal Hosp, Dept Neuro Surg, Varanasi 221005, Uttar Pradesh, India; [Pandey, Deepa] Cent Hosp DLW, Dept Clin Microbiol, Varanasi, Uttar Pradesh, India; [Jha, Ravi Prakash] IMS BHU, Sir Sunder Lal Hosp, Div Biostat, Dept Community Med, Varanasi, Uttar Pradesh, India; [Rai, Sunil Kumar; Singh, Royana] IMS BHU, Sir Sunder Lal Hosp, Dept Anat, Varanasi, Uttar Pradesh, India; [Chauhan, Richa Singh] IMS BHU, Sir Sunder Lal Hosp, Dept Radio Diag, Varanasi, Uttar Pradesh, India; [Pandey, Sharad] Rajindra Hosp, Dept Gen Surg, Govt Med Coll, Patiala, Punjab, India		Pandey, S (corresponding author), BHU, IMS, Sir Sunder Lal Hosp, Dept Neuro Surg, Varanasi 221005, Uttar Pradesh, India.	drsharad23@yahoo.com	PANDEY, SHARAD/AAE-1404-2020; Jha, Ravi Prakash/ABC-6588-2020	PANDEY, SHARAD/0000-0002-3542-5864; Jha, Ravi Prakash/0000-0001-5230-1436			[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Boucher BA, 1998, CLIN PHARMACOKINET, V35, P209, DOI 10.2165/00003088-199835030-00004; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Greenberg MS, 2010, HDB NEUROSURGERY, P85; Gururaj G, 1999, NIMHANS J, V17, P407; Guzel A, 2010, AM J EMERG MED, V28, P399, DOI 10.1016/j.ajem.2008.12.025; Health Policy Advisory Committee on Technology, 2013, TECHN BRIEF BIOM DIA; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; KOSIK KS, 1987, J NEUROSCI, V7, P3142; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Papa Linda, 2008, Expert Opin Med Diagn, V2, P937, DOI 10.1517/17530059.2.8.937; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zemlan FP, 1999, J NEUROCHEM, V73, P437; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	24	6	6	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2017	31	3					356	363		10.1080/02688697.2017.1297378			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FG8IM	WOS:000410673800020	28293977				2022-02-06	
J	Reddy, A; Ownsworth, T; King, J; Shields, C				Reddy, Avneel; Ownsworth, Tamara; King, Joshua; Shields, Cassandra			A biopsychosocial investigation of changes in self-concept on the Head Injury Semantic Differential Scale	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Self-concept; Traumatic brain injury; Neuropsychological functioning	ACQUIRED BRAIN-INJURY; GOOD-OLD-DAYS; QUALITY-OF-LIFE; DAYS BIAS; SOCIAL DESIRABILITY; VERBAL FLUENCY; FOLLOW-UP; REHABILITATION; IDENTITY; MEMORY	This study aimed to investigate the influence of the "good-old-days" bias, neuropsychological functioning and cued recall of life events on self-concept change. Forty seven adults with TBI (70% male, 1-5 years post-injury) and 47 matched controls rated their past and present self-concept on the Head Injury Semantic Differential Scale (HISD) III. TBI participants also completed a battery of neuropsychological tests. The matched control group of 47 were from a sample of 78 uninjured participants who were randomised to complete either the Social Readjustment Rating ScaleRevised (cued recall) or HISD (non-cued recall) first. Consistent with the good-old-days bias, participants with TBI rated their pre-injury self-concept as more positive than their present self-concept and the present self-concept of controls (p<.05). More positive pre-injury self-concept ratings were related to lower estimated premorbid IQ and poorer verbal fluency and delayed memory (p<.05). For uninjured participants, cued recall, life events and event appraisals each accounted for unique variance in self-concept change (p<.01) after controlling for negative affect. The cued recall group rated their past self-concept as significantly more negative than the non-cued group (p<.01). Overall, the good-old-days bias, neuropsychological functioning and cued recall influenced reports of self-concept change by affecting retrospective ratings of past self-concept. Further research is needed to investigate the impact of contextual cues on self-concept change after TBI.	[Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld, Australia; Griffith Univ, Menzies Hlth Inst Queensland, Mt Gravatt, Qld, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld, Australia.	t.ownsworth@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094	Griffith University Behavioural Basis of Health publication scheme	The authors would like to acknowledge the support of funding from the Griffith University Behavioural Basis of Health publication scheme.	Addis DR, 2004, MEMORY, V12, P56, DOI 10.1080/09658210244000423; Army Individual Test Battery, 1944, MAN DIR SCOR; Beadle E., 2015, J HEAD TRAUMA REHABI; Benton A., 1976, MULTILINGUAL APHASIA; Bryan-Hancock C, 2010, INJURY PREV, V16, pA99, DOI 10.1136/ip.2010.029215.356; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P42, DOI 10.1080/09602011.2010.525947; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Ellis-Hill CS, 2000, CLIN REHABIL, V14, P279, DOI 10.1191/026921500671231410; Feinberg TE, 2011, CONSCIOUS COGN, V20, P75, DOI 10.1016/j.concog.2010.09.017; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Fotopoulou A, 2008, NEUROPSYCHOL REHABIL, V18, P541, DOI 10.1080/09602010802083545; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Harter S., 2012, CONSTRUCTION SELF; Hayes, 2018, INTRO MEDIATION MODE; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Hobson CJ, 2001, INT J STRESS MANAGE, V8, P299, DOI 10.1023/A:1017565632657; Hobson CJ, 1998, INT J STRESS MANAGE, V5, P1, DOI 10.1023/A:1022978019315; HOLMES TH, 1967, SCHEDULE RECENT EXPE; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; James W., 1890, PRINCIPLES PSYCHOL; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; Kolb B., 2007, FUNDAMENTALS HUMAN N; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Levack W. M., 2014, BMJ OPEN, V4, DOI 10.1136/bmjpen-2013-004630; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Linley PA, 2008, J SOC CLIN PSYCHOL, V27, P877, DOI 10.1521/jscp.2008.27.8.877; MARKUS H, 1986, J PERS SOC PSYCHOL, V51, P858, DOI 10.1037/0022-3514.51.4.858; Marsh H. W., 1992, SELF DEFINITIONAL ME, P44; Monroe SM, 2008, ANNU REV CLIN PSYCHO, V4, P33, DOI 10.1146/annurev.clinpsy.4.022007.141207; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Orth U, 2010, J PERS SOC PSYCHOL, V98, P645, DOI 10.1037/a0018769; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2016, NEUROPSYCHOL REHABIL, V26, P1, DOI 10.1080/09602011.2014.977924; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Randolph C., 1998, REPEATABLE BATTERY A; Rosenberg M., 1965, SOC ADOLESCENT SELF; Secrest JA, 2007, REHABIL NURS, V32, P158, DOI 10.1002/j.2048-7940.2007.tb00170.x; Shadden BB, 2007, J MED SPEECH-LANG PA, V15, P99; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss D. T., 2007, HUMAN FRONTAL LOBES, V2, P292; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tabachnick BG., 2012, USING MULTIVARIATE S; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; THOITS PA, 1991, SOC PSYCHOL QUART, V54, P101, DOI 10.2307/2786929; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Vigil-Colet A, 2013, PSICOTHEMA, V25, P342, DOI 10.7334/psicothema2012.297; Watkins PC, 1996, J ABNORM PSYCHOL, V105, P34, DOI 10.1037/0021-843X.105.1.34; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832	67	6	6	1	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	8					1103	1123		10.1080/09602011.2015.1114499			21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FH0QE	WOS:000410844800002	26605423				2022-02-06	
J	Reslan, S; Axelrod, BN				Reslan, Summar; Axelrod, Bradley N.			Evaluating the Medical Symptom Validity Test (MSVT) in a Sample of Veterans Between the Ages of 18 to 64	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Effort testing; genuine memory impairment profile; medical symptom validity test; performance validity	TRAUMATIC BRAIN-INJURY; MEMORY IMPAIRMENT; DEMENTIA PROFILE; NEUROPSYCHOLOGICAL ASSESSMENT; CLASSIFICATION ACCURACY; TEST-PERFORMANCE; HIGH SPECIFICITY	The purpose of the current study was to compare three potential profiles of the Medical Symptom Validity Test (MSVT; Pass, Genuine Memory Impairment Profile [GMIP], and Fail) on other freestanding and embedded performance validity tests (PVTs). Notably, a quantitatively computed version of the GMIP was utilized in this investigation. Data obtained from veterans referred for a neuropsychological evaluation in a metropolitan Veteran Affairs medical center were included (N=494). Individuals age 65 and older were not included to exclude individuals with dementia from this investigation. The sample revealed 222 (45%) in the Pass group. Of the 272 who failed the easy subtests of the MSVT, 221 (81%) met quantitative criteria for the GMIP and 51 (19%) were classified as Fail. The Pass group failed fewer freestanding and embedded PVTs and obtained higher raw scores on all PVTs than both GMIP and Fail groups. The differences in performances of the GMIP and Fail groups were minimal. Specifically, GMIP protocols failed fewer freestanding PVTs than the Fail group; failure on embedded PVTs did not differ between GMIP and Fail. The MSVT GMIP incorporates the presence of clinical correlates of disability to assist with this distinction, but future research should consider performances on other freestanding measures of performance validity to differentiate cognitive impairment from invalidity.	[Reslan, Summar] Rehabil Inst Michigan, Detroit Med Ctr, Detroit, MI USA; [Axelrod, Bradley N.] John D Dingell Dept Vet Affairs Med Ctr, Detroit, MI USA		Reslan, S (corresponding author), Rehabil Inst Michigan, 261 Mack Ave, Detroit, MI 48201 USA.	sreslan@dmc.org					Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P147, DOI 10.1080/23279095.2014.880842; Army Individual Test Battery, 1944, MAN DIR SCOR; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Bortnik KE, 2013, APPL NEUROPSYCH-ADUL, V20, P233, DOI 10.1080/09084282.2012.695757; Bruing J. L., 1977, COMPUTATIONAL HDB ST; Carone Dominic A, 2009, Appl Neuropsychol, V16, P309, DOI 10.1080/09084280903297883; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Green P., 2003, GREENS WORD MEMORY T; Green P., 2008, ADV INTERPRETATION P; Green P, 2004, GREENS MED SYMPTOM V; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Meehl P.E., 1954, CLIN VERSUS STAT PRE; MEEHL PE, 1996, CLIN VERSUS STAT PRE; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Psychological Corporation, 2009, ADV CLIN SOL WAIS 4; Rienstra A, 2013, ARCH CLIN NEUROPSYCH, V28, P463, DOI 10.1093/arclin/act026; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 2009, TEST PREMORBID FUNCT; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wolfson, 1993, HALSTEAD REITAN NEUR	38	6	6	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	2					132	139		10.1080/23279095.2015.1107565			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EM1CJ	WOS:000395055400005	27045467				2022-02-06	
J	Ribeiro, MC; Santos, A; Riachi, LG; Rodrigues, ACB; Coelho, GC; Marcellini, PS; Bento, CAD; de Maria, CAB				Ribeiro, Mariana Carvalho; Santos, Andria; Riachi, Liza Ghassan; Babo Rodrigues, Antonio Carlos; Coelho, Geraldo Ceni; Marcellini, Paulo Sergio; de Melo Bento, Cleonice Alves; Bastos de Maria, Carlos Alberto			The effects of roasted yerba mate (Hex paraguariensis A. ST. Hil.) consumption on glycemia and total serum creatine phosphokinase in patients with traumatic brain injury	JOURNAL OF FUNCTIONAL FOODS			English	Article						Mate tea; TBI patient; Chlorogenic acid; Glycemia and CPK	FREEZE CONCENTRATION TECHNOLOGY; ILEX-PARAGUARIENSIS; CHLOROGENIC ACIDS; ANTIOXIDANT ACTIVITY; CEREBROSPINAL-FLUID; PHENOLIC-COMPOUNDS; AQUEOUS EXTRACT; GLUCOSE-UPTAKE; CAFFEINE; INDIVIDUALS	Severe traumatic brain injury (TBI) patients were treated with non-commercial roasted mate tea (MT). Plants were identified botanically and roasted at 200 degrees C for 20 min. Eight patients were selected, of whom 4 were non-treated and 4 received MT in nasoenteric tube or oral diet for 14 days. MT-treated patients received infusion twice a day (7 g 300 mL(-1) each). No significant difference (p < 0.05) was observed concerning glycemia levels between non-treated and MT-treated groups, although this last had better glycemic profile and received less insulin. This result suggested, for the first time, a possible relationship between MT administration and improvement in the glycemic control in institutionalized patients. As compared with non-treated group, MT-treated group had significant (p < 0.05) decrease in serum creatine phosphokinase (CPK). The findings from the principal components analysis in conjunction with Person's correlation suggested, for the first time, positive correlation between MT consumption and lower CPK levels in TBI patients. (C) 2016 Elsevier Ltd. All rights reserved.	[Ribeiro, Mariana Carvalho] Fed Univ Rio de Janeiro State UNIRIO, Sch Nutr, Food & Nutr Postgrad Program, Av Pasteur, BR-22290240 Rio De Janeiro, Brazil; [Ribeiro, Mariana Carvalho; Santos, Andria; Babo Rodrigues, Antonio Carlos] Getulio Vargas State Hosp, Ave Lobo Jr, BR-21070061 Rio De Janeiro, Brazil; [Riachi, Liza Ghassan; Bastos de Maria, Carlos Alberto] Nursing Sch UNIRIO, Nursing & Biosci Postgrad Program, Av Pasteur 296, BR-22290240 Rio De Janeiro, Brazil; [Coelho, Geraldo Ceni] Fed Univ South Frontier, Post Grad Program Environm Sci & Technol, Campus Chapeco,Av Fernando Machado 108 E, BR-89802112 Chapeco, SC, Brazil; [Marcellini, Paulo Sergio] Biomed Inst UNIRIO, Dept Biochem, Rua Frei Caneca 94,Sala A-401, BR-20211040 Rio De Janeiro, Brazil; [de Melo Bento, Cleonice Alves] Biomed Inst UNIRIO, Dept Microbiol & Parasitol, Rua Frei Caneca 94,Sala D-405, BR-20211040 Rio De Janeiro, Brazil; [Bastos de Maria, Carlos Alberto] Univ Fed Estado Rio de Janeiro, Collect Hlth Dept, Inst Biomed, Rio de Janeiro, RJ, Brazil		de Maria, CAB (corresponding author), Fed Univ Rio de Janeiro State UNIRIO, Collect Hlth Dept, Inst Biomed, Rua Frei Caneca 94,Sala A-411, BR-20211040 Rio De Janeiro, Brazil.	marianacr83@yahoo.com.br; andria.nutricionista@gmail.com; lizagr00@gmail.com; babomed@globo.com; cenicoelho@gmail.com; marcellinips@yahoo.com; cbento@globo.com; carreb@uol.com.br	Rodrigues, Antonio Carlos Carlos/D-6477-2018; de maria, carlos/B-8585-2013; Coelho, Geraldo Ceni/I-2532-2012	Rodrigues, Antonio Carlos Carlos/0000-0003-2308-4625; Coelho, Geraldo/0000-0002-6816-6424	CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	The authors thank CAPES and CNPq for financial support. The authors are thankful to the volunteers and their families who participated in the study and to Getulio Vargas State Hospital staff.	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Arcari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003; Boeck CR, 2013, MOL CELL BIOCHEM, V384, P129, DOI 10.1007/s11010-013-1790-8; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Bose P., 2015, BRAIN NEUROTRAUMA MO, P2; Boaventura BCB, 2015, LWT-FOOD SCI TECHNOL, V62, P948, DOI 10.1016/j.lwt.2015.02.028; Boaventura BCB, 2013, FOOD RES INT, V53, P686, DOI 10.1016/j.foodres.2012.07.042; Cardozo EL, 2007, J FOOD COMPOS ANAL, V20, P553, DOI 10.1016/j.jfca.2007.04.007; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; CLIFFORD MN, 1990, FOOD CHEM, V35, P13, DOI 10.1016/0308-8146(90)90126-O; Fernandes ES, 2012, NUTRITION, V28, P1157, DOI 10.1016/j.nut.2012.04.011; Filip R, 2001, FITOTERAPIA, V72, P774, DOI 10.1016/S0367-326X(01)00331-8; Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x; Heck CI, 2008, J AGR FOOD CHEM, V56, P8394, DOI 10.1021/jf801748s; Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360; Huang DW, 2009, J AGR FOOD CHEM, V57, P7687, DOI 10.1021/jf901376x; Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005; kano H. T., 2013, RES MONOGRAPH BIOMED, P1; Khajavikhan J., 2016, J CLIN DIAGNOSTIC RE, V10, P11; Klein GA, 2011, J AM COLL NUTR, V30, P320, DOI 10.1080/07315724.2011.10719975; Lehavi A, 2015, OBES SURG, V25, P1923, DOI 10.1007/s11695-015-1626-6; Lusardi TA, 2012, EXP NEUROL, V234, P161, DOI 10.1016/j.expneurol.2011.12.026; Marques V, 2009, FOOD CHEM, V113, P1370, DOI 10.1016/j.foodchem.2008.08.086; Neergheen VS, 2010, TOXICOLOGY, V278, P229, DOI 10.1016/j.tox.2009.10.010; Ng C. F., 2016, J ETHNOPHARMACOL, VS0378-8741, P30124; Oliveira DM, 2008, J AGR FOOD CHEM, V56, P10527, DOI 10.1021/jf8021404; Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008; Pagliosa CM, 2010, FOOD CHEM, V122, P173, DOI 10.1016/j.foodchem.2010.02.040; Pang J, 2008, ARCH BIOCHEM BIOPHYS, V476, P178, DOI 10.1016/j.abb.2008.02.019; Pontes PV, 2002, J SCI FOOD AGR, V82, P1177, DOI 10.1002/jsfa.1163; Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092; Puangpraphant S, 2009, J AGR FOOD CHEM, V57, P8873, DOI 10.1021/jf902255h; Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640; Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539; TRUGO LC, 1991, FOOD CHEM, V42, P81, DOI 10.1016/0308-8146(91)90008-C; Valerga J, 2013, EUR J LIPID SCI TECH, V115, P513, DOI 10.1002/ejlt.201200304; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Zhang B, 2015, KOREAN J PHYSIOL PHA, V19, P491, DOI 10.4196/kjpp.2015.19.6.491; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041	40	6	6	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1756-4646			J FUNCT FOODS	J. Funct. Food.	JAN	2017	28						240	245		10.1016/j.jff.2016.11.024			6	Food Science & Technology; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology; Nutrition & Dietetics	EJ0FW	WOS:000392885000027		hybrid			2022-02-06	
J	Rumalla, K; Gondi, KT; Reddy, AY; Mittal, MK				Rumalla, Kavelin; Gondi, Keerthi T.; Reddy, Adithi Y.; Mittal, Manoj K.			Association of Parkinson's disease with hospitalization for traumatic brain injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Parkinson's disease; traumatic brain injury; Nationwide Inpatient Sample; falls; risk factors	RISK-FACTORS; OLDER-ADULTS; HEAD-INJURY; FALLS; PREVENTION; HEARING; COMORBIDITY; MANAGEMENT; FRACTURES; ARTHRITIS	Purpose: The goal of our study was to determine if patients with Parkinson's disease (PD) are more susceptible to hospitalization for traumatic brain injury (TBI). Methods: The US Nationwide Inpatient Sample database was queried (2004- 2011) to identify cohorts of patients with PD (N = 1 047 656) and without PD (N = 115 95 173). The age range of the study population was 60-89 years. The incidence of TBI among patients with PD was compared to the incidence of TBI in patients without PD. A multivariate logistic regression model, adjusted for all covariates that significantly differed in the bivariate analyses, was used to determine if PD was an independent predictor of TBI hospitalization. Results: The incidence of TBI hospitalization was significantly higher (relative risk: 1.76, 95% CI: 1.73-1.80) in the PD cohort. The PD cohort with TBI had fewer comorbidities and risk factors for falls/ TBI compared to the non-PD cohort with TBI. The multivariable analysis, adjusting for other TBI risk factors, revealed that PD status increased the likelihood of TBI hospitalization (odds ratio: 2.99, 95% CI: 2.93-3.05). Conclusion: Our study shows that patients with PD are more susceptible to hospitalization for TBI. A greater proportion of fall-related TBI occurs in patients with PD compared to patients without PD. Further research is needed to prevent falls in PD patients to avoid TBI.	[Rumalla, Kavelin; Gondi, Keerthi T.; Reddy, Adithi Y.] Univ Missouri, Kansas City Sch Med, Kansas City, MO 64110 USA; [Mittal, Manoj K.] Univ Kansas, Med Ctr, Dept Neurol, MS 2012,3599 Rainbow Blvd, Kansas City, KS 66160 USA		Mittal, MK (corresponding author), Univ Kansas, Med Ctr, Dept Neurol, MS 2012,3599 Rainbow Blvd, Kansas City, KS 66160 USA.	mmittal2@kumc.edu	Kavelin Rumalla, Neurosurgery PGY-1/AAS-6131-2021	Kavelin Rumalla, Neurosurgery PGY-1/0000-0002-2063-9587			Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP), 2015, INTR HCUP NAT INP SA; Allen NE, 2013, PARK DIS, V2013; Amboni M, 2013, MOVEMENT DISORD, V28, P1520, DOI 10.1002/mds.25674; Barrett-Connor E, 2009, OSTEOPOROSIS INT, V20, P715, DOI 10.1007/s00198-008-0748-2; Brenton-Rule A, 2015, SEMIN ARTHRITIS RHEU, V44, P389, DOI 10.1016/j.semarthrit.2014.08.001; Canning CG, 2015, NEUROLOGY, V84, P304, DOI 10.1212/WNL.0000000000001155; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Carvalho A, 2015, CLIN INTERV AGING, V10, P183, DOI 10.2147/CIA.S68779; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dashtipour K, 2015, PARK DIS, V2015; De Giorgi Alfredo, 2012, G Ital Nefrol, V29, P293; de Jong MR, 2013, THER ADV DRUG SAF, V4, P147, DOI 10.1177/2042098613486829; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Dharmarajan TS, 2006, J AM MED DIR ASSOC, V7, P287, DOI 10.1016/j.jamda.2005.10.010; Faul M, 2010, TRAUMATIC BRAIN INJU; Fink HA, 2005, J AM GERIATR SOC, V53, P1559, DOI 10.1111/j.1532-5415.2005.53464.x; Gazibara T, 2014, GERIATR NURS, V35, P364, DOI 10.1016/j.gerinurse.2014.05.001; Gray P, 2000, J Neurosci Nurs, V32, P222; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Jorgensen TSH, 2014, SCAND J PUBLIC HEALT, V42, P287, DOI 10.1177/1403494813516831; Katada Ryuichi, 2011, Japanese Journal of Alcohol Studies & Drug Dependence, V46, P424; Kegelmeyer DA, 2013, GAIT POSTURE, V38, P20, DOI 10.1016/j.gaitpost.2012.10.027; Kucinski A, 2015, BEHAV NEUROSCI, V129, P96, DOI 10.1037/bne0000048; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Lai SW, 2013, GERIATR GERONTOL INT, V13, P513, DOI 10.1111/j.1447-0594.2012.00960.x; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Louis ED, 2007, NEUROEPIDEMIOLOGY, V29, P39, DOI 10.1159/000108916; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meindorfner C, 2005, MOVEMENT DISORD, V20, P832, DOI 10.1002/mds.20412; Ocampo-Chan S, 2014, PERCEPT MOTOR SKILL, V118, P274, DOI 10.2466/15.PMS.118k12w2; Oguh O, 2012, NEUROHOSPITALIST, V2, P28, DOI 10.1177/1941874411427734; Parashos SA, 2013, J PARKINSON DIS, V3, P515, DOI 10.3233/JPD-130249; Perex-Castrillon JL, 2005, AM J HYPERTENS, V18, P146, DOI 10.1016/j.amjhyper.2004.08.016; Ridgel AL, 2016, J SCI MED SPORT, V19, P12, DOI 10.1016/j.jsams.2015.01.005; Roig M, 2009, RESP MED, V103, P1257, DOI 10.1016/j.rmed.2009.03.022; Rumalla K, 2015, LARYNGOSCOPE, V125, P720, DOI 10.1002/lary.24974; Shribman S, 2014, J NEUROL, V261, P1153, DOI 10.1007/s00415-014-7333-8; Singh R, 2007, J NEUROL NEUROSUR PS, V78, P363, DOI 10.1136/jnnp.2006.103440; Sleeman KE, 2013, PALLIATIVE MED, V27, P840, DOI 10.1177/0269216313490436; Stevens JA, 2005, J SAFETY RES, V36, P409, DOI 10.1016/j.jsr.2005.08.001; Stubbs B, 2015, GEN HOSP PSYCHIAT, V37, P126, DOI 10.1016/j.genhosppsych.2015.01.004; Tan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094379; Tanner CM, 1996, NEUROL CLIN, V14, P317, DOI 10.1016/S0733-8619(05)70259-0; Tsang WWN, 2013, J PHYSIOTHER, V59, P55, DOI 10.1016/S1836-9553(13)70148-6; Uc EY, 2009, NEUROLOGY, V73, P1103, DOI 10.1212/WNL.0b013e3181bacf6e; Viljanen A, 2009, J GERONTOL A-BIOL, V64, P312, DOI 10.1093/gerona/gln015; Vitale C, 2012, MOVEMENT DISORD, V27, P1530, DOI 10.1002/mds.25149; Woodford H, 2005, MOVEMENT DISORD, V20, P1104, DOI 10.1002/mds.20485	50	6	7	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.		2017	127	4					326	333		10.1080/00207454.2016.1239196			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EK5SW	WOS:000393987200007	27647380				2022-02-06	
B	Schumacher, M; Zhu, XY; Guennoun, R		DeKloet, ER; Pfaff, DW; Joels, M		Schumacher, Michael; Zhu, Xiaoyan; Guennoun, Rachida			Progesterone: Synthesis, Metabolism, Mechanism of Action, and Effects in the Nervous System	HORMONES, BRAIN AND BEHAVIOR, VOL 3: MOLECULAR AND CELLULAR MECHANISMS, 3RD EDITION			English	Article; Book Chapter							PERIPHERAL BENZODIAZEPINE-RECEPTOR; DIAZEPAM-BINDING INHIBITOR; ACUTE REGULATORY PROTEIN; TRAUMATIC BRAIN-INJURY; GAMMA-AMINOBUTYRIC-ACID; SEX STEROID ASSAYS; 3-BETA-HYDROXYSTEROID DEHYDROGENASE/DELTA(5)-DELTA(4) ISOMERASE; NEUROACTIVE PREGNANOLONE ISOMERS; CEREBRAL-ARTERY OCCLUSION; TANDEM MASS-SPECTROMETRY		[Schumacher, Michael; Zhu, Xiaoyan; Guennoun, Rachida] Univ Paris Sud, Inserm, U1195, Le Kremlin Bicetre, France; [Schumacher, Michael; Zhu, Xiaoyan; Guennoun, Rachida] Univ Paris Saclay, Le Kremlin Bicetre, France		Schumacher, M (corresponding author), Univ Paris Sud, Inserm, U1195, Le Kremlin Bicetre, France.; Schumacher, M (corresponding author), Univ Paris Saclay, Le Kremlin Bicetre, France.		Schumacher, Michael/G-3581-2013	Schumacher, Michael/0000-0001-6117-5371			ABRAHAM GE, 1975, J STEROID BIOCHEM, V6, P261, DOI 10.1016/0022-4731(75)90141-7; Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806; Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; Akk G, 2005, J NEUROSCI, V25, P11605, DOI 10.1523/JNEUROSCI.4173-05.2005; Akk G, 2010, CURR NEUROPHARMACOL, V8, P1, DOI 10.2174/157015910790909539; AKWA Y, 1993, CR ACAD SCI III-VIE, V316, P410; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Aouad M, 2009, PAIN, V147, P54, DOI 10.1016/j.pain.2009.08.001; Backstrom T, 2005, EUR J PHARMACOL, V512, P15, DOI 10.1016/j.ejphar.2005.01.049; Backstrom T, 2014, PROG NEUROBIOL, V113, P88, DOI 10.1016/j.pneurobio.2013.07.005; Banks WA, 2012, ENDOCRINOLOGY, V153, P4111, DOI 10.1210/en.2012-1435; Bansal Y, 2014, EUR J MED CHEM, V76, P31, DOI 10.1016/j.ejmech.2014.01.060; Baranda-Avila N, 2009, J STEROID BIOCHEM, V113, P259, DOI 10.1016/j.jsbmb.2009.01.008; Barbar E, 2009, MOL CELL ENDOCRINOL, V300, P89, DOI 10.1016/j.mce.2008.12.007; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Bastida CM, 2002, BIOCHEM BIOPH RES CO, V293, P106, DOI 10.1016/S0006-291X(02)00191-2; Baulieu E.-E., 1981, P INT S HELD WENN GR, P3; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Belelli D, 2003, J NEUROSCI, V23, P10013; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Belyaeva OV, 2007, ENDOCRINOLOGY, V148, P2148, DOI 10.1210/en.2006-1491; BENAVIDES J, 1983, J NEUROCHEM, V41, P1744, DOI 10.1111/j.1471-4159.1983.tb00888.x; Benmessahel Y, 2004, GLIA, V45, P213, DOI 10.1002/glia.10326; Beyenburg S, 1999, NEUROREPORT, V10, P3067, DOI 10.1097/00001756-199909290-00035; Beyer C, 2002, NEUROREPORT, V13, P877, DOI 10.1097/00001756-200205070-00028; BEYER C, 1995, PHYSIOL BEHAV, V58, P985, DOI 10.1016/0031-9384(95)00141-5; Beyer C., 1989, PHARM BIOCH BEHAV, V31, P919; Bicikova M, 2013, J STEROID BIOCHEM, V133, P77, DOI 10.1016/j.jsbmb.2012.08.009; Bitran D, 2000, PSYCHOPHARMACOLOGY, V151, P64, DOI 10.1007/s002130000471; Blaustein JD, 2003, ANN NY ACAD SCI, V1007, P238, DOI 10.1196/annals.1286.023; BLAUSTEIN JD, 1980, NEUROENDOCRINOLOGY, V31, P403, DOI 10.1159/000123110; BOGIC L, 1988, ENDOCRINOLOGY, V122, P2735, DOI 10.1210/endo-122-6-2735; Boney-Montoya J, 2010, MOL ENDOCRINOL, V24, P346, DOI 10.1210/me.2009-0429; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Bordet T, 2008, J PHARMACOL EXP THER, V326, P623, DOI 10.1124/jpet.108.139410; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Bose HS, 2002, ENDOCR RES, V28, P295, DOI 10.1081/ERC-120016800; Bouchard P, 2014, GYNECOL ENDOCRINOL, V30, P683, DOI 10.3109/09513590.2014.950647; Bouguen G, 2015, STEROIDS, V103, P64, DOI 10.1016/j.steroids.2014.12.022; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Brinton RD, 2013, NAT REV ENDOCRINOL, V9, P241, DOI 10.1038/nrendo.2013.31; Buccafusco JJ, 2009, NEUROTHERAPEUTICS, V6, P4, DOI 10.1016/j.nurt.2008.10.031; Butenandt A, 1934, BER DTSCH CHEM GES, V67, P1440, DOI 10.1002/cber.19340670831; Byrns MC, 2014, J STEROID BIOCHEM, V139, P173, DOI 10.1016/j.jsbmb.2013.01.015; Camacho-Arroyo I, 1998, NEUROREPORT, V9, P3993, DOI 10.1097/00001756-199812210-00001; Campbell BCV, 2015, INT J STROKE, V10, P153, DOI 10.1111/ijs.12186; Caruso D, 2015, J STEROID BIOCHEM, V146, P74, DOI 10.1016/j.jsbmb.2014.03.012; Cascio C, 2015, STEROIDS, V103, P31, DOI 10.1016/j.steroids.2015.08.002; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; Chan JR, 2000, MOL BIOL CELL, V11, P2283, DOI 10.1091/mbc.11.7.2283; Chan JR, 1998, P NATL ACAD SCI USA, V95, P10459, DOI 10.1073/pnas.95.18.10459; Chapman JC, 2005, REPROD BIOL ENDOCRIN, V3, P1, DOI 10.1186/1477-7827-3-11; CHAPMAN JC, 1992, BIOL REPROD, V47, P992, DOI 10.1095/biolreprod47.6.992; Chen SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024293; CHENG YJ, 1973, ENDOCRINOLOGY, V93, P1157, DOI 10.1210/endo-93-5-1157; Cherradi N, 1995, J STEROID BIOCHEM, V55, P507, DOI 10.1016/0960-0760(95)00199-9; Chetyrkin SV, 2001, J BIOL CHEM, V276, P22278, DOI 10.1074/jbc.M102076200; Chop JH, 2008, J REPROD DEVELOP, V54, P408, DOI 10.1262/jrd.20045; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; Coirini H, 2003, J NEUROCHEM, V84, P119, DOI 10.1046/j.1471-4159.2003.01512.x; Coirini H, 2002, NEUROSCIENCE, V113, P883, DOI 10.1016/S0306-4522(02)00224-5; COMPAGNONE NA, 1995, ENDOCRINOLOGY, V136, P2689, DOI 10.1210/en.136.6.2689; Concas A, 1998, P NATL ACAD SCI USA, V95, P13284, DOI 10.1073/pnas.95.22.13284; Conneely OM, 2002, RECENT PROG HORM RES, V57, P339, DOI 10.1210/rp.57.1.339; CONNEELY OM, 1989, J BIOL CHEM, V264, P14062; Cook JB, 2014, NEUROPSYCHOPHARMACOL, V39, P1978, DOI 10.1038/npp.2014.46; CORPECHOT C, 1983, BRAIN RES, V270, P119, DOI 10.1016/0006-8993(83)90797-7; COSTA E, 1991, LIFE SCI, V49, P325, DOI 10.1016/0024-3205(91)90440-M; Crawford AH, 2014, EXP NEUROL, V260, P50, DOI 10.1016/j.expneurol.2014.04.027; Culty M, 2015, STEROIDS, V103, P105, DOI 10.1016/j.steroids.2015.08.011; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; De Geyter C, 2002, HUM REPROD, V17, P933, DOI 10.1093/humrep/17.4.933; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Desarnaud F, 1998, J NEUROCHEM, V71, P1765; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Do Rego Jean Luc, 2012, Front Endocrinol (Lausanne), V3, P4, DOI 10.3389/fendo.2012.00004; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; DOHLER KD, 1974, ENDOCRINOLOGY, V94, P1003; DOHLER KD, 1975, ENDOCRINOLOGY, V97, P898; Ebner MJ, 2006, ENDOCRINOLOGY, V147, P179, DOI 10.1210/en.2005-1065; Edlow BL, 2013, NEUROCRIT CARE, V19, P364, DOI 10.1007/s12028-013-9870-x; El-Etr M, 2015, GLIA, V63, P104, DOI 10.1002/glia.22736; Elman I, 1997, LIFE SCI, V61, P1705, DOI 10.1016/S0024-3205(97)00776-5; Etgen AM, 2001, HORM BEHAV, V40, P169, DOI 10.1006/hbeh.2001.1676; Faivre E, 2005, STEROIDS, V70, P418, DOI 10.1016/j.steroids.2005.02.012; FAJER AB, 1971, J PHYSIOL-LONDON, V214, P115, DOI 10.1113/jphysiol.1971.sp009422; Fan JJ, 2015, P NATL ACAD SCI USA, V112, P7261, DOI 10.1073/pnas.1502670112; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Faupel-Badger JM, 2010, CANCER EPIDEM BIOMAR, V19, P292, DOI 10.1158/1055-9965.EPI-09-0643; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; FEDER HH, 1969, ENDOCRINOLOGY, V84, P171, DOI 10.1210/endo-84-1-171; FEDER HH, 1968, J ENDOCRINOL, V41, P563, DOI 10.1677/joe.0.0410563; Ferzaz B, 2002, J PHARMACOL EXP THER, V301, P1067, DOI 10.1124/jpet.301.3.1067; Finn DA, 2006, CNS DRUG REV, V12, P53, DOI 10.1111/j.1527-3458.2006.00053.x; Follesa P, 2004, EUR J PHARMACOL, V500, P413, DOI 10.1016/j.ejphar.2004.07.041; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2015, CELL STEM CELL, V16, P576, DOI 10.1016/j.stem.2015.05.010; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Frye CA, 2006, NEUROSCIENCE, V138, P1007, DOI 10.1016/j.neuroscience.2005.06.015; Fu XD, 2010, ENDOCR-RELAT CANCER, V17, P431, DOI 10.1677/ERC-09-0258; Furlan AJ, 2015, NEW ENGL J MED, V372, P2347, DOI 10.1056/NEJMe1503217; Furukawa A, 1998, J NEUROCHEM, V71, P2231; Gago N, 2004, J NEUROSCI RES, V78, P770, DOI 10.1002/jnr.20348; Gago N, 2003, MOL CELL NEUROSCI, V22, P162, DOI 10.1016/S1044-7431(02)00030-1; Gago N, 2001, GLIA, V36, P295, DOI 10.1002/glia.1117; Gaignard P, 2015, ENDOCRINOLOGY, V156, P2893, DOI 10.1210/en.2014-1913; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Garay L, 2009, BRAIN RES, V1283, P177, DOI 10.1016/j.brainres.2009.04.057; Genazzani AR, 1998, J CLIN ENDOCR METAB, V83, P2099, DOI 10.1210/jc.83.6.2099; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Giatti S, 2009, NEUROSCIENCE, V164, P520, DOI 10.1016/j.neuroscience.2009.08.005; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Gonzalez-Flores O, 2011, NEUROCHEM INT, V59, P671, DOI 10.1016/j.neuint.2011.06.013; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Griffin LD, 1999, P NATL ACAD SCI USA, V96, P13512, DOI 10.1073/pnas.96.23.13512; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Grimm S. L., 2016, J MOL BIOL; GUARNERI P, 1994, J NEUROCHEM, V63, P86; GUARNERI P, 1995, BRAIN RES, V683, P65, DOI 10.1016/0006-8993(95)00343-O; Guennoun R, 2015, J STEROID BIOCHEM, V146, P48, DOI 10.1016/j.jsbmb.2014.09.001; GUENNOUN R, 1995, MOL BRAIN RES, V30, P287, DOI 10.1016/0169-328X(95)00016-L; Guennoun R, 1997, EUR J NEUROSCI, V9, P2236, DOI 10.1111/j.1460-9568.1997.tb01642.x; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Guerra-Araiza C, 2001, BRAIN RES BULL, V54, P13, DOI 10.1016/S0361-9230(00)00410-X; Guidotti A, 2001, BRAIN RES REV, V37, P110, DOI 10.1016/S0165-0173(01)00129-1; GUTAI JP, 1977, J CLIN ENDOCR METAB, V44, P116, DOI 10.1210/jcem-44-1-116; Gyles SL, 2001, J BIOL CHEM, V276, P34888, DOI 10.1074/jbc.M102063200; Hagan CR, 2012, MOL CELL ENDOCRINOL, V357, P43, DOI 10.1016/j.mce.2011.09.017; Haim S, 2003, J ENDOCRINOL INVEST, V26, P1013, DOI 10.1007/BF03348201; HALL PF, 1985, VITAM HORM, V42, P315; Handelsman DJ, 2013, J CLIN ENDOCR METAB, V98, P3971, DOI 10.1210/jc.2013-3375; Hartmann M, 1934, HELV CHIM ACTA, V17, P878, DOI 10.1002/hlca.193401701111; Havlikova H, 2006, J CLIN ENDOCR METAB, V91, P3092, DOI 10.1210/jc.2005-2785; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Henderson J, 2005, J ENDOCRINOL, V184, P5, DOI 10.1677/joe.1.06000; Henderson YC, 2007, PLACENTA, V28, P152, DOI 10.1016/j.placenta.2006.03.008; Herd MB, 2007, PHARMACOL THERAPEUT, V116, P20, DOI 10.1016/j.pharmthera.2007.03.007; Hertig A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.011; Higashi T, 2004, J PHARMACEUT BIOMED, V36, P429, DOI 10.1016/j.jpba.2004.07.012; Higashi T, 2009, BIOL PHARM BULL, V32, P1636, DOI 10.1248/bpb.32.1636; Hill KK, 2012, MOL CELL ENDOCRINOL, V348, P418, DOI 10.1016/j.mce.2011.07.017; Hill M, 2010, J STEROID BIOCHEM, V122, P114, DOI 10.1016/j.jsbmb.2010.05.007; HOLZBAUER M, 1969, NATURE, V221, P572, DOI 10.1038/221572b0; Hosie AM, 2007, PHARMACOL THERAPEUT, V116, P7, DOI 10.1016/j.pharmthera.2007.03.011; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Hsing AW, 2007, CANCER EPIDEM BIOMAR, V16, P1004, DOI 10.1158/1055-9965.EPI-06-0792; Hsu HJ, 2006, MOL CELL ENDOCRINOL, V248, P160, DOI 10.1016/j.mce.2005.10.011; HU ZY, 1987, P NATL ACAD SCI USA, V84, P8215, DOI 10.1073/pnas.84.23.8215; HU ZY, 1989, BIOCHEM BIOPH RES CO, V161, P917, DOI 10.1016/0006-291X(89)92686-7; Huhtaniemi IT, 2012, EUR J ENDOCRINOL, V166, P983, DOI 10.1530/EJE-11-1051; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.0305-1846.2003.00515.x; Ibanez C, 2003, PROG NEUROBIOL, V71, P49, DOI 10.1016/j.pneurobio.2003.09.002; Ibanez C, 2003, ENDOCRINOLOGY, V144, P2902, DOI 10.1210/en.2002-0073; Inoue T, 2002, J CLIN ENDOCR METAB, V87, P5325, DOI 10.1210/jc.2002-012096; Inquimbert P, 2008, J NEUROSCI, V28, P3427, DOI 10.1523/JNEUROSCI.5076-07.2008; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Ishida M, 2003, J REPROD DEVELOP, V49, P79; Ishida M, 2007, J REPROD DEVELOP, V53, P499, DOI 10.1262/jrd.18125; Ishihara Y, 2013, J STEROID BIOCHEM, V135, P1, DOI 10.1016/j.jsbmb.2012.12.013; Ishikura S, 2004, BIOL PHARM BULL, V27, P1939, DOI 10.1248/bpb.27.1939; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Issop L, 2013, MOL CELL ENDOCRINOL, V371, P34, DOI 10.1016/j.mce.2012.12.003; Iwata M, 2012, BRIT J ANAESTH, V109, P935, DOI 10.1093/bja/aes340; Jacobsen BM, 2012, MOL CELL ENDOCRINOL, V357, P18, DOI 10.1016/j.mce.2011.09.016; Jahagirdar V, 2012, J NEUROENDOCRINOL, V24, P1126, DOI 10.1111/j.1365-2826.2012.02318.x; Jayakumar AR, 2002, J NEUROCHEM, V83, P1226, DOI 10.1046/j.1471-4159.2002.01261.x; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Johnston GAR, 2005, CURR PHARM DESIGN, V11, P1867, DOI 10.2174/1381612054021024; Jorda EG, 2005, APOPTOSIS, V10, P91, DOI 10.1007/s10495-005-6064-9; JungTestas I, 1996, J STEROID BIOCHEM, V58, P77, DOI 10.1016/0960-0760(96)00009-X; JUNGTESTAS I, 1989, ENDOCRINOLOGY, V125, P2083; KALRA PS, 1977, ENDOCRINOLOGY, V101, P1821, DOI 10.1210/endo-101-6-1821; KARAVOLAS HJ, 1976, ENDOCRINOLOGY, V98, P164, DOI 10.1210/endo-98-1-164; KARAVOLAS HJ, 1979, J STEROID BIOCHEM, V11, P863, DOI 10.1016/0022-4731(79)90022-0; Karchewski LA, 2004, EUR J NEUROSCI, V20, P671, DOI 10.1111/j.1460-9568.2004.03530.x; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; KATO J, 1993, J STEROID BIOCHEM, V47, P173, DOI 10.1016/0960-0760(93)90072-5; Keller AF, 2004, J NEUROSCI, V24, P907, DOI 10.1523/JNEUROSCI.4642-03.2004; Kellogg CK, 1999, DEV BRAIN RES, V115, P17, DOI 10.1016/S0165-3806(99)00041-3; Ketha H, 2014, CURR OPIN ENDOCRINOL, V21, P217, DOI 10.1097/MED.0000000000000068; Kimoto T, 2001, ENDOCRINOLOGY, V142, P3578, DOI 10.1210/en.142.8.3578; King SR, 2002, J NEUROSCI, V22, P10613; Kipp M, 2009, FRONT NEUROENDOCRIN, V30, P188, DOI 10.1016/j.yfrne.2009.04.004; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kohchi C, 1998, BRAIN RES, V801, P233, DOI 10.1016/S0006-8993(98)00585-X; KORNEYEV A, 1993, J NEUROCHEM, V61, P1515, DOI 10.1111/j.1471-4159.1993.tb13647.x; Kourrich S, 2012, TRENDS NEUROSCI, V35, P762, DOI 10.1016/j.tins.2012.09.007; KRAUS WL, 1993, MOL ENDOCRINOL, V7, P1603, DOI 10.1210/me.7.12.1603; KRIEGER NR, 1989, J NEUROCHEM, V52, P1866, DOI 10.1111/j.1471-4159.1989.tb07269.x; Krone N, 2009, BEST PRACT RES CL EN, V23, P181, DOI 10.1016/j.beem.2008.10.014; Kuhlmann AC, 2000, J NEUROCHEM, V74, P1694, DOI 10.1046/j.1471-4159.2000.0741694.x; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2010, NEUROSCIENCE, V166, P94, DOI 10.1016/j.neuroscience.2009.12.012; Labombarda F, 2013, NEUROPHARMACOLOGY, V71, P46, DOI 10.1016/j.neuropharm.2013.03.010; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Lacor P, 1999, BRAIN RES, V815, P70, DOI 10.1016/S0006-8993(98)01105-6; Lambert Jeremy J, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS48, DOI 10.1016/j.psyneuen.2009.08.009; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; Lassmann H, 2008, CURR OPIN NEUROL, V21, P242, DOI 10.1097/WCO.0b013e3282fee94a; Lauber ME, 1996, ENDOCRINOLOGY, V137, P2718, DOI 10.1210/en.137.7.2718; Lee JS, 2006, J CLIN ENDOCR METAB, V91, P3791, DOI 10.1210/jc.2005-2378; LEGOASCOGNE C, 1987, SCIENCE, V237, P1212, DOI 10.1126/science.3306919; LEGOASCOGNE C, 1989, J NEUROENDOCRINOL, V1, P153, DOI 10.1111/j.1365-2826.1989.tb00095.x; Leonelli E, 2005, MECH AGEING DEV, V126, P1159, DOI 10.1016/j.mad.2005.06.001; Levine JE, 2001, FRONT NEUROENDOCRIN, V22, P69, DOI 10.1006/frne.2001.0210; Li JH, 2015, STEROIDS, V103, P89, DOI 10.1016/j.steroids.2015.03.016; Liere P, 2015, EXPERT REV ENDOCRINO, V10, P463, DOI 10.1586/17446651.2015.1063997; Liere P, 2009, J LIPID RES, V50, P2430, DOI 10.1194/jlr.M900162-JLR200; Light A, 2013, STEROIDS, V78, P633, DOI 10.1016/j.steroids.2012.12.016; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Lopez V, 2009, J COMP NEUROL, V512, P124, DOI 10.1002/cne.21883; Luetjens CM, 2006, J ENDOCRINOL, V189, P529, DOI 10.1677/joe.1.06348; MACLUSKY NJ, 1978, NATURE, V274, P276, DOI 10.1038/274276a0; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Maldonado-Devincci AM, 2014, PSYCHOPHARMACOLOGY, V231, P3281, DOI 10.1007/s00213-014-3552-z; Mani SK, 2012, NEUROENDOCRINOLOGY, V96, P152, DOI 10.1159/000338668; MANN DR, 1973, P SOC EXP BIOL MED, V142, P1226; Mansour MF, 2016, J STEROID BIOCHEM, V161, P45, DOI 10.1016/j.jsbmb.2016.02.003; MARTINI L, 1993, J STEROID BIOCHEM, V47, P195, DOI 10.1016/0960-0760(93)90075-8; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P609, DOI 10.1016/j.pbb.2006.07.032; McBane SE, 2014, PHARMACOTHERAPY, V34, P410, DOI 10.1002/phar.1394; MCEWEN BS, 1979, ANNU REV NEUROSCI, V2, P65, DOI 10.1146/annurev.ne.02.030179.000433; MCEWEN BS, 1991, J STEROID BIOCHEM, V39, P223, DOI 10.1016/0960-0760(91)90067-F; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Melcangi RC, 1999, J NEUROSCI RES, V56, P349, DOI 10.1002/(SICI)1097-4547(19990515)56:4<349::AID-JNR3>3.0.CO;2-H; Melcangi RC, 2005, BRAIN RES REV, V48, P328, DOI 10.1016/j.brainresrev.2004.12.021; MELCANGI RC, 1994, BRAIN RES, V639, P202, DOI 10.1016/0006-8993(94)91731-0; Melcangi RC, 1998, ENDOCRINE, V8, P65, DOI 10.1385/ENDO:8:1:65; Melcangi RC, 1998, J STEROID BIOCHEM, V65, P295, DOI 10.1016/S0960-0760(98)00030-2; MELCANGI RC, 1988, J STEROID BIOCHEM, V31, P173, DOI 10.1016/0022-4731(88)90051-9; Melcangi RC, 2014, PROG NEUROBIOL, V113, P1, DOI 10.1016/j.pneurobio.2013.09.005; Melcangi RC, 2013, J SEX MED, V10, P2598, DOI 10.1111/jsm.12269; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Mellon SH, 2001, INT REV NEUROBIOL, V46, P33; MENSAHNYAGAN AG, 1994, J NEUROSCI, V14, P7306; Midzak A, 2015, BIOCHEM SOC T, V43, P572, DOI 10.1042/BST20150061; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Miller WL, 2005, ENDOCRINOLOGY, V146, P2544, DOI 10.1210/en.2005-0096; Mills CD, 2005, MOL CELL NEUROSCI, V30, P228, DOI 10.1016/j.mcn.2005.07.010; Mitterling KL, 2010, J COMP NEUROL, V518, P2729, DOI 10.1002/cne.22361; MOCCHETTI I, 1991, NEUROPHARMACOLOGY, V30, P1365, DOI 10.1016/S0028-3908(11)80003-1; MOHLER H, 1995, ADV BIOCHEM PSYCHOPH, V48, P41; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Mukai Y, 2008, BIOL PHARM BULL, V31, P1646, DOI 10.1248/bpb.31.1646; Mulac-Jericevic B, 2004, REPRODUCTION, V128, P139, DOI 10.1530/rep.1.00189; Nacusi LP, 2011, NAT REV UROL, V8, P378, DOI 10.1038/nrurol.2011.67; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Oettel M, 2004, Aging Male, V7, P236; Ohlsson C, 2013, J CLIN ENDOCR METAB, V98, pE1097, DOI 10.1210/jc.2012-3861; OONK RB, 1990, J BIOL CHEM, V265, P22392; Pang YF, 2013, ENDOCRINOLOGY, V154, P283, DOI 10.1210/en.2012-1772; PAPADOPOULOS V, 1992, P NATL ACAD SCI USA, V89, P5113, DOI 10.1073/pnas.89.11.5113; PAPADOPOULOS V, 1991, ENDOCRINOLOGY, V129, P1481, DOI 10.1210/endo-129-3-1481; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2014, ENDOCRINOLOGY, V155, P15, DOI 10.1210/en.2013-2033; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Parizek A, 2005, J CLIN ENDOCR METAB, V90, P395, DOI 10.1210/jc.2004-0444; PARSONS B, 1982, J NEUROSCI, V2, P1446; Patte-Mensah C, 2006, J MOL NEUROSCI, V28, P17, DOI 10.1385/JMN:28:1:17; Patte-Mensah C, 2005, P NATL ACAD SCI USA, V102, P9044, DOI 10.1073/pnas.0502968102; Patte-Mensah C, 2004, J COMP NEUROL, V477, P286, DOI 10.1002/cne.20251; Patte-Mensah C, 2004, CELL MOL LIFE SCI, V61, P2274, DOI 10.1007/s00018-004-4235-4; Patte-Mensah C, 2003, J NEUROCHEM, V86, P1233, DOI 10.1046/j.1471-4159.2003.01935.x; PAUL SM, 1992, FASEB J, V6, P2311, DOI 10.1096/fasebj.6.6.1347506; Peluso JJ, 2014, REPRODUCTION, V147, pR169, DOI 10.1530/REP-13-0582; Penning TM, 1997, ENDOCR REV, V18, P281, DOI 10.1210/er.18.3.281; Penning TM, 2003, J STEROID BIOCHEM, V85, P247, DOI 10.1016/S0960-0760(03)00236-X; Penning TM, 2011, J STEROID BIOCHEM, V125, P46, DOI 10.1016/j.jsbmb.2011.01.009; Petersen SL, 2013, J NEUROENDOCRINOL, V25, P991, DOI 10.1111/jne.12060; Pfaff D, 2002, TRENDS NEUROSCI, V25, P45, DOI 10.1016/S0166-2236(00)02084-1; Piekorz RP, 2005, MOL ENDOCRINOL, V19, P431, DOI 10.1210/me.2004-0302; Pinna G, 2003, P NATL ACAD SCI USA, V100, P2035, DOI 10.1073/pnas.0337642100; PODUSLO JF, 1995, J NEUROCHEM, V65, P149; Poisbeau P, 2005, J NEUROSCI, V25, P11768, DOI 10.1523/JNEUROSCI.3841-05.2005; Poisbeau P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00174; Poletti A, 1998, STEROIDS, V63, P246, DOI 10.1016/S0039-128X(98)00018-X; Puia G, 2003, NEUROPHARMACOLOGY, V44, P49, DOI 10.1016/S0028-3908(02)00341-6; Quadros PS, 2008, DEV NEUROBIOL, V68, P1378, DOI 10.1002/dneu.20664; Quadros PS, 2008, ENDOCRINOLOGY, V149, P3054, DOI 10.1210/en.2007-1133; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; RAINBOW TC, 1982, NATURE, V300, P648, DOI 10.1038/300648a0; Ravikumar B, 2016, NEUROPHARMACOLOGY, V108, P229, DOI 10.1016/j.neuropharm.2016.03.053; RESKO JA, 1969, SCIENCE, V164, P70, DOI 10.1126/science.164.3875.70; Robert F, 2001, EUR J NEUROSCI, V13, P916, DOI 10.1046/j.0953-816x.2001.01463.x; ROBERT PH, 1999, SCI PRACT NEUROPSYCH, P125; ROMEO E, 1993, J PHARMACOL EXP THER, V267, P462; Romeo RD, 2005, STRESS, V8, P265, DOI 10.1080/10253890500489320; Romeo RD, 2010, FRONT NEUROENDOCRIN, V31, P232, DOI 10.1016/j.yfrne.2010.02.004; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rudolph LM, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12405; Rupprecht R, 2003, PSYCHONEUROENDOCRINO, V28, P139, DOI 10.1016/S0306-4530(02)00064-1; RUPPRECHT R, 1993, NEURON, V11, P523, DOI 10.1016/0896-6273(93)90156-L; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; Saalmann YB, 2007, J NEUROENDOCRINOL, V19, P272, DOI 10.1111/j.1365-2826.2006.01527.x; Sakamoto H, 2001, J COMP NEUROL, V439, P291, DOI 10.1002/cne.1351; Santoro N, 2016, J CLIN ENDOCR METAB, V101, P1318, DOI 10.1210/jc.2016-1271; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; SCHAEFFER C, 1987, ACTA ENDOCRINOL-COP, V114, P440, DOI 10.1530/acta.0.1140440; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Schumacher M, 2015, STEROIDS, V103, P42, DOI 10.1016/j.steroids.2015.08.013; Schumacher M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00010; Schumacher M, 2008, CURR OPIN PHARMACOL, V8, P740, DOI 10.1016/j.coph.2008.10.002; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Selvaraj V, 2015, TRENDS ENDOCRIN MET, V26, P341, DOI 10.1016/j.tem.2015.02.007; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; Serra M, 1999, BRIT J PHARMACOL, V127, P177, DOI 10.1038/sj.bjp.0702530; Serra M, 2002, J PSYCHOPHARMACOL, V16, P133, DOI 10.1177/026988110201600203; Shibuya K, 2003, BBA-GEN SUBJECTS, V1619, P301, DOI 10.1016/S0304-4165(02)00489-0; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Sierra A, 2003, EUR J NEUROSCI, V18, P1458, DOI 10.1046/j.1460-9568.2003.02872.x; SIMARD J, 1995, J STEROID BIOCHEM, V53, P127, DOI 10.1016/0960-0760(95)00043-Y; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Singh C, 2012, NEUROBIOL AGING, V33, P1493, DOI 10.1016/j.neurobiolaging.2011.06.008; Sitruk-Ware R, 2008, MATURITAS, V61, P151, DOI 10.1016/j.maturitas.2004.01.001; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slotta KH, 1934, BER DTSCH CHEM GES, V67, P1270, DOI 10.1002/cber.19340670729; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Soustiel JF, 2008, EXP NEUROL, V214, P201, DOI 10.1016/j.expneurol.2008.08.008; SPARKES RS, 1991, DNA CELL BIOL, V10, P359, DOI 10.1089/dna.1991.10.359; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Stanczyk FZ, 2001, CONTRACEPTION, V64, P1, DOI 10.1016/S0010-7824(01)00222-0; Starling EH, 1905, LANCET, V2, P339; Steiger JL, 2004, PHARMACOL THERAPEUT, V101, P259, DOI 10.1016/j.pharmthera.2003.12.002; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stenman UH, 2013, BEST PRACT RES CL EN, V27, P823, DOI 10.1016/j.beem.2013.10.007; STERNAU LL, 1989, STROKE, V20, P281, DOI 10.1161/01.STR.20.2.281; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Stoffel-Wagner B, 2001, EUR J ENDOCRINOL, V145, P669, DOI 10.1530/eje.0.1450669; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Takase M, 1999, ENDOCRINOLOGY, V140, P1936, DOI 10.1210/en.140.4.1936; Talaber G, 2015, STEROIDS, V103, P58, DOI 10.1016/j.steroids.2015.06.010; Thomas P, 2007, ENDOCRINOLOGY, V148, P705, DOI 10.1210/en.2006-0974; Thomas P, 2013, STEROIDS, V78, P583, DOI 10.1016/j.steroids.2013.01.003; Thomas P, 2012, NEUROENDOCRINOLOGY, V96, P162, DOI 10.1159/000339822; Titus MA, 2014, PROSTATE, V74, P235, DOI 10.1002/pros.22745; TSUTSUI K, 1995, BRAIN RES, V678, P1; Tuckey RC, 2005, PLACENTA, V26, P273, DOI 10.1016/j.placenta.2004.06.012; Ukena K, 1998, ENDOCRINOLOGY, V139, P137, DOI 10.1210/en.139.1.137; Ukena K, 1999, ENDOCRINOLOGY, V140, P805, DOI 10.1210/en.140.2.805; Ulbrich C, 2012, J STEROID BIOCHEM, V131, P10, DOI 10.1016/j.jsbmb.2012.01.007; Uzunov DP, 1996, P NATL ACAD SCI USA, V93, P12599, DOI 10.1073/pnas.93.22.12599; Veiga S, 2005, J NEUROSCI RES, V80, P129, DOI 10.1002/jnr.20430; Verleye M, 2005, PHARMACOL BIOCHEM BE, V82, P712, DOI 10.1016/j.pbb.2005.11.013; VERMA A, 1989, ANNU REV PHARMACOL, V29, P307; VERMEULEN A, 1976, J STEROID BIOCHEM, V7, P1, DOI 10.1016/0022-4731(76)90156-4; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wang C, 2008, STEROIDS, V73, P1345, DOI 10.1016/j.steroids.2008.05.004; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; Wang JM, 2008, BRAIN RES REV, V57, P398, DOI 10.1016/j.brainresrev.2007.08.010; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Waters EM, 2008, J COMP NEUROL, V511, P34, DOI 10.1002/cne.21826; Wehrenberg U, 2001, J NEUROCHEM, V76, P1879, DOI 10.1046/j.1471-4159.2001.00207.x; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Wendler A, 2012, STEROIDS, V77, P1002, DOI 10.1016/j.steroids.2011.12.023; Whiting PJ, 2003, CURR OPIN DRUG DISC, V6, P648; Wiebe JP, 2006, ENDOCR-RELAT CANCER, V13, P717, DOI 10.1677/erc.1.01010; Wiebe JP, 2015, J STEROID BIOCHEM, V149, P27, DOI 10.1016/j.jsbmb.2015.01.004; WINTERSTEINER OSKAR, 1934, JOUR BIOL CHEM, V107, P321; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu AHB, 2013, CLIN CHIM ACTA, V420, P4, DOI 10.1016/j.cca.2012.10.026; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; YOUNG J, 1994, ENDOCRINE, V2, P505; Yousuf S, 2013, NEUROSCIENCE, V239, P92, DOI 10.1016/j.neuroscience.2012.10.017; Yu CG, 2015, J NEUROSCI RES, V93, P199, DOI 10.1002/jnr.23503; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079; Zhang J, 1997, BIOCHEM J, V322, P175, DOI 10.1042/bj3220175; Zitzmann M, 2005, J CLIN ENDOCR METAB, V90, P6603, DOI 10.1210/jc.2005-0847; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	417	6	6	1	9	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			978-0-12-803592-4				2017							215	244		10.1016/B978-0-12-803592-4.00054-7			30	Behavioral Sciences; Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism; Neurosciences	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism; Neurosciences & Neurology	BJ5SR	WOS:000426260700014					2022-02-06	
J	Senapathi, TGA; Wiryana, M; Aribawa, IGNM; Ryalino, C				Senapathi, Tjokorda Gde Agung; Wiryana, Made; Aribawa, I. Gusti Ngurah Mahaalit; Ryalino, Christopher			Bispectral index value correlates with Glasgow Coma Scale in traumatic brain injury patients	OPEN ACCESS EMERGENCY MEDICINE			English	Article						decreased consciousness; head injury; BIS monitor; consciousness level; anesthesia depth; prediction; association	LINEAR-REGRESSION PREDICTION; INTUBATED PATIENTS; MOTOR SCORES; VERBAL SCORE; CONSCIOUSNESS; EYE	Background: Accuracy of consciousness level assessment is very important. It may determine and influence further clinical decisions, thus influences patients' outcomes. The widest method in determining the level of awareness is the Glasgow Coma Scale (GCS). Despite its common use, GCS scores obtained by one clinician may differ from others depending on their interpretations and past experience. One of the tools used to assess the level of consciousness objectively is bispectral index (BIS). The aim of this study was to identify the correlation between BIS and GCS score in patients with traumatic brain injury. Patients and Methods: A total of 78 patients who were admitted to emergency room for traumatic brain injury were included in this study. One observer evaluated the GCS of all patients to minimize subjectivity. Another investigator then obtained the BIS values for each patient. Spearman's rank correlation coefficient was used to determine whether GCS correlated with BIS value. Results: In 78 patients, the BIS was found to be significantly correlated with GCS (r= 0.744, p< 0.01). The BIS values increased with an increasing GCS. Mean BIS values of mild, moderate, and severe head injury were 88.1 +/- 5.6, 72.1 > 11.1, and 60.4 +/- 11.7, respectively. Conclusion: In this study, a significant correlation existed between GCS and BIS. This finding suggests that BIS may be used for assessing GCS in patients with traumatic brain injury. However, the scatters of BIS values for any GCS level may limit the BIS in predicting GCS accurately.	[Senapathi, Tjokorda Gde Agung; Wiryana, Made; Aribawa, I. Gusti Ngurah Mahaalit; Ryalino, Christopher] Udayana Univ, Sanglah Gen Hosp, Dept Anesthesiol & Intens Care, Denpasar 80114, Bali, Indonesia		Ryalino, C (corresponding author), Udayana Univ, Sanglah Gen Hosp, Dept Anesthesiol & Intens Care, Denpasar 80114, Bali, Indonesia.	ryalino@gmail.com	Ryalino, Christopher/K-1673-2019; Senapathi, Tjokorda Gde Agung/I-4232-2016	Ryalino, Christopher/0000-0001-9618-6230; Senapathi, Tjokorda Gde Agung/0000-0002-7479-6190			Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Dou L, 2014, WORLD J EMERG MED, V5, P53, DOI [10.5847/wjem.j.issn.1920-8642.2014.01.009, 10.5847/wjem.j.1920-8642.2014.01.009]; Fabregas N, 2004, ANESTHESIOLOGY, V101, P43, DOI 10.1097/00000542-200407000-00009; Gill M, 2003, ACAD EMERG MED, V10, P175, DOI 10.1197/aemj.10.2.175; Jung JY, 2013, KOREAN J ANESTHESIOL, V64, P246, DOI 10.4097/kjae.2013.64.3.246; Matis G, 2008, ACTA NEUROL BELG, V108, P75; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Nasraway SA, 2002, CRIT CARE MED, V30, P1483, DOI 10.1097/00003246-200207000-00014; Nunes RR, 2012, REV BRAS ANESTESIOL, V62, P105, DOI 10.1016/S0034-7094(12)70109-5; Paul Danie B, 2006, J Clin Monit Comput, V20, P399, DOI 10.1007/s10877-006-9045-9; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; Teasdale G, 2014, NURS TIMES, V110, P12; Wang XF, 2013, TURK J MED SCI, V43, P718, DOI 10.3906/sag-1209-76	14	6	7	0	4	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1500			OPEN ACCESS EMERG M	Open Access Emerg. Med.		2017	9						43	46		10.2147/OAEM.S130643			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	ES5GB	WOS:000399565000001	28435334	Green Submitted, Green Published, gold			2022-02-06	
J	Sharma, B; Tomaszczyk, JC; Dawson, D; Turner, GR; Colella, B; Green, REA				Sharma, Bhanu; Tomaszczyk, Jennifer C.; Dawson, Deirdre; Turner, Gary R.; Colella, Brenda; Green, Robin E. A.			Feasibility of online self-administered cognitive training in moderate-severe brain injury	DISABILITY AND REHABILITATION			English	Article						Brain games; cognitive rehabilitation; cognitive training; environmental enrichment; feasibility; neurodegeneration; TBI; traumatic brain injury	HEALTHY OLDER-ADULTS; ENVIRONMENTAL ENRICHMENT; GENDER-DIFFERENCES; DIFFUSION-TENSOR; DENTATE GYRUS; UNITED-STATES; PILOT; PLASTICITY; ADHERENCE; INTERVENTIONS	Purpose: Cognitive environmental enrichment (C-EE) offers promise for offsetting neural decline that is observed in chronic moderate-severe traumatic brain injury (TBI). Brain games are a delivery modality for C-EE that can be self-administered over the Internet without therapist oversight. To date, only one study has examined the feasibility of self-administered brain games in TBI, and the study focused predominantly on mild TBI. Therefore, the primary purpose of the current study was to examine the feasibility of self-administered brain games in moderate-severe TBI. A secondary and related purpose was to examine the feasibility of remote monitoring of any C-EE-induced adverse symptoms with a self-administered evaluation tool. Method: Ten patients with moderate-severe TBI were asked to complete 12 weeks (60min/day, five days/week) of online brain games with bi-weekly self-evaluation, intended to measure any adverse consequences of cognitive training (e.g., fatigue, eye strain). Results: There was modest weekly adherence (42.6%4.4%, averaged across patients and weeks) and 70% patient retention; of the seven retained patients, six completed the self-evaluation questionnaire at least once/week for each week of the study. Conclusions: Even patients with moderate-severe TBI can complete a demanding, online C-EE intervention and a self-administered symptom evaluation tool with limited therapist oversight, though at daily rate closer to 30 than 60min per day. Further self-administered C-EE research is underway in our lab, with more extensive environmental support. Implications for Rehabilitation Online brain games (which may serve as a rehabilitation paradigm that can help offset the neurodegeneration observed in chronic TBI) can be feasibly self-administered by moderate-to-severe TBI patients. Brain games are a promising therapy modality, as they can be accessed by all moderate-to-severe TBI patients irrespective of geographic location, clinic and/or therapist availability, or impairments that limit mobility and access to rehabilitation services. Future efficacy trials that examine the effect of brain games for offsetting neurodegeneration in moderate-to-severe TBI patients are warranted.	[Sharma, Bhanu; Dawson, Deirdre; Green, Robin E. A.] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Sharma, Bhanu; Tomaszczyk, Jennifer C.; Dawson, Deirdre; Colella, Brenda; Green, Robin E. A.] Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave,Room 11-207, Toronto, ON M5G 2A2, Canada; [Dawson, Deirdre] Rotman Res Inst, Toronto, ON, Canada; [Dawson, Deirdre] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Turner, Gary R.] York Univ, Dept Psychol, Toronto, ON, Canada		Green, REA (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave,Room 11-207, Toronto, ON M5G 2A2, Canada.	Robin.Green@uhn.ca	Dawson, Deirdre/I-8882-2014	Dawson, Deirdre/0000-0001-7517-6121; Green, Robin/0000-0001-9451-3963	Physicians' Services Incorporated Foundation [12-43]; Canada Research Chair in Traumatic Brain Injury [950-211602]; Canadian Institutes for Health Research Post-Doctoral FellowshipCanadian Institutes of Health Research (CIHR)	This work was supported by the Physicians' Services Incorporated Foundation under Grant # 12-43, the Canada Research Chair in Traumatic Brain Injury under Grant 950-211602, and the Canadian Institutes for Health Research Post-Doctoral Fellowship.	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; [Anonymous], 2001, GUIDE PATIENT RECRUI; [Anonymous], 2014, J ORTHOPAED SPORTS P, V44, P555; Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Arundine A, 2012, J HEAD TRAUMA REHAB, V27, P104, DOI 10.1097/HTR.0b013e3182125591; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Bamidis PD, 2014, NEUROSCI BIOBEHAV R, V44, P206, DOI 10.1016/j.neubiorev.2014.03.019; Barnes DE, 2009, ALZ DIS ASSOC DIS, V23, P205, DOI 10.1097/WAD.0b013e31819c6137; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Berg KM, 2004, J GEN INTERN MED, V19, P1111, DOI 10.1111/j.1525-1497.2004.30445.x; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Cavallini E, 2010, AGING CLIN EXP RES, V22, P314, DOI [10.1007/BF03337728, 10.3275/6704]; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Curlik DM, 2013, NEUROPHARMACOLOGY, V64, P506, DOI 10.1016/j.neuropharm.2012.07.027; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dobrossy MD, 2004, EUR J NEUROSCI, V19, P159, DOI 10.1111/j.1460-9568.2004.03105.x; Eckroth-Bucher M, 2009, AM J ALZHEIMERS DIS, V24, P234, DOI 10.1177/1533317509332624; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Frasca Diana, 2013, Front Hum Neurosci, V7, P31, DOI 10.3389/fnhum.2013.00031; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Hoeppner BB, 2013, ALCOHOL CLIN EXP RES, V37, P1779, DOI 10.1111/acer.12159; Jak AJ, 2013, NEUROPSYCHOL REV, V23, P13, DOI 10.1007/s11065-013-9226-5; Jung CK, 2012, CEREB CORTEX, V24, P377, DOI DOI 10.1093/CERCOR/BHS31; Kapp M.K., 2012, GAMIFICATION LEARNIN; Kazdin A. E., 2013, BEHAV MODIFICATION A, V7th; Kelly ME, 2014, AGEING RES REV, V15, P28, DOI 10.1016/j.arr.2014.02.004; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kobayashi S, 2002, J NEUROSCI RES, V70, P340, DOI 10.1002/jnr.10442; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; Lebowitz MS, 2012, J REHABIL RES DEV, V49, P1547, DOI 10.1682/JRRD.2011.07.0133; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lovden M, 2011, CEREB CORTEX, V21, P1435, DOI 10.1093/cercor/bhq230; Lovden M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.013; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Manteuffel M, 2014, J WOMENS HEALTH, V23, P112, DOI 10.1089/jwh.2012.3972; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Miller LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00506; Mitchell MS, 2013, AM J PREV MED, V45, P658, DOI 10.1016/j.amepre.2013.06.017; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Oosenbrug E, 2016, CAN J CARDIOL, V32, P1316, DOI 10.1016/j.cjca.2016.01.036; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Park DC, 2014, PSYCHOL SCI, V25, P103, DOI 10.1177/0956797613499592; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Patterson JM, 2008, J CYST FIBROS, V7, P154, DOI 10.1016/j.jcf.2007.07.008; Peretz C, 2011, NEUROEPIDEMIOLOGY, V36, P91, DOI 10.1159/000323950; Rosen AC, 2011, J ALZHEIMERS DIS, V26, P349, DOI 10.3233/JAD-2011-0009; Schmutte Timothy, 2007, Behav Sleep Med, V5, P39; Shanyinde M, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-117; Shatil E, 2010, NEUROREHABILITATION, V26, P143, DOI 10.3233/NRE-2010-0546; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Starkstein SE, 2014, PSYCHIAT CLIN N AM, V37, P103, DOI 10.1016/j.psc.2013.10.002; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Tarraga L, 2006, J NEUROL NEUROSUR PS, V77, P1116, DOI 10.1136/jnnp.2005.086074; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tickle-Degnen L, 2013, AM J OCCUP THER, V67, P171, DOI 10.5014/ajot.2013.006270; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Valero J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016832; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; van Teijlingen ER, 2001, J ADV NURS, V34, P289, DOI 10.1046/j.1365-2648.2001.01757.x; Wang Y., 2014, UNDERSTANDING TRAUMA, P99; Whitehead AL, 2014, CONTEMP CLIN TRIALS, V38, P130, DOI 10.1016/j.cct.2014.04.001; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Zahodne LB, 2011, J INT NEUROPSYCH SOC, V17, P1039, DOI 10.1017/S1355617711001044; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	83	6	6	1	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	14					1380	1390		10.1080/09638288.2016.1195453			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU1NT	WOS:000400787800003	27414703				2022-02-06	
J	Shijo, K; Sutton, RL; Ghavim, SS; Harris, NG; Bartnik-Olson, BL				Shijo, Katsunori; Sutton, Richard L.; Ghavim, Sima S.; Harris, Neil G.; Bartnik-Olson, Brenda L.			Metabolic fate of glucose in rats with traumatic brain injury and pyruvate or glucose treatments: A NMR spectroscopy study	NEUROCHEMISTRY INTERNATIONAL			English	Article						Controlled cortical impact; Ethyl pyruvate; Glucose; Oxidative metabolism; Pentose phosphate pathway; Sodium pyruvate	CONTROLLED CORTICAL IMPACT; PENTOSE-PHOSPHATE PATHWAY; IMPROVES CEREBRAL METABOLISM; CONTUSION INJURY; P-31-NMR SPECTROSCOPY; OXIDATIVE-METABOLISM; HIPPOCAMPAL-NEURONS; HEMORRHAGIC-SHOCK; NAD(+) DEPLETION; IONIC FLUXES	Administration of sodium pyruvate (SP; 9.08 mu mol/kg, i.p.), ethyl pyruvate (EP; 0.34 mu mol/kg, i.p.) or glucose (GLC; 11.1 mu mol/kg, i.p.) to rats after unilateral controlled cortical impact (CCI) injury has been reported to reduce neuronal loss and improve cerebral metabolism. In the present study these doses of each fuel or 8% saline (SAL; 5.47 nmoles/kg) were administered immediately and at 1, 3, 6 and 23 h postCCI. At 24 h all CCI groups and non-treated Sham injury controls were infused with [1,2 C-13] glucose for 68 min(13)C nuclear magnetic resonance (NMR) spectra were obtained from cortex + hippocampus tissues from left (injured) and right (contralateral) hemispheres. All three fuels increased lactate labeling to a similar degree in the injured hemisphere. The amount of lactate labeled via the pentose phosphate and pyruvate recycling (PPP + PR) pathway increased in CCI-SAL and was not improved by SP, EP, and GLC treatments. Oxidative metabolism, as assessed by glutamate labeling, was reduced in CCI-SAL animals. The greatest improvement in oxidative metabolism was observed in animals treated with SP and fewer improvements after EP or GLC treatments. Compared to SAL, all three fuels restored glutamate and glutamine labeling via pyruvate carboxylase (PC), suggesting improved astrocyte metabolism following fuel treatment Only SP treatments restored the amount of [4 C-13] glutamate labeled by the PPP + PR pathway to sham levels. Milder injury effects in the contralateral hemisphere appear normalized by either SP or EP treatments, as increases in the total pool of C-13 lactate and labeling of lactate in glycolysis, or decreases in the ratio of PC/PDH labeling of glutamine, were found only for CCI-SAL and CCI-GLC groups compared to Sham. The doses of SP, EP and GLC examined in this study all enhanced lactate labeling and restored astrocyte-specific PC activity but differentially affected neuronal metabolism after CCI injury. The restoration of astrocyte metabolism by all three fuel treatments may partially underlie their abilities to improve cerebral glucose utilization and to reduce neuronal loss following CCI injury. (C) 2016 Elsevier Ltd. All rights reserved.	[Shijo, Katsunori; Sutton, Richard L.; Ghavim, Sima S.; Harris, Neil G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Brain Injury Res Ctr, Box 956901, Los Angeles, CA 90095 USA; [Bartnik-Olson, Brenda L.] Loma Linda Univ, Sch Med, Dept Radiol, Loma Linda, CA USA; [Shijo, Katsunori] Nihon Univ, Dept Neurol Surg, Sch Med, Itabashi Ku, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan		Bartnik-Olson, BL (corresponding author), Loma Linda Univ, Dept Radiol, Med Ctr, 11234 Anderson St,Room B623, Loma Linda, CA 92354 USA.	sijyou.katsunori@nihon-u.ac.jp; rsutton@ucla.edu; sghavim@mednet.ucla.edu; ngharris@ucla.edu; bbartnik@llu.edu		Bartnik-Olson, Brenda/0000-0002-1137-9437; Harris, Neil/0000-0002-1965-6750	UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [PO1NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	This work was supported by the UCLA Brain Injury Research Center and award PO1NS058489 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is the sole responsibility of the authors and does not necessarily represent official views of the NINDS or the National Institutes of Health.	Alessandri B, 1999, ACT NEUR S, V75, P25; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; BADARGOFFER RS, 1990, BIOCHEM J, V266, P133, DOI 10.1042/bj2660133; BAQUER NZ, 1988, CURR TOP CELL REGUL, V29, P265; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Cruz F, 1999, NMR BIOMED, V12, P451, DOI 10.1002/(SICI)1099-1492(199911)12:7<451::AID-NBM571>3.3.CO;2-5; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Gonzalez SV, 2005, J NEUROCHEM, V95, P284, DOI 10.1111/j.1471-4159.2005.03365.x; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Harris NG, 1996, J NEUROCHEM, V67, P2030; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; HOTHERSALL JS, 1982, J NEUROCHEM, V39, P1325, DOI 10.1111/j.1471-4159.1982.tb12574.x; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Le Belle JE, 2002, NMR BIOMED, V15, P37, DOI 10.1002/nbm.740; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; McKenna Mary C, 2013, Front Endocrinol (Lausanne), V4, P191, DOI 10.3389/fendo.2013.00191; MICCHELI A, 1988, CELL MOL BIOL, V34, P591; Mongan PD, 2003, J SURG RES, V112, P180, DOI 10.1016/S0022-4804(03)00148-3; Mongan PD, 2001, AM J PHYSIOL-HEART C, V281, pH854, DOI 10.1152/ajpheart.2001.281.2.H854; Morken TS, 2014, NEUROCHEM RES, V39, P556, DOI 10.1007/s11064-013-1014-3; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Ralser M., 2007, J BIOL-LONDON, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rose ME, 2002, BRAIN RES, V935, P40, DOI 10.1016/S0006-8993(02)02445-9; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Schousboe A., 2015, NEUROCHEM RES; SCHRADER MC, 1993, BIOCHIM BIOPHYS ACTA, V1182, P162, DOI 10.1016/0925-4439(93)90138-Q; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; Shijo K, 2015, BRAIN RES, V1614, P94, DOI 10.1016/j.brainres.2015.04.022; Sonnewald U, 2010, NEUROCHEM RES, V35, P1916, DOI 10.1007/s11064-010-0257-5; Sugimori H, 1996, BRAIN RES BULL, V40, P263, DOI 10.1016/0361-9230(96)00052-4; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; SUTTON RL, 1994, ACTA NEUROCHIR, P446; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tabatabaie T, 1996, ARCH BIOCHEM BIOPHYS, V336, P290, DOI 10.1006/abbi.1996.0560; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Xing GQ, 2012, NEUROSCI LETT, V525, P140, DOI 10.1016/j.neulet.2012.07.055; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zeng JY, 2007, J CEREBR BLOOD F MET, V27, P304, DOI 10.1038/sj.jcbfm.9600335; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2012, ANESTHESIOLOGY, V116, P73, DOI 10.1097/ALN.0b013e31823d7731	79	6	7	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2017	102						66	78		10.1016/j.neuint.2016.11.014			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EI2YN	WOS:000392356100006	27919624	Green Accepted			2022-02-06	
J	Steel, J; Ferguson, A; Spencer, E; Togher, L				Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth; Togher, Leanne			Social communication assessment during post-traumatic amnesia and the post-acute period after traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; speech-language pathology; communication assessment; post-traumatic amnesia; post-acute	SPEECH-LANGUAGE PATHOLOGISTS; MINIMALLY CONSCIOUS STATE; COGNITIVE-COMMUNICATION; FOLLOW-UP; INCOG RECOMMENDATIONS; HEAD-INJURY; ABILITIES; RECOVERY; SKILLS; QUESTIONNAIRE	Background: Social communication impairment is a persisting and debilitating consequence of traumatic brain injury (TBI). However, there has been little empirical speech-language pathology (SLP) study focusing on the early stage of recovery after TBI, including during post-traumatic amnesia (PTA). This research reports on social communication presentation and recovery during late PTA and the post-acute period, assessed with standardized measures.Method: Using mixed-methods case study research, four participants with severe TBI were assessed with social communication assessment measures over the later stages of PTA and/or at PTA emergence, and at follow-up three months later. Assessment tools included the Measure of Cognitive Linguistic Abilities Family Questionnaire, the La Trobe Communication Questionnaire and The Profile of Pragmatic Impairment in Communication and included patient and friend/family perspectives.Results: It was possible to identify a profile of social communication disorder on SLP measures for participants during PTA that persisted at follow-up, but with decreased severity. Self and friend/family member ratings of social communication indicated an increased awareness of social difficulty at three months after PTA emergence.Conclusion: Findings provided information about presentation and course of recovery of social communication ability for participants in the early stage of rehabilitation after TBI. These findings have implications for timing and methods of SLP assessment during PTA.	[Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth] Univ Newcastle, Deparment Speech Pathol, Newcastle, NSW, Australia; [Steel, Joanne; Ferguson, Alison; Togher, Leanne] Moving Ahead, NHMRC Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [Togher, Leanne] Univ Sydney, Dept Speech Pathol, Sydney, NSW, Australia		Steel, J (corresponding author), Univ Newcastlem, Sch Off, Sch Humanities & Social Sci, Callaghan Campus,1st Floor,McMullin Bldg, Callaghan, NSW 2308, Australia.	Joanne.Steel@uon.edu.au	Steel, Joanne/AAA-2744-2022; Togher, Leanne/AAC-7083-2019; Steel, Joanne/M-2585-2018	Steel, Joanne/0000-0002-5478-5865; Steel, Joanne/0000-0002-5478-5865; Togher, Leanne/0000-0002-4518-6748			Ahmed S, 2000, BRAIN INJURY, V14, P765; Appleton S, 2011, BRAIN IMPAIR, V12, P210; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Code, 2014, SOCIAL COMMUNICATION, P1; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Copley A, 2015, BRAIN INJURY, V29, P1309, DOI 10.3109/02699052.2015.1043343; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Damico J. S., 1985, COMMUNICATION SKILLS, P165; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Douglas JM, 2016, J SPEECH LANG HEAR R, P1; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Ellmo W, 1995, MEASURE COGNITIVE LI; Finch E, 2016, ARCH PHYS MED REHABI; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Grice H. P., 1975, SYNTAX SEMANTICS, P41; GRICE HP, 1978, PRAGMATICS, V0001, P00013; Hagen C, 1980, RANCHO LEVELS COGNIT; Hays SJ, 2004, APHASIOLOGY, V18, P693, DOI 10.1080/02687030444000183; Joanette Y, 2004, PROTOCOLE MONTREAL E; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; Linscott RJ, 2005, SCHIZOPHR RES, V75, P225, DOI 10.1016/j.schres.2004.10.007; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McDonald S, 2014, SOCIAL COMMUNICATION; McDonald S., 2002, AWARENESS SOCIAL INF; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Short J, 2014, INT J SPEECH-LANG PA, V16, P219, DOI 10.3109/17549507.2014.882413; Smith VH, 2001, BRAIN IMPAIR, V2, P29, DOI DOI 10.1375/BRIM.2.1.29; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Steel J, 2016, BRAIN INJURY, V30, P1131, DOI 10.1080/02699052.2016.1174785; Steel J, 2015, NEUROREHABILITATION, V37, P221, DOI 10.3233/NRE-151255; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Symonds CP., 1937, MENTAL DISORDER FOLL, P1081; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Tate RL, 2010, COMPENDIUM TESTS SCA; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Turner-Stokes L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006051	54	6	6	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	10					1320	1330		10.1080/02699052.2017.1332385			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4GH	WOS:000415961800009	28657359				2022-02-06	
J	Steel, J; Ferguson, A; Spencer, E; Togher, L				Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth; Togher, Leanne			Language and cognitive communication disorder during post-traumatic amnesia: Profiles of recovery after TBI from three cases	BRAIN INJURY			English	Article						Cognitive communication; post-traumatic amnesia; speech-language pathology; traumatic brain injury; assessment	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; MINIMALLY CONSCIOUS STATE; INCOG RECOMMENDATIONS; CONFUSIONAL STATE; CLINICAL-PRACTICE; FOLLOW-UP; EMERGENCE; REHABILITATION; PATTERNS	Background: There has been limited empirical speech-language pathology (SLP) study of language and cognitive communication during post-traumatic amnesia (PTA) and the early stages after TBI. The purpose of the current research was to explore the potential means and utility of assessing cognitive communication during PTA and the post-acute recovery period.& para;& para;Method: This research used a longitudinal mixed methods design to describe language and cognitive communication assessment and recovery profiles of three patients with TBI. Cognitive communication was assessed with repeated standardised and non-standardised methods during PTA (rated with Westmead PTA Scale) and at follow-up 3 months after PTA emergence.& para;& para;Results: All participants demonstrated a profile of language and cognitive communication strengths and weaknesses during PTA and the post-acute period, also evident at follow-up. Improvement occurred gradually throughout PTA, although with Individual fluctuation across test occasions. There was no marked change in communication function immediately before and after PTA emergence, indicating that cognitive communication ability and those functions measured on the Westmead PTA Scale (memory and orientation) did not recover at the same rate.& para;& para;Conclusion: It was feasible to assess language and cognitive communication throughout PTA and the post-acute period, and early assessment results were relevant to the patient's ongoing communicative function. It is suggested that early and repeated SLP assessment may contribute to the prediction of persisting cognitive communication issues.	[Steel, Joanne; Ferguson, Alison; Spencer, Elizabeth] Univ Newcastle, Speech Pathol, Newcastle, NSW, Australia; [Togher, Leanne] Univ Sydney, Speech Pathol, Sydney, NSW, Australia; [Steel, Joanne; Ferguson, Alison; Togher, Leanne] Moving Ahead, NHMRC Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia		Steel, J (corresponding author), Univ Newcastle, Sch Humanities & Social Sci, Sch Off, Callaghan Campus,1st Floor,McMullin Bldg, Callaghan, NSW 2308, Australia.	Joanne.Steel@uon.edu.au	Togher, Leanne/AAC-7083-2019; Steel, Joanne/M-2585-2018; Steel, Joanne/AAA-2744-2022	Steel, Joanne/0000-0002-5478-5865; Steel, Joanne/0000-0002-5478-5865; Togher, Leanne/0000-0002-4518-6748			Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Body R., 2006, BRAIN IMPAIR, V7, P212, DOI DOI 10.1375/BRIM.7.3.212; Chapman, 2008, SYSTEMATIC ANAL LANG; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Code, 2014, SOCIAL COMMUNICATION, P1; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; CRESWELL JW, 1994, RES DESIGN QUALITATI; CROOKES G, 1990, APPL LINGUIST, V11, P183, DOI 10.1093/applin/11.2.183; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; del Toro CM, 2011, J SPEECH LANG HEAR R, V54, P1089, DOI 10.1044/1092-4388(2010/09-0119); Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Ellis C, 2009, NEUROREHABILITATION, V24, P255, DOI 10.3233/NRE-2009-0476; Ellmo W, 1995, MEASURE COGNITIVE LI; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Frank EM, 1996, J MED SPEECH-LANG PA, V4, P81; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Graves RE, 2004, J CLIN EXP NEUROPSYC, V26, P891, DOI 10.1080/13803390490510716; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; GRUEN AK, 1990, J COMMUN DISORD, V23, P163, DOI 10.1016/0021-9924(90)90020-Y; Hagen C, 1980, RANCHO LEVELS COGNIT; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HALPERN H, 1973, J SPEECH HEAR DISORD, V38, P162, DOI 10.1044/jshd.3802.162; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Holland A., 1982, CLIN APH C MINN; HOUGH MS, 1990, BRAIN LANG, V38, P253, DOI 10.1016/0093-934X(90)90114-V; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kaplan E, 1983, BOSTON NAMING TEST; Kennedy M, 1991, COMMUNICATION DISORD, P124; Keohane C, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P157, DOI 10.1017/CBO9780511581083.013; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Kossatz HE, 1982, SO DACKEL 22 BILDERG; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Loban Walter, 1976, LANGUAGE DEV KINDERG; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McDonald S, 2014, SOCIAL COMMUNICATION; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Nakase-Thompson R, 2005, BRAIN INJURY, V19, P685, DOI 10.1080/02699050400025331; Nakase-Thompson R, 2004, MISSISSIPPIS APHASIA; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Pamerson A, 1942, LANCET, V2, P717; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2014, HDB NEUROPSYCHOLOGY, P49; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Smith VH, 2001, BRAIN IMPAIR, V2, P29, DOI DOI 10.1375/BRIM.2.1.29; Snow P, 2002, REPORT CRIMINOLOGY R; Snow PC, 2005, PSYCHOL CRIME LAW, V11, P239, DOI 10.1080/1068316042000209323; Steel J, 2015, THESIS; Steel J, 2017, BRAIN INJURY, V31, P1320, DOI 10.1080/02699052.2017.1332385; Steel J, 2016, BRAIN INJURY, V30, P1131, DOI 10.1080/02699052.2016.1174785; Steel J, 2015, NEUROREHABILITATION, V37, P221, DOI 10.3233/NRE-151255; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate RL, 2010, COMPENDIUM TESTS SCA; Tate RL, 2008, BRAIN IMPAIR, V9, P282, DOI 10.1375/brim.9.3.282; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Togher L., 2000, BRAIN DAM B, P1; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Vukovic M, 2008, J COMMUN DISORD, V41, P531, DOI 10.1016/j.jcomdis.2008.04.001; WEINSTEIN EA, 1963, NEUROPSYCHOLOGIA, V1, P79, DOI 10.1016/0028-3932(63)90001-0; WEINSTEIN EA, 1952, AMA ARCH NEUROL PSY, V67, P72, DOI 10.1001/archneurpsyc.1952.02320130078008; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Wertz RT, 1984, LANGUAGE DISORDERS A; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; WIIG EH, 1974, PERCEPT MOTOR SKILL, V38, P171, DOI 10.2466/pms.1974.38.1.171; WIIG Elizabeth H. Elizabeth W., 1988, NEUROPSYCHOLOGICAL S, P186; Willinck L, 1996, CAULFIELD LANGUAGE C; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002	92	6	6	2	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1889	1902		10.1080/02699052.2017.1373200			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500023	28945465				2022-02-06	
J	Wild, J; Younus, JM; Malekpour, M; Neuhaus, N; Widom, K; Rapp, M; Leonard, D; Baro, S; Dove, J; Hunsinger, M; Blansfield, J; Shabahang, M; Torres, D				Wild, Jeffrey; Younus, Jabran M.; Malekpour, Mahdi; Neuhaus, Nina; Widom, Kenneth; Rapp, Megan; Leonard, Diane; Baro, Susan; Dove, James; Hunsinger, Marie; Blansfield, Joseph; Shabahang, Mohsen; Torres, Denise			The Effect of Interhospital Transfers on the Outcome of Rural Trauma	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting of the Trauma-Association-of-Canada	APR 10-11, 2015	Calgary, CANADA	Trauma Assoc Canada			MAJOR TRAUMA; PROSPECTIVE COHORT; CARE; MORTALITY; SYSTEM; LEVEL; TRANSPORT; IMPACT; FACILITIES; CENTERS	Urban areas house the majority of the population in the United States but trauma deaths occur more commonly in rural areas. In this study, we aimed to investigate if direct patient admission to a Level I trauma center improves outcomes in rural trauma. We retrospectively reviewed data in our trauma database from January 2008 to the end of December 2012 to compare the overall outcomes between direct admissions (DAs) and interhospital transfers (IHTs). Of the 6118 patients who met the inclusion criteria, 59.5 per cent were in the DA group and 40.5 per cent in the IHT group. Injury severity score was similar between the two groups but severe traumatic brain injury was more common (P=0.001) in the DA group. Hospital length of stay, complication rate, and inhospital mortality were not different between the two groups (all P> 0.2). In multivariate analysis, there was no difference in survival between the two modes of admission (odds ratio, 95% confidence interval: 0.91, 0.69-1.20, P=0.51). We concluded that rural trauma IHTs had no detrimental impact on the outcome. Prospective studies would better elucidate factors associated with patient outcomes in rural trauma.	[Wild, Jeffrey; Younus, Jabran M.; Malekpour, Mahdi; Neuhaus, Nina; Widom, Kenneth; Rapp, Megan; Leonard, Diane; Baro, Susan; Dove, James; Hunsinger, Marie; Blansfield, Joseph; Shabahang, Mohsen; Torres, Denise] Geisinger Med Ctr, Sect Trauma & Acute Care Surg, Dept Surg, 100 North Acad Ave,MC 21-69, Danville, PA 17822 USA		Wild, J (corresponding author), Geisinger Med Ctr, Sect Trauma & Acute Care Surg, Dept Surg, 100 North Acad Ave,MC 21-69, Danville, PA 17822 USA.	jlwild@geisinger.edu	Malekpour, Mahdi/B-6174-2009	Malekpour, Mahdi/0000-0002-7337-3479			Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Carr BG, 2006, PREHOSP EMERG CARE, V10, P198, DOI 10.1080/10903120500541324; Cummings G, 2000, J EMERG MED, V18, P349, DOI 10.1016/S0736-4679(99)00227-9; Esposito T J, 1995, Prehosp Disaster Med, V10, P161; Esposito TJ, 1995, PREHOSP DISASTER MED, V10, P166; Garwe T, 2011, J TRAUMA, V70, P1118, DOI 10.1097/TA.0b013e3181e243b8; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Helling TS, 2010, J TRAUMA, V69, P1362, DOI 10.1097/TA.0b013e3181d75250; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Larson JT, 2004, J TRAUMA, V56, P89, DOI 10.1097/01.TA.0000061163.35582.A5; MCNICHOLL BP, 1994, INJURY, V25, P251, DOI 10.1016/0020-1383(94)90073-6; Meisler R, 2010, ACTA ANAESTH SCAND, V54, P218, DOI 10.1111/j.1399-6576.2009.02075.x; Newgard CD, 2007, J TRAUMA, V63, P965, DOI 10.1097/TA.0b013e31803c5665; Nirula R, 2010, J TRAUMA, V69, P595, DOI 10.1097/TA.0b013e3181ee6e32; Osterwalder JJ, 2002, J TRAUMA, V52, P1030, DOI 10.1097/00005373-200206000-00003; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; Rogers FB, 1997, ARCH SURG-CHICAGO, V132, P376; Rosenthal TC, 2000, JAMA-J AM MED ASSOC, V284, P2034, DOI 10.1001/jama.284.16.2034; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Vernberg Dee Katherine, 2010, J Trauma Nurs, V17, P142, DOI 10.1097/JTN.0b013e3181f52114; Young JS, 1998, AM SURGEON, V64, P88	21	6	6	1	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JAN	2017	83	1					39	44					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	EK7ZP	WOS:000394144000023	28234124				2022-02-06	
J	Wu, JZ; Pan, CS; Wimer, BM; Rosen, CL				Wu, John Z.; Pan, Christopher S.; Wimer, Bryan M.; Rosen, Charles L.			Finite element simulations of the head-brain responses to the top impacts of a construction helmet: Effects of the neck and body mass	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Finite element analysis; brain injury; helmet design; soft tissue mechanics	HUMAN SKIN; BEHAVIOR; MODEL; SHEAR; VALIDATION; INJURY; TISSUE	Traumatic brain injuries are among the most common severely disabling injuries in the United States. Construction helmets are considered essential personal protective equipment for reducing traumatic brain injury risks at work sites. In this study, we proposed a practical finite element modeling approach that would be suitable for engineers to optimize construction helmet design. The finite element model includes all essential anatomical structures of a human head (i.e. skin, scalp, skull, cerebrospinal fluid, brain, medulla, spinal cord, cervical vertebrae, and discs) and all major engineering components of a construction helmet (i.e. shell and suspension system). The head finite element model has been calibrated using the experimental data in the literature. It is technically difficult to precisely account for the effects of the neck and body mass on the dynamic responses, because the finite element model does not include the entire human body. An approximation approach has been developed to account for the effects of the neck and body mass on the dynamic responses of the head-brain. Using the proposed model, we have calculated the responses of the head-brain during a top impact when wearing a construction helmet. The proposed modeling approach would provide a tool to improve the helmet design on a biomechanical basis.	[Wu, John Z.; Pan, Christopher S.; Wimer, Bryan M.] NIOSH, 1095 Willowdale Rd, Morgantown, WV 26505 USA; [Rosen, Charles L.] West Virginia Univ, Dept Neurosurg, Morgantown, WV USA		Pan, CS (corresponding author), NIOSH, 1095 Willowdale Rd, Morgantown, WV 26505 USA.	cpan@cdc.gov			CDC foundationUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by a research grant of CDC foundation. The authors want to express their gratitude to Turner Construction Company, Liberty Mutual Insurance, Zurich Insurance Group, and ACE Group for their generous donations to that research grant via CDC Foundation.	Afshari A, 2008, International Journal of Simulation Modelling, V7, P42, DOI 10.2507/DSIMM07(1)4.099; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bilston LE, 1996, ANN BIOMED ENG, V24, P67; Eppinger R. H., 1996, TRAUMATIC BRAIN INJU, P39; Faul M., 2010, TECHNICAL REPORT; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; GILCHRIST A, 1987, J OCCUP ACCID, V9, P199, DOI 10.1016/0376-6349(87)90012-5; HARDY CH, 1973, J APPL MECH-T ASME, V40, P838, DOI 10.1115/1.3423172; Hendriks FM, 2003, SKIN RES TECHNOL, V9, P274, DOI 10.1034/j.1600-0846.2003.00019.x; Hendriks FM, 2004, SKIN RES TECHNOL, V10, P231, DOI 10.1111/j.1600-0846.2004.00077.x; KENNER VH, 1972, INT J MECH SCI, V14, P557, DOI 10.1016/0020-7403(72)90056-2; Kimpara H, 2006, J BIOMECH ENG-T ASME, V128, P772, DOI 10.1115/1.2264394; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kwon H, 2011, P 18 INT C COMP MAT; Long J, 2015, COMPUT METHOD BIOMEC, V18, P24, DOI 10.1080/10255842.2013.774382; Mazuchowski E., 2003, BIOMECHANICAL PROPER; MILLS NJ, 1993, SAFETY SCI, V16, P221, DOI 10.1016/0925-7535(93)90045-F; Nahum A. M., 1977, P 21 STAPP CAR CRASH, P339; Patel A., 2012, INGENIO TEOLOGIA DRA, P95; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Prasad P, 1985, TECHNICAL REPORT; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Schmidt H, 2015, J APPL BIOMATER FUNC, V13, P66, DOI 10.5301/jabfm.5000176; Shorten M. R., 2003, SPORTS SURFACES RISK; Suderman BL, 2014, ACCIDENT ANAL PREV, V73, P116, DOI 10.1016/j.aap.2014.08.011; Teng T, 2012, P IMECHE L, V227, P82; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Tse KM, 2015, ACCIDENT ANAL PREV, V79, P13, DOI 10.1016/j.aap.2015.03.012; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Wu JZ, 2003, J MECH MED BIOL, V3, DOI 10.1142/S0219519403000788; Wu JZ, 2016, Z ANGEW MATH PHYS, V67, DOI 10.1007/s00033-015-0598-7; Yamada H., 1970, STRENGTH BIOL MAT; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang J, 2010, COMPUT AIDED DES APP, V7, P59, DOI DOI 10.3722/cadaps.2010.59-73	38	6	6	0	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	JAN	2017	231	1					58	68		10.1177/0954411916678017			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	EP5HH	WOS:000397409100006	28097935	Green Accepted			2022-02-06	
J	Xiong, XG; Liang, QH; Zhang, CH; Wang, Y; Huang, W; Peng, WJ; Wang, Z; Xia, ZA				Xiong, Xin-gui; Liang, Qinghua; Zhang, Chunhu; Wang, Yang; Huang, Wei; Peng, Weijun; Wang, Zhe; Xia, Zi-an			Serum Proteome Alterations in Patients with Cognitive Impairment after Traumatic Brain Injury Revealed by iTRAQ-Based Quantitative Proteomics	BIOMED RESEARCH INTERNATIONAL			English	Article							LIPOPROTEIN-LIPASE; ALZHEIMERS-DISEASE; POTENTIAL BIOMARKERS; PROTEINS; IDENTIFICATION; DYSFUNCTION; PATHWAYS; RISK	Background. Cognitive impairment is the leading cause of traumatic brain injury-(TBI-) related disability; however, the underlying pathogenesis of this dysfunction is not completely understood. Methods. Using an isobaric tagging for relative and absolute quantitation-(iTRAQ-) based quantitative proteomic approach, serum samples from healthy control subjects, TBI patients with cognitive impairment, and TBI patients without cognitive impairment were analysed to identify differentially expressed proteins (DEPs) related to post-TBI cognitive impairment. In addition, DEPs were further analysed using bioinformatic platforms and validated using enzyme-linked immunosorbent assays (ELISA). Results. A total of 56 DEPs were identified that were specifically related to TBI-induced cognitive impairment. Bioinformatic analysis revealed that a wide variety of cellular and metabolic processes and some signaling pathways were involved in the pathophysiology of cognitive deficits following TBI. Five randomly selected DEPs were validated using ELISA in an additional 105 cases, and the results also supported the experimental findings. Conclusions. Despite limitations, our findings will facilitate further studies of the pathological mechanisms underlying TBI-induced cognitive impairment and provide new methods for the research and development of neuroprotective agents. However, further investigation on a large cohort is warranted.	[Xiong, Xin-gui; Liang, Qinghua; Zhang, Chunhu; Wang, Yang; Huang, Wei] Cent South Univ, Inst Integrated Med, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Peng, Weijun; Wang, Zhe; Xia, Zi-an] Cent South Univ, Xiangya Hosp 2, Dept Integrated Tradit Chinese & Western Med, Changsha 410011, Hunan, Peoples R China		Peng, WJ; Wang, Z; Xia, ZA (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Integrated Tradit Chinese & Western Med, Changsha 410011, Hunan, Peoples R China.	pengweijun1987@gmail.com; ericwangzhe@126.com; xia.zian@csu.edu.cn	Peng, Weijun/M-5131-2014	Peng, Weijun/0000-0002-4506-0942	Young Scientists Fund of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81102564, 81603670]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373705]	This work was supported by the Young Scientists Fund of the National Natural Science Foundation of China (Grant nos. 81102564, 81603670) and the National Natural Science Foundation of China (Grant no. 81373705). The authors also thank Gene Denovo Co. (Guangzhou, People's Republic of China) for technical support.	Amar MJA, 2015, J PHARMACOL EXP THER, V352, P227, DOI 10.1124/jpet.114.220418; Arias-Vasquez A, 2007, NEUROGENETICS, V8, P189, DOI 10.1007/s10048-007-0089-x; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; El Kadmiri N, 2014, PATHOL BIOL, V62, P333, DOI 10.1016/j.patbio.2014.08.002; Gong HL, 2013, J HISTOCHEM CYTOCHEM, V61, P857, DOI 10.1369/0022155413505601; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Huang J, 2011, NEUROSCIENCE, V192, P598, DOI 10.1016/j.neuroscience.2011.06.050; Huang W, 2015, RSC ADV, V5, P86088, DOI 10.1039/c5ra18743e; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Kunutsor SK, 2016, EUR J EPIDEMIOL, V31, P1149, DOI 10.1007/s10654-016-0184-0; Li MY, 2016, ONCOTARGET, V7, P37226, DOI 10.18632/oncotarget.9362; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Morawska MM, 2016, J NEUROSCI, V36, P3422, DOI 10.1523/JNEUROSCI.3274-15.2016; Muenchhoff J, 2015, J ALZHEIMERS DIS, V43, P1355, DOI 10.3233/JAD-141266; Norup A, 2011, NEUROPSYCHOL REHABIL, V21, P306, DOI 10.1080/09602011.2011.558766; O'Day DH, 2015, J ALZHEIMERS DIS, V46, P553, DOI 10.3233/JAD-142772; O'Day DH, 2004, BIOCHEM BIOPH RES CO, V320, P1051, DOI 10.1016/j.bbrc.2004.06.070; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sharma R, 2015, J PROTEOME RES, V14, P2466, DOI 10.1021/pr501324n; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15615; Wang Q, 2016, NEUROSCIENCE, V330, P291, DOI 10.1016/j.neuroscience.2016.05.055; Wang XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28600; White NMA, 2014, ONCOTARGET, V5, P506, DOI 10.18632/oncotarget.1529; Wu P, 2013, J NEUROTRAUM, V30, P775, DOI 10.1089/neu.2012.2391; Xian XD, 2009, J NEUROSCI, V29, P4681, DOI 10.1523/JNEUROSCI.0297-09.2009; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xu DD, 2014, PROTEOMICS, V14, P322, DOI 10.1002/pmic.201300383; Xu N, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004326; Xu YF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1351-5; Yang H, 2015, NEUROSCIENCE, V290, P1, DOI 10.1016/j.neuroscience.2014.12.068; Yang HJ, 2016, J MOL NEUROSCI, V60, P517, DOI 10.1007/s12031-016-0845-1; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Zhan Y, 2014, EUR PSYCHIAT, V29, P307, DOI 10.1016/j.eurpsy.2014.03.004; Zhang P, 2016, J PROTEOMICS, V133, P93, DOI 10.1016/j.jprot.2015.12.014; Zhang XP, 2012, ANALYST, V137, P490, DOI 10.1039/c1an15551b	43	6	6	2	14	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2017	2017								8572509	10.1155/2017/8572509			13	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	EL8GQ	WOS:000394858700001	28251161	Green Published, gold, Green Submitted			2022-02-06	
J	Ye, YQ; Yang, YX; Chen, C; Li, Z; Jia, YF; Su, XH; Wang, CX; He, XS				Ye, Yuqin; Yang, Yongxiang; Chen, Chen; Li, Ze; Jia, Yanfeng; Su, Xinhong; Wang, Chaoxian; He, Xiaosheng			Electroacupuncture Improved Hippocampal Neurogenesis following Traumatic Brain Injury in Mice through Inhibition of TLR4 Signaling Pathway	STEM CELLS INTERNATIONAL			English	Article							TOLL-LIKE RECEPTORS; CEREBRAL ISCHEMIA-REPERFUSION; DOMAIN-CONTAINING ADAPTER; STEM-CELL PROLIFERATION; NF-KAPPA-B; REGULATORY FACTOR-3; BLOOD-FLOW; ACUPUNCTURE; DIFFERENTIATION; STROKE	The protective role of electroacupuncture (EA) treatment in diverse neurological diseases such as ischemic stroke is well acknowledged. However, whether and how EA act on hippocampal neurogenesis following traumatic brain injury (TBI) remains poorly understood. This study aims to investigate the effect of EA on hippocampal neurogenesis and neurological functions, as well as its underlying association with toll-like receptor 4 (TLR4) signaling in TBI mice. BrdU/NeuN immunofluorescence was performed to label newborn neurons in the hippocampus after EA treatment. Water maze test and neurological severity score were used to evaluate neurological function posttrauma. The hippocampal level of TLR4 and downstream molecules and inflammatory cytokines were, respectively, detected by Western blot and enzyme-linked immunosorbent assay. EA enhanced hippocampal neurogenesis and inhibited TLR4 expression at 21, 28, and 35 days after TBI, but the beneficial effects of EA on posttraumatic neurogenesis and neurological functions were attenuated by lipopolysaccharide-induced TLR4 activation. In addition, EA exerted an inhibitory effect on both TLR4/Myd88/NF-kappa B and TLR4/TRIF/NF-kappa B pathways, as well as the inflammatory cytokine expression in the hippocampus following TBI. In conclusion, EA promoted hippocampal neurogenesis and neurological recovery through inhibition of TLR4 signaling pathway posttrauma, which may be a potential approach to improve the outcome of TBI.	[Ye, Yuqin; Yang, Yongxiang; Su, Xinhong; Wang, Chaoxian; He, Xiaosheng] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Ye, Yuqin] Hunan Normal Univ, Dept Neurosurg, PLA Hosp 163, Affiliated Hosp 2, Changsha 410000, Hunan, Peoples R China; [Yang, Yongxiang] PLA 422nd Hosp, Dept Neurol, Zhanjiang 524005, Peoples R China; [Chen, Chen] Fourth Mil Med Univ, Inst Psychol, Xian 710032, Shaanxi, Peoples R China; [Li, Ze; Jia, Yanfeng] Fourth Peoples Hosp Shaanxi Prov, Dept Neurosurg, Xian 710034, Shaanxi, Peoples R China		He, XS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China.	hexiaos@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171155, 81471264]; Fourth Military Medical University [2016XC178, 2016XC210]	The present work was supported by grants from the National Natural Science Foundation of China (81171155 and 81471264 to Dr. Xiaosheng He), Science and Technology Development Fund of Fourth Military Medical University (2016XC178 and 2016XC210 to Dr. Xiaosheng He).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Barak B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00272; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Carty M, 2011, BIOCHEM PHARMACOL, V81, P825, DOI 10.1016/j.bcp.2011.01.003; Ceniceros S, 1998, SOUTH MED J, V91, P1121, DOI 10.1097/00007611-199812000-00005; Chuang CH, 2013, ACUPUNCT MED, V31, P395, DOI 10.1136/acupmed-2013-010406; Covacu R, 2009, J IMMUNOL, V182, P6889, DOI 10.4049/jimmunol.0802907; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Du YH, 2011, NEUROL RES, V33, P101, DOI 10.1179/016164110X12714125204317; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Fang H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-27; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Gao Y, 2009, BIOL PHARM BULL, V32, P1665, DOI 10.1248/bpb.32.1665; Garate I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-8; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Kim JH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-22; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Lan L, 2013, INT J MOL MED, V31, P75, DOI 10.3892/ijmm.2012.1184; Lan XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050783; Lee H, 2007, NEUROL RES, V29, pS49, DOI 10.1179/016164107X172211; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li X, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/195397; Lu DP, 2013, MED ACUPUNCT, V25, P311, DOI 10.1089/acu.2012.0921; Lu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19521; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Nam MH, 2013, INT REV NEUROBIOL, V111, P67, DOI 10.1016/B978-0-12-411545-3.00004-3; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Okano H, 2006, E SCHERING RES FDN W, V60, P215; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Rabinstein AA, 2003, NEUROLOGIST, V9, P137, DOI 10.1097/00127893-200305000-00002; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rivest Serge, 2011, Expert Rev Neurother, V11, P783, DOI 10.1586/ern.11.64; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shen M. H., 2016, EVID-BASED COMPL ALT, V2016; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tao J, 2010, NEUROL RES, V32, P198, DOI 10.1179/174313209X414506; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vorhees CV, 2014, NEUROTOXICOL TERATOL, V45, P75, DOI 10.1016/j.ntt.2014.07.003; Wang J, 2009, BRAIN RES BULL, V80, P89, DOI 10.1016/j.brainresbull.2009.04.020; Wang Q, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-24; Wong V., 2011, COCHRANE DB SYST REV, V5; Wong V, 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007700.PUB3; Wong V., 2012, COCHRANE DB SYST REV, V12; Wu ZQ, 2016, EVID-BASED COMPL ALT, V2016, P1; Xiong L, 2003, CHINESE MED J-PEKING, V116, P108; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang EJ, 2016, MOL NEUROBIOL, V53, P7228, DOI 10.1007/s12035-015-9610-7; Ye Y, 2016, NEURAL PLAST, V2016, DOI DOI 10.1155/2016/8072156280186795153466; Ye YQ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4959523; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Zhang HS, 2016, BRAIN RES, V1643, P130, DOI 10.1016/j.brainres.2016.05.003; Zhang YK, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-112; Zhao JH, 2015, MOL MED REP, V12, P6911, DOI 10.3892/mmr.2015.4279; Zhou HJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-127	66	6	6	2	9	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-966X	1687-9678		STEM CELLS INT	Stem Cells Int.		2017	2017								5841814	10.1155/2017/5841814			13	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FD1YK	WOS:000407332400001	28848607	Green Submitted, Green Published, gold			2022-02-06	
J	Barry, DM; Ettenhofer, ML				Barry, David M.; Ettenhofer, Mark L.			Assessment of Performance Validity Using Embedded Saccadic and Manual Indices on a Continuous Performance Test	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Malingering/symptom validity testing; Assessment; Head injury; Traumatic brain injury; Attention	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; ADULT INTELLIGENCE SCALE; REACTION-TIME TESTS; SYMPTOM VALIDITY; EYE-MOVEMENTS; HEAD-INJURY; RESPONSE BIAS; DIGIT SPAN; TEST-II	Objective: In addition to manual (i.e., "button press") metrics, oculomotor metrics demonstrate considerable promise as tools for detecting invalid responding in neurocognitive assessment. This study was conducted to evaluate saccadic and manual metrics from a computerized continuous performance test as embedded indices of performance validity. Method: Receiver operating characteristic analyses, logistic regressions, and ANOVAs were performed to evaluate saccadic and manual metrics in classification of healthy adults instructed to feign deficits ("Fake Bad" group; n = 24), healthy adults instructed to perform their best ("Best Effort" group; n = 26), and adults with a history of mild traumatic brain injury (TBI) who passed a series of validity indices ("mTBI-Pass" group; n = 19). Results: Several saccadic and manual metrics achieved outstanding classification accuracy between Fake Bad versus Best Effort and mTBIPass groups, including variability (consistency) of saccadic and manual response time (RT), saccadic commission errors, and manual omission errors. Very large effect sizes were obtained between Fake Bad and Best Effort groups (Cohen's d range: 1.89-2.90; r range: .75-.78) as well as between Fake Bad and mTBI-Pass groups (Cohen's d range: 1.32-2.21; r range: .69-.71). The Fake Bad group consistently had higher saccadic and manual RT variability, more saccadic commission errors, and more manual omission errors than the Best Effort and mTBI-Pass groups. Conclusions: These findings are the first to demonstrate that eye movements can be used to detect invalid responding in neurocognitive assessment. These results also provide compelling evidence that concurrently measured saccadic and manual metrics can detect invalid responding with high levels of sensitivity and specificity.	[Barry, David M.; Ettenhofer, Mark L.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Med & Clin Psychol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Barry, DM (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Med & Clin Psychol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	david.m.barry.mil@mail.mil	Ettenhofer, Mark L./J-7171-2019	Ettenhofer, Mark L./0000-0001-9381-7578	Uniformed Services University of the Health Sciences [R027LP]; American Psychological Association	This work was supported by Uniformed Services University of the Health Sciences [Grant R027LP to M.L.E.] and the American Psychological Association [dissertation research award to D.M.B.]	Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Arnett P., 2013, SECONDARY INFLUENCES; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Browndyke J. N., 2013, MILD TRAUMATIC BRAIN, P303; Bush, 2013, MILD TRAUMATIC BRAIN, P1; Bush S.S., 2013, MILD TRAUMATIC BRAIN, P57; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Conners C.K., 2004, CONNERS CONTINUOUS P; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Dallal G. E., 2013, RANDOMIZATION PLANS; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Duchowski A., 2007, EYE TRACKING METHODO; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Ettenhofer ML, 2016, J CLIN EXP NEUROPSYC, V38, P96, DOI 10.1080/13803395.2015.1089978; Exton C, 2009, INT REV PSYCHIATR, V21, P8, DOI 10.1080/09540260802675106; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gooding DC, 2008, BRAIN COGNITION, V68, P371, DOI 10.1016/j.bandc.2008.08.024; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2004, MED SYMPTOM VALIDITY; Green P., 1996, WORD MEMORY TEST USE; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greenberg LK, 2016, TEST VARIABLES ATTEN; Greiffenstein M. F., 2013, MILD TRAUMATIC BRAIN, pxiii; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hannula DE, 2012, PSYCHOL SCI, V23, P278, DOI 10.1177/0956797611429799; Hartman David E, 2008, Appl Neuropsychol, V15, P226, DOI 10.1080/09084280802324572; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Henry GK, 2005, CLIN NEUROPSYCHOL, V19, P121, DOI 10.1080/13854040490516604; Holdnack JA., 2001, WECHSLER TEST ADULT; HSIAO JK, 1989, ARCH GEN PSYCHIAT, V46, P664; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Johnson R, 2003, BIOL PSYCHOL, V64, P217, DOI 10.1016/j.biopsycho.2003.07.006; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Leark RA, 2002, ARCH CLIN NEUROPSYCH, V17, P335, DOI 10.1016/S0887-6177(01)00118-4; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; MCNEIL BJ, 1984, MED DECIS MAKING, V4, P137, DOI 10.1177/0272989X8400400203; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Olk B, 2003, NEUROREPORT, V14, P151, DOI 10.1097/00001756-200301200-00028; Ono MY, 2011, BRAIN INJURY, V25, P237, DOI 10.3109/02699052.2010.541893; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; Reitan R, 1985, HALSTEAD REITAN NEUR; Reynolds CR, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P351, DOI 10.1007/978-1-4614-0442-2_13; Rogers R., 2008, CLIN ASSESSMENT MALI, P411; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Sharpe JA, 2008, BRAIN COGNITION, V68, P241, DOI 10.1016/j.bandc.2008.08.015; Shum DHK, 2004, ARCH CLIN NEUROPSYCH, V19, P817, DOI 10.1016/j.acn.2003.10.002; Slick D., 1997, VSVT VICTORIA SYMPTO; Slick D. J., 2012, PEDIAT FORENSIC NEUR, P113; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Stevens A., 2010, GERMAN J PSYCHIAT, V13, P1; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Suhr J.A., 2007, ASSESSMENT MALINGERE, P131; Suhr JA, 2011, ARCH CLIN NEUROPSYCH, V26, P1, DOI 10.1093/arclin/acq094; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; van Stockum S, 2008, NEUROPSYCHOLOGIA, V46, P3108, DOI 10.1016/j.neuropsychologia.2008.07.002; Vendemia JMC, 2005, BEHAV NEUROL, V16, P25, DOI 10.1155/2005/804026; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Weinborn M, 2012, CLIN NEUROPSYCHOL, V26, P832, DOI 10.1080/13854046.2012.686630; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	98	6	6	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2016	31	8					963	975		10.1093/arclin/acw070			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EJ1MM	WOS:000392974600013	27625047	hybrid			2022-02-06	
J	Bethea, A; Samanta, D; Willis, JA; Lucente, FC; Chumbe, JT				Bethea, Audis; Samanta, Damayanti; Willis, John A.; Lucente, Franck C.; Chumbe, Julton Tomanguillo			Substance exposure and helmet use in all-terrain vehicle accidents: Nine years of experience at a level 1 trauma center	JOURNAL OF SAFETY RESEARCH			English	Article						Injury diagnosis; Helmet; ATV; Drugs; Alcohol	UNITED-STATES; INJURIES; CRASHES; RIDERS	Introduction: The surging popularity of all-terrain vehicles (ATV) in the United States has caused an "epidemic of injuries and mortality." The U.S. Consumer Product Safety Commission reported 99,600 injuries and 426 fatalities from ATV accidents in 2013. The aim of this study was to examine the relationship between helmet use and positive toxicology screenings on outcomes in ATV accident victims. Methods: This is a retrospective study of patients admitted to a Level 1 Trauma Center in southwestern West Virginia following an ATV accident between 2005 and 2013. Data were obtained from the institution's Trauma Registry. Results: A total of 1,857 patients were admitted during the study period with 39 (1.9%) reported deaths. Positive serum alcohol and/or urine drug screens were obtained in 66.4% of the patients tested (n = 1,293). Those with positive screenings were 9.5% less likely to utilize a helmet (13.2% vs. 22.7%, p < 0.001); and the lack of helmet use was associated with an increase in traumatic brain injury (57.1% vs. 41.7%, p < 0.001). Positivity for substances or the lack of helmet use was significantly associated with higher morbidity. Lack of helmet use resulted in a 3.94-fold increase in the risk of discharge in a vegetative state or death. Conclusions: Drugs and alcohol use may predispose riders to be less likely to wear helmets and significantly increase the risk of a poor clinical outcome following an ATV accident. Rigorous efforts should be made to enhance safety measures through educational endeavors and amendment of current regulations to promote safe and responsible use of ATVs. Practical applications: Modification of regulatory requirements should be considered in order to mandate the wearing of helmets during ATV operation. In addition, expansion of safety programs should be considered in an effort to improve availability, affordability and awareness of safe ATV practices. (C) 2016 National Safety Council and Elsevier Ltd. All rights reserved.	[Bethea, Audis; Samanta, Damayanti; Chumbe, Julton Tomanguillo] Charleston Area Med Ctr, Ctr Hlth Serv & Outcomes Res, 501 Morris St, Charleston, WV 25301 USA; [Willis, John A.] Charleston Area Med Ctr, Associated Radiologists Inc, 501 Morris St, Charleston, WV 25301 USA; [Lucente, Franck C.] Charleston Area Med Ctr, WVU Phys Charleston, 501 Morris St, Charleston, WV 25301 USA		Bethea, A (corresponding author), West Virginia Clin & Translat Sci Inst, Trauma Surg, 501 Morris St, Charleston, WV 25301 USA.; Bethea, A (corresponding author), West Virginia Clin & Translat Sci Inst, 501 Morris St, Charleston, WV 25301 USA.	traumaresearchcamc@gmail.com; damayanti.samanta@camc.org; raddocjw@gmail.com; clucente@suddenlink.net; julton.tomanguillochumbe@camc.org			National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER	Audis Bethea is a research scientist for the West Virginia Clinical Translational Science Institute. "Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number U54GM104942. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."; Damayanti Samanta is a member of the West Virginia Clinical Translational Science Institute. "Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number U54GM104942. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."; Julton Tomanguillo Chumbe is a member of the West Virginia Clinical Translational Science Institute. "Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number U54GM104942. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."	Adams LE, 2013, J TRAUMA ACUTE CARE, V75, pS296, DOI 10.1097/TA.0b013e318292421f; [Anonymous], STAT ATV INF; [Anonymous], 2013, ANN REP ATV REL DEAT; Balthrop PM, 2007, J TRAUMA, V62, P1163, DOI 10.1097/01.ta.0000229814.08289.9a; Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; Hall AJ, 2009, AM J PREV MED, V36, P311, DOI 10.1016/j.amepre.2008.11.019; Helmkamp JC, 2008, AM J PREV MED, V34, P39, DOI 10.1016/j.amepre.2007.09.016; Mazotas I, 2014, J TRAUMA ACUTE CARE, V77, P103, DOI 10.1097/TA.0000000000000266; Mullins RJ, 2007, J AM COLL SURGEONS, V204, P216, DOI 10.1016/j.jamcollsurg.2006.10.025; RODGERS GB, 1990, ACCIDENT ANAL PREV, V22, P47, DOI 10.1016/0001-4575(90)90006-7; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; Rostas Jack W, 2014, J Trauma Acute Care Surg, V76, P201, DOI 10.1097/TA.0b013e3182a994ff; SMITH SM, 1986, JAMA-J AM MED ASSOC, V255, P2454, DOI 10.1001/jama.255.18.2454; White LC, 2013, INT J PEDIATR OTORHI, V77, P414, DOI 10.1016/j.ijporl.2012.11.043; Williams AF, 2014, J SAFETY RES, V50, P117, DOI 10.1016/j.jsr.2014.05.001	15	6	6	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	DEC	2016	59						61	67		10.1016/j.jsr.2016.09.006			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	EE6NU	WOS:000389730300007	27847000	Green Accepted			2022-02-06	
J	Deep, NL; Fletcher, GP; Nelson, KD; Patel, AC; Barrs, DM; Bendok, BR; Hoxworth, JM				Deep, Nicholas L.; Fletcher, Geoffrey P.; Nelson, Kent D.; Patel, Ameet C.; Barrs, David M.; Bendok, Bernard R.; Hoxworth, Joseph M.			Magnetic Resonance Imaging Assessment of Vascular Contact of the Facial Nerve in the Asymptomatic Patient	JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE			English	Article						neurovascular compression; microvascular decompression; hemifacial spasm; asymptomatic; MRI; facial nerve	HEMIFACIAL SPASM; MICROVASCULAR DECOMPRESSION; NEUROVASCULAR COMPRESSION; TRIGEMINAL NEURALGIA; ZONE; VISUALIZATION; MYELIN	ObjectiveThe objective of this study was to determine the prevalence of facial nerve vascular contact on magnetic resonance imaging (MRI) in patients without hemifacial spasm (HFS). Study DesignOur radiology database was queried to identify consecutive adult patients without a history of HFS, intracranial tumor, brain radiation therapy, intracranial surgery, traumatic brain injury, or trigeminal nerve vascular compression. One hundred high-resolution MRIs of the posterior fossa were independently reviewed by two neuroradiologists for facial nerve vascular contact (200 sides). Main Outcome MeasuresThe prevalence of vascular nerve contact in the non-HFS patient, the location of contact along the facial nerve, the culprit vessel, and severity of compression was recorded. ResultsThe presence of vascular contact in the non-HFS patient may be as high as 53%. It is typically mild to moderate in severity, most commonly involves the cisternal portion, and usually caused by the anterior inferior cerebellar artery. ConclusionVascular contact of the facial nerve is frequently identified in asymptomatic individuals but tends to be more peripheral and mild compared with previous descriptions of neurovascular contact in HFS patients. These results should be considered in assessing the candidacy of HFS patients for microvascular decompression.	[Deep, Nicholas L.; Barrs, David M.] Mayo Clin, Dept Otorhinolaryngol, Phoenix, AZ USA; [Fletcher, Geoffrey P.; Nelson, Kent D.; Patel, Ameet C.; Hoxworth, Joseph M.] Mayo Clin, Neuroradiol Div, Dept Radiol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA; [Bendok, Bernard R.] Mayo Clin, Dept Neurol Surg, Phoenix, AZ USA		Hoxworth, JM (corresponding author), Mayo Clin, Neuroradiol Div, Dept Radiol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	hoxworth.joseph@mayo.edu					Antonini G, 2014, PAIN, V155, P1464, DOI 10.1016/j.pain.2014.04.020; AUGER RG, 1990, ARCH NEUROL-CHICAGO, V47, P1233, DOI 10.1001/archneur.1990.00530110095023; BARKER FG, 1995, J NEUROSURG, V82, P201, DOI 10.3171/jns.1995.82.2.0201; Campos-Benitez M, 2008, J NEUROSURG, V109, P416, DOI 10.3171/JNS/2008/109/9/0416; De Ridder D, 2002, NEUROSURGERY, V51, P427, DOI 10.1097/00006123-200208000-00023; El Refaee E, 2013, NEUROSURGERY, V73, P58, DOI 10.1227/01.neu.0000429838.38342.e2; FLEISS JL, 2003, WILEY SERIES PROBABI, P760; Fukuda H, 2003, SURG NEUROL, V59, P93, DOI 10.1016/S0090-3019(02)00993-X; Guclu B, 2011, ACTA NEUROCHIR, V153, P2365, DOI 10.1007/s00701-011-1168-1; HAINES SJ, 1980, J NEUROSURG, V52, P381, DOI 10.3171/jns.1980.52.3.0381; HARDY DG, 1978, J NEUROSURG, V49, P669, DOI 10.3171/jns.1978.49.5.0669; Hughes M, 2015, NEUROGRAPHICS, V5, P1; Hughes MA, 2015, AM J NEURORADIOL, V36, P768, DOI 10.3174/ajnr.A4174; Huo W J, 2015, CLIN NEURORADIOL; Kakizawa Y, 2008, J NEUROSURG, V108, P483, DOI 10.3171/JNS/2008/108/3/0483; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lovely TJ, 1998, NEUROSURG QUART, V8, P92, DOI 10.1097/00013414-199806000-00003; Miller LE, 2012, BRIT J NEUROSURG, V26, P438, DOI 10.3109/02688697.2011.641613; Naraghi R, 2007, J NEUROSURG, V107, P1154, DOI 10.3171/JNS-07/12/1154; Raslan AM, 2009, J NEUROSURG, V111, P733, DOI 10.3171/2009.3.JNS08393; Sekula RF, 2014, MOVEMENT DISORD, V29, P1299, DOI 10.1002/mds.25947; Suthipongchai Suthisuk, 2004, Journal of the Medical Association of Thailand, V87, P219; Suzuki M, 2015, OR SURG OR MED OR PA, V119, P113, DOI 10.1016/j.oooo.2014.09.013; Tan NC, 2002, QJM-INT J MED, V95, P493, DOI 10.1093/qjmed/95.8.493; Tarnaris A, 2007, BRIT J NEUROSURG, V21, P375, DOI 10.1080/02688690701474564; TASH R, 1991, AM J NEURORADIOL, V12, P839; Tomii M, 2003, J NEUROSURG, V99, P121, DOI 10.3171/jns.2003.99.1.0121; Zhong J, 2012, CLIN NEUROL NEUROSUR, V114, P846, DOI 10.1016/j.clineuro.2012.01.021; Zhong J, 2011, INT J SURG, V9, P254, DOI 10.1016/j.ijsu.2010.12.004	29	6	6	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6331	2193-634X		J NEUROL SURG PART B	Journal of Neurol. Surg. Part B	DEC	2016	77	6					503	509		10.1055/s-0036-1584196			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ED4NK	WOS:000388826100011	27857878	Green Published, Bronze			2022-02-06	
J	Horvat, CM; Mtaweh, H; Bell, MJ				Horvat, Christopher M.; Mtaweh, Haifa; Bell, Michael J.			Management of the Pediatric Neurocritical Care Patient	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; neurocritical care; neuromonitoring; pediatric stroke; status epilepticus; neurologic emergencies	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; ARTERIAL ISCHEMIC-STROKE; ASPARTATE RECEPTOR ENCEPHALITIS; CEREBRAL PERFUSION-PRESSURE; NEAR-INFRARED SPECTROSCOPY; STATUS EPILEPTICUS; INTRACRANIAL-PRESSURE; TRANSCRANIAL DOPPLER; UNITED-STATES	Pediatric neurocritical care is a growing subspecialty of pediatric intensive care that focuses on the management of acute neurological diseases in children. A brief history of the field of pediatric neurocritical care is provided. Neuromonitoring strategies for children are reviewed. Management of major categories of acute childhood central neurologic diseases are reviewed, including treatment of diseases associated with intracranial hypertension, seizures and status epilepticus, stroke, central nervous system infection and inflammation, and hypoxic-ischemic injury.	[Horvat, Christopher M.; Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Horvat, Christopher M.; Bell, Michael J.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Mtaweh, Haifa] Toronto Sick Childrens Hosp, Dept Pediat, Toronto, ON, Canada; [Bell, Michael J.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA		Bell, MJ (corresponding author), Dept Crit Care Med Neurol Surg & Pediat, Pediat Neurocrit Care, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040686] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS081041] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS081041] Funding Source: NIH RePORTER		Abend NS, 2015, J CLIN NEUROPHYSIOL, V32, P486, DOI 10.1097/WNP.0000000000000198; Abend NS, 2015, EPILEPSY BEHAV, V49, P223, DOI 10.1016/j.yebeh.2015.03.007; Abend NS, 2014, CURR OPIN PEDIATR, V26, P668, DOI 10.1097/MOP.0000000000000154; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0330-3; Acker SN, 2015, PEDIATR SURG INT, V31, P1041, DOI 10.1007/s00383-015-3789-6; Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Adil MM, 2016, PEDIATR NEUROL, V56, P25, DOI 10.1016/j.pediatrneurol.2015.11.002; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Askalan R, 2015, BRAIN RES, V1629, P94, DOI 10.1016/j.brainres.2015.10.020; Au AK, 2011, PEDIATR CRIT CARE ME, V12, P566, DOI 10.1097/PCC.0b013e3181fe3420; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Bhate TD, 2015, RESUSCITATION, V97, P1, DOI 10.1016/j.resuscitation.2015.08.023; Binder U, 2014, CLIN MICROBIOL INFEC, V20, P60, DOI 10.1111/1469-0691.12566; Bonds BW, 2015, J TRAUMA ACUTE CARE, V79, P85, DOI 10.1097/TA.0000000000000698; Bonfield CM, 2015, J INFECTION, V71, pS42, DOI 10.1016/j.jinf.2015.04.012; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Brouwer MC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub5; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Chamberlain JM, 2014, JAMA-J AM MED ASSOC, V311, P1652, DOI 10.1001/jama.2014.2625; Chen XQ, 2014, PEDIATR NEUROL, V50, P243, DOI 10.1016/j.pediatrneurol.2013.10.015; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Choi JI, 2014, CHILD NERV SYST, V30, P1011, DOI 10.1007/s00381-013-2349-4; Chung MG, 2016, PEDIATR CRIT CARE ME, V17, P150, DOI 10.1097/PCC.0000000000000588; Claassen J, 2015, NEUROCRIT CARE, V23, pS136, DOI 10.1007/s12028-015-0172-3; Clews S, 2015, ARCH DIS CHILDHOOD-E, V100, P282, DOI 10.1136/edpract-2014-307402; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Czaikowski BL, 2014, J NEUROSCI NURS, V46, P79, DOI 10.1097/JNN.0000000000000041; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; De Gaudio M, 2010, J CHEMOTHERAPY, V22, P226, DOI 10.1179/joc.2010.22.4.226; DeCourcey DD, 2013, PEDIATR CRIT CARE ME, V14, P694, DOI 10.1097/PCC.0b013e3182975cab; Drayna PC, 2011, PEDIATR EMERG CARE, V27, P432, DOI 10.1097/PEC.0b013e3182188442; Earley CJ, 1998, NEUROLOGY, V51, P169, DOI 10.1212/WNL.51.1.169; Epstein D, 2005, PEDIATR RES, V58, P987, DOI 10.1203/01.PDR.0000182822.16263.3D; Esposito S, 2015, AUTOIMMUN REV, V14, P923, DOI 10.1016/j.autrev.2015.06.002; Fan Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093264; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Forsyth RJ, 2015, COCHRANE DB SYST REV, V11; FOUNTAIN NB, 1995, J CLIN NEUROPHYSIOL, V12, P326; Fox CK, 2012, NEUROLOGY, V79, P420, DOI 10.1212/WNL.0b013e3182616fd7; Freilich ER, 2014, CURR OPIN PEDIATR, V26, P655, DOI 10.1097/MOP.0000000000000152; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Fullerton HJ, 2007, PEDIATRICS, V119, P495, DOI 10.1542/peds.2006-2791; Gable MS, 2012, CLIN INFECT DIS, V54, P899, DOI 10.1093/cid/cir1038; GAMBARDELLA G, 1993, CHILD NERV SYST, V9, P470, DOI 10.1007/BF00393552; George PM, 2015, NEURON, V87, P297, DOI 10.1016/j.neuron.2015.05.041; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Graves JM, 2014, J AM COLL RADIOL, V11, P717, DOI 10.1016/j.jacr.2013.12.002; GREWAL M, 1991, J PEDIATR SURG, V26, P1161, DOI 10.1016/0022-3468(91)90323-L; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Hendaus Mohammed A, 2013, Glob J Health Sci, V5, P54, DOI 10.5539/gjhs.v5n6p54; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Huded Vikram, 2015, J Vasc Interv Neurol, V8, P13; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; Jain AR, 2009, CURR TREAT OPTION NE, V11, P120, DOI 10.1007/s11940-009-0015-7; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jordan LC, 2012, NEUROLOGY, V79, P400, DOI 10.1212/WNL.0b013e318261715f; Kalanuria AA, 2013, SEMIN NEUROL, V33, P133, DOI 10.1055/s-0033-1348961; Kanal KM, 2015, AM J ROENTGENOL, V204, pW293, DOI 10.2214/AJR.14.12997; Kapur J, 1997, J NEUROSCI, V17, P7532, DOI 10.1523/jneurosci.17-19-07532.1997; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Kharbanda AB, 2015, ACAD EMERG MED, V22, P670, DOI 10.1111/acem.12689; Kim JS, 2014, PEDIATR EMERG CARE, V30, P525, DOI 10.1097/PEC.0000000000000183; Kim WH, 2015, J KOREAN NEUROSURG S, V58, P125, DOI 10.3340/jkns.2015.58.2.125; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochar GS, 2014, J CHILD NEUROL, V29, P1299, DOI 10.1177/0883073813514293; Kumar R, 2014, CRIT CARE MED, V42, P1775, DOI 10.1097/CCM.0000000000000298; LaRovere KL, 2015, J ULTRAS MED, V34, P2121, DOI 10.7863/ultra.15.02016; LaRovere KL, 2013, PEDIATR NEUROL, V48, P206, DOI 10.1016/j.pediatrneurol.2012.12.006; Lenzer J, 2003, BRIT MED J, V327, P624, DOI 10.1136/bmj.327.7415.624; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Mallick AA, 2014, LANCET NEUROL, V13, P35, DOI 10.1016/S1474-4422(13)70290-4; McTague A, 2012, SEIZURE-EUR J EPILEP, V21, P529, DOI 10.1016/j.seizure.2012.05.010; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Moreau JF, 2013, PEDIATR CRIT CARE ME, V14, P801, DOI 10.1097/PCC.0b013e31828aa71f; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; MOULTON C, 1991, BRIT MED J, V303, P1240, DOI 10.1136/bmj.303.6812.1240; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Nagdyman N, 2005, INTENS CARE MED, V31, P846, DOI 10.1007/s00134-005-2618-0; Naim MY, 2015, J THORAC CARDIOV SUR, V150, P169, DOI 10.1016/j.jtcvs.2015.03.045; Negrini B, 2000, PEDIATRICS, V105, P316, DOI 10.1542/peds.105.2.316; Nielsen K, 2012, EMERG MED J, V29, P887, DOI 10.1136/emermed-2011-200119; Noje C, 2013, PEDIATR NEUROL, V49, P237, DOI 10.1016/j.pediatrneurol.2013.04.009; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Owen-Reece H, 1999, BRIT J ANAESTH, V82, P418, DOI 10.1093/bja/82.3.418; Paolicchi F, 2014, AM J ROENTGENOL, V202, P1309, DOI 10.2214/AJR.13.11741; Patel DM, 2014, J NEUROSURG-PEDIATR, V13, P440, DOI 10.3171/2014.1.PEDS13447; Perez Augusto, 2003, Pediatr Crit Care Med, V4, P33; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Pitfield AF, 2012, PEDIATR EMERG CARE, V28, P200, DOI 10.1097/PEC.0b013e318243fb72; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Prasad M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003723.pub3; Price L, 2016, TRANSL RES TRAUM BRA; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Reith FCM, 2016, INTENS CARE MED, V42, P3, DOI 10.1007/s00134-015-4124-3; Rhee E, 2014, PEDIATR TRANSPLANT, V18, pE88, DOI 10.1111/petr.12241; Rivkin MJ, 2015, STROKE, V46, P880, DOI 10.1161/STROKEAHA.114.008210; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Rosa M, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0174-y; Safdieh JE, 2008, NEUROLOGY, V70, P943, DOI 10.1212/01.wnl.0000305960.85546.5f; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Scheer S, 2016, J PEDIATR HEALTH CAR, V30, P347, DOI 10.1016/j.pedhc.2015.09.004; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Shah S, 2016, CAN J NEUROL SCI, V43, P105, DOI 10.1017/cjn.2015.307; Sharma D, 2013, PEDIATR ANESTH, V23, P84, DOI 10.1111/pan.12031; Sharma D, 2010, J CLIN NEUROSCI, V17, P1583, DOI 10.1016/j.jocn.2010.04.009; Sidebotham P, 2015, SEIZURE-EUR J EPILEP, V30, P113, DOI 10.1016/j.seizure.2015.05.003; Stewart CP, 2010, NEUROLOGY, V75, P1501, DOI 10.1212/WNL.0b013e3181f9619e; Stewart CL, 2013, J PEDIATR SURG, V48, P2106, DOI 10.1016/j.jpedsurg.2013.05.009; Stidd David A, 2014, Neurointervention, V9, P94, DOI 10.5469/neuroint.2014.9.2.94; Stippler M, 2012, J NEUROSURG-PEDIATR, V10, P383, DOI 10.3171/2012.8.PEDS12165; Stone JJ, 2013, J NEUROSURG-PEDIATR, V11, P15, DOI 10.3171/2012.9.PEDS1298; Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384; Tirupathi S, 2009, SEIZURE-EUR J EPILEP, V18, P630, DOI 10.1016/j.seizure.2009.07.006; Tolunay O, 2015, NEUROENDOCRINOL LETT, V36, P578; Topjian AA, 2014, NEUROCRIT CARE, V21, P294, DOI 10.1007/s12028-013-9946-7; Tully I, 2015, SEIZURE-EUR J EPILEP, V29, P153, DOI 10.1016/j.seizure.2015.04.002; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604; Verlhac S, 2011, PEDIATR RADIOL, V41, pS153, DOI 10.1007/s00247-011-2038-y; Viaro F, 2015, NEUROLOGIST, V20, P48, DOI 10.1097/NRL.0000000000000050; Wainwright MS, 2014, SEMIN PEDIATR NEUROL, V21, P248, DOI 10.1016/j.spen.2014.10.006; Westra SJ, 2014, PEDIATR RADIOL, V44, P525, DOI 10.1007/s00247-014-3087-9; Westra SJ, 2014, PEDIATR RADIOL, V44, P515, DOI 10.1007/s00247-014-3139-1; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; Wijdicks EFM, 2011, MAYO CLIN PROC, V86, P903, DOI 10.4065/mcp.2010.0815; Wijdicks EFM, 2013, FAMOUS 1 PAPERS NEUR; Wright WL, 2012, CURR NEUROL NEUROSCI, V12, P466, DOI 10.1007/s11910-012-0284-5; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yock-Corrales A, 2011, ANN EMERG MED, V58, P156, DOI 10.1016/j.annemergmed.2010.10.013	143	6	6	0	6	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	DEC	2016	36	6					492	501		10.1055/s-0036-1592107			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EE0PT	WOS:000389282100004	27907953	Green Accepted			2022-02-06	
J	Lai, JS; Hammel, J; Jerousek, S; Goldsmith, A; Miskovic, A; Baum, C; Wong, AW; Dashner, J; Heinemann, AW				Lai, Jin-Shei; Hammel, Joy; Jerousek, Sara; Goldsmith, Arielle; Miskovic, Ana; Baum, Carolyn; Wong, Alex W.; Dashner, Jessica; Heinemann, Allen W.			An Item Bank to Measure Systems, Services, and Policies: Environmental Factors Affecting People With Disabilities	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Environment; International Classification of Functioning; Disability and Health; Patient outcome assessment; Quality of life; Rehabilitation; Surveys and questionnaires	SPINAL-CORD-INJURY; INSIDER PERSPECTIVE; BRAIN-INJURY; PARTICIPATION; STROKE; BARRIERS; HEALTH; REHABILITATION; CRITERIA; UNIDIMENSIONALITY	Objectives: To develop a measure of perceived systems, services, and policies facilitators (see Chapter 5 of the International Classification of Functioning, Disability and Health) for people with neurologic disabilities and to evaluate the effect of perceived systems, services, and policies facilitators on health-related quality of life. Design: Qualitative approaches to develop and refine items. Confirmatory factor analysis including 1-factor confirmatory factor analysis and bifactor analysis to evaluate unidimensionality of items. Rasch analysis to identify misfitting items. Correlational and analysis of variance methods to evaluate construct validity. Setting: Community-dwelling individuals participated in telephone interviews or traveled to the academic medical centers where this research took place. Participants: Participants (N=571) had a diagnosis of spinal cord injury, stroke, or traumatic brain injury. They were 18 years or older and English speaking. Interventions: Not applicable. Main Outcome Measures: An item bank to evaluate environmental access and support levels of services, systems, and policies for people with disabilities. Results: We identified a general factor defined as "access and support levels of the services, systems, and policies at the level of community living" and 3 local factors defined as "health services," "community living," and "community resources." The systems, services, and policies measure correlated moderately with participation measures: Community Participation Indicators (CPI) - Involvement, CPI - Control over Participation, Quality of Life in Neurological Disorders - Ability to Participate, Quality of Life in Neurological Disorders - Satisfaction with Role Participation, Patient-Reported Outcomes Measurement Information System (PROMIS) Ability to Participate, PROMIS Satisfaction with Role Participation, and PROMIS Isolation. Conclusions: The measure of systems, services, and policies facilitators contains items pertaining to health services, community living, and community resources. Investigators and clinicians can measure perceptions of systems, services, and policies resources reliably with the items described here. Moderate relations between systems, services, and policies facilitators and PROMIS and CPI variables provide support for the measurement and theory of environmental effects on social functioning related to participation. 2016 by the American Congress of Rehabilitation Medicine	[Lai, Jin-Shei] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci & Pediat, 633 N St Clair,19th Floor, Chicago, IL 60611 USA; [Hammel, Joy] Univ Illinois, Dept Occupat Therapy, Chicago, IL USA; [Jerousek, Sara; Goldsmith, Arielle; Miskovic, Ana; Heinemann, Allen W.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Baum, Carolyn; Wong, Alex W.; Dashner, Jessica] Washington Univ, Program Occupat Therapy, St Louis, MO USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Lai, JS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci & Pediat, 633 N St Clair,19th Floor, Chicago, IL 60611 USA.	js-lai@northwestern.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685	National Institute on Disability, Independent Living, and Rehabilitation Research through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes grant [H133B090024]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research through a Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes grant (grant no. H133B090024).	Anderson S, 2013, SCAND J CARING SCI, V27, P820, DOI 10.1111/j.1471-6712.2012.01086.x; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Barr Victoria J, 2003, Hosp Q, V7, P73; Bond T, 2001, APPL RASCH MODEL FUN; Braveman PA, 2011, AM J PUBLIC HEALTH, V101, pS149, DOI 10.2105/AJPH.2010.300062; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Choi SW, 2009, APPL PSYCH MEAS, V33, P419, DOI 10.1177/0146621608327801; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Courtney-Long EA, 2015, MMWR-MORBID MORTAL W, V64, P777, DOI 10.15585/mmwr.MM6429a2; Enderby PM, 1986, DISABIL REHABIL, V8, P166, DOI DOI 10.3109/03790798709166209; Fougeyrollas P, 1997, ICIDH ENV FACTORS IN, V9, P32; Freeman JA, 2000, J NEUROL NEUROSUR PS, V69, P728, DOI 10.1136/jnnp.69.6.728; GIBBONS RD, 1992, PSYCHOMETRIKA, V57, P423, DOI 10.1007/BF02295430; Gignac MAM, 2000, J GERONTOL B-PSYCHOL, V55, pP362, DOI 10.1093/geronb/55.6.P362; Gray DB, 2008, DISABIL REHABIL, V30, P434, DOI 10.1080/09638280701625377; Hahn EA, 2010, QUAL LIFE RES, V19, P1035, DOI 10.1007/s11136-010-9654-0; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hammel J, 2006, TOP STROKE REHABIL, V13, P43, DOI 10.1310/5X2G-V1Y1-TBK7-Q27E; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Hammell KRW, 2010, DISABIL REHABIL, V32, P1209, DOI 10.3109/09638280903420325; Hartman-Maeir A, 2007, DISABIL REHABIL, V29, P559, DOI 10.1080/09638280600924996; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iezzoni LI, 2011, HEALTH AFFAIR, V30, P1947, DOI 10.1377/hlthaff.2011.0613; Kendall E, 2009, DISABIL REHABIL, V31, P2164, DOI 10.3109/09638280902939734; Kessler Foundation National Organization on Disability, SURV EMPL AM DIS OCT; Keysor JJ, 2005, J REHABIL MED, V37, P37, DOI 10.1080/16501970410014830; Lai JS, 2006, QUAL LIFE RES, V15, P1179, DOI 10.1007/s11136-006-0060-6; Lai JS, 2014, PSYCHO-ONCOLOGY, V23, P1133, DOI 10.1002/pon.3522; Lai JS, 2014, QUAL LIFE RES, V23, P1049, DOI 10.1007/s11136-013-0548-9; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; Lai JS, 2011, J PEDIATR PSYCHOL, V36, P766, DOI 10.1093/jpepsy/jsr005; Lawton M. P., 1982, AGING ENV THEORETICA, P33; Magasi S, 2015, ARCH PHYS MED REHAB, V96, P569, DOI 10.1016/j.apmr.2014.12.002; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McColl M.A., 1998, INTRO DISABILITY; McDonald R, 1999, TEST THEORY UNIFIED; Noreau Luc, 2014, Top Spinal Cord Inj Rehabil, V20, P249, DOI 10.1310/sci2004-249; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; Secker Barbara, 2006, BMC Med Ethics, V7, pE9; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Wilkinson G.S., 2006, WRAT 4 WIDE RANGE AC; Wolf TJ, 2009, AM J OCCUP THER, V63, P621, DOI 10.5014/ajot.63.5.621; World Health Organization, 2008, CLOSING GAP GENERATI; World Health Organization, 2007, INT CLASS FUNCT DIS	51	6	7	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2016	97	12					2102	2112		10.1016/j.apmr.2016.06.010			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EE7GM	WOS:000389783900010	27422348				2022-02-06	
J	Macdonald, I; Hauber, R				Macdonald, Ian; Hauber, Roxanne			Educating Parents on Sports-Related Concussions	JOURNAL OF NEUROSCIENCE NURSING			English	Article						awareness; children; education; interventions; knowledge; parents; perception; prevention; sports-related concussion; SRC	BRAIN-INJURY; YOUTH; PERCEPTIONS; KNOWLEDGE	Purpose: Approximately 30 million children and adolescents in the United States participate in various forms of organized sports, and incidents of traumatic brain injuries in emergency departments have increased to 62% from 2001 to 2009. Knowledge, information, and preventive interventions appear to have been well disseminated among athletic personnel at the professional, collegiate, and high school levels. Research regarding parents' perceptions and knowledge of sports-related concussions (SRCs) however is lacking. This project aims to determine the impact of interventions designed to improve parental awareness of SRCs. Methods: The study used a demographic information sheet and a postintervention survey design. These surveys were to determine the impact of three distinct educational tools presented on the perceptions and knowledge of SRCs in a group of parents with children actively involved in sports. Results: Forty-seven participants completed the demographic information sheet, most of them African American and have at least one child competing in high school contact sports. Furthermore, 85.1% of the parents felt that SRCs are a critical issue, although only 46.8% of the parents have ever sought out information to learn more about SRC. Twenty-nine individuals participated in the posteducational survey after the intervention, and most parents perceived that all three educational tools were written and presented in a fashion that changed their perception, awareness, and knowledge base of SRCs. These parents however stated that none of the interventions captured their attention enough to want to go to a professional for further information. Conclusions: Findings from this study suggest that parents know what educational approaches work best for them. However, it also suggests that a one-time educational intervention is not sufficient to move many parents to be proactive. The scarcity of published studies speaks to the need for further research to determine the most effective approaches to engage all involved groups in an integrated approach to ensure that children can be safely involved in sports without jeopardizing their future.	[Macdonald, Ian] Florida State Univ, Tallahassee, FL 32306 USA; [Hauber, Roxanne] Florida State Univ, Coll Nursing, Acad Affairs, Tallahassee, FL 32306 USA		Macdonald, I (corresponding author), Florida State Univ, Tallahassee, FL 32306 USA.	idm05@my.fsu.edu					Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Centers for Disease Control and Prevention, 2011, CONC SPORTS PLAY GET; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; Holston J., 2013, KNOW IMPACT CONCUSSI; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Pribble JM, 2004, INJURY PREV, V10, P159, DOI 10.1136/ip.2003.004754; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123	11	6	6	0	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	DEC	2016	48	6					297	302		10.1097/JNN.0000000000000212			6	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	ED3BB	WOS:000388723100004	27824798				2022-02-06	
J	Pasquesi, SA; Liu, YS; Margulies, SS				Pasquesi, Stephanie A.; Liu, Yishan; Margulies, Susan S.			Repeated Loading Behavior of Pediatric Porcine Common Carotid Arteries	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						vessel; stiffness; mechanical properties; vascular; longitudinal; whiplash	MECHANICAL-PROPERTIES; BLOOD-PRESSURE; FUNCTIONAL-PROPERTIES; FAILURE PROPERTIES; ELASTIC PROPERTIES; ABDOMINAL-AORTA; SHEAR STRAIN; WALL-MOTION; IN-VIVO; MOVEMENTS	Rapid flexion and extension of the neck may occur during scenarios associated with traumatic brain injury (TBI), and understanding the mechanical response of the common carotid artery (CCA) to longitudinal stretch may enhance understanding of contributing factors that may influence CCA vasospasm and exacerbate ischemic injury associated with TBI. Immature (4-week-old) porcine CCAs were tested under subcatastrophic (1.5 peak stretch ratio) cyclic loading at 3Hz for 30 s. Under subcatastrophic cyclic longitudinal extension, the immature porcine CCA displays softening behavior. This softening can be represented by decreasing peak stress and increasing corner stretch values with an increasing number of loading cycles. This investigation is an important first step in the exploration of fatiguelike behavior in arterial tissue that may be subjected to repeated longitudinal loads.	[Pasquesi, Stephanie A.; Liu, Yishan; Margulies, Susan S.] Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA		Margulies, SS (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 South 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu			American Heart AssociationAmerican Heart Association [12PRE12040315]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 NS069545, R21 HD078842]; University of Pennsylvania Rachleff Scholars Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD078842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545] Funding Source: NIH RePORTER	We would like to thank Amy Clevenger and Jill Ralston for their technical assistance. We are grateful for the support of the American Heart Association (12PRE12040315), the National Institutes of Health (U01 NS069545 and R21 HD078842), and the University of Pennsylvania Rachleff Scholars Program. The authors (Pasquesi, Liu, and Margulies) have no relationships or obligations with individuals or organizations that could bias our findings.	Adham M, 1996, J SURG RES, V64, P32, DOI 10.1006/jsre.1996.0302; Aggoun Y, 2000, HEART, V84, P290, DOI 10.1136/heart.84.3.290; Armentano RL, 2006, CRYOBIOLOGY, V52, P17, DOI 10.1016/j.cryobiol.2005.09.001; Bell ED, 2013, J BIOMECH, V46, P91, DOI 10.1016/j.jbiomech.2012.10.015; BENETOS A, 1993, AM J PHYSIOL, V265, pH1132, DOI 10.1152/ajpheart.1993.265.4.H1132; Bia D, 2005, TRANSPL INT, V18, P1346, DOI 10.1111/j.1432-2277.2005.00220.x; Bia Daniel, 2006, Cell and Tissue Banking, V7, P183, DOI 10.1007/s10561-005-0655-0; Carew EO, 2000, ANN BIOMED ENG, V28, P1093, DOI 10.1114/1.1310221; Cheng SK, 2009, J BIOMECH, V42, P1360, DOI 10.1016/j.jbiomech.2009.03.023; Cinthio M, 2005, IEEE T ULTRASON FERR, V52, P1300, DOI 10.1109/TUFFC.2005.1509788; Cinthio M, 2006, AM J PHYSIOL-HEART C, V291, pH394, DOI 10.1152/ajpheart.00988.2005; Cinthio M, 2010, ULTRASOUND MED BIOL, V36, P697, DOI 10.1016/j.ultrasmedbio.2010.02.016; Clevenger AC, 2015, J NEUROTRAUM, V32, P120, DOI 10.1089/neu.2014.3570; COX RH, 1977, AM J PHYSIOL, V233, pH256, DOI 10.1152/ajpheart.1977.233.2.H256; DOBRIN P, 1975, EXPERIENTIA, V31, P1295, DOI 10.1007/BF01945788; DUCKLES SP, 1976, STROKE, V7, P174, DOI 10.1161/01.STR.7.2.174; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Dye WW, 2007, J APPL PHYSIOL, V103, P664, DOI 10.1152/japplphysiol.00118.2007; Eshel H, 2001, ANN BIOMED ENG, V29, P164, DOI 10.1114/1.1349697; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul M, 2010, TRAUMATIC BRAIN INJU; Friess SH, 2011, NEUROSURGERY, V69, P1139, DOI 10.1227/NEU.0b013e3182284aa1; Fung YC., 1993, BIOMECHANICS MECH PR, DOI [10.1007/978-1-4757-2257-4, DOI 10.1007/978-1-4757-2257-4]; Garcia A, 2012, BIORHEOLOGY, V49, P271, DOI 10.3233/BIR-2012-0606; Garcia A, 2011, MED ENG PHYS, V33, P665, DOI 10.1016/j.medengphy.2011.01.016; Garcia A, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023371; Golemati S, 2003, ULTRASOUND MED BIOL, V29, P387, DOI 10.1016/S0301-5629(02)00760-3; Humphrey JD, 2009, J BIOMECH, V42, P1, DOI 10.1016/j.jbiomech.2008.11.011; itny R., 2010, B APPL MECH, V6, P1, DOI DOI 10.1007/978-3-642-13039-7_194; Langerak SE, 2001, TRANSPLANT INT, V14, P248, DOI 10.1007/s001470100309; LANIR Y, 1974, J BIOMECH, V7, P171, DOI 10.1016/0021-9290(74)90058-X; LANNE T, 1994, J VASC SURG, V20, P218; LEE MC, 1992, J BIOMECH, V25, P925, DOI 10.1016/0021-9290(92)90232-P; LITALIEN GJ, 1994, AM J PHYSIOL, V267, pH574, DOI 10.1152/ajpheart.1994.267.2.H574; Maher E, 2012, J BIOMECH, V45, P1393, DOI 10.1016/j.jbiomech.2012.02.026; Masson I, 2011, BIOMECH MODEL MECHAN, V10, P867, DOI 10.1007/s10237-010-0279-6; Masson I, 2009, MED ENG PHYS, V31, P825, DOI 10.1016/j.medengphy.2009.03.009; Miersch A, 2013, PEDIATR NEPHROL, V28, P2343, DOI 10.1007/s00467-013-2562-0; Miller KS, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006340; Monson KL, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002935; Monson KL, 2008, ANN BIOMED ENG, V36, P2028, DOI 10.1007/s10439-008-9578-9; NAKAYAMA K, 1982, AM J PHYSIOL, V242, pH760, DOI 10.1152/ajpheart.1982.242.5.H760; Ning JF, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002700; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; Oishi Y, 2013, HEART VESSELS, V28, P222, DOI 10.1007/s00380-011-0229-y; Persson M, 2003, CLIN PHYSIOL FUNCT I, V23, P247, DOI 10.1046/j.1475-097X.2003.00504.x; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Pukacki F, 2000, EUR J VASC ENDOVASC, V20, P21, DOI 10.1053/ejvs.2000.1120; Quinn KP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004205; Safar ME, 2000, STROKE, V31, P782, DOI 10.1161/01.STR.31.3.782; Shah Chirag S, 2006, Stapp Car Crash J, V50, P217; Silver FH, 2003, ANN BIOMED ENG, V31, P793, DOI 10.1114/1.1581287; Stabouli S, 2012, HELL J CARDIOL, V53, P41; Stemper BD, 2007, J SURG RES, V139, P236, DOI 10.1016/j.jss.2006.09.001; Svedlund S, 2011, CLIN PHYSIOL FUNCT I, V31, P32, DOI 10.1111/j.1475-097X.2010.00976.x; TANAKA TT, 1974, J BIOMECH, V7, P357, DOI 10.1016/0021-9290(74)90031-1; Tanaka Y, 1998, EUR J PHARMACOL, V356, P225, DOI 10.1016/S0014-2999(98)00547-0; Tonge TK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025105; Tozzi P, 2001, AM J PHYSIOL-HEART C, V280, pH2300, DOI 10.1152/ajpheart.2001.280.5.H2300; Wagenseil JE, 2012, J CARDIOVASC TRANSL, V5, P264, DOI 10.1007/s12265-012-9349-8; Wan W, 2010, ANN BIOMED ENG, V38, P3605, DOI 10.1007/s10439-010-0114-3; WEIZSACKER HW, 1983, J BIOMECH, V16, P703, DOI 10.1016/0021-9290(83)90080-5; Williams C, 2009, ACTA BIOMATER, V5, P993, DOI 10.1016/j.actbio.2008.11.028; Yli-Ollila H, 2013, ULTRASOUND MED BIOL, V39, P1168, DOI 10.1016/j.ultrasmedbio.2013.01.018; Zahnd G, 2011, ULTRASOUND MED BIOL, V37, P1421, DOI 10.1016/j.ultrasmedbio.2011.05.843; Zanchi A, 1997, J HYPERTENS, V15, P1415, DOI 10.1097/00004872-199715120-00008	67	6	7	0	2	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	DEC	2016	138	12							124502	10.1115/1.4033883			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	ED3HE	WOS:000388739400012	27306415	Green Published			2022-02-06	
J	Taubman, B; McHugh, J; Rosen, F; Elci, OU				Taubman, Bruce; McHugh, Jennifer; Rosen, Florence; Elci, Okan U.			Repeat Concussion and Recovery Time in a Primary Care Pediatric Office	JOURNAL OF CHILD NEUROLOGY			English	Article						previous concussion; prolonged recovery; quick recovery	SPORT-RELATED CONCUSSION; PROLONGED RECOVERY; HIGH-SCHOOL; SYMPTOMS; CHILDREN; SCALE	The authors enrolled 95 patients in a primary care office who presented with a concussion. Of these patients, 63% were sport concussions. The authors matched 90 of these patients to children in the authors' practice presenting for sports physicals or regular check-ups in the following demographics: age, participating in a particular sport, having attention-deficit disorder/attention-deficit hyperactivity disorder, gender, and grade. The authors found the odds of recurrent concussions, in a primary care pediatric office, to be a ratio of 2.909 (95% confidence interval 1.228-7.287). Recovery time for repeat concussion versus an initial concussion was analyzed. Patients with a recurrent concussion after a year recovered an average of 12.0 days after injury versus 13.4 days for those with no previous concussion (NS). Patients with a recurrent concussion within a year recovered a mean of 6.27 (SD 1.29) days sooner than patients with no previous concussion (P < .0001). This unexpected finding is preliminary, and the authors encourage further research.	[Taubman, Bruce; McHugh, Jennifer; Rosen, Florence] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Gen Pediat,Advocare Cherry Hill P, 600 W Marlton Pike, Cherry Hill, NJ 08002 USA; [Elci, Okan U.] Childrens Hosp Philadelphia, Westat Biostat & Data Management Core, Philadelphia, PA 19104 USA		Taubman, B (corresponding author), Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Gen Pediat,Advocare Cherry Hill P, 600 W Marlton Pike, Cherry Hill, NJ 08002 USA.	taubman@email.chop.edu	Taubman, Bruce/ABG-4612-2020	Taubman, Bruce/0000-0002-7976-1907			Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Guskiewicz BM, 2003, CURR SPORT MED REP, V2, P24; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Institute of Medicine and National Research Council, 2013, SPORTS REL CONC YOUT; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Taubman B, J CHILD NEUROL; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	21	6	6	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2016	31	14					1607	1610		10.1177/0883073816667194			4	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	EB7DG	WOS:000387545600015	27625013				2022-02-06	
J	Koyama, T; Skattum, J; Engelsen, P; Eken, T; Gaarder, C; Naess, PA				Koyama, Tomohide; Skattum, Jorunn; Engelsen, Peder; Eken, Torsten; Gaarder, Christine; Naess, Pal Aksel			Surgical intervention for paediatric liver injuries is almost history - a 12-year cohort from a major Scandinavian trauma centre	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Children; Hepatic trauma; Nonoperative management; Angiographic embolization; Traumatic bile leak	BLUNT HEPATIC-TRAUMA; SOLID-ORGAN INJURY; HOLLOW VISCERAL INJURY; NONOPERATIVE MANAGEMENT; ABDOMINAL-TRAUMA; CHILDREN; EMBOLIZATION; SPLEEN; EXPERIENCE; DIAGNOSIS	Background: Although nonoperative management (NOM) has become standard care, optimal treatment of liver injuries in children is still challenging since many of these patients have multiple injuries. Moreover, the role of angiography remains poorly defined, and a high index of suspicion of complications is warranted. This study reviews treatment and outcomes in children with liver injuries at a major Scandinavian trauma centre over a 12-year period. Methods: Patients <17 years old with liver injury admitted to Oslo University Hospital Ullevaal during the period 2002-2013 were retrospectively reviewed. Data were compiled from the institutional trauma registry and medical records. Results: A total of 66 children were included. The majority was severely injured as reflected by a median injury severity score of 20.5 (mean 22.2). NOM was attempted in 60 (90.9%) patients and was successful in 57, resulting in a NOM success rate of 95.0% [95% CI 89.3 to 100]. Only one of the three NOM failures was liver related, occurred in the early part of the study period, and consisted in operative placement of drains for bile leak. Two (3.0%) patients underwent angiographic embolization (AE). Complications occurred in 18 (27.3% [95 % CI 16.2 to 38.3]) patients. Only 2 (3.0%) patients had liver related complications, in both cases bile leak. Six (9.1%) patients underwent therapeutic laparotomy for non-liver related injuries. Two (3.0%) patients died secondary to traumatic brain injury. Discussion: This single institution paediatric liver injury cohort confirms high attempted NOM and NOM success rates even in patients with high grade injuries and multiple accompanying injuries. AE can be a useful NOM adjunct in the treatment of paediatric liver injuries, but is seldom indicated. Moreover, bile leak is the most common liver-related complication and the need for liver-related surgery is very infrequent. Conclusion: NOM is the treatment of choice in almost all liver injuries in children, with operative management and interventional radiology very infrequently indicated.	[Koyama, Tomohide; Skattum, Jorunn; Gaarder, Christine; Naess, Pal Aksel] Oslo Univ Hosp Ullevaal, Dept Traumatol, POB 4950Nydalen, N-0424 Oslo, Norway; [Engelsen, Peder] Univ Oslo, Sch Med, Oslo, Norway; [Eken, Torsten] Oslo Univ Hosp Ullevaal, Dept Anesthesiol, Oslo, Norway; [Naess, Pal Aksel] Univ Oslo, Oslo, Norway		Koyama, T (corresponding author), Oslo Univ Hosp Ullevaal, Dept Traumatol, POB 4950Nydalen, N-0424 Oslo, Norway.	t-koyama@office.nifty.jp	Eken, Torsten/B-4994-2013	Eken, Torsten/0000-0002-5943-4538			Allen GS, 1998, J TRAUMA, V45, P69, DOI 10.1097/00005373-199807000-00014; AMROCH D, 1992, J PEDIATR SURG, V27, P466, DOI 10.1016/0022-3468(92)90338-8; Campbell BT, 2010, J PEDIATR SURG, V45, P925, DOI 10.1016/j.jpedsurg.2010.02.021; DeLuca JA, 2007, AM SURGEON, V73, P37; Fallon SC, 2013, J PEDIATR SURG, V48, pE9, DOI 10.1016/j.jpedsurg.2013.02.066; Gaines BA, 2009, J TRAUMA, V67, pS135, DOI 10.1097/TA.0b013e3181adc17a; Giss SR, 2006, J TRAUMA, V61, P334, DOI 10.1097/01.ta.0000197605.27190.2c; Gross M, 1999, J PEDIATR SURG, V34, P811, DOI 10.1016/S0022-3468(99)90378-0; Hackam DJ, 2002, J PEDIATR SURG, V37, P386, DOI 10.1053/jpsu.2002.30822; Holmes JH, 2005, J TRAUMA, V59, P1309, DOI 10.1097/01.ta.0000197366.38404.79; Kiankhooy A, 2010, J TRAUMA, V68, P526, DOI 10.1097/TA.0b013e3181d3e5b7; Kulaylat AN, 2014, J PEDIATR SURG, V49, P424, DOI 10.1016/j.jpedsurg.2013.07.015; Kumar R, 2002, PEDIATR SURG INT, V18, P98, DOI 10.1007/s003830100662; Landau A, 2006, INJURY, V37, P66, DOI 10.1016/j.injury.2005.07.013; Leone RJ, 2001, AM SURGEON, V67, P138; Mazotas I, 2014, J TRAUMA ACUTE CARE, V77, P103, DOI 10.1097/TA.0000000000000266; Miller K, 1998, J PEDIATR SURG, V33, P1459, DOI 10.1016/S0022-3468(98)90474-2; MOORE EE, 1995, J TRAUMA, V38, P323, DOI 10.1097/00005373-199503000-00001; Nance ML, 2000, J PEDIATR SURG, V35, P1300, DOI 10.1053/jpsu.2000.9301; Nellensteijn D, 2009, EUR J PEDIATR SURG, V19, P358, DOI 10.1055/s-0029-1224132; OLDHAM KT, 1984, J PEDIATR SURG, V19, P457, DOI 10.1016/S0022-3468(84)80275-4; Ong CCP, 2012, J PEDIATR SURG, V47, P2316, DOI 10.1016/j.jpedsurg.2012.09.050; Paddock HN, 2004, AM SURGEON, V70, P1068; Pryor JP, 2001, J PEDIATR SURG, V36, P974, DOI 10.1053/jpsu.2001.24720; Richardson JD, 2005, J AM COLL SURGEONS, V200, P648, DOI 10.1016/j.jamcollsurg.2004.11.005; Ritchie AH, 2006, CAN J RURAL MED, V11, P283; Shults RA, 2013, PEDIATRICS, V132, P282, DOI 10.1542/peds.2013-0751; Sjovall A, 1997, J PEDIATR SURG, V32, P1169, DOI 10.1016/S0022-3468(97)90676-X; Stylianos S, 2002, J PEDIATR SURG, V37, P453, DOI 10.1053/jpsu.2002.30860	29	6	6	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 29	2016	24								139	10.1186/s13049-016-0329-x			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EG3QA	WOS:000390958600001	27899118	Green Published, gold			2022-02-06	
